PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Makowski, L; Noland, RC; Koves, TR; Xing, WB; Ilkayeva, OR; Muehlbauer, MJ; Stevens, RD; Muoio, DM				Makowski, Liza; Noland, Robert C.; Koves, Timothy R.; Xing, Weibing; Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Muoio, Deborah M.			Metabolic profiling of PPAR alpha(-/-) mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation	FASEB JOURNAL			English	Article						beta-oxidation; metabolomics; liver; skeletal muscle; acylcarnitine; organic acid; starvation	ACTIVATED-RECEPTOR-ALPHA; ACYL-COA DEHYDROGENASE; PPAR-ALPHA; SKELETAL-MUSCLE; GENE-EXPRESSION; ACETYLTRANSFERASE ACTIVITY; HEMODIALYSIS-PATIENTS; SARCOPENIC OBESITY; INSULIN-RESISTANCE; MASS-SPECTROMETRY	Peroxisome proliferator-activated receptor-alpha (PPAR alpha) is a master transcriptional regulator of beta-oxidation and a prominent target of hypolipidemic drugs. To gain deeper insights into the systemic consequences of impaired fat catabolism, we used quantitative, mass spectrometry-based metabolic profiling to investigate the fed-to-fasted transition in PPAR alpha(+/+) and PPAR alpha(-/-) mice. Compared to PPAR alpha(+/+) animals, acylcarnitine profiles of PPAR alpha(-/-) mice revealed 2- to 4-fold accumulation of long-chain species in the plasma, whereas short-chain species were reduced by as much as 69% in plasma, liver, and skeletal muscle. These results reflect a metabolic bottleneck downstream of carnitine palmitoyltransferase-1, a mitochondrial enzyme that catalyzes the first step in beta-oxidation. Organic and amino acid profiles of starved PPAR alpha(-/-) mice suggested compromised citric acid cycle flux, enhanced urea cycle activity, and increased amino acid catabolism. PPAR alpha(-/-) mice had 40-50% lower plasma and tissue levels of free carnitine, corresponding with diminished hepatic expression of genes involved in carnitine biosynthesis and transport. One week of oral carnitine supplementation conferred partial metabolic recovery in the PPAR alpha(-/-) mice. In summary, comprehensive metabolic profiling revealed novel biomarkers of defective fat oxidation, while also highlighting the potential value of supplemental carnitine as a therapy and diagnostic tool for metabolic disorders.-Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Muoio, D. M. Metabolic profiling of PPAR alpha(-/-) mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23, 586-604 (2009)	[Makowski, Liza; Noland, Robert C.; Koves, Timothy R.; Xing, Weibing; Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Muoio, Deborah M.] Duke Univ, Sch Med, Div Metab Endocrinol & Nutr, Durham, NC USA; [Koves, Timothy R.] Duke Univ, Sch Med, Dept Med, Div Geriatr, Durham, NC 27706 USA; [Muoio, Deborah M.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [Makowski, Liza; Noland, Robert C.; Koves, Timothy R.; Xing, Weibing; Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Muoio, Deborah M.] Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University	Muoio, DM (corresponding author), 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	muoio@duke.edu	Koves, Tim/I-4806-2012; Muoio, Debbie Marie/E-1147-2012; Makowski, Liza/B-8062-2012; Noland, Robert/N-1982-2017	Koves, Tim/0000-0001-8763-5866; Noland, Robert/0000-0001-5543-3450; Makowski, Liza/0000-0002-5337-8037; Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health [P30-AG028716, K99-AA017376-01, F32-DK080609]; American Diabetes Association; John A. Hartford Duke Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK080609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA017376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); John A. Hartford Duke Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Barbara Abbott (National Institute of Environmental Health Sciences, Raleigh, NC, USA) for sharing her mouse colony and Chris Newgard for his thoughtful evaluation of this article. We thank the dedicated staff of the Metabolomics and Biomarker Core of the Sarah W. Stedman Nutrition and Metabolism Center. This work was supported by National Institutes of Health grants P30-AG028716 (D.M.M.), K99-AA017376-01 (L. M.), and F32-DK080609 ( R. N.); the American Diabetes Association ( D. M. M.); and a John A. Hartford Duke Center for Excellence award (T. R. K).	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson SR, 2008, METABOLISM, V57, P347, DOI 10.1016/j.metabol.2007.10.009; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Asai T, 2006, CARDIOVASC RES, V70, P566, DOI 10.1016/j.cardiores.2006.02.005; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Atherton HJ, 2006, PHYSIOL GENOMICS, V27, P178, DOI 10.1152/physiolgenomics.00060.2006; Barton BE, 2001, IMMUNOL RES, V23, P41, DOI 10.1385/IR:23:1:41; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; Biolo G, 2008, NEPHROL DIAL TRANSPL, V23, P991, DOI 10.1093/ndt/gfm664; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; BLUMBERG D, 1995, METABOLISM, V44, P145, DOI 10.1016/0026-0495(95)90255-4; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Edgar AD, 1998, TOXICOL LETT, V98, P13, DOI 10.1016/S0378-4274(98)00042-3; Finck BN, 2002, J MOL CELL CARDIOL, V34, P1249, DOI 10.1006/jmcc.2002.2061; GIOVENALI P, 1994, KIDNEY INT, V46, P1616, DOI 10.1038/ki.1994.460; Gloerich J, 2005, J LIPID RES, V46, P716, DOI 10.1194/jlr.M400337-JLR200; Grarnignano G, 2006, NUTRITION, V22, P136, DOI 10.1016/j.nut.2005.06.003; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLY DP, 1990, P NATL ACAD SCI USA, V87, P9236, DOI 10.1073/pnas.87.23.9236; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee SST, 1996, ANN NY ACAD SCI, V804, P524, DOI 10.1111/j.1749-6632.1996.tb18642.x; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mansouri RM, 2008, ENDOCRINOLOGY, V149, P3215, DOI 10.1210/en.2007-1339; MOODY DE, 1974, RES COMMUN CHEM PATH, V9, P501; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Owen KQ, 2001, J ANIM SCI, V79, P3104; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; PAUL HS, 1986, AM J PHYSIOL, V251, pE311, DOI 10.1152/ajpendo.1986.251.3.E311; Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Primassin S, 2008, PEDIATR RES, V63, P632, DOI 10.1203/PDR.0b013e31816ff6f0; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Roubenoff R, 2000, ANN NY ACAD SCI, V904, P553; Satapati S, 2008, DIABETES, V57, P2012, DOI 10.2337/db08-0226; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; SIAMI G, 1991, NEPHRON, V57, P306, DOI 10.1159/000186280; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Steiber AL, 2004, CLIN NUTR, V23, P27, DOI 10.1016/S0261-5614(03)00085-2; Stevens RD, 2000, CLIN CHEM, V46, P727; Thyfault John P, 2006, J Cardiometab Syndr, V1, P184, DOI 10.1111/j.1559-4564.2006.05629.x; Thyfault JP, 2007, AM J PHYSIOL-CELL PH, V292, pC729, DOI 10.1152/ajpcell.00311.2006; TURNBULL DM, 1984, NEW ENGL J MED, V311, P1232, DOI 10.1056/NEJM198411083111906; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Villareal DT, 2004, OBES RES, V12, P913, DOI 10.1038/oby.2004.111; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a	69	87	90	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					586	604		10.1096/fj.08-119420	http://dx.doi.org/10.1096/fj.08-119420			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18945875	Green Published			2022-12-25	WOS:000262892900030
J	Avenson, TJ; Ahn, TK; Niyogi, KK; Ballottari, M; Bassi, R; Fleming, GR				Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Ballottari, Matteo; Bassi, Roberto; Fleming, Graham R.			Lutein Can Act as a Switchable Charge Transfer Quencher in the CP26 Light-harvesting Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL-CATION FORMATION; HIGHER-PLANTS; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; LHCA PROTEINS; ANTENNA; MECHANISM; ZEAXANTHIN; ELECTRON; PHOTOPROTECTION	Energy-dependent quenching of excitons in photosystem II of plants, or qE, has been positively correlated with the transient production of carotenoid radical cation species. Zeaxanthin was shown to be the donor species in the CP29 antenna complex. We report transient absorbance analyses of CP24 and CP26 complexes that bind lutein and zeaxanthin in the L1 and L2 domains, respectively. For CP24 complexes, the transient absorbance difference profiles give a reconstructed transient absorbance spectrum with a single peak centered at similar to 980 nm, consistent with zeaxanthin radical cation formation. In contrast, CP26 gives constants for the decay components probed at 940 and 980 nm of 144 and 194 ps, a transient absorbance spectrum that has a main peak at 980 nm, and a substantial shoulder at 940 nm. This suggests the presence of two charge transfer quenching sites in CP26 involving zeaxanthin radical cation and lutein radical cation species. Wealso show that lutein radical cation formation in CP26 is dependent on binding of zeaxanthin to the L2 domain, implying that zeaxanthin acts as an allosteric effector of charge transfer quenching involving lutein in the L1 domain.	[Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Verona	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Ballottari, Matteo/N-1916-2019	Ahn, Tae Kyu/0000-0002-7474-6513; Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446	Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-AC02-05CH11231]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy [DE-AC03-76SF000098]; Korea Research Foundation [KRF-2006-214-C00037]; Korean Government (MOEHRD); National Research Initiative Competitive [2006-03279]	Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy(United States Department of Energy (DOE)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy(United States Department of Energy (DOE)); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Research Initiative Competitive(United States Department of Agriculture (USDA))	This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract DE-AC02-05CH11231 and by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy under Contract DE-AC03-76SF000098 (to G. R. F. and K. K. N.), by the Korea Research Foundation Grant KRF-2006-214-C00037 funded by the Korean Government (MOEHRD) (to T. K. A.), and by the National Research Initiative Competitive Grant 2006-03279 (to T. J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 These authors contributed equally to this work.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Galinato MGI, 2007, PHOTOSYNTH RES, V94, P67, DOI 10.1007/s11120-007-9218-5; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Han RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P538, DOI 10.1562/2005-09-30-RA-705; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ihalainen JA, 2005, J PHYS CHEM B, V109, P21150, DOI 10.1021/jp0519316; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c	44	63	63	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2830	2835		10.1074/jbc.M807192200	http://dx.doi.org/10.1074/jbc.M807192200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18990705	hybrid			2022-12-25	WOS:000262700900026
J	Schredelseker, J; Dayal, A; Schwerte, T; Franzini-Armstrong, C; Grabner, M				Schredelseker, Johann; Dayal, Anamika; Schwerte, Thorsten; Franzini-Armstrong, Clara; Grabner, Manfred			Proper Restoration of Excitation-Contraction Coupling in the Dihydropyridine Receptor beta(1)-null Zebrafish Relaxed Is an Exclusive Function of the beta(1a) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-III-LOOP; DYSGENIC SKELETAL-MUSCLE; CALCIUM-CHANNEL; CA2+ CURRENT; CHARGE MOVEMENTS; BETA-1A SUBUNIT; ALPHA(1S); EXPRESSION; ABSENCE; TRANSIENTS	The paralyzed zebrafish strain relaxed carries a null mutation for the skeletal muscle dihydropyridine receptor (DHPR) beta(1a) subunit. Lack of beta(1a) results in (i) reduced membrane expression of the pore forming DHPR alpha(1S) subunit, (ii) elimination of alpha(1S) charge movement, and (iii) impediment of arrangement of the DHPRs in groups of four (tetrads) opposing the ryanodine receptor (RyR1), a structural prerequisite for skeletal muscle-type excitation-contraction (EC) coupling. In this study we used relaxed larvae and isolated myotubes as expression systems to discriminate specific functions of beta(1a) from rather general functions of beta isoforms. Zebrafish and mammalian beta 1a subunits quantitatively restored alpha(1S) triad targeting and charge movement as well as intracellular Ca2+ release, allowed arrangement of DHPRs in tetrads, and most strikingly recovered a fully motile phenotype in relaxed larvae. Interestingly, the cardiac/neuronal beta(2a) as the phylogenetically closest, and the ancestral housefly beta(M) as the most distant isoform to beta(1a) also completely recovered alpha(1S) triad expression and charge movement. However, both revealed drastically impaired intracellular Ca2+ transients and very limited tetrad formation compared with beta(1a). Consequently, larval motility was either only partially restored (beta(2a)-injected larvae) or not restored at all (beta(M)). Thus, our results indicate that triad expression and facilitation of 1,4-dihydropyridine receptor (DHPR) charge movement are common features of all tested beta subunits, whereas the efficient arrangement of DHPRs in tetrads and thus intact DHPR-RyR1 coupling is only promoted by the beta(1a) isoform. Consequently, we postulate a model that presents beta(1a) as an allosteric modifier of alpha(1S) conformation enabling skeletal muscle-type EC coupling.	[Schredelseker, Johann; Dayal, Anamika; Grabner, Manfred] Innsbruck Med Univ, Div Biochem Pharmacol, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria; [Schwerte, Thorsten] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Medical University of Innsbruck; University of Innsbruck; University of Pennsylvania	Grabner, M (corresponding author), Innsbruck Med Univ, Div Biochem Pharmacol, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria.	manfred.grabner@i-med.ac.at	Schwerte, Thorsten/K-6549-2019; Schwerte, Thorsten/A-6088-2009; Tuluc, Petronel/C-2527-2011	Schwerte, Thorsten/0000-0002-6330-8817; Schredelseker, Johann/0000-0002-6657-0466; Dayal, Anamika/0000-0001-8075-8812	National Institutes of Health [HL-48093]; Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research [FWF-16098-B04]; Medizinische Forschungsforderung Innsbruck [MFI-6180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048093, R37HL048093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research(Austrian Science Fund (FWF)); Medizinische Forschungsforderung Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-48093 (to C.F.-A.). This work was also supported by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research Grant FWF-16098-B04 (to M.G.) and Medizinische Forschungsforderung Innsbruck Grant MFI-6180 (to J.S.).	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2003, BIOPHYS J, V84, P942, DOI 10.1016/S0006-3495(03)74911-X; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Coronado R, 2004, BIOL RES, V37, P565; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; Garcia K, 2008, J PHYSIOL-LONDON, V586, P727, DOI 10.1113/jphysiol.2007.147959; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; GRABNER M, 1994, J BIOL CHEM, V269, P23668; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Granato M, 1996, DEVELOPMENT, V123, P399; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Haffter P, 1996, DEVELOPMENT, V123, P1; Hirata H, 2004, DEVELOPMENT, V131, P5457, DOI 10.1242/dev.01410; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Kugler G, 2004, ARCH BIOCHEM BIOPHYS, V427, P91, DOI 10.1016/j.abb.2004.04.007; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MORTON ME, 1987, J BIOL CHEM, V262, P11904; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Neuhuber B, 1998, J BIOL CHEM, V273, P9110, DOI 10.1074/jbc.273.15.9110; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; Nusslein-Volhard C, 2002, ZEBRAFISH; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Schwerte T, 2000, J EXP BIOL, V203, P1659; Sheridan DC, 2003, BIOPHYS J, V85, P3739, DOI 10.1016/S0006-3495(03)74790-0; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Slavik KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1475, DOI 10.1152/ajpcell.1997.272.5.C1475; Strube C, 1998, BIOPHYS J, V75, P207, DOI 10.1016/S0006-3495(98)77507-1; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	63	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1242	1251		10.1074/jbc.M807767200	http://dx.doi.org/10.1074/jbc.M807767200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008220	Green Published, hybrid			2022-12-25	WOS:000262122900060
J	Haimerl, F; Erhardt, A; Sass, G; Tiegs, G				Haimerl, Florian; Erhardt, Annette; Sass, Gabriele; Tiegs, Gisa			Down-regulation of the De-ubiquitinating Enzyme Ubiquitin-specific Protease 2 Contributes to Tumor Necrosis Factor-alpha-induced Hepatocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; TNF-ALPHA; DEUBIQUITINATING ENZYMES; JNK ACTIVATION; C-FLIP; PROSTATE-CANCER; RAT HEPATOCYTES; TERMINAL KINASE; D-GALACTOSAMINE	Tumor necrosis factor-alpha(TNF alpha) stimulation of hepatocytes induces either cell survival or apoptosis, which seems to be regulated by the ubiquitin-proteasome system. Here we investigated the role of TNF alpha-induced down-modulation of the deubiquitinating enzyme USP2 for hepatocyte survival. Inhibition of hepatocyte apoptosis by pre-treatment with TNF alpha (TNF alpha tolerance) was analyzed in the mouse model of galactosamine/TNF alpha-induced liver injury and in actinomycin D/TNF alpha-treated primary mouse hepatocytes. The role of USP2 for TNF alpha-induced hepatocyte survival was studied using small interference RNA or an expression clone. Injection of mice or preincubation of hepatocytes with TNF alpha caused a rapid down-regulation of hepatic USP2-41kD, the predominant USP2 isoform in the liver. In vitro an artificial knockdown of USP2 inhibited actinomycin D/TNF alpha-induced hepatocyte apoptosis, which was associated with elevated levels of the anti-apoptotic protein c-Flip(L/S) and a concomitant decrease of cellular levels of the ubiquitin-ligase Itch, a negative regulator of c-Flip. USP2-41kD overexpression abrogated TNF alpha tolerance in vitro, prevented accumulation of c-Flip(L/S) and resulted in elevated levels of Itch. Accordingly, c-Flip(L/S) protein levels were elevated in livers of TNF alpha-tolerant mice, which correlated to a switch from JNK and ERK to p38 signaling after galactosamine/TNF re-challenge. Our results indicate that TNF alpha-induced USP2 down-regulation is an effective cytoprotective mechanism in hepatocytes. Hence, USP2 could be a novel pharmacological target, and specific USP2 inhibitors might be potential candidates for the treatment of inflammation-related apoptotic liver damage.	[Haimerl, Florian; Tiegs, Gisa] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Erhardt, Annette; Sass, Gabriele; Tiegs, Gisa] Univ Med Ctr Hamburg Eppendorf, Div Expt Immunol & Hepatol, D-20246 Hamburg, Germany	University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tiegs, G (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	g.tiegs@uke.de	Erhardt, Annette/AAS-5350-2021		Deutsche Forschungsgemeinschaft [TI 169/7-3,4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant TI 169/7-3,4). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Baek SH, 1997, J BIOL CHEM, V272, P25560, DOI 10.1074/jbc.272.41.25560; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gewies A, 2003, CANCER RES, V63, P682; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kim Dong-Joon, 2008, J Mol Signal, V3, P2, DOI 10.1186/1750-2187-3-2; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; LEIST M, 1995, AM J PATHOL, V146, P1220; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Lim SJ, 2006, ONCOL REP, V16, P1131; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; Mathew R, 2006, CLIN CANCER RES, V12, P3648, DOI 10.1158/1078-0432.CCR-06-0620; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Perez D, 2003, J VIROL, V77, P2651, DOI 10.1128/JVI.77.4.2651-2662.2003; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; RIJCKEN WRP, 1995, GLYCOBIOLOGY, V5, P495, DOI 10.1093/glycob/5.5.495; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Sass G, 2005, BIOCHEM J, V385, P537, DOI 10.1042/BJ20040279; Sass G, 2002, INFLAMM RES, V51, P229, DOI 10.1007/PL00000298; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Takai S, 2007, LAB INVEST, V87, P572, DOI 10.1038/labinvest.3700544; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wilkinson KD, 1999, J NUTR, V129, P1933, DOI 10.1093/jn/129.11.1933; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Zang GQ, 2000, WORLD J GASTROENTERO, V6, P688; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	56	48	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					495	504		10.1074/jbc.M803533200	http://dx.doi.org/10.1074/jbc.M803533200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001362	hybrid			2022-12-25	WOS:000261974800054
J	Neidt, EM; Scott, BJ; Kovar, DR				Neidt, Erin M.; Scott, Bonnie J.; Kovar, David R.			Formin Differentially Utilizes Profilin Isoforms to Rapidly Assemble Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; CAPPING PROTEIN; CAENORHABDITIS-ELEGANS; ADP-ACTIN; C-ELEGANS; CYTOKINESIS; DOMAIN; POLYMERIZATION; ELONGATION; MONOMERS	Cells contain multiple formin isoforms that drive the assembly of profilin-actin for diverse processes. Given that many organisms also contain several profilin isoforms, specific formin/profilin pairs might be matched to optimally stimulate actin polymerization. We utilized a combination of bulk actin polymerization and single filament total internal reflection fluorescence microscopy assays to measure the effect of different profilin isoforms on the actin assembly properties of the cytokinesis formins from fission yeast (Cdc12p) and the nematode worm (CYK-1). We discovered that Cdc12p only effectively utilizes the single fission yeast profilin isoform SpPRF. Conversely, CYK-1 prefers the essential worm cytokinesis profilin CePFN-1 to the two non-essential worm profilin isoforms (SpPRF = CePFN-1 > CePFN-2 > CePFN-3). Chimeras containing the profilin-binding formin homology 1 (FH1) domain from one formin and the barbed-end associated FH2 domain from the other formin, revealed that both the FH1 and FH2 domains help confer profilin isoform specialization. Although the Cdc12p and CYK-1 FH1 domains cannot differentiate between profilin isoforms in the absence of actin, formin FH1 domains appear to preferentially select specific isoforms of profilin-actin. Surprisingly, analysis of profilin point mutants revealed that differences in highly conserved residues in both the poly-L-proline and actin binding regions of profilin do not explain their differential utilization by formin. Therefore, rapid formin-mediated elongation of profilin-actin depends upon favorable interactions of profilin-actin with the FH1 domain as well as the barbed-end associated FH2 domain. Specific formin FH1FH2 domains are tailored to optimally utilize actin bound to particular profilin isoforms.	[Neidt, Erin M.; Scott, Bonnie J.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kovar, DR (corresponding author), 920 East 58th St,Suite 915 E, Chicago, IL 60637 USA.	drkovar@uchicago.edu						Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Ono S, 1999, CELL MOTIL CYTOSKEL, V43, P128, DOI 10.1002/(SICI)1097-0169(1999)43:2&lt;128::AID-CM4&gt;3.0.CO;2-C; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Swan KA, 1998, J CELL SCI, V111, P2017; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3	34	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					673	684		10.1074/jbc.M804201200	http://dx.doi.org/10.1074/jbc.M804201200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18978356	hybrid			2022-12-25	WOS:000261974800072
J	Sebag, JA; Hinkle, PM				Sebag, Julien A.; Hinkle, Patricia M.			Regions of Melanocortin 2 (MC2) Receptor Accessory Protein Necessary for Dual Topology and MC2 Receptor Trafficking and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL GLUCOCORTICOID DEFICIENCY; POSITIVELY CHARGED RESIDUES; ACTIVITY-MODIFYING PROTEINS; FLUORESCENCE COMPLEMENTATION; TRANSMEMBRANE ORIENTATION; RESISTANCE SYNDROMES; MEMBRANE; VISUALIZATION; MRAP; RAMPS	MRAP, melanocortin 2 (MC2) receptor accessory protein, is required for trafficking by the MC2 (ACTH) receptor. MRAP is a single transmembrane protein that forms highly unusual antiparallel homodimers. We used molecular complementation to ask where MRAP achieves dual topology. Fragments of yellow fluorescent protein (YFP) were fused to the NH2 or COOH terminus of MRAP such that YFP fluorescence could occur only in antiparallel homodimers; fluorescence was present in the endoplasmic reticulum. MRAP retained dual topology after deletion of most of the amino terminus. In contrast, deletion of residues 31-37, just NH2-terminal to the transmembrane domain, forced MRAP into a single N-exo/C-cyt orientation and blocked its ability to promote MC2 receptor trafficking and homodimerize. When the transmembrane domain of MRAP was replaced with the corresponding region from RAMP3, dual topology was retained but MRAP was inactive. Insertion of MRAP residues 29-37 conferred dual topology to RAMP3, normally in an N-exo/C-cyt orientation. When expressed with MRAP Delta 1-30, MRAP Delta 10-20, or MRAP Delta 21-30, MC2 receptor was localized on the plasma membrane but unable to respond to ACTH. Residues 18-21 of MRAP were critical; MC2 receptor expressed with MRAP(18-21A) localized to the plasma membrane but did not bind I-125-ACTH or increase cAMP in response to ACTH. A newly identified MRAP homolog, MRAP2, lacks amino acids (LDYI21)-L-18 of MRAP and, like MRAP(18-21A), allows MC2 receptor trafficking but not signaling. MRAP2 with an LDYI insertion functions like MRAP. These results demonstrate that MRAP not only facilitates MC2 receptor trafficking but also allows properly localized receptor to bind ACTH and consequently signal.	[Sebag, Julien A.; Hinkle, Patricia M.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	Patricia_Hinkle@urmc.rochester.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	National Institutes of Health [DK19974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19974 ( to P. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Chan LF, 2008, HORM RES, V69, P75, DOI 10.1159/000111810; CHAN LF, 2008, END SOC ANN M SAN FR; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Cooray SN, 2008, ENDOCRINOLOGY, V149, P1935, DOI 10.1210/en.2007-1463; Cooray Sadani N., 2008, V13, P99, DOI 10.1159/000134828; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; Kuwasako K, 2003, J BIOL CHEM, V278, P22623, DOI 10.1074/jbc.M302571200; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Metherell LA, 2006, BEST PRACT RES CL EN, V20, P547, DOI 10.1016/j.beem.2006.09.002; Modan-Moses D, 2006, J CLIN ENDOCR METAB, V91, P3713, DOI 10.1210/jc.2006-0687; Parameswaran N, 2006, TRENDS BIOCHEM SCI, V31, P631, DOI 10.1016/j.tibs.2006.09.006; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0	29	94	95	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					610	618		10.1074/jbc.M804413200	http://dx.doi.org/10.1074/jbc.M804413200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981183	Green Published, hybrid			2022-12-25	WOS:000261974800066
J	Starostina, E; Xu, AG; Lin, HP; Pikielny, CW				Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.			A Drosophila Protein Family Implicated in Pheromone Perception Is Related to Tay-Sachs GM2-Activator Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ODORANT-BINDING PROTEINS; MALE COURTSHIP BEHAVIOR; MITE ALLERGEN DER-F-2; CRYSTAL-STRUCTURE; TASTE RECEPTORS; SENSITIVE NEURONS; OLFACTORY NEURONS; PSI-BLAST; MELANOGASTER; EXPRESSION	Low volatility, lipid-like cuticular hydrocarbon pheromones produced by Drosophila melanogaster females play an essential role in triggering and modulating mating behavior, but the chemosensory mechanisms involved remain poorly understood. Recently, we showed that the CheB42a protein, which is expressed in only 10 pheromone-sensing taste hairs on the front legs of males, modulates progression to late stages of male courtship behavior in response to female-specific cuticular hydrocarbons. Here we report that expression of all 12 genes in the CheB gene family is predominantly or exclusively gustatory-specific, and occurs in many different, often non-overlapping patterns. Only the Gr family of gustatory receptor genes displays a comparable variety of gustatory-specific expression patterns. Unlike Grs, however, expression of all but one CheB gene is sexually dimorphic. Like CheB42a, other CheBs may therefore function specifically in gustatory perception of pheromones. We also show that CheBs belong to the ML superfamily of lipid-binding proteins, and are most similar to human GM2-activator protein (GM2-AP). In particular, GM2-AP residues involved in ligand binding are conserved in CheBs but not in other ML proteins. Finally, CheB42a is specifically secreted into the inner lumen of pheromone-sensing taste hairs, where pheromones interact with membrane-bound receptors. We propose that CheB proteins interact directly with lipid-like Drosophila pheromones and modulate their detection by the gustatory signal transduction machinery. Furthermore, as loss of GM2-AP in Tay-Sachs disease prevents degradation of GM2 gangliosides and results in neurodegeneration, the function of CheBs in pheromone response may involve biochemical mechanisms critical for lipid metabolism in human neurons.	[Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.] Dartmouth Med Sch, Ctr Neurosci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Pikielny, CW (corresponding author), Dartmouth Med Sch, Dept Genet, Vail 604, Hanover, NH 03755 USA.	CWP@Dartmouth.edu			National Institutes of Health NIDCD [RO1DC04284, R01DC007911]; Howard Hughes Medical Institute to Dartmouth Medical School [76200-560801]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007911, R01DC004284] Funding Source: NIH RePORTER	National Institutes of Health NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute to Dartmouth Medical School(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health NIDCD Grants RO1DC04284 and R01DC007911 ( to C. W. P.). This work was also supported by Award 76200-560801 from the Biomedical Research Support Program for Medical Schools from the Howard Hughes Medical Institute to Dartmouth Medical School. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, PHEROMONES ANIMAL BE; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Berger AC, 2005, EUKARYOT CELL, V4, P1851, DOI 10.1128/EC.4.11.1851-1862.2005; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BRAND AH, 1993, DEVELOPMENT, V118, P401; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; DIVIACCO S, 1992, GENE, V122, P313, DOI 10.1016/0378-1119(92)90220-J; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Huang X, 2007, DEVELOPMENT, V134, P3733, DOI 10.1242/dev.004572; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Mahuran DJ, 1998, BBA-LIPID LIPID MET, V1393, P1, DOI 10.1016/S0005-2760(98)00057-5; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suzuki M, 2006, BIOCHEM BIOPH RES CO, V339, P679, DOI 10.1016/j.bbrc.2005.11.065; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VENARD R, 1989, NEUROBIOLOGY OF SENSORY SYSTEMS, P377; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Wright CS, 2004, J MOL BIOL, V342, P585, DOI 10.1016/j.jmb.2004.07.063; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Wright CS, 2005, BIOCHEMISTRY-US, V44, P13510, DOI 10.1021/bi050668w; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zufall F, 2007, CURR OPIN NEUROBIOL, V17, P483, DOI 10.1016/j.conb.2007.07.012	67	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					585	594		10.1074/jbc.M806474200	http://dx.doi.org/10.1074/jbc.M806474200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952610	Green Published, hybrid			2022-12-25	WOS:000261974800064
J	Beyer, S; Kristensen, MM; Jensen, KS; Johansen, JV; Staller, P				Beyer, Sophie; Kristensen, Malene Maag; Jensen, Kim Steen; Johansen, Jens Vilstrup; Staller, Peter			The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN NEUROBLASTOMA-CELLS; TISSUE OXYGEN DISTRIBUTION; GENE-EXPRESSION; FACTOR-I; CHROMATIN MODIFICATIONS; FACTOR 1-ALPHA; H3 LYSINE-9; PHD FINGER; CANCER	Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins. Histone methylation occurs on arginine and lysine residues and is involved in the regulation of gene transcription. A dynamic control of these modifications is exerted by histone methyltransferases and the recently discovered histone demethylases. Here we show that the hypoxia-inducible factor HIF-1 alpha binds to specific recognition sites in the genes encoding the jumonji family histone demethylases JMJD1A and JMJD2B and induces their expression. Accordingly, hypoxic cells express elevated levels of JMJD1A and JMJD2B mRNA and protein. Furthermore, we find increased expression of JMJD1A and JMJD2B in renal cancer cells that have lost the von Hippel Lindau tumor suppressor protein VHL and therefore display a deregulated expression of hypoxia-inducible factor. Studies on ectopically expressed JMJD1A and JMJD2B indicate that both proteins retain their histone lysine demethylase activity in hypoxia and thereby might impact the hypoxic gene expression program.	[Beyer, Sophie; Kristensen, Malene Maag; Jensen, Kim Steen; Johansen, Jens Vilstrup; Staller, Peter] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Johansen, Jens Vilstrup] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Staller, P (corresponding author), Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	peter.staller@bric.ku.dk		Hjorth-Jensen, Kim/0000-0001-5415-9525; Vilstrup Johansen, Jens/0000-0001-7094-6801	Biotech Research and Innovation Centre; Danish Cancer Society; Danish Cancer Research Foundation; Lykfeldts Legat; Novo Nordisk Foundation	Biotech Research and Innovation Centre; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Lykfeldts Legat; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Biotech Research and Innovation Centre, the Danish Cancer Society, the Danish Cancer Research Foundation, Lykfeldts Legat, and the Novo Nordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This rticle must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam MF, 1999, HEAD NECK-J SCI SPEC, V21, P146, DOI 10.1002/(SICI)1097-0347(199903)21:2<146::AID-HED8>3.0.CO;2-U; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Birner P, 2000, CANCER RES, V60, P4693; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maina EN, 2005, ONCOGENE, V24, P4549, DOI 10.1038/sj.onc.1208649; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Murata H, 2002, CANCER RES, V62, P7004; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; POLLARD PJ, 2008, J BIOCH IN PRESS; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Stratmann R, 1997, J NEUROPATH EXP NEUR, V56, P1242, DOI 10.1097/00005072-199711000-00009; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAUPEL P, 1991, CANCER RES, V51, P3316; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang ZQ, 2000, CANCER RES, V60, P4735	83	246	253	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36542	36552		10.1074/jbc.M804578200	http://dx.doi.org/10.1074/jbc.M804578200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984585	hybrid, Green Published			2022-12-25	WOS:000261840500052
J	Robakis, T; Bak, B; Lin, SH; Bernard, DJ; Scheiffele, P				Robakis, Thalia; Bak, Beata; Lin, Shu-huei; Bernard, Daniel J.; Scheiffele, Peter			An Internal Signal Sequence Directs Intramembrane Proteolysis of a Cellular Immunoglobulin Domain Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INHIBIN-BINDING-PROTEIN; VIRUS CORE PROTEIN; PEPTIDE PEPTIDASE; ASPARTIC PROTEASES; TNF-ALPHA; CLEAVAGE; PRESENILIN; GENE; IDENTIFICATION	Precursor proteolysis is a crucial mechanism for regulating protein structure and function. Signal peptidase (SP) is an enzyme with a well defined role in cleaving N-terminal signal sequences but no demonstrated function in the proteolysis of cellular precursor proteins. We provide evidence that SP mediates intraprotein cleavage of IgSF1, a large cellular Ig domain protein that is processed into two separate Ig domain proteins. In addition, our results suggest the involvement of signal peptide peptidase (SPP), an intramembrane protease, which acts on substrates that have been previously cleaved by SP. We show that IgSF1 is processed through sequential proteolysis by SP and SPP. Cleavage is directed by an internal signal sequence and generates two separate Ig domain proteins from a polytopic precursor. Our findings suggest that SP and SPP function are not restricted to N-terminal signal sequence cleavage but also contribute to the processing of cellular transmembrane proteins.	[Robakis, Thalia; Lin, Shu-huei; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, Dept Neurosci, New York, NY 10032 USA; [Bak, Beata; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	Columbia University; McGill University	Scheiffele, P (corresponding author), Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch	Robakis, Thalia/AAQ-5277-2020	Robakis, Thalia/0000-0003-2919-2555; Bernard, Daniel/0000-0001-5365-5586	Natural Sciences and Engineering Research Council of Canada Discovery; Joseph and Esther Klingenstein Fund; Alfred P. Sloan Foundation; Searle Scholar Program; Irma T. Hirschl Trust; John Merck Fund; Medical Scientist Training Program training program at Columbia University; Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Joseph and Esther Klingenstein Fund(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholar Program; Irma T. Hirschl Trust; John Merck Fund; Medical Scientist Training Program training program at Columbia University; Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant ( to D.J.B.) and funds from the Joseph and Esther Klingenstein Fund, The Alfred P. Sloan Foundation, The Searle Scholar Program, The Irma T. Hirschl Trust, and The John Merck Fund( to P. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Medical Scientist Training Program training program at Columbia University.; Supported by a Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernard DJ, 2003, MOL CELL BIOL, V23, P4882, DOI 10.1128/MCB.23.14.4882-4891.2003; Bernard DJ, 2001, MOL ENDOCRINOL, V15, P654, DOI 10.1210/me.15.4.654; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Chapman SC, 2001, MOL ENDOCRINOL, V15, P668, DOI 10.1210/me.15.4.668; Chong HR, 2000, ENDOCRINOLOGY, V141, P2600, DOI 10.1210/en.141.7.2600; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; DE SB, 1999, NATURE, V398, P518; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Frattini A, 1998, GENE, V214, P1, DOI 10.1016/S0378-1119(98)00253-4; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HAEUPTLE MT, 1989, J CELL BIOL, V108, P1227, DOI 10.1083/jcb.108.4.1227; Hegde RS, 1999, TRENDS CELL BIOL, V9, P132, DOI 10.1016/S0962-8924(99)01504-4; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LILJESTROM P, 1991, J VIROL, V65, P147; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Pekosz A, 1998, P NATL ACAD SCI USA, V95, P13233, DOI 10.1073/pnas.95.22.13233; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; STOCKS CE, 1995, J VIROL, V69, P8123, DOI 10.1128/JVI.69.12.8123-8126.1995; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	44	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36369	36376		10.1074/jbc.M807527200	http://dx.doi.org/10.1074/jbc.M807527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981173	Green Published, hybrid			2022-12-25	WOS:000261840500034
J	Song, HP; Luo, J; Luo, WJ; Weng, JS; Wang, ZQ; Li, BX; Li, DL; Liu, MY				Song, Huiping; Luo, Jian; Luo, Weijia; Weng, Jinsheng; Wang, Zhiqiang; Li, Baoxing; Li, Dali; Liu, Mingyao			Inactivation of G-protein-coupled Receptor 48 (Gpr48/Lgr4) Impairs Definitive Erythropoiesis at Midgestation through Down-regulation of the ATF4 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; ACTIVATING TRANSCRIPTION FACTOR-4; STAT5A(-/-)5B(-/-) MICE; POSTNATAL-DEVELOPMENT; TARGETED DISRUPTION; CELL-PROLIFERATION; TYROSINE RESIDUES; FETAL ANEMIA; YOLK-SAC; STAT5	G-protein-coupled receptors (GPCRs), one of the most versatile groups of cell surface receptors, can recognize specific ligands from neural, hormonal, and paracrine organs and regulate cell growth, proliferation, and differentiation. Gpr48/LGR4 is a recently identified orphan GPCR with unknown functions. To reveal the functions of Gpr48 in vivo, we generated Gpr48(-/-) mice and found that Gpr48(-/-) fetuses displayed transient anemia during midgestation and abnormal definitive erythropoiesis. The dramatic decrease of definitive erythroid precursors (Ter119(pos) population) in Gpr48(-/-) fetal liver at E13.5 was confirmed by histological analysis and blood smear assays. Real-time PCR analyses showed that in Gpr48(-/-) mice both adult hemoglobin alpha and beta chains were decreased while embryonic hemoglobin chains (zeta, beta H1, and epsilon y) were increased, providing another evidence for the impairment of definitive erythropoiesis. Furthermore, proliferation was suppressed in Gpr48(-/-) fetal liver with decreased c-Myc and cyclin D1 expression, whereas apoptosis was unaffected. ATF4, a key transcription factor in erythropoiesis, was down-regulated in Gpr48(-/-) fetal livers during midgestation stage through the cAMP-PKA-CREB pathway, suggesting that Gpr48 regulated definitive erythropoiesis	[Song, Huiping; Luo, Weijia; Weng, Jinsheng; Liu, Mingyao] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Song, Huiping; Luo, Weijia; Weng, Jinsheng; Liu, Mingyao] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Song, Huiping; Wang, Zhiqiang] N China Coal Med Univ, Tangshan 063000, Peoples R China; [Song, Huiping; Li, Baoxing] So Med Univ, Shanxi Prov Tissue Bank, Taiyuan 030006, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; East China Normal University; East China Normal University; North China University of Science & Technology; Southern Medical University - China	Liu, MY (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Luo, Jian/H-3362-2016	Luo, Jian/0000-0003-3583-0154; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health [5R01HL064792, 1R01CA106479]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01HL064792 and 1R01CA106479 (to M.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boer AK, 2003, EXP HEMATOL, V31, P512, DOI 10.1016/S0301-472X(03)00075-4; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fischer C, 2004, BIOL REPROD, V70, P371, DOI 10.1095/biolreprod.103.021600; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P109; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P107; Gao Yun, 2006, Hokkaido Igaku Zasshi, V81, P101; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Loh ED, 2000, CYTOGENET CELL GENET, V89, P2, DOI 10.1159/000015576; Loh ED, 2001, BIOCHEM BIOPH RES CO, V282, P757, DOI 10.1006/bbrc.2001.4625; Marchese A, 1999, TRENDS PHARMACOL SCI, V20, P370, DOI 10.1016/S0165-6147(99)01366-8; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mitchell DC, 2006, J BIOL CHEM, V281, P51, DOI 10.1074/jbc.M506245200; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palis J, 1999, DEVELOPMENT, V126, P5073; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Samakoglu S, 2001, BLOOD, V97, P2213, DOI 10.1182/blood.V97.8.2213; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	61	48	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36687	36697		10.1074/jbc.M800721200	http://dx.doi.org/10.1074/jbc.M800721200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955481	hybrid, Green Published			2022-12-25	WOS:000261840500067
J	Vacaresse, N; Moller, B; Danielsen, EM; Okada, M; Sap, J				Vacaresse, Nathalie; Moller, Bente; Danielsen, E. Michael; Okada, Masato; Sap, Jan			Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTP alpha Is Substrate-specific and Compatible with Lipid Raft Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; PTP-ALPHA; DOWN-REGULATION; RECEPTOR; ADHESION; PHOSPHORYLATION; CD45; MEMBRANE; PAXILLIN; CELLS	Src family tyrosine kinases (SFKs) function in multiple signaling pathways, raising the question of how appropriate regulation and substrate choice are achieved. SFK activity is modulated by several protein-tyrosine phosphatases, among which RPTP alpha and SHP2 are the best established. We studied how RPTP alpha affects substrate specificity and regulation of c-Src and Fyn in response to epidermal growth factor and platelet-derived growth factor. We find that RPTP alpha, in a growth factor-specific manner, directs the specificity of these kinases toward a specific subset of SFK substrates, particularly the focal adhesion protein Paxillin and the lipid raft scaffolding protein Cbp/PAG. A significant fraction of RPTP alpha is present in lipid rafts, where its targets Fyn and Cbp/PAG reside, and growth factor-mediated SFK activation within this compartment is strictly dependent on RPTP alpha. Forced concentration of RPTP alpha into lipid rafts is compatible with activation of Fyn. Finally, RPTP alpha-induced phosphorylation of Paxillin and Cbp/PAG induces recruitment of the SFK inhibitory kinase Csk, indicative of negative feedback loops limiting SFK activation by RPTP alpha . Our findings indicate that individual SFK-controlling PTPs play important and specific roles in dictating SFK substrate specificity and regulatory mechanism.	[Vacaresse, Nathalie; Moller, Bente; Sap, Jan] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Vacaresse, Nathalie; Moller, Bente; Sap, Jan] Univ Copenhagen, Inst Biomed Sci, DK-2200 Copenhagen N, Denmark; [Danielsen, E. Michael] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Vacaresse, Nathalie; Sap, Jan] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Osaka 5650871, Japan	University of Copenhagen; University of Copenhagen; New York University; Osaka University	Sap, J (corresponding author), Univ Paris 07, UFR Sci Vivant, UMR Epigenet & Destin Cellulaire, Batiment Lamarck,Case 7042, F-75014 Paris, France.	jan.sap@univ-paris-diderot.fr			National Cancer Institute [R01 CA87005]; Danish Cancer Society; NATIONAL CANCER INSTITUTE [R01CA087005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA87005 from the National Cancer Institute. This work was also supported by funds from the Danish Cancer Society (to J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chen X, 2001, J BIOL CHEM, V276, P34617, DOI 10.1074/jbc.M103995200; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Dalgarno D, 2006, CHEM BIOL DRUG DES, V67, P46, DOI 10.1111/j.1747-0285.2005.00316.x; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Le HT, 2006, J NEUROCHEM, V98, P1798, DOI 10.1111/j.1471-4159.2006.04075.x; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	45	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35815	35824		10.1074/jbc.M807964200	http://dx.doi.org/10.1074/jbc.M807964200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948260	Green Published, hybrid			2022-12-25	WOS:000261687900056
J	Evnouchidou, I; Momburg, F; Papakyriakou, A; Chroni, A; Leondiadis, L; Chang, SC; Goldberg, AL; Stratikos, E				Evnouchidou, Irini; Momburg, Frank; Papakyriakou, Athanasios; Chroni, Angeliki; Leondiadis, Leondios; Chang, Shih-Chung; Goldberg, Alfred L.; Stratikos, Efstratios			The Internal Sequence of the Peptide-Substrate Determines Its N-Terminus Trimming by ERAP1	PLOS ONE			English	Article								Background: Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims N-terminally extended antigenic peptide precursors down to mature antigenic peptides for presentation by major histocompatibility complex (MHC) class I molecules. ERAP1 has unique properties for an aminopeptidase being able to trim peptides in vitro based on their length and the nature of their C-termini. Methodology/Principal Findings: In an effort to better understand the molecular mechanism that ERAP1 uses to trim peptides, we systematically analyzed the enzyme's substrate preferences using collections of peptide substrates. We discovered strong internal sequence preferences of peptide N-terminus trimming by ERAP1. Preferences were only found for positively charged or hydrophobic residues resulting to trimming rate changes by up to 100 fold for single residue substitutions and more than 40,000 fold for multiple residue substitutions for peptides with identical N-termini. Molecular modelling of ERAP1 revealed a large internal cavity that carries a strong negative electrostatic potential and is large enough to accommodate peptides adjacent to the enzyme's active site. This model can readily account for the strong preference for positively charged side chains. Conclusions/Significance: To our knowledge no other aminopeptidase has been described to have such strong preferences for internal residues so distal to the N-terminus. Overall, our findings indicate that the internal sequence of the peptide can affect its trimming by ERAP1 as much as the peptide's length and C-terminus. We therefore propose that ERAP1 recognizes the full length of its peptide-substrate and not just the N- and C-termini. It is possible that ERAP1 trimming preferences influence the rate of generation and the composition of antigenic peptides in vivo.	[Evnouchidou, Irini; Leondiadis, Leondios; Stratikos, Efstratios] IRRP, Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece; [Momburg, Frank] German Canc Res Ctr, Dept Mol Immunol, Heidelberg, Germany; [Papakyriakou, Athanasios] Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece; [Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biol, Aghia Paraskevi, Greece; [Chang, Shih-Chung] Natl Taiwan Univ, Dept Biochem Sci & Technol, Inst Microbiol & Biochem, Taipei, Taiwan; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	National Centre of Scientific Research "Demokritos"; Helmholtz Association; German Cancer Research Center (DKFZ); National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; National Taiwan University; Harvard University; Harvard Medical School	Evnouchidou, I (corresponding author), IRRP, Natl Ctr Sci Res Demokritos, Aghia Paraskevi, Greece.	stratos@rrp.demokritos.gr	Evnouchidou, Irini/Z-3072-2019; Papakyriakou, Athanasios/K-7033-2012; Hsiao, Wei-Hung/B-9931-2013; Stratikos, Efstratios/N-2969-2014	Papakyriakou, Athanasios/0000-0003-3931-6232; Stratikos, Efstratios/0000-0002-3566-2309; Chroni, Angeliki/0000-0003-3107-1189; CHANG, SHIH-CHUNG/0000-0002-5015-8178	The Medical Foundation, Boston; Marie-Curie; NCSR; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	The Medical Foundation, Boston; Marie-Curie(European Commission); NCSR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by funding by The Medical Foundation, Boston (Charles A. King Grant to E.S.), by a Marie-Curie International Reintegration Grant (E.S.) a NCSR "Demokritos" "Demoerevna 2007" research grant (E.S) and by the National Institutes of Health (A.L.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano W.L., PYMOL MOL GRAPHICS S; Falk K, 2002, NAT IMMUNOL, V3, P1121, DOI 10.1038/ni1202-1121; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; Papakyriakou A, 2007, BIOCHEMISTRY-US, V46, P8753, DOI 10.1021/bi700253q; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	41	71	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3658	10.1371/journal.pone.0003658	http://dx.doi.org/10.1371/journal.pone.0003658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987748	Green Published, gold, Green Submitted			2022-12-25	WOS:000265134500005
J	Wang, L; Xu, Y; Zhang, C; Ma, Q; Joo, SH; Kim, SK; Xu, ZH; Chong, K				Wang, Lei; Xu, Yunyuan; Zhang, Cui; Ma, Qibin; Joo, Se-Hwan; Kim, Seong-Ki; Xu, Zhihong; Chong, Kang			OsLIC, a Novel CCCH-Type Zinc Finger Protein with Transcription Activation, Mediates Rice Architecture via Brassinosteroids Signaling	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENE-EXPRESSION; GREEN-REVOLUTION; ARABIDOPSIS; MUTANT; ELONGATION; INTERACTS; PREVENTS; HOMOLOG; BIOMASS	Rice architecture is an important agronomic trait and a major limiting factor for its high productivity. Here we describe a novel CCCH-type zinc finger gene, OsLIC (Oraza sativa leaf and tiller angle increased controller), which is involved in the regulation of rice plant architecture. OsLIC encoded an ancestral and unique CCCH type zinc finge protein. It has many orthologous in other organisms, ranging from yeast to humane. Suppression of endogenous OsLIC expression resulted in drastically increased leaf and tiller angles, shortened shoot height, and consequently reduced grain production in rice. OsLIC is predominantly expressed in rice collar and tiller bud. Genetic analysis suggested that OsLIC is epistatic to d2-1, whereas d61-1 is epistatic to OsLIC. Interestingly, sterols were significantly higher in level in transgenic shoots than in the wild type. Genome-wide expression analysis indicated that brassinosteroids (BRs) signal transduction was activated in transgenic lines. Moreover, transcription of OsLIC was induced by 24-epibrassinolide. OsLIC, with a single CCCH motif, displayed binding activity to double-stranded DNA and single-stranded polyrA, polyrU and polyrG but not polyrC. It contains a novel conserved EELR domain among eukaryotes and displays transcriptional activation activity in yeast. OsLIC may be a transcription activator to control rice plant architecture.	[Wang, Lei; Xu, Yunyuan; Zhang, Cui; Ma, Qibin; Xu, Zhihong; Chong, Kang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, Beijing, Peoples R China; [Joo, Se-Hwan; Kim, Seong-Ki] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chinese Academy of Sciences; Institute of Botany, CAS; Chung Ang University	Wang, L (corresponding author), Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA.	chongk@ibcas.ac.cn	ma, qibin/HDO-2133-2022	Zhang, Cui/0000-0002-6119-5572; WANG, LEI/0000-0002-4912-5387	Major State Basic Research Program of the P. R. China [2005CB120806]; National Science Foundation of China for Distinguished Young Scholars [30525026]; Innovation Grant of the Chinese Academy of Sciences	Major State Basic Research Program of the P. R. China(National Basic Research Program of China); National Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Grant of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Major State Basic Research Program of the P. R. China (2005CB120806), the National Science Foundation of China for Distinguished Young Scholars (30525026) and the Innovation Grant of the Chinese Academy of Sciences.	Arai R, 2003, ADV SPACE RES-SERIES, V31, P1833, DOI 10.1016/S0273-1177(03)80022-4; Bai FW, 2002, ACTA VIROL, V46, P85; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; de Vries SC, 2007, DEV CELL, V13, P162, DOI 10.1016/j.devcel.2007.07.009; Duan K, 2006, PLANT J, V47, P519, DOI 10.1111/j.1365-313X.2006.02804.x; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; GOMPERTS M, 1990, ONCOGENE, V5, P1081; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Huang NN, 2002, DEVELOPMENT, V129, P747; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lan LF, 2004, PLANT MOL BIOL, V54, P471, DOI 10.1023/B:PLAN.0000038254.58491.c7; Lee S, 2008, PLANT J, V54, P93, DOI 10.1111/j.1365-313X.2008.03406.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Murata T, 2000, BIOCHEM BIOPH RES CO, V274, P526, DOI 10.1006/bbrc.2000.3182; Nagano H, 2005, GENES GENET SYST, V80, P351, DOI 10.1266/ggs.80.351; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sambrook J., MOL CLONING LAB MANU; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schmitz RJ, 2005, DEVELOPMENT, V132, P5471, DOI 10.1242/dev.02170; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Sinclair TR, 1999, SCIENCE, V283, P1456; Tabara H, 1999, DEVELOPMENT, V126, P1; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Wang L, 2006, CELL RES, V16, P916, DOI 10.1038/sj.cr.7310111; Wang SY, 2007, CHINESE PHYS LETT, V24, P664, DOI 10.1088/0256-307X/24/3/021; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang ZY, 2006, CELL RES, V16, P427, DOI 10.1038/sj.cr.7310054; Xu YY, 2005, PLANT MOL BIOL, V57, P773, DOI 10.1007/s11103-005-0952-9; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang Guangxiao, 2004, Genomics Proteomics & Bioinformatics, V2, P77; Yang GX, 2000, PLANT CELL PHYSIOL, V41, P1243, DOI 10.1093/pcp/pcd050; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	47	127	163	12	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3521	10.1371/journal.pone.0003521	http://dx.doi.org/10.1371/journal.pone.0003521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953406	gold, Green Published			2022-12-25	WOS:000265130500004
J	Venkatesan, N; Barre, L; Magdalou, J; Mainard, D; Netter, P; Fournel-Gigleux, S; Ouzzine, M				Venkatesan, Narayanan; Barre, Lydia; Magdalou, Jacques; Mainard, Didier; Netter, Patrick; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed			Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair	FASEB JOURNAL			English	Article						glycosyltransferases; proteoglycans; regulation; gene silencing	GROWTH-FACTOR-BETA; CAENORHABDITIS-ELEGANS; THERAPEUTIC STRATEGIES; PROTEOGLYCAN SYNTHESIS; RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE; PROTEIN-KINASE; KEY ENZYME; CROSS-TALK; TGF-BETA	Osteoarthritis and rheumatoid arthritis are characterized by loss of proteoglycans (PGs) and their glycosaminoglycan (GAG) chains that are essential for cartilage function. Here, we investigated the role of glycosyltransferases (GTs) responsible for PG-GAG chain assembly during joint cartilage destruction and repair processes. At various times after antigen-induced arthritis (AIA) and papain-induced cartilage repair in rats, PG synthesis and deposition, expression of GTs, and GAG chain composition were analyzed. Our data showed that expression of the GT xylosyltransferase I (XT-I) gene initiating PG-GAG chain synthesis was significantly reduced in AIA rat cartilage and was associated with a decrease in PG synthesis. Interestingly, interleukin-1 beta, the main proinflammatory cytokine incriminated in joint diseases, down-regulated the XT-I gene expression with a concomitant decrease in PG synthesis in rat cartilage explants ex vivo. However, cartilage from papain-injected rat knees showed up-regulation of XT-I gene expression and increased PG synthesis at early stages of cartilage repair, a process associated with up-regulation of TGF-beta 1 gene expression and mediated by p38 mitogen-activated protein kinase activation. Consistently, silencing of XT-I expression by intraarticular injection of XT-I shRNA in rat knees prevented cartilage repair by decreasing PG synthesis and content. These findings show that GTs play a key role in the loss of PG-GAGs in joint diseases and identify novel targets for stimulating cartilage repair.-Venkatesan, N., Barre, L., Magdalou, J., Mainard, D., Netter, P., Fournel-Gigleux, S., Ouzzine, M. Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair. FASEB J. 23, 813-822 (2009)	[Venkatesan, Narayanan; Barre, Lydia; Magdalou, Jacques; Mainard, Didier; Netter, Patrick; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Ouzzine, M (corresponding author), Univ Nancy 1, CNRS, UMR 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	ouzzine@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950	Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche (ANR) [BLAN08-3_313970]; Ligue Regionale contre le Cancer; Contrat de Programme de Recherche Clinique; Programme Hospitalier de Recherche Clinique Centre Hospitalier Universitaire Nancy	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Regionale contre le Cancer(Ligue nationale contre le cancer); Contrat de Programme de Recherche Clinique; Programme Hospitalier de Recherche Clinique Centre Hospitalier Universitaire Nancy	This work was supported by the Programme National de Recherches sur les Maladies Osteo-Articulaire from the Institut National de la Sante et de la Recherche Medicale, The Agence Nationale de la Recherche (ANR BLAN08-3_313970), the Ligue Regionale contre le Cancer, the Contrat de Programme de Recherche Clinique, and the Programme Hospitalier de Recherche Clinique Centre Hospitalier Universitaire Nancy. We thank Pr. M. W. H. Coughtrie for critical reading of the manuscript.	Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; Blom AB, 2007, CURR DRUG TARGETS, V8, P283, DOI 10.2174/138945007779940179; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CSSZABO G, 1995, ARTHRITIS RHEUM, V38, P660, DOI 10.1002/art.1780380514; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Feldmann M, 2001, CURR DIRECT AUTOIMMU, V3, P188; Firestein G.S, 1997, TXB RHEUMATOLOGY, P851; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; LOO FA, 1992, J RHEUMATOL, V19, P348; Lubberts E, 1999, J IMMUNOL, V163, P4546; MANKIN HJ, 1971, J CLIN INVEST, V50, P1712, DOI 10.1172/JCI106660; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Poole AR, 2007, OSTEOARTHR DIAGN MED, V4, P27; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Saklatvala J, 2007, CURR DRUG TARGETS, V8, P305, DOI 10.2174/138945007779940115; SANDY JD, 1984, ARTHRITIS RHEUM, V27, P388, DOI 10.1002/art.1780270405; SCHWARTZ ER, 1981, ARTHRITIS RHEUM-US, V24, P1528, DOI 10.1002/art.1780241212; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Studer RK, 2005, J ORTHOP RES, V23, P454, DOI 10.1016/j.orthres.2004.08.012; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; THOMPSON RC, 1979, J BONE JOINT SURG AM, V61, P407, DOI 10.2106/00004623-197961030-00017; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; vanderKraan PM, 1997, J RHEUMATOL, V24, P543; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; YOSHINO S, 1995, CELL IMMUNOL, V163, P55, DOI 10.1006/cimm.1995.1098	33	24	24	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					813	822		10.1096/fj.08-118166	http://dx.doi.org/10.1096/fj.08-118166			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001053				2022-12-25	WOS:000265506300017
J	Pawlak, J; Mackessy, SP; Sixberry, NM; Stura, EA; Le Du, MH; Menez, R; Foo, CS; Menez, A; Nirthanan, S; Kini, RM				Pawlak, Joanna; Mackessy, Stephen P.; Sixberry, Nicole M.; Stura, Enrico A.; Le Du, Marie Helene; Menez, Renee; Foo, Chun Shin; Menez, Andre; Nirthanan, Selvanayagam; Kini, R. Manjunatha			Irditoxin, a novel covalently linked heterodimeric three-finger toxin with high taxon-specific neurotoxicity	FASEB JOURNAL			English	Article						postsynaptic neurotoxin; acetylcholine receptor; neuromuscular junction; snake venom	NICOTINIC ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; MOLECULAR EVOLUTION; BUNGARUS-CANDIDUS; COLUBRID SNAKES; COBRA VENOM; EXPRESSION; CLONING; COMPLEX; IDENTIFICATION	A novel heterodimeric three-finger neurotoxin, irditoxin, was isolated from venom of the brown treesnake Boiga irregularis (Colubridae). Irditoxin subunit amino acid sequences were determined by Edman degradation and cDNA sequencing. The crystal structure revealed two subunits with a three-finger protein fold, typical for "nonconventional" toxins such as denmotoxin, bucandin, and candoxin. This is the first colubrid three-finger toxin dimer, covalently connected via an interchain disulfide bond. Irditoxin showed taxon-specific lethality toward birds and lizards and was nontoxic toward mice. It produced a potent neuromuscular blockade at the avian neuromuscular junction (IC50 = 10 nM), comparable to alpha-bungarotoxin, but was three orders of magnitude less effective at the mammalian neuromuscular junction. Covalently linked heterodimeric three-finger toxins found in colubrid venoms constitute a new class of venom peptides, which may be a useful source of new neurobiology probes and therapeutic leads. - Pawlak, J., Mackessy, S. P., Sixberry, N. M., Stura, E. A., Le Du, M. H., Menez, R., Foo, C. S., Menez, A., Nirthanan, S., Kini, R. M. Irditoxin, a novel covalently linked heterodimeric three-finger toxin with high taxon-specific neurotoxicity. FASEB J. 23, 534-545 (2009)	[Kini, R. Manjunatha] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Prot Sci Lab, Singapore 117543, Singapore; [Mackessy, Stephen P.; Sixberry, Nicole M.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Stura, Enrico A.; Le Du, Marie Helene; Menez, Renee; Menez, Andre] CEA, Dept Ingn & Etud Prot, Gif Sur Yvette, France; [Foo, Chun Shin; Nirthanan, Selvanayagam] Natl Inst Neurosci, Neuropharmacol & Lead Discovery Lab, Singapore, Singapore; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	National University of Singapore; University of Northern Colorado; CEA; UDICE-French Research Universities; Universite Paris Saclay; National Neuroscience Institute (NNI); Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Prot Sci Lab, Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Mackessy, Stephen/GPT-0793-2022; Kini, Manjunatha/H-8029-2012; Nirthanan, Selvanayagam/ABI-4281-2020; Stura, Enrico A./A-2793-2010	Stura, Enrico A./0000-0001-6718-2118; Kini, Manjunatha/0000-0002-6100-3251; Mackessy, Stephen/0000-0003-4515-2545; Nirthanan, S. Niru/0000-0001-9888-8447	Biomedical Research Council (BMRC), Agency for Science and Technology, Singapore [01/1/21/18/072, 07/1/21/19/490, 06/1/33/19/481]; U.S. Geological Service Biological Resources Division [00CRAG0014]	Biomedical Research Council (BMRC), Agency for Science and Technology, Singapore(Agency for Science Technology & Research (A*STAR)); U.S. Geological Service Biological Resources Division	This manuscript is dedicated to the memory of our esteemed colleague and friend, Professor A. Menez. We thank W. H. Heyborne for assistance during purification and toxicity assays; F. Qualls and C. Terrell for assistance in obtaining snakes from Guam, and the Guam Department of Natural Resources for export permits for brown treesnakes; C. Fruchart-Gaillard, D. Servent and other employees of DIEP (CEA) for their counsel and invaluable help. This work was supported by research grants from the Biomedical Research Council (BMRC), Agency for Science and Technology, Singapore, to R.M.K. (BMRC grants 01/1/21/18/072 and 07/1/21/19/490) and S.N. (BMRC grant 06/1/33/19/481) and from the U.S. Geological Service Biological Resources Division to S.P.M. (grant 00CRAG0014).	Afifiyan F, 1998, TOXICON, V36, P1871, DOI 10.1016/S0041-0101(98)00108-1; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Banerjee Y, 2005, J BIOL CHEM, V280, P42601, DOI 10.1074/jbc.M508987200; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Chiappinelli VA, 1996, TOXICON, V34, P1243, DOI 10.1016/S0041-0101(96)00110-9; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DEWAN JC, 1994, BIOCHEMISTRY-US, V33, P13147, DOI 10.1021/bi00248a026; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; Endo T., 1991, P165; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Hill RE, 2000, TOXICON, V38, P1663, DOI 10.1016/S0041-0101(00)00091-X; Hill RE, 1997, TOXICON, V35, P671, DOI 10.1016/S0041-0101(96)00174-2; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; Mackessy SP, 2002, J TOXICOL-TOXIN REV, V21, P43, DOI 10.1081/TXR-120004741; MENEZ A, 1980, BIOCHEMISTRY-US, V19, P4166, DOI 10.1021/bi00559a005; MENEZ A, 1984, J PHYSIOLOGY PARIS, V79, P196; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Nirthanan S, 2003, TOXICON, V41, P397, DOI 10.1016/S0041-0101(02)00388-4; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pahari S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-175; Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Pawlak J, 2006, TOXICON, V48, P278, DOI 10.1016/j.toxicon.2006.05.013; Poh SL, 2002, EUR J BIOCHEM, V269, P4247, DOI 10.1046/j.1432-1033.2002.03113.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; SMITH LA, 1990, J TOXICOL-TOXIN REV, V9, P243, DOI 10.3109/15569549009033116; TAMIYA T, 1985, BIOCHIMIE, V67, P185, DOI 10.1016/S0300-9084(85)80046-8; Teixeira-Clerc F, 2002, J BIOL CHEM, V277, P25741, DOI 10.1074/jbc.M200534200; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; VON HG, 1986, NUCLEIC ACIDS RES, V14, P4683	49	140	144	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					534	545		10.1096/fj.08-113555	http://dx.doi.org/10.1096/fj.08-113555			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18952712				2022-12-25	WOS:000262892900025
J	Ramakrishnan, NA; Drescher, MJ; Barretto, RL; Beisel, KW; Hatfield, JS; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Barretto, Roberto L.; Beisel, Kirk W.; Hatfield, James S.; Drescher, Dennis G.			Calcium-dependent Binding of HCN1 Channel Protein to Hair Cell Stereociliary Tip Link Protein Protocadherin 15 CD3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; INWARDLY RECTIFYING CURRENTS; PACEMAKER CHANNELS; INNER-EAR; CATION CHANNELS; MOLECULAR CHARACTERIZATION; INSTANTANEOUS CURRENT; IONIC COMPOSITION; SUPPORTING CELLS; RAT COCHLEA	The cytoplasmic amino terminus of HCN1, the primary full-length HCN isoform expressed in trout saccular hair cells, was found by yeast two-hybrid protocols to bind the cytoplasmic carboxyl-terminal domain of a protocadherin 15a-like protein. HCN1 was immunolocalized to discrete sites on saccular hair cell stereocilia, consistent with gradated distribution expected for tip link sites of protocadherin 15a. HCN1 message was also detected in cDNA libraries of rat cochlear inner and outer hair cells, and HCN1 protein was immunolocalized to cochlear hair cell stereocilia. As predicted by the trout hair cell model, the amino terminus of rat organ of Corti HCN1 was found by yeast two-hybrid analysis to bind the carboxyl terminus of protocadherin 15 CD3, a tip link protein implicated in mechanosensory transduction. Specific binding between HCN1 and protocadherin 15 CD3 was confirmed with pull-down assays and surface plasmon resonance analysis, both predicting dependence on Ca2+. In the presence of calcium chelators, binding between HCN1 and protocadherin 15 CD3 was characterized by a K-D = 2.39 x 10(-7) M. Ca2+ at 26.5-68.0 mu M promoted binding, with K-D = 5.26 x 10(-8) M (at 61 mu M Ca2+). Binding by deletion mutants of protocadherin 15 CD3 pointed to amino acids 158-179 (GenBank (TM) accession number XP_238200), with homology to the comparable region in trout hair cell protocadherin 15a-like protein, as necessary for binding to HCN1. Amino terminus binding of HCN1 to HCN1, hypothesized to underlie HCN1 channel formation, was also found to be Ca2+-dependent, although the binding was skewed toward a lower effective maximum [Ca2+] than for the HCN1 interaction with protocadherin 15 CD3. Competition may therefore exist in vivo between the two binding sites for HCN1, with binding of HCN1 to protocadherin 15 CD3 favored between 26.5 and 68 mu M Ca2+. Taken together, the evidence supports a role for HCN1 in mechanosensory transduction of inner ear hair cells.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Barretto, Roberto L.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Beisel, Kirk W.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Hatfield, James S.] Vet Affairs Med Ctr, Electron Microscopy Lab, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Creighton University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, 261 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [DC04076, DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC04076 and DC000156. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article ( available	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Barritt LC, 1999, MOL BRAIN RES, V68, P42, DOI 10.1016/S0169-328X(99)00078-9; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher DG, 2004, NEUROSCIENCE, V127, P737, DOI 10.1016/j.neuroscience.2004.05.037; DRESCHER DG, 1989, BRAIN RES, V485, P225, DOI 10.1016/0006-8993(89)90565-9; Drescher MJ, 2006, NEUROSCIENCE, V142, P139, DOI 10.1016/j.neuroscience.2006.05.065; Drescher MJ, 1997, MOL BRAIN RES, V45, P325, DOI 10.1016/S0169-328X(97)00007-7; DRESCHER MJ, 1991, J NEUROCHEM, V56, P658, DOI 10.1111/j.1471-4159.1991.tb08200.x; ENGER PS, 1964, COMP BIOCHEM PHYSIOL, V11, P131, DOI 10.1016/0010-406X(64)90100-8; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Ghanem TA, 2008, BIOL BULL-US, V214, P83, DOI 10.2307/25066662; HARASZTOSI C, 2008, ASS RES OT ABSTR, V31, P654; HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484, DOI 10.1152/jn.1995.73.4.1484; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V438, P8, DOI 10.1007/s004240050873; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Khan KM, 2002, NEUROSCIENCE, V111, P291, DOI 10.1016/S0306-4522(02)00020-9; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; Martin P, 2003, J NEUROSCI, V23, P4533; Masetto S, 1997, J NEUROPHYSIOL, V78, P1913, DOI 10.1152/jn.1997.78.4.1913; Mistrik P, 2006, PFLUG ARCH EUR J PHY, V452, P718, DOI 10.1007/s00424-006-0095-0; NAM JH, 2008, ASS RES OT ABSTR, V31, P658; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; RAMAKRISHNAN NA, 2007, ASS RES OT ABSTR, V30, P31; Ricci AJ, 2006, J MEMBRANE BIOL, V209, P71, DOI 10.1007/s00232-005-0834-8; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rusch A, 1998, J NEUROSCI, V18, P7487; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; SEWELL WF, 1993, HEARING RES, V70, P131, DOI 10.1016/0378-5955(93)90150-Y; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SRINIVASAN A, 2008, ASS RES OT ABSTR, V31, P655; STERKERS O, 1984, AM J PHYSIOL, V247, pF602, DOI 10.1152/ajprenal.1984.247.4.F602; Sugihara I, 1996, J PHYSIOL-LONDON, V495, P665, DOI 10.1113/jphysiol.1996.sp021624; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	50	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3227	3238		10.1074/jbc.M806177200	http://dx.doi.org/10.1074/jbc.M806177200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19008224	hybrid, Green Published			2022-12-25	WOS:000262700900066
J	Pattanaik, P; Bethel, CR; Hujer, AM; Hujer, KM; Distler, AM; Taracila, M; Anderson, VE; Fritsche, TR; Jones, RN; Pagadala, SRR; van den Akker, F; Buynak, JD; Bonomo, RA				Pattanaik, Priyaranjan; Bethel, Christopher R.; Hujer, Andrea M.; Hujer, Kristine M.; Distler, Anne M.; Taracila, Magdalena; Anderson, Vernon E.; Fritsche, Thomas R.; Jones, Ronald N.; Pagadala, Sundar Ram Reddy; van den Akker, Focco; Buynak, John D.; Bonomo, Robert A.			Strategic Design of an Effective beta-Lactamase Inhibitor LN-1-255, A 6-ALKYLIDENE-2 '-SUBSTITUTED PENICILLIN SULFONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE BACTEREMIA; ESCHERICHIA-COLI; CLAVULANIC ACID; CLASS-A; RESISTANCE; SHV-1; INACTIVATION; TAZOBACTAM; COMMUNITY; CRYSTALLOGRAPHY	In an effort to devise strategies for overcoming bacterial beta-lactamases, we studied LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone inhibitor. By possessing a catecholic functionality that resembles a natural bacterial siderophore, LN-1-255 is unique among beta-lactamase inhibitors. LN-1-255 combined with piperacillin was more potent against Escherichia coli DH10B strains bearing bla(SHV) extended-spectrum and inhibitor-resistant beta-lactamases than an equivalent amount of tazobactam and piperacillin. In addition, LN-1-255 significantly enhanced the activity of ceftazidime and cefpirome against extended-spectrum cephalosporin and Sme-1 containing carbapenem-resistant clinical strains. LN-1-255 inhibited SHV-1 and SHV-2 beta-lactamases with nM affinity (K-I = 110 +/- 10 and 100 +/- 10 nM, respectively). When LN-1-255 inactivated SHV beta-lactamases, a single intermediate was detected by mass spectrometry. The crystal structure of LN-1-255 in complex with SHV-1 was determined at 1.55 angstrom resolution. Interestingly, this novel inhibitor forms a bicyclic aromatic intermediate with its carbonyl oxygen pointing out of the oxyanion hole and forming hydrogen bonds with Lys-234 and Ser-130 in the active site. Electron density for the "tail" of LN-1-255 is less ordered and modeled in two conformations. Both conformations have the LN-1-255 carboxyl group interacting with Arg-244, yet the remaining tails of the two conformations diverge. The observed presence of the bicyclic aromatic intermediate with its carbonyl oxygen positioned outside of the oxyanion hole provides a rationale for the stability of this inhibitory intermediate. The 2 '-substituted penicillin sulfone, LN-1-255, is proving to be an important lead compound for novel beta-lactamase inhibitor design.	[Pattanaik, Priyaranjan; Anderson, Vernon E.; van den Akker, Focco] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Distler, Anne M.; Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bethel, Christopher R.; Hujer, Andrea M.; Hujer, Kristine M.; Taracila, Magdalena; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH 44106 USA; [Pagadala, Sundar Ram Reddy; Buynak, John D.] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA; [Fritsche, Thomas R.; Jones, Ronald N.] JMI Labs, N Liberty, IA 52317 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Southern Methodist University; JMI Laboratories	van den Akker, F (corresponding author), Case Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	fxv5@case.edu; robert.bonomo@med.va.gov	Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R01 AI062968, RO1 AI063517-01]; Robert A. Welch Foundation [N-0871]; Geriatric Research Education and Clinical Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062968, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Geriatric Research Education and Clinical Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI062968 (to F. V. D. A.), RO1 AI063517-01 (to R. A. B.), and the Robert A. Welch Foundation (J. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; supported by Grant N-0871 from the Robert A. Welch Foundation.; Supported by a grant from the Veterans Affairs Merit Review Program, Geriatric Research Education and Clinical Care.	Beharry Z, 2004, BIOCHEM BIOPH RES CO, V313, P541, DOI 10.1016/j.bbrc.2003.11.158; Bethel CR, 2006, ANTIMICROB AGENTS CH, V50, P4124, DOI 10.1128/AAC.00848-06; Bonomo RA, 2001, BBA-PROTEIN STRUCT M, V1547, P196, DOI 10.1016/S0167-4838(01)00175-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Buynak JD, 2000, BIOORG MED CHEM LETT, V10, P853, DOI 10.1016/S0960-894X(00)00098-6; Buynak JD, 2004, CURR MED CHEM, V11, P1951, DOI 10.2174/0929867043364847; Buynak JD, 1999, BIOORG MED CHEM LETT, V9, P1997, DOI 10.1016/S0960-894X(99)00325-X; Buynak JD, 2000, BIOORG MED CHEM LETT, V10, P847, DOI 10.1016/S0960-894X(00)00094-9; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Chakraborty R, 2007, BIOMETALS, V20, P263, DOI 10.1007/s10534-006-9060-9; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; CHEN YL, 1986, TETRAHEDRON LETT, V27, P3449, DOI 10.1016/S0040-4039(00)84819-4; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOULDS CD, 1985, J CHEM SOC P1, P964; Helfand MS, 2006, CLIN INFECT DIS, V43, P1415, DOI 10.1086/508891; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Hujer AM, 2002, ANTIMICROB AGENTS CH, V46, P3971, DOI 10.1128/AAC.46.12.3971-3977.2002; Hujer AM, 2001, BBA-PROTEIN STRUCT M, V1547, P37, DOI 10.1016/S0167-4838(01)00164-9; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Kalp M, 2007, J BIOL CHEM, V282, P21588, DOI 10.1074/jbc.C700080200; Kotapati S, 2005, J INFECTION, V51, P211, DOI 10.1016/j.jinf.2005.01.005; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P2844, DOI 10.1128/JCM.43.6.2844-2849.2005; Rice LB, 2000, ANTIMICROB AGENTS CH, V44, P362, DOI 10.1128/AAC.44.2.362-367.2000; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P104, DOI 10.1111/j.1469-0691.2007.01866.x; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Thomson JM, 2007, BIOCHEMISTRY-US, V46, P11361, DOI 10.1021/bi700792a; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200	43	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					945	953		10.1074/jbc.M806833200	http://dx.doi.org/10.1074/jbc.M806833200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18955486	Green Published, hybrid			2022-12-25	WOS:000262122900030
J	Pu, YM; Garfield, SH; Kedei, N; Blumberg, PM				Pu, Yongmei; Garfield, Susan H.; Kedei, Noemi; Blumberg, Peter M.			Characterization of the Differential Roles of the Twin C1a and C1b Domains of Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; 12-MYRISTATE 13-ACETATE; INDUCED TRANSLOCATION; THERAPEUTIC TARGET; DOWN-REGULATION; NIH 3T3-CELLS; DIACYLGLYCEROL; ACTIVATION; LIGANDS; PKC	Classic and novel protein kinase C (PKC) isozymes contain two zinc finger motifs, designated "C1a" and "C1b" domains, which constitute the recognition modules for the second messenger diacylglycerol (DAG) or the phorbol esters. However, the individual contributions of these tandem C1 domains to PKC function and, reciprocally, the influence of protein context on their function remain uncertain. In the present study, we prepared PKC delta constructs in which the individual C1a and C1b domains were deleted, swapped, or substituted for one another to explore these issues. As isolated fragments, both the delta C1a and delta C1b domains potently bound phorbol esters, but the binding of [H-3] phorbol 12,13-dibutyrate ([H-3]PDBu) by the delta C1a domain depended much more on the presence of phosphatidylserine than did that of the delta C1b domain. In intact PKC delta, the delta C1b domain played the dominant role in [H-3]PDBu binding, membrane translocation, and down-regulation. A contribution from the delta C1a domain was nonetheless evident, as shown by retention of [H-3]PDBu binding at reduced affinity, by increased [H-3]PDBu affinity upon expression of a second delta C1a domain substituting for the delta C1b domain, and by loss of persistent plasma membrane translocation for PKC delta expressing only the delta C1b domain, but its contribution was less than predicted from the activity of the isolated domain. Switching the position of the delta C1b domain to the normal position of the delta C1a domain (or vice versa) had no apparent effect on the response to phorbol esters, suggesting that the specific position of the C1 domain within PKC delta was not the primary determinant of its activity.	[Garfield, Susan H.; Blumberg, Peter M.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pu, Yongmei; Kedei, Noemi; Blumberg, Peter M.] Lab Canc Biol & Genet, Mol Mech Tumor Promot Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37,Rm 4048,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov			National Institutes of Health; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC005270, ZICBC010858, ZIABC005270, Z01BC010858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	AHMED S, 1993, J BIOL CHEM, V268, P10709; Anderson PW, 2007, CURR OPIN NEPHROL HY, V16, P397, DOI 10.1097/MNH.0b013e3281ead025; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Bogi K, 1998, CANCER RES, V58, P1423; Braun DC, 2005, MOL CANCER THER, V4, P141; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Choi SH, 2006, CANCER RES, V66, P7261, DOI 10.1158/0008-5472.CAN-05-4177; Choi Y, 2007, J MED CHEM, V50, P3465, DOI 10.1021/jm0702579; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Giorgione J, 2003, BIOCHEMISTRY-US, V42, P11194, DOI 10.1021/bi0350046; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; IKKAWA U, 1983, J BIOL CHEM, V258, P11442; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Mach UR, 2006, CHEMMEDCHEM, V1, P307, DOI 10.1002/cmdc.200500068; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mosior M, 1996, BIOCHEMISTRY-US, V35, P1612, DOI 10.1021/bi952031q; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nowak I, 2007, CURR TOP MED CHEM, V7, P355, DOI 10.2174/156802607779941260; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1371, DOI 10.2174/1381612043384907; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rozengurt E, 1997, BIOCHEM SOC T, V25, P565, DOI 10.1042/bst0250565; SHIEH HL, 1995, MOL CARCINOGEN, V12, P166, DOI 10.1002/mc.2940120308; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	46	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1302	1312		10.1074/jbc.M804796200	http://dx.doi.org/10.1074/jbc.M804796200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001377	hybrid, Green Published			2022-12-25	WOS:000262122900065
J	Wang, JH; Bian, CJ; Li, J; Couch, FJ; Wu, KJ; Zhao, RC				Wang, Jinhua; Bian, Chunjing; Li, Jing; Couch, Fergus J.; Wu, Kangjian; Zhao, Robert Chunhua			Poly(ADP-ribose) Polymerase-1 Down-regulates BRCA2 Expression through the BRCA2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE BRCA2; BREAST-CANCER; OVARIAN CANCERS; DNA-DAMAGE; KAPPA-B; BINDING; PROTEIN; TRANSCRIPTION; COACTIVATOR; MUTATIONS	Expression of the BRCA2 tumor suppressor gene is tightly linked to its roles in DNA damage repair and maintenance of chromosomal stability and genomic integrity. Three transcription factors that activate (USF, NF-kappa B, and Elf1) and a single factor that represses (SLUG) BRCA2 promoter activity have been reported. In addition, a 67-bp region (-582 to -516) associated with inhibition of promoter activity has been identified. However, it remains unclear how the 67-bp region contributes to regulation of BRCA2 expression. Here, we describe the affinity purification of a 120-kDa protein that binds to a silencer-binding region within the 67-bp repression region of the BRCA2 promoter. Mass spectrometry revealed the identity of the protein as poly-(ADP-ribose) polymerase-1 (Parp-1). Gel shift, antibody super-shift, and chromatin immunoprecipitation (ChIP) assays demonstrated that Parp-1 is associated with the BRCA2 promoter both in vitro and in vivo. Furthermore, Parp-1 inhibitors (either 3-AB or NU1025) and Parp-1 gene specific siRNA resulted in increased levels of endogenous BRCA2 expression. Inhibition of Parp-1 activity (by 3-AB) reduced histone 3 lysine 9 acetylation and blocked Parp-1 binding to the BRCA2 promoter. These results indicate that Parp-1 down-regulates BRCA2 expression through an interaction with a repression region of the BRCA2 promoter.	[Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Sch Basic Med, Ctr Excellence Tissue Engn, Beijing 100730, Peoples R China; [Couch, Fergus J.; Wu, Kangjian] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Mayo Clinic; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, KJ (corresponding author), Room 258-14 Bldg,180 Wyeth Res 401 N Middletown R, Pearl River, NY 10965 USA.	wuk@wyeth.com; chunhuaz@public.tpt.tj.cn			National Institutes of Health [R01CA116167]; NCI; Ruth L. Kirschstein National Research Training Award; Ministry of Science and Technology of PR China [2006AA02A109]; NATIONAL CANCER INSTITUTE [R01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of PR China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grant CA116167 and NCI Sponsored Program in Research Excellence (SPORE) in Breast Cancer to the Mayo Clinic (to F.J.C.) and a Ruth L. Kirschstein National Research Training Award (to K.W.). This work was also supported from the "863 Projects" of Ministry of Science and Technology of PR China Grant No. 2006AA02A109 (to R.C.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bertwistle D, 1997, CANCER RES, V57, P5485; BONGGUN JU, 2006, SCIENCE, V312, P1798; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Collins N, 1997, BRIT J CANCER, V76, P1150, DOI 10.1038/bjc.1997.526; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu K, 2000, J BIOL CHEM, V275, P35548, DOI 10.1074/jbc.M004390200; Wu KJ, 2003, J BIOL CHEM, V278, P15652, DOI 10.1074/jbc.M211297200; Zhang Z, 2002, VIROLOGY, V296, P107, DOI 10.1006/viro.2002.1385	33	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36249	36256		10.1074/jbc.M803693200	http://dx.doi.org/10.1074/jbc.M803693200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990703	hybrid, Green Published			2022-12-25	WOS:000261840500020
J	Chou, CJ; Herman, D; Gottesfeld, JM				Chou, C. James; Herman, David; Gottesfeld, Joel M.			Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; CATALYTIC-ACTIVITY; FRIEDREICH ATAXIA; HDAC INHIBITORS; FAMILY; CANCER; ASSAY; SUPPRESSES; ACETYLASES; CHROMATIN	Histone deacetylase (HDAC) inhibitors, including various benzamides and hydroxamates, are currently in clinical development for a broad range of human diseases, including cancer and neurodegenerative diseases. We recently reported the identification of a family of benzamide-type HDAC inhibitors that are relatively non-toxic compared with the hydroxamates. Members of this class of compounds have shown efficacy in cell-based and mouse models for the neurodegenerative diseases Friedreich ataxia and Huntington disease. Considerable differences in IC50 values for the various HDAC enzymes have been reported for many of the HDAC inhibitors, leading to confusion as to the HDAC isotype specificities of these compounds. Here we show that a benzamide HDAC inhibitor, a pimelic diphenylamide (106), is a class I HDAC inhibitor, demonstrating no activity against class II HDACs. 106 is a slow, tight-binding inhibitor of HDACs 1, 2, and 3, although inhibition for these enzymes occurs through different mechanisms. Inhibitor 106 also has preference toward HDAC3 with K-i of similar to 14 nM, 15 times lower than the Ki for HDAC1. In comparison, the hydroxamate suberoylanilide hydroxamic acid does not discriminate between these enzymes and exhibits a fast-on/fast-off inhibitory mechanism. These observations may explain a paradox involving the relative activities of pimelic diphenylamides versus hydroxamates as gene activators.	[Chou, C. James; Herman, David; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gottesfeld, JM (corresponding author), 10550 N Torrey Pines Rd,MB 27, La Jolla, CA 92037 USA.	joelg@scripps.edu	Chou, C. James/I-6563-2012	Gottesfeld, Joel/0000-0002-4643-5777	National Institutes of Health [R21-NS055781]; Repligen Corporation, Waltham, MA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Repligen Corporation, Waltham, MA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-NS055781. This work was also supported by Repligen Corporation, Waltham, MA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bonfils C, 2008, CLIN CANCER RES, V14, P3441, DOI 10.1158/1078-0432.CCR-07-4427; Butler LM, 2000, CANCER RES, V60, P5165; CORNISHBOWDEN A, 1975, BIOCHEM J, V149, P305, DOI 10.1042/bj1490305; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DUGGLEBY RG, 1982, BIOCHEMISTRY-US, V21, P3364, DOI 10.1021/bi00257a018; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones P, 2008, BIOORG MED CHEM LETT, V18, P3456, DOI 10.1016/j.bmcl.2008.02.026; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Siliphaivanh P, 2007, BIOORG MED CHEM LETT, V17, P4619, DOI 10.1016/j.bmcl.2007.05.080; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; TORNHEIM K, 1994, ANAL BIOCHEM, V221, P53, DOI 10.1006/abio.1994.1377; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Wong JC, 2003, J AM CHEM SOC, V125, P5586, DOI 10.1021/ja0341440	37	156	167	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35402	35409		10.1074/jbc.M807045200	http://dx.doi.org/10.1074/jbc.M807045200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18953021	hybrid, Green Published			2022-12-25	WOS:000261687900011
J	Blake, S; Deem, SL; Strindberg, S; Maisels, F; Momont, L; Isia, IB; Douglas-Hamilton, I; Karesh, WB; Kock, MD				Blake, Stephen; Deem, Sharon L.; Strindberg, Samantha; Maisels, Fiona; Momont, Ludovic; Isia, Inogwabini-Bila; Douglas-Hamilton, Iain; Karesh, William B.; Kock, Michael D.			Roadless Wilderness Area Determines Forest Elephant Movements in the Congo Basin	PLOS ONE			English	Article							PROTECTED AREAS; AFRICAN ELEPHANTS; CONSERVATION; ROADS; EXTINCTION	A dramatic expansion of road building is underway in the Congo Basin fuelled by private enterprise, international aid, and government aspirations. Among the great wilderness areas on earth, the Congo Basin is outstanding for its high biodiversity, particularly mobile megafauna including forest elephants (Loxodonta africana cyclotis). The abundance of many mammal species in the Basin increases with distance from roads due to hunting pressure, but the impacts of road proliferation on the movements of individuals are unknown. We investigated the ranging behaviour of forest elephants in relation to roads and roadless wilderness by fitting GPS telemetry collars onto a sample of 28 forest elephants living in six priority conservation areas. We show that the size of roadless wilderness is a strong determinant of home range size in this species. Though our study sites included the largest wilderness areas in central African forests, none of 4 home range metrics we calculated, including core area, tended toward an asymptote with increasing wilderness size, suggesting that uninhibited ranging in forest elephants no longer exists. Furthermore we show that roads outside protected areas which are not protected from hunting are a formidable barrier to movement while roads inside protected areas are not. Only 1 elephant from our sample crossed an unprotected road. During crossings her mean speed increased 14-fold compared to normal movements. Forest elephants are increasingly confined and constrained by roads across the Congo Basin which is reducing effective habitat availability and isolating populations, significantly threatening long term conservation efforts. If the current road development trajectory continues, forest wildernesses and the forest elephants they contain will collapse.	[Blake, Stephen; Strindberg, Samantha; Maisels, Fiona; Karesh, William B.; Kock, Michael D.] Wildlife Conservat Soc, Bronx, NY USA; [Blake, Stephen; Deem, Sharon L.] Univ Missouri, Whitney R Harris World Ecol Ctr, Dept Biol, St Louis, MO USA; [Blake, Stephen] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Deem, Sharon L.] St Louis Zoo, WildCare Inst, St Louis, MO USA; [Momont, Ludovic] Museum Natl Hist Nat, Menagerie Jardin Plantes, Lab Conservat Especes, Museum CNRS, Paris, France; [Isia, Inogwabini-Bila] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Douglas-Hamilton, Iain] Langata Link Complex, Save the Elephants, Nairobi, Kenya; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 2JD, England	Wildlife Conservation Society; University of Missouri System; University of Missouri Saint Louis; Max Planck Society; Museum National d'Histoire Naturelle (MNHN); University of Kent; University of Oxford	Blake, S (corresponding author), Wildlife Conservat Soc, Bronx, NY USA.	sblakewcs@gmail.com	Maisels, Fiona/E-7382-2015; Karesh, William/AAU-9084-2020	Maisels, Fiona/0000-0002-0778-0615; Karesh, William/0000-0001-6042-2860; Inogwabini, Bila-Isia/0000-0002-6897-2477	African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS); United States Agency for International Development (US-AID CARPE); Save the Elephants; The Especes Phares Project; Central African Protected Areas Network of the European Union; Wildlife conservation Society; WWF-US; Columbus Zoo; Society for Conservation and Development	African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); United States Agency for International Development (US-AID CARPE)(United States Agency for International Development (USAID)); Save the Elephants; The Especes Phares Project; Central African Protected Areas Network of the European Union; Wildlife conservation Society; WWF-US; Columbus Zoo; Society for Conservation and Development	This research was funded by the African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS), the United States Agency for International Development (US-AID CARPE), Save the Elephants, The Especes Phares Project and the Central African Protected Areas Network of the European Union, Wildlife conservation Society, WWF-US, Columbus Zoo and the Society for Conservation and Development. Richard Ruggiero of USFWS strongly supported this project.	ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Chapman CA, 1998, AM J PRIMATOL, V45, P127; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Powell RA, 2000, METH C CONS, P65; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Spinage C.A., 1994, ELEPHANTS; Strittholt JR, 2001, CONSERV BIOL, V15, P1742, DOI 10.1046/j.1523-1739.2001.99577.x; Team RDC, 2019, R LANG ENV STAT COMP; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; White L.J.T., 2001, AFRICAN RAIN FOREST; Whyte Ian J., 2003, P332; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	37	131	133	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3546	10.1371/journal.pone.0003546	http://dx.doi.org/10.1371/journal.pone.0003546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958284	Green Submitted, gold, Green Published			2022-12-25	WOS:000265130900008
J	Pontes, MH; Babst, M; Lochhead, R; Oakeson, K; Smith, K; Dale, C				Pontes, Mauricio H.; Babst, Markus; Lochhead, Robert; Oakeson, Kelly; Smith, Kari; Dale, Colin			Quorum Sensing Primes the Oxidative Stress Response in the Insect Endosymbiont, Sodalis glossinidius	PLOS ONE			English	Article							CARBAPENEM ANTIBIOTIC PRODUCTION; LACTONE SIGNAL MOLECULES; III SECRETION SYSTEMS; HEAT-SHOCK PROTEINS; VIBRIO-FISCHERI; SINORHIZOBIUM-MELILOTI; ERWINIA-CAROTOVORA; IRON; BIOSYNTHESIS; GENES	Background: Sodalis glossinidius, a maternally transmitted bacterial endosymbiont of tsetse flies (Glossina spp.), uses an acylated homoserine lactone (AHL)-based quorum sensing system to modulate gene expression in accordance with bacterial cell density. The S. glossinidius quorum sensing system relies on the function of two regulatory proteins; SogI (a LuxI homolog) synthesizes a signaling molecule, characterized as N-(3-oxohexanoyl) homoserine lactone (OHHL), and SogR1 (a LuxR homolog) interacts with OHHL to modulate transcription of specific target genes. Methodology/Principal Findings: We used a tiling microarray to analyze the S. glossinidius transcriptome in the presence and absence of exogenous OHHL. The major finding is that OHHL increases transcription of a large number of genes that are known to be involved in the oxidative stress response. We also show that the obligate symbiont of the rice weevil, Sitophilus oryzae (SOPE), maintains copies of the quorum sensing regulatory genes that are found in S. glossinidius. Molecular evolutionary analyses indicate that these sequences are evolving under stabilizing selection, consistent with the maintenance of their functions in the SOPE symbiosis. Finally, the expression studies in S. glossinidius also reveal that quorum sensing regulates the expression of a cryptic, degenerate gene (carA) that arose from an ancient deletion in the last common ancestor of S. glossinidius and SOPE. Conclusions/Significance: This oxidative stress response is likely mandated under conditions of dense intracellular symbiont infection, when intense metabolic activity is expected to generate a heavy oxidative burden. Such conditions are known to arise in the bacteriocytes of grain weevils, which harbor dense intracellular infections of symbiotic bacteria that are closely related to S. glossinidius. The presence of a degenerate carA sequence in S. glossinidius and SOPE indicates the potential for neofunctionalization to occur during the process of genome degeneration.	[Pontes, Mauricio H.; Babst, Markus; Lochhead, Robert; Oakeson, Kelly; Smith, Kari; Dale, Colin] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Pontes, MH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	pontes.biology@utah.edu	Lochhead, Robert/AAT-9942-2020; Pontes, Mauricio H./AAV-1024-2020	Pontes, Mauricio H./0000-0002-2618-2039; Lochhead, Robert/0000-0001-7726-0466; Oakeson, Kelly/0000-0001-9070-4850	National Science Foundation [EF-0523818]	National Science Foundation(National Science Foundation (NSF))	Research in our laboratory is supported by a National Science Foundation award EF-0523818 to CD.	Aksoy S, 1997, INSECT MOL BIOL, V6, P183, DOI 10.1111/j.1365-2583.1997.tb00086.x; Andersson RA, 2000, MOL PLANT MICROBE IN, V13, P384, DOI 10.1094/MPMI.2000.13.4.384; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Broughton WJ, 2006, J BACTERIOL, V188, P3654, DOI 10.1128/JB.188.10.3654-3663.2006; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Dale C, 2005, MOL BIOL EVOL, V22, P758, DOI 10.1093/molbev/msi061; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Darby AC, 2005, J BACTERIOL, V187, P5003, DOI 10.1128/JB.187.14.5003-5007.2005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies BW, 2007, J BACTERIOL, V189, P2101, DOI 10.1128/JB.01377-06; DAZZO FB, 1991, J BACTERIOL, V173, P5371, DOI 10.1128/jb.173.17.5371-5384.1991; DeLoney-Marino CR, 2003, APPL ENVIRON MICROB, V69, P7527, DOI 10.1128/AEM.69.12.7527-7530.2003; Derzelle S, 2002, APPL ENVIRON MICROB, V68, P3780, DOI 10.1128/AEm.68.8.3780-3789.2002; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 2005, CELL MICROBIOL, V7, P293, DOI 10.1111/j.1462-5822.2004.00461.x; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McFall-Ngai M, 1998, NEW DEVELOPMENTS IN MARINE BIOTECHNOLOGY, P273; MCGOWAN S, 1995, MICROBIOL-SGM, V141, P541, DOI 10.1099/13500872-141-3-541; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; McGowan SJ, 1997, MOL MICROBIOL, V26, P545, DOI 10.1046/j.1365-2958.1997.6001974.x; Miller JH., 1992, SHORT COURSE BACTERI, P72; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Niehaus K, 1998, MOL PLANT MICROBE IN, V11, P906, DOI 10.1094/MPMI.1998.11.9.906; Nyholm SV, 2002, APPL ENVIRON MICROB, V68, P5113, DOI 10.1128/AEM.68.10.5113-5122.2002; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; QUANDT J, 1992, MOL PLANT MICROBE IN, V5, P420, DOI 10.1094/MPMI-5-420; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; ROLFE B, 1968, J BACTERIOL, V96, P515, DOI 10.1128/JB.96.2.515-524.1968; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Zhu J, 2003, APPL ENVIRON MICROB, V69, P6949, DOI 10.1128/AEM.69.11.6949-6953.2003; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	80	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3541	10.1371/journal.pone.0003541	http://dx.doi.org/10.1371/journal.pone.0003541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958153	gold, Green Submitted, Green Published			2022-12-25	WOS:000265130900004
J	Dardente, H; Mendoza, J; Fustin, JM; Challet, E; Hazlerigg, DG				Dardente, Hugues; Mendoza, Jorge; Fustin, Jean-Michel; Challet, Etienne; Hazlerigg, David G.			Implication of the F-Box Protein FBXL21 in Circadian Pacemaker Function in Mammals	PLOS ONE			English	Article							REV-ERB; CLOCK; ALPHA; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; REVEALS; CRYPTOCHROME; COMPONENT; TICKING	In mammals, the circadian clock relies on interlocked feedback loops involving clock genes and their protein products. Posttranslational modifications control intracellular trafficking, functionality and degradation of clock proteins and are keys to the functioning of the clock as recently exemplified for the F-Box protein Fbxl3. The SCFFbxl3 complex directs degradation of CRY1/2 proteins and Fbxl3 murine mutants have a slower clock. To assess whether the role of Fbxl3 is phylogenetically conserved, we investigated its function in the sheep, a diurnal ungulate. Our data show that Fbxl3 function is conserved and further reveal that its closest homologue, the F-Box protein Fbxl21, also binds to CRY1 which impairs its repressive action towards the transcriptional activators CLOCK/BMAL1. However, while Fbxl3 appears to be ubiquitously expressed, Fbxl21 expression is tissue-specific. Furthermore, and in sharp contrast with Fbxl3, Fbxl21 is highly expressed within the suprachiasmatic nuclei, site of the master clock, where it displays marked circadian oscillations apparently driven by members of the PAR-bZIP family. Finally, for both Fbxl3 and Fbxl21 we identified and functionally characterized novel splice-variants, which might reduce CRY1 proteasomal degradation dependent on cell context. Altogether, these data establish Fbxl21 as a novel circadian clock-controlled gene that plays a specific role within the mammalian circadian pacemaker.	[Dardente, Hugues; Fustin, Jean-Michel; Hazlerigg, David G.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Mendoza, Jorge; Challet, Etienne] Inst Neurosci Cellulaires Integratives, Dept Neurobiol Rythmes, UMR7168, Strasbourg, France	University of Aberdeen	Dardente, H (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	h.dardente@abdn.ac.uk	Fustin, Jean-Michel/R-6621-2019; DARDENTE, Hugues/ABI-5590-2020; Challet, Etienne/ABF-7553-2020	Fustin, Jean-Michel/0000-0002-6200-6075; DARDENTE, Hugues/0000-0001-7209-5940; Challet, Etienne/0000-0001-9416-9496	UK Biotechnology and Biological Sciences Research Council; Agence Nationale pour la Recherche; Centre National de la Recherche Scientifique	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	HD and DGH are supported by the UK Biotechnology and Biological Sciences Research Council for continuing support. JM and EC are supported by grants from the Agence Nationale pour la Recherche Jeunes Chercheurs/Jeunes Chercheuses and Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Forrest ARR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r5; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schoenhard JA, 2002, AM J PHYSIOL-CELL PH, V283, pC103, DOI 10.1152/ajpcell.00541.2001; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	39	38	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3530	10.1371/journal.pone.0003530	http://dx.doi.org/10.1371/journal.pone.0003530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953409	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130500008
J	Kedinger, V; Alpy, F; Baguet, A; Polette, M; Stoll, I; Chenard, MP; Tomasetto, C; Rio, MC				Kedinger, Valerie; Alpy, Fabien; Baguet, Aurelie; Polette, Myriam; Stoll, Isabelle; Chenard, Marie-Pierre; Tomasetto, Catherine; Rio, Marie-Christine			Tumor Necrosis Factor Receptor-Associated Factor 4 Is a Dynamic Tight Junction-Related Shuttle Protein Involved in Epithelium Homeostasis	PLOS ONE			English	Article								Background: Despite numerous in vivo evidences that Tumor Necrosis Factor Receptor-Associated Factor 4 (TRAF4) plays a key biological function, how it works at the cellular and molecular level remains elusive. Methodology/Principal Findings: In the present study, we show using immunofluorescence and immuohistochemistry that TRAF4 is a novel player at the tight junctions (TJs). TRAF4 is connected to assembled TJs in confluent epithelial cells, but accumulates in the cytoplasm and/or nucleus when TJs are open in isolated cells or EGTA-treated confluent cells. In vivo, TRAF4 is consistently found at TJs in normal human mammary epithelia as well as in well-differentiated in situ carcinomas. In contrast, TRAF4 is never localized at the plasma membrane of poorly-differentiated invasive carcinomas devoid of correct TJs, but is observed in the cytoplasm and/or nucleus of the cancer cells. Moreover, TRAF4 TJ subcellular localization is remarkably dynamic. Fluorescence recovery after photobleaching (FRAP) experiments show that TRAF4 is highly mobile and shuttles between TJs and the cytoplasm. Finally, we show that intracellular TRAF4 potentiates ERK1/2 phosphorylation in proliferating HeLa cells, an epithelial cell line known to be devoid of TJs. Conclusions/Significance: Collectively, our data strongly support the new concept of TJs as a dynamic structure. Moreover, our results implicate TRAF4 in one of the emerging TJ-dependent signaling pathways that responds to cell polarity by regulating the cell proliferation/differentiation balance, and subsequently epithelium homeostasis. Drastic phenotypes or lethality in TRAF4-deficient mice and drosophila strongly argue in favor of such a function.	[Kedinger, Valerie; Alpy, Fabien; Baguet, Aurelie; Stoll, Isabelle; Tomasetto, Catherine; Rio, Marie-Christine] Univ Strasbourg 1, INSERM, IGBMC, Dept Canc Biol,CNRS,UMR 7104,U596, Illkirch Graffenstaden, France; [Polette, Myriam] Hop Maison Blanche CHU, Lab Pol Bouin, UMR S 514, INSERM, Reims, France; [Chenard, Marie-Pierre] Univ Hautepierre, Ctr Hosp, Serv Anat Pathol Gen, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg	Kedinger, V (corresponding author), Univ Strasbourg 1, INSERM, IGBMC, Dept Canc Biol,CNRS,UMR 7104,U596, Illkirch Graffenstaden, France.	rio@igbmc.u-strasbg.fr	Tomasetto, Catherine Laure/J-2783-2014; Chenard, Marie-Pierre/O-2373-2016; POLETTE, Myriam/P-5147-2016; Alpy, Fabien/ABD-5893-2020; Alpy, Fabien/H-8941-2016	Tomasetto, Catherine Laure/0000-0002-1811-5848; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720; Baguet, Aurelie/0000-0001-7792-3282; POLETTE, Myriam/0000-0001-8173-3246	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Ha'pital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer; Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer; Fond National pour la Sante ACI; Ruban Rose prize; Fondation pour la Recherche Medicale fellowship	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ha'pital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer(Ligue nationale contre le cancer); Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer(Institut National du Cancer (INCA) France); Fond National pour la Sante ACI; Ruban Rose prize; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale)	This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Hapital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and the Ligue Nationale Francaise contre le Cancer and the Comites du Haut-Rhin et du Bas-Rhin, the Institut National du Cancer, Fond National pour la Sante ACI 2004 2007 (CanceropAle Grand-Est), and the Ruban Rose prize. V. K. was a recipient of a Fondation pour la Recherche Medicale fellowship.	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baguet A, 2007, J CELL SCI, V120, P2774, DOI 10.1242/jcs.009225; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Bieche I, 1996, CANCER RES, V56, P3886; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Camilleri-Broet S, 2007, ONCOGENE, V26, P142, DOI 10.1038/sj.onc.1209762; CAVALOC Y, 1994, EMBO J, V13, P2639, DOI 10.1002/j.1460-2075.1994.tb06554.x; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Chung JY, 2002, J CELL SCI, V115, P679; Cohen D, 2003, METHODS, V30, P269, DOI 10.1016/S1046-2023(03)00033-1; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; Gilles C, 2003, CANCER RES, V63, P2658; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Harder JL, 2008, CELL, V133, DOI 10.1016/j.cell.2008.06.002; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Lele T, 2006, J CELL BIOCHEM, V99, P1334, DOI 10.1002/jcb.20997; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Spiryda LB, 1998, J NEUROSCI RES, V54, P282, DOI 10.1002/(SICI)1097-4547(19981015)54:2<282::AID-JNR16>3.3.CO;2-2; Takai E, 2005, INT J ONCOL, V27, P645; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Wang ZL, 2005, ONCOGENE, V24, P4412, DOI 10.1038/sj.onc.1208634	37	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3518	10.1371/journal.pone.0003518	http://dx.doi.org/10.1371/journal.pone.0003518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953416	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130500003
J	Wang, C; Yu, J; Kallen, CB				Wang, Cheng; Yu, Jie; Kallen, Caleb B.			Two Estrogen Response Element Sequences Near the PCNA Gene Are Not Responsible for Its Estrogen-Enhanced Expression in MCF7 Cells	PLOS ONE			English	Article								Background: The proliferating cell nuclear antigen (PCNA) is an essential component of DNA replication, cell cycle regulation, and epigenetic inheritance. High expression of PCNA is associated with poor prognosis in patients with breast cancer. The 5'-region of the PCNA gene contains two computationally-detected estrogen response element (ERE) sequences, one of which is evolutionarily conserved. Both of these sequences are of undocumented cis-regulatory function. We recently demonstrated that estradiol (E2) enhances PCNA mRNA expression in MCF7 breast cancer cells. MCF7 cells proliferate in response to E2. Methodology/Principal Findings: Here, we demonstrate that E2 rapidly enhanced PCNA mRNA and protein expression in a process that requires ER alpha as well as de novo protein synthesis. One of the two upstream ERE sequences was specifically bound by ER alpha-containing protein complexes, in vitro, in gel shift analysis. Yet, each ERE sequence, when cloned as a single copy, or when engineered as two tandem copies of the ERE-containing sequence, was not capable of activating a luciferase reporter construct in response to E2. In MCF7 cells, neither ERE-containing genomic region demonstrated E2-dependent recruitment of ER alpha by sensitive ChIP-PCR assays. Conclusion/Significance: We conclude that E2 enhances PCNA gene expression by an indirect process and that computational detection of EREs, even when evolutionarily conserved and when near E2-responsive genes, requires biochemical validation.	[Wang, Cheng; Yu, Jie; Kallen, Caleb B.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA	Emory University	Wang, C (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.	caleb.kallen@emory.edu		Kallen, Caleb/0000-0002-4156-6719	Research Scientist Development Program; NIH [5K12HD00849]; Society for Gynecologic Investigation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER	Research Scientist Development Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Gynecologic Investigation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	CBK is supported by a grant from the Research Scientist Development Program (NIH-5K12HD00849) and by the Society for Gynecologic Investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1993, ANTICANCER RES, V13, P533; ALDER H, 1992, NUCLEIC ACIDS RES, V20, P1769, DOI 10.1093/nar/20.7.1769; ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BASERGA R, 1991, J CELL SCI, V98, P433; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bouras T, 2002, CANCER RES, V62, P1289; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; DUBIK D, 1992, ONCOGENE, V7, P1587; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Horita K, 2001, EUR J HISTOCHEM, V45, P73; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang DY, 1996, J BIOL CHEM, V271, P1218, DOI 10.1074/jbc.271.2.1218; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; Jin VX, 2004, NUCLEIC ACIDS RES, V32, P6627, DOI 10.1093/nar/gkh1005; Kamalakaran S, 2005, J BIOL CHEM, V280, P21491, DOI 10.1074/jbc.M409176200; Kannabiran C, 1999, ONCOGENE, V18, P7825, DOI 10.1038/sj.onc.1203294; KANNABIRAN C, 1993, J VIROL, V67, P507, DOI 10.1128/JVI.67.1.507-515.1993; Kato T, 2000, BRIT J CANCER, V82, P404, DOI 10.1054/bjoc.1999.0934; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KONIECKI J, 1991, CANCER RES, V51, P1465; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; LABRIE C, 1993, MOL CELL BIOL, V13, P1697, DOI 10.1128/MCB.13.3.1697; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lee BH, 1997, P NATL ACAD SCI USA, V94, P4481, DOI 10.1073/pnas.94.9.4481; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; Li YY, 2003, FEBS LETT, V544, P112, DOI 10.1016/S0014-5793(03)00485-X; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Loven MA, 2001, MOL CELL ENDOCRINOL, V181, P151, DOI 10.1016/S0303-7207(01)00491-9; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; Nardulli AM, 1996, MOL ENDOCRINOL, V10, P694, DOI 10.1210/me.10.6.694; NARITA T, 1993, JPN J CLIN ONCOL, V23, P20; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; SCHIMMELPENNING H, 1993, VIRCHOWS ARCH A, V423, P273, DOI 10.1007/BF01606890; SCHONBORN I, 1995, J CANCER RES CLIN, V121, P115, DOI 10.1007/BF01202223; Schultz-Norton JR, 2007, NUCLEIC ACIDS RES, V35, P5028, DOI 10.1093/nar/gkm533; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; SheenChen SM, 1997, ARCH SURG-CHICAGO, V132, P264; Shimomura Y, 1998, J CLIN ENDOCR METAB, V83, P2192, DOI 10.1210/jc.83.6.2192; SHIPMANAPPASAMY P, 1990, J BIOL CHEM, V265, P19180; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Tang SS, 2004, NUCLEIC ACIDS RES, V32, P6212, DOI 10.1093/nar/gkh943; Tommasi S, 1999, J BIOL CHEM, V274, P27829, DOI 10.1074/jbc.274.39.27829; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	87	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3523	10.1371/journal.pone.0003523	http://dx.doi.org/10.1371/journal.pone.0003523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949048	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126400008
J	Lower, M; Weydig, C; Metzler, D; Reuter, A; Starzinski-Powitz, A; Wessler, S; Schneider, G				Loewer, Martin; Weydig, Christiane; Metzler, Dirk; Reuter, Andreas; Starzinski-Powitz, Anna; Wessler, Silja; Schneider, Gisbert			Prediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA	PLOS ONE			English	Article								Exported proteases of Helicobacter pylori (H. pylori) are potentially involved in pathogen-associated disorders leading to gastric inflammation and neoplasia. By comprehensive sequence screening of the H. pylori proteome for predicted secreted proteases, we retrieved several candidate genes. We detected caseinolytic activities of several such proteases, which are released independently from the H. pylori type IV secretion system encoded by the cag pathogenicity island (cagPAI). Among these, we found the predicted serine protease HtrA (Hp1019), which was previously identified in the bacterial secretome of H. pylori. Importantly, we further found that the H. pylori genes hp1018 and hp1019 represent a single gene likely coding for an exported protein. Here, we directly verified proteolytic activity of HtrA in vitro and identified the HtrA protease in zymograms by mass spectrometry. Overexpressed and purified HtrA exhibited pronounced proteolytic activity, which is inactivated after mutation of Ser205 to alanine in the predicted active center of HtrA. These data demonstrate that H. pylori secretes HtrA as an active protease, which might represent a novel candidate target for therapeutic intervention strategies.	[Loewer, Martin; Starzinski-Powitz, Anna; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, CMP, Frankfurt, Germany; [Weydig, Christiane; Wessler, Silja] Paul Ehrlich Inst, Junior Res Grp, Langen, Germany; [Metzler, Dirk] Goethe Univ, Inst Comp Sci, Frankfurt, Germany; [Reuter, Andreas] Paul Ehrlich Inst, Dept Allergol, Langen, Germany	Goethe University Frankfurt; Paul Ehrlich Institute; Goethe University Frankfurt; Paul Ehrlich Institute	Lower, M (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, CMP, Frankfurt, Germany.	gisbert.schneider@modlab.de	Wessler, Silja/C-6309-2015; Metzler, Dirk/K-2797-2014	Wessler, Silja/0000-0001-7011-6162; Metzler, Dirk/0000-0003-1027-135X; Schneider, Gisbert/0000-0001-6706-1084; Reuter, Andreas/0000-0002-6082-9000	Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany); Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany); Jurgen-Manchot Stiftung; Paul-Ehrlich Institut Langen (Germany); Deutsche Forschungsgemeinschaft [SFB-579]	Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany); Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany); Jurgen-Manchot Stiftung; Paul-Ehrlich Institut Langen (Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany), the Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany), the Jurgen-Manchot Stiftung, the Paul-Ehrlich Institut Langen (Germany), and the Deutsche Forschungsgemeinschaft (SFB-579, project A11).	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; ALBRECHT M, 2008, MOL NUTR FO IN PRESS; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823, DOI 10.1152/ajpgi.2001.281.3.G823; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; HILLENKAMP F, 1990, METHOD ENZYMOL, V193, P280, DOI 10.1016/0076-6879(90)93420-P; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Min DQ, 2002, J IMMUNOL, V168, P2449, DOI 10.4049/jimmunol.168.5.2449; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Pflock M, 2004, FEMS MICROBIOL LETT, V234, P51, DOI 10.1016/j.femsle.2004.03.023; Piotrowski J, 1997, J PHYSIOL PHARMACOL, V48, P345; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wessler S, 2000, J BIOL CHEM, V275, P3629, DOI 10.1074/jbc.275.5.3629; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	36	66	68	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3510	10.1371/journal.pone.0003510	http://dx.doi.org/10.1371/journal.pone.0003510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946507	gold, Green Submitted, Green Published			2022-12-25	WOS:000265126200010
J	Wiersinga, WJ; Wieland, CW; Roelofs, JJTH; van der Poll, T				Wiersinga, W. Joost; Wieland, Catharina W.; Roelofs, Joris J. T. H.; van der Poll, Tom			MyD88 Dependent Signaling Contributes to Protective Host Defense against Burkholderia pseudomallei	PLOS ONE			English	Article								Background: Toll-like receptors (TLRs) have a central role in the recognition of pathogens and the initiation of the innate immune response. Myeloid differentiation primary-response gene 88 (MyD88) and TIR-domain-containing adaptor protein inducing IFN beta (TRIF) are regarded as the key signaling adaptor proteins for TLRs. Melioidosis, which is endemic in SE-Asia, is a severe infection caused by the gram-negative bacterium Burkholderia pseudomallei. We here aimed to characterize the role of MyD88 and TRIF in host defense against melioidosis. Methodology and Principal Findings: First, we found that MyD88, but not TRIF, deficient whole blood leukocytes released less TNF alpha upon stimulation with B. pseudomallei compared to wild-type (WT) cells. Thereafter we inoculated MyD88 knockout (KO), TRIF mutant and WT mice intranasally with B. pseudomallei and found that MyD88 KO, but not TRIF mutant mice demonstrated a strongly accelerated lethality, which was accompanied by significantly increased bacterial loads in lungs, liver and blood, and grossly enhanced liver damage compared to WT mice. The decreased bacterial clearance capacity of MyD88 KO mice was accompanied by a markedly reduced early pulmonary neutrophil recruitment and a diminished activation of neutrophils after infection with B. pseudomallei. MyD88 KO leukocytes displayed an unaltered capacity to phagocytose and kill B. pseudomallei in vitro. Conclusions: MyD88 dependent signaling, but not TRIF dependent signaling, contributes to a protective host response against B. pseudomallei at least in part by causing early neutrophil recruitment towards the primary site of infection.	[Wiersinga, W. Joost; Wieland, Catharina W.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunity Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Wiersinga, W. Joost; Wieland, Catharina W.; van der Poll, Tom] Academ Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Academ Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Wiersinga, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunity Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.wiersinga@amc.uva.nl		Roelofs, Joris/0000-0001-9595-6571; Wiersinga, Willem/0000-0003-2277-1343	Dutch Foundation for Tropical Research (WOTRO)	Dutch Foundation for Tropical Research (WOTRO)	We acknowledge the support of the Dutch Foundation for Tropical Research (WOTRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Apisarnthananarak P, 2006, CLIN INFECT DIS, V43, P1618, DOI 10.1086/509643; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iimuro Y, 2007, J GASTROEN HEPATOL, V22, pS57, DOI 10.1111/j.1440-1746.2006.04651.x; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Leaver SK, 2007, CRIT CARE MED, V35, P1404, DOI 10.1097/01.CCM.0000261883.16943.4B; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Nance SC, 2008, J LEUKOC BIOL; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Power MR, 2004, J BIOL CHEM, V279, P49315, DOI 10.1074/jbc.M402111200; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Russell DG, 2007, CELL MICROBIOL, V9, P849, DOI 10.1111/j.1462-5822.2007.00920.x; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga Willem Joost, 2007, Curr Infect Dis Rep, V9, P366, DOI 10.1007/s11908-007-0057-5; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	58	61	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3494	10.1371/journal.pone.0003494	http://dx.doi.org/10.1371/journal.pone.0003494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946505	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126200002
J	Inglis, KJ; Chereau, D; Brigham, EF; Chiou, SS; Schobel, S; Frigon, NL; Yu, M; Caccavello, RJ; Nelson, S; Motter, R; Wright, S; Chian, D; Santiago, P; Soriano, F; Ramos, C; Powell, K; Goldstein, JM; Babcock, M; Yednock, T; Bard, F; Basi, GS; Sham, H; Chilcote, TJ; McConlogue, L; Griswold-Prenner, I; Anderson, JP				Inglis, Kelly J.; Chereau, David; Brigham, Elizabeth F.; Chiou, San-San; Schoebel, Susanne; Frigon, Normand L.; Yu, Mei; Caccavello, Russell J.; Nelson, Seth; Motter, Ruth; Wright, Sarah; Chian, David; Santiago, Pamela; Soriano, Ferdie; Ramos, Carla; Powell, Kyle; Goldstein, Jason M.; Babcock, Michael; Yednock, Ted; Bard, Frederique; Basi, Guriqbal S.; Sham, Hing; Chilcote, Tamie J.; McConlogue, Lisa; Griswold-Prenner, Irene; Anderson, John P.			Polo-like Kinase 2 (PLK2) Phosphorylates alpha-Synuclein at Serine 129 in Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; SYNAPTIC PLASTICITY; PROTEIN-KINASE; DEMENTIA; MUTATION; SER-129; IDENTIFICATION; NEUROTOXICITY; DUPLICATION	Several neurological diseases, including Parkinson disease and dementia with Lewy bodies, are characterized by the accumulation of alpha-synuclein phosphorylated at Ser-129 (p-Ser-129). The kinase or kinases responsible for this phosphorylation have been the subject of intense investigation. Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons. PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay. Inhibitors of PLK kinases inhibited alpha-synuclein phosphorylation both in primary cortical cell cultures and in mouse brain in vivo. Finally, specific knockdown of PLK2 expression by transduction with short hairpin RNA constructs or by knock-out of the plk2 gene reduced p-Ser-129 levels. These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.	[Inglis, Kelly J.; Chereau, David; Brigham, Elizabeth F.; Chiou, San-San; Schoebel, Susanne; Frigon, Normand L.; Yu, Mei; Caccavello, Russell J.; Nelson, Seth; Motter, Ruth; Wright, Sarah; Chian, David; Santiago, Pamela; Soriano, Ferdie; Ramos, Carla; Powell, Kyle; Goldstein, Jason M.; Babcock, Michael; Yednock, Ted; Bard, Frederique; Basi, Guriqbal S.; Sham, Hing; Chilcote, Tamie J.; McConlogue, Lisa; Griswold-Prenner, Irene; Anderson, John P.] Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Anderson, JP (corresponding author), Elan Pharmaceut Inc, 800 Gateway Blvd, San Francisco, CA 94080 USA.	john.p.anderson@elan.com		Goldstein, Jason/0000-0003-1558-1832; Wright, Sarah/0000-0002-3156-3792				Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Baba M, 1998, AM J PATHOL, V152, P879; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; CHILCOTE TJ, 2007, Patent No. 2007089862; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mirzaei H, 2006, ANAL CHEM, V78, P2422, DOI 10.1021/ac051978n; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	33	166	172	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2598	2602		10.1074/jbc.C800206200	http://dx.doi.org/10.1074/jbc.C800206200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004816	Green Published, hybrid			2022-12-25	WOS:000262700900002
J	Bailey, LK; Campbell, LJ; Evetts, KA; Littlefield, K; Rajendra, E; Nietlispach, D; Owen, D; Mott, HR				Bailey, Laura K.; Campbell, Louise J.; Evetts, Katrina A.; Littlefield, Keily; Rajendra, Eeson; Nietlispach, Daniel; Owen, Darerca; Mott, Helen R.			The Structure of Binder of Arl2 (BART) Reveals a Novel G Protein Binding Domain IMPLICATIONS FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; ARF-LIKE; COFACTOR-D; ROTATIONAL DIFFUSION; EFFECTOR PROTEINS; NMR-SPECTROSCOPY; PDE-DELTA; COMPLEX; GTPASES	The ADP-ribosylation factor-like (Arl) family of small G proteins are involved in the regulation of diverse cellular processes. Arl2 does not appear to be membrane localized and has been implicated as a regulator of microtubule dynamics. The downstream effector for Arl2, Binder of Arl 2 (BART) has no known function but, together with Arl2, can enter mitochondria and bind the adenine nucleotide transporter. We have solved the solution structure of BART and show that it forms a novel fold composed of six alpha-helices that form three interlocking "L" shapes. Analysis of the backbone dynamics reveals that the protein is highly anisotropic and that the loops between the central helices are dynamic. The regions involved in the binding of Arl2 were mapped onto the surface of BART and are found to localize to these loop regions. BART has faces of differing charge and structural elements, which may explain how it can interact with other proteins.	[Bailey, Laura K.; Campbell, Louise J.; Evetts, Katrina A.; Littlefield, Keily; Rajendra, Eeson; Nietlispach, Daniel; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Rajendra, Eeson/0000-0002-5301-054X; Nietlispach, Daniel/0000-0003-4364-9291	Medical Research Council [G120/608]; Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Medical Research Council Grant G120/608. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Effros R M, 1986, J Thorac Imaging, V1, P54, DOI 10.1097/00005382-198603000-00007; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Hillig RC, 2000, STRUCTURE, V8, P1239, DOI 10.1016/S0969-2126(00)00531-1; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Hubbard S. J., 1993, NACCESS; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nietlispach D, 2002, J AM CHEM SOC, V124, P11199, DOI 10.1021/ja025865m; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	47	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					992	999		10.1074/jbc.M806167200	http://dx.doi.org/10.1074/jbc.M806167200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981177	hybrid			2022-12-25	WOS:000262122900035
J	Sirpio, S; Allahverdiyeva, Y; Holmstrom, M; Khrouchtchova, A; Haldrup, A; Battchikova, N; Aro, EM				Sirpioe, Sari; Allahverdiyeva, Yagut; Holmstrom, Maija; Khrouchtchova, Anastassia; Haldrup, Anna; Battchikova, Natalia; Aro, Eva-Mari			Novel Nuclear-encoded Subunits of the Chloroplast NAD(P)H Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; NDH-1 COMPLEXES; THERMOSYNECHOCOCCUS-ELONGATUS; PHOTOSYNTHETIC MEMBRANES; EXTINCTION COEFFICIENTS; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES; CHLOROPHYLL-A; PROTEINS	The NAD(P) H dehydrogenase (NDH) complex functions in photosystem I cyclic electron transfer in higher plant chloroplasts and is crucial for plant responses to environmental stress. Chloroplast NDH complex is a close relative to cyanobacterial NDH-1L complex, and all fifteen subunits so far identified in NDH-1L have homologs in the chloroplast NDH complex. Here we report on the identification of two nuclear-encoded proteins NDH48 and NDH45 in higher plant chloroplasts and show their intimate association with the NDH complex. These two membrane proteins are shown to interact with each other and with the NDH complex enriched in stroma thylakoids. Moreover, the deficiency of either the NDH45 protein or the NDH48 protein in respective mutant plants leads to severe defects in both the accumulation and the function of the NDH complex. The NDH48 and NDH45 proteins are not components of the hydrophilic connecting domain of the NDH complex but are strongly attached to the hydrophobic membrane domain. We conclude that NDH48 and NDH45 are novel nuclear-encoded subunits of the chloroplast NDH complex and crucial both for the stable structure and function of the NDH complex.	[Sirpioe, Sari; Allahverdiyeva, Yagut; Holmstrom, Maija; Battchikova, Natalia; Aro, Eva-Mari] Univ Turku, Dept Biol Plant Physiol & Mol Biol, FI-20014 Turku, Finland; [Khrouchtchova, Anastassia; Haldrup, Anna] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, VKR Res Ctr Proact Plants, DK-1871 Frederiksberg C, Denmark	University of Turku; University of Copenhagen	Aro, EM (corresponding author), Univ Turku, Dept Biol Plant Physiol & Mol Biol, FI-20014 Turku, Finland.	evaaro@utu.fi	Allahverdiyeva, Yagut/I-5652-2013; Aro, Eva-Mari/Q-8664-2017	Allahverdiyeva, Yagut/0000-0002-9262-1757; Aro, Eva-Mari/0000-0002-2922-1435; Haldrup, Anna/0000-0002-2348-7072	Academy of Finland and Biological Interactions Graduate School	Academy of Finland and Biological Interactions Graduate School(Academy of Finland)	This work was supported by the Academy of Finland and Biological Interactions Graduate School. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allahverdiyeva Y, 2005, BBA-BIOENERGETICS, V1709, P69, DOI 10.1016/j.bbabio.2005.06.004; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munshi MK, 2006, PLANT PHYSIOL, V141, P737, DOI 10.1104/pp.106.080267; Muraoka R, 2006, PLANT PHYSIOL, V142, P1683, DOI 10.1104/pp.106.088682; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; OGAWA T, 1992, PLANT PHYSIOL, V99, P1604, DOI 10.1104/pp.99.4.1604; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Peng LW, 2008, J BIOL CHEM, V283, P34873, DOI 10.1074/jbc.M803207200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rintamaki E, 1996, J BIOL CHEM, V271, P14870, DOI 10.1074/jbc.271.25.14870; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Romano PGN, 2004, PLANT PHYSIOL, V134, P1244, DOI 10.1104/pp.104.041186; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu H, 2008, PLANT CELL PHYSIOL, V49, P835, DOI 10.1093/pcp/pcn058; Shimizu H, 2007, PLANT J, V52, P539, DOI 10.1111/j.1365-313X.2007.03256.x; Sirpio S, 2007, BIOCHEM J, V406, P415, DOI 10.1042/BJ20070460; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	40	48	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					905	912		10.1074/jbc.M805404200	http://dx.doi.org/10.1074/jbc.M805404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18974055	hybrid			2022-12-25	WOS:000262122900025
J	Valtcheva, N; Nestorov, P; Beck, A; Russwurm, M; Hillenbrand, M; Weinmeister, P; Feil, R				Valtcheva, Nadejda; Nestorov, Peter; Beck, Alexander; Russwurm, Michael; Hillenbrand, Matthias; Weinmeister, Pascal; Feil, Robert			The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CYCLIC-NUCLEOTIDE ANALOGS; HUMAN PLATELETS; ALPHA; GMP; NO; HYPERTENSION; MECHANISMS; ISOFORMS; ISOZYME	Small-molecule modulators of cGMP signaling are of interest to basic and clinical research. The cGMP-dependent protein kinase type I (cGKI) is presumably a major mediator of cGMP effects, and the cGMP analogue Rp-8-Br-PET-cGMPS (Rp-PET) (chemical name: beta-phenyl-1,N-2-etheno-8-bromoguanosine-3', 5'-cyclic monophosphorothioate, Rp-isomer) is currently considered one of the most permeable, selective, and potent cGKI inhibitors available for intact cell studies. Here, we have evaluated the properties of Rp-PET using cGKI-expressing and cGKI-deficient primary vascular smooth muscle cells (VSMCs), purified cGKI isozymes, and an engineered cGMP sensor protein. cGKI activity in intact VSMCs was monitored by cGMP/cGKI-stimulated cell growth and phosphorylation of vasodilator-stimulated phosphoprotein. Unexpectedly, Rp-PET (100 mu M) did not efficiently antagonize activation of cGKI by the agonist 8-Br-cGMP (100 mu M) in intact VSMCs. Moreover, in the absence of 8-Br-cGMP, Rp-PET (100 mu M) stimulated cell growth in a cGKI alpha-dependent manner. Kinase assays with purified cGKI isozymes confirmed the previously reported inhibition of the cGMP-stimulated enzyme by Rp-PET in vitro. However, in the absence of the agonist cGMP, Rp-PET partially activated the cGKI alpha isoform. Experiments with a fluorescence resonance energy transfer-based construct harboring the cGMP binding sites of cGKI suggested that binding of Rp-PET induces a conformational change similar to the agonist cGMP. Together, these findings indicate that Rp-PET is a partial cGKI alpha agonist that under certain conditions stimulates rather than inhibits cGKI activity in vitro and in intact cells. Data obtained with Rp-PET as cGKI inhibitor should be interpreted with caution and not be used as sole evidence to dissect the role of cGKI in signaling processes.	[Valtcheva, Nadejda; Nestorov, Peter; Hillenbrand, Matthias; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [Beck, Alexander] Zentrum Klin Massenspektrometrie GmbH, D-74076 Heilbronn, Germany; [Russwurm, Michael] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany; [Weinmeister, Pascal] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Eberhard Karls University of Tubingen; Ruhr University Bochum; Technical University of Munich	Feil, R (corresponding author), Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	robert.feil@uni-tuebingen.de	Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feil R, 2005, TRENDS MOL MED, V11, P71, DOI 10.1016/j.molmed.2004.12.001; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Kramer RH, 1996, J NEUROSCI, V16, P1285; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Weinmeister P, 2008, MOL BIOL CELL, V19, P4434, DOI 10.1091/mbc.E08-04-0370; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; WYATT TA, 1991, RES COMMUN CHEM PATH, V74, P3	41	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					556	562		10.1074/jbc.M806161200	http://dx.doi.org/10.1074/jbc.M806161200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19008225	hybrid			2022-12-25	WOS:000261974800061
J	Cabart, P; Lee, J; Willis, IM				Cabart, Pavel; Lee, JaeHoon; Willis, Ian M.			Facilitated Recycling Protects Human RNA Polymerase III from Repression by Maf1 in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REINITIATION; SACCHAROMYCES-CEREVISIAE; ACCURATE TRANSCRIPTION; TERMINATION; COMPLEX; INITIATION; TFIIIB; DEPHOSPHORYLATION; PROMOTE; EXTRACT	Yeast cells synthesize similar to 3-6 million molecules of tRNA every cell cycle at a rate of similar to 2-4 transcripts/gene/s. This high rate of transcription is achieved through many rounds of reinitiation by RNA polymerase (pol) III on stable DNA-bound complexes of the initiation factor TFIIIB. Studies in yeast have shown that the rate of reinitiation is increased by facilitated recycling, a process that involves the repeated reloading of the polymerase on the same transcription unit. However, when nutrients become limiting or stress conditions are encountered, RNA pol III transcription is rapidly repressed through the action of the conserved Maf1 protein. Here we examine the relationship between Maf1-mediated repression and facilitated recycling in a human RNA pol III in vitro system. Using an immobilized template transcription assay, we demonstrate that facilitated recycling is conserved from yeast to humans. We assessed the ability of recombinant human Maf1 to inhibit different steps in transcription before and after preinitiation complex assembly. We show that recombinant Maf1 can inhibit the recruitment of TFIIIB and RNA pol III to immobilized templates. However, RNA pol III bound to preinitiation complexes or in elongation complexes is protected from repression by Maf1 and can undergo several rounds of initiation. This indicates that recombinant Maf1 is unable to inhibit facilitated recycling. The data suggest that additional biochemical steps may be necessary for rapid Maf1-dependent repression of RNA pol III transcription.	[Cabart, Pavel; Lee, JaeHoon; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	willis@aecom.yu.edu		Willis, Ian/0000-0001-6599-2395; Cabart, Pavel/0000-0003-0065-367X	National Institutes of Health [GM42728]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42728. This work was also supported by funds from the Albert Einstein College of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; DEAN N, 1988, MOL CELL BIOL, V8, P3017, DOI 10.1128/MCB.8.8.3017; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ferrari R, 2004, P NATL ACAD SCI USA, V101, P13442, DOI 10.1073/pnas.0403851101; Ferrari R, 2008, CELL MOL BIOL LETT, V13, P112, DOI 10.2478/s11658-007-0041-y; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KOVELMAN R, 1990, GENE DEV, V4, P646, DOI 10.1101/gad.4.4.646; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Liao YL, 2006, MOL CELL BIOL, V26, P5946, DOI 10.1128/MCB.00689-06; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Phizicky EM, 2005, P NATL ACAD SCI USA, V102, P11127, DOI 10.1073/pnas.0504843102; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SEGALL J, 1980, J BIOL CHEM, V255, P1986; STANDRING DN, 1981, P NATL ACAD SCI-BIOL, V78, P5963, DOI 10.1073/pnas.78.10.5963; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wang ZX, 1998, MOL CELL, V1, P749, DOI 10.1016/S1097-2765(00)80074-X; Wang ZX, 2000, EMBO J, V19, P6823, DOI 10.1093/emboj/19.24.6823; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005	35	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36108	36117		10.1074/jbc.M807538200	http://dx.doi.org/10.1074/jbc.M807538200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974046	hybrid, Green Published			2022-12-25	WOS:000261840500006
J	Chandor-Proust, A; Berteau, O; Douki, T; Gasparutto, D; Ollagnier-De-Choudens, S; Fontecave, M; Atta, M				Chandor-Proust, Alexia; Berteau, Olivier; Douki, Thierry; Gasparutto, Didier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed			DNA Repair and Free Radicals, New Insights into the Mechanism of Spore Photoproduct Lyase Revealed by Single Amino Acid Substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; ENZYME; ADENOSYLMETHIONINE; SUPERFAMILY; PROTEIN; IRON; 5-THYMINYL-5,6-DIHYDROTHYMINE; SULFUR; DIMERS; LESION	The major DNA photoproduct in UV-irradiated Bacillus subtilis spores is the thymine dimer named spore photoproduct (SP, 5-(alpha-thyminyl)-5,6-dihydrothymine). The SP lesion has been found to be efficiently repaired by SP lyase (SPL) a very specific enzyme that reverses the SP to two intact thymines, at the origin of the great resistance of the spores to UV irradiation. SPL belongs to a superfamily of [4Fe-4S] iron-sulfur enzymes, called "Radical-SAM." Here, we show that the single substitution of cysteine 141 into alanine, a residue fully conserved in Bacillus species and previously shown to be essential for spore DNA repair in vivo, has a major impact on the outcome of the SPL-dependent repair reaction in vitro. Indeed the modified enzyme catalyzes the almost quantitative conversion of the SP lesion into one thymine and one thymine sulfinic acid derivative. This compound results from the trapping of the allyl-type radical intermediate by dithionite, used as reducing agent in the reaction mixture. Implications of the data reported here regarding the repair mechanism and the role of Cys-141 are discussed.	[Chandor-Proust, Alexia; Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Chandor-Proust, Alexia; Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] CNRS, UMR5249, Grenoble, France; [Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] Univ Grenoble 1, F-38081 Grenoble, France; [Douki, Thierry; Gasparutto, Didier] Univ Grenoble 1, CEA, Lab Les Acides Nucle,Direct Sci Mat,UMR E3, Serv Chim Inorgan & Biol,Inst Nanosci & Cryogen, F-38054 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecave, M (corresponding author), CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France.	marc.fontecave@cea.fr; mohamed.atta@cea.fr	Thierry, Douki/H-2108-2018; Berteau, Olivier/AAF-9080-2019; Chandor-Proust, Alexia/C-1109-2013	Thierry, Douki/0000-0002-5022-071X; Berteau, Olivier/0000-0002-3434-5168; Chandor-Proust, Alexia/0000-0002-4827-3281; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659				BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buis JM, 2006, J BIOL CHEM, V281, P25994, DOI 10.1074/jbc.M603931200; Chandor A, 2006, J BIOL CHEM, V281, P26922, DOI 10.1074/jbc.M602297200; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; DONNELLAN JE, 1965, SCIENCE, V149, P308, DOI 10.1126/science.149.3681.308; Fajardo-Cavazos P, 2005, CURR MICROBIOL, V51, P331, DOI 10.1007/s00284-005-0052-8; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frey PA, 2006, CHEM REV, V106, P3302, DOI 10.1021/cr050292s; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Halliwell B., 2007, FREE RADICALS BIOL M; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Mehl RA, 1999, ORG LETT, V1, P1065, DOI 10.1021/ol9908676; Ni JS, 1996, ANAL CHEM, V68, P1989, DOI 10.1021/ac960270t; Pieck JC, 2006, J BIOL CHEM, V281, P36317, DOI 10.1074/jbc.M607053200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Rebeil R, 2001, P NATL ACAD SCI USA, V98, P9038, DOI 10.1073/pnas.161278998; Rebeil R, 1998, J BACTERIOL, V180, P4879, DOI 10.1128/JB.180.18.4879-4885.1998; Romieu A, 2000, ORG LETT, V2, P1085, DOI 10.1021/ol005643y; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Slieman TA, 2000, J BACTERIOL, V182, P6412, DOI 10.1128/JB.182.22.6412-6417.2000; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; VARGHESE AJ, 1970, BIOCHEM BIOPH RES CO, V38, P484, DOI 10.1016/0006-291X(70)90739-4	25	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36361	36368		10.1074/jbc.M806503200	http://dx.doi.org/10.1074/jbc.M806503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957420	hybrid, Green Published			2022-12-25	WOS:000261840500033
J	Martin, S; Bouschet, T; Jenkins, EL; Nishimune, A; Henley, JM				Martin, Stephane; Bouschet, Tristan; Jenkins, Emma L.; Nishimune, Atsushi; Henley, Jeremy M.			Bidirectional Regulation of Kainate Receptor Surface Expression in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SYNAPTIC-TRANSMISSION; AMPA RECEPTORS; TRAFFICKING; PROTEINS; SUMOYLATION; MOTILITY; SUBUNITS; ROLES; GREEN	Kainate receptors (KARs) are crucial for the regulation of both excitatory and inhibitory neurotransmission, but little is known regarding the mechanisms controlling KAR surface expression. We used super ecliptic pHluorin (SEP)-tagged KAR subunit GluR6a to investigate real-time changes in KAR surface expression in hippocampal neurons. Sindbis virus-expressed SEP-GluR6 subunits efficiently co-assembled with native KAR subunits to form heteromeric receptors. Diffuse surface-expressed dendritic SEP-GluR6 is rapidly internalized following either N-methyl-D-aspartate or kainate application. Sustained kainate or transient N-methyl-D-aspartate application resulted in a slow decrease of base-line surface KAR levels. Surprisingly, however, following the initial loss of surface receptors, a short kainate application caused a long lasting increase in surface-expressed KARs to levels significantly greater than those prior to the agonist challenge. These data suggest that after initial endocytosis, transient agonist activation evokes increased KAR exocytosis and reveal that KAR surface expression is bidirectionally regulated. This process may provide a mechanism for hippocampal neurons to differentially adapt their physiological responses to changes in synaptic activation and extrasynaptic glutamate concentration.	[Martin, Stephane; Bouschet, Tristan; Jenkins, Emma L.; Nishimune, Atsushi; Henley, Jeremy M.] Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast,Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast,Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bristol.ac.uk	Bouschet, Tristan/C-8265-2019; Martin, Stéphane/G-5954-2012; Henley, Jeremy M/A-2776-2009	Bouschet, Tristan/0000-0002-7858-6115; Martin, Stéphane/0000-0001-6771-7645; Henley, Jeremy/0000-0003-3589-8335	Wellcome Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council; European Union (GRIPPANT); MRC [G0601810] Funding Source: UKRI; Medical Research Council [G0601810] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (GRIPPANT)(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust, the Medical Research Council, the Biotechnology and Biological Sciences Research Council and the European Union (GRIPPANT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Coussen F, 2006, BIOCHEM SOC T, V34, P927, DOI 10.1042/BST0340927; Fleck MW, 2003, J NEUROSCI, V23, P1219; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X	20	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36435	36440		10.1074/jbc.M806447200	http://dx.doi.org/10.1074/jbc.M806447200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955488	hybrid, Green Published			2022-12-25	WOS:000261840500041
J	Ramalingam, JK; Hunke, C; Gao, XH; Grurber, G; Preiser, PR				Ramalingam, Jeya Kumar; Hunke, Cornelia; Gao, Xiaohong; Gruerber, Gerhard; Preiser, Peter Rainer			ATP/ADP Binding to a Novel Nucleotide Binding Domain of the Reticulocyte-binding Protein Py235 of Plasmodium yoelii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; METHANOSARCINA-MAZEI GO1; HOST-CELL SELECTION; SECONDARY STRUCTURE; RHOPTRY-PROTEIN; RODENT MALARIA; CIRCUMSPOROZOITE PROTEIN; PHENOTYPIC VARIATION; MEROZOITE PROTEINS; HUMAN ERYTHROCYTES	The mechanism by which a malaria merozoite recognizes a suitable host cell is mediated by a cascade of receptor-ligand interactions. In addition to the availability of the appropriate receptors, intracellular ATP plays an important role in determining whether erythrocytes are suitable for merozoite invasion. Recent work has shown that ATP secreted from erythrocytes signals a number of cellular processes. To determine whether ATP signaling might be involved in merozoite invasion, we investigated whether known plasmodium invasion proteins contain nucleotide binding motifs. Domain mapping identified a putative nucleotide binding region within all members of the reticulocyte-binding protein homologue (RBL) family analyzed. A representative domain, termed here nucleotide binding domain 94 (NBD94), was expressed and demonstrated to specifically bind to ATP. Nucleotide affinities of NBD94 were determined by fluorescence correlation spectroscopy, where an increase in the binding of ATP is observed compared with ADP analogues. ATP binding was reduced by the known F1F0-ATP synthase inhibitor 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. Fluorescence quenching and circular dichroism spectroscopy of NBD94 after binding of different nucleotides provide evidence for structural changes in this protein. Our data suggest that different structural changes induced by ATP/ADP binding to RBL could play an important role during the invasion process.	[Hunke, Cornelia; Gruerber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore; [Ramalingam, Jeya Kumar; Gao, Xiaohong; Preiser, Peter Rainer] Nanyang Technol Univ, Sch Biol Sci, Div Genom & Genet, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grurber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg; PRPreiser@ntu.edu.sg	Preiser, Peter R/A-2201-2011	Gao, Xiaohong Annie/0000-0002-7270-2576; , Peter/0000-0003-4331-7000	Agency for Science, Technology and Research (A*STAR) Biomedical Research Council [06/1/22/19/456]; Academic Research Council [MLC03/03]	Agency for Science, Technology and Research (A*STAR) Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Academic Research Council	This work was supported by Agency for Science, Technology and Research (A*STAR) Biomedical Research Council Grant 06/1/22/19/456 and Academic Research Council Grant MLC03/03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DLUZEWSKI AR, 1983, PARASITOLOGY, V87, P429, DOI 10.1017/S0031182000082950; DLUZEWSKI AR, 1983, MOL BIOCHEM PARASIT, V9, P145, DOI 10.1016/0166-6851(83)90106-8; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; GAO X, 2008, R PLOS PATHOG, V4; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; GOLENDA CF, 1990, J HISTOCHEM CYTOCHEM, V38, P475, DOI 10.1177/38.4.2181019; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; JARRA W, 1989, PARASITE IMMUNOL, V11, P1, DOI 10.1111/j.1365-3024.1989.tb00644.x; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MEIS JFGM, 1992, ACTA TROP, V50, P227, DOI 10.1016/0001-706X(92)90079-D; MEIS JFGM, 1992, PARASITOL RES, V78, P165, DOI 10.1007/BF00931660; Ogun SA, 2006, MOL BIOCHEM PARASIT, V147, P140, DOI 10.1016/j.molbiopara.2006.02.001; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; OLSON JA, 1982, J CELL BIOL, V95, P757, DOI 10.1083/jcb.95.3.757; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; RANGACHARI K, 1986, NATURE, V324, P364, DOI 10.1038/324364a0; RANGACHARI K, 1989, MOL BIOCHEM PARASIT, V34, P63, DOI 10.1016/0166-6851(89)90020-0; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Roos M, 1998, J BIOL CHEM, V273, P924, DOI 10.1074/jbc.273.2.924; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schafer HJ, 2001, BIOCHEM BIOPH RES CO, V286, P1218, DOI 10.1006/bbrc.2001.5502; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Svergun DI, 1998, BIOPHYS J, V75, P2212, DOI 10.1016/S0006-3495(98)77665-9; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBER J, 1994, J BIOL CHEM, V269, P20462; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343	71	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36386	36396		10.1074/jbc.M803102200	http://dx.doi.org/10.1074/jbc.M803102200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957411	Green Published, Green Accepted			2022-12-25	WOS:000261840500036
J	Sawano, Y; Hatano, K; Miyakawa, T; Tanokura, M				Sawano, Yoriko; Hatano, Ken-ichi; Miyakawa, Takuya; Tanokura, Masaru			Absolute Side-chain Structure at Position 13 Is Required for the Inhibitory Activity of Bromein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-PROTEINASE-INHIBITOR; BOWMAN-BIRK INHIBITOR; AMINO-ACID-SEQUENCES; BROMELAIN-INHIBITOR; PINEAPPLE STEM; PROTEASE INHIBITORS; SECONDARY STRUCTURE; VI; TRYPSIN; PAPAIN	Bromelain isoinhibitor (bromein), a cysteine proteinase inhibitor from pineapple stem, has a unique double-chain structure. The bromein precursor protein includes three homologous inhibitor domains, each containing an interchain peptide between the light and heavy chains. The interchain peptide in the single-chain precursor is immediately processed by bromelain, a target proteinase. In the present study, to clarify the essential inhibitory site of bromein, we constructed 44 kinds of site-directed and deletion mutants and investigated the inhibitory activity of each toward bromelain. As a result, the complete chemical structure of Leu(13) in the light chain was revealed to be essential for inhibition. Pro(12) prior to the leucine residue was also involved in the inhibitory activity and would control the location of the leucine side chain by the fixed phi dihedral angle of proline. Furthermore, the five-residue length of the interchain peptide was strictly required for the inhibitory activity. On the other hand, no inhibitory activity against bromelain was observed by the substitution of proline for the N terminus residue Thr(15) of the interchain peptide. In summary, these mutational analyses of bromein demonstrated that the appropriate position and conformation of Leu(13) are absolutely crucial for bromelain inhibition.	[Sawano, Yoriko; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Hatano, Ken-ichi] Gunma Univ, Fac Engn, Dept Chem & Chem Biol, Gunma 3768515, Japan	University of Tokyo; Gunma University	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research and by the 21st Century Center of Excellence Program from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRETT AJ, 1986, BIOCHEM J, V236, P312, DOI 10.1042/bj2360312; Brauer ABE, 2002, BIOCHEMISTRY-US, V41, P10608, DOI 10.1021/bi026050t; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; HARRY JB, 1970, EUR J BIOCHEM, V16, P174, DOI 10.1111/j.1432-1033.1970.tb01069.x; Hatano K, 2003, BIOL CHEM, V384, P93, DOI 10.1515/BC.2003.010; HATANO K, 1995, EUR J BIOCHEM, V232, P335, DOI 10.1111/j.1432-1033.1995.335zz.x; Hatano K, 1998, J BIOCHEM-TOKYO, V124, P457, DOI 10.1093/oxfordjournals.jbchem.a022135; Hatano K, 1996, P JPN ACAD B-PHYS, V72, P104, DOI 10.2183/pjab.72.104; Hatano K, 1996, BIOCHEMISTRY-US, V35, P5379, DOI 10.1021/bi952754+; Hatano KI, 2006, BIOPOLYMERS, V81, P309, DOI 10.1002/bip.20419; Hatano KI, 2002, BIOL CHEM, V383, P1151, DOI 10.1515/BC.2002.126; Heinrikson R L, 1976, Methods Enzymol, V45, P740; KRIZAJ I, 1993, FEBS LETT, V333, P15, DOI 10.1016/0014-5793(93)80366-3; Lenarcic B, 1998, BIOL CHEM, V379, P105; MITCHEL REJ, 1970, J BIOL CHEM, V245, P3485; Murachi T., 1970, METHOD ENZYMOL, V19, P273, DOI [10.1016/0076-6879(70)19021-5, DOI 10.1016/0076-6879(70)19021-5]; PERLSTEIN S H, 1973, Journal of Supramolecular Structure, V1, P249, DOI 10.1002/jss.400010309; Prakash B, 1996, J MOL EVOL, V42, P560, DOI 10.1007/BF02352286; Qi RF, 2005, ACTA BIOCH BIOPH SIN, V37, P283, DOI 10.1111/j.1745-7270.2005.00048.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; REDDY MN, 1975, J BIOL CHEM, V250, P1741; RITONJA A, 1989, FEBS LETT, V247, P419, DOI 10.1016/0014-5793(89)81383-3; Sawano Y, 2005, BIOL CHEM, V386, P491, DOI 10.1515/BC.2005.058; Sawano Y, 2002, J BIOL CHEM, V277, P28222, DOI 10.1074/jbc.M202600200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHRODER E, 1993, FEBS LETT, V315, P38, DOI 10.1016/0014-5793(93)81128-M; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Umezawa H, 1976, Methods Enzymol, V45, P678; WERNER MH, 1991, BIOCHEMISTRY-US, V30, P3356, DOI 10.1021/bi00228a002; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Yamamoto Y, 1999, FEBS LETT, V448, P257, DOI 10.1016/S0014-5793(99)00382-8	32	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36338	36343		10.1074/jbc.M806748200	http://dx.doi.org/10.1074/jbc.M806748200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948264	Green Published, hybrid			2022-12-25	WOS:000261840500030
J	van Loo, KMJ; Dejaegere, T; van Zweeden, M; van Schijndel, JE; Wijmenga, C; Trip, MD; Martens, GJM				van Loo, Karen M. J.; Dejaegere, Tim; van Zweeden, Martine; van Schijndel, Jessica E.; Wijmenga, Cisca; Trip, Mieke D.; Martens, Gerard J. M.			Male-Specific Association between a gamma-Secretase Polymorphism and Premature Coronary Atherosclerosis	PLOS ONE			English	Article								Background: Atherosclerosis is a common multifactorial disease resulting from an interaction between susceptibility genes and environmental factors. The causative genes that contribute to atherosclerosis are elusive. Based on recent findings with a Wistar rat model, we speculated that the gamma-secretase pathway may be associated with atherosclerosis. Methodology/Principal Findings: We have tested for association of premature coronary atherosclerosis with a non-synonymous single-nucleotide polymorphism (SNP) in the gamma-secretase component APH1B (Phe217Leu; rs1047552), a SNP previously linked to Alzheimer's disease. Analysis of a Dutch Caucasian cohort (780 cases; 1414 controls) showed a higher prevalence of the risk allele in the patients (odds ratio (OR) = 1.35), albeit not statistically different from the control population. Intriguingly, after gender stratification, the difference was significant in males (OR = 1.63; p = 0.033), but not in females (OR = 0.50; p = 0.20). Since Phe217Leu-mutated APH1B showed reduced gamma-secretase activity in mouse embryonic fibroblasts, the genetic variation is likely functional. Conclusion/Significance: We conclude that, in a male-specific manner, disturbed gamma-secretase signalling may play a role in the susceptibility for premature coronary atherosclerosis.	[van Loo, Karen M. J.; van Zweeden, Martine; van Schijndel, Jessica E.; Martens, Gerard J. M.] Radboud Univ Nijmegen, Dept Mol Anim Physiol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Dejaegere, Tim] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Dejaegere, Tim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands; [Wijmenga, Cisca] Univ Groningen, Med Ctr, Dept Genet, NL-9700 AB Groningen, Netherlands; [Trip, Mieke D.] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands	Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	van Loo, KMJ (corresponding author), Radboud Univ Nijmegen, Dept Mol Anim Physiol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	Martens, Gerard JM/D-1925-2010; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; 	Dutch Top Institute Pharma [T5-209]	Dutch Top Institute Pharma	This work was performed within the framework of project T5-209 of the Dutch Top Institute Pharma.	Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; Ellenbroek BA, 2000, PSYCHOPHARMACOLOGY, V148, P124, DOI 10.1007/s002130050033; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Horejsi B, 2000, PHYSIOL RES, V49, pS63; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morita H, 1997, J Cardiol, V29, P309; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Poli M, 2008, NEUROBIOL AGING, V29, P1494, DOI 10.1016/j.neurobiolaging.2007.03.019; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; Rebeck GW, 2001, MOL BRAIN RES, V87, P238, DOI 10.1016/S0169-328X(01)00006-7; Riksen NR, 2003, J CARDIOVASC PHARM, V41, P625, DOI 10.1097/00005344-200304000-00016; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Salazar LA, 2000, CLIN CHIM ACTA, V300, P139, DOI 10.1016/S0009-8981(00)00308-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Schulz Susanne, 2002, Hum Mutat, V20, P404, DOI 10.1002/humu.9070; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Smits BW, 2002, J CARDIOVASC PHARM, V40, P678, DOI 10.1097/00005344-200211000-00005; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3662	10.1371/journal.pone.0003662	http://dx.doi.org/10.1371/journal.pone.0003662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987747	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134500008
J	Thompson, O; Kleino, I; Crimaldi, L; Gimona, M; Saksela, K; Winder, SJ				Thompson, Oliver; Kleino, Iivari; Crimaldi, Luca; Gimona, Mario; Saksela, Kalle; Winder, Steve J.			Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts	PLOS ONE			English	Article								Background: Dystroglycan is a ubiquitously expressed cell adhesion receptor best understood in its role as part of the dystrophin glycoprotein complex of mature skeletal muscle. Less is known of the role of dystroglycan in more fundamental aspects of cell adhesion in other cell types, nor of its role in myoblast cell adhesion. Principal Findings: We have examined the role of dystroglycan in the early stages of myoblast adhesion and spreading and found that dystroglycan initially associates with other adhesion proteins in large puncta morphologically similar to podosomes. Using a human SH3 domain phage display library we identified Tks5, a key regulator of podosomes, as interacting with beta-dystroglycan. We verified the interaction by immunoprecipitation, GST-pulldown and immunfluorescence localisation. Both proteins localise to puncta during early phases of spreading, but importantly following stimulation with phorbol ester, also localise to structures indistinguishable from podosomes. Dystroglycan overexpression inhibited podosome formation by sequestering Tks5 and Src. Mutation of dystroglycan tyrosine 890, previously identified as a Src substrate, restored podosome formation. Conclusions: We propose therefore, that Src-dependent phosphorylation of beta-dystroglycan results in the formation of a Src/dystroglycan complex that drives the SH3-mediated association between dystroglycan and Tks5 which together regulate podosome formation in myoblasts.	[Thompson, Oliver; Winder, Steve J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Kleino, Iivari; Saksela, Kalle] Univ Helsinki, Hosp, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Crimaldi, Luca; Gimona, Mario] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Chieti, Italy	University of Sheffield; University of Helsinki; Consorzio Mario Negri Sud	Thompson, O (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	s.winder@sheffield.ac.uk		Saksela, Kalle/0000-0003-0827-122X; Thompson, Oliver/0000-0002-4134-8674; Kleino, Iivari/0000-0001-6219-8575	Wellcome Trust [GR077544AIA]; White Rose PhD Studentship; MRC [G00000114]; Academy of Finland; Sigrid Juselius Foundation; Helsinki University Hospital EVO; European Union [002573]	Wellcome Trust(Wellcome TrustEuropean Commission); White Rose PhD Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital EVO; European Union(European Commission)	The light microscopy imaging centre at the University of Sheffield was funded by a grant from the Wellcome Trust (GR077544AIA), Oliver Thompson was supported by a White Rose PhD Studentship, the work was also supported by MRC grant G00000114 to Steve Winder, grants from the Academy of Finland, the Sigrid Juselius Foundation, and Helsinki University Hospital EVO funds to Kalle Saksela and a Marie Curie Excellence grant 002573 from the European Union to Mario Gimona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Anderson C, 2007, DEV DYNAM, V236, P2627, DOI 10.1002/dvdy.21259; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; BARZAIDEL R, 2007, NAT CELL BIOL, V99, P858; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; BELKIN AM, 1995, EXP CELL RES, V221, P132, DOI 10.1006/excr.1995.1360; Belkin AM, 1996, CELL ADHES COMMUN, V4, P281, DOI 10.3109/15419069609010772; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Gad A, 2008, CELL MOTIL CYTOSKEL, V65, P614, DOI 10.1002/cm.20287; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; James M, 2000, J CELL SCI, V113, P1717; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Pereboev AV, 2001, BBA-GEN SUBJECTS, V1527, P54, DOI 10.1016/S0304-4165(01)00147-7; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Russett B.M., 2000, HDB WAR STUDIES, VII, P93; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; THOMPSON O, 2007, GAFSA FOCUS BIOCH GE, P364; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; ZHANG D, 1995, J CELL SCI, V108, P2285; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	60	53	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3638	10.1371/journal.pone.0003638	http://dx.doi.org/10.1371/journal.pone.0003638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982058	Green Published, gold, Green Accepted			2022-12-25	WOS:000265134300008
J	Yoon, KJ; Phelps, DA; Bush, RA; Remack, JS; Billups, CA; Khoury, JD				Yoon, Karina Jin; Phelps, Doris A.; Bush, Rebecca A.; Remack, Joanna S.; Billups, Catherine A.; Khoury, Joseph D.			ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma	PLOS ONE			English	Article								The actin cytoskeleton is a primary determinant of tumor cell motility and metastatic potential. Motility and metastasis are thought to be regulated, in large part, by the interaction of membrane proteins with cytoplasmic linker proteins and of these linker proteins, in turn, with actin. However, complete membrane-to-actin linkages have been difficult to identify. We used co-immunoprecipitation and competitive peptide assays to show that intercellular adhesion molecule-2 (ICAM-2)/alpha-actinin/actin may comprise such a linkage in neuroblastoma cells. ICAM-2 expression limited the motility of these cells and redistributed actin fibers in vitro, and suppressed development of disseminated tumors in an in vivo model of metastatic neuroblastoma. Consistent with these observations, immunohistochemical analysis demonstrated ICAM-2 expression in primary neuroblastoma tumors exhibiting features that are associated with limited metastatic disease and more favorable clinical outcome. In neuroblastoma cell lines, ICAM-2 expression did not affect AKT activation, tumorigenic potential or chemosensitivity, as has been reported for some types of transfected cells. The observed ICAM-2- mediated suppression of metastatic phenotype is a novel function for this protein, and the interaction of ICAM-2/alpha-actinin/actin represents the first complete membrane-linker protein-actin linkage to impact tumor cell motility in vitro and metastatic potential in an in vivo model. Current work focuses on identifying specific protein domains critical to the regulation of neuroblastoma cell motility and metastasis and on determining if these domains represent exploitable therapeutic targets.	[Yoon, Karina Jin; Phelps, Doris A.; Bush, Rebecca A.; Remack, Joanna S.] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Billups, Catherine A.] St Jude Childrens Hosp, Dept Biostat, Memphis, TN USA; [Khoury, Joseph D.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Yoon, KJ (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	karina.yoon@stjude.org	Bush, Rebecca/D-3458-2018	Bush, Rebecca/0000-0003-0388-5134	American Lebanese Syrian Associated Charities [CA21765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by CA21765 and American Lebanese Syrian Associated Charities.	Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Carpenito C, 1997, SCAND J IMMUNOL, V45, P248, DOI 10.1046/j.1365-3083.1997.d01-391.x; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; GLUCK U, 1994, J CELL SCI, V107, P1773; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Huang MT, 2006, BLOOD, V107, P4721, DOI 10.1182/blood-2005-11-4683; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; IINO H, 1994, CANCER, V73, P1324, DOI 10.1002/1097-0142(19940301)73:5<1324::AID-CNCR2820730503>3.0.CO;2-W; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; KLEINMAN HK, 1998, CURRENT PROTOCOLS CE; Kobayashi H, 2004, CLIN CANCER RES, V10, P572, DOI 10.1158/1078-0432.CCR-1323-03; Kotovuori A, 1999, J IMMUNOL, V162, P6613; KUHLMAN PA, 1992, FEBS LETT, V304, P201, DOI 10.1016/0014-5793(92)80619-R; KUHLMAN PA, 1994, FEBS LETT, V339, P297, DOI 10.1016/0014-5793(94)80434-6; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; MARIS JM, 2006, CANC MED, V7, P1990; Melero I, 2003, CLIN CANCER RES, V9, P3546; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; NORTAMO P, 1991, J IMMUNOL, V146, P2530; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Pietersz GA, 2001, VACCINE, V19, P1397, DOI 10.1016/S0264-410X(00)00373-X; Reiss Y, 1999, INT IMMUNOL, V11, P1527, DOI 10.1093/intimm/11.9.1527; Reyes-Mugica M, 1998, LAB INVEST, V78, P669; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SCHWAB M, 2000, PATHOLOGY GENETICS T, P153; Simon T, 2004, J PEDIAT HEMATOL ONC, V26, P791; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; SUN CX, 2002, J CELL SCI; Tanaka H, 2004, CLIN CANCER RES, V10, P4885, DOI 10.1158/1078-0432.CCR-0393-03; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thompson J, 2001, CANCER CHEMOTH PHARM, V47, P211, DOI 10.1007/s002800000235; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	46	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3629	10.1371/journal.pone.0003629	http://dx.doi.org/10.1371/journal.pone.0003629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978946	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134200011
J	Karnowski, A; Cao, C; Matthias, G; Carotta, S; Corcoran, LM; Martensson, IL; Skok, JA; Matthias, P				Karnowski, Alexander; Cao, Chun; Matthias, Gabriele; Carotta, Sebastian; Corcoran, Lynn M.; Martensson, Inga-Lill; Skok, Jane A.; Matthias, Patrick			Silencing and Nuclear Repositioning of the lambda 5 Gene Locus at the Pre-B Cell Stage Requires Aiolos and OBF-1	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; COACTIVATOR; IKAROS; EXPRESSION; RECEPTOR; DIFFERENTIATION; REPRESSION; SELECTION	The chromatin regulator Aiolos and the transcriptional coactivator OBF-1 have been implicated in regulating aspects of B cell maturation and activation. Mice lacking either of these factors have a largely normal early B cell development. However, when both factors are eliminated simultaneously a block is uncovered at the transition between pre-B and immature B cells, indicating that these proteins exert a critical function in developing B lymphocytes. In mice deficient for Aiolos and OBF-1, the numbers of immature B cells are reduced, small pre-BII cells are increased and a significant impairment in immunoglobulin light chain DNA rearrangement is observed. We identified genes whose expression is deregulated in the pre-B cell compartment of these mice. In particular, we found that components of the pre-BCR, such as the surrogate light chain genes lambda 5 and VpreB, fail to be efficiently silenced in double-mutant mice. Strikingly, developmentally regulated nuclear repositioning of the lambda 5 gene is impaired in pre-B cells lacking OBF-1 and Aiolos. These studies uncover a novel role for OBF-1 and Aiolos in controlling the transcription and nuclear organization of genes involved in pre-BCR function.	[Karnowski, Alexander; Cao, Chun; Matthias, Gabriele; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Karnowski, Alexander; Carotta, Sebastian; Corcoran, Lynn M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Martensson, Inga-Lill] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, London WC1E 6BT, England; [Skok, Jane A.] NYU, Sch Med, New York, NY USA	Friedrich Miescher Institute for Biomedical Research; Novartis; Walter & Eliza Hall Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; University College London; New York University	Karnowski, A (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	patrick.matthias@fmi.ch	Corcoran, Lynn M/C-9316-2013; Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; Martensson, Inga-Lill/0000-0003-3415-0560	Novartis Research Foundation; BBSRC, UK; The Wellcome Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	Novartis Research Foundation; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Wellcome Trust Fund(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Novartis Research Foundation (to PM), the BBSRC, UK (to ILM) and The Wellcome Trust Fund (to JAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Brunner C, 2006, NUCLEIC ACIDS RES, V34, P1807, DOI 10.1093/nar/gkl131; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Friedl EM, 1996, J BIOL CHEM, V271, P13927, DOI 10.1074/jbc.271.24.13927; Georgopoulos K, 1997, CURR OPIN IMMUNOL, V9, P222, DOI 10.1016/S0952-7915(97)80139-2; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Johnson K, 2005, MOL IMMUNOL, V42, P749, DOI 10.1016/j.molimm.2004.06.039; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim U, 2003, P NATL ACAD SCI USA, V100, P8868, DOI 10.1073/pnas.1033108100; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lacorazza HD, 2001, J IMMUNOL, V167, P5689, DOI 10.4049/jimmunol.167.10.5689; Laumen H, 2004, NUCLEIC ACIDS RES, V32, P1577, DOI 10.1093/nar/gkh327; LILLYCROP KA, 1994, MOL CELL BIOL, V14, P7633, DOI 10.1128/MCB.14.11.7633; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Martin DA, 2007, J IMMUNOL, V179, P4996, DOI 10.4049/jimmunol.179.8.4996; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; PARKER MJ, 2005, EMBO J; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; SAMA G, 2002, ATLAS CERAMBYCIDAE E, V1, P1; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; ten Boekel E, 1999, CURR TOP MICROBIOL, V246, P3; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; van den Brandt J, 2005, J IMMUNOL, V174, P7845, DOI 10.4049/jimmunol.174.12.7845; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang YH, 1998, J IMMUNOL, V161, P1132; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zou XG, 2003, J IMMUNOL, V170, P1354, DOI 10.4049/jimmunol.170.3.1354	72	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3568	10.1371/journal.pone.0003568	http://dx.doi.org/10.1371/journal.pone.0003568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974788	Green Published, gold			2022-12-25	WOS:000265131500003
J	Wiley, CD; Matundan, HH; Duselis, AR; Isaacs, AT; Vrana, PB				Wiley, Christopher D.; Matundan, Harry H.; Duselis, Amanda R.; Isaacs, Alison T.; Vrana, Paul B.			Patterns of Hybrid Loss of Imprinting Reveal Tissue- and Cluster-Specific Regulation	PLOS ONE			English	Article							DNA METHYLATION; DISTAL CHROMOSOME-7; HYDATIDIFORM MOLES; GENE-EXPRESSION; CANDIDATE GENE; CELL-CYCLE; LOCUS; DELETION; PEG10; H19	Background: Crosses between natural populations of two species of deer mice, Peromyscus maniculatus (BW), and P. polionotus (PO), produce parent-of-origin effects on growth and development. BW females mated to PO males (bwxpo) produce growth-retarded but otherwise healthy offspring. In contrast, PO females mated to BW males (POxBW) produce overgrown and severely defective offspring. The hybrid phenotypes are pronounced in the placenta and include POxBW conceptuses which lack embryonic structures. Evidence to date links variation in control of genomic imprinting with the hybrid defects, particularly in the POxBW offspring. Establishment of genomic imprinting is typically mediated by gametic DNA methylation at sites known as gDMRs. However, imprinted gene clusters vary in their regulation by gDMR sequences. Methodology/Principal Findings: Here we further assess imprinted gene expression and DNA methylation at different cluster types in order to discern patterns. These data reveal POxBW misexpression at the Kcnq1ot1 and Peg3 clusters, both of which lose ICR methylation in placental tissues. In contrast, some embryonic transcripts (Peg10, Kcnq1ot1) reactivated the silenced allele with little or no loss of DNA methylation. Hybrid brains also display different patterns of imprinting perturbations. Several cluster pairs thought to use analogous regulatory mechanisms are differentially affected in the hybrids. Conclusions/Significance: These data reinforce the hypothesis that placental and somatic gene regulation differs significantly, as does that between imprinted gene clusters and between species. That such epigenetic regulatory variation exists in recently diverged species suggests a role in reproductive isolation, and that this variation is likely to be adaptive.	[Wiley, Christopher D.; Matundan, Harry H.; Duselis, Amanda R.; Isaacs, Alison T.; Vrana, Paul B.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Wiley, CD (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA.	pvrana@uci.edu		Isaacs, Alison/0000-0002-2452-3338; Wiley, Christopher/0000-0002-7699-6866	U.S. National Science Foundation [MCB-0517754]	U.S. National Science Foundation(National Science Foundation (NSF))	Funded by the U.S. National Science Foundation (MCB-0517754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima T, 2000, GENOMICS, V67, P248, DOI 10.1006/geno.2000.6266; Arima T, 2006, GENOMICS, V88, P650, DOI 10.1016/j.ygeno.2006.07.005; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; DAWSON WD, 1993, GROWTH DEVELOP AGING, V57, P121; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Duselis AR, 2007, REPROD FERT DEVELOP, V19, P695, DOI 10.1071/RD07015; Duselis AR, 2007, HUM MOL GENET, V16, P808, DOI 10.1093/hmg/ddm025; Duselis AR, 2005, GENESIS, V43, P155, DOI 10.1002/gene.20166; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Fisher RA, 2003, PLACENTA, V24, pS111, DOI 10.1053/plac.2002.0939; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; FUKUDA Y, 1979, J EXP ZOOL, V207, P481, DOI 10.1002/jez.1402070316; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kainz B, 2007, INT J CANCER, V121, P1984, DOI 10.1002/ijc.22929; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Khatib H, 2005, MAMM GENOME, V16, P545, DOI 10.1007/s00335-005-0029-8; Kohda M, 2001, MOL CARCINOGEN, V31, P184, DOI 10.1002/mc.1053; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LI JY, 2007, MOL CELLULAR BIOL; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Loschiavo M, 2007, MAMM GENOME, V18, P75, DOI 10.1007/s00335-006-0083-x; Mackay DJG, 2006, HUM GENET, V119, P179, DOI 10.1007/s00439-005-0127-4; MADDOCK MB, 1979, J EXP ZOOL, V209, P417, DOI 10.1002/jez.1402090307; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; MEISTRICH ML, 2003, CHROMOSOMA; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MONK M, 1987, DEVELOPMENT, V99, P371; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Panichkul PC, 2005, J SOC GYNECOL INVEST, V12, P376, DOI 10.1016/j.jsgi.2005.02.011; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RIKKE BA, 1995, GENETICS, V139, P901; ROGERS JF, 1970, J REPROD FERTIL, V21, P255; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sandell LL, 2003, P NATL ACAD SCI USA, V100, P4622, DOI 10.1073/pnas.0230424100; Schmidt JV, 2000, GENE DEV, V14, P1997; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Shi W, 2004, GENESIS, V39, P65, DOI 10.1002/gene.20027; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Tanaka K, 2001, ONCOLOGY-BASEL, V60, P268, DOI 10.1159/000055328; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Van den Veyver IB, 2006, HUM REPROD UPDATE, V12, P233, DOI 10.1093/humupd/dmk005; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; Vrana PB, 2007, J MAMMAL, V88, P5, DOI 10.1644/06-MAMM-S-013R1.1; Vrana PB, 2006, METH MOLEC MED, V121, P439; Vrana PB, 2000, NAT GENET, V25, P120, DOI 10.1038/75518; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Vrana PB, 2001, DEV GENES EVOL, V211, P523, DOI 10.1007/s00427-001-0188-x; WAKE N, 1978, J NATL CANCER I, V60, P51, DOI 10.1093/jnci/60.1.51; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Zaitoun I, 2008, J ANIM SCI, V86, P25, DOI 10.2527/jas.2007-0150	78	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3572	10.1371/journal.pone.0003572	http://dx.doi.org/10.1371/journal.pone.0003572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958286	Green Published, gold			2022-12-25	WOS:000265131100025
J	Michlewska, S; Dransfield, I; Megson, IL; Rossi, AG				Michlewska, Sylwia; Dransfield, Ian; Megson, Ian L.; Rossi, Adriano G.			Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha	FASEB JOURNAL			English	Article						efferocytosis; interleukin-10; glucocorticoids; soluble TNF-receptors	NF-KAPPA-B; RHEUMATOID-ARTHRITIS; IN-VITRO; PROINFLAMMATORY CYTOKINES; THERAPEUTIC TARGET; AGING NEUTROPHILS; CELLS; RESOLUTION; CLEARANCE; KINASE	Apoptosis of inflammatory cells and their subsequent clearance (efferocytosis) by macrophages (M phi s) are key mechanisms orchestrating successful resolution of inflammation. Although the powerful proinflammatory agents lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNF-alpha) influence rates of inflammatory cell apoptosis, little is known about their effects on efferocytosis. We have demonstrated that LPS and TNF-alpha potently inhibit efferocytosis of neutrophils by monocyte-derived M phi s. Inhibition was both concentration and time dependent, although the effect of TNF-alpha was more rapid. We have found that soluble TNF receptor-I attenuated LPS inhibition of phagocytosis, indicating that TNF-alpha production is critical. Inhibition of efferocytosis by LPS was found to be positively associated with M phi production of TNF-alpha, but negatively with interleukin-10 (IL-10) release. A critical role for IL-10 in the regulation of phagocytosis was suggested by 2 important findings: LPS inhibition was observed more rapidly in the presence of an antihuman IL-10 receptor-alpha antibody, and efferocytosis by IL-10-deficient M phi s was markedly reduced compared to wild-type M phi s. Furthermore, exogenous IL-10 and glucocorticoids reversed inhibitory effects of LPS on efferocytosis via suppression of TNF-alpha production. We suggest that efferocytosis is regulated in an autocrine manner by pro-and anti-inflammatory mediators, and the inflammatory milieu determines whether inflammation successfully resolves.-Michlewska, S., Dransfield, I., Megson, I. L., Rossi, A. G. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of proinflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J. 23, 844-854 (2009)	[Michlewska, Sylwia; Dransfield, Ian; Megson, Ian L.; Rossi, Adriano G.] Univ Edinburgh, Sch Med, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Michlewska, S (corresponding author), Univ Edinburgh, Sch Med, Queens Med Res Inst, MRC Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	s.michlewska@sms.ed.ac.uk	Megson, Ian L/K-2195-2012; Poubelle, Patrice E/G-6537-2013	Megson, Ian L/0000-0001-8287-2459; Dransfield, Ian/0000-0001-5848-7059	Medical Research Council [G0601481] Funding Source: Medline; MRC [G0601481] Funding Source: UKRI; Medical Research Council [G9900991B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BRENNAN FM, 1989, LANCET, V2, P244; Charles P, 1999, J IMMUNOL, V163, P1521; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; DE WMR, 1991, J EXP MED, V174, P1209; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fan H, 2003, CYTOKINE, V22, P126, DOI 10.1016/S1043-4666(03)00122-4; Feldmann M, 2005, J AUTOIMMUN, V25, P26, DOI 10.1016/j.jaut.2005.09.006; FELDMANN M, 1994, CIRC SHOCK, V43, P179; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Feldmann M, 1996, J INFLAMM, V47, P90; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Hart SP, 2004, J IMMUNOL, V172, P1882, DOI 10.4049/jimmunol.172.3.1882; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Liu YQ, 1999, J IMMUNOL, V162, P3639; MAINI RN, 1995, CLIN EXP IMMUNOL, V101, P207; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; McColl A, 2007, THESCIENTIFICWORLDJO, V7, P1165, DOI 10.1100/tsw.2007.224; McPhillips K, 2007, J IMMUNOL, V178, P8117, DOI 10.4049/jimmunol.178.12.8117; Michlewska S, 2007, AUTOIMMUNITY, V40, P267, DOI 10.1080/08916930701357208; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772_2772_2783; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ogden CA, 2005, J IMMUNOL, V174, P3015, DOI 10.4049/jimmunol.174.5.3015; REN Y, 1995, J IMMUNOL, V154, P2366; Ren Y, 2008, J IMMUNOL, V180, P4978, DOI 10.4049/jimmunol.180.7.4978; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rossi AG, 1998, J IMMUNOL, V160, P3562; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Ward C, 2005, EUR J IMMUNOL, V35, P2728, DOI 10.1002/eji.200425561; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144	41	148	152	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					844	854		10.1096/fj.08-121228	http://dx.doi.org/10.1096/fj.08-121228			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18971259	Green Submitted			2022-12-25	WOS:000265506300020
J	Sheldon, H; Andre, M; Legg, JA; Heal, P; Herbert, JM; Sainson, R; Sharma, AS; Kitajewski, JK; Heath, VL; Bicknell, R				Sheldon, Helen; Andre, Maud; Legg, John A.; Heal, Paul; Herbert, John M.; Sainson, Richard; Sharma, Anshula S.; Kitajewski, Jan K.; Heath, Victoria L.; Bicknell, Roy			Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors	FASEB JOURNAL			English	Article						roundabouts; angiogenesis; cell signaling	ROUNDABOUT RECEPTOR; N-WASP; GUIDANCE RECEPTORS; TUMOR ANGIOGENESIS; MAGIC ROUNDABOUT; SLIT; COMPLEX; MIDLINE; MIGRATION; PROTEIN	This study aimed to further elucidate the function of Roundabout proteins in endothelium. We show that both Robo1 and Robo4 are present in human umbilical vein endothelial cells (HUVECs) and have knocked expression down using small interfering RNA (siRNA) technology. Roundabout knockout endothelial cells were then studied in a variety of in vitro assays. We also performed a yeast 2-hybrid analysis using the intracellular domain of Robo4 as bait to identify interacting proteins and downstream signaling. Both Robo1 and Robo4 siRNA knockdown and transfection of Robo4-green fluorescent protein inhibited endothelial cell movement and disrupted tube formation on Matrigel. Consistent with a role in regulating cell movement, yeast 2-hybrid and glutathione-S-transferase pulldown analyses show Robo4 binding to a Wiskott-Aldrich syndrome protein (WASP), neural Wiskott-Aldrich syndrome protein, and WASP-interacting protein actin-nucleating complex. We have further shown that Robo1 forms a heterodimeric complex with Robo4, and that transfection of Robo4GFP into HUVECs induces filopodia formation. We finally show using Robo1 knockdown cells that Robo1 is essential for Robo4-mediated filopodia induction. Our results favor a model whereby Slit2 binding to a Robo1/Robo4 heterodimer activates actin nucleation-promoting factors to promote endothelial cell migration. - Sheldon, H., Andre, M., Legg, J. A., Heal, P., Herbert, J. M., Sainson, R., Sharma, A. S., Kitajewski, J. K., Heath, V. L., Bicknell, R. Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors. FASEB J. 23, 513-522 (2009)	[Bicknell, Roy] Univ Birmingham, Sch Med, Inst Biomed Res, Canc Res UK,Angiogenesis Grp, Birmingham B15 2TT, W Midlands, England; [Sheldon, Helen; Andre, Maud; Heal, Paul; Bicknell, Roy] Univ Oxford, Inst Mol Med, Mol Angiogenesis Grp, Canc Res UK, Oxford, England; [Sainson, Richard] Univ Oxford, Inst Mol Med, Growth Factor Grp, Canc Res UK, Oxford, England; [Sharma, Anshula S.; Kitajewski, Jan K.] Columbia Univ, Dept Pathol & OB GYN, New York, NY USA	Cancer Research UK; University of Birmingham; Cancer Research UK; University of Oxford; Cancer Research UK; University of Oxford; Columbia University	Bicknell, R (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Canc Res UK,Angiogenesis Grp, Birmingham B15 2TT, W Midlands, England.	r.bicknell@bham.ac.uk	Xiao, Yang/B-5668-2012	Sheldon, Helen/0000-0002-0945-5496; Bicknell, Roy/0000-0002-0941-8919	Cancer Research UK [A6766]; European Union [FP6 LSHC-CT-2003-503233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062454] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Cancer Research UK grant A6766 and European Union FP6 LSHC-CT-2003-503233 grant "STROMA." We thank Laura M. Machesky and Guillaume Bompard for the WASP and NWASP constructs. H. S., M. A., and J.A.L. contributed equally to the work. They designed and performed research and helped write the paper. P. H. designed and performed the modified Boyden chamber assay. J.M.H. carried out the bioinformatics analysis of the yeast 2-hybrid experiments. A.S.N. made recombinant adenoviruses (vital new reagents). J.K.K. advised on the design of experiments. V. L. H. assisted with some experiments and helped write the paper. R. B. conceived and supervised the entire project, including the writing of the paper.	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X	31	93	102	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					513	522		10.1096/fj.07-098269	http://dx.doi.org/10.1096/fj.07-098269			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18948384	Green Published			2022-12-25	WOS:000262892900023
J	Mene-Saffrane, L; Dubugnon, L; Chetelat, A; Stolz, S; Gouhier-Darimont, C; Farmer, EE				Mene-Saffrane, Laurent; Dubugnon, Lucie; Chetelat, Aurore; Stolz, Stephanie; Gouhier-Darimont, Caroline; Farmer, Edward E.			Nonenzymatic Oxidation of Trienoic Fatty Acids Contributes to Reactive Oxygen Species Management in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; SIGNAL-TRANSDUCTION; SALICYLIC-ACID; DEFENSE; MUTANT; PATHWAYS; RESISTANCE; JASMONATE; STRESS; EXPRESSION	In higher plants such as Arabidopsis thaliana, omega-3 trienoic fatty acids (TFAs), represented mainly by alpha-linolenic acid, serve as precursors of jasmonic acid (JA), a potent lipid signal molecule essential for defense. The JA-independent roles of TFAs were investigated by comparing the TFA- and JA-deficient fatty acid desaturase triple mutant (fad3-2 fad7-2 fad8 (fad3 fad7 fad8)) with the aos (allene oxide synthase) mutant that contains TFAs but is JA-deficient. When challenged with the fungus Botrytis, resistance of the fad3 fad7 fad8 mutant was reduced when compared with the aos mutant, suggesting that TFAs play a role in cell survival independently of being the precursors of JA. An independent genetic approach using the lesion mimic mutant accelerated cell death2 (acd2-2) confirmed the importance of TFAs in containing lesion spread, which was increased in the lines in which the fad3 fad7 fad8 and acd2-2 mutations were combined when compared with the aos acd2-2 lines. Malondialdehyde, found to result from oxidative TFA fragmentation during lesion formation, was measured by gas chromatography-mass spectrometry. Its levels correlated with the survival of the tissue. Furthermore, plants lacking TFAs overproduced salicylic acid (SA), hydrogen peroxide, and transcripts encoding several SA-regulated and SA biosynthetic proteins. The data suggest a physiological role for TFAs as sinks for reactive oxygen species.	[Mene-Saffrane, Laurent; Dubugnon, Lucie; Chetelat, Aurore; Stolz, Stephanie; Gouhier-Darimont, Caroline; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Mène-Saffrané, Laurent/A-7440-2013; Farmer, Edward E/H-1635-2011	Mène-Saffrané, Laurent/0000-0002-1763-7871; 	Swiss National Science Foundation (NSF); University of Lausanne genomics; Swiss NSF [3100A0101711]	Swiss National Science Foundation (NSF)(Swiss National Science Foundation (SNSF)); University of Lausanne genomics; Swiss NSF(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Foundation (NSF) (National Center of Competence in Research "Plant Survival"), a University of Lausanne genomics grant, and Swiss NSF Grant 3100A0101711. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Frankel E. N., 2005, OILY PRESS LIPID LIB, V18; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; HARWOOD JL, 1987, METHOD ENZYMOL, V148, P475; HARWOOD JL, 1982, BIOCH PLANTS COMPREH, V4; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Poulson ME, 2002, PHOTOSYNTH RES, V72, P55, DOI 10.1023/A:1016054027464; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Rozhon W, 2005, ANAL BIOANAL CHEM, V382, P1620, DOI 10.1007/s00216-005-3326-x; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Shah J, 2001, PLANT J, V25, P563, DOI 10.1046/j.1365-313x.2001.00992.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yeo HC, 1999, METHOD ENZYMOL, V300, P70	40	79	82	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1702	1708		10.1074/jbc.M807114200	http://dx.doi.org/10.1074/jbc.M807114200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996838	hybrid			2022-12-25	WOS:000262330100039
J	Ju, PC; Pages, G; Riek, RP; Chen, PC; Torres, AM; Bansal, PS; Kuyucak, S; Kuchel, PW; Vandenberg, JI				Ju, Pengchu; Pages, Guilhem; Riek, R. Peter; Chen, Po-chia; Torres, Allan M.; Bansal, Paramjit S.; Kuyucak, Serdar; Kuchel, Philip W.; Vandenberg, Jamie I.			The Pore Domain Outer Helix Contributes to Both Activation and Inactivation of the hERG K+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; MOLECULAR-DYNAMICS; BIOLOGICAL MACROMOLECULES; CARDIAC-ARRHYTHMIA; NMR-SPECTROSCOPY; ALPHA-HELIX; PROTEINS; IDENTIFICATION; RECTIFICATION; SENSITIVITY	Ion flow in many voltage-gated K+ channels (VGK), including the (human ether-a-go-go-related gene) hERG channel, is regulated by reversible collapse of the selectivity filter. hERG channels, however, exhibit low sequence homology to other VGKs, particularly in the outer pore helix (S5) domain, and we hypothesize that this contributes to the unique activation and inactivation kinetics in hERG K+ channels that are so important for cardiac electrical activity. The S5 domain in hERG identified by NMR spectroscopy closely corresponded to the segment predicted by bioinformatics analysis of 676 members of the VGK superfamily. Mutations to approximately every third residue, from Phe(551) to Trp(563), affected steady state activation, whereas mutations to approximately every third residue on an adjacent face and spanning the entire S5 segment perturbed inactivation, suggesting that the whole span of S5 experiences a rearrangement associated with inactivation. We refined a homology model of the hERG pore domain using constraints from the mutagenesis data with residues affecting inactivation pointing in toward S6. In this model the three residues with maximum impact on activation (W563A, F559A, and F551A) face out toward the voltage sensor. In addition, the residues that when mutated to alanine, or from alanine to valine, that did not express (Ala(561), His(562), Ala(565), Trp(568), and Ile(571)), all point toward the pore helix and contribute to close hydrophobic packing in this region of the channel.	[Ju, Pengchu; Riek, R. Peter; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Div Mol Cardiol & Biophys, Darlinghurst, NSW 2010, Australia; [Ju, Pengchu; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Pages, Guilhem; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Chen, Po-chia; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Torres, Allan M.] Univ Western Sydney, Sch Biomed & Hlth Sci, Penrith, NSW 1797, Australia; [Bansal, Paramjit S.] Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Sydney; University of Sydney; Western Sydney University; Australian Nuclear Science & Technology Organisation	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Div Mol Cardiol & Biophys, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Torres, Allan/GSN-4624-2022; Chen, Po-chia/J-4521-2019; Kuyucak, Serdar/AAH-8417-2021; Vandenberg, Jamie I/B-6608-2013; Pages, Guilhem/B-5422-2010	Chen, Po-chia/0000-0003-2272-2082; Vandenberg, Jamie I/0000-0002-3859-3716; Pages, Guilhem/0000-0001-9368-5237; Kuchel, Philip/0000-0003-4100-7332; Kuyucak, Serdar/0000-0003-4315-9532	National Health and Medical Research Council [459002]; Australian Research Council [DP0450808]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Project Grant 459002 from the National Health and Medical Research Council (to J. I. V. and S. K.) and Project Grant DP0450808 from the Australian Research Council (to P. W. K. and J. I. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHCROFT FM, 2001, ION CHANNELS DIS; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2007, P NATL ACAD SCI USA, V104, P13827, DOI 10.1073/pnas.0703934104; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; RIEK RP, 1995, J THEOR BIOL, V172, P245; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider R, 2008, J AM CHEM SOC, V130, P7427, DOI 10.1021/ja800190c; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zangger K, 2008, TOXICON, V52, P246, DOI 10.1016/j.toxicon.2008.05.011	51	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1000	1008		10.1074/jbc.M806400200	http://dx.doi.org/10.1074/jbc.M806400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18996846	Green Published, hybrid			2022-12-25	WOS:000262122900036
J	Stevens, C; Lin, Y; Harrison, B; Burch, L; Ridgway, RA; Sansom, O; Hupp, T				Stevens, Craig; Lin, Yao; Harrison, Ben; Burch, Lindsay; Ridgway, Rachel A.; Sansom, Owen; Hupp, Ted			Peptide Combinatorial Libraries Identify TSC2 as a Death-associated Protein Kinase (DAPK) Death Domain-binding Protein and Reveal a Stimulatory Role for DAPK in mTORC1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; INDUCED APOPTOSIS; GENE-PRODUCTS; CELL-DEATH; PHOSPHORYLATION; AUTOPHAGY; SURVIVAL; ERK; S6; IDENTIFICATION	Death-associated protein kinase (DAPK) is a multidomain enzyme that plays a central role in autophagic and apoptotic signaling, although the protein-protein interactions regulating DAPK functions are not well defined. Peptide aptamer libraries were used to identify the tumor suppressor protein tuberin (TSC2) as a novel DAPK death domain-binding protein, and we evaluated whether DAPK is a positive or negative effector of the TSC2-regulated mammalian target of rapamycin (mTORC1) signaling pathway. Binding studies using death domain miniproteins invitro and deletion analysis in vivo determined that the death domain of DAPK is the major site for the interaction with TSC2. Recombinant DAPK phosphorylates TSC2 in vitro, and DAPK kinase activity is stimulated by growth factor signaling. Transfection of DAPK promotes phosphorylation of TSC2 in vivo, whereas short interfering RNA-mediated attenuation of DAPK reduces growth factor-stimulated phosphorylation of TSC2. DAPK-dependent phosphorylation leads to TSC1-TSC2 complex dissociation, and consequently manipulation of DAPK by transfection or short interfering RNA demonstrated that DAPK is a positive regulator of mTORC1 in response to growth factor activation. Epistatic studies suggest that DAPK functions downstream from the RAS-MEK-ERK and phosphatidylinositol 3-kinase-AKT growth factor signaling pathways. DAPK(+/-) mouse embryo fibroblasts have attenuated mTORC1 signaling compared with DAPK(+/+) counterparts, and overexpression of DAPK in DAPK(+/-) MEFs stimulates mTORC1 activity. These data uncover a novel interaction between DAPK and TSC2 proteins that has revealed a positive link between growth factor stimulation of DAPK and mTORC1 signaling that may ultimately affect autophagy, cell survival, or apoptosis.	[Stevens, Craig; Lin, Yao; Harrison, Ben; Burch, Lindsay; Hupp, Ted] Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Labs P53, Edinburgh EH4 2XR, Midlothian, Scotland; [Ridgway, Rachel A.; Sansom, Owen] CRUK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Edinburgh; Beatson Institute	Hupp, T (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Labs P53, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		, yao/0000-0002-0493-0155; Sansom, Owen J./0000-0001-9540-3010; Harrison, Benjamin/0000-0002-6078-5060	Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium	Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bialik S, 2004, CELL DEATH DIFFER, V11, P631, DOI 10.1038/sj.cdd.4401386; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cohen O, 1999, J CELL BIOL, V146, P141; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; Henshall DC, 2003, J NEUROCHEM, V86, P1260, DOI 10.1046/j.1471-4159.2003.01934.x; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200; Jin YJ, 2003, J BIOL CHEM, V278, P51587, DOI 10.1074/jbc.M309165200; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kuo JC, 2003, J CELL SCI, V116, P4777, DOI 10.1242/jcs.00794; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lin Y, 2007, J BIOL CHEM, V282, P16792, DOI 10.1074/jbc.M611559200; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schumacher AM, 2006, BIOCHEMISTRY-US, V45, P13614, DOI 10.1021/bi060413y; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wang WJ, 2007, MOL CELL, V27, P701, DOI 10.1016/j.molcel.2007.06.037	43	66	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					334	344		10.1074/jbc.M805165200	http://dx.doi.org/10.1074/jbc.M805165200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974095	hybrid			2022-12-25	WOS:000261974800038
J	Sakr, SW; Potter-Perigo, S; Kinsella, MG; Johnson, PY; Braun, KR; Goueffic, Y; Rosenfeld, ME; Wight, TN				Sakr, Sana W.; Potter-Perigo, Susan; Kinsella, Michael G.; Johnson, Pamela Y.; Braun, Kathleen R.; Goueffic, Yann; Rosenfeld, Michael E.; Wight, Thomas N.			Hyaluronan Accumulation Is Elevated in Cultures of Low Density Lipoprotein Receptor-deficient Cells and Is Altered by Manipulation of Cell Cholesterol Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELL; FAT-FED RABBITS; ENDOPLASMIC-RETICULUM STRESS; WHHL-RABBIT; FAMILIAL HYPERCHOLESTEROLEMIA; PLASMA-MEMBRANE; ANIMAL-MODEL; LDL RECEPTOR; GLYCOSAMINOGLYCAN SYNTHESIS; ATHEROSCLEROTIC LESIONS	The extracellular matrix molecule hyaluronan (HA) accumulates in human atherosclerotic lesions. Yet the reasons for this accumulation have not been adequately addressed. Because abnormalities in lipid metabolism promote atherosclerosis, we have asked whether disrupted cholesterol homeostasis alters HA accumulation in low density lipoprotein receptor-deficient cell cultures. Cultured aortic smooth muscle cells (ASMC) from Watanabe heritable hyperlipidemic (WHHL) rabbits and skin fibroblasts from homozygous patients with familial hypercholesterolemia accumulated 2-4-fold more HA than corresponding cells from age- and sex-matched normolipidemic rabbits and individuals. This occurred in both cell-associated and secreted HA fractions and was independent of cell density or medium serum concentration. WHHL ASMC cultures synthesized twice the proportion of high molecular mass HA(> 2 x 10(6) Da) as normal rabbit ASMC but showed a lower capacity to degrade exogenous [H-3] HA. Most importantly, cholesterol depletion or blocking cholesterol synthesis markedly reduced HA accumulation in WHHL ASMC cultures, whereas cholesterol replenishment or stimulation of cholesterol synthesis restored elevated HA levels. We conclude the following: 1) maintaining normal HA levels in cell cultures requires normal cell cholesterol homeostasis; 2) HA degradation may contribute to but is not the predominant mechanism to increase high molecular mass HA accumulation in low density lipoprotein receptor-deficient WHHL ASMC cultures; and 3) elevated accumulation of HA depends on cellular or membrane cholesterol content and, potentially, intact cholesterol-rich microdomains.	[Sakr, Sana W.; Potter-Perigo, Susan; Kinsella, Michael G.; Johnson, Pamela Y.; Braun, Kathleen R.; Goueffic, Yann; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Nutr, Seattle, WA 98195 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Goueffic, Yann/L-7438-2015		National Institutes of Health [HL 18645, DK 02456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 18645 and DK 02456. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGREN UM, 1994, ANAL BIOCHEM, V217, P311, DOI 10.1006/abio.1994.1124; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BJORKERUD S, 1995, BBA-MOL CELL RES, V1268, P237, DOI 10.1016/0167-4889(95)00065-Z; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chajara A, 2001, ATHEROSCLEROSIS, V157, P293, DOI 10.1016/S0021-9150(00)00727-9; Chajara A, 2000, ARTERIOSCL THROM VAS, V20, P1480, DOI 10.1161/01.ATV.20.6.1480; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Christian AE, 1997, J LIPID RES, V38, P2264; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dattilo JB, 1998, ANN VASC SURG, V12, P168, DOI 10.1007/s100169900136; ECSEDI GG, 1986, METHOD FIND EXP CLIN, V8, P535; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 1998, AM J PATHOL, V152, P533; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; FU ST, 1972, ARCH PATHOL, V94, P466; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; IKEDA U, 1994, ATHEROSCLEROSIS, V110, P87, DOI 10.1016/0021-9150(94)90071-X; Ilangumaran S, 1998, BLOOD, V91, P3901; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kaneko E, 2000, CORONARY ARTERY DIS, V11, P599, DOI 10.1097/00019501-200012000-00005; KITA T, 1981, P NATL ACAD SCI-BIOL, V78, P2268, DOI 10.1073/pnas.78.4.2268; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEVESQUE H, 1994, ATHEROSCLEROSIS, V105, P51, DOI 10.1016/0021-9150(94)90007-8; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; MCGUIRE PG, 1987, J CELL PHYSIOL, V133, P267, DOI 10.1002/jcp.1041330210; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Papakonstantinou E, 1998, ATHEROSCLEROSIS, V138, P79, DOI 10.1016/S0021-9150(98)00006-9; PHILIPSON LH, 1984, J BIOL CHEM, V259, P5017; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; ROSENFELD ME, 1987, ARTERIOSCLEROSIS, V7, P9, DOI 10.1161/01.ATV.7.1.9; ROSENFELD ME, 1987, ARTERIOSCLEROSIS, V7, P24, DOI 10.1161/01.ATV.7.1.24; ROSENFELD ME, 1988, ARTERIOSCLEROSIS, V8, P338, DOI 10.1161/01.ATV.8.4.338; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; SCOTT LJ, 1987, ATHEROSCLEROSIS, V63, P145, DOI 10.1016/0021-9150(87)90114-6; Seike M, 2006, J DERMATOL SCI, V41, P197, DOI 10.1016/j.jdermsci.2005.10.008; Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038; SHIMADA Y, 1981, EUR J BIOCHEM, V118, P557, DOI 10.1111/j.1432-1033.1981.tb05555.x; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; SRINIVASAN SR, 1980, ATHEROSCLEROSIS, V36, P25, DOI 10.1016/0021-9150(80)90195-1; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; TANZAWA K, 1980, FEBS LETT, V118, P81, DOI 10.1016/0014-5793(80)81223-3; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; WATANABE Y, 1980, ATHEROSCLEROSIS, V36, P261, DOI 10.1016/0021-9150(80)90234-8; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WIECZOREK AJ, 1985, ARTERIOSCLEROSIS, V5, P434, DOI 10.1161/01.ATV.5.5.434; WIGHT TN, 1999, GLYCOFORUM; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	77	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36195	36204		10.1074/jbc.M807772200	http://dx.doi.org/10.1074/jbc.M807772200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948257	hybrid, Green Published			2022-12-25	WOS:000261840500014
J	Kimman, TG; Banus, S; Reijmerink, N; Reimerink, J; Stelma, FF; Koppelman, GH; Thijs, C; Postma, DS; Kerkhof, M				Kimman, Tjeerd G.; Banus, Sander; Reijmerink, Naomi; Reimerink, Johan; Stelma, Foekje F.; Koppelman, Gerard H.; Thijs, Carel; Postma, Dirkje S.; Kerkhof, Marjan			Association of Interacting Genes in the Toll-Like Receptor Signaling Pathway and the Antibody Response to Pertussis Vaccination	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; BORDETELLA-PERTUSSIS; TLR4 POLYMORPHISMS; CELL RESPONSES; INFECTION; OX40; ACTIVATION; DISEASE; MICE; CD14	Background: Activation of the Toll-like receptor (TLR) signaling pathway through TLR4 may be important in the induction of protective immunity against Bordetella pertussis with TLR4-mediated activation of dendritic and B cells, induction of cytokine expression, and reversal of tolerance as crucial steps. We examined whether single nucleotide polymorphisms (SNPs) in genes of the TLR4 pathway and their interaction are associated with the response to whole-cell vaccine (WCV) pertussis vaccination in 490 one-year-old children. Methodology/Principal Findings: We analyzed associations of 75 haplotype-tagging SNPs in genes in the TLR4 signaling pathway with pertussis toxin (PT)-IgG titers. We found significant associations between the PT-IgG titer and SNPs in CD14, TLR4, TOLLIP, TIRAP, IRAK3, IRAK4, TICAM1, and TNFRSF4 in one or more of the analyses. The strongest evidence for association was found for two SNPs (rs5744034 and rs5743894) in TOLLIP that were almost completely in linkage disequilibrium, provided statistically significant associations in all tests with the lowest p-values, and displayed a dominant mode of inheritance. However, none of these single gene associations would withstand correction for multiple testing. In addition, Multifactor Dimensionality Reduction Analysis, an approach that does not need correction for multiple testing, showed significant and strong two and three locus interactions between SNPs in TOLLIP (rs4963060), TLR4 (rs6478317) and IRAK1 (rs1059703). Conclusions/Significance: We have identified significant interactions between genes in the TLR pathway in the induction of vaccine-induced immunity. These interactions underline that these genes are functionally related and together form a true biological relationship in a protein-protein interaction network. Practically all our findings may be explained by genetic variation in directly or indirectly interacting proteins at the extra-and intracytoplasmic sites of the cell membrane of antigen-presenting cells, B cells, or both. Fine tuning of interacting proteins in the TLR pathway appears important for the induction of an optimal vaccine response.	[Kimman, Tjeerd G.; Banus, Sander; Reimerink, Johan] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Kimman, Tjeerd G.] Cent Vet Inst, Lelystad, Netherlands; [Reijmerink, Naomi; Postma, Dirkje S.] Univ Groningen, Med Ctr, Dept Pulmonol, Groningen, Netherlands; [Stelma, Foekje F.] Acad Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Med Ctr, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Thijs, Carel] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht Nutrim, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, Maastricht, Netherlands; [Kerkhof, Marjan] Univ Groningen, Med Ctr, Dept Epidemiol, NL-9700 AB Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Maastricht University; University of Groningen	Kimman, TG (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	tg.kimman@rivm.nl	Thijs, Carel/H-8340-2019; Koppelman, Gerard/AAG-9187-2020	Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252				Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Banus HA, 2006, INFECT IMMUN, V74, P2596, DOI 10.1128/IAI.74.5.2596-2605.2006; Banus S, 2007, CLIN VACCINE IMMUNOL, V14, P1377, DOI 10.1128/CVI.00175-07; Banus S, 2007, IMMUNOGENETICS, V59, P555, DOI 10.1007/s00251-007-0227-5; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bruss JB, 2002, INFECT IMMUN, V70, P4600, DOI 10.1128/IAI.70.8.4600-4608.2002; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dudbridge Frank, 2006, Human Genomics, V2, P310; Elston RC, 2006, STAT MED, V25, P3049, DOI 10.1002/sim.2650; Girard Dorota Z, 2002, Paediatr Drugs, V4, P299, DOI 10.2165/00128072-200204050-00003; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hori T, 2006, INT J HEMATOL, V83, P17, DOI 10.1532/IJH97.05151; Humphreys IR, 2003, J EXP MED, V198, P1237, DOI 10.1084/jem.20030351; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Kimman T.G., 2001, GENETICS INFECT DIS; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Moore JH, 2008, EUR J HUM GENET, V16, P143, DOI 10.1038/sj.ejhg.5201936; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Munks MW, 2004, IMMUNOLOGY, V112, P559, DOI 10.1111/j.1365-2567.2004.01917.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sabatti Chiara, 2007, Methods Mol Biol, V376, P195; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shin HJ, 2007, MOL CELLS, V24, P119; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; van Buuren S., 1999, PGVGZ99054 TNO; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	50	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3665	10.1371/journal.pone.0003665	http://dx.doi.org/10.1371/journal.pone.0003665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987746	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134500010
J	Rajagovindan, R; Ding, MZ				Rajagovindan, Rajasimhan; Ding, Mingzhou			Decomposing Neural Synchrony: Toward an Explanation for Near-Zero Phase-Lag in Cortical Oscillatory Networks	PLOS ONE			English	Article							GRANGER CAUSALITY; VISUOMOTOR INTEGRATION; NEURONAL OSCILLATIONS; BETA-OSCILLATIONS; FREQUENCIES; MECHANISM; COHERENCE; DYNAMICS; BINDING; CORTEX	Background: Synchronized oscillation in cortical networks has been suggested as a mechanism for diverse functions ranging from perceptual binding to memory formation to sensorimotor integration. Concomitant with synchronization is the occurrence of near-zero phase-lag often observed between network components. Recent theories have considered the importance of this phenomenon in establishing an effective communication framework among neuronal ensembles. Methodology/Principal Findings: Two factors, among possibly others, can be hypothesized to contribute to the near-zero phase-lag relationship: (1) positively correlated common input with no significant relative time delay and (2) bidirectional interaction. Thus far, no empirical test of these hypotheses has been possible for lack of means to tease apart the specific causes underlying the observed synchrony. In this work simulation examples were first used to illustrate the ideas. A quantitative method that decomposes the statistical interdependence between two cortical areas into a feed-forward, a feed-back and a common-input component was then introduced and applied to test the hypotheses on multichannel local field potential recordings from two behaving monkeys. Conclusion/Significance: The near-zero phase-lag phenomenon is important in the study of large-scale oscillatory networks. A rigorous mathematical theorem is used for the first time to empirically examine the factors that contribute to this phenomenon. Given the critical role that oscillatory activity is likely to play in the regulation of biological processes at all levels, the significance of the proposed method may extend beyond systems neuroscience, the level at which the present analysis is conceived and performed.	[Rajagovindan, Rajasimhan; Ding, Mingzhou] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Rajagovindan, R (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	mingzhou.ding@bme.ufl.edu			NIH [MH079388, MH070498]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070498, R01MH079388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grants MH079388 and MH070498.	Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cassidy M, 2003, J NEUROSCI METH, V127, P95, DOI 10.1016/S0165-0270(03)00129-8; Chawla D, 2001, NEURAL NETWORKS, V14, P727, DOI 10.1016/S0893-6080(01)00043-0; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Liang HL, 2002, NEUROREPORT, V13, P2011, DOI 10.1097/00001756-200211150-00004; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; MACKLIN JT, 1982, MON NOT R ASTRON SOC, V199, P1119, DOI 10.1093/mnras/199.4.1119; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Slotnick SD, 2002, P NATL ACAD SCI USA, V99, P6440, DOI 10.1073/pnas.092514899; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X; Wang X, 2008, NEUROIMAGE, V41, P767, DOI 10.1016/j.neuroimage.2008.03.025; Wang X, 2007, INT J NEURAL SYST, V17, P71, DOI 10.1142/S0129065707000944; Witham CL, 2007, EUR J NEUROSCI, V26, P2677, DOI 10.1111/j.1460-9568.2007.05890.x; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wu JH, 2008, J NEUROSCI METH, V167, P367, DOI 10.1016/j.jneumeth.2007.08.022; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	42	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3649	10.1371/journal.pone.0003649	http://dx.doi.org/10.1371/journal.pone.0003649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987745	Green Published, gold, Green Submitted			2022-12-25	WOS:000265134500001
J	Chou, CJ; O'Hare, T; Lefebvre, S; Alvarez, D; Tyner, JW; Eide, CA; Druker, BJ; Gottesfeld, JM				Chou, C. James; O'Hare, Thomas; Lefebvre, Sophie; Alvarez, David; Tyner, Jeffrey W.; Eide, Christopher A.; Druker, Brian J.; Gottesfeld, Joel M.			Growth Arrest of BCR-ABL Positive Cells with a Sequence-Specific Polyamide-Chlorambucil Conjugate	PLOS ONE			English	Article								Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome. Imatinib, a selective inhibitor of the Bcr-Abl tyrosine kinase, has significantly improved the clinical outcome of patients with CML. However, subsets of patients lose their response to treatment through the emergence of imatinib-resistant cells, and imatinib treatment is less durable for patients with late stage CML. Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance, a cocktail therapy of different kinase inhibitors and additional chemotherapeutics may be needed for complete remission of CML in some cases. Chlorambucil has been used for treatment of B cell chronic lymphocytic leukemia, non-Hodgkin's and Hodgkin's disease. Here we report that a DNA sequence-specific pyrrole-imidazole polyamide-chlorambucil conjugate, 1R-Chl, causes growth arrest of cells harboring both unmutated BCR-ABL and three imatinib resistant strains. 1R-Chl also displays selective toxicities against activated lymphocytes and a high dose tolerance in a murine model.	[Chou, C. James; Lefebvre, Sophie; Alvarez, David; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [O'Hare, Thomas; Tyner, Jeffrey W.; Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Canc Inst, Div Hematol & Med Oncol, Portland, OR USA	Scripps Research Institute; Oregon Health & Science University	Chou, CJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu	Chou, C. James/I-6563-2012	Gottesfeld, Joel/0000-0002-4643-5777; Eide, Christopher/0000-0001-8835-8928; Tyner, Jeffrey/0000-0002-2133-0960; Druker, Brian/0000-0001-8331-8206	National Cancer Institute [CA107311]; Defense [CM043013]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA107311] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Defense; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant CA107311 and Defense grant CM043013 (Joel M. Gottesfeld), and Howard Hughes Medical Institute (Brian J. Druker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2006, CELL CYCLE, V5, P1537, DOI 10.4161/cc.5.14.2913; Brooks N, 1997, BIOORGAN MED CHEM, V5, P1497, DOI 10.1016/S0968-0896(97)00096-5; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chou CJ, 2008, MOL CANCER THER, V7, P769, DOI 10.1158/1535-7163.MCT-08-0130; Deininger MWN, 2000, CANCER RES, V60, P2049; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Farkas ME, 2007, BIOORGAN MED CHEM, V15, P6927, DOI 10.1016/j.bmc.2007.07.019; Jahagirdar BN, 2001, EXP HEMATOL, V29, P543, DOI 10.1016/S0301-472X(01)00633-6; Lockhart AC, 2004, CLIN CANCER RES, V10, P468, DOI 10.1158/1078-0432.CCR-0658-03; Nicolle A, 2004, LEUKEMIA LYMPHOMA, V45, P271, DOI 10.1080/10428190310001595704; Nimmanapalli R, 2002, CURR OPIN ONCOL, V14, P616, DOI 10.1097/00001622-200211000-00005; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Oyoshi T, 2003, J AM CHEM SOC, V125, P4752, DOI 10.1021/ja029196o; Robak T, 2002, LEUKEMIA, V16, P1015, DOI 10.1038/sj.leu.2402531; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shinohara K, 2004, J AM CHEM SOC, V126, P5113, DOI 10.1021/ja031673v; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tsai SM, 2007, NUCLEIC ACIDS RES, V35, P307, DOI 10.1093/nar/gkl1025; Urbaniak MD, 2004, J MED CHEM, V47, P4710, DOI 10.1021/jm040790d; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Weiss GR, 1998, CLIN CANCER RES, V4, P53; Wurtz NR, 2000, CHEM BIOL, V7, P153, DOI 10.1016/S1074-5521(00)00085-5	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3593	10.1371/journal.pone.0003593	http://dx.doi.org/10.1371/journal.pone.0003593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974832	gold, Green Submitted, Green Published			2022-12-25	WOS:000265131700014
J	Ogurtsov, AY; Marino-Ramirez, L; Johnson, GR; Landsman, D; Shabalina, SA; Spiridonov, NA				Ogurtsov, Aleksey Y.; Marino-Ramirez, Leonardo; Johnson, Gibbes R.; Landsman, David; Shabalina, Svetlana A.; Spiridonov, Nikolay A.			Expression Patterns of Protein Kinases Correlate with Gene Architecture and Evolutionary Rates	PLOS ONE			English	Article								Background: Protein kinase (PK) genes comprise the third largest superfamily that occupy similar to 2% of the human genome. They encode regulatory enzymes that control a vast variety of cellular processes through phosphorylation of their protein substrates. Expression of PK genes is subject to complex transcriptional regulation which is not fully understood. Principal Findings: Our comparative analysis demonstrates that genomic organization of regulatory PK genes differs from organization of other protein coding genes. PK genes occupy larger genomic loci, have longer introns, spacer regions, and encode larger proteins. The primary transcript length of PK genes, similar to other protein coding genes, inversely correlates with gene expression level and expression breadth, which is likely due to the necessity to reduce metabolic costs of transcription for abundant messages. On average, PK genes evolve slower than other protein coding genes. Breadth of PK expression negatively correlates with rate of non-synonymous substitutions in protein coding regions. This rate is lower for high expression and ubiquitous PKs, relative to low expression PKs, and correlates with divergence in untranslated regions. Conversely, rate of silent mutations is uniform in different PK groups, indicating that differing rates of non-synonymous substitutions reflect variations in selective pressure. Brain and testis employ a considerable number of tissue-specific PKs, indicating high complexity of phosphorylation-dependent regulatory network in these organs. There are considerable differences in genomic organization between PKs up-regulated in the testis and brain. PK genes up-regulated in the highly proliferative testicular tissue are fast evolving and small, with short introns and transcribed regions. In contrast, genes up-regulated in the minimally proliferative nervous tissue carry long introns, extended transcribed regions, and evolve slowly. Conclusions/Significance: PK genomic architecture, the size of gene functional domains and evolutionary rates correlate with the pattern of gene expression. Structure and evolutionary divergence of tissue-specific PK genes is related to the proliferative activity of the tissue where these genes are predominantly expressed. Our data provide evidence that physiological requirements for transcription intensity, ubiquitous expression, and tissue-specific regulation shape gene structure and affect rates of evolution.	[Ogurtsov, Aleksey Y.; Marino-Ramirez, Leonardo; Landsman, David; Shabalina, Svetlana A.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Johnson, Gibbes R.; Spiridonov, Nikolay A.] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Proteins, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA)	Ogurtsov, AY (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	shabalin@ncbi.nlm.nih.gov; nikolay.spiridonov@fda.hhs.gov	Mariño-Ramírez, Leonardo/N-5395-2019; Mariño-Ramírez, Leonardo/I-5759-2013; Shabalina, Svetlana/N-8939-2013; Spiridonov, Nikolay/B-6287-2014; Landsman, David/GZK-5496-2022; Landsman, David/C-5923-2009	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Shabalina, Svetlana/0000-0003-2272-7473; Landsman, David/0000-0002-9819-6675	Intramural Research Program of the National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM000084] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; Bernat JA, 2006, HUM MOL GENET, V15, P2098, DOI 10.1093/hmg/ddl133; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Borck G, 2006, HUM MUTAT, V27, P731, DOI 10.1002/humu.20380; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CHEN KH, 1993, FEBS LETT, V325, P210, DOI 10.1016/0014-5793(93)81075-B; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Crocitto LE, 1997, J UROLOGY, V158, P1599, DOI 10.1016/S0022-5347(01)64287-3; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GODBOUT M, 1994, J NEUROSCI, V14, P1; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2000, CURR BIOL, V10, pR757, DOI 10.1016/S0960-9822(00)00744-2; HARDIE DG, 1994, CELL SIGNAL, V6, P813; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochetov AV, 1998, FEBS LETT, V440, P351, DOI 10.1016/S0014-5793(98)01482-3; Kondrashov AS, 2002, HUM MOL GENET, V11, P669, DOI 10.1093/hmg/11.6.669; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Nakayama T, 2006, HYPERTENSION, V48, P512, DOI 10.1161/01.HYP.0000233877.84343.d7; NAZIPOVA NN, 1995, COMPUT APPL BIOSCI, V11, P423; Ogurtsov AY, 2002, BIOINFORMATICS, V18, P1703, DOI 10.1093/bioinformatics/18.12.1703; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Quintaje SB, 2008, MOL CELL PROTEOMICS, V7, P1409, DOI 10.1074/mcp.R700001-MCP200; Sgourou A, 2004, BRIT J HAEMATOL, V124, P828, DOI 10.1111/j.1365-2141.2004.04835.x; Shabalina SA, 1999, GENET RES, V74, P23, DOI 10.1017/S0016672399003821; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Shabalina SA, 2003, NUCLEIC ACIDS RES, V31, P5433, DOI 10.1093/nar/gkg751; Shabalina SA, 2001, TRENDS GENET, V17, P373, DOI 10.1016/S0168-9525(01)02344-7; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; SUNYER T, 1990, P NATL ACAD SCI USA, V87, P278, DOI 10.1073/pnas.87.1.278; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Tanaka H, 2001, MOL HUM REPROD, V7, P211, DOI 10.1093/molehr/7.3.211; Theil T, 1998, DEVELOPMENT, V125, P443; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248; Zhang Y, 2004, BIOINFORMATICS, V20, P2390, DOI 10.1093/bioinformatics/bth256; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	71	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3599	10.1371/journal.pone.0003599	http://dx.doi.org/10.1371/journal.pone.0003599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974838	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131700020
J	Ibanez, C; Ramos, A; Acebo, P; Contreras, A; Casado, R; Allona, I; Aragoncillo, C				Ibanez, Cristian; Ramos, Alberto; Acebo, Paloma; Contreras, Angela; Casado, Rosa; Allona, Isabel; Aragoncillo, Cipriano			Overall Alteration of Circadian Clock Gene Expression in the Chestnut Cold Response	PLOS ONE			English	Article							LOW-TEMPERATURE; TARGETED DEGRADATION; OSCILLATOR FUNCTION; DORMANCY INDUCTION; CAMBIAL MERISTEM; GROWTH CESSATION; MOLECULAR-BASES; ARABIDOPSIS; REGULATORS; PRR7	Cold acclimation in woody plants may have special features compared to similar processes in herbaceous plants. Recent studies have shown that circadian clock behavior in the chestnut tree (Castanea sativa) is disrupted by cold temperatures and that the primary oscillator feedback loop is not functional at 4 degrees C or in winter. In these conditions, CsTOC1 and CsLHY genes are constantly expressed. Here, we show that this alteration also affects CsPRR5, CsPRR7 and CsPRR9. These genes are homologous to the corresponding Arabidopsis PSEUDO-RESPONSE REGULATOR genes, which are also components of the circadian oscillator feedback network. The practically constant presence of mRNAs of the 5 chestnut genes at low temperature reveals an unknown aspect of clock regulation and suggests a mechanism regulating the transcription of oscillator genes as a whole.	[Ibanez, Cristian; Ramos, Alberto; Acebo, Paloma; Contreras, Angela; Casado, Rosa; Allona, Isabel; Aragoncillo, Cipriano] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Ibanez, C (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	isabel.allona@upm.es	Allona, Isabel/J-5972-2014	Allona, Isabel/0000-0002-7012-2850; CONTRERAS MOGOLLON, ANGELA BIBIANA/0000-0003-3780-8428	Spanish Ministerio de Educacion y Ciencia [AGL2005-00080, fellowship]; Chilean Government-BID [fellowship]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Chilean Government-BID	This research was supported by the Spanish Ministerio de Educacion y Ciencia, grant no. AGL2005-00080 and a predoctoral fellowship (A.C.). C.I. holds a fellowship awarded by the Chilean Government-BID.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Allona I, 1998, P NATL ACAD SCI USA, V95, P9693, DOI 10.1073/pnas.95.16.9693; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bookout A. L., 2006, CURRENT PROTOCOLS MO; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHIARAMAGNONE M, 2005, BRAIN RES MOL BRAIN, V133, P281; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Druart N, 2007, PLANT J, V50, P557, DOI 10.1111/j.1365-313X.2007.03077.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eriksson ME, 2003, PLANTA, V218, P159, DOI 10.1007/s00425-003-1106-4; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Farre EM, 2007, PLANT J, V52, P548, DOI 10.1111/j.1365-313X.2007.03258.x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Miwa K, 2006, PLANT CELL PHYSIOL, V47, P601, DOI 10.1093/pcp/pcj027; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; NITSCH J. P., 1957, PROC AMER SOC HORT SCI, V70, P526; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vallone D, 2007, AM J PHYSIOL-REG I, V292, pR160, DOI 10.1152/ajpregu.00370.2006; WAREING PF, 1956, ANNU REV PLANT PHYS, V7, P191, DOI 10.1146/annurev.pp.07.060156.001203; WEISER CJ, 1970, SCIENCE, V169, P1269, DOI 10.1126/science.169.3952.1269; Welling A, 2008, PLANT PHYSIOL, V147, P1199, DOI 10.1104/pp.108.117812; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	55	53	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3567	10.1371/journal.pone.0003567	http://dx.doi.org/10.1371/journal.pone.0003567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958171	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131100023
J	Vitko, I; Shcheglovitov, A; Baumgart, JP; Arias-Olguin, II; Murbartian, J; Arias, JM; Perez-Reyes, E				Vitko, Iuliia; Shcheglovitov, Aleksandr; Baumgart, Joel P.; Arias-Olguin, Imilla I.; Murbartian, Janet; Arias, Juan Manuel; Perez-Reyes, Edward			Orientation of the Calcium Channel beta Relative to the alpha(1)2.2 Subunit Is Critical for Its Regulation of Channel Activity	PLOS ONE			English	Article								Background: The Ca-v beta subunits of high voltage-activated Ca2+ channels control the trafficking and biophysical properties of the alpha(1) subunit. The Ca-v beta-alpha(1) interaction site has been mapped by crystallographic studies. Nevertheless, how this interaction leads to channel regulation has not been determined. One hypothesis is that beta s regulate channel gating by modulating movements of IS6. A key requirement for this direct-coupling model is that the linker connecting IS6 to the alpha-interaction domain (AID) be a rigid structure. Methodology/Principal Findings: The present study tests this hypothesis by altering the flexibility and orientation of this region in alpha(1)2.2, then testing for Ca-v beta regulation using whole cell patch clamp electrophysiology. Flexibility was induced by replacement of the middle six amino acids of the IS6-AID linker with glycine (PG6). This mutation abolished beta 2a and beta 3 subunits ability to shift the voltage dependence of activation and inactivation, and the ability of beta 2a to produce non-activating currents. Orientation of Ca-v beta with respect to alpha(1)2.2 was altered by deletion of 1, 2, or 3 amino acids from the IS6-AID linker (Bdel1, Bdel2, Bdel3, respectively). Again, the ability of Ca-v beta subunits to regulate these biophysical properties were totally abolished in the Bdel1 and Bdel3 mutants. Functional regulation by Ca-v beta subunits was rescued in the Bdel2 mutant, indicating that this part of the linker forms beta-sheet. The orientation of beta with respect to a was confirmed by the bimolecular fluorescence complementation assay. Conclusions/Significance: These results show that the orientation of the Ca-v beta subunit relative to the alpha(1)2.2 subunit is critical, and suggests additional points of contact between these subunits are required for Ca-v beta to regulate channel activity.	[Vitko, Iuliia; Shcheglovitov, Aleksandr; Baumgart, Joel P.; Arias-Olguin, Imilla I.; Murbartian, Janet; Arias, Juan Manuel; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Vitko, I (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	eperez@virginia.edu	Baumgart, Joel/K-3139-2014	Baumgart, Joel/0000-0002-1109-2567; Murbartian, Janet/0000-0001-5776-1167	University of Virginia	University of Virginia	This work was funded by the University of Virginia. The University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Feng ZP, 2001, J BIOL CHEM, V276, P45051, DOI 10.1074/jbc.M107784200; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Helton TD, 2002, J NEUROSCI, V22, P1573, DOI 10.1523/JNEUROSCI.22-05-01573.2002; Hering S, 2002, TRENDS PHARMACOL SCI, V23, P509, DOI 10.1016/S0165-6147(02)02104-1; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; LEUNG AT, 1988, J BIOL CHEM, V263, P994; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539, DOI 10.1152/ajpcell.1996.271.5.C1539; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Ringer S, 1883, J Physiol, V4, P29; Sandoz G, 2004, P NATL ACAD SCI USA, V101, P6267, DOI 10.1073/pnas.0306804101; Sandoz G, 2001, EUR J NEUROSCI, V14, P987, DOI 10.1046/j.0953-816x.2001.01728.x; Schjott JM, 2003, J BIOL CHEM, V278, P33936, DOI 10.1074/jbc.M302059200; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967	57	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3560	10.1371/journal.pone.0003560	http://dx.doi.org/10.1371/journal.pone.0003560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958281	gold, Green Submitted, Green Published			2022-12-25	WOS:000265131100018
J	Dacher, M; Smith, BH				Dacher, Matthieu; Smith, Brian H.			Olfactory Interference during Inhibitory Backward Pairing in Honey Bees	PLOS ONE			English	Article							LONG-TERM-MEMORY; PROBOSCIS EXTENSION REFLEX; APIS-MELLIFERA; SUCROSE RESPONSIVENESS; DROSOPHILA-MELANOGASTER; ODOR REPRESENTATION; SIDE-SPECIFICITY; PROTEIN-KINASE; ANTENNAL LOBE; BEHAVIOR	Background: Restrained worker honey bees are a valuable model for studying the behavioral and neural bases of olfactory plasticity. The proboscis extension response (PER; the proboscis is the mouthpart of honey bees) is released in response to sucrose stimulation. If sucrose stimulation is preceded one or a few times by an odor (forward pairing), the bee will form a memory for this association, and subsequent presentations of the odor alone are sufficient to elicit the PER. However, backward pairing between the two stimuli (sucrose, then odor) has not been studied to any great extent in bees, although the vertebrate literature indicates that it elicits a form of inhibitory plasticity. Methodology/Principal Findings: If hungry bees are fed with sucrose, they will release a long lasting PER; however, this PER can be interrupted if an odor is presented 15 seconds (but not 7 or 30 seconds) after the sucrose (backward pairing). We refer to this previously unreported process as olfactory interference. Bees receiving this 15 second backward pairing show reduced performance after a subsequent single forward pairing (excitatory conditioning) trial. Analysis of the results supported a relationship between olfactory interference and a form of backward pairing-induced inhibitory learning/memory. Injecting the drug cimetidine into the deutocerebrum impaired olfactory interference. Conclusions/Significance: Olfactory interference depends on the associative link between odor and PER, rather than between odor and sucrose. Furthermore, pairing an odor with sucrose can lead either to association of this odor to PER or to the inhibition of PER by this odor. Olfactory interference may provide insight into processes that gate how excitatory and inhibitory memories for odor-PER associations are formed.	[Dacher, Matthieu; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Dacher, M (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	matthieu.dacher@free.fr	Dacher, Matthieu/F-8407-2010; Hernández, Juan/AAC-6250-2020	Dacher, Matthieu/0000-0001-8607-2889; 	NIH [RR014166, DC007997]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007997] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by the NIH grants (NCRR grant RR014166 and NIDCD grant DC007997) to BHS. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Benard J, 2006, ANIM COGN, V9, P257, DOI 10.1007/s10071-006-0032-9; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bouton ME, 2004, NEUROSCI BIOBEHAV R, V28, P663, DOI 10.1016/j.neubiorev.2004.09.001; Couvillon PA, 2003, J COMP PSYCHOL, V117, P31, DOI 10.1037/0735-7036.117.1.31; Dacher M, 2005, NEUROSCIENCE, V130, P37, DOI 10.1016/j.neuroscience.2004.09.006; DACHER M, 2008, PHYSL BEHAV IN PRESS; Deglise P, 2003, BEHAV NEUROSCI, V117, P540, DOI 10.1037/0735-7044.117.3.540; Deisig N, 2002, LEARN MEMORY, V9, P112, DOI 10.1101/lm.41002; Deisig N, 2001, LEARN MEMORY, V8, P70, DOI 10.1101/lm.8.2.70; Denniston JC, 2007, BEHAV PROCESS, V74, P274, DOI 10.1016/j.beproc.2006.11.003; DETHIER VG, 1963, KNOW FLY; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Erber J, 1997, J COMP PHYSIOL A, V181, P355, DOI 10.1007/s003590050121; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Erber J, 1998, J COMP PHYSIOL A, V183, P737, DOI 10.1007/s003590050296; Erber J, 2000, J COMP PHYSIOL A, V186, P557, DOI 10.1007/s003590000111; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Farooqui T, 2003, J NEUROSCI, V23, P5370; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Gauthier M, 2006, NEUROBIOL LEARN MEM, V86, P164, DOI 10.1016/j.nlm.2006.02.003; Gisselmann G, 2004, NEUROSCI LETT, V372, P151, DOI 10.1016/j.neulet.2004.09.031; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Giurfa M, 2004, LEARN MEMORY, V11, P294, DOI 10.1101/lm.63604; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Haupt SS, 2005, BEHAV BRAIN RES, V165, P12, DOI 10.1016/j.bbr.2005.06.030; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Hussaini SA, 2007, LEARN MEMORY, V14, P678, DOI 10.1101/lm.471307; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Kisch J, 1999, BEHAV BRAIN RES, V99, P93, DOI 10.1016/S0166-4328(98)00076-X; KLOPPENBURG P, 1995, J COMP NEUROL, V363, P333, DOI 10.1002/cne.903630213; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; KRASNE FB, 1995, ANNU REV PSYCHOL, V46, P585, DOI 10.1146/annurev.ps.46.020195.003101; LEE ET, 2003, STAT METHODS SURVIVA, P534; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pelz C, 1997, J EXP BIOL, V200, P837; Ray S, 1997, J APICULT RES, V36, P108, DOI 10.1080/00218839.1997.11100936; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sachse Silke, 2006, Front Zool, V3, P22, DOI 10.1186/1742-9994-3-22; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Shafir S, 2005, ANIM BEHAV, V69, P859, DOI 10.1016/j.anbehav.2004.07.011; Shafir S, 1999, ANIM BEHAV, V57, P1055, DOI 10.1006/anbe.1998.1078; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vogel EH, 2004, BRAIN RES BULL, V63, P173, DOI 10.1016/j.brainresbull.2004.01.005; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	97	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3513	10.1371/journal.pone.0003513	http://dx.doi.org/10.1371/journal.pone.0003513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946512	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126200012
J	Martin, J; Duncan, FJ; Keiser, T; Shin, S; Kusewitt, DF; Oberyszyn, T; Satoskar, AR; VanBuskirk, AM				Martin, Jason; Duncan, F. Jason; Keiser, Tracy; Shin, Samuel; Kusewitt, Donna F.; Oberyszyn, Tatiana; Satoskar, Abhay R.; VanBuskirk, Anne M.			Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC)	FASEB JOURNAL			English	Article						angiogenesis; tumorigenesis; edema	HUMAN BREAST-CANCER; REGULATORY ROLE; UNITED-STATES; EXPRESSION; CELLS; P53; INFLAMMATION; HYPOXIA; DAMAGE; PHOTOCARCINOGENESIS	Mounting evidence suggests that macrophage migration inhibitory factor (MIF) may serve as an important link between chronic inflammation and cancer development. The proinflammatory and proangiogenic activities of MIF position it as a potentially important player in the development and progression of nonmelanoma skin cancer (NMSC). To assess the role of MIF in the development and progression of NMSC, we exposed MIF-/- BALB/c mice to acute and chronic ultraviolet B (UVB) irradiation. Our studies demonstrate that MIF-/- BALB/c mice have a significantly diminished acute inflammatory response to UVB exposure compared to wild-type mice, as measured by myeloperoxidase activity, dermal neutrophil infiltration, and edematous response. Relative to wild-type mice, MIF-/- mice also show significantly lower vascular endothelial growth factor (VEGF) concentrations in whole skin and significantly lower 8-oxo-dG adduct concentrations in epidermal DNA following UVB exposure. Furthermore, MIF-/- mice showed significant increases in p53 activity, epidermal thickness, and epidermal cell proliferation following acute UVB insult. In response to chronic UVB exposure, MIF-/- mice showed a 45% reduction in tumor incidence, significantly less angiogenesis, and delayed tumor progression when compared to their wild-type counterparts. These data indicate that MIF plays an important role in UVB-induced NMSC development and progression.-Martin, J., Duncan, F. J., Keiser, T., Shin, S., Kusewitt, D. F., Oberyszyn, T., Satoskar, A. R., VanBuskirk, A. M. Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC). FASEB J. 23, 720-730 (2009)	[Keiser, Tracy; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Martin, Jason; Duncan, F. Jason; Shin, Samuel; VanBuskirk, Anne M.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Kusewitt, Donna F.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Oberyszyn, Tatiana; VanBuskirk, Anne M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [VanBuskirk, Anne M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Satoskar, AR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	satoskar.2@osu.edu	Oberyszyn, Tatiana/E-3774-2011; Kusewitt, Donna F/E-8107-2011; Satoskar, Abhay/AAB-7748-2019	Oberyszyn, Tatiana/0000-0002-5308-0855				Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bando H, 2003, BIOMED PHARMACOTHER, V57, P333, DOI 10.1016/S0753-3322(03)00098-2; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Besaratinia A, 2005, P NATL ACAD SCI USA, V102, P10058, DOI 10.1073/pnas.0502311102; Bolontrade MF, 1998, CARCINOGENESIS, V19, P2107, DOI 10.1093/carcin/19.12.2107; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brash DE, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P136; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Budiyanto A, 2002, PHOTOCHEM PHOTOBIOL, V76, P397, DOI 10.1562/0031-8655(2002)076<0397:FOCPDA>2.0.CO;2; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chen JG, 2001, DERMATOL SURG, V27, P1035, DOI 10.1046/j.1524-4725.2001.01004.x; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chuang TY, 1999, J EUR ACAD DERMATOL, V12, P126, DOI 10.1016/S0926-9959(98)00147-0; Cooke MS, 2000, FREE RADICAL RES, V33, P369, DOI 10.1080/10715760000300911; Dahle Jostein, 2005, J Carcinog, V4, P11, DOI 10.1186/1477-3163-4-11; Daun JM, 2000, AM J PHYSIOL-REG I, V279, pR1043, DOI 10.1152/ajpregu.2000.279.3.R1043; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; De Haes P, 2005, J PHOTOCH PHOTOBIO B, V78, P141, DOI 10.1016/j.jphotobiol.2004.09.010; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Ehrhart JC, 2003, PHOTOCH PHOTOBIO SCI, V2, P825, DOI 10.1039/b302281a; Ferrara N, 2001, Am J Physiol Cell Physiol, V280, pC1358; Gerber B, 2002, PHOTOCHEM PHOTOBIOL, V76, P664, DOI 10.1562/0031-8655(2002)076<0664:UESOS>2.0.CO;2; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hatton JL, 2007, J INVEST DERMATOL, V127, P1507, DOI 10.1038/sj.jid.5700746; HAWK JLM, 1988, BRIT J DERMATOL, V118, P27, DOI 10.1111/j.1365-2133.1988.tb01746.x; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kobayashi S, 1999, HEPATOLOGY, V29, P1752, DOI 10.1002/hep.510290610; Koong AC, 2000, CANCER RES, V60, P883; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; LUNDBERG C, 1983, INFLAMMATION, V7, P247, DOI 10.1007/BF00917262; Marks Robin, 1995, Journal of Dermatology (Tokyo), V22, P853, DOI 10.1111/j.1346-8138.1995.tb03935.x; Meyer-Siegler K, 1998, DIAGN MOL PATHOL, V7, P44, DOI 10.1097/00019606-199802000-00008; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2005, FRONT BIOSCI-LANDMRK, V10, P12, DOI 10.2741/1501; OSTERLIND A, 1991, Current Opinion in Oncology, V3, P355; Piskin G, 2005, ARCH DERMATOL RES, V296, P339, DOI 10.1007/s00403-004-0522-z; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Sams RL, 2002, TOXICOL APPL PHARM, V184, P136, DOI 10.1006/taap.2002.9498; Sasaki S, 2004, KIDNEY INT, V65, P469, DOI 10.1111/j.1523-1755.2004.00394.x; SAVAGE JE, 1993, J INVEST DERMATOL, V101, P532, DOI 10.1111/1523-1747.ep12365905; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Strom SS, 1997, CLIN PLAST SURG, V24, P627; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; van der Kemp PA, 2002, PHOTOCHEM PHOTOBIOL, V76, P640, DOI 10.1562/0031-8655(2002)076<0640:UBIIOH>2.0.CO;2; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Wilgus TA, 2000, PROSTAG OTH LIPID M, V62, P367, DOI 10.1016/S0090-6980(00)00089-7; Wilgus TA, 2003, MOL CARCINOGEN, V38, P49, DOI 10.1002/mc.10141; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Wulff BC, 2008, PHOTOCHEM PHOTOBIOL, V84, P317, DOI 10.1111/j.1751-1097.2007.00257.x; Zhang Wei, 2002, Hepatobiliary Pancreat Dis Int, V1, P577	68	35	38	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					720	730		10.1096/fj.08-119628	http://dx.doi.org/10.1096/fj.08-119628			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18952710				2022-12-25	WOS:000265506300008
J	Garcia-Maceira, P; Mateo, J				Garcia-Maceira, P.; Mateo, J.			Silibinin inhibits hypoxia-inducible factor-1 alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy	ONCOGENE			English	Article						hypoxia-inducible factor-1 alpha; silibinin; cancer; mTOR; angiogenesis	ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; FACTOR 1-ALPHA; VEGF EXPRESSION; GENE-EXPRESSION; NITRIC-OXIDE; O-2 TENSION; FACTOR-I; MTOR; RAPAMYCIN	The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents an appealing chemotherapeutic target. Silibinin is a nontoxic flavonoid reported to exhibit anticancer properties. However, the mechanisms by which silibinin inhibits tumour growth are not fully understood. In this study, silibinin was found to inhibit hypoxiainduced HIF-1 alpha accumulation and HIF-1 transcriptional activity in human cervical (HeLa) and hepatoma (Hep3B) cells. Neither HIEF-1 alpha protein degradation rate nor HIEF-1 alpha steady-state mRNA level was affected by silibinin. Rather, we found that suppression of HIF-1 alpha accumulation by silibinin correlated with strong dephosphorylation of mammalian target of rapamycin (mTOR) and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1), a pathway known to regulate HIEF-1 alpha expression at the translational level. Silibinin also activated Akt, a mechanistic feature exhibited by established mTOR inhibitors in many tumour cells. Moreover, silibinin reduced hypoxia-induced vascular endothelial growth factor (VEGF) release by HeLa and Hep3B cells, and this effect was potentiated by the PI3K/Akt inhibitor LY294002. Finally, silibinin was found to be a potent inhibitor of cell proliferation. These results show that silibinin is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity.	[Garcia-Maceira, P.; Mateo, J.] CNIC, Dept Regenerat Cardiol, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Mateo, J (corresponding author), CNIC, Dept Regenerat Cardiol, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	jmateo@cnic.es	de Castro, Jesus Mateo/N-4434-2014	de Castro, Jesus Mateo/0000-0003-4459-7083	ISCIII [FIS03-0924, FIS07-1168]; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Spanish Ministry of Health and Consumer Affairs; Pro-CNIC Foundation	ISCIII(Instituto de Salud Carlos III); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Spanish Ministry of Health and Consumer Affairs(Spanish Government); Pro-CNIC Foundation	This work was supported by grants from ISCIII (FIS03-0924 and FIS07-1168 to JM). PG-M holds a fellowship from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Bancaja predoctoral program. CNIC is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-CNIC Foundation.	Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Bhatia N, 1999, CANCER LETT, V147, P77, DOI 10.1016/S0304-3835(99)00276-1; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Brown JM, 1998, CANCER RES, V58, P1408; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Deep G, 2008, ONCOGENE, V27, P3986, DOI 10.1038/onc.2008.45; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Lah JJ, 2007, WORLD J GASTROENTERO, V13, P5299, DOI 10.3748/wjg.v13.i40.5299; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Varghese L, 2005, CLIN CANCER RES, V11, P8441, DOI 10.1158/1078-0432.CCR-05-1646; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wellington K, 2001, BIODRUGS, V15, P465, DOI 10.2165/00063030-200115070-00005; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Wright G, 2003, J BIOL CHEM, V278, P20235, DOI 10.1074/jbc.M301391200; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541; Zi XL, 1998, CLIN CANCER RES, V4, P1055; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	49	131	135	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					313	324		10.1038/onc.2008.398	http://dx.doi.org/10.1038/onc.2008.398			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18978810				2022-12-25	WOS:000262550300001
J	Lito, P; Mets, BD; Appledorn, DM; Maher, VM; McCormick, JJ				Lito, Piro; Mets, Bryan D.; Appledorn, Daniel M.; Maher, Veronica M.; McCormick, J. Justin			Sprouty 2 Regulates DNA Damage-induced Apoptosis in Ras-transformed Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ACTIVATION; GROWTH; PATHWAY; MDM2; P53; DIFFERENTIATION; EXPRESSION; MODULATION; INHIBITION	We have reported that expression of Sprouty 2 (Spry2) is necessary for tumor formation by HRas(V12)-transformed fibroblasts. We now report on the role of Spry2 in the inhibition of UV254 nm radiation-induced apoptosis in HRas(V12)- transformed human fibroblasts. Silencing Spry2 in this context resulted in increased apoptosis, associated with decreased Akt activation and decreased phosphorylation of HDM2 at Ser-166, which has been shown to stabilize HDM2. As a consequence, when cells with silenced Spry2 were UV-irradiated, they exhibited diminished levels of HDM2 and elevated levels of p53. In agreement with these findings, overexpression of Spry2 in the parental non-transformed fibroblasts led to increased Akt activation and to the stabilization of HDM2. It also led to diminished expression of p53 and decreased apoptosis following UV irradiation. Silencing Spry2 in HRas-transformed cells decreased Rac1 activation, but independent expression of Spry2 in the non-transformed parental cells had no effect on Rac1, suggesting a specific involvement in the activation of Rac1 by Ras. Silencing Spry2 in HRas(V12)- transformed cells resulted in diminished interaction between HRas and Tiam1, a Rac1-specific nucleotide exchange factor. Expression of constitutively active Rac1 in cells with silenced Spry2 partly reversed the effect of Spry2 down-regulation. Furthermore, loss of Spry2 expression in HRas(V12)- transformed cells augmented the cytotoxicity of the DNA-damaging, chemotherapeutic agent cisplatin, a process that was also reversed by active Rac1. Together, these data show that Spry2 inhibits apoptosis in response to DNA damage by regulating Akt, HDM2, and p53, by a process mediated partly by Rac1.	[McCormick, J. Justin] Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	McCormick, JJ (corresponding author), Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, Food Safety & Toxicolo Bldg, E Lansing, MI 48824 USA.	mccormi1@msu.edu			National Institutes of Health [CA098305]; Department of Health and Human Services; Michigan State University; College of Human Medicine; NATIONAL CANCER INSTITUTE [R01CA098305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Michigan State University; College of Human Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA098305 from the Department of Health and Human Services ( to J. J. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Research Assistantship from the Michigan State University, College of Human Medicine.	Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Eom YW, 2001, BIOCHEM BIOPH RES CO, V285, P825, DOI 10.1006/bbrc.2001.5233; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KONDO S, 1995, ONCOGENE, V10, P2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Messina S, 2004, BIOCHEM BIOPH RES CO, V320, P493, DOI 10.1016/j.bbrc.2004.06.003; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Saniger ML, 2006, J CELL BIOCHEM, V98, P650, DOI 10.1002/jcb.20801; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yip HT, 2006, ARCH OTOLARYNGOL, V132, P317, DOI 10.1001/archotol.132.3.317; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	50	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					848	854		10.1074/jbc.M808045200	http://dx.doi.org/10.1074/jbc.M808045200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008219	Green Published, hybrid			2022-12-25	WOS:000262122900019
J	Nie, J; Sage, EH				Nie, Jing; Sage, E. Helene			SPARC Inhibits Adipogenesis by Its Enhancement of beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; ACTIVATED-RECEPTOR-GAMMA; NULL MICE EXHIBIT; MATRICELLULAR PROTEIN SPARC; IN-VITRO; ADIPOCYTE DIFFERENTIATION; GROWTH-FACTOR; E-CADHERIN; OSTEOCLAST DIFFERENTIATION; GENE-TRANSCRIPTION	SPARC (secreted protein acidic and rich in cysteine) modulates interactions between cells and extracellular matrix and is enriched in white adipose tissue. We have reported that SPARC-null mice accumulate significantly more fat than wild-type mice and maintain relatively high levels of serum leptin. We now show that SPARC inhibits adipogenesis in vitro. Specifically, recombinant SPARC inhibited (a) adipocyte differentiation of stromal-vascular cells isolated from murine white adipose tissue and (b) the expression of adipogenic transcription factors and adipocyte-specific genes. SPARC induced the accumulation and nuclear translocation of beta-catenin and subsequently enhanced the interaction of beta-catenin and T cell/lymphoid enhancer factor 1. The activity of integrin-linked kinase was required for the effect of SPARC on beta-catenin accumulation as well as extracellular matrix remodeling. During adipogenesis, fusiform preadipocytes change into sphere-shaped adipocytes and convert the extracellular matrix from a fibronectin-rich stroma to a laminin-rich basal lamina. SPARC retarded the morphological changes exhibited by preadipocytes during differentiation. In the presence of SPARC, the deposition of fibronectin was enhanced, and that of laminin was inhibited; in parallel, the expression of alpha 5 integrin was enhanced, and that of alpha 6 integrin was inhibited. Lithium chloride, which enhances the accumulation of beta-catenin, also inhibited the expression of alpha 6 integrin. These findings demonstrate a role for SPARC in adipocyte morphogenesis and in signaling processes leading to terminal differentiation.	[Nie, Jing; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center	Sage, EH (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	hsage@benaroyaresearch.org			National Institutes of Health [R01-GM40711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM40711 (to E.H.S.).	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Brekken Rolf A., 2001, Matrix Biology, V19, P816; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Niimi T, 1997, MATRIX BIOL, V16, P223, DOI 10.1016/S0945-053X(97)90011-1; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Weaver MS, 2006, J CELL BIOCHEM, V97, P423, DOI 10.1002/jcb.20654; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zhao L, 2000, J BIOL CHEM, V275, P16845, DOI 10.1074/jbc.275.22.16845	60	112	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1279	1290		10.1074/jbc.M808285200	http://dx.doi.org/10.1074/jbc.M808285200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990699	hybrid, Green Published			2022-12-25	WOS:000262122900063
J	Powell, AJ; Tomberg, J; Deacon, AM; Nicholas, RA; Davies, C				Powell, Ailsa J.; Tomberg, Joshua; Deacon, Ashley M.; Nicholas, Robert A.; Davies, Christopher			Crystal Structures of Penicillin-binding Protein 2 from Penicillin-susceptible and -resistant Strains of Neisseria gonorrhoeae Reveal an Unexpectedly Subtle Mechanism for Antibiotic Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM RESISTANCE; AMINO-ACID SUBSTITUTIONS; MOSAIC-LIKE STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; REDUCED SUSCEPTIBILITY; ESCHERICHIA-COLI; ACTIVE-SITE; PEPTIDOGLYCAN STRUCTURE; ENTEROCOCCUS-FAECIUM; LEVEL RESISTANCE	Penicillin-binding protein 2 (PBP2) from N. gonorrhoeae is the major molecular target for beta-lactam antibiotics used to treat gonococcal infections. PBP2 from penicillin-resistant strains of N. gonorrhoeae harbors an aspartate insertion after position 345 (Asp-345a) and 4-8 additional mutations, but how these alter the architecture of the protein is unknown. We have determined the crystal structure of PBP2 derived from the penicillin-susceptible strain FA19, which shows that the likely effect of Asp-345a is to alter a hydrogen-bonding network involving Asp-346 and the SXN triad at the active site. We have also solved the crystal structure of PBP2 derived from the penicillin-resistant strain FA6140 that contains four mutations near the C terminus of the protein. Although these mutations lower the second order rate of acylation for penicillin by 5-fold relative to wild type, comparison of the two structures shows only minor structural differences, with the positions of the conserved residues in the active site essentially the same in both. Kinetic analyses indicate that two mutations, P551S and F504L, are mainly responsible for the decrease in acylation rate. Melting curves show that the four mutations lower the thermal stability of the enzyme. Overall, these data suggest that the molecular mechanism underlying antibiotic resistance contributed by the four mutations is subtle and involves a small but measurable disordering of residues in the active site region that either restricts the binding of antibiotic or impedes conformational changes that are required for acylation by beta-lactam antibiotics.	[Tomberg, Joshua; Nicholas, Robert A.] SLAC Natl Accelerator Lab, Stanford, CA 94025 USA; [Powell, Ailsa J.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Deacon, Ashley M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill	Nicholas, RA (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, Stanford, CA 94025 USA.	nicholas@med.unc.edu; davies@musc.edu		Nicholas, Robert/0000-0003-2507-8974	National Institutes of Health [GM66861, AI36901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM66861(to C. D.) and AI36901 (to R. A. N.).	Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], 1992, CHEM B LACTAMS; Antignac A, 2003, J BIOL CHEM, V278, P31529, DOI 10.1074/jbc.M304607200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; BRANNIGAN JA, 1990, MOL MICROBIOL, V4, P913, DOI 10.1111/j.1365-2958.1990.tb00664.x; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CANNON JG, 1984, ANNU REV MICROBIOL, V38, P111; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; DOWSON CG, 1989, MOL MICROBIOL, V3, P35, DOI 10.1111/j.1365-2958.1989.tb00101.x; FARUKI H, 1986, ANTIMICROB AGENTS CH, V30, P856, DOI 10.1128/AAC.30.6.856; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; Ghuysen Jean-Marie, 1994, Trends in Microbiology, V2, P372, DOI 10.1016/0966-842X(94)90614-9; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gill MJ, 1998, ANTIMICROB AGENTS CH, V42, P2799, DOI 10.1128/AAC.42.11.2799; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Ito M, 2005, ANTIMICROB AGENTS CH, V49, P137, DOI 10.1128/AAC.49.1.137-143.2005; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06; Macheboeuf P, 2005, P NATL ACAD SCI USA, V102, P577, DOI 10.1073/pnas.0407186102; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Olesky M, 2002, ANTIMICROB AGENTS CH, V46, P2811, DOI 10.1128/AAC.46.9.2811-2820.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Ropp PA, 1997, J BACTERIOL, V179, P2783, DOI 10.1128/jb.179.8.2783-2787.1997; Rybkine T, 1998, J INFECT DIS, V178, P159, DOI 10.1086/515605; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Schultz D E, 1991, Protein Expr Purif, V2, P339, DOI 10.1016/1046-5928(91)90092-W; Severin A, 1996, J BACTERIOL, V178, P1788, DOI 10.1128/jb.178.7.1788-1792.1996; SPARLING PF, 1975, J BACTERIOL, V124, P740, DOI 10.1128/JB.124.2.740-749.1975; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; Stefanova ME, 2004, EUR J BIOCHEM, V271, P23, DOI 10.1046/j.1432-1033.2003.03886.x; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Takahata S, 2006, ANTIMICROB AGENTS CH, V50, P3638, DOI 10.1128/AAC.00626-06; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Wang SA, 2003, CLIN INFECT DIS, V37, P849, DOI 10.1086/377500; Whiley DM, 2007, ANTIMICROB AGENTS CH, V51, P3111, DOI 10.1128/AAC.00306-07; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yamada M, 2008, ANTIMICROB AGENTS CH, V52, P2053, DOI 10.1128/AAC.01456-07; YOCUM RR, 1979, P NATL ACAD SCI USA, V76, P2730, DOI 10.1073/pnas.76.6.2730	74	63	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1202	1212		10.1074/jbc.M805761200	http://dx.doi.org/10.1074/jbc.M805761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18986991	hybrid, Green Published			2022-12-25	WOS:000262122900056
J	Bhattacharya, A; Muller, FL; Liu, YH; Sabia, M; Liang, HY; Song, W; Jang, YC; Ran, QT; Van Remmen, H				Bhattacharya, Arunabh; Muller, Florian L.; Liu, Yuhong; Sabia, Marian; Liang, Hanyu; Song, Wook; Jang, Youngmok C.; Ran, Qitao; Van Remmen, Holly			Denervation Induces Cytosolic Phospholipase A(2)-mediated Fatty Acid Hydroperoxide Generation by Muscle Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AGING SKELETAL-MUSCLE; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; SELENOORGANIC COMPOUND; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; BIOLOGICAL-SYSTEMS; INDUCED APOPTOSIS; MICE DEFICIENT	Previously, we demonstrated that mitochondria from denervated muscle exhibited dramatically higher Amplex Red dependent fluorescence (thought to be highly specific for hydrogen peroxide) compared with control muscle mitochondria. We now demonstrate that catalase only partially inhibits the Amplex Red signal in mitochondria from denervated muscle. In contrast, ebselen (a glutathione peroxidase mimetic and inhibitor of fatty acid hydroperoxides) significantly inhibits the Amplex Red signal. This suggests that the majority of the Amplex Red signal in mitochondria from denervated muscle is not derived from hydrogen peroxide. Because Amplex Red cannot react with substrates in the lipid environment, we hypothesize that lipid hydroperoxides formed within the mitochondrial lipid bilayer are released as fatty acid hydroperoxides and react with the Amplex Red probe. We also suggest that the release of fatty acid hydroperoxides from denervated muscle mitochondria may be an important determinant of muscle atrophy. In support of this, muscle atrophy and the Amplex Red signal are inhibited in caloric restricted mice and in transgenic mice that overexpress the lipid hydroperoxide-detoxifying enzyme glutathione peroxidase 4. Finally, we propose that cytosolic phospholipase A(2) may be a potential source of these hydroperoxides.	[Bhattacharya, Arunabh; Liu, Yuhong; Liang, Hanyu; Song, Wook; Ran, Qitao; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Bhattacharya, Arunabh; Muller, Florian L.; Liu, Yuhong; Liang, Hanyu; Jang, Youngmok C.; Ran, Qitao; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sabia, Marian; Ran, Qitao; Van Remmen, Holly] S Texas Vet Hlth Care Syst, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Texas Res Pk Campus,15355 Lambda Dr, San Antonio, TX 78245 USA.	vanremmen@uthscsa.edu	Liang, Hanyu/A-1066-2010	Muller, Florian/0000-0001-7568-2948	National Institutes of Health [AG20591]; Muscular Dystrophy Association [MDA 3879]; Veterans Affairs merit grant; NATIONAL INSTITUTE ON AGING [P01AG020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Veterans Affairs merit grant(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG20591 (to H. V. R.). This work was also supported by Muscular Dystrophy Association Grant MDA 3879 (to H. V. R.) and a Veterans Affairs merit grant (to H. V. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Belikova NA, 2007, INT J RADIAT ONCOL, V69, P176, DOI 10.1016/j.ijrobp.2007.03.043; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brigelius-Flohe R, 2000, ATHEROSCLEROSIS, V152, P307, DOI 10.1016/S0021-9150(99)00486-4; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; BROWN WF, 1972, J NEUROL NEUROSUR PS, V35, P845, DOI 10.1136/jnnp.35.6.845; Brown WF, 1997, MUSCLE NERVE, pS70; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859; Engelbrecht AM, 2007, PROSTAG LEUKOTR ESS, V77, P37, DOI 10.1016/j.plefa.2007.06.002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Gabryel B, 2007, CELL BIOL INT, V31, P958, DOI 10.1016/j.cellbi.2007.03.005; Girotti AW, 1998, J LIPID RES, V39, P1529; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Haq S, 2003, NAT MED, V9, P944, DOI 10.1038/nm891; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Klivenyi P, 1998, J NEUROCHEM, V71, P2634; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; MAIORINO M, 1988, BIOCHEM PHARMACOL, V37, P2267, DOI 10.1016/0006-2952(88)90591-6; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Nakano M, 1998, CELL MOL NEUROBIOL, V18, P565, DOI 10.1023/A:1020257532357; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Ran QT, 2006, J NEUROSCI RES, V84, P202, DOI 10.1002/jnr.20868; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005; Thomas CK, 2006, MUSCLE NERVE, V33, P21, DOI 10.1002/mus.20400; THOMAS JP, 1990, J BIOL CHEM, V265, P454; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WICKS KL, 1991, AM J PHYSIOL, V260, pC841, DOI 10.1152/ajpcell.1991.260.4.C841; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Yagi K, 1996, BIOCHEM BIOPH RES CO, V219, P486, DOI 10.1006/bbrc.1996.0260; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	54	58	58	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					46	55		10.1074/jbc.M806311200	http://dx.doi.org/10.1074/jbc.M806311200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001413	Green Published, hybrid			2022-12-25	WOS:000261974800006
J	Kosugi, S; Hasebe, M; Matsumura, N; Takashima, H; Miyamoto-Sato, E; Tomita, M; Yanagawa, H				Kosugi, Shunichi; Hasebe, Masako; Matsumura, Nobutaka; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Tomita, Masaru; Yanagawa, Hiroshi			Six Classes of Nuclear Localization Signals Specific to Different Binding Grooves of Importin alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DISPLAY; IN-VITRO SELECTION; KARYOPHERIN-ALPHA; NUCLEOCYTOPLASMIC TRANSPORT; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL BASIS; PROTEIN; RECOGNITION; SEQUENCES; VIRUS	The importin alpha/beta pathway mediates nuclear import of proteins containing the classical nuclear localization signals (NLSs). Although the consensus sequences of the classical NLSs have been defined, there are still many NLSs that do not match the consensus rule and many nonfunctional sequences that match the consensus. We report here six different NLS classes that specifically bind to distinct binding pockets of importin alpha. By screening of random peptide libraries using an mRNA display, we selected peptides bound by importin alpha and identified six classes of NLSs, including three novel classes. Two noncanonical classes (class 3 and class 4) specifically bound the minor binding pocket of importin alpha, whereas the classical monopartite NLSs (class 1 and class 2) bound to the major binding pocket. Using a newly developed universal green fluorescent protein expression system, we found that these NLS classes, including plant-specific class 5 NLSs and bipartite NLSs, fundamentally require the regions outside the core basic residues for their activity and have specific residues or patterns that confer the activities differently between yeast, plants, and mammals. Furthermore, amino acid replacement analyses revealed that the consensus basic patterns of the classical NLSs are not essential for activity, thereby generating more unconventional patterns, including redox-sensitive NLSs. These results explain the causes of the NLS diversity. The defined consensus patterns and properties of importin alpha-dependent NLSs provide useful information for identifying NLSs.	[Kosugi, Shunichi; Hasebe, Masako; Tomita, Masaru; Yanagawa, Hiroshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Kosugi, Shunichi; Matsumura, Nobutaka; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 2238522, Japan	Keio University; Keio University	Yanagawa, H (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan.	hyana@bio.keio.ac.jp		Kosugi, Shunichi/0000-0002-5882-9255	Ministry of Agriculture, Forestry, and Fisheries of Japan [SY-1114]; Yamagata prefectural government and Tsuruoka City	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Yamagata prefectural government and Tsuruoka City	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Rice Genome Project SY-1114) and from the Yamagata prefectural government and Tsuruoka City. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim BJ, 2007, J BIOL CHEM, V282, P30029, DOI 10.1074/jbc.M703705200; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kosugi S, 2002, PLANT PHYSIOL, V128, P833, DOI 10.1104/pp.010642; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Oishi T, 2006, BIOCHEM BIOPH RES CO, V340, P125, DOI 10.1016/j.bbrc.2005.11.161; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Shoji K, 1998, GENE, V212, P279, DOI 10.1016/S0378-1119(98)00175-9; Shoya Y, 1998, J VIROL, V72, P9755, DOI 10.1128/JVI.72.12.9755-9762.1998; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521	40	388	422	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					478	485		10.1074/jbc.M807017200	http://dx.doi.org/10.1074/jbc.M807017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001369	hybrid			2022-12-25	WOS:000261974800052
J	Ludwig, M; Cracknell, JA; Vincent, KA; Armstrong, FA; Lenz, O				Ludwig, Marcus; Cracknell, James A.; Vincent, Kylie A.; Armstrong, Fraser A.; Lenz, Oliver			Oxygen-tolerant H-2 Oxidation by Membrane-bound [NiFe] Hydrogenases of Ralstonia Species COPING WITH LOW LEVEL H-2 IN AIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-EUTROPHUS H16; ACTIVE-SITE; DESULFOVIBRIO-GIGAS; CARBON-MONOXIDE; ALLOCHROMATIUM-VINOSUM; ATMOSPHERIC HYDROGEN; ACTIVATION; INHIBITION; O-2; MICROORGANISMS	Knallgas bacteria such as certain Ralstonia spp. are able to obtain metabolic energy by oxidizing trace levels of H-2 using O-2 as the terminal electron acceptor. The [NiFe] hydrogenases produced by these organisms are unusual in their ability to oxidize H-2 in the presence of O-2, which is a potent inactivator of most hydrogenases through attack at the active site. To probe the origin of this unusual O-2 tolerance, we conducted a study on the membrane-bound hydrogenase from Ralstonia eutropha H16 and that of the closely related organism Ralstonia metallidurans CH34, which was purified using a new heterologous overproduction system. Direct electrochemical methods were used to determine apparent inhibition constants for O-2 inhibition of H-2 oxidation (K-I(app)(O2)) for each enzyme. These values were at least 2 orders of magnitude higher than those of "standard" [NiFe] hydrogenases. Amino acids close to the active site were exchanged in the membrane-bound hydrogenase of R. eutropha H16 for those from standard hydrogenases to probe the role of individual residues in conferring O-2 sensitivity. Michaelis constants for H-2 (K-M(H2)) were determined, and for some mutants these were increased more than 20-fold relative to the wild type. Mutations resulting in membrane-bound hydrogenase enzymes with increased K-M(H2) or decreased K-I(app)(O2) values were associated with impaired lithoautotrophic growth in the presence of high O-2 concentrations.	[Ludwig, Marcus; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Cracknell, James A.; Vincent, Kylie A.; Armstrong, Fraser A.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford OX1 3QR, England	Humboldt University of Berlin; University of Oxford	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	oliver.lenz@rz.hu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019; Vincent, Kylie/H-1224-2011	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Vincent, Kylie/0000-0001-6444-9382	Biotechnology and Biological Sciences Research Council [BB/D52222X/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Armstrong FA, 2005, PHILOS T ROY SOC A, V363, P937, DOI 10.1098/rsta.2004.1528; Bard A. J., 2001, ELECTROCHEMICAL METH; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CAMMACK R, 1986, BIOCHIMIE, V68, P85, DOI 10.1016/S0300-9084(86)81072-0; Cammack R., 1997, HYDROGEN FUEL LEARNI; COLBEAU A, 1981, BIOCHIM BIOPHYS ACTA, V662, P271, DOI 10.1016/0005-2744(81)90039-5; CONRAD R, 1988, ADV MICROB ECOL, V10, P231; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; CONRAD R, 1983, FEMS MICROBIOL LETT, V18, P207; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Guo RB, 2008, SOIL BIOL BIOCHEM, V40, P1149, DOI 10.1016/j.soilbio.2007.12.007; Jones AK, 2003, J AM CHEM SOC, V125, P8505, DOI 10.1021/ja035296y; KEEFE RG, 1995, ARCH BIOCHEM BIOPHYS, V317, P449, DOI 10.1006/abbi.1995.1187; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2005, J AM CHEM SOC, V127, P6595, DOI 10.1021/ja0424934; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; LITTLEWOOD D, 1956, BIOCHIM BIOPHYS ACTA, V20, P399, DOI 10.1016/0006-3002(56)90308-0; Miller J.H., 1972, EXPT MOL GENETICS; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; PODZUWEIT HG, 1987, BIOCHIM BIOPHYS ACTA, V905, P435, DOI 10.1016/0005-2736(87)90473-1; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Prather MJ, 2003, SCIENCE, V302, P581, DOI 10.1126/science.1091060; Rahn T, 2003, NATURE, V424, P918, DOI 10.1038/nature01917; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; SCHINK B, 1980, BIOCHEM BIOPH RES CO, V95, P1563, DOI 10.1016/S0006-291X(80)80076-3; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIGNAIS PM, 1982, BIOCHIM BIOPHYS ACTA, V681, P519, DOI 10.1016/0005-2728(82)90195-5; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Vincent KA, 2006, J AM CHEM SOC, V128, P7448, DOI 10.1021/ja061732f; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WANG R, 1971, PLANT PHYSIOL, V48, P108, DOI 10.1104/pp.48.1.108; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	58	104	105	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					465	477		10.1074/jbc.M803676200	http://dx.doi.org/10.1074/jbc.M803676200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990688	hybrid			2022-12-25	WOS:000261974800051
J	Townsend, DM; Manevich, Y; He, L; Hutchens, S; Pazoles, CJ; Tew, KD				Townsend, Danyelle M.; Manevich, Yefim; He, Lin; Hutchens, Steven; Pazoles, Christopher J.; Tew, Kenneth D.			Novel Role for Glutathione S-Transferase pi REGULATOR OF PROTEIN S-GLUTATHIONYLATION FOLLOWING OXIDATIVE AND NITROSATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX; PEROXIREDOXIN; GLUTAREDOXIN; ACTIVATION; SITE; GST	Glutathione S-transferase Pi (GST pi) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GST pi potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GST pi is itself redox-regulated. S-Glutathionylation on Cys(47) and Cys(101) autoregulates GST pi, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GST pi multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GST pi and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs.	[Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Manevich, Yefim; He, Lin; Hutchens, Steven; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Pazoles, Christopher J.] Novelos Inc, Newton, MA 02458 USA	Medical University of South Carolina; Medical University of South Carolina	Tew, KD (corresponding author), 96 Johnathan Lucas St, Charleston, SC 29425 USA.	tewk@musc.edu			National Institutes of Health [CA08660, CA117259]; South Carolina Centers of Excellence program; NATIONAL CANCER INSTITUTE [R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Centers of Excellence program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA08660 and CA117259. This work was also supported by the South Carolina Centers of Excellence program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Findlay VJ, 2004, MOL PHARMACOL, V65, P1070, DOI 10.1124/mol.65.5.1070; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Keefer LK, 2003, ANNU REV PHARMACOL, V43, P585, DOI 10.1146/annurev.pharmtox.43.100901.135831; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Lo HW, 2008, MOL CANCER RES, V6, P843, DOI 10.1158/1541-7786.MCR-07-2105; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rosario LA, 2000, MOL PHARMACOL, V58, P167, DOI 10.1124/mol.58.1.167; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Tanaka T, 1997, CANCER RES, V57, P3644; TEW KD, 1994, CANCER RES, V54, P4313; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200	30	225	235	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					436	445		10.1074/jbc.M805586200	http://dx.doi.org/10.1074/jbc.M805586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990698	hybrid, Green Published			2022-12-25	WOS:000261974800048
J	Anastasia, L; Papini, N; Colazzo, F; Palazzolo, G; Tringali, C; Dileo, L; Piccoli, M; Conforti, E; Sitzia, C; Monti, E; Sampaolesi, M; Tettamanti, G; Venerando, B				Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Tringali, Cristina; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Monti, Eugenio; Sampaolesi, Maurilio; Tettamanti, Guido; Venerando, Bruno			NEU3 Sialidase Strictly Modulates GM3 Levels in Skeletal Myoblasts C2C12 Thus Favoring Their Differentiation and Protecting Them from Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GROWTH-FACTOR RECEPTOR; CELL-DIFFERENTIATION; ACTIVE CASPASE-3; TYROSINE KINASE; CRUCIAL ROLE; OVEREXPRESSION; ACTIVATION; GLYCOSYLATION; INVOLVEMENT	Membrane-bound sialidase NEU3, often referred to as the "ganglioside sialidase," has a critical regulatory function on the sialoglycosphingolipid pattern of the cell membrane, with an anti-apoptotic function, especially in cancer cells. Although other sialidases have been shown to be involved in skeletal muscle differentiation, the role of NEU3 had yet to be disclosed. Herein we report that NEU3 plays a key role in skeletal muscle differentiation by strictly modulating the ganglioside content of adjacent cells, with special regard to GM3. Induced down-regulation of NEU3 in murine C2C12 myoblasts, even when partial, totally inhibits their capability to differentiate by increasing the GM3 level above a critical point, which causes epidermal growth factor receptor inhibition (and ultimately its down-regulation) and an higher responsiveness of myoblasts to the apoptotic stimuli.	[Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Tringali, Cristina; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Venerando, Bruno] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy; [Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Tettamanti, Guido; Venerando, Bruno] IRCCS, Policlin San Donato, Lab Stem Cells Tissue Engn, I-20097 San Donato Milanese, Italy; [Monti, Eugenio] Univ Brescia, Dept Biomed & Biotechnol Sci, I-25123 Brescia, Italy; [Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Stem Cell Res Inst, B-3000 Louvain, Belgium; [Sampaolesi, Maurilio] Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy	University of Milan; IRCCS Policlinico San Donato; University of Brescia; KU Leuven; University Hospital Leuven; University of Pavia	Anastasia, L (corresponding author), Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy.	luigi.anastasia@unimi.it; bruno.venerando@unimi.it	Piccoli, Marco/S-3731-2019; papini, nadia/M-2425-2017; Anastasia, Luigi/AAN-1964-2020; sitzia, Clementina/L-2736-2019; Sampaolesi, Maurilio/H-6509-2013; Tringali, Cristina Alessandra/Q-7259-2017	Piccoli, Marco/0000-0002-9461-2715; papini, nadia/0000-0003-4066-4955; Anastasia, Luigi/0000-0002-0712-2161; Sampaolesi, Maurilio/0000-0002-2422-3757; Tringali, Cristina Alessandra/0000-0002-0632-6197; MONTI, Eugenio/0000-0002-4742-7445; COLAZZO, FRANCESCA/0000-0002-5782-1606; Sitzia, Clementina/0000-0001-5415-7597	Research Projects of National Interest; Italian Ministries of Health and Research; Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato	Research Projects of National Interest(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministries of Health and Research(Ministry of Education, Universities and Research (MIUR)); Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato	This work was supported by Research Projects of National Interest (to B. V., E. M., and G. T.), the Italian Ministries of Health and Research, and the Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fanzani A, 2003, FEBS LETT, V547, P183, DOI 10.1016/S0014-5793(03)00709-9; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Formigli L, 2007, EUR J HISTOCHEM, V51, P21; Haga Y, 2008, BBA-GEN SUBJECTS, V1780, P393, DOI 10.1016/j.bbagen.2007.10.018; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; LESKAWA KC, 1988, MOL CELL BIOCHEM, V83, P47; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; MILJAN EA, 2002, SCI STKE, pRE15; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Rohn TT, 2004, EXP CELL RES, V295, P215, DOI 10.1016/j.yexcr.2003.12.029; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Sato K, 1996, BIOCHEM BIOPH RES CO, V221, P826, DOI 10.1006/bbrc.1996.0681; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; TRUDEL GC, 1992, BIOCHEM BIOPH RES CO, V184, P125, DOI 10.1016/0006-291X(92)91167-O; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	42	43	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36265	36271		10.1074/jbc.M805755200	http://dx.doi.org/10.1074/jbc.M805755200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18945680	Green Published, hybrid			2022-12-25	WOS:000261840500022
J	Cheng, SJ; Sultana, S; Goss, DJ; Gallie, DR				Cheng, Shijun; Sultana, Shemaila; Goss, Dixie J.; Gallie, Daniel R.			Translation Initiation Factor 4B Homodimerization, RNA Binding, and Interaction with Poly(A)-binding Protein Are Enhanced by Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION; RECOGNITION MOTIF; PHOSPHORYLATION STATE; HELICASE ACTIVITY; MESSENGER-RNA; WHEAT; EIF4B; AFFINITY; CHROMATOGRAPHY; EIFISO4F	The eukaryotic translation initiation factor (eIF) 4B promotes the RNA-dependent ATP hydrolysis activity and ATP-dependent RNA helicase activity of eIF4A and eIF4F during translation initiation. eIF4B also helps to organize the assembly of the translational machinery through its interactions with eIF4A, eIF4G, eIF3, the (polyA)-binding protein (PABP), and RNA. Although the function of eIF4B is conserved among plants, animals, and yeast, eIF4B is one of the least conserved of initiation factors at the sequence level. Mammalian eIF4B is a constitutive dimer; however, conflicting reports have suggested that plant eIF4B may exist as a monomer or a dimer. In this study, we show that eIF4B from wheat can form a dimer and we identify the region responsible for its dimerization. Zinc stimulated homodimerization of eIF4B and bound eIF4B with a K-d of 19.7 nM. Zinc increased the activity of the eIF4B C-terminal RNA-binding domain specifically. Zinc promoted the interaction between eIF4B and PABP but not the interaction between eIF4B and eIF4A or eIFiso4G, demonstrating that the effect of zinc was highly specific. The interaction between PABP and eIFiso4G was also stimulated by zinc but required significantly higher levels of zinc. Interestingly zinc abolished the ability of eIFiso4G to compete with eIF4B in binding to their overlapping binding sites in PABP by preferentially promoting the interaction between eIF4B and PABP. Our observations suggest that wheat eIF4B can dimerize but requires zinc. Moreover zinc controls the partner protein selection of PABP such that the interaction with eIF4B is preferred over eIFiso4G.	[Cheng, Shijun; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Sultana, Shemaila; Goss, Dixie J.] CUNY, Grad Ctr, New York, NY 10065 USA; [Sultana, Shemaila; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	University of California System; University of California Riverside; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			United States Department of Agriculture [2003-35100-13375]; University of California Agricultural Experiment Station; National Science Foundation [MCB-0814051]	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of California Agricultural Experiment Station(University of California System); National Science Foundation(National Science Foundation (NSF))	This work was supported by United States Department of Agriculture Grant 2003-35100-13375 and the University of California Agricultural Experiment Station (to D. R. G.) and by National Science Foundation Grant MCB-0814051 (to D.J.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARAK P, 1993, DEV PLANT SOIL SCI, V55, P1; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Cheng S, 2007, J BIOL CHEM, V282, P25247, DOI 10.1074/jbc.M702193200; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; LONGNECKER NE, 1993, DEV PLANT SOIL SCI, V55, P79; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Metz AM, 1999, BIOCHEM BIOPH RES CO, V266, P314, DOI 10.1006/bbrc.1999.1814; MILBURN SC, 1990, EMBO J, V9, P2783, DOI 10.1002/j.1460-2075.1990.tb07466.x; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; PORATH J, 1988, TRAC-TREND ANAL CHEM, V7, P254, DOI 10.1016/0165-9936(88)85074-X; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; TRAKSHEL GM, 1988, BIOCHEM J, V252, P127, DOI 10.1042/bj2520127; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	26	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36140	36153		10.1074/jbc.M807716200	http://dx.doi.org/10.1074/jbc.M807716200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977752	Green Published, hybrid			2022-12-25	WOS:000261840500009
J	Fiuza, M; Canova, MJ; Patin, D; Letek, M; Zanella-Cleon, I; Becchi, M; Mateos, LM; Mengin-Lecreulx, D; Molle, V; Gil, JA				Fiuza, Maria; Canova, Marc J.; Patin, Delphine; Letek, Michal; Zanella-Cleon, Isabelle; Becchi, Michel; Mateos, Luis M.; Mengin-Lecreulx, Dominique; Molle, Virginie; Gil, Jose A.			The MurC Ligase Essential for Peptidoglycan Biosynthesis Is Regulated by the Serine/Threonine Protein Kinase PknA in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALANINE LIGASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CELL-DIVISION; PHOSPHINATE INHIBITORS; PHOSPHORYLATION SITES; CORYNEFORM BACTERIA; AMINO-ACIDS; STEPS; IDENTIFICATION	The Mur ligases play an essential role in the biosynthesis of bacterial cell-wall peptidoglycan and thus represent attractive targets for the design of novel antibacterials. These enzymes catalyze the stepwise formation of the peptide moiety of the peptidoglycan disaccharide peptide monomer unit. MurC is responsible of the addition of the first residue (L-alanine) onto the nucleotide precursor UDP-MurNAc. Phosphorylation of proteins by Ser/Thr protein kinases has recently emerged as a major physiological mechanism of regulation in prokaryotes. Herein, the hypothesis of a phosphorylation-dependent mechanism of regulation of the MurC activity was investigated in Corynebacterium glutamicum. We showed that MurC was phosphorylated in vitro by the PknA protein kinase. An analysis of the phosphoamino acid content indicated that phosphorylation exclusively occurred on threonine residues. Six phosphoacceptor residues were identified by mass spectrometry analysis, and we confirmed that mutagenesis to alanine residues totally abolished PknA-dependent phosphorylation of MurC. In vitro and in vivo ligase activity assays showed that the catalytic activity of MurC was impaired following mutation of these threonine residues. Further in vitro assays revealed that the activity of the MurC-phosphorylated isoform was severely decreased compared with the non-phosphorylated protein. To our knowledge, this is the first demonstration of a MurC ligase phosphorylation in vitro. The finding that phosphorylation is correlated with a decrease in MurC enzymatic activity could have significant consequences in the regulation of peptidoglycan biosynthesis.	[Zanella-Cleon, Isabelle; Becchi, Michel; Molle, Virginie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 BioSci, F-69637 Lyon 07, France; [Fiuza, Maria; Letek, Michal; Mateos, Luis M.; Gil, Jose A.] Univ Leon, Fac Biol, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain; [Patin, Delphine; Mengin-Lecreulx, Dominique] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Mengin-Lecreulx, Dominique] CNRS, Lab Enveloppes Bacteriennes & Antibiot, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Leon; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Molle, V (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 BioSci, 7 Passage Vercors, F-69637 Lyon 07, France.	vmolle@ibcp.fr; jagils@unileon.es	Letek, Michal/K-3903-2019; Gil, José A./L-1800-2019; Letek, Michal/C-6345-2008; Letek, Michal/AAH-4292-2019; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; MOLLE, Virginie/D-4050-2019; Gil, Jose A./C-3902-2009	Letek, Michal/0000-0002-9509-5174; Gil, José A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; MOLLE, Virginie/0000-0002-6573-3411; Gil, Jose A./0000-0002-5069-2637; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	Region Rhone-Alpes; CNRS, the University of Lyon (France); National Research Agency [ANR-06-MIME-027-01 t]; Junta de Castilla y Leon [LE040A07]; Ministerio de Ciencia y Tecnologia (Spain) [BIO2008-00519, BIO2005-02723]; CNRS; Universite Paris-Sud XI [8619]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS, the University of Lyon (France)(Centre National de la Recherche Scientifique (CNRS)); National Research Agency(French National Research Agency (ANR)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud XI	This work was supported in part by grants from the Region Rhone-Alpes (to M. C.); by the CNRS, the University of Lyon (France), and the National Research Agency (ANR-06-MIME-027-01 to V.M.); by the Junta de Castilla y Leon (Ref. LE040A07 to J.A.G.); by the Ministerio de Ciencia y Tecnologia (Spain) (Grants BIO2008-00519 and BIO2005-02723 to J.A.G. and L.M.M.); and by the CNRS and Universite Paris-Sud XI (Grant UMR 8619 to D.M.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Barbosa MDFS, 2002, ANAL BIOCHEM, V306, P17, DOI 10.1006/abio.2001.5691; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bendt AK, 2003, PROTEOMICS, V3, P1637, DOI 10.1002/pmic.200300494; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; Bouhss A, 1997, BIOCHEMISTRY-US, V36, P11556, DOI 10.1021/bi970797f; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Cohen-Gonsaud M, 2004, J BIOMOL NMR, V30, P373, DOI 10.1007/s10858-004-3466-x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deva T, 2006, ACTA CRYSTALLOGR D, V62, P1466, DOI 10.1107/S0907444906038376; Ehmann DE, 2004, BBA-PROTEINS PROTEOM, V1698, P167, DOI 10.1016/j.bbapap.2003.11.006; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kotnik M, 2007, CURR PHARM DESIGN, V13, P2283; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; LIGER D, 1995, EUR J BIOCHEM, V230, P80, DOI 10.1111/j.1432-1033.1995.0080i.x; LUGTENBERG EJ, 1972, J BACTERIOL, V110, P35, DOI 10.1128/JB.110.1.35-40.1972; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; SANTAMARIA RI, 1987, GENE, V56, P199, DOI 10.1016/0378-1119(87)90137-5; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Strancar K, 2006, BIOORG MED CHEM LETT, V16, P343, DOI 10.1016/j.bmcl.2005.09.086; Strancar K, 2007, ARCH PHARM, V340, P127, DOI 10.1002/ardp.200600191; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; VANHEIJENOORT J, 1996, ESCHERICHIA COLI SAL, P1025; Vicente M, 2006, FEMS MICROBIOL REV, V30, P841, DOI 10.1111/j.1574-6976.2006.00038.x; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Zawadzke LE, 2008, ASSAY DRUG DEV TECHN, V6, P95, DOI 10.1089/adt.2007.114	40	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36553	36563		10.1074/jbc.M807175200	http://dx.doi.org/10.1074/jbc.M807175200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974047	Green Published, hybrid			2022-12-25	WOS:000261840500053
J	Mackenzie, PI; Rogers, A; Treloar, J; Jorgensen, BR; Miners, JO; Meech, R				Mackenzie, Peter I.; Rogers, Anne; Treloar, Joanna; Jorgensen, Bo R.; Miners, John O.; Meech, Robyn			Identification of UDP Glycosyltransferase 3A1 as a UDP N- Acetylglucosaminyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; BILE-ACIDS; IN-VITRO; GLUCURONOSYLTRANSFERASE 2B7; SUBSTRATE-SPECIFICITY; DRUG GLUCURONIDATION; NOMENCLATURE UPDATE; GENE SUPERFAMILY; HUMAN BILIRUBIN; ASPARTIC-ACID	The UDP glycosyltransferases (UGT) attach sugar residues to small lipophilic chemicals to alter their biological properties and enhance elimination. Of the four families present in mammals, two families, UGT1 and UGT2, use UDP glucuronic acid to glucuronidate bilirubin, steroids, bile acids, drugs, and many other endogenous chemicals and xenobiotics. UGT8, in contrast, uses UDP galactose to galactosidate ceramide, an important step in the synthesis of glycosphingolipids and cerebrosides. The function of the fourth family, UGT3, is unknown. Here we report the cloning, expression, and functional characterization of UGT3A1. This enzyme catalyzes the transfer of N-acetylglucosamine from UDP N-acetylglucosamine to ursodeoxycholic acid (3 alpha, 7 beta-dihydroxy-5 beta-cholanoic acid). The enzyme uses ursodeoxycholic acid and UDP N-acetylglucosamine in preference to other primary and secondary bile acids, and other UDP sugars such as UDP glucose, UDP glucuronic acid, UDP galactose, and UDP xylose. In addition to ursodeoxycholic acid, UGT3A1 has activity toward 17 alpha-estradiol, 17 beta-estradiol, and the prototypic substrates of the UGT1 and UGT2 forms, 4-nitrophenol and 1-naphthol. A polymorphic UGT3A1 variant containing a C121G substitution was catalytically inactive. UGT3A1 is found in the liver and kidney, and to a lesser, in the gastrointestinal tract. These data describe the first characterization of a member of the UGT3 family. Its activity and distribution suggest that UGT3A1 may have an important role in the metabolism and elimination of ursodeoxycholic acid in therapies for ameliorating the symptoms of cholestasis or for dissolving gallstones.	[Mackenzie, Peter I.; Rogers, Anne; Treloar, Joanna; Jorgensen, Bo R.; Miners, John O.; Meech, Robyn] Flinders Univ S Australia, Sch Med, Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Mackenzie, PI (corresponding author), Flinders Univ S Australia, Sch Med, Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, Bedford Pk, SA 5042, Australia.	Peter.Mackenzie@flinders.edu.au		Mackenzie, Peter/0000-0002-0697-6878; miners, john/0000-0001-9555-9453; Meech, Robyn/0000-0002-6831-0801				Bosio A, 1996, GENOMICS, V34, P69, DOI 10.1006/geno.1996.0242; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dykens JA, 2005, ANN NY ACAD SCI, V1052, P116, DOI 10.1196/annals.1347.008; GALL WE, 1999, BIOCH MOL BIOL, V70, P101; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Ikegawa S, 1999, ANAL SCI, V15, P625, DOI 10.2116/analsci.15.625; Itaaho K, 2008, DRUG METAB DISPOS, V36, P2307, DOI 10.1124/dmd.108.022731; JIN CJ, 1993, CARCINOGENESIS, V14, P2637, DOI 10.1093/carcin/14.12.2637; Kubota T, 2007, MOL PHARMACOL, V72, P1054, DOI 10.1124/mol.107.037952; Li D, 2007, J BIOL CHEM, V282, P36514, DOI 10.1074/jbc.M703107200; Mackenzie P, 2003, BIOCHEM PHARMACOL, V65, P417, DOI 10.1016/S0006-2952(02)01522-8; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MACKENZIE PI, 1995, REV BIOCHEM TOXICOL, V11, P29; MARSCHALL HU, 1992, J CLIN INVEST, V89, P1981, DOI 10.1172/JCI115806; MARSCHALL HU, 1994, J LIPID RES, V35, P1599; MARSCHALL HU, 1994, HEPATOLOGY, V20, P845, DOI 10.1002/hep.1840200412; MATERN H, 1990, FEBS LETT, V270, P11, DOI 10.1016/0014-5793(90)81223-B; MATERN S, 1984, J CLIN INVEST, V74, P402, DOI 10.1172/JCI111435; McClean J, 2008, EXP NEUROL, V210, P41, DOI 10.1016/j.expneurol.2007.09.027; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Miners JO, 2004, ANNU REV PHARMACOL, V44, P1, DOI 10.1146/annurev.pharmtox.44.101802.121546; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Nakagomi M, 1999, STEROIDS, V64, P301, DOI 10.1016/S0039-128X(99)00007-0; Patana AS, 2007, MOL PHARMACOL, V72, P604, DOI 10.1124/mol.107.036871; PAUMGARTNER G, 1994, SCAND J GASTROENTERO, V29, P27, DOI 10.3109/00365529409103622; Paumgartner Gustav, 2004, Clin Liver Dis, V8, P67, DOI 10.1016/S1089-3261(03)00135-1; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200; SENAFI SB, 1994, BIOCHEM J, V303, P233, DOI 10.1042/bj3030233; Senay C, 2002, BBA-PROTEIN STRUCT M, V1597, P90, DOI 10.1016/S0167-4838(02)00266-2; Tang CY, 2003, DRUG METAB DISPOS, V31, P37, DOI 10.1124/dmd.31.1.37; Toran-Allerand CD, 2005, ENDOCRINOLOGY, V146, P3843, DOI 10.1210/en.2004-1616; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Williams JA, 2002, DRUG METAB DISPOS, V30, P1266, DOI 10.1124/dmd.30.11.1266; Xiong Y, 2008, DRUG METAB DISPOS, V36, P517, DOI 10.1124/dmd.107.016469	41	64	64	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36205	36210		10.1074/jbc.M807961200	http://dx.doi.org/10.1074/jbc.M807961200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981171	Green Published, hybrid			2022-12-25	WOS:000261840500015
J	Zauner, S; Zahringer, U; Lindner, B; Warnecke, D; Sperling, P				Zaeuner, Simone; Zaehringer, Ulrich; Lindner, Buko; Warnecke, Dirk; Sperling, Petra			Identification and Functional Characterization of the 2-Hydroxy Fatty N-Acyl-Delta 3(E)-desaturase from Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B(5) FUSION PROTEIN; SEED OIL; ACYL (E)-DELTA(3)-UNSATURATION; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; HIGHER-PLANTS; ACIDS PRESENT; CEREBROSIDES; FUNGI; SPHINGOLIPIDS	Delta 3( E)-Unsaturated fatty acids are characteristic components of glycosylceramides from some fungi, including also human-and plant-pathogenic species. The function and genetic basis for this unsaturation is unknown. For Fusarium graminearum, which is pathogenic to grasses and cereals, we could show that the level of Delta 3-unsaturation of glucosylceramide (GlcCer) was highest at low temperatures and decreased when the fungus was grown above 28 degrees C. With a bioinformatics approach, we identified a new family of polypeptides carrying the histidine box motifs characteristic for membrane-bound desaturases. One of the corresponding genes was functionally characterized as a sphingolipid-Delta 3(E)-desaturase. Deletion of the candidate gene in F. graminearum resulted in loss of the Delta 3(E)-double bond in the fatty acyl moiety of GlcCer. Heterologous expression of the corresponding cDNA from F. graminearum in the yeast Pichia pastoris led to the formation of Delta 3(E)-unsaturated GlcCer.	[Zaeuner, Simone; Warnecke, Dirk; Sperling, Petra] Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany; [Zaeuner, Simone; Warnecke, Dirk; Sperling, Petra] Univ Hamburg, Bot Gardens, D-22609 Hamburg, Germany; [Zaehringer, Ulrich; Lindner, Buko] Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany	University of Hamburg; University of Hamburg; Forschungszentrum Borstel	Warnecke, D (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	warnecke@botanik.uni-hamburg.de	Lindner, Buko/G-9731-2014		Deutsche Forschungsgemeinschaft [SP 967/1-1, Li 448/1-4, SFB470]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SP 967/1-1 (to S.Z.), Grant Li 448/1-4 (to B.L. and U.Z.), and Grant SFB470. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BAGBY MO, 1965, J AM OIL CHEM SOC, V42, P50, DOI 10.1007/BF02558255; BARTON PG, 1975, J BIOL CHEM, V250, P4470; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Duarte RS, 1998, BBA-LIPID LIPID MET, V1390, P186, DOI 10.1016/S0005-2760(97)00179-3; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; KENRICK JR, 1986, PLANT PHYSIOL, V81, P946, DOI 10.1104/pp.81.4.946; KLEIMAN R, 1966, LIPIDS, V1, P301, DOI 10.1007/BF02532670; KLEIMAN R, 1971, LIPIDS, V6, P617, DOI 10.1007/BF02531145; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Maier FJ, 2005, FEMS YEAST RES, V5, P653, DOI 10.1016/j.femsyr.2004.12.008; Miedaner T, 2000, Z PFLANZENK PFLANZEN, V107, P124; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P81, DOI 10.1093/oxfordjournals.pcp.a076516; NIRENBERG HI, 1981, CAN J BOT, V59, P1599, DOI 10.1139/b81-217; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Sperling P, 2001, ARCH BIOCHEM BIOPHYS, V388, P293, DOI 10.1006/abbi.2001.2308; Sperling P, 2001, FEBS LETT, V494, P90, DOI 10.1016/S0014-5793(01)02332-8; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; SUUTARI M, 1995, ARCH MICROBIOL, V164, P212, DOI 10.1007/s002030050256; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo MS, 2000, J LIPID RES, V41, P797; Toledo MS, 1999, BIOCHEMISTRY-US, V38, P7294, DOI 10.1021/bi982898z; Toledo MS, 2001, GLYCOBIOLOGY, V11, P113, DOI 10.1093/glycob/11.2.113; Tonon T, 2004, FEBS LETT, V563, P28, DOI 10.1016/S0014-5793(04)00241-8; VILLASBOAS MH, 1994, CHEM PHYS LIPIDS, V70, P11; Wada H, 2007, PHOTOSYNTH RES, V92, P205, DOI 10.1007/s11120-007-9203-z; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4; WOLLENWEBER HW, 1985, ARCH MICROBIOL, V142, P6, DOI 10.1007/BF00409228	45	13	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36734	36742		10.1074/jbc.M807264200	http://dx.doi.org/10.1074/jbc.M807264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981185	Green Published, hybrid			2022-12-25	WOS:000261840500071
J	Hayashida, K; Stahl, PD; Park, PW				Hayashida, Kazutaka; Stahl, Philip D.; Park, Pyong Woo			Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR; CELL-ADHESION; TYROSINE PHOSPHORYLATION; PSEUDOMONAS-AERUGINOSA; SOLUBLE SYNDECAN-1; EPITHELIAL-CELLS; CYTOPLASMIC DOMAINS; RECEPTOR ACTIVATION; VIRULENCE FACTOR	The ectodomain shedding of syndecan-1, a major cell surface heparan sulfate proteoglycan, modulates molecular and cellular processes central to the pathogenesis of inflammatory diseases. Syndecan-1 shedding is a highly regulated process in which outside-in signaling accelerates the proteolytic cleavage of syndecan-1 ectodomains at the cell surface. Several extracellular agonists that induce syndecan-1 shedding and metalloproteinases that cleave syndecan-1 ectodomains have been identified, but the intracellular mechanisms that regulate syndecan-1 shedding are largely unknown. Here we examined the role of the syndecan-1 cytoplasmic domain in the regulation of agonist-induced syndecan-1 shedding. Our results showed that the syndecan-1 cytoplasmic domain is essential because mutation of invariant cytoplasmic Tyr residues abrogates ectodomain shedding, but not because it is Tyr phosphorylated upon shedding stimulation. Instead, our data showed that the syndecan-1 cytoplasmic domain binds to Rab5, a small GTPase that regulates intracellular trafficking and signaling events, and this interaction controls the onset of syndecan-1 shedding. Syndecan-1 cytoplasmic domain bound specifically to Rab5 and preferentially to inactive GDP-Rab5 over active GTP-Rab5, and shedding stimulation induced the dissociation of Rab5 from the syndecan-1 cytoplasmic domain. Moreover, the expression of dominant-negative Rab5, unable to exchange GDP for GTP, interfered with the agonist-induced dissociation of Rab5 from the syndecan-1 cytoplasmic domain and significantly inhibited syndecan-1 shedding induced by several distinct agonists. Based on these data, we propose that Rab5 is a critical regulator of syndecan-1 shedding that serves as an on-off molecular switch through its alternation between the GDP-bound and GTP-bound forms.	[Hayashida, Kazutaka; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL)	Park, PW (corresponding author), 320 Longwood Ave,Enders 144, Boston, MA 02115 USA.	Pyong.Park@childrens.harvard.edu	Stahl, Philip/D-6315-2012		National Institutes of Health [HL69050, HL81474]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081474, R01HL069050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL69050 and HL81474. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrian E, 2005, J CELL PHYSIOL, V204, P178, DOI 10.1002/jcp.20287; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Carey DJ, 1997, BIOCHEM J, V327, P1; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hayashida K, 2006, J BIOL CHEM, V281, P24365, DOI 10.1074/jbc.M509320200; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Joensuu H, 2002, CANCER RES, V62, P5210; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; LI GP, 1993, J BIOL CHEM, V268, P24475; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Rodman JS, 2000, J CELL SCI, V113, P183; Seidel C, 2003, TRANSPLANTATION, V76, P423, DOI 10.1097/01.TP.0000074316.76104.A5; SLACK BE, 1995, J BIOL CHEM, V270, P8337, DOI 10.1074/jbc.270.14.8337; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vita F, 1996, EXP CELL RES, V227, P367, DOI 10.1006/excr.1996.0286; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	55	56	56	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35435	35444		10.1074/jbc.M804172200	http://dx.doi.org/10.1074/jbc.M804172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957427	Green Published, hybrid			2022-12-25	WOS:000261687900015
J	Ito, A; Suganami, T; Yamauchi, A; Degawa-Yamauchi, M; Tanaka, M; Kouyama, R; Kobayashi, Y; Nitta, N; Yasuda, K; Hirata, Y; Kuziel, WA; Takeya, M; Kanegasaki, S; Kamei, Y; Ogawa, Y				Ito, Ayaka; Suganami, Takayoshi; Yamauchi, Akira; Degawa-Yamauchi, Mikako; Tanaka, Miyako; Kouyama, Ryuji; Kobayashi, Yuko; Nitta, Nao; Yasuda, Kazuki; Hirata, Yukio; Kuziel, William A.; Takeya, Motohiro; Kanegasaki, Shiro; Kamei, Yasutomi; Ogawa, Yoshihiro			Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; PPAR-GAMMA; FATTY-ACIDS; MICE; INFLAMMATION; CHEMOTAXIS; ADIPONECTIN; DIET; INFILTRATION	The MCP-1 (monocyte chemoattractant protein-1)/CCR2 (CC motif chemokine receptor-2) pathway may play a role in macrophage infiltration into obese adipose tissue. Here we investigated the role of CCR2 in the recruitment of bone marrow-derived macrophages into obese adipose tissue in vitro and in vivo. Using the TAXIScan device, which can measure quantitatively the directionality and velocity of cell migration at time lapse intervals in vitro, we demonstrated that bone marrow cells (BMCs) from wild type mice migrate directly toward MCP-1 or culture medium conditioned by adipose tissue explants of genetically obese ob/ob mice, which are efficiently suppressed by pharmacological blockade of CCR2 signaling. The number of F4/80-positive macrophages was reduced in the adipose tissue from high fat diet-fed obese KKA(y) or ob/ob mice treated with a CCR2 antagonist propagermanium relative to vehicle-treated groups. We also found that the number of macrophages is reduced in the adipose tissue from ob/ob mice reconstituted with CR2(-/-) BMCs (ob/ob + CCR2(-/-) BMCs) relative to those with CCR2(+/+) BMCs (ob/ob + CCR2(+/+) BMCs). Expression of mRNAs for CD11c and TLR4 (Toll-like receptor 4) markers of proinflammatory M1 macrophages was also decreased in the adipose tissue from ob/ob + CCR2(-/-) BMCs relative to ob/ob + CCR2(+/+) BMCs, whereas mannose receptor and CD163, markers of anti-inflammatory M2 macrophages, were unchanged. This study provides in vivo and in vitro evidence that CCR2 in bone marrow cells plays an important role in the recruitment of macrophages into obese adipose tissue.	[Ito, Ayaka; Suganami, Takayoshi; Tanaka, Miyako; Kouyama, Ryuji; Kamei, Yasutomi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Bunkyo Ku, Tokyo 1138510, Japan; [Kouyama, Ryuji; Hirata, Yukio] Tokyo Med & Dent Univ, Dept Clin & Mol Endocrinol, Bunkyo Ku, Tokyo 1138510, Japan; [Tanaka, Miyako; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Global Ctr Excellence Program Int Res, Ctr Mol Sci Tooth & Bone Dis, Meguro Ku, Tokyo 1138510, Japan; [Yamauchi, Akira; Degawa-Yamauchi, Mikako; Kobayashi, Yuko; Nitta, Nao; Kanegasaki, Shiro] ECI Inc, Cent Lab, Meguro Ku, Tokyo 1530042, Japan; [Yasuda, Kazuki] Int Med Ctr Japan, Res Inst, Dept Metab Disorder, Shinjuku Ku, Tokyo 1628655, Japan; [Kuziel, William A.] Prot Design Labs Inc, Dept Autoimmune & Inflammatory Dis, Fremont, CA 94555 USA; [Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; Kumamoto University	Ogawa, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	ogawa.mmm@mri.tmd.ac.jp	Tanaka, Miyako/B-2805-2016; Kanegasaki, Shiro/AAM-4921-2021; Yamauchi, Akira/F-2202-2010; Nitta, Nao/J-8231-2019; SUGANAMI, Takayoshi/A-9475-2016	Tanaka, Miyako/0000-0002-5655-5633; Yamauchi, Akira/0000-0001-9205-6922; Nitta, Nao/0000-0002-9093-9016; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Smoking Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Ministry of Health, Labour, and Welfare of Japan and research grants from the Takeda Science Foundation and Smoking Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; JOHN TJ, 1976, LIFE SCI, V18, P177; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maki W, 2002, J IMMUNOL, V169, P2346, DOI 10.4049/jimmunol.169.5.2346; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; NELSON RD, 1975, J IMMUNOL, V115, P1650; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	42	122	123	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35715	35723		10.1074/jbc.M804220200	http://dx.doi.org/10.1074/jbc.M804220200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18977759	hybrid			2022-12-25	WOS:000261687900045
J	Margolin, Y; Shafirovich, V; Geacintov, NE; Demott, MS; Dedon, PC				Margolin, Yelena; Shafirovich, Vladimir; Geacintov, Nicholas E.; Demott, Michael S.; Dedon, Peter C.			DNA Sequence Context as a Determinant of the Quantity and Chemistry of Guanine Oxidation Produced by Hydroxyl Radicals and One-electron Oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-IRRADIATED DNA; STRAND BREAKS; PARAMAGNETIC-RESONANCE; SELECTIVE OXIDATION; CHEMICAL-STABILITY; RADIATION-DAMAGE; EXONUCLEASE-III; GGG TRIPLETS; PLASMID DNA; DUPLEX DNA	DNA sequence context has emerged as a critical determinant of the location and quantity of nucleobase damage caused by many oxidizing agents. However, the complexity of nucleobase and 2-deoxyribose damage caused by strong oxidants such as ionizing radiation and the Fenton chemistry of Fe2+-EDTA/H2O2 poses a challenge to defining the location of nucleobase damage and the effects of sequence context on damage chemistry in DNA. To address this problem, we developed a gel-based method that allows quantification of nucleobase damage in oxidized DNA by exploiting Escherichia coli exonuclease III to remove fragments containing direct strand breaks and abasic sites. The rigor of the method was verified in studies of guanine oxidation by photooxidized riboflavin and nitrosoperoxycarbonate, for which different effects of sequence context have been demonstrated by other approaches (Margolin, Y., Cloutier, J. F., Shafirovich, V., Geacintov, N. E., and Dedon, P. C. (2006) Nat. Chem. Biol. 2, 365-366). Using duplex oligodeoxynucleotides containing all possible three-nucleotide sequence contexts for guanine, the method was used to assess the role of DNA sequence context in hydroxyl radical-induced guanine oxidation associated with gamma-radiation and Fe2+-EDTA/H2O2. The results revealed both differences and similarities for G oxidation by hydroxyl radicals and by one-electron oxidation by riboflavin-mediated photooxidation, which is consistent with the predominance of oxidation pathways for hydroxyl radicals other than one-electron oxidation to form guanine radical cations. Although the relative quantities of G oxidation produced by hydroxyl radicals were more weakly correlated with sequence-specific ionization potential than G oxidation produced by riboflavin, damage produced by both hydroxyl radical generators and riboflavin within two- and three-base runs of G showed biases in location that are consistent with a role for electron transfer in defining the location of the damage products. Furthermore, both gamma-radiation and Fe2+-EDTA/H2O2 showed relatively modest effects of sequence context on the proportions of different damage products sensitive to E. coli formamidopyrimidine DNA glycosylase and hot piperidine, although GT-containing sequence contexts displayed subtle biases in damage chemistry (formamidopyrimidine DNA glycosylase/piperidine ratio). Overall, the results are consistent with the known chemistry of guanine oxidation by hydroxyl radical and demonstrate that charge migration plays a relatively minor role in determining the location and chemistry of hydroxyl radical-mediated oxidative damage to guanine in DNA.	[Margolin, Yelena; Demott, Michael S.; Dedon, Peter C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Margolin, Yelena; Demott, Michael S.; Dedon, Peter C.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Shafirovich, Vladimir; Geacintov, Nicholas E.] NYU, Dept Chem & Radiat, New York, NY 10003 USA; [Shafirovich, Vladimir; Geacintov, Nicholas E.] NYU, Solid State Lab, New York, NY 10003 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); New York University; New York University	Dedon, PC (corresponding author), MIT, Dept Biol Engn, NE47-277,77 Massachusetts Ave, Cambridge, MA 02139 USA.	pcdedon@mit.edu		Dedon, Peter/0000-0003-0011-3067	National Institutes of Health [CA110261 (NCI), ES002109]; NATIONAL CANCER INSTITUTE [R01CA110261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA110261 (NCI) and ES002109 (NIEHS Center grant). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; BECKER D, 1993, ADV RADIAT BIOL, V17, P121; BERNHARD WA, 1989, J PHYS CHEM-US, V93, P2187, DOI 10.1021/j100343a003; Box HC, 1999, RADIAT RES, V152, P575, DOI 10.2307/3580252; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; CADET J, 1994, J AM CHEM SOC, V116, P7403, DOI 10.1021/ja00095a052; CADET J, 1985, INT J RADIAT BIOL, V47, P127, DOI 10.1080/09553008514550201; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Candeias LP, 2000, CHEM-EUR J, V6, P475, DOI 10.1002/(SICI)1521-3765(20000204)6:3<475::AID-CHEM475>3.0.CO;2-E; Crean C, 2008, CHEMBIOCHEM, V9, P1985, DOI 10.1002/cbic.200800105; CULLIS PM, 1992, J CHEM SOC PERK T 2, P1409, DOI 10.1039/p29920001409; Cullis PM, 1996, CHEM COMMUN, P985, DOI 10.1039/cc9960000985; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DEDON PC, 1992, CHEM RES TOXICOL, V5, P311, DOI 10.1021/tx00027a001; Dedon PC, 2008, CHEM RES TOXICOL, V21, P206, DOI 10.1021/tx700283c; Delaney JC, 2008, CHEM RES TOXICOL, V21, P232, DOI 10.1021/tx700292a; Ding H, 2007, J AM CHEM SOC, V129, P772, DOI 10.1021/ja0678931; DIZDAROGLU M, 1986, FASEB J, V45, P1626; Doddridge ZA, 1998, J AM CHEM SOC, V120, P10998, DOI 10.1021/ja9816234; Douki T, 2002, CHEM RES TOXICOL, V15, P445, DOI 10.1021/tx0155909; Douki T, 1999, INT J RADIAT BIOL, V75, P571; Frelon S, 2002, J CHEM SOC PERK T 1, P2866, DOI 10.1039/b207532f; Gasparutto D, 1998, J AM CHEM SOC, V120, P10283, DOI 10.1021/ja980674y; Giese B, 2001, NATURE, V412, P318, DOI 10.1038/35085542; Greenberg MM, 2004, BIOCHEMISTRY-US, V43, P8178, DOI 10.1021/bi0496236; GREGOLI S, 1982, RADIAT RES, V89, P238, DOI 10.2307/3575770; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Haraguchi K, 2002, J AM CHEM SOC, V124, P3263, DOI 10.1021/ja012135q; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Ito K, 1997, BIOCHEMISTRY-US, V36, P1774, DOI 10.1021/bi9620161; ITO T, 1993, INT J RADIAT BIOL, V63, P289, DOI 10.1080/09553009314550391; Joffe A, 2003, CHEM RES TOXICOL, V16, P1528, DOI 10.1021/tx034142t; JONES GDD, 1994, INT J RADIAT BIOL, V66, P441, DOI 10.1080/09553009414551431; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; KOPPENOL WH, 1984, J PHYS CHEM-US, V88, P99, DOI 10.1021/j150645a024; KOW YW, 1989, BIOCHEMISTRY-US, V28, P3280, DOI 10.1021/bi00434a024; Leipold MD, 2000, BIOCHEMISTRY-US, V39, P14984, DOI 10.1021/bi0017982; Luo GM, 2001, FEBS LETT, V492, P29, DOI 10.1016/S0014-5793(01)02226-8; Margolin Y, 2006, NAT CHEM BIOL, V2, P365, DOI 10.1038/nchembio796; Matter B, 2006, NUCLEIC ACIDS RES, V34, P5449, DOI 10.1093/nar/gkl596; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; MILLIGAN JR, 1993, RADIAT RES, V133, P151, DOI 10.2307/3578350; Misiaszek R, 2004, J BIOL CHEM, V279, P32106, DOI 10.1074/jbc.M313904200; MurataKamiya N, 1997, J RADIAT RES, V38, P121, DOI 10.1269/jrr.38.121; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Patrzyc HB, 2001, RADIAT RES, V155, P634, DOI 10.1667/0033-7587(2001)155[0634:DLAPID]2.0.CO;2; Paul T, 2000, BIOCHEMISTRY-US, V39, P4129, DOI 10.1021/bi991463o; Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Purkayastha S, 2004, J PHYS CHEM B, V108, P18377, DOI 10.1021/jp048539x; Purkayastha S, 2007, RADIAT RES, V168, P357, DOI 10.1667/RR0964.1; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7; Ravanat JL, 2003, J AM CHEM SOC, V125, P2030, DOI 10.1021/ja028608q; REINKE LA, 1994, FREE RADICAL BIO MED, V16, P485, DOI 10.1016/0891-5849(94)90126-0; Rodriguez H, 1997, CANCER RES, V57, P2394; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; RUSH JD, 1986, J BIOL CHEM, V261, P6730; Saito I, 1998, J AM CHEM SOC, V120, P12686, DOI 10.1021/ja981888i; SAWYER DT, 1993, J AM CHEM SOC, V115, P5817, DOI 10.1021/ja00066a057; Senthilkumar K, 2003, J AM CHEM SOC, V125, P13658, DOI 10.1021/ja037027d; SEVILLA MD, 1991, J PHYS CHEM-US, V95, P3409, DOI 10.1021/j100161a080; Shafirovich V, 2004, TOP CURR CHEM, V237, P129, DOI 10.1007/b94475; Spassky A, 1997, BIOCHEMISTRY-US, V36, P6571, DOI 10.1021/bi962761d; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Tretyakova NY, 2000, CHEM RES TOXICOL, V13, P658, DOI 10.1021/tx000083x; Tretyakova NY, 2000, MUTAT RES-FUND MOL M, V447, P287, DOI 10.1016/S0027-5107(99)00221-3; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; von Sonntag C., 2006, FREE RADICAL INDUCED; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; WINK DA, 1994, P NATL ACAD SCI USA, V91, P6604, DOI 10.1073/pnas.91.14.6604; Yang X, 2004, P NATL ACAD SCI USA, V101, P17588, DOI 10.1073/pnas.0405157101; Yoshioka Y, 1999, J AM CHEM SOC, V121, P8712, DOI 10.1021/ja991032t	79	37	39	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35569	35578		10.1074/jbc.M806809200	http://dx.doi.org/10.1074/jbc.M806809200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948263	hybrid, Green Published			2022-12-25	WOS:000261687900029
J	Matsuura, A; Ito, M; Sakaidani, Y; Kondo, T; Murakami, K; Furukawa, K; Nadano, D; Matsuda, T; Okajima, T				Matsuura, Aiko; Ito, Makiko; Sakaidani, Yuta; Kondo, Tatsuhiko; Murakami, Kosuke; Furukawa, Koichi; Nadano, Daita; Matsuda, Tsukasa; Okajima, Tetsuya			O-Linked N-Acetylglucosamine Is Present on the Extracellular Domain of Notch Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; LIGAND-BINDING; PROTEIN O-FUCOSYL-TRANSFERASE-1; CYTOPLASMIC PROTEINS; FUCOSYL-TRANSFERASE; DELTA INTERACTIONS; DROSOPHILA NOTCH; MODIFIES NOTCH; FRINGE; GLYCOSYLATION	Rare types of glycosylation often occur in a domain-specific manner and are involved in specific biological processes. In particular, O-fucose glycans are reported to regulate the functions of EGF domain-containing proteins such as Notch receptors. In the course of mass spectrometric analysis of O-glycans displayed on Drosophila Notch receptors expressed in S2 cells, we found an unusual O-linked N-acetylhexosamine (HexNAc) modification which occurs at a site distinct from those of O-fucose and O-glucose glycosylations. Modification site mapping by mass spectrometry and amino acid substitution studies revealed that O-HexNAc modification occurs on a serine or threonine located between the fifth and sixth cysteines within the EGF domain. This modification occurs simultaneously along with other closely positioned O-glycosylations. This modification was determined to be O-beta-GlcNAc by galactosyltransferase labeling and beta-N-acetyl-hexosaminidase digestion experiments and by immunoblotting with a specific antibody. O-GlcNAc modification occurs at multiple sites on Notch epidermal growth factor repeats. O-GlcNAc modification was also found on the extracellular domain of Delta, a ligand for Notch receptors. Although the O-GlcNAc modification is known to regulate a wide range of cellular processes, the list of known modified proteins has previously been limited to intracellular proteins in animals. Thus, the finding of O-GlcNAc modification in extracellular environments predicts a distinct glycosylation process that might be associated with a novel regulatory mechanism for Notch receptor activity.	[Matsuura, Aiko; Ito, Makiko; Sakaidani, Yuta; Kondo, Tatsuhiko; Murakami, Kosuke; Nadano, Daita; Matsuda, Tsukasa; Okajima, Tetsuya] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Furukawa, Koichi; Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan	Nagoya University; Nagoya University	Okajima, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Dept Appl Mol Biosci, Furo Cho, Nagoya, Aichi 4648601, Japan.	tokajima@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program; Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program	Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program(Takeda Science Foundation (TSF)Uehara Memorial Foundation)	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program ( to T. O., D. N. and T. M.), the Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program ( to T. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABEIJON C, 1988, P NATL ACAD SCI USA, V85, P1010, DOI 10.1073/pnas.85.4.1010; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BJOERN S, 1991, J BIOL CHEM, V266, P11051; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; JONES MD, 1994, ANAL BIOCHEM, V216, P135, DOI 10.1006/abio.1994.1017; KEARSE KP, 1991, ARCH BIOCHEM BIOPHYS, V290, P543, DOI 10.1016/0003-9861(91)90579-8; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2000, J BIOL CHEM, V275, P40498, DOI 10.1074/jbc.M006902200; Okajima T, 2008, J BIOCHEM, V144, P1, DOI 10.1093/jb/mvn016; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Previato JO, 1998, J BIOL CHEM, V273, P14982, DOI 10.1074/jbc.273.24.14982; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang F, 2003, J BIOL CHEM, V278, P51395, DOI 10.1074/jbc.M308756200; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200	37	131	132	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35486	35495		10.1074/jbc.M806202200	http://dx.doi.org/10.1074/jbc.M806202200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948267	hybrid			2022-12-25	WOS:000261687900020
J	Mori, J; Pearce, AC; Spalton, JC; Grygielska, B; Eble, JA; Tomlinson, MG; Senis, YA; Watson, SP				Mori, Jun; Pearce, Andrew C.; Spalton, Jennifer C.; Grygielska, Beata; Eble, Johannes A.; Tomlinson, Michael G.; Senis, Yotis A.; Watson, Steve P.			G6b-B Inhibits Constitutive and Agonist-induced Signaling by Glycoprotein VI and CLEC-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; CELL ADHESION MOLECULE-1; TONIC B-CELL; HUMAN PLATELETS; TYROSINE PHOSPHORYLATION; INTRACYTOPLASMIC DOMAIN; DISTINCT PATHWAYS; GENE-EXPRESSION; COLLAGEN; ACTIVATION	Platelets play an essential role in wound healing by forming thrombi that plug holes in the walls of damaged blood vessels. To achieve this, platelets express a diverse array of cell surface receptors and signaling proteins that induce rapid platelet activation. In this study we show that two platelet glycoprotein receptors that signal via an immunoreceptor tyrosine-based activation motif (ITAM) or an ITAM-like domain, namely the collagen receptor complex glycoprotein VI (GPVI)-FcR gamma-chain and the C-type lectin- like receptor 2 (CLEC-2), respectively, support constitutive (i. e. agonist-independent) signaling in a cell line model using a nuclear factor of activated T-cells (NFAT) transcriptional reporter assay that can detect low level activation of phospholipase C gamma(PLC gamma). Constitutive and agonist signaling by both receptors is dependent on Src and Syk family kinases, and is inhibited by G6b-B, a platelet immunoglobulin receptor that has two immunoreceptor tyrosine-based inhibitory motifs in its cytosolic tail. Mutation of the conserved tyrosines in the two immunoreceptor tyrosine-based inhibitory motifs prevents the inhibitory action of G6b-B. Interestingly, the inhibitory activity of G6b-B is independent of the Src homology 2 (SH2)-domain containing tyrosine phosphatases, SHP1 and SHP2, and the inositol 5'-phosphatase, SHIP. Constitutive signaling via Src and Syk tyrosine kinases is observed in platelets and is associated with tyrosine phosphorylation of GPVI-FcR gamma-chain and CLEC-2. We speculate that inhibition of constitutive signaling through Src and Syk tyrosine kinases by G6b-B may help to prevent unwanted platelet activation.	[Mori, Jun; Pearce, Andrew C.; Spalton, Jennifer C.; Tomlinson, Michael G.; Senis, Yotis A.; Watson, Steve P.] Univ Birmingham, Biomed Res Inst, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Eble, Johannes A.] Frankfurt Univ Hosp, Excellence Cluster Cardio Pulm Syst, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany	University of Birmingham; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Watson, SP (corresponding author), Univ Birmingham, Biomed Res Inst, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	s.p.watson@bham.ac.uk	Watson, Stephen P/Q-6292-2016; Senis, Yotis/AAD-7183-2021	Watson, Stephen P/0000-0002-7846-7423; Tomlinson, Michael/0000-0002-1189-0091; Senis, Yotis/0000-0002-0947-9957	British Heart Foundation; Deutsche Forschungsgemeinschaft [Eb177/5-1]; Medical Research Council [G0400247] Funding Source: researchfish; MRC [G0400247] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the British Heart Foundation, The Wellcome Trust, and Deutsche Forschungsgemeinschaft Grant Eb177/5-1 (to J.A.E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; BIJSTERBOSCH MK, 1985, J EXP MED, V162, P1825, DOI 10.1084/jem.162.6.1825; BLAKE RA, 1993, BIOCHEM J, V290, P471, DOI 10.1042/bj2900471; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cicmil M, 2002, BLOOD, V99, P137, DOI 10.1182/blood.V99.1.137; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; de Vet ECJM, 2001, J BIOL CHEM, V276, P42070, DOI 10.1074/jbc.M103214200; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dhanjal TS, 2007, PLATELETS, V18, P56, DOI 10.1080/09537100600881396; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Grande SM, 2007, IMMUNOL REV, V218, P214, DOI 10.1111/j.1600-065X.2007.00535.x; INAZU T, 1990, BIOCHEM BIOPH RES CO, V170, P259, DOI 10.1016/0006-291X(90)91268-W; Isnardi I, 2006, IMMUNOL LETT, V104, P156, DOI 10.1016/j.imlet.2005.11.027; Jones KL, 2001, BLOOD, V98, P1456, DOI 10.1182/blood.V98.5.1456; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Moroi M, 2003, THROMB HAEMOSTASIS, V89, P996; Muraille E, 2000, IMMUNOL LETT, V72, P7, DOI 10.1016/S0165-2478(00)00162-0; Newland SA, 2007, BLOOD, V109, P4806, DOI 10.1182/blood-2006-09-047449; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; van Oers NSC, 1998, J IMMUNOL, V160, P163; Verbrugge A, 2006, EUR J IMMUNOL, V36, P190, DOI 10.1002/eji.200535226; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; Watson SP, 2001, THROMB HAEMOSTASIS, V86, P276	52	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35419	35427		10.1074/jbc.M806895200	http://dx.doi.org/10.1074/jbc.M806895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955485	Green Published, hybrid			2022-12-25	WOS:000261687900013
J	Upreti, M; Galitovskaya, EN; Chu, R; Tackett, AJ; Terrano, DT; Granell, S; Chambers, TC				Upreti, Meenakshi; Galitovskaya, Elena N.; Chu, Rong; Tackett, Alan J.; Terrano, David T.; Granell, Susana; Chambers, Timothy C.			Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL-INDUCED APOPTOSIS; PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; DNA-DAMAGE; CELL-DEATH; DEAMIDATION; BCL-X(L); FAMILY; MITOCHONDRIA; SENSITIVITY	Vinblastine and other microtubule inhibitors used as antimitotic cancer drugs characteristically promote the phosphorylation of the key anti-apoptotic protein, Bcl-xL. However, putative sites of phosphorylation have been inferred based on potential recognition by JNK, and no direct biochemical analysis has been performed. In this study we used protein purification and mass spectrometry to identify Ser-62 as a single major site in vivo. Site-directed mutagenesis confirmed Ser-62 to be the site of Bcl-xL phosphorylation induced by several microtubule inhibitors tested. Vinblastine-treated cells overexpressing a Ser-62 -> Ala mutant showed highly significantly reduced apoptosis compared with cells expressing wild-type Bcl-xL. Co-immunoprecipitation revealed that phosphorylation caused wild-type Bcl-xL to release bound Bax, whereas phospho-defective Bcl-xL retained the ability to bind Bax. In contrast, phospho-mimic (Ser-62 -> Asp) Bcl-xL exhibited a reduced capacity to bind Bax. Functional tests were performed by transiently co-transfecting Bax in the context of different Bcl-xL mutants. Co-expression of wild-type or phospho-defective Bcl-xL counteracted the adverse effects of Bax expression on cell viability, whereas phospho-mimic Bcl-xL failed to provide the same level of protection against Bax. These studies suggest that Bcl-xL phosphorylation induced by microtubule inhibitors plays a key pro-apoptotic role at least in part by disabling the ability of Bcl-xL to bind Bax.	[Upreti, Meenakshi; Galitovskaya, Elena N.; Chu, Rong; Tackett, Alan J.; Terrano, David T.; Granell, Susana; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Mail Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	ChambersTimothyC@uams.edu	granell, susana/H-2734-2012		National Institutes of Health [CA109821]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460, P20RR015569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109821 (NCI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amundson SA, 2000, CANCER RES, V60, P6101; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Han J, 2002, ANAL BIOCHEM, V310, P215, DOI 10.1016/S0003-2697(02)00376-7; Ibrado AM, 1997, CANCER RES, V57, P1109; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Rowinsky E. K., 1998, CHEMOTHERAPY SOURCE, P387; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Upreti M, 2006, J BIOL CHEM, V281, P15941, DOI 10.1074/jbc.M512586200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001	31	70	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35517	35525		10.1074/jbc.M805019200	http://dx.doi.org/10.1074/jbc.M805019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974096	Green Published, hybrid			2022-12-25	WOS:000261687900023
J	Zhang, J; Gao, ZG; Yin, J; Quon, MJ; Ye, JP				Zhang, Jin; Gao, Zhanguo; Yin, Jun; Quon, Michael J.; Ye, Jianping			S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-alpha Signaling through IKK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-1 TYROSINE PHOSPHORYLATION; NECROSIS-FACTOR INHIBITION; MULTIPLE SERINE KINASES; RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; SKELETAL-MUSCLE; KAPPA-B; MAMMALIAN TARGET; 3T3-L1 ADIPOCYTES; FATTY-ACID	S6K1 (p70S6K) is a serine kinase downstream from Akt in the insulin signaling pathway that is involved in negative feedback regulation of insulin action. S6K1 is also activated by TNF-alpha, a pro- inflammatory cytokine. However, its role remains to be characterized. In the current study, we elucidated a mechanism for S6K1 to mediate TNF-alpha-induced insulin resistance in adipocytes and hepatocytes. S6K1 was phosphorylated at Thr-389 in response to TNF-alpha. This led to phosphorylation of IRS-1 by S6K1 at multiple serine residues including Ser-270, Ser-307, Ser-636, and Ser-1101 in human IRS-1 (Ser-265, Ser-302, Ser-632, and Ser- 1097, in rodent IRS-1). Direct phosphorylation of these sites by S6K1 was observed in an in vitro kinase assay using purified IRS-1 and S6K1. Phosphorylation of all these serines was increased in the adipose tissue of obese mice. RNAi knockdown demonstrated an important role for S6K1 in mediating TNF-alpha-induced IRS-1 inhibition that led to impaired insulin-stimulated glucose uptake in adipocytes. A point mutant of IRS-1 (S270A) impaired association of IRS-1 with S6K1 resulting in diminished phosphorylation of IRS-1 at three other S6K1 phosphorylation sites (Ser- 307, Ser- 636, and Ser- 1101). Expression of a dominant negative S6K1 mutant prevented TNF-induced Ser- 270 phosphorylation and IRS-1 protein degradation. Moreover, in IKK2 (but not IKK1)-null cells, TNF-alpha treatment did not result in Thr-389 phosphorylation of S6K1. We present a new mechanism for TNF-alpha to induce insulin resistance that involves activation of S6K by an IKK2-dependent pathway. S6K directly phosphorylates IRS-1 on multiple serine residues to inhibit insulin signaling.	[Zhang, Jin; Gao, Zhanguo; Yin, Jun; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Quon, Michael J.] Natl Ctr Complementary & Alternat Med, Diabet Unit, NIH, Bethesda, MD 20892 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	National Institutes of Health Intramural Research Program (NCCAM) [1P30 DK072476]; NIH Grant [DK68036]; ADA Research Award [7-07-RA-189]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [ZIAAT000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R56DK068036, R01DK068036] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA Research Award; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NCCAM) ( to M. J. Q.), NIDDK CNRU Grant 1P30 DK072476 ( Genomic Core), and the NIH Grant DK68036 and ADA Research Award 7-07-RA-189 ( to J. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Dey D, 2005, CELL PHYSIOL BIOCHEM, V16, P217, DOI 10.1159/000089847; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Patti ME, 2004, NAT MED, V10, P1049, DOI 10.1038/nm1004-1049; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Peraldi P, 1997, J CLIN INVEST, V100, P1863, DOI 10.1172/JCI119715; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	50	207	223	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35375	35382		10.1074/jbc.M806480200	http://dx.doi.org/10.1074/jbc.M806480200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952604	Green Published, hybrid			2022-12-25	WOS:000261687900008
J	Inaba, K; Suzuki, M; Maegawa, K; Akiyama, S; Ito, K; Akiyama, Y				Inaba, Kenji; Suzuki, Mamoru; Maegawa, Ken-ichi; Akiyama, Shuji; Ito, Koreaki; Akiyama, Yoshinori			A Pair of Circularly Permutated PDZ Domains Control RseP, the S2P Family Intramembrane Protease of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE-STRESS-RESPONSE; EXTRACYTOPLASMIC STRESS; REGULATED PROTEOLYSIS; SIGMA(E); YAEL; DEGS; RECOGNITION; BINDING; INHIBITION; CLEAVAGE	The sigma(E) pathway of extracytoplasmic stress responses in Escherichia coli is activated through sequential cleavages of the anti-sigma(E) protein, RseA, by membrane proteases DegS and RseP. Without the first cleavage by DegS, RseP is unable to cleave full-length RseA. We previously showed that a PDZ-like domain in the RseP periplasmic region is essential for this negative regulation of RseP. We now isolated additional deregulated RseP mutants. Many of the mutations affected a periplasmic region that is N-terminal to the previously defined PDZ domain. We expressed these regions and determined their crystal structures. Consistent with a recent prediction, our results indicate that RseP has tandem, circularly permutated PDZ domains (PDZ-N and PDZ-C). Strikingly, almost all the strong mutations have been mapped around the ligand binding cleft region in PDZ-N. These results together with those of an in vitro reaction reproducing the two-step RseA cleavage suggest that the proteolytic function of RseP is controlled by ligand binding to PDZ-N.	[Ito, Koreaki; Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Inaba, Kenji; Maegawa, Ken-ichi] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Akiyama, Shuji] JST, PRESTO, Saitama 3320012, Japan; [Akiyama, Shuji] RIKEN Harima Inst, Hyogo 6795148, Japan	Kyoto University; Kyushu University; Osaka University; Japan Science & Technology Agency (JST); RIKEN	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	yakiyama@virus.kyoto-u.ac.jp	Suzuki, Mamoru/G-6576-2016	Suzuki, Mamoru/0000-0001-7071-5093; AKIYAMA, Shuji/0000-0002-7184-189X; Inaba, Kenji/0000-0001-8229-0467	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Kyushu University Interdisciplinary Program in Education and Projects in Research Development; Grants-in-Aid for Scientific Research [20247020, 19GS0314] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Program in Education and Projects in Research Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science (to Y.A.,K. Inaba, and K. Ito) and from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to S.A. and Y.A.), by "Targeted Proteins Research Program from MEXT, Japan (to M.S.), and by Kyushu University Interdisciplinary Program in Education and Projects in Research Development (to K. Inaba). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohn C, 2004, MOL MICROBIOL, V52, P427, DOI 10.1111/j.1365-2958.2004.03985.x; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Harris BZ, 2001, J CELL SCI, V114, P3219; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2005, JPN J APPL PHYS 1, V44, P8684, DOI 10.1143/JJAP.44.8684; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Kanehara K, 2003, EMBO J, V22, P6389, DOI 10.1093/emboj/cdg602; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Koide K, 2008, J BIOL CHEM, V283, P9562, DOI 10.1074/jbc.M709984200; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Rudolph MG, 2003, ACTA CRYSTALLOGR D, V59, P290, DOI 10.1107/S0907444902021704; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	49	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35042	35052		10.1074/jbc.M806603200	http://dx.doi.org/10.1074/jbc.M806603200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945679	Green Published, hybrid			2022-12-25	WOS:000261469100061
J	Hung, J; Colicos, MA				Hung, Johanna; Colicos, Michael A.			Astrocytic Ca2+ Waves Guide CNS Growth Cones to Remote Regions of Neuronal Activity	PLOS ONE			English	Article								Activity plays a critical role in network formation during developmental, experience-dependent, and injury related remodeling. Here we report a mechanism by which axon trajectory can be altered in response to remote neuronal activity. Using photoconductive stimulation to trigger high frequency action potentials in rat hippocampal neurons in vitro, we find that activity functions as an attractive cue for growth cones in the local environment. The underlying guidance mechanism involves astrocyte Ca2+ waves, as the connexin-43 antagonist carbenoxolone abolishes the attraction when activity is initiated at a distance greater than 120 mm. The asymmetric growth cone filopodia extension that precedes turning can be blocked with CNQX (10 mu M), but not with the ATP and adenosine receptor antagonists suramin (100 mu M) and alloxazine (4 mu M), suggesting non-NMDA glutamate receptors on the growth cone mediate the interaction with astrocytes. These results define a potential long-range signalling pathway for activity-dependent axon guidance in which growth cones turn towards directional, temporally coordinated astrocyte Ca2+ waves that are triggered by neuronal activity. To assess the viability of the guidance effect in an injury paradigm, we performed the assay in the presence of conditioned media from lipopolysaccharide (LPS) activated purified microglial cultures, as well as directly activating the glia present in our co-cultures. Growth cone attraction was not inhibited under these conditions, suggesting this mechanism could be used to guide regeneration following axonal injury.	[Hung, Johanna; Colicos, Michael A.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada	University of Calgary	Hung, J (corresponding author), Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada.	mcolicos@ucalgary.ca			CIHR; AIF; AHFMR; HSFC	CIHR(Canadian Institutes of Health Research (CIHR)); AIF; AHFMR(Alberta Heritage Foundation for Medical Research); HSFC(Heart & Stroke Foundation of Canada)	This work was supported by CIHR and AIF grants to M.C. M.C. is an AHFMR Scholar and an HSFC Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; FONTANA A, 1987, IMMUNOL REV, V100, P185, DOI 10.1111/j.1600-065X.1987.tb00532.x; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Fu WM, 1997, NEUROREPORT, V8, P2005, DOI 10.1097/00001756-199705260-00041; Goda Y, 2006, NAT PROTOC, V1, P461, DOI 10.1038/nprot.2006.67; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Hassinger TD, 1996, P NATL ACAD SCI USA, V93, P13268, DOI 10.1073/pnas.93.23.13268; Innocenti B, 2000, J NEUROSCI, V20, P1800; KATER SB, 1994, PROG BRAIN RES, V102, P4999; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McFarlane S, 2000, BIOCHEM CELL BIOL, V78, P563, DOI 10.1139/bcb-78-5-563; McKenna WL, 2008, J NEUROCHEM, V104, P1081, DOI 10.1111/j.1471-4159.2007.05040.x; Miller RF, 2004, GLIA, V47, P275, DOI 10.1002/glia.20073; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Mundigl O, 1998, J NEUROSCI, V18, P93; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PATEL NB, 1984, J NEUROSCI, V4, P2939; Ponimaskin E, 2007, MOL NEUROBIOL, V35, P278, DOI 10.1007/s12035-007-0023-0; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Starovoytov A, 2005, J NEUROPHYSIOL, V93, P1090, DOI 10.1152/jn.00836.2004; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	55	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3692	10.1371/journal.pone.0003692	http://dx.doi.org/10.1371/journal.pone.0003692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002247	gold, Green Submitted, Green Published			2022-12-25	WOS:000265166000003
J	Mehraj, V; Hatcher, J; Akhtar, S; Rafique, G; Beg, MA				Mehraj, Vikram; Hatcher, Juanita; Akhtar, Saeed; Rafique, Ghazala; Beg, Mohammad Asim			Prevalence and Factors Associated with Intestinal Parasitic Infection among Children in an Urban Slum of Karachi	PLOS ONE			English	Article							HELMINTH INFECTIONS; HOOKWORM INFECTION; COMMUNITY; DIARRHEA; GROWTH; RISK	Background: Intestinal parasitic infections are endemic worldwide and have been described as constituting the greatest single worldwide cause of illness and disease. Poverty, illiteracy, poor hygiene, lack of access to potable water and hot and humid tropical climate are the factors associated with intestinal parasitic infections. The study aimed to estimate prevalence and identify factors associated with intestinal parasitic infections among 1 to 5 years old children residing in an urban slum of Karachi Pakistan. Methods and Principal Findings: A cross sectional survey was conducted from February to June 2006 in Ghosia Colony Gulshan Town Karachi, Pakistan. A simple random sample of 350 children aged 1-5 years was collected. The study used structured pre-tested questionnaire, anthropometric tools and stool tests to obtain epidemiological and disease data. Data were analyzed using appropriate descriptive, univariate and multivariable logistic regression methods. The mean age of participants was 2.8 years and 53% were male. The proportions of wasted, stunted and underweight children were 10.4%, 58.9% and 32.7% respectively. The prevalence of Intestinal parasitic infections was estimated to be 52.8% (95% CI: 46.1; 59.4). Giardia lamblia was the most common parasite followed by Ascaris lumbricoides, Blastocystis hominis and Hymenolepis nana. About 43% children were infected with single parasite and 10% with multiple parasites. Age {Adjusted Odds Ratio (aOR) = 1.5; 95% CI: 1.1; 1.9}, living in rented households (aOR = 2.0; 95% CI: 1.0; 3.9) and history of excessive crying (aOR = 1.9; 95% CI: 1.0; 3.4) were significantly associated with intestinal parasitic infections. Conclusions: Intestinal parasites are highly prevalent in this setting and poverty was implicated as an important risk factor for infection. Effective poverty reduction programmes and promotion of deworming could reduce intestinal parasite carriage. There is a need for mass scale campaigns to create awareness about health and hygiene.	[Mehraj, Vikram; Beg, Mohammad Asim] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Mehraj, Vikram; Hatcher, Juanita; Akhtar, Saeed; Rafique, Ghazala] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Mehraj, Vikram] Univ Aix Marseille 2, Fac Med, Ctr Natl Rech Sci, Unite Mixte Rech 6236, Marseille, France; [Akhtar, Saeed] Kuwait Univ, Fac Med, Dept Community Med & Behavioral Sci, Safat 13060, Kuwait	Aga Khan University; Aga Khan University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Kuwait University	Mehraj, V (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	masim.beg@aku.edu	Akhtar, Saeed/AAG-2334-2021	Akhtar, Saeed/0000-0002-1261-788X	International Maternal and Child Health Research Training Program, NIH [5 D43 TW05497-03]; Aga Khan University; University of Alabama at Birmingham; FOGARTY INTERNATIONAL CENTER [D43TW005497] Funding Source: NIH RePORTER	International Maternal and Child Health Research Training Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aga Khan University; University of Alabama at Birmingham; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We acknowledge International Maternal and Child Health Research Training Program (FIC, NIH # 5 D43 TW05497-03) of Aga Khan University (AKU) and University of Alabama at Birmingham (UAB) for providing financial support in the development of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Akbar K, 2003, J Ayub Med Coll Abbottabad, V15, P28; AKPEDE GO, 1995, J ROY SOC HEALTH, V115, P164, DOI 10.1177/146642409511500309; Akpede GO, 1995, J ROY SOC HEALTH, V115, P173; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P145; [Anonymous], WORLD URB PROSP 2005; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; *CDC, 2001, EP INF; CDC DPDx, 2006, LAB ID PAR PUBL HLTH; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Curtale F, 1998, HEALTH POLICY PLANN, V13, P423, DOI 10.1093/heapol/13.4.423; Ensink JHJ, 2005, T ROY SOC TROP MED H, V99, P809, DOI 10.1016/j.trstmh.2005.01.005; Glickman LT, 1999, INT J EPIDEMIOL, V28, P169, DOI 10.1093/ije/28.1.169; Harpham T, 2002, J TROP PEDIATRICS, V48, P128, DOI 10.1093/tropej/48.3.128; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Iacono G, 2005, DIGEST LIVER DIS, V37, P432, DOI 10.1016/j.dld.2005.01.009; Kaur Ravinder, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P725; Kucik CJ, 2004, AM FAM PHYSICIAN, V69, P1161; Lunn PG, 1999, J NUTR, V129, P872, DOI 10.1093/jn/129.4.872; MARTI H, 1993, J CLIN MICROBIOL, V31, P3044, DOI 10.1128/JCM.31.11.3044-3045.1993; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Muniz PT, 2002, ANN TROP MED PARASIT, V96, P503, DOI 10.1179/000349802125001311; Naish S, 2004, ACTA TROP, V91, P177, DOI 10.1016/j.actatropica.2004.04.004; Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010; Pegelow K., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P173; Pillai D.R., 2003, CURR TREATMENT OPTIO, V5, P207; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Siddiqui M I, 2002, J Pak Med Assoc, V52, P315; *SPSS, 2005, STAT PACK SOC SCI; SRINIVASAN V, 1987, T ROY SOC TROP MED H, V81, P973, DOI 10.1016/0035-9203(87)90369-5; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Tahir Z., 2002, BIOMEDICA, V18, P74; WAQAR SN, 2003, INFECT DIS J PAK, V12, P73; WENDER EH, 1976, AM J PSYCHIAT, V133, P20; WHO, 2006, GEOGR DISTR US FACTS; WHO, 2006, SOFTWARE ASSESSING G; 1998, DISTRICT CENSUS REPO; 2005, KARACHI CITY INFORM	39	139	145	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3680	10.1371/journal.pone.0003680	http://dx.doi.org/10.1371/journal.pone.0003680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WR	18997865	Green Published, gold			2022-12-25	WOS:000265165500003
J	Camas, FM; Poyatos, JF				Camas, Francisco M.; Poyatos, Juan F.			What Determines the Assembly of Transcriptional Network Motifs in Escherichia coli?	PLOS ONE			English	Article							REGULATORY NETWORK; HIERARCHICAL STRUCTURE; EVOLUTION; GROWTH; ORGANIZATION; INTEGRATION; PROTEIN	Transcriptional networks are constituted by a collection of building blocks known as network motifs. Why do motifs appear? An adaptive model of motif emergence was recently questioned in favor of neutralist scenarios. Here, we provide a new picture of motif assembly in Escherichia coli which partially clarifies these contrasting explanations. This is based on characterizing the linkage between motifs and sensing or response specificity of their constituent transcriptional factors (TFs). We find that sensing specificity influences the distribution of autoregulation, while the tendency of a TF to establish feed-forward loops (FFLs) depends on response specificity, i.e., regulon size. Analysis of the latter pattern reveals that coregulation between large regulon-size TFs is common under a network neutral model, leading to the assembly of a great number of FFLs and bifans. In addition, neutral exclusive regulation also leads to a collection of single input modules - the fourth basic motif. On the whole, and even under the conservative neutralist scenario considered, a substantial group of regulatory structures revealed adaptive. These structures visibly function as fully-fledged working units.	[Camas, Francisco M.; Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Camas, FM (corresponding author), CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain.	jpoyatos@cnb.csic.es			Ministerio de Educacion y Ciencia (MEC) [Formacion de Profesorado Universitario fellowship, FIS2006-10368]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government)	This work was supported in part by a Ministerio de Educacion y Ciencia (MEC) Formacion de Profesorado Universitario fellowship (F.M.C.), and MEC Grant FIS2006-10368 (to J.F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Artzy-Randrup Y, 2004, SCIENCE, V305; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Banzhaf Wolfgang, 2004, Journal of Biological Physics and Chemistry, V4, P85, DOI 10.4024/2040405.jbpc.04.02; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; Cordero OX, 2006, MOL BIOL EVOL, V23, P1931, DOI 10.1093/molbev/msl060; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; ISHIZUKA H, 1994, EMBO J, V13, P3077, DOI 10.1002/j.1460-2075.1994.tb06606.x; Janga SC, 2007, NUCLEIC ACIDS RES, V35, P6963, DOI 10.1093/nar/gkm743; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazurie A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r35; Milo R, 2004, SCIENCE, V305; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Ward JJ, 2007, PLOS COMPUT BIOL, V3, P1993, DOI 10.1371/journal.pcbi.0030198; Warren PB, 2004, J MOL BIOL, V342, P1379, DOI 10.1016/j.jmb.2004.07.074; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3657	10.1371/journal.pone.0003657	http://dx.doi.org/10.1371/journal.pone.0003657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987754	Green Submitted, gold, Green Published			2022-12-25	WOS:000265134500004
J	Sun, YM; Cooper, M; Finch, S; Lin, HH; Chen, ZF; Williams, BP; Buckley, NJ				Sun, Yuh-Man; Cooper, Megan; Finch, Sophie; Lin, Hsuan-Hwai; Chen, Zhou-Feng; Williams, Brenda P.; Buckley, Noel J.			Rest-Mediated Regulation of Extracellular Matrix Is Crucial for Neural Development	PLOS ONE			English	Article							TARGET GENES; RE-1 SILENCER; STEM-CELLS; IN-VIVO; FATE; TRANSCRIPTION; REPRESSION; IDENTIFICATION; PRECURSORS; EXPRESSION	Neural development from blastocysts is strictly controlled by intricate transcriptional programmes that initiate the down-regulation of pluripotent genes, Oct4, Nanog and Rex1 in blastocysts followed by up-regulation of lineage-specific genes as neural development proceeds. Here, we demonstrate that the expression pattern of the transcription factor Rest mirrors those of pluripotent genes during neural development from embryonic stem (ES) cells and an early abrogation of Rest in ES cells using a combination of gene targeting and RNAi approaches causes defects in this process. Specifically, Rest ablation does not alter ES cell pluripotency, but impedes the production of Nestin(+) neural stem cells, neural progenitor cells and neurons, and results in defective adhesion, decrease in cell proliferation, increase in cell death and neuronal phenotypic defects typified by a reduction in migration and neurite elaboration. We also show that these Rest-null phenotypes are due to the dysregulation of its direct or indirect target genes, Lama1, Lamb1, Lamc1 and Lama2 and that these aberrant phenotypes can be rescued by laminins.	[Sun, Yuh-Man; Cooper, Megan; Finch, Sophie; Lin, Hsuan-Hwai; Williams, Brenda P.; Buckley, Noel J.] Kings Coll London, James Black Ctr, CCBB, Inst Psychiat, London WC2R 2LS, England; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, Psychiat & Dev Biol, St Louis, MO 63130 USA	University of London; King's College London; Washington University (WUSTL)	Sun, YM (corresponding author), Kings Coll London, James Black Ctr, CCBB, Inst Psychiat, London WC2R 2LS, England.	yuh-man.sun@iop.kcl.ac.uk	Buckley, Noel J/B-9675-2012; Sun, Yuh-Man/N-1579-2014	Buckley, Noel J/0000-0003-1152-0653; Sun, Yuh-Man/0000-0002-8863-4280; Williams, Brenda Patricia/0000-0003-4690-5932	Neuroscience, IOP, King's College London, UK; Wellcome Trust	Neuroscience, IOP, King's College London, UK; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a start up fund (Y-M. Sun) from Neuroscience, IOP, King's College London, UK and Wellcome Trust grants (N. J. Buckley).	Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017; Aumailley M, 2000, J CELL SCI, V113, P259; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Colognato H, 2005, TRENDS NEUROSCI, V28, P480, DOI 10.1016/j.tins.2005.07.004; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; EKBLOM P, 1996, LAMININS; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; LAWSON KA, 1992, CIBA F SYMP, V165, P3; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Olguin P, 2006, J NEUROSCI, V26, P2820, DOI 10.1523/JNEUROSCI.5037-05.2006; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Thiel G, 1999, NATURWISSENSCHAFTEN, V86, P1, DOI 10.1007/s001140050561; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	43	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3656	10.1371/journal.pone.0003656	http://dx.doi.org/10.1371/journal.pone.0003656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987749	Green Published, gold, Green Submitted			2022-12-25	WOS:000265134500003
J	Martinato, F; Cesaroni, M; Amati, B; Guccione, E				Martinato, Francesca; Cesaroni, Matteo; Amati, Bruno; Guccione, Ernesto			Analysis of Myc-Induced Histone Modifications on Target Chromatin	PLOS ONE			English	Article								The c-myc proto-oncogene is induced by mitogens and is a central regulator of cell growth and differentiation. The c-myc product, Myc, is a transcription factor that binds a multitude of genomic sites, estimated to be over 10-15% of all promoter regions. Target promoters generally pre-exist in an active or poised chromatin state that is further modified by Myc, contributing to fine transcriptional regulation (activation or repression) of the afferent gene. Among other mechanisms, Myc recruits histone acetyl-transferases to target chromatin and locally promotes hyper-acetylation of multiple lysines on histones H3 and H4, although the identity and combination of the modified lysines is unknown. Whether Myc dynamically regulates other histone modifications (or marks) at its binding sites also remains to be addressed. Here, we used quantitative chromatin immunoprecipitation (qChIP) to profile a total of 24 lysine-acetylation and -methylation marks modulated by Myc at target promoters in a human B-cell line with a regulatable c-myc transgene. Myc binding promoted acetylation of multiple lysines, primarily of H3K9, H3K14, H3K18, H4K5 and H4K12, but significantly also of H4K8, H4K91 and H2AK5. Dimethylation of H3K79 was also selectively induced at target promoters. A majority of target promoters showed co-induction of multiple marks - in various combinations - correlating with recruitment of the two HATs tested (Tip60 and HBO1), incorporation of the histone variant H2A.Z and transcriptional activation. Based on this and previous findings, we surmise that Myc recruits the Tip60/p400 complex to achieve a coordinated histone acetylation/exchange reaction at activated promoters. Our data are also consistent with the additive and redundant role of multiple acetylation events in transcriptional activation.	[Martinato, Francesca; Cesaroni, Matteo; Amati, Bruno; Guccione, Ernesto] IFOM IEO, Dept Expt Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Martinato, F (corresponding author), IFOM IEO, Dept Expt Oncol, Milan, Italy.	bruno.amati@ifom-ieo-campus.it; eguccione@imcb.a-star.edu.sg	Amati, Bruno/AAM-3418-2020; guccione, ernesto/G-9874-2011	Amati, Bruno/0000-0002-2958-1799	Italian Association for Cancer Research (AIRC) [fellowship]; Ricerca Finalizzata" program of the Italian Health Ministry	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata" program of the Italian Health Ministry	This work was supported by grants from the Italian Association for Cancer Research (AIRC) and the "Ricerca Finalizzata" program of the Italian Health Ministry to BA, and by a fellowship from the Italian Association for Cancer Research (FIRC) to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; GUCCIONE E, 2007, NATURE; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; KUSCH T, 2004, ACETYLATION TIP60 IS; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; LOIDL P, 1994, CHROMOSOMA, V103, P441; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SQUATRITO M, 2006, TRENDS CELL IN PTRDD; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	78	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3650	10.1371/journal.pone.0003650	http://dx.doi.org/10.1371/journal.pone.0003650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985155	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134400012
J	Dupaigne, P; Lavelle, C; Justome, A; Lafosse, S; Mirambeau, G; Lipinski, M; Pietrement, O; Le Cam, E				Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Mirambeau, Gilles; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric			Rad51 Polymerization Reveals a New Chromatin Remodeling Mechanism	PLOS ONE			English	Article								Rad51 protein is a well known protagonist of homologous recombination in eukaryotic cells. Rad51 polymerization on single-stranded DNA and its role in presynaptic filament formation have been extensively documented. Rad51 polymerizes also on double-stranded DNA but the significance of this filament formation remains unclear. We explored the behavior of Saccharomyces cerevisiae Rad51 on dsDNA and the influence of nucleosomes on Rad51 polymerization mechanism to investigate its putative role in chromatin accessibility to recombination machinery. We combined biochemical approaches, transmission electron microscopy (TEM) and atomic force microscopy (AFM) for analysis of the effects of the Rad51 filament on chromatinized templates. Quantitative analyses clearly demonstrated the occurrence of chromatin remodeling during nucleoprotein filament formation. During Rad51 polymerization, recombinase proteins moved all the nucleosomal arrays in front of the progressing filament. This polymerization process had a powerful remodeling effect, as Rad51 destabilized the nucleosomes along considerable stretches of DNA. Similar behavior was observed with RecA. Thus, recombinase polymerization is a powerful mechanism of chromatin remodeling. These remarkable features open up new possibilities for understanding DNA recombination and reveal new types of ATP-dependent chromatin dynamics.	[Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Mirambeau, Gilles; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric] CNRS, Inst Canc Gustave Roussy, Lab Microscopie Mol & Cellulaire, UMR Interact Mol & Canc 8126, Villejuif, France; [Dupaigne, Pauline; Lavelle, Christophe; Justome, Anthony; Lafosse, Sophie; Lipinski, Marc; Pietrement, Olivier; Le Cam, Eric] Univ Paris Sud, Villejuif, France; [Mirambeau, Gilles] Univ Paris 06, UFR Sci Vie, Div Biochim, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Dupaigne, P (corresponding author), CNRS, Inst Canc Gustave Roussy, Lab Microscopie Mol & Cellulaire, UMR Interact Mol & Canc 8126, Villejuif, France.	olivier.pietrement@igr.fr; elecam@igr.fr	Dupaigne, Pauline/C-6873-2019; Lavelle, Christophe/F-2377-2013; PIETREMENT, Olivier/T-2555-2017	Le cam, Eric/0000-0002-6832-6117; PIETREMENT, Olivier/0000-0002-0018-7202; Mirambeau, Gilles/0000-0001-8308-4948; Dupaigne, Pauline/0000-0001-7033-4055	CNRS; ANR; Ligue contre le Cancer; ARC; INCa; Region Ile de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Ligue contre le Cancer(Ligue nationale contre le cancer); ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); Region Ile de France(Region Ile-de-France)	This work was supported by grants from CNRS, ANR, Ligue contre le Cancer, ARC, INCa and Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; EGGLESTON AK, 1995, J BIOL CHEM, V270, P2024, DOI 10.1074/jbc.270.5.2024; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; Kwon Y, 2007, DNA REPAIR, V6, P1496, DOI 10.1016/j.dnarep.2007.04.012; Lavelle C, 2007, BIOCHIMIE, V89, P516, DOI 10.1016/j.biochi.2006.09.019; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Pastre D, 2006, LANGMUIR, V22, P6651, DOI 10.1021/la053387y; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sauvageau S, 2005, MOL CELL BIOL, V25, P4377, DOI 10.1128/MCB.25.11.4377-4387.2005; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Sivolob A, 2003, J MOL BIOL, V326, P49, DOI 10.1016/S0022-2836(02)01372-4; Sivolob A, 1999, J MOL BIOL, V285, P1081, DOI 10.1006/jmbi.1998.2380; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	44	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3643	10.1371/journal.pone.0003643	http://dx.doi.org/10.1371/journal.pone.0003643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982066	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134300012
J	Mandl, RCW; Schnack, HG; Zwiers, MP; van der Schaaf, A; Kahn, RS; Pol, HEH				Mandl, Rene C. W.; Schnack, Hugo G.; Zwiers, Marcel P.; van der Schaaf, Arjen; Kahn, Rene S.; Pol, Hilleke E. Hulshoff			Functional Diffusion Tensor Imaging: Measuring Task-Related Fractional Anisotropy Changes in the Human Brain along White Matter Tracts	PLOS ONE			English	Article								Background: Functional neural networks in the human brain can be studied from correlations between activated gray matter regions measured with fMRI. However, while providing important information on gray matter activation, no information is gathered on the co-activity along white matter tracts in neural networks. Methodology/Principal Findings: We report on a functional diffusion tensor imaging (fDTI) method that measures task-related changes in fractional anisotropy (FA) along white matter tracts. We hypothesize that these fractional anisotropy changes relate to morphological changes of glial cells induced by axonal activity although the exact physiological underpinnings of the measured FA changes remain to be elucidated. As expected, these changes are very small as compared to the physiological noise and a reliable detection of the signal change would require a large number of measurements. However, a substantial increase in signal-to-noise ratio was achieved by pooling the signal over the complete fiber tract. Adopting such a tract-based statistics enabled us to measure the signal within a practically feasible time period. Activation in the sensory thalamocortical tract and optic radiation in eight healthy human subjects was found during tactile and visual stimulation, respectively. Conclusions/Significance: The results of our experiments indicate that these FA changes may serve as a functional contrast mechanism for white matter. This noninvasive fDTI method may provide a new approach to study functional neural networks in the human brain.	[Mandl, Rene C. W.; Schnack, Hugo G.; van der Schaaf, Arjen; Kahn, Rene S.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Zwiers, Marcel P.] Radboud Univ Nijmegen, Ctr Cognitive Neuroimaging, Donders Inst Brain, Cognit & Behaviour, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Mandl, RCW (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	r.mandl@umcutrecht.nl	Mandl, René C.W./AAU-7037-2020; Zwiers, Marcel P/D-2968-2009; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Van+Der+Schaaf, Arjen/AEX-0530-2022	Zwiers, Marcel P/0000-0001-5483-2935; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Van+Der+Schaaf, Arjen/0000-0003-4067-7975	Dutch Organization for Medical Research NWO ZON-MW VIDI Program [917.46.370]	Dutch Organization for Medical Research NWO ZON-MW VIDI Program	This work was supported by a grant from the Dutch Organization for Medical Research NWO ZON-MW VIDI Program (H.E.H., 917.46.370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AW, 1996, MAGN RESON MED, V35, P162, DOI 10.1002/mrm.1910350206; Armitage P., 2002, STAT METHODS MED RES; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beshay JE, 2005, GLIA, V51, P121, DOI 10.1002/glia.20192; Blankenburg F, 2003, SCIENCE, V299, P1864, DOI 10.1126/science.1080806; Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; CATANI M, 2005, RISES FALLS DISCONNE; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; COLES JAD, 2005, NEUROGLIA; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; Gulani V, 1999, MAGNET RESON MED, V41, P241, DOI 10.1002/(SICI)1522-2594(199902)41:2<241::AID-MRM5>3.0.CO;2-E; HARDY TL, 1979, APPL NEUROPHYSIOL, V42, P335; Harshbarger TB, 2006, NMR BIOMED, V19, P1020, DOI 10.1002/nbm.1067; Iguchi Y, 2005, CLIN NEUROPHYSIOL, V116, P1077, DOI 10.1016/j.clinph.2004.12.005; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Kandel E., 2000, PRINCIPLES NEURAL SC; Kennan Richard P., 1995, P110; Le Bihan D., 2006, P NATL ACAD SCI US, V103, P8263; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lu H, 2003, MAGNET RESON MED, V50, P263, DOI 10.1002/mrm.10519; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Mesulam M, 2005, ANN NEUROL, V57, P5, DOI 10.1002/ana.20368; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; Pol HEH, 2004, NEUROIMAGE, V21, P27, DOI 10.1016/j.neuroimage.2003.09.026; Prichard JW, 1995, NMR BIOMED, V8, P359, DOI 10.1002/nbm.1940080709; RANSOM BR, 1985, J NEUROSCI, V5, P532; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Skare S, 2000, MAGN RESON IMAGING, V18, P659, DOI 10.1016/S0730-725X(00)00153-3; Sommer IEC, 2004, BRIT J PSYCHIAT, V184, P128, DOI 10.1192/bjp.184.2.128; Stroman PW, 2008, MAGN RESON MED, V59, P700, DOI 10.1002/mrm.21534; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Sykova E, 2003, NEUROIMAGE, V18, P214, DOI 10.1016/S1053-8119(02)00014-9; Sykova E, 2000, NEUROCHEM INT, V36, P397, DOI 10.1016/S0197-0186(99)00131-X; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810	46	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3631	10.1371/journal.pone.0003631	http://dx.doi.org/10.1371/journal.pone.0003631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982065	Green Submitted, gold, Green Published			2022-12-25	WOS:000265134300002
J	Krishnan, K; Salomonis, N; Guo, S				Krishnan, Keerthi; Salomonis, Nathan; Guo, Su			Identification of Spt5 Target Genes in Zebrafish Development Reveals Its Dual Activity In Vivo	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTOR; CHROMATIN-STRUCTURE; MICROARRAY DATA; P-TEFB; PROTEIN; ACTIVATION; EXPRESSION; PROMOTER; TAT	Spt5 is a conserved essential protein that represses or stimulates transcription elongation in vitro. Immunolocalization studies on Drosophila polytene chromosomes suggest that Spt5 is associated with many loci throughout the genome. However, little is known about the prevalence and identity of Spt5 target genes in vivo during development. Here, we identify direct target genes of Spt5 using fog(sk8) zebrafish mutant, which disrupts the foggy/spt5 gene. We identified that fog(sk8) and their wildtype siblings differentially express less than 5% of genes examined. These genes participate in diverse biological processes from stress response to cell fate specification. Up-regulated genes exhibit shorter overall gene length compared to all genes examined. Through chromatin immunoprecipitation in zebrafish embryos, we identified a subset of developmentally critical genes that are bound by both Spt5 and RNA polymerase II. The protein occupancy patterns on these genes are characteristic of both repressive and stimulatory elongation regulation. Together our findings establish Spt5 as a dual regulator of transcription elongation in vivo and identify a small but diverse set of target genes critically dependent on Spt5 during development.	[Krishnan, Keerthi; Salomonis, Nathan; Guo, Su] Univ Calif San Francisco, Dept Biopharm Sci, Programs Human Genet & Pharm Sci & Pharmacogenom, San Francisco, CA 94143 USA; [Salomonis, Nathan] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Krishnan, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	suguo@itsa.ucsf.edu			NIH [NS042626]; UCSF [Graduate Student Research Award]; J. David Gladstone Institutes [T32GM07175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; J. David Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH grant NS042626. K. Krishnan was a recipient of a UCSF Graduate Student Research Award. N. Salomonis was supported by the J. David Gladstone Institutes and T32GM07175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Blackwell TK, 2003, CURR BIOL, V13, pR915, DOI 10.1016/j.cub.2003.11.013; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dudoit S, 2003, BIOTECHNIQUES, P45; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kawahara A, 2005, P NATL ACAD SCI USA, V102, P361, DOI 10.1073/pnas.0408726102; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim D, 2001, MOL CELLS, V11, P267; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lavoie SB, 2001, J MOL BIOL, V312, P675, DOI 10.1006/jmbi.2001.4991; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pei Y, 2003, J BIOL CHEM, V278, P43346, DOI 10.1074/jbc.M307319200; POLLARD KS, 2002, CYBERNETICS INFORM, V2, P318; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Stachora AA, 1997, FEBS LETT, V409, P74, DOI 10.1016/S0014-5793(97)00486-9; SWANSON MS, 1992, GENETICS, V132, P325; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; THISSE B, 2004, EXPRESSION ZEBRAFISH; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WINSTON F, 1984, GENETICS, V107, P179; Winston F, 2001, GENOME BIOL, V2; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Wu-Baer F, 1998, J MOL BIOL, V277, P179, DOI 10.1006/jmbi.1997.1601; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	61	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3621	10.1371/journal.pone.0003621	http://dx.doi.org/10.1371/journal.pone.0003621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978947	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000265134200008
J	Tundup, S; Pathak, N; Ramanadham, M; Mukhopadhyay, S; Murthy, KJR; Ehtesham, NZ; Hasnain, SE				Tundup, Smanla; Pathak, Niteen; Ramanadham, M.; Mukhopadhyay, Sangita; Murthy, K. J. R.; Ehtesham, Nasreen Z.; Hasnain, Seyed E.			The Co-Operonic PE25/PPE41 Protein Complex of Mycobacterium tuberculosis Elicits Increased Humoral and Cell Mediated Immune Response	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERFERON-GAMMA; GENE-EXPRESSION; BCG VACCINE; PE; ANTIGEN; PPE; RV2430C; ESAT-6; TRANSLOCATION	Background: Many of the PE/PPE proteins are either surface localized or secreted outside and are thought to be a source of antigenic variation in the host. The exact role of these proteins are still elusive. We previously reported that the PPE41 protein induces high B cell response in TB patients. The PE/PPE genes are not randomly distributed in the genome but are organized as operons and the operon containing PE25 and PPE41 genes co-transcribe and their products interact with each other. Methodology/Principal Finding: We now describe the antigenic properties of the PE25, PPE41 and PE25/PPE41 protein complex coded by a single operon. The PPE41 and PE25/PPE41 protein complex induces significant (p<.0001) B cell response in sera derived from TB patients and in mouse model as compared to the PE25 protein. Further, mice immunized with the PE25/PPE41 complex and PPE41 proteins showed significant (p<0.00001) proliferation of splenocyte as compared to the mice immunized with the PE25 protein and saline. Flow cytometric analysis showed 15-22% enhancement of CD8(+) and CD4(+) T cell populations when immunized with the PPE41 or PE25/PPE41 complex as compared to a marginal increase (8-10%) in the mice immunized with the PE25 protein. The PPE41 and PE25/PPE41 complex can also induce higher levels of IFN-gamma, TNF-alpha and IL-2 cytokines. Conclusion: While this study documents the differential immunological respo nse to the complex of PE and PPE vis-a-vis the individual proteins, it also highlights their potential as a candidate vaccine against tuberculosis.	[Tundup, Smanla; Pathak, Niteen; Mukhopadhyay, Sangita; Hasnain, Seyed E.] Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India; [Tundup, Smanla; Ramanadham, M.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Murthy, K. J. R.] Mahavir Hosp, Immunol Unit, Hyderabad, Andhra Pradesh, India; [Ehtesham, Nasreen Z.] Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] HCU Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Tundup, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India.	vc@uohyd.ernet.in	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020	Mukhopadhyay, Sangita/0000-0002-5511-3315; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), India; Bose National Fellow of the Ministry of Science & Technology, Government of India; CSIR [Senior Research Fellow]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Bose National Fellow of the Ministry of Science & Technology, Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The financial support for the work carried out was provided by the Department of Biotechnology (DBT), India. Seyed E. Hasnain is a J.C. Bose National Fellow of the Ministry of Science & Technology, Government of India. S. T. is a CSIR Senior Research Fellow.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; BREWER TF, 1995, CLIN INFECT DIS, V20, P126, DOI 10.1093/clinids/20.1.126; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2004, PROTEIN EXPRES PURIF, V36, P249, DOI 10.1016/j.pep.2004.03.016; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Valliere S, 2005, INFECT IMMUN, V73, P6711, DOI 10.1128/IAI.73.10.6711-6720.2005; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Ganguly N, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-24; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	35	57	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3586	10.1371/journal.pone.0003586	http://dx.doi.org/10.1371/journal.pone.0003586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974870	Green Published, gold			2022-12-25	WOS:000265131700009
J	Brudevold, R; Hole, T; Hammerstrom, J				Brudevold, Robert; Hole, Torstein; Hammerstrom, Jens			Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SERUM FERRITIN; HEREDITARY HEMOCHROMATOSIS; METABOLIC SYNDROME; STORES; PREVALENCE	Objective: During the last 10 years we have experienced an increasing number of referrals due to hyperferritinemia. This is probably due to increased awareness of hereditary hemochromatosis, and the availability of a genetic test for this condition. Most of these referred patients were over-weight middle-aged men with elevated ferritin levels, but without the hemochromatosis-predisposing gene mutations. We evaluated the relationship between hyperferritinemia and the metabolic syndrome in 40 patients. Methods: Forty consecutive patients referred for hyperferritinemia were investigated. The examination programme included medical history, clinical investigation and venous blood samples drawn after an overnight fast. This resulted in 34 patients with unexplained hyperferritinemia, which were further examined. Liver biopsy was successfully performed in 29 subjects. Liver iron stores were assessed morphologically, and by quantitative phlebotomy in 16 patients. Results: The majority of the patients had markers of the metabolic syndrome, and 18 patients (52%) fulfilled the IDF-criteria for the metabolic syndrome. Mean body mass index was elevated (28,8 +/- 4,2), mean diastolic blood pressure was 88,5 +/- 10,5 mmHg, and mean fasting insulin C-peptide 1498 +/- 539 pmol/l. Liver histology showed steatosis and nuclear glycogen inclusions in most patients (19 out of 29). Only four patients had increased iron stores by histology, of which two could be explained by alcohol consumption. Fourteen of 16 patients normalized ferritin levels after phlebotomy of a cumulative blood amount corresponding to normal iron stores. Ferritin levels were significantly related to insulin C-peptide level (p<0.002) and age (p<0.002). Conclusion: The present results suggest that liver steatosis and insulin resistance but not increased iron load is frequently seen in patients referred for suspected hemochromatosis on the basis of hyperferritinemia. The ferritin level seems to be positively associated to insulin resistance.	[Brudevold, Robert; Hole, Torstein] Aalesund Hosp, Dept Med, Alesund, Norway; [Hammerstrom, Jens] St Olavs Hosp, Dept Med, Trondheim, Norway; [Hole, Torstein; Hammerstrom, Jens] Norwegian Univ Sci & Technol NTNU, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Brudevold, R (corresponding author), Aalesund Hosp, Dept Med, Alesund, Norway.	robert.brudevold@helse-sunnmore.no						Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; CARAMIA F, 1968, J CLIN PATHOL, V21, P19, DOI 10.1136/jcp.21.1.19; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DINNEEN SF, 1994, MAYO CLIN PROC, V69, P13, DOI 10.1016/S0025-6196(12)61605-X; DINNEEN SF, 1992, IRISH J MED SCI, V161, P636, DOI 10.1007/BF02983771; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hernandez C, 2005, DIABETIC MED, V22, P97, DOI 10.1111/j.1464-5491.2004.01331.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hsueh WA, 2003, AM J CARDIOL, V92, p10J, DOI 10.1016/S0002-9149(03)00611-8; Jandl J.H., 1996, BLOOD TXB HEMATOLOGY; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; SEARLE J, 1987, PATHOLOGY LIVER; Sjoholm A, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7; Tavill AS, 2001, HEPATOLOGY, V33, P1321, DOI 10.1053/jhep.2001.24783; Tuomainen TP, 1997, DIABETES CARE, V20, P426, DOI 10.2337/diacare.20.3.426; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; WORWOOD M, 1986, CLIN SCI, V70, P215, DOI 10.1042/cs0700215; Worwood M, 1994, IRON METABOLISM HLTH, P449	30	50	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3547	10.1371/journal.pone.0003547	http://dx.doi.org/10.1371/journal.pone.0003547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958176	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130900009
J	Kimura, T; Yamashita, S; Nakao, S; Park, JM; Murayama, M; Mizoroki, T; Yoshiike, Y; Sahara, N; Takashima, A				Kimura, Tetsuya; Yamashita, Shunji; Nakao, Shinobu; Park, Jung-Mi; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Sahara, Naruhiko; Takashima, Akihiko			GSK-3 beta Is Required for Memory Reconsolidation in Adult Brain	PLOS ONE			English	Article								Activation of GSK-3 beta is presumed to be involved in various neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory disturbances during early stages of the disease. The normal function of GSK-3 beta in adult brain is not well understood. Here, we analyzed the ability of heterozygote GSK-3 beta knockout (GSK+/-) mice to form memories. In the Morris water maze (MWM), learning and memory performance of GSK+/- mice was no different from that of wild-type (WT) mice for the first 3 days of training. With continued learning on subsequent days, however, retrograde amnesia was induced in GSK+/- mice, suggesting that GSK+/- mice might be impaired in their ability to form long-term memories. In contextual fear conditioning (CFC), context memory was normally consolidated in GSK+/- mice, but once the original memory was reactivated, they showed reduced freezing, suggesting that GSK+/- mice had impaired memory reconsolidation. Biochemical analysis showed that GSK-3 beta was activated after memory reactivation in WT mice. Intraperitoneal injection of a GSK-3 inhibitor before memory reactivation impaired memory reconsolidation in WT mice. These results suggest that memory reconsolidation requires activation of GSK-3 beta in the adult brain.	[Kimura, Tetsuya; Yamashita, Shunji; Nakao, Shinobu; Park, Jung-Mi; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Sahara, Naruhiko; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan	RIKEN	Takashima, A (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Biedenkapp JC, 2004, BEHAV NEUROSCI, V118, P956, DOI 10.1037/0735-7044.118.5.956; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Imahori K, 1997, J BIOCHEM, V121, P179; Iqbal K, 1996, ANN NY ACAD SCI, V777, P132, DOI 10.1111/j.1749-6632.1996.tb34411.x; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; O'Brien WT, 2007, BIOL PSYCHIAT, V61, P139, DOI 10.1016/j.biopsych.2006.11.008; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Riccio DC, 2002, INTEGR PHYS BEH SCI, V37, P245, DOI 10.1007/BF02734247; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	40	111	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3540	10.1371/journal.pone.0003540	http://dx.doi.org/10.1371/journal.pone.0003540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958152	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130900003
J	Min, SH; Kim, DM; Heo, YS; Kim, YI; Kim, HM; Kim, J; Han, YM; Kim, IC; Yoo, OJ				Min, S-H; Kim, D. M.; Heo, Y-S; Kim, Y-I; Kim, H. M.; Kim, J.; Han, Y-M; Kim, I-C; Yoo, O-J			New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53	ONCOGENE			English	Article						p53 target; phosphatase of regenerating liver 1; PRL-1; EGR; PI3K	TUMOR-SUPPRESSOR PROTEIN; GENE-EXPRESSION; TYROSINE PHOSPHATASES; CANCER-CELLS; GROWTH; ACTIVATION; METASTASIS; INVASION; PHOSPHORYLATION; MDM2	Most of the p53 target genes, all except MDM2, COP1 and PIRH2, perform functions in apoptosis, differentiation and cell cycle arrest. The aforementioned oncogenes downregulate p53 through a negative feedback mechanism, and thus contribute to tumor development. In this study, we report a new p53 target, PRL-1, which is believed to be a significant regulator in the development and metastasis of a variety of cancer types. Phosphatase of regenerating liver 1 (PRL-1) overexpression reduced the levels of endogenous and exogenous p53 proteins, and inhibited p53-mediated apoptosis. On the other hand, the ablation of PRL-1 by small interfering RNA (siRNA) increased p53 protein levels. The p53 downregulation was mediated by p53 ubiquitination and subsequent proteasomal degradation. Furthermore, p53 ubiquitination by PRL-1 was achieved through two independent pathways, by inducing PIRH2 transcription and by inducing MDM2 phosphorylation through Akt signaling. In addition, we showed that the PRL-1 gene harbors a p53 response element in the first intron, and its transcription is regulated by the p53 protein. These findings imply that the new oncogenic p53 target, PRL-1, may contribute to tumor development by the downregulation of p53 by a negative feedback mechanism.	[Yoo, O-J] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr, Dept Biol Sci, Taejon 305701, South Korea; [Kim, D. M.] Chonnam Natl Univ, Higher Educ Ctr Bioregulator Res BK21, Kwangju, South Korea; [Kim, I-C] Chonnam Natl Univ, Dept Biol, Kwangju, South Korea; [Yoo, O-J] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chonnam National University; Chonnam National University; Korea Advanced Institute of Science & Technology (KAIST)	Yoo, OJ (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr, Dept Biol Sci, Taejon 305701, South Korea.	ojyoo@kaist.ac.kr	Kim, Ho Min/G-2712-2011; Yoo, Ook Joon/C-1860-2011		Ministry of Science and Technology of Korea [M1040101001-06N0101-00110]	Ministry of Science and Technology of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	We thank Dr Sung Hyun Kang and Dr Kwang Hee Bae (KRIBB) for providing the FLAG-PRL-1. This work was supported by funding from the Ministry of Science and Technology of Korea (M1040101001-06N0101-00110).	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Daoud SS, 2003, CANCER RES, V63, P2782; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; Huang JH, 1998, ONCOGENE, V17, P401, DOI 10.1038/sj.onc.1201951; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kim SB, 2007, CELL DEATH DIFFER, V14, P982, DOI 10.1038/sj.cdd.4402083; Kobayashi D, 2002, ANTICANCER RES, V22, P3963; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; McMahon SB, 1996, J LEUKOCYTE BIOL, V60, P159, DOI 10.1002/jlb.60.2.159; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Weizer-Stern O, 2007, BRIT J HAEMATOL, V138, P253, DOI 10.1111/j.1365-2141.2007.06638.x; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200	36	34	38	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					545	554		10.1038/onc.2008.409	http://dx.doi.org/10.1038/onc.2008.409			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997816				2022-12-25	WOS:000262866500008
J	Bailey, S; Rapson, T; Johnson-Winters, K; Astashkin, AV; Enemark, JH; Kappler, U				Bailey, Susan; Rapson, Trevor; Johnson-Winters, Kayunta; Astashkin, Andrei V.; Enemark, John H.; Kappler, Ulrike			Molecular Basis for Enzymatic Sulfite Oxidation HOW THREE CONSERVED ACTIVE SITE RESIDUES SHAPE ENZYME ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; CYTOCHROME-C OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; PULSED EPR; OXIDASE; BIOLOGY; EXPRESSION; CATALYSIS; INSIGHTS; COMPLEX	Sulfite dehydrogenases (SDHs) catalyze the oxidation and detoxification of sulfite to sulfate, a reaction critical to all forms of life. Sulfite-oxidizing enzymes contain three conserved active site amino acids (Arg-55, His-57, and Tyr-236) that are crucial for catalytic competency. Here we have studied the kinetic and structural effects of two novel and one previously reported substitution (R55M, H57A, Y236F) in these residues on SDH catalysis. Both Arg-55 and His-57 were found to have key roles in substrate binding. An R55M substitution increased K-m(sulfite)(app) by 2-3 orders of magnitude, whereas His-57 was required for maintaining a high substrate affinity at low pH when the imidazole ring is fully protonated. This effect may be mediated by interactions of His-57 with Arg-55 that stabilize the position of the Arg-55 side chain or, alternatively, may reflect changes in the protonation state of sulfite. Unlike what is seen for SDHWT and SDHY236F, the catalytic turnover rates of SDHR55M and SDHH57A are relatively insensitive to pH (similar to 60 and 200 s(-1), respectively). On the structural level, striking kinetic effects appeared to correlate with disorder (in SDHH57A and SDHY236F) or absence of Arg-55 (SDHR55M), suggesting that Arg-55 and the hydrogen bonding interactions it engages in are crucial for substrate binding and catalysis. The structure of SDHR55M has sulfate bound at the active site, a fact that coincides with a significant increase in the inhibitory effect of sulfate in SDHR55M. Thus, Arg-55 also appears to be involved in enabling discrimination between the substrate and product in SDH.	[Rapson, Trevor; Kappler, Ulrike] Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia; [Bailey, Susan] Daresbury Lab, Sci & Technol Facil Council, Mol Biophys Grp, Warrington WA4 4AD, Cheshire, England; [Johnson-Winters, Kayunta; Astashkin, Andrei V.; Enemark, John H.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Queensland; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); University of Arizona	Kappler, U (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia.	u.kappler@uq.edu.au	Enemark, John/AAQ-4395-2020; Kappler, Ulrike/A-9483-2013; Rapson, Trevor/B-3510-2012	Kappler, Ulrike/0000-0002-2642-1319; Rapson, Trevor/0000-0003-1289-0146	National Institutes of Health [GM-37773]; University of Queensland; Science and Technology Facilities Council Daresbury Laboratory; Ruth L. Kirschstein National Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Queensland(University of Queensland); Science and Technology Facilities Council Daresbury Laboratory; Ruth L. Kirschstein National Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-37773 (to J.H.E.). This work was also supported by a grant and fellowship from the University of Queensland (to U. K.), an Endeavor International Postgraduate Research Scholarship from the University of Queensland (to T. D. R.), and by the Science and Technology Facilities Council Daresbury Laboratory (for S. B.). This work was also supported by a Ruth L. Kirschstein National Service Award (to K.J.-W.).	Astashkin AV, 2006, CONCEPT MAGN RESON B, V29B, P125, DOI 10.1002/cmr.b.20064; Astashkin AV, 2002, J AM CHEM SOC, V124, P6109, DOI 10.1021/ja0115417; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; AYLWARD GH, 1971, SI CHEM DATA, P122; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; *CCP4, 1994, ACTA CRYSTALLOGR D, V10, P760; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; DeLano W, 2002, PYMOL 0 99; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; ENEMARK JH, 2006, J CHEM SOC DA, V29, P3501; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Feng CJ, 2003, J AM CHEM SOC, V125, P14696, DOI 10.1021/ja038197t; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kappler U, 2002, FEBS LETT, V529, P208, DOI 10.1016/S0014-5793(02)03344-6; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Kappler U, 2006, BIOCHEMISTRY-US, V45, P9696, DOI 10.1021/bi060058b; Karakas E, 2005, J BIOL CHEM, V280, P33506, DOI 10.1074/jbc.M505035200; KARAKAS E, 2005, J CHEM SOC DA, V21, P3459; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RAJAGOPALAN KV, 1980, MOLYBDENUM MOLYBDENU, P243; Ridge JP, 2002, BIOCHEMISTRY-US, V41, P15762, DOI 10.1021/bi0266582; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; SUZUKI I, 1994, METHOD ENZYMOL, V243, P447; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	37	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2053	2063		10.1074/jbc.M807718200	http://dx.doi.org/10.1074/jbc.M807718200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19004819	hybrid, Green Published			2022-12-25	WOS:000262545600013
J	Gale, SE; Westover, EJ; Dudley, N; Krishnan, K; Merlin, S; Scherrer, DE; Han, XL; Zhai, XH; Brockman, HL; Brown, RE; Covey, DF; Schaffer, JE; Schlesinger, P; Ory, DS				Gale, Sarah E.; Westover, Emily J.; Dudley, Nicole; Krishnan, Kathiresan; Merlin, Sean; Scherrer, David E.; Han, Xianlin; Zhai, Xiuhong; Brockman, Howard L.; Brown, Rhoderick E.; Covey, Douglas F.; Schaffer, Jean E.; Schlesinger, Paul; Ory, Daniel S.			Side Chain Oxygenated Cholesterol Regulates Cellular Cholesterol Homeostasis through Direct Sterol-Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHOLESTEROL; DENSITY-LIPOPROTEIN CHOLESTEROL; PLASMA-MEMBRANE; SENSING DOMAIN; NPC1 PROTEIN; IN-VITRO; OXYSTEROLS; BINDING; CELLS; SCAP	Side chain oxysterols exert cholesterol homeostatic effects by suppression of sterol regulatory element-binding protein maturation and promoting degradation of hydroxymethylglutaryl-CoA reductase. To examine whether oxysterol-membrane interactions contribute to the regulation of cellular cholesterol homeostasis, we synthesized the enantiomer of 25-hydroxycholesterol. Using this unique oxysterol probe, we provide evidence that oxysterol regulation of cholesterol homeostatic responses is not mediated by enantiospecific oxysterol-protein interactions. We show that side chain oxysterols, but not steroid ringmodified oxysterols, exhibit membrane expansion behavior in phospholipid monolayers and bilayers in vitro. This behavior is non-enantiospecific and is abrogated by increasing the saturation of phospholipid acyl chain constituents. Moreover, we extend these findings into cultured cells by showing that exposure to saturated fatty acids at concentrations that lead to endoplasmic reticulum membrane phospholipid remodeling inhibits oxysterol activity. These studies implicate oxysterol-membrane interactions in acute regulation of sterol homeostatic responses and provide new insights into the mechanism through which oxysterols regulate cellular cholesterol balance.	[Ory, Daniel S.] Washington Univ, Sch Med, Cardiovasc Res Ctr, Dept Med, St Louis, MO 63110 USA; [Westover, Emily J.; Krishnan, Kathiresan; Covey, Douglas F.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Merlin, Sean; Schlesinger, Paul; Ory, Daniel S.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zhai, Xiuhong; Brockman, Howard L.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System	Ory, DS (corresponding author), Washington Univ, Sch Med, Cardiovasc Res Ctr, Dept Med, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	dory@wustl.edu	Schlesinger, Paul H/C-6049-2012	Brown, Rhoderick/0000-0002-7337-3604	National Institutes of Health [HL67773, HL83762, GM47969, DK54268, HL49180, GM45928, P30 DK56341, 5T32HL007275-29]; Hormel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK054268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928, P01GM047969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67773 (to D.S.O.and D.F.C.), HL83762 (to D.S.O.), GM47969 (to D.F.C.), DK54268 (to J.E.S.), HL49180 (to H.L.B.), GM45928(to R.E.B.), and P30 DK56341 and by Training Grant 5T32HL007275-29 (to E.J.W.and N.D.).This work was also supported by the Hormel Foundation (to H.L.B. and R.E.B.).The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Aittoniemi J, 2006, J PHYS CHEM B, V110, P25562, DOI 10.1021/jp064931u; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kauffman JM, 2000, J LIPID RES, V41, P991; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; LANGE Y, 1994, J BIOL CHEM, V269, P3411; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Phillips JE, 2001, ATHEROSCLEROSIS, V159, P125, DOI 10.1016/S0021-9150(01)00504-4; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rex S, 1998, BIOCHEMISTRY-US, V37, P2336, DOI 10.1021/bi971009p; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Westover EJ, 2006, STEROIDS, V71, P484, DOI 10.1016/j.steroids.2006.01.007; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Worgall TS, 2002, J BIOL CHEM, V277, P3878, DOI 10.1074/jbc.M102393200	35	57	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1755	1764		10.1074/jbc.M807210200	http://dx.doi.org/10.1074/jbc.M807210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996837	hybrid, Green Published			2022-12-25	WOS:000262330100046
J	Bottomley, MJ; Cirillo, A; Orsatti, L; Ruggeri, L; Fisher, TS; Santoro, JC; Cummings, RT; Cubbon, RM; Lo Surdo, P; Calzetta, A; Noto, A; Baysarowich, J; Mattu, M; Talamo, F; De Francesco, R; Sparrow, CP; Sitlani, A; Carfi, A				Bottomley, Matthew J.; Cirillo, Agostino; Orsatti, Laura; Ruggeri, Lionello; Fisher, Timothy S.; Santoro, Joseph C.; Cummings, Richard T.; Cubbon, Rose M.; Lo Surdo, Paola; Calzetta, Alessandra; Noto, Alessia; Baysarowich, Jennifer; Mattu, Marco; Talamo, Fabio; De Francesco, Raffaele; Sparrow, Carl P.; Sitlani, Ayesha; Carfi, Andrea			Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTASE SUBTILISIN/KEXIN TYPE-9; DENSITY-LIPOPROTEIN RECEPTORS; PCSK9 GENE; SECRETED PCSK9; MOLECULAR-BASIS; LDL RECEPTORS; MUTATIONS; BINDING; DECREASES; HOMOLOGY	PCSK9 regulates low density lipoprotein receptor (LDLR) levels and consequently is a target for the prevention of atherosclerosis and coronary heart disease. Here we studied the interaction, of LDLR EGF(A/AB) repeats with PCSK9. We show that PCSK9 binds the EGF(AB) repeats in a pH-dependent manner. Although the PCSK9 C-terminal domain is not involved in LDLR binding, PCSK9 autocleavage is required. Moreover, we report the x-ray structure of the PCSK9 Delta C-EGF(AB) complex at neutral pH. Compared with the low pH PCSK9-EGF(A) structure, the new structure revealed rearrangement of the EGF( A) His-306 side chain and disruption of the salt bridge with PCSK9 Asp-374, thus suggesting the basis for enhanced interaction at low pH. In addition, the structure of PCSK9 Delta C bound to EGF(AB)(H306Y), a mutant associated with familial hypercholesterolemia (FH), reveals that the Tyr-306 side chain forms a hydrogen bond with PCSK9 Asp-374, thus mimicking His-306 in the low pH conformation. Consistently, Tyr-306 confers increased affinity for PCSK9. Importantly, we found that although the EGF(AB)(H306Y)-PCSK9 interaction is pH-independent, LDLRH306Y binds PCSK9 50-fold better at low pH, suggesting that factors other than His-306 contribute to the pH dependence of PCSK9-LDLR binding. Further, we determined the structures of EGF(AB) bound to PCSK9 Delta C containing the FH-associated D374Y and D374H mutations, revealing additional interactions with EGF(A) mediated by Tyr-374/His-374 and providing a rationale for their disease phenotypes. Finally, we report the inhibitory properties of EGF repeats in a cellular assay measuring LDL uptake.	[Bottomley, Matthew J.; Cirillo, Agostino; Orsatti, Laura; Ruggeri, Lionello; Lo Surdo, Paola; Calzetta, Alessandra; Noto, Alessia; Mattu, Marco; Talamo, Fabio; De Francesco, Raffaele; Carfi, Andrea] Ist Ric Biol Mol P Angeletti, Dept Biochem, I-00040 Pomezia, Italy; [Fisher, Timothy S.; Santoro, Joseph C.; Cummings, Richard T.; Cubbon, Rose M.; Baysarowich, Jennifer; Sparrow, Carl P.; Sitlani, Ayesha] Merck Res Labs, Div Cardiovasc Dis, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Bottomley, MJ (corresponding author), Ist Ric Biol Mol P Angeletti, Dept Biochem, Via Pontina Km 30-600, I-00040 Pomezia, Italy.	matthew_bottomley@merck.com; andrea_carfi@merck.com	De Francesco, Raffaele/J-6003-2012; Fisher, Timothy S/D-8517-2011	De Francesco, Raffaele/0000-0001-8754-5123; Fisher, Timothy S/0000-0002-8909-313X				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day INM, 1997, HUM MUTAT, V10, P116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Jeyarajah S, 1998, J AM SOC MASS SPECTR, V9, P157, DOI 10.1016/S1044-0305(97)00247-X; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	38	102	119	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1313	1323		10.1074/jbc.M808363200	http://dx.doi.org/10.1074/jbc.M808363200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001363	Green Published, hybrid			2022-12-25	WOS:000262122900066
J	Flamand, N; Luo, M; Peters-Golden, M; Brock, TG				Flamand, Nicolas; Luo, Ming; Peters-Golden, Marc; Brock, Thomas G.			Phosphorylation of Serine 271 on 5-Lipoxygenase and Its Role in Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECREASED LEUKOTRIENE-B4 SYNTHESIS; ARACHIDONIC-ACID; ALVEOLAR MACROPHAGES; IN-VITRO; IMPORT; LOCALIZATION; METABOLISM; TRANSLOCATION; ACTIVATION; SEQUENCE	The enzyme 5-lipoxygenase (5-LO) initiates the biosynthesis of leukotrienes, inflammatory mediators involved in immune diseases and defense. The subcellular localization of 5-LO is regulated, with nuclear import commonly leading to increased leukotriene production. We report here that 5-LO is constitutively phosphorylated on Ser-271 in transfected NIH 3T3 cells. This residue is nested in a classical nuclear export sequence, and phosphorylated Ser-271 5-LO was exclusively found in the nucleus by immunofluorescence and by fractionation techniques. Mutation of Ser-271 to Ala allowed nuclear export of 5-LO that was blocked by the specific nuclear export inhibitor leptomycin b, suggesting that phosphorylation of Ser-271 serves to interfere with exportin-1-mediated nuclear export. Consistent with previous reports that purified 5-LO can be phosphorylated on Ser-271 in vitro by MAPK-activated protein kinase 2, the nuclear export of 5-LO was increased by either treatment with the p38 inhibitor SB 203,580 or co-expression of a kinase-deficient p38 MAPK. Nuclear export of 5-LO can also be induced by KN-93, an inhibitor of Ca2+/calmodulin-dependent kinase II, and the effects of SB 203,580 plus KN-93 are additive. Finally, HeLa cells, which lack nuclear 5-LO, also lack constitutive phosphorylation of Ser-271. Taken together, these results indicate that the phosphorylation of Ser-271 serves to inhibit the nuclear export of 5-LO. This action works in concert with nuclear import, which is regulated by phosphorylation on Ser-523, to determine the subcellular distribution of 5-LO, which in turn regulates leukotriene biosynthesis.	[Flamand, Nicolas] Univ Laval, Ctr Rech, Hop Laval, Quebec City, PQ G1V 4G5, Canada; [Flamand, Nicolas; Luo, Ming; Peters-Golden, Marc; Brock, Thomas G.] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Laval University; University of Michigan System; University of Michigan	Flamand, N (corresponding author), Univ Laval, Ctr Rech, Hop Laval, Off M2653,2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada.	Nicolas.Flamand@crhl.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200	National Institutes of Health [RO1 AI43955, HL50496, HL078727]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL078727, R01HL050496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1 AI43955, HL50496, and HL078727. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anstead GM, 2003, J LEUKOCYTE BIOL, V74, P982, DOI 10.1189/jlb.0203064; BALTER MS, 1989, J LAB CLIN MED, V114, P662; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Biernacki WA, 2003, THORAX, V58, P294, DOI 10.1136/thorax.58.4.294; Brock TG, 1998, BIOCHEM J, V329, P519; Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Brock TG, 1999, J IMMUNOL, V162, P1669; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Cap P, 2005, ALLERGY, V60, P171, DOI 10.1111/j.1398-9995.2005.00675.x; Cederholm T, 2000, J INTERN MED, V247, P715, DOI 10.1046/j.1365-2796.2000.00691.x; CHEN XS, 1995, J BIOL CHEM, V270, P17993, DOI 10.1074/jbc.270.30.17993; Coffey MJ, 1996, J IMMUNOL, V157, P393; Coffey MJ, 2004, PROSTAG LEUKOTR ESS, V71, P185, DOI 10.1016/j.plefa.2004.03.012; COFFEY MJ, 1994, PROSTAG OTH LIPID M, V48, P313, DOI 10.1016/0090-6980(94)90031-0; Covin RB, 1998, AM J PHYSIOL-LUNG C, V275, pL303, DOI 10.1152/ajplung.1998.275.2.L303; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; DEMITSU T, 1989, INT J IMMUNOPHARMACO, V11, P801, DOI 10.1016/0192-0561(89)90134-3; Drazen J M, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P251; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Gosselin J, 2005, J IMMUNOL, V174, P1587, DOI 10.4049/jimmunol.174.3.1587; Hanaka H, 2002, BIOCHEM J, V361, P505, DOI 10.1042/0264-6021:3610505; Healy AM, 1999, J BIOL CHEM, V274, P29812, DOI 10.1074/jbc.274.42.29812; Hemak J, 2002, J MOL MODEL, V8, P102, DOI 10.1007/s00894-002-0076-y; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Jones SM, 2002, J BIOL CHEM, V277, P38550, DOI 10.1074/jbc.M206070200; JUBIZ W, 1984, PROSTA LEUKOTR MED, V14, P305, DOI 10.1016/0262-1746(84)90114-8; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; LAVIOLETTE M, 1986, J CLIN INVEST, V77, P54, DOI 10.1172/JCI112301; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Lutteke T, 2003, BIOINFORMATICS, V19, P2482, DOI 10.1093/bioinformatics/btg337; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mayatepek E, 1999, J INFECT DIS, V179, P714, DOI 10.1086/314619; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Meng WY, 2002, J BIOL CHEM, V277, P37401, DOI 10.1074/jbc.C200418200; MOQBEL R, 1983, CLIN EXP IMMUNOL, V52, P519; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; SHINDO K, 1995, EUR RESPIR J, V8, P605; SKERRETT SJ, 1990, J IMMUNOL, V144, P1052; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; Vliagoftis H, 2002, J IMMUNOL, V169, P4551, DOI 10.4049/jimmunol.169.8.4551; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; WIRTH JJ, 1985, J IMMUNOL, V134, P1989; Zimmerman TL, 2006, J BIOL CHEM, V281, P15434, DOI 10.1074/jbc.M508277200	57	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					306	313		10.1074/jbc.M805593200	http://dx.doi.org/10.1074/jbc.M805593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18978352	Green Published, hybrid			2022-12-25	WOS:000261974800035
J	Wilson, BJ; Harada, R; Leduy, L; Hollenberg, MD; Nepveu, A				Wilson, Brian J.; Harada, Ryoko; LeDuy, Lam; Hollenberg, Morley D.; Nepveu, Alain			CUX1 Transcription Factor Is a Downstream Effector of the Proteinase- activated Receptor 2 (PAR(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT DISPLACEMENT PROTEIN; SMOOTH-MUSCLE-CELLS; CUT HOMEODOMAIN PROTEINS; DNA-BINDING; S-PHASE; THROMBIN RECEPTOR; CANCER-CELLS; CYCLOOXYGENASE-2 EXPRESSION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS	Proteinase-activated receptors (PARs) are G-protein-coupled receptors that have been linked to an array of cellular processes, including inflammation, migration, and proliferation. Although signal transduction downstream of PARs has been actively investigated, little is known about the mechanisms that lead to changes in transcriptional programs. Here we show that the CUX1 homeodomain protein is a downstream effector of PAR(2). Treatment of epithelial and fibroblastic cells with trypsin or the PAR(2)-activating peptide (PAR(2)-AP) caused a rapid increase in CUX1 DNA binding activity. The stimulation of CUX1 was specific to PAR(2) because no effect was observed with thrombin or the PAR(1)-AP. Using a panel of recombinant CUX1 proteins, the regulation was found to involve the cut repeat 3 (CR3) and the cut homeodomain, two DNA binding domains that are present in all CUX1 isoforms. Expression analysis in cux1(-/-) mouse embryo fibroblasts led to the identification of three genes that are regulated downstream of both PAR(2) and CUX1 as follows: interleukin-1 alpha, matrix metalloproteinase-10, and cyclo-oxygenase-2. p110CUX1 was able to activate each of these genes, both in reporter assays and following the infection of cells. Moreover, the treatment of Hs578T breast tumor cells with trypsin led to a rapid recruitment of p110 CUX1 to the promoter of these genes and to a concomitant increase in their mRNA steady-state levels. Altogether, these results suggest a model whereby activation of PAR(2) triggers a signaling cascade that culminates with the stimulation of p110 CUX1 DNA binding and the transcriptional activation of target genes.	[Wilson, Brian J.; Harada, Ryoko; LeDuy, Lam; Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Nepveu, Alain] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada	McGill University; University of Calgary; McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020; Hollenberg, Morley/AFV-6966-2022		Canadian Institute of Health Research of Canada [MOP-11590]; Canadian Institute of Health Research operating; Research Institute of the McGill University Health Centre	Canadian Institute of Health Research of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research operating(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre	This work was supported in part by Canadian Institute of Health Research of Canada Grant MOP-11590 (toA.N.) and in part by Canadian Institute of Health Research operating grant (to M.D.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1; Supported by a fellowship from the Research Institute of the McGill University Health Centre.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; ANDRES V, 1992, DEVELOPMENT, V116, P321; Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Berger P, 2001, J APPL PHYSIOL, V91, P1372, DOI 10.1152/jappl.2001.91.3.1372; Berger P, 2001, J APPL PHYSIOL, V91, P995, DOI 10.1152/jappl.2001.91.2.995; Bretschneider E, 1999, BRIT J PHARMACOL, V126, P1735, DOI 10.1038/sj.bjp.0702509; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chambers LS, 2003, AM J PHYSIOL-LUNG C, V285, pL619, DOI 10.1152/ajplung.00416.2002; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Dorn GW, 2000, MOL PHARMACOL, V57, P278; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Holzhausen M, 2005, J DENT RES, V84, P154, DOI 10.1177/154405910508400209; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; Huang YQ, 2001, THROMB HAEMOSTASIS, V86, P1094; Kamath L, 2001, CANCER RES, V61, P5933; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Major CD, 2003, ARTERIOSCL THROM VAS, V23, P931, DOI 10.1161/01.ATV.0000070100.47907.26; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moffatt JD, 2002, AM J RESP CELL MOL, V26, P680, DOI 10.1165/ajrcmb.26.6.4693; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Okamoto T, 2001, J NEURAL TRANSM, V108, P125, DOI 10.1007/s007020170083; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; REUNING U, 1994, BLOOD, V84, P3700, DOI 10.1182/blood.V84.11.3700.bloodjournal84113700; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shi XL, 2004, MOL CANCER RES, V2, P395; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950; Uehara A, 2003, J IMMUNOL, V170, P5690, DOI 10.4049/jimmunol.170.11.5690; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com	71	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					36	45		10.1074/jbc.M803808200	http://dx.doi.org/10.1074/jbc.M803808200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952606	hybrid			2022-12-25	WOS:000261974800005
J	Su'etsugu, M; Nakamura, K; Keyamura, K; Kudo, Y; Katayama, T				Su'etsugu, Masayuki; Nakamura, Kenta; Keyamura, Kenji; Kudo, Yuka; Katayama, Tsutomu			Hda Monomerization by ADP Binding Promotes Replicase Clamp-mediated DnaA-ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; SLIDING CLAMP; TRANSLATION INITIATION; COUPLED INACTIVATION; BACILLUS-SUBTILIS; GAMMA-COMPLEX; IN-VITRO; PROTEIN; AAA(+); CYCLE	ATP-DnaA is the initiator of chromosomal replication in Escherichia coli, and the activity of DnaA is regulated by the regulatory inactivation of the DnaA (RIDA) system. In this system, the Hda protein promotes DnaA-ATP hydrolysis to produce inactive ADP-DnaA in a mechanism that is mediated by the DNA-loaded form of the replicase sliding clamp. In this study, we first revealed that hda translation uses an unusual initiation codon, CUG, located downstream of the annotated initiation codon. The CUG initiation codon could be used for restricting the Hda level, as this initiation codon has a low translation efficiency, and the cellular Hda level is only similar to 100 molecules per cell. Hda translated using the correct reading frame was purified and found to have a high RIDA activity in vitro. Moreover, we found that Hda has a high affinity for ADP but not for other nucleotides, including ATP. ADP-Hda was active in the RIDA system in vitro and stable in a monomeric state, whereas apo-Hda formed inactive homomultimers. Both ADP-Hda and apo-Hda could form complexes with the DNA-loaded clamp; however, only ADP-Hda-DNA-clamp complexes were highly functional in the following interaction with DnaA. Formation of ADP-Hda was also observed in vivo, and mutant analysis suggested that ADP binding is crucial for cellular Hda activity. Thus, we propose that ADP is a crucial Hda ligand that promotes the activated conformation of the protein. ADP-dependent monomerization might enable the arginine finger of the Hda AAA(+) domain to be accessible to ATP bound to the DnaA AAA(+) domain.	[Su'etsugu, Masayuki; Nakamura, Kenta; Keyamura, Kenji; Kudo, Yuka; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Katayama, Tsutomu/0000-0001-9994-1684; Su'estugu, Masayuki/0000-0001-6695-4032	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Banack T, 2005, J BACTERIOL, V187, P8507, DOI 10.1128/JB.187.24.8507-8510.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2006, J STRUCT BIOL, V156, P220, DOI 10.1016/j.jsb.2006.02.007; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koh DCY, 2006, VIRUS RES, V122, P35, DOI 10.1016/j.virusres.2006.06.008; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; NEUHARD J, 1987, ESCHERICHIA COLI SAL, P1579; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; O'Donnell SM, 2001, J BACTERIOL, V183, P1277, DOI 10.1128/JB.183.4.1277-1283.2001; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x	49	33	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36118	36131		10.1074/jbc.M803158200	http://dx.doi.org/10.1074/jbc.M803158200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977760	hybrid, Green Published			2022-12-25	WOS:000261840500007
J	Yoshida, R; Takaesu, G; Yoshida, H; Okamoto, F; Yoshioka, T; Choi, Y; Akira, S; Kawai, T; Yoshimura, A; Kobayashi, T				Yoshida, Ryoko; Takaesu, Giichi; Yoshida, Hideyuki; Okamoto, Fuyuki; Yoshioka, Tomoko; Choi, Yongwon; Akira, Shizuo; Kawai, Taro; Yoshimura, Akihiko; Kobayashi, Takashi			TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; ADAPTER PROTEIN; VIRAL-INFECTION; GENE INDUCTION; CUTTING EDGE; KINASE TAK1	Type I interferons (IFN-alpha/beta) are essential for immune defense against viruses and induced through the actions of the cytoplasmic helicases, RIG-I and MDA5, and their downstream adaptor molecule IPS-1. TRAF6 and the downstream kinase TAK1 have been shown to be essential for the production of proinflammatory cytokines through the TLR/MyD88/TRIF pathway. Although binding of TRAF6 with IPS-1 has been demonstrated, the role of the TRAF6 pathway in IFN alpha/beta production has not been fully understood. Here, we demonstrate that TRAF6 is critical for IFN-alpha/beta induction in response to viral infection and intracellular double-stranded RNA, poly(I:C). Activation of NF-kappa B, JNK, and p38, but not IRF3, was impaired in TRAF6-deficient mouse embryo fibroblasts in response to vesicular stomatitis virus and poly(I:C). However, TAK1 was not required for IFN-beta induction in this process, since normal IFN-alpha/beta production was observed in TAK1-deficient mouse embryo fibroblasts. Instead, another MAP3K, MEKK1, was important for the activation of the IFN-beta promoter in response to poly(I:C). Forced expression of MEKK1 in combination with IRF3 was sufficient for the induction of IFN-beta, whereas suppression of MEKK1 expression by small interfering RNA inhibited the induction of IFN-beta by poly(I:C). These data suggest that IPS-1 requires TRAF6 and MEKK1 to activate NF-kappa B and mitogen-activated protein kinases that are critical for the optimal induction of type I interferons.	[Kobayashi, Takashi] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; [Takaesu, Giichi; Kobayashi, Takashi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Akira, Shizuo; Kawai, Taro] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Akira, Shizuo] EARTO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Yoshimura, Akihiko] CREST, JST, Kawaguchi, Saitama 332001, Japan	Kyushu University; Keio University; Keio University; University of Pennsylvania; Pennsylvania Medicine; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Kobayashi, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takashik@bioreg.kyushu-u.ac.jp	Akira, Shizuo/C-3134-2009; Yoshimura, Akihiko/K-5515-2013	Kawai, Taro/0000-0001-7510-4662; Takaesu, Giichi/0000-0002-1581-1055	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Nakatomi Foundation; Takeda Science Foundation; Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research	This study was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Nakatomi Foundation, the Takeda Science Foundation, the Kato Memorial Trust Foundation for Nanbyo Research, the Suzuken Memorial Foundation, the Japan Intractable Disease Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Astellas Foundation for Research on Metabolic Disorders, the Yakult Bioscience Research Foundation, and the Princess Takamatsu Cancer Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	74	79	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36211	36220		10.1074/jbc.M806576200	http://dx.doi.org/10.1074/jbc.M806576200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984593	hybrid, Green Published			2022-12-25	WOS:000261840500016
J	Xiaos, GP; Lundblad, EW; Izadjoo, M; Altman, S				Xiaos, Gaoping; Lundblad, Eirik W.; Izadjoo, Mina; Altman, Sidney			Inhibition of Expression in Escherichia coli of a Virulence Regulator MgIB of Francisella tularensis Using External Guide Sequence Technology	PLOS ONE			English	Article								External guide sequences (EGSs) have successfully been used to inhibit expression of target genes at the post-transcriptional level in both prokaryotes and eukaryotes. We previously reported that EGS accessible and cleavable sites in the target RNAs can rapidly be identified by screening random EGS (rEGS) libraries. Here the method of screening rEGS libraries and a partial RNase T1 digestion assay were used to identify sites accessible to EGSs in the mRNA of a global virulence regulator MglB from Francisella tularensis, a Gram-negative pathogenic bacterium. Specific EGSs were subsequently designed and their activities in terms of the cleavage of mglB mRNA by RNase P were tested in vitro and in vivo. EGS73, EGS148, and EGS155 in both stem and M1 EGS constructs induced mglB mRNA cleavage in vitro. Expression of stem EGS73 and EGS155 in Escherichia coli resulted in significant reduction of the mglB mRNA level coded for the F. tularensis mglB gene inserted in those cells.	[Xiaos, Gaoping; Lundblad, Eirik W.; Altman, Sidney] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Lundblad, Eirik W.] Univ Hosp N Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrob Resistance, Tromso, Norway; [Izadjoo, Mina] Armed Forces Inst Pathol, Washington, DC USA	Yale University; UiT The Arctic University of Tromso; University Hospital of North Norway; United States Department of Defense	Xiaos, GP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	sidney.altman@yale.edu			Defense Threat Reduction Agency [W81XWH-06-2-0066]; Fulbright Foundation; Research Council of Norway; Northern Norway Regional Health Authority Medical Research Program	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Fulbright Foundation; Research Council of Norway(Research Council of Norway); Northern Norway Regional Health Authority Medical Research Program	This work was supported by Defense Threat Reduction Agency Grant W81XWH-06-2-0066, the Fulbright Foundation (E.W.L.), Research Council of Norway grants (to E.W.L.), and Northern Norway Regional Health Authority Medical Research Program grants (to E.W.L.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN S, 1993, P NATL ACAD SCI USA, V90, P10898, DOI 10.1073/pnas.90.23.10898; BAER MF, 1990, METHOD ENZYMOL, V181, P569; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bistue AJCS, 2007, ANTIMICROB AGENTS CH, V51, P1918, DOI 10.1128/AAC.01500-06; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Guerrier-Takada C, 2000, METHOD ENZYMOL, V313, P442; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; Hansen A, 2001, MOL MICROBIOL, V41, P131, DOI 10.1046/j.1365-2958.2001.02467.x; Kim K, 2007, BBA-GENE STRUCT EXPR, V1769, P603, DOI 10.1016/j.bbaexp.2007.09.001; Ko JH, 2008, RNA, V14, P1656, DOI 10.1261/rna.1120508; Ko JH, 2007, P NATL ACAD SCI USA, V104, P7815, DOI 10.1073/pnas.0701715104; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lundblad EW, 2008, P NATL ACAD SCI USA, V105, P2354, DOI 10.1073/pnas.0711977105; McKinney J, 2001, P NATL ACAD SCI USA, V98, P6605, DOI 10.1073/pnas.121180398; McKinney JS, 2004, NUCLEIC ACIDS RES, V32, P848, DOI 10.1093/nar/gkh219; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3719	10.1371/journal.pone.0003719	http://dx.doi.org/10.1371/journal.pone.0003719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005569	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166200007
J	Seko, Y; Azuma, N; Takahashi, Y; Makino, H; Morito, T; Muneta, T; Matsumoto, K; Saito, H; Sekiya, I; Umezawa, A				Seko, Yuko; Azuma, Noriyuki; Takahashi, Yoriko; Makino, Hatsune; Morito, Toshiyuki; Muneta, Takeshi; Matsumoto, Kenji; Saito, Hirohisa; Sekiya, Ichiro; Umezawa, Akihiro			Human Sclera Maintains Common Characteristics with Cartilage throughout Evolution	PLOS ONE			English	Article								Background: The sclera maintains and protects the eye ball, which receives visual inputs. Although the sclera does not contribute significantly to visual perception, scleral diseases such as refractory scleritis, scleral perforation and pathological myopia are considered incurable or difficult to cure. The aim of this study is to identify characteristics of the human sclera as one of the connective tissues derived from the neural crest and mesoderm. Methodology/Principal Findings: We have demonstrated microarray data of cultured human infant scleral cells. Hierarchical clustering was performed to group scleral cells and other mesenchymal cells into subcategories. Hierarchical clustering analysis showed similarity between scleral cells and auricular cartilage-derived cells. Cultured micromasses of scleral cells exposed to TGF-beta s and BMP2 produced an abundant matrix. The expression of cartilage-associated genes, such as Indian hedge hog, type X collagen, and MMP13, was up-regulated within 3 weeks in vitro. These results suggest that human 'sclera'-derived cells can be considered chondrocytes when cultured ex vivo. Conclusions/Significance: Our present study shows a chondrogenic potential of human sclera. Interestingly, the sclera of certain vertebrates, such as birds and fish, is composed of hyaline cartilage. Although the human sclera is not a cartilaginous tissue, the human sclera maintains chondrogenic potential throughout evolution. In addition, our findings directly explain an enigma that the sclera and the joint cartilage are common targets of inflammatory cells in rheumatic arthritis. The present global gene expression database will contribute to the clarification of the pathogenesis of developmental diseases such as high myopia.	[Seko, Yuko; Takahashi, Yoriko; Makino, Hatsune; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan; [Seko, Yuko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Morito, Toshiyuki; Muneta, Takeshi] Tokyo Med & Dent Univ, Sect Orthopaed Surg, Tokyo, Japan; [Matsumoto, Kenji; Saito, Hirohisa] Natl Inst Child & Hlth Dev, Dept Allergy & Immunol, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Sect Cartilage Regen, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU)	Seko, Y (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Saito, Hirohisa/0000-0002-6630-8337; Muneta, Takeshi/0000-0003-1018-2939	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation; Cardiovascular Disease from the Ministry of Health, Labor and Welfare; Ministry of Health, Labor and Welfare.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation(Terumo Life Science Foundation); Cardiovascular Disease from the Ministry of Health, Labor and Welfare; Ministry of Health, Labor and Welfare.(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists; a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Health and Labor Sciences Research Grants; by a Research grant on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation; by the Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a grant from the Terumo Life Science Foundation; by a Research Grant for Cardiovascular Disease from the Ministry of Health, Labor and Welfare; and by a Grant for Child Health and Development from the Ministry of Health, Labor and Welfare.	Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; ARCHER CW, 1990, J CELL SCI, V97, P361; BARR CC, 1981, OPHTHALMOLOGY, V88, P1269; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; Connon CJ, 2004, EXP EYE RES, V78, P909, DOI 10.1016/j.exer.2004.01.005; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; ISAAK BL, 1986, OPHTHALMOLOGY, V93, P681; JAYSON MIV, 1971, ANN RHEUM DIS, V30, P343, DOI 10.1136/ard.30.4.343; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SEGAWA Y, J ORTHOPAED IN PRESS; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; SEKO Y, 1995, OPHTHALMIC RES, V27, P144, DOI 10.1159/000267651; SEKO Y, 1995, INVEST OPHTH VIS SCI, V36, P1183; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Tsuruga Y, 2008, TRANSPL P, V40, P617, DOI 10.1016/j.transproceed.2008.02.007; Van Camp G, 2006, AM J HUM GENET, V79, P449, DOI 10.1086/506478; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Young T, 2003, MOL VIS, V9, P508; Zhou J, 2006, INVEST OPHTH VIS SCI, V47, P1794, DOI 10.1167/iovs.05-0759	34	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3709	10.1371/journal.pone.0003709	http://dx.doi.org/10.1371/journal.pone.0003709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002264	Green Submitted, Green Published, gold			2022-12-25	WOS:000265166000009
J	Enoch, MA; Shen, PH; Ducci, F; Yuan, QP; Liu, JX; White, KV; Albaugh, B; Hodgkinson, CA; Goldman, D				Enoch, Mary-Anne; Shen, Pei-Hong; Ducci, Francesca; Yuan, Qiaoping; Liu, Jixia; White, Kenneth V.; Albaugh, Bernard; Hodgkinson, Colin A.; Goldman, David			Common Genetic Origins for EEG, Alcoholism and Anxiety: The Role of CRH-BP	PLOS ONE			English	Article								The resting EEG is a dynamic index of cortical activation, cognitive function and consciousness and is therefore an intermediate phenotype for many behaviors in which arousal is implicated such as anxiety and alcoholism. We performed a dense whole genome linkage scan using 3878 unlinked SNPs in a large pedigree derived from a population isolate sample of 328 Plains American Indians. Alpha (8-13 Hz), theta (4-8 Hz) and beta (13-30 Hz) EEG power was heritable (0.58-0.27) and stable over a 2 year period (r = 0.82-0.53). Genetic correlations between frequency bands were high (0.75). Linkage peaks for EEG power in all three frequency bands converged on chromosome 5q13-14 with genome-wide significant LOD scores of 3.5 (empirical p<0.0001) for alpha and beta power. A logical candidate gene, corticotropin releasing hormone-binding protein (CRH-BP), was located at the apex of these convergent linkage peaks. CRH-BP was significantly associated with alpha power in the Plains Indians and also in a replication sample of 188 Caucasians. Moreover, the same SNPs and haplotypes, located within the CRH-BP haplotype block, were also associated with anxiety disorders in the Plains Indians and alcohol use disorders in the Caucasians. CRH-BP modulates CRH which influences cortical and hippocampal EEG activity and is the primary mediator of the neuroendocrine stress response. Our results suggest a likely role for CRH-BP in stress-related alcoholism and highlight the use of the resting EEG as an intermediate phenotype for arousal-related behaviors such as anxiety and addiction.	[Enoch, Mary-Anne; Shen, Pei-Hong; Ducci, Francesca; Yuan, Qiaoping; Liu, Jixia; White, Kenneth V.; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Albaugh, Bernard] Ctr Human Behav Studies Inc, Weatherford, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Enoch, MA (corresponding author), NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA.	maenoch@niaaa.nih.gov	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Shen, Pei-Hong/0000-0002-8031-9374; Yuan, Qiaoping/0000-0002-5880-8702; Hodgkinson, Colin/0000-0002-5365-8119	Intramural Research Program of NIAAA, NIH; Office of Research on Minority Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, ZIAAA000281, ZIAAA000280] Funding Source: NIH RePORTER	Intramural Research Program of NIAAA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program of NIAAA, NIH, and in part by the Office of Research on Minority Health.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Anokhin AP, 2006, BIOL PSYCHOL, V71, P289, DOI 10.1016/j.biopsycho.2005.06.004; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bauer LO, 2001, NEUROPSYCHOPHARMACOL, V25, P332, DOI 10.1016/S0893-133X(01)00236-6; Behan DP, 1997, J NEUROCHEM, V68, P2053; BERRIDGE CW, 1994, BRAIN RES BULL, V35, P597, DOI 10.1016/0361-9230(94)90174-0; Bruijnzeel AW, 2005, BRAIN RES REV, V49, P505, DOI 10.1016/j.brainresrev.2005.01.007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chan RKW, 2000, NEUROSCIENCE, V101, P115, DOI 10.1016/S0306-4522(00)00322-5; Chapman CA, 1999, J NEUROSCI, V19, P8637; Coles M. G. H., 1986, PSYCHOPHYSIOLOGY SYS, P183; COPPOLA R, 1979, ELECTROEN CLIN NEURO, V46, P224, DOI 10.1016/0013-4694(79)90073-7; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Edgar JC, 2005, EVENT RELATED POTENT; EHLERS CL, 1990, BIOL PSYCHIAT, V27, P631, DOI 10.1016/0006-3223(90)90531-6; Enoch MA, 1999, ALCOHOL CLIN EXP RES, V23, P1312, DOI 10.1111/j.1530-0277.1999.tb04352.x; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Finn PR, 1999, ALCOHOL CLIN EXP RES, V23, P256, DOI 10.1111/j.1530-0277.1999.tb04108.x; Gelernter J, 2007, BIOL PSYCHIAT, V61, P119, DOI 10.1016/j.biopsych.2006.08.023; Ghosh S, 2003, AM J MED GENET B, V118B, P66, DOI 10.1002/ajmg.b.10057; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Hughes SW, 2007, INT J PSYCHOPHYSIOL, V64, P3, DOI 10.1016/j.ijpsycho.2006.08.004; Jedema HP, 2004, J NEUROSCI, V24, P9703, DOI 10.1523/JNEUROSCI.2830-04.2004; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; KOZELKA JW, 1990, J CLIN NEUROPHYSIOL, V7, P191, DOI 10.1097/00004691-199004000-00004; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leal SM, 2005, HUM HERED, V60, P119, DOI 10.1159/000088914; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Miller R, 2007, INT J PSYCHOPHYSIOL, V64, P18, DOI 10.1016/j.ijpsycho.2006.07.009; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP, P97; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; ORNSTEIN K, 1987, J NEURAL TRANSM, V70, P183, DOI 10.1007/BF01253597; PAGE ME, 1993, NEUROSCI LETT, V164, P81, DOI 10.1016/0304-3940(93)90862-F; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; Rangaswamy M, 2004, INT J PSYCHOPHYSIOL, V51, P239, DOI 10.1016/j.ijpsycho.2003.09.003; Rangaswamy M, 2003, ALCOHOL CLIN EXP RES, V27, P607, DOI 10.1097/01.ALC.0000060523.95470.8F; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Smit CM, 2006, INT J PSYCHOPHYSIOL, V61, P235, DOI 10.1016/j.ijpsycho.2005.10.004; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tang YQ, 2007, BEHAV GENET, V37, P302, DOI 10.1007/s10519-006-9133-0; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VOGEL F, 1970, HUMANGENETIK, V10, P91, DOI 10.1007/BF00295509; Wang B, 2007, PSYCHOPHARMACOLOGY, V193, P283, DOI 10.1007/s00213-007-0782-3; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Woods RJ, 1999, J CLIN ENDOCR METAB, V84, P2788, DOI 10.1210/jc.84.8.2788; Woods RJ, 1997, J CLIN ENDOCR METAB, V82, P1566, DOI 10.1210/jc.82.5.1566; Zietsch BP, 2007, BIOL PSYCHOL, V75, P154, DOI 10.1016/j.biopsycho.2007.01.004	58	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3620	10.1371/journal.pone.0003620	http://dx.doi.org/10.1371/journal.pone.0003620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974851	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131700032
J	Noble, W; Garwood, C; Stephenson, J; Kinsey, AM; Hanger, DP; Anderton, BH				Noble, Wendy; Garwood, Claire; Stephenson, John; Kinsey, Anna M.; Hanger, Diane P.; Anderton, Brian H.			Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease	FASEB JOURNAL			English	Article						caspase-3; therapeutic; neurodegeneration; tauopathy; beta-amyloid	AMYOTROPHIC-LATERAL-SCLEROSIS; PAIRED HELICAL FILAMENTS; CEREBELLAR GRANULE NEURONS; MOUSE MODEL; MICROGLIAL ACTIVATION; HUNTINGTONS-DISEASE; CASPASE-CLEAVAGE; CELL-DEATH; NEUROFIBRILLARY TANGLES; IN-VIVO	Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles of hyperphosphorylated, aggregated tau protein and extracellular deposits of beta-amyloid peptide. Increased beta-amyloid levels are thought to precede tangle formation, but tau pathology is more closely related to neuronal death. Minocycline, a tetracycline derivative, has potent antiinflammatory, antiapoptotic, and neuroprotective effects in several models of neurodegenerative disease, including models of AD with amyloid pathology. We have used both in vitro and in vivo models of AD to determine whether minocycline may have therapeutic efficacy against tau pathology. In primary cortical neurons, minocycline prevents beta-amyloid-induced neuronal death, reduces caspase-3 activation, and lowers generation of caspase-3-cleaved tau fragments. Treatment of tangle-forming transgenic mice (htau line) with minocycline results in reduced levels of tau phosphorylation and insoluble tau aggregates. The in vivo effects of minocycline are also associated with reduced caspase-3 activation and lowered tau cleavage by caspase-3. In tau mice, we find that conformational changes in tau are susceptible to minocycline treatment, but are not directly associated with the amount of tau fragments produced, highlighting a dissociation between the development of these pathological tau species. These results suggest a possible novel therapeutic role for minocycline in the treatment of AD and related tauopathies.-Noble, W., Garwood, C., Stephenson, J., Kinsey, A. M., Hanger, D. P., Anderton, B. H. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease. FASEB J. 23, 739-750 (2009)	[Noble, Wendy; Garwood, Claire; Stephenson, John; Hanger, Diane P.; Anderton, Brian H.] Kings Coll London, Inst Psychiat, Dept Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Kinsey, Anna M.] Kings Coll London, Inst Psychiat, Div Old Age Psychiat, MRC Ctr Neurodegenerat Res, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Noble, W (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, MRC Ctr Neurodegenerat Res, PO37,Crespigny Pk, London SE5 8AF, England.	wendy.noble@iop.kcl.ac.uk	Hanger, Diane/C-5697-2009; Noble, Wendy/C-3756-2009	Hanger, Diane/0000-0002-3044-9816; Noble, Wendy/0000-0002-7898-4295; Garwood, Claire/0000-0001-8611-177X; Kinsey, Anna/0000-0001-8987-5353	Medical Research Council; Alzheimer's Society UK; Alzheimer's Research Trust; MRC [G0700355] Funding Source: UKRI; Alzheimers Research UK [ART-EG2004A-1] Funding Source: researchfish; Medical Research Council [G0700355] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society UK; Alzheimer's Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Professor Peter Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for his generous gift of tau antibodies. This work was supported by the Medical Research Council, the Alzheimer's Society UK, and the Alzheimer's Research Trust.	Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; Castanares M, 2005, BIOCHEM BIOPH RES CO, V337, P663, DOI 10.1016/j.bbrc.2005.09.101; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317; Diguet E, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.10818; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P267, DOI 10.1016/S0197-4580(97)80306-5; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; Leigh PN, 2008, LANCET NEUROL, V7, P119, DOI 10.1016/S1474-4422(08)70006-1; Lin SZ, 2003, LIFE SCI, V72, P1635, DOI 10.1016/S0024-3205(02)02442-6; Marks N, 1999, NEUROCHEM INT, V35, P195, DOI 10.1016/S0197-0186(99)00061-3; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang WH, 2003, ANN NEUROL, V53, P267, DOI 10.1002/ana.10476; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	54	94	95	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2009	23	3					739	750		10.1096/fj.08-113795	http://dx.doi.org/10.1096/fj.08-113795			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001528				2022-12-25	WOS:000265506300010
J	Pacheco, B; Maccarana, M; Goodlett, DR; Malmstrom, A; Malmstrom, L				Pacheco, Benny; Maccarana, Marco; Goodlett, David R.; Malmstrom, Anders; Malmstrom, Lars			Identification of the Active Site of DS-epimerase 1 and Requirement of N-Glycosylation for Enzyme Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DERMATAN SULFATE; LINKED OLIGOSACCHARIDES; MODIFYING ENZYMES; MECHANISM; BIOSYNTHESIS; LYASE; ALIGNMENTS; RESOLUTION; SUBSTRATE	Dermatan sulfate is a highly sulfated polysaccharide and has a variety of biological functions in development and disease. Iduronic acid domains in dermatan sulfate, which are formed by the action of two DS-epimerases, have a key role in mediating these functions. We have identified the catalytic site and three putative catalytic residues in DS-epimerase 1, His-205, Tyr-261, and His-450, by tertiary structure modeling and amino acid conservation to heparinase II. These residues were systematically mutated to alanine or more conserved residues, which resulted in complete loss of epimerase activity. Based on these data and the close relationship between lyase and epimerase reactions, we propose a model where His-450 functions as a general base abstracting the C5 proton from glucuronic acid. Subsequent cleavage of the glycosidic linkage by Tyr-261 generates a 4,5-unsaturated hexuronic intermediate, which is protonated at the C5 carbon by His-205 from the side of the sugar plane opposite to the side of previous proton abstraction. Concomitant recreation of the glycosidic linkage ends the reaction, generating iduronic acid. In addition, we show that proper N-glycosylation of DS-epimerase 1 is required for enzyme activity. This study represents the first description of the structural basis for epimerization by a glycosaminoglycan epimerase.	[Pacheco, Benny; Maccarana, Marco; Malmstrom, Anders] Lund Univ, Dept Expt Med Sci, Biomed Ctr D12, SE-22184 Lund, Sweden; [Goodlett, David R.; Malmstrom, Lars] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Lund University; University of Washington; University of Washington Seattle	Pacheco, B (corresponding author), Lund Univ, Dept Expt Med Sci, Biomed Ctr D12, Tornavagen 10, SE-22184 Lund, Sweden.	benny.pacheco@med.lu.se	Malmström, Lars/R-4991-2019; maccarana, marco/AAB-4764-2021	Malmström, Lars/0000-0001-9885-9312; Maccarana, Marco/0000-0003-3549-8921; Malmstrom, Anders/0000-0002-6691-146X	Swedish Research Council; Greta and Johan Kock Foundation; Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; Osterlund Foundation	This work was supported by the Swedish Research Council, the Greta and Johan Kock Foundation, and the Osterlund Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; FRANSSON LA, 1982, J BIOL CHEM, V257, P6333; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; Misura KMS, 2006, P NATL ACAD SCI USA, V103, P5361, DOI 10.1073/pnas.0509355103; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Yusa A, 2005, BIOCHEM J, V388, P115, DOI 10.1042/BJ20041573; Yusa A, 2006, J BIOL CHEM, V281, P20393, DOI 10.1074/jbc.M600140200	29	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1741	1747		10.1074/jbc.M805479200	http://dx.doi.org/10.1074/jbc.M805479200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004833	hybrid			2022-12-25	WOS:000262330100044
J	Garneau, L; Klein, H; Banderali, U; Longpre-Lauzon, A; Parent, L; Sauve, R				Garneau, Line; Klein, Helene; Banderali, Umberto; Longpre-Lauzon, Ariane; Parent, Lucie; Sauve, Remy			Hydrophobic Interactions as Key Determinants to the KCa3.1 Channel Closed Configuration AN ANALYSIS OF KCa3.1 MUTANTS CONSTITUTIVELY ACTIVE IN ZERO Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; NUCLEOTIDE-GATED CHANNELS; POTASSIUM CHANNEL; ACTIVATION GATE; GATING DOMAIN; SMOOTH-MUSCLE; IONIC-RADII; CONDUCTANCE; PORE; CANCER	In this study we present evidence that residue Val(282) in the S6 transmembrane segment of the calcium-activated KCa3.1 channel constitutes a key determinant of channel gating. A Gly scan of the S6 transmembrane segment first revealed that the substitutions A279G and V282G cause the channel to become constitutively active in zero Ca2+. Constitutive activity was not observed when residues extending from Cys(276) to Ala(286), other than Ala(279) and Val(282), were substituted to Gly. The accessibility of Cys engineered at Val(275) deep in the channel cavity was next investigated for the ion-conducting V275C/V282G mutant and closed V275C channel in zero Ca2+ using Ag+ as probe. These experiments demonstrated that internal Ag+ ions have free access to the channel cavity independently of the channel conducting state, arguing against an activation gate located at the S6 segment C-terminal end. Experiments were also conducted where Val(282) was substituted by residues differing in size and/or hydrophobicity. We found a strong correlation between constitutive activity in zero Ca2+ and the hydrophobic energy for side chain burial. Single channel recordings showed finally that constitutive activation in zero Ca2+ is better explained by a model where the channel is locked in a low conducting state with a high open probability rather than resulting from a change in the open/closed energy balance that would favor channel openings to a full conducting state in the absence of Ca2+. We conclude that hydrophobic interactions involving Val(282) constitute key determinants to KCa3.1 gating by modulating the ion conducting state of the selectivity filter through an effect on the S6 transmembrane segment.	[Garneau, Line; Klein, Helene; Banderali, Umberto; Longpre-Lauzon, Ariane; Parent, Lucie; Sauve, Remy] Univ Montreal, Dept Physiol, Grp Etud Prot Membranaires, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sauve, R (corresponding author), Univ Montreal, Dept Physiol, Grp Etud Prot Membranaires, Fac Med, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	remy.sauve@umontreal.ca	Banderali, Umberto/AAW-2463-2021		Canadian Institutes of Health Research [MOP 7769]; Canadian Cystic Fibrosis Foundation; Canadian Heart & Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Canadian Heart & Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research (MOP 7769), from the Canadian Cystic Fibrosis Foundation and from the Canadian Heart & Stroke Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Banderali U, 2004, J GEN PHYSIOL, V124, P333, DOI 10.1085/jgp.200409145; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BENZAQUEN LR, 1995, NAT MED, V1, P534, DOI 10.1038/nm0695-534; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P601, DOI 10.1085/jgp.200709828; Choe H, 2000, J GEN PHYSIOL, V115, P391, DOI 10.1085/jgp.115.4.391; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Flynn GE, 2003, J GEN PHYSIOL, V121, P563, DOI 10.1085/jgp.200308819; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Klein H, 2007, J GEN PHYSIOL, V129, P299, DOI 10.1085/jgp.200609726; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; SAUVE R, 1986, J MEMBRANE BIOL, V92, P269, DOI 10.1007/BF01869395; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Simoes M, 2002, J GEN PHYSIOL, V120, P99, DOI 10.1085/jgp.20028586; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zadek B, 2006, J GEN PHYSIOL, V127, P673, DOI 10.1085/jgp.200609534; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	46	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					389	403		10.1074/jbc.M805700200	http://dx.doi.org/10.1074/jbc.M805700200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996847	hybrid			2022-12-25	WOS:000261974800044
J	Hsu, YH; Johnson, DA; Traugh, JA				Hsu, Yuan-Hao; Johnson, David A.; Traugh, Jolinda A.			Analysis of Conformational Changes during Activation of Protein Kinase Pak2 by Amide Hydrogen/Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-PAK; CRYSTAL-STRUCTURES; HYDROGEN-EXCHANGE; CATALYTIC SUBUNIT; ALPHA-PAK; CDC42; PHOSPHORYLATION; AUTOPHOSPHORYLATION; MECHANISM; PAK2/GAMMA-PAK	During apoptotic stress, protein kinase Pak2 is cleaved by caspase 3 to form a heterotetramer that is constitutively activated following autophosphorylation. The active protein kinase migrates slightly slower than the inactive holoenzyme when analyzed by gel filtration, suggesting an expanded conformation. Activation of Pak2 comprises a series of structural changes resulting from caspase cleavage, ATP binding, and autophosphorylation of Pak2. Changes at each step were individually analyzed by amide hydrogen/deuterium exchange coupled with mass spectrometry and compared with inactive Pak2. The auto-inhibited form was shown to bind ATP in the active site, with minor changes in the glycine loop and the autoinhibitory domain (AID). Caspase cleavage produced significant changes in solvent accessibility in the AID and upper lobe of the catalytic domain. Cleavage of ATP-bound Pak2 relaxes the allosteric inhibition, as shown by increased solvent accessibility in the upper and lower lobes, including the G-helix, facilitating the autophosphorylation of two sites required for activation, Ser-141 in the regulatory domain and Thr-402 in the catalytic domain. Autophosphorylation increased the amide hydrogen/deuterium exchange solvent accessibility of the contact region between the AID and the G-helix, the E-F loop, and the N terminus. Thus, activation of Pak2 via caspase cleavage is associated with structural relaxation of Pak2 that allows for complete autophosphorylation, resulting in a more comprehensive solvent-exposed and conformationally dynamic enzyme.	[Hsu, Yuan-Hao; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Johnson, David A.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Traugh, JA (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	jolinda.traugh@ucr.edu	hsu, yuan-hao/B-5744-2009		National Institutes of Health [GM26738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM26738 (to J. A. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Huang ZD, 2003, J BIOL CHEM, V278, P13101, DOI 10.1074/jbc.M212557200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; OETTING WS, 1986, J BIOL CHEM, V261, P1649; Orton KC, 2004, J BIOL CHEM, V279, P38649, DOI 10.1074/jbc.M407337200; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Roig J, 2000, J BIOL CHEM, V275, P16933, DOI 10.1074/jbc.M001627200; Roig J, 2001, VITAM HORM, V62, P167, DOI 10.1016/S0083-6729(01)62004-1; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Tu H, 1999, MOL CELL BIOL, V19, P602; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; Tuazon PT, 1997, BIOCHEMISTRY-US, V36, P16059, DOI 10.1021/bi9717845; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	35	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36397	36405		10.1074/jbc.M805581200	http://dx.doi.org/10.1074/jbc.M805581200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984590	Green Published, hybrid			2022-12-25	WOS:000261840500037
J	Yamaguchi, M; Terao, Y; Mori, Y; Hamada, S; Kawabata, S				Yamaguchi, Masaya; Terao, Yutaka; Mori, Yuka; Hamada, Shigeyuki; Kawabata, Shigetada			PfbA, a Novel Plasmin- and Fibronectin-binding Protein of Streptococcus pneumoniae, Contributes to Fibronectin-dependent Adhesion and Antiphagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL SURFACE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; GROUP-A STREPTOCOCCI; EPITHELIAL-CELLS; VIRULENCE FACTORS; FACTOR-H; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BACTERIAL PATHOGENS; PYOGENES CHALLENGE; SEQUENCE-ANALYSIS	Streptococcus pneumoniae is a major causative agent of mortality throughout the world. The initial event in invasive pneumococcal disease is the attachment of pneumococci to epithelial cells in the upper respiratory tract. Several bacterial proteins can bind to host extracellular matrix proteins and function as adhesins and invasins. To identify adhesins or invasins on the pneumococcal cell surface, we searched for several proteins with an LPXTG anchoring motif in the whole-genome sequence of Streptococcus pneumoniae and identified one, which we called PfbA ((p) under bar lasmin- and (f) under bar ibronectin-(b) under bar inding (p) under bar rotein (A) under bar), that bound to human serum proteins. Immunofluorescence microscopy and fluorescence-activated cell sorter analysis revealed that PfbA was expressed on the pneumococcal cell surface. A Delta pfbA mutant strain was only half as competent as the wild-type strain at adhering to and invading lung and laryngeal epithelial cells. In addition, epithelial cells infected with Delta pfbA showed morphological changes, including cell flattening and a loss of microvilli, that did not occur in cells infected with the wild-type strain. The mutant strain also exhibited a weaker antiphagocytotic activity than wild type in human peripheral blood. Moreover, the growth of wild-type bacteria in human whole blood containing anti-PfbA antibodies was reduced by similar to 50% after 3 h compared with its growth without the antibody. These results suggest that PfbA is an important factor in the development of pneumococcal infections.	[Yamaguchi, Masaya; Terao, Yutaka; Mori, Yuka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Nihon Univ, Adv Res Inst Sci & Humanities, Dept Life Sci, Tokyo 1028251, Japan	Osaka University; Nihon University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science (JSPS); Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation)	This study was supported in part by a grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, grants-in-aid for Scientific Research (B), by the Japan Society for the Promotion of Science (JSPS) Fellows from JSPS, and by grants from the Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Butler JC, 1996, J INFECT DIS, V174, P986, DOI 10.1093/infdis/174.5.986; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duthy TG, 2002, INFECT IMMUN, V70, P5604, DOI 10.1128/IAI.70.10.5604-5611.2002; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Gutierrez F, 2006, J INFECTION, V53, P166, DOI 10.1016/j.jinf.2005.11.006; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1999, INFECT IMMUN, V67, P1683; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hyland KA, 2007, INFECT IMMUN, V75, P3188, DOI 10.1128/IAI.01745-06; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jedrzejas MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P891, DOI 10.2741/1299; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Oishi K, 2006, RESPIROLOGY, V11, P429, DOI 10.1111/j.1440-1843.2006.00867.x; Okada N, 1997, J BIOL CHEM, V272, P26978, DOI 10.1074/jbc.272.43.26978; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rigden DJ, 2003, CRIT REV BIOCHEM MOL, V38, P143, DOI 10.1080/713609215; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Suzuki N, 2005, J CLIN MICROBIOL, V43, P4528, DOI 10.1128/JCM.43.9.4528-4534.2005; Talay Susanne R., 2005, V12, P90, DOI 10.1159/000081691; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Yamaguchi M, 2006, MICROBES INFECT, V8, P2791, DOI 10.1016/j.micinf.2006.08.010; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	64	72	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36272	36279		10.1074/jbc.M807087200	http://dx.doi.org/10.1074/jbc.M807087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974092	Green Published, hybrid			2022-12-25	WOS:000261840500023
J	Goicoechea, SM; Bednarski, B; Garcia-Mata, R; Prentice-Dunn, H; Kim, HJ; Otey, CA				Goicoechea, S. M.; Bednarski, B.; Garcia-Mata, R.; Prentice-Dunn, H.; Kim, H. J.; Otey, C. A.			Palladin contributes to invasive motility in human breast cancer cells	ONCOGENE			English	Article						podosomes; migration; actin; metastasis	SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX DEGRADATION; INFLUENCES ZYXIN LOCALIZATION; PROTEIN PALLADIN; BINDING PARTNER; ACTIN CYTOSKELETON; DORSAL RUFFLES; ALPHA-ACTININ; PODOSOMES; INVADOPODIA	Cancer metastasis involves multiple steps including detachment of the metastatic cells from neighboring cells, the acquisition of motility and invasion to other tissue. All of these steps require the reorganization of the actin cytoskeleton. In this study, we found that the protein palladin, a molecular scaffold with an important function in actin organization, is expressed at higher overall levels in tumors compared with benign breast tissue, and also expressed significantly higher in four invasive breast cancer cell lines when compared with four non-invasive cell lines. In addition, we found that palladin plays a key role in the formation of podosomes. Podosomes are actin-rich structures that function in adhesion and matrix degradation, and have been found in many invasive cell types. Our results show that phorbol ester treatment stimulated the formation of palladin-containing podosomes in invasive, but not in non-invasive cell lines. More importantly, palladin knockdown resulted in decreased podosome formation and a significant reduction in transwell migration and invasive motility. Palladin overexpression induced podosome formation in the non-invasive MCF7 cells, which are otherwise unable to form podosomes, suggesting that palladin plays a critical role in the assembly of podosomes. Overall, these results indicate that palladin overexpression contributes to the invasive behavior of metastatic cells.	[Goicoechea, S. M.; Prentice-Dunn, H.; Otey, C. A.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Bednarski, B.; Kim, H. J.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Garcia-Mata, R.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Goicoechea, SM (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, 103 Mason Farm Rd,5320 MBRB, Chapel Hill, NC 27599 USA.	sgoico@med.unc.edu		Goicoechea, Silvia/0000-0003-1107-389X; Garcia-Mata, Rafael/0000-0002-7116-4411	NIH [GM61743, CA09688]; NIH K08 [CA098240]; NATIONAL CANCER INSTITUTE [K08CA098240, T32CA009688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH K08(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the following former lab members for their assistance in the early stages of this project: Dr Mana Parast, Amir Aghajanian and Xinshuo Wang. We thank Xiaoya Ding and Dave Cowan for help with immunohistochemistry. We also thank Dr Cercina Onesto for kindly sharing the breast cancer cell lines. This work was supported by NIH Grant GM61743 (to CO). HJK was supported by NIH K08 Grant CA098240 and BB was supported by NIH training Grant CA09688.	Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hatakeyama H, 2006, PROTEOMICS, V6, P6300, DOI 10.1002/pmic.200600488; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Kelly T, 1998, CLIN EXP METASTAS, V16, P501, DOI 10.1023/A:1006538200886; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; MONSKY WL, 1994, CANCER RES, V54, P5702; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Ryu B, 2001, CANCER RES, V61, P1833; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Suehara Y, 2006, PROTEOMICS, V6, P4402, DOI 10.1002/pmic.200600196; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Welsch T, 2007, CANCER LETT, V255, P205, DOI 10.1016/j.canlet.2007.04.008; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	50	61	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					587	598		10.1038/onc.2008.408	http://dx.doi.org/10.1038/onc.2008.408			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18978809	Green Accepted, Green Submitted			2022-12-25	WOS:000262866500012
J	Bellingham, SA; Coleman, LA; Masters, CL; Camakaris, J; Hill, AF				Bellingham, Shayne A.; Coleman, Louise A.; Masters, Colin L.; Camakaris, James; Hill, Andrew F.			Regulation of Prion Gene Expression by Transcription Factors SP1 and Metal Transcription Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; AMYLOID PRECURSOR PROTEIN; COPPER HOMEOSTASIS; FACTOR MTF-1; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; RESPONSE ELEMENT; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MENKES DISEASE	Prion diseases are associated with the conformational conversion of the host-encoded cellular prion protein into an abnormal pathogenic isoform. Reduction in prion protein levels has potential as a therapeutic approach in treating these diseases. Key targets for this goal are factors that affect the regulation of the prion protein gene. Recent in vivo and in vitro studies have suggested a role for prion protein in copper homeostasis. Copper can also induce prion gene expression in rat neurons. However, the mechanism involved in this regulation remains to be determined. We hypothesized that transcription factors SP1 and metal transcription factor-1(MTF-1) may be involved in copper-mediated regulation of human prion gene. To test the hypothesis, we utilized human fibroblasts that are deleted or overexpressing the Menkes protein (MNK), a major mammalian copper efflux protein. Menkes deletion fibroblasts have high intracellular copper, whereas Menkes overexpressed fibroblasts have severely depleted intracellular copper. We have utilized this system previously to demonstrate copper-dependent regulation of the Alzheimer amyloid precursor protein. Here we demonstrate that copper depletion in MNK overexpressed fibroblasts decreases cellular prion protein and PRNP gene levels. Conversely, expression of transcription factors SP1 and/or MTF-1 significantly increases prion protein levels and up-regulates prion gene expression in copper-replete MNK deletion cells. Furthermore, siRNA "knockdown" of SP1 or MTF-1 in MNK deletion cells decreases prion protein levels and down-regulates prion gene expression. These data support a novel mechanism whereby SP1 and MTF-1 act as copper-sensing transcriptional activators to regulate human prion gene expression and further support a role for the prion protein to function in copper homeostasis. Expression of the prion protein is a vital component for the propagation of prion diseases; thus SP1 and MTF-1 represent new targets in the development of key therapeutics toward modulating the expression of the cellular prion protein and ultimately the prevention of prion disease.	[Bellingham, Shayne A.; Coleman, Louise A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Coleman, Louise A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Coleman, Louise A.; Camakaris, James] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Masters, Colin L.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hill, AF (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Bellingham, Shayne A/E-5665-2012	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; 	National Health and Medical Research Council Program; Australian Research Council	National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by a National Health and Medical Research Council Program grant (to A.F.H. and C.L.M.) and an Australian Research Council discovery grant (to S.A.B.). A.F.H. is a shareholder in and consultant to D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, therapeutics, and decontamination. D-Gen markets the ICSM18 antibody used in this study.	Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Asante EA, 2004, NEUROSCI LETT, V360, P33, DOI 10.1016/j.neulet.2004.01.049; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, BRAIN RES BULL, V55, P165, DOI 10.1016/S0361-9230(01)00453-1; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burke R, 2008, INT J BIOCHEM CELL B, V40, P1850, DOI 10.1016/j.biocel.2008.01.021; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; CAMAKARIS J, 1980, BIOCHEM GENET, V18, P117, DOI 10.1007/BF00504364; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cereghetti GM, 2001, BIOPHYS J, V81, P516, DOI 10.1016/S0006-3495(01)75718-9; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; Du T, 2008, PROTEOMICS, V8, P1819, DOI 10.1002/pmic.200700895; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Heicklen-Klein A, 2000, J NEUROCHEM, V75, P1408, DOI 10.1046/j.1471-4159.2000.0751408.x; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; LI Y, 2008, MOL CELL BIOL; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Miura T, 1999, BIOCHEMISTRY-US, V38, P11560, DOI 10.1021/bi9909389; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Ogra Y, 2001, J BIOL CHEM, V276, P16534, DOI 10.1074/jbc.M100570200; Opazo C, 2003, BIOMETALS, V16, P91, DOI 10.1023/A:1020795422185; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PUCKETT C, 1991, AM J HUM GENET, V49, P320; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; SCHUG J, 1997, TESS TRANSCRIPTIONAL; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509	70	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1291	1301		10.1074/jbc.M804755200	http://dx.doi.org/10.1074/jbc.M804755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990686	hybrid			2022-12-25	WOS:000262122900064
J	Pichiorri, F; Okumura, H; Nakamura, T; Garrison, PN; Gasparini, P; Suh, SS; Druck, T; McCorkell, KA; Barnes, LD; Croce, CM; Huebner, K				Pichiorri, Flavia; Okumura, Hiroshi; Nakamura, Tatsuya; Garrison, Preston N.; Gasparini, Pierluigi; Suh, Sung-Suk; Druck, Teresa; McCorkell, Kelly A.; Barnes, Larry D.; Croce, Carlo M.; Huebner, Kay			Correlation of Fragile Histidine Triad (Fhit) Protein Structural Features with Effector Interactions and Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; INDUCED APOPTOSIS; TUMORIGENICITY; GENE; LUNG; MODULATION; EXPRESSION; FAMILY	We have previously shown that Fhit tumor suppressor protein interacts with Hsp60 chaperone machinery and ferredoxin reductase (Fdxr) protein. Fhit-effector interactions are associated with a Fhit-dependent increase in Fdxr stability, followed by generation of reactive oxygen species and apoptosis induction under conditions of oxidative stress. To define Fhit structural features that affect interactions, downstream signaling, and biological outcomes, we used cancer cells expressing Fhit mutants with amino acid substitutions that alter enzymatic activity, enzyme substrate binding, or phosphorylation at tyrosine 114. Gastric cancer cell clones stably expressing mutants that do not bind substrate or cannot be phosphorylated showed decreased binding to Hsp60 and Fdxr and reduced mitochondrial localization. Expression of Fhit or mutants that bind interactor proteins results in oxidative damage and accumulation of cells in G(2)/M or sub-G(1) fractions after peroxide treatment; non-interacting mutants are defective in these biological effects. Gastric cancer clones expressing noncomplexing Fhit mutants show reduction of Fhit tumor suppressor activity, confirming that substrate binding, interaction with heat shock proteins, mitochondrial localization, and interaction with Fdxr are important for Fhit tumor suppressor function.	[Pichiorri, Flavia; Okumura, Hiroshi; Nakamura, Tatsuya; Gasparini, Pierluigi; Suh, Sung-Suk; Druck, Teresa; McCorkell, Kelly A.; Croce, Carlo M.; Huebner, Kay] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Garrison, Preston N.; Barnes, Larry D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio	Huebner, K (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, BRT Rm 916,460 W 12th Ave, Columbus, OH 43210 USA.	kay.huebner@osumc.edu	Young, Richard A/F-6495-2012; Gasparini, Pierluigi/ABA-2811-2021	Young, Richard A/0000-0001-8855-8647; Gasparini, Pierluigi/0000-0001-8311-8845	National Institutes of Health [CA77738, CA132453, CA115965]; Associazione Italiana Ricerca Cancro; NATIONAL CANCER INSTITUTE [R01CA115965, P01CA077738, R01CA132453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77738, CA132453, and CA115965 ( USPHS). This work was also supported by grants from the Associazione Italiana Ricerca Cancro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; BERNET D, 1991, FEBS LETT, V283, P286, DOI 10.1016/0014-5793(91)80609-7; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Garrison PN, 2005, BIOCHEMISTRY-US, V44, P6286, DOI 10.1021/bi047670s; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ishii H, 2001, CANCER RES, V61, P1578; Ji L, 1999, CANCER RES, V59, P3333; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pace HC, 1998, P NATL ACAD SCI USA, V95, P5484, DOI 10.1073/pnas.95.10.5484; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schmutte C, 1998, CANCER RES, V58, P4537; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200	22	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1040	1049		10.1074/jbc.M806638200	http://dx.doi.org/10.1074/jbc.M806638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004824	Green Published, hybrid			2022-12-25	WOS:000262122900040
J	Shin, JH; Heo, GY; Kelman, Z				Shin, Jae-Ho; Heo, Gun-Young; Kelman, Zvi			The Methanothermobacter thermautotrophicus MCM Helicase Is Active as a Hexameric Ring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; METHANOBACTERIUM-THERMOAUTOTROPHICUM MCM; COLI DNAB HELICASE; SULFOLOBUS-SOLFATARICUS; ESCHERICHIA-COLI; COMPLEX; MECHANISM; TRANSLOCATION; POLYMORPHISM; REVEALS	The minichromosome maintenance (MCM) complex is thought to function as the replicative helicase in archaea and eukarya. The structure of the single MCM protein homologue from the archaeon Methanothermobacter thermautotrophicus is not yet clear, and hexameric, heptameric, octameric, and dodecameric structures, open rings, and filamentous structures have been reported. Using a combination of biochemical and structural analysis, it is shown here that the M. thermautotrophicus MCM helicase is active as a hexamer.	[Heo, Gun-Young; Kelman, Zvi] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; [Shin, Jae-Ho] Kyungpook Natl Univ, Coll Agr & Life Sci, Div Appl Biol & Chem, Taegu 702701, South Korea	University System of Maryland; University of Maryland Baltimore; Kyungpook National University	Kelman, Z (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	kelman@umbi.umd.edu			National Science Foundation [MCB-0815646]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0815646 from the National Science Foundation ( to Z.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Kasiviswanathan R, 2005, NUCLEIC ACIDS RES, V33, P4940, DOI 10.1093/nar/gki807; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; Pucci B, 2004, J BIOL CHEM, V279, P49222, DOI 10.1074/jbc.M408967200; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin Jae-Ho, 2006, BIOS, V77, P37, DOI 10.1893/0005-3155(2006)77[37:RACAPC]2.0.CO;2; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Tropea Joseph E, 2007, Methods Mol Biol, V363, P1, DOI 10.1007/978-1-59745-209-0_1; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	35	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					540	546		10.1074/jbc.M806803200	http://dx.doi.org/10.1074/jbc.M806803200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001412	hybrid			2022-12-25	WOS:000261974800059
J	Khrapunov, S; Cheng, H; Hegde, S; Blanchard, J; Brenowitz, M				Khrapunov, Sergei; Cheng, Huiyong; Hegde, Subray; Blanchard, John; Brenowitz, Michael			Solution Structure and Refolding of the Mycobacterium tuberculosis Pentapeptide Repeat Protein MfpA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; AGGREGATION; SEGMENTS; MIMICRY; DNA	The pentapeptide repeat is a recently discovered protein fold. Mycobacterium tuberculosis MfpA is a founding member of the pentapeptide repeat protein (PRP) family that confers resistance to the antibiotic fluoroquinolone by binding to DNA gyrase and inhibiting its activity. The size, shape, and surface potential of MfpA mimics duplex DNA. As an initial step in a comprehensive biophysical analysis of the role of PRPs in the regulation of cellular topoisomerase activity and conferring antibiotic resistance, we have explored the solution structure and refolding of MfpA by fluorescence spectroscopy, CD, and analytical centrifugation. A unique CD spectrum for the pentapeptide repeat fold is described. This spectrum reveals a native structure whose beta-strands and turns within the right-handed quadrilateral beta-helix that define the PRP fold differ from canonical secondary structure types. MfpA refolded from urea or guanidium by dialysis or dilution forms stable aggregates of monomers whose secondary and tertiary structure are not native. In contrast, MfpA refolded using a novel "time-dependent renaturation" protocol yields protein with native secondary, tertiary, and quaternary structure. The generality of "time-dependent renaturation" to other proteins and denaturation methods is discussed.	[Khrapunov, Sergei; Cheng, Huiyong; Hegde, Subray; Blanchard, John; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Khrapunov, S (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Khrapunov, Sergei/R-8124-2019	Khrapunov, Sergei/0000-0002-6181-9525	National Institutes of Health, NIGMS [R01-GM079618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079618] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01-GM079618. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin RL, 2002, ADV PROTEIN CHEM, V62, P361; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Dryden DTF, 2006, TRENDS BIOTECHNOL, V24, P378, DOI 10.1016/j.tibtech.2006.06.004; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kathir KM, 2005, J BIOL CHEM, V280, P29682, DOI 10.1074/jbc.M504389200; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P452; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li Fusheng, 2002, Methods Mol Biol, V182, P19; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; Matsuo K, 2005, J BIOCHEM, V138, P79, DOI 10.1093/jb/mvi101; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Schmid F, 2005, PROTEIN FOLDING HANDBOOK, P916, DOI 10.1002/9783527619498.ch25; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; TANFORD C, 1968, ADV PROTEIN CHEM, V23, P12; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Uversky VN, 1999, PROTEIN SCI, V8, P161; VENYAMINOV SY, 1994, ANAL BIOCHEM, V222, P176, DOI 10.1006/abio.1994.1470; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wang Y, 1996, PROTEIN SCI, V5, P1898, DOI 10.1002/pro.5560050916	34	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36290	36299		10.1074/jbc.M804702200	http://dx.doi.org/10.1074/jbc.M804702200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977756	Green Published, hybrid			2022-12-25	WOS:000261840500025
J	Madrid, DC; Ting, LM; Waller, KL; Schramm, VL; Kim, K				Madrid, Dennis C.; Ting, Li-Min; Waller, Karena L.; Schramm, Vern L.; Kim, Kami			Plasmodium falciparum Purine Nucleoside Phosphorylase Is Critical for Viability of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMIAUTOMATED MICRODILUTION TECHNIQUE; DEFICIENT ERYTHROCYTE CULTURE; TRANSITION-STATE ANALOG; ADENOSINE-DEAMINASE; SALVAGE PATHWAYS; GENE-EXPRESSION; PLASMA-MEMBRANE; IMMUCILLIN-H; IDENTIFICATION; INHIBITORS	Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P.falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Delta pfpnp). Lysates of the Delta pfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Delta pfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Delta pfpnp parasites. The Delta pfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P.falciparum and validate PfPNP as the target of immucillins.	[Madrid, Dennis C.; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Div Infect Dis, Dept Med, Bronx, NY 10461 USA; [Waller, Karena L.] Albert Einstein Coll Med, Div Cardiol, Dept Med, Bronx, NY 10461 USA; [Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kim, K (corresponding author), 1300 Morris Pk Ave,Ullmann 1225, Bronx, NY 10461 USA.	kkim@aecom.yu.edu		Kim, Kami/0000-0003-3384-152X; Waller, Karena/0000-0001-8786-4407	National Institutes of Health [5 F31 AI056665-4, T32-CM007288]; AECOM Medical Science Training Program [R01 AI049512, R21AI052469]; United States Army Research [W81XWH-05-2-0025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI056665, R21AI052469, R01AI049512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AECOM Medical Science Training Program; United States Army Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NSRA 5 F31 AI056665-4 (to D.C.M.), T32-CM007288 (AECOM Medical Science Training Program), R01 AI049512 (to V.L.S.), and R21AI052469 ( to K. K.). This work was also supported by United States Army Research Grant W81XWH-05-2-0025 (to K.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahi H, 1996, PARASITOLOGY, V113, P19, DOI 10.1017/S0031182000066233; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Berman P A, 1991, Adv Exp Med Biol, V309A, P165; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; DADDONA PE, 1984, J BIOL CHEM, V259, P1472; DADDONA PE, 1986, J BIOL CHEM, V261, P1667; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Evans GB, 2001, J ORG CHEM, V66, P5723, DOI 10.1021/jo0155613; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL BIOCHEM PARASIT, V110, P1, DOI 10.1016/S0166-6851(00)00249-8; Gandhi V, 2005, BLOOD, V106, P4253, DOI 10.1182/blood-2005-03-1309; Gandhi V, 2007, SEMIN ONCOL, V34, pS8, DOI 10.1053/j.seminoncol.2007.11.003; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Kadekoppala M, 2001, MOL BIOCHEM PARASIT, V112, P211, DOI 10.1016/S0166-6851(00)00368-6; Keough DT, 1999, MOL BIOCHEM PARASIT, V98, P29, DOI 10.1016/S0166-6851(98)00139-X; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDERWEYDEN MB, 1976, J BIOL CHEM, V251, P5448; Wang P, 2002, MOL BIOCHEM PARASIT, V123, P1, DOI 10.1016/S0166-6851(02)00105-6; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	42	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35899	35907		10.1074/jbc.M807218200	http://dx.doi.org/10.1074/jbc.M807218200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957439	Green Published, hybrid			2022-12-25	WOS:000261687900065
J	Tanous, C; Soutourina, O; Raynal, B; Hullo, MF; Mervelet, P; Gilles, AM; Noirot, P; Danchin, A; England, P; Martin-Verstraete, I				Tanous, Catherine; Soutourina, Olga; Raynal, Bertrand; Hullo, Marie-Francoise; Mervelet, Peggy; Gilles, Anne-Marie; Noirot, Philippe; Danchin, Antoine; England, Patrick; Martin-Verstraete, Isabelle			The CymR Regulator in Complex with the Enzyme CysK Controls Cysteine Metabolism in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; SYNTHASE COMPLEX; PYRIDOXAL 5'-PHOSPHATE; GLUTAMINE-SYNTHETASE; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; GLOBAL REGULATOR; GENE-EXPRESSION	Several enzymes have evolved as sensors in signal transduction pathways to control gene expression, thereby allowing bacteria to adapt efficiently to environmental changes. We recently identified the master regulator of cysteine metabolism in Bacillus subtilis, CymR, which belongs to the poorly characterized Rrf2 family of regulators. We now report that the signal transduction mechanism controlling CymR activity in response to cysteine availability involves the formation of a stable complex with CysK, a key enzyme for cysteine biosynthesis. We carried out a comprehensive quantitative characterization of this regulator-enzyme interaction by surface plasmon resonance and analytical ultracentrifugation. We also showed that O-acetylserine plays a dual role as a substrate of CysK and as an effector modulating the CymR-CysK complex formation. The ability of B. subtilis CysK to bind to CymR appears to be correlated to the loss of its capacity to form a cysteine synthase complex with CysE. We propose an original model, supported by the determination of the intracellular concentrations of the different partners, by which CysK positively regulates CymR in sensing the bacterial cysteine pool.	[Raynal, Bertrand; England, Patrick] Inst Pasteur, F-75724 Paris 15, France; [Tanous, Catherine; Soutourina, Olga; Hullo, Marie-Francoise; Gilles, Anne-Marie; Danchin, Antoine; Martin-Verstraete, Isabelle] Inst Pasteur, Unite Genet Genomes Bacteriens, F-75724 Paris 15, France; [Tanous, Catherine; Soutourina, Olga; Hullo, Marie-Francoise; Gilles, Anne-Marie; Danchin, Antoine; Martin-Verstraete, Isabelle] Inst Pasteur, CNRS, URA2171, F-75724 Paris 15, France; [England, Patrick] Inst Pasteur, CNRS, URA2185, F-75724 Paris 15, France; [Mervelet, Peggy; Noirot, Philippe] INRA, Unite Genet Microbienne, F-78352 Jouy En Josas, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay	England, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.	patrick.england@pasteur.fr; isabelle.martin-verstraete@pasteur.fr	Soutourina, Olga/F-2042-2015; Martin-Verstraete, Isabelle/R-7109-2019	Martin-Verstraete, Isabelle/0000-0002-8376-7690; Danchin, Antoine/0000-0002-6350-5001; Soutourina, Olga/0000-0001-6439-7228; ENGLAND, Patrick/0000-0001-6410-5918; raynal, Bertrand/0000-0001-5634-0408	Centre National de la Recherche Scientifique [URA 2171]; Agence National de la Recherche [NT05-2-44860]; Institut Pasteur [PTR256]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission)	This work was supported by Centre National de la Recherche Scientifique Grant URA 2171, Agence National de la Recherche Grant NT05-2-44860, and Institut Pasteur Grant PTR256. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albanesi D, 2005, J BACTERIOL, V187, P7631, DOI 10.1128/JB.187.22.7631-7638.2005; Auger S, 2005, BIOCHIMIE, V87, P231, DOI 10.1016/j.biochi.2004.09.007; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bertoldi M, 2005, BIOCHEM J, V389, P885, DOI 10.1042/BJ20050279; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; Clausen T, 2000, EMBO J, V19, P831, DOI 10.1093/emboj/19.5.831; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GAGNON Y, 1994, J BIOL CHEM, V269, P7473; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guedon E, 2006, AMINO ACID BIOSYNTHE, P1, DOI [10.1007/7171_2006_060, DOI 10.1007/7171_2006_060]; Holtmann G, 2004, J BACTERIOL, V186, P1683, DOI 10.1128/JB.186.6.1683-1693.2004; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; James P, 1996, GENETICS, V144, P1425; Joly N, 2004, J BIOL CHEM, V279, P33123, DOI 10.1074/jbc.M403615200; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Liszewska F, 2007, BBA-PROTEINS PROTEOM, V1774, P450, DOI 10.1016/j.bbapap.2007.02.009; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Schreiber V, 2000, MOL MICROBIOL, V35, P765, DOI 10.1046/j.1365-2958.2000.01747.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; van der Ploeg JR, 2001, FEMS MICROBIOL LETT, V201, P29, DOI 10.1016/S0378-1097(01)00225-7; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Viguier C, 2005, FEMS MICROBIOL LETT, V246, P235, DOI 10.1016/j.femsle.2005.04.012; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wray LV, 2005, J BIOL CHEM, V280, P33298, DOI 10.1074/jbc.M504957200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	56	68	71	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35551	35560		10.1074/jbc.M805951200	http://dx.doi.org/10.1074/jbc.M805951200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974048	hybrid, Green Published			2022-12-25	WOS:000261687900027
J	Zhang, Y; Turner, JG				Zhang, Yi; Turner, John G.			Wound-Induced Endogenous Jasmonates Stunt Plant Growth by Inhibiting Mitosis	PLOS ONE			English	Article								When plants are repeatedly injured their growth is stunted and the size of organs such as leaves is greatly reduced. The basis of this effect is not well-understood however, even though it reduces yield of crops injured by herbivory, and produces dramatic effects exemplified in ornamental bonsai plants. We have investigated the genetic and physiological basis of this "bonsai effect" by repeatedly wounding leaves of the model plant Arabidopsis. This treatment stunted growth by 50% and increased the endogenous content of jasmonate (JA), a growth inhibitor, by seven-fold. Significantly, repeated wounding did not stunt the growth of the leaves of mutants unable to synthesise JA, or unable to respond to JA including coi1, jai3, myc2, but not jar1. The stunted growth did not result from reduced cell size, but resulted instead from reduced cell number, and was associated with reduced expression of CycB1;2. Wounding caused systemic disappearance of constitutively expressed JAZ1::GUS. Wounding also activates plant immunity. We show that a gene, 12-oxo-phytodienoate reductase, which catalyses a step in JA biosynthesis, and which we confirm is not required for defence, is however required for wound-induced stunting. Our data suggest that intermediates in the JA biosynthetic pathway activate defence, but a primary function of wound-induced JA is to stunt growth through the suppression of mitosis.	[Zhang, Yi; Turner, John G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Zhang, Y (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	j.g.turner@uea.ac.uk			China Scholarship Council; University of East Anglia; BBSRC	China Scholarship Council(China Scholarship Council); University of East Anglia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	YZ was in receipt of a scholarship from the China Scholarship Council and University of East Anglia, and the research was funded by the BBSRC.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chouinard A, 2005, ECOSCIENCE, V12, P506, DOI 10.2980/i1195-6860-12-4-506.1; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; DATHE W, 1981, PLANTA, V153, P530, DOI 10.1007/BF00385537; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Flescher E, 2007, CANCER LETT, V245, P1, DOI 10.1016/j.canlet.2006.03.001; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; JEFFERSON RA, 1987, EMBO J, V6, P3901; KORNER C, 1989, AUST J PLANT PHYSIOL, V16, P443, DOI 10.1071/PP9890443; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mussig C, 2000, J PLANT PHYSIOL, V157, P143, DOI 10.1016/S0176-1617(00)80184-4; NGUYEN T, 2006, MECH JASMONATE INDUC; Parchmann S, 1997, PLANT PHYSIOL, V115, P1057, DOI 10.1104/pp.115.3.1057; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Poveda K, 2003, OECOLOGIA, V135, P601, DOI 10.1007/s00442-003-1228-1; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stelmach BA, 1998, PHYTOCHEMISTRY, V47, P539, DOI 10.1016/S0031-9422(97)00547-5; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Swiatek A, 2004, FEBS LETT, V572, P118, DOI 10.1016/j.febslet.2004.07.018; Swiatek A, 2002, PLANT PHYSIOL, V128, P201, DOI 10.1104/pp.010592; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; UEDA J, 1982, PHYSIOL PLANTARUM, V54, P249, DOI 10.1111/j.1399-3054.1982.tb00255.x; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; YAMANE H, 1980, AGR BIOL CHEM TOKYO, V44, P2857, DOI 10.1080/00021369.1980.10864412; YAN Y, 2007, PLANT CELL	53	218	221	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3699	10.1371/journal.pone.0003699	http://dx.doi.org/10.1371/journal.pone.0003699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002244	gold, Green Published, Green Submitted			2022-12-25	WOS:000265165600005
J	Tucker, NP; Hicks, MG; Clarke, TA; Crack, JC; Chandra, G; Le Brun, NE; Dixon, R; Hutchings, MI				Tucker, Nicholas P.; Hicks, Matthew G.; Clarke, Thomas A.; Crack, Jason C.; Chandra, Govind; Le Brun, Nick E.; Dixon, Ray; Hutchings, Matthew I.			The Transcriptional Repressor Protein NsrR Senses Nitric Oxide Directly via a [2Fe-2S] Cluster	PLOS ONE			English	Article								The regulatory protein NsrR, a member of the Rrf2 family of transcription repressors, is specifically dedicated to sensing nitric oxide ( NO) in a variety of pathogenic and non-pathogenic bacteria. It has been proposed that NO directly modulates NsrR activity by interacting with a predicted [Fe-S] cluster in the NsrR protein, but no experimental evidence has been published to support this hypothesis. Here we report the purification of NsrR from the obligate aerobe Streptomyces coelicolor. We demonstrate using UV-visible, near UV CD and EPR spectroscopy that the protein contains an NO-sensitive [2Fe-2S] cluster when purified from E. coli. Upon exposure of NsrR to NO, the cluster is nitrosylated, which results in the loss of DNA binding activity as detected by bandshift assays. Removal of the [2Fe-2S] cluster to generate apo-NsrR also resulted in loss of DNA binding activity. This is the first demonstration that NsrR contains an NO-sensitive [2Fe-2S] cluster that is required for DNA binding activity.	[Tucker, Nicholas P.; Chandra, Govind; Dixon, Ray] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England; [Hicks, Matthew G.; Clarke, Thomas A.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Crack, Jason C.; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich, Norfolk, England; [Hutchings, Matthew I.] Univ E Anglia, Sch Med, Hlth Policy & Practice, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of East Anglia; University of East Anglia	Tucker, NP (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich, Norfolk, England.	nick.tucker@bbsrc.ac.uk; m.hutchings@uea.ac.uk	Hutchings, Matt/D-1923-2009; Hicks, Matthew/I-3689-2012; clarke, tom/D-1837-2009	Hutchings, Matt/0000-0001-6628-5940; clarke, tom/0000-0002-6234-1914; Le Brun, Nick/0000-0001-9780-4061; Crack, Jason C./0000-0002-4979-1910; Chandra, Govind/0000-0002-7882-6676; Dixon, Ray/0000-0002-6348-639X; Tucker, Nicholas/0000-0002-6331-3704	Research Councils UK Fellowships; Biotechnology and Biological Sciences Research Council [F009429/1, A51065X/1]; Biotechnology and Biological Sciences Research Council [BB/D009588/1, BBS/E/J/00000016, BB/F009429/1] Funding Source: researchfish; BBSRC [BB/F009429/1, BB/D009588/1] Funding Source: UKRI	Research Councils UK Fellowships; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Research Councils UK Fellowships to MIH and TAC. We are grateful to the Biotechnology and Biological Sciences Research Council for financial support [grant numbers F009429/1 to MIH and A51065X/1 to RAD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; CAMMACK R, 1980, NATURE, V286, P442, DOI 10.1038/286442a0; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Couture MMJ, 2001, BIOCHEMISTRY-US, V40, P84, DOI 10.1021/bi001780r; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; De Mot R, 2007, ARCH MICROBIOL, V188, P257, DOI 10.1007/s00203-007-0243-8; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kimura S, 2005, BIOCHEM J, V388, P869, DOI 10.1042/BJ20042077; Lane N, 2007, NATURE, V449, P778, DOI 10.1038/449778a; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Overton TW, 2006, J BIOL CHEM, V281, P33115, DOI 10.1074/jbc.M607056200; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; Tucker NP, 2008, J BIOL CHEM, V283, P908, DOI 10.1074/jbc.M705850200; Tucker NP, 2004, J BACTERIOL, V186, P6656, DOI 10.1128/JB.186.19.6656-6660.2004; Vanin AF, 1998, NITRIC OXIDE-BIOL CH, V2, P224, DOI 10.1006/niox.1998.0180; WIESNER W, 1988, J BIOL CHEM, V263, P13725	35	107	109	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3623	10.1371/journal.pone.0003623	http://dx.doi.org/10.1371/journal.pone.0003623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989365	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000265134600001
J	Griguer, CE; Oliva, CR; Gobin, E; Marcorelles, P; Benos, DJ; Lancaster, JR; Gillespie, GY				Griguer, Corinne E.; Oliva, Claudia R.; Gobin, Eric; Marcorelles, Pascale; Benos, Dale J.; Lancaster, Jack R., Jr.; Gillespie, G. Yancey			CD133 Is a Marker of Bioenergetic Stress in Human Glioma	PLOS ONE			English	Article								Mitochondria dysfunction and hypoxic microenvironment are hallmarks of cancer cell biology. Recently, many studies have focused on isolation of brain cancer stem cells using CD133 expression. In this study, we investigated whether CD133 expression is regulated by bioenergetic stresses affecting mitochondrial functions in human glioma cells. First, we determined that hypoxia induced a reversible up-regulation of CD133 expression. Second, mitochondrial dysfunction through pharmacological inhibition of the Electron Transport Chain (ETC) produced an up-regulation of CD133 expression that was inversely correlated with changes in mitochondrial membrane potential. Third, generation of stable glioma cells depleted of mitochondrial DNA showed significant and stable increases in CD133 expression. These glioma cells, termed rho(0) or rho(0), are characterized by an exaggerated, uncoupled glycolytic phenotype and by constitutive and stable up-regulation of CD133 through many cell passages. Moreover, these rho(0) cells display the ability to form "tumor spheroids'' in serumless medium and are positive for CD133 and the neural progenitor cell marker, nestin. Under differentiating conditions, rho(0) cells expressed multi-lineage properties. Reversibility of CD133 expression was demonstrated by transfering parental mitochondria to rho(0) cells resulting in stable trans-mitochondrial "cybrid'' clones. This study provides a novel mechanistic insight about the regulation of CD133 by environmental conditions (hypoxia) and mitochondrial dysfunction (genetic and chemical). Considering these new findings, the concept that CD133 is a marker of brain tumor stem cells may need to be revised.	[Griguer, Corinne E.; Oliva, Claudia R.; Gillespie, G. Yancey] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Benos, Dale J.; Lancaster, Jack R., Jr.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL USA; [Lancaster, Jack R., Jr.] Univ Alabama, Dept Anesthesiol, Birmingham, AL USA; [Griguer, Corinne E.; Lancaster, Jack R., Jr.] Univ Alabama, Ctr Free Radical Biol, Birmingham, AL USA; [Griguer, Corinne E.; Benos, Dale J.; Gillespie, G. Yancey] Univ Alabama, Ctr Glial Biol Med, Birmingham, AL USA; [Lancaster, Jack R., Jr.; Gillespie, G. Yancey] Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL USA; [Oliva, Claudia R.] Univ Alabama, Dept Microbiol, Birmingham, AL USA; [Gobin, Eric; Marcorelles, Pascale] CHU Brest, Hop Morvan, Pole Biol Pathol, Serv Anat Pathol, Dept Med, Brest, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; CHU Brest; Universite de Bretagne Occidentale	Griguer, CE (corresponding author), Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA.	cgriguer@uab.edu		Gillespie, George/0000-0001-6436-9542; Oliva, Claudia/0000-0003-0624-5490; , Corinne/0000-0003-3877-5031	American Brain Tumor Association; UAB Brain Tumor SPORE [Career Development Award]; U.S. Public Health Service NIH [P50CA97247, P01 CA 071933, HL074391, HL71189, CA101952]; NATIONAL CANCER INSTITUTE [P01CA071933, R01CA101952, P50CA097247] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074391, R01HL071189] Funding Source: NIH RePORTER	American Brain Tumor Association; UAB Brain Tumor SPORE; U.S. Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Brain Tumor Association (C.E.G.) and a Career Development Award from the UAB Brain Tumor SPORE (C.E.G.), U.S. Public Health Service NIH grant P50CA97247 and P01 CA 071933 (G.Y.G.), NIH research grants HL074391 and HL71189 (J.R.L., Jr.) and NIH research grant CA101952 (D.J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barnhart BC, 2007, CANCER METAST REV, V26, P261, DOI 10.1007/s10555-007-9053-3; Beckner ME, 2005, LAB INVEST, V85, P1457, DOI 10.1038/labinvest.3700355; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P621, DOI 10.4161/cbt.4.6.1818; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Bouzier AK, 1998, J BIOL CHEM, V273, P27162, DOI 10.1074/jbc.273.42.27162; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; BROWN GC, 1992, BIOCHEM J, V284, P1; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GILLIES RJ, 2007, J BIOENERG BIOMEMBR; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2007, J NEURO-ONCOL, V81, P9, DOI 10.1007/s11060-006-9201-6; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; LEWIS LD, 1992, ANTIMICROB AGENTS CH, V36, P2061, DOI 10.1128/AAC.36.9.2061; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Morange M, 2007, ONCOGENE, V26, P7607, DOI 10.1038/sj.onc.1210583; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PEEK R, 1993, J CELL SCI, V106, P929; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sakariassen PO, 2007, NEOPLASIA, V9, P882, DOI 10.1593/neo.07658; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Turcotte ML, 2002, BRIT J CANCER, V86, P619, DOI 10.1038/sj.bjc.6600087; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zheng L, 2007, INT J INF SECUR, V6, P67, DOI 10.1007/s10207-007-0019-9; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	53	193	203	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3655	10.1371/journal.pone.0003655	http://dx.doi.org/10.1371/journal.pone.0003655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985161	Green Submitted, Green Published, gold			2022-12-25	WOS:000265134400015
J	Aon, MA; Roussel, MR; Cortassa, S; O'Rourke, B; Murray, DB; Beckmann, M; Lloyd, D				Aon, Miguel A.; Roussel, Marc R.; Cortassa, Sonia; O'Rourke, Brian; Murray, Douglas B.; Beckmann, Manfred; Lloyd, David			The Scale-Free Dynamics of Eukaryotic Cells	PLOS ONE			English	Article							MITOCHONDRIAL ION CHANNELS; SACCHAROMYCES-CEREVISIAE; RESPIRATORY OSCILLATIONS; BIOLOGICAL RHYTHMS; CONTINUOUS-CULTURE; ORGANIZATION; YEAST; CLOCK; BENZODIAZEPINE; ARCHITECTURE	Temporal organization of biological processes requires massively parallel processing on a synchronized time-base. We analyzed time-series data obtained from the bioenergetic oscillatory outputs of Saccharomyces cerevisiae and isolated cardiomyocytes utilizing Relative Dispersional (RDA) and Power Spectral (PSA) analyses. These analyses revealed broad frequency distributions and evidence for long-term memory in the observed dynamics. Moreover RDA and PSA showed that the bioenergetic dynamics in both systems show fractal scaling over at least 3 orders of magnitude, and that this scaling obeys an inverse power law. Therefore we conclude that in S. cerevisiae and cardiomyocytes the dynamics are scale-free in vivo. Applying RDA and PSA to data generated from an in silico model of mitochondrial function indicated that in yeast and cardiomyocytes the underlying mechanisms regulating the scale-free behavior are similar. We validated this finding in vivo using single cells, and attenuating the activity of the mitochondrial inner membrane anion channel with 4-chlorodiazepam to show that the oscillation of NAD(P)H and reactive oxygen species (ROS) can be abated in these two evolutionarily distant species. Taken together these data strongly support our hypothesis that the generation of ROS, coupled to redox cycling, driven by cytoplasmic and mitochondrial processes, are at the core of the observed rhythmicity and scale-free dynamics. We argue that the operation of scale-free bioenergetic dynamics plays a fundamental role to integrate cellular function, while providing a framework for robust, yet flexible, responses to the environment.	[Aon, Miguel A.; Cortassa, Sonia; O'Rourke, Brian] Johns Hopkins Univ, Inst Mol Cardiobiol, Baltimore, MD 21218 USA; [Roussel, Marc R.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Murray, Douglas B.] Keio Univ, Inst Advanced Biosci, Tokyo 108, Japan; [Beckmann, Manfred] Univ Wales Coll Cardiff, Inst Biol Sci, Cardiff CF1 3NS, S Glam, Wales; [Lloyd, David] Cardiff Univ, Cardiff Sch Biosci, Microbiol Grp, Cardiff, S Glam, Wales	Johns Hopkins University; University of Lethbridge; Keio University; Cardiff University; Cardiff University	Aon, MA (corresponding author), Johns Hopkins Univ, Inst Mol Cardiobiol, Baltimore, MD 21218 USA.	maon1@jhmi.edu; lloydd@Cardiff.ac.uk	Cortassa, Sonia/AAO-1633-2020; Beckmann, Manfred/AAX-9979-2021; Roussel, Marc/A-8957-2011; Lloyd, David/D-2483-2010	Cortassa, Sonia/0000-0001-7224-9858; Roussel, Marc/0000-0002-7795-4756; O'Rourke, Brian/0000-0002-5548-4853; Lloyd, David/0000-0002-5656-0571; Beckmann, Manfred/0000-0002-4320-5001	NIH [R37-HL54598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grant R37-HL54598. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Alon U, 2007, INTRO SYSTEMS BIOL D; Aon M. A., 2007, MOL SYSTEM BIOENERGE, P111; Aon MA, 2000, CELL BIOL INT, V24, P581, DOI 10.1006/cbir.2000.0572; Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; AON MA, 1993, MOL CELL BIOCHEM, V120, P1, DOI 10.1007/BF00925979; Aon MA, 2004, MOL CELL BIOCHEM, V256, P169, DOI 10.1023/B:MCBI.0000009867.54552.09; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Aon MA., 1997, DYNAMIC BIOL ORG FUN, V1st edn; Aon MA, 2007, FEBS LETT, V581, P8, DOI 10.1016/j.febslet.2006.11.068; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Aon MA, 2006, BIOPHYS J, V91, P4317, DOI 10.1529/biophysj.106.087817; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Brodin LA, 1998, COMPUT CARDIOL, V25, P253, DOI 10.1109/CIC.1998.731781; Brodsky VY, 2006, BIOL REV, V81, P143, DOI 10.1017/S1464793105006937; Brown DA, 2008, CARDIOVASC RES, V79, P141, DOI 10.1093/cvr/cvn053; Brown J., 2000, SCALING BIOL; CHANCE B, 1973, BIOL BIOCH OSCILLATI; CHANDRASHEKARAN MK, 2005, TIME LIVING WORLD; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V316, P969, DOI 10.1016/j.bbrc.2004.02.162; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Kwak WJ, 2003, FEMS MICROBIOL LETT, V219, P99, DOI 10.1016/S0378-1097(02)01198-9; Li CM, 2006, P NATL ACAD SCI USA, V103, P16254, DOI 10.1073/pnas.0604860103; LLOYD AL, 1993, BIOSYSTEMS, V29, P77, DOI 10.1016/0303-2647(93)90085-Q; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lloyd D, 2003, MITOCHONDRION, V3, P139, DOI 10.1016/j.mito.2003.08.002; LLOYD D, 1993, BIOL REV, V68, P563, DOI 10.1111/j.1469-185X.1993.tb01244.x; Lloyd D, 2000, REDOX STATE AND CIRCADIAN RHYTHMS, P85; LLOYD D, 1985, BIOSENSORS, V1, P179, DOI 10.1016/0265-928X(85)80003-1; LLOYD D, 1982, CELL DIVISION CYCLE; Lloyd D, 2007, BIOESSAYS, V29, P465, DOI 10.1002/bies.20575; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Murray DB, 1999, MICROBIOL-SGM, V145, P2739, DOI 10.1099/00221287-145-10-2739; Murray DB, 1998, FEBS LETT, V431, P297, DOI 10.1016/S0014-5793(98)00777-7; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Murray DB, 2001, J BACTERIOL, V183, P7253, DOI 10.1128/JB.183.24.7253-7259.2001; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Roussel MR, 2007, FEBS J, V274, P1011, DOI 10.1111/j.1742-4658.2007.05651.x; Slocinska M, 2004, ACTA BIOCHIM POL, V51, P953; Sohn HY, 2000, YEAST, V16, P1185, DOI 10.1002/1097-0061(20000930)16:13<1185::AID-YEA619>3.0.CO;2-W; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; West B.J., 1995, LURE MODERN SCI FRAC; West BJ, 1999, PHYSICA A, V270, P552, DOI 10.1016/S0378-4371(99)00175-2; WEST BJ, 1999, PHYSL PROMISCUITY PR; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Yates F. Eugene, 1993, P189; YATES FE, 1992, METHOD ENZYMOL, V210, P636; Zhou T, 2005, J THEOR BIOL, V236, P438, DOI 10.1016/j.jtbi.2005.03.023; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	74	56	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3624	10.1371/journal.pone.0003624	http://dx.doi.org/10.1371/journal.pone.0003624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982073	Green Published, Green Accepted, gold			2022-12-25	WOS:000265134300001
J	Liu, G; Min, HY; Yue, SB; Chen, CZ				Liu, Gwen; Min, Hyeyoung; Yue, Sibiao; Chen, Chang-Zheng			Pre-miRNA Loop Nucleotides Control the Distinct Activities of mir-181a-1 and mir-181c in Early T Cell Development	PLOS ONE			English	Article								Background: Mature miRNAs can often be classified into large families, consisting of members with identical seeds (nucleotides 2 through 7 of the mature miRNAs) and highly homologous similar to 21-nucleotide (nt) mature miRNA sequences. However, it is unclear whether members of a miRNA gene family, which encode identical or nearly identical mature miRNAs, are functionally interchangeable in vivo. Methods and Findings: We show that mir-181a-1, but not mir-181c, can promote CD4 and CD8 double-positive (DP) T cell development when ectopically expressed in thymic progenitor cells. The distinct activities of mir-181a-1 and mir-181c are largely determined by their unique pre-miRNA loop nucleotides-not by the one-nucleotide difference in their mature miRNA sequences. Moreover, the activity of mir-181a-1 on DP cell development can be quantitatively influenced by nucleotide changes in its pre-miRNA loop region. We find that both the strength and the functional specificity of miRNA genes can be controlled by the pre-miRNA loop nucleotides. Intriguingly, we note that mutations in the pre-miRNA loop regions affect pre-miRNA and mature miRNA processing, but find no consistent correlation between the effects of pre-miRNA loop mutations on the levels of mature miRNAs and the activities of the mir-181a-1/c genes. Conclusions: These results demonstrate that pre-miRNA loop nucleotides play a critical role in controlling the activity of miRNA genes and that members of the same miRNA gene families could have evolved to achieve different activities via alterations in their pre-miRNA loop sequences, while maintaining identical or nearly identical mature miRNA sequences.	[Liu, Gwen; Min, Hyeyoung; Yue, Sibiao; Chen, Chang-Zheng] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University	Liu, G (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.	czchen@stanford.edu	yue, sibiao/M-2610-2014	Chen, Chang-Zheng/0000-0002-1620-242X	NIH [R01-HL081612]; Baxter and Terman faculty awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter and Terman faculty awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH R01-HL081612 grant and the Baxter and Terman faculty awards (to C.-Z. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Forsyth D, 1907, Q J MED, V1, P287; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	27	93	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3592	10.1371/journal.pone.0003592	http://dx.doi.org/10.1371/journal.pone.0003592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974849	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131700013
J	Perez, LE; Desponts, C; Parquet, N; Kerr, WG				Perez, Lia E.; Desponts, Caroline; Parquet, Nancy; Kerr, William G.			SH2-Inositol Phosphatase 1 Negatively Influences Early Megakaryocyte Progenitors	PLOS ONE			English	Article								Background: The SH2-containing-5'-inositol phosphatase-1 (SHIP) influences signals downstream of cytokine/chemokine receptors that play a role in megakaryocytopoiesis, including thrombopoietin, stromal-cell-derived-Factor-1/CXCL-12 and interleukin-3. We hypothesize that SHIP might control megakaryocytopoiesis through effects on proliferation of megakaryocyte progenitors (MKP) and megakaryocytes (MK). Methodology and Principal Findings: Herein, we report the megakaryocytic phenotype and MK functional assays of hematopoietic organs of two strains of SHIP deficient mice with deletion of the SHIP promoter/first exon or the inositol phosphatase domain. Both SHIP deficient strains exhibit a profound increase in MKP numbers in bone marrow (BM), spleen and blood as analyzed by flow cytometry (Lin(-)c-Kit(+)CD41(+)) and functional assays (CFU-MK). SHIP deficient MKP display increased phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT-3), protein kinase B (PKB/AKT) and extracellular signal-regulated kinases (ERKs). Despite increased MKP content, total body number of mature MK (Lin(-)c-kit(-)CD41(+)) are not significantly changed as SHIP deficient BM contains reduced MK while spleen MK numbers are increased. Reduction of CXCR-4 expression in SHIP deficient MK may influence MK localization to the spleen instead of the BM. Endomitosis, process involved in MK maturation, was preserved in SHIP deficient MK. Circulating platelets and red blood cells are also reduced in SHIP deficient mice. Conclusions/Significance: SHIP may play an important role in regulation of essential signaling pathways that control early megakaryocytopoiesis in vivo.	[Parquet, Nancy] H Lee Moffit Comprehens Canc Ctr & Res Inst, Blood & Marrow Transplantat Program, Tampa, FL USA; [Desponts, Caroline; Kerr, William G.] H Lee Moffitt Comprehens Canc Ctr & Res Inst, Immunol Program, Tampa, FL USA; [Desponts, Caroline] Scripps Res Inst, Dept Chem, San Diego, CA USA	H Lee Moffitt Cancer Center & Research Institute; Scripps Research Institute	Perez, LE (corresponding author), H Lee Moffit Comprehens Canc Ctr & Res Inst, Blood & Marrow Transplantat Program, Tampa, FL USA.	William.Kerr@moffitt.org	Kerr, William G/B-8616-2015	Kerr, William G/0000-0002-4720-7135	NIH [RO1 DK54767, RO1 HL72523]; Moffitt Cancer Center; NHLBI [1 K08 HL77662-01A1]; Newman Scholar of the Leukemia and Lymphoma Society of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077662, R01HL072523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Newman Scholar of the Leukemia and Lymphoma Society of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the NIH (RO1 DK54767, RO1 HL72523) and academic development funds from Moffitt Cancer Center. LEP is supported by NHLBI K08 Career Development Award (1 K08 HL77662-01A1). WGK is The Newman Scholar of the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BURSTEIN SA, 1981, J CELL PHYSIOL, V109, P333, DOI 10.1002/jcp.1041090217; BURSTEIN SA, 1983, CLIN HAEMATOL, V12, P3; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Desponts C, 2006, BLOOD, V107, P4338, DOI 10.1182/blood-2005-12-5021; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Helgason CD, 2003, BLOOD, V102, P3541, DOI 10.1182/blood-2002-12-3939; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; KAUSHANSKY K, 1994, STEM CELLS, V12, P91; KAUSHANSKY K, 1994, STEM CELLS S1, V12, P96; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Kuter D J, 1996, Stem Cells, V14 Suppl 1, P88; Lane WJ, 2000, BLOOD, V96, P4152; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; LOK S, 1994, STEM CELLS, V12, P586, DOI 10.1002/stem.5530120606; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; MOODY JL, 2004, BLOOD; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Perez LE, 2004, EXP HEMATOL, V32, P300, DOI 10.1016/j.exphem.2003.12.005; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438	37	15	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3565	10.1371/journal.pone.0003565	http://dx.doi.org/10.1371/journal.pone.0003565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958162	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131100021
J	Quintana, FJ; Solomon, A; Cohen, IR; Nussbaum, G				Quintana, Francisco J.; Solomon, Aderet; Cohen, Irun R.; Nussbaum, Gabriel			Induction of IgG3 to LPS via Toll-Like Receptor 4 Co-Stimulation	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; B-CELLS; MONOCLONAL-ANTIBODIES; CPG DNA; ACTIVATION; RESPONSES; IMMUNE; MICE; LIPOPOLYSACCHARIDE; INNATE	B-cells integrate antigen-specific signals transduced via the B-cell receptor (BCR) and antigen non-specific co-stimulatory signals provided by cytokines and CD40 ligation in order to produce IgG antibodies. Toll-like receptors (TLRs) also provide co-stimulation, but the requirement for TLRs to generate T-cell independent and T-cell dependent antigen specific antibody responses is debated. Little is known about the role of B-cell expressed TLRs in inducing antigen-specific antibodies to antigens that also activate TLR signaling. We found that mice lacking functional TLR4 or its adaptor molecule MyD88 harbored significantly less IgG3 natural antibodies to LPS, and required higher amounts of LPS to induce anti-LPS IgG3. In vitro, BCR and TLR4 signaling synergized, lowering the threshold for production of T-cell independent IgG3 and IL-10. Moreover, BCR and TLR4 directly associate through the transmembrane domain of TLR4. Thus, in vivo, BCR/TLR synergism could facilitate the induction of IgG3 antibodies against microbial antigens that engage both innate and adaptive B-cell receptors. Vaccines might exploit BCR/TLR synergism to rapidly induce antigen-specific antibodies before significant T-cell responses arise.	[Quintana, Francisco J.] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Quintana, Francisco J.; Cohen, Irun R.; Nussbaum, Gabriel] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Solomon, Aderet; Nussbaum, Gabriel] Hebrew Univ Jerusalem, Hadassah Sch Dental Med, Inst Dental Sci, IL-91905 Jerusalem, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science; Hebrew University of Jerusalem	Quintana, FJ (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		Juvenile Diabetes Research Foundation International; Center for the Study of Emerging Diseases, Jerusalem; International Human Frontier Science Program Organization	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Center for the Study of Emerging Diseases, Jerusalem; International Human Frontier Science Program Organization(Human Frontier Science Program)	Part of the study was supported by a grant from the Juvenile Diabetes Research Foundation International. Aspects of the study were funded by a grant from the Center for the Study of Emerging Diseases, Jerusalem. FJQ was supported by a long-term fellowship from the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; COHEN IR, 1966, SCIENCE, V152, P1257, DOI 10.1126/science.152.3726.1257; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; DURHAM JA, 1988, J CLIN MICROBIOL, V26, P885, DOI 10.1128/JCM.26.5.885-889.1988; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fang T, 2001, J IMMUNOL, V167, P3846, DOI 10.4049/jimmunol.167.7.3846; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gianotti L, 1996, BURNS, V22, P120, DOI 10.1016/0305-4179(95)00100-X; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Hopkins WJ, 2003, J INFECT DIS, V187, P418, DOI 10.1086/367963; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MINER KM, 1986, INFECT IMMUN, V52, P56, DOI 10.1128/IAI.52.1.56-62.1986; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Quintana FJ, 2001, J AUTOIMMUN, V17, P191, DOI 10.1006/jaut.2001.0544; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Rifkin IR, 2003, NAT IMMUNOL, V4, P650, DOI 10.1038/ni0703-650; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCOTT DW, 1970, CLIN EXP IMMUNOL, V6, P313; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; SPELLMAN JM, 1979, INFECT IMMUN, V24, P371, DOI 10.1128/IAI.24.2.371-378.1979; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	53	27	27	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3509	10.1371/journal.pone.0003509	http://dx.doi.org/10.1371/journal.pone.0003509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946502	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126200009
J	Tyagi, R; Shenoy, AR; Visweswariah, SS				Tyagi, Richa; Shenoy, Avinash R.; Visweswariah, Sandhya S.			Characterization of an Evolutionarily Conserved Metallophosphoesterase That Is Expressed in the Fetal Brain and Associated with the WAGR Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; WILMS TUMOR ASSOCIATION; BIOCHEMICAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN PHOSPHATASES; MUTATIONAL ANALYSIS; HUMAN CHROMOSOME-11; ACID-PHOSPHATASE; ANIRIDIA REGION; PHYSICAL MAP	Among the human diseases that result from chromosomal aberrations, a de novo deletion in chromosome 11p13 is clinically associated with a syndrome characterized by Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR). Not all genes in the deleted region have been characterized biochemically or functionally. We have recently identified the first Class III cyclic nucleotide phosphodiesterase, Rv0805, from Mycobacterium tuberculosis, which biochemically and structurally belongs to the superfamily of metallophosphoesterases. We performed a large scale bioinformatic analysis to identify orthologs of the Rv0805 protein and identified many eukaryotic genes that included the human 239FB gene present in the region deleted in the WAGR syndrome. We report here the first detailed biochemical characterization of the rat 239FB protein and show that it possesses metallophosphodiesterase activity. Extensive mutational analysis identified residues that are involved in metal interaction at the binuclear metal center. Generation of a rat 239FB protein with a mutation corresponding to a single nucleotide polymorphism seen in human 239FB led to complete inactivation of the protein. A close ortholog of 239FB is found in adult tissues, and biochemical characterization of the 239AB protein demonstrated significant hydrolytic activity against 2',3'-cAMP, thus representing the first evidence for a Class III cyclic nucleotide phosphodiesterase in mammals. Highly conserved orthologs of the 239FB protein are found in Caenorhabditis elegans and Drosophila and, coupled with available evidence suggesting that 239FB is a tumor suppressor, indicate the important role this protein must play in diverse cellular events.	[Tyagi, Richa; Shenoy, Avinash R.; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; tyagi, richa/A-7261-2015	Visweswariah, Sandhya/0000-0003-2786-7344; Shenoy, Avinash/0000-0001-6228-9303	Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India	Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaDepartment of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India.	BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BONETTA L, 1990, SCIENCE, V250, P994, DOI 10.1126/science.2173146; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; COMPTON DA, 1988, CELL, V55, P827, DOI 10.1016/0092-8674(88)90138-9; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EKRYLANDER B, 1991, J BONE MINER RES, V6, P365; FANTES JA, 1995, GENOMICS, V25, P447, DOI 10.1016/0888-7543(95)80045-N; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GAWIN B, 1995, GENOMICS, V30, P37, DOI 10.1006/geno.1995.0006; GESSLER M, 1989, GENOMICS, V5, P43, DOI 10.1016/0888-7543(89)90084-0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1989, AM J HUM GENET, V44, P486; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; HANSON IM, 1992, GENOMICS, V13, P1331, DOI 10.1016/0888-7543(92)90060-6; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; KOONIN EV, 1993, MOL MICROBIOL, V8, P785, DOI 10.1111/j.1365-2958.1993.tb01622.x; Lin YS, 2005, COMP BIOCHEM PHYS B, V141, P71, DOI 10.1016/j.cbpc.2005.01.011; McMillen L, 2003, BIOCHEM J, V372, P625, DOI 10.1042/BJ20021800; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Schwartz F, 1997, GENE, V194, P57, DOI 10.1016/S0378-1119(97)00149-2; SCHWARTZ F, 1994, HUM GENET, V94, P658; SCHWARTZ F, 1995, GENOMICS, V29, P526, DOI 10.1006/geno.1995.9973; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; SHIPMAN R, 1993, HUM GENET, V91, P455; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Uppenberg J, 1999, J MOL BIOL, V290, P201, DOI 10.1006/jmbi.1999.2896; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; ZANKOWALCZEWSKA M, 1987, BIOCHEMISTRY-US, V26, P1194, DOI 10.1021/bi00378a030; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	52	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5217	5228		10.1074/jbc.M805996200	http://dx.doi.org/10.1074/jbc.M805996200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19004815	hybrid			2022-12-25	WOS:000263416600052
J	Yadav, G; Prasad, RLA; Jha, BK; Rai, V; Bhakuni, V; Datta, K				Yadav, Gitanjali; Prasad, Ramachandra L. A.; Jha, Babal Kant; Rai, Vivek; Bhakuni, Vinod; Datta, Kasturi			Evidence for Inhibitory Interaction of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae Hyaluronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; LYASE; PURIFICATION; ENZYME; CHONDROITINASES; DEGRADATION; COMPLEXES; SUBSTRATE; INVASION; RECEPTOR	Bacterial hyaluronan lyase enzymes are the major virulence factors that enable greater microbial ingress by cleaving hyaluronan (HA) polymers present predominantly in extracellular space of vertebrates. Based on the premise that effective inhibitors may bind to and stabilize HA thereby protecting it from degradation, here we investigated inhibitory activity of human hyaluronan-binding protein 1 (HABP1) on bacterial hyaluronidase because it is highly specific to HA and localized on the cell surface. Biochemical characterization revealed that HABP1 is a competitive inhibitor of Streptococcus pneumoniae hyaluronate lyase (SpnHL) with an IC50 value of 22 mu M. This is thus the first report of an endogenous protein inhibitor that may be used during natural antibacterial defense. Our findings also support a novel multipronged mechanism for the high efficacy of HABP1-mediated inhibition based on structural modeling of enzyme, substrate, and inhibitor. Evidence from docking simulations and contact interface interactions showed that the inherent charge asymmetry of HABP1 plays a key role in the inhibitory activity. This novel role of HABP1 may pave the way for peptide inhibitors as alternatives to synthetic chemicals in antibacterial research.	[Yadav, Gitanjali; Rai, Vivek] Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi 110067, India; [Prasad, Ramachandra L. A.; Jha, Babal Kant; Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, Biochem Lab, New Delhi 110067, India; [Bhakuni, Vinod] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Yadav, G (corresponding author), Natl Inst Plant Genome Res, Computat Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	gy@nipgr.res.in; kdatta@mail.jnu.ac.in	RAI, VIVEK/D-5002-2009; jha, babal k/B-1803-2010	jha, babal k/0000-0002-7660-5255; Yadav, Gitanjali/0000-0001-6591-9964	Department of Biotechnology; Department of Science and Technology; Department of Biotechnology, Government of India	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by the Department of Biotechnology and Department of Science and Technology.; Supported by the Innovative Young Biotechnologist Award by the Department of Biotechnology, Government of India.	Akhtar MS, 2003, J BIOL CHEM, V278, P25509, DOI 10.1074/jbc.M301894200; Asada M, 1997, BIOSCI BIOTECH BIOCH, V61, P1030, DOI 10.1271/bbb.61.1030; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; BRODYAGIN N A, 1970, Byulleten' Eksperimental'noi Biologii i Meditsiny, V70, P52; Chain E, 1939, NATURE, V144, P977, DOI 10.1038/144977b0; Csoka TB, 1997, INVAS METAST, V17, P297; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DAY TD, 1950, NATURE, V166, P785, DOI 10.1038/166785b0; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DEB TB, 2001, HYALURONAN, V1, P365; DeLano WL, 2002, PYMOL USERS MANUAL; DORFMAN A, 1948, J BIOL CHEM, V174, P621; FISZERSZAFARZ B, 1968, P SOC EXP BIOL MED, V129, P300; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; HAAS E, 1946, J BIOL CHEM, V163, P63; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Ito S, 2000, VIROLOGY, V266, P110, DOI 10.1006/viro.1999.0054; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jha BK, 2003, J BIOL CHEM, V278, P27464, DOI 10.1074/jbc.M206696200; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; KUPPUSAMY UR, 1990, BIOCHEM PHARMACOL, V40, P397, DOI 10.1016/0006-2952(90)90709-T; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P15125, DOI 10.1074/jbc.M011102200; MATHEWS MB, 1955, PHYSIOL REV, V35, P381, DOI 10.1152/physrev.1955.35.2.381; MEYER K, 1951, J BIOL CHEM, V188, P485; Mio K, 2001, Methods Mol Biol, V171, P391; RAPPORT MM, 1951, J BIOL CHEM, V192, P283; Rigden DJ, 2006, GLYCOBIOLOGY, V16, P757, DOI 10.1093/glycob/cwj116; Schaerer MT, 2001, J BIOL CHEM, V276, P26597, DOI 10.1074/jbc.M102534200; Spickenreither M, 2006, BIOORG MED CHEM LETT, V16, P5313, DOI 10.1016/j.bmcl.2006.07.087; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Suzuki K, 2002, J ENZYM INHIB MED CH, V17, P183, DOI 10.1080/14756360290032930; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Udabage L, 2003, GLYCOCONJUGATE J, V20, P461, DOI 10.1023/B:GLYC.0000038292.71098.35; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x	48	14	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3897	3905		10.1074/jbc.M804246200	http://dx.doi.org/10.1074/jbc.M804246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19004836	hybrid			2022-12-25	WOS:000262872500058
J	Karbarz, MJ; Six, DA; Raetz, CRH				Karbarz, Mark J.; Six, David A.; Raetz, Christian R. H.			Purification and Characterization of the Lipid A 1-Phosphatase LpxE of Rhizobium leguminosarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPOPOLYSACCHARIDE CORE GLYCOSYLATION; AGROBACTERIUM-TUMEFACIENS C58; ESCHERICHIA-COLI; EXPRESSION CLONING; SALMONELLA-TYPHIMURIUM; PYRIDOXAL-PHOSPHATE; A BIOSYNTHESIS; MUTANT LACKING; GENE	LpxE, a membrane-bound phosphatase found in Rhizobium leguminosarum and some other Gram-negative bacteria, selectively dephosphorylates the 1-position of lipid A on the outer surface of the inner membrane. LpxE belongs to the family of lipid phosphate phosphatases that contain a tripartite active site motif and six predicted transmembrane helices. Here we report the purification and characterization of R. leguminosarum LpxE. A modified lpxE gene, encoding a protein with an N-terminal His(6) tag, was expressed in Escherichia coli. The protein was solubilized with Triton X-100 and purified to near-homogeneity. Gel electrophoresis reveals a molecular weight consistent with the predicted 31 kDa. LpxE activity is dependent upon Triton X-100, optimal near pH6.5, and Mg2+-independent. The H197A and R133A substitutions inactivate LpxE, as does treatment with diethyl pyrocarbonate. In a mixed micelle assay system, the apparent Km for the precursor lipid IVA is 11 mu M. Substrates containing the 3-deoxy-D-manno-oct-2-ulosonic acid disaccharide are dephosphorylated at similar rates to lipid IVA, whereas glycerophospholipids like phosphatidic acid or phosphatidylglycerol phosphate are very poor substrates. However, an LpxE homologue present in Agrobacterium tumefaciens is selective for phosphatidylglycerol phosphate, demonstrating the importance of determining substrate specificity before assigning the functions of LpxE-related proteins. The availability of purified LpxE will facilitate the preparation of novel 1-dephosphorylated lipid A molecules that are not readily accessible by chemical methods.	[Karbarz, Mark J.; Six, David A.; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711	National Institutes of Health [R37-GM-51796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051796, T32GM008558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-GM-51796 (to C. R. H. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; Basu SS, 1999, J BIOL CHEM, V274, P11150, DOI 10.1074/jbc.274.16.11150; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Bienzle U, 2002, LIVER TRANSPLANT, V8, P562, DOI 10.1053/jlts.2002.33699; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432; Kadrmas JL, 1996, J BIOL CHEM, V271, P32119, DOI 10.1074/jbc.271.50.32112; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; Karbarz MJ, 2003, J BIOL CHEM, V278, P39269, DOI 10.1074/jbc.M305830200; Keenleyside WJ, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P331; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; MATSUYAMA T, 1992, J BIOCHEM-TOKYO, V112, P258, DOI 10.1093/oxfordjournals.jbchem.a123887; MATTHEWS KS, 1991, METHOD ENZYMOL, V208, P468; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Miles E W, 1977, Methods Enzymol, V47, P431; Miller J. H., 1972, EXPT MOL GENETICS, P433; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que NLS, 2000, J BIOL CHEM, V275, P28017; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12120, DOI 10.1074/jbc.M300379200; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12109, DOI 10.1074/jbc.M300378200; QURESHI N, 1982, J BIOL CHEM, V257, P1808; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; RAETZ CRH, 1972, BIOCHEMISTRY-US, V11, P2229, DOI 10.1021/bi00762a004; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sambrook J, 2001, MOL CLONING LAB MANU; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Stukey J, 1997, PROTEIN SCI, V6, P469; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	72	23	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					414	425		10.1074/jbc.M808390200	http://dx.doi.org/10.1074/jbc.M808390200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984595	hybrid, Green Published			2022-12-25	WOS:000261974800046
J	Durkin, SS; Guo, X; Fryrear, KA; Mihaylova, VT; Gupta, SK; Belgnaoui, SM; Haoudi, A; Kupfer, GM; Semmes, OJ				Durkin, Sarah S.; Guo, Xin; Fryrear, Kimberly A.; Mihaylova, Valia T.; Gupta, Saurabh K.; Belgnaoui, S. Mehdi; Haoudi, Abdelali; Kupfer, Gary M.; Semmes, O. John			HTLV-1 Tax Oncoprotein Subverts the Cellular DNA Damage Response via Binding to DNA-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; DOUBLE-STRAND BREAKS; I TAX; CATALYTIC SUBUNIT; CHROMOSOMAL INSTABILITY; FUNCTIONAL INTERACTION; TELOMERE LENGTH; REPAIR; CELLS; AUTOPHOSPHORYLATION	Human T-cell leukemia virus type-1 is the causative agent for adult T-cell leukemia. Previous research has established that the viral oncoprotein Tax mediates the transformation process by impairing cell cycle control and cellular response to DNA damage. We showed previously that Tax sequesters huChk2 within chromatin and impairs the response to ionizing radiation. Here we demonstrate that DNA-dependent protein kinase (DNA-PK) is a member of the Tax.Chk2 nuclear complex. The catalytic subunit, DNA-PKcs, and the regulatory subunit, Ku70, were present. Tax-containing nuclear extracts showed increased DNA-PK activity, and specific inhibition of DNA-PK prevented Tax-induced activation of Chk2 kinase activity. Expression of Tax induced foci formation and phosphorylation of H2AX. However, Tax-induced constitutive signaling of the DNA-PK pathway impaired cellular response to new damage, as reflected in suppression of ionizing radiation-induced DNA-PK phosphorylation and gamma H2AX stabilization. Tax co-localized with phospho-DNA-PK into nuclear speckles and a nuclear excluded Tax mutant sequestered endogenous phospho-DNA-PK into the cytoplasm, suggesting that Tax interaction with DNA-PK is an initiating event. Wealso describe a novel interaction between DNA-PK and Chk2 that requires Tax. We propose that Tax binds to and stabilizes a protein complex with DNA-PK and Chk2, resulting in a saturation of DNA-PK-mediated damage repair response.	[Durkin, Sarah S.; Guo, Xin; Fryrear, Kimberly A.; Gupta, Saurabh K.; Belgnaoui, S. Mehdi; Haoudi, Abdelali; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Prote, Norfolk, VA 23507 USA; [Mihaylova, Valia T.; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, New Haven, CT 06520 USA	Eastern Virginia Medical School; Yale University	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Prote, Lewis Hall,700 W Olney Rd, Norfolk, VA 23507 USA.	semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		NCI [CA-76595]; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA-76595 from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; CUSTER RP, 1985, AM J PATHOL, V120, P464; Derse D, 2004, FRONT BIOSCI-LANDMRK, V9, P2495, DOI 10.2741/1411; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; FURUKAWA Y, 1992, BLOOD, V80, P1012; Gabet AS, 2003, ONCOGENE, V22, P3734, DOI 10.1038/sj.onc.1206468; GESSAIN A, 1985, LANCET, V2, P407; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Hosoi Y, 2004, INT J ONCOL, V25, P461; Itoyama A, 2001, BLOOD, V97, P3612, DOI 10.1182/blood.V97.11.3612; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Liu LX, 2003, HEPATO-GASTROENTEROL, V50, P1496; Majone F, 2000, J BIOL CHEM, V275, P32906, DOI 10.1074/jbc.C000538200; MAJONE F, 1993, VIROLOGY, V193, P456, DOI 10.1006/viro.1993.1145; Majone F, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-45; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Morimoto H, 2005, AM J HEMATOL, V78, P100, DOI 10.1002/ajh.20259; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; OSAME M, 1986, LANCET, V1, P1031; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; Pise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Saggioro D, 1999, EXP CELL RES, V247, P525, DOI 10.1006/excr.1998.4381; Saitou M, 2001, J HUM GENET, V46, P706, DOI 10.1007/s100380170004; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sibon D, 2006, J CLIN INVEST, V116, P974, DOI 10.1172/JCI27198; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Van PL, 2001, J VIROL, V75, P396, DOI 10.1128/JVI.75.1.396-407.2001; Veuger SJ, 2003, CANCER RES, V63, P6008; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	78	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36311	36320		10.1074/jbc.M804931200	http://dx.doi.org/10.1074/jbc.M804931200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957425	Green Published, hybrid			2022-12-25	WOS:000261840500027
J	Mortimer, SE; Xu, D; McGrew, D; Hamaguchi, N; Lim, HC; Bowne, SJ; Daiger, SP; Hedstrom, L				Mortimer, Sarah E.; Xu, Dong; McGrew, Dharia; Hamaguchi, Nobuko; Lim, Hoong Chuin; Bowne, Sara J.; Daiger, Stephen P.; Hedstrom, Lizbeth			IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; BINDING PROTEINS; IN-VITRO; IDENTIFICATION; MUTATIONS; DOMAIN; COMPLEXES	IMP dehydrogenase (IMPDH) catalyzes the pivotal step in guanine nucleotide biosynthesis. Here we show that both IMPDH type 1 (IMPDH1) and IMPDH type 2 are associated with polyribosomes, suggesting that these housekeeping proteins have an unanticipated role in translation regulation. This interaction is mediated by the subdomain, a region of disputed function that is the site of mutations that cause retinal degeneration. The retinal isoforms of IMPDH1 also associate with polyribosomes. The most common disease-causing mutation, D226N, disrupts the polyribosome association of at least one retinal IMPDH1 isoform. Finally, we find that IMPDH1 is associated with polyribosomes containing rhodopsin mRNA. Because any perturbation of rhodopsin expression can trigger apoptosis in photoreceptor cells, these observations suggest a likely pathological mechanism for IMPDH1-mediated hereditary blindness. We propose that IMPDH coordinates the translation of a set of mRNAs, perhaps by modulating localization or degradation.	[Mortimer, Sarah E.; Xu, Dong; Hamaguchi, Nobuko; Lim, Hoong Chuin; Hedstrom, Lizbeth] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [McGrew, Dharia] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Bowne, Sara J.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA	Brandeis University; Brandeis University; Brandeis University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biochem, MS 009,415 South St, Waltham, MA 02454 USA.	hedstrom@brandeis.edu			National Institutes of Health [GM54403, EY17325, EY014170, GM07956]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY007142, R21EY017325, R01EY014170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54403 and EY17325 (to L. H.) and EY014170 (to S. P. D.), and GM07956 (Macromolecular Structure and Mechanism Training Grant to S. E. M.). This work was also supported by grant from the Foundation Fighting Blindness (to S. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; CARR SF, 1993, J BIOL CHEM, V268, P27286; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cornuel JF, 2002, BIOCHIMIE, V84, P279, DOI 10.1016/S0300-9084(02)01400-1; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Grover S, 2004, OPHTHALMOLOGY, V111, P1910, DOI 10.1016/j.ophtha.2004.03.039; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hedstrom L, 1999, CURR MED CHEM, V6, P545; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOLMES EW, 1974, BIOCHIM BIOPHYS ACTA, V364, P209, DOI 10.1016/0005-2744(74)90006-0; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kerman A, 2003, ADV EXP MED BIOL, V533, P13; MATSUNO K, 1995, BIOSCI BIOTECH BIOCH, V59, P231, DOI 10.1271/bbb.59.231; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SENDA M, 1994, LIFE SCI, V54, P1917, DOI 10.1016/0024-3205(94)90150-3; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Spellicy CJ, 2007, MOL VIS, V13, P1866; Sung CH, 2000, INT REV CYTOL, V195, P215; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Wada Y, 2005, INVEST OPHTH VIS SCI, V46, P1735, DOI 10.1167/iovs.04-1197; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WEBER G, 1992, ADV ENZYME REGUL, V32, P57; Whitehead JP, 2004, TRAFFIC, V5, P739, DOI 10.1111/j.1600-0854.2004.00217.x; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	56	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36354	36360		10.1074/jbc.M806143200	http://dx.doi.org/10.1074/jbc.M806143200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974094	hybrid, Green Published			2022-12-25	WOS:000261840500032
J	Yang, JH; Yang, L; Qu, ZL; Weiss, JN				Yang, Jun-Hai; Yang, Ling; Qu, Zhilin; Weiss, James N.			Glycolytic Oscillations in Isolated Rabbit Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; MYOCARDIAL SUBSTRATE METABOLISM; (ROS)-INDUCED ROS RELEASE; CARDIAC MYOCYTES; CREATINE-KINASE; ATP HYDROLYSIS; FREE-RADICALS; HEART-CELLS; RAT HEARTS; ISCHEMIA	Previous studies have shown that glycolysis can oscillate periodically, driven by feedback loops in regulation of key glycolytic enzymes by free ADP and other metabolites. Here we show both theoretically and experimentally in cardiac myocytes that when the capacity of oxidative phosphorylation and the creatine kinase system to buffer the cellular ATP/ADP ratio is suppressed, glycolysis can cause large scale periodic oscillations in cellular ATP levels (0.02-0.067 Hz), monitored from gliben-clamide-sensitive changes in action potential duration or intracellular free Mg2+. Action potential duration oscillations originate primarily from glycolysis, since they 1) occur in the presence of cyanide or rotenone, 2) are suppressed by iodoacetate, 3) are accompanied by at most very small mitochondrial membrane potential oscillations, and 4) exhibit an anti-phase relationship to NADH fluorescence. By uncoupling energy supply-demand balance, glycolytic oscillations may promote injury and electrophysiological heterogeneity during acute metabolic stresses, such as acute myocardial ischemia in which both oxidative phosphorylation and creatine kinase activity are inhibited.	[Qu, Zhilin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Qu, ZL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, 675 Charles Young Dr S,3645 MRL, Los Angeles, CA 90095 USA.	zqu@mednet.ucla.edu	Yang, Ling/D-2368-2011		National Institutes of Health; NHLBI [P01 HL-080111, R01 HL-071870]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, P01HL080111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants P01 HL-080111 and R01 HL-071870. This work was also supported by the Laubisch and Kawata Endowments. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Brady NR, 2006, ANTIOXID REDOX SIGN, V8, P1651, DOI 10.1089/ars.2006.8.1651; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; CHANCE B, 1972, AM J PHYSIOL, V223, P207, DOI 10.1152/ajplegacy.1972.223.1.207; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Dolder M, 2001, BIOL SIGNAL RECEPT, V10, P93; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Ferrero JM, 1996, CIRC RES, V79, P208, DOI 10.1161/01.RES.79.2.208; Geraldes CFGC, 1997, MOL CELL BIOCHEM, V170, P53, DOI 10.1023/A:1006899932108; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDHABER JI, 1989, J CLIN INVEST, V83, P1800, DOI 10.1172/JCI114085; HESS B, 1968, H-S Z PHYSIOL CHEM, V349, P1567, DOI 10.1515/bchm2.1968.349.2.1567; HIGGINS J, 1964, P NATL ACAD SCI USA, V51, P989, DOI 10.1073/pnas.51.6.989; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Mekhfi H, 1996, CIRC RES, V78, P1016, DOI 10.1161/01.RES.78.6.1016; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Rehring TF, 1998, AM J PHYSIOL-HEART C, V275, pH805, DOI 10.1152/ajpheart.1998.275.3.H805; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Ryu SY, 2005, J MOL CELL CARDIOL, V39, P874, DOI 10.1016/j.yjmcc.2005.08.011; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Sasaki N, 2001, AM J PHYSIOL-HEART C, V280, pH1882, DOI 10.1152/ajpheart.2001.280.4.H1882; Schaefer S, 1997, CARDIOVASC RES, V35, P90, DOI 10.1016/S0008-6363(97)00087-4; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Silva AS, 2006, GENET MOL RES, V5, P525; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; van Beek JHGM, 2007, AM J PHYSIOL-CELL PH, V293, pC815, DOI 10.1152/ajpcell.00355.2006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Weiss RG, 1996, CIRC RES, V79, P435, DOI 10.1161/01.RES.79.3.435; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; YANG WCT, 1977, LIFE SCI, V21, P1171, DOI 10.1016/0024-3205(77)90117-5; Zhou LF, 2006, AM J PHYSIOL-HEART C, V291, pH1036, DOI 10.1152/ajpheart.01382.2005; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	42	38	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36321	36327		10.1074/jbc.M804794200	http://dx.doi.org/10.1074/jbc.M804794200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948270	Green Published, hybrid			2022-12-25	WOS:000261840500028
J	Ren, KH; Jin, HX; Bian, CJ; He, HW; Liu, X; Zhang, SH; Wang, YG; Shao, RG				Ren, Kaihuan; Jin, Haixia; Bian, Chunjing; He, Hongwei; Liu, Xia; Zhang, Shenghua; Wang, Yiguang; Shao, Rong-Guang			MR-1 Modulates Proliferation and Migration of Human Hepatoma HepG2 Cells through Myosin Light Chains-2 (MLC2)/Focal Adhesion Kinase (FAK)/Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; RHO-KINASE; REGULATED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; FOCAL ADHESIONS; STRESS FIBERS; GROWTH-FACTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The key of cell migration process on solid substrates is phosphorylation of myosin light chain-2 (MLC2), which is implicated in a variety of intracellular functions. The previous data show that MLC2 interacts with a novel human gene, myofibrillogenesis regulator 1 (MR-1). Here, we reported that MR-1 was specially overexpressed in human hepatoma HepG2 cells. Transient treatment of cells with small interfering RNA (siRNA) against MR-1 or stable transfection of cells with plasmid expressing MR-1-siRNA led to inhibitions of cell proliferation, migration, and adhesion. Following down-regulation of MR-1, the phosphorylations of MLC2, focal adhesion kinase (FAK), and Akt were dramatically decreased, and the formation of stress fiber was destroyed by MR-1-siRNAs in hepatoma HepG2 cells. In addition, exogenous MR-1-induced as well as inherent phosphorylations of FAK and Akt were decreased by MLC kinase (MLCK) inhibitor, and F-actin polymerization inhibitor also decreased phosphorylations of FAK and Akt. Correspondingly, MR-1-enhanced migration of cells was also inhibited by these two inhibitors. These indicated that MLC2 activation and intact actin cytoskeleton were pivotal for MR-1 function. In vivo data showed that MR-1-siRNA markedly inhibited growth of human HepG2. This study suggested that overexpression of MR-1 was associated with cancer cell proliferation and migration through MLC2 and that MR-1 might be a potential cancer therapeutic target.	[Ren, Kaihuan; Jin, Haixia; He, Hongwei; Liu, Xia; Zhang, Shenghua; Wang, Yiguang; Shao, Rong-Guang] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing 100050, Peoples R China; [Bian, Chunjing] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Shao, RG (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, 1 Tiantan Xili, Beijing 100050, Peoples R China.	shaor@bbn.cn	jin, haixia/HGA-9179-2022; He, Hongwei/G-5759-2010	He, Hongwei/0000-0002-9159-091X	National Natural Science Foundation of China (NSFC) [30772583]; National 973 Program [2002CB513108]; Ministry of Education [20070023017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); Ministry of Education	This work was supported by National Natural Science Foundation of China (NSFC) Grant 30772583), National 973 Program Grant 2002CB513108, and Ministry of Education Grant 20070023017. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Acconcia F, 2006, CANCER RES, V66, P11030, DOI 10.1158/0008-5472.CAN-06-2676; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Hakuma N, 2005, CANCER RES, V65, P10776, DOI 10.1158/0008-5472.CAN-05-0060; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Ilic D, 1998, J CELL BIOL, V143, P547; ILLC D, 1995, NATURE, V377, P539; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Li TB, 2004, ACTA BIOCH BIOPH SIN, V36, P412, DOI 10.1093/abbs/36.6.412; Liu TG, 2004, CANCER GENE THER, V11, P748, DOI 10.1038/sj.cgt.7700753; Liu XH, 2006, AM J PHYSIOL-HEART C, V290, pH279, DOI 10.1152/ajpheart.00247.2005; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; Masuda T, 2005, CLIN CANCER RES, V11, P4012, DOI 10.1158/1078-0432.CCR-05-0087; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Roovers K, 2003, MOL CELL BIOL, V23, P4283, DOI 10.1128/MCB.23.12.4283-4294.2003; Roovers K, 2003, DEV CELL, V5, P273, DOI 10.1016/S1534-5807(03)00206-5; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vasiliev JM, 2004, INT J DEV BIOL, V48, P425, DOI 10.1387/ijdb.041806jv; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; WILSON AK, 1992, CANCER METAST REV, V11, P79, DOI 10.1007/BF00047605; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	50	39	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35598	35605		10.1074/jbc.M802253200	http://dx.doi.org/10.1074/jbc.M802253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948272	hybrid			2022-12-25	WOS:000261687900032
J	Jia, L; Berman, BP; Jariwala, U; Yan, XT; Cogan, JP; Walters, A; Chen, T; Buchanan, G; Frenkel, B; Coetzee, GA				Jia, Li; Berman, Benjamin P.; Jariwala, Unnati; Yan, Xiting; Cogan, Jon P.; Walters, Allison; Chen, Ting; Buchanan, Grant; Frenkel, Baruch; Coetzee, Gerhard A.			Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity	PLOS ONE			English	Article								Background: The androgen receptor (AR) is a steroid-activated transcription factor that binds at specific DNA locations and plays a key role in the etiology of prostate cancer. While numerous studies have identified a clear connection between AR binding and expression of target genes for a limited number of loci, high-throughput elucidation of these sites allows for a deeper understanding of the complexities of this process. Methodology/Principal Findings: We have mapped 189 AR occupied regions (ARORs) and 1,388 histone H3 acetylation (AcH3) loci to a 3% continuous stretch of human genomic DNA using chromatin immunoprecipitation (ChIP) microarray analysis. Of 62 highly reproducible ARORs, 32 (52%) were also marked by AcH3. While the number of ARORs detected in prostate cancer cells exceeded the number of nearby DHT-responsive genes, the AcH3 mark defined a subclass of ARORs much more highly associated with such genes - 12% of the genes flanking AcH3+ARORs were DHT-responsive, compared to only 1% of genes flanking AcH3-ARORs. Most ARORs contained enhancer activities as detected in luciferase reporter assays. Analysis of the AROR sequences, followed by site-directed ChIP, identified binding sites for AR transcriptional coregulators FoxA1, CEBP beta, NFI and GATA2, which had diverse effects on endogenous AR target gene expression levels in siRNA knockout experiments. Conclusions/Significance: We suggest that only some ARORs function under the given physiological conditions, utilizing diverse mechanisms. This diversity points to differential regulation of gene expression by the same transcription factor related to the chromatin structure.	[Jia, Li; Walters, Allison; Buchanan, Grant; Coetzee, Gerhard A.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Jia, Li; Coetzee, Gerhard A.] Univ So Calif, Dept Urol, Los Angeles, CA USA; [Jariwala, Unnati; Cogan, Jon P.; Frenkel, Baruch] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Frenkel, Baruch] Univ So Calif, Dept Orthoped Surg, Los Angeles, CA USA; [Jia, Li; Walters, Allison; Coetzee, Gerhard A.] Univ So Calif, Norris Canc Ctr, Los Angeles, CA USA; [Jariwala, Unnati; Cogan, Jon P.; Frenkel, Baruch] Univ So Calif, Inst Genet Med, Los Angeles, CA USA; [Yan, Xiting; Chen, Ting] Univ So Calif, Dept Biol Sci, Los Angeles, CA USA; [Berman, Benjamin P.] Univ So Calif, Keck Sch Med, Mol & Computat Biol Program, Epigenome Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Jia, L (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	frenkel@usc.edu; coetzee@usc.edu	BERMAN, BENJAMIN/AAT-3720-2021; Berman, Benjamin P/D-5942-2014; li, jia/GVT-7587-2022; Coetzee, Gerhard/AAG-8439-2019; Jia, li/GPW-8015-2022; coetzee, Gerhard/AAT-6203-2020	BERMAN, BENJAMIN/0000-0002-2099-9005; Berman, Benjamin P/0000-0002-2099-9005; Coetzee, Gerhard/0000-0001-8820-8364; Cogan, Jon/0000-0001-9327-8711	Department of Defense [W81XWH-05-1-0025, W81XWH-04-1-0823]; National Institutes of Health [CA109147, LM008991, PAR-02-021, DK071122, CA009142-26, T32CA009659]; NSF [0241102]; American Cancer Society [IRG - 58-007-48]; Prostate Cancer Foundation; Alfred P Sloan; National Health and Medical Research Council of Australia [CJ Martin Biomedical Fellowship]; NIH/NCI [P30CA014089-30]; NIH/NCRR [RR10600-01, CA62528-01, RR14514-01]; NATIONAL CANCER INSTITUTE [P30CA014089, T32CA009142, T32CA009659, C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK071122, R01DK071122] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Prostate Cancer Foundation; Alfred P Sloan(Alfred P. Sloan Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support From: W81XWH-05-1-0025 to BF and W81XWH-04-1-0823 to GAC from the Department of Defense. CA109147 to GAC, LM008991 to TC, PAR-02-021 to TC, DK071122 to BF, and CA009142-26 to BPB from the National Institutes of Health. NSF 0241102 to TC from the National Science Foundation, #IRG - 58-007-48 to LJ from an American Cancer Society Institutional Research Grant. Awards from the Prostate Cancer Foundation to GAC and Alfred P Sloan to TC. GB is a recipient of a National Health and Medical Research Council of Australia CJ Martin Biomedical Fellowship, and UJ is supported by NIH training grant T32CA009659. The experiments were conducted in facilities (i) supported by P30CA014089-30 from the NIH/NCI and (ii) constructed with support from Research Facilities Improvement Program Grant Number C06 (RR10600-01, CA62528-01, RR14514-01) from the NIH/NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cesena TI, 2007, MOL GENET METAB, V90, P126, DOI 10.1016/j.ymgme.2006.10.006; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2007, CANCER J, V13, P70, DOI 10.1097/PPO.0b013e31803c6e3b; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Gonzalez MI, 2002, MOL CELL ENDOCRINOL, V190, P39, DOI 10.1016/S0303-7207(02)00035-7; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hudson ME, 2006, BIOTECHNIQUES, V41, P673, DOI 10.2144/000112322; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; Jenster G, 1999, SEMIN ONCOL, V26, P407; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jia L, 2005, CANCER RES, V65, P8003, DOI 10.1158/0008-5472.CAN-04-3679; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Jia L, 2003, MOL CANCER RES, V1, P385; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MASSIE CE, 2007, NEW ANDROGEN RECEPTO; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; THALMANN GN, 1994, CANCER RES, V54, P2577; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yin H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-158; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009	52	122	123	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3645	10.1371/journal.pone.0003645	http://dx.doi.org/10.1371/journal.pone.0003645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997859	gold, Green Published, Green Submitted			2022-12-25	WOS:000265165500001
J	Kulkarni, H; Marconi, VC; Agan, BK; McArthur, C; Crawford, G; Clark, RA; Dolan, MJ; Ahuja, SK				Kulkarni, Hemant; Marconi, Vincent C.; Agan, Brian K.; McArthur, Carole; Crawford, George; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			Role of CCL3L1-CCR5 Genotypes in the Epidemic Spread of HIV-1 and Evaluation of Vaccine Efficacy	PLOS ONE			English	Article								Background: Polymorphisms in CCR5, the major coreceptor for HIV, and CCL3L1, a potent CCR5 ligand and HIV-suppressive chemokine, are determinants of HIV-AIDS susceptibility. Here, we mathematically modeled the potential impact of these genetic factors on the epidemic spread of HIV, as well as on its prevention. Methods and Results: Ro, the basic reproductive number, is a fundamental concept in explaining the emergence and persistence of epidemics. By modeling sexual transmission among HIV+/HIV- partner pairs, we find that Ro estimates, and concordantly, the temporal and spatial patterns of HIV outgrowth are highly dependent on the infecting partners' CCL3L1-CCR5 genotype. Ro was least and highest when the infected partner possessed protective and detrimental CCL3L1-CCR5 genotypes, respectively. The modeling data indicate that in populations such as Pygmies with a high CCL3L1 gene dose and protective CCR5 genotypes, the spread of HIV might be minimal. Additionally, Pc, the critical vaccination proportion, an estimate of the fraction of the population that must be vaccinated successfully to eradicate an epidemic was <1 only when the infected partner had a protective CCL3L1-CCR5 genotype. Since in practice Pc cannot be >1, to prevent epidemic spread, population groups defined by specific CCL3L1-CCR5 genotypes might require repeated vaccination, or as our models suggest, a vaccine with an efficacy of >70%. Further, failure to account for CCL3L1-CCR5-based genetic risk might confound estimates of vaccine efficacy. For example, in a modeled trial of 500 subjects, misallocation of CCL3L1-CCR5 genotype of only 25 (5%) subjects between placebo and vaccine arms results in a relative error of similar to 12% from the true vaccine efficacy. Conclusions: CCL3L1-CCR5 genotypes may impact on the dynamics of the HIV epidemic and, consequently, the observed heterogeneous global distribution of HIV infection. As Ro is lowest when the infecting partner has beneficial CCL3L1-CCR5 genotypes, we infer that therapeutic vaccines directed towards reducing the infectivity of the host may play a role in halting epidemic spread. Further, CCL3L1-CCR5 genotype may provide critical guidance for optimizing the design and evaluation of HIV-1 vaccine trials and prevention programs.	[Kulkarni, Hemant; Crawford, George; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA; [Marconi, Vincent C.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD USA; [Marconi, Vincent C.; Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Infect Dis Serv, Lackland AFB, TX USA; [Marconi, Vincent C.; Dolan, Matthew J.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [McArthur, Carole] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO USA; [Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr, Dept Med, Microbiol & Immunol & Biochem, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; San Antonio Military Medical Center; University of Missouri System; University of Missouri Kansas City; United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio	Kulkarni, H (corresponding author), S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA.	kulkarnih@uthscsa.edu; ahujas@uthscsa.edu	Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022; Clark, Robert/Q-6764-2019; Kulkarni, Hemant/AEM-5750-2022; Marconi, Vincent/AFK-5812-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Clark, Robert/0000-0002-4892-3619; Agan, Brian/0000-0002-5114-1669; McArthur, Carole/0000-0002-9286-8362	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System; MERIT [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine; HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System(US Department of Veterans Affairs); MERIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine; HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) and other awards (AI043279 and MH069270) from the NIH to S.K.A. S.K.A. is also supported by a VA MERIT award and is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the DoD HIV Natural History Study cohort and staff involved in this work was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting the views of the Departments of the Army, Navy, Air Force, or the Department of Defense.	Abu-Raddad LJ, 2007, JAIDS-J ACQ IMM DEF, V45, P454, DOI 10.1097/QAI.0b013e3180959a94; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; An P, 2000, AIDS, V14, P2117, DOI 10.1097/00002030-200009290-00007; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Andre FE, 2003, VACCINE, V21, P593, DOI 10.1016/S0264-410X(02)00702-8; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Aquaro S, 2001, J VIROL, V75, P4402, DOI 10.1128/JVI.75.9.4402-4406.2001; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blower S., 2003, AIDS Reviews, V5, P113; Blower SM, 2001, P NATL ACAD SCI USA, V98, P3618, DOI 10.1073/pnas.061029998; Buve A, 2002, IUBMB LIFE, V53, P193, DOI 10.1080/15216540212641; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Garber DA, 2004, LANCET INFECT DIS, V4, P397, DOI 10.1016/S1473-3099(04)01056-4; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hendrickson SL, 2008, JAIDS-J ACQ IMM DEF, V48, P263, DOI 10.1097/QAI.0b013e31816fdc5f; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Hutcheson HB, 2008, VACCINE, V26, P2951, DOI 10.1016/j.vaccine.2007.12.054; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; KINOSHITAMOLEKA R, 2007, LOW PREVALENCE HIV O, P1; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kulkarni H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003165; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; LUO M, 2007, CAHR C; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Mokili J, 2005, J NEUROVIROL, V11, P66, DOI 10.1080/13550280590923008; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; Mulanga C, 2004, AIDS, V18, P832, DOI 10.1097/00002030-200403260-00024; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; Ndembi N, 2003, AIDS RES HUM RETROV, V19, P435, DOI 10.1089/088922203765551773; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; *NIH, 2001, AIDS VACC TRIALS CON; Nolan D, 2004, AIDS, V18, P1231, DOI 10.1097/00002030-200406180-00001; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Pepin J, 2005, TROP MED INT HEALTH, V10, P627, DOI 10.1111/j.1365-3156.2005.01441.x; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rutjens E, 2003, FRONT BIOSCI-LANDMRK, V8, pD1134, DOI 10.2741/1125; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; SADAM M, 2008, CCL361 VAR GEN COP N; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Shalekoff S, 2008, JAIDS-J ACQ IMM DEF, V48, P245, DOI 10.1097/QAI.0b013e31816fdc77; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Struyf S, 2001, EUR J IMMUNOL, V31, P2170, DOI 10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D; Sullivan AD, 2001, P NATL ACAD SCI USA, V98, P10214, DOI 10.1073/pnas.181325198; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Valdez H, 1999, JAMA-J AM MED ASSOC, V282, P734, DOI 10.1001/jama.282.8.734; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927; Xin XM, 1999, FEBS LETT, V457, P219, DOI 10.1016/S0014-5793(99)01035-2; Zekeng L, 2001, PHILOS T ROY SOC B, V356, P799, DOI 10.1098/rstb.2001.0858; Zimet GD, 2000, INT J STD AIDS, V11, P143, DOI 10.1258/0956462001915570; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	96	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3671	10.1371/journal.pone.0003671	http://dx.doi.org/10.1371/journal.pone.0003671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989363	Green Submitted, Green Published, gold			2022-12-25	WOS:000265134600007
J	Saba, R; Goodman, CD; Huzarewich, RLCH; Robertson, C; Booth, SA				Saba, Reuben; Goodman, Chelsey D.; Huzarewich, Rhiannon L. C. H.; Robertson, Catherine; Booth, Stephanie A.			A miRNA Signature of Prion Induced Neurodegeneration	PLOS ONE			English	Article								MicroRNAs (miRNAs) are small, non-coding RNA molecules which are emerging as key regulators of numerous cellular processes. Compelling evidence links miRNAs to the control of neuronal development and differentiation, however, little is known about their role in neurodegeneration. We used microarrays and RT-PCR to profile miRNA expression changes in the brains of mice infected with mouse-adapted scrapie. We determined 15 miRNAs were de-regulated during the disease processes; miR-342-3p, miR-320, let-7b, miR-328, miR-128, miR-139-5p and miR-146a were over 2.5 fold up-regulated and miR-338-3p and miR-337-3p over 2.5 fold down-regulated. Only one of these miRNAs, miR-128, has previously been shown to be de-regulated in neurodegenerative disease. De-regulation of a unique subset of miRNAs suggests a conserved, disease-specific pattern of differentially expressed miRNAs is associated with prion-induced neurodegeneration. Computational analysis predicted numerous potential gene targets of these miRNAs, including 119 genes previously determined to be also de-regulated in mouse scrapie. We used a co-ordinated approach to integrate miRNA and mRNA profiling, bioinformatic predictions and biochemical validation to determine miRNA regulated processes and genes potentially involved in disease progression. In particular, a correlation between miRNA expression and putative gene targets involved in intracellular protein-degradation pathways and signaling pathways related to cell death, synapse function and neurogenesis was identified.	[Saba, Reuben; Goodman, Chelsey D.; Huzarewich, Rhiannon L. C. H.; Robertson, Catherine; Booth, Stephanie A.] Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada; [Saba, Reuben; Booth, Stephanie A.] Univ Manitoba, Fac Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3T 2N2, Canada	Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Manitoba	Saba, R (corresponding author), Publ Hlth Agcy Canada, Canadian Sci Ctr Human & Anim Hlth, Natl Microbiol Lab, Winnipeg, MB, Canada.	Stephanie_Booth@phac-aspc.gc.ca	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	PHAC; Canadian Biotechnology Strategy Fund	PHAC; Canadian Biotechnology Strategy Fund	PHAC. Canadian Biotechnology Strategy Fund: Genomics Initiative for Government Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; DOHURA K, 1995, MICROB PATHOGENESIS, V18, P1, DOI 10.1016/S0882-4010(05)80008-7; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Greenwood AD, 2005, J MOL BIOL, V349, P487, DOI 10.1016/j.jmb.2005.03.076; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HELLWEG R, 1994, LIFE SCI, V55, P2165, DOI 10.1016/0024-3205(94)00397-1; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; JEFFREY M, 1995, NEUROPATH APPL NEURO, V21, P41, DOI 10.1111/j.1365-2990.1995.tb01027.x; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KITAMOTO T, 1992, AM J PATHOL, V141, P271; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Martinez T, 2007, EUR J NEUROSCI, V26, P51, DOI 10.1111/j.1460-9568.2007.05646.x; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Saba Reuben, 2006, BMC Biotechnol, V6, P47, DOI 10.1186/1472-6750-6-47; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	57	198	203	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3652	10.1371/journal.pone.0003652	http://dx.doi.org/10.1371/journal.pone.0003652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987751	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134500002
J	Barnighausen, T; Wallrauch, C; Welte, A; McWalter, TA; Mbizana, N; Viljoen, J; Graham, N; Tanser, F; Puren, A; Newell, ML				Barnighausen, Till; Wallrauch, Claudia; Welte, Alex; McWalter, Thomas A.; Mbizana, Nhlanhla; Viljoen, Johannes; Graham, Natalie; Tanser, Frank; Puren, Adrian; Newell, Marie-Louise			HIV Incidence in Rural South Africa: Comparison of Estimates from Longitudinal Surveillance and Cross-Sectional cBED Assay Testing	PLOS ONE			English	Article								Background: The BED IgG-Capture Enzyme Immunoassay (cBED assay), a test of recent HIV infection, has been used to estimate HIV incidence in cross-sectional HIV surveys. However, there has been concern that the assay overestimates HIV incidence to an unknown extent because it falsely classifies some individuals with non-recent HIV infections as recently infected. We used data from a longitudinal HIV surveillance in rural South Africa to measure the fraction of people with non-recent HIV infection who are falsely classified as recently HIV-infected by the cBED assay (the long-term false-positive ratio (FPR)) and compared cBED assay-based HIV incidence estimates to longitudinally measured HIV incidence. Methodology/Principal Findings: We measured the long-term FPR in individuals with two positive HIV tests (in the HIV surveillance, 2003-2006) more than 306 days apart (sample size n = 1,065). We implemented four different formulae to calculate HIV incidence using cBED assay testing (n = 11,755) and obtained confidence intervals (CIs) by directly calculating the central 95(th) percentile of incidence values. We observed 4,869 individuals over 7,685 person-years for longitudinal HIV incidence estimation. The long-term FPR was 0.0169 (95% CI 0.0100-0.0266). Using this FPR, the cross-sectional cBED-based HIV incidence estimates (per 100 people per year) varied between 3.03 (95% CI 2.44-3.63) and 3.19 ( 95% CI 2.57-3.82), depending on the incidence formula. Using a long-term FPR of 0.0560 based on previous studies, HIV incidence estimates varied between 0.65 (95% CI 0.00-1.32) and 0.71 (95% CI 0.00-1.43). The longitudinally measured HIV incidence was 3.09 per 100 people per year (95% CI 2.69-3.52), after adjustment to the sex-age distribution of the sample used in cBED assay-based estimation. Conclusions/Significance: In a rural community in South Africa with high HIV prevalence, the long-term FPR of the cBED assay is substantially lower than previous estimates. The cBED assay performs well in HIV incidence estimation if the locally measured long-term FPR is used, but significantly underestimates incidence when a FPR estimate based on previous studies in other settings is used.	[Barnighausen, Till; Wallrauch, Claudia; Mbizana, Nhlanhla; Viljoen, Johannes; Graham, Natalie; Tanser, Frank; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Welte, Alex; McWalter, Thomas A.] Univ Witwatersrand, Sch Computat & Appl Math, ZA-2050 Wits, South Africa; [Welte, Alex] Univ Stellenbosch, DST NRF, SACEMA, ZA-7600 Stellenbosch, South Africa; [Puren, Adrian] Natl Inst Communicable Dis, Johannesburg, South Africa; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1E 6BT, England	University of Kwazulu Natal; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; National Institute for Communicable Diseases (NICD); University of London; University College London	Barnighausen, T (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	tbarnighausen@africacentre.ac.za	Tanser, Frank/ABE-8326-2021; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019; Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Newell, Marie-Louise/0000-0002-1074-7699; Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Tanser, Frank/0000-0001-9797-0000; McWalter, Thomas/0000-0002-2163-4112	Wellcome Trust [GR065377/Z/01/B, GR065377/Z/01/H]; Centers for Disease Control and Prevention (CDC) [5U62PS022901]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS022901] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by grants from the Wellcome Trust through grants to the Africa Centre for Health and Population Studies, University of KwaZulu-Natal, South Africa (GR065377/Z/01/B), and the Africa Centre's Demographic Surveillance Information System (GR065377/Z/01/H), which funds the population-based HIV surveillance. In addition, this publication was supported by Cooperative Agreement Number 5U62PS022901 from Centers for Disease Control and Prevention (CDC). Till Barnighausen and Frank Tanser were supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the any of the funding organizations. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript.	ANDERSON RN, 1998, NATL VITAL STAT REP, V47, P20; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; *CDC, 2007, US BED HIV 1 CAPT EI; Celentano DD, 2000, ARCH INTERN MED, V160, P535, DOI 10.1001/archinte.160.4.535; *DHS, 2008, ALL SURV COUNTR; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Gupta SB, 2007, AIDS RES HUM RETROV, V23, P1475, DOI 10.1089/aid.2006.0240; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; HERBST K, 2008, ADULT MORTALIT UNPUB; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Jiang Y, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000304696.62508.8a; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Loschen S, 2008, J CLIN MICROBIOL, V46, P341, DOI 10.1128/JCM.01055-07; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; MCWALTER TA, 2008, RELATING RECENT INFE; MCWALTER TA, 2008, ESTIMATION PROPORTIO; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Nesheim S, 2005, AIDS RES HUM RETROV, V21, P537, DOI 10.1089/aid.2005.21.537; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; SHISANA O, 2005, S AFRICAN NATL HIV P; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; UNAIDS Reference Group for Estimates MaP, 2005, STAT US BED ASS EST; WELTE A, 2008, AIDS RES HU IN PRESS; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840; Wolday D, 2007, J INTERN MED, V261, P132, DOI 10.1111/j.1365-2796.2006.01740.x; World Health Organisation, 2007, WHO CAS DEF HIV SURV	39	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3640	10.1371/journal.pone.0003640	http://dx.doi.org/10.1371/journal.pone.0003640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982059	Green Published, gold			2022-12-25	WOS:000265134300010
J	Teichmann, MDH; Wegner, FV; Fink, RHA; Chamberlain, JS; Launikonis, BS; Martinac, B; Friedrich, O				Teichmann, Martin D. H.; Wegner, Frederic V.; Fink, Rainer H. A.; Chamberlain, Jeffrey S.; Launikonis, Bradley S.; Martinac, Boris; Friedrich, Oliver			Inhibitory Control Over Ca2+ Sparks via Mechanosensitive Channels Is Disrupted in Dystrophin Deficient Muscle but Restored by Mini-Dystrophin Expression	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSVERSE TUBULAR SYSTEM; SKELETAL-MUSCLE; MDX MOUSE; CALCIUM INFLUX; GENE-THERAPY; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTORS; ANIMAL-MODELS; IN-SITU	Background: In dystrophic skeletal muscle, osmotic stimuli somehow relieve inhibitory control of dihydropyridine receptors (DHPR) on spontaneous sarcoplasmic reticulum elementary Ca2+ release events (ECRE) in high Ca2+ external environments. Such 'uncontrolled' Ca2+ sparks were suggested to act as dystrophic signals. They may be related to mechanosensitive pathways but the mechanisms are elusive. Also, it is not known whether truncated dystrophins can correct the dystrophic disinhibition. Methodology/Principal Findings: We recorded ECRE activity in single intact fibers from adult wt, mdx and mini-dystrophin expressing mice (MinD) under resting isotonic conditions and following hyper-/hypo-osmolar external shock using confocal microscopy and imaging techniques. Isotonic ECRE frequencies were small in wt and MinD fibers, but were markedly increased in mdx fibers. Osmotic challenge dramatically increased ECRE activity in mdx fibers. Sustained osmotic challenge induced marked exponential ECRE activity adaptation that was three times faster in mdx compared to wt and MinD fibers. Rising external Ca2+ concentrations amplified osmotic ECRE responses. The eliminated ECRE suppression in intact osmotically stressed mdx fibers was completely and reversibly resuscitated by streptomycine (200 mu M), spider peptide GsMTx-4 (5 mu M) and Gd3+ (20 mu M) that block unspecific, specific cationic and Ca2+ selective mechanosensitive channels (MsC), respectively. ECRE morphology was not substantially altered by membrane stress. During hyperosmotic challenge, membrane potentials were polarised and a putative depolarisation through aberrant MsC negligible excluding direct activation of ECRE through tubular depolarisation. Conclusions/Significance: Dystrophin suppresses spontaneous ECRE activity by control of mechanosensitive pathways which are suggested to interact with the inhibitory DHPR loop to the ryanodine receptor. MsC-related disinhibition prevails in dystrophic muscle and can be resuscitated by transgenic mini-dystrophin expression. Our results have important implications for the pathophysiology of DMD where abnormal MsC in dystrophic muscle confer disruption of microdomain Ca2+ homeostasis. MsC blockers should have considerable therapeutic potential if more muscle specific compounds can be found.	[Teichmann, Martin D. H.; Wegner, Frederic V.; Fink, Rainer H. A.; Friedrich, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany; [Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Launikonis, Bradley S.; Martinac, Boris; Friedrich, Oliver] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4067, Australia	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; University of Queensland	Teichmann, MDH (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Bergheimer Str 58, Heidelberg, Germany.	oliver.friedrich@physiologie.uni-heidelberg.de	Launikonis, Bradley/K-6256-2015; Martinac, Boris/A-7178-2018	Launikonis, Bradley/0000-0003-0700-4867; Martinac, Boris/0000-0001-8422-7082; Friedrich, Oliver/0000-0003-2238-2049; von Wegner, Frederic/0000-0002-6779-9959; Chamberlain, Jeffrey/0000-0001-5299-0059	Australian Research Council International Linkage Fellowship [LX0882427]; German National Merit Foundation	Australian Research Council International Linkage Fellowship(Australian Research Council); German National Merit Foundation	This study was partly supported by an Australian Research Council International Linkage Fellowship (LX0882427) to O.F. and a scholarship of the German National Merit Foundation to M.D.H.T. This study is part of a doctorate thesis (Dr.med.) of M.D.H.T.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Carlson CG, 2005, NEUROBIOL DIS, V20, P719, DOI 10.1016/j.nbd.2005.05.003; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2001, BRIT J PHARMACOL, V132, P1047, DOI 10.1038/sj.bjp.0703907; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; DiFranco M, 2005, J MEMBRANE BIOL, V208, P141, DOI 10.1007/s00232-005-0825-9; FINK RHA, 1990, J PHYSIOL-LONDON, V420, P337, DOI 10.1113/jphysiol.1990.sp017916; FRANCO A, 1991, BIOPHYS J, V59, P1164, DOI 10.1016/S0006-3495(91)82332-3; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; Fraser JA, 2006, J MUSCLE RES CELL M, V27, P591, DOI 10.1007/s10974-006-9091-4; Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002; Friedrich O, 2002, J MEMBRANE BIOL, V188, P11, DOI 10.1007/s00232-001-0168-0; FRIEDRICH O, 2004, J PHYSL, P251; Friedrich O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001762; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Haarmann CS, 2005, BIOCHEM J, V387, P429, DOI 10.1042/BJ20040786; Han RZ, 2006, CELL CALCIUM, V40, P299, DOI 10.1016/j.ceca.2006.04.016; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HUTTER OF, 1992, J INHERIT METAB DIS, V15, P565, DOI 10.1007/BF01799615; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Imbert N, 1996, NEUROMUSCULAR DISORD, V6, P351, DOI 10.1016/0960-8966(96)00351-3; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Khammari A, 1998, CAN J PHYSIOL PHARM, V76, P1161, DOI 10.1139/cjpp-76-12-1161; KIRSCH WG, 2001, J PHYSL, P379; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; LAMB GD, 1993, J PHYSIOL-LONDON, V464, P629, DOI 10.1113/jphysiol.1993.sp019655; Lansman JB, 2006, CLIN EXP PHARMACOL P, V33, P649, DOI 10.1111/j.1440-1681.2006.04393.x; Launikonis BS, 2000, J PHYSIOL-LONDON, V526, P299, DOI 10.1111/j.1469-7793.2000.00299.x; Launikonis BS, 2002, J PHYSIOL-LONDON, V538, P607, DOI 10.1113/jphysiol.2001.012920; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Maier F, 1999, MUSCLE NERVE, V22, P578, DOI 10.1002/(SICI)1097-4598(199905)22:5<578::AID-MUS5>3.3.CO;2-K; Mallouk N, 2002, BIOPHYS J, V82, P3012, DOI 10.1016/S0006-3495(02)75642-7; Marchand E, 2004, EXP CELL RES, V297, P363, DOI 10.1016/j.yexcr.2004.02.032; Marini J F, 1991, Neuromuscul Disord, V1, P397, DOI 10.1016/0960-8966(91)90003-B; Martin CA, 2003, J MUSCLE RES CELL M, V24, P407, DOI 10.1023/A:1027356410698; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Plant DR, 2003, AM J PHYSIOL-CELL PH, V285, pC522, DOI 10.1152/ajpcell.00369.2002; Sieber MA, 2008, J MAGN RESON IMAGING, V27, P955, DOI 10.1002/jmri.21368; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Von Wegner F, 2006, BIOPHYS J, V90, P2151, DOI 10.1529/biophysj.105.069930; Von Wegner F, 2007, IEEE T MED IMAGING, V26, P925, DOI 10.1109/TMI.2007.895471; Wang SQ, 2004, CIRC RES, V94, P1011, DOI 10.1161/01.RES.0000125883.68447.A1; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Whitehead NP, 2006, NEUROMUSCULAR DISORD, V16, P845, DOI 10.1016/j.nmd.2006.07.024; Woods CE, 2005, J PHYSIOL-LONDON, V568, P867, DOI 10.1113/jphysiol.2005.089318; WOODS CE, 2004, J PHYSL, P59; Yeung EW, 2003, J PHYSIOL-LONDON, V552, P449, DOI 10.1113/jphysiol.2003.047373; YEUNG EW, 2005, J PHYSL, P367; Zhou JS, 2006, AM J PHYSIOL-CELL PH, V290, pC539, DOI 10.1152/ajpcell.00592.2004; Zhou JS, 2005, J GEN PHYSIOL, V126, P301, DOI 10.1085/jgp.200509353	87	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3644	10.1371/journal.pone.0003644	http://dx.doi.org/10.1371/journal.pone.0003644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982068	gold, Green Submitted, Green Published			2022-12-25	WOS:000265134300013
J	Biswas, S; Russell, RJ; Jackson, CJ; Vidovic, M; Ganeshina, O; Oakeshott, JG; Claudianos, C				Biswas, Sunita; Russell, Robyn J.; Jackson, Colin J.; Vidovic, Maria; Ganeshina, Olga; Oakeshott, John G.; Claudianos, Charles			Bridging the Synaptic Gap: Neuroligins and Neurexin I in Apis mellifera	PLOS ONE			English	Article							CELL-ADHESION; MUSHROOM BODIES; HONEY-BEE; INHIBITORY SYNAPSES; ALPHA-NEUREXINS; CA2+ BINDING; PROTEIN; ACETYLCHOLINESTERASE; DOMAIN; BETA	Vertebrate studies show neuroligins and neurexins are binding partners in a trans-synaptic cell adhesion complex, implicated in human autism and mental retardation disorders. Here we report a genetic analysis of homologous proteins in the honey bee. As in humans, the honeybee has five large (31-246 kb, up to 12 exons each) neuroligin genes, three of which are tightly clustered. RNA analysis of the neuroligin-3 gene reveals five alternatively spliced transcripts, generated through alternative use of exons encoding the cholinesterase-like domain. Whereas vertebrates have three neurexins the bee has just one gene named neurexin I (400 kb, 28 exons). However alternative isoforms of bee neurexin I are generated by differential use of 12 splice sites, mostly located in regions encoding LNS subdomains. Some of the splice variants of bee neurexin I resemble the vertebrate alpha- and beta-neurexins, albeit in vertebrates these forms are generated by alternative promoters. Novel splicing variations in the 39 region generate transcripts encoding alternative trans-membrane and PDZ domains. Another 39 splicing variation predicts soluble neurexin I isoforms. Neurexin I and neuroligin expression was found in brain tissue, with expression present throughout development, and in most cases significantly up-regulated in adults. Transcripts of neurexin I and one neuroligin tested were abundant in mushroom bodies, a higher order processing centre in the bee brain. We show neuroligins and neurexins comprise a highly conserved molecular system with likely similar functional roles in insects as vertebrates, and with scope in the honeybee to generate substantial functional diversity through alternative splicing. Our study provides important prerequisite data for using the bee as a model for vertebrate synaptic development.	[Biswas, Sunita; Ganeshina, Olga; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Biswas, Sunita; Vidovic, Maria] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT, Australia; [Biswas, Sunita; Russell, Robyn J.; Jackson, Colin J.; Oakeshott, John G.; Claudianos, Charles] CSIRO Entomol, Canberra, ACT, Australia	University of Queensland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Biswas, S (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	c.claudianos@uq.edu.au	Russell, Robyn/C-5449-2008; Jackson, Colin J/C-1500-2008; Oakeshott, John G/B-5365-2009	Russell, Robyn/0000-0001-5600-3305; Jackson, Colin J/0000-0001-6150-3822; Oakeshott, John G/0000-0001-8324-7874; Claudianos, Charles/0000-0002-9799-9572	Australian National University [PhD Scholarship Award]	Australian National University(Australian National University)	Australian National University PhD Scholarship Award to Sunita Biswas	Andres C, 1997, P NATL ACAD SCI USA, V94, P8173, DOI 10.1073/pnas.94.15.8173; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dong HH, 2004, J NEUROSCI, V24, P8950, DOI 10.1523/JNEUROSCI.2106-04.2004; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gilbert M, 2001, GLIA, V34, P151, DOI 10.1002/glia.1050; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hata Y, 1996, J NEUROSCI, V16, P2488; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Kenyon F.C, 1896, AM NAT, V30, P643, DOI [10.1086/276450, DOI 10.1086/276450]; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon JY, 2004, GENOMICS, V83, P600, DOI 10.1016/j.ygeno.2003.10.008; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LIAO J, 1993, J NEUROCHEM, V61, P1127, DOI 10.1111/j.1471-4159.1993.tb03629.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; MOBBS PG, 1984, J INSECT PHYSIOL, V30, P43, DOI 10.1016/0022-1910(84)90107-0; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Mungenast AE, 2005, J NEUROENDOCRINOL, V17, P208, DOI 10.1111/j.1365-2826.2005.01293.x; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OBRO NF, 2008, CANC LETT, DOI DOI 10.1016/J.CAN6ET.2007.11.030; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rissone A, 2007, MOL BIOL EVOL, V24, P236, DOI 10.1093/molbev/msl147; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell RJ, 1996, INSECT BIOCHEM MOLEC, V26, P235, DOI 10.1016/0965-1748(95)00081-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Sambrook J, 2001, MOL CLONING LAB MANU; Sarmiento JM, 2004, J BIOL CHEM, V279, P47017, DOI 10.1074/jbc.M410011200; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; SUSSMAN JL, 1993, CHEM-BIOL INTERACT, V87, P187, DOI 10.1016/0009-2797(93)90042-W; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Tsigelny I, 2000, PROTEIN SCI, V9, P180; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vidovic M, 2007, DEV NEUROBIOL, V67, P233, DOI 10.1002/dneu.20341; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	112	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3542	10.1371/journal.pone.0003542	http://dx.doi.org/10.1371/journal.pone.0003542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974885	Green Published, gold			2022-12-25	WOS:000265131700001
J	Lazzari, V; Charles, C; Tafforeau, P; Vianey-Liaud, M; Aguilar, JP; Jaeger, JJ; Michaux, J; Viriot, L				Lazzari, Vincent; Charles, Cyril; Tafforeau, Paul; Vianey-Liaud, Monique; Aguilar, Jean-Pierre; Jaeger, Jean-Jacques; Michaux, Jacques; Viriot, Laurent			Mosaic Convergence of Rodent Dentitions	PLOS ONE			English	Article							MAMMALIAN TEETH; MUROID RODENTS; PHYLOGENY; MICROWEAR; MASTICATION; RAT	Background: Understanding mechanisms responsible for changes in tooth morphology in the course of evolution is an area of investigation common to both paleontology and developmental biology. Detailed analyses of molar tooth crown shape have shown frequent homoplasia in mammalian evolution, which requires accurate investigation of the evolutionary pathways provided by the fossil record. The necessity of preservation of an effective occlusion has been hypothesized to functionally constrain crown morphological changes and to also facilitate convergent evolution. The Muroidea superfamily constitutes a relevant model for the study of molar crown diversification because it encompasses one third of the extant mammalian biodiversity. Methodology/Principal Findings: Combined microwear and 3D-topographic analyses performed on fossil and extant muroid molars allow for a first quantification of the relationships between changes in crown morphology and functionality of occlusion. Based on an abundant fossil record and on a well resolved phylogeny, our results show that the most derived functional condition associates longitudinal chewing and non interlocking of cusps. This condition has been reached at least 7 times within muroids via two main types of evolutionary pathways each respecting functional continuity. In the first type, the flattening of tooth crown which induces the removal of cusp interlocking occurs before the rotation of the chewing movement. In the second type however, flattening is subsequent to rotation of the chewing movement which can be associated with certain changes in cusp morphology. Conclusion/Significance: The reverse orders of the changes involved in these different pathways reveal a mosaic evolution of mammalian dentition in which direction of chewing and crown shape seem to be partly decoupled. Either can change in respect to strong functional constraints affecting occlusion which thereby limit the number of the possible pathways. Because convergent pathways imply distinct ontogenetic trajectories, new Evo/Devo comparative studies on cusp morphogenesis are necessary.	[Lazzari, Vincent; Vianey-Liaud, Monique; Aguilar, Jean-Pierre] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, F-34095 Montpellier, France; [Lazzari, Vincent; Tafforeau, Paul] European Synchrotron Radiat Facil, BP220, Grenoble, France; [Charles, Cyril; Jaeger, Jean-Jacques] Univ Poitiers, CNRS, UMR 6046, Inst Int Paleoprimatol Paleontol Humaine, Evolut, Poitiers, France; [Michaux, Jacques] Univ Montpellier 2, CNRS, UMR 5554, Ecole Pratique Hautes Etudes Inst Sci Evolut, F-34095 Montpellier, France; [Viriot, Laurent] Univ Lyon 1, INRA, CNRS, UMR 5242, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Lazzari, V (corresponding author), Univ Bonn, Steinmann Inst, D-5300 Bonn, Germany.	lazzari@uni-bonn.de; Laurent.Viriot@univ-poitiers.fr	Charles, Cyril/E-7606-2011	Charles, Cyril/0000-0002-6930-039X; Tafforeau, Paul/0000-0002-5962-1683; Lazzari, Vincent/0000-0002-8210-2646; Viriot, Laurent/0000-0003-2092-588X	Institut des Sciences de l'Evolution of the Universite de Montpellier 2; Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers; European Synchrotron Radiation Facility; Ministere de la Recherche [PhD fellowships]; Alexander von Humboldt Foundation [research fellow]; QUENOTTES ANR project; NSF RHOI "Small Mammals" [BCS-0321893]	Institut des Sciences de l'Evolution of the Universite de Montpellier 2; Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers; European Synchrotron Radiation Facility; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); QUENOTTES ANR project(French National Research Agency (ANR)); NSF RHOI "Small Mammals"(National Science Foundation (NSF))	This study was supported by the Institut des Sciences de l'Evolution of the Universite de Montpellier 2 (MVL, JM, JPA, VL), the Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers (JJJ, LV), the European Synchrotron Radiation Facility (PT) and PhD fellowships of the Ministere de la Recherche (VL, CC). VL is a research fellow of Alexander von Humboldt Foundation. This is publication ISEM (UMR 5554 CNRS) n ISE-M2008-092. Scientific missions of CC and LV have been financially supported by the QUENOTTES ANR project and NSF RHOI "Small Mammals" (Award #BCS-0321893).	Butler PM., 1985, EVOLUTIONARY RELATIO, P381; Butler PM., 1980, PALAEOVERTEBRATA MEM, V9 Ext, P249; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Darviche D., 1978, THESIS U MONTPELLIER; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Feist M, 2005, AM J BOT, V92, P1152, DOI 10.3732/ajb.92.7.1152; Fejfar Oldrich, 1999, P365; HERSHKOVITZ P, 1962, EVOLUTION NEOTROPICA, P46; HIIEMAE KM, 1968, J ZOOL, V154, P139; HIKIDA T, 1980, Japanese Journal of Ecology, V30, P109; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jacobs Louis L., 2005, P63; Jaeger J. J., 1977, Palaeovertebrata, V8, P1; Janis C.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P367; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; JERNVALL J, 1999, PALEONTOLOGICA ELECT, V2; Kalin Daniel, 1999, P373; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; OFFERMANS M, 1990, J MORPHOL, V205, P353, DOI 10.1002/jmor.1052050310; Osborn, 1907, EVOLUTION MAMMALIAN, P48; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sese C., 1989, AM MUS NOVIT, V11, P185; SOLOUNIAS N, 1993, J ZOOL, V229, P421, DOI 10.1111/j.1469-7998.1993.tb02646.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TONG H, 1989, MEMOIRES SOC GEOLOGI, P155; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WEIJS WA, 1975, J MORPHOL, V145, P107, DOI 10.1002/jmor.1051450107; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197	40	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3607	10.1371/journal.pone.0003607	http://dx.doi.org/10.1371/journal.pone.0003607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974837	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131700023
J	Geier, F; Lohmann, JU; Gerstung, M; Maier, AT; Timmer, J; Fleck, C				Geier, Florian; Lohmann, Jan U.; Gerstung, Moritz; Maier, Annette T.; Timmer, Jens; Fleck, Christian			A Quantitative and Dynamic Model for Plant Stem Cell Regulation	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; ARABIDOPSIS SHOOT; WUSCHEL; CLV3; GROWTH; POPULATION; EXPRESSION; CYTOKININS; CLAVATA; GENES	Plants maintain pools of totipotent stem cells throughout their entire life. These stem cells are embedded within specialized tissues called meristems, which form the growing points of the organism. The shoot apical meristem of the reference plant Arabidopsis thaliana is subdivided into several distinct domains, which execute diverse biological functions, such as tissue organization, cell-proliferation and differentiation. The number of cells required for growth and organ formation changes over the course of a plants life, while the structure of the meristem remains remarkably constant. Thus, regulatory systems must be in place, which allow for an adaptation of cell proliferation within the shoot apical meristem, while maintaining the organization at the tissue level. To advance our understanding of this dynamic tissue behavior, we measured domain sizes as well as cell division rates of the shoot apical meristem under various environmental conditions, which cause adaptations in meristem size. Based on our results we developed a mathematical model to explain the observed changes by a cell pool size dependent regulation of cell proliferation and differentiation, which is able to correctly predict CLV3 and WUS over-expression phenotypes. While the model shows stem cell homeostasis under constant growth conditions, it predicts a variation in stem cell number under changing conditions. Consistent with our experimental data this behavior is correlated with variations in cell proliferation. Therefore, we investigate different signaling mechanisms, which could stabilize stem cell number despite variations in cell proliferation. Our results shed light onto the dynamic constraints of stem cell pool maintenance in the shoot apical meristem of Arabidopsis in different environmental conditions and developmental states.	[Geier, Florian; Gerstung, Moritz; Timmer, Jens; Fleck, Christian] Univ Freiburg, Dept Math & Phys, Freiburg, Germany; [Geier, Florian] Univ Freiburg, Dept Biol, D-7800 Freiburg, Germany; [Lohmann, Jan U.; Maier, Annette T.] Max Plank Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Lohmann, Jan U.] Heidelberg Univ, D-6900 Heidelberg, Germany; [Gerstung, Moritz] Swiss Fed Inst Technol, D BSSE, Dept Biosyst Sci & Engn, Basel, Switzerland; [Timmer, Jens] Freiburg Inst Advanced Studies, Freiburg, Germany; [Geier, Florian; Fleck, Christian] Ctr Biol Syst Analysis, Freiburg, Germany	University of Freiburg; University of Freiburg; Max Planck Society; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Geier, F (corresponding author), Univ Freiburg, Dept Math & Phys, Freiburg, Germany.	jlohmann@meristemania.org	Lohmann, Jan/T-3776-2019; Fleck, Christian/D-1620-2012	Lohmann, Jan/0000-0003-3667-187X; Fleck, Christian/0000-0002-6371-4495; Gerstung, Moritz/0000-0001-6709-963X	EU FP6 COSBICS [512060]; BMBF NGFN II [101 35 05 201]; Konrad Adenauer Foundation; EMBO; HFSP; Max Plack Society	EU FP6 COSBICS; BMBF NGFN II(Federal Ministry of Education & Research (BMBF)); Konrad Adenauer Foundation; EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Max Plack Society	This project was supported by EU FP6 COSBICS project (512060), by BMBF NGFN II 101 35 05 201 to FG, a Ph.D. fellowship of the Konrad Adenauer Foundation to ATM and funds from the EMBO Young Investigator Programme, a Career Development Award from HFSP and the Max Plack Society to JUL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brand U, 2001, BIOESSAYS, V23, P134, DOI 10.1002/1521-1878(200102)23:2&lt;134::AID-BIES1020&gt;3.0.CO;2-3; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Gross-Hardt R, 2003, J CELL SCI, V116, P1659, DOI 10.1242/jcs.00406; Heisler MG, 2007, CURR OPIN PLANT BIOL, V10, P92, DOI 10.1016/j.pbi.2006.11.005; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Reddy GV, 2007, NAT REV MOL CELL BIO, V8, P491, DOI 10.1038/nrm2188; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sharma VK, 2003, P NATL ACAD SCI USA, V100, P11823, DOI 10.1073/pnas.1834206100; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Veit B, 2006, PLANT MOL BIOL, V60, P793, DOI 10.1007/s11103-006-0033-8; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928	32	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3553	10.1371/journal.pone.0003553	http://dx.doi.org/10.1371/journal.pone.0003553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958283	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131100012
J	Ma, LJ; Walter, B; DeGuzman, A; Muller, HK; Walker, AM				Ma, Lisa J.; Walter, Barbara; DeGuzman, Ariel; Muller, H. Konrad; Walker, Ameae M.			Trans-Epithelial Immune Cell Transfer during Suckling Modulates Delayed-Type Hypersensitivity in Recipients as a Function of Gender	PLOS ONE			English	Article								Introduction: Breast feeding has long term effects on the developing immune system which outlive passive immunization of the neonate. We have investigated the transfer of milk immune cells and examined the result of transfer once the recipients were adult. Methods: Non-transgenic mouse pups were foster-nursed by green fluorescent protein (GFP) transgenic dams for 3 weeks and the fate of GFP+ cells was followed by FACS analysis, immunohistochemistry and RT-PCR for GFP and appropriate immune cell markers. Pups suckled by non-transgenic dams served as controls. Results: Despite a preponderance of B cells and macrophages in the stomach contents of the pups, most cells undergoing trans-epithelial migration derived from the 3-4% of milk cells positive for T lymphocyte markers. These cells homed to the spleen and thymus, with maximal accumulation at 3-4 weeks. By sensitizing dams with an antigen which elicits a T cell-mediated delayed-type-hypersensitivity (DTH) response, we determined that nursing by a sensitized dam (compared to a non-sensitized dam) amplified a subsequent DTH response in females and yet suppressed one in males. Discussion: These results suggest that clinical evaluation weighing the pros and cons of nursing male versus female children by mothers with genetically-linked hypersensitivity diseases, such as celiac disease and eczema, or those in regions of the world with endemic DTH-eliciting diseases, such as tuberculosis, may be warranted.	[Ma, Lisa J.; DeGuzman, Ariel; Walker, Ameae M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Walter, Barbara] Univ Calif Riverside, Inst Integrative Genome Biol, Riverside, CA USA; [Muller, H. Konrad] Univ Tasmania, Hobart, Tas 7001, Australia	University of California System; University of California Riverside; University of California System; University of California Riverside; University of Tasmania	Ma, LJ (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	ameae.walker@ucr.edu			California Breast Cancer Research Program [10PB-0127]; Cancer Federation; Frances Marlatt Baugh award	California Breast Cancer Research Program; Cancer Federation; Frances Marlatt Baugh award	This work was supported by California Breast Cancer Research Program grant 10PB-0127 and a grant from the Cancer Federation to AMW. L Ma was a recipient of the Frances Marlatt Baugh award during this period. The study sponsors played no role in study design or collection, analysis and interpretation of the data nor in the writing of the manuscript or decision to publish.	Agostoni Carlo, 2001, Nutrition and Health (Bicester), V15, P183; Arvola M, 2000, BIOL REPROD, V63, P1817, DOI 10.1095/biolreprod63.6.1817; BOASS A, 1963, AM J PHYSIOL, V204, P101, DOI 10.1152/ajplegacy.1963.204.1.101; CALLAGHAN JM, 1990, J CELL SCI, V95, P563; CAMPBELL DA, 1984, TRANSPLANTATION, V37, P340, DOI 10.1097/00007890-198404000-00004; CARLSTEN H, 1989, IMMUNOLOGY, V68, P209; Ellis LA, 1997, J NUTR, V127, pS985, DOI 10.1093/jn/127.5.985S; Goldman AS, 1996, J MAMMARY GLAND BIOL, V1, P251, DOI 10.1007/BF02018078; HEAD JR, 1977, TRANSPLANT P, V9, P1465; HUGHES A, 1988, IMMUNOLOGY, V64, P213; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Ma LJ, 2007, J ENDOCRINOL, V193, P291, DOI 10.1677/JOE-06-0024; MIDDLETON PA, 1984, CELL IMMUNOL, V88, P421, DOI 10.1016/0008-8749(84)90175-8; MIKKELSEN HB, 1988, CELL TISSUE RES, V252, P301; MILLER SC, 1981, J REPROD IMMUNOL, V3, P187, DOI 10.1016/0165-0378(81)90060-7; Oddy W H, 2001, Breastfeed Rev, V9, P11; Oddy Wendy H, 2002, Breastfeed Rev, V10, P5; PITT J, 1977, PEDIATR RES, V11, P906, DOI 10.1203/00006450-197708000-00011; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SCHLESINGER JJ, 1977, LANCET, V2, P529; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; SEELIG LL, 1981, TRANSPLANT P, V13, P1245; SHELDRAKE RF, 1985, RES VET SCI, V39, P10, DOI 10.1016/S0034-5288(18)31762-4; SILVERS WK, 1975, J IMMUNOL, V115, P1117; TATEMATSU M, 1975, CELL DIFFER DEV, V4, P285, DOI 10.1016/0045-6039(75)90013-5; Tuboly S, 2002, ADV EXP MED BIOL, V503, P107; TUBOLY S, 1995, ACTA VET HUNG, V43, P105; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x	32	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3562	10.1371/journal.pone.0003562	http://dx.doi.org/10.1371/journal.pone.0003562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958163	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131100019
J	Haskell-Luevano, C; Schaub, JW; Andreasen, A; Haskell, KR; Moore, MC; Koerper, LM; Rouzaud, F; Baker, HV; Millard, WJ; Walter, G; Litherland, SA; Xiang, ZM				Haskell-Luevano, Carrie; Schaub, Jay W.; Andreasen, Amy; Haskell, Kim R.; Moore, Marcus C.; Koerper, Lorraine M.; Rouzaud, Francois; Baker, Henry V.; Millard, William J.; Walter, Glenn; Litherland, S. A.; Xiang, Zhimin			Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse	FASEB JOURNAL			English	Article						energy homeostasis; leptin; insulin; alpha-melanocyte stimulating hormone	AGOUTI-RELATED PROTEIN; BODY-COMPOSITION ANALYSIS; FRAMESHIFT MUTATION; ARCUATE NUCLEUS; MORBID-OBESITY; FOOD-INTAKE; IN-VIVO; PROOPIOMELANOCORTIN NEURONS; MOLECULAR-CLONING; RAT HYPOTHALAMUS	Exercise is a mechanism for maintenance of body weight in humans. Morbidly obese human patients have been shown to possess single nucleotide polymorphisms in the melanocortin-4 receptor (MC4R). MC4R knockout mice have been well characterized as a genetic model that possesses phenotypic metabolic disorders, including obesity, hyperphagia, hyperinsulinemia, and hyperleptinemia, similar to those observed in humans possessing dysfunctional hMC4Rs. Using this model, we examined the effect of voluntary exercise of MC4R knockout mice that were allowed access to a running wheel for a duration of 8 wk. Physiological parameters that were measured included body weight, body composition of fat and lean mass, food consumption, body length, and blood levels of cholesterol and nonfasted glucose, insulin, and leptin. At the termination of the experiment, hypothalamic mRNA expression levels of neuropeptide Y (NPY), agouti-related protein (AGRP), proopiomelanocortin (POMC), cocaine-and amphetamine-regulated transcript (CART), orexin, brain-derived neurotropic factor (BDNF), phosphatase with tensin homology (Pten), melanocortin-3 receptor (MC3R), and NPY-Y1R were determined. In addition, islet cell distribution and function in the pancreas were examined. In the exercising MC4R knockout mice, the pancreatic islet cell morphology and other physiological parameters resembled those observed in the wild-type littermate controls. Gene expression profiles identified exercise as having a significant effect on hypothalamic POMC, orexin, and MC3R levels. Genotype had a significant effect on AGRP, POMC, CART, and NPY-Y1R, with an exercise and genotype interaction effect on NPY gene expression. These data support the hypothesis that voluntary exercise can prevent the genetic predisposition of melanocortin-4 receptor-associated obesity and diabetes.-Haskell-Luevano, C., Schaub, J. W., Andreasen, A., Haskell, K. R., Moore, M. C., Koerper, L. M., Rouzaud, F., Baker, H. V., Millard, W. J., Walter, G., Litherland, S. A., Xiang, Z. Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse. FASEB J. 23, 642-655 (2009)	[Haskell-Luevano, Carrie; Schaub, Jay W.; Andreasen, Amy; Haskell, Kim R.; Moore, Marcus C.; Koerper, Lorraine M.; Rouzaud, Francois; Millard, William J.; Xiang, Zhimin] Univ Florida, Dept Pharmacodynam, Coll Pharm, Gainesville, FL 32610 USA; [Baker, Henry V.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Walter, Glenn] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Litherland, S. A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Haskell-Luevano, C (corresponding author), Univ Florida, Dept Pharmacodynam, Coll Pharm, POB 100487, Gainesville, FL 32610 USA.	carrie@cop.ufl.edu		Baker, Henry/0000-0002-8273-5320	American Diabetes Association Research Award; National Institutes of Health [RO1DK057080]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057080] Funding Source: NIH RePORTER	American Diabetes Association Research Award(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Diabetes Association Research Award and National Institutes of Health grant RO1DK057080 (C. H. L.). We thank Dr. Dennis Huszar and Millennium Pharmaceuticals (Cambridge, MA, USA) for providing the MC4RKO mice. We thank Dr. Maureen Keller-Wood, Dr. Charles Wood, and Dr. Hendrik Luesch for the expert technical assistance and discussions regarding the RT-PCR experiments, Dr. Maureen Keller-Wood for assistance with the statistical analysis, and Dr. Martha Campbell-Thompson and the Pathology Molecular Core for help with pancreatic islet cell staining and quantitation.	BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Bagnol D, 1999, J NEUROSCI, V19; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828; Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; CARPENTER KJ, 1958, AM J PHYSIOL, V193, P499, DOI 10.1152/ajplegacy.1958.193.3.499; Che FY, 2005, J BIOL CHEM, V280, P4451, DOI 10.1074/jbc.M411178200; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Chiu S, 2004, OBES RES, V12, P1243, DOI 10.1038/oby.2004.158; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Coutinho AE, 2006, PHYSIOL BEHAV, V87, P360, DOI 10.1016/j.physbeh.2005.10.006; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Daniels D, 2003, BRAIN RES, V986, P1, DOI 10.1016/S0006-8993(03)03162-7; De Souza J, 2000, NEUROENDOCRINOLOGY, V72, P126, DOI 10.1159/000054579; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Dubern B, 2001, J PEDIATR-US, V139, P204, DOI 10.1067/mpd.2001.116284; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Garris DR, 2004, PATHOBIOLOGY, V71, P231, DOI 10.1159/000080056; GOODRICK CL, 1978, PHYSIOL BEHAV, V21, P345, DOI 10.1016/0031-9384(78)90093-8; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Grill HJ, 1998, J NEUROSCI, V18, P10128; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; HAGAN MM, 2000, AM J PHYSIOL-REG I, V52, P83; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Haskell-Luevano C, 2001, REGUL PEPTIDES, V99, P1, DOI 10.1016/S0167-0115(01)00234-8; Hinney A, 2000, EUR J PHARMACOL, V410, P147, DOI 10.1016/S0014-2999(00)00812-8; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Irani BG, 2005, BIOCHEM BIOPH RES CO, V326, P638, DOI 10.1016/j.bbrc.2004.11.084; Jegou S, 2000, J NEUROENDOCRINOL, V12, P501, DOI 10.1046/j.1365-2826.2000.00477.x; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; KONDA Y, 1994, J BIOL CHEM, V269, P13162; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Krude H, 2000, TRENDS ENDOCRIN MET, V11, P15, DOI 10.1016/S1043-2760(99)00213-1; Levin BE, 2006, INT J OBESITY, V30, P722, DOI 10.1038/sj.ijo.0803192; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Marsh DJ, 1999, BRAIN RES, V848, P66, DOI 10.1016/S0006-8993(99)01962-9; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Mergen M, 2001, J CLIN ENDOCR METAB, V86, P3448, DOI 10.1210/jc.86.7.3448; Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Narath E, 2001, EXP GERONTOL, V36, P1699, DOI 10.1016/S0531-5565(01)00145-0; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Patterson CM, 2008, AM J PHYSIOL-REG I, V294, pR290, DOI 10.1152/ajpregu.00661.2007; Proneth B, 2006, CHEM BIOL DRUG DES, V67, P215, DOI 10.1111/j.1747-0285.2006.00362.x; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Sina M, 1999, AM J HUM GENET, V65, P1501, DOI 10.1086/302660; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vink T, 2001, MOL PSYCHIATR, V6, P325, DOI 10.1038/sj.mp.4000854; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yuan Q, 2004, OBES RES, V12, P1179, DOI 10.1038/oby.2004.147	85	48	55	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					642	655		10.1096/fj.08-109686	http://dx.doi.org/10.1096/fj.08-109686			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18971258	Green Published			2022-12-25	WOS:000262892900035
J	Guigon, CJ; Zhao, L; Willingham, MC; Cheng, SY				Guigon, C. J.; Zhao, L.; Willingham, M. C.; Cheng, S-Y			PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer	ONCOGENE			English	Article						thyroid cancer; Pten; carcinogenesis; mouse model; mutations	PROTEIN-KINASE-B; COWDEN-DISEASE; GERMLINE MUTATIONS; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTION FACTORS; SUPPRESSOR GENE; LIGAND-BINDING; BETA-RECEPTOR; HORMONE; RESISTANCE	Inactivation and silencing of PTEN have been observed in multiple cancers, including follicular thyroid carcinoma. PTEN (phosphatase and tensin homologue deleted from chromosome 10) functions as a tumour suppressor by opposing the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signalling pathway. Despite correlative data, how deregulated PTEN signalling leads to thyroid carcinogenesis is not known. Mice harbouring a dominant-negative mutant thyroid hormone receptor beta (TR beta(PV/PV) mice) spontaneously develop follicular thyroid carcinoma and distant metastases similar to human cancer. To elucidate the role of PTEN in thyroid carcinogenesis, we generated TR beta(PV/PV) mice haploinsufficient for Pten (TR beta(PV/PV)Pten(+/-) mouse). PTEN deficiency accelerated the progression of thyroid tumour and increased the occurrence of metastasis spread to the lung in TR beta(PV/PV)Pten(+/-) mice, thereby significantly reducing their survival as compared with TR beta(PV/PV)Pten(+/+) mice. AKT activation was further increased by two-fold in TR beta(PV/PV)Pten(+/-) mice thyroids, leading to increased activity of the downstream mammalian target of rapamycin (mTOR)-p70S6K signalling and decreased activity of the forkhead family member FOXO3a. Consistently, cyclin D1 expression was increased. Apoptosis was decreased as indicated by increased expression of nuclear factor-kappa B (NF-kappa B) and decreased caspase-3 activity in the thyroids of TR beta(PV/PV)Pten(+/-) mice. Our results indicate that PTEN deficiency resulted in increased cell proliferation and survival in the thyroids of TR beta(PV/PV)Pten(+/-) mice. Altogether, our study provides direct evidence to indicate that in vivo, PTEN is a critical regulator in the follicular thyroid cancer progression and invasiveness.	[Cheng, S-Y] NCI, Gene Regulat Sect, Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Willingham, M. C.] Wake Forest Univ, Dept Pathol, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University	Cheng, SY (corresponding author), NCI, Gene Regulat Sect, Mol Biol Lab, Ctr Canc Res, 37 Convent Dr,Room 5128, Bethesda, MD 20892 USA.	chengs@mail.nih.gov	guigon, celine/L-3518-2017	guigon, celine/0000-0002-4489-4304	Center for Cancer Research; National Cancer Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011191, ZIABC008752] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	;We thank Dr Hao Ying for assistance in the determination of thyroid function tests. This research was supported by the Intramural Research Program of Center for Cancer Research, National Cancer Institute, National Institutes of Health.	ABDELLATIF MM, 2008, J SURG RES IN PRESS; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 2002, ANN NY ACAD SCI, V968, P213, DOI 10.1111/j.1749-6632.2002.tb04337.x; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kato Y, 2006, ONCOGENE, V25, P2736, DOI 10.1038/sj.onc.1209299; Kim CS, 2005, ENDOCRINOLOGY, V146, P4456, DOI 10.1210/en.2005-0172; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001237; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MEIER CA, 1992, MOL ENDOCRINOL, V6, P248, DOI 10.1210/me.6.2.248; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rivas M, 2003, MOL CELL ENDOCRINOL, V213, P31, DOI 10.1016/j.mce.2003.10.029; Schlumberger M, 1998, PRESSE MED, V27, P1479; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shepherd PR, 1997, DIABETOLOGIA, V40, P1172, DOI 10.1007/s001250050803; Sherman SI, 1998, CANCER-AM CANCER SOC, V83, P1012; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Uppal S, 2007, INT J CLIN PRACT, V61, P645, DOI 10.1111/j.1742-1241.2006.00896.x; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Yeager N, 2007, CANCER RES, V67, P959, DOI 10.1158/0008-5472.CAN-06-3524; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; Ying H, 2003, CARCINOGENESIS, V24, P1467, DOI 10.1093/carcin/bgg111	37	73	74	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					509	517		10.1038/onc.2008.407	http://dx.doi.org/10.1038/onc.2008.407			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997818	Green Accepted			2022-12-25	WOS:000262866500005
J	Wen, J; Li, R; Lu, Y; Shupnik, MA				Wen, J.; Li, R.; Lu, Y.; Shupnik, M. A.			Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions	ONCOGENE			English	Article						tamoxifen resistance; BRCA1; ER alpha; coactivators; corepressors	HORMONE-BETA-PROMOTER; RNA-POLYMERASE-II; PROGESTERONE-RECEPTOR; IN-VIVO; ANTIESTROGEN RESISTANCE; SIGNALING PATHWAYS; TISSUE-SPECIFICITY; CYCLE PROGRESSION; UBIQUITIN LIGASE; RESPONSE ELEMENT	The breast cancer susceptibility gene 1 (BRCA1) is mutated in approximately 50% of hereditary breast cancers, and its expression is decreased in 30-40% of sporadic breast cancers, suggesting a general role in breast cancer development. BRCA1 physically and functionally interacts with estrogen receptor-alpha (ER alpha) and several transcriptional regulators. We investigated the relationship between cellular BRCA1 levels and tamoxifen sensitivity. Decreasing BRCA1 expression in breast cancer cells by small interfering RNA alleviated tamoxifen-mediated growth inhibition and abolished tamoxifen suppression of several endogenous ER-targeted genes. ER-stimulated transcription and cytoplasmic signaling was increased without detectable changes in ER or ER coregulator expression. Co-immunoprecipitation studies showed that with BRCA1 knockdown, tamoxifen-bound ER alpha was inappropriately associated with coactivators, and not effectively with corepressors. Chromatin immuno-precipitation studies demonstrated that with tamoxifen, BRCA1 knockdown did not change ER alpha promoter occupancy, but resulted in increased coactivator and decreased corepressor recruitment onto the endogenous cyclin D1 promoter. Our results suggest that decreased BRCA1 levels modify ER alpha-mediated transcription and regulation of cell proliferation in part by altering ER alpha-coregulator association. In the presence of tamoxifen, decreased BRCA1 expression results in increased coactivator and decreased corepressor recruitment on ER-regulated gene promoters.	[Wen, J.; Shupnik, M. A.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Li, R.; Lu, Y.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA; [Shupnik, M. A.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA	University of Virginia; University of Texas System; University of Texas Health San Antonio; University of Virginia	Shupnik, MA (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Jefferson Pk Ave,POB 800578, Charlottesville, VA 22908 USA.	mas3x@virginia.edu		Lu, Yunzhe/0000-0001-7542-6848	National Institutes of Health [DK57082, CA93506]; University of Virginia Cancer Center [P30-CA44579]; Women's Oncology Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA093506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064604, R01DK057082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Cancer Center; Women's Oncology Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Sarah E Aiyar for technical advice and Dr Sarah Parsons for HER2 antibodies. The authors acknowledge support of the National Institutes of Health (DK57082 to MA Shupnik and CA93506 to R Li), the University of Virginia Cancer Center (P30-CA44579) and Women's Oncology Fund (MA Shupnik).	Basu A, 2005, FRONT BIOSCI-LANDMRK, V10, P2346, DOI 10.2741/1703; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Bissonauth V, 2008, CANCER DETECT PREV, V32, P52, DOI 10.1016/j.cdp.2008.01.005; Chen YM, 1996, CANCER RES, V56, P3168; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Curtin D, 2004, MOL ENDOCRINOL, V18, P1263, DOI 10.1210/me.2003-0221; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; DUBIK D, 1992, ONCOGENE, V7, P1587; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fan SJ, 2002, CANCER RES, V62, P141; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Fink M, 2006, STRAHLENTHER ONKOL, V182, P53; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Girault I, 2003, CLIN CANCER RES, V9, P1259; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Graham JD, 1995, J BIOL CHEM, V270, P30693, DOI 10.1074/jbc.270.51.30693; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Horner-Glister E, 2005, J MOL ENDOCRINOL, V35, P421, DOI 10.1677/jme.1.01784; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; Jones LP, 2005, ONCOGENE, V24, P3554, DOI 10.1038/sj.onc.1208426; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Lin VY, 2003, J BIOL CHEM, V278, P38125, DOI 10.1074/jbc.M303882200; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Ma YX, 2007, MOL ENDOCRINOL, V21, P1905, DOI 10.1210/me.2006-0397; Ma YX, 2005, ONCOGENE, V24, P1831, DOI 10.1038/sj.onc.1208190; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Murphy L, 2004, CLIN CANCER RES, V10, P1354, DOI 10.1158/1078-0432.CCR-03-0112; Murphy LC, 2000, CANCER RES, V60, P6266; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Razandi M, 2004, MOL CELL BIOL, V24, P5900, DOI 10.1128/MCB.24.13.5900-5913.2004; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Schreihofer DA, 2001, ENDOCRINOLOGY, V142, P3361, DOI 10.1210/en.142.8.3361; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Srinivas G, 2004, MOL CARCINOGEN, V39, P15, DOI 10.1002/mc.10164; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Thasni KA, 2008, ANN ONCOL, V19, P696, DOI 10.1093/annonc/mdm557; Tsai HW, 2004, ENDOCRINOLOGY, V145, P2730, DOI 10.1210/en.2003-1470; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu JW, 2005, ENDOCRINOLOGY, V146, P2031, DOI 10.1210/en.2004-0409; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	56	40	40	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					575	586		10.1038/onc.2008.405	http://dx.doi.org/10.1038/onc.2008.405			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997820	Green Accepted			2022-12-25	WOS:000262866500011
J	Nicklay, JJ; Shechter, D; Chitta, RK; Garcia, BA; Shabanowitz, J; Allis, CD; Hunt, DF				Nicklay, Joshua J.; Shechter, David; Chitta, Raghu K.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Allis, C. David; Hunt, Donald F.			Analysis of Histones in Xenopus laevis II. MASS SPECTROMETRY REVEALS AN INDEX OF CELL TYPE-SPECIFIC MODIFICATIONS ON H3 AND H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; POSTTRANSLATIONAL MODIFICATIONS; COMBINATORIAL MODIFICATION; CHROMATIN MODIFICATIONS; SEQUENCE-ANALYSIS; ACETYLATION; METHYLATION; BINDING; PHOSPHORYLATION; TETRAHYMENA	Epigenetic information is hypothesized to be encoded in histone variants and post-translational modifications. Varied cell-and locus-specific combinations of these epigenetic marks are likely contributors to regulation of chromatin-templated transactions, including transcription, replication, recombination, and repair. Therefore, the relative abundance of histone modifications in a given cell type is a potential index of cell fate and specificity. Here, we utilize mass spectrometry techniques to characterize the relative abundance index of cell type-specific modifications on histones H3 and H4 in distinct cell types from the frog Xenopus laevis, including the sperm, the stored predeposition histones in the egg, the early embryo equivalent pronuclei, cultured somatic cells, and erythrocytes. We used collisionally associated dissociation to identify the modifications present on histone H3 in a variety of cell types, resolving 26 distinctly modified H3 peptides. We employed the electron transfer dissociation fragmentation technique in a "middle-down" approach on the H4 N-terminal tail to explore the overlap of post-translational modifications. We observed 66 discrete isoforms of the H4 1-23 fragment in four different cell types. Isolation of the stored, predeposition histone H4 from the frog egg also revealed a more varied pattern of modifications than the previously known diacetylation on Lys(5) and Lys(12). The developmental transitions of modifications on H3 and H4 were strikingly varied, implying a strong correlation of the histone code with cell type and fate. Our results are consistent with a histone code index for each cell type and uncover potential cross-talk between modifications on a single tail.	[Nicklay, Joshua J.; Chitta, Raghu K.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA; [Shechter, David; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA	University of Virginia; University of Virginia; Rockefeller University	Hunt, DF (corresponding author), McCormick Rd, Charlottesville, VA 22901 USA.	dfh@virgina.edu	Shechter, David/B-4660-2008; Hunt, Donald F/I-6936-2012	Shechter, David/0000-0001-9388-6004; Hunt, Donald F/0000-0003-2815-6368	National Institutes of Health [GM075486, GM37537, GM53512]; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R01GM037537, F32GM075486, R37GM053512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Research Service Award/Kirschstein Fellowship GM075486 (to D. S.), Grant GM37537 (to D. F. H.), and Grant GM53512 (to C. D. A.). This work was also supported by Rockefeller University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Mackay CL, 2008, ANAL CHEM, V80, P4147, DOI 10.1021/ac702452d; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schmitt A, 2002, FEBS LETT, V518, P23, DOI 10.1016/S0014-5793(02)02630-3; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	40	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1075	1085		10.1074/jbc.M807274200	http://dx.doi.org/10.1074/jbc.M807274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957437	Green Published, hybrid			2022-12-25	WOS:000262122900044
J	Bruland, N; Wubbeler, JH; Steinbuchel, A				Bruland, Nadine; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander			3-Mercaptopropionate Dioxygenase, a Cysteine Dioxygenase Homologue, Catalyzes the Initial Step of 3-Mercaptopropionate Catabolism in the 3,3-Thiodipropionic Acid-degrading Bacterium Variovorax paradoxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANOSULFUR COMPOUNDS; IDENTIFICATION; DEGRADATION; CYSTEAMINE; THIOLS; DIMETHYLSULFONIOPROPIONATE; DESULFURIZATION; MECHANISM; PROTEIN	The thioether 3,3-thiodipropionic acid can be used as precursor substrate for biotechnological synthesis of 3-mercaptopropionic acid-containing polythioesters. Therefore, the hitherto unknown catabolism of this compound was elucidated to engineer novel and improved polythioester biosynthesis pathways in the future. Bacteria capable of using 3,3-thiodipropionic acid as the sole source of carbon and energy for growth were enriched from the environment. From eleven isolates, TBEA3, TBEA6, and SFWT were morphologically and physiologically characterized. Their 16 S rDNAs and other features affiliated these isolates to the beta-subgroup of the proteobacteria. Tn5::mob mutagenesis of isolate Variovorax paradoxus TBEA6 yielded ten mutants fully or partially impaired in growth on 3,3-thiodipropionic acid. Genotypic characterization of two 3,3-thiodipropionic acid-negative mutants demonstrated the involvement of a bacterial cysteine dioxygenase (EC 1.13.11.22) homologue in the further catabolism of the 3,3-thiodipropionic acid cleavage product 3-mercaptopropionic acid. Detection of 3-sulfinopropionate in the supernatant of one of these mutants during cultivation on 3,3-thiodipropionic acid as well as in vivo and in vitro enzyme assays using purified protein demonstrated oxygenation of 3-mercaptopropionic acid to 3-sulfinopropionate by this enzyme; cysteine and cysteamine were not used as substrate. Beside cysteine dioxygenase and cysteamine dioxygenase, this 3-mercaptopropionic acid dioxygenase is the third example for a thiol dioxygenase and the first report about the microbial catabolism of 3-mercaptopropionic acid. Insertion of Tn5:: mob in a gene putatively coding for a family III acyl-CoA-transferase resulted in the accumulation of 3-sulfinopropionate during cultivation on 3,3-thiodipropionic acid, indicating that this compound is further metabolized to 3-sulfinopropionyl-CoA and subsequently to propionyl-CoA.	[Bruland, Nadine; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander] Univ Munster, Inst Mol Mikrobiol & Biotechnol, D-48149 Munster, Germany	University of Munster	Steinbuchel, A (corresponding author), Univ Munster, Inst Mol Mikrobiol & Biotechnol, Corrensstr 3, D-48149 Munster, Germany.	steinbu@uni-muenster.de						Aboulmagd E, 2000, ARCH MICROBIOL, V174, P297, DOI 10.1007/s002030000206; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; APPELL RB, 1995, SYNTHETIC COMMUN, V25, P3589, DOI 10.1080/00397919508015494; CAVALLINI D, 1966, J BIOL CHEM, V241, P3189; CAVALLINI D, 1975, FEBS LETT, V56, P348, DOI 10.1016/0014-5793(75)81124-0; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; Chai SC, 2006, J BIOL CHEM, V281, P15774, DOI 10.1074/jbc.M601269200; DEVEREUX R, 1995, MOL MICROBIAL ECOLOG, P509; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Elbanna K, 2003, INT J SYST EVOL MICR, V53, P1165, DOI 10.1099/ijs.0.02562-0; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; Greene EA, 2000, ARCH MICROBIOL, V174, P111, DOI 10.1007/s002030000184; JOLLESBE.B, 1974, EUR J BIOCHEM, V42, P349, DOI 10.1111/j.1432-1033.1974.tb03346.x; Kamagata Y, 1997, APPL ENVIRON MICROB, V63, P2266, DOI 10.1128/AEM.63.6.2266-2272.1997; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P156, DOI 10.1128/AEM.56.1.156-161.1990; KIENE RP, 1988, APPL ENVIRON MICROB, V54, P2208, DOI 10.1128/AEM.54.9.2208-2212.1988; KIENE RP, 1988, NATURE, V332, P148, DOI 10.1038/332148a0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li FL, 2005, APPL ENVIRON MICROB, V71, P276, DOI 10.1128/AEM.71.1.276-281.2005; Liu SJ, 2000, APPL ENVIRON MICROB, V66, P739, DOI 10.1128/AEM.66.2.739-743.2000; Lutke-Eversloh T, 2003, FEMS MICROBIOL LETT, V221, P191, DOI 10.1016/S0378-1097(03)00185-X; Lutke-Eversloh T, 2001, MICROBIOL-UK, V147, P11; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; MCFALL E, 1996, ESCHERICHIA COLI SAL, P358; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mishra RN, 2002, BIOTECHNIQUES, V33, P830, DOI 10.2144/02334st07; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishino SF, 2006, APPL ENVIRON MICROB, V72, P1040, DOI 10.1128/AEM.72.2.1040-1044.2006; OELMULLER U, 1990, J MICROBIOL METH, V11, P73, DOI 10.1016/0167-7012(90)90050-G; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; REYNOLDS RC, 1974, TOXICOL APPL PHARM, V28, P133, DOI 10.1016/0041-008X(74)90138-0; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Schmalenberger A, 2007, ENVIRON MICROBIOL, V9, P535, DOI 10.1111/j.1462-2920.2006.01172.x; SCOTT G, 1968, CHEM COMMUN, P1572, DOI 10.1039/c19680001572; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; VAIRAVAMURTHY A, 1987, NATURE, V329, P623, DOI 10.1038/329623a0; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; Weber N, 2006, J AGR FOOD CHEM, V54, P2957, DOI 10.1021/jf0530502; Willems A, 2005, BERGEYS MANUALR SYST, P732; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	53	60	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					660	672		10.1074/jbc.M806762200	http://dx.doi.org/10.1074/jbc.M806762200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001372	hybrid			2022-12-25	WOS:000261974800071
J	Kaur, AP; Lansky, IB; Wilks, A				Kaur, Ajinder P.; Lansky, Ila B.; Wilks, Angela			The Role of the Cytoplasmic Heme-binding Protein (PhuS) of Pseudomonas aeruginosa in Intracellular Heme Trafficking and Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; SIGNAL-TRANSDUCTION SYSTEM; GENE-REGULATION; OPPORTUNISTIC PATHOGEN; EXPRESSION ANALYSIS; PYOCYANIN; IDENTIFICATION; ACQUISITION; BIOSYNTHESIS; OXYGENASE	The cytoplasmic heme-binding protein PhuS, encoded within the Fur-regulated Pseudomonas heme utilization (phu) operon, has previously been shown to traffic heme to the iron-regulated heme oxygenase (HO). We further investigate the role of PhuS in heme trafficking to HO on disruption of the phuS and hemO genes in a Pseudomonas aeruginosa siderophore-deficient and wild-type background. Previous studies have shown that deletion of hemO prevents the cells from utilizing heme as the sole source of iron. However, disruption of phuS alone resulted in a slow growth phenotype, consistent with its role as a heme-trafficking protein to HO. Furthermore, in contrast to the hemO and hemO/phuS deletion strains, the phuS knockout prematurely produced pyocyanin in the presence of heme. Western blot analysis of PhuS protein levels in the wild-type strain showed that Fur-regulation of the phu operon could be derepressed in the presence of heme. In addition the premature onset of pyocyanin production requires both heme and a functional HO. Suppression of the phenotype on increasing the external heme concentration suggested that the decreased heme-flux through HO results in premature production of pyocyanin. The premature production of pyocyanin was not due to lower intracellular iron levels as a result of decreased heme flux through HO. However, transcriptional analysis of the phuS mutants indicates that the cells are sensing iron deprivation. The present data suggest that PhuS has a dual function in trafficking heme to HO, and in directly or indirectly sensing and maintaining iron and heme homeostasis.	[Kaur, Ajinder P.; Lansky, Ila B.; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu			National Institutes of Health [AI-55912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055912, R01AI055912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-55912 (to A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5364, DOI 10.1128/jb.170.11.5364-5367.1988; Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bibb LA, 2005, INFECT IMMUN, V73, P7406, DOI 10.1128/IAI.73.11.7406-7412.2005; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bollinger N, 2001, J BACTERIOL, V183, P1990, DOI 10.1128/JB.183.6.1990-1996.2001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Cornelis P, 2004, MICROBIOL-SGM, V150, P752, DOI 10.1099/mic.0.27086-0; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Juhas M, 2005, FEMS MICROBIOL LETT, V242, P287, DOI 10.1016/j.femsle.2004.11.020; Kaur AP, 2007, BIOCHEMISTRY-US, V46, P2994, DOI 10.1021/bi061722r; Kerr JR, 1999, J CLIN PATHOL, V52, P385, DOI 10.1136/jcp.52.5.385; Kim EJ, 2005, MICROBIOL-SGM, V151, P1127, DOI 10.1099/mic.0.27566-0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller RA, 1996, INFECT IMMUN, V64, P182, DOI 10.1128/IAI.64.1.182-188.1996; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palma M, 2003, ARCH MICROBIOL, V180, P374, DOI 10.1007/s00203-003-0602-z; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; WELLS IC, 1952, J BIOL CHEM, V196, P331; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zheng P, 2007, J BIOTECHNOL, V132, P342, DOI 10.1016/j.jbiotec.2007.08.013	61	44	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					56	66		10.1074/jbc.M806068200	http://dx.doi.org/10.1074/jbc.M806068200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990702	Green Published, hybrid			2022-12-25	WOS:000261974800007
J	Yang, IY; Hashimoto, K; de Wind, N; Blair, IA; Moriya, M				Yang, In-Young; Hashimoto, Keiji; de Wind, Niels; Blair, Ian A.; Moriya, Masaaki			Two Distinct Translesion Synthesis Pathways across a Lipid Peroxidation-derived DNA Adduct in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ETA; ERROR-PRONE; DEOXYGUANOSINE ADDUCT; OXIDATIVE STRESS; LOW FIDELITY; Y-FAMILY; ZETA; REV1; IOTA; GENE	Translesion DNA synthesis (TLS) of damaged DNA templates is catalyzed by specialized DNA polymerases. To probe the cellular TLS mechanism, a host-vector system consisting of mouse fibroblasts and a replicating plasmid bearing a single DNA adduct was developed. This system was used to explore the TLS mechanism of a heptanone-etheno-dC (H-epsilon dC) adduct, an endogenous lesion produced by lipid peroxidation. In wild-type cells, H-epsilon dC almost exclusively directed incorporation of dT and dA. Whereas knockout of the Y family TLS polymerase genes, Polh, Polk, or Poli, did not qualitatively affect these TLS events, inactivation of the Rev3 gene coding for a subunit of polymerase zeta or of the Rev1 gene abolished TLS associated with dA, but not dT, insertion. The analysis of results of the cellular studies and in vitro TLS studies using purified polymerases has revealed that the insertion of dA and dT was catalyzed by different polymerases in cells. While insertion of dT can be catalyzed by polymerase eta, kappa, and iota, insertion of dA is catalyzed by an unidentified polymerase that cannot catalyze extension from the resulting dA terminus. Therefore, the extension from this terminus requires the activity of polymerase zeta-REV1. These results provide new insight into how cells use different TLS pathways to overcome a synthesis block.	[Yang, In-Young; Hashimoto, Keiji; Moriya, Masaaki] SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; [de Wind, Niels] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Moriya, M (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA.	maki@pharm.stonybrook.edu			National Institutes of Health [CA76163, CA47995, CA91016, ES11297, ES013508]; EU-IP [FP6-51211]; NATIONAL CANCER INSTITUTE [R56CA076163, R01CA076163, R01CA091016, P01CA047995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, R01ES011297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU-IP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA76163, CA47995, CA91016, ES11297, and ES013508. This work was also supported by Grant EU-IP FP6-51211. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Camenisch G, 1996, NUCLEIC ACIDS RES, V24, P3707, DOI 10.1093/nar/24.19.3707; Davidson JF, 2002, MUTAT RES-FUND MOL M, V509, P17, DOI 10.1016/S0027-5107(02)00228-2; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; SCOTT S, 2006, MUTAT RES, V608, P1; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Williams MV, 2006, J BIOL CHEM, V281, P10127, DOI 10.1074/jbc.M600178200; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	42	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					191	198		10.1074/jbc.M806414200	http://dx.doi.org/10.1074/jbc.M806414200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981176	Green Published, hybrid			2022-12-25	WOS:000261974800022
J	Dvir-Ginzberg, M; Gagarina, V; Lee, EJ; Hall, DJ				Dvir-Ginzberg, Mona; Gagarina, Viktoria; Lee, Eun-Jin; Hall, David J.			Regulation of Cartilage-specific Gene Expression in Human Chondrocytes by SirT1 and Nicotinamide Phosphoribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTIONAL REPRESSION; CELL-SURVIVAL; CHONDROGENESIS; PROTEIN; PGC-1-ALPHA; CHROMATIN; COMPLEX; SOX9; ASSOCIATION	SirT1 is an NAD-dependent histone deacetylase that regulates gene expression, differentiation, development, and organism life span. Here we investigate the function of SirT1 in human chondrocytes derived from osteoarthritic patients. Elevation of SirT1 protein levels or activity in these chondrocytes led to a dramatic increase in cartilage-specific gene expression, whereas a reduction in SirT1 levels or activity significantly lowered cartilage gene expression. SirT1 associated with the cartilage-specific transcription factor Sox9, enhancing transcription from the collagen 2(alpha 1) promoter in a Sox9-dependent fashion. Consistent with this association, SirT1 was targeted to the collagen 2(alpha 1) enhancer and promoter, which in turn recruited the coactivators GCN5, PGC1 alpha, and p300. This led to elevated marks of active chromatin within the promoter; that is, acetylated histone K9/K14 and histone H4K5 as well as trimethylated histone H3K4. Finally, alterations in the NAD salvage pathway enzyme nicotinamide phosphoribosyltransferase led to changes in NAD levels, SirT activity, and cartilage-specific gene expression in human chondrocytes. SirT1, nicotinamide phosphoribosyltransferase, and NAD may, therefore, provide a positive function in human cartilage by elevating expression of genes encoding cartilage extracellular matrix.	[Dvir-Ginzberg, Mona; Gagarina, Viktoria; Lee, Eun-Jin; Hall, David J.] NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hall, DJ (corresponding author), 50 South Dr,Rm 1524, Bethesda, MD 20892 USA.	halld@mail.nih.gov	Dvir-Ginzberg, Mona/AAZ-9858-2021	Dvir-Ginzberg, Mona/0000-0003-3089-6875; Lee, Eun-Jin/0000-0001-5718-542X	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041141, ZIAAR041141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by the National Institutes of Health (Intramural Research Program of the NIAMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chung YL, 2003, MOL THER, V8, P707, DOI 10.1016/S1525-0016(03)00235-1; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Dharmavaram RM, 1997, J BIOL CHEM, V272, P26918, DOI 10.1074/jbc.272.43.26918; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978	47	149	161	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36300	36310		10.1074/jbc.M803196200	http://dx.doi.org/10.1074/jbc.M803196200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957417	Green Published, hybrid			2022-12-25	WOS:000261840500026
J	Lutzner, N; Kalbacher, H				Luetzner, Nicolas; Kalbacher, Hubert			Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HUMAN DENDRITIC CELLS; CYSTEINE PROTEASES; INVARIANT CHAIN; IN-VIVO; INDUCED ARTHRITIS; MOLECULES; PEPTIDES; PREDICTION; LYSOSOMES	Cathepsin S (CatS) is a lysosomal cysteine protease belonging to the papain superfamily. Because of the relatively broad substrate specificity of this family, a specific substrate for CatS is not yet known. Based on a detailed study of the CatS endopeptidase specificity, using six series of internally quenched fluorescent peptides, we were able to design a specific substrate for CatS. The peptide series was based on the sequence GRWHTVGL-RWE-Lys(Dnp)-DArg-NH2, which shows only one single cleavage site between Gly and Leu and where every substrate position between P-3 and P-3' was substituted with up to 15 different amino acids. The endopeptidase specificity of CatS was mainly determined by the P-2, P-1', and the P-3' substrate positions. Based on this result, systematically modified substrates were synthesized. Two of these modified substrates, Mca-GRWPP-MGLPWE-Lys(Dnp)-DArg-NH2 and Mca- GRWHPMGAPWE-Lys(Dnp)-DArg-NH2, did not react with the purified cysteine proteases cathepsin B (CatB) and cathepsin L (CatL). Using a specific CatS inhibitor, we could further show that these two peptides were not cleaved by endosomal fractions of antigen presenting cells (APCs), when CatS was inhibited and related cysteine proteases cathepsin B, H, L and X were still active. Although aspartic proteases like cathepsin E and cathepsin D were also present, our substrates were suitable to quantify cathepsin S activity specifically in APCs, including B cells, macrophages, and dendritic cells without the use of any protease inhibitor. We find that CatS activity differs significantly not only between the three types of professional APCs but also between endosomal and lysosomal compartments.	[Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany; [Luetzner, Nicolas; Kalbacher, Hubert] Univ Tubingen, Interfac Inst Biochem, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Kalbacher, H (corresponding author), Univ Tubingen, Med & Nat Sci Res Ctr, Ob Himmelreich 7, D-72074 Tubingen, Germany.	kalbacher@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 685]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 685. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Biroc SL, 2001, ARTHRITIS RHEUM, V44, P703, DOI 10.1002/1529-0131(200103)44:3<703::AID-ANR120>3.3.CO;2-U; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMME D, 1994, J BIOL CHEM, V269, P30238; BROMME D, 1989, BIOCHEM J, V264, P475; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Chain BM, 2005, J IMMUNOL, V174, P1791, DOI 10.4049/jimmunol.174.4.1791; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Kramer G, 2007, PROTEIN EXPRES PURIF, V54, P147, DOI 10.1016/j.pep.2007.02.007; Lautwein A, 2004, J LEUKOCYTE BIOL, V75, P844, DOI 10.1189/jlb.0803367; Lautwein A, 2002, EUR J IMMUNOL, V32, P3348, DOI 10.1002/1521-4141(200212)32:12<3348::AID-IMMU3348>3.0.CO;2-S; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Reich M, 2007, J LEUKOCYTE BIOL, V81, P990, DOI 10.1189/jlb.1006600; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Ruckrich T, 2006, BIOL CHEM, V387, P1503, DOI 10.1515/BC.2006.188; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Schuler Mathias M., 2007, V409, P75; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Sinzger C, 2006, J GEN VIROL, V87, P1853, DOI 10.1099/vir.0.81595-0; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x	39	49	53	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36185	36194		10.1074/jbc.M806500200	http://dx.doi.org/10.1074/jbc.M806500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957408	Green Published, hybrid			2022-12-25	WOS:000261840500013
J	Zhao, YX; Coloff, JL; Ferguson, EC; Jacobs, SR; Cui, K; Rathmell, JC				Zhao, Yuxing; Coloff, Jonathan L.; Ferguson, Emily C.; Jacobs, Sarah R.; Cui, Kai; Rathmell, Jeffrey C.			Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDEPENDENT SURVIVAL; COLORECTAL-CANCER CELLS; WILD-TYPE P53; HEMATOPOIETIC-CELLS; MEMBRANE PERMEABILIZATION; TRANSPORTER EXPRESSION; APOPTOTIC RESPONSES; SIGNALING PATHWAY; FACTOR WITHDRAWAL; BH3-ONLY PROTEIN	Growth factor stimulation and oncogenic transformation lead to increased glucose metabolism that may provide resistance to cell death. We have previously demonstrated that elevated glucose metabolism characteristic of stimulated or cancerous cells can stabilize the anti-apoptotic Bcl-2 family protein Mcl-1 through inhibition of GSK-3. Here we show that the proapoptotic Bcl-2 family protein, Puma, is also metabolically regulated. Growth factor deprivation led to the loss of glucose uptake and induction of Puma. Maintenance of glucose uptake after growth factor withdrawal by expression of the glucose transporter, Glut1, however, suppressed Puma up-regulation and attenuated growth factor withdrawal-induced activation of Bax, DNA fragmentation, and cell death. Conversely, glucose deprivation led to Puma induction even in the presence of growth factor. This regulation of Puma expression was a central component in cell death as a consequence of growth factor or glucose deprivation because Puma deficiency suppressed both of these cell death pathways. Puma induction in growth factor or glucose withdrawal was dependent on p53 in cell lines and in activated primary T lymphocytes because p53 deficiency suppressed Puma induction and delayed Bax and caspase activation, DNA fragmentation, and loss of clonogenic survival. Importantly, although p53 levels did not change or were slightly reduced, p53 activity was suppressed by elevated glucose metabolism to inhibit Puma induction after growth factor withdrawal. These data show that p53 is metabolically regulated and that glucose metabolism initiates a signaling mechanism to inhibit p53 activation and suppress Puma induction, thus promoting an anti-apoptotic balance to Bcl-2 family protein expression that supports cell survival.	[Zhao, Yuxing; Coloff, Jonathan L.; Ferguson, Emily C.; Jacobs, Sarah R.; Cui, Kai; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Sarah W Stedman Ctr Nutr & Metab, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.	jeff.rathmell@duke.edu			National Institutes of Health [RO1 CA123350]; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA123350 (to J.C.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BLANDINO G, 1995, ONCOGENE, V10, P731; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goetz AW, 2001, CANCER RES, V61, P7635; Gottlieb E, 1996, CELL GROWTH DIFFER, V7, P301; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grayson JM, 2001, J IMMUNOL, V167, P1333, DOI 10.4049/jimmunol.167.3.1333; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Ohkusu-Tsukada K, 1999, J IMMUNOL, V163, P1966; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Semenza G L, 2001, Novartis Found Symp, V240, P251; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	51	84	88	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36344	36353		10.1074/jbc.M803580200	http://dx.doi.org/10.1074/jbc.M803580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990690	Green Published, hybrid			2022-12-25	WOS:000261840500031
J	Deng, WW; Shi, MD; Han, MF; Zhong, J; Li, ZH; Li, WN; Hu, Y; Yan, LC; Wang, J; He, Y; Tang, H; Deubel, V; Luo, XP; Ning, Q; Sun, B				Deng, Weiwen; Shi, Mude; Han, Meifang; Zhong, Jin; Li, Zhenhu; Li, Weina; Hu, Yu; Yan, Lingchen; Wang, Jie; He, Ying; Tang, Hong; Deubel, Vincent; Luo, Xiaoping; Ning, Qin; Sun, Bing			Negative Regulation of Virus-triggered IFN-beta Signaling Pathway by Alternative Splicing of TBK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TANK-BINDING KINASE-1; EPSTEIN-BARR-VIRUS; RIG-I; ANTIVIRAL RESPONSES; GENE-TRANSCRIPTION; UBIQUITIN LIGASE; VIRAL-INFECTION; ADAPTER PROTEIN	Induction of Type I IFNs is a central event in antiviral responses and must be tightly controlled. The protein kinase TBK1 is critically involved in virus-triggered type I IFN signaling. In this study, we identify an alternatively spliced isoform of TBK1, termed TBK1s, which lacks exons 3-6. Upon Sendai virus (SeV) infection, TBK1s is induced in both human and mouse cells and binds to RIG-1, disrupting the interaction between RIG-I and VISA. Consistent with that result, overexpression of TBK1s inhibits IRF3 nuclear translocation and leads to a shutdown of SeV-triggered IFN-beta production. Taken together, our data indicate that TBK1s plays an inhibitory role in virus-triggered IFN-beta signaling pathways.	[Han, Meifang; Li, Weina; Luo, Xiaoping; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp Tongji, Coll Med, Dept Infect Dis, Wuhan 430030, Peoples R China; [Deng, Weiwen; Shi, Mude; Li, Zhenhu; Hu, Yu; Yan, Lingchen; Wang, Jie; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhong, Jin; He, Ying; Deubel, Vincent; Sun, Bing] Chinese Acad Sci, Inst Pasteur, Shanghai 200025, Peoples R China; [Tang, Hong] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100101, Peoples R China; [Sun, Bing] Shanghai Univ E Inst, Div Immunol, Shanghai 200041, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ning, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp Tongji, Coll Med, Dept Infect Dis, Wuhan 430030, Peoples R China.	qning@tjh.tjmu.edu.cn; bsun@sibs.ac.cn	Deng, Weiwen/A-1646-2013; Zhong, Jin/M-6859-2018	Hu, Yu/0000-0002-9511-9383; Han, Meifang/0000-0002-1948-8128; Zhong, Jin/0000-0002-3554-1275	National Natural Science Foundation of China [30325018, 30530700, 30623003, 30421005]; CAS Project [KSCX1-YW-R-43]; National Key Project 973 [2005CB522901, 2006CB504300, 2007CB512404, 2007CB512900]; Technology Commission of Shanghai Municipality [04DZ14902, 04DZ19108, 06DZ22032, 04DZ19112, 07XD14033, 064319034, 07DZ22916]; 863 key projects [2006AA02A247]; Ministry of Health of China [2008ZX10206]; EU [SP5B-CT-2006-044161]; E-institutes of Shanghai Universities, Immunology Division	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Project(Chinese Academy of Sciences); National Key Project 973(National Basic Research Program of China); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); 863 key projects(National High Technology Research and Development Program of China); Ministry of Health of China; EU(European Commission); E-institutes of Shanghai Universities, Immunology Division	This work was supported in part by Grants 30325018, 30530700, 30623003, and 30421005 from the National Natural Science Foundation of China and CAS Project KSCX1-YW-R-43, Grants 2005CB522901, 2006CB504300, and 2007CB512404, 2007CB512900 of the National Key Project 973, Grants 04DZ14902, 04DZ19108, 06DZ22032, 04DZ19112, 07XD14033, 064319034, and 07DZ22916 of the Technology Commission of Shanghai Municipality, Grant 2006AA02A247 of 863 key projects, Grant 2008ZX10206 from the Ministry of Health of China, EU Project SP5B-CT-2006-044161, and a grant from the E-institutes of Shanghai Universities, Immunology Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Karpova AY, 2000, GENE DEV, V14, P2813, DOI 10.1101/gad.813800; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lee EJ, 2006, BIOCHEM BIOPH RES CO, V347, P882, DOI 10.1016/j.bbrc.2006.06.145; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748	44	34	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35590	35597		10.1074/jbc.M805775200	http://dx.doi.org/10.1074/jbc.M805775200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18977754	hybrid			2022-12-25	WOS:000261687900031
J	Li, W; Huntington, JA				Li, Wei; Huntington, James A.			The Heparin Binding Site of Protein C Inhibitor Is Protease-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TISSUE DISTRIBUTION; MOLECULAR-CLONING; BASIC RESIDUES; ANTITHROMBIN; COMPLEX; ACTIVATION; MECHANISM; RECOGNITION; THROMBOSIS	Protein C inhibitor (PCI) is a member of the serpin family of protease inhibitors with many biological functions and broad inhibitory specificity. Its major targets in blood are thrombin and activated protein C (APC), and the inhibition of both enzymes can be accelerated by glycosaminoglycans, including heparin. Acceleration of thrombin and APC inhibition by PCI requires that both protease and inhibitor bind to the same heparin chain to form a bridged Michaelis complex. However, the position of the heparin binding site of APC is opposite to that of thrombin, and formation of the bridged complexes must require either radical reorientation of the proteases relative to PCI or alternate heparin binding modes for PCI. In this study, we investigate how heparin bridges thrombin and APC to PCI by determining the effect of mutations in and around the putative heparin binding site of PCI. We found that heparin binds PCI in a linear fashion along helix H to bridge thrombin, consistent with our recent crystal structure (3B9F), but that it must rotate by similar to 60 degrees to engage Arg-229 to bridge APC. To gain insight into the possible modes of heparin binding to PCI, we solved a crystal structure of cleaved PCI bound to an octasaccharide heparin fragment to 1.55 angstrom resolution. The structure reveals a binding mode across the N terminus of helix H to engage Arg-229 and align the heparin binding site of APC. Amolecular model for the heparin-bridged PCI.APC complex was built based on mutagenesis and structural data.	[Li, Wei; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk			Medical Research Council Senior Non-clinical Fellowship; Medical Research Council [G117/444, G0601596] Funding Source: researchfish; MRC [G0601596, G117/444] Funding Source: UKRI	Medical Research Council Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Senior Non-clinical Fellowship. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carroll VA, 1997, ARTERIOSCL THROM VAS, V17, P114, DOI 10.1161/01.ATV.17.1.114; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRENTH J, 1992, J CRYST GROWTH, V122, P107, DOI 10.1016/0022-0248(92)90233-9; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; GARG HG, 2005, CHEM BIOL HEPARIN HE, P367; Geiger M, 1996, IMMUNOPHARMACOLOGY, V32, P53, DOI 10.1016/0162-3109(96)00013-6; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Huntington JA, 2003, STRUCTURE, V11, P205, DOI 10.1016/S0969-2126(02)00944-9; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Kolbel T, 2006, J VASC SURG, V43, P935, DOI 10.1016/j.jvs.2006.01.019; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Meijers JCM, 2002, BRIT J HAEMATOL, V118, P604, DOI 10.1046/j.1365-2141.2002.03652.x; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; TOLLEFSEN DM, 1994, ANN NY ACAD SCI, V714, P21, DOI 10.1111/j.1749-6632.1994.tb12027.x; VANDERMEER FJM, 1989, THROMB HAEMOSTASIS, V62, P756; Wakita T, 1998, FEBS LETT, V429, P263, DOI 10.1016/S0014-5793(98)00613-9; Yang LK, 2002, BIOCHEMISTRY-US, V41, P6149, DOI 10.1021/bi015899r; ZechmeisterMachhart M, 1996, IMMUNOPHARMACOLOGY, V32, P96, DOI 10.1016/0162-3109(95)00062-3	35	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36039	36045		10.1074/jbc.M805974200	http://dx.doi.org/10.1074/jbc.M805974200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974053	hybrid			2022-12-25	WOS:000261687900078
J	Mohn, WW; van der Geize, R; Stewart, GR; Okamoto, S; Liu, J; Dijkhuizen, L; Eltis, LD				Mohn, William W.; van der Geize, Robert; Stewart, Gordon R.; Okamoto, Sachi; Liu, Jie; Dijkhuizen, Lubbert; Eltis, Lindsay D.			The Actinobacterial mce4 Locus Encodes a Steroid Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELL ENTRY; MYCOBACTERIUM-TUBERCULOSIS; CHOLESTEROL; MACROPHAGES; OPERONS; RHODOCOCCUS; PROTEINS; SURVIVAL; GENE; ATP	Bioinformatic analyses have suggested that Mce proteins in diverse actinobacteria are components of complex ATP-binding cassette transporter systems, comprising more than eight distinct proteins. In Mycobacterium tuberculosis, these proteins are implicated in interactions of this deadly pathogen with its human host. Here, we provide direct evidence that the Mce4 system of Rhodococcus jostii RHA1 is a steroid uptake system. Transcriptional analyses indicate that the system is encoded by an 11-gene operon, up-regulated 4.0-fold during growth on cholesterol versus on pyruvate. Growth of RHA1 on cholesterol and uptake of radiolabeled cholesterol both required expression of genes in the mce4 operon encoding two permeases plus eight additional proteins of unknown function. Cholesterol uptake was ATP-dependent and exhibited Michaelis-Menten kinetics with a K-m of 0.6 +/- 0.1 mu M. This uptake system was also essential for growth of RHA1 on beta-sitosterol, 5-alpha-cholestanol, and 5-alpha-cholestanone. Bioinformatic analysis revealed that all mce4 loci in sequenced genomes are linked to steroid metabolism genes. Thus, we predict that all Mce4 systems are steroid transporters. The transport function of the Mce4 system is consistent with proposed roles of cholesterol and its metabolism in the pathogenesis of M. tuberculosis.	[Mohn, William W.; Stewart, Gordon R.; Okamoto, Sachi; Liu, Jie; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [van der Geize, Robert; Dijkhuizen, Lubbert] Univ Groningen, Dept Microbiol, NL-9751 NN Haren, Netherlands	University of British Columbia; University of Groningen	Mohn, WW (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wmohn@interchange.ubc.ca	Dijkhuizen, Lubbert/K-3539-2019; Eltis, Lindsay D/J-8272-2015; Dijkhuizen, Lubbert/E-9454-2014	Dijkhuizen, Lubbert/0000-0003-2312-7162; Eltis, Lindsay D/0000-0002-6774-8158; 	Discovery Grants from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Discovery Grants from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada( to W. W. M. and L. D. E.) and an Operating Grant from the Canadian Institutes of Health Research ( to W. W. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGARWAL N, 1983, BIOCHIM BIOPHYS ACTA, V723, P150, DOI 10.1016/0005-2728(83)90114-7; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Av-Gay Y, 2000, CAN J MICROBIOL, V46, P826, DOI 10.1139/cjm-46-9-826; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P469; Casali N, 2002, INFECT IMMUN, V70, P6846, DOI 10.1128/IAI.70.12.6846-6852.2002; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; El-Shazly S, 2007, J MED MICROBIOL, V56, P1145, DOI 10.1099/jmm.0.47095-0; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Haile Y, 2002, FEMS IMMUNOL MED MIC, V33, P125, DOI 10.1111/j.1574-695X.2002.tb00581.x; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kumar A, 2003, INFECT IMMUN, V71, P6083, DOI 10.1128/IAI.71.10.6083-6087.2003; Lu SW, 2006, ANAL BIOCHEM, V353, P7, DOI 10.1016/j.ab.2006.01.044; MATHUR M, 1992, J BIOL CHEM, V267, P19388; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mitra D, 2005, TUBERCULOSIS, V85, P337, DOI 10.1016/j.tube.2005.08.010; Nakashima N, 2004, BIOTECHNOL BIOENG, V86, P136, DOI 10.1002/bit.20024; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parrish NM, 2004, J ANTIMICROB CHEMOTH, V54, P722, DOI 10.1093/jac/dkh408; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Senaratne RH, 2008, J MED MICROBIOL, V57, P164, DOI 10.1099/jmm.0.47454-0; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Sutcliffe IC, 1998, ANTON LEEUW INT J G, V74, P49, DOI 10.1023/A:1001747726820; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104	36	147	151	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35368	35374		10.1074/jbc.M805496200	http://dx.doi.org/10.1074/jbc.M805496200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955493	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-25	WOS:000261687900007
J	Remaud, S; Audibert, A; Gho, M				Remaud, Sylvie; Audibert, Agnes; Gho, Michel			S-Phase Favours Notch Cell Responsiveness in the Drosophila Bristle Lineage	PLOS ONE			English	Article								We have studied cell sensitivity to Notch pathway signalling throughout the cell cycle. As model system, we used the Drosophila bristle lineage where at each division N plays a crucial role in fate determination. Using in vivo imaging, we followed this lineage and activated the N-pathway at different moments of the secondary precursor cell cycle. We show that cells are more susceptible to respond to N-signalling during the S-phase. Thus, the period of heightened sensitivity coincided with the period of the S-phase. More importantly, modifications of S-phase temporality induced corresponding changes in the period of the cell's reactivity to N-activation. Moreover, S-phase abolition was correlated with a decrease in the expression of tramtrack, a downstream N-target gene. Finally, N cell responsiveness was modified after changes in chromatin packaging. We suggest that high-order chromatin structures associated with the S-phase create favourable conditions that increase the efficiency of the transcriptional machinery with respect to N-target genes.	[Remaud, Sylvie; Audibert, Agnes; Gho, Michel] Univ Paris 06, UMR 7622, Paris, France; [Remaud, Sylvie; Audibert, Agnes; Gho, Michel] CNRS, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Remaud, S (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	Michel.Gho@snv.jussieu.fr	Audibert, Agnès/ABG-2084-2021		ARC [3291]; ANR [05-BLAN-0133]; CNRS; UPMC; FRM	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; FRM(Fondation pour la Recherche Medicale)	ARC (grant 3291), ANR (grant 05-BLAN-0133), CNRS, UPMC, FRM to SR.	Ambros V, 1999, DEVELOPMENT, V126, P1947; Armstrong JA, 2005, GENETICS, V170, P1761, DOI 10.1534/genetics.105.041327; Audibert A, 2005, DEVELOPMENT, V132, P2287, DOI 10.1242/dev.01797; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; EISSENBERG JC, 1992, GENETICS, V131, P345; Elfring LK, 1998, GENETICS, V148, P251; Falbo KB, 2006, J CELL BIOCHEM, V97, P684, DOI 10.1002/jcb.20752; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; HOLTZER H, 1975, Q REV BIOPHYS, V8, P523, DOI 10.1017/S0033583500001980; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Negre N, 2003, MECH DEVELOP, V120, P253, DOI 10.1016/S0925-4773(02)00419-7; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Schweisguth F, 1999, P NATL ACAD SCI USA, V96, P11382, DOI 10.1073/pnas.96.20.11382; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; TAMKUN JW, 1995, CURR OPIN GENET DEV, V5, P473, DOI 10.1016/0959-437X(95)90051-H; USUI K, 1992, DEVELOPMENT, V116, P601; Vanderwaal RP, 2001, J CELL PHYSIOL, V187, P236, DOI 10.1002/jcp.1073; Wang SW, 1997, DEVELOPMENT, V124, P4435; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XU T, 1992, DEVELOPMENT, V115, P913; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3646	10.1371/journal.pone.0003646	http://dx.doi.org/10.1371/journal.pone.0003646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985153	Green Submitted, Green Published, gold			2022-12-25	WOS:000265134400009
J	Seoane, M; Iglesias, P; Gonzalez, T; Dominguez, F; Fraga, M; Aliste, C; Forteza, J; Costoya, JA				Seoane, Marcos; Iglesias, Pablo; Gonzalez, Teresa; Dominguez, Fernando; Fraga, Maximo; Aliste, Carlos; Forteza, Jeronimo; Costoya, Jose A.			Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression	PLOS ONE			English	Article								Senescence is one of the main barriers against tumor progression. Oncogenic signals in primary cells result in oncogene-induced senescence (OIS), crucial for protection against cancer development. It has been described in premalignant lesions that OIS requires DNA damage response (DDR) activation, safeguard of the integrity of the genome. Here we demonstrate how the cellular mechanisms involved in oncogenic transformation in a model of glioma uncouple OIS and DDR. We use this tumor type as a paradigm of oncogenic transformation. In human gliomas most of the genetic alterations that have been previously identified result in abnormal activation of cell growth signaling pathways and deregulation of cell cycle, features recapitulated in our model by oncogenic Ras expression and retinoblastoma (Rb) inactivation respectively. In this scenario, the absence of pRb confers a proliferative advantage and activates DDR to a greater extent in a DNA lesion-independent fashion than cells that express only HRas(V12). Moreover, Rb loss inactivates the stress kinase DDR-associated p38MAPK by specific Wip1-dependent dephosphorylation. Thus, Rb loss acts as a switch mediating the transition between premalignant lesions and cancer through DDR modulation. These findings may have important implications for the understanding the biology of gliomas and anticipate a new target, Wip1 phosphatase, for novel therapeutic strategies.	[Seoane, Marcos; Iglesias, Pablo; Costoya, Jose A.] Univ Santiago De Compostela, Mol Oncol Lab, Dept Fisioloxia, Fac Med, Santiago De Compostela, Spain; [Gonzalez, Teresa; Dominguez, Fernando] Univ Santiago Compostela, Serv Galego Saude, Fdn Galega Med Xenom, Santiago De Compostela, Spain; [Fraga, Maximo; Aliste, Carlos; Forteza, Jeronimo] Univ Santiago Compostela, Dept Anat Patol Ciencias Forenses, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Seoane, M (corresponding author), Univ Santiago De Compostela, Mol Oncol Lab, Dept Fisioloxia, Fac Med, Santiago De Compostela, Spain.	josea.costoya@usc.es	Souto, Marcos Seoane/I-3380-2018; Costoya, Jose A./B-2718-2009; Fraga, Máximo/AAC-9417-2020	Costoya, Jose A./0000-0003-3691-6419; Iglesias Vazquez, Pablo/0000-0003-2506-5313; dominguez, fernando/0000-0002-5003-4335; Fraga Rodriguez, Maximo/0000-0001-6185-9562	Spanish Ministry of Education and Science [SAF2005-00306]; Xunta de Galicia [PGIDIT05PXIB20801PR, 2007/064]; Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Programme (Spanish Ministry of Education and Science)	Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Ramon y Cajal Programme (Spanish Ministry of Education and Science)(Spanish Government)	This study was supported by Spanish Ministry of Education and Science (SAF2005-00306) and Xunta de Galicia grants (PGIDIT05PXIB20801PR); Grupos emerxentes 2007/064) (J.A.C.), and by Fundacion de Investigacion Medica Mutua Madrilena (J.A.C., P.I.). J.A.C. is an Investigator of Ramon y Cajal Programme (Spanish Ministry of Education and Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding H, 2001, CANCER RES, V61, P3826; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; HE J, 1995, CANCER RES, V55, P4833; HE J, 1994, CANCER RES, V54, P5804; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Ichimura K, 1996, ONCOGENE, V13, P1065; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; JEN J, 1994, CANCER RES, V54, P6353; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marino S, 2000, GENE DEV, V14, P994; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Powers JT, 2004, MOL CANCER RES, V2, P203; QUELLE DE, 1995, CELL, V83, P993; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rathore A, 1999, Pathol Oncol Res, V5, P21, DOI 10.1053/paor.1999.0021; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rich JN, 2001, CANCER RES, V61, P3556; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Uhrbom L, 2002, CANCER RES, V62, P5551; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	57	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3632	10.1371/journal.pone.0003632	http://dx.doi.org/10.1371/journal.pone.0003632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985151	Green Published, gold, Green Submitted			2022-12-25	WOS:000265134400007
J	Marrone, A; Ballantyne, J				Marrone, April; Ballantyne, Jack			Sequence Specificity of BAL 31 Nuclease for ssDNA Revealed by Synthetic Oligomer Substrates Containing Homopolymeric Guanine Tracts	PLOS ONE			English	Article								Background: The extracellular nuclease from Alteromonas espejiana, BAL 31 catalyzes the degradation of single-stranded and linear duplex DNA to 5'-mononucleotides, cleaves negatively supercoiled DNA to the linear duplex form, and cleaves duplex DNA in response to the presence of apurinic sites. Principal Findings: In this work we demonstrate that BAL 31 activity is affected by the presence of guanine in singlestranded DNA oligomers. Specifically, nuclease activity is shown to be affected by guanine's presence in minimal homopolymeric tracts in the middle of short oligomer substrates and also by its presence at the 39 end of ten and twenty base oligomers. GNC rich regions in dsDNA are known to cause a decrease in the enzyme's nuclease activity which has been attributed to the increased thermal stability of these regions, thus making it more difficult to unwind the strands required for enzyme access. Our results indicate that an additional phenomenon could be wholly or partly responsible for the loss of activity in these GNC rich regions. Thus the presence of a guanine tract per se impairs the enzyme's functionality, possibly due to the tract's bulky nature and preventing efficient progression through the active site. Conclusions: This study has revealed that the general purpose BAL 31 nuclease commonly used in molecular genetics exhibits a hithertofore non-characterized degree of substrate specificity with respect to single-stranded DNA (ssDNA) oligomers. Specifically, BAL 31 nuclease activity was found to be affected by the presence of guanine in ssDNA oligomers.	[Marrone, April; Ballantyne, Jack] Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA; [Marrone, April; Ballantyne, Jack] Natl Ctr Forens Sci, Orlando, FL USA	State University System of Florida; University of Central Florida	Marrone, A (corresponding author), Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu		Ballantyne, Jack/0000-0002-9681-2120	State of Florida	State of Florida	This work was funded by the State of Florida to the UCF Center for Forensic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GRAY HB, 1975, NUCLEIC ACIDS RES, V2, P1459, DOI 10.1093/nar/2.9.1459; HAUSER CR, 1991, GENET ANAL-BIOMOL E, V8, P139, DOI 10.1016/1050-3862(91)90022-J; HENRIQUEZ V, 1990, NUCLEIC ACIDS RES, V18, P6735, DOI 10.1093/nar/18.22.6735; LEGERSKI RJ, 1978, NUCLEIC ACIDS RES, V5, P1445, DOI 10.1093/nar/5.5.1445; LIPSETT MN, 1964, J BIOL CHEM, V239, P1250; LU T, 1995, BBA-PROTEIN STRUCT M, V1251, P125, DOI 10.1016/0167-4838(95)00091-8; Miller J.N., 2000, STAT CHEMOMETRICS AN, Vfourth; PONCZ M, 1982, P NATL ACAD SCI-BIOL, V79, P4298, DOI 10.1073/pnas.79.14.4298; RALPH RK, 1962, J AM CHEM SOC, V84, P2265, DOI 10.1021/ja00870a055; TALMADGE K, 1980, GENE, V12, P235, DOI 10.1016/0378-1119(80)90105-5; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; WEI CF, 1983, J BIOL CHEM, V258, P3506; ZHEN WP, 1986, BIOCHEMISTRY-US, V25, P6598, DOI 10.1021/bi00369a039; ZHOU XG, 1990, BIOCHIM BIOPHYS ACTA, V1049, P83, DOI 10.1016/0167-4781(90)90087-I	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3595	10.1371/journal.pone.0003595	http://dx.doi.org/10.1371/journal.pone.0003595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974878	Green Published, gold			2022-12-25	WOS:000265131700016
J	Dent, AE; Bergmann-Leitner, ES; Wilson, DW; Tisch, DJ; Kimmel, R; Vulule, J; Sumba, PO; Beeson, JG; Angov, E; Moormann, AM; Kazura, JW				Dent, Arlene E.; Bergmann-Leitner, Elke S.; Wilson, Danny W.; Tisch, Daniel J.; Kimmel, Rhonda; Vulule, John; Sumba, Peter Odada; Beeson, James G.; Angov, Evelina; Moormann, Ann M.; Kazura, James W.			Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults	PLOS ONE			English	Article								Background: Antibodies that impair Plasmodium falciparum merozoite invasion and intraerythrocytic development are one of several mechanisms that mediate naturally acquired immunity to malaria. Attempts to correlate anti-malaria antibodies with risk of infection and morbidity have yielded inconsistent results. Growth inhibition assays (GIA) offer a convenient method to quantify functional antibody activity against blood stage malaria. Methods: A treatment-time-to-infection study was conducted over 12-weeks in a malaria holoendemic area of Kenya. Plasma collected from healthy individuals (98 children and 99 adults) before artemether-lumefantrine treatment was tested by GIA in three separate laboratories. Results: Median GIA levels varied with P. falciparum line (D10, 8.8%; 3D7, 34.9%; FVO, 51.4% inhibition). The magnitude of growth inhibition decreased with age in all P. falciparum lines tested with the highest median levels among children,4 years compared to adults (e.g. 3D7, 45.4% vs. 30.0% respectively, p = 0.0003). Time-to-infection measured by weekly blood smears was significantly associated with level of GIA controlling for age. Upper quartile inhibition activity was associated with less risk of infection compared to individuals with lower levels (e.g. 3D7, hazard ratio = 1.535, 95% CI = 1.012-2.329; p = 0.0438). Various GIA methodologies had little effect on measured parasite growth inhibition. Conclusion: Plasma antibody-mediated growth inhibition of blood stage P. falciparum decreases with age in residents of a malaria holoendemic area. Growth inhibition assay may be a useful surrogate of protection against infection when outcome is controlled for age.	[Dent, Arlene E.; Tisch, Daniel J.; Kimmel, Rhonda; Moormann, Ann M.; Kazura, James W.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bergmann-Leitner, Elke S.; Angov, Evelina] Walter Reed Army Inst Res, Silver Spring, MD USA; [Wilson, Danny W.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wilson, Danny W.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Vulule, John; Sumba, Peter Odada] Kenya Govt Med Res Ctr, Kisumu, Kenya	Case Western Reserve University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter & Eliza Hall Institute; University of Melbourne; Kenya Medical Research Institute	Dent, AE (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	jxk14@po.cwru.edu	Bergmann-Leitner, Elke S./B-3548-2011; Tisch, Daniel/Q-5044-2019; Bergmann-Leitner, Elke/I-5431-2019; Wilson, Danny W/E-6186-2019	Bergmann-Leitner, Elke S./0000-0002-8571-8956; Bergmann-Leitner, Elke/0000-0002-8571-8956; Wilson, Danny W/0000-0002-5073-1405; Moormann, Ann/0000-0003-1113-2829	NIH [AI43906, AI0702427]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043906, U01AI043906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by NIH grant AI43906 (JWK) and the National Health and Medical Research Council of Australia (Career Development Award and project grant to JGB; postgraduate scholarship to DWW). AED was supported by NIH training grant AI0702427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDT AR, 1994, PARASITOLOGY, V108, pS19, DOI 10.1017/S0031182000075685; Bergmann-Leitner ES, 2008, AM J TROP MED HYG, V78, P468, DOI 10.4269/ajtmh.2008.78.468; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bolad A, 2003, AM J TROP MED HYG, V68, P728, DOI 10.4269/ajtmh.2003.68.728; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Dent A, 2006, J IMMUNOL, V177, P7139, DOI 10.4049/jimmunol.177.10.7139; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; DRUILHE P, 1994, IMMUNOL LETT, V41, P115, DOI 10.1016/0165-2478(94)90118-X; Eisen DP, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-86; Flyg BW, 1997, CLIN EXP IMMUNOL, V107, P321; Good MF, 2005, TRENDS IMMUNOL, V26, P295, DOI 10.1016/j.it.2005.04.005; GRIMBERG BT, 2008, MONITORING PLASMODIU; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; JACOBBERGER JW, 1992, CELL PROLIFERAT, V25, P431, DOI 10.1111/j.1365-2184.1992.tb01452.x; John CC, 2004, INFECT IMMUN, V72, P5135, DOI 10.1128/IAI.72.9.5135-5142.2004; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MCCALLUM FJ, 2008, PLOSONE IN PRESS; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Miller LH, 1998, NAT MED, V4, P520, DOI 10.1038/nm0598supp-520; Mlambo G, 2007, EXP PARASITOL, V115, P211, DOI 10.1016/j.exppara.2006.08.003; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Newbold CI, 1997, ANN TROP MED PARASIT, V91, P551, DOI 10.1080/00034989760923; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sarr JB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-117; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; SY NE, 1990, AM J TROP MED HYG, V43, P243, DOI 10.4269/ajtmh.1990.43.243; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032; Yone CLRP, 2005, INFECT IMMUN, V73, P2281, DOI 10.1128/IAI.73.4.2281-2287.2005	64	61	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3557	10.1371/journal.pone.0003557	http://dx.doi.org/10.1371/journal.pone.0003557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958285	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131100015
J	Ratier, L; Urrutia, M; Paris, G; Zarebski, L; Frasch, AC; Goldbaum, FA				Ratier, Laura; Urrutia, Mariela; Paris, Gaston; Zarebski, Laura; Frasch, Alberto C.; Goldbaum, Fernando A.			Relevance of the Diversity among Members of the Trypanosoma Cruzi Trans-Sialidase Family Analyzed with Camelids Single-Domain Antibodies	PLOS ONE			English	Article							AMINO-ACID REPEATS; RANGELI SIALIDASE; IN-VITRO; INHIBITORS; INFECTION; ENZYME; SERA; APOPTOSIS; INCREASE; IMMUNITY	The sialic acid present in the protective surface mucin coat of Trypanosoma cruzi is added by a membrane anchored trans-sialidase (TcTS), a modified sialidase that is expressed from a large gene family. In this work, we analyzed single domain camelid antibodies produced against trans-sialidase. Llamas were immunized with a recombinant trans-sialidase and inhibitory single-domain antibody fragments were obtained by phage display selection, taking advantage of a screening strategy using an inhibition test instead of the classic binding assay. Four single domain antibodies displaying strong trans-sialidase inhibition activity against the recombinant enzyme were identified. They share the same complementarity-determining region 3 length (17 residues) and have very similar sequences. This result indicates that they likely derived from a unique clone. Probably there is only one structural solution for tight binding inhibitory antibodies against the TcTS used for immunization. To our surprise, this single domain antibody that inhibits the recombinant TcTS, failed to inhibit the enzymatic activity present in parasite extracts. Analysis of individual recombinant trans-sialidases showed that enzymes expressed from different genes were inhibited to different extents (from 8 to 98%) by the llama antibodies. Amino acid changes at key positions are likely to be responsible for the differences in inhibition found among the recombinant enzymes. These results suggest that the presence of a large and diverse trans-sialidase family might be required to prevent the inhibitory response against this essential enzyme and might thus constitute a novel strategy of T. cruzi to evade the host immune system.	[Ratier, Laura; Frasch, Alberto C.] Univ Nacl Gen San Martin CONICET, Inst Invest Biotecchnol Inst Tecnol Chascomus IIB, Buenos Aires, DF, Argentina; [Urrutia, Mariela; Paris, Gaston; Zarebski, Laura; Goldbaum, Fernando A.] Inst Investigaciones Bioquim Buenos Aires CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Ratier, L (corresponding author), Univ Nacl Gen San Martin CONICET, Inst Invest Biotecchnol Inst Tecnol Chascomus IIB, Buenos Aires, DF, Argentina.	cfrasch@iib.unsam.edu.ar; fgoldbaum@leloir.org.ar	; Paris, Gaston/J-6100-2014	Urrutia, Mariela/0000-0002-5224-9735; Goldbaum, Fernando/0000-0001-6235-3002; Frasch, Alberto Carlos/0000-0001-7532-653X; Paris, Gaston/0000-0001-5984-7394	National Institutes of Health [AI060645-01]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the National Institutes of Health, grant AI060645-01 to ACF, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The work of ACF and FAG was partially supported by International Research Scholar grants from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Agusti R, 2004, GLYCOBIOLOGY, V14, P659, DOI 10.1093/glycob/cwh079; Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Buscaglia CA, 1998, J INFECT DIS, V177, P431, DOI 10.1086/514199; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buscaglia CA, 1999, BLOOD, V93, P2025, DOI 10.1182/blood.V93.6.2025.406k19_2025_2032; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Fontanella GH, 2008, VACCINE, V26, P2322, DOI 10.1016/j.vaccine.2008.02.060; FRASCH ACC, 1994, PARASITOLOGY, V108, pS37, DOI 10.1017/S0031182000075703; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; LEGUIZAMON MS, 1994, INFECT IMMUN, V62, P3441; LEGUIZAMON MS, 1994, J INFECT DIS, V170, P1570, DOI 10.1093/infdis/170.6.1570; Leguizamon MS, 1997, J INFECT DIS, V175, P1272, DOI 10.1086/593697; Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; PEREIRACHIOCCOLA VL, 1994, INFECT IMMUN, V62, P2973, DOI 10.1128/IAI.62.7.2973-2978.1994; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001; POLLEVICK GD, 1993, MOL BIOCHEM PARASIT, V59, P171, DOI 10.1016/0166-6851(93)90018-S; Rastam L, 1996, INT J EPIDEMIOL, V25, P953, DOI 10.1093/ije/25.5.953; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tomlinson S, 1996, NAT BIOTECHNOL, V14, P717, DOI 10.1038/nbt0696-717; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878	47	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3524	10.1371/journal.pone.0003524	http://dx.doi.org/10.1371/journal.pone.0003524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949046	Green Submitted, gold, Green Published			2022-12-25	WOS:000265126400009
J	Di Capite, J; Shirley, A; Nelson, C; Bates, G; Parekh, AB				Di Capite, Joseph; Shirley, Anna; Nelson, Charmaine; Bates, Grant; Parekh, Anant B.			Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes	FASEB JOURNAL			English	Article						paracrine signal; mast cells	SEASONAL ALLERGIC RHINITIS; HUMAN MAST-CELLS; CURRENT I-CRAC; PLASMA-MEMBRANE; CYSLT(1) RECEPTOR; CALCIUM-CHANNELS; STORE DEPLETION; C-4 SECRETION; PORE SUBUNIT; RELEASE	Mast cells are key components of the immune system, where they help orchestrate the inflammatory response. Aberrant mast cell activation is linked to a variety of allergic diseases, including asthma, eczema, rhinitis, and nasal polyposis, which in combination affect up to 20% of the population in industrialized countries. On activation, mast cells release a variety of signals that target the bronchi and vasculature and recruit other immune cells to the inflammatory site. Prominent among such signals are the cysteinyl leukotrienes, a family of potent proinflammatory lipid mediators comprising leukotriene C-4 (LTC4), LTD4, and LTE4. LTC4, the parent compound, is secreted from mast cells following Ca2+ influx through store-operated calcium release-activated calcium ( CRAC) channels. Here, we show that activated mast cells release a paracrine signal that evokes Ca2+ signals in spatially separate resting mast cells. The paracrine signal was identified as a cysteinyl leukotriene because 1) RNAi knockdown or pharmacological block of the 5-lipoxygenase enzyme prevented activated mast cells from stimulating resting cells. 2) Block of cysteinyl leukotriene type I receptors on resting mast cells with the clinically prescribed receptor antagonist montelukast prevented their activation by active mast cells. 3) RNAi knockdown of cysteinyl leukotriene type I receptors on resting cells prevented them from responding to the paracrine signal derived from activated mast cells. 4) Purified LTC4 evoked Ca2+ signals in mast cells that were identical to those triggered by the paracrine signal. Low levels of stimulus intensity released sufficient levels of leukotriene to activate resting cells. Leukotriene secretion still occurred tens of minutes after stimulation, suggesting a role as a long-lasting trigger in mast cell activation. Stimulation of the cysteinyl leukotriene receptor activated CRAC channels and evoked prominent store-operated Ca2+ entry. This resulted in further cysteinyl leukotriene production, triggering a positive feedback cascade. Acutely isolated mast cells from patients with allergic rhinitis exhibited store-operated Ca2+ influx through CRAC channels and responded to cysteinyl leukotrienes. Histological analysis of samples taken from patients revealed clustering of mast cells, often located within 20 mu m of each other, a distance sufficient for paracrine signaling by leukotrienes to operate effectively. We conclude that a positive-feedback cascade involving CRAC channels and cysteinyl leukotrienes constitute a novel mechanism for sustaining mast cell activation.-Di Capite, J., Shirley, A., Nelson, C., Bates, G., Parekh, A. B. Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes. FASEB J. 23, 894-905 (2009)	[Di Capite, Joseph; Shirley, Anna; Nelson, Charmaine; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Bates, Grant] John Radcliffe Hosp, Dept Ear Nose & Throat Surg, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; Medical Research Council [G0601485] Funding Source: researchfish; MRC [G0601485] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Programme Grant to A. B. P. J.D.C. holds a Christopher Welch Scholarship.	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Beindl W, 1996, MOL PHARMACOL, V50, P415; Borish L, 2003, J ALLERGY CLIN IMMUN, V112, P1021, DOI 10.1016/j.jaci.2003.09.015; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2007, J IMMUNOL, V179, P5255, DOI 10.4049/jimmunol.179.8.5255; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; CRETICOS PS, 1984, NEW ENGL J MED, V310, P1626, DOI 10.1056/NEJM198406213102502; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hsieh Jie-Cheng, 2004, Pediatric Asthma Allergy & Immunology, V17, P59, DOI 10.1089/088318704322994958; Kawano T, 2003, J ALLERGY CLIN IMMUN, V112, P369, DOI 10.1067/mai.2003.1636; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lynch KR, 1999, NATURE, V399, P789; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peters-Golden M, 2006, CLIN EXP ALLERGY, V36, P689, DOI 10.1111/j.1365-2222.2006.02498.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney J W Jr, 2001, Mol Interv, V1, P84; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sjostrom M, 2002, BBA-MOL CELL BIOL L, V1583, P53, DOI 10.1016/S1388-1981(02)00160-9; Steinke JW, 2004, CURR ALLERGY ASTHM R, V4, P217, DOI 10.1007/s11882-004-0029-x; TAKASAKA T, 1986, ACTA OTO-LARYNGOL, P39; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; van Adelsberg J, 2003, ALLERGY, V58, P1268, DOI 10.1046/j.1398-9995.2003.00261.x; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Volovitz B, 1999, J ALLERGY CLIN IMMUN, V104, P1162, DOI 10.1016/S0091-6749(99)70008-4; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	48	33	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2009	23	3					894	905		10.1096/fj.08-118935	http://dx.doi.org/10.1096/fj.08-118935			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18978154				2022-12-25	WOS:000265506300025
J	Kitagaki, J; Yang, Y; Saavedra, JE; Colburn, NH; Keefer, LK; Perantoni, AO				Kitagaki, J.; Yang, Y.; Saavedra, J. E.; Colburn, N. H.; Keefer, L. K.; Perantoni, A. O.			Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53	ONCOGENE			English	Article						JS-K; nitric oxide (NO); ubiquitin; tumor; apoptosis; p53	IN-VITRO; BETA-CATENIN; APOPTOSIS; CANCER; DESTRUCTION; TRANSLATION; GLUTATHIONE; PATHWAYS; SYSTEM; GROWTH	Nitric oxide (NO) is a major effector molecule in cancer prevention. A number of studies have shown that NO prodrug JS-K (O-2-(2,4-dinitrophenyl) 1-[(4-ethoxy-carbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate) induces apoptotic cell death in vitro and in vivo, indicating that it is a promising new therapeutic for cancer. However, the mechanism of its tumor-killing activity remains unclear. Ubiquitin plays an important role in the regulation of tumorigenesis and cell apoptosis. Our earlier report has shown that inactivation of the ubiquitin system through blocking E1(ubiquitin-activating enzyme) activity preferentially induces apoptosis in p53-expressing transformed cells. As E1 has an active cysteine residue that could potentially interact with NO, we hypothesized that JS-K could inactivate E1 activity. E1 activity was evaluated by detecting ubiquitin-E1 conjugates through immunoblotting. JS-K strikingly inhibits the ubiquitin-E1 thioester formation in cells in a dose-dependent manner with an IC50 of approximately 2 mu M, whereas a JS-K analog that cannot release NO did not affect these levels in cells. Moreover, JS-K decreases total ubiquitylated proteins and increases p53 levels, which is mainly regulated by ubiquitin and proteasomal degradation. Furthermore, JS-K preferentially induces cell apoptosis in p53-expressing transformed cells. These findings indicate that JS-K inhibits E1 activity and kills transformed cells harboring wild-type p53.	[Kitagaki, J.; Yang, Y.; Perantoni, A. O.] Natl Canc Inst Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Natl Inst Hlth, Frederick, MD 21702 USA; [Saavedra, J. E.] Natl Canc Inst Frederick, Basic Res Program, SAIC Frederick, Ctr Canc Res,Natl Inst Hlth, Frederick, MD 21702 USA; [Colburn, N. H.] Natl Canc Inst Frederick, Lab Canc Prevent, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Keefer, L. K.] Natl Canc Inst Frederick, Comparat Carcinogenesis Lab, Ctr Canc Res, Natl Inst Hlth, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Perantoni, AO (corresponding author), Natl Canc Inst Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bldg 538,Rm 221,1050 Boyles St, Frederick, MD 21702 USA.	yangyili@ncifcrf.gov; peranton@ncifcrf.gov	Keefer, Larry K/N-3247-2014	Keefer, Larry K/0000-0001-7489-9555	NIH; National Cancer Institute; Center for Cancer Research; National Cancer Institute [NOI-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010025, ZIABC011188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the NIH Fellows Editorial Board for revisions of this paper. This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and by National Cancer Institute Contract No. NOI-CO-12400 to SAIC Inc. JK was a fellow of the Japanese Society for the Promotion of Science.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Liu J, 2004, MOL CANCER THER, V3, P709; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Ren ZG, 2003, J CELL PHYSIOL, V197, P426, DOI 10.1002/jcp.10380; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Shami PJ, 2006, J MED CHEM, V49, P4356, DOI 10.1021/jm060022h; Shami PJ, 2003, MOL CANCER THER, V2, P409; Simeone AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2095; Turchi JJ, 2006, P NATL ACAD SCI USA, V103, P4337, DOI 10.1073/pnas.0601001103; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Ying L, 2007, CANCER RES, V67, P1407, DOI 10.1158/0008-5472.CAN-06-2149	26	47	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					619	624		10.1038/onc.2008.401	http://dx.doi.org/10.1038/onc.2008.401			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18978812	Green Accepted			2022-12-25	WOS:000262866500015
J	Elzinga, BM; Twomey, C; Powell, JC; Harte, F; McCarthy, JV				Elzinga, Baukje M.; Twomey, Ciara; Powell, James C.; Harte, Frances; McCarthy, Justin V.			Interleukin-1 Receptor Type 1 Is a Substrate for gamma-Secretase-dependent Regulated Intramembrane Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; P75 NEUROTROPHIN RECEPTOR; C-TERMINAL FRAGMENT; SOLUBLE CYTOKINE RECEPTORS; TOLL-LIKE RECEPTORS; PRESENILIN FUNCTION; BETA-CATENIN; MOLECULAR-MECHANISM; LIGAND-BINDING; SHEDDING LIGHT	Biochemical and genetic studies have revealed that the presenilins interact with several proteins and are involved in the regulated intramembrane proteolysis of numerous type 1 membrane proteins, thereby linking presenilins to a range of cellular processes. In this study, we report the characterization of a highly conserved tumor necrosis factor receptor-associated factor-6 (TRAF6) consensus-binding site within the hydrophilic loop domain of presenilin-1 (PS-1). In coimmunoprecipitation studies we indicate that presenilin-1 interacts with TRAF6 and interleukin-1 receptor-associated kinase 2. Substitution of presenilin-1 residues Pro-374 and Glu-376 by site-directed mutagenesis greatly reduces the ability of PS1 to associate with TRAF6. By studying these interactions, we also demonstrate that the interleukin-1 receptor type 1 (IL-1R1) undergoes intramembrane proteolytic processing, mediated by presenilin-dependent gamma-secretase activity. A metalloprotease-dependent proteolytic event liberates soluble IL-1R1 ectodomain and produces an similar to 32-kDa C-terminal domain. This IL-1R1 C-terminal domain is a substrate for subsequent gamma-secretase cleavage, which generates an similar to 26-kDa intracellular domain. Specific pharmacological gamma-secretase inhibitors, expression of dominant negative presenilin-1, or presenilin deficiency independently inhibit generation of the IL-1 beta 1 intracellular domain. Attenuation of gamma-secretase activity also impairs responsiveness to IL-1-stimulated activation of the MAPKs and cytokine secretion. Thus, TRAF6 and interleukin receptor-associated kinase 2 are novel binding partners for PS1, and IL-1R1 is a new substrate for presenilin-dependent gamma-secretase cleavage. These findings also suggest that regulated intramembrane proteolysis may be a control mechanism for IL-1R1-mediated signaling.	[McCarthy, Justin V.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Analyt & Biol Chem Res Facil, Signal Transduct Lab, Cork, Ireland	University College Cork	McCarthy, JV (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Analyt & Biol Chem Res Facil, Signal Transduct Lab, Cavanagh Pharm Bldg, Cork, Ireland.	jv.mccarthy@ucc.ie	mccarthy, justin/AAG-7550-2019	mccarthy, justin/0000-0002-2667-7365	Science Foundation Ireland [02/IN1/B218]; Irish Research Council for Science, Engineering, and Technology [SC/2003/544/Y, IC/2004/103]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland Grant 02/IN1/B218 and the Irish Research Council for Science, Engineering, and Technology Grants SC/2003/544/Y and IC/2004/103. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama S, 2004, J BIOL CHEM, V279, P36616, DOI 10.1074/jbc.M406610200; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunkan AL, 2005, MOL CELL NEUROSCI, V29, P65, DOI 10.1016/j.mcn.2004.12.012; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; Cowan JW, 2005, J BIOL CHEM, V280, P19331, DOI 10.1074/jbc.M500621200; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; CURTIS BM, 1990, J IMMUNOL, V144, P1295; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; DOWER SK, 1989, J IMMUNOL, V142, P4314; Drevlow BE, 1996, ARTHRITIS RHEUM-US, V39, P257, DOI 10.1002/art.1780390212; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; Fernandez-Botran R, 2002, EXPERT OPIN BIOL TH, V2, P585, DOI 10.1517/14712598.2.6.585; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; GALLIS B, 1989, J IMMUNOL, V143, P3235; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kim JW, 2001, J CELL BIOL, V153, P457, DOI 10.1083/jcb.153.3.457; Kim MY, 2005, BIOCHEM BIOPH RES CO, V332, P609, DOI 10.1016/j.bbrc.2005.05.001; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Li JH, 2002, J NEUROCHEM, V82, P1540, DOI 10.1046/j.1471-4159.2002.01105.x; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Liu QA, 1999, ANN NY ACAD SCI, V887, P92, DOI 10.1111/j.1749-6632.1999.tb07925.x; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Mantovani A, 1998, ANN NY ACAD SCI, V840, P338, DOI 10.1111/j.1749-6632.1998.tb09573.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Maraver A, 2007, BLOOD, V110, P3218, DOI 10.1182/blood-2007-01-070359; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICOLETTI F, 1994, EUR J IMMUNOL, V24, P1843, DOI 10.1002/eji.1830240818; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; SLACK J, 1993, J BIOL CHEM, V268, P2513; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Twomey C, 2006, FEBS LETT, V580, P4015, DOI 10.1016/j.febslet.2006.06.035; Uemura K, 2007, NEUROSCIENCE, V145, P5, DOI 10.1016/j.neuroscience.2006.12.022; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yagi T, 2008, P NATL ACAD SCI USA, V105, P979, DOI 10.1073/pnas.0707755105; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	130	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1394	1409		10.1074/jbc.M803108200	http://dx.doi.org/10.1074/jbc.M803108200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996842	hybrid			2022-12-25	WOS:000262330100007
J	Hao, Q; Wang, L; Zhao, ZJ; Tang, H				Hao, Qin; Wang, Linping; Zhao, Z. Joe; Tang, Hua			Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR; NUCLEAR-LOCALIZATION; TYROSINE KINASE; DEFICIENT MICE; ACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; VEGF; NEOVASCULARIZATION	Angiogenesis, the formation of new blood vessels, plays a crucial role in normal physiological processes and in various pathological conditions. In the present study, we have investigated the physiological function of a newly described serine/threonine protein kinase D2 (PKD2) in aspects of endothelial cell biology involved in angiogenesis. We found that PKD2 was expressed in primary human endothelial cells from different tissues and was a critical PKD isoform mediating the phosphorylation of PKD substrates in endothelial cells. By using small interference RNAs that target different PKD2 regions, we found that silencing PKD2, but not PKD1 isoform, markedly inhibited the proliferation, migration, and in vitro angiogenesis of endothelial cells cultured in EGM-2 complete medium. We further showed that PKD2, but not PKD1, was required for the expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 that are two key growth factor receptors involved in angiogenesis. These findings indicate that PKD2 plays a pivotal role in endothelial cell proliferation and migration necessary for angiogenesis at least in part through modulation of the expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.	[Hao, Qin; Wang, Linping; Tang, Hua] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA; [Zhao, Z. Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Oklahoma System; University of Oklahoma Health Sciences Center	Tang, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Biochem, 11937 US Highway 271, Tyler, TX 75708 USA.	hua.tang@uthct.edu			American Heart Association [0855188F]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant-in-Aid 0855188F ( to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Jacobs J, 2007, DRUG DISCOV TODAY, V12, P1040, DOI 10.1016/j.drudis.2007.08.018; Liu P, 2007, FEBS LETT, V581, P1377, DOI 10.1016/j.febslet.2007.02.055; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papazyan R, 2006, BIOCHEM BIOPH RES CO, V342, P685, DOI 10.1016/j.bbrc.2006.02.013; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Ronicke V, 1996, CIRC RES, V79, P277, DOI 10.1161/01.RES.79.2.277; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; Tang H, 2002, J BIOL CHEM, V277, P5441, DOI 10.1074/jbc.M110673200; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					799	806		10.1074/jbc.M807546200	http://dx.doi.org/10.1074/jbc.M807546200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001381	hybrid			2022-12-25	WOS:000262122900014
J	Singh, K; Sinha, S; Malonia, SK; Bist, P; Tergaonkar, V; Chattopadhyay, S				Singh, Kamini; Sinha, Surajit; Malonia, Sunil Kumar; Bist, Pradeep; Tergaonkar, Vinay; Chattopadhyay, Samit			Tumor Suppressor SMAR1 Represses I kappa B alpha Expression and Inhibits p65 Transactivation through Matrix Attachment Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA LOCUS; HISTONE DEACETYLATION; THERAPEUTIC TARGET; GENE-EXPRESSION; NUCLEAR-MATRIX; CANCER-CELLS; IKK-ALPHA; ACTIVATION; CHROMATIN; TRANSCRIPTION	Aberrant NF-kappa B activity promotes tumorigenesis. However, NF-kappa B also inhibits tumor growth where tumor suppressor pathways remain unaltered. Thus, its role in tumorigenesis depends upon the function of other cellular factors. Tumor suppressor SMAR1 down-modulated in high grade breast cancers is regulated by p53 and is reported to interact and stabilize p53. Because both SMAR1 and NF-kappa B are involved in tumorigenesis, we investigated the effect of SMAR1 upon NF-kappa B activity. We show that SMAR1 induction by doxorubicin or overexpression produces functional NF-kappa B complexes that are competent for binding to NF-kappa B consensus sequence. However, SMAR1 induced p65-p50 complex is phosphorylation- and transactivation deficient. Induction of functional NF-kappa B complexes stems from down-regulation of I kappa B alpha transcription through direct binding of SMAR1 to the matrix attachment region site present in I kappa B alpha promoter and recruitment of corepressor complex. Real time PCR array for NF-kappa B target genes revealed that SMAR1 down-regulates a subset of NF-kappa B target genes that are involved in tumorigenesis. We also show that SMAR1 inhibits tumor necrosis factor alpha-induced induction of NF-kappa B suggesting that activation of NF-kappa B by SMAR1 is independent and different from classical pathway. Thus, for the first time we report that a tumor suppressor protein SMAR1 can modulate NF-kappa B transactivation and inhibit tumorigenesis by regulating NF-kappa B target genes.	[Singh, Kamini; Sinha, Surajit; Malonia, Sunil Kumar; Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Bist, Pradeep; Tergaonkar, Vinay] Inst Mol & Cellular Biol, Singapore 138673, Singapore	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chattopadhyay, S (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune 411007, Maharashtra, India.	samit@nccs.res.in	Malonia, Sunil/ABH-2506-2020; Malonia, Sunil/AAA-2470-2019; BIST, PRADEEP/AAG-7986-2019; Malonia, Sunil/AAX-3008-2020	Malonia, Sunil/0000-0002-2727-5165	Department of Biotechnology; Indian Council of Medical Research (ICMR), New Delhi, India	Department of Biotechnology; Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Department of Biotechnology and Indian Council of Medical Research (ICMR), New Delhi, India. The costs of publication of this article were defrayed in part by the payment of page charges.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Cortes J, 1997, LEUKEMIA LYMPHOMA, V26, P251, DOI 10.3109/10428199709051774; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goswami A, 2006, CANCER RES, V66, P2889, DOI 10.1158/0008-5472.CAN-05-4458; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Jalota-Badhwar A, 2007, J BIOL CHEM, V282, P9902, DOI 10.1074/jbc.M608434200; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kaul-Ghanekar R, 2005, J BIOL CHEM, V280, P9450, DOI 10.1074/jbc.M412206200; Kaul-Ghanekar R, 2004, NUCLEIC ACIDS RES, V32, P4862, DOI 10.1093/nar/gkh807; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Perkins ND, 2003, ONCOGENE, V22, P7553, DOI 10.1038/sj.onc.1207139; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	63	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1267	1278		10.1074/jbc.M801088200	http://dx.doi.org/10.1074/jbc.M801088200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981184	hybrid			2022-12-25	WOS:000262122900062
J	Vincent, HA; Deutscher, MP				Vincent, Helen A.; Deutscher, Murray P.			The Roles of Individual Domains of RNase R in Substrate Binding and Exoribonuclease Activity THE NUCLEASE DOMAIN IS SUFFICIENT FOR DIGESTION OF STRUCTURED RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CSPE; RIBOSOMAL-PROTEIN S1; ACID MELTING ACTIVITY; MESSENGER-RNA; RIBONUCLEASE-II; POLYNUCLEOTIDE PHOSPHORYLASE; SHOCK PROTEIN; TRANSCRIPTION ANTITERMINATION; PHYLOGENETIC DISTRIBUTION; SECONDARY STRUCTURE	RNase R and RNase II are the two representatives from the RNR family of processive, 3' to 5' exoribonucleases in Escherichia coli. Although RNase II is specific for single-stranded RNA, RNase R readily degrades through structured RNA. Furthermore, RNase R appears to be the only known 3' to 5' exoribonuclease that is able to degrade through double-stranded RNA without the aid of a helicase activity. Consequently, its functional domains and mechanism of action are of great interest. Using a series of truncated RNase R proteins we show that the cold-shock and S1 domains contribute to substrate binding. The cold-shock domains appear to play a role in substrate recruitment, whereas the S1 domain is most likely required to position substrates for efficient catalysis. Most importantly, the nuclease domain alone, devoid of the cold-shock and S1 domains, is sufficient for RNase R to bind and degrade structured RNAs. Moreover, this is a unique property of the nuclease domain of RNase R because this domain in RNase II stalls as it approaches a duplex. We also show that the nuclease domain of RNase R binds RNA more tightly than the nuclease domain of RNase II. This tighter binding may help to explain the difference in catalytic properties between RNase R and RNase II.	[Vincent, Helen A.; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Vincent, Helen/GZK-3422-2022		National Institutes of Health [GM16317]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cannistraro VJ, 1999, BBA-PROTEIN STRUCT M, V1433, P170, DOI 10.1016/S0167-4838(99)00136-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Jiang WN, 1997, J BIOL CHEM, V272, P196; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; KOLB A, 1977, P NATL ACAD SCI USA, V74, P2379, DOI 10.1073/pnas.74.6.2379; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114; Phadtare S, 2004, J MOL BIOL, V337, P147, DOI 10.1016/j.jmb.2004.01.023; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Phadtare S, 2002, J BIOL CHEM, V277, P7239, DOI 10.1074/jbc.M111496200; Phadtare S, 2005, NUCLEIC ACIDS RES, V33, P5583, DOI 10.1093/nar/gki859; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; SZER W, 1976, BIOCHEM BIOPH RES CO, V70, P957, DOI 10.1016/0006-291X(76)90685-9; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; THOMAS JO, 1978, J MOL BIOL, V123, P163, DOI 10.1016/0022-2836(78)90319-4; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	41	44	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					486	494		10.1074/jbc.M806468200	http://dx.doi.org/10.1074/jbc.M806468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004832	hybrid, Green Published			2022-12-25	WOS:000261974800053
J	Beckman, JW; Wang, QX; Guengerich, FP				Beckman, Jeff W.; Wang, Qixin; Guengerich, F. Peter			Kinetic Analysis of Correct Nucleotide Insertion by a Y-family DNA Polymerase Reveals Conformational Changes Both Prior to and following Phosphodiester Bond Formation as Detected by Tryptophan Fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; I KLENOW FRAGMENT; SULFOLOBUS-SOLFATARICUS; CRYSTAL-STRUCTURES; INDUCED-FIT; STRUCTURAL BASIS; MOLECULAR-BASIS; FINGER DOMAIN; ERROR-PRONE; FIDELITY	The Sulfolobus solfataricus Y-family DNA polymerase Dpo4 is a model for translesion replication and has been used in the analysis of individual steps involved in catalysis. The role of conformational changes has not been clear. Introduction of Trp residues into the Trp-devoid wild-type protein provided fluorescence probes of these events, particularly in the case of mutants T239W and N188W. With both mutants, a rapid increase in Trp fluorescence was observed only in the case of normal base pairing (G:C), was saturable with respect to dCTP concentration, and occurred in the absence of phosphodiester bond formation. A subsequent decrease in the Trp fluorescence occurred when phosphodiester bond formation was permitted, and these rates were independent of the dCTP concentration. This step is relatively slow and is attributed to a conformational relaxation step occurring after pyrophosphate release, which was measured and shown to be fast in a separate experiment. The measured rate of release of DNA from Dpo4 was rapid and is not rate-limiting. Overall, the measurements provide a kinetic scheme for Dpo4 different than generally accepted for replicative polymerases or proposed for Dpo4 and other Y-family polymerases: the initial enzyme.DNA.dNTP complex undergoes a rapid (18 s(-1)), reversible (21 s(-1)) conformational change, followed by relatively rapid phosphodiester bond formation (11 s(-1)) and then fast release of pyrophosphate, followed by a rate- limiting relaxation of the active conformation (2 s(-1)) and then rapid DNA release, yielding an overall steady-state k(cat) of <1 s(-1).	[Beckman, Jeff W.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Beckman, Jeff W.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Wang, Qixin] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES010375, P30 ES000267]; United States Public Health Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F.P.G.) and P30 ES000267 (to F.P.G.) from the United States Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Cramer J, 2005, J BIOL CHEM, V280, P40552, DOI 10.1074/jbc.M504481200; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson Kenneth A., 2003, P1; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Maniatis T., 1982, MOL CLONING LAB MANU; McCulloch SD, 2004, NUCLEIC ACIDS RES, V32, P4665, DOI 10.1093/nar/gkh777; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Roettger MP, 2008, BIOCHEMISTRY-US, V47, P9718, DOI 10.1021/bi800689d; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36711	36723		10.1074/jbc.M806785200	http://dx.doi.org/10.1074/jbc.M806785200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984592	hybrid, Green Published			2022-12-25	WOS:000261840500069
J	Expert, D; Boughammoura, A; Franza, T				Expert, Dominique; Boughammoura, Aida; Franza, Thierry			Siderophore-controlled Iron Assimilation in the Enterobacterium Erwinia chrysanthemi EVIDENCE FOR THE INVOLVEMENT OF BACTERIOFERRITIN AND THE Suf IRON-SULFUR CLUSTER ASSEMBLY MACHINERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; GENETIC-ANALYSIS; PROTEIN; FERRITIN; YGGX; ACQUISITION; FRATAXIN; BINDING; IDENTIFICATION	The intracellular fate of iron acquired by bacteria during siderophore-mediated assimilation is poorly understood. We investigated this question in the pathogenic enterobacterium Erwinia chrysanthemi. This bacterium produces two siderophores, chrysobactin and achromobactin, during plant infection. We analyzed the distribution of iron into cytosolic proteins in bacterial cells supplied with Fe-59-chrysobactin using native gel electrophoresis. A parental strain and mutants deficientin bacterioferritin(bfr), mini-ferritin (dps), ferritin (ftnA), bacterioferredoxin (bfd), or iron-sulfur cluster assembly machinery (sufABCDSE) were studied. In the parental strain, we observed two rapidly Fe-59-labeled protein signals identified as bacterioferritin and an iron pool associated to the protein chain-elongation process. In the presence of increased Fe-59-chrysobactin concentrations, we detected mini-ferritin bound iron. Iron incorporation into bacterioferritin was severely reduced in nonpolar sufA, sufB, sufD, sufS, and sufE mutants but not in a sufC background. Iron recycling from bacterioferritin did not occur in bfd and sufC mutants. Iron depletion caused a loss of aconitase activity, whereas ferric chrysobactin supplementation stimulated the production of active aconitase in parental cells and in bfr and bfd mutants. Aconitase activity in sufA, sufB, sufD, sufS, and sufE mutant strains was 10 times lower than that in parental cells. In the sufC mutant, it was twice as low as that in the parental strain. Defects observed in the mutants were not caused by altered ferric chrysobactin transport. Our data demonstrate a functional link between bacterioferritin, bacterioferredoxin, and the Suf protein machinery resulting in optimal bacterial growth and a balanced distribution of iron between essential metalloproteins.	[Expert, Dominique; Boughammoura, Aida; Franza, Thierry] Univ Paris 06, INRA, UMR 217, Lab Interact Plantes Pathogenes, F-75005 Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite	Expert, D (corresponding author), 16 Rue Claude Bernard, F-75005 Paris, France.	expert@agroparistech.fr		Thierry, Franza/0000-0003-3147-8210; Boughammoura, Aida/0000-0002-3718-2886	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This work was supported by the Institut National de la Recherche Agronomique. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1989, J BACTERIOL, V171, P3940, DOI 10.1128/jb.171.7.3940-3947.1989; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Franza T, 1999, MOL PLANT MICROBE IN, V12, P119, DOI 10.1094/MPMI.1999.12.2.119; FRANZA T, 1991, MOL MICROBIOL, V5, P1319, DOI 10.1111/j.1365-2958.1991.tb00778.x; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Garg RP, 1996, BIOCHEMISTRY-US, V35, P6297, DOI 10.1021/bi9600862; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gralnick JA, 2003, J BIOL CHEM, V278, P20708, DOI 10.1074/jbc.M301577200; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; KREWULAK KD, 2008, J BIOCH BIOPHYS ACTA, V1778, P1781; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; LUCASLENARD J, 1971, ANNU REV BIOCHEM, V40, P409, DOI 10.1146/annurev.bi.40.070171.002205; Matzanke BF, 1997, TRANSITION METALS IN MICROBIAL METABOLISM, P117; MENARD R, 1993, J BACTERIOL, V175, P5899; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; NEILANDS JB, 1991, BIOL MET, V4, P1, DOI 10.1007/BF01135550; Osborne MJ, 2005, PROTEIN SCI, V14, P1673, DOI 10.1110/ps.051358105; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854; Pomposiello PJ, 2003, J BACTERIOL, V185, P6624, DOI 10.1128/JB.185.22.6624-6632.2003; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quail MA, 1996, BIOCHEM BIOPH RES CO, V229, P635, DOI 10.1006/bbrc.1996.1856; Rauscher L, 2002, J BIOL CHEM, V277, P2385, DOI 10.1074/jbc.M107530200; RESIBOIS A, 1984, VIROLOGY, V137, P102, DOI 10.1016/0042-6822(84)90013-8; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; WALKER AC, 1976, P NATL ACAD SCI USA, V73, P1126, DOI 10.1073/pnas.73.4.1126; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; ZAZIALOV AV, 2003, CELL, V114, P113	59	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36564	36572		10.1074/jbc.M807749200	http://dx.doi.org/10.1074/jbc.M807749200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990691	Green Published, hybrid			2022-12-25	WOS:000261840500054
J	Fredriksson, K; Tjader, I; Keller, P; Petrovic, N; Ahlman, B; Scheele, C; Wernerman, J; Timmons, JA; Rooyackers, O				Fredriksson, Katarina; Tjader, Inga; Keller, Pernille; Petrovic, Natasa; Ahlman, Bo; Scheele, Camilla; Wernerman, Jan; Timmons, James A.; Rooyackers, Olav			Dysregulation of Mitochondrial Dynamics and the Muscle Transcriptome in ICU Patients Suffering from Sepsis Induced Multiple Organ Failure	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BLOOD-GLUCOSE CONTROL; GENE-EXPRESSION; PROTEIN-SYNTHESIS; INFLAMMATORY RESPONSE; RECEPTOR EXPRESSION; ATROPHY INVOLVE; INSULIN; TRANSLATION; DYSFUNCTION	Background: Septic patients treated in the intensive care unit (ICU) often develop multiple organ failure including persistent skeletal muscle dysfunction which results in the patient's protracted recovery process. We have demonstrated that muscle mitochondrial enzyme activities are impaired in septic ICU patients impairing cellular energy balance, which will interfere with muscle function and metabolism. Here we use detailed phenotyping and genomics to elucidate mechanisms leading to these impairments and the molecular consequences. Methodology/Principal Findings: Utilising biopsy material from seventeen patients and ten age-matched controls we demonstrate that neither mitochondrial in vivo protein synthesis nor expression of mitochondrial genes are compromised. Indeed, there was partial activation of the mitochondrial biogenesis pathway involving NRF2a/GABP and its target genes TFAM, TFB1M and TFB2M yet clearly this failed to maintain mitochondrial function. We therefore utilised transcript profiling and pathway analysis of ICU patient skeletal muscle to generate insight into the molecular defects driving loss of muscle function and metabolic homeostasis. Gene ontology analysis of Affymetrix analysis demonstrated substantial loss of muscle specific genes, a global oxidative stress response related to most probably cytokine signalling, altered insulin related signalling and a substantial overlap between patients and muscle wasting/inflammatory animal models. MicroRNA 21 processing appeared defective suggesting that post-transcriptional protein synthesis regulation is altered by disruption of tissue microRNA expression. Finally, we were able to demonstrate that the phenotype of skeletal muscle in ICU patients is not merely one of inactivity, it appears to be an actively remodelling tissue, influenced by several mediators, all of which may be open to manipulation with the aim to improve clinical outcome. Conclusions/Significance: This first combined protein and transcriptome based analysis of human skeletal muscle obtained from septic patients demonstrated that losses of mitochondria and muscle mass are accompanied by sustained protein synthesis (anabolic process) while dysregulation of transcription programmes appears to fail to compensate for increased damage and proteolysis. Our analysis identified both validated and novel clinically tractable targets to manipulate these failing processes and pursuit of these could lead to new potential treatments.	[Fredriksson, Katarina; Tjader, Inga; Scheele, Camilla; Wernerman, Jan; Rooyackers, Olav] Karolinska Univ Hosp, Dept Anesthesiol & Intens Care, Karolinska Inst, Stockholm, Sweden; [Keller, Pernille; Timmons, James A.] Heriot Watt Univ, Edinburgh EH14 4AS, Midlothian, Scotland; [Ahlman, Bo] Karolinska Inst, CLINTEC, Dept Surg, Stockholm, Sweden; [Petrovic, Natasa; Timmons, James A.] Stockholm Univ, Wenner Gren Inst, Arrhenius Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Heriot Watt University; Karolinska Institutet; Stockholm University	Fredriksson, K (corresponding author), Karolinska Univ Hosp, Dept Anesthesiol & Intens Care, Karolinska Inst, Stockholm, Sweden.	olav.rooyackers@ki.se	Scheele, Camilla/S-6401-2017; Timmons, James A/M-6350-2019; Scheele, Camilla/AAA-3599-2020; Timmons, James A/J-4698-2014	Scheele, Camilla/0000-0002-6055-9709; Timmons, James A/0000-0002-2255-1220; Scheele, Camilla/0000-0002-6055-9709; Timmons, James A/0000-0002-2255-1220	Swedisch Research Council [04210, 14244]; Karolinska Research Foundation; Karolinska University Hospital; Heriot-Watt University	Swedisch Research Council; Karolinska Research Foundation; Karolinska University Hospital(Karolinska Institutet); Heriot-Watt University	These studies were supported by grants from the Swedisch Research Council (grants 04210 and 14244), Karolinska Research Foundation, Karolinska University Hospital Research Funds and Heriot-Watt University Funds. None of the sponsors or funders were involved in design or conduct of the study or the manuscript.	Almon RR, 2007, PHYSIOL GENOMICS, V30, P282, DOI 10.1152/physiolgenomics.00242.2006; Banwell BL, 2003, NEUROLOGY, V61, P1779, DOI 10.1212/01.WNL.0000098886.90030.67; Boczkowski J, 1999, FASEB J, V13, P1637, DOI 10.1096/fasebj.13.12.1637; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; BONE RC, 1992, JAMA-J AM MED ASSOC, V267, P1518, DOI 10.1001/jama.267.11.1518; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; CORBUCCI GG, 1985, CIRC SHOCK, V15, P15; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Cree MG, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-9; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; De Jonghe B, 1998, INTENS CARE MED, V24, P1242, DOI 10.1007/s001340050757; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fink Mitchell P, 2004, Curr Opin Crit Care, V10, P279, DOI 10.1097/01.ccx.0000130150.33814.71; Flaring UB, 2003, INTENS CARE MED, V29, P2193, DOI 10.1007/s00134-003-2031-5; Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x; Fredriksson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1044, DOI 10.1152/ajpendo.00218.2006; GASPARETTO A, 1983, LANCET, V2, P1486; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; HELLIWELL TR, 1990, J NEUROL SCI S, V98, P329; HENNIG G, 1975, FEBS LETT, V59, P142, DOI 10.1016/0014-5793(75)80361-9; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu ZY, 2007, DIABETES, V56, P2449, DOI 10.2337/db06-1731; Januszkiewicz A, 2005, CLIN SCI, V108, P179, DOI 10.1042/CS20040271; Keller C, 2005, J APPL PHYSIOL, V99, P2075, DOI 10.1152/japplphysiol.00590.2005; Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; MCNURLAN MA, 1994, AM J PHYSIOL, V267, pE102, DOI 10.1152/ajpendo.1994.267.1.E102; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robinson CE, 1999, ENDOCRINOLOGY, V140, P1586, DOI 10.1210/en.140.4.1586; Rooyackers OE, 1997, CLIN SCI, V92, P189, DOI 10.1042/cs0920189; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; STEPHENS FB, 2005, FASEB J; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Sugiura T, 2006, J PHYSIOL SCI, V56, P393, DOI 10.2170/physiolsci.RP006906; Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thorell A, 2004, J CLIN ENDOCR METAB, V89, P5382, DOI 10.1210/jc.2004-1118; Timmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Wiik A, 2005, ACTA PHYSIOL SCAND, V184, P105, DOI 10.1111/j.1365-201X.2005.01433.x	69	115	119	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3686	10.1371/journal.pone.0003686	http://dx.doi.org/10.1371/journal.pone.0003686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997871	Green Published, Green Submitted, gold			2022-12-25	WOS:000265165500009
J	Catano, G; Kulkarni, H; He, W; Marconi, VC; Agan, BK; Landrum, M; Anderson, S; Delmar, J; Telles, V; Song, L; Castiblanco, J; Clark, RA; Dolan, MJ; Ahuja, SK				Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Delmar, Judith; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles	PLOS ONE			English	Article								A recent genome-wide association study (GWAS) suggested that polymorphisms in or around the genes HCP5, HLA-C and ZNRD1 confer restriction against HIV-1 viral replication or disease progression. Here, we also find that these alleles are associated with different aspects of HIV disease, albeit mainly in European Americans. Additionally, we offer that because the GWAS cohort was a subset of HIV-positive individuals, selected based in part on having a low viral load, the observed associations for viral load are magnified compared with those we detect in a large well-characterized prospective natural history cohort of HIV-1-infected persons. We also find that because of linkage disequilibrium (LD) patterns, the dominant viral load- and disease-influencing associations for the ZNRD1 or HLA-C and HCP5 alleles are apparent mainly when these alleles are present in HLA-A10- or HLA-B*57-containing haplotypes, respectively. ZNRD1 alleles lacking HLA-A10 did not confer disease protection whereas ZNRD1-A10 haplotypes did. When examined in isolation, the HCP5-G allele associates with a slow disease course and lower viral loads. However, in multivariate models, after partitioning out the protective effects of B*57, the HCP5-G allele associates with disease-acceleration and enhanced viral replication; these associations for HCP5-G are otherwise obscured because of the very strong LD between this allele and a subset of protective B*57 alleles. Furthermore, HCP5 and HLA-C alleles stratify B*57-containing genotypes into those that associate with either striking disease retardation or progressive disease, providing one explanation for the long-standing conundrum of why some HLA-B*57-carrying individuals are long-term non-progressors, whereas others exhibit progressive disease. Collectively, these data generally underscore the strong dependence of genotype-phenotype relationships upon cohort design, phenotype selection, LD patterns and populations studied. They specifically demonstrate that the influence of ZNRD1 alleles on disease progression rates are attributable to HLA-A10, help clarify the relationship between the HCP5, HLA-C and HLA-B*57 alleles, and reaffirm a critical role of HLA-B*57 alleles in HIV disease. Furthermore, as the protective B*57-containing genotypes convey striking salutary effects independent of their strong impact on viral control, it is conceivable that T cell-based therapeutic vaccine strategies aimed at reducing viral loads may be inadequate for limiting AIDS progression, raising the potential need for complementary strategies that target viral load- independent determinants of pathogenesis.	[Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Ahuja, Sunil K.] Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Catano, Gabriel; Kulkarni, Hemant; He, Weijing; Telles, Vanessa; Song, Li; Castiblanco, John; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; [Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Delmar, Judith; Dolan, Matthew J.] Uniformed Serv Univ Hlth Sci, IDCRP, Bethesda, MD USA; [Marconi, Vincent C.; Agan, Brian K.; Landrum, Michael; Delmar, Judith; Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Agan, Brian K.; Landrum, Michael; Anderson, Stephanie; Dolan, Matthew J.] Wilford Hall US Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol, San Antonio, TX USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Catano, G (corresponding author), Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA.	mdolan@hjf.org; ahujas@uthscsa.edu	Clark, Robert/Q-6764-2019; CASTIBLANCO, JOHN/B-6599-2009; Catano, Gabriel/AAQ-5387-2020; Kulkarni, Hemant/AEM-5750-2022; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/AFK-5812-2022	Clark, Robert/0000-0002-4892-3619; CASTIBLANCO, JOHN/0000-0002-7965-9822; Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; CASTIBLANCO, JOHN/0000-0003-2556-3697; Agan, Brian/0000-0002-5114-1669	Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System; MERIT award [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF); HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326, R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System; MERIT award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF); HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System, and by a MERIT award (R37046326) and other awards (AI043279 and MH069270) from the NIH (to S.K.A.). S.K.A. is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the WHMC cohort was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2007, JAIDS-J ACQ IMM DEF, V45, P454, DOI 10.1097/QAI.0b013e3180959a94; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blower S., 2003, AIDS Reviews, V5, P113; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Catano G, 2008, J INFECT DIS, V198, P72, DOI 10.1086/588712; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DEBAKKER PIW, 2008, KEYST S MOL CELL BIO; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Dorak MT, 2006, GENES IMMUN, V7, P450, DOI 10.1038/sj.gene.6364315; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gilbert PB, 2003, BIOMETRICS, V59, P531, DOI 10.1111/1541-0420.00063; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Goulder P, 1996, AIDS, V10, P1441, DOI 10.1097/00002030-199610000-00025; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Henry WK, 2006, JAMA-J AM MED ASSOC, V296, P1523, DOI 10.1001/jama.296.12.1523; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Klenerman P, 1996, AIDS, V10, P348, DOI 10.1097/00002030-199603000-00023; Kurane I, 2003, J CLIN VIROL, V27, P38, DOI 10.1016/S1386-6532(02)00109-9; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; *NIH, 2001, AIDS VACC TRIALS CON; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Smith Miranda Z, 2005, Sex Health, V2, P53, DOI 10.1071/SH04057; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; vanBaalen CA, 1996, J GEN VIROL, V77, P1659, DOI 10.1099/0022-1317-77-8-1659; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075	60	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3636	10.1371/journal.pone.0003636	http://dx.doi.org/10.1371/journal.pone.0003636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982067	Green Submitted, gold, Green Published			2022-12-25	WOS:000265134300006
J	Lecca, D; Trincavelli, ML; Gelosa, P; Sironi, L; Ciana, P; Fumagalli, M; Villa, G; Verderio, C; Grumelli, C; Guerrini, U; Tremoli, E; Rosa, P; Cuboni, S; Martini, C; Buffo, A; Cimino, M; Abbracchio, MP				Lecca, Davide; Trincavelli, Maria Letizia; Gelosa, Paolo; Sironi, Luigi; Ciana, Paolo; Fumagalli, Marta; Villa, Giovanni; Verderio, Claudia; Grumelli, Carlotta; Guerrini, Uliano; Tremoli, Elena; Rosa, Patrizia; Cuboni, Serena; Martini, Claudia; Buffo, Annalisa; Cimino, Mauro; Abbracchio, Maria P.			The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair	PLOS ONE			English	Article								Deciphering the mechanisms regulating the generation of new neurons and new oligodendrocytes, the myelinating cells of the central nervous system, is of paramount importance to address new strategies to replace endogenous damaged cells in the adult brain and foster repair in neurodegenerative diseases. Upon brain injury, the extracellular concentrations of nucleotides and cysteinyl-leukotrienes (cysLTs), two families of endogenous signaling molecules, are markedly increased at the site of damage, suggesting that they may act as "danger signals'' to alert responses to tissue damage and start repair. Here we show that, in brain telencephalon, GPR17, a recently deorphanized receptor for both uracil nucleotides and cysLTs (e. g., UDPglucose and LTD(4)), is normally present on neurons and on a subset of parenchymal quiescent oligodendrocyte precursor cells. We also show that induction of brain injury using an established focal ischemia model in the rodent induces profound spatiotemporal-dependent changes of GPR17. In the lesioned area, we observed an early and transient up-regulation of GPR17 in neurons expressing the cellular stress marker heat shock protein 70. Magnetic Resonance Imaging in living mice showed that the in vivo pharmacological or biotechnological knock down of GPR17 markedly prevents brain infarct evolution, suggesting GPR17 as a mediator of neuronal death at this early ischemic stage. At later times after ischemia, GPR17 immuno-labeling appeared on microglia/macrophages infiltrating the lesioned area to indicate that GPR17 may also acts as a player in the remodeling of brain circuitries by microglia. At this later stage, parenchymal GPR17(+) oligodendrocyte progenitors started proliferating in the peri-injured area, suggesting initiation of remyelination. To confirm a specific role for GPR17 in oligodendrocyte differentiation, the in vitro exposure of cortical pre-oligodendrocytes to the GPR17 endogenous ligands UDPglucose and LTD4 promoted the expression of myelin basic protein, confirming progression toward mature oligodendrocytes. Thus, GPR17 may act as a "sensor'' that is activated upon brain injury on several embryonically distinct cell types, and may play a key role in both inducing neuronal death inside the ischemic core and in orchestrating the local remodeling/repair response. Specifically, we suggest GPR17 as a novel target for therapeutic manipulation to foster repair of demyelinating wounds, the types of lesions that also occur in patients with multiple sclerosis.	[Lecca, Davide; Gelosa, Paolo; Sironi, Luigi; Ciana, Paolo; Fumagalli, Marta; Villa, Giovanni; Guerrini, Uliano; Tremoli, Elena; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Trincavelli, Maria Letizia; Cuboni, Serena; Martini, Claudia] Univ Pisa, Dept Psychiat, Neurobiol, Pharmacol & Biotechnol, I-56100 Pisa, Italy; [Villa, Giovanni] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Verderio, Claudia; Grumelli, Carlotta; Rosa, Patrizia] Univ Milan, CNR, Inst Neurosci, I-20122 Milan, Italy; [Tremoli, Elena] IRCCS, Monzino Cardiol Ctr, Milan, Italy; [Buffo, Annalisa] Univ Turin, Dept Neurosci, I-10124 Turin, Italy; [Cimino, Mauro] Univ Urbino, Inst Pharmacol & Pharmacognosy, I-61029 Urbino, Italy	University of Milan; University of Pisa; IRCCS Bonino Pulejo; Consiglio Nazionale delle Ricerche (CNR); University of Milan; IRCCS Centro Cardiologico Monzino; University of Turin; University of Urbino	Lecca, D (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	mariapia.abbracchio@unimi.it	Verderio, Claudia/K-4415-2016; tremoli, elena/C-1035-2011; Sironi, Luigi/S-8174-2016; Lecca, Davide/A-8850-2010; Buffo, Annalisa/O-7207-2019; Abbracchio, Maria Pia/B-9342-2014; Fumagalli, Marta/AEP-4117-2022; Martini, Claudia/AAC-4089-2019; Buffo, Annalisa/K-4560-2016; Gelosa, Paolo/K-5210-2016; Messier, Claude/A-2322-2008; Ciana, Paolo/F-9224-2012; Trincavelli, Maria Letizia/M-1921-2015; TREMOLI, ELENA/I-8126-2018	Verderio, Claudia/0000-0001-7216-5873; Lecca, Davide/0000-0002-3258-363X; Buffo, Annalisa/0000-0001-7637-0006; Abbracchio, Maria Pia/0000-0002-7833-3388; Martini, Claudia/0000-0001-9379-3027; Buffo, Annalisa/0000-0001-7637-0006; Gelosa, Paolo/0000-0003-4442-537X; Messier, Claude/0000-0002-4791-1763; Trincavelli, Maria Letizia/0000-0001-8124-977X; Rosa, Patrizia/0000-0002-2590-6955; SIRONI, LUIGI/0000-0002-4738-3454; CIANA, PAOLO/0000-0001-5771-5638; Fumagalli, Marta/0000-0002-0158-842X; TREMOLI, ELENA/0000-0002-0929-6106	Italian Ministry of Education; Progetti FIRB2003 [RBNE03YA3L_009]; COFIN-MIUR [2006059022]; CARIPLO Foundation [2006/0882]; University of Milan; Fondazione CRT; Centro Neurolesi "Bonino-Pulejo", Messina, Italy [fellowship]	Italian Ministry of Education; Progetti FIRB2003; COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO Foundation(Fondazione Cariplo); University of Milan; Fondazione CRT(Fondazione CRT); Centro Neurolesi "Bonino-Pulejo", Messina, Italy	This project was supported by the Italian Ministry of Education, Progetti FIRB2003 #RBNE03YA3L_009 and COFIN-MIUR 2006059022 "PURINOCEPTORS AND NEUROPROTECTION" to MPA, and by the CARIPLO Foundation Grant 2006/0882 "GENOMICS AND PROTEOMICS OF G PROTEIN-COUPLED RECEPTORS: NOVEL TARGETS FOR THE DIAGNOSIS AND PREVENTION OF HUMAN DISEASES" to prof. Francesco Clementi, University of Milan, by the Progetto Alfieri, Fondazione CRT to AB. GV has been supported by a fellowship by the Centro Neurolesi "Bonino-Pulejo", Messina, Italy.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Armstrong JN, 1996, NEUROSCIENCE, V74, P685, DOI 10.1016/0306-4522(96)00164-9; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Blasius R, 1998, J NEUROCHEM, V70, P1357; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Drazen JM, 2003, ADV EXP MED BIOL, V525, P1; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; Guerrini U, 2002, STROKE, V33, P825, DOI 10.1161/hs0302.104111; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Menegon A, 2002, J NEUROSCI, V22, P7016; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Samuelsson B, 2000, AM J RESP CRIT CARE, V161, pS2, DOI 10.1164/ajrccm.161.supplement_1.ltta-1; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Stein CA, 2001, J CLIN INVEST, V108, P641, DOI 10.1172/JCI13885; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tepper JM, 1997, J NEUROSCI, V17, P2519; Van Oekelen D, 2003, BRAIN RES REV, V42, P123, DOI 10.1016/S0165-0173(03)00153-X	37	178	189	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3579	10.1371/journal.pone.0003579	http://dx.doi.org/10.1371/journal.pone.0003579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974869	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131700005
J	Pulskens, WP; Teske, GJ; Butter, LM; Roelofs, JJ; van der Poll, T; Florquin, S; Leemans, JC				Pulskens, Wilco P.; Teske, Gwendoline J.; Butter, Loes M.; Roelofs, Joris J.; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							CYTOKINE PRODUCTION; CUTTING EDGE; IFN-GAMMA; TLR4; ISCHEMIA; CELLS; TOLL-LIKE-RECEPTOR-4; PROLIFERATION; INHIBITION; ACTIVATION	Toll-like receptors (TLRs) can detect endogenous danger molecules released upon tissue injury resulting in the induction of a proinflammatory response. One of the TLR family members, TLR4, is constitutively expressed at RNA level on renal epithelium and this expression is enhanced upon renal ischemia/reperfusion (I/R) injury. The functional relevance of this organ-specific upregulation remains however unknown. We therefore investigated the specific role of TLR4 and the relative contribution of its two downstream signaling cascades, the MyD88-dependent and TRIF-dependent cascades in renal damage by using TLR4-/-, MyD88-/- and TRIF-mutant mice that were subjected to renal ischemia/reperfusion injury. Our results show that TLR4 initiates an exaggerated proinflammatory response upon I/R injury, as reflected by lower levels of chemokines and infiltrating granulocytes, less renal damage and a more preserved renal function in TLR4-/- 2 mice as compared to wild type mice. In vitro studies demonstrate that renal tubular epithelial cells can coordinate an immune response to ischemic injury in a TLR4-dependent manner. In vivo we found that epithelial- and leukocyte-associated functional TLR4 contribute in a similar proportion to renal dysfunction and injury as assessed by bone marrow chimeric mice. Surprisingly, no significant differences were found in renal function and inflammation in MyD88-/- and TRIF-mutant mice compared with their wild types, suggesting that selective targeting of TLR4 directly may be more effective for the development of therapeutic tools to prevent I/R injury than targeting the intracellular pathways used by TLR4. In conclusion, we identified TLR4 as a cellular sentinel for acute renal damage that subsequently controls the induction of an innate immune response.	[Pulskens, Wilco P.; Teske, Gwendoline J.; Butter, Loes M.; Roelofs, Joris J.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pulskens, WP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	w.p.pulskens@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Pulskens, Wilco/P-6023-2015; Florquin, Sandrine/B-8242-2012	Pulskens, Wilco/0000-0001-9697-3189; Florquin, Sandrine/0000-0002-9676-1722; Roelofs, Joris/0000-0001-9595-6571	Dutch Scientific Organization	Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO))	This study has been founded by Dutch Scientific Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Fitzgerald KA, 2000, MICROBES INFECT, V2, P933, DOI 10.1016/S1286-4579(00)00396-8; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoshino K, 1999, J IMMUNOL, V162, P3749; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kim BS, 2005, TRANSPLANTATION, V79, P1370, DOI 10.1097/01.TP.0000158355.83327.62; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; MORSE HC, 1992, J IMMUNOL, V149, P3129; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893; Schnare M, 2006, INT ARCH ALLERGY IMM, V139, P75, DOI 10.1159/000090001; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimamoto A, 2006, ANN THORAC SURG, V82, P2017, DOI 10.1016/j.athoracsur.2006.06.079; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wang K, 2007, CHEM BIODIVERS, V4, P514, DOI 10.1002/cbdv.200790044; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; WU H, 2007, J CLIN INVEST; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029	42	179	193	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3596	10.1371/journal.pone.0003596	http://dx.doi.org/10.1371/journal.pone.0003596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974879	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131700017
J	Izzotti, A; Calin, GA; Arrigo, P; Steele, VE; Croce, CM; De Flora, S				Izzotti, Alberto; Calin, George A.; Arrigo, Patrizio; Steele, Vernon E.; Croce, Carlo M.; De Flora, Silvio			Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke	FASEB JOURNAL			English	Article						mirnome; transcriptome; proteome; microarrays	GENE-EXPRESSION; CANCER; CHEMOPREVENTION; POLYMORPHISM; CARCINOGENS; INHIBITION; MODULATION; APOPTOSIS; PROFILES; GENOME	Although microRNAs have been investigated extensively in cancer research, little is known regarding their response to noxious agents in apparently healthy tissues. We analyzed the expression of 484 miRNAs in the lungs of rats exposed to environmental cigarette smoke (ECS) for 28 days. ECS down-regulated 126 miRNAs (26.0%) at least 2-fold and 24 miRNAs more than 3-fold. We previously demonstrated that 107 of 4858 genes (2.9%) and 50 of 518 proteins (9.7%) were up-regulated by ECS in the same tissue, which is consistent with the role of microRNAs as negative regulators of gene expression. The most remarkably down-regulated microRNAs belonged to the families of let-7, miR-10, miR-26, miR-30, miR-34, miR-99, miR-122, miR-123, miR-124, miR-125, miR-140, miR-145, miR-146, miR-191, miR-192, miR-219, miR-222, and miR-223, which regulate stress response, apoptosis, proliferation, angiogenesis, and expression of genes. In contrast, miR-294, an inhibitor of transcriptional repressor genes, was up-regulated by ECS. There was a strong parallelism in dysregulation of rodent microRNAs and their human homologues, which are often transcribed from genes localized in fragile sites deleted in lung cancer. Five ECS-down-regulated microRNAs are known to be affected by single nucleotide polymorphisms. Thus, changes in microRNA expression are an early event following exposure to cigarette smoke.-Izzotti, A., Calin, G. A., Arrigo, P., Steele, V. E., Croce, C. M., De Flora, S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23, 806-812 (2009)	[Izzotti, Alberto; De Flora, Silvio] Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Arrigo, Patrizio] CNR, Inst Study Macromol, Genoa, Italy; [Steele, Vernon E.] NCI, Rockville, MD USA; [Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Genoa; University of Texas System; UTMD Anderson Cancer Center; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Via Pastore 1, I-16132 Genoa, Italy.	sdf@unige.it	Young, Richard A/F-6495-2012; Calin, George/E-9390-2011	Young, Richard A/0000-0001-8855-8647; izzotti, alberto/0000-0002-8588-0347; Calin, George/0000-0001-6704-5615; arrigo, patrizio/0000-0002-6735-0211	U.S. National Cancer Institute [N01-CN 53301]	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the U.S. National Cancer Institute (contract N01-CN 53301).	Balansky R, 1996, CANCER RES, V56, P1642; Balansky R, 2007, CARCINOGENESIS, V28, P2236, DOI 10.1093/carcin/bgm122; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; De Flora S, 2003, CANCER RES, V63, P793; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Izzotti A, 2005, MUTAT RES-FUND MOL M, V591, P212, DOI 10.1016/j.mrfmmm.2005.03.032; Izzotti A, 2005, EUR J CANCER, V41, P1864, DOI 10.1016/j.ejca.2005.04.011; Izzotti A, 2004, CANCER RES, V64, P8566, DOI 10.1158/0008-5472.CAN-04-1420; Izzotti A, 2004, FASEB J, V18, P1559, DOI 10.1096/fj.04-1877fje; Izzotti A, 2003, FASEB J, V17, P1127, DOI 10.1096/fj.02-0967fje; Izzotti A, 1999, CARCINOGENESIS, V20, P1499, DOI 10.1093/carcin/20.8.1499; Izzotti A, 2007, CARCINOGENESIS, V28, P892, DOI 10.1093/carcin/bgl208; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; *US DEP HHS, 1989, DHHS PUBL, P43; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	43	349	367	1	46	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					806	812		10.1096/fj.08-121384	http://dx.doi.org/10.1096/fj.08-121384			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18952709	Green Published			2022-12-25	WOS:000265506300016
J	Nithianantham, S; Xu, M; Yamada, M; Ikegami, A; Shoham, M; Han, YW				Nithianantham, Stanley; Xu, Minghua; Yamada, Mitsunori; Ikegami, Akihiko; Shoham, Menachem; Han, Yiping W.			Crystal Structure of FadA Adhesin from Fusobacterium nucleatum Reveals a Novel Oligomerization Motif, the Leucine Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; COLICIN-E3; BACTERIA; CELLS; MICE	Many bacterial appendages have filamentous structures, often composed of repeating monomers assembled in a head-to-tail manner. The mechanisms of such linkages vary. We report here a novel protein oligomerization motif identified in the FadA adhesin from the Gram-negative bacterium Fusobacterium nucleatum. The 2.0 angstrom crystal structure of the secreted form of FadA (mFadA) reveals two antiparallel alpha-helices connected by an intervening 8-residue hairpin loop. Leucine-leucine contacts play a prominent dual intra- and intermolecular role in the structure and function of FadA. First, they comprise the main association between the two helical arms of the monomer; second, they mediate the head-to-tail association of monomers to form the elongated polymers. This leucine-mediated filamentous assembly of FadA molecules constitutes a novel structural motif termed the "leucine chain." The essential role of these residues in FadA is corroborated by mutagenesis of selected leucine residues, which leads to the abrogation of oligomerization, filament formation, and binding to host cells.	[Nithianantham, Stanley; Shoham, Menachem] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Xu, Minghua; Yamada, Mitsunori; Ikegami, Akihiko; Han, Yiping W.] Case Western Reserve Univ, Dept Periodont, Cleveland, OH 44106 USA; [Han, Yiping W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Han, YW (corresponding author), 2123 Abington Rd,Rm 3580, Cleveland, OH 44106 USA.	yiping.han@case.edu			National Institutes of Health [RO1DE14924, KO2DE16102, R21DE17165]; Philip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K02DE016102, R21DE017165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DE14924, KO2DE16102, and R21DE17165 (to Y.W.H.). This work was also supported by a grant from the Philip Morris External Research Program (to Y.W.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P9, DOI 10.1007/BF02718273; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Nithianantham S, 2006, ACTA CRYSTALLOGR F, V62, P1215, DOI 10.1107/S1744309106045593; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200	21	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3865	3872		10.1074/jbc.M805503200	http://dx.doi.org/10.1074/jbc.M805503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18996848	hybrid, Green Published			2022-12-25	WOS:000262872500055
J	Bonetto, S; Spadola, L; Buchanan, AG; Jermutus, L; Lund, J				Bonetto, Stephane; Spadola, Loredana; Buchanan, Andrew G.; Jermutus, Lutz; Lund, John			Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gamma RI	FASEB JOURNAL			English	Article						effector functions; phage display; single-chain homodimer; molecular modeling; discontinuous interface; consensus sequence	AFFINITY IGE RECEPTOR; CRYSTAL-STRUCTURE; BINDING PEPTIDE; PHAGE DISPLAY; INTERACTION SITES; MOLECULAR-BASIS; COMPLEX; RECOGNITION; FRAGMENT; DOMAIN	Identification of short, structured peptides able to mimic potently protein-protein interfaces remains a challenge in drug discovery. We report here the use of a naive cyclic peptide phage display library to identify peptide ligands able to recognize and mimic IgG1-Fc functions with Fc gamma RI. Selection by competing off binders to Fc gamma RI with IgG1 allowed the isolation of a family of peptides sharing the common consensus sequence TX2CXX theta PXLLGC Phi XE (theta represents a hydrophobic residue, Phi is usually an acidic residue, and X is any residue) and able to inhibit IgG1 binding to Fc gamma RI. In soluble form, these peptides antagonize superoxide generation mediated by IgG1. In complexed form, they trigger phagocytosis and a superoxide burst. Unlike IgG, these peptides are strictly Fc gamma RI-specific among the Fc gamma Rs. Molecular modeling studies suggest that these peptides can adopt 2 distinct and complementary conformers, each able to mimic the discontinuous interface contacts constituted by the C gamma 2-A and -B chains of Fc for Fc gamma RI. In addition, by covalent homodimerization, we engineered a synthetic bivalent 37-mer peptide that retains the ability to trigger effector functions. We demonstrate here that it is feasible to maintain IgG-Fc function within a small structured peptide. These peptides represent a new format for modulation of effector functions. Bonetto, S., Spadola, L., Buchanan, A. G., Jermutus, L. Lund, J. Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gamma RI. FASEB J. 23, 575-585 (2009)	[Bonetto, Stephane; Buchanan, Andrew G.; Jermutus, Lutz; Lund, John] MedImmune, Res, Cambridge CB21 6GH, England; [Spadola, Loredana] AstraZeneca R&D, DECS Global Cpds Sci, Molndal, Sweden	AstraZeneca; Medimmune; AstraZeneca	Jermutus, L (corresponding author), MedImmune, Res, Granta Pk,Milstein Bldg, Cambridge CB21 6GH, England.	jermutusl@medimmune.com; lundj@medimmune.com	Jermutus, Lutz/AAU-2047-2020	Buchanan, Andrew/0000-0002-5191-7682				Berntzen G, 2006, PROTEIN ENG DES SEL, V19, P121, DOI 10.1093/protein/gzj011; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cendron AC, 2008, MOL IMMUNOL, V45, P307, DOI 10.1016/j.molimm.2007.06.152; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; England BP, 2000, P NATL ACAD SCI USA, V97, P6862, DOI 10.1073/pnas.110053997; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LU ZY, 1992, EUR J IMMUNOL, V22, P2819, DOI 10.1002/eji.1830221110; LUND J, 1992, MOL IMMUNOL, V29, P53, DOI 10.1016/0161-5890(92)90156-R; LUND J, 1991, J IMMUNOL, V147, P2657; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Marino M, 2000, NAT BIOTECHNOL, V18, P735, DOI 10.1038/77296; MORGAN A, 1995, IMMUNOLOGY, V86, P319; Mori T, 2004, CURR PHARM DESIGN, V10, P2335, DOI 10.2174/1381612043383944; Nakamura GR, 2002, P NATL ACAD SCI USA, V99, P1303, DOI 10.1073/pnas.022635599; Nakamura GR, 2001, BIOCHEMISTRY-US, V40, P9828, DOI 10.1021/bi0109360; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; POUND JD, 1993, MOL IMMUNOL, V30, P233, DOI 10.1016/0161-5890(93)90052-D; Qiu XQ, 2007, NAT BIOTECHNOL, V25, P921, DOI 10.1038/nbt1320; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; SARMAY G, 1992, MOL IMMUNOL, V29, P633, DOI 10.1016/0161-5890(92)90200-H; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Schweitzer-Stenner R, 2005, J IMMUNOL, V174, P4461, DOI 10.4049/jimmunol.174.8.4461; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sheridan JA, 1999, J PEPT SCI, V5, P555, DOI 10.1002/(SICI)1099-1387(199912)5:12<555::AID-PSC220>3.0.CO;2-G; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Stamos J, 2004, STRUCTURE, V12, P1289, DOI 10.1016/j.str.2004.04.015; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Wong C, 2001, CANCER IMMUNOL IMMUN, V50, P93, DOI 10.1007/s002620100174	49	10	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					575	585		10.1096/fj.08-117069	http://dx.doi.org/10.1096/fj.08-117069			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18957574	Green Published, hybrid			2022-12-25	WOS:000262892900029
J	Chen, SC; Lin, YH; Yu, HC; Liaw, SH				Chen, Sheng-Chia; Lin, Yu-Hsin; Yu, Hui-Chia; Liaw, Shwu-Huey			Complex Structure of Bacillus subtilis RibG: THE REDUCTION MECHANISM DURING RIBOFLAVIN BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL DEAMINASE-REDUCTASE; DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INHIBITORS; FOLATE	Bacterial RibG is a potent target for antimicrobial agents, because it catalyzes consecutive deamination and reduction steps in the riboflavin biosynthesis. In the N-terminal deaminase domain of Bacillus subtilis RibG, structure-based mutational analyses demonstrated that Glu(51) and Lys(79) are essential for the deaminase activity. In the C-terminal reductase domain, the complex structure with the substrate at 2.56-angstrom resolution unexpectedly showed a ribitylimino intermediate bound at the active site, and hence suggested that the ribosyl reduction occurs through a Schiff base pathway. Lys(151) seems to have evolved to ensure specific recognition of the deaminase product rather than the substrate. Glu(290), instead of the previously proposed Asp(199), would seem to assist in the proton transfer in the reduction reaction. A detailed comparison reveals that the reductase and the pharmaceutically important enzyme, dihydrofolate reductase involved in the riboflavin and folate biosyntheses, share strong conservation of the core structure, cofactor binding, catalytic mechanism, even the substrate binding architecture.	[Yu, Hui-Chia; Liaw, Shwu-Huey] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Yu, Hui-Chia; Liaw, Shwu-Huey] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Chen, Sheng-Chia; Lin, Yu-Hsin; Liaw, Shwu-Huey] Natl Yang Ming Univ, Struct Biol Program, Taipei 11221, Taiwan; [Chen, Sheng-Chia] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Lin, Yu-Hsin] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 11221, Taiwan; [Liaw, Shwu-Huey] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liaw, SH (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan.	shliaw@ym.edu.tw			National Science Council [NSC96-2311-B010017]; Ministry of Education; Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by National Science Council (NSC96-2311-B010017) and a grant from the Ministry of Education, Aim for the Top University Plan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; Behm-Ansmant I, 2004, J BIOL CHEM, V279, P52998, DOI 10.1074/jbc.M409581200; BRESLER SE, 1977, GENETIKA+, V13, P2007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; BYSTROFF C, 1990, BIOCHEMISTRY-US, V29, P3263, DOI 10.1021/bi00465a018; Chatwell L, 2006, J MOL BIOL, V359, P1334, DOI 10.1016/j.jmb.2006.04.045; Chen SC, 2006, J BIOL CHEM, V281, P7605, DOI 10.1074/jbc.M510254200; Cody V, 1999, BIOCHEMISTRY-US, V38, P4303, DOI 10.1021/bi982728m; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; DIETRICH R, 1979, J AM CHEM SOC, V101, P6144, DOI 10.1021/ja00514a059; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Graupner M, 2002, J BACTERIOL, V184, P1952, DOI 10.1128/JB.184.7.1952-1957.2002; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Kaiser J, 2007, ANAL BIOCHEM, V365, P52, DOI 10.1016/j.ab.2007.02.033; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumasaka T, 2007, J BIOL CHEM, V282, P37103, DOI 10.1074/jbc.M704476200; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; Magalhaes MLB, 2008, BIOCHEMISTRY-US, V47, P6499, DOI 10.1021/bi800264g; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Stenmark P, 2007, J MOL BIOL, V373, P48, DOI 10.1016/j.jmb.2006.12.009; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e	33	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1725	1731		10.1074/jbc.M805820200	http://dx.doi.org/10.1074/jbc.M805820200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986985	hybrid			2022-12-25	WOS:000262330100042
J	Bajaj, G; Zhang, Y; Schimerlik, MI; Hau, AM; Yang, J; Filtz, TM; Kioussi, C; Ishmael, JE				Bajaj, Gaurav; Zhang, Yong; Schimerlik, Michael I.; Hau, Andrew M.; Yang, Jing; Filtz, Theresa M.; Kioussi, Chrissa; Ishmael, Jane E.			N-Methyl-D-aspartate Receptor Subunits Are Non-myosin Targets of Myosin Regulatory Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT INACTIVATION; ERM-LIKE PROTEIN; NONMUSCLE MYOSIN; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; FUNCTIONAL-ANALYSIS; ALPHA-ACTININ; C-TERMINUS; RAT-BRAIN; II MYOSIN	Excitatory synapses contain multiple members of the myosin superfamily of molecular motors for which functions have not been assigned. In this study we characterized the molecular determinants of myosin regulatory light chain (RLC) binding to two major subunits of the N-methyl-D-aspartate receptor (NR). Myosin RLC bound to NR subunits in a manner that could be distinguished from the interaction of RLC with the neck region of non-muscle myosin II-B (NMII-B) heavy chain; NR-RLC interactions did not require the addition of magnesium, were maintained in the absence of the fourth EF-hand domain of the light chain, and were sensitive to RLC phosphorylation. Equilibrium fluorescence spectroscopy experiments indicate that the affinity of myosin RLC for NR1 is high (30 nM) in the context of the isolated light chain. Binding was not favored in the context of a recombinant NMII-B subfragment one, indicating that if the RLC is already bound to NMII-B it is unlikely to form a bridge between two binding partners. We report that sequence similarity in the "GXXXR" portion of the incomplete IQ2 motif found in NMII heavy chain isoforms likely contributes to recognition of NR2A as a non-myosin target of the RLC. Using site-directed mutagenesis to disrupt NR2A-RLC binding in intact cells, we find that RLC interactions facilitate trafficking of NR1/NR2A receptors to the cell membrane. We suggest that myosin RLC can adopt target-dependent conformations and that a role for this light chain in protein trafficking may be independent of the myosin II complex.	[Bajaj, Gaurav; Zhang, Yong; Hau, Andrew M.; Yang, Jing; Filtz, Theresa M.; Kioussi, Chrissa; Ishmael, Jane E.] Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97331 USA; [Schimerlik, Michael I.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Ishmael, JE (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97331 USA.	jane.ishmael@oregonstate.edu		Kioussi, Chrissa/0000-0001-8226-9908; Filtz, Theresa/0000-0002-5348-1114	National Institutes of Health [R01AR054406, P30-ES000210]; American Heart Association Award [P30-ES000210, 0060435Z]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Award(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by National Institutes of Health Grants R01AR054406 and P30-ES000210. This work was also supported by American Heart Association Award 0060435Z, P30-ES000210.	Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; Boyne JR, 2000, J CELL SCI, V113, P4533; Chan W, 2005, J BIOL CHEM, V280, P23741, DOI 10.1074/jbc.M502767200; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; FEINSTEIN DL, 1991, MOL BRAIN RES, V10, P97, DOI 10.1016/0169-328X(91)90099-J; Franke JD, 2006, CELL MOTIL CYTOSKEL, V63, P604, DOI 10.1002/cm.20148; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guillaud L, 2003, J NEUROSCI, V23, P131; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HENG D, 2006, MOL CELL PROTEOMICS, V5, P1158; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Ishmael JE, 1996, J NEUROCHEM, V67, P1500; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kioussi C, 2007, BRAIN RES BULL, V74, P439, DOI 10.1016/j.brainresbull.2007.07.024; Knowlton MN, 2004, ZEBRAFISH, V1, P133, DOI 10.1089/zeb.2004.1.133; Knowlton MN, 2003, DEV BIOL, V264, P407, DOI 10.1016/j.ydbio.2003.09.001; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Maeda M, 2000, DEV BIOL, V223, P114, DOI 10.1006/dbio.2000.9736; MALENCIK DA, 1988, BIOCHEMISTRY-US, V27, P1941, DOI 10.1021/bi00406a021; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P3480, DOI 10.1021/bi00257a035; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Olsson PA, 2000, BIOCHEM BIOPH RES CO, V279, P879, DOI 10.1006/bbrc.2000.4028; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Shannon KB, 2000, CURR BIOL, V10, P727, DOI 10.1016/S0960-9822(00)00539-X; Stevens RC, 1998, J CELL BIOL, V142, P711, DOI 10.1083/jcb.142.3.711; Szymanski PT, 1999, BIOCHEMISTRY-US, V38, P3778, DOI 10.1021/bi981394y; Szymanski PT, 2004, J MUSCLE RES CELL M, V25, P7, DOI 10.1023/B:JURE.0000021349.47697.bf; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TAUBMAN MB, 1987, J CELL BIOL, V104, P1505, DOI 10.1083/jcb.104.6.1505; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Terrak M, 2002, ACTA CRYSTALLOGR D, V58, P1882, DOI 10.1107/S0907444902013951; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wakabayashi Y, 2006, J BIOL CHEM, V281, P27669, DOI 10.1074/jbc.R600013200; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WANG YL, 1994, FEBS LETT, V348, P244, DOI 10.1016/0014-5793(94)00613-X; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; ZAVODNY PJ, 1988, NUCLEIC ACIDS RES, V16, P1214, DOI 10.1093/nar/16.3.1214; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang Y, 2006, MOL PHARMACOL, V70, P860, DOI 10.1124/mol.105.021923	68	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1252	1266		10.1074/jbc.M801861200	http://dx.doi.org/10.1074/jbc.M801861200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18945678	Green Published, hybrid			2022-12-25	WOS:000262122900061
J	Bernardo, LMD; Johansson, LUM; Skarfstad, E; Shingler, V				Bernardo, Lisandro M. D.; Johansson, Linda U. M.; Skarfstad, Eleonore; Shingler, Victoria			sigma(54)-Promoter Discrimination and Regulation by ppGpp and DksA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; SIGMA(54)-DEPENDENT PO PROMOTER; COLI RNA-POLYMERASE; GUANOSINE TETRAPHOSPHATE PPGPP; TRANSCRIPTIONAL ACTIVATOR DMPR; PSEUDOMONAS-PUTIDA; ESCHERICHIA-COLI; GROWTH-PHASE; PU PROMOTER; TOL PLASMID	The sigma(54)-factor controls expression of a variety of genes in response to environmental cues. Much previous work has implicated the nucleotide alarmone ppGpp and its co-factor DksA in control of sigma(54)-dependent transcription in the gut commensal Escherichia coli, which has evolved to live under very different environmental conditions than Pseudomonas putida. Here we compared ppGpp/DksA mediated control of sigma(54)-dependent transcription in these two organisms. Our in vivo experiments employed P. putida mutants and manipulations of factors implicated in ppGpp/DksA mediated control of sigma(54)-dependent transcription in combination with a series of sigma(54)-promoters with graded affinities for sigma(54)-RNA polymerase. For in vitro analysis we used a P. putida-based reconstituted sigma(54)-transcription assay system in conjunction with DNA-binding plasmon resonance analysis of native and heterologous sigma(54)-RNA polymerase holoenzymes. In comparison with E. coli, ppGpp/DksA responsive sigma(54)-transcription in the environmentally adaptable P. putida was found to be more robust under low energy conditions that occur upon nutrient depletion. The mechanism behind this difference can be traced to reduced promoter discrimination of low affinity sigma(54)-promoters that is conferred by the strong DNA binding properties of the P. putida sigma(54)-RNA polymerase holoenzyme.	[Bernardo, Lisandro M. D.; Johansson, Linda U. M.; Skarfstad, Eleonore; Shingler, Victoria] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Umea University	Shingler, V (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	victoria.shingler@molbiol.umu.se		Holmfeldt, Linda/0000-0003-4140-3423; Shingler, Victoria/0000-0002-7349-1678	J. C. Kempe Foundation; Swedish Research Council	J. C. Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by grants from the J. C. Kempe Foundation and the Swedish Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Beck LL, 2007, TRENDS MICROBIOL, V15, P530, DOI 10.1016/j.tim.2007.09.008; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Carmona M, 1999, J BIOL CHEM, V274, P33790, DOI 10.1074/jbc.274.47.33790; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; CASHEL M, 1974, ANAL BIOCHEM, V57, P100, DOI 10.1016/0003-2697(74)90056-6; DE LV, 1994, METHOD ENZYMOL, V235, P386; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; FERNANDEZ S, 1994, J BACTERIOL, V176, P5052, DOI 10.1128/jb.176.16.5052-5058.1994; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 2001, J BACTERIOL, V183, P2952, DOI 10.1128/JB.183.9.2952-2956.2001; Johansson LUM, 2008, MOL MICROBIOL, V70, P709, DOI 10.1111/j.1365-2958.2008.06440.x; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; KOHLER T, 1989, J BACTERIOL, V171, P4326; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Macchi R, 2003, J BIOL CHEM, V278, P27695, DOI 10.1074/jbc.M303031200; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Murphy H, 2003, METHOD ENZYMOL, V371, P596; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; PerezMartin J, 1996, J MOL BIOL, V258, P562, DOI 10.1006/jmbi.1996.0269; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarand I, 2008, ENVIRON MICROBIOL, V10, P1320, DOI 10.1111/j.1462-2920.2007.01546.x; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; SHINGLER V, 2004, PSEUDOMONAS, V2, P451; Szalewska-Palasz A, 2007, J BIOL CHEM, V282, P18046, DOI 10.1074/jbc.M610181200; Sze CC, 2002, J BACTERIOL, V184, P760, DOI 10.1128/JB.184.3.760-770.2002; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Sze CC, 1996, J BACTERIOL, V178, P3727, DOI 10.1128/jb.178.13.3727-3735.1996; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Valls M, 2002, J BIOL CHEM, V277, P2169, DOI 10.1074/jbc.M108162200; VALLS M, 2004, PSEUDOMONAS VIRULENC, V2, P289; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Wikstrom P, 2001, J MOL BIOL, V314, P971, DOI 10.1006/jmbi.2000.5212; XIAO H, 1991, J BIOL CHEM, V266, P5980	60	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					828	838		10.1074/jbc.M807707200	http://dx.doi.org/10.1074/jbc.M807707200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008221	hybrid			2022-12-25	WOS:000262122900017
J	Gao, X; Lorinczi, M; Hill, KS; Brooks, NC; Dokainish, H; Ireton, K; Elferink, LA				Gao, Xiu; Lorinczi, Marta; Hill, Kristen S.; Brooks, Natasha C.; Dokainish, Hatem; Ireton, Keith; Elferink, Lisa A.			Met Receptor Tyrosine Kinase Degradation Is Altered in Response to the Leucine-rich Repeat of the Listeria Invasion Protein Internalin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DOMAIN BINDING-SITE; DOWN-REGULATION; SIGNALING PATHWAY; SURFACE PROTEIN; C-CBL; MONOCYTOGENES; COMPLEX; CELLS; INLB	Entry of the bacterial pathogen Listeria monocytogenes into host epithelial cells is critical for infection and virulence. One major pathway for Listeria entry involves binding of the bacterial protein Internalin B to the host receptor tyrosine kinase Met ( hepatocyte growth factor receptor). Activation of Met and downstream signaling cascades is critical for Listeria entry. Internalin B is composed of several structural domains including an N-terminal leucine-rich repeat that is sufficient for binding Met and stimulating downstream signal transduction. Internalin B is monomeric, whereas the leucine-rich repeat is dimeric when expressed as an isolated fragment. The different quaternary states of Internalin B and the leucine-rich repeat suggest that these two Met ligands might cause distinct biological effects. Here we demonstrate that Internalin B and the leucine-rich repeat fragment exhibit agonist properties that differentially influence Met down-regulation in lysosomes. Specifically, Met stability is increased in response to the leucine-rich repeat fragment compared with Internalin B. Interestingly, Internalin B and the leucine-rich repeat stimulate equivalent rates of clathrin-mediated Met internalization. However, the leucine-rich repeat is defective in promoting lysosomal down-regulation of Met and instead enhances receptor recycling to the cell surface. In addition, the leucine-rich repeat causes prolonged Met activation ( phosphorylation) and increased cell motility compared with Internalin B. Taken together, our findings indicate that individual domains of Internalin B differentially regulate Met trafficking. The ability of the leucine-rich repeat fragment to promote Met recycling could account for the increased cell motility induced by this ligand.	[Gao, Xiu; Lorinczi, Marta; Hill, Kristen S.; Brooks, Natasha C.; Elferink, Lisa A.] Univ Texas Galveston, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77555 USA; [Elferink, Lisa A.] Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Dokainish, Hatem] Univ Toronto, Dept Mol Genet, Toronto, ON M55 1A8, Canada; [Ireton, Keith] Univ Cent Florida, Burnett Sch Biomol Sci, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Toronto; State University System of Florida; University of Central Florida	Elferink, LA (corresponding author), Univ Texas Galveston, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77555 USA.	laelferi@utmb.edu		Hill, Kristen/0000-0003-3757-2822	National Institutes of Health [CA-112605, CA-119075]; National Science Foundation [IBN-343739]; Canadian Institutes of Health Research [MT-15497]; NATIONAL CANCER INSTITUTE [R01CA119075, R21CA112605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-112605 and CA-119075 ( to L. A. E.). This work was also supported by National Science Foundation Grant IBN-343739 ( to L. A. E.) and Canadian Institutes of Health Research Grant MT-15497 ( to K. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hubbard SR, 2006, CELL, V125, P1029, DOI 10.1016/j.cell.2006.05.028; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kjelsberg C, 1997, AM J PHYSIOL-RENAL, V272, pF222, DOI 10.1152/ajprenal.1997.272.2.F222; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Prat M, 1998, J CELL SCI, V111, P237; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	59	5	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					774	783		10.1074/jbc.M805989200	http://dx.doi.org/10.1074/jbc.M805989200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990695	Green Published, hybrid			2022-12-25	WOS:000262122900011
J	Lafrance-Vanasse, J; Lefebvre, M; Di Lello, P; Sygusch, J; Omichinski, JG				Lafrance-Vanasse, Julien; Lefebvre, Maryse; Di Lello, Paola; Sygusch, Jurgen; Omichinski, James G.			Crystal Structures of the Organomercurial Lyase MerB in Its Free and Mercury-bound Forms INSIGHTS INTO THE MECHANISM OF METHYLMERCURY DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID-BEARING STRAIN; RESISTANCE; PROTEIN; MODEL; GENES; EXPRESSION; IDENTIFICATION; CATALYSIS; SOFTWARE; SYSTEM	Bacteria resistant to methylmercury utilize two enzymes (MerA and MerB) to degrade methylmercury to the less toxic elemental mercury. The crucial step is the cleavage of the carbon-mercury bond of methylmercury by the organomercurial lyase (MerB). In this study, we determined high resolution crystal structures of MerB in both the free (1.76-angstrom resolution) and mercury-bound (1.64-angstrom resolution) states. The crystal structure of free MerB is very similar to the NMR structure, but important differences are observed when comparing the two structures. In the crystal structure, an amino-terminal alpha-helix that is not present in the NMR structure makes contact with the core region adjacent to the catalytic site. This interaction between the amino-terminal helix and the core serves to bury the active site of MerB. The crystal structures also provide detailed insights into the mechanism of carbon-mercury bond cleavage by MerB. The structures demonstrate that two conserved cysteines (Cys-96 and Cys-159) play a role in substrate binding, carbon-mercury bond cleavage, and controlled product (ionic mercury) release. In addition, the structures establish that an aspartic acid (Asp-99) in the active site plays a crucial role in the proton transfer step required for the cleavage of the carbon-mercury bond. These findings are an important step in understanding the mechanism of carbon-mercury bond cleavage by MerB.	[Lafrance-Vanasse, Julien; Lefebvre, Maryse; Di Lello, Paola; Sygusch, Jurgen; Omichinski, James G.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Univ Montreal, Dept Biochem, CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca; jg.omichinski@umontreal.ca	di lello, paola/C-8605-2013; Lafrance-Vanasse, Julien/B-1952-2009; Lafrance-Vanasse, Julien/ABG-9263-2020	Lafrance-Vanasse, Julien/0000-0001-8807-6277	Natural Science and Engineering Council of Canada; Canadian Institutes of Health Research (CIHR)	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Science and Engineering Council of Canada (to J. G. O. and J. S.) and Canadian Institutes of Health Research (CIHR) (to J. S). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER, V42; BEGLEY TP, 1986, BIOCHEMISTRY-US, V25, P7186, DOI 10.1021/bi00370a063; BEGLEY TP, 1986, BIOCHEMISTRY-US, V25, P7192, DOI 10.1021/bi00370a064; Benison GC, 2004, BIOCHEMISTRY-US, V43, P8333, DOI 10.1021/bi049662h; Bizily SP, 1999, P NATL ACAD SCI USA, V96, P6808, DOI 10.1073/pnas.96.12.6808; Bizily SP, 2000, NAT BIOTECHNOL, V18, P213, DOI 10.1038/72678; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Che DS, 2006, IN VITRO CELL DEV-PL, V42, P228, DOI 10.1079/IVP2006771; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOPINATH E, 1987, J AM CHEM SOC, V109, P7903, DOI 10.1021/ja00259a061; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang CC, 1999, GENE, V239, P361, DOI 10.1016/S0378-1119(99)00388-1; Lyyra S, 2007, PLANT BIOTECHNOL J, V5, P254, DOI 10.1111/j.1467-7652.2006.00236.x; Melnick JG, 2007, SCIENCE, V317, P225, DOI 10.1126/science.1144314; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; MOORE B, 1960, LANCET, V2, P453; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pitts KE, 2002, BIOCHEMISTRY-US, V41, P10287, DOI 10.1021/bi0259148; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; RICHMOND MH, 1964, NATURE, V202, P1360, DOI 10.1038/2021360a0; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; SCHOTTEL JL, 1978, J BIOL CHEM, V253, P4341; SUMMERS AO, 1974, J BACTERIOL, V119, P242, DOI 10.1128/JB.119.1.242-249.1974; SUMMERS AO, 1986, ANNU REV MICROBIOL, V40, P607, DOI 10.1146/annurev.mi.40.100186.003135; Taubner LM, 2006, BIOCHEMISTRY-US, V45, P12240, DOI 10.1021/bi061089+; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wilhelm M, 2004, EUR J INORG CHEM, P2301, DOI 10.1002/ejic.200300907	37	35	37	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					938	944		10.1074/jbc.M807143200	http://dx.doi.org/10.1074/jbc.M807143200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004822	hybrid			2022-12-25	WOS:000262122900029
J	Lin, HT; Bavro, VN; Barrera, NP; Frankish, HM; Velamakanni, S; van Veen, HW; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Lin, Hong Ting; Bavro, Vassiliy N.; Barrera, Nelson P.; Frankish, Helen M.; Velamakanni, Saroj; van Veen, Hendrik W.; Robinson, Carol V.; Borges-Walmsley, M. Ines; Walmsley, Adrian R.			MacB ABC Transporter Is a Dimer Whose ATPase Activity and Macrolide-binding Capacity Are Regulated by the Membrane Fusion Protein MacA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX TRANSPORTER; ESCHERICHIA-COLI; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CASSETTE TRANSPORTER; ACRB; PUMP; MECHANISM; STATE; DETERGENT	Gram-negative bacteria utilize specialized machinery to translocate drugs and protein toxins across the inner and outer membranes, consisting of a tripartite complex composed of an inner membrane secondary or primary active transporter (IMP), a periplasmic membrane fusion protein, and an outer membrane channel. We have investigated the assembly and function of the MacAB/TolC system that confers resistance to macrolides in Escherichia coli. The membrane fusion protein MacA not only stabilizes the tripartite assembly by interacting with both the inner membrane protein MacB and the outer membrane protein TolC, but also has a role in regulating the function of MacB, apparently increasing its affinity for both erythromycin and ATP. Analysis of the kinetic behavior of ATP hydrolysis indicated that MacA promotes and stabilizes the ATP-binding form of the MacB transporter. For the first time, we have established unambiguously the dimeric nature of a noncanonic ABC transporter, MacB that has an N-terminal nucleotide binding domain, by means of nondissociating mass spectrometry, analytical ultracentrifugation, and atomic force microscopy. Structural studies of ABC transporters indicate that ATP is bound between a pair of nucleotide binding domains to stabilize a conformation in which the substrate-binding site is outward-facing. Consequently, our data suggest that in the presence of ATP the same conformation of MacB is promoted and stabilized by MacA. Thus, MacA would facilitate the delivery of drugs by MacB to TolC by enhancing the binding of drugs to it and inducing a conformation of MacB that is primed and competent for binding TolC. Our structural studies are an important first step in understanding how the tripartite complex is assembled.	[Lin, Hong Ting; Frankish, Helen M.; Borges-Walmsley, M. Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PU, England; [Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Velamakanni, Saroj; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	Durham University; University of Oxford; University of Cambridge; University of Cambridge	Borges-Walmsley, MI (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.i.borges-walmsley@durham.ac.uk; a.r.walmsley@durham.ac.uk	van Veen, Hendrik W./A-4162-2008; Bavro, Vassiliy/I-4846-2019	van Veen, Hendrik W./0000-0002-9658-8077; Bavro, Vassiliy/0000-0003-2330-8924; robinson, carol/0000-0001-7829-5505; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/F008333/1] Funding Source: researchfish; BBSRC [BB/F008333/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (Durham group). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Elkins CA, 2003, J BACTERIOL, V185, P5349, DOI 10.1128/JB.185.18.5349-5356.2003; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; Hanson CL, 2003, BIOPHYS J, V85, P3802, DOI 10.1016/S0006-3495(03)74795-X; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lengqvist J, 2004, J BIOL CHEM, V279, P13311, DOI 10.1074/jbc.M310958200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stroebel D, 2007, BBA-BIOMEMBRANES, V1768, P1567, DOI 10.1016/j.bbamem.2007.03.008; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Vediyappan G, 2006, J BACTERIOL, V188, P3757, DOI 10.1128/JB.00038-06; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	50	74	82	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1145	1154		10.1074/jbc.M806964200	http://dx.doi.org/10.1074/jbc.M806964200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18955484	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000262122900051
J	Wang, ZH; Wang, YX; Hegg, EL				Wang, Zhihong; Wang, Yuxin; Hegg, Eric L.			Regulation of the Heme A Biosynthetic Pathway DIFFERENTIAL REGULATION OF HEME A SYNTHASE AND HEME O SYNTHASE IN SACCHAROMYCES CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; BACILLUS-SUBTILIS-CTAA; A BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; FUNCTIONAL-ROLE; ACTIVATOR HAP1; BC(1) COMPLEX; HUMAN-CELLS; YEAST	The assembly and activity of cytochrome c oxidase is dependent on the availability of heme A, one of its essential cofactors. In eukaryotes, two inner mitochondrial membrane proteins, heme O synthase (Cox10) and heme A synthase (Cox15), are required for heme A biosynthesis. In this report, we demonstrate that in Saccharomyces cerevisiae the transcription of COX15 is regulated by Hap1, a transcription factor whose activity is positively controlled by intracellular heme concentration. Conversely, COX10, the physiological partner of COX15, does not share the same regulatory mechanism with COX15. Interestingly, protein quantification identified an 8: 1 protein ratio between Cox15 and Cox10. Together, these results suggest that heme A synthase and/or heme O synthase might play a new, unidentified role in addition to heme A biosynthesis.	[Wang, Zhihong; Wang, Yuxin; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA	Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA.	erichegg@msu.edu	Wang, Zhihong/J-3175-2015	Wang, Zhihong/0000-0003-3686-6618	National Institutes of Health [GM66236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM66236 ( to E. L. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Beauvoit B, 1999, EUR J BIOCHEM, V263, P118, DOI 10.1046/j.1432-1327.1999.00475.x; Brown BM, 2004, BIOCHEMISTRY-US, V43, P13541, DOI 10.1021/bi048469k; Brown KR, 2002, BIOCHEMISTRY-US, V41, P10906, DOI 10.1021/bi0203536; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hach A, 2000, J BIOL CHEM, V275, P248, DOI 10.1074/jbc.275.1.248; HALDI ML, 1995, MOL GEN GENET, V248, P229, DOI 10.1007/BF02190805; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kennedy MA, 1999, BBA-GENE STRUCT EXPR, V1445, P110, DOI 10.1016/S0167-4781(99)00035-4; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V393, P207, DOI 10.1006/abbi.2001.2497; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Morrison MS, 2005, BIOCHEMISTRY-US, V44, P12554, DOI 10.1021/bi050893d; Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; PUUSTINEN A, 1991, P NATL ACAD SCI USA, V88, P6122, DOI 10.1073/pnas.88.14.6122; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; SILVERMAN SJ, 1982, MOL CELL BIOL, V2, P1212, DOI 10.1128/MCB.2.10.1212; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; SVENSSON B, 1993, MOL MICROBIOL, V10, P193, DOI 10.1111/j.1365-2958.1993.tb00915.x; SVENSSON B, 1994, J BACTERIOL, V176, P6663, DOI 10.1128/JB.176.21.6663-6671.1994; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; URBANGRIMAL D, 1986, EUR J BIOCHEM, V156, P511, DOI 10.1111/j.1432-1033.1986.tb09610.x; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803; Zhuang JY, 2006, BIOCHEMISTRY-US, V45, P12530, DOI 10.1021/bi060565t	55	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					839	847		10.1074/jbc.M804167200	http://dx.doi.org/10.1074/jbc.M804167200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18953022	Green Published, hybrid			2022-12-25	WOS:000262122900018
J	Wang, L; Li, SJ; Sidhu, A; Zhu, L; Liang, Y; Freedman, RB; Wang, CC				Wang, Lei; Li, Sheng-jian; Sidhu, Ateesh; Zhu, Li; Liang, Yi; Freedman, Robert B.; Wang, Chih-chen			Reconstitution of Human Ero1-L alpha/Protein-Disulfide Isomerase Oxidative Folding Pathway in Vitro POSITION-DEPENDENT DIFFERENCES IN ROLE BETWEEN THE a AND a ' DOMAINS OF PROTEIN-DISULFIDE ISOMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; CRYSTAL-STRUCTURE; BINDING SITE; REDOX STATE; GLUTATHIONE; ERP57; YEAST; ERO1; THIOREDOXIN	Protein-disulfide isomerase (PDI), a critical enzyme responsible for oxidative protein folding in the eukaryotic endoplasmic reticulum, is composed of four thioredoxin domains a, b, b', a', and a linker x between b' and a'. Ero1-L alpha, an oxidase for human PDI (hPDI), has been determined to have one molecular flavin adenine dinucleotide (FAD) as its prosthetic group. Oxygen consumption assays with purified recombinant Ero1-L alpha revealed that it utilizes oxygen as a terminal electron acceptor producing one disulfide bond and one molecule of hydrogen peroxide per dioxygen molecule consumed. Exogenous FAD is not required for recombinant Ero1-L alpha activity. By monitoring the reactivation of denatured and reduced RNase A, we reconstituted the Ero1-L alpha/hPDI oxidative folding system in vitro and determined the enzymatic activities of hPDI in this system. Mutagenesis studies suggested that the a' domain of hPDI is much more active than the a domain in Ero1-L alpha-mediated oxidative folding. A domain swapping study revealed that one catalytic thioredoxin domain to the C-terminal of bb' x, whether a or a' , is essential in Ero1-L alpha-mediated oxidative folding. These data, combined with a pull-down assay and isothermal titration calorimetry measurements, enabled the minimal element for binding with Ero1-L alpha be mapped to the b' xa' fragment of hPDI.	[Wang, Lei; Li, Sheng-jian; Zhu, Li; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Lei; Li, Sheng-jian; Zhu, Li] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Sidhu, Ateesh; Freedman, Robert B.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Warwick; Wuhan University	Wang, CC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	chihwang@sun5.ibp.ac.cn	Liang, Yi/V-1396-2017; li, shengjian/B-4866-2013	Liang, Yi/0000-0002-7349-8300; Wang, Lei/0000-0002-5071-5800	Chinese Ministry of Science and Technology [2006CB910903, 2006CB806508, 2006CB910301]; Chinese Natural Science Foundation [30620130109]; UK BBSRC (Biotechnology and Biological Sciences Research Council) [BB/D017807/1, PA1339]; Biotechnology and Biological Sciences Research Council [BB/D017807/1] Funding Source: researchfish; BBSRC [BB/D017807/1] Funding Source: UKRI	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); UK BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants 2006CB910903, 2006CB806508, and 2006CB910301 from the Chinese Ministry of Science and Technology; 30620130109 from the Chinese Natural Science Foundation; BB/D017807/1 from the UK BBSRC (Biotechnology and Biological Sciences Research Council); and by a UK/China Partnering Award (PA1339) from the BBSRC (to A. S., L. W., and R. B. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	35	118	118	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					199	206		10.1074/jbc.M806645200	http://dx.doi.org/10.1074/jbc.M806645200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001419	hybrid			2022-12-25	WOS:000261974800023
J	Williams, NK; Lucet, IS; Klinken, SP; Ingley, E; Rossjohn, J				Williams, Neal K.; Lucet, Isabelle S.; Klinken, S. Peter; Ingley, Evan; Rossjohn, Jamie			Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; ERYTHROPOIETIN-INDUCED DIFFERENTIATION; MYELOGENOUS LEUKEMIA-CELLS; BCR-ABL; PROSTATE-CANCER; DEFICIENT MICE; RESISTANT; ACTIVATION; REGRESSION; BMS-354825	The Src-family protein-tyrosine kinase (PTK) Lyn is the most important Src-family kinase in B cells, having both inhibitory and stimulatory activity that is dependent on the receptor, ligand, and developmental context of the B cell. An important role for Lyn has been reported in acute myeloid leukemia and chronic myeloid leukemia, as well as certain solid tumors. Although several Src-family inhibitors are available, the development of Lyn-specific inhibitors, or inhibitors with reduced off-target activity to Lyn, has been hampered by the lack of structural data on the Lyn kinase. Here we report the crystal structure of the non-liganded form of Lyn kinase domain, as well as in complex with three different inhibitors: the ATP analogue AMP-PNP; the pan Src kinase inhibitor PP2; and the BCR-Abl/Src-family inhibitor Dasatinib. The Lyn kinase domain was determined in its "active" conformation, but in the unphosphorylated state. All three inhibitors are bound at the ATP-binding site, with PP2 and Dasatinib extending into a hydrophobic pocket deep in the substrate cleft, thereby providing a basis for the Src-specific inhibition. Analysis of sequence and structural differences around the active site region of the Src-family PTKs were evident. Accordingly, our data provide valuable information for the further development of therapeutics targeting Lyn and the important Src-family of kinases.	[Williams, Neal K.; Lucet, Isabelle S.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Ingley, Evan] Univ Western Australia, Cell Signalling Grp, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Ingley, Evan] Univ Western Australia, Med Res Ctr, Perth, WA 6000, Australia; [Klinken, S. Peter; Ingley, Evan] Univ Western Australia, Lab Canc Med, Perth, WA 6000, Australia	Monash University; University of Western Australia; University of Western Australia; University of Western Australia	Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au	Rossjohn, Jamie/F-9032-2013; Ingley, Evan/C-2401-2013	Rossjohn, Jamie/0000-0002-2020-7522; Ingley, Evan/0000-0002-8112-9134	National Health and Medical Research Council (NHMRC) of Australia [303101, 403987, 313714]; Medical Research Foundation of Royal Perth Hospital; Centre for Food and Genomic Medicine	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation of Royal Perth Hospital; Centre for Food and Genomic Medicine	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (303101, 403987, and 513714), the Medical Research Foundation of Royal Perth Hospital, and the Centre for Food and Genomic Medicine and by a NHMRC Industry Fellowship (to N.K.W.) and ARC Federation Fellowship (to J.R.).	Bates RC, 2001, CANCER RES, V61, P5275; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Chin H, 1998, BLOOD, V91, P3734; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Golas JM, 2003, CANCER RES, V63, P375; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Lannutti BJ, 2004, BLOOD, V103, P3736, DOI 10.1182/blood-2003-10-3566; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 2000, GENE DEV, V14, P1027; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Robinson D, 1998, J BIOMED SCI, V5, P93, DOI 10.1159/000025318; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	45	49	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					284	291		10.1074/jbc.M807850200	http://dx.doi.org/10.1074/jbc.M807850200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984583	Green Published, hybrid			2022-12-25	WOS:000261974800032
J	Caloca, MJ; Zugaza, JL; Bustelo, XR				Caloca, Maria J.; Zugaza, Jose L.; Bustelo, Xose R.			Mechanistic Analysis of the Amplification and Diversification Events Induced by Vav Proteins in B-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVATION; CELL-RECEPTOR SIGNALS; GDP/GTP EXCHANGE; GROWTH-FACTOR; KINASE-C; PROTOONCOGENE PRODUCT; 3-KINASE ACTIVATION; BINDING PROTEINS; RAS ACTIVATION; T-CELLS	Vav proteins participate in the assembly of a multibranched signal transduction pathway in lymphocytes, including the stimulation of the phosphatidylinositol 3-kinase/protein kinase B and the phospholipase C-gamma/Ras GDP-releasing protein/Ras/Erk routes. In the present work, we used a genetic approach in chicken DT40 B-cell lines to investigate additional elements of the Vav route, the synergisms existing among the different Vav signaling branches, and the activities exerted by wild-type and oncogenic Vav proteins in B-lymphocytes. We show here that the Vav pathway is ramified in B-lymphocytes in additional diacylglycerol-dependent signaling branches such as those involving protein kinase C, protein kinase D, and phospholipase D. By using side-by-side comparisons of the activation levels of those signal transduction pathways in inhibitor-treated and knockout DT40 cells, we show that B-cells have different requirements regarding Vav proteins for the activation of antigen receptor downstream elements. Furthermore, we have detected interpathway cross-talk at the level of the most proximal elements but not among the most distal effector molecules of the Vav route. Finally, we show that the oncogenic versions of Vav1 and RhoA can activate alternative routes that could contribute to signal amplification and diversification events in transformed lymphocytes.	[Bustelo, Xose R.] Univ Salamanca, CSIC, Ctr Invest Canc, E-37007 Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Campus Unamuno, E-37007 Salamanca, Spain.	xbustelo@usal.es	Caloca, María-José/K-9357-2014; Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022	Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; Caloca, Maria-Jose/0000-0002-1003-2685	NCI [5R01-CA73735-12]; European Union; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-CA73735-12 (to X. R. B.) from NCI. All Spanish funding is co-sponsored by Fondo de Desarrollo Regional of the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2002, FRONT BIOSCI, V7, pD24, DOI 10.2741/bustelo; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; BUSTELO XR, 2008, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A002361.002301; BUSTELO XR, 2008, UCSD NAT MOL PAGES, DOI DOI 10.1038/MP.A002362.002301; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; Couceiro JR, 2005, EXP CELL RES, V308, P364, DOI 10.1016/j.yexcr.2005.04.035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Hess JA, 1998, J BIOL CHEM, V273, P20517, DOI 10.1074/jbc.273.32.20517; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; Hitomi T, 1999, FEBS LETT, V445, P371, DOI 10.1016/S0014-5793(99)00153-2; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schuebel KE, 1996, ONCOGENE, V13, P363; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Vigorito E, 2004, J IMMUNOL, V173, P3209, DOI 10.4049/jimmunol.173.5.3209; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; WU J, 1995, MOL CELL BIOL, V15, P4337; YEO EJ, 1994, J BIOL CHEM, V269, P27823; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	54	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36454	36464		10.1074/jbc.M803814200	http://dx.doi.org/10.1074/jbc.M803814200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974050	Green Published, hybrid			2022-12-25	WOS:000261840500043
J	Coudevylle, N; Montaville, P; Leonov, A; Zweckstetter, M; Becker, S				Coudevylle, Nicolas; Montaville, Pierre; Leonov, Andrei; Zweckstetter, Markus; Becker, Stefan			Structural Determinants for Ca2+ and Phosphatidylinositol 4,5-Bisphosphate Binding by the C2A Domain of Rabphilin-3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NMR STRUCTURE DETERMINATION; CORE VESICLE EXOCYTOSIS; PIP2 BINDING; PC12 CELLS; PHOSPHOINOSITIDE REGULATION; DIPOLAR COUPLINGS; MEMBRANE-BINDING; PLASMA-MEMBRANE; PKC-ALPHA	Rabphilin-3A is a neuronal C2 domain tandem containing protein involved in vesicle trafficking. Both its C2 domains (C2A and C2B) are able to bind phosphatidylinositol 4,5-bisphosphate, a key player in the neurotransmitter release process. The rabphilin-3A C2A domain has previously been shown to bind inositol-1,4,5-trisphosphate (IP3; phosphatidylinositol 4,5-bisphosphate headgroup) in a Ca2+-dependent manner with a relatively high affinity (50 mu M) in the presence of saturating concentrations of Ca2+. Moreover, IP3 and Ca2+ binding to the C2A domain mutually enhance each other. Here we present the Ca2+-bound solution structure of the C2A domain. Structural comparison with the previously published Ca2+-free crystal structure revealed that Ca2+ binding induces a conformational change of Ca2+ binding loop 3(CBL3). Our IP3 binding studies as well as our IP3-C2A docking model show the active involvement of CBL3 in IP3 binding, suggesting that the conformational change on CBL3 upon Ca2+ binding enables the interaction with IP3 and vice versa, in line with a target-activated messenger affinity mechanism. Our data provide detailed structural insight into the functional properties of the rabphilin-3A C2A domain and reveal for the first time the structural determinants of a target-activated messenger affinity mechanism.	[Coudevylle, Nicolas; Montaville, Pierre; Leonov, Andrei; Zweckstetter, Markus; Becker, Stefan] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany	Max Planck Society	Becker, S (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	sabe@nmr.mpibpc.mpg.de		montaville, Pierre/0000-0002-9931-3482; Zweckstetter, Markus/0000-0002-2536-6581	MaxPlanck Society	MaxPlanck Society(Max Planck Society)	This work was supported by the MaxPlanck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Biadene M, 2006, ACTA CRYSTALLOGR D, V62, P793, DOI 10.1107/S0907444906017537; Bolsover SR, 2003, J BIOL CHEM, V278, P10282, DOI 10.1074/jbc.M212145200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremona O, 2001, J CELL SCI, V114, P1041; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Keller R., 2004, COMPUTER AIDED RESON, V1; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; MIYAZAKI M, 1994, BIOCHEM BIOPH RES CO, V205, P460, DOI 10.1006/bbrc.1994.2688; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Montaville P, 2006, J BIOMOL NMR, V36, P20, DOI 10.1007/s10858-005-6051-z; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Osborne SL, 2006, J NEUROCHEM, V98, P336, DOI 10.1111/j.1471-4159.2006.03892.x; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Alfaro JA, 2004, J MOL BIOL, V335, P1117, DOI 10.1016/j.jmb.2003.10.080; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Selvan S, 2007, IEEE T IMAGE PROCESS, V16, P2688, DOI 10.1109/TIP.2007.908082; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Willshaw A, 2004, FEBS LETT, V559, P13, DOI 10.1016/S0014-5793(03)01513-8; Zhang Y, 2001, FEBS LETT, V497, P99, DOI 10.1016/S0014-5793(01)02450-4; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	53	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35918	35928		10.1074/jbc.M804094200	http://dx.doi.org/10.1074/jbc.M804094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945677	Green Published, hybrid			2022-12-25	WOS:000261687900067
J	Yerushalmi, U; Teicher, M				Yerushalmi, Uri; Teicher, Mina			Evolving Synaptic Plasticity with an Evolutionary Cellular Development Model	PLOS ONE			English	Article								Since synaptic plasticity is regarded as a potential mechanism for memory formation and learning, there is growing interest in the study of its underlying mechanisms. Recently several evolutionary models of cellular development have been presented, but none have been shown to be able to evolve a range of biological synaptic plasticity regimes. In this paper we present a biologically plausible evolutionary cellular development model and test its ability to evolve different biological synaptic plasticity regimes. The core of the model is a genomic and proteomic regulation network which controls cells and their neurites in a 2D environment. The model has previously been shown to successfully evolve behaving organisms, enable gene related phenomena, and produce biological neural mechanisms such as temporal representations. Several experiments are described in which the model evolves different synaptic plasticity regimes using a direct fitness function. Other experiments examine the ability of the model to evolve simple plasticity regimes in a task-based fitness function environment. These results suggest that such evolutionary cellular development models have the potential to be used as a research tool for investigating the evolutionary aspects of synaptic plasticity and at the same time can serve as the basis for novel artificial computational systems.	[Yerushalmi, Uri; Teicher, Mina] Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University	Yerushalmi, U (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel.	uri.yerushalmi@gmail.com			DIP	DIP	This work was supported by a DIP grant for compositionality.	[Anonymous], 1989, GENETIC ALGORITHM SE; Astor JC, 2000, ARTIF LIFE, V6, P189, DOI 10.1162/106454600568834; BENTLEY PJ, 1999, WAYS GROW DESIGNS CO, P35; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Cangelosi A, 1997, NEURAL PROCESS LETT, V6, P91, DOI 10.1023/A:1009615807222; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DELLAERT F, 1994, COEVOLVING BODY BRAI; DELLAERT F, 1996, DEV MODEL EVOLUTION; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; FEDERICI D, 2005, EVOLVING DEV SPIKING; Floreano D, 2001, THEOR BIOSCI, V120, P225, DOI 10.1078/1431-7613-00042; GERARD B, 1990, P 17 ACM SIGPLAN SIG, P81; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; HARP SA, 1989, 3RD P INT C GEN ALG, P360; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1994, PHYS TODAY, V47, P40, DOI 10.1063/1.881412; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; JAKOBI N, 1995, HARNESSING MORPHOGEN; Kitano H., 1995, ARTIF LIFE, V2, P79; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; MONTANA D, 1989, P INT JOINT C ART IN; REIL T, 1999, DYNAMICS GENE EXPRES, P457; Ruppin E, 2002, NAT REV NEUROSCI, V3, P132, DOI 10.1038/nrn729; RUST AG, 1998, DEV ORG ARTIFICIAL N; RUST AG, 2000, ARTIFICIAL LIFE, V7; SIMS K, 1994, COMPUT GRAPH, V28, P15; SIMS K, 1994, ARTIF LIFE, V1, P535; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; THOMAS B, 1993, EVOL COMPUT, V1, P1; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; YERUSHALMI U, 2006, REGULATION NETWORK B; Yerushalmi U, 2007, B MATH BIOL, V69, P2261, DOI 10.1007/s11538-007-9219-8; Yerushalmi U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001863; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3697	10.1371/journal.pone.0003697	http://dx.doi.org/10.1371/journal.pone.0003697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002249	Green Published, gold, Green Submitted			2022-12-25	WOS:000265165600004
J	Andersson, A; Isaksson, M; Wefer, J; Norling, A; Flores-Morales, A; Rorsman, F; Kampe, O; Harris, RA; Lobell, A				Andersson, Asa; Isaksson, Magnus; Wefer, Judit; Norling, Anna; Flores-Morales, Amilcar; Rorsman, Fredrik; Kampe, Olle; Harris, Robert A.; Lobell, Anna			Impaired Autoimmune T Helper 17 Cell Responses Following DNA Vaccination against Rat Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article								Background: We have previously shown that vaccination with DNA encoding the encephalitogenic peptide myelin oligodendrocyte glycoprotein (MOG)(91-108) (pMOG) suppresses MOG(91-108)-induced rat Experimental Autoimmune Encephalomyelitis (EAE), a model for human Multiple Sclerosis (MS). The suppressive effect of pMOG is dependent on inclusion of CpG DNA in the plasmid backbone and is associated with early induction of Interferon (IFN)-beta. Principal Findings: In this study we examined the mechanisms underlying pMOG-induced protection. We found that in the DNA vaccinated cohort proinflammatory Interleukin (IL)-17 and IL-21 responses were dramatically reduced compared to in the control group, but that the expression of Foxp3 and Tumor Growth Factor (TGF)-beta 1, which are associated with regulatory T cells, was not enhanced. Moreover, genes associated with Type I IFNs were upregulated. To delineate the role of IFN-beta in the protective mechanism we employed short interfering RNA (siRNA) to IFN-beta in the DNA vaccine. SiRNA to IFN-beta completely abrogated the protective effects of the vaccine, demonstrating that a local early elaboration of IFN-beta is important for EAE protection. IL-17 responses comparable to those in control rats developed in rats injected with the IFN-beta-silencing DNA vaccine. Conclusions: We herein demonstrate that DNA vaccination protects from proinflammatory Th17 cell responses during induction of EAE. The mechanism involves IFN-beta as IL-17 responses are rescued by silencing of IFN-beta during DNA vaccination.	[Andersson, Asa; Wefer, Judit; Harris, Robert A.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Asa] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Isaksson, Magnus; Norling, Anna; Rorsman, Fredrik; Kampe, Olle; Lobell, Anna] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Flores-Morales, Amilcar] Karolinska Inst, Dept Mol Med, Stockholm, Sweden	Karolinska Institutet; University of California System; University of California Los Angeles; Uppsala University; Karolinska Institutet	Andersson, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	Anna.Lobell@medsci.uu.se	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Kampe, Olle/0000-0001-6091-9914; Andersson, Anders/0000-0002-3627-6899	Montel Williams MS foundation; Petrus and Augusta Hedlunds foundation; Swedish Foundation for Strategic Research; Center for Autoimmunity and inflammation at Uppsala University; Ake Wiberg foundation; Tore Nilson foundation; Karolinska Institutet; Socialstyrelsen; Swedish Association for Neurologically disabled; Swedish Research Council	Montel Williams MS foundation; Petrus and Augusta Hedlunds foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Center for Autoimmunity and inflammation at Uppsala University; Ake Wiberg foundation; Tore Nilson foundation; Karolinska Institutet(Karolinska Institutet); Socialstyrelsen; Swedish Association for Neurologically disabled; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Montel Williams MS foundation (A. Lobell), Petrus and Augusta Hedlunds foundation (A. Lobell), the "Network for Inflammation research" funded by the Swedish Foundation for Strategic Research (A. Lobell), Center for Autoimmunity and inflammation at Uppsala University (A. Lobell and O. Kampe), Ake Wiberg foundation (A. Lobell), Tore Nilson foundation (A. Lobell), Karolinska Institutet funds (A. Lobell), Socialstyrelsen funds (A. Lobell), the Swedish Association for Neurologically disabled (A. Lobell) and the Swedish Research Council (O. Kampe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial, personal, or professional interests that have influenced the paper.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BETTELLI E, 2007, CURR OPIN IMMUNOL; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Koike F, 2003, J NEUROIMMUNOL, V139, P109, DOI 10.1016/S0165-5728(03)00155-3; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lobell A, 1999, J IMMUNOL, V163, P4754; Lobell A, 1998, J EXP MED, V187, P1543, DOI 10.1084/jem.187.9.1543; Lobell A, 2003, J IMMUNOL, V170, P1806, DOI 10.4049/jimmunol.170.4.1806; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller A, 1996, J NEUROIMMUNOL, V64, P151, DOI 10.1016/0165-5728(95)00164-6; Muhallab S, 2002, SCAND J IMMUNOL, V55, P264, DOI 10.1046/j.0300-9475.2002.01038.x; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Silver PB, 2007, J IMMUNOL, V179, P5146, DOI 10.4049/jimmunol.179.8.5146; Stahlberg N, 2004, ENDOCRINOLOGY, V145, P1972, DOI 10.1210/en.2003-0874; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallin H, 1999, J IMMUNOL, V163, P6306; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wefer J, 2004, J NEUROIMMUNOL, V149, P66, DOI 10.1016/j.jneuroim.2003.12.012; Weissert R, 2000, P NATL ACAD SCI USA, V97, P1689, DOI 10.1073/pnas.030390097	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3682	10.1371/journal.pone.0003682	http://dx.doi.org/10.1371/journal.pone.0003682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997868	Green Submitted, Green Published, gold			2022-12-25	WOS:000265165500005
J	Dehlin, M; Bokarewa, M; Rottapel, R; Foster, SJ; Magnusson, M; Dahlberg, LE; Tarkowski, A				Dehlin, Mats; Bokarewa, Maria; Rottapel, Robert; Foster, Simon J.; Magnusson, Mattias; Dahlberg, Leif E.; Tarkowski, Andrej			Intra-Articular Fms-Like Tyrosine Kinase 3 Ligand Expression Is a Driving Force in Induction and Progression of Arthritis	PLOS ONE			English	Article							FLT3 LIGAND; DIFFERENTIATION; SUBSETS	Background: One of the hallmarks of rheumatoid arthritis ( RA) is hyperplasia and inflammation of the synovial tissue being characterized by in situ occurrence of highly differentiated leukocytes. Fms-like tyrosine kinase 3 (Flt3) has a crucial role in hematopoiesis, regulation of cell proliferation, differentiation and apoptosis. Typically, Flt3 is expressed on early myeloid and lymphoid progenitors and is activated by its soluble ligand (Flt3-L). The highly differentiated cellular pattern in the synovium of the RA patients made us hypothesize that Flt3-L, with its ability to induce proliferation and differentiation, could be of importance in induction and/or progression of arthritis. Methodology/Principal Findings: To investigate occurrence of Flt3-L in RA we have measured its levels in matched serum and synovial fluid samples from 130 patients and 107 controls. To analyse the pro-inflammatory role of Flt3-L, we continuously overexpressed this protein locally in healthy mouse joints using homologous B-cell line transfected with Flt3-L gene. Additionally, recombinant Flt3-L was instillated intra-articularly in combination with peptidoglycans, a Toll Like Receptor 2-ligand with stong arthritogenic properties. Our results show significantly higher levels of Flt3-L in the synovial fluid as compared to serum levels in RA subjects (p=0.0001). In addition, RA synovial fluid levels of Flt-3-L were significantly higher than these obtained from synovial fluids originating fromnon-inflammatory joint diseases (p=0.022). Intra-articular administration of B-cell line transfected with Flt3-L gene resulted in highly erosive arthritis while inoculation of the same B-cell line without hyperexpression of Flt3-L did not induce erosivity and only in a minority of cases caused synovial proliferation! Flt3-ligand potentiated peptidoglycan induced arthritis as compared to mice injected with peptidoglycan alone (p < 0.05). Conclusions/Significance: Our findings indicate that Flt3-L is strongly expressed at the site of inflammation in human RA. It exerts both pro-inflammatory and tissue destructive properties once in the joint cavity. Owing to these properties, treatment attempts to neutralize this molecule should be considered in RA.	[Dehlin, Mats; Bokarewa, Maria; Magnusson, Mattias; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Dahlberg, Leif E.] UMAS, Univ Hosp, Dept Orthopaed, Malmo, Sweden	University of Gothenburg; University of Toronto; University of Sheffield; Lund University; Skane University Hospital	Dehlin, M (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	mats.dehlin@vgregion.se	Bokarewa, Maria I/A-8114-2019; magnusson, mattias/G-2079-2011	Bokarewa, Maria I/0000-0001-9424-5145; magnusson, mattias/0000-0002-6565-4027; Rottapel, Robert/0000-0002-6024-5558	Goteborg Medical Society; Swedish Association Against Rheumatism; King Gustav V's Foundation; Swedish Medical Research Council; Nanna Svartz Foundation; University of Goteborg; A.-G. Crafoord Foundation; Borje Dahlin Foundation; European Union; Inflammation Network; Rune And Ulla Amlovs Foundation; A. M. E. Wolff Foundation	Goteborg Medical Society; Swedish Association Against Rheumatism; King Gustav V's Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Nanna Svartz Foundation; University of Goteborg; A.-G. Crafoord Foundation; Borje Dahlin Foundation; European Union(European Commission); Inflammation Network; Rune And Ulla Amlovs Foundation; A. M. E. Wolff Foundation	This work was supported by the Goteborg Medical Society, Swedish Association Against Rheumatism, King Gustav V's Foundation, Swedish Medical Research Council, Nanna Svartz Foundation, University of Goteborg, A.-G. Crafoord Foundation, Borje Dahlin Foundation, European Union grants, Inflammation Network, Rune And Ulla Amlovs Foundation, and A. M. E. Wolff Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Liu ZQ, 2001, ARTHRITIS RES, V3, P375, DOI 10.1186/ar330; Maraskovsky E, 2000, BLOOD, V96, P878, DOI 10.1182/blood.V96.3.878.015k15_878_884; Namikawa R, 1996, BLOOD, V87, P1881; Papayannopoulou T, 1997, BLOOD, V90, P620, DOI 10.1182/blood.V90.2.620.620_620_629; Rappold I, 1997, BLOOD, V90, P111; Rosnet O, 1996, LEUKEMIA, V10, P238; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Rusten LS, 1996, BLOOD, V87, P1317, DOI 10.1182/blood.V87.4.1317.bloodjournal8741317; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169	12	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3633	10.1371/journal.pone.0003633	http://dx.doi.org/10.1371/journal.pone.0003633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982072	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000265134300003
J	Fan, XX; Martin-Brown, S; Florens, L; Li, R				Fan, Xiaoxue; Martin-Brown, Skylar; Florens, Laurence; Li, Rong			Intrinsic Capability of Budding Yeast Cofilin to Promote Turnover of Tropomyosin-Bound Actin Filaments	PLOS ONE			English	Article							BINDING-PROTEIN; TROPONIN COMPLEX; ARP2/3 COMPLEX; F-ACTIN; CABLES; POLYMERIZATION; STABILIZES; MECHANISM; ISOFORMS; FORMIN	The ability of actin filaments to function in cell morphogenesis and motility is closely coupled to their dynamic properties. Yeast cells contain two prominent actin structures, cables and patches, both of which are rapidly assembled and disassembled. Although genetic studies have shown that rapid actin turnover in patches and cables depends on cofilin, how cofilin might control cable disassembly remains unclear, because tropomyosin, a component of actin cables, is thought to protect actin filaments against the depolymerizing activity of ADF/cofilin. We have identified cofilin as a yeast tropomyosin (Tpm1) binding protein through Tpm1 affinity column and mass spectrometry. Using a variety of assays, we show that yeast cofilin can efficiently depolymerize and sever yeast actin filaments decorated with either Tpm1 or mouse tropomyosins TM1 and TM4. Our results suggest that yeast cofilin has the intrinsic ability to promote actin cable turnover, and that the severing activity may rely on its ability to bind Tpm1.	[Fan, Xiaoxue; Martin-Brown, Skylar; Florens, Laurence; Li, Rong] Stowers Inst Med Res, Kansas City, MO USA	Stowers Institute for Medical Research	Fan, XX (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	rli@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650	National Institutes of Health [GM057063, GM066311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066311, R01GM057063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health GM057063 and GM066311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami R, 2002, BIOCHEMISTRY-US, V41, P5907, DOI 10.1021/bi0116745; ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Asakura T, 1998, ONCOGENE, V16, P121, DOI 10.1038/sj.onc.1201487; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1989, BIOCHEMISTRY-US, V28, P8501, DOI 10.1021/bi00447a035; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FATTOUM A, 1983, BIOCHEMISTRY-US, V22, P1187, DOI 10.1021/bi00274a031; Florens Laurence, 2006, V328, P159; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HITCHCOCK SE, 1976, CELL, V7, P531, DOI 10.1016/0092-8674(76)90203-8; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; Maciver SK, 2002, GENOME BIOL, V3; McGough Amy, 2001, Results and Problems in Cell Differentiation, V32, P135; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Wawro B, 2007, BIOCHEMISTRY-US, V46, P8146, DOI 10.1021/bi700686p; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; WEGNER A, 1982, J MOL BIOL, V161, P217, DOI 10.1016/0022-2836(82)90149-8; WEIGT C, 1990, FEBS LETT, V260, P266, DOI 10.1016/0014-5793(90)80119-4; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	40	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3641	10.1371/journal.pone.0003641	http://dx.doi.org/10.1371/journal.pone.0003641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982060	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134300011
J	Mankowski, JL; Queen, SE; Fernandez, CS; Tarwater, PM; Karper, JM; Adams, RJ; Kent, SJ				Mankowski, Joseph L.; Queen, Suzanne E.; Fernandez, Caroline S.; Tarwater, Patrick M.; Karper, Jami M.; Adams, Robert J.; Kent, Stephen J.			Natural Host Genetic Resistance to Lentiviral CNS Disease: A Neuroprotective MHC Class I Allele in SIV-Infected Macaques	PLOS ONE			English	Article								Human immunodeficiency virus (HIV) infection frequently causes neurologic disease even with anti-retroviral treatment. Although associations between MHC class I alleles and acquired immunodeficiency syndrome (AIDS) have been reported, the role MHC class I alleles play in restricting development of HIV-induced organ-specific diseases, including neurologic disease, has not been characterized. This study examined the relationship between expression of the MHC class I allele Mane-A*10 and development of lentiviral-induced central nervous system (CNS) disease using a well-characterized simian immunodeficiency (SIV)/pigtailed macaque model. The risk of developing CNS disease (SIV encephalitis) was 2.5 times higher for animals that did not express the MHC class I allele Mane-A* 10 (P = 0.002; RR = 2.5). Animals expressing the Mane-A* 10 allele had significantly lower amounts of activated macrophages, SIV RNA, and neuronal dysfunction in the CNS than Mane-A*10 negative animals (P<0.001). Mane-A*10 positive animals with the highest CNS viral burdens contained SIV gag escape mutants at the Mane-A*10-restricted KP9 epitope in the CNS whereas wild type KP9 sequences dominated in the brain of Mane-A*10 negative animals with comparable CNS viral burdens. These concordant findings demonstrate that particular MHC class I alleles play major neuroprotective roles in lentiviral-induced CNS disease.	[Mankowski, Joseph L.; Queen, Suzanne E.; Karper, Jami M.; Adams, Robert J.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Fernandez, Caroline S.; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Tarwater, Patrick M.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Texas Tech University System; Texas Tech University	Mankowski, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	jmankows@jhmi.edu	Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891	NIH [RR019995, NS055651, NS047984, NS055648, HL75840, MH69116, MH070306]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR019995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306, R01MH069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984, R01NS055648] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH RR019995 (RJA). In addition, animal studies were supported by NIH NS055651, NS047984, NS055648, HL75840, MH69116, and MH070306.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Babas T, 2006, AIDS, V20, P197, DOI 10.1097/01.aids.0000198078.24584.21; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Cherry CL, 2008, AIDS RES HUM RETROV, V24, P117, DOI 10.1089/aid.2007.0168; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; FELLAY J, 2007, WHOLE GENOME ASS STU; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; McCrossan M, 2006, BRAIN, V129, P503, DOI 10.1093/brain/awh695; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moniuszko M, 2003, J VIROL, V77, P12346, DOI 10.1128/JVI.77.22.12346-12351.2003; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Pratt BF, 2006, IMMUNOGENETICS, V58, P995, DOI 10.1007/s00251-006-0164-8; Sauermann Ulrike, 2001, Current Molecular Medicine (Hilversum), V1, P515; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Smith MZ, 2005, J MED PRIMATOL, V34, P282, DOI 10.1111/j.1600-0684.2005.00126.x; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	25	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3603	10.1371/journal.pone.0003603	http://dx.doi.org/10.1371/journal.pone.0003603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978944	Green Published, gold			2022-12-25	WOS:000265134200002
J	Ding, Y; Larson, G; Rivas, G; Lundberg, C; Geller, L; Ouyang, C; Weitzel, J; Archambeau, J; Slater, J; Daly, MB; Benson, AB; Kirkwood, JM; O'Dwyer, PJ; Sutphen, R; Stewart, JA; Johnson, D; Nordborg, M; Krontiris, TG				Ding, Yan; Larson, Garrett; Rivas, Guillermo; Lundberg, Cathryn; Geller, Louis; Ouyang, Ching; Weitzel, Jeffrey; Archambeau, John; Slater, Jerry; Daly, Mary B.; Benson, Al B.; Kirkwood, John M.; O'Dwyer, Peter J.; Sutphen, Rebecca; Stewart, James A.; Johnson, David; Nordborg, Magnus; Krontiris, Theodore G.			Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk	PLOS ONE			English	Article								Previously, a candidate gene linkage approach on brother pairs affected with prostate cancer identified a locus of prostate cancer susceptibility at D3S1234 within the fragile histidine triad gene (FHIT), a tumor suppressor that induces apoptosis. Subsequent association tests on 16 SNPs spanning approximately 381 kb surrounding D3S1234 in Americans of European descent revealed significant evidence of association for a single SNP within intron 5 of FHIT. In the current study, resequencing and genotyping within a 28.5 kb region surrounding this SNP further delineated the association with prostate cancer risk to a 15 kb region. Multiple SNPs in sequences under evolutionary constraint within intron 5 of FHIT defined several related haplotypes with an increased risk of prostate cancer in European-Americans. Strong associations were detected for a risk haplotype defined by SNPs 138543, 142413, and 152494 in all cases (Pearson's chi(2) = 12.34, df 1, P = 0.00045) and for the homozygous risk haplotype defined by SNPs 144716, 142413, and 148444 in cases that shared 2 alleles identical by descent with their affected brothers (Pearson's chi(2) = 11.50, df 1, P = 0.00070). In addition to highly conserved sequences encompassing SNPs 148444 and 152413, population studies revealed strong signatures of natural selection for a 1 kb window covering the SNP 144716 in two human populations, the European American (pi = 0.0072, Tajima's D = 3.31, 14 SNPs) and the Japanese (pi = 0.0049, Fay & Wu's H = 8.05, 14 SNPs), as well as in chimpanzees (Fay & Wu's H = 8.62, 12 SNPs). These results strongly support the involvement of the FHIT intronic region in an increased risk of prostate cancer.	[Ding, Yan; Larson, Garrett; Rivas, Guillermo; Lundberg, Cathryn; Geller, Louis; Ouyang, Ching; Krontiris, Theodore G.] Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA; [Weitzel, Jeffrey] City of Hope, Dept Canc Genet, Duarte, CA USA; [Archambeau, John; Slater, Jerry] Loma Linda Sch Med, Dept Radiat Med, Loma Linda, CA USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Populat Sci, Philadelphia, PA USA; [Benson, Al B.] Northwestern Univ, Sch Med, Robert J Lurie Comprehensive Canc Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA; [Kirkwood, John M.] Univ Pittsburgh, Canc Ctr, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA; [O'Dwyer, Peter J.] Univ Penn, Canc Ctr, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Sutphen, Rebecca] Univ S Florida, H. Lee Moffitt Canc Ctr & Res Inst, Interdisciplinary Oncol Program, Tampa, FL USA; [Stewart, James A.] Univ Wisconsin, Sch Med, Comprehensive Canc Ctr, Madison, WI 53706 USA; [Johnson, David] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Nordborg, Magnus] Univ Southern California, Dept Mol & Computat Biol, Biol Sci, Los Angeles, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Loma Linda University; Fox Chase Cancer Center; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University	Ding, Y (corresponding author), Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA.	tkrontir@coh.org		Nordborg, Magnus/0000-0001-7178-9748	NIH [AG15720, HG-002790]; DOE [PC020680]; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [RC4CA153828, R01CA106414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YD, GL, GR, CL, CO, TGK were supported by NIH AG15720, DOE PC020680, and the Beckman Research Institute of the City of Hope. LG, JW, JA, JS, MBD, ABB, JMK, PJO, RS, JAS, DJ were supported by NIH AG15720. MN was supported by NIH HG-002790.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chizhikov V, 2002, ONCOGENE, V21, P2398, DOI 10.1038/sj.onc.1205310; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DUDBRIDGE E, 2006, UNPHASED USER GUIDE; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fay JC, 2000, GENETICS, V155, P1405; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fouts RL, 2003, CANCER-AM CANCER SOC, V97, P1447, DOI 10.1002/cncr.11201; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guo ZY, 2000, PROSTATE, V43, P101; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Larson GP, 2005, CANCER RES, V65, P805; Latil A, 1998, ONCOGENE, V16, P1863, DOI 10.1038/sj.onc.1201703; Levin AM, 2007, CANCER EPIDEM BIOMAR, V16, P1294, DOI 10.1158/1055-9965.EPI-06-1054; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson HH, 1998, CANCER RES, V58, P1804; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Preacher KJ, 2001, CALCULATION CHI SQUA; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Rhim JS, 1997, CANCER RES, V57, P576; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Sozzi G, 1998, CANCER RES, V58, P5032; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Vecchione A, 2001, CLIN CANCER RES, V7, P1306; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu N, 2003, GENETICS, V164, P1511	50	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3533	10.1371/journal.pone.0003533	http://dx.doi.org/10.1371/journal.pone.0003533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953408	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000265130500010
J	Boris Schmid, V; Kesmir, C; de Boer, RJ				Boris Schmid, V; Kesmir, Can; de Boer, Rob J.			The Specificity and Polymorphism of the MHC Class I Prevents the Global Adaptation of HIV-1 to the Monomorphic Proteasome and TAP	PLOS ONE			English	Article								The large diversity in MHC class I molecules in a population lowers the chance that a virus infects a host to which it is pre-adapted to escape the MHC binding of CTL epitopes. However, viruses can also lose CTL epitopes by escaping the monomorphic antigen processing components of the pathway (proteasome and TAP) that create the epitope precursors. If viruses were to accumulate escape mutations affecting these monomorphic components, they would become pre-adapted to all hosts regardless of the MHC polymorphism. To assess whether viruses exploit this apparent vulnerability, we study the evolution of HIV-1 with bioinformatic tools that allow us to predict CTL epitopes, and quantify the frequency and accumulation of antigen processing escapes. We found that within hosts, proteasome and TAP escape mutations occur frequently. However, on the population level these escapes do not accumulate: the total number of predicted epitopes and epitope precursors in HIV-1 clade B has remained relatively constant over the last 30 years. We argue that this lack of adaptation can be explained by the combined effect of the MHC polymorphism and the high specificity of individual MHC molecules. Because of these two properties, only a subset of the epitope precursors in a host are potential epitopes, and that subset differs between hosts. We estimate that upon transmission of a virus to a new host 39%-66% of the mutations that caused epitope precursor escapes are released from immune selection pressure.	[Boris Schmid, V; Kesmir, Can; de Boer, Rob J.] Univ Utrecht, Inst Theoret Phys, NL-3508 TA Utrecht, Netherlands; [Kesmir, Can] Univ Utrecht, Acad Biomed Ctr, NL-3508 TC Utrecht, Netherlands	Utrecht University; Utrecht University	Boris Schmid, V (corresponding author), Univ Utrecht, Inst Theoret Phys, NL-3508 TA Utrecht, Netherlands.	boris.schmid@gmail.com	de Boer, Rob/B-6050-2011; Schmid, Boris V./P-9013-2016; Kesmir, Can/B-9410-2011	de Boer, Rob/0000-0002-2130-691X; Schmid, Boris V./0000-0003-0452-623X; 	Utrecht University; Netherlands Organization for Scientific Research	Utrecht University; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by Utrecht University and the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Barouch DH, 2005, NAT IMMUNOL, V6, P247, DOI 10.1038/ni1167; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Beekman NJ, 2000, J IMMUNOL, V164, P1898, DOI 10.4049/jimmunol.164.4.1898; BERGMANN CC, 1994, J VIROL, V68, P5306, DOI 10.1128/JVI.68.8.5306-5310.1994; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Brander C, 1999, J VIROL, V73, P10191, DOI 10.1128/JVI.73.12.10191-10198.1999; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Burroughs NJ, 2004, IMMUNOGENETICS, V56, P311, DOI 10.1007/s00251-004-0691-0; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Kutsch O, 2002, AIDS RES HUM RETROV, V18, P1319, DOI 10.1089/088922202320886361; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lundegaard C, 2006, TRENDS BIOTECHNOL, V24, P537, DOI 10.1016/j.tibtech.2006.10.001; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Maurer K, 2008, JAIDS-J ACQ IMM DEF, V48, P133, DOI 10.1097/QAI.0b013e31816fdc4a; Milicic A, 2005, J IMMUNOL, V175, P4618, DOI 10.4049/jimmunol.175.7.4618; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; PARKER KC, 1994, J IMMUNOL, V152, P163; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Poon AFY, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030045; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Scheliens IMM, 2008, AIDS, V22, P33, DOI 10.1097/QAD.0b013e3282f15622; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SLADE RW, 1992, GENETICS, V132, P861; SNELL GD, 1968, FOLIA BIOL-PRAGUE, V14, P335; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; van Baalen CA, 2002, EUR J IMMUNOL, V32, P2644, DOI 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R; Walker BA, 2005, IMMUNOGENETICS, V57, P232, DOI 10.1007/s00251-005-0786-2; WHITNEY JB, 1985, P NATL ACAD SCI USA, V82, P7646, DOI 10.1073/pnas.82.22.7646; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zafiropoulos A, 2004, P ROY SOC B-BIOL SCI, V271, pS53, DOI 10.1098/rsbl.2003.0088; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	75	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3525	10.1371/journal.pone.0003525	http://dx.doi.org/10.1371/journal.pone.0003525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949050	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126400010
J	Edelstein, C; Philips, B; Pfaffinger, D; Scanu, AM				Edelstein, Celina; Philips, Binu; Pfaffinger, Ditta; Scanu, Angelo M.			The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin	FASEB JOURNAL			English	Article						human embryonic kidney cells; HEK 293; kringle V; monoclonal antibody T15		Lipoprotein (a) [Lp(a)], a cardiovascular risk factor, is a low-density lipoprotein (LDL) variant shown to bind to oxidized phospholipids (oxPLs); however, its binding mode and origin have not been clearly established. We isolated both LDL and Lp(a) from the plasma of a population of high-Lp(a) subjects and in each Lp(a) particle separated apolipoprotein(a) [apo(a)], from the LDL component, Lp(a(-)). These products were assayed by an ELISA using monoclonal antibody T15 with a known specificity for oxPLs. In each subject, the T15 reactivity was confined to apo(a). Moreover, the amount of oxPL bound to apo(a) was unaffected by plasma Lp(a) levels and apo(a) size polymorphism. We have previously shown that kringle V (KV) is the site of oxPL linkage in human apo(a). In this work, we expressed in human embryonic kidney cells a KV-containing recombinant that, when purified from the medium, contained oxPLs. In summary, in human plasma Lp(a), the oxPLs are located in apo(a) and not in the circulating LDLs, suggesting a cellular origin. This latter concept is supported by the studies in which an expressed KV-containing apo(a) microdomain exhibited oxPL reactivity. Thus, apo(a) can undergo potentially pathogenic posttranslational modifications in a cellular environment able to generate oxPL.-Edelstein, C., Philips, B., Pfaffinger, D., Scanu, A. M. The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin. FASEB J. 23, 950-956 (2009)	[Edelstein, Celina; Philips, Binu; Pfaffinger, Ditta; Scanu, Angelo M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Scanu, Angelo M.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Scanu, AM (corresponding author), Univ Chicago, Dept Med, MC5041,5841 S Maryland Ave, Chicago, IL 60637 USA.	ascanu@medicine.bsd.uchicago.edu			U. S. National Institutes of Health, National Heart, Lung and Blood Institute (NIH-NLBI) [HL63200]; NIH-NHLBI Cardiovascular Pathophysiology and Biochemistry [T31 HL07237]	U. S. National Institutes of Health, National Heart, Lung and Blood Institute (NIH-NLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NHLBI Cardiovascular Pathophysiology and Biochemistry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by U. S. National Institutes of Health, National Heart, Lung and Blood Institute (NIH-NLBI) grant HL63200. B. P. was supported by NIH-NHLBI Cardiovascular Pathophysiology and Biochemistry training grant T31 HL07237.	Bergmark C, 2008, J LIPID RES, V49, P2230, DOI 10.1194/jlr.M800174-JLR200; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Edelstein C, 1996, J LIPID RES, V37, P1786; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Edelstein C, 1995, BIOCHEMISTRY-US, V34, P16483, DOI 10.1021/bi00050a032; FLESS GM, 1989, J LIPID RES, V30, P651; FLESS GM, 1994, BIOCHEMISTRY-US, V33, P13492, DOI 10.1021/bi00249a038; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; JOY ST, 2008, VASC DIS PREV, V5, P1; Klezovitch O, 2001, J BIOL CHEM, V276, P46864, DOI 10.1074/jbc.M107943200; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; PHILIPS B, 2008, VASC DIS PREV, V5, P150; PHILIPS B, 2008, ANN C ART THROMB VAS, V161, P37; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; Scanu AM, 1999, TRENDS CARDIOVAS MED, V9, P196, DOI 10.1016/S1050-1738(00)00020-7; SCANU AM, 1995, BBA-LIPID LIPID MET, V1256, P1, DOI 10.1016/0005-2760(95)00012-2; Scanu AM, 2008, AM J CARDIOL, V101, p44B, DOI 10.1016/j.amjcard.2008.02.031; Scanu Angelo M, 2003, Curr Atheroscler Rep, V5, P106, DOI 10.1007/s11883-003-0081-3; Schneider M, 2005, J LIPID RES, V46, P769, DOI 10.1194/jlr.M400467-JLR200; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Tsimikas S, 2003, J AM COLL CARDIOL, V41, P360, DOI 10.1016/S0735-1097(02)02769-9; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	23	10	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					950	956		10.1096/fj.08-122002	http://dx.doi.org/10.1096/fj.08-122002			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001055	Green Published			2022-12-25	WOS:000265506300030
J	Mavridou, DAI; Stevens, JM; Goddard, AD; Willis, AC; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Stevens, Julie M.; Goddard, Alan D.; Willis, Antony C.; Ferguson, Stuart J.; Redfield, Christina			Control of Periplasmic Interdomain Thiol: Disulfide Exchange in the Transmembrane Oxidoreductase DsbD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CYTOCHROME-C MATURATION; ACTIVE-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TERMINAL DOMAIN; BOND FORMATION; PK(A) VALUES; PROTEIN; MECHANISM	The bacterial protein DsbD transfers reductant from the cytoplasm to the otherwise oxidizing environment of the periplasm. This reducing power is required for several essential pathways, including disulfide bond formation and cytochrome c maturation. DsbD includes a transmembrane domain (tmDsbD) flanked by two globular periplasmic domains (nDsbD/cDsbD); each contains a cysteine pair involved in electron transfer via a disulfide exchange cascade. The final step in the cascade involves reduction of the Cys(103) -Cys(109) disulfide of nDsbD by Cys(461) of cDsbD. Here we show that a complex between the globular periplasmic domains is trapped in vivo only when both are linked by tmDsbD. We have found previously (Mavridou, D. A., Stevens, J.M., Ferguson, S.J., & Redfield, C. ( 2007) J. Mol. Biol. 370, 643-658) that the attacking cysteine ( Cys461) in isolated cDsbD has a high pK(a) value (10.5) that makes this thiol relatively unreactive toward the target disulfide in nDsbD. Here we show using NMR that active-site pK(a) values change significantly when cDsbD forms a complex with nDsbD. This modulation of pK(a) values is critical for the specificity and function of cDsbD. Uncomplexed cDsbD is a poor nucleophile, allowing it to avoid nonspecific reoxidation; however, in complex with nDsbD, the nucleophilicity of cDsbD increases permitting reductant transfer. The observation of significant changes in active-site pK(a) values upon complex formation has wider implications for understanding reactivity in thiol: disulfide oxidoreductases.	[Mavridou, Despoina A. I.; Stevens, Julie M.; Goddard, Alan D.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Willis, Antony C.] Univ Oxford, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Goddard, Alan/E-9328-2013; Mavridou, Despoina/ABG-5940-2020	Mavridou, Despoina/0000-0002-7449-1151; Redfield, Christina/0000-0001-7297-7708; Goddard, Alan/0000-0003-4950-7470	Biotechnology and Biological Sciences Research Council [BBD5230191, BBE0048651, BB/E004865/1] Funding Source: Medline; Wellcome Trust [079440] Funding Source: Medline; BBSRC [BB/E004865/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ausubel FM, 2003, CURRENT PROTOCOLS MO; Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Katzen F, 2003, P NATL ACAD SCI USA, V100, P10471, DOI 10.1073/pnas.1334136100; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014	29	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3219	3226		10.1074/jbc.M805963200	http://dx.doi.org/10.1074/jbc.M805963200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004826	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000262700900065
J	Arscott, WT; LaBauve, AE; May, V; Wesley, UV				Arscott, W. T.; LaBauve, A. E.; May, V.; Wesley, U. V.			Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation	ONCOGENE			English	Article						DPPIV; neuroblastoma; apoptosis; chemokine; migration and invasion	PROSTATE-CANCER CELLS; DEAMINASE COMPLEXING PROTEIN; BONE-MARROW METASTASES; ADENOSINE-DEAMINASE; TUMOR-GROWTH; MALIGNANT PHENOTYPE; SURFACE PEPTIDASES; PROGENITOR CELLS; CARCINOMA CELLS; IN-VITRO	Imbalanced protease expression and activities may contribute to the development of cancers, including neuroblastoma (NB). NB is a fatal childhood cancer of the sympathetic nervous system that frequently overexpresses mitogenic peptides, chemokines and their receptors. Dipeptidyl peptidase IV (DPPIV), a cell surface serine protease, inactivates or degrades some of these bioactive peptides and chemokines, thereby regulating cell proliferation and survival. Our studies show that DPPIV is expressed in normal neural crest-derived structures, including superior cervical and dorsal root ganglion cells, sciatic nerve, and in adrenal glands, but its expression is greatly decreased or lost in cells derived from NB, their malignant counterpart. Restoration of DPPIV expression in NB cells led to their differentiation in association with increased expression of the neural marker MAP2 and decreased expression of chemokines, including stromal-derived factor 1 (SDF1) and its receptor CXCR4. Furthermore, DPPIV promoted apoptosis, and inhibited SDF1-mediated in vitro cell migration and angiogenic potential. These changes were accompanied by caspase activation and decreased levels of phospho-Akt and MMP9 activity, which are downstream effectors of SDF1-CXCR4 signaling. Importantly, DPPIV suppressed the tumorigenic potential of NB cells in a xenotransplantation mouse model. These data support a potential role for DPPIV in inhibiting NB growth and progression.	[Arscott, W. T.; LaBauve, A. E.; Wesley, U. V.] Univ Vermont, Vermont Canc Ctr, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [May, V.] Univ Vermont, Vermont Canc Ctr, Dept Anat & Neurobiol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Wesley, UV (corresponding author), Univ Vermont, Vermont Canc Ctr, Dept Microbiol & Mol Genet, 316A,HSRF,149 Beaumont Ave, Burlington, VT 05405 USA.	uwesley@uvm.edu		Arscott, William/0000-0003-0110-8569	National Center for Research Resources-National Institute of Health (NCRR) [COBRE 2 P20 RR016435-P4Y6]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER	National Center for Research Resources-National Institute of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Grant, Neuroscience COBRE 2 P20 RR016435-P4Y6 from the National Center for Research Resources-National Institute of Health (NCRR). We thank the Department of Microbiology and Molecular Genetics and the Vermont Cancer Center (VCC) for their support. We thank Drs Cynthia Forehand, Diane Jaworski, Rodney Parsons, Marcus Bosenberg, Rae Nishi and Cedric Wesley for helpful discussions and critical review of the paper. We thank the staff at the VCC and COBRE-Neuroscience core facilities for their technical help.	Abbott CA, 1997, ADV EXP MED BIOL, V421, P161; Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Airoldi I, 2008, CANCER IMMUNOL IMMUN, V57, P541, DOI 10.1007/s00262-007-0392-2; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbero S, 2003, CANCER RES, V63, P1969; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bogenrieder T, 1997, PROSTATE, V33, P225; Bonfil RD, 2007, UROL ONCOL-SEMIN ORI, V25, P407, DOI 10.1016/j.urolonc.2007.05.008; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Castel V, 2007, CLIN TRANSL ONCOL, V9, P478, DOI 10.1007/s12094-007-0091-7; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Dai J, 2001, CLIN CANCER RES, V7, P1370; DINJENS WNM, 1990, J PATHOL, V160, P195, DOI 10.1002/path.1711600303; Dobers J, 2000, EUR J BIOCHEM, V267, P5093, DOI 10.1046/j.1432-1327.2000.01571.x; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Gabrilovac J, 2003, LIFE SCI, V73, P151, DOI 10.1016/S0024-3205(03)00257-1; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Golubkov VS, 2007, CELL CYCLE, V6, P147, DOI 10.4161/cc.6.2.3706; Guyon A, 2007, J MOL ENDOCRINOL, V38, P365, DOI 10.1677/JME-06-0013; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Kajiyama H, 2006, ANN NY ACAD SCI, V1086, P233, DOI 10.1196/annals.1377.007; KENNY AJ, 1989, LANCET, V2, P785; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Li ZJ, 2007, EXPERT OPIN THER TAR, V11, P1611, DOI 10.1517/14728222.11.12.1611; Maris JM, 2008, LANCET, V371, P1142, DOI 10.1016/S0140-6736(08)60500-0; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2008, LANCET ONCOL, V9, P195, DOI 10.1016/S1470-2045(08)70046-9; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; MORRISON ME, 1993, J EXP MED, V177, P1135, DOI 10.1084/jem.177.4.1135; Nakagawara A, 2004, PROG BRAIN RES, V146, P233, DOI 10.1016/S0079-6123(03)46015-9; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nanus DM, 2003, CLIN CANCER RES, V9, P6307; Nevo I, 2004, IMMUNOL LETT, V92, P163, DOI 10.1016/j.imlet.2003.10.019; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Pethiyagoda CL, 2001, CLIN EXP METASTAS, V18, P391, DOI 10.1023/A:1010930918055; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; SAKAMOTO J, 1993, J SURG ONCOL, V52, P124, DOI 10.1002/jso.2930520214; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Scharpe S, 2001, Verh K Acad Geneeskd Belg, V63, P5; SCHRADER WP, 1987, J HISTOCHEM CYTOCHEM, V35, P443, DOI 10.1177/35.4.3546489; Sedo A, 1994, Sb Lek, V95, P285; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Terauchi M, 2005, ONCOLOGY-BASEL, V69, P52, DOI 10.1159/000087476; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tsuji T, 2004, INT J HEMATOL, V80, P254, DOI 10.1532/IJH97.04066; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Vasudevan SA, 2005, WORLD J SURG, V29, P317, DOI 10.1007/s00268-004-7820-7; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wesley UV, 1999, J EXP MED, V190, P311, DOI 10.1084/jem.190.3.311; Wesley UV, 2004, INT J CANCER, V109, P855, DOI 10.1002/ijc.20091; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025	67	44	48	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					479	491		10.1038/onc.2008.402	http://dx.doi.org/10.1038/onc.2008.402			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18978811	Green Accepted			2022-12-25	WOS:000262866500002
J	Nakayama, M; Hisatsune, J; Yamasaki, E; Isomoto, H; Kurazono, H; Hatakeyama, M; Azuma, T; Yamaoka, Y; Yahiro, K; Moss, J; Hirayama, T				Nakayama, Masaaki; Hisatsune, Junzo; Yamasaki, Eiki; Isomoto, Hajime; Kurazono, Hisao; Hatakeyama, Masanori; Azuma, Takeshi; Yamaoka, Yoshio; Yahiro, Kinnosuke; Moss, Joel; Hirayama, Toshiya			Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GASTRIC EPITHELIAL-CELLS; BETA-CATENIN SIGNAL; AZ-521 CELLS; VACUOLATING TOXIN; WNT PATHWAY; ACTIVATION; PROTEIN; INDUCTION; CYTOTOXIN	Helicobacter pylori VacA toxin contributes to the pathogenesis and severity of gastric injury. We found that incubation of AZ-521 cells with VacA resulted in phosphorylation of protein kinase B (Akt) and glycogen synthase kinase-3 beta (GSK3 beta) through a PI3K-dependent pathway. Following phosphorylation and inhibition of GSK3 beta,beta-catenin was released from a GSK3 beta/beta-catenin complex, with subsequent nuclear translocation. Methyl-beta-cyclodextrin (MCD) and phosphatidylinositol-specific phospholipase C (PIPLC), but not 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) and bafilomycin A1, inhibited VacA-induced phosphorylation of Akt, indicating that it does not require VacA internalization and is independent of vacuolation. VacA treatment of AZ-521 cells transfected with TOPtkLuciferase reporter plasmid or control FOPtkLucifease reporter plasmid resulted in activation of TOPtkLuciferase, but not FOPtkLucifease. In addition, VacA transactivated the beta-catenin-dependent cyclin D1 promoter in a luciferase reporter assay. Infection of AZ-521 cells by a vacA mutant strain of H. pylori failed to induce phosphorylation of Akt and GSK3 beta, or release of beta-catenin from a GSK3 beta/beta-catenin complex. Taken together, these results support the conclusion that VacA activates the PI3K/Akt signaling pathway, resulting in phosphorylation and inhibition of GSK3 beta, and subsequent translocation of beta-catenin to the nucleus, consistent with effects of VacA on beta-catenin-regulated transcriptional activity. These data introduce the possibility that Wnt-dependent signaling might play a role in the pathogenesis of H. pylori infection, including the development of gastric cancer.	[Nakayama, Masaaki; Hisatsune, Junzo; Hirayama, Toshiya] Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 8528523, Japan; [Yamasaki, Eiki; Kurazono, Hisao] Obihiro Univ Agr & Vet Med, Dept Appl Vet Med & Publ Hlth, Obihiro, Hokkaido 0808555, Japan; [Isomoto, Hajime] Nagasaki Univ, Dept Endoscopy, Sch Med, Nagasaki 8528523, Japan; [Hatakeyama, Masanori] Hokkaido Univ, Div Mol Oncol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Azuma, Takeshi] Kobe Univ, Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan; [Yamaoka, Yoshio] Michael E DeBakey Vet Affairs Med Ctr, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA; [Yahiro, Kinnosuke; Moss, Joel] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Obihiro University of Agriculture & Veterinary Medicine; Nagasaki University; Hokkaido University; Kobe University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp		Yahiro, Kinnosuke/0000-0002-9813-0780; Yamaoka, Yoshio/0000-0002-1222-5819	Intramural Research Program of the NHLBI; National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health (to J. M.). This work was also supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Clements WM, 2002, CANCER RES, V62, P3503; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; D'Elios MM, 2007, CLIN CHIM ACTA, V381, P32, DOI 10.1016/j.cca.2007.02.026; Doucas H, 2005, EUR J CANCER, V41, P365, DOI 10.1016/j.ejca.2004.11.005; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Hisatsune J, 2007, INFECT IMMUN, V75, P4472, DOI 10.1128/IAI.00500-07; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kurashima Y, 2008, INT J CANCER, V122, P823, DOI 10.1002/ijc.23190; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Li Y, 2004, MOL BIOL CELL, V15, P1946, DOI 10.1091/mbc.e03-08-0618; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; MANETTI R, 1995, INFECT IMMUN, V63, P4476, DOI 10.1128/IAI.63.11.4476-4480.1995; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200; Nakayama M, 2006, INFECT IMMUN, V74, P6571, DOI 10.1128/IAI.00356-06; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; PAPINI E, 1993, MOL MICROBIOL, V7, P323, DOI 10.1111/j.1365-2958.1993.tb01123.x; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; Szabo IL, 2002, EXP BIOL MED, V227, P412, DOI 10.1177/153537020222700607; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601	36	101	110	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1612	1619		10.1074/jbc.M806981200	http://dx.doi.org/10.1074/jbc.M806981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996844	hybrid, Green Published			2022-12-25	WOS:000262330100029
J	Jarczowski, F; Jahreis, G; Erdmann, F; Schierhorn, A; Fischer, G; Edlich, F				Jarczowski, Franziska; Jahreis, Guenther; Erdmann, Frank; Schierhorn, Angelika; Fischer, Gunter; Edlich, Frank			FKBP36 Is an Inherent Multifunctional Glyceraldehyde-3-phosphate Dehydrogenase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACHYTENE PRIMARY SPERMATOCYTES; GENE-EXPRESSION; RAT TESTES; HSP90; TISSUES; PROTEIN; CELLS; GAPDH; RNA	FKBP36 has been previously shown to be a crucial factor in spermatogenesis because of its interplay with the synaptonemal complex protein SCPI. Here we show that beyond this function, FKBP36 forms complexes with glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) and Hsp90. Both proteins bind independently to different sites of the FKBP36 tetratricopeptide repeat domain. The interaction between FKBP36 and GAPDH directly inhibits the catalytic activity of GAPDH. In addition, FKBP36 expression causes a significant reduction of the GAPDH level and activity in COS-7 cells. Particularly in the cytosolic fraction, GAPDH was depleted by FKBP36 expression. Thus, FKBP36 diminishes GAPDH activity by direct interaction and down-regulation of GAPDH, which represents a previously unknown mechanism of GAPDH regulation and a novel function of FKBP36 in testis-specific signaling.	[Jarczowski, Franziska; Jahreis, Guenther; Erdmann, Frank; Schierhorn, Angelika; Fischer, Gunter; Edlich, Frank] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society	Edlich, F (corresponding author), NINDS, Surg Neurol Branch, NIH, Porter Neurosci Res Ctr, 35 Convent Dr,MSC 3704, Bethesda, MD 20892 USA.	fischer@enzyme-halle.mpg.de; edlichf@ninds.nih.gov	Erdmann, Frank/AAF-1091-2021	Erdmann, Frank/0000-0001-5261-0984	Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft	Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; Banerjee K, 1998, ALCOHOL CLIN EXP RES, V22, P2093, DOI 10.1111/j.1530-0277.1998.tb05921.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Buchczyk DP, 2003, BIOL CHEM, V384, P237, DOI 10.1515/BC.2003.026; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; HENIS YI, 1980, P NATL ACAD SCI-BIOL, V77, P5055, DOI 10.1073/pnas.77.9.5055; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; MEUNIER JC, 1978, EUR J BIOCHEM, V82, P483, DOI 10.1111/j.1432-1033.1978.tb12042.x; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mohr S, 1996, J BIOL CHEM, V271, P4209; Nagradova NK, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1067, DOI 10.1023/A:1012472627801; NAKAMURA M, 1984, ANDROLOGIA, V16, P446; NAKAMURA M, 1984, BIOL REPROD, V30, P1187, DOI 10.1095/biolreprod30.5.1187; Olah J, 2006, FEBS LETT, V580, P5807, DOI 10.1016/j.febslet.2006.09.037; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SMITH DF, 1993, J BIOL CHEM, V268, P18365; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Welch JE, 2006, MOL REPROD DEV, V73, P1052, DOI 10.1002/mrd.20235; Welch JE, 2000, J ANDROL, V21, P328; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; ZAKERI ZF, 1987, MOL CELL BIOL, V7, P1791, DOI 10.1128/MCB.7.5.1791; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	33	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					766	773		10.1074/jbc.M709779200	http://dx.doi.org/10.1074/jbc.M709779200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001379	hybrid			2022-12-25	WOS:000262122900010
J	Agopian, A; Gros, E; Aldrian-Herrada, G; Bosquet, N; Clayette, P; Divita, G				Agopian, Audrey; Gros, Edwige; Aldrian-Herrada, Gudrun; Bosquet, Nathalie; Clayette, Pascal; Divita, Gilles			A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANGSTROM RESOLUTION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; DNA-SYNTHESIS; PRIMER GRIP; DIMERIZATION; SUBUNIT; P66; TEMPLATE	The biologically active form of human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT) is a heterodimer. The formation of RT is a two-step mechanism, including a rapid protein-protein interaction "the dimerization step,"followed by conformational changes "the maturation step,"yielding the biologically active form of the enzyme. We have previously proposed that the heterodimeric organization of RT constitutes an interesting target for the design of new inhibitors. Here, we propose a new class of RT inhibitors that targets protein-protein interactions and conformational changes involved in the maturation of heterodimeric reverse transcriptase. Based on a screen of peptides derived from the thumb domain of this enzyme, we have identified a short peptide PAW that inhibits the maturation step and blocks viral replication at subnano-molar concentrations. PAW only binds dimeric RT and stabilizes it in an inactive/non-processive conformation. From a mechanistic point of view, PAW prevents proper binding of primer/template by affecting the structural dynamics of the thumb/fingers of p66 subunit. Taken together, these results demonstrate that HIV-1 RT maturation constitutes an attractive target for AIDS chemotherapeutics.	[Agopian, Audrey; Gros, Edwige; Aldrian-Herrada, Gudrun; Divita, Gilles] UM1, UM2, CNRS,UMR 5237, Dept Mol Biophys & Therapeut,Ctr Rech Biochim Mac, F-34293 Montpellier, France; [Bosquet, Nathalie; Clayette, Pascal] SPI BIO Commissariat Energie Atom, F-9226 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay	Divita, G (corresponding author), UM1, UM2, CNRS,UMR 5237, Dept Mol Biophys & Therapeut,Ctr Rech Biochim Mac, 1919 Route Mende, F-34293 Montpellier, France.	gilles.divita@crbm.cnrs.fr	DIVITA, GILLES/AAV-9214-2021	Aldrian, Gudrun/0000-0002-7899-0572	CNRS; Agence Nationale de Recherche sur le SIDA and SIDACTION; Targeting Replication and Integration of HIV HIV; European Community [LSHB-CT-2003-503480]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherche sur le SIDA and SIDACTION(ANRS); Targeting Replication and Integration of HIV HIV; European Community(European Commission)	This work was supported in part by the CNRS and by a grant from the Agence Nationale de Recherche sur le SIDA and SIDACTION. This work is part of the program "Targeting Replication and Integration of HIV HIV" supported by the European Community (EC, Grant LSHB-CT-2003-503480).	Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; Cabodevilla JF, 2001, EUR J BIOCHEM, V268, P1163, DOI 10.1046/j.1432-1327.2001.01939.x; Camarasa MJ, 2006, ANTIVIR RES, V71, P260, DOI 10.1016/j.antiviral.2006.05.021; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Depollier J, 2005, BIOCHEMISTRY-US, V44, P1909, DOI 10.1021/bi0484264; DIVITA G, 1993, BIOCHEMISTRY-US, V32, P7966, DOI 10.1021/bi00082a018; DIVITA G, 1994, J BIOL CHEM, V269, P13080; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; DIVITA G, 1995, J MOL BIOL, V245, P508, DOI 10.1006/jmbi.1994.0042; DIVITA G, 1995, J BIOL CHEM, V270, P28642, DOI 10.1074/jbc.270.48.28642; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Ghosh M, 1996, BIOCHEMISTRY-US, V35, P8553, DOI 10.1021/bi952773j; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUANG SC, 1992, BIOCHEM BIOPH RES CO, V184, P986, DOI 10.1016/0006-291X(92)90688-H; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris MC, 1999, J BIOL CHEM, V274, P24941, DOI 10.1074/jbc.274.35.24941; Morris MC, 1999, BIOCHEMISTRY-US, V38, P15097, DOI 10.1021/bi9914558; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mulky A, 2004, J VIROL, V78, P7089, DOI 10.1128/JVI.78.13.7089-7096.2004; MULLER B, 1989, J BIOL CHEM, V264, P13975; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; RESTLE T, 1990, J BIOL CHEM, V265, P8986; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Roisin A, 2004, J BIOL CHEM, V279, P9208, DOI 10.1074/jbc.M311594200; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sluis-Cremer N, 2002, MOL PHARMACOL, V62, P398, DOI 10.1124/mol.62.2.398; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Tachedjian G, 2005, FEBS LETT, V579, P379, DOI 10.1016/j.febslet.2004.11.099; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Tachedjian Gilda, 2003, Curr Opin Investig Drugs, V4, P966; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581	48	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					254	264		10.1074/jbc.M802199200	http://dx.doi.org/10.1074/jbc.M802199200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952602	Green Submitted, hybrid			2022-12-25	WOS:000261974800029
J	Belenky, P; Christensen, KC; Gazzaniga, F; Pletnev, AA; Brenner, C				Belenky, Peter; Christensen, Kathryn C.; Gazzaniga, Francesca; Pletnev, Alexandre A.; Brenner, Charles			Nicotinamide Riboside and Nicotinic Acid Riboside Salvage in Fungi and Mammals QUANTITATIVE BASIS FOR Urh1 AND PURINE NUCLEOSIDE PHOSPHORYLASE FUNCTION IN NAD(+) METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 PROTEIN; SIRTUINS; METHYLTHIOADENOSINE; POLY(ADP-RIBOSE); RIBOHYDROLASE; PURIFICATION; SYNTHETASE; MECHANISM; SUBSTRATE; ESTABLISH	NAD(+) is a co-enzyme for hydride transfer enzymes and an essential substrate of ADP-ribose transfer enzymes and sirtuins, the type III protein lysine deacetylases related to yeast Sir2. Supplementation of yeast cells with nicotinamide riboside extends replicative lifespan and increases Sir2-dependent gene silencing by virtue of increasing net NAD(+) synthesis. Nicotinamide riboside elevates NAD(+) levels via the nicotinamide riboside kinase pathway and by a pathway initiated by splitting the nucleoside into a nicotinamide base followed by nicotinamide salvage. Genetic evidence has established that uridine hydrolase, purine nucleoside phosphorylase, and methylthioadenosine phosphorylase are required for Nrk-independent utilization of nicotinamide riboside in yeast. Here we show that mammalian purine nucleoside phosphorylase but not methylthioadenosine phosphorylase is responsible for mammalian nicotinamide riboside kinase-independent nicotinamide riboside utilization. We demonstrate that so-called uridine hydrolase is 100-fold more active as a nicotinamide riboside hydrolase than as a uridine hydrolase and that uridine hydrolase and mammalian purine nucleoside phosphorylase cleave nicotinic acid riboside, whereas the yeast phosphorylase has little activity on nicotinic acid riboside. Finally, we show that yeast nicotinic acid riboside utilization largely depends on uridine hydrolase and nicotinamide riboside kinase and that nicotinic acid riboside bioavailability is increased by ester modification.	[Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Brenner, C (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA.	charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Belenky, Peter/0000-0002-1682-945X	National Institutes of Health Training [T32GM008704]; Shaklee Corp.; National Science Foundation [MCB-0822581]; Div Of Molecular and Cellular Bioscience [0946313] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaklee Corp.; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Training Grant T32GM008704 (to P. B.). This work was also supported in part by a grant from the Shaklee Corp. and by National Science Foundation Grant MCB-0822581 (to C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chattopadhyay MK, 2006, BIOCHEM BIOPH RES CO, V343, P203, DOI 10.1016/j.bbrc.2006.02.144; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P253, DOI 10.1016/0003-9861(87)90101-9; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lee HC, 2000, CHEM IMMUNOL, V75, P39; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lovane E, 2008, BIOCHEMISTRY-US, V47, P4418, DOI 10.1021/bi702448s; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; MAGNI G, 1975, J BIOL CHEM, V250, P9; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mao C, 1998, BIOCHEMISTRY-US, V37, P7135, DOI 10.1021/bi9723919; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Markert ML, 1997, HUM MUTAT, V9, P118, DOI 10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mitterbauer R, 2002, APPL ENVIRON MICROB, V68, P1336, DOI 10.1128/AEM.68.3.1336-1343.2002; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; ROWEN JW, 1951, J BIOL CHEM, V193, P497; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schramm Vern L, 2008, Nucleic Acids Symp Ser (Oxf), P75, DOI 10.1093/nass/nrn038; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Wojcik M, 2006, J BIOL CHEM, V281, P33395, DOI 10.1074/jbc.M607111200; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194	43	58	61	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					158	164		10.1074/jbc.M807976200	http://dx.doi.org/10.1074/jbc.M807976200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001417	Green Published, hybrid			2022-12-25	WOS:000261974800018
J	Li, W; Danilenko, DM; Bunting, S; Ganesan, R; Sa, S; Ferrando, R; Wu, TD; Kolumam, GA; Ouyang, W; Kirchhofer, D				Li, Wei; Danilenko, Dimitry M.; Bunting, Stuart; Ganesan, Rajkumar; Sa, Susan; Ferrando, Ronald; Wu, Thomas D.; Kolumam, Ganesh A.; Ouyang, Wenjun; Kirchhofer, Daniel			The Serine Protease Marapsin Is Expressed in Stratified Squamous Epithelia and Is Up-regulated in the Hyperproliferative Epidermis of Psoriasis and Regenerating Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; GENE-EXPRESSION; ADAPTIVE IMMUNITY; POTENTIAL ROLE; MESSENGER-RNA; SKIN; CELLS; RECEPTORS; CYTOKINE; PANCREAS	The trypsin-like serine protease marapsin is a member of the large protease gene cluster at human chromosome 16p13.3, which also contains the structurally related proteases testisin, tryptase epsilon, tryptase gamma, and EOS. To gain insight into the biological functions of marapsin, we undertook a detailed gene expression analysis. It showed that marapsin expression was restricted to tissues containing stratified squamous epithelia and was absent or only weakly expressed in all other tissues, including the pancreas. Marapsin was constitutively expressed in nonkeratinizing stratified squamous epithelia of human esophagus, tonsil, cervix, larynx, and cornea. In the keratinizing stratified squamous epidermis of skin, however, its expression was induced only during epidermal hyperproliferation, such as in psoriasis and in murine wound healing. In fact, marapsin was the second most strongly up-regulated protease in psoriatic lesions, where expression was localized to the upper region of the hyperplastic epidermis. Similarly, in the hyperproliferative epithelium of regenerating murine skin wounds, marapsin localized to the suprabasal layers, where keratinocytes undergo squamous differentiation. The transient up-regulation of marapsin, which closely correlated with re-epithelialization, was virtually absent in a genetic mouse model of delayed wound closure. These results suggested a function during the process of re-epithelialization. Furthermore, in reconstituted human epidermis, a model system of epidermal differentiation, members of the IL-20 subfamily of cytokines, such as IL-22, induced marapsin expression. Consistent with a physiologic role in marapsin regulation, IL-22 was also strongly expressed in re-epithelializing skin wounds. Marapsin's restricted expression, localization, and cytokine-inducible expression suggest a role in the terminal differentiation of keratinocytes in hyperproliferating squamous epithelia.	[Li, Wei; Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Danilenko, Dimitry M.; Sa, Susan; Ferrando, Ronald] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bunting, Stuart; Kolumam, Ganesh A.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com	Ouyang, Wenjun/ABA-8763-2020; Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921				Adachi W, 2006, INVEST OPHTH VIS SCI, V47, P3801, DOI 10.1167/iovs.06-0216; Bhagwandin VJ, 2003, J BIOL CHEM, V278, P3363, DOI 10.1074/jbc.M209353200; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Fitch PM, 2006, BIOCHEM SOC T, V34, P279, DOI 10.1042/BST0340279; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; Inoue N, 1998, J INVEST DERMATOL, V110, P923, DOI 10.1046/j.1523-1747.1998.00212.x; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; KAWASHIMA I, 1987, DNA-J MOLEC CELL BIO, V6, P163, DOI 10.1089/dna.1987.6.163; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Layfield LJ, 2001, DIAGN CYTOPATHOL, V25, P38, DOI 10.1002/dc.1099; Ling JML, 2006, BIOCHEM CELL BIOL, V84, P275, DOI 10.1139/O06-044; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Robbins, 1999, PATHOLOGIC BASIS DIS; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Tanaka N, 2000, BRIT J DERMATOL, V143, P728, DOI 10.1046/j.1365-2133.2000.03766.x; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; vanBergen BH, 1996, ARCH DERMATOL RES, V288, P458, DOI 10.1007/s004030050083; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wong GW, 2005, BIOCHEM BIOPH RES CO, V336, P579, DOI 10.1016/j.bbrc.2005.08.137; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	44	28	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					218	228		10.1074/jbc.M806267200	http://dx.doi.org/10.1074/jbc.M806267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18948266	hybrid			2022-12-25	WOS:000261974800025
J	Song, XF; Coffa, S; Fu, HA; Gurevich, VV				Song, Xiufeng; Coffa, Sergio; Fu, Haian; Gurevich, Vsevolod V.			How Does Arrestin Assemble MAPKs into a Signaling Complex?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTIN; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; REGULATED KINASES; FUNCTIONAL-CHARACTERIZATION; INOSITOL HEXAKISPHOSPHATE; SELF-ASSOCIATION; CONE ARRESTIN	Arrestins bind active phosphorylated G protein-coupled receptors, precluding G protein activation and channeling signaling to alternative pathways. Arrestins also function as mitogen-activated protein kinase (MAPK) scaffolds, bringing together three components of MAPK signaling modules. Here we have demonstrated that all four vertebrate arrestins interact with JNK3, MKK4, and ASK1, but only arrestin3 facilitates JNK3 activation. Thus, the functional specificity of arrestins is not determined by differential binding of the kinases. Using receptor binding-impaired mutant, we have shown that free arrestin3 readily promotes JNK3 phosphorylation. We identified key arrestin-binding elements in JNK3 and ASK1 and investigated the molecular interactions of arrestin2 and arrestin3 and their individual domains with the components of the two MAPK cascades, ASK1-MKK4-JNK3 and c-Raf-1-MEK1-ERK2. We found that both arrestin domains interact with all six kinases. These findings shed new light on the mechanism of arrestin-mediated MAPK activation and the spatial arrangement of the three kinases on arrestin molecule.	[Song, Xiufeng; Coffa, Sergio; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Vanderbilt University; Emory University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,PRB,Rm 418, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V. V. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed MR, 2008, J NEUROCHEM, V104, P1622, DOI 10.1111/j.1471-4159.2007.05104.x; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 2004, TIPS, V25, P59; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; LUO J, 2008, MOL PHARM, V74, P312; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waetzig V, 2003, J BIOL CHEM, V278, P567, DOI 10.1074/jbc.M207391200; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	72	109	114	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					685	695		10.1074/jbc.M806124200	http://dx.doi.org/10.1074/jbc.M806124200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001375	hybrid, Green Published			2022-12-25	WOS:000261974800073
J	Caswell, CC; Barczyk, M; Keene, DR; Lukomska, E; Gullberg, DE; Lukomski, S				Caswell, Clayton C.; Barczyk, Malgorzata; Keene, Douglas R.; Lukomska, Ewa; Gullberg, Donald E.; Lukomski, Slawomir			Identification of the First Prokaryotic Collagen Sequence Motif That Mediates Binding to Human Collagen Receptors, Integrins alpha(2)beta(1) and alpha(11)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; BACILLUS-ANTHRACIS; SURFACE PROTEIN; SCL2 PROTEINS; ALPHA(1)BETA(1); GLYCOPROTEIN; RECOGNITION; GFOGER; SITES	Many pathogenic bacteria interact with human integrins to enter host cells and to augment host colonization. Group A Streptococcus (GAS) employs molecular mimicry by direct interactions between the cell surface streptococcal collagen-like protein-1 (Scl1) and the human collagen receptor, integrin alpha(2)beta(1). The collagen-like (CL) region of the Scl1 protein mediates integrin-binding, although, the integrin binding motif was not defined. Here, we used molecular cloning and site-directed mutagenesis to identify the GLPGER sequence as the alpha(2)beta(1) and the alpha(11)beta(1) binding motif. Electron microscopy experiments mapped binding sites of the recombinant alpha(2)-integrin-inserted domain to the GLPGER motif of the recombinant Scl (rScl) protein. rScl proteins and a synthetic peptide harboring the GLPGER motif mediated the attachment of C2C12-alpha 2 + myoblasts expressing the alpha(2)beta(1) integrin as the sole collagen receptor. The C2C12-alpha(11) + myoblasts expressing the alpha(11)beta(1) integrin also attached to GLPGER-harboring rScl proteins. Furthermore, the C2C12-alpha(11) + cells attached to rScl1 more efficiently than C2C12-alpha(2) + cells, suggesting that the alpha(11)beta(1) integrin may have a higher binding affinity for the GLPGER sequence. Human endothelial cells and dermal fibroblasts adhered to rScl proteins, indicating that multiple cell types may recognize and bind the Scl proteins via their collagen receptors. This work is a stepping stone toward defining the utilization of collagen receptors by microbial collagen-like proteins that are expressed by pathogenic bacteria.	[Caswell, Clayton C.; Lukomska, Ewa; Lukomski, Slawomir] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Lukomski, Slawomir] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Barczyk, Malgorzata; Gullberg, Donald E.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA	West Virginia University; West Virginia University; University of Bergen	Lukomski, S (corresponding author), W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Box 9177, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437	National Institutes of Health [AI50666]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI50666 (to S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; BUJNICKI JM, 2003, FUNCTIONAL GENOMICS, P10; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; DAVIES M, 1992, KIDNEY INT, V41, P671, DOI 10.1038/ki.1992.103; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785; Gullberg Donald E., 2002, Progress in Histochemistry and Cytochemistry, V37, P3, DOI 10.1016/S0079-6336(02)80008-0; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Layton BE, 2008, J MOL EVOL, V66, P539, DOI 10.1007/s00239-008-9111-7; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Waller LN, 2005, J BACTERIOL, V187, P4592, DOI 10.1128/JB.187.13.4592-4597.2005; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; ZUTTER MM, 1990, AM J PATHOL, V137, P113	40	64	66	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36168	36175		10.1074/jbc.M806865200	http://dx.doi.org/10.1074/jbc.M806865200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990704	hybrid, Green Published			2022-12-25	WOS:000261840500011
J	Higashi, S; Oeda, M; Yamamoto, K; Miyazaki, K				Higashi, Shouichi; Oeda, Miwa; Yamamoto, Kazuhiro; Miyazaki, Kaoru			Identification of Amino Acid Residues of Matrix Metalloproteinase-7 Essential for Binding to Cholesterol Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; GELATINASE-A; MATRILYSIN; INHIBITOR; PRECURSOR; FRAGMENT; PROTEOLYSIS; PROGRESSION; SYNDECAN-1; MIGRATION	Matrix metalloproteinase-7 (MMP-7; matrilysin) induces homotypic adhesion of colon cancer cells by cleaving cell surface protein(s) and enhances their metastatic potential. Our previous study (Yamamoto, K., Higashi, S., Kioi, M., Tsunezumi, J., Honke, K., and Miyazaki, K. (2006) J. Biol. Chem. 281, 9170-9180) demonstrated that binding of MMP-7 to cell surface cholesterol sulfate (CS) is essential for the cell membrane-associated proteolytic action of the protease. To determine the region of MMP-7 essential for binding to CS, we constructed chimeric proteases consisting of various parts of MMP-7 and those of the catalytic domain of MMP-2; the latter protease does not have an affinity for CS. Studies of these chimeric proteases and other mutants of MMP-7 revealed that Ile(29), Arg(33), Arg(51), and Trp(55), in the internal sequence, and the C-terminal three residues corresponding to residues 171-173 of MMP-7 are essential for binding to CS. An MMP-7 mutant, which had the internal 4 residues at positions 29, 33, 51, and 55 of MMP-7 replaced with the corresponding residues of MMP-2 and the C-terminal 3 residues deleted, had essentially no affinity for CS. This mutant and wild-type MMP-7 showed similar proteolytic activity toward fibronectin, whereas the mutant lacked the ability to induce the colon cancer cell aggregation. In the three-dimensional structure of MMP-7, the residues essential for binding to CS are located on the molecular surface in the opposite side of the catalytic cleft of the protease. Therefore, it is assumed that the active site of MMP-7 bound to cell surface is directed outside. We speculate that the direction of the cell-bound MMP-7 makes it feasible for the protease to cleave its substrates on cell surface.	[Higashi, Shouichi; Oeda, Miwa; Yamamoto, Kazuhiro; Miyazaki, Kaoru] Yokohama City Univ, Int Grad Sch Arts & Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp	Yamamoto, Kazuhiro/AAD-9650-2019		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Ganguly B, 2007, FEBS LETT, V581, P5723, DOI 10.1016/j.febslet.2007.11.042; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Higashi S, 2003, BIOCHEMISTRY-US, V42, P6514, DOI 10.1021/bi020643m; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Ishikawa T, 1996, CANCER LETT, V107, P5, DOI 10.1016/0304-3835(96)04336-4; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Mitsiades N, 2001, CANCER RES, V61, P577; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagashima Y, 1997, INT J CANCER, V72, P441, DOI 10.1002/(SICI)1097-0215(19970729)72:3<441::AID-IJC11>3.0.CO;2-F; Noe V, 2001, J CELL SCI, V114, P111; Oneda H, 1999, J BIOCHEM-TOKYO, V126, P905, DOI 10.1093/oxfordjournals.jbchem.a022533; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	29	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35735	35744		10.1074/jbc.M806285200	http://dx.doi.org/10.1074/jbc.M806285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955490	hybrid			2022-12-25	WOS:000261687900047
J	Jung, H; Seong, HA; Ha, H				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Murine Protein Serine/Threonine Kinase 38 Activates Apoptosis Signal-regulating Kinase 1 via Thr(838) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NM23-H1 TUMOR-SUPPRESSOR; SERINE-THREONINE KINASE; HEMATOPOIETIC-CELLS; ASK1; INHIBITOR; DISSOCIATION; THIOREDOXIN; PROTEASES; CLONING; PATHWAY	Murine protein serine/threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family that plays an important role in various cellular processes, including cell cycle, signaling pathways, and self-renewal of stem cells. Here we demonstrate a functional association between MPK38 and apoptosis signal-regulating kinase 1 (ASK1). The physical association between MPK38 and ASK1 was mediated through their carboxyl-terminal regulatory domains and was increased by H2O2 or tumor necrosis factor alpha treatment. The use of kinase-dead MPK38 and ASK1 mutants revealed that MPK38-ASK1 complex formation was dependent on the activities of both kinases. Ectopic expression of wild-type MPK38, but not kinase-dead MPK38, stimulated ASK1 activity by Thr(838) phosphorylation and enhanced ASK1-mediated signaling to both JNK and p38 kinases. However, the phosphorylation of MKK6 and p38 by MPK38 was not detectable. In addition, MPK38-mediated ASK1 activation was induced through the increased interaction between ASK1 and its substrate MKK3. MPK38 also stimulated H2O2-mediated apoptosis by enhancing the ASK1 activity through Thr(838) phosphorylation. These results suggest that MPK38 physically interacts with ASK1 in vivo and acts as a positive upstream regulator of ASK1.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Biotechnol Res Inst, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Biotechnol Res Inst, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			Korea Science and Engineering Foundation [R0A-2007-000-20006-0]; Chungbuk National University	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Chungbuk National University	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20006-0 and in part by Chungbuk National University Grant 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Yang Y, 1999, APPL BIOCHEM BIOTECH, V80, P13, DOI 10.1385/ABAB:80:1:13; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	35	55	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34541	34553		10.1074/jbc.M807219200	http://dx.doi.org/10.1074/jbc.M807219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948261	Green Published, hybrid			2022-12-25	WOS:000261469100008
J	Maehama, T; Tanaka, M; Nishina, H; Murakami, M; Kanaho, Y; Hanada, K				Maehama, Tomohiko; Tanaka, Masahiko; Nishina, Hiroshi; Murakami, Makoto; Kanaho, Yasunori; Hanada, Kentaro			RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUFFICIENCY; MAMMALIAN TARGET; EXOCYST COMPLEX; DEPENDENT MANNER; RHEB GTPASE; PHOSPHORYLATION SITE; RAPAMYCIN MTOR; S6 KINASE-1; RAG GTPASES; TSC2	Cells sense nutrients present in the extracellular environment and modulate the activities of intracellular signaling systems in response to nutrient availability. This study demonstrates that RalA and its activator RalGDS participate in nutrient sensing and are indispensable for activation of mammalian target of rapamycin complex 1 (mTORC1) induced by extracellular nutrients. Knockdown of RalA or RalGDS abolished amino acid- and glucose-induced mTORC1 activation, as judged by phosphorylation of S6 kinase and eukaryotic translation initiation factor 4E-binding protein 1. The amount of GTP-bound RalA increased in response to increased amino acid availability. In addition, RalA knockdown suppressed Rheb-induced S6 kinase phosphorylation, and the constitutively active form of RalA induced mTORC1 activation in the absence of Rheb. These results collectively suggest that RalGDS and RalA act downstream of Rheb and that RalA activation is a crucial step in nutrient-induced mTORC1 activation.	[Maehama, Tomohiko; Tanaka, Masahiko; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tanaka, Masahiko; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Tokyo 1138613, Japan; [Murakami, Makoto] Japan Sci & Technol Corp, PRESTO, Saitama 3320012, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan	National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Maehama, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tmaehama@nih.go.jp	Maehama, Tomohiko/AAX-8926-2020; Maehama, Tomohiko/HGB-4896-2022	Maehama, Tomohiko/0000-0002-9685-2317; Hanada, Kentaro/0000-0003-1383-2781	Japanese Ministry of Education, Culture, Sports, Science, and Technology [18057028, 20054024, 19370058, 19657044]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 18057028, 20054024, 19370058, and 19657044 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	46	64	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35053	35059		10.1074/jbc.M805822200	http://dx.doi.org/10.1074/jbc.M805822200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948269	Green Published, hybrid			2022-12-25	WOS:000261469100062
J	Stokasimov, E; McKane, M; Rubenstein, PA				Stokasimov, Ema; McKane, Melissa; Rubenstein, Peter A.			Role of Intermonomer Ionic Bridges in the Stabilization of the Actin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; F-ACTIN; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL MOVEMENT; DEPOLYMERIZING FACTOR; INTERACTING PROTEIN-1; REGULATORY PROTEINS; CELLULAR FUNCTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	Filament formation is required for most of the functions of actin. However, the intermonomer interactions that stabilize F-actin have not been elucidated because of a lack of an F-actin crystal structure. The Holmes muscle actin model suggests that an ionic interaction between Arg-39 of one monomer and Glu-167 of an adjacent monomer in the same strand contributes to this stabilization. Yeast actin has an Ala-167 instead. F-actin molecular dynamics modeling predicts another interaction between Arg-39 of one monomer and Asp-275 of an opposing strand monomer. In Toxoplasma gondii actin, which forms short stubby filaments, the Asp-275 equivalent is replaced by Arg leading to a potential filament-destabilizing charge-charge repulsion. Using yeast actin, we tested the effect of A167E as a potential stabilizer and A167R and D275R as potential filament disruptors. All mutations caused abnormal growth and mitochondrial malfunction. A167E and D275R actins polymerize normally and form relatively normal appearing filaments. A167R nucleates filaments more slowly and forms filament bundles. The R39D/A167R double mutant, which re-establishes an ionic bond in the opposite orientation, reverses this polymerization and bundling defect. Stoichiometric amounts of yeast cofilin have little effect on wild-type and A167E filaments. However, D275R and A167R actin depolymerization is profound with cofilin. Although our results suggest that disruption of an interaction between Arg-39 and Asp-275 is not sufficient to cause fragmentation, it suggests that it changes filament stability thereby disposing it for enhanced cofilin depolymerizing effects. Ala-167 results demonstrate the in vivo and in vitro importance of another potential Arg-39 ionic interaction.	[Stokasimov, Ema; McKane, Melissa; Rubenstein, Peter A.] Univ Iowa Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 ( to P. A. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benchaar SA, 2007, BIOCHEMISTRY-US, V46, P225, DOI 10.1021/bi0610754; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; COOK RK, 1992, J BIOL CHEM, V267, P9430; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GANCEDO C, 1968, EUR J BIOCHEM, V5, P165, DOI 10.1111/j.1432-1033.1968.tb00353.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; IIDA K, 1993, GENE, V124, P115; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamal JKA, 2007, P NATL ACAD SCI USA, V104, P7910, DOI 10.1073/pnas.0611283104; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Ojala PJ, 2001, BIOCHEMISTRY-US, V40, P15562, DOI 10.1021/bi0117697; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; RICKARD JE, 1986, J MOL BIOL, V191, P273, DOI 10.1016/0022-2836(86)90264-0; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SIKORSKI RS, 1989, GENETICS, V122, P19; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Yang HC, 2001, METHOD CELL BIOL, V65, P333, DOI 10.1016/S0091-679X(01)65020-9; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	53	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34844	34854		10.1074/jbc.M804419200	http://dx.doi.org/10.1074/jbc.M804419200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945676	Green Published, hybrid			2022-12-25	WOS:000261469100040
J	Song, GS; Wang, L				Song, Guisheng; Wang, Li			MiR-433 and miR-127 Arise from Independent Overlapping Primary Transcripts Encoded by the miR-433-127 Locus	PLOS ONE			English	Article							GENE STRUCTURE; MICRORNAS; RECEPTOR	MicroRNAs play significant roles in development, metabolism and carcinogenesis, however, limited information is available about their primary transcripts and the transcriptional regulation of the microRNA genes. We report here the cloning of two primary miRNAs (pri-miR-433 and pri-miR-127) encoded by the miR-433-127 locus. Using both database mining and experimental methods, we isolated the full-length primary transcripts of the mouse miR-433 and miR-127 and demonstrated that they overlapped in a 59-39 unidirectional way. These two miRNA genes are expressed in a compact space by using overlapping coding regions. This is the first report to identify an economical structure for miR-433 and miR-127 genes, which may be a novel way of miRNA gene to maximize the genetic information in order to fit the complex physiological function of mammalian organism.	[Song, Guisheng; Wang, Li] Univ Utah, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Song, GS (corresponding author), Univ Utah, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	wang@hsc.utah.edu	song, guisheng/E-4913-2011		American Liver Foundation [Liver Scholar Award]; American Association for the Study of Liver Diseases [Liver Scholar Award]; American Diabetes Association [Junior Faculty Award]; NIH NIDDK [DK080440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	American Liver Foundation; American Association for the Study of Liver Diseases; American Diabetes Association(American Diabetes Association); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by funds from American Liver Foundation/American Association for the Study of Liver Diseases (Liver Scholar Award), American Diabetes Association (Junior Faculty Award), NIH NIDDK DK080440 to L.W.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batshake B, 1996, BIOCHEM BIOPH RES CO, V227, P70, DOI 10.1006/bbrc.1996.1469; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herzog H, 1997, GENOMICS, V41, P315, DOI 10.1006/geno.1997.4684; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SONG GS, 2008, NUCL ACIDS RES  0906; Zhou CC, 2003, GENE, V305, P161, DOI 10.1016/S0378-1119(02)01235-0	24	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3574	10.1371/journal.pone.0003574	http://dx.doi.org/10.1371/journal.pone.0003574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974780	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131500006
J	Dolman, G				Dolman, Gaynor			Evidence for Differential Assortative Female Preference in Association with Refugial Isolation of Rainbow Skinks in Australia's Tropical Rainforests	PLOS ONE			English	Article							SEXUAL SELECTION; COMPARATIVE PHYLOGEOGRAPHY; POPULATION-GENETICS; EVOLUTION; SPECIATION; PATTERNS; DIVERGENCE; MODELS; DISPERSAL; COMPLEX	Background: Divergence driven by female preference can give rise to pre-mating isolation more rapidly than post-mating isolation can evolve through the accumulation of allelic incompatibilities. Moreover pre-mating isolation may be more effective at maintaining morphological differentiation between divergent populations. In the context of Australian rainforest endemic skinks that were historically subjected to refugial isolation, this study examined the following predictions: 1) that assortative female preference is associated with more recent divergence of southern C. rubrigularis (SRED) and C. rhomboidalis (BLUE), but not with deeply divergent S-RED and northern C. rubrigularis (N-RED); and 2) that upon secondary contact, morphological differentiation is maintained between S-RED and BLUE, whereas N-RED and S-RED remain morphogically indistinguishable. Principal Findings: Female preference trials found no evidence for assortative female preference between N-RED and SRED, supporting a previous genetic hybrid zone study which inferred post-mating but no pre-mating isolation. In contrast there is evidence for assortative female preference between S-RED and BLUE, with BLUE females preferring to associate with BLUE males, but S-RED females showing no preference. Multi-locus coalescent analyses, used to estimate post-divergence gene-flow between proximally located S-RED and BLUE populations, rejected zero gene-flow from BLUE to S-RED and thus RED and BLUE have maintained morphological differentiation despite secondary contact. Morphometric analyses confirmed a lack of morphological divergence between N-RED and S-RED and established that BLUE is morphologically divergent from RED in traits other than throat colour. Conclusions/Significance: Long-term isolation has been sufficient to generate post-mating isolation but no morphological divergence between N-RED and S-RED. In contrast, greater morphological differentiation is associated with evidence for assortative female preference between more recently diverged S-RED and BLUE. Combined with previous estimates of lineage-wide gene flow, these results are consistent with the suggestion that assortative female preference is more effective than post-mating isolation in maintaining morphological differentiation between divergent populations.	[Dolman, Gaynor] CSIRO Sustainable Ecosyst, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Dolman, Gaynor] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Dolman, G (corresponding author), CSIRO Sustainable Ecosyst, Australian Natl Wildlife Collect, Canberra, ACT, Australia.	gaynor.dolman@csiro.au	Dolman, Gaynor/CAH-1635-2022; Dolman, Gaynor/I-4497-2015	Dolman, Gaynor/0000-0001-7611-6841	CRC for Tropical Rainforest Ecology and Management	CRC for Tropical Rainforest Ecology and Management(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by a Student Research Support Scheme grant from the CRC for Tropical Rainforest Ecology and Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 1996, EVOLUTION, V50, P1024, DOI 10.1111/j.1558-5646.1996.tb02343.x; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Chapple DG, 2005, MOL ECOL, V14, P1215, DOI 10.1111/j.1365-294X.2005.02486.x; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; COYNE JA, 2004, SPECIATION, P383; Dobzhansky T., 1937; Dolman G, 2006, EVOLUTION, V60, P573, DOI 10.1554/05-487.1; Dolman G, 2004, MOL ECOL NOTES, V4, P185, DOI 10.1111/j.1471-8286.2004.00609.x; DOUGHTY P, 1994, ANIM BEHAV, V47, P227, DOI 10.1006/anbe.1994.1029; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Fisher R.A., 1930, GENETICAL THEORY NAT; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; INGRAM G, 1989, Memoirs of the Queensland Museum, V27, P443; KANESHIRO KY, 1980, EVOLUTION, V34, P437, DOI 10.1111/j.1558-5646.1980.tb04833.x; Kershaw A. P., 2005, Tropical rainforests: past, present and future, P374; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lane Amanda M., 2006, Herpetological Review, V37, P46; Langkilde T, 2003, HERPETOL J, V13, P141; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Muller HJ, 1942, BIOL S, V6, P71; Nielsen R, 2001, GENETICS, V158, P885; Ord TJ, 2006, J EVOLUTION BIOL, V19, P797, DOI 10.1111/j.1420-9101.2005.01050.x; ORR HA, 1995, GENETICS, V139, P1805; Phillips BL, 2004, EVOLUTION, V58, P1536; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Smadja C, 2004, J EVOLUTION BIOL, V17, P165, DOI 10.1046/j.1420-9101.2003.00647.x; Stuart-Fox DM, 2004, P ROY SOC B-BIOL SCI, V271, P2249, DOI 10.1098/rspb.2004.2802; Stuart-Fox DM, 2001, AUST J ZOOL, V49, P119, DOI 10.1071/ZO00092; Sumner J, 2001, MOL ECOL, V10, P1917, DOI 10.1046/j.0962-1083.2001.01337.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; WATANABE TK, 1979, SCIENCE, V205, P906, DOI 10.1126/science.205.4409.906; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WHITTIER J, 1994, HERPETOLOGY AUSTR DI, P305; Williams SE, 1997, P ROY SOC B-BIOL SCI, V264, P709, DOI 10.1098/rspb.1997.0101; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wong BBM, 2004, J EVOLUTION BIOL, V17, P701, DOI 10.1046/j.1420-9101.2003.00651.x	49	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3499	10.1371/journal.pone.0003499	http://dx.doi.org/10.1371/journal.pone.0003499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958149	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131100002
J	Fomenko, DE; Novoselov, SV; Natarajan, SK; Lee, BC; Koc, A; Carlson, BA; Lee, TH; Kim, HY; Hatfield, DL; Gladyshev, VN				Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Koc, Ahmet; Carlson, Bradley A.; Lee, Tae-Hyung; Kim, Hwa-Young; Hatfield, Dolph L.; Gladyshev, Vadim N.			MsrB1 (Methionine-R-sulfoxide Reductase 1) Knock-out Mice ROLES OF MsrB1 IN REDOX REGULATION AND IDENTIFICATION OF A NOVEL SELENOPROTEIN FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN OXIDATION; LIFE-SPAN; A MSRA; MOUSE; SELENIUM; CELLS; MITOCHONDRIAL; MAMMALS; STRESS; DAMAGE	Protein oxidation has been linked to accelerated aging and is a contributing factor to many diseases. Methionine residues are particularly susceptible to oxidation, but the resulting mixture of methionine R-sulfoxide (Met-RO) and methionine S-sulfoxide (Met-SO) can be repaired by thioredoxin-dependent enzymes MsrB and MsrA, respectively. Here, we describe a knock-out mouse deficient in selenoprotein MsrB1, the main mammalian MsrB located in the cytosol and nucleus. In these mice, in addition to the deletion of 14-kDa MsrB1, a 5-kDa selenoprotein form was specifically removed. Further studies revealed that the 5-kDa protein occurred in both mouse tissues and human HEK 293 cells; was down-regulated by MsrB1 small interfering RNA, selenium deficiency, and selenocysteine tRNA mutations; and was immunoprecipitated and recognized by MsrB1 antibodies. Specific labeling with Se-75 and mass spectrometry analyses revealed that the 5-kDa selenoprotein corresponded to the C-terminal sequence of MsrB1. The MsrB1 knock-out mice lacked both 5-and 14-kDa MsrB1 forms and showed reduced MsrB activity, with the strongest effect seen in liver and kidney. In addition, MsrA activity was decreased by MsrB1 deficiency. Liver and kidney of the MsrB1 knock-out mice also showed increased levels of malondialdehyde, protein carbonyls, protein methionine sulfoxide, and oxidized glutathione as well as reduced levels of free and protein thiols, whereas these parameters were little changed in other organs examined. Overall, this study established an important contribution of MsrB1 to the redox control in mouse liver and kidney and identified a novel form of this protein.	[Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, TR-35430 Izmir, Turkey; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, CCR,NIH, Bethesda, MD 20892 USA; [Lee, Tae-Hyung; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Aging Associated Vasc Dis Res Ctr, Taegu 705717, South Korea	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Izmir Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeungnam University	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; KOÇ, AHMET/ABI-3322-2020; Gladyshev, Vadim N/A-9894-2013	KOÇ, AHMET/0000-0003-3484-2137; Novoselov, Sergey/0000-0003-0104-6492; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518, RR017675]; Korea Science and Engineering Foundation [R13-2005-005-01004-0]; NATIONAL CANCER INSTITUTE [ZIABC005317, ZIABC010889] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V.N.G.) and the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D.L.H.). The Nebraska Redox Biology Center is supported by National Institutes of Health Grant RR017675.This work was also supported by Korea Science and Engineering Foundation Grant R13-2005-005-01004-0 (to H.Y.K.). The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.	Burke D, 2002, ANIM COGN, V5, P79, DOI 10.1007/s10071-002-0131-1; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; HAYASHI R, 1985, ANAL BIOCHEM, V149, P521, DOI 10.1016/0003-2697(85)90608-6; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Kim HY, 2004, BIOCHEM BIOPH RES CO, V320, P1277, DOI 10.1016/j.bbrc.2004.06.078; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2107, DOI 10.1167/iovs.05-0018; Moskovitz J, 2003, P NATL ACAD SCI USA, V100, P7486, DOI 10.1073/pnas.1332607100; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P947, DOI 10.1111/j.1440-1746.2006.04231.x; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Oien D, 2007, AMINO ACIDS, V32, P603, DOI 10.1007/s00726-006-0448-1; Oien DB, 2008, FREE RADICAL BIO MED, V45, P193, DOI 10.1016/j.freeradbiomed.2008.04.003; Pal R, 2007, EXP BRAIN RES, V180, P765, DOI 10.1007/s00221-007-0903-6; Picot CR, 2006, EXP GERONTOL, V41, P663, DOI 10.1016/j.exger.2006.03.011; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Uthus EO, 2007, BIOL TRACE ELEM RES, V115, P265, DOI 10.1007/BF02686001; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	27	94	95	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5986	5993		10.1074/jbc.M805770200	http://dx.doi.org/10.1074/jbc.M805770200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18990697	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000263560600062
J	Rousseau, E; Kojima, R; Hoffner, G; Djian, P; Bertolotti, A				Rousseau, Erwann; Kojima, Rieko; Hoffner, Guylaine; Djian, Philippe; Bertolotti, Anne			Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; REGULATORY PARTICLE; NEURODEGENERATIVE DISEASES; EXPANDED POLYGLUTAMINE; GLUTAMINE REPEATS; BINDING PROTEIN; 26S PROTEASOME; AGGREGATION; DEGRADATION	Deposition of misfolded proteins with a polyglutamine expansion is a hallmark of Huntington disease and other neurodegenerative disorders. Impairment of the proteolytic function of the proteasome has been reported to be both a cause and a consequence of polyglutamine accumulation. Here we found that the proteasomal chaperones that unfold proteins to be degraded by the proteasome but also have non-proteolytic functions colocalized with huntingtin inclusions both in primary neurons and in Huntington disease patients and formed a complex independently of the proteolytic particle. Overexpression of Rpt4 or Rpt6 facilitated aggregation of mutant huntingtin and ataxin-3 without affecting proteasomal degradation. Conversely, reducing Rpt6 or Rpt4 levels decreased the number of inclusions in primary neurons, indicating that endogenous Rpt4 and Rpt6 facilitate inclusion formation. In vitro reconstitution experiments revealed that purified 19S particles promote mutant huntingtin aggregation. When fused to the ornithine decarboxylase destabilizing sequence, proteins with expanded polyglutamine were efficiently degraded and did not aggregate. We propose that aggregation of proteins with expanded polyglutamine is not a consequence of a proteolytic failure of the 20S proteasome. Rather, aggregation is elicited by chaperone subunits of the 19S particle independently of proteolysis.	[Rousseau, Erwann; Kojima, Rieko; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hoffner, Guylaine; Djian, Philippe] Ctr Univ St Peres, Univ Paris Descartes, Unite Propre Rech 2228, CNRS, F-75006 Paris, France	MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Bertolotti, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk	Hoffner, Guylaine/A-4310-2009; HOFFNER, Guylaine/C-1563-2018	HOFFNER, Guylaine/0000-0001-7027-7919; Djian, Philippe/0000-0001-9586-0254	Fondation pour La Recherche sur le Cerveau; Fondation NRJ-Institut de France; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [MC_U105185860] Funding Source: researchfish	Fondation pour La Recherche sur le Cerveau; Fondation NRJ-Institut de France(Fondation de France); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was initiated with support from the Fondation pour La Recherche sur le Cerveau and the Fondation NRJ-Institut de France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Baker SP, 2005, CELL, V123, P361, DOI 10.1016/j.cell.2005.10.013; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hoffner G, 2002, J CELL SCI, V115, P941; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rousseau E, 2004, P NATL ACAD SCI USA, V101, P9648, DOI 10.1073/pnas.0403015101; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zouambia M, 2008, PROTEOMICS, V8, P1221, DOI 10.1002/pmic.200700679	55	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1917	1929		10.1074/jbc.M806256200	http://dx.doi.org/10.1074/jbc.M806256200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986984	hybrid, Green Published			2022-12-25	WOS:000262330100062
J	Kress, E; Rezza, A; Nadjar, J; Samarut, J; Plateroti, M				Kress, Elsa; Rezza, Amelie; Nadjar, Julien; Samarut, Jacques; Plateroti, Michelina			The Frizzled-related sFRP2 Gene Is a Target of Thyroid Hormone Receptor alpha 1 and Activates beta-Catenin Signaling in Mouse Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 GENE; TR-ALPHA; PROTEIN EXPRESSION; WNT; COLON; LIVER; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; ASSOCIATION	The thyroid hormone receptor TR alpha 1 regulates intestinal development and homeostasis by controlling epithelial proliferation in the crypts. This involves positive control of the Wnt/beta-catenin pathway. To further investigate the effect of thyroid hormone-TR alpha 1 signaling on the intestinal epithelium proliferating compartment, we performed a comparative transcription profile analysis on laser microdissected crypt cells recovered from wild type animals with normal or perturbed hormonal status, as well as from TR knock-out mice. Statistical analysis and an in silico approach allowed us to identify 179 differentially regulated genes and to group them into organized functional networks. We focused on the "cell cycle/cell proliferation" network and, in particular, on the Frizzled-related protein sFRP2, whose expression was greatly increased in response to thyroid hormones. In vitro and in vivo analyses showed that the expression of sFRP2 is directly regulated by TR alpha 1 and that it activates beta-catenin signaling via Frizzled receptors. Indeed, sFRP2 stabilizes beta-catenin, activates its target genes, and enhances cell proliferation. In conclusion, these new data, in conjunction with our previous results, indicate a complex interplay between TR alpha 1 and components of the Wnt/beta-catenin pathway. Moreover, we describe in this study a novel mechanism of action of sFRP2, responsible for the activation of beta-catenin signaling.	[Kress, Elsa; Rezza, Amelie; Nadjar, Julien; Samarut, Jacques; Plateroti, Michelina] Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,Inst Genom Fonctionnelle Lyon, F-69364 Lyon 07, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Plateroti, M (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,Inst Genom Fonctionnelle Lyon, 46 Allee Italie, F-69364 Lyon 07, France.	Michela.Plateroti@ens-lyon.fr	Samarut, Jacques/AAD-2587-2019; Plateroti, Michelina/F-2928-2017		Reseau National des Genopoles [186]; Agence Nationale pour la Recherche [ANR-06-BLAN-0232-01]; Ligue Nationale Contre le Cancer; European Network of excellence CRESCENDO	Reseau National des Genopoles; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Network of excellence CRESCENDO	This work was supported in part by the Reseau National des Genopoles Project 186, Agence Nationale pour la Recherche Grant ANR-06-BLAN-0232-01, Program Equipe Labelisee of the Ligue Nationale Contre le Cancer, and the European Network of excellence CRESCENDO. The costs of publication of this article were defrayed in part by the payment of page charges.	Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bockhorn M, 2007, EUR SURG RES, V39, P58, DOI 10.1159/000098443; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Columbano A, 2006, ENDOCRINOLOGY, V147, P3211, DOI 10.1210/en.2005-1561; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Horkko TT, 2006, INT J CANCER, V118, P1653, DOI 10.1002/ijc.21556; IISHI H, 1992, INT J CANCER, V50, P974, DOI 10.1002/ijc.2910500625; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kress E, 2008, MOL ENDOCRINOL, V22, P47, DOI 10.1210/me.2007-0278; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Lee JL, 2003, IN VITRO CELL DEV-AN, V39, P221; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lynch J, 2003, ONCOGENE, V22, P6395, DOI 10.1038/sj.onc.1206770; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Natsume H, 2003, BIOCHEM BIOPH RES CO, V309, P408, DOI 10.1016/j.bbrc.2003.08.019; PASQUINI JM, 1994, DEV NEUROSCI-BASEL, V16, P1, DOI 10.1159/000112080; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; ROSE DP, 1981, ARCH INTERN MED, V141, P1161, DOI 10.1001/archinte.141.9.1161; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang CS, 2002, CANCER LETT, V175, P121, DOI 10.1016/S0304-3835(01)00722-4; Wang HY, 2004, FRONT BIOSCI-LANDMRK, V9, P1043, DOI 10.2741/1310; Wang YS, 1996, J BIOL CHEM, V271, P4468; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9	57	95	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1234	1241		10.1074/jbc.M806548200	http://dx.doi.org/10.1074/jbc.M806548200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001373	Green Published, hybrid			2022-12-25	WOS:000262122900059
J	Sasaki, Y; Negishi, H; Koyama, R; Anbo, N; Ohori, K; Idogawa, M; Mita, H; Toyota, M; Imai, K; Shinomura, Y; Tokino, T				Sasaki, Yasushi; Negishi, Hideaki; Koyama, Ryota; Anbo, Naoki; Ohori, Kanae; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Imai, Kohzoh; Shinomura, Yasuhisa; Tokino, Takashi			p53 Family Members Regulate the Expression of the Apolipoprotein D Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; ADENOVIRUS-MEDIATED TRANSFER; BREAST-CANCER CELLS; KINASE C-ABL; DIRECT TARGET; DNA-DAMAGE; DIFFERENTIAL EXPRESSION; RECOMBINANT ADENOVIRUS; APOPTOTIC RESPONSE; SPONTANEOUS TUMORS	p73 and p63 are members of the p53 gene family that play an important role in development and homeostasis, mainly by regulating transcription of a variety of genes. We report here that apolipoproteinD( apoD), a member of the lipocalin superfamily of lipid transport proteins, is a direct transcriptional target of the p53 family member genes. We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. In addition, apoD transcription is activated in response to cisplatin in a manner dependent on endogenous p73. By using small interference RNA designed to target p73, we demonstrated that silencing endogenous p73 abolishes induction of apoD transcription following cisplatin treatment. We also identified a p73/p63- binding site in the promoter of the apoD gene that is responsive to the p53 family members. The ectopic expression of TAp73 as well as the addition of recombinant human apoD to culture medium induced the osteoblastic differentiation of the human osteosarcoma cell line Saos-2, as assessed by alkaline phosphatase activity. Importantly, apoD knockdown abrogated p73-mediated alkaline phosphatase induction. Moreover, TAp73-mediated apoD expression was able to induce morphological differentiation, as well as expression of neuronal markers, in the human neuroblastoma cell line SH-SY5Y. These results suggest that apoD induction may mediate the activity of p73 in normal development.	[Sasaki, Yasushi; Negishi, Hideaki; Koyama, Ryota; Anbo, Naoki; Ohori, Kanae; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Tokino, Takashi] Sapporo Med Univ, Canc Res Inst, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Sasaki, Yasushi; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Imai, Kohzoh; Shinomura, Yasuhisa] Sapporo Med Univ, Canc Res Inst, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University	Tokino, T (corresponding author), Sapporo Med Univ, Canc Res Inst, Dept Mol Biol, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tokino@sapmed.ac.jp	Idogawa, Masashi/B-5208-2008; Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019	Idogawa, Masashi/0000-0002-8507-1726; Sasaki, Yasushi/0000-0002-3500-8059	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for cancer research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agami R, 1999, NATURE, V399, P809; Bouvet M, 1998, CANCER RES, V58, P2288; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Das S, 2005, CANCER GENE THER, V12, P417, DOI 10.1038/sj.cgt.7700803; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EL DW, 1993, CELL, V75, P817; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frank DK, 1998, CLIN CANCER RES, V4, P2521; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gong JG, 1999, NATURE, V399, P806; Hunter S, 2005, HUM PATHOL, V36, P987, DOI 10.1016/j.humpath.2005.06.018; Hunter S, 2002, J NEUROPATH EXP NEUR, V61, P275, DOI 10.1093/jnen/61.3.275; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Jin DC, 2006, INT J ONCOL, V29, P1591; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalman J, 2000, NEUROL RES, V22, P330; Kobayashi D, 1996, J BIOCHEM, V119, P475; LopezBoado YS, 1997, CANCER RES, V57, P4091; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; McNeish IA, 2004, GENE THER, V11, P497, DOI 10.1038/sj.gt.3302238; MEIRI KF, 1991, J CELL BIOL, V112, P991, DOI 10.1083/jcb.112.5.991; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Navarro A, 2004, J HISTOCHEM CYTOCHEM, V52, P1031, DOI 10.1369/jhc.3a6213.2004; Nishizaki M, 1999, CLIN CANCER RES, V5, P1015; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Oshima Y, 2007, CANCER BIOL THER, V6, P1058, DOI 10.4161/cbt.6.7.4320; Perez-Juste G, 1999, J BIOL CHEM, V274, P5026, DOI 10.1074/jbc.274.8.5026; Pozniak CD, 2002, J NEUROSCI, V22, P9800; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Sasaki Y, 2003, CANCER RES, V63, P8145; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Sasaki Y, 2001, GENE THER, V8, P1401, DOI 10.1038/sj.gt.3301538; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; SUGIMOTO K, 1994, J STEROID BIOCHEM, V51, P167, DOI 10.1016/0960-0760(94)90090-6; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Utsunomiya T, 2005, INT J CANCER, V116, P105, DOI 10.1002/ijc.20986; Vazquez J, 2000, GYNECOL ONCOL, V76, P340, DOI 10.1006/gyno.1999.5678; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; WEECH PK, 1991, PROG LIPID RES, V30, P259, DOI 10.1016/0163-7827(91)90023-X; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zheng XJ, 2001, FEBS LETT, V489, P4, DOI 10.1016/S0014-5793(00)02437-6	68	19	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					872	883		10.1074/jbc.M807185200	http://dx.doi.org/10.1074/jbc.M807185200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001418	hybrid			2022-12-25	WOS:000262122900022
J	Miallau, L; Faller, M; Chiang, J; Arbing, M; Guo, F; Cascio, D; Eisenberg, D				Miallau, Linda; Faller, Michael; Chiang, Janet; Arbing, Mark; Guo, Feng; Cascio, Duilio; Eisenberg, David			Structure and Proposed Activity of a Member of the VapBC Family of Toxin-Antitoxin Systems VapBC-5 FROM MYCOBACTERIUM TUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PIN DOMAINS; DNA; ANTIDOTE; BACTERIA; COMPLEX; MODULES; STRESS	In prokaryotes, cognate toxin-antitoxin pairs have long been known, but no three-dimensional structure has been available for any given complex from Mycobacterium tuberculosis. Here we report the crystal structure and activity of a member of the VapBC family of complexes from M. tuberculosis. The toxin VapC-5 is a compact, 150 residues, two domain alpha/beta protein. Bent around the toxin is the VapB-5 antitoxin, a 33-residue alpha-helix. Assays suggest that the toxin is an Mg-enabled endoribonuclease, inhibited by the antitoxin. The lack of DNase activity is consistent with earlier suggestions that the complex represses its own operon. Furthermore, analysis of the interactions in the binding of the antitoxin to the toxin suggest that exquisite control is required to protect the bacteria cell from toxic VapC-5.	[Miallau, Linda; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Faller, Michael; Guo, Feng; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 611 Charles Young E Dr, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Miallau, linda/G-9804-2011		National Institutes of Health [23616-002-06 F3:02, TBSGC R01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 23616-002-06 F3:02 and TBSGC R01.	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080	36	106	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					276	283		10.1074/jbc.M805061200	http://dx.doi.org/10.1074/jbc.M805061200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952600	hybrid, Green Published			2022-12-25	WOS:000261974800031
J	Raber, ML; Freeman, MF; Townsend, CA				Raber, Mary L.; Freeman, Michael F.; Townsend, Craig A.			Dissection of the Stepwise Mechanism to beta-Lactam Formation and Elucidation of a Rate-determining Conformational Change in beta-Lactam Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-CATALYZED REACTIONS; BARRIER HYDROGEN-BOND; CLAVULANIC ACID; STREPTOMYCES-CLAVULIGERUS; TRIOSEPHOSPHATE ISOMERASE; CARBAPENAM SYNTHETASE; CHEMICAL MECHANISMS; KINETIC MECHANISM; TRANSITION-STATE; PRODUCT RELEASE	Clavulanic acid is a widely used beta-lactamase inhibitor whose key beta-lactam core is formed by beta-lactam synthetase. beta-Lactam synthetase exhibits a Bi-Ter mechanism consisting of two chemical steps, acyl-adenylation followed by beta-lactam formation. (PPi)-P-32-ATP exchange assays showed the first irreversible step of catalysis is acyl-adenylation. From a small, normal solvent isotope effect (1.38 +/- 0.04), it was concluded that beta-lactam synthesis contributes at least partially to k(cat). Site-specific mutation of Lys-443 identified this residue as the ionizable group at pK(a) similar to 8.1 apparent in the pH-k(cat) profile that stabilizes the beta-lactam-forming step. Viscosity studies demonstrated that a protein conformational change was also partially rate-limiting on kcat attenuating the observed solvent isotope effect on beta-lactam formation. Adherence to Kramers' theory gave a slope of 1.66 +/- 0.08 from a plot of log((o)k(cat)/k(cat)) versus log(eta/eta(o)) consistent with opening of a structured loop visible in x-ray data preceding product release. Internal "friction" within the enzyme contributes to a slope of > 1 in this analysis. Correspondingly, earlier in the catalytic cycle ordering of a mobile active site loop upon substrate binding was manifested by an inverse solvent isotope effect (0.67 +/- 0.15) on k(cat)/K-m. The increased second-order rate constant in heavy water was expected from ordering of this loop over the active site imposing torsional strain. Finally, an Eyring plot displayed a large enthalpic change accompanying loop movement (Delta H double dagger similar to 20 kcal/mol) comparable to the chemical barrier of beta-lactam formation.	[Raber, Mary L.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Freeman, Michael F.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Townsend, CA (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	ctownsend@jhu.edu	Johnson, Mary L Raber/AAF-3596-2020; Freeman, Michael/AIA-1555-2022	Johnson, Mary L Raber/0000-0003-4334-114X; Freeman, Michael/0000-0002-0491-9618	National Institutes of Health [AI014937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937, R01AI014937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI014937. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALMAGOR A, 1992, BIOPHYS J, V61, P480, DOI 10.1016/S0006-3495(92)81852-0; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Anslyn E.V., 2006, MODERN PHYS ORGANIC, P365; Arnett SO, 2007, BIOCHEMISTRY-US, V46, P9337, DOI 10.1021/bi0618464; Bachmann BO, 2000, BIOCHEMISTRY-US, V39, P11187, DOI 10.1021/bi000709i; Bachmann BO, 1998, P NATL ACAD SCI USA, V95, P9082, DOI 10.1073/pnas.95.16.9082; Baggaley KH, 1997, NAT PROD REP, V14, P309, DOI 10.1039/np9971400309; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Boehlein SK, 1998, BIOCHEMISTRY-US, V37, P13230, DOI 10.1021/bi981058h; Bott RR, 2003, BIOCHEMISTRY-US, V42, P10545, DOI 10.1021/bi034773m; BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Chopra S, 2006, BIOCHEMISTRY-US, V45, P6596, DOI 10.1021/bi052504l; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; CLELAND WW, 1987, BIOORG CHEM, V15, P283, DOI 10.1016/0045-2068(87)90026-5; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frisch C, 2001, J MOL BIOL, V308, P69, DOI 10.1006/jmbi.2001.4577; GAVISH B, 1979, BIOCHEMISTRY-US, V18, P1269, DOI 10.1021/bi00574a023; GAVISH B, 1980, PHYS REV LETT, V44, P1160, DOI 10.1103/PhysRevLett.44.1160; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hung, 2007, J MICROBIOL BIOTECHN, V17, P1538; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; Jensen SE, 1999, ANTON LEEUW INT J G, V75, P125, DOI 10.1023/A:1001755724055; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Kershaw NJ, 2005, CHEM COMMUN, P4251, DOI 10.1039/b505964j; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Li RF, 2000, J BACTERIOL, V182, P4087, DOI 10.1128/JB.182.14.4087-4095.2000; Li RF, 2006, METAB ENG, V8, P240, DOI 10.1016/j.ymben.2006.01.003; Lloyd MD, 1999, TETRAHEDRON, V55, P10201, DOI 10.1016/S0040-4020(99)00547-5; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; MASSEY V, 1966, J BIOL CHEM, V241, P2347; MCELROY WD, 1967, SCIENCE, V157, P150, DOI 10.1126/science.157.3785.150; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Miller MT, 2003, J BIOL CHEM, V278, P40996, DOI 10.1074/jbc.M307901200; Miller MT, 2002, P NATL ACAD SCI USA, V99, P14752, DOI 10.1073/pnas.232361199; Mukherjee A, 2007, BIOCHEMISTRY-US, V46, P3975, DOI 10.1021/bi602502j; NG KM, 1991, BIOPHYS CHEM, V39, P57, DOI 10.1016/0301-4622(91)85006-C; Northrop DB, 2000, BIOPHYS J, V79, P1621, DOI 10.1016/S0006-3495(00)76412-5; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; NORTHROP DB, 1996, HIGH PRESSURE EFFECT, P222; OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787; Otero C, 2005, J MOL CATAL B-ENZYM, V32, P225, DOI 10.1016/j.molcatb.2004.12.008; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; QUINN DM, 1985, BIOCHEMISTRY-US, V24, P3144, DOI 10.1021/bi00334a011; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; RAINES RT, 1987, BIOCHEMISTRY-US, V26, P7014, DOI 10.1021/bi00396a024; REBHOLZ KL, 1991, BIOCHEM BIOPH RES CO, V176, P65, DOI 10.1016/0006-291X(91)90890-J; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Schlarb-Ridley BG, 2005, BIOCHEMISTRY-US, V44, P6232, DOI 10.1021/bi047322q; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen R. L, 1978, TRANSIT STATES BIOCH, P225; Sierks MR, 1997, BIOTECHNOL PROGR, V13, P601, DOI 10.1021/bp9700824; Silver LL, 2007, EXPERT OPIN THER PAT, V17, P1175, DOI 10.1517/13543776.17.9.1175; Simpson IN, 2003, J ANTIBIOT, V56, P838, DOI 10.7164/antibiotics.56.838; Sleeman MC, 2002, BIOORG MED CHEM LETT, V12, P597, DOI 10.1016/S0960-894X(01)00806-X; TAYLOR JR, 1997, INTRO ERROR ANAL, P57; Toulokhonova L, 2003, J BIOL CHEM, V278, P4582, DOI 10.1074/jbc.M210471200; Townsend CA, 2002, CURR OPIN CHEM BIOL, V6, P583, DOI 10.1016/S1367-5931(02)00392-7; VANPELT JE, 1984, ARCH BIOCHEM BIOPHYS, V230, P250, DOI 10.1016/0003-9861(84)90106-1	69	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					207	217		10.1074/jbc.M805390200	http://dx.doi.org/10.1074/jbc.M805390200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18955494	Green Published, hybrid			2022-12-25	WOS:000261974800024
J	Kitamura, M; Okuyama, M; Tanzawa, F; Mori, H; Kitago, Y; Watanabe, N; Kimura, A; Tanaka, I; Yao, M				Kitamura, Momoyo; Okuyama, Masayuki; Tanzawa, Fumiko; Mori, Haruhide; Kitago, Yu; Watanabe, Nobuhisa; Kimura, Atsuo; Tanaka, Isao; Yao, Min			Structural and Functional Analysis of a Glycoside Hydrolase Family 97 Enzyme from Bacteroides thetaiotaomicron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MALTOGENIC AMYLASE; ALPHA-GLUCOSIDASE; PROTEIN; CLASSIFICATION; STARCH; CYCLOMALTODEXTRINASE; NEOPULLULANASE; COMBINATION; PULLULAN	SusB, an 84-kDa alpha-glucoside hydrolase involved in the starch utilization system (sus) of Bacteroides thetaiotaomicron, belongs to glycoside hydrolase (GH) family 97. We have determined the enzymatic characteristics and the crystal structures in free and acarbose-bound form at 1.6 angstrom resolution. SusB hydrolyzes the alpha-glucosidic linkage, with inversion of anomeric configuration liberating the beta-anomer of glucose as the reaction product. The substrate specificity of SusB, hydrolyzing not only alpha-1,4-glucosidic linkages but also alpha-1,6-, alpha-1,3-, and alpha-1,2-glucosidic linkages, is clearly different from other well known glucoamylases belonging to GH15. The structure of SusB was solved by the single-wavelength anomalous diffraction method with sulfur atoms as anomalous scatterers using an in-house x-ray source. SusB includes three domains as follows: the N-terminal, catalytic, and C-terminal domains. The structure of the SusB-acarbose complex shows a constellation of carboxyl groups at the catalytic center; Glu(532) is positioned to provide protonic assistance to leaving group departure, with Glu(439) and Glu(508) both positioned to provide base-catalyzed assistance for inverting nucleophilic attack by water. A structural comparison with other glycoside hydrolases revealed significant similarity between the catalytic domain of SusB and those of alpha-retaining glycoside hydrolases belonging to GH27, -36, and -31 despite the differences in catalytic mechanism. SusB and the other retaining enzymes appear to have diverged from a common ancestor and individually acquired the functional carboxyl groups during the process of evolution. Furthermore, sequence comparison of the active site based on the structure of SusB indicated that GH97 included both retaining and inverting enzymes.	[Kitamura, Momoyo; Kitago, Yu; Watanabe, Nobuhisa; Tanaka, Isao; Yao, Min] Hokkaido Univ, Grad Sch Agr, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Okuyama, Masayuki; Tanzawa, Fumiko; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Grad Sch Agr, Fac Appl Biosci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Yao, M (corresponding author), Hokkaido Univ, Grad Sch Agr, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	Watanabe, Nobuhisa/B-1187-2008; Okuyama, Masayuki/D-8739-2012; yao, min/F-5287-2011; Mori, Haruhide/B-7777-2012; Mori, Haruhide/AAV-6374-2021	Watanabe, Nobuhisa/0000-0002-0118-5815; Okuyama, Masayuki/0000-0001-7013-6032; yao, min/0000-0003-1687-5904; Mori, Haruhide/0000-0001-7346-9131; Kitago, Yu/0000-0003-2325-6917	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DElla JN, 1996, J BACTERIOL, V178, P7173; Della JN, 1996, J BACTERIOL, V178, P7180; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hughes CV, 2003, ORAL MICROBIOL IMMUN, V18, P309, DOI 10.1034/j.1399-302X.2003.00091.x; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kitago Y, 2005, ACTA CRYSTALLOGR D, V61, P1013, DOI 10.1107/S0907444905012734; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mikami B, 1999, BIOCHEMISTRY-US, V38, P7050, DOI 10.1021/bi9829377; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mosi R, 1998, BIOCHEMISTRY-US, V37, P17192, DOI 10.1021/bi981109a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SMITH KA, 1991, J BACTERIOL, V173, P2962, DOI 10.1128/JB.173.9.2962-2968.1991; SVENSSON B, 1992, CARBOHYD RES, V227, P29, DOI 10.1016/0008-6215(92)85059-9; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	40	71	75	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36328	36337		10.1074/jbc.M806115200	http://dx.doi.org/10.1074/jbc.M806115200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981178	Green Published, hybrid			2022-12-25	WOS:000261840500029
J	Pochynyuk, O; Bugaj, V; Rieg, T; Insel, PA; Mironova, E; Vallon, V; Stockand, JD				Pochynyuk, Oleh; Bugaj, Vladislav; Rieg, Timo; Insel, Paul A.; Mironova, Elena; Vallon, Volker; Stockand, James D.			Paracrine Regulation of the Epithelial Na+ Channel in the Mammalian Collecting Duct by Purinergic P2Y(2) Receptor Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES CL-SECRETION; CONDUCTANCE K-CHANNEL; APICAL P2 RECEPTORS; PRINCIPAL CELLS; LUMINAL P2Y(2); MEDIATED INHIBITION; SODIUM-TRANSPORT; PLASMA-MEMBRANE; ATP RELEASE; 3-OH KINASE	Growing evidence implicates a key role for extracellular nucleotides in cellular regulation, including of ion channels and renal function, but the mechanisms for such actions are inadequately defined. We investigated purinergic regulation of the epithelial Na+ channel (ENaC) in mammalian collecting duct. We find that ATP decreases ENa Cactivity in both mouse and rat collecting duct principal cells. ATP and other nucleotides, including UTP, decrease ENaC activity via apical P2Y(2) receptors. ENaC in collecting ducts isolated from mice lacking this receptor have blunted responses to ATP. P2Y2 couples to ENaC via PLC; direct activation of PLC mimics ATP action. Tonic regulation of ENaC in the collecting duct occurs via locally released ATP; scavenging endogenous ATP and inhibiting P2 receptors, in the absence of other stimuli, rapidly increases ENaC activity. Moreover, ENaC has greater resting activity in collecting ducts from P2Y(2)(-/-) mice. Loss of collecting duct P2Y(2) receptors in the knock- out mouse is the primary defect leading to increased ENaC activity based on the ability of direct PLC stimulation to decrease ENaC activity in collecting ducts from P2Y(2)(-/-) mice in a manner similar to ATP in collecting ducts from wild-type mice. These findings demonstrate that locally released ATP acts in an autocrine/paracrine manner to tonically regulate ENaC in mammalian collecting duct. Loss of this intrinsic regulation leads to ENaC hyperactivity and contributes to hypertension that occurs in P2Y(2) receptor(-/-) mice. P2Y(2) receptor activation by nucleotides thus provides physiologically important regulation of ENaC and electrolyte handling in mammalian kidney.	[Pochynyuk, Oleh; Bugaj, Vladislav; Mironova, Elena; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Rieg, Timo; Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rieg, Timo; Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of California System; University of California San Diego	Pochynyuk, O (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	pochynyuk@uthscsa.edu	Rieg, Timo/W-7478-2019	Rieg, Timo/0000-0001-6082-662X; Stockand, James/0000-0002-3817-4319; Vallon, Volker/0000-0002-9211-2063	National Institutes of Health [R01DK59594, R01DK70571, R01DK56248, R01DK28602, R01GM66232]; American Heart Association (AHA) [0640054N, 0655232Y, 085062F]; German Research Foundation [RI1535/3-1, 3-2]; National Kidney Foundation Fellowship; Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056248, R01DK028602, R01DK070571, R01DK059594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); German Research Foundation(German Research Foundation (DFG)); National Kidney Foundation Fellowship; Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK59594 and R01DK70571 (to J.D.S.), R01DK56248 and R01DK28602 (to V.V.), and R01GM66232 (to P.A.I.). This work was also supported by American Heart Association (AHA) Established Investigator Award 0640054N (to J.D.S.), AHA Grant-in-Aid 0655232Y (to V.V.), AHA Fellowship 085062F (to O.P.), German Research Foundation Grants RI1535/3-1 and 3-2 (to T. R.), a National Kidney Foundation Fellowship (to T. R.), and the Research Service of the Department of Veterans Affairs (to V.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Cuffe JE, 2000, J PHYSIOL-LONDON, V524, P77, DOI 10.1111/j.1469-7793.2000.00077.x; Deetjen P, 2000, J AM SOC NEPHROL, V11, P1798, DOI 10.1681/ASN.V11101798; ECELBARGER CA, 1994, AM J PHYSIOL-RENAL, V267, pF998, DOI 10.1152/ajprenal.1994.267.6.F998; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Gamper Nikita, 2006, V337, P27; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Li DM, 2006, AM J PHYSIOL-RENAL, V290, pF806, DOI 10.1152/ajprenal.00352.2005; Li LZ, 2007, BIOCHEM BIOPH RES CO, V359, P438, DOI 10.1016/j.bbrc.2007.05.143; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Ma HP, 2002, AM J PHYSIOL-RENAL, V282, pF501, DOI 10.1152/ajprenal.00147.2001; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Matos JE, 2007, PFLUG ARCH EUR J PHY, V454, P977, DOI 10.1007/s00424-007-0248-9; Matos JE, 2005, J PHYSIOL-LONDON, V564, P269, DOI 10.1113/jphysiol.2004.080002; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Poulsen AN, 2005, PFLUG ARCH EUR J PHY, V450, P227, DOI 10.1007/s00424-005-1388-4; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Shirley DG, 2005, AM J PHYSIOL-RENAL, V288, pF1243, DOI 10.1152/ajprenal.00152.2004; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sun P, 2006, AM J PHYSIOL-RENAL, V291, pF1192, DOI 10.1152/ajprenal.00112.2006; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Thomas J, 2001, J MEMBRANE BIOL, V183, P115, DOI 10.1007/s00232-001-0059-4; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Vekaria RM, 2006, J AM SOC NEPHROL, V17, P1841, DOI 10.1681/ASN.2005111171; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Wildman SS, 2005, J AM SOC NEPHROL, V16, P2586, DOI 10.1681/ASN.2005020130; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Xie Y, 2008, PURINERG SIGNAL, V4, P125, DOI 10.1007/s11302-007-9053-3; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005	51	106	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36599	36607		10.1074/jbc.M807129200	http://dx.doi.org/10.1074/jbc.M807129200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981175	Green Published, hybrid			2022-12-25	WOS:000261840500058
J	Bych, K; Netz, DJA; Vigani, G; Bill, E; Lill, R; Pierik, AJ; Balk, J				Bych, Katrine; Netz, Daili J. A.; Vigani, Gianpiero; Bill, Eckhard; Lill, Roland; Pierik, Antonio J.; Balk, Janneke			The Essential Cytosolic Iron-Sulfur Protein Nbp35 Acts without Cfd1 Partner in the Green Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS; LOCALIZATION; EXPRESSION; MATURATION; SCAFFOLD; VECTORS; IMPORT; GENES	In photosynthetic eukaryotes assembly components of iron-sulfur (Fe-S) cofactors have been studied in plastids and mitochondria, but how cytosolic and nuclear Fe-S cluster proteins are assembled is not known. We have characterized a plant P loop NTPase with sequence similarity to Nbp35 of yeast and mammals, a protein of the cytosolic Cfd1-Nbp35 complex mediating Fe-S cluster assembly. Genome analysis revealed that NBP35 is conserved in the green lineage but that CFD1 is absent. Moreover, plant and algal NBP35 proteins lack the characteristic CXXC motif in the C terminus, thought to be required for Fe-S cluster binding. Nevertheless, chemical reconstitution and spectroscopy showed that Arabidopsis (At) NBP35 bound a [4Fe-4S] cluster in the C terminus as well as a stable [4Fe-4S] cluster in the N terminus. Holo-AtNBP35 was able to transfer an Fe-S cluster to an apoprotein in vitro. When expressed in yeast, AtNBP35 bound Fe-55 dependent on the cysteine desulfurase Nfs1 and was able to partially rescue the growth of a cfd1 mutant but not of an nbp35 mutant. The AtNBP35 gene is constitutively expressed in planta, and its disruption was associated with an arrest of embryo development. These results show that despite considerable divergence from the yeast Cfd1-Nbp35 Fe-S scaffold complex, AtNBP35 has retained similar Fe-S cluster binding and transfer properties and performs an essential function.	[Bych, Katrine; Vigani, Gianpiero; Balk, Janneke] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Netz, Daili J. A.; Lill, Roland; Pierik, Antonio J.] Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany; [Bill, Eckhard] MPI Bioanorgan Chem, D-45470 Mulheim, Germany	University of Cambridge; Philipps University Marburg	Balk, J (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	jb511@cam.ac.uk	Pierik, Antonio J/G-1108-2010; Vigani, Gianpiero/R-5539-2019	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; Vigani, Gianpiero/0000-0001-8852-3866	Royal Society; Danish Research Agency; Carlsberg Foundation; Ministero dell'Istruzione, dell'Universita` e della Ricerca; Deutsche Forschungsgemeinschaft [593, GRK 1216]; Fonds der Chemischen Industrie	Royal Society(Royal Society of London); Danish Research Agency; Carlsberg Foundation(Carlsberg Foundation); Ministero dell'Istruzione, dell'Universita` e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This research was funded by the Royal Society (to J.B.), the Danish Research Agency and the Carlsberg Foundation (to K.B.), Ministero dell'Istruzione, dell'Universita` e della Ricerca (to G.V.), Deutsche Forschungsgemeinschaft (SFB 593 and TR1, Gottfried-Wilhelm Leibniz Programm, and GRK 1216), and Fonds der Chemischen Industrie (to R.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cavazza C, 2008, J INORG BIOCHEM, V102, P1359, DOI 10.1016/j.jinorgbio.2008.01.027; FERREIRA GC, 1994, J BIOL CHEM, V269, P7062; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Godman J, 2008, GENETICS, V179, P59, DOI 10.1534/genetics.107.086033; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kessler D, 2005, PHOTOSYNTH RES, V86, P391, DOI 10.1007/s11120-005-5913-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Leon S, 2005, FEBS LETT, V579, P1930, DOI 10.1016/j.febslet.2005.02.038; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Peeters NM, 2000, J MOL EVOL, V50, P413, DOI 10.1007/s002390010044; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Prime TA, 2000, ELECTROPHORESIS, V21, P3488, DOI 10.1002/1522-2683(20001001)21:16&lt;3488::AID-ELPS3488&gt;3.0.CO;2-3; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; SALTER AH, 1992, PLANT MOL BIOL, V20, P569, DOI 10.1007/BF00040617; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	42	50	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35797	35804		10.1074/jbc.M807303200	http://dx.doi.org/10.1074/jbc.M807303200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957412	hybrid, Green Submitted			2022-12-25	WOS:000261687900054
J	Higashimoto, T; Chan, N; Lee, YK; Zandi, E				Higashimoto, Tomoyasu; Chan, Nymph; Lee, Yung-Kang; Zandi, Ebrahim			Regulation of I kappa B Kinase Complex by Phosphorylation of gamma-Binding Domain of I kappa B Kinase beta by Polo-like Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IKK-BETA; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; TUMOR-CELLS; CYCLIN D1; ACTIVATION; PROTEIN; IDENTIFICATION; CANCER	I kappa B kinase (IKK) complex is a key regulator of NF-kappa B pathways. Signal-induced interaction of the IKK gamma ( NEMO) subunit with the C-terminal IKK gamma/NEMO-binding domain (gamma BD) of IKK beta is an essential interaction for IKK regulation. Underlying regulatory mechanism(s) of this interaction are not known. Phosphorylation of gamma BD has been suggested to play a regulatory role for IKK activation. However, a kinase that phosphorylates gamma BD has not been identified. In this study, we used a C-terminal fragment of IKK beta as substrate and purified Polo-like kinase 1 (Plk1) from HeLa cell extracts by standard chromatography as a gamma BD kinase. Plk1 phosphorylates serines 733, 740, and 750 in the gamma BD of IKK beta in vitro. Phosphorylating gamma BD with Plk1 decreased its affinity for IKK gamma in pulldown assay. We generated phosphoantibodies against serine 740 and showed that gamma BD is phosphorylated in vivo. Expressing a constitutively active Plk1 in mammalian cells reduced tumor necrosis factor (TNF)-induced IKK activation, resulting in decreased phosphorylation of endogenous I kappa B alpha and reduced NF-kappa B activation. To activate endogenous Plk1, cells were treated with nocodazole, which reduced TNF-induced IKK activation, and increased the phosphorylation of gamma BD. Knocking down Plk1 in mammalian cells restored TNF-induced IKK activation in nocodazole-treated cells. Activation of Plk1 inhibited TNF-induced expression of cyclin D1. In cells in which Plk1 was knocked down, TNF alpha increased expression of cyclin D1 and the proportion of cells in the S phase of the cell cycle. Taken together, this study shows that phosphorylation regulates the interaction of gamma BD of IKK beta with IKK gamma and therefore plays a critical role for IKK activation. Moreover, we identify Plk1 as a gamma BD kinase, which negatively regulates TNF-induced IKK activation and cyclin D1 expression, thereby affecting cell cycle regulation. Untimely activation of cyclin D1 by TNF alpha can provide a potential mechanism for an involvement of TNF alpha in inflammation-induced cancer.	[Higashimoto, Tomoyasu; Zandi, Ebrahim] USC, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Nymph] USC, Norris Comprehens Canc Ctr, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA; [Lee, Yung-Kang] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Zandi, E (corresponding author), USC, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Keck Sch Med, 1441 Eastlake Ave,Norris 6429, Los Angeles, CA 90033 USA.	Zandi@usc.edu		Higashimoto, Tomoyasu/0000-0003-0435-065X	National Institutes of Health [R01 MG065325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MG065325 (to E.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fujiki H, 2000, CANCER DETECT PREV, V24, P91; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; Higashimoto T, 2006, CYTOKINE, V34, P39, DOI 10.1016/j.cyto.2006.03.015; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsvetkov L, 2005, CELL CYCLE, V4, P166, DOI 10.4161/cc.4.1.1348; VOLLAND S, 1994, INT J CANCER, V56, P698, DOI 10.1002/ijc.2910560515; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang LC, 2005, J BIOL CHEM, V280, P7634, DOI 10.1074/jbc.M413384200; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Zandi E, 1997, GENE DEV, V11, P1299, DOI 10.1101/gad.11.10.1299; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	50	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35354	35367		10.1074/jbc.M806258200	http://dx.doi.org/10.1074/jbc.M806258200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957422	hybrid, Green Published			2022-12-25	WOS:000261687900006
J	Toschi, A; Lee, E; Gadir, N; Ohh, M; Foster, DA				Toschi, Alfredo; Lee, Evan; Gadir, Noga; Ohh, Michael; Foster, David A.			Differential Dependence of Hypoxia-inducible Factors 1 alpha and 2 alpha on mTORC1 and mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; PHOSPHOLIPASE-D; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; SURVIVAL SIGNAL; KIDNEY CANCER; RAPAMYCIN; HIF	Constitutive expression of hypoxia-inducible factor (HIF) has been implicated in several proliferative disorders. Constitutive expression of HIF1 alpha and HIF2 alpha has been linked to a number of human cancers, especially renal cell carcinoma (RCC), in which HIF2 alpha expression is the more important contributor. Expression of HIF1 alpha is dependent on the mammalian target of rapamycin (mTOR) and is sensitive to rapamycin. In contrast, there have been no reports linking HIF2 alpha expression with mTOR. mTOR exists in two complexes, mTORC1 and mTORC2, which are differentially sensitive to rapamycin. We report here that although there are clear differences in the sensitivity of HIF1 alpha and HIF2 alpha to rapamycin, both HIF1 alpha and HIF2 alpha expression is dependent on mTOR. HIF1 alpha expression was dependent on both Raptor (a constituent of mTORC1) and Rictor (a constitutive of mTORC2). In contrast, HIF2 alpha was dependent only on the mTORC2 constituent Rictor. These data indicate that although HIF1 alpha is dependent on both mTORC1 and mTORC2, HIF2 alpha is dependent only on mTORC2. We also examined the dependence of HIF alpha expression on the mTORC2 substrate Akt, which exists as three different isoforms, Akt1, Akt2, and Akt3. Interestingly, the expression of HIF2 alpha was dependent on Akt2, whereas that of HIF1 alpha was dependent on Akt3. Because HIF2 alpha is apparently more critical in RCC, this study underscores the importance of targeting mTORC2 and perhaps Akt2 signaling in RCC and other proliferative disorders in which HIF2 alpha has been implicated.	[Toschi, Alfredo; Lee, Evan; Gadir, Noga; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Ohh, Michael] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	City University of New York (CUNY) System; Hunter College (CUNY); University of Toronto	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu			National Institutes of Health [CA46677]; NCl and SCORE [GM60654]; Research Centers in Minority Institutions Award [RR-03037]; Department of Biological Sciences at Hunter College; Canadian Cancer Society of the National Cancer Institute of Canada; NATIONAL CANCER INSTITUTE [R01CA046677, R29CA046677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM060654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCl and SCORE; Research Centers in Minority Institutions Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Biological Sciences at Hunter College; Canadian Cancer Society of the National Cancer Institute of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA46677 from NCl and SCORE Grant GM60654 (to D. A. F.) and by Research Centers in Minority Institutions Award RR-03037 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Department of Biological Sciences at Hunter College. This work was also supported by grants from the Canadian Cancer Society of the National Cancer Institute of Canada (to M.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster David A, 2004, Expert Rev Anticancer Ther, V4, P691, DOI 10.1586/14737140.4.4.691; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Gadir N, 2007, CELL CYCLE, V6, P2840, DOI 10.4161/cc.6.22.4921; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Toschi A, 2008, ONCOGENE, V27, P2746, DOI 10.1038/sj.onc.1210927; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	38	231	237	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34495	34499		10.1074/jbc.C800170200	http://dx.doi.org/10.1074/jbc.C800170200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945681	Green Published, hybrid			2022-12-25	WOS:000261469100003
J	Zhu, CH; Kim, J; Shay, JW; Wright, WE				Zhu, Chun-Hong; Kim, Jinyong; Shay, Jerry W.; Wright, Woodring E.			SGNP: An Essential Stress Granule/Nucleolar Protein Potentially Involved in 5.8s rRNA Processing/Transport	PLOS ONE			English	Article								Background: Stress Granules (SG) are sites of accumulation of stalled initiation complexes that are induced following a variety of cellular insults. In a genetic screen for factors involved in protecting human myoblasts from acute oxidative stress, we identified a gene encoding a protein we designate SGNP (Stress Granule and Nucleolar Protein). Methodology/Principal Findings: A gene-trap insertional mutagenesis screen produced one insertion that conferred resistance to sodium arsenite. RT-PCR/39 RACE was used to identify the endogenous gene expressed as a GFP-fusion transcript. SGNP is localized in both the cytoplasm and nucleolus and defines a non-nucleolar compartment containing 5.8S rRNA, a component of the 60S ribosomal subunit. Under oxidative stress, SGNP nucleolar localization decreases and it rapidly co-localizes with stress granules. The decrease in nucleolar SGNP following oxidative stress was accompanied by a large increase in nucleolar 5.8S rRNA. Knockdown of SGNP with shRNA increased global mRNA translation but induced growth arrest and cell death. Conclusions: These results suggest that SGNP is an essential gene that may be involved in ribosomal biogenesis and translational control in response to oxidative stress.	[Zhu, Chun-Hong; Kim, Jinyong; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, CH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Shay, Jerry W/F-7878-2011		American Heart Association [0525069Y]; National Institutes of Health [AG07992]; NATIONAL INSTITUTE ON AGING [R01AG007992] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by American Heart Association postdoctoral fellowship No. 0525069Y (C-H Z), and National Institutes of Health grant AG07992 (WEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YH, 1999, J NEUROSCI, V19, P10338; DANOVA M, 1988, BIOL CELL, V64, P23, DOI 10.1016/0248-4900(88)90089-5; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; HODGES D, 1992, MECH DEVELOP, V37, P127, DOI 10.1016/0925-4773(92)90075-U; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Skuk D, 1998, CELL TRANSPLANT, V7, P427, DOI 10.1016/S0963-6897(98)00029-3; Smythe GM, 2000, MOL THER, V1, P304, DOI 10.1006/mthe.2000.0049; Suzuki N, 2001, GENETICS, V158, P613; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	24	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3716	10.1371/journal.pone.0003716	http://dx.doi.org/10.1371/journal.pone.0003716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005571	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166200004
J	Lee, PS; Patel, SR; Christiani, DC; Bajwa, E; Stossel, TP; Waxman, AB				Lee, Po-Shun; Patel, Sanjay R.; Christiani, David C.; Bajwa, Ednan; Stossel, Thomas P.; Waxman, Aaron B.			Plasma Gelsolin Depletion and Circulating Actin in Sepsis-A Pilot Study	PLOS ONE			English	Article								Background: Depletion of the circulating actin-binding protein, plasma gelsolin (pGSN) has been described in septic patients and animals. We hypothesized that the extent of pGSN reduction correlates with outcomes of septic patients and that circulating actin is a manifestation of sepsis. Methodology/Principal Findings: We assayed pGSN in plasma samples from non-surgical septic patients identified from a pre-existing database which prospectively enrolled patients admitted to adult intensive care units at an academic hospital. We identified 21 non-surgical septic patients for the study. Actinemia was detected in 17 of the 21 patients, suggesting actin released into circulation from injured tissues is a manifestation of sepsis. Furthermore, we documented the depletion of pGSN in human clinical sepsis, and that the survivors had significantly higher pGSN levels than the non-survivors (163 +/- 47 mg/L vs. 89 +/- 48 mg/L, p = 0.01). pGSN levels were more strongly predictive of 28-day mortality than APACHE III scores. For every quartile reduction in pGSN, the odds of death increased 3.4-fold. Conclusion: We conclude that circulating actin and pGSN deficiency are associated with early sepsis. The degree of pGSN deficiency correlates with sepsis mortality. Reversing pGSN deficiency may be an effective treatment for sepsis.	[Lee, Po-Shun] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Lee, Po-Shun; Christiani, David C.; Bajwa, Ednan; Stossel, Thomas P.; Waxman, Aaron B.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Po-Shun; Stossel, Thomas P.] Brigham & Womens Hosp, Translat Med Div, Boston, MA USA; [Patel, Sanjay R.] Case Western Reserve Univ, Univ Hosp Cleveland, Div Pulmonary & Critical Care Med, Cleveland, OH USA; [Christiani, David C.; Bajwa, Ednan; Waxman, Aaron B.] Mass Gen Hosp, Pulmonary & Critical Care Unit, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Harvard University; Massachusetts General Hospital	Lee, PS (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	plee4@partners.org	Waxman, Aaron/I-8659-2019; Waxman, Aaron/L-7450-2019	Waxman, Aaron/0000-0001-7797-0361; Patel, Sanjay/0000-0002-9142-5172; Bajwa, Ednan/0000-0001-9026-1009	NIH [5R01HL074859-04]; AHA [0735620N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH 5R01HL074859-04, AHA Scientist Development Grant 0735620N. The funding institutions played no role in the designed of the study or in the preparation of this manuscript.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1984, J BIOL CHEM, V259, P3262; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SMITH DB, 1988, BLOOD, V72, P214; SMITH DB, 1987, J LAB CLIN MED, V110, P189; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	28	46	57	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3712	10.1371/journal.pone.0003712	http://dx.doi.org/10.1371/journal.pone.0003712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002257	Green Submitted, gold, Green Published			2022-12-25	WOS:000265166000012
J	Durand, PM; Naidoo, K; Coetzer, TL				Durand, Pierre M.; Naidoo, Kubendran; Coetzer, Theresa L.			Evolutionary Patterning: A Novel Approach to the Identification of Potential Drug Target Sites in Plasmodium falciparum	PLOS ONE			English	Article							AMINO-ACID SITES; COLI GLYCEROL KINASE; ESCHERICHIA-COLI; PURIFYING SELECTION; POSITIVE SELECTION; TRYPANOSOMA-BRUCEI; MALARIA PARASITES; BINDING SURFACES; SEQUENCE; AQUAGLYCEROPORIN	Malaria continues to be the most lethal protozoan disease of humans. Drug development programs exhibit a high attrition rate and parasite resistance to chemotherapeutic drugs exacerbates the problem. Strategies that limit the development of resistance and minimize host side-effects are therefore of major importance. In this study, a novel approach, termed evolutionary patterning (EP), was used to identify suitable drug target sites that would minimize the emergence of parasite resistance. EP uses the ratio of non-synonymous to synonymous substitutions (omega) to assess the patterns of evolutionary change at individual codons in a gene and to identify codons under the most intense purifying selection (omega <= 0.1). The extreme evolutionary pressure to maintain these residues implies that resistance mutations are highly unlikely to develop, which makes them attractive chemotherapeutic targets. Method validation included a demonstration that none of the residues providing pyrimethamine resistance in the Plasmodium falciparum dihydrofolate reductase enzyme were under extreme purifying selection. To illustrate the EP approach, the putative P. falciparum glycerol kinase (PfGK) was used as an example. The gene was cloned and the recombinant protein was active in vitro, verifying the database annotation. Parasite and human GK gene sequences were analyzed separately as part of protozoan and metazoan clades, respectively, and key differences in the evolutionary patterns of the two molecules were identified. Potential drug target sites containing residues under extreme evolutionary constraints were selected. Structural modeling was used to evaluate the functional importance and drug accessibility of these sites, which narrowed down the number of candidates. The strategy of evolutionary patterning and refinement with structural modeling addresses the problem of targeting sites to minimize the development of drug resistance. This represents a significant advance for drug discovery programs in malaria and other infectious diseases.	[Durand, Pierre M.; Naidoo, Kubendran; Coetzer, Theresa L.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa	University of Witwatersrand	Durand, PM (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	pierre.durand@wits.ac.za		Durand, Pierre M./0000-0002-9614-1371	National Research Foundation [GUN 2069449]; National Health Laboratory Service Research Trust; University of the Witwatersrand Endowment Fund; National Bioinformatics Network Travel Fund	National Research Foundation; National Health Laboratory Service Research Trust; University of the Witwatersrand Endowment Fund; National Bioinformatics Network Travel Fund	National Research Foundation (SA) GUN 2069449, National Health Laboratory Service Research Trust, University of the Witwatersrand Endowment Fund, National Bioinformatics Network Travel Fund	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CREAVIN T, 2004, DRUG DISCOV TODAY, V3, P178; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; Furlong RF, 2008, J MOL EVOL, V66, P384, DOI 10.1007/s00239-008-9092-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Ho CK, 2001, J BIOL CHEM, V276, P46182, DOI 10.1074/jbc.M108706200; Holbrook JD, 2007, DRUG DISCOV TODAY, V12, P826, DOI 10.1016/j.drudis.2007.08.015; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; INA Y, 1995, J MOL EVOL, V40, P190, DOI 10.1007/BF00167113; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 2002, CURR OPIN STRUC BIOL, V12, P21, DOI 10.1016/S0959-440X(02)00284-1; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LJUNGSTROM I, 2004, MR4ATCC; Agosto JAM, 2006, MOL GENET METAB, V88, P334, DOI 10.1016/j.ymgme.2006.01.002; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PETTIGREW DW, 1990, BIOCHEMISTRY-US, V29, P8620, DOI 10.1021/bi00489a018; Philippe H, 2001, TRENDS BIOCHEM SCI, V26, P414, DOI 10.1016/S0968-0004(01)01877-1; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Searls DB, 2003, NAT REV DRUG DISCOV, V2, P613, DOI 10.1038/nrd1152; SELTZER WK, 1986, LIFE SCI, V39, P1417, DOI 10.1016/0024-3205(86)90545-X; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thomas MA, 2003, MOL BIOL EVOL, V20, P964, DOI 10.1093/molbev/msg110; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	70	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3685	10.1371/journal.pone.0003685	http://dx.doi.org/10.1371/journal.pone.0003685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997863	gold, Green Submitted, Green Published			2022-12-25	WOS:000265165500008
J	Kamath, AT; Rochat, AF; Valenti, MP; Agger, EM; Lingnau, K; Andersen, P; Lambert, PH; Siegrist, CA				Kamath, Arun T.; Rochat, Anne-Francoise; Valenti, Mario P.; Agger, Else Marie; Lingnau, Karen; Andersen, Peter; Lambert, Paul-Henri; Siegrist, Claire-Anne			Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31 (R) Adjuvant	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; EARLY-LIFE; IMMUNE-RESPONSES; CPG OLIGODEOXYNUCLEOTIDES; VACCINE ANTIGENS; INNATE IMMUNITY; TUBERCULOSIS; SYSTEM; MYCOBACTERIAL; INFECTIONS	Background: With the exception of some live vaccines, e. g. BCG, subunit vaccines formulated with "classical" adjuvants do not induce similar responses in neonates as in adults. The usual neonatal profile is characterized by lower levels of TH1-associated biomarkers. This has hampered the development of new neonatal vaccines for diseases that require early protection. Tuberculosis is one of the major targets for neonatal immunization. In this study, we assessed the immunogenicity of a novel candidate vaccine comprising a mycobacterial fusion protein, Ag85B-ESAT-6, in a neonatal murine immunization model. Methods/Findings: The Ag85B-ESAT-6 fusion protein was formulated either with a classical alum based adjuvant or with the novel IC31 (R) adjuvant. Following neonatal or adult immunization, 3 parameters were studied in vivo: (1) CD4(+) T cell responses, (2) vaccine targeting/activation of dendritic cells (DC) and (3) protection in a surrogate mycobacterial challenge model. Conversely to Alum, IC31 (R) induced in both age groups strong Th1 and Th17 responses, characterized by multifunctional T cells expressing IL-2 and TNF-alpha with or without IFN-gamma. In the draining lymph nodes, a similarly small number of DC contained the adjuvant and/or the antigen following neonatal or adult immunization. Expression of CD40, CD80, CD86 and IL-12p40 production was focused on the minute adjuvant-bearing DC population. Again, DC targeting/activation was similar in adults and neonates. These DC/T cell responses resulted in an equivalent reduction of bacterial growth following infection with M. bovis BCG, whereas no protection was observed when Alum was used as adjuvant. Conclusion: Neonatal immunization with the IC31 (R)- adjuvanted Ag85B-ESAT-6 subunit vaccine elicited adult-like multifunctional protective anti-mycobacterial T cell responses through the induction of an adult pattern of in vivo DC activation.	[Kamath, Arun T.; Rochat, Anne-Francoise; Valenti, Mario P.; Lambert, Paul-Henri; Siegrist, Claire-Anne] Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland; [Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Lingnau, Karen] Intercell AG, Vienna, Austria	University of Geneva; World Health Organization; Statens Serum Institut; Intercell	Kamath, AT (corresponding author), Univ Geneva, World Hlth Org Collaborating Ctr Vaccinol & Neona, Dept Pathol Immunol, Geneva, Switzerland.	Claire-Anne.Siegrist@unige.ch		Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Swiss Office Federal of Education and Sciences (OFES)	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Office Federal of Education and Sciences (OFES)	This study was funded by the European Commission (contract no. LSHP-CT-2003-503367) and the Swiss Office Federal of Education and Sciences (OFES).	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Barrios C, 1996, EUR J IMMUNOL, V26, P2666, DOI 10.1002/eji.1830261118; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Jong R, 1998, SCIENCE, V280, P1435; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; GILLIS S, 1978, J IMMUNOL, V120, P2027; Gold MC, 2006, PEDIATR RES, V60, P34, DOI 10.1203/01.pdr.0000220352.13547.f4; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Ito S, 2005, J IMMUNOL, V174, P777, DOI 10.4049/jimmunol.174.2.777; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; KNUF M, 2008, J PEDIAT, V152, P660; KNUF M, 2008, J PEDIAT, V152, pE651; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; Kovarik J, 2000, VIROLOGY, V268, P122, DOI 10.1006/viro.1999.0159; Kovarik J, 2001, IMMUNOLOGY, V102, P67, DOI 10.1046/j.1365-2567.2001.01158.x; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mandalakas Anna M, 2005, Semin Pediatr Infect Dis, V16, P93, DOI 10.1053/j.spid.2005.01.001; Martinez X, 2003, VIROLOGY, V305, P428, DOI 10.1006/viro.2002.1775; Miles DJC, 2008, CLIN VACCINE IMMUNOL, V15, P995, DOI 10.1128/CVI.00037-08; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Regner M, 2004, J IMMUNOL, V173, P2669, DOI 10.4049/jimmunol.173.4.2669; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Riedl K, 2008, VACCINE, V26, P3461, DOI 10.1016/j.vaccine.2008.04.029; Roduit C, 2002, INFECT IMMUN, V70, P3521, DOI 10.1128/IAI.70.7.3521-3528.2002; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	47	58	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3683	10.1371/journal.pone.0003683	http://dx.doi.org/10.1371/journal.pone.0003683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997860	Green Submitted, Green Published, gold			2022-12-25	WOS:000265165500006
J	Widmann, T; Sester, U; Gartner, BC; Schubert, J; Pfreundschuh, M; Kohler, H; Sester, M				Widmann, Thomas; Sester, Urban; Gaertner, Barbara C.; Schubert, Joerg; Pfreundschuh, Michael; Koehler, Hans; Sester, Martina			Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article								Cytomegalovirus (CMV) infection is the most frequent viral complication in patients after allogeneic stem cell transplantation. As CMV replication is tightly controlled by the cellular arm of specific immunity, the kinetics of CMV-specific T cells in association with individual reactivation episodes were prospectively analyzed in 40 allogeneic transplant recipients in a routine clinical setting and evaluated as determinant of impaired CMV control. Antigen-specific CD4 and CD8 T cells were quantified directly from whole blood using intracellular cytokine staining after specific stimulation and MHC class I multimers, respectively. Highly dynamic intraindividual changes of CMV-specific CD4 T cells were observed in patients experiencing CMV viremia. Episodes of CMV reactivation were associated with a drop of CMV-specific CD4 T cells that reincreased after viral clearance (p < 0.0001). Furthermore, levels of CMV-specific CD4 T cells at the onset of viremia inversely correlated with peak viral load thereafter (p = 0.02). In contrast, CMV-peptide specific CD8 T cells did not show any association with viremia (p = 0.82). Interestingly, therapeutic dosages of cyclosporine A and corticosteroids led to a dose-dependent reduction of CMV-specific T-cell functions, indicating a causal link between intensified immunosuppressive treatment and CMV reactivation. In conclusion, levels of CMV-specific CD4 T cells inversely correlate with reactivation episodes and may represent a valuable measure to individually guide antiviral therapy after stem cell transplantation.	[Widmann, Thomas; Schubert, Joerg; Pfreundschuh, Michael] Univ Clin Saarland, Dept Internal Med 1, Homburg, Germany; [Sester, Urban; Koehler, Hans; Sester, Martina] Univ Clin Saarland, Dept Internal Med IV, Homburg, Germany; [Gaertner, Barbara C.] Univ Clin Saarland, Dept Virol, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Widmann, T (corresponding author), Univ Clin Saarland, Dept Internal Med 1, Homburg, Germany.	martina.sester@uks.eu	Sester, Martina/AAA-3383-2022	Sester, Martina/0000-0001-5482-0002; Sester, Urban/0000-0003-4007-5595	Deutsche Jose Carreras Leukamie Stiftung; HOMFOR	Deutsche Jose Carreras Leukamie Stiftung; HOMFOR	Financial support was given by the Deutsche Jose Carreras Leukamie Stiftung e.V. and HOMFOR to M.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Avetisyan G, 2007, BONE MARROW TRANSPL, V40, P865, DOI 10.1038/sj.bmt.1705825; Avetisyan G, 2006, BONE MARROW TRANSPL, V38, P687, DOI 10.1038/sj.bmt.1705507; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Boeckh M, 1996, BLOOD, V88, P4063, DOI 10.1182/blood.V88.10.4063.bloodjournal88104063; Breinig T, 2006, METHODS, V38, P77, DOI 10.1016/j.ymeth.2005.09.016; Einsele H, 2004, HUM IMMUNOL, V65, P558, DOI 10.1016/j.humimm.2004.02.003; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; Foster AE, 2002, BIOL BLOOD MARROW TR, V8, P501, DOI 10.1053/bbmt.2002.v8.pm12374455; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Ganepola S, 2007, BONE MARROW TRANSPL, V39, P293, DOI 10.1038/sj.bmt.1705585; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hebart H, 2002, BLOOD, V99, P3830, DOI 10.1182/blood.V99.10.3830; Hebart H, 2004, HUM IMMUNOL, V65, P432, DOI 10.1016/j.humimm.2004.02.022; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Lilleri D, 2008, HAEMATOLOGICA, V93, P248, DOI 10.3324/haematol.11912; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Ljungman P, 2007, BEST PRACT RES CL HA, V20, P209, DOI 10.1016/j.beha.2006.09.003; Micklethwaite K, 2007, BIOL BLOOD MARROW TR, V13, P707, DOI 10.1016/j.bbmt.2007.02.004; Nicholson VA, 1997, BONE MARROW TRANSPL, V19, P37, DOI 10.1038/sj.bmt.1700612; Ozdemir E, 2002, BLOOD, V100, P3690, DOI 10.1182/blood-2002-05-1387; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; REUSSER P, 1991, BLOOD, V78, P1373; RIDDELL SR, 1992, SCIENCE, V257, P238; Sester M, 2003, TRANSPLANTATION, V76, P1229, DOI 10.1097/01.TP.0000083894.61333.56; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sester U, 2005, AM J TRANSPLANT, V5, P1483, DOI 10.1111/j.1600-6143.2005.00871.x; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603	32	68	71	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3634	10.1371/journal.pone.0003634	http://dx.doi.org/10.1371/journal.pone.0003634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982061	Green Published, gold			2022-12-25	WOS:000265134300004
J	Chen, YH; Su, LH; Huang, YC; Wang, YT; Kao, YY; Sun, CH				Chen, Yi-Hsiu; Su, Li-Hsin; Huang, Yu-Chang; Wang, Yi-Ting; Kao, Yu-Yun; Sun, Chin-Hung			UPF1, a Conserved Nonsense-Mediated mRNA Decay Factor, Regulates Cyst Wall Protein Transcripts in Giardia lamblia	PLOS ONE			English	Article								The Giardia lamblia cyst wall is required for survival outside the host and infection. Three cyst wall protein (cwp) genes identified to date are highly up-regulated during encystation. However, little is known of the molecular mechanisms governing their gene regulation. Messenger RNAs containing premature stop codons are rapidly degraded by a nonsense-mediated mRNA decay (NMD) system to avoid production of non-functional proteins. In addition to RNA surveillance, NMD also regulates thousands of naturally occurring transcripts through a variety of mechanisms. It is interesting to know the NMD pathway in the primitive eukaryotes. Previously, we have found that the giardial homologue of a conserved NMD factor, UPF1, may be functionally conserved and involved in NMD and in preventing nonsense suppression. In this study, we tested the hypothesis that NMD factors can regulate some naturally occurring transcripts in G. lamblia. We found that overexpression of UPF1 resulted in a significant decrease of the levels of CWP1 and cyst formation and of the endogenous cwp1-3, and myb2 mRNA levels and stability. This indicates that NMD could contribute to the regulation of the cwp1-3 and myb2 transcripts, which are key to G. lamblia differentiation into cyst. Interestingly, we also found that UPF1 may be involved in regulation of eight other endogenous genes, including up-regulation of the translation elongation factor gene, whose product increases translation which is required for NMD. Our results indicate that NMD factor could contribute to the regulation of not only nonsense containing mRNAs, but also mRNAs of the key encystation-induced genes and other endogenous genes in the early-diverging eukaryote, G. lamblia.	[Chen, Yi-Hsiu; Su, Li-Hsin; Huang, Yu-Chang; Wang, Yi-Ting; Kao, Yu-Yun; Sun, Chin-Hung] Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei 10764, Taiwan	National Taiwan University	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei 10764, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [96-2320-B-002-040-MY3]; National Health Research Institutes in Taiwan [NHRI-EX96-9510NC, NHRI-EX97-9510NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Science Council (NSC 96-2320-B-002-040-MY3) and the National Health Research Institutes (NHRI-EX96-9510NC and NHRI-EX97-9510NC) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dahlseid JN, 1998, GENETICS, V150, P1019; Ford AS, 2006, EUKARYOT CELL, V5, P301, DOI 10.1128/EC.5.2.301-312.2006; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; HASHIMOTO T, 1994, MOL BIOL EVOL, V11, P65; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Kebaara B, 2003, NUCLEIC ACIDS RES, V31, P3157, DOI 10.1093/nar/gkg430; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Li L, 2006, MOL MICROBIOL, V59, P202, DOI 10.1111/j.1365-2958.2005.04896.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Ondarza R. N., 2007, Infectious Disorders - Drug Targets, V7, P266, DOI 10.2174/187152607782110059; Page MF, 1999, MOL CELL BIOL, V19, P5943; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Sanders J, 1996, J CELL SCI, V109, P1113; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Taylor R, 2005, EUKARYOT CELL, V4, P2066, DOI 10.1128/EC.4.12.2066-2077.2005; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang WR, 2006, MOL CELL BIOL, V26, P3390, DOI 10.1128/MCB.26.9.3390-3400.2006; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992	47	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3609	10.1371/journal.pone.0003609	http://dx.doi.org/10.1371/journal.pone.0003609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974834	Green Submitted, gold, Green Published			2022-12-25	WOS:000265131700025
J	Menon, BB; Dou, Z; Heinhorst, S; Shively, JM; Cannon, GC				Menon, Balaraj B.; Dou, Zhicheng; Heinhorst, Sabine; Shively, Jessup M.; Cannon, Gordon C.			Halothiobacillus neapolitanus Carboxysomes Sequester Heterologous and Chimeric RubisCO Species	PLOS ONE			English	Article								Background: The carboxysome is a bacterial microcompartment that consists of a polyhedral protein shell filled with ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCO), the enzyme that catalyzes the first step of CO(2) fixation via the Calvin-Benson-Bassham cycle. Methodology/Principal Findings: To analyze the role of RubisCO in carboxysome biogenesis in vivo we have created a series of Halothiobacillus neapolitanus RubisCO mutants. We identified the large subunit of the enzyme as an important determinant for its sequestration into alpha-carboxysomes and found that the carboxysomes of H. neapolitanus readily incorporate chimeric and heterologous RubisCO species. Intriguingly, a mutant lacking carboxysomal RubisCO assembles empty carboxysome shells of apparently normal shape and composition. Conclusions/Significance: These results indicate that carboxysome shell architecture is not determined by the enzyme they normally sequester. Our study provides, for the first time, clear evidence that carboxysome contents can be manipulated and suggests future nanotechnological applications that are based upon engineered protein microcompartments.	[Menon, Balaraj B.; Dou, Zhicheng; Heinhorst, Sabine; Cannon, Gordon C.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Shively, Jessup M.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29631 USA	University of Southern Mississippi; Clemson University	Menon, BB (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	gordon.cannon@usm.edu			National Science Foundation [MCB-0818680, DBI-0619455, DMR-0213883]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants MCB-0818680, DBI-0619455 and DMR-0213883 from the National Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICHAY D, 1993, PLANT MOL BIOL, V23, P465, DOI 10.1007/BF00019295; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Baker SH, 1998, J BACTERIOL, V180, P4133, DOI 10.1128/JB.180.16.4133-4139.1998; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cai F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/s00203-007-0305-y; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Cannon GC, 2003, CURR MICROBIOL, V46, P115, DOI 10.1007/s00284-002-3825-3; Cannon GC, 2002, FUNCT PLANT BIOL, V29, P175, DOI 10.1071/PP01200; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; ENGLISH RS, 1995, APPL ENVIRON MICROB, V61, P3256, DOI 10.1128/AEM.61.9.3256-3260.1995; Getzoff TP, 1998, PLANT PHYSIOL, V116, P695, DOI 10.1104/pp.116.2.695; Heinhorst S, 2002, CURR MICROBIOL, V45, P115, DOI 10.1007/s00284-001-0094-5; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Hernandez JM, 1996, J BACTERIOL, V178, P347, DOI 10.1128/jb.178.2.347-356.1996; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Ludwig M, 2000, J PHYCOL, V36, P1109, DOI 10.1046/j.1529-8817.2000.00028.x; ORUS MI, 1995, PLANT PHYSIOL, V107, P1159, DOI 10.1104/pp.107.4.1159; PIERCE J, 1989, P NATL ACAD SCI USA, V86, P5753, DOI 10.1073/pnas.86.15.5753; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shively J. M., 2006, COMPLEX INTRACELLULA; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; Wang YL, 2001, ARCH BIOCHEM BIOPHYS, V396, P35, DOI 10.1006/abbi.2001.2555; Whitney SM, 2003, PLANT PHYSIOL, V133, P287, DOI 10.1104/pp.103.026146; Yoshizawa Y, 2004, J BACTERIOL, V186, P5685, DOI 10.1128/JB.186.17.5685-5691.2004; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	40	66	71	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3570	10.1371/journal.pone.0003570	http://dx.doi.org/10.1371/journal.pone.0003570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974784	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131500005
J	Sanchez-Fernandez, MA; Gallois, A; Riedl, T; Jurdic, P; Hoflack, B				Sanchez-Fernandez, Maria Arantzazu; Gallois, Anne; Riedl, Thilo; Jurdic, Pierre; Hoflack, Bernard			Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling	PLOS ONE			English	Article								Background: Bone remodeling relies on the tightly regulated interplay between bone forming osteoblasts and bone digesting osteoclasts. Several studies have now described the molecular mechanisms by which osteoblasts control osteoclastogenesis and bone degradation. It is currently unclear whether osteoclasts can influence bone rebuilding. Methodology/Principal Findings: Using in vitro cell systems, we show here that mature osteoclasts, but not their precursors, secrete chemotactic factors recognized by both mature osteoblasts and their precursors. Several growth factors whose expression is upregulated during osteoclastogenesis were identified by DNA microarrays as candidates mediating osteoblast chemotaxis. Our subsequent functional analyses demonstrate that mature osteoclasts, whose platelet-derived growth factor bb (PDGF-bb) expression is reduced by siRNAs, exhibit a reduced capability of attracting osteoblasts. Conversely, osteoblasts whose platelet-derived growth factor receptor beta (PDGFR-beta) expression is reduced by siRNAs exhibit a lower capability of responding to chemotactic factors secreted by osteoclasts. Conclusions/Significance: We conclude that, in vitro mature osteoclasts control osteoblast chemotaxis via PDGF-bb/PDGFR-beta signaling. This may provide one key mechanism by which osteoclasts control bone formation in vivo.	[Sanchez-Fernandez, Maria Arantzazu; Riedl, Thilo; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Gallois, Anne; Jurdic, Pierre] Univ Claude Bernard Lyon 1, INRA, CNRS, Ecole Normale Superieure Lyon, Inst Genom Fonction, Lyon, France	Technische Universitat Dresden; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Sanchez-Fernandez, MA (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020		TU-Dresden [HWP-1207]; BMBF [0313815B]; DFG [TRR 13/2-08, HO 2584/2-1, HO 2584/1-1]; Fondation pour la Recherche Medicale;  [SMWK-EFRE 1203]	TU-Dresden(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported in part by grants from TU-Dresden (HWP-1207), SMWK-EFRE 1203, BMBF (0313815B) and DFG (TRR 13/2-08, HO 2584/2-1, HO 2584/1-1) as well as by Fondation pour la Recherche Medicale (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chandrasekhar S, 1996, J CELL PHYSIOL, V169, P481, DOI 10.1002/(SICI)1097-4652(199612)169:3<481::AID-JCP8>3.0.CO;2-K; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kallin A, 2004, J BIOL CHEM, V279, P17897, DOI 10.1074/jbc.M312996200; Kaminski WE, 2001, BLOOD, V97, P1990, DOI 10.1182/blood.V97.7.1990; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kawamata A, 2008, J CELL BIOCHEM, V103, P1037, DOI 10.1002/jcb.21660; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TOKUNAGA A, 2008, J BONE MINER RES; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	41	78	87	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3537	10.1371/journal.pone.0003537	http://dx.doi.org/10.1371/journal.pone.0003537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953417	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130500012
J	Kim, C; Jeon, D; Kim, YH; Lee, CJ; Kim, H; Shin, HS				Kim, Chanki; Jeon, Daejong; Kim, Young-Hoon; Lee, C. Justin; Kim, Hyun; Shin, Hee-Sup			Deletion of N-type Ca2+ Channel Ca(v)2.2 Results in Hyperaggressive Behaviors in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL RAPHE NUCLEUS; CEREBROSPINAL-FLUID MONOAMINE; LONG-TERM POTENTIATION; KNOCK-OUT MICE; AGGRESSIVE-BEHAVIOR; ANTERIOR HYPOTHALAMUS; ALPHA(1B) SUBUNIT; CALCIUM-CHANNELS; RAT-BRAIN; PERSONALITY-DISORDERS	Voltage-dependent N-type Ca2+ channels play important roles in the regulation of diverse neuronal functions in the brain, but little is known about its role in social aggressive behaviors. Mice lacking the alpha 1B subunit (Ca(v)2.2) of N-type Ca2+ channels showed markedly enhanced aggressive behaviors to an intruder mouse in the resident-intruder test. The dorsal raphe nucleus (DRN), which contains serotonin neurons, is known to be involved in aggression in animals. We thus examined the DRN neurons in the Ca(v)2.2-deficient (Cav2.2(-/-)) mice. Microinjection of omega-conotoxin GVIA, an N-type Ca2+ channel-specific blocker, into the DRN of wild type mice resulted in escalated aggression, mimicking the phenotypes of Ca(v)2.2(-/-). Electrophysiological analysis showed increased firing activity of serotonin neurons with a reduced inhibitory neurotransmission in the Ca(v)2.2(-/-) DRN. Ca(v)2.2(-/-) mice showed an elevated level of arginine vasopressin, an aggression-related hormone, in the cerebrospinal fluid. In addition, Ca(v)2.2(-/-) mice showed an increase of serotonin in the hypothalamus. These results suggest that N-type Ca2+ channels at the DRN have a key role in the control of aggression.	[Kim, Chanki; Jeon, Daejong; Lee, C. Justin; Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Kim, Chanki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Young-Hoon] Inje Univ, Paik Inst Clin Res, Pusan 614735, South Korea; [Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 1261, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Inje University; Korea University; Korea University Medicine (KU Medicine)	Shin, HS (corresponding author), 39-1 Hawolgok Dong, Seoul 136791, South Korea.	shin@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Jeon, Daejong/C-1814-2011	Jeon, Daejong/0000-0002-6998-7603; Lee, C Justin/0000-0002-3555-0980; Kim, Hyun/0000-0002-7210-5798	Ministry of Science and Technology, Korea; Chemoinformatics program, the Center-of-Excellence program; Korea Institute of Science and Technology, Korea	Ministry of Science and Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea); Chemoinformatics program, the Center-of-Excellence program; Korea Institute of Science and Technology, Korea(Korea Institute of Science & Technology (KIST))	This work was supported by a National Honor Scientist grant from the Ministry of Science and Technology, Korea, and the Chemoinformatics program, the Center-of-Excellence program, and the Top-Brand program in Korea Institute of Science and Technology, Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Bannai M, 2007, PSYCHOPHARMACOLOGY, V193, P295, DOI 10.1007/s00213-007-0780-5; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Casanovas JM, 1997, BRIT J PHARMACOL, V122, P733, DOI 10.1038/sj.bjp.0701420; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; Coccaro EF, 1998, ARCH GEN PSYCHIAT, V55, P708, DOI 10.1001/archpsyc.55.8.708; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; de Boer SF, 2000, NEUROPSYCHOPHARMACOL, V23, P20, DOI 10.1016/S0893-133X(00)00092-0; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DEVRIES GJ, 1985, J COMP NEUROL, V233, P236, DOI 10.1002/cne.902330206; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fountoulakis KN, 2008, CURR OPIN PSYCHIATR, V21, P84, DOI 10.1097/YCO.0b013e3282f31137; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; Haller J, 1996, J NEUROENDOCRINOL, V8, P361, DOI 10.1046/j.1365-2826.1996.04654.x; Halperin JM, 1997, BIOL PSYCHIAT, V41, P682, DOI 10.1016/S0006-3223(96)00168-0; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; IVERSEN LL, 1966, J NEUROCHEM, V13, P671, DOI 10.1111/j.1471-4159.1966.tb09874.x; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; Jorgensen H, 2003, J NEUROENDOCRINOL, V15, P564, DOI 10.1046/j.1365-2826.2003.01032.x; Kang SJ, 2008, MOL CELLS, V25, P124; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; la Cour CM, 2004, J NEUROCHEM, V89, P886, DOI 10.1111/j.1471-4159.2004.02367.x; Larsen PJ, 1996, NEUROSCIENCE, V70, P963, DOI 10.1016/0306-4522(95)00415-7; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Matter JM, 1998, BRAIN BEHAV EVOLUT, V51, P23; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; MOS J, 1993, EUR J PHARMACOL, V238, P411, DOI 10.1016/0014-2999(93)90877-K; MUEHLENKAMP F, 1995, PHARMACOL BIOCHEM BE, V50, P671, DOI 10.1016/0091-3057(95)00351-7; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Newton PM, 2004, J NEUROSCI, V24, P9862, DOI 10.1523/JNEUROSCI.3446-04.2004; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pudovkina OL, 2003, SYNAPSE, V50, P77, DOI 10.1002/syn.10245; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; SIJBESMA H, 1991, PHARMACOL BIOCHEM BE, V38, P447, DOI 10.1016/0091-3057(91)90305-L; Summers CH, 1998, NEUROSCIENCE, V87, P489, DOI 10.1016/S0306-4522(98)00144-4; Summers CH, 2001, BRAIN BEHAV EVOLUT, V57, P283, DOI 10.1159/000047246; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; Tao R, 2003, BRAIN RES, V961, P109, DOI 10.1016/S0006-8993(02)03851-9; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Vacher CM, 2002, J NEUROSCI, V22, P1513, DOI 10.1523/JNEUROSCI.22-05-01513.2002; van der Vegt BJ, 2003, HORM BEHAV, V44, P199, DOI 10.1016/S0018-506X(03)00132-6; van der Vegt BJ, 2003, BEHAV NEUROSCI, V117, P667, DOI 10.1037/0735-7044.117.4.667; VANDEKAR LD, 1991, ANNU REV PHARMACOL, V31, P289; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.896	61	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2738	2745		10.1074/jbc.M807179200	http://dx.doi.org/10.1074/jbc.M807179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004821	hybrid			2022-12-25	WOS:000262700900016
J	Studelska, DR; Mandik-Nayak, L; Zhou, XD; Pan, J; Weiser, P; McDowell, LM; Lu, H; Liapis, H; Allen, PM; Shih, FF; Zhang, LJ				Studelska, Daniel R.; Mandik-Nayak, Laura; Zhou, Xiaodong; Pan, Jing; Weiser, Peter; McDowell, Lynda M.; Lu, Hong; Liapis, Helen; Allen, Paul M.; Shih, Fei F.; Zhang, Lijuan			High Affinity Glycosaminoglycan and Autoantigen Interaction Explains Joint Specificity in a Mouse Model of Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCURONIDASE ACTIVITY; HEPARAN-SULFATE; NEGATIVE ASSOCIATION; ARTICULAR-CARTILAGE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; PREGNANCY; ISOMERASE; SERUM; SCHIZOPHRENIA	In the K/BxN mouse model of rheumatoid arthritis, autoantibodies specific for glucose-6-phosphate isomerase (GPI) can transfer joint-specific inflammation to most strains of normal mice. Binding of GPI and autoantibody to the joint surface is a prerequisite for joint-specific inflammation. However, how GPI localizes to the joint remains unclear. We show that glycosaminoglycans (GAGs) are the high affinity (83 nM) joint receptors for GPI. The binding affinity and structural differences between mouse paw/ankle GAGs and elbows/knee GAGs correlated with the distal to proximal disease severity in these joints. We found that cartilage surface GPI binding was greatly reduced by either chondroitinase ABC or beta-glucuronidase treatment. We also identified several inhibitors that inhibit both GPI/GAG interaction and GPI enzymatic activities, which suggests that the GPI GAG-binding domain overlaps with the active site of GPI enzyme. Our studies raise the possibility that GAGs are the receptors for other autoantigens involved in joint-specific inflammatory responses.	[Studelska, Daniel R.; Mandik-Nayak, Laura; Zhou, Xiaodong; Pan, Jing; Weiser, Peter; McDowell, Lynda M.; Lu, Hong; Liapis, Helen; Allen, Paul M.; Shih, Fei F.; Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shih, FF (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Fei.F.Shih@pfizer.com; ljzhang@wustl.edu	Zhou, Xiaodong/B-4017-2011		National Institutes of Health [GM069968, AI031238]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069968 (to L. Z.) and AI031238 (to P. M. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Barrett JH, 1999, ARTHRITIS RHEUM, V42, P1219, DOI 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G; BIJLSMA JWJ, 1988, ANN RHEUM DIS, V47, P350, DOI 10.1136/ard.47.4.350-b; Carpintero A, 1996, CLIN CHIM ACTA, V255, P153, DOI 10.1016/0009-8981(96)06403-0; Coleman P, 1998, HISTOCHEM J, V30, P519, DOI 10.1023/A:1003291303380; Coleman PJ, 1998, J PHYSIOL-LONDON, V509, P695, DOI 10.1111/j.1469-7793.1998.695bm.x; Conrad H. E., 1998, HEPARIN BINDING PROT; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRARA M, 1979, ISRAEL J MED SCI, V15, P746; Godfrey RG, 2000, CLIN EXP RHEUMATOL, V18, P649; Gorwood P, 2004, SCHIZOPHR RES, V66, P21, DOI 10.1016/S0920-9964(03)00017-3; HAYDU G G, 1950, Rheumatism, V6, P133; HOWELL EE, 1981, MOL CELL BIOCHEM, V37, P101, DOI 10.1007/BF02354933; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; KAHANA SE, 1960, J BIOL CHEM, V235, P2178; Kavanagh E, 1999, J HISTOCHEM CYTOCHEM, V47, P1603, DOI 10.1177/002215549904701212; KERR LD, 1991, J RHEUMATOL, V18, P1739; Kurup RKA, 2001, NEUROSCI RES COMMUN, V28, P95, DOI 10.1002/nrc.1009; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Liu JJ, 2001, CHEM BIOL, V8, P701, DOI 10.1016/S1074-5521(01)00045-X; Mandik-Nayak L, 2002, P NATL ACAD SCI USA, V99, P14368, DOI 10.1073/pnas.182549099; MAROUDAS A, 1976, J ANAT, V122, P335; Matsumoto I, 2005, ARTHRITIS RES THER, V7, pR1183, DOI 10.1186/ar1802; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Matsumoto I, 2003, ARTHRITIS RHEUM-US, V48, P944, DOI 10.1002/art.10898; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Mills JL, 1998, METABOLISM, V47, P1140, DOI 10.1016/S0026-0495(98)90290-6; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; PALMBLAD J, 1991, RHEUM DIS CLIN N AM, V17, P351; Rantapaa-Dahlqvist S, 2005, SCAND J RHEUMATOL, V34, P83, DOI 10.1080/03009740510017689; SAHA AK, 1991, CLIN CHIM ACTA, V199, P311, DOI 10.1016/0009-8981(91)90125-V; Schaller M, 2005, ANN RHEUM DIS, V64, P743, DOI 10.1136/ard.2004.025502; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SKOLDSTAM L, 1991, RHEUM DIS CLIN N AM, V17, P363; SNOWDEN JM, 1976, BIOCHIM BIOPHYS ACTA, V428, P726; SPECTOR TD, 1992, AM J REPROD IMMUNOL, V28, P222, DOI 10.1111/j.1600-0897.1992.tb00797.x; Stone WS, 2004, AM J MED GENET B, V127B, P5, DOI 10.1002/ajmg.b.20132; Studelska DR, 2006, GLYCOBIOLOGY, V16, P65, DOI 10.1093/glycob/cwj037; SVENSON KLG, 1988, METABOLISM, V37, P125, DOI 10.1016/S0026-0495(98)90005-1; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Watanabe H, 1996, CANCER RES, V56, P2960; WEITZNER H A, 1952, Perm Found Med Bull, V10, P119; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Wu ZLL, 2002, FASEB J, V16, P539, DOI 10.1096/fj.01-0807com; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	53	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2354	2362		10.1074/jbc.M806458200	http://dx.doi.org/10.1074/jbc.M806458200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18948258	Green Published, hybrid			2022-12-25	WOS:000262545600044
J	Pence, MG; Blans, P; Zink, CN; Hollis, T; Fishbein, JC; Perrino, FW				Pence, Matthew G.; Blans, Patrick; Zink, Charles N.; Hollis, Thomas; Fishbein, James C.; Perrino, Fred W.			Lesion Bypass of N-2-Ethylguanine by Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINOR-GROOVE ADDUCT; ESCHERICHIA-COLI; TRANSLESION SYNTHESIS; NUCLEOTIDE INCORPORATION; SEQUENTIAL ACTION; KLENOW FRAGMENT; IOTA; REPLICATION; METAL; FIDELITY	Nucleotide incorporation and extension opposite N-2-ethyl-Gua by DNA polymerase i was measured and structures of the DNA polymerase i-N-2-ethyl-Gua complex with incoming nucleotides were solved. Efficiency and fidelity of DNA polymerase i opposite N-2-ethyl-Gua was determined by steady state kinetic analysis with Mg2+ or Mn2+ as the activating metal. DNA polymerase i incorporates dCMP opposite N-2-ethyl-Gua and unadducted Gua with similar efficiencies in the presence of Mg2+ and with greater efficiencies in the presence of Mn2+. However, the fidelity of nucleotide incorporation by DNA polymerase i opposite N-2-ethyl-Gua and Gua using Mn2+ is lower relative to that using Mg2+ indicating a metal-dependent effect. DNA polymerase i extends from the N-2-ethyl-Gua: Cyt3' terminus more efficiently than from the Gua:Cyt base pair. Together these kinetic data indicate that the DNA polymerase i catalyzed reaction is well suited for N-2-ethyl-Gua bypass. The structure of DNA polymerase with N-2-ethyl-Gua at the active site reveals the adducted base in the syn configuration when the correct incoming nucleotide is present. Positioning of the ethyl adduct into the major groove removes potential steric overlap between the adducted template base and the incoming dCTP. Comparing structures of DNA polymerase i complexed with N-2-ethyl-Gua and Gua at the active site suggests movements in the DNA polymerase i polymerase-associated domain to accommodate the adduct providing direct evidence that DNA polymerase i efficiently replicates past a minor groove DNA adduct by positioning the adducted base in the syn configuration.	[Pence, Matthew G.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; [Pence, Matthew G.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Blans, Patrick; Zink, Charles N.; Fishbein, James C.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; University System of Maryland; University of Maryland Baltimore	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [GM069962, CA52881]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA052881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069962 (to F. W. P.) and CA52881 (to J. C. F.). This work was also supported by American Cancer Society Grant RSG-04-187-01-GMC (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG JL, 1997, CARCINOGENESIS, V18, P632; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Johnson RE, 2006, MOL CELL BIOL, V26, P6435, DOI 10.1128/MCB.00851-06; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Perrino FW, 2005, CHEM RES TOXICOL, V18, P1451, DOI 10.1021/tx050114u; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RABKIN SD, 1983, P NATL ACAD SCI-BIOL, V80, P1541, DOI 10.1073/pnas.80.6.1541; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; SIROVER MA, 1976, P NATL ACAD SCI USA, V73, P2331, DOI 10.1073/pnas.73.7.2331; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Tissier A, 2000, GENE DEV, V14, P1642; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	47	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1732	1740		10.1074/jbc.M807296200	http://dx.doi.org/10.1074/jbc.M807296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18984581	Green Published, hybrid			2022-12-25	WOS:000262330100043
J	Lu, ZB; Wang, LB; Dunaway-Mariano, D; Allen, KN				Lu, Zhibing; Wang, Liangbing; Dunaway-Mariano, Debra; Allen, Karen N.			Structure-Function Analysis of 2-Keto-3-deoxy-D-glycero-D-galactonononate-9-phosphate Phosphatase Defines Specificity Elements in Type C0 Haloalkanoate Dehalogenase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME SUPERFAMILY; CRYSTAL-STRUCTURE; ACID; PROGRAM; DIVERSIFICATION; BIOCHEMISTRY; REPLACEMENT; DIVERSITY; SOFTWARE; SYNTHASE	The phosphotransferases of the haloalkanoate dehalogenase superfamily (HADSF) act upon a wide range of metabolites in all eukaryotes and prokaryotes and thus constitute a significant force in cell function. The challenge posed for biochemical function assignment of HADSF members is the identification of the structural determinants that target a specific metabolite. The "8KDOP" subfamily of the HADSF is defined by the known structure and catalytic activity of 2-keto-3-deoxy-8-phospho-D-manno-octulosonic acid (KDO-8-P) phosphatase. Homologues of this enzyme have been uniformly annotated as KDO-8-P phosphatase. One such gene, BT1713, from the Bacteroides thetaiotaomicron genome was recently found to encode the enzyme 2-keto-3-deoxy-D-glycero-D-galacto-9-phosphonononic acid (KDN-9-P) phosphatase in the biosynthetic pathway of the 9-carbon alpha-keto acid, 2-keto-3-deoxy-D-glycero-D-galactonononic acid (KDN). To find the structural elements that provide substrate- specific interactions and to allow identification of genomic sequence markers, the x-ray crystal structures of BT1713 liganded to the cofactor Mg2+ and complexed with tungstate or VO3-/Neu5Ac were determined to 1.1, 1.85, and 1.63 angstrom resolution, respectively. The structures define the active site to be at the subunit interface and, as confirmed by steady-state kinetics and site-directed mutagenesis, reveal Arg-64*, Lys-67*, and Glu-56 to be the key residues involved in sugar binding that are essential for BT1713 catalytic function. Bioinformatic analyses of the differentially conserved residues between BT1713 and KDO-8-P phosphatase homologues guided by the knowledge of the structure-based specificity determinants define Glu-56 and Lys-67* to be the key residues that can be used in future annotations.	[Wang, Liangbing; Dunaway-Mariano, Debra] Univ New Mexico, Dept Chem & Biol Chem, Albuquerque, NM 87131 USA; [Lu, Zhibing; Allen, Karen N.] Boston Univ, Dept Chem, Boston, MA 02215 USA	University of New Mexico; Boston University	Dunaway-Mariano, D (corresponding author), Univ New Mexico, Dept Chem & Biol Chem, Albuquerque, NM 87131 USA.	dd39@unm.edu; drkallen@bu.edu	Allen, Karen N./J-7045-2019	Allen, Karen N./0000-0001-7296-0551	National Institutes of Health [GM61099]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM61099 (to K.N.A. and D.D.-M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felts RL, 2007, BIOCHEMISTRY-US, V46, P11110, DOI 10.1021/bi701016m; Higgins D G, 1994, Methods Mol Biol, V25, P307; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JF, 2002, PROTEINS, V46, P393, DOI 10.1002/prot.10057; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Reaves ML, 2008, BMB REP, V41, P72, DOI 10.5483/BMBRep.2008.41.1.072; Tanner ME, 2005, BIOORG CHEM, V33, P216, DOI 10.1016/j.bioorg.2005.01.005; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veige AS, 2003, INORG CHEM, V42, P6204, DOI 10.1021/ic0300114; Wang LB, 2008, CHEM BIOL, V15, P893, DOI 10.1016/j.chembiol.2008.08.005; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200	30	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1224	1233		10.1074/jbc.M807056200	http://dx.doi.org/10.1074/jbc.M807056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18986982	Green Published, hybrid			2022-12-25	WOS:000262122900058
J	Pilpa, RM; Robson, SA; Villareal, VA; Wong, ML; Phillips, M; Clubb, RT				Pilpa, Rosemarie M.; Robson, Scott A.; Villareal, Valerie A.; Wong, Melissa L.; Phillips, Martin; Clubb, Robert T.			Functionally Distinct NEAT (NEAr Transporter) Domains within the Staphylococcus aureus IsdH/HarA Protein Extract Heme from Methemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; HUMAN HAPTOGLOBIN; IRON ACQUISITION; SERINE-PROTEASE; ISDC; BINDING; SYSTEM; IDENTIFICATION	The pathogen Staphylococcus aureus uses iron-regulated surface determinant (Isd) proteins to scavenge the essential nutrient iron from host hemoproteins. The IsdH protein (also known as HarA) is a receptor for hemoglobin (Hb), haptoglobin (Hp), and the Hb-Hp complex. It contains three NEAT (NEAr Transporter) domains: IsdHN1, IsdHN2, and IsdHN3. Here we show that they have different functions; IsdHN1 binds Hb and Hp, whereas IsdHN3 captures heme that is released from Hb. The staphylococcal IsdB protein also functions as an Hb receptor. Primary sequence homology to IsdH indicates that it will also employ functionally distinct NEAT domains to bind heme and Hb. We have used site-directed mutagenesis and surface plasmon resonance methods to localize the Hp and Hb binding surface on IsdHN1. High affinity binding to these structurally unrelated proteins requires residues located within a conserved aromatic motif that is positioned at the end of the beta-barrel structure. Interestingly, this site is quite malleable, as other NEAT domains use it to bind heme. We also demonstrate that the IsdC NEAT domain can capture heme directly from Hb, suggesting that there are multiple pathways for heme transfer across the cell wall.	[Clubb, Robert T.] Univ Calif Los Angeles, DOE, Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, DOE, Inst Genom & Prote, Dept Chem & Biochem, 611 Charles E Young Dr, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Robson, Scott/0000-0002-0529-0399	National Institutes of Health [AI52217]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217. This work was also supported by Department of Energy Grant DE-FC-03-87ER60615.	Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ettrich R, 2002, BIOL CHEM, V383, P1667, DOI 10.1515/BC.2002.187; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; OKUDA M, 1992, BIOCHIM BIOPHYS ACTA, V1136, P143, DOI 10.1016/0167-4889(92)90249-B; Pilpa RM, 2005, J BIOMOL NMR, V33, P137, DOI 10.1007/s10858-005-2898-2; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	39	92	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1166	1176		10.1074/jbc.M806007200	http://dx.doi.org/10.1074/jbc.M806007200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18984582	Green Published, hybrid			2022-12-25	WOS:000262122900053
J	Greenwood, C; Selth, LA; Dirac-Svejstrup, AB; Svejstrup, JQ				Greenwood, Catherine; Selth, Luke A.; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.			An Iron-Sulfur Cluster Domain in Elp3 Important for the Structural Integrity of Elongator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; POLYMERASE-II HOLOENZYME; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; HOLO-ELONGATOR; IN-VIVO; COMPLEX; GENES; SUBUNIT; TRANSCRIPTION	The Elongator complex functions in diverse cellular processes, such as RNA polymerase II transcription and tRNA modification. The Elp3 subunit possesses a C-terminal histone acetyltransferase (HAT) domain and an N-terminal sequence that resembles an iron-sulfur (FeS) cluster motif. The HAT domain is well characterized, but the role of the FeS cluster is unknown, although one report proposed that it might be involved in catalyzing histone demethylation. We investigated the importance and function of the yeast Elp3 FeS cluster by a combination of genetic and biochemical means. To minimize oxidation of the Elp3 FeS cluster during purification, we also developed a novel tandem affinity tag and an accompanying isolation procedure that enables purification of tagged proteins to virtual homogeneity within a few hours of cell disruption. Our results failed to support a role for Elongator in histone demethylation. Moreover FeS cluster integrity was not required for the HAT or RNA binding activities of Elongator. However, a fully functional FeS cluster was required for Elongator integrity and for the association of the complex with its accessory factors Kti11 and Kti12. In contrast, the association of Elongator with RNA polymerase II in chromatin was unaffected by FeS cluster mutations. Together our data support the idea that the Elp3 FeS cluster is essential for normal Elongator function in vivo primarily as a structural, rather than catalytic, domain.	[Greenwood, Catherine; Selth, Luke A.; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Selth, Luke/AAH-4823-2021	Selth, Luke/0000-0002-4686-1418; Svejstrup, Jesper/0000-0003-4964-6147	European Molecular Biology Organization; Cancer Research UK	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	This work was supported by a European Molecular Biology Organization long term postdoctoral fellowship (to L.A.S.) and by a grant from Cancer Research UK (to J.Q.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BUTLER AR, 1991, YEAST, V7, P617, DOI 10.1002/yea.320070610; Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gilbert C., 2006, CURRENT PROTOCOLS MO; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jablonowski D, 2001, MOL MICROBIOL, V42, P1095, DOI 10.1046/j.1365-2958.2001.02705.x; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kishida M, 1996, BIOSCI BIOTECH BIOCH, V60, P798, DOI 10.1271/bbb.60.798; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2005, J BIOL CHEM, V280, P19454, DOI 10.1074/jbc.M413373200; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yajima H, 1997, BIOSCI BIOTECH BIOCH, V61, P704, DOI 10.1271/bbb.61.704; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	35	41	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					141	149		10.1074/jbc.M805312200	http://dx.doi.org/10.1074/jbc.M805312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986986	hybrid			2022-12-25	WOS:000261974800016
J	Tallent, MK; Varghis, N; Skorobogatko, Y; Hernandez-Cuebas, L; Whelan, K; Vocadlo, DJ; Vosseller, K				Tallent, Melanie K.; Varghis, Neal; Skorobogatko, Yuliya; Hernandez-Cuebas, Lisa; Whelan, Kelly; Vocadlo, David J.; Vosseller, Keith			In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; LONG-TERM POTENTIATION; ACTIVATED PROTEIN-KINASES; ESTROGEN-RECEPTOR-BETA; RNA-POLYMERASE-II; SYNAPSIN-I; NEUROTRANSMITTER RELEASE; POSTTRANSLATIONAL MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; PRESYNAPTIC PLASTICITY	O-Linked N-acetylglucosamine (O-GlcNAc) is a cytosolic and nuclear carbohydrate post-translational modification most abundant in brain. We recently reported uniquely extensive O-GlcNAc modification of proteins that function in synaptic vesicle release and post-synaptic signal transduction. Here we examined potential roles for O-GlcNAc in mouse hippocampal synaptic transmission and plasticity. O-GlcNAc modifications and the enzyme catalyzing their addition (O-GlcNAc transferase) were enriched in hippocampal synaptosomes. Pharmacological elevation or reduction of O-GlcNAc levels had no effect on Schaffer collateral CA1 basal hippocampal synaptic transmission. However, in vivo elevation of O-GlcNAc levels enhanced long term potentiation (LTP), an electrophysiological correlate to some forms of learning/memory. Reciprocally, pharmacological reduction of O-GlcNAc levels blocked LTP. Additionally, elevated O-GlcNAc led to reduced paired-pulse facilitation, a form of short term plasticity attributed to presynaptic mechanisms. Synapsin I and II are presynaptic proteins that increase synaptic vesicle availability for release when phosphorylated, thus contributing to hippocampal synaptic plasticity. Synapsins are among the most extensively O-GlcNAc- modified proteins known. Elevating O-GlcNAc levels increased phosphorylation of Synapsin I/II at serine 9 (cAMP-dependent protein kinase substrate site), serine 62/67 (Erk 1/2 (MAPK 1/2) substrate site), and serine 603 (calmodulin kinase II site). Activation-specific phosphorylation events on Erk 1/2 and calmodulin kinase II, two proteins required for CA1 hippocampal LTP establishment, were increased in response to elevation of O-GlcNAc levels. Thus, O-GlcNAc is a novel regulatory signaling component of excitatory synapses, with specific roles in synaptic plasticity that involve interplay with phosphorylation.	[Tallent, Melanie K.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Varghis, Neal; Skorobogatko, Yuliya; Hernandez-Cuebas, Lisa; Whelan, Kelly; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Drexel University; Drexel University; Simon Fraser University	Vosseller, K (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	keith.vosseller@drexelmed.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Alzheimer's Association [NIRG-07-59591]; Drexel University	Alzheimer's Association(Alzheimer's Association); Drexel University	This work was supported in part by Grant NIRG-07-59591( to K. V.) from the Alzheimer's Association and start-up funds from Drexel University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Dobrunz LE, 2002, NATURE, V415, P277, DOI 10.1038/415277a; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fiumara F, 2004, J CELL SCI, V117, P5145, DOI 10.1242/jcs.01388; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619; GOOLD R, 1994, EUR J BIOCHEM, V224, P229, DOI 10.1111/j.1432-1033.1994.tb20016.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hvalby O, 2006, J PHYSIOL-LONDON, V571, P75, DOI 10.1113/jphysiol.2005.100685; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lisman J., 2006, SCI STKE, V2006, pr; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	65	101	103	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					174	181		10.1074/jbc.M807431200	http://dx.doi.org/10.1074/jbc.M807431200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004831	hybrid			2022-12-25	WOS:000261974800020
J	Zhao, GY; Chen, XL; Zhao, HL; Xie, BB; Zhou, BC; Zhang, YZ				Zhao, Guo-Yan; Chen, Xiu-Lan; Zhao, Hui-Lin; Xie, Bin-Bin; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Hydrolysis of Insoluble Collagen by Deseasin MCP-01 from Deep-sea Pseudoalteromonas sp SM9913 COLLAGENOLYTIC CHARACTERS, COLLAGEN-BINDING ABILITY OF C-TERMINAL POLYCYSTIC KIDNEY DISEASE DOMAIN, AND IMPLICATION FOR ITS NOVEL ROLE IN DEEP-SEA SEDIMENTARY PARTICULATE ORGANIC NITROGEN DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN O-7; PIVOTAL ROLE; GENE; CHITINASE; PROTEASES; MO-1; PSYCHROTOLERANT; THERMOPHILE; EXPRESSION; AUTOLYSIS	Collagens are the most abundant proteins in marine animals and their degradation is important for the recycling of marine nitrogen. However, it is rather unclear how marine collagens are degraded because few marine collagenolytic proteases are studied in detail. Deseasins are a new type of multidomain subtilases. Here, the collagenolytic activity of deseasin MCP-01, the type example of deseasins, was studied. MCP-01 had broad substrate specificity to various type collagens from terrestrial and marine animals. It completely decomposed insoluble collagen into soluble peptides and amino acids, and was more prone to degrade marine collagen than terrestrial collagen. Thirty-seven cleavage sites of MCP-01 on bovine collagen chains were elucidated, showing the cleavage is various but specific. As the main extracellular cold-adapted protease from deep-sea bacterium Pseudoalteromonas sp. SM9913, MCP-01 displayed high activity at low temperature and alkaline range. Our data also showed that the C-terminal polycystic kidney disease (PKD) domain of MCP-01 was able to bind insoluble collagen and facilitate the insoluble collagen digestion by MCP-01. Site-directed mutagenesis demonstrated that Trp-36 of the PKD domain played a key role in its binding to insoluble collagen. It is the first time that the structure and function of a marine collagenolytic protease, deseasin MCP-01, has been studied in detail. Moreover, the PKD domain was experimentally proven to bind to insoluble protein for the first time. These results imply that MCP-01 would play an important role in the degradation of deep-sea sedimentary particulate organic nitrogen.	[Zhao, Guo-Yan; Chen, Xiu-Lan; Zhao, Hui-Lin; Xie, Bin-Bin; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			Hi-Tech Research and Development Program of China [2006AA09Z414, 2007AA091903]; National Natural Science Foundation of China [30770040]; Program for New Century Excellent Talents in University [NCET-06-0578]; Foundation for Young Excellent Scientists in Shandong Province [2006BS02002]; COMRA [DYXM-115-02-2-6]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation for Young Excellent Scientists in Shandong Province; COMRA	The work was supported by Hi-Tech Research and Development Program of China Grants 2006AA09Z414 and 2007AA091903, National Natural Science Foundation of China Grant 30770040, Program for New Century Excellent Talents in University Grant NCET-06-0578, Foundation for Young Excellent Scientists in Shandong Province Grant 2006BS02002, and COMRA Program Grant DYXM-115-02-2-6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Brunnegard J, 2004, PROG OCEANOGR, V63, P159, DOI 10.1016/j.pocean.2004.09.004; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; CAWSTON TE, 2004, HDB PROTEOLYTIC ENZY, P472; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2007, BIOCHEM BIOPH RES CO, V358, P704, DOI 10.1016/j.bbrc.2007.04.193; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Chen XL, 2003, BIOTECHNOL LETT, V25, P1763, DOI 10.1023/A:1026040012947; DREISBACH JH, 1978, J BACTERIOL, V135, P521, DOI 10.1128/JB.135.2.521-527.1978; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; HENRIET P, 2004, HDB PROTEOLYTIC ENZY, P486; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kurata A, 2007, INT J SYST EVOL MICR, V57, P1549, DOI 10.1099/ijs.0.65084-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; MERKEL JR, 1975, APPL MICROBIOL, V29, P145, DOI 10.1128/AEM.29.2.145-151.1975; MERKEL JR, 1978, BIOCHEMISTRY-US, V17, P2857, DOI 10.1021/bi00607a025; Miyake R, 2005, J BACTERIOL, V187, P4140, DOI 10.1128/JB.187.12.4140-4148.2005; Miyamoto K, 2002, J BACTERIOL, V184, P1865, DOI 10.1128/JB.184.7.1865-1872.2002; Nagy T, 1998, FEBS LETT, V429, P312, DOI 10.1016/S0014-5793(98)00625-5; Oda K, 1996, J BIOCHEM, V120, P564; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOMME P, 1995, ENZYMATIC DEGRADATIO, V618, P142; WAITE JH, 1980, J BIOL CHEM, V255, P3596; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN, P43	35	57	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36100	36107		10.1074/jbc.M804438200	http://dx.doi.org/10.1074/jbc.M804438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977758	Green Published, hybrid			2022-12-25	WOS:000261840500005
J	Ludwig, T; Theissen, SM; Morton, MJ; Caplan, MJ				Ludwig, Thomas; Theissen, Sarah M.; Morton, Michael J.; Caplan, Michael J.			The Cytoplasmic Tail Dileucine Motif LL572 Determines the Glycosylation Pattern of Membrane-type 1 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DARBY CANINE KIDNEY; LOCAL PROTEOLYTIC ACTIVITY; TUMOR-CELL INVASION; 1-MATRIX METALLOPROTEINASE; SORTING SIGNALS; TISSUE INHIBITOR; SIALIC ACIDS; MT1-MMP; SURFACE; ACTIVATION	Membrane-type 1 matrix metalloproteinase (MT1-MMP; MMP-14) drives fundamental physiological and pathological processes, due to its ability to process a broad spectrum of substrates. Because subtle changes in its activity can produce profound physiological effects, MT1-MMP is tightly regulated. Currently, many aspects of this regulation remain to be elucidated. It has recently been discovered that O-linked glycosylation defines the substrate spectrum of MT1-MMP. We hypothesized that a mutual interdependency exists between MT1-MMP trafficking and glycosylation. Lectin precipitation, metabolic labeling, enzymatic deglycosylation, and site-directed mutagenesis studies demonstrate that the LL572 motif in the cytoplasmic tail of MT1-MMP influences the composition of the complex O-linked carbohydrates attached to the hinge region of the protein. This influence appears to be independent from major effects on cell surface trafficking. MT1-MMP undergoes extensive processing after its synthesis. The origins and the molecular characters of its multiple forms are incompletely understood. Here, we develop and present a model for the sequential, post-translational processing of MT1-MMP that defines stages in the post-synthetic pathway pursued by the protein.	[Ludwig, Thomas; Theissen, Sarah M.] BIOQUANT Zentrum, German Canc Res Ctr Heidelberg, D-69120 Heidelberg, Germany; [Ludwig, Thomas; Morton, Michael J.; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Yale University	Ludwig, T (corresponding author), BIOQUANT Zentrum, German Canc Res Ctr Heidelberg, BQ 0009 NWG Ludwig,Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	t.ludwig@dkfz.de	Theissen, Sarah Maria/J-1570-2019; Ludwig, Thomas/A-5691-2011	Theissen, Sarah Maria/0000-0002-3341-5953; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK17433, DK072614]; Deutsche Forschungsgemeinschaft [LU 854/2-1, LU 854/3-1]; FRONTIER program of the Excellence Initiative at Heidelberg University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072614, P01DK017433, R56DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRONTIER program of the Excellence Initiative at Heidelberg University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17433 and DK072614 ( to M. J. C.). This work was also supported by the Deutsche Forschungsgemeinschaft ( Grants LU 854/2-1 and LU 854/3-1) and the FRONTIER program of the Excellence Initiative at Heidelberg University ( to T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kusick S, 2005, J CELL PHYSIOL, V204, P767, DOI 10.1002/jcp.20328; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306; Ludwig T, 2005, J CELL PHYSIOL, V202, P690, DOI 10.1002/jcp.20168; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; LUDWIG T, 2006, NANOMATERIALS CANC D, P377; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Osenkowski P, 2005, J BIOL CHEM, V280, P26160, DOI 10.1074/jbc.M414379200; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shaw Leslie M., 2004, V294, P97; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Urena JM, 1999, J CELL SCI, V112, P773; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yarema KJ, 2001, GENOME BIOL, V2; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zanetta JP, 2001, GLYCOBIOLOGY, V11, P663, DOI 10.1093/glycob/11.8.663; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	55	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35410	35418		10.1074/jbc.M801816200	http://dx.doi.org/10.1074/jbc.M801816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955496	Green Published, hybrid			2022-12-25	WOS:000261687900012
J	Langer, M; Malykhin, A; Maeda, K; Chakrabarty, K; Williamson, KS; Feasley, CL; West, CM; Metcalf, JP; Coggeshall, KM				Langer, Marybeth; Malykhin, Alexander; Maeda, Kenichiro; Chakrabarty, Kaushik; Williamson, Kelly S.; Feasley, Christa L.; West, Christopher M.; Metcalf, Jordan P.; Coggeshall, K. Mark			Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article								We hypothesized that the peptidoglycan component of B. anthracis may play a critical role in morbidity and mortality associated with inhalation anthrax. To explore this issue, we purified the peptidoglycan component of the bacterial cell wall and studied the response of human peripheral blood cells. The purified B. anthracis peptidoglycan was free of non-covalently bound protein but contained a complex set of amino acids probably arising from the stem peptide. The peptidoglycan contained a polysaccharide that was removed by mild acid treatment, and the biological activity remained with the peptidoglycan and not the polysaccharide. The biological activity of the peptidoglycan was sensitive to lysozyme but not other hydrolytic enzymes, showing that the activity resides in the peptidoglycan component and not bacterial DNA, RNA or protein. B. anthracis peptidoglycan stimulated monocytes to produce primarily TNF alpha; neutrophils and lymphocytes did not respond. Peptidoglycan stimulated monocyte p38 mitogen-activated protein kinase and p38 activity was required for TNFa production by the cells. We conclude that peptidoglycan in B. anthracis is biologically active, that it stimulates a proinflammatory response in monocytes, and uses the p38 kinase signal transduction pathway to do so. Given the high bacterial burden in pulmonary anthrax, these findings suggest that the inflammatory events associated with peptidoglycan may play an important role in anthrax pathogenesis.	[Langer, Marybeth; Malykhin, Alexander; Maeda, Kenichiro; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Chakrabarty, Kaushik; Metcalf, Jordan P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Pulmonary & Crit Care Div, Oklahoma City, OK USA; [Williamson, Kelly S.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Program, Oklahoma City, OK USA; [Feasley, Christa L.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Langer, M (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Mark-Coggeshall@omrf.ouhsc.edu			NIH [1U19 AI062629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 1U19 AI062629	Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chakrabarty K, 2006, INFECT IMMUN, V74, P4430, DOI 10.1128/IAI.00446-06; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; Cleret A, 2006, J INFECT DIS, V194, P86, DOI 10.1086/504686; Coffey R G, 1992, Immunol Ser, V57, P301; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; DAYNES RA, 1991, J EXP MED, V174, P1323, DOI 10.1084/jem.174.6.1323; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DUBRAVEC DB, 1990, P NATL ACAD SCI USA, V87, P6758, DOI 10.1073/pnas.87.17.6758; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; EZZELL JW, 1988, INFECT IMMUN, V56, P349, DOI 10.1128/IAI.56.2.349-356.1988; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Garrido G, 2004, PHARMACOL RES, V50, P165, DOI 10.1016/j.phrs.2003.12.020; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hattar K, 2006, CRIT CARE MED, V34, P835, DOI 10.1097/01.CCM.0000202204.01230.44; Heninger S, 2006, INFECT IMMUN, V74, P6067, DOI 10.1128/IAI.00719-06; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; IWASAKI H, 1986, J BACTERIOL, V167, P508, DOI 10.1128/jb.167.2.508-516.1986; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; KALECHMAN Y, 1993, CELL IMMUNOL, V148, P114, DOI 10.1006/cimm.1993.1095; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Myhre AE, 2004, INFECT IMMUN, V72, P1311, DOI 10.1128/IAI.72.3.1311-1317.2004; NAGAO S, 1990, INFECT IMMUN, V58, P536, DOI 10.1128/IAI.58.2.536-542.1990; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Rhie GE, 2003, P NATL ACAD SCI USA, V100, P10925, DOI 10.1073/pnas.1834478100; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Standiford TJ, 2000, CURR PHARM DESIGN, V6, P633, DOI 10.2174/1381612003400533; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Vollmer W, 2008, FEMS MICROBIOL REV; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723; Zhang X, 2001, ANN RHEUM DIS, V60, P269, DOI 10.1136/ard.60.3.269	64	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3706	10.1371/journal.pone.0003706	http://dx.doi.org/10.1371/journal.pone.0003706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002259	Green Submitted, gold, Green Published			2022-12-25	WOS:000265166000006
J	Ben-Shachar, D; Karry, R				Ben-Shachar, Dorit; Karry, Rachel			Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SUBUNIT GENE NDUFV2; BASAL GANGLIA; ELECTRON-TRANSPORT; FRONTAL-CORTEX; HUMAN BRAIN; UBIQUINONE OXIDOREDUCTASE; NEUROLEPTIC MEDICATIONS; AXONAL-TRANSPORT; EXPRESSION	Background: Mitochondrial dysfunction was reported in schizophrenia, bipolar disorder and major depression. The present study investigated whether mitochondrial complex I abnormalities show disease-specific characteristics. Methodology/Principal Findings: mRNA and protein levels of complex I subunits NDUFV1, NDUFV2 and NADUFS1, were assessed in striatal and lateral cerebellar hemisphere postmortem specimens and analyzed together with our previous data from prefrontal and parieto-occipital cortices specimens of patients with schizophrenia, bipolar disorder, major depression and healthy subjects. A disease-specific anatomical pattern in complex I subunits alterations was found. Schizophrenia-specific reductions were observed in the prefrontal cortex and in the striatum. The depressed group showed consistent reductions in all three subunits in the cerebellum. The bipolar group, however, showed increased expression in the parieto-occipital cortex, similar to those observed in schizophrenia, and reductions in the cerebellum, yet less consistent than the depressed group. Conclusions/Significance: These results suggest that the neuroanatomical pattern of complex I pathology parallels the diversity and similarities in clinical symptoms of these mental disorders.	[Ben-Shachar, Dorit; Karry, Rachel] Rambam Med Ctr, Psychobiol Lab, Dept Psychiat, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology	Ben-Shachar, D (corresponding author), Rambam Med Ctr, Psychobiol Lab, Dept Psychiat, Haifa, Israel.	shachar@tx.technion.ac.il	Ben-Shachar, Dorit/D-4703-2015	Ben-Shachar, Dorit/0000-0003-2317-1489	Stanley Medical Research Institute	Stanley Medical Research Institute	Funding for this study was provided by The Stanley Medical Research Institute Grant. The Stanley Medical Research Institute had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Afifi Adel K, 2003, Semin Pediatr Neurol, V10, P3, DOI 10.1016/S1071-9091(02)00003-7; Aleman A, 2002, SCHIZOPHR RES, V57, P315, DOI 10.1016/S0920-9964(01)00291-2; AlMousawi AH, 1996, BRIT J PSYCHIAT, V169, P509, DOI 10.1192/bjp.169.4.509; ALNAES E, 1975, ROLE MITOCHONDRIA TR, P285; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Baethge C, 2005, BIPOLAR DISORD, V7, P136, DOI 10.1111/j.1399-5618.2004.00175.x; Bahn S, 2001, J CHEM NEUROANAT, V22, P79, DOI 10.1016/S0891-0618(01)00099-0; Barnes J, 2000, NEUROPSYCHOLOGIA, V38, P1148, DOI 10.1016/S0028-3932(00)00025-7; Barrientos A, 1998, J NEUROSCI RES, V53, P475, DOI 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0.CO;2-3; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; BENSHACHAR D, 2008, J MOL NEUROSCI; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Bertolino A, 2003, BIOL PSYCHIAT, V53, P906, DOI 10.1016/S0006-3223(02)01911-X; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Buchsbaum MS, 1998, SCHIZOPHRENIA BULL, V24, P343, DOI 10.1093/oxfordjournals.schbul.a033331; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P966; BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516; Carlson Paul J, 2006, NeuroRx, V3, P22, DOI 10.1016/j.nurx.2005.12.009; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; CHAN P, 1994, J NEUROCHEM, V62, P2484, DOI 10.1046/j.1471-4159.1994.62062484.x; Chouinard G, 1999, SCHIZOPHR RES, V38, P101, DOI 10.1016/S0920-9964(99)00012-2; Corson PW, 2002, BIOL PSYCHIAT, V52, P855, DOI 10.1016/S0006-3223(02)01421-X; Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Daneluzzo E, 2002, SCHIZOPHR RES, V56, P129, DOI 10.1016/S0920-9964(01)00277-8; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Deicken RF, 2000, REV NEUROSCIENCE, V11, P147; Desco M, 2003, PSYCHIAT RES-NEUROIM, V122, P125, DOI 10.1016/S0925-4927(02)00124-5; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dror N, 2002, MOL PSYCHIATR, V7, P995, DOI 10.1038/sj.mp.4001116; Dunn RT, 2002, BIOL PSYCHIAT, V51, P387, DOI 10.1016/S0006-3223(01)01244-6; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; FUJIMOTO T, 1992, ACTA PSYCHIAT SCAND, V86, P455, DOI 10.1111/j.1600-0447.1992.tb03297.x; Fukuzako H, 1999, AM J PSYCHIAT, V156, P1205; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GARCIA O, 2005, INCREASED MITOCHONDR, P183; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GREENWOOD SM, 2007, MITOCHONDRIAL DYSFUN, P26235; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HAN AL, 1989, ARCH BIOCHEM BIOPHYS, V275, P166, DOI 10.1016/0003-9861(89)90360-3; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; HEATH RG, 1980, BIOL PSYCHIAT, V15, P243; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jayakumar PN, 2006, ACTA PSYCHIAT SCAND, V114, P346, DOI 10.1111/j.1600-0447.2006.00836.x; Jensen JE, 2006, PSYCHIAT RES-NEUROIM, V146, P127, DOI 10.1016/j.pscychresns.2005.11.004; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012; Kato T, 2005, INT REV NEUROBIOL, V63, P21, DOI 10.1016/S0074-7742(05)63002-4; KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; KIMURA M, 1995, NEUROSCI RES, V22, P353, DOI 10.1016/0168-0102(95)00914-F; Knable MB, 2002, MOL PSYCHIATR, V7, P392, DOI 10.1038/sj.mp.4001034; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Laifenfeld D, 2005, BIOL PSYCHIAT, V57, P716, DOI 10.1016/j.biopsych.2004.12.016; Laugel V, 2007, PEDIATR NEUROL, V36, P54, DOI 10.1016/j.pediatrneurol.2006.08.007; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Manji HK, 2000, BIOL PSYCHIAT, V48, P518, DOI 10.1016/S0006-3223(00)00929-X; Martorell L, 2006, EUR J HUM GENET, V14, P520, DOI 10.1038/sj.ejhg.5201606; Maurer I, 1997, MOL CELL BIOCHEM, V174, P255, DOI 10.1023/A:1006872911332; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; MEHLERWEX C, 2006, EUR CHILD ADOLESC PS; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; MIZUNO Y, 1990, J NEUROL SCI, V96, P49, DOI 10.1016/0022-510X(90)90056-S; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; MULCRONE J, 1995, SCHIZOPHR RES, V14, P203, DOI 10.1016/0920-9964(94)00040-F; Nitschke MF, 2005, PROG BRAIN RES, V148, P151, DOI 10.1016/S0079-6123(04)48013-3; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0; Prince JA, 1997, J PHARMACOL EXP THER, V280, P261; PRZEDBORSKI S, 1993, ANN NEUROL, V34, P715, DOI 10.1002/ana.410340515; Rapoport M, 2000, J NEUROPSYCH CLIN N, V12, P193, DOI 10.1176/appi.neuropsych.12.2.193; Reddy R, 2003, PROSTAG LEUKOTR ESS, V69, P401, DOI 10.1016/j.plefa.2003.08.011; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Smith KA, 2002, BRIT J PSYCHIAT, V181, P411, DOI 10.1192/bjp.181.5.411; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189; Swerdlow RH, 2006, J NEUROL SCI, V247, P224, DOI 10.1016/j.jns.2006.05.053; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Thach WT, 2007, CEREBELLUM, V6, P163, DOI 10.1080/14734220701373530; Thomas EA, 2003, MOL PSYCHIATR, V8, P167, DOI 10.1038/sj.mp.4001223; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Volz HP, 2000, BIOL PSYCHIAT, V47, P954, DOI 10.1016/S0006-3223(00)00235-3; Washizuka S, 2006, AM J MED GENET B, V141B, P301, DOI 10.1002/ajmg.b.30285; WEINBACH EC, 1986, BIOCHEM PHARMACOL, V35, P1445, DOI 10.1016/0006-2952(86)90108-5; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; White RJ, 1996, J NEUROSCI, V16, P5688; Xu C, 2008, BIPOLAR DISORD, V10, P105, DOI 10.1111/j.1399-5618.2008.00535.x; Yildiz-Yesiloglu A, 2006, PSYCHIAT RES-NEUROIM, V147, P1, DOI 10.1016/j.pscychresns.2005.12.004	117	140	151	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3676	10.1371/journal.pone.0003676	http://dx.doi.org/10.1371/journal.pone.0003676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989376	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134600009
J	Chen, JD; Futami, K; Petillo, D; Peng, J; Wang, PF; Knol, J; Li, Y; Khoo, SK; Huang, D; Qian, CN; Zhao, P; Dykyma, K; Zhang, R; Cao, B; Yang, XJ; Furge, K; Williams, BO; Teh, BT				Chen, Jindong; Futami, Kunihiko; Petillo, David; Peng, Jun; Wang, Pengfei; Knol, Jared; Li, Yan; Khoo, Sok-Kean; Huang, Dan; Qian, Chao-Nan; Zhao, Ping; Dykyma, Karl; Zhang, Racheal; Cao, Brian; Yang, Ximing J.; Furge, Kyle; Williams, Bart O.; Teh, Bin Tean			Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia	PLOS ONE			English	Article								The Birt-Hogg-Dube (BHD) disease is a genetic cancer syndrome. The responsible gene, BHD, has been identified by positional cloning and thought to be a novel tumor suppressor gene. BHD mutations cause many types of diseases including renal cell carcinomas, fibrofolliculomas, spontaneous pneumothorax, lung cysts, and colonic polyps/cancers. By combining Gateway Technology with the Ksp-Cre gene knockout system, we have developed a kidney-specific BHD knockout mouse model. BHD flox/flox/Ksp-Cre mice developed enlarged kidneys characterized by polycystic kidneys, hyperplasia, and cystic renal cell carcinoma. The affected BHD flox/flox/Ksp-Cre mice died of renal failure at approximate three weeks of age, having blood urea nitrogen levels over tenfold higher than those of BHD flox/+/Ksp-Cre and wild-type littermate controls. We further demonstrated that these phenotypes were caused by inactivation of BHD and subsequent activation of the mTOR pathway. Application of rapamycin, which inhibits mTOR activity, to the affected mice led to extended survival and inhibited further progression of cystogenesis. These results provide a correlation of kidney-targeted gene inactivation with renal carcinoma, and they suggest that the BHD product FLCN, functioning as a cyst and tumor suppressor, like other hamartoma syndrome-related proteins such as PTEN, LKB1, and TSC1/2, is a component of the mTOR pathway, constituting a novel FLCN-mTOR signaling branch that regulates cell growth/proliferation.	[Chen, Jindong; Futami, Kunihiko; Petillo, David; Li, Yan; Khoo, Sok-Kean; Huang, Dan; Qian, Chao-Nan; Zhang, Racheal; Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Futami, Kunihiko] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Peng, Jun] Cleveland Clin, Genom Med Inst, Cleveland, OH USA; [Wang, Pengfei] Stowers Inst Med Res, Kansas City, MO USA; [Knol, Jared; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Cancinogenesis, Grand Rapids, MI USA; [Khoo, Sok-Kean] Van Andel Res Inst, Lab Germline Modificat & Cytogenet, Grand Rapids, MI USA; [Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China; [Zhao, Ping; Cao, Brian] Van Andel Res Inst, Lab Antibody Technol, Grand Rapids, MI USA; [Dykyma, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Yang, Ximing J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Teh, Bin Tean] Natl Canc Ctr, NCCS, VARI Translat Canc Res Lab, Singapore, Singapore	Van Andel Institute; Tokyo University of Marine Science & Technology; Cleveland Clinic Foundation; Stowers Institute for Medical Research; Van Andel Institute; Van Andel Institute; Sun Yat Sen University; Van Andel Institute; Van Andel Institute; Northwestern University; Feinberg School of Medicine; National Cancer Centre Singapore (NCCS)	Chen, JD (corresponding author), Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA.	jin-dong.chen@vai.org; bin.teh@vai.org	FUTAMI, Kunihiko/O-1964-2014; Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Teh, Bin Tean/0000-0003-1514-1124; Khoo, Sok Kean/0000-0003-3836-5497	Japan Amway [postdoctoral fellowship]; National Cancer Center [postdoctoral fellowship]; Van Andel Foundation	Japan Amway; National Cancer Center; Van Andel Foundation	K.F. and S.K.K. were funded by the Japan Amway and the National Cancer Center postdoctoral fellowship grant, respectively. J.K. was supported by the Frederik and Lena Meijer student internship. This work was also supported by the Van Andel Foundation.	Azoulay S, 2007, VIRCHOWS ARCH, V451, P905, DOI 10.1007/s00428-007-0483-7; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Deshpande R B, 1986, J Postgrad Med, V32, P239; FELDBERG MAM, 1982, AM J ROENTGENOL, V138, P953, DOI 10.2214/ajr.138.5.953; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Han KR, 2004, UROL ONCOL-SEMIN ORI, V22, P410, DOI 10.1016/S1078-1439(03)00173-X; HARTMAN DS, 1992, AM J ROENTGENOL, V159, P1235, DOI 10.2214/ajr.159.6.1442390; HARTMAN DS, 1986, UROLOGY, V28, P145, DOI 10.1016/0090-4295(86)90109-3; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Khoo SK, 2003, CANCER RES, V63, P4583; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindor NM, 2001, INT J DERMATOL, V40, P653, DOI 10.1046/j.1365-4362.2001.01287-4.x; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Nassir A, 2002, UROLOGY, V60, P421, DOI 10.1016/S0090-4295(02)01742-9; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, CURR MOL MED, V4, P887, DOI 10.2174/1566524043359737; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Toro J R, 2002, J Med Genet, V39, pE10, DOI 10.1136/jmg.39.2.e10; Truong LD, 2003, ADV ANAT PATHOL, V10, P135, DOI 10.1097/00125480-200305000-00003; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Wang P., 2006, TRANSGENICS, V4, P215; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Welsch MJ, 2005, INT J DERMATOL, V44, P668, DOI 10.1111/j.1365-4632.2004.02095.x; Yousef George M., 2005, Int. braz j urol., V31, P465, DOI 10.1590/S1677-55382005000500008; Yousef GM, 2005, INT BRAZ J UROL, V31, P467	36	108	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3581	10.1371/journal.pone.0003581	http://dx.doi.org/10.1371/journal.pone.0003581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974783	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131500009
J	Tougard, C; Renvoise, E; Petitjean, A; Quere, JP				Tougard, Christelle; Renvoise, Elodie; Petitjean, Amelie; Quere, Jean-Pierre			New Insight into the Colonization Processes of Common Voles: Inferences from Molecular and Fossil Evidence	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; GLACIAL REFUGIA; MICROTUS-ARVALIS; COMPARATIVE PHYLOGEOGRAPHY; GENETIC-STRUCTURE; DNA POLYMORPHISM; NORTHERN REFUGIA; URSUS-ARCTOS; EUROPE; POPULATIONS	Elucidating the colonization processes associated with Quaternary climatic cycles is important in order to understand the distribution of biodiversity and the evolutionary potential of temperate plant and animal species. In Europe, general evolutionary scenarios have been defined from genetic evidence. Recently, these scenarios have been challenged with genetic as well as fossil data. The origins of the modern distributions of most temperate plant and animal species could predate the Last Glacial Maximum. The glacial survival of such populations may have occurred in either southern (Mediterranean regions) and/or northern (Carpathians) refugia. Here, a phylogeographic analysis of a widespread European small mammal (Microtus arvalis) is conducted with a multidisciplinary approach. Genetic, fossil and ecological traits are used to assess the evolutionary history of this vole. Regardless of whether the European distribution of the five previously identified evolutionary lineages is corroborated, this combined analysis brings to light several colonization processes of M. arvalis. The species' dispersal was relatively gradual with glacial survival in small favourable habitats in Western Europe (from Germany to Spain) while in the rest of Europe, because of periglacial conditions, dispersal was less regular with bottleneck events followed by postglacial expansions. Our study demonstrates that the evolutionary history of European temperate small mammals is indeed much more complex than previously suggested. Species can experience heterogeneous evolutionary histories over their geographic range. Multidisciplinary approaches should therefore be preferentially chosen in prospective studies, the better to understand the impact of climatic change on past and present biodiversity.	[Tougard, Christelle; Renvoise, Elodie; Petitjean, Amelie] Univ Bourgogne, CNRS, UMR, uB 5561, F-21004 Dijon, France; [Quere, Jean-Pierre] Ctr Biol Gest Populat, Campus Int Baillarguet, INRA, UMR 1062, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE; Institut de Recherche pour le Developpement (IRD)	Tougard, C (corresponding author), Univ Montpellier 2, CNRS Um2, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France.	Christelle.Tougard@univ-montp2.fr			CNRS (French Government)	CNRS (French Government)(Centre National de la Recherche Scientifique (CNRS))	CNRS (French Government) provided financial support for the experiment realization. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Baker RJ, 1996, NATURE, V380, P707, DOI 10.1038/380707a0; BENNETT KD, 1997, EVOLUTION ECOLOGY PA, P259; BENOIT M, 2007, FOURRAGES, V191, P347; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bilton DT, 1998, P ROY SOC B-BIOL SCI, V265, P1219, DOI 10.1098/rspb.1998.0423; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; CAMPY M, 1993, QUATERNARY RES, V40, P318, DOI 10.1006/qres.1993.1085; Chaline J, 1999, ANN ZOOL FENN, V36, P239; CHALINE J, 1989, 27 S GALL PREH ED CN, P97; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Delattre P, 1996, LANDSCAPE ECOL, V11, P279, DOI 10.1007/BF02059855; DELATTRE P, 1992, AGR ECOSYST ENVIRON, V39, P153, DOI 10.1016/0167-8809(92)90051-C; Delattre P, 1999, LANDSCAPE ECOL, V14, P401, DOI 10.1023/A:1008022727025; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubey S, 2007, J EVOLUTION BIOL, V20, P1799, DOI 10.1111/j.1420-9101.2007.01382.x; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; *EPICA COMM MEMB, 2004, NATURE, V0429; EVIN J, 1989, 27 S GALL PREH, P53; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; GIRAUDOUX P, 1994, ACTA OECOL, V15, P385; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guiter F, 2003, QUATERN INT, V111, P59, DOI 10.1016/S1040-6182(03)00015-6; Haase M, 2003, J EVOLUTION BIOL, V16, P415, DOI 10.1046/j.1420-9101.2003.00542.x; Haring E, 2000, J ZOOL SYST EVOL RES, V38, P231, DOI 10.1046/j.1439-0469.2000.384139.x; Haynes S, 2003, MOL ECOL, V12, P951, DOI 10.1046/j.1365-294X.2003.01795.x; Heckel G, 2005, EVOLUTION, V59, P2231; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; HOWELL N, 1989, J MOL EVOL, V29, P157, DOI 10.1007/BF02100114; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; Jaarola M, 2004, HEREDITY, V92, P228, DOI 10.1038/sj.hdy.6800400; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Klotz S, 2003, GLOBAL PLANET CHANGE, V36, P277, DOI 10.1016/S0921-8181(02)00222-9; Kotlik P, 2001, MOL ECOL, V10, P2177, DOI 10.1046/j.0962-1083.2001.01344.x; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; LELOUARN H, 2003, RONGEURS FRANCE; LELOUARN H, 1970, ANN ZOOL ECOL ANIM, V2, P423; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; MILLS JN, 1995, METHODS TRAPPING SMA; Mitchell-Jones AJ, 1999, ATLAS EUROPEAN MAMMA, P484; Muller UC, 2003, QUATERNARY RES, V59, P235, DOI 10.1016/S0033-5894(03)00005-X; Nesbo CL, 1999, MOL ECOL, V8, P1387, DOI 10.1046/j.1365-294x.1999.00699.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRIMAULT J, 2007, GROTTE TAILLIS COTEA, P150; Rafinski J, 2000, HEREDITY, V84, P610, DOI 10.1046/j.1365-2540.2000.00707.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLATKIN M, 1991, GENETICS, V129, P555; Sommer R, 2004, MAMMAL REV, V34, P249, DOI 10.1111/j.1365-2907.2004.00043.x; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; SPITZ F, 1977, Bulletin OEPP, V7, P165; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stewart JR, 2003, SCIENCE, V299, P825; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Tougard C, 2001, MOL PHYLOGENET EVOL, V19, P34, DOI 10.1006/mpev.2000.0903; Tougard C, 2008, BIOL J LINN SOC, V93, P309, DOI 10.1111/j.1095-8312.2007.00926.x; Triant DA, 2006, GENETICA, V128, P95, DOI 10.1007/s10709-005-5538-6; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; van Kolfschoten T., 1996, EARLY MIDDLE PLEISTO, P227, DOI DOI 10.1201/9781003077879-16; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	80	51	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3532	10.1371/journal.pone.0003532	http://dx.doi.org/10.1371/journal.pone.0003532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958287	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131100006
J	Gupta, S; Kuhnisch, J; Mustafa, A; Lhotak, S; Schlachterman, A; Slifker, MJ; Klein-Szanto, A; High, KA; Austin, RC; Kruger, WD				Gupta, Sapna; Kuehnisch, Jirko; Mustafa, Aladdin; Lhotak, Sarka; Schlachterman, Alexander; Slifker, Michael J.; Klein-Szanto, Andres; High, Katherine A.; Austin, Richard C.; Kruger, Warren D.			Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia	FASEB JOURNAL			English	Article						osteoporosis; ER stress; inborn error of metabolism; sulfur metabolism	ENDOPLASMIC-RETICULUM STRESS; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; HOMOCYSTEINE METABOLISM; GENE-EXPRESSION; NATURAL-HISTORY; RISK-FACTOR; B-VITAMINS; FOLIC-ACID; HOMOCYSTINURIA	Untreated cystathionine beta-synthase (CBS) deficiency in humans is characterized by extremely elevated plasma total homocysteine (tHcy>200 mu M), with thrombosis as the major cause of morbidity. Treatment with vitamins and diet leads to a dramatic reduction in thrombotic events, even though patients often still have severe elevations in tHcy (>80 mu M). To understand the difference between extreme and severe hyperhomocysteinemia, we have examined two mouse models of CBS deficiency: Tg-hCBS Cbs(-/-) mice, with a mean serum tHcy of 169 mu M, and Tg-I278T Cbs(-/-) mice, with a mean tHcy of 296 mu M. Only Tg-I278T Cbs(-/-) animals exhibited strong biological phenotypes, including facial alopecia, osteoporosis, endoplasmic reticulum (ER) stress in the liver and kidney, and a 20% reduction in mean survival time. Metabolic profiling of serum and liver reveals that Tg-I278T Cbs(-/-) mice have significantly elevated levels of free oxidized homocysteine but not protein-bound homocysteine in serum and elevation of all forms of homocysteine and S-adenosylhomocysteine in the liver compared to Tg- hCBS Cbs(-/-) mice. RNA profiling of livers indicate that Tg-I278T Cbs(-/-) and Tg- hCBS Cbs(-/-) mice have unique gene signatures, with minimal overlap. Our results indicate that there is a clear pathogenic threshold effect for tHcy and bring into question the idea that mild elevations in tHcy are directly pathogenic. Gupta, S., Kuhnisch, J., Mustafa, A., Lhotak, S., Schlachterman, A., Slifker, M. J., Klein-Szanto, A., High, K. A., Austin, R. C., Kruger, W. D. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 23, 883-893 (2009)	[Slifker, Michael J.; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Biostat Facil, Philadelphia, PA 19111 USA; [Kuehnisch, Jirko] Charite, Inst Med Genet, Berlin, Germany; [Lhotak, Sarka; Austin, Richard C.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Schlachterman, Alexander; High, Katherine A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McMaster University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, Biostat Facil, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	High, Katherine A./AAB-9322-2020; Kühnisch, Jirko/M-3744-2019; Kruger, Warren/Y-2541-2018; Kühnisch, Jirko/L-7761-2013; kruger, warren/A-6407-2008; Klein-Szanto, A./E-6218-2010	Kühnisch, Jirko/0000-0003-4744-5421; kruger, warren/0000-0002-4990-3695; 	National Institutes of Health [HL16237, CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Sequencing, DNA Microarray, Biostatistics and Bioinformatics, Transgenic Mouse, and Laboratory Animal facilities of Fox Chase Cancer Center for their assistance. This work was supported by grants HL16237 and CA06927 from the National Institutes of Health and an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center.	Aijarnali MN, 2008, J CLIN INVEST, V118, P1825, DOI 10.1172/JCI32878; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glushchenko AV, 2007, ANTIOXID REDOX SIGN, V9, P1883, DOI 10.1089/ars.2007.1809; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Jacobsen DW, 1998, CLIN CHEM, V44, P1833; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Kraus JP, 1999, HUM MUTAT, V13, P362; Kruger WD, 2003, HUM MUTAT, V22, P434, DOI 10.1002/humu.10290; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MALLOY MH, 1981, AM J CLIN NUTR, V34, P2619, DOI 10.1093/ajcn/34.12.2619; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1985, AM J HUM GENET, V37, P1; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Robert K, 2005, ANAT REC PART A, V282A, P1, DOI 10.1002/ar.a.20145; Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; UELAND PM, 1982, PHARMACOL REV, V34, P223; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Zhang YL, 2006, J CHEM ENG JPN, V39, P587, DOI 10.1252/jcej.39.587	42	85	94	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					883	893		10.1096/fj.08-120584	http://dx.doi.org/10.1096/fj.08-120584			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18987302	Green Published			2022-12-25	WOS:000265506300024
J	Pickl, M; Ries, CH				Pickl, M.; Ries, C. H.			Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab	ONCOGENE			English	Article						HER2 signaling; membrane raft; trastuzumab; 3D cell culture	HERCEPTIN-INDUCED INHIBITION; HUMAN-BREAST; LIPID RAFTS; IN-VIVO; CANCER; GROWTH; ERBB2; OVEREXPRESSION; KINASE; CELLS	Three-dimensional (3D) cell culture techniques are frequently used to model alterations in tissue architecture critically important for tumor development. Here, we report on a detailed comparison of a spheroid model of human epidermal growth factor receptor (HER2) over-expressing cancer cells with the traditional monolayer culture. In 2D culture, HER2 and HER3 form heterodimers, whereas in multicellular spheroids HER2 homodimers are formed. These homodimers localize in membrane rafts, resulting in enhanced inhibition of the proliferation of cancer cells with trastuzumab (Herceptin), a monoclonal antibody specifically targeting HER2. Within the tumor spheroids, HER2 homodimerization leads to enhanced activation of HER2 and results in a switch in signaling pathways from phosphoinositide 3-kinase (PI3K) to mitogen-activated protein kinase (MAPK). Diminished PI3K signaling is accompanied by the activation of the integrin beta 4/Rac1/PAK 2 signaling cascade. We propose that the described 3D culture system may better reflect some in vivo aspects of HER signaling and can be used to further improve the understanding of the molecular mechanisms of trastuzumab action. Furthermore, the described human multicellular tumor spheroids may allow identification of new targets for the treatment of HER2-positive breast cancer patients who currently benefit suboptimally from trastuzumab treatment.	[Pickl, M.; Ries, C. H.] Roche Diagnost GmbH, Pharmaceut Res Oncol, D-82377 Penzberg, Germany	Roche Holding	Ries, CH (corresponding author), Roche Diagnost GmbH, Pharmaceut Res Oncol, Nonnenwald 2, D-82377 Penzberg, Germany.	carola.ries@roche.com						Engelman JA, 1998, J BIOL CHEM, V273, P20448, DOI 10.1074/jbc.273.32.20448; Guo Hua, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P140; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; MILJAN EA, 2002, SCI STKE, pRE15; Mocanu MM, 2005, CANCER LETT, V227, P201, DOI 10.1016/j.canlet.2005.01.028; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sottocornola E, 2006, FEBS J, V273, P1821, DOI 10.1111/j.1742-4658.2006.05203.x; Sottocornola E, 2003, BBA-MOL CELL BIOL L, V1635, P55, DOI 10.1016/j.bbalip.2003.10.006; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yakes FM, 2002, CANCER RES, V62, P4132; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	32	292	295	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					461	468		10.1038/onc.2008.394	http://dx.doi.org/10.1038/onc.2008.394			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18978815	Bronze			2022-12-25	WOS:000262550300013
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Extracellular Protons Regulate Human ENaC by Modulating Na+ Self-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; EXHALED BREATH CONDENSATE; HISTIDINE-RESIDUES; ALPHA-SUBUNIT; TRANSPORT; ACTIVATION; ACIDIFICATION; EXPRESSION; CLONING; PH	The epithelial Na+ channel, ENaC, is exposed to a wide range of proton concentrations in the kidney, lung, and sweat duct. We, therefore, tested whether pH alters ENaC activity. In Xenopus oocytes expressing human alpha-, beta-, and gamma ENaC, amiloride-sensitive current was altered by protons in the physiologically relevant range ( pH 8.5-6.0). Compared with pH 7.4, acidic pH increased ENaC current, whereas alkaline pH decreased current (pH(50) = 7.2). Acidic pH also increased ENaC current in H441 epithelia and in human primary airway epithelia. In contrast to human ENaC, pH did not alter rat ENaC current, indicating that there are species differences in ENaC regulation by protons. This resulted predominantly from species differences in gamma ENaC. Maneuvers that lock ENaC in a high open-probability state ("DEG" mutation, proteolytic cleavage) abolished the effect of pHon human ENaC, indicating that protons alter ENaC current by modulating channel gating. Previous work showed that ENaC gating is regulated in part by extracellular Na+ ("Na+ self-inhibition"). Based on several observations, we conclude that protons regulate ENaC by altering Na+ self-inhibition. First, protons reduced Na+ self- inhibition in a dose-dependent manner. Second, ENaC regulation by pH was abolished by removing Na+ from the extracellular bathing solution. Third, mutations that alter Na+ self- inhibition produced corresponding changes in ENaC regulation by pH. Together, the data support a model in which protons modulate ENaC gating by relieving Na+ self- inhibition. We speculate that this may be an important mechanism to facilitate epithelial Na+ transport under conditions of acidosis.	[Snyder, Peter M.] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant ( to P. M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; ALAWQATI Q, 1977, AM J PHYSIOL, V233, pF502, DOI 10.1152/ajprenal.1977.233.6.F502; Awayda MS, 2000, AM J PHYSIOL-CELL PH, V279, pC1896, DOI 10.1152/ajpcell.2000.279.6.C1896; BATLLE DC, 1986, METABOLISM, V35, P852, DOI 10.1016/0026-0495(86)90228-3; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P597, DOI 10.1016/j.iac.2007.09.006; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; KAISER D, 1974, PFLUG ARCH EUR J PHY, V349, P63, DOI 10.1007/BF00587917; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; LEAF A, 1964, AM J PHYSIOL, V207, P547, DOI 10.1152/ajplegacy.1964.207.3.547; LEVI H, 1949, NATURE, V164, P928, DOI 10.1038/164928a0; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Paget-Brown AO, 2006, CHEST, V129, P426, DOI 10.1378/chest.129.2.426; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; ROSE BD, 1984, CLIN PHYSL ACID BASE, P225; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Zhang P, 1999, BIOPHYS J, V77, P3043, DOI 10.1016/S0006-3495(99)77135-3	40	66	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					792	798		10.1074/jbc.M806954200	http://dx.doi.org/10.1074/jbc.M806954200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990692	hybrid, Green Published			2022-12-25	WOS:000262122900013
J	Guo, SL; Burnette, R; Zhao, L; Vanderford, NL; Poitout, V; Hagman, DK; Henderson, E; Ozcan, S; Wadzinski, BE; Stein, R				Guo, Shuangli; Burnette, Ryan; Zhao, Li; Vanderford, Nathan L.; Poitout, Vincent; Hagman, Derek K.; Henderson, Eva; Ozcan, Sabire; Wadzinski, Brian E.; Stein, Roland			The Stability and Transactivation Potential of the Mammalian MafA Transcription Factor Are Regulated by Serinei 65 Phosphorylation.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; PANCREATIC BETA-CELLS; DNA-BINDING ACTIVITY; KEY REGULATOR; EXPRESSION; GLUCOSE; PROTEIN; ACTIVATOR; TYROSINE; RIPE3B1	The level of the MafA transcription factor is regulated by a variety of effectors of beta cell function, including glucose, fatty acids, and insulin. Here, we show that phosphorylation at Ser(65) of mammalian MafA influences both protein stability and transactivation potential. Replacement of Ser65 with Glu to mimic phosphorylation produced a protein that was as unstable as the wild type, whereas Asp or Ala mutation blocked degradation. Analysis of MafA chimeric and deletion constructs suggests that protein phosphorylation at Ser65 alone represents the initial degradation signal, with ubiquitinylation occurring within the C terminus (amino acids 234-359). Although only wild type MafA and S65E were polyubiquitinylated, both S65D and S65E potently stimulated transactivation compared with S65A. Phosphorylation at Ser(14) also enhanced activation, although it had no impact on protein turnover. The mobility of MafA S65A was profoundly affected upon SDS-PAGE, with the S65E and S65D mutants influenced less due to their ability to serve as substrates for glycogen synthase kinase 3, which acts at neighboring N-terminal residues after Ser65 phosphorylation. Our observations not only illustrate the sensitivity of the cellular transcriptional and degradation machinery to phosphomimetic mutants at Ser65, but also demonstrate the singular importance of phosphorylation at this amino acid in regulating MafA activity.	[Stein, Roland] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wadzinski, Brian E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Vanderford, Nathan L.; Ozcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Poitout, Vincent; Hagman, Derek K.] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Montreal, PQ H2X 1P1, Canada	Vanderbilt University; Vanderbilt University; University of Kentucky; Universite de Montreal	Stein, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 723 Light Hall, Nashville, TN 37232 USA.	roland.stein@vanderbilt.edu		Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health [P01 DK42502]; Molecular Endocrinology Training Program Postdoctoral Training [5T32 DK07563-20]; Diabetes and Endocrinology [5T32 DK007061-34, R01 DK58096, F32 DK070406, R01 DK067581, DK70787]; American Heart Association; Molecular Biology Core Laboratory; Vanderbilt University Diabetes Research and Training Center [P60DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042502, R01DK058096, P60DK020593, R01DK067581, T32DK007061, F32DK070406, R01DK070787, T32DK007563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Endocrinology Training Program Postdoctoral Training; Diabetes and Endocrinology; American Heart Association(American Heart Association); Molecular Biology Core Laboratory; Vanderbilt University Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK42502 ( to R. S.), Molecular Endocrinology Training Program Postdoctoral Training Grant 5T32 DK07563-20 (to R. B.), Postdoctoral Research Training Grant in Diabetes and Endocrinology 5T32 DK007061-34 to ( N. L. V.), Grant R01 DK58096 ( to V. P.), Postdoctoral Fellowship F32 DK070406 ( to D. K. H.), Grant R01 DK067581 ( to S. O.), and Grant DK70787 ( to B. E. W.). This work was also supported by an American Heart Association Predoctoral fellowship ( to N. L. V.). Partial support was also provided to the Molecular Biology Core Laboratory by the Vanderbilt University Diabetes Research and Training Center ( United States Public Health Service Grant P60DK20593). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Civil A, 2002, NUCLEIC ACIDS RES, V30, P975, DOI 10.1093/nar/30.4.975; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Matsuoka T, 2001, J BIOL CHEM, V276, P22071, DOI 10.1074/jbc.M010321200; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sii-Felice K, 2005, FEBS LETT, V579, P3547, DOI 10.1016/j.febslet.2005.04.086; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	37	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					759	765		10.1074/jbc.M806314200	http://dx.doi.org/10.1074/jbc.M806314200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004825	Green Published, hybrid			2022-12-25	WOS:000262122900009
J	Hammarberg, T; Hamberg, M; Wetterholm, A; Hansson, H; Samuelsson, B; Haeggstrom, JZ				Hammarberg, Tove; Hamberg, Mats; Wetterholm, Anders; Hansson, Henrik; Samuelsson, Bengt; Haeggstrom, Jesper Z.			Mutation of a Critical Arginine in Microsomal Prostaglandin E Synthase-1 Shifts the Isomerase Activity to a Reductase Activity That Converts Prostaglandin H-2 into Prostaglandin F-2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; E-2 SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; PURIFICATION; ENZYME	Microsomal prostaglandin E synthase type 1 (mPGES-1) converts prostaglandin endoperoxides, generated from arachidonic acid by cyclooxygenases, into prostaglandin E-2. This enzyme belongs to the membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) family of integral membrane proteins, and because of its link to inflammatory conditions and preferential coupling to cyclooxygenase 2, it has received considerable attention as a drug target. Based on the high resolution crystal structure of human leukotriene C-4 synthase, a model of mPGES-1 has been constructed in which the tripeptide co-substrate glutathione is bound in a horseshoe-shaped conformation with its thiol group positioned in close proximity to Arg-126. Mutation of Arg-126 into an Ala or Gln strongly reduces the enzyme's prostaglandin E synthase activity (85-95%), whereas mutation of a neighboring Arg-122 does not have any significant effect. Interestingly, R126A and R126Q mPGES-1 exhibit a novel, glutathione-dependent, reductase activity, which allows conversion of prostaglandin H-2 into prostaglandin F-2 alpha. Our data show that Arg-126 is a catalytic residue in mPGES-1 and suggest that MAPEG enzymes share significant structural components of their active sites.	[Hammarberg, Tove; Hamberg, Mats; Wetterholm, Anders; Samuelsson, Bengt; Haeggstrom, Jesper Z.] Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Hansson, Henrik] Swedish Univ Agr Sci, Dept Mol Biol, S-75124 Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se		Hansson, Henrik/0000-0002-6003-2982; Hamberg, Mats/0000-0002-8910-7810	Swedish Research Council [10350, 20854]; Linneus; CERIC [2001-2553]; CIDaT consortium (Vinnova); Sorderberg Foundation; European Commission FP6 [LSHM-CT2004-005033]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus; CERIC; CIDaT consortium (Vinnova)(Vinnova); Sorderberg Foundation; European Commission FP6(European CommissionEuropean Commission Joint Research Centre)	The work was supported by Swedish Research Council Grants 10350, 20854, Linneus Grant CERIC, and 2001-2553, the CIDaT consortium (Vinnova), the Sorderberg Foundation, and European Commission FP6 Grant LSHM-CT2004-005033.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Burgess JR, 1997, BIOCHEM MOL BIOL INT, V41, P217; BURGESS JR, 1989, BIOCHEM BIOPH RES CO, V158, P497, DOI 10.1016/S0006-291X(89)80076-2; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; LANDS W, 1971, ANN NY ACAD SCI, V180, P107, DOI 10.1111/j.1749-6632.1971.tb53190.x; MIYAMOTO T, 1974, P NATL ACAD SCI USA, V71, P3645, DOI 10.1073/pnas.71.9.3645; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0	20	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					301	305		10.1074/jbc.M808365200	http://dx.doi.org/10.1074/jbc.M808365200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984580	hybrid, Green Published			2022-12-25	WOS:000261974800034
J	Sharff, KA; Song, WX; Luo, XJ; Tang, N; Luo, JY; Chen, J; Bi, Y; He, BC; Huang, JY; Li, XM; Jiang, W; Zhu, GH; Su, YX; He, Y; Shen, JK; Wang, Y; Chen, L; Zuo, GW; Liu, B; Pan, XC; Reid, RR; Luu, HH; Haydon, RC; He, TC				Sharff, Katie A.; Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Li, Xinmin; Jiang, Wei; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Shen, Jikun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; Pan, Xiaochuan; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan			Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION FACTORS; GENE; TARGET; CBFA1; EXPRESSION; NOTCH; BMP	Pluripotent mesenchymal stem cells (MSCs) are bone marrow stromal progenitor cells that can differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. We previously demonstrated that bone morphogenetic protein (BMP) 9 is one of the most potent and yet least characterized BMPs that are able to induce osteogenic differentiation of MSCs both in vitro and in vivo. Here, we conducted gene expression-profiling analysis and identified that Hey1 of the hairy/Enhancer of split-related repressor protein basic helix-loop-helix family was among the most significantly up-regulated early targets in BMP9-stimulated MSCs. We demonstrated that Hey1 expression was up-regulated at the immediate early stage of BMP9-induced osteogenic differentiation. Chromatin immunoprecipitation analysis indicated that Hey1 may be a direct target of the BMP9-induced Smad signaling pathway. Silencing Hey1 expression diminished BMP9-induced osteogenic differentiation both in vitro and in vivo and led to chondrogenic differentiation. Likewise, constitutive Hey1 expression augmented BMP9-mediated bone matrix mineralization. Hey1 and Runx2 were shown to act synergistically in BMP9-induced osteogenic differentiation, and Runx2 expression significantly decreased in the absence of Hey1, suggesting that Runx2 may function downstream of Hey1. Accordingly, the defective osteogenic differentiation caused by Hey1 knockdown was rescued by exogenous Runx2 expression. Thus, our findings suggest that Hey1, through its interplay with Runx2, may play an important role in regulating BMP9-induced osteoblast lineage differentiation of MSCs.	[Sharff, Katie A.; Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Jiang, Wei; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Shen, Jikun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China; [Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; He, Tong-Chuan] Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med, Chongqing 400016, Peoples R China; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pan, Xiaochuan] Univ Chicago, Med Ctr, Dept Radiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; University of California System; University of California Los Angeles; University of Chicago; University of Chicago Medical Center	Haydon, RC (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA.	rhaydon@surgery.bsd.uchicago.edu			National Institutes of Health [CA106569, AR50142, AR054381]; American Cancer Society; The Brinson Foundation; Orthopaedic Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); The Brinson Foundation; Orthopaedic Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106569, AR50142, and AR054381 (to R. C. H., T. C. H., and H. H. L.). This work was also supported by research grants from the American Cancer Society (to T. C. H. and H. H. L.), The Brinson Foundation (to T. C. H.), and the Orthopaedic Research and Education Foundation (OREF) (to R. C. H. and H. H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fuke S, 2006, J NEUROSCI RES, V84, P1555, DOI 10.1002/jnr.21062; Gu K, 2004, CELLS TISSUES ORGANS, V176, P28, DOI 10.1159/000075025; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; KANG Q, 2008, STEM CELLS DEV, V18, P545, DOI DOI 10.1089/SCD.2008.0130; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	57	152	166	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					649	659		10.1074/jbc.M806389200	http://dx.doi.org/10.1074/jbc.M806389200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986983	Green Published, hybrid			2022-12-25	WOS:000261974800070
J	Uray, IP; Shen, Q; Seo, HS; Kim, H; Lamph, WW; Bissonnette, RP; Brown, PH				Uray, Ivan P.; Shen, Qiang; Seo, Hye-Sook; Kim, HeeTae; Lamph, William W.; Bissonnette, Reid P.; Brown, Powel H.			Rexinoid-induced Expression of IGFBP-6 Requires RAR beta-dependent Permissive Cooperation of Retinoid Receptors and AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; II IGF-II; GROWTH-FACTOR; MAMMARY TUMORIGENESIS; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; TRANSGENIC MICE; 9-CIS-RETINOIC ACID; BINDING PROTEIN-6	The synthetic rexinoid bexarotene (Targretin, LGD 1069) inhibits the formation of both estrogen receptor-negative and estrogen receptor-positive breast cancer in preclinical models and controls the expression of growth-regulatory biomarkers, such as IGFBP-6 (insulin-like growth factor-binding protein 6), RAR beta, or cyclin D1. In this study, we identified a classical retinoic acid-responsive element in the first intron in the IGFBP-6 gene adjacent to a consensus AP-1 binding site, both elements essential for rexinoid-induced expression of IGFBP-6. In chromatin binding experiments, bexarotene increased the occupancy of the identified enhancer element by RXR alpha, RAR alpha, cJun, cFos, and p300. In normal mammary epithelial cells and T47D breast cancer cells, small interfering RNA-mediated knockdown of all RXR isoforms or RAR beta, but not RAR alpha or RAR gamma alone, blocked the induction of IGFBP-6 by bexarotene. Simultaneous knockdown of RAR alpha and RAR gamma abrogated both the induction of RAR alpha and the up-regulation and secretion of IGFBP-6. The suppression of either RAR beta or cJun by small interfering RNA blocked the recruitment of RXR alpha and cJun to the enhancer. These results demonstrate a novel cooperative interaction between retinoid receptors and AP-1 orchestrated by RAR alpha and highlight a novel mechanism by which RAR gamma can mediate the cancer-preventive effects of rexinoids.	[Uray, Ivan P.; Shen, Qiang; Seo, Hye-Sook; Kim, HeeTae; Brown, Powel H.] Baylor Coll Med, Breast Canc Ctr, Houston, TX 77030 USA; [Uray, Ivan P.; Shen, Qiang; Brown, Powel H.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lamph, William W.; Bissonnette, Reid P.] Ligand Pharmaceut Ltd, San Diego, CA 92121 USA	Baylor College of Medicine; Baylor College of Medicine; Ligand Pharmaceuticals	Brown, PH (corresponding author), 1 Baylor Plaza,MS 600, Houston, TX 77030 USA.	pbrown@breastcenter.tmc.edu		Shen, Qiang/0000-0002-1491-5434; Brown, Powel/0000-0002-3398-163X	National Institutes of Health; NCI [RO1 CA10121, RO1 CA78480, U19 CA086809]; NATIONAL CANCER INSTITUTE [U19CA086809, R01CA078480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants RO1 CA10121, RO1 CA78480, and U19 CA086809 (to P.H.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BACH LA, 1994, ENDOCRINOLOGY, V135, P2168, DOI 10.1210/en.135.5.2168; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; Chambery D, 2000, GROWTH HORM IGF RES, V10, P349, DOI 10.1054/ghir.2000.0179; Cohen MH, 2001, ONCOLOGIST, V6, P4, DOI 10.1634/theoncologist.6-1-4; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; DiSepio D, 1999, Mol Cell Biol Res Commun, V1, P7, DOI 10.1006/mcbr.1999.0101; Giani C, 1996, BREAST CANCER RES TR, V41, P43, DOI 10.1007/BF01807035; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; Kaulsay KK, 1999, EUR J ENDOCRINOL, V140, P164, DOI 10.1530/eje.0.1400164; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kong G, 2005, CANCER RES, V65, P3462, DOI 10.1158/0008-5472.CAN-03-2912; LI XS, 1995, J CELL PHYSIOL, V165, P449, DOI 10.1002/jcp.1041650302; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Liby K, 2006, CLIN CANCER RES, V12, P5902, DOI 10.1158/1078-0432.CCR-06-1119; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; LIPPMAN SM, 1992, JNCI-J NATL CANCER I, V13, P111; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Mita K, 2007, JPN J CLIN ONCOL, V37, P575, DOI 10.1093/jjco/hym066; Moon RC, 1997, BREAST CANCER RES TR, V46, P181, DOI 10.1023/A:1005995925246; MOON RC, 1979, CANCER RES, V39, P1339; OSBORNE CK, 1989, MOL ENDOCRINOL, V3, P1701, DOI 10.1210/mend-3-11-1701; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Sachdev D, 2006, J MAMMARY GLAND BIOL, V11, P27, DOI 10.1007/s10911-006-9010-8; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; Sirchia SM, 2002, CANCER RES, V62, P2455; Sueoka N, 2000, AM J RESP CELL MOL, V23, P297, DOI 10.1165/ajrcmb.23.3.4013; Teplitzky SR, 2001, CANCER LETT, V168, P155, DOI 10.1016/S0304-3835(01)00548-1; Virmani AK, 2000, J NATL CANCER I, V92, P1303, DOI 10.1093/jnci/92.16.1303; Wan HS, 1999, CANCER RES, V59, P3518; Wan HS, 2001, CANCER RES, V61, P556; WARRELL RP, 1994, LEUKEMIA, V8, P929; Wu K, 2000, CLIN CANCER RES, V6, P3696; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Zhu YL, 2006, INT J ONCOL, V29, P1581; Zhuang Y, 2003, MOL CANCER RES, V1, P619	40	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					345	353		10.1074/jbc.M804721200	http://dx.doi.org/10.1074/jbc.M804721200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957410	hybrid, Green Published			2022-12-25	WOS:000261974800039
J	Yin, WB; Grundmann, A; Cheng, J; Li, SM				Yin, Wen-Bing; Grundmann, Alexander; Cheng, Jun; Li, Shu-Ming			Acetylaszonalenin Biosynthesis in Neosartorya fischeri IDENTIFICATION OF THE BIOSYNTHETIC GENE CLUSTER BY GENOMIC MINING AND FUNCTIONAL PROOF OF THE GENES BY BIOCHEMICAL INVESTIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRENYLATED INDOLE-DERIVATIVES; MOLD METABOLITES ROQUEFORTINE; ASPERGILLUS-FUMIGATUS; N-PRENYLTRANSFERASE; BLUE CHEESE; PENICILLIUM; ALKALOIDS; PURIFICATION; SYNTHASE; TRYPTOPHAN	Based on the structural information of acetylaszonalenin isolated from Neosartorya fischeri, a putative biosynthetic gene cluster was identified in the genome sequence of this fungus by genomic mining. This cluster consists of three genes coding for a putative non-ribosomal peptide synthetase (AnaPS), a prenyltransferase (AnaPT), and an acetyltransferase (AnaAT). The coding sequences of anaPT and anaAT were cloned in pQE70 and pQE60, respectively, and overexpressed in Escherichia coli. The soluble His(6) fusion proteins were purified to near homogeneity and characterized biochemically. The structures of the enzymatic products were elucidated by NMR and mass spectroscopy analysis. AnaPT was found to catalyze the reverse prenylation of (R)-benzodiazepinedione at position C3 of the indole moiety in the presence of dimethylallyl diphosphate, resulting in formation of aszonalenin. AnaAT was found to catalyze the acetylation of aszonalenin at position N1 of the indoline moiety in the presence of acetyl coenzyme A, resulting in formation of acetylaszonalenin. K-m values of AnaPT were determined for dimethylallyl diphosphate at 156 mu M and for (R)-benzodiazepinedione at 232 mu M. K-m values of AnaAT were determined for acetyl coenzyme A at 96 mu M and for aszonalenin at 61 mu M. The turnover numbers of the AnaPT and AnaAT reactions were determined at 1.5 and 0.14 s(-1), respectively.	[Yin, Wen-Bing; Grundmann, Alexander; Cheng, Jun; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany	Philipps University Marburg	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol, Deutsch Str 17A, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de	Yin, Wen-Bing/AAF-4825-2021	yin, wen bing/0000-0002-9184-3198	Deutsche Forschungsgemeinschaft [SPP1152]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant SPP1152 (to S.-M. Li). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 2006, MYCOPATHOLOGIA, V162, P143, DOI 10.1007/s11046-006-0049-2; ARAI K, 1989, CHEM PHARM BULL, V37, P2937; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, P158; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; BARROW CJ, 1994, J NAT PROD, V57, P471, DOI 10.1021/np50106a005; BARROW KD, 1979, J CHEM SOC CHEM COMM, P225, DOI 10.1039/c39790000225; BHAT B, 1993, TETRAHEDRON, V49, P10663, DOI 10.1016/S0040-4020(01)81556-8; BHAT B, 1990, J CHEM SOC CHEM COMM, P1518, DOI 10.1039/c39900001518; Capon RJ, 2003, ORG BIOMOL CHEM, V1, P1856, DOI 10.1039/b302306k; DEGUZMAN FS, 1992, J NAT PROD, V55, P931, DOI 10.1021/np50085a013; ELLESTAD GA, 1973, J ORG CHEM, V38, P4204, DOI 10.1021/jo00963a024; Finoli C, 2001, J FOOD PROTECT, V64, P246, DOI 10.4315/0362-028X-64.2.246; GEBLER JC, 1992, ARCH BIOCHEM BIOPHYS, V296, P308, DOI 10.1016/0003-9861(92)90577-J; GORSTALLMAN CP, 1982, J CHEM SOC CHEM COMM, P652, DOI 10.1039/c39820000652; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Grundmann A, 2008, CHEMBIOCHEM, V9, P2059, DOI 10.1002/cbic.200800240; Hayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1697, DOI 10.1271/bbb.70110; HOCHLOWSKI JE, 1993, J ANTIBIOT, V46, P380, DOI 10.7164/antibiotics.46.380; HODGE RP, 1988, J NAT PROD, V51, P66, DOI 10.1021/np50055a008; Jones MG, 2007, MICROBIOL-SGM, V153, P1, DOI 10.1099/mic.0.2006/001479-0; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; KIMURA Y, 1982, TETRAHEDRON LETT, V23, P225, DOI 10.1016/S0040-4039(00)86791-X; Kozlovsky AG, 2001, APPL BIOCHEM MICRO+, V37, P253, DOI 10.1023/A:1010225017054; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Rank C, 2006, TETRAHEDRON LETT, V47, P6099, DOI 10.1016/j.tetlet.2006.06.086; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; RESHETILOVA TA, 1995, MICROBIOLOGY+, V64, P27; Ruan HL, 2008, CHEMBIOCHEM, V9, P1044, DOI 10.1002/cbic.200700723; Rundberget T, 2004, INT J FOOD MICROBIOL, V90, P181, DOI 10.1016/S0168-1605(03)00291-5; Sambrook J, 2001, MOL CLONING LAB MANU, P4; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; SCOTT PM, 1976, J AGR FOOD CHEM, V24, P865, DOI 10.1021/jf60206a028; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; Stocking EM, 2000, J AM CHEM SOC, V122, P9089, DOI 10.1021/ja993593q; TAKASE S, 1985, TETRAHEDRON, V41, P3037, DOI 10.1016/S0040-4020(01)96656-6; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Tokai T, 2005, MICROBIOL-SGM, V151, P509, DOI 10.1099/mic.0.27435-0; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wakana D., 2006, MYCOTOXINS, V56, P3, DOI DOI 10.2520/MYC0.56.3; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	48	128	133	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					100	109		10.1074/jbc.M807606200	http://dx.doi.org/10.1074/jbc.M807606200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001367	hybrid			2022-12-25	WOS:000261974800012
J	Cassese, A; Esposito, I; Fiory, F; Barbagallo, APM; Paturzo, F; Mirra, P; Ulianich, L; Giacco, F; Iadicicco, C; Lombardi, A; Oriente, F; Van Obberghen, E; Beguinot, F; Formisano, P; Miele, C				Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Van Obberghen, Emmanuel; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia			In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; CELL-PROLIFERATION; GLUCOSE-METABOLISM; SRC KINASE; KAPPA-B; V-SRC; ACTIVATION; ALPHA	Chronic hyperglycemia promotes insulin resistance at least in part by increasing the formation of advanced glycation end products (AGEs). We have previously shown that in L6 myotubes human glycated albumin (HGA) induces insulin resistance by activating protein kinase C alpha(PKC alpha). Here we show that HGA-induced PKC alpha activation is mediated by Src. Coprecipitation experiments showed that Src interacts with both the receptor for AGE (RAGE) and PKC alpha in HGA-treated L6 cells. A direct interaction of PKC alpha with Src and insulin receptor substrate-1 (IRS-1) has also been detected. In addition, silencing of IRS-1 expression abolished HGA-induced RAGE-PKC alpha co-precipitation. AGEs were able to induce insulin resistance also in vivo, as insulin tolerance tests revealed a significant impairment of insulin sensitivity in C57/BL6 mice fed a high AGEs diet (HAD). In tibialis muscle of HAD-fed mice, insulin-induced glucose uptake and protein kinase B phosphorylation were reduced. This was paralleled by a 2.5-fold increase in PKC alpha activity. Similarly to in vitro observations, Src phosphorylation was increased in tibialis muscle of HAD-fed mice, and co-precipitation experiments showed that Src interacts with both RAGE and PKC alpha. These results indicate that AGEs impairment of insulin action in the muscle might be mediated by the formation of a multimolecular complex including RAGE/IRS-1/Src and PKC alpha	[Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia] Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia] Univ Naples Federico 2, CNR, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Van Obberghen, Emmanuel] Univ Nice Sophia Antipolis, INSERM, Fac Med, IFR 50,U907,Ex U145, F-06107 Nice, France	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Miele, C (corresponding author), Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Via Sergio Pansini 5, I-80131 Naples, Italy.	c.miele@ieos.cnr.it	Formisano, Pietro/J-4237-2018; Ulianich, Luca/ABD-2530-2020; ORIENTE, Francesco/J-6652-2018	Formisano, Pietro/0000-0001-7020-6870; ORIENTE, Francesco/0000-0003-4375-4526	European Foundation; GlaxoSmithKline Programme; Consiglio Nazionale delle Ricerche Grant RSLT; European Community FP6 EUGENE2 [LSHM-CT-2004-512013]; PRE-POBEDIA; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universitae della Ricerca Scientifica [PRIN, FIRB RBNE0155LB]; INSERM; Universite de Nice-Sophia-Antipolis; Conseil Regional PACA; Conseil General des Alpes-Maritimes; Fondation de France; PRND	European Foundation(European Science Foundation (ESF)); GlaxoSmithKline Programme(GlaxoSmithKline); Consiglio Nazionale delle Ricerche Grant RSLT(Consiglio Nazionale delle Ricerche (CNR)); European Community FP6 EUGENE2(European Commission); PRE-POBEDIA; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universitae della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Nice-Sophia-Antipolis; Conseil Regional PACA(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur); Fondation de France(Fondation de France); PRND	This work was supported by the European Foundation for the Study of Diabetes and the GlaxoSmithKline Programme for the Study of Metabolic Toxicity in Diabetes, Consiglio Nazionale delle Ricerche Grant RSLT, European Community FP6 EUGENE2 Grant LSHM-CT-2004-512013 and PRE-POBEDIA, by grants from the Associazione Italiana per la Ricerca sul Cancro, and by the Ministero dell'Universitae della Ricerca Scientifica Grants PRIN and FIRB RBNE0155LB. The work in Nice was supported by European Community FP6 EUGENE2 Grant LSHM-CT-2004-512013, the INSERM, Universite de Nice-Sophia-Antipolis, Conseil Regional PACA and Conseil General des Alpes-Maritimes, the Fondation de France (Paris, France, 2007-2008), and the PRND (Programme de Recherche Nationale sur le Diabete, France, 2003-2007). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Brizzi MF, 2002, DIABETES, V51, P3311, DOI 10.2337/diabetes.51.11.3311; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; CHIN JE, 1993, J BIOL CHEM, V268, P6338; Cho HM, 2005, MOL CELLS, V19, P60; DAVIDSON MB, 1994, AM J PHYSIOL-ENDOC M, V267, pE808, DOI 10.1152/ajpendo.1994.267.6.E808; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Flyvbjerg A, 2000, DIABETOLOGIA, V43, P1205, DOI 10.1007/s001250051515; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; Formisano P, 2001, J ENDOCRINOL INVEST, V24, P460, DOI 10.1007/BF03351048; HAGER SR, 1991, AM J PHYSIOL, V260, pE353, DOI 10.1152/ajpendo.1991.260.3.E353; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; HE C, 2001, DIABETES S1, V50, P48; He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308; Hoffmann S, 2002, GRAEF ARCH CLIN EXP, V240, P996, DOI 10.1007/s00417-002-0568-6; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Idris I, 2002, ANN NY ACAD SCI, V967, P176; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Khare S, 1997, J CLIN INVEST, V99, P1831, DOI 10.1172/JCI119350; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; LIN R, 2001, DIABETES S2, V50, P48; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu XJ, 2006, CELL SIGNAL, V18, P2071, DOI 10.1016/j.cellsig.2006.04.007; Makita Z, 1995, J DIABETES COMPLICAT, V9, P265, DOI 10.1016/1056-8727(95)80018-A; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OBRIEN J, 1989, CRIT REV FOOD SCI, V28, P211, DOI 10.1080/10408398909527499; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; RuggieroLopez D, 1997, DIABETES RES CLIN PR, V34, P135, DOI 10.1016/S0168-8227(96)01352-6; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tajiri Y, 1997, ENDOCRINOLOGY, V138, P273, DOI 10.1210/en.138.1.273; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Treins C, 2001, J BIOL CHEM, V276, P43836, DOI 10.1074/jbc.M106534200; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Vlassara H, 2000, HOSP PRACT, V35, P25, DOI 10.3810/hp.2000.11.218; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; ZANG Q, 1995, CELL GROWTH DIFFER, V6, P1367	54	82	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36088	36099		10.1074/jbc.M801698200	http://dx.doi.org/10.1074/jbc.M801698200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955497	Green Published, hybrid			2022-12-25	WOS:000261840500004
J	EnayetAllah, AE; Luria, A; Luo, BB; Tsai, HJ; Sura, P; Hammock, BD; Grant, DF				EnayetAllah, Ahmed E.; Luria, Ayala; Luo, Beibei; Tsai, Hsing-Ju; Sura, Priyanka; Hammock, Bruce D.; Grant, David F.			Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE REGULATION; ACTIVATED-RECEPTOR-ALPHA; EPOXYEICOSATRIENOIC ACIDS; PPAR-GAMMA; MICE; HYPERTENSION; METABOLISM; INHIBITORS; ATHEROSCLEROSIS; ROSIGLITAZONE	Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/ cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a similar to 25% decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be similar to 2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only orhydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.	[EnayetAllah, Ahmed E.; Luo, Beibei; Sura, Priyanka; Grant, David F.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Luria, Ayala; Tsai, Hsing-Ju; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Luria, Ayala; Tsai, Hsing-Ju; Hammock, Bruce D.] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA	University of Connecticut; University of California System; University of California Davis; University of California System; University of California Davis	Grant, DF (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	david.grant@uconn.edu			National Institutes of Health [ES011630]; University of Connecticut Foundation; National Institute of Environmental Health [R37 ES002710]; National Institute of Environmental Health Sciences Superfund Basic Research Program [P42 ES004699]; University of Connecticut Tobacco-related Disease Research Program New Investigator Award [16KT-0037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES011630, R37ES002710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Foundation; National Institute of Environmental Health; National Institute of Environmental Health Sciences Superfund Basic Research Program; University of Connecticut Tobacco-related Disease Research Program New Investigator Award(University of California System); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES011630. This work was also supported by a grant from the University of Connecticut Foundation. Additional funding was from the National Institute of Environmental Health Sciences R37 ES002710, the National Institute of Environmental Health Sciences Superfund Basic Research Program P42 ES004699 and the University of Connecticut Tobacco-related Disease Research Program New Investigator Award 16KT-0037. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; BORHAN B, 1995, ANAL BIOCHEM, V231, P188, DOI 10.1006/abio.1995.1520; Capdevila JH, 2001, BIOCHEM BIOPH RES CO, V285, P571, DOI 10.1006/bbrc.2001.5167; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Derosa G, 2006, CLIN THER, V28, P679, DOI 10.1016/j.clinthera.2006.05.012; Enayetallah AE, 2006, BIOCHEM BIOPH RES CO, V341, P254, DOI 10.1016/j.bbrc.2005.12.180; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fang X, 2005, J PHARMACOL EXP THER, V314, P260, DOI 10.1124/jpet.105.085605; Ferreira AVM, 2006, METABOLISM, V55, P731, DOI 10.1016/j.metabol.2006.01.020; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; INOUE N, 1993, BIOL PHARM BULL, V16, P1004; Jin LM, 2006, FASEB J, V20, P539, DOI 10.1096/fj.05-4341fje; Johnston TP, 2001, INT J PHARMACEUT, V229, P75, DOI 10.1016/S0378-5173(01)00834-1; Jones PD, 2006, BIOORG MED CHEM LETT, V16, P5212, DOI 10.1016/j.bmcl.2006.07.009; Klopotek A, 2006, EXP BIOL MED, V231, P1365, DOI 10.1177/153537020623100810; Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Llaverias G, 2006, BIOCHEM PHARMACOL, V71, P605, DOI 10.1016/j.bcp.2005.11.022; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; MIMURA K, 1994, DIABETIC MED, V11, P685, DOI 10.1111/j.1464-5491.1994.tb00333.x; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Robins SJ, 2006, CURR OPIN LIPIDOL, V17, P431; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Tran KL, 2005, BIOCHEMISTRY-US, V44, P12179, DOI 10.1021/bi050842g; Watanabe T, 2006, ANAL CHIM ACTA, V559, P37, DOI 10.1016/j.aca.2005.11.049; Wei Q, 2007, ATHEROSCLEROSIS, V190, P26, DOI 10.1016/j.atherosclerosis.2006.02.021	45	47	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36592	36598		10.1074/jbc.M806315200	http://dx.doi.org/10.1074/jbc.M806315200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974052	hybrid, Green Published			2022-12-25	WOS:000261840500057
J	Luthra, A; Mahmood, A; Arora, A; Ramachandran, R				Luthra, Amit; Mahmood, Anjum; Arora, Ashish; Ramachandran, Ravishankar			Characterization of Rv3868, an Essential Hypothetical Protein of the ESX-1 Secretion System in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESAT-6-CFP-10 COMPLEX; PHAGOSOME MATURATION; CALMETTE-GUERIN; BOVIS BCG; VIRULENCE; ESAT-6; OLIGOMERIZATION; ATTENUATION; SEQUENCE; ATPASE	Rv3868, a conserved hypothetical protein of the ESAT-6 secretion system of Mycobacterium tuberculosis, is essential for the secretion of at least four virulence factors. Each protein chain is similar to 63 kDa and assembles into a hexamer. Limited proteolysis demonstrates that it consists of two domains joined by a linker. The N-terminal domain is a compact, helical domain of similar to 30 kDa and apparently functions to regulate the ATPase activity of the C-terminal domain and the oligomerization. The nucleotide binding site is situated in the C-terminal domain, which exhibits ATP-dependent self-association. It is also the oligomerization domain. Dynamic fluorescence quenching studies demonstrate that the domain is proximal to the C terminus in the apoprotein and exhibits a specific movement upon ATP binding. In silico modeling of the domains suggests that Arg-429 of a neighboring subunit forms a part of the binding site upon oligomerization. Mutational analysis of binding site residues demonstrates that the Arg-429 functions as the important "sensor arginine" in AAA-ATPases. Protein NMR experiments involving CFP-10 and activity assays rule out a general chaperone-like function for Rv3868. On the other hand, ATP-dependent "open-close" movements of the individual domains apparently enable it to interact and transfer energy to co-proteins in the ESX-1 pathway.	[Luthra, Amit; Mahmood, Anjum; Arora, Ashish; Ramachandran, Ravishankar] Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, POB 173,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Ramachandran, Ravishankar/D-1979-2010	Ramachandran, Ravishankar/0000-0002-0723-9861	Intramural [MLP007]; Council of Scientific and Industrial Research, India [CMM0017]; Central Drug Research Institute	Intramural; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Central Drug Research Institute	This work was supported by Intramural Grant MLP007, and computational support was from the Council of Scientific and Industrial Research, India, Grant CMM0017. This is communication 7469 from the Central Drug Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferreira RM, 2006, PROTEIN EXPRES PURIF, V47, P384, DOI 10.1016/j.pep.2006.02.006; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Georlette D, 2004, BIOPHYS J, V86, P1089, DOI 10.1016/S0006-3495(04)74184-3; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maier UG, 2000, MOL BIOL EVOL, V17, P576, DOI 10.1093/oxfordjournals.molbev.a026337; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nowak E, 2006, STRUCTURE, V14, P275, DOI 10.1016/j.str.2005.10.006; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PURKEY RM, 1977, EUR J BIOCHEM, V75, P303, DOI 10.1111/j.1432-1033.1977.tb11530.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOSHIAKI H, 1983, BIOCHIM BIOPHYS ACTA, V742, P496; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	40	30	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36532	36541		10.1074/jbc.M807144200	http://dx.doi.org/10.1074/jbc.M807144200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974091	Green Published, hybrid			2022-12-25	WOS:000261840500051
J	Sun, BF; Hong, J; Zhang, P; Dong, XC; Shen, X; Lin, DH; Ding, JP				Sun, Bingfa; Hong, Jing; Zhang, Peng; Dong, Xianchi; Shen, Xu; Lin, Donghai; Ding, Jianping			Molecular Basis of the Interaction of Saccharomyces cerevisiae Eaf3 Chromo Domain with Methylated H3K36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSAGE COMPENSATION COMPLEX; HISTONE H3 TAIL; FUNCTIONAL-INTEGRATION; STRUCTURAL BASIS; BINDING MODULES; MSL COMPLEX; LYSINE 9; TRANSCRIPTION; ACETYLATION; PROTEIN	Eaf3 is a component of both NuA4 histone acetyltransferase and Rpd3S histone deacetylase complexes in Saccharomyces cerevisiae. It is involved in the regulation of the global pattern of histone acetylation that distinguishes promoters from coding regions. Eaf3 contains a chromo domain at the N terminus that can bind to methylated Lys-36 of histone H3 (H3K36). We report here the crystal structures of the Eaf3 chromo domain in two truncation forms. Unlike the typical HP1 and Polycomb chromo domains, which contain a large groove to bind the modified histone tail, the Eaf3 chromo domain assumes an autoinhibited chromo barrel domain similar to the human MRG15 chromo domain. Compared with other chromo domains, the Eaf3 chromo domain contains a unique 38-residue insertion that folds into two short beta-strands and a long flexible loop to flank the beta-barrel core. Both isothermal titration calorimetry and surface plasmon resonance studies indicate that the interaction between the Eaf3 chromo domain and the trimethylated H3K36 peptide is relatively weak, with a K-D of similar to 10(-4) M. NMR titration studies demonstrate that the methylated H3K36 peptide is bound to the cleft formed by the C-terminal alpha-helix and the beta-barrel core. Site-directed mutagenesis study and in vitro binding assay results show that the conserved aromatic residues Tyr-23, Tyr-81, Trp-84, and Trp-88, which form a hydrophobic pocket at one end of the beta-barrel, are essential for the binding of the methylated H3K36. These results reveal the molecular mechanism of the recognition and binding of the methylated H3K36 by Eaf3 and provide new insights into the functional roles of the Eaf3 chromo domain.	[Hong, Jing; Shen, Xu; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Bingfa; Zhang, Peng; Dong, Xianchi; Ding, Jianping] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 201203, Peoples R China; [Sun, Bingfa; Zhang, Peng; Dong, Xianchi; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 201203, Peoples R China; [Dong, Xianchi] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; jpding@sibs.ac.cn	Dong, Xianchi/C-1393-2015	Dong, Xianchi/0000-0001-5121-1236; Sun, Bingfa/0000-0001-5001-5065; zhang, peng/0000-0003-0408-2923; ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302, 2007CB914304]; National Natural Science Foundation of China [30570379, 30570352, 30623002, 30730028]; Chinese Academy of Sciences [KSCX2-YW-R-107, KSCX2-YW-R-104]; Science and Technology Commission of Shanghai Municipality [07XD14032, 07DZ22009]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302, and 2007CB914304; National Natural Science Foundation of China Grants 30570379, 30570352, 30623002, and 30730028; Chinese Academy of Sciences Grants KSCX2-YW-R-107 and KSCX2-YW-R-104; and Science and Technology Commission of Shanghai Municipality Grants 07XD14032 and 07DZ22009. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fujita M, 2002, MECH DEVELOP, V114, P61, DOI 10.1016/S0925-4773(02)00058-8; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morales V, 2005, MOL CELL BIOL, V25, P5947, DOI 10.1128/MCB.25.14.5947-5954.2005; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	45	53	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36504	36512		10.1074/jbc.M806564200	http://dx.doi.org/10.1074/jbc.M806564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984594	Green Published, hybrid			2022-12-25	WOS:000261840500048
J	Tsika, RW; Schramm, C; Simmer, G; Fitzsimons, DP; Moss, RL; Ji, J				Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Fitzsimons, Daniel P.; Moss, Richard L.; Ji, Juan			Overexpression of TEAD-1 in Transgenic Mouse Striated Muscles Produces a Slower Skeletal Muscle Contractile Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; CREATINE-KINASE GENE; GLYCOGEN-SYNTHASE KINASE-3; M-CAT ELEMENTS; FIBER-TYPE; ENHANCER FACTOR-1; CARDIAC-MUSCLE; DEVELOPMENTAL REGULATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS	TEA domain (TEAD) transcription factors serve important functional roles during embryonic development and in striated muscle gene expression. Our previous work has implicated a role for TEAD-1 in the fast-to-slow fiber-type transition in response to mechanical overload. To investigate whether TEAD-1 is a modulator of slow muscle gene expression in vivo, we developed transgenic mice expressing hemagglutinin (HA)-tagged TEAD-1 under the control of the muscle creatine kinase promoter. We show that striated muscle-restricted HA-TEAD-1 expression induced a transition toward a slow muscle contractile protein phenotype, slower shortening velocity (V-max), and longer contraction and relaxation times in adult fast twitch extensor digitalis longus muscle. Notably, HA-TEAD-1 overexpression resulted in an unexpected activation of GSK-3 alpha/beta and decreased nuclear beta-catenin and NFATc1/c3 protein. These effects could be reversed in vivo by mechanical overload, which decreased muscle creatine kinase-driven TEAD-1 transgene expression, and in cultured satellite cells by TEAD-1-specific small interfering RNA. These novel in vivo data support a role for TEAD-1 in modulating slow muscle gene expression.	[Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Ji, Juan] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO 65211 USA; [Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Ji, Juan] Univ Missouri, Sch Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Fitzsimons, Daniel P.; Moss, Richard L.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison	Tsika, RW (corresponding author), Univ Missouri, Sch Med, Dept Biochem, 440D Bond Life Sci Ctr, Columbia, MO 65211 USA.	tsikar@missouri.edu			National Institutes of Health, NIAMS [AR41464, AR47197]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041464, R01AR047197] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grants AR41464 and AR47197 (to R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; BOOTH FW, 1996, HDB PHYSL, V12, P1075; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Issa LL, 2006, DEV BIOL, V293, P104, DOI 10.1016/j.ydbio.2006.01.019; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Kaneko KJ, 2007, GENESIS, V45, P577, DOI 10.1002/dvg.20330; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; LARKIN SB, 1999, HEART DEV, P307; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; MOSS RL, 1995, REV PHYSIOL BIOCH P, V126, P1, DOI 10.1007/BFb0049775; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nguyen QGV, 2003, J BIOL CHEM, V278, P46494, DOI 10.1074/jbc.M308194200; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Potthoff MJ, 2007, CURR OPIN RHEUMATOL, V19, P542, DOI 10.1097/BOR.0b013e3282efb761; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; SAWADA A, 2008, MOL CELL BI IN PRESS; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shen TS, 2007, J PHYSIOL-LONDON, V579, P535, DOI 10.1113/jphysiol.2006.120048; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Swoap SJ, 1998, AM J PHYSIOL-CELL PH, V274, pC681, DOI 10.1152/ajpcell.1998.274.3.C681; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tothova J, 2006, J CELL SCI, V119, P1604, DOI 10.1242/jcs.02875; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; Tsika GL, 1996, AM J PHYSIOL-CELL PH, V271, pC690, DOI 10.1152/ajpcell.1996.271.2.C690; Tsika R W, 1994, Exerc Sport Sci Rev, V22, P361; TSIKA RW, 1995, AM J PHYSIOL-CELL PH, V269, pC665, DOI 10.1152/ajpcell.1995.269.3.C665; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vyas DR, 1999, J BIOL CHEM, V274, P30832, DOI 10.1074/jbc.274.43.30832; Vyas DR, 2001, J BIOL CHEM, V276, P1173, DOI 10.1074/jbc.M007750200; Wiedenman JL, 1996, AM J PHYSIOL-CELL PH, V270, pC1111, DOI 10.1152/ajpcell.1996.270.4.C1111; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788	75	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36154	36167		10.1074/jbc.M807461200	http://dx.doi.org/10.1074/jbc.M807461200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18978355	Green Published, hybrid			2022-12-25	WOS:000261840500010
J	Yamazoe, M; Nishitani, C; Takahashi, M; Katoh, T; Ariki, S; Shimizu, T; Mitsuzawa, H; Sawada, K; Voelker, DR; Takahashi, H; Kuroki, Y				Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Katoh, Tsuyoshi; Ariki, Shigeru; Shimizu, Takeyuki; Mitsuzawa, Hiroaki; Sawada, Kaku; Voelker, Dennis R.; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Surfactant Protein D Inhibits Lipopolysaccharide (LPS)-induced Inflammatory Cell Responses by Altering LPS Binding to Its Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; EXTRACELLULAR TLR4 DOMAIN; SITE-DIRECTED MUTAGENESIS; BRONCHOALVEOLAR LAVAGE; ALVEOLAR MACROPHAGES; OLIGOMERIC STRUCTURE; SIGNAL-TRANSDUCTION; ALPHA SECRETION; IN-VIVO; MD-2	Pulmonary surfactant protein D (SP-D) is a member of the collectin family that plays an important role in regulating innate immunity of the lung. We examined the mechanisms by which SP-D modulates lipopolysaccharide (LPS)-elicited inflammatory cell responses. SP-D bound to a complex of recombinant soluble forms of Toll-like receptor 4 (TLR4) and MD-2 with high affinity and down-regulated tumor necrosis factor-alpha secretion and NF-kappa B activation elicited by rough and smooth LPS, in alveolar macrophages and TLR4/MD-2-transfected HEK293 cells. Cell surface binding of both serotypes of LPS to TLR4/MD-2-expressing cells was attenuated by SP-D. In addition, SP-D significantly reduced MD-2 binding to both serotypes of LPS. A chimera containing the N-terminal region and the collagenous domain of surfactant protein A, and the coiled-coil neck and lectin domains of SP-D, was a weak inhibitor of LPS-induced cell responses and MD-2 binding to LPS, compared with native SP-D. The collagenase-resistant fragment consisting of the neck plus the carbohydrate recognition domain of SP-D also was a very weak inhibitor of LPS activation. This study demonstrates that SP-D down-regulates LPS-elicited inflammatory responses by altering LPS binding to its receptors and reveals the importance of the correct oligomeric structure of the protein in this process.	[Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Ariki, Shigeru; Shimizu, Takeyuki; Mitsuzawa, Hiroaki; Sawada, Kaku; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Yamazoe, Masami; Sawada, Kaku; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Mitsuzawa, Hiroaki] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Katoh, Tsuyoshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; [Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; [Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Ariki, Shigeru; Shimizu, Takeyuki; Sawada, Kaku; Kuroki, Yoshio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Asahikawa Medical College; National Jewish Health; Japan Science & Technology Agency (JST)	Kuroki, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	kurokiy@sapmed.ac.jp	Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Science, Sports and Culture, Japan; Akiyama Foundation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture, Japan and by Akiyama Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; AUSBEL FM, 1992, CURRENT PROTOCOLS MO; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CROUCH E, 1994, J BIOL CHEM, V269, P17311; CROUCH E, 1994, J BIOL CHEM, V269, P15808; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; HANCOCK REW, 1994, N COMP BIOC, V27, P263, DOI DOI 10.1016/S0167-7306(08)60415-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ikegami M, 2006, AM J RESP CRIT CARE, V173, P1342, DOI 10.1164/rccm.200509-1485OC; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; Mitsuzawa H, 2006, J IMMUNOL, V177, P8133, DOI 10.4049/jimmunol.177.11.8133; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PERSSON A, 1990, J BIOL CHEM, V265, P5755; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; RUST K, 1991, ARCH BIOCHEM BIOPHYS, V290, P116, DOI 10.1016/0003-9861(91)90597-C; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; VOSS T, 1988, J MOL BIOL, V201, P219, DOI 10.1016/0022-2836(88)90448-2; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200	45	74	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35878	35888		10.1074/jbc.M807268200	http://dx.doi.org/10.1074/jbc.M807268200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18990700	hybrid			2022-12-25	WOS:000261687900063
J	Qian, CM; Li, SD; Jakoncic, J; Zeng, L; Walsh, MJ; Zhou, MM				Qian, Chengmin; Li, Side; Jakoncic, Jean; Zeng, Lei; Walsh, Martin J.; Zhou, Ming-Ming			Structure and Hemimethylated CpG Binding of the SRA Domain from Human UHRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METHYL-CPG; PROTEIN; ICBP90; DNA; HETEROCHROMATINIZATION; FAMILY; CELLS; DNMT1	Human UHRF1((u) under bar biquitin-like P (H) under barD and (R) under bar ING (f) under bar inger (1) under bar) functions to maintain CpG DNA methylation patterns through DNA replication by co-localizing with the DNA methyltransferase DNMT1 at chromatin in mammals. Recent studies show that UHRF1 binds selectively to hemimethylated CpG via its conserved SRA ((S) under bar ET-and (R) under bar ING finger-(a) under bar ssociated) domain. However, the underlying molecular mechanism is not known. Here, we report a 1.95 angstrom resolution crystal structure of the SRA domain of human UHRF1. Using NMR structure-guided mutagenesis, electrophoretic mobility shift assay, and fluorescence anisotropy analysis, we determined key amino acid residues for methyl-DNA binding that are conserved in the SRA domain.	[Qian, Chengmin; Zeng, Lei; Zhou, Ming-Ming] New York Univ, Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Li, Side; Walsh, Martin J.] New York Univ, Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; United States Department of Energy (DOE); Brookhaven National Laboratory	Zhou, MM (corresponding author), New York Univ, Mt Sinai Sch Med, Dept Struct & Chem Biol, 1425 Madison Ave,POB 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu	Qian, Chengmin/E-9881-2010	Qian, Chengmin/0000-0003-4491-4421	NMR; Brookhaven National Laboratory [X4C, X6A]; National Institutes of Health [GM073207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073207] Funding Source: NIH RePORTER	NMR; Brookhaven National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health, Grant GM073207 (to M.-M.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. We acknowledge the use of the NMR facilities at the New York Structural Biology Center and thank the staff at the Brookhaven National Laboratory (beamlines X4C and X6A) for facilitating x-ray data collection. We also thank A. Plotnikov and G. Chai for helpful discussion.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; CITTERIO E, 2004, MOL CELL BIOL, V28, P705; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hopfner R, 2002, ANTICANCER RES, V22, P3165; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Liu SM, 2007, PLANT J, V52, P914, DOI 10.1111/j.1365-313X.2007.03286.x; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Schaaf GJ, 2005, FASEB J, V19, P404, DOI 10.1096/fj.04-2104fje; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	28	68	70	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34490	34494		10.1074/jbc.C800169200	http://dx.doi.org/10.1074/jbc.C800169200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945682	hybrid, Green Published			2022-12-25	WOS:000261469100002
J	Merlo, E; Romano, A				Merlo, Emiliano; Romano, Arturo			Memory Extinction Entails the Inhibition of the Transcription Factor NF-kappa B	PLOS ONE			English	Article							LONG-TERM-MEMORY; CRAB CHASMAGNATHUS-GRANULATUS; PROTEIN-SYNTHESIS; FEAR EXTINCTION; CONDITIONED FEAR; RAT HIPPOCAMPUS; DANGER STIMULUS; RECONSOLIDATION; CONSOLIDATION; HABITUATION	In contextual memories, an association between a positive or negative reinforcement and the contextual cues where the reinforcement occurs is formed. The re-exposure to the context without reinforcement can lead to memory extinction or reconsolidation, depending on the number of events or duration of a single event of context re-exposure. Extinction involves the temporary waning of the previously acquired conditioned response. The molecular processes underlying extinction and the mechanisms which determine if memory will reconsolidate or extinguish after retrieval are not well characterized, particularly the role of transcription factors and gene expression. Here we studied the participation of a transcription factor, NF-kappa B, in memory extinction. In the crab context-signal memory, the activation of NF-kappa B plays a critical role in consolidation and reconsolidation, memory processes that are well characterized in this model. The administration of a NF-kappa B inhibitor, sulfasalazine prior to extinction session impeded spontaneous recovery. Moreover, reinstatement experiments showed that the original memory was not affected and that NF-kappa B inhibition by sulfasalazine impaired spontaneous recovery strengthening the ongoing memory extinction process. Interestingly, in animals with fully consolidated memory, a brief re-exposure to the training context induced neuronal NF-kappa B activation and reconsolidation, while prolonged re-exposure induced NF-kappa B inhibition and memory extinction. These data constitutes a novel insight into the molecular mechanisms involved in the switch between memory reconsolidation and extinction. Moreover, we propose the inhibition of NF-kappa B as the engaged mechanism underlying extinction, supporting a novel approach for the pharmacological enhancement of this memory process. The accurate description of the molecular mechanisms that support memory extinction is potentially useful for developing new strategies and drug candidates for therapeutic treatments of the maladaptive memory disorders such as post-traumatic stress, phobias, and drug addiction.	[Merlo, Emiliano; Romano, Arturo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIByNE,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Merlo, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Neurobiol Memoria, Dept Fisiol Biol Mol & Celular,IFIByNE,CONICET, Ciudad Univ,Pab 2, Buenos Aires, DF, Argentina.	aromano@fbmc.fcen.uba.ar	Merlo, Emiliano/S-5328-2019	Merlo, Emiliano/0000-0001-9162-6858; Romano, Arturo/0000-0002-8457-0494	FONCYT-PICT Argentina [26095]; CONICET PIP [5466]; University of Buenos Aires UBACYT [X251]	FONCYT-PICT Argentina(ANPCyTFONCyT); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires UBACYT(University of Buenos Aires)	This work was supported by FONCYT-PICT 26095 Argentina, CONICET PIP 5466 and University of Buenos Aires UBACYT X251 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOUTON ME, 1991, CURRENT TOPICS IN ANIMAL LEARNING : BRAIN, EMOTION, AND COGNITION, P25; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Davis M, 2006, J TRAUMA STRESS, V19, P571, DOI 10.1002/jts.20149; FALLS WA, 1992, J NEUROSCI, V12, P854; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Freudenthal R, 1998, NEUROSCI LETT, V242, P143, DOI 10.1016/S0304-3940(98)00059-7; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GLEESON RA, 1977, COMP BIOCHEM PHYS A, V56, P411, DOI 10.1016/0300-9629(77)90258-4; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HOEGER U, 1989, COMP BIOCHEM PHYS C, V92, P323, DOI 10.1016/0742-8413(89)90062-5; Howell DC, 1987, STAT METHODS PSYCHOL; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lin CH, 2003, J NEUROSCI, V23, P8310; Lin CH, 2003, J NEUROSCI, V23, P1574; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; LOZADA M, 1990, PHYSIOL BEHAV, V47, P35, DOI 10.1016/0031-9384(90)90039-7; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; PEDREIRA ME, 1995, PHARMACOL BIOCHEM BE, V52, P385, DOI 10.1016/0091-3057(95)00124-F; Pedreira ME, 1998, ANIM LEARN BEHAV, V26, P34, DOI 10.3758/BF03199160; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Pereyra P, 2000, NEUROBIOL LEARN MEM, V74, P119, DOI 10.1006/nlme.1999.3945; Perez-Cuesta LM, 2007, LEARN MEMORY, V14, P101, DOI 10.1101/lm.413507; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; ROMANO A, 1990, BEHAV NEURAL BIOL, V53, P113, DOI 10.1016/0163-1047(90)90882-7; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Romano A, 2006, BIOL BULL-US, V210, P280, DOI 10.2307/4134564; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rothbaum BO, 2002, AM J PSYCHOTHER, V56, P59, DOI 10.1176/appi.psychotherapy.2002.56.1.59; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tomsic D, 1998, ANIM LEARN BEHAV, V26, P196, DOI 10.3758/BF03199212; Vianna MR, 2003, NEUROBIOL LEARN MEM, V79, P199, DOI 10.1016/S1074-7427(03)00003-0; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298	53	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3687	10.1371/journal.pone.0003687	http://dx.doi.org/10.1371/journal.pone.0003687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432WR	18997870	Green Published, gold, Green Submitted			2022-12-25	WOS:000265165500010
J	Muzzi, A; Moschioni, M; Covacci, A; Rappuoli, R; Donati, C				Muzzi, Alessandro; Moschioni, Monica; Covacci, Antonello; Rappuoli, Rino; Donati, Claudio			Pilus Operon Evolution in Streptococcus pneumoniae Is Driven by Positive Selection and Recombination	PLOS ONE			English	Article							DIVERSIFYING SELECTION; PLASMODIUM-FALCIPARUM; ANTIGENIC DIVERSITY; SEQUENCE; ADAPTATION; SITES; POLYMORPHISM; POPULATIONS; VIRULENCE; PATTERNS	Background: The evolution of bacterial organelles involved in host-pathogen interactions is subject to intense and competing selective pressures due to the need to maintain function while escaping the host immune response. To characterize the interplay of these forces in an important pathogen, we sequenced the rlrA islet, a chromosomal region encoding for a pilus-like structure involved in adherence to lung epithelial cells in vitro and in colonization in a murine model of infection, in 44 clinical isolates of Streptococcus pneumoniae. Results: We found that the rrgA and rrgB genes, encoding the main structural components of the pilus, are under the action of positive selection. In contrast, the rrgC gene, coding for a component present in low quantities in the assembled pilus, and the srtB, srtC and srtD genes, coding for three sortase enzymes essential for pilus assembly but probably not directly exposed to the host immune system, show no evidence of positive selection. We found several events of homologous recombination in the region containing these genes, identifying 4 major recombination hotspots. An analysis of the most recent recombination events shows a high level of mosaicism of the region coding for the rrgC, srtB, srtC and srtD genes. Conclusions: In the rlrA islet, the genes coding for proteins directly exposed to the host immune response are under the action of positive selection, and exist in distinct forms in the population of circulating strains. The genes coding for proteins not directly exposed on the surface of the bacterial cell are more conserved probably due to the homogenizing effect of recombination.	[Muzzi, Alessandro; Moschioni, Monica; Covacci, Antonello; Rappuoli, Rino; Donati, Claudio] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	Muzzi, A (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	claudio.donati@novartis.com	Donati, Claudio/AAF-1246-2020; Donati, Claudio/J-5180-2012	Donati, Claudio/0000-0001-8688-1651				Anisimova M, 2003, GENETICS, V164, P1229; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Baum J, 2003, GENETICS, V163, P1327; Boyd EF, 1998, J MOL EVOL, V47, P258, DOI 10.1007/PL00006383; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fearnhead P, 2001, GENETICS, V159, P1299; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Guttman DS, 2006, MOL BIOL EVOL, V23, P2342, DOI 10.1093/molbev/msl103; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hudson RR, 2001, GENETICS, V159, P1805; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MOSCHIONI M, 2008, J INFECT DIS; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Polley SD, 2001, GENETICS, V158, P1505; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Urwin R, 2002, MOL BIOL EVOL, V19, P1686, DOI 10.1093/oxfordjournals.molbev.a003991; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3660	10.1371/journal.pone.0003660	http://dx.doi.org/10.1371/journal.pone.0003660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987753	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134500006
J	Irrcher, I; Ljubicic, V; Kirwan, AF; Hood, DA				Irrcher, Isabella; Ljubicic, Vladimir; Kirwan, Angie F.; Hood, David A.			AMP-Activated Protein Kinase-Regulated Activation of the PGC-1 alpha Promoter in Skeletal Muscle Cells	PLOS ONE			English	Article								The mechanisms by which PGC-1 alpha gene expression is controlled in skeletal muscle remains largely undefined. Thus, we sought to investigate the transcriptional regulation of PGC-1 alpha using AICAR, an activator of AMPK, that is known to increase PGC-1 alpha expression. A 2.2 kb fragment of the human PGC-1 alpha promoter was cloned and sequence analysis revealed that this TATA-less sequence houses putative consensus sites including a GC-box, a CRE, several IRSs, a SRE, binding sites for GATA, MEF2, p 53, NF-kappa B, and EBox binding proteins. AMPK activation for 24 hours increased PGC-1 alpha promoter activity with concomitant increases in mRNA expression. The effect of AICAR on transcriptional activation was mediated by an overlapping GATA/EBox binding site at 2495 within the PGC-1 alpha promoter based on gel shift analyses that revealed increases in GATA/EBox DNA binding. Mutation of the EBox within the GATA/EBox binding site in the promoter reduced basal promoter activity and completely abolished the AICAR effect. Supershift analyses identified USF-1 as a DNA binding transcription factor potentially involved in regulating PGC-1 alpha promoter activity, which was confirmed in vivo by ChIP. Overexpression of either GATA-4 or USF-1 alone increased the p851 PGC-1 alpha promoter activity by 1.7- and 2.0-fold respectively, while co-expression of GATA-4 and USF-1 led to an additive increase in PGC-1 alpha promoter activity. The USF-1-mediated increase in PGC-1 alpha promoter activation led to similar increases at the mRNA level. Our data identify a novel AMPK-mediated regulatory pathway that regulates PGC-1 alpha gene expression. This could represent a potential therapeutic target to control PGC-1 alpha expression in skeletal muscle.	[Ljubicic, Vladimir; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Ljubicic, Vladimir; Hood, David A.] York Univ, Muscle Hlth Res Ctr, N York, ON M3J 1P3, Canada; [Irrcher, Isabella; Kirwan, Angie F.; Hood, David A.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada	Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	dhood@yorku.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada [scholarships]; Heart and Stroke Foundation of Canada [scholarships]; Canada Research Chair in Cell Physiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chair in Cell Physiology(Canada Research Chairs)	This project was funded by the Canadian Institutes of Health Research, and the Natural Science and Engineering Research Council of Canada (NSERC; DAH). II and VL were recipients of scholarships from NSERC. VL was the recipient of a scholarship from the Heart and Stroke Foundation of Canada. DAH is the holder of a Canada Research Chair in Cell Physiology. The funding sources had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, and in the preparation, review, or approval of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Connor MK, 2001, J BIOL CHEM, V276, P15898, DOI 10.1074/jbc.M100272200; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Feingold K, 2004, AM J PHYSIOL-ENDOC M, V286, pE201, DOI 10.1152/ajpendo.00205.2003; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luo X, 1996, MOL CELL BIOL, V16, P1367; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Moore ML, 2001, J BIOL CHEM, V276, P1026, DOI 10.1074/jbc.M009352200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Planavila A, 2005, BBA-MOL CELL BIOL L, V1736, P120, DOI 10.1016/j.bbalip.2005.08.001; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu D, 2002, BIOCHEM BIOPH RES CO, V294, P245, DOI 10.1016/S0006-291X(02)00464-3	52	150	153	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3614	10.1371/journal.pone.0003614	http://dx.doi.org/10.1371/journal.pone.0003614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974883	Green Published, gold			2022-12-25	WOS:000265131700028
J	Gumy, C; Chandsawangbhuwana, C; Dzyakanchuk, AA; Kratschmar, DV; Baker, ME; Odermatt, A				Gumy, Christel; Chandsawangbhuwana, Charlie; Dzyakanchuk, Anna A.; Kratschmar, Denise V.; Baker, Michael E.; Odermatt, Alex			Dibutyltin Disrupts Glucocorticoid Receptor Function and Impairs Glucocorticoid-Induced Suppression of Cytokine Production	PLOS ONE			English	Article								Background: Organotins are highly toxic and widely distributed environmental chemicals. Dibutyltin (DBT) is used as stabilizer in the production of polyvinyl chloride plastics, and it is also the major metabolite formed from tributyltin (TBT) in vivo. DBT is immunotoxic, however, the responsible targets remain to be defined. Due to the importance of glucocorticoids in immune-modulation, we investigated whether DBT could interfere with glucocorticoid receptor (GR) function. Methodology: We used HEK-293 cells transiently transfected with human GR as well as rat H4IIE hepatoma cells and native human macrophages and human THP-1 macrophages expressing endogenous receptor to study organotin effects on GR function. Docking of organotins was used to investigate the binding mechanism. Principal Findings: We found that nanomolar concentrations of DBT, but not other organotins tested, inhibit ligand binding to GR and its transcriptional activity. Docking analysis indicated that DBT inhibits GR activation allosterically by inserting into a site close to the steroid-binding pocket, which disrupts a key interaction between the A-ring of the glucocorticoid and the GR. DBT inhibited glucocorticoid-induced expression of phosphoenolpyruvate carboxykinase (PEPCK) and tyrosine-aminotransferase (TAT) and abolished the glucocorticoid-mediated transrepression of TNF-alpha-induced NF-kappa B activity. Moreover, DBT abrogated the glucocorticoid-mediated suppression of interleukin-6 (IL-6) and TNF-alpha production in lipopolysaccharide (LPS)-stimulated native human macrophages and human THP-1 macrophages. Conclusions: DBT inhibits ligand binding to GR and subsequent activation of the receptor. By blocking GR activation, DBT may disturb metabolic functions and modulation of the immune system, providing an explanation for some of the toxic effects of this organotin.	[Gumy, Christel; Dzyakanchuk, Anna A.; Kratschmar, Denise V.; Odermatt, Alex] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gumy, Christel] Univ Bern, Dept Nephrol & Hypertens, CH-3012 Bern, Switzerland; [Chandsawangbhuwana, Charlie; Baker, Michael E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Bern; University of California System; University of California San Diego	Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu; Alex.Odermatt@unibas.ch		Baker, Michael/0000-0003-4387-3269; Winter, denise V./0000-0002-3764-1747; Odermatt, Alex/0000-0002-6820-2712	Swiss National Science Foundation [310000-112279, 4050-066575]; Novartis Chair of Molecular and Systems Toxicology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Chair of Molecular and Systems Toxicology	This work was supported by grants from the Swiss National Science Foundation (No 310000-112279 and NRP50 "Endocrine Disruptors" No 4050-066575). A.O. has a Novartis Chair of Molecular and Systems Toxicology. The authors of this manuscript have nothing to declare.	Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Atanasov AG, 2005, ENVIRON HEALTH PERSP, V113, P1600, DOI 10.1289/ehp.8209; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhosle NB, 2004, CHEMOSPHERE, V57, P897, DOI 10.1016/j.chemosphere.2004.06.037; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chicano JJ, 2001, BBA-BIOMEMBRANES, V1510, P330, DOI 10.1016/S0005-2736(00)00365-5; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Evans SM, 2000, SCI TOTAL ENVIRON, V258, P73, DOI 10.1016/S0048-9697(00)00507-6; FENT K, 2005, HDB ENV CHEM, V5, DOI DOI 10.1007/1698_1005_1050; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Gennari A, 2000, TOXICOL APPL PHARM, V169, P185, DOI 10.1006/taap.2000.9076; GRUN F, 2006, MOL ENDOCRINOL; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Inadera H, 2005, TOXICOL LETT, V159, P226, DOI 10.1016/j.toxlet.2005.05.015; Jenkins SM, 2004, DEV BRAIN RES, V151, P1, DOI 10.1016/j.devbrainres.2004.03.015; Kannan K, 1999, ARCH ENVIRON CON TOX, V36, P462, DOI 10.1007/PL00006619; Kato T, 2004, EUR J IMMUNOL, V34, P1312, DOI 10.1002/eji.200324667; KRAJNC EI, 1984, TOXICOL APPL PHARM, V75, P363, DOI 10.1016/0041-008X(84)90176-5; Liu JY, 2002, J AGR FOOD CHEM, V50, P6683, DOI 10.1021/jf025712i; MERKORD J, 1989, EXP PATHOL-JENA, V36, P59, DOI 10.1016/S0232-1513(89)80113-6; Merkord J, 2001, HUM EXP TOXICOL, V20, P386, DOI 10.1191/096032701682692964; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nakanishi T, 2005, MOL ENDOCRINOL, V19, P2502, DOI 10.1210/me.2004-0397; Nielsen JB, 2002, ENVIRON RES, V88, P129, DOI 10.1006/enrs.2001.4321; Odermatt A, 2006, J STEROID BIOCHEM, V102, P222, DOI 10.1016/j.jsbmb.2006.09.010; Ohhira S, 2003, ARCH TOXICOL, V77, P138, DOI 10.1007/s00204-002-0428-5; Omura Minoru, 2004, Environ Sci, V11, P123; Rebuffat AG, 2004, MOL CELL ENDOCRINOL, V214, P27, DOI 10.1016/j.mce.2003.11.027; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sadiki AI, 1999, CHEMOSPHERE, V38, P1541, DOI 10.1016/S0045-6535(98)00374-9; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SEINEN W, 1977, TOXICOL APPL PHARM, V42, P213, DOI 10.1016/0041-008X(77)90211-3; SNOEIJ NJ, 1988, INT J IMMUNOPHARMACO, V10, P891, DOI 10.1016/0192-0561(88)90014-8; Sternberg RM, 2006, AQUAT TOXICOL, V78, P233, DOI 10.1016/j.aquatox.2006.03.004; Takahashi S, 1999, ARCH ENVIRON CON TOX, V37, P50, DOI 10.1007/s002449900489; Takahashi S, 1999, ENVIRON POLLUT, V106, P213, DOI 10.1016/S0269-7491(99)00068-8; Tschopp CM, 2006, BLOOD, V108, P2290, DOI 10.1182/blood-2006-03-010348; Ueno S, 2003, ARCH TOXICOL, V77, P173, DOI 10.1007/s00204-002-0429-4; Ueno S, 1997, ARCH TOXICOL, V71, P513, DOI 10.1007/s002040050421; Whalen MM, 1999, ENVIRON RES, V81, P108, DOI 10.1006/enrs.1999.3968; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102	43	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3545	10.1371/journal.pone.0003545	http://dx.doi.org/10.1371/journal.pone.0003545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958157	Green Published, Green Submitted, gold			2022-12-25	WOS:000265130900007
J	Roark, EA; Haldar, K				Roark, Everett A.; Haldar, Kasturi			Effects of Lysosomal Membrane Protein Depletion on the Salmonella-Containing Vacuole	PLOS ONE			English	Article								Salmonella is an intracellular bacterial pathogen that replicates within a membrane-bound vacuole in host cells. The major lysosomal membrane proteins 1 and 2 (LAMP-1 and LAMP-2) are recruited to the Salmonella-containing vacuole as well as Salmonella-associated filaments (Sifs) that emerge from the vacuole. LAMP-1 is a dominant membrane marker for the vacuole and Sifs. Its colocalization with both is dependent on a major secreted bacterial virulence protein, SifA. Here, we show that SifA is required for the recruitment of LAMP-2 and can be used as a second independent marker for both the bacterial vacuolar membrane and Sifs. Further, RNAi studies revealed that in LAMP-1 depleted cells, the bacteria remain membrane bound as measured by their association with LAMP-2 protein. In contrast, LAMP-2 depletion increased the amount of LAMP-1 free bacteria. Together, the data suggests that despite its abundance, LAMP-1 is not essential, but LAMP-2 may be partially important for the Salmonella-containing vacuolar membrane.	[Roark, Everett A.; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Roark, Everett A.; Haldar, Kasturi] Northwestern Univ, Dept Pathol, Chicago, IL USA	University of Notre Dame; Northwestern University	Haldar, K (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014		Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award [1-U54-057153]; Diversifying Higher Education Faculty in Illinois Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Diversifying Higher Education Faculty in Illinois Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the VA merit award (K.H.). K.H. acknowledges membership within and support from the Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award 1-U54-057153). This work was also supported by the Diversifying Higher Education Faculty in Illinois Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Finlay BB, 2000, PHILOS T ROY SOC B, V355, P623, DOI 10.1098/rstb.2000.0603; GALAN JE, 1989, P NATL ACAD SCI USA, V58, P1879; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; JONES BD, 1994, INFECT IMMUN, V62, P3745, DOI 10.1128/IAI.62.9.3745-3752.1994; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; MILLS SD, 1994, MICROB PATHOGENESIS, V17, P409, DOI 10.1006/mpat.1994.1086; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; PORTILLO FG, 1995, J CELL BIOL, V129, P81; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; ZWEU E, 2008, TROP MED INT HEALTH, V13, P532	36	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3538	10.1371/journal.pone.0003538	http://dx.doi.org/10.1371/journal.pone.0003538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958159	Green Submitted, Green Published, gold			2022-12-25	WOS:000265130900002
J	Egea, PF; Napetschnig, J; Walter, P; Stroud, RM				Egea, Pascal F.; Napetschnig, Johanna; Walter, Peter; Stroud, Robert M.			Structures of SRP54 and SRP19, the Two Proteins that Organize the Ribonucleic Core of the Signal Recognition Particle from Pyrococcus furiosus	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NUCLEOTIDE SPECIFICITY; ANGSTROM RESOLUTION; NUCLEAR EXPORT; GTPASES FFH; INDUCED FIT; S-DOMAIN; 4.5S RNA; COMPLEX; BINDING	In all organisms the Signal Recognition Particle (SRP), binds to signal sequences of proteins destined for secretion or membrane insertion as they emerge from translating ribosomes. In Archaea and Eucarya, the conserved ribonucleoproteic core is composed of two proteins, the accessory protein SRP19, the essential GTPase SRP54, and an evolutionarily conserved and essential SRP RNA. Through the GTP-dependent interaction between the SRP and its cognate receptor SR, ribosomes harboring nascent polypeptidic chains destined for secretion are dynamically transferred to the protein translocation apparatus at the membrane. We present here high-resolution X-ray structures of SRP54 and SRP19, the two RNA binding components forming the core of the signal recognition particle from the hyper-thermophilic archaeon Pyrococcus furiosus (Pfu). The 2.5 angstrom resolution structure of free Pfu-SRP54 is the first showing the complete domain organization of a GDP bound full-length SRP54 subunit. In its ras-like GTPase domain, GDP is found tightly associated with the protein. The flexible linker that separates the GTPase core from the hydrophobic signal sequence binding M domain, adopts a purely alpha-helical structure and acts as an articulated arm allowing the M domain to explore multiple regions as it scans for signal peptides as they emerge from the ribosomal tunnel. This linker is structurally coupled to the GTPase catalytic site and likely to propagate conformational changes occurring in the M domain through the SRP RNA upon signal sequence binding. Two different 1.8 angstrom resolution crystal structures of free Pfu-SRP19 reveal a compact, rigid and well-folded protein even in absence of its obligate SRP RNA partner. Comparison with other SRP19.SRP RNA structures suggests the rearrangement of a disordered loop upon binding with the RNA through a reciprocal induced-fit mechanism and supports the idea that SRP19 acts as a molecular scaffold and a chaperone, assisting the SRP RNA in adopting the conformation required for its optimal interaction with the essential subunit SRP54, and proper assembly of a functional SRP.	[Egea, Pascal F.; Walter, Peter; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Napetschnig, Johanna] Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Rockefeller University	Egea, PF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	pascal@msg.ucsf.edu; stroud@msg.ucsf.edu	egea, pascal/V-7662-2019; Egea, Pascal Francois/AAI-2759-2020	egea, pascal/0000-0003-4432-8625; 	NIH [GM60641]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM60641 to R.M.S. that supports P.F.E and NIH grants to P.W. P.W is an investigator from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alavian CN, 2004, BIOCHEM BIOPH RES CO, V313, P351, DOI 10.1016/j.bbrc.2003.11.126; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bhuiyan SH, 2000, NUCLEIC ACIDS RES, V28, P1365, DOI 10.1093/nar/28.6.1365; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Ciufo LF, 2000, CURR BIOL, V10, P1256, DOI 10.1016/S0960-9822(00)00743-0; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, PROTEINS, V54, P222, DOI 10.1002/prot.10598; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Hainzl T, 2005, RNA, V11, P1043, DOI 10.1261/rna.2080205; Hainzl T, 2002, NATURE, V417, P767, DOI 10.1038/nature00768; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Maeshima H, 2001, FEBS LETT, V507, P336, DOI 10.1016/S0014-5793(01)02996-9; Maity TS, 2007, J MOL BIOL, V369, P512, DOI 10.1016/j.jmb.2007.03.032; Maity TS, 2006, BIOCHEMISTRY-US, V45, P14955, DOI 10.1021/bi060890g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oubridge C, 2002, MOL CELL, V9, P1251, DOI 10.1016/S1097-2765(02)00530-0; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pakhomova ON, 2002, J MOL BIOL, V317, P145, DOI 10.1006/jmbi.2002.5411; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Sauer-Eriksson AE, 2003, CURR OPIN STRUC BIOL, V13, P64, DOI 10.1016/S0959-440X(02)00010-6; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Strub MP, 2003, STRUCTURE, V11, P1359, DOI 10.1016/j.str.2003.09.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tozik I, 2002, NUCLEIC ACIDS RES, V30, P4166, DOI 10.1093/nar/gkf548; Wild K, 2001, SCIENCE, V294, P598, DOI 10.1126/science.1063839; Yin JM, 2004, RNA, V10, P574, DOI 10.1261/rna.5232404; Yurist S, 2007, J BACTERIOL, V189, P276, DOI 10.1128/JB.01410-06	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3528	10.1371/journal.pone.0003528	http://dx.doi.org/10.1371/journal.pone.0003528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953414	Green Published, gold			2022-12-25	WOS:000265130500006
J	Gonnord, P; Delarasse, C; Auger, R; Benihoud, K; Prigent, M; Cuif, MH; Lamaze, C; Kanellopoulos, JM				Gonnord, P.; Delarasse, C.; Auger, R.; Benihoud, K.; Prigent, M.; Cuif, M. H.; Lamaze, C.; Kanellopoulos, J. M.			Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts	FASEB JOURNAL			English	Article						degradation; membrane microdomains; posttranslational modification	ESCHERICHIA-COLI HEMOLYSIN; CELL-SURFACE EXPRESSION; RAT SUBMANDIBULAR-GLAND; MEMBRANE DOMAINS; P2X(7) RECEPTOR; ENDOPLASMIC-RETICULUM; PORE FORMATION; PROTEIN PALMITOYLATION; CYSTEINE RESIDUES; PLASMA-MEMBRANE	The P2X7 receptor (P2X7R) is an ATP-gated cationic channel expressed by hematopoietic, epithelial, and neuronal cells. Prolonged ATP exposure leads to the formation of a nonselective pore, which can result in cell death. We show that P2X7R is associated with detergent-resistant membranes (DRMs) in both transfected human embryonic kidney (HEK) cells and primary macrophages independently from ATP binding. The DRM association requires the posttranslational modification of P2X7R by palmitic acid. Treatment of cells with the palmitic acid analog 2-bromopalmitate as well as mutations of cysteine to alanine residues abolished P2X7R palmitoylation. Substitution of the 17 intracellular cysteines of P2X7R revealed that 4 regions of the carboxyl terminus domain are involved in palmitoylation. Palmitoylation-defective P2X7R mutants showed a dramatic decrease in cell surface expression because of their retention in the endoplasmic reticulum and proteolytic degradation. Taken together, our data demonstrate that P2X7R palmitoylation plays a critical role in its association with the lipid microdomains of the plasma membrane and in the regulation of its half-life.-Gonnord, P., Delarasse, C., Auger, R., Benihoud, K., Prigent, M., Cuif, M. H., Lamaze, C., Kanellopoulos, J. M. Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. FASEB J. 23, 795-805 (2009)	[Gonnord, P.; Delarasse, C.; Auger, R.; Benihoud, K.; Kanellopoulos, J. M.] Univ Paris Sud, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, Paris, France; [Prigent, M.; Cuif, M. H.] Univ Paris Sud, Inst Genet & Microbiol, CNRS, UMR 8621, Paris, France; [Lamaze, C.] CNRS, UMR 144, Lab Traf Signalisat & Ciblage Intracellulaires, Inst Curie,Ctr Rech, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Lamaze, C (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, UMR 8619, F-91405 Orsay, France.	christophe.lamaze@curie.fr; kanellopoulos@u-psud.fr	Delarasse, Cecile/K-8234-2017; , BENIHOUD/O-4334-2019; Lamaze, Christophe/M-4912-2017	Delarasse, Cecile/0000-0001-9739-4306; LAMAZE, Christophe/0000-0001-5430-2707	CNRS; Gefluc; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer (ARC) [3143]; Agence Nationale de la Recherche [BLAN0211]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Gefluc; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	We are grateful to Keith Mitchell for his advice and help during DRM preparation. We warmly thank Dr. David Holowka and Dr. Yann Percherancier for critical review of our manuscript. This work was supported by CNRS and Gefluc. P. G. was supported by a grant from the Fondation pour la Recherche Medicale. Work in C.L.'s laboratory was supported by grants from the Association pour la Recherche sur le Cancer (ARC no. 3143) and Agence Nationale de la Recherche (no. BLAN0211).	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Barnes NC, 2006, IMMUNOL LETT, V104, P118, DOI 10.1016/j.imlet.2005.11.007; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; BOUVIER M, 1995, BIOCHEM SOC T, V23, P577, DOI 10.1042/bst0230577; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Gao ZH, 1999, BIOCHEM J, V342, P387, DOI 10.1042/0264-6021:3420387; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Garcia-Marcos M, 2006, BBA-BIOMEMBRANES, V1758, P796, DOI 10.1016/j.bbamem.2006.05.008; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MOUILLAC B, 1992, J BIOL CHEM, V267, P21733; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Renner U, 2007, MOL PHARMACOL, V72, P502, DOI 10.1124/mol.107.037085; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Sadeghi HM, 1997, MOL PHARMACOL, V52, P21, DOI 10.1124/mol.52.1.21; SEDWICK CE, 2002, SCI STKE, pRE2; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Tanaka K, 1998, ENDOCRINOLOGY, V139, P803, DOI 10.1210/en.139.2.803; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141	53	97	99	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					795	805		10.1096/fj.08-114637	http://dx.doi.org/10.1096/fj.08-114637			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18971257				2022-12-25	WOS:000265506300015
J	Smith, AP; Verrecchia, A; Faga, G; Doni, M; Perna, D; Martinato, F; Guccione, E; Amati, B				Smith, A. P.; Verrecchia, A.; Faga, G.; Doni, M.; Perna, D.; Martinato, F.; Guccione, E.; Amati, B.			A positive role for Myc in TGF beta-induced Snail transcription and epithelial-to-mesenchymal transition	ONCOGENE			English	Article						TGF beta; Myc; Snail; EMT	E-CADHERIN EXPRESSION; ACTIVATOR INHIBITOR-1 GENE; EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; C-MYC; SMAD PROTEINS; TARGET GENES; IN-VIVO; REPRESSION; P15(INK4B)	Myc and transforming growth factor-beta (TGF beta) signaling are mutually antagonistic, that is Myc suppresses the activation of TGF beta-induced genes, whereas TGF beta represses c-myc transcription. Here, we report a positive role for Myc in the TGF beta response, consisting in the induction of an epithelial-to-mesenchymal transition (EMT) and the activation of the EMT-associated gene Snail. Knockdown of either Myc or the TGF beta effectors SMAD3/4 in epithelial cells eliminated Snail induction by TGF beta. Both Myc and SMAD complexes targeted the Snail promoter in vivo, DNA binding occurring in a mutually independent manner. Myc was bound prior to TGF beta treatment, and was required for rapid Snail activation upon SMAD binding induced by TGF beta. On the other hand, c-myc downregulation by TGF beta was a slower event, occurring after Snail induction. The response of Snail to another cytokine, hepatocyte growth factor (HGF), also depended on Myc and SMAD4. Thus, contrary to their antagonistic effects on Cip1 and INK4b, Myc and SMADs cooperate in signal-dependent activation of Snail in epithelial cells. Although Myc also targeted the Snail promoter in serum-stimulated fibroblasts, it was dispensable for its activation in these conditions, further illustrating that the action of Myc in transcriptional regulation is context-dependent. Our findings suggest that Myc and TGF beta signaling may cooperate in promoting EMT and metastasis in carcinomas.	[Smith, A. P.; Verrecchia, A.; Faga, G.; Doni, M.; Perna, D.; Martinato, F.; Guccione, E.; Amati, B.] IFOM IEO Campus, European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Amati, B (corresponding author), IFOM IEO Campus, European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Verrecchia, Alessandro/AAQ-6454-2020; Amati, Bruno/AAM-3418-2020; Doni, Mirko/ABA-9174-2021; Faga, Giovanni/AAB-5540-2021; Doni, Mirko/AAN-6027-2020; guccione, ernesto/G-9874-2011	Verrecchia, Alessandro/0000-0002-8596-6650; Doni, Mirko/0000-0001-7099-2701; Amati, Bruno/0000-0002-2958-1799	Association for Cancer Research (AIRC); International Association for Cancer Research (AICR)	Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research (AICR)	We thank Gioacchino Natoli and Stefano Campaner for critical reading of the paper; all members of the Amati lab for discussion and feedback throughout this work; Giuseppina Giardina for help with lentiviruses; Gabriele Bucci for bioinformatic support; Peter ten Dijke, Thordur Oskarsson and Andreas Trumpp for cell lines; Pier Giuseppe Pelicci for his continuous support and enthusiasm. This work was supported by grants from the Italian Association for Cancer Research (AIRC) and the International Association for Cancer Research (AICR).	ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 1999, J CELL SCI, V112, P4557; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zha YH, 2007, CELL BIOL INT, V31, P1089, DOI 10.1016/j.cellbi.2007.03.023	53	97	99	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					422	430		10.1038/onc.2008.395	http://dx.doi.org/10.1038/onc.2008.395			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18978814				2022-12-25	WOS:000262550300010
J	Hasan, MK; Cheung, C; Kaul, Z; Shah, N; Sakaushi, S; Sugimoto, K; Oka, S; Kaul, SC; Wadhwa, R				Hasan, Md. Kamrul; Cheung, Caroline; Kaul, Zeenia; Shah, Navjot; Sakaushi, Shinji; Sugimoto, Kenji; Oka, Shigenori; Kaul, Sunil C.; Wadhwa, Renu			CARF Is a Vital Dual Regulator of Cellular Senescence and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; HISTONE H3; CENTROSOME DUPLICATION; CANCER DEVELOPMENT; TUMOR SUPPRESSION; HUMAN FIBROBLASTS; P53 RESTORATION; PROTEIN; PHOSPHORYLATION	The tumor suppressor protein, p53, is central to the pathways that monitor the stress, DNA damage repair, cell cycle, aging, and cancer. Highly complex p53 networks involving its upstream sensors and regulators, downstream effectors and regulatory feedback loops have been identified. CARF (Collaborator of ARF) was shown to enhance ARF-dependent and -independent wild-type p53 function. Here we report that (i) CARF overexpression causes premature senescence of human fibroblasts, (ii) it is vital for replicative and stress-induced senescence, and (iii) the lack of CARF function causes aneuploidy and apoptosis. We provide evidence that CARF plays a dual role in regulating p53-mediated senescence and apoptosis, the two major tumor suppressor mechanisms.	[Hasan, Md. Kamrul; Cheung, Caroline; Kaul, Zeenia; Shah, Navjot; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Kaul, Zeenia] Univ Sydney, Childrens Med Res Inst, Fac Med, Westmead, NSW 2145, Australia; [Sakaushi, Shinji; Sugimoto, Kenji; Oka, Shigenori] Osaka Prefecture Univ, Lab Mol Biol & Cell Informat, Grad Sch Life & Environm Sci, Naka Ku, Osaka 5998531, Japan; [Oka, Shigenori] Nagase & Co Ltd, Recombinant Prot Developing Team, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo 6512241, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Children's Medical Research Institute - Australia; University of Sydney; Nagase & Co., Ltd.	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	NEDO (New Energy and Industrial Technology Development Organization) of Japan	NEDO (New Energy and Industrial Technology Development Organization) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by grants from the NEDO (New Energy and Industrial Technology Development Organization) of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; CHEUNG CT, 2008, MECH AGEING IN PRESS; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Gire V, 2005, M S-MED SCI, V21, P491, DOI 10.1051/medsci/2005215491; Gniadecki R, 2000, CELL MOL BIOL, V46, P121; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hampel B, 2005, AGING CELL, V4, P325, DOI 10.1111/j.1474-9726.2005.00180.x; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hasan MK, 2008, INT J ONCOL, V32, P663; Hasan MK, 2004, BIOCHEM J, V380, P605, DOI 10.1042/BJ20040337; Hasan MK, 2002, J BIOL CHEM, V277, P37765, DOI 10.1074/jbc.M204177200; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kaul SC, 2006, ANN NY ACAD SCI, V1067, P217, DOI 10.1196/annals.1354.026; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; Sugimoto K, 2002, CELL STRUCT FUNCT, V27, P457, DOI 10.1247/csf.27.457; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadhwa R, 2003, EXP GERONTOL, V38, P245, DOI 10.1016/S0531-5565(02)00180-8; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	38	30	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1664	1672		10.1074/jbc.M805778200	http://dx.doi.org/10.1074/jbc.M805778200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19001376	hybrid			2022-12-25	WOS:000262330100035
J	Wikstrom, M; Kelly, AA; Georgiev, A; Eriksson, HM; Klement, MR; Bogdanov, M; Dowhan, W; Wieslander, A				Wikstrom, Malin; Kelly, Amelie A.; Georgiev, Alexander; Eriksson, Hanna M.; Klement, Maria Rosen; Bogdanov, Mikhail; Dowhan, William; Wieslander, Ake			Lipid-engineered Escherichia coli Membranes Reveal Critical Lipid Headgroup Size for Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHOLEPLASMA-LAIDLAWII MEMBRANES; PHOSPHOLIPID-COMPOSITION; SPONTANEOUS CURVATURE; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; TOPOLOGICAL ORGANIZATION; LIPOSOMAL MEMBRANES; INDIVIDUAL LIPIDS; LATERAL PRESSURE; LACTOSE PERMEASE; ACYL CHAINS	Escherichia coli membranes have a substantial bilayer curvature stress due to a large fraction of the nonbilayer-prone lipid phosphatidylethanolamine, and a mutant (AD93) lacking this lipid is severely crippled in several membrane-associated processes. Introduction of four lipid glycosyltransferases from Acholeplasma laidlawii and Arabidopsis thaliana, synthesizing large amounts of two nonbilayer-prone, and two bilayer-forming gluco-and galacto-lipids, (i) restored the curvature stress with the two nonbilayer lipids, and (ii) diluted the high negative lipid surface charge in all AD93 bilayers. Surprisingly, the bilayer-forming diglucosyl-diacylglycerol was almost as good in improving AD93 membrane processes as the two nonbilayer-prone glucosyl-diacylglycerol and galactosyl-diacylglycerol lipids, strongly suggesting that lipid surface charge dilution by these neutral lipids is very important for E. coli. Increased acyl chain length and unsaturation, plus cardiolipin (nonbilayer-prone) content, were probably also beneficial in the modified strains. However, despite a correct transmembrane topology for the transporter LacY in the diglucosyl-diacylglycerol clone, active transport failed in the absence of a nonbilayer-prone glycolipid. The corresponding digalactosyl-diacylglycerol bilayer lipid did not restore AD93 membrane processes, despite analogous acyl chain and cardiolipin contents. Chain ordering, probed by bis-pyrene lipids, was substantially lower in the digalactosyldiacylglycerol strain lipids due to its extended headgroup. Hence, a low surface charge density of anionic lipids is important in E. coli membranes, but is inefficient if the headgroup of the diluting lipid is too large. This strongly indicates that a certain magnitude of the curvature stress is crucial for the bilayer in vivo.	[Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Wikstrom, Malin; Kelly, Amelie A.; Georgiev, Alexander; Eriksson, Hanna M.; Klement, Maria Rosen; Wieslander, Ake] Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	University of Texas System; University of Texas Health Science Center Houston; Stockholm University	Dowhan, W (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	William.Dowhan@uth.tmc.edu; ake@dbb.su.se	Georgiev, Alexander/D-3258-2011; Bogdanov, Mikhail/J-3695-2017	Georgiev, Alexander/0000-0001-5669-5962; 	National Institutes of Health [R37 GM20478]; Swedish Research Council and the Wenner-Gren Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council and the Wenner-Gren Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM20478 (to W. D.). This work was also supported by the Swedish Research Council and the Wenner-Gren Foundations (to A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Andersson AS, 1998, BBA-BIOMEMBRANES, V1369, P94, DOI 10.1016/S0005-2736(97)00212-5; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Ces O., 2006, SIGNAL TRANSDUCT, V6, P112, DOI [10.1002/sita.200500079, DOI 10.1002/SITA.200500079]; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P10710; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Guan L, 2006, P NATL ACAD SCI USA, V103, P1723, DOI 10.1073/pnas.0510922103; Holzl G, 2006, P NATL ACAD SCI USA, V103, P7512, DOI 10.1073/pnas.0600525103; Howard KP, 1996, J AM CHEM SOC, V118, P3345, DOI 10.1021/ja952971y; IWAMOTO K, 1982, BIOCHIM BIOPHYS ACTA, V691, P44, DOI 10.1016/0005-2736(82)90212-7; JARRELL HC, 1987, BIOCHEMISTRY-US, V26, P1805, DOI 10.1021/bi00381a003; Karlsson OP, 1996, BIOCHEMISTRY-US, V35, P10094, DOI 10.1021/bi9602876; Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4; KELLY A, 2007, P 17 C PLANT LIP, P25; KILLIAN JA, 1994, BBA-BIOMEMBRANES, V1189, P225; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; Lindblom G, 2002, BIOCHEMISTRY-US, V41, P11512, DOI 10.1021/bi0263098; Mannock DA, 2004, CURR OPIN COLLOID IN, V8, P426, DOI 10.1016/j.cocis.2004.01.009; Mannock DA, 2001, EUR BIOPHYS J BIOPHY, V30, P537, DOI 10.1007/s002490010185z; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; NAVARRO J, 1984, BIOCHEMISTRY-US, V23, P130, DOI 10.1021/bi00296a021; Oradd G, 2000, BBA-BIOMEMBRANES, V1468, P329, DOI 10.1016/S0005-2736(00)00273-X; OSTERBERG F, 1995, BBA-LIPID LIPID MET, V1257, P18, DOI 10.1016/0005-2760(95)00042-B; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; RIVAS E, 1969, J MOL BIOL, V41, P261, DOI 10.1016/0022-2836(69)90391-X; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Storm P, 2003, EUR J BIOCHEM, V270, P1699, DOI 10.1046/j.1432-1033.2003.03527.x; Sun C, 2007, J BACTERIOL, V189, P1171, DOI 10.1128/JB.01589-06; SUNAMOTO J, 1980, J BIOCHEM-TOKYO, V88, P1219, DOI 10.1093/oxfordjournals.jbchem.a133089; Templer RH, 1998, FARADAY DISCUSS, V111, P41; THURMOND RL, 1994, BIOCHEMISTRY-US, V33, P13178, DOI 10.1021/bi00249a004; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; WIESLANDER A, 1987, BIOCHIM BIOPHYS ACTA, V901, P250, DOI 10.1016/0005-2736(87)90121-0; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; XIANG TX, 1993, BIOPHYS J, V65, P1108, DOI 10.1016/S0006-3495(93)81156-1; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	62	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					954	965		10.1074/jbc.M804482200	http://dx.doi.org/10.1074/jbc.M804482200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981182	Green Published, hybrid			2022-12-25	WOS:000262122900031
J	Chen, YH; Caldwell, JM; Pereira, E; Baker, RW; Sanchez, Y				Chen, Yinhuai; Caldwell, Julie M.; Pereira, Elizabeth; Baker, Robert W.; Sanchez, Yolanda			ATR(Mec1) Phosphorylation-independent Activation of Chk1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASES; BUDDING YEAST; S-PHASE; REPLICATION; PATHWAYS; RAD53; AUTOINHIBITION; MECHANISMS	The conserved protein kinase Chk1 is a player in the defense against DNA damage and replication blocks. The current model is that after DNA damage or replication blocks, ATR(Mec1) phosphorylates Chk1 on the non-catalytic C-terminal domain. However, the mechanism of activation of Chk1 and the function of the Chk1 C terminus in vivo remains largely unknown. In this study we used an in vivo assay to examine the role of the C terminus of Chk1 in the response to DNA damage and replication blocks. The conserved ATR(Mec1) phosphorylation sites were essential for the checkpoint response to DNA damage and replication blocks in vivo; that is, that mutation of the sites caused lethality when DNA replication was stalled by hydroxyurea. Despite this, loss of the ATR(Mec1) phosphorylation sites did not change the kinase activity of Chk1 in vitro. Furthermore, a single amino acid substitution at an invariant leucine in a conserved domain of the non-catalytic C terminus restored viability to cells expressing the ATR(Mec1) phosphorylation site-mutated protein and relieved the requirement of an upstream mediator for Chk1 activation. Our findings show that a single amino acid substitution in the C terminus, which could lead to an allosteric change in Chk1, allows it to bypass the requirement of the conserved ATR(Mec1) phosphorylation sites for checkpoint function.	[Pereira, Elizabeth; Baker, Robert W.; Sanchez, Yolanda] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Chen, Yinhuai; Caldwell, Julie M.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Dartmouth College; Norris Cotton Cancer Center; University System of Ohio; University of Cincinnati	Sanchez, Y (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	Yolanda.Sanchez@Dartmouth.edu			National Institutes of Health (NIEHS) [P30 ES06096, U01 ES11038]; NCI [RO1 CA84463]; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA084463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, U01ES011038] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 ES06096 and U01 ES11038 (NIEHS) and RO1 CA84463 (NCI) to Y.S.). This work was also supported by Pew Scholars Program in the Biomedical Sciences to Y.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Caldwell JM, 2008, J CELL BIOL, V180, P1073, DOI 10.1083/jcb.200706009; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; James P, 1996, GENETICS, V144, P1425; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Liu QH, 2000, GENE DEV, V14, P1448; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Navas TA, 1996, GENE DEV, V10, P2632, DOI 10.1101/gad.10.20.2632; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Purdy A, 2005, J CELL SCI, V118, P3305, DOI 10.1242/jcs.02454; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schollaert KL, 2004, MOL BIOL CELL, V15, P4051, DOI 10.1091/mbc.e03-11-0792; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; SIKORSKI RS, 1989, GENETICS, V122, P19; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; WEINERT TA, 1993, GENETICS, V134, P63; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652	27	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					182	190		10.1074/jbc.M806530200	http://dx.doi.org/10.1074/jbc.M806530200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984588	hybrid, Green Published			2022-12-25	WOS:000261974800021
J	Li, YH; Ghavampur, S; Bondallaz, P; Will, L; Grenningloh, G; Puschel, AW				Li, Ying-Hua; Ghavampur, Sharang; Bondallaz, Percy; Will, Lena; Grenningloh, Gabriele; Pueschel, Andreas W.			Rnd1 Regulates Axon Extension by Enhancing the Microtubule Destabilizing Activity of SCG10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN SCG10; NEURITE OUTGROWTH; RHO-GTPASES; PC12 CELLS; ACTIN CYTOSKELETON; GROWTH-FACTOR; IN-VITRO; ROCK-I; STATHMIN	The GTPase Rnd1 affects actin dynamics antagonistically to Rho and has been implicated in the regulation of neurite outgrowth, dendrite development, and axon guidance. Here we show that Rnd1 interacts with the microtubule regulator SCG10. This interaction requires a central domain of SCG10 comprising about 40 amino acids located within the N-terminal half of a putative alpha-helical domain and is independent of phosphorylation at the four identified phosphorylation sites that regulate SCG10 activity. Rnd1 enhances the microtubule destabilizing activity of SCG10 and both proteins colocalize in neurons. Knockdown of Rnd1 or SCG10 by RNAi suppressed axon extension, indicating a critical role for both proteins during neuronal differentiation. Overexpression of Rnd1 in neurons induces the formation of multiple axons. The effect of Rnd1 on axon extension depends on SCG10. These results indicate that SCG10 acts as an effector downstream of Rnd1 to regulate axon extensions by modulating microtubule organization.	[Li, Ying-Hua; Ghavampur, Sharang; Will, Lena; Pueschel, Andreas W.] Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany; [Bondallaz, Percy; Grenningloh, Gabriele] Univ Lausanne, CHU Vaudois, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland	University of Munster; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Puschel, AW (corresponding author), Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB 629, SPP 1090]; Swiss National Science Foundation [3100AO-10425]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 629 and SPP 1090 (to A. W. P.) and the Swiss National Science Foundation Grant 3100AO-10425 (to G. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C. Section 1734 solely to indicate this fact.	Antonsson B, 1997, PROTEIN EXPRES PURIF, V9, P295, DOI 10.1006/prep.1996.0679; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Aoki J, 2000, BIOCHEM BIOPH RES CO, V278, P604, DOI 10.1006/bbrc.2000.3842; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Harada A, 2005, J BIOL CHEM, V280, P18418, DOI 10.1074/jbc.M411356200; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ishikawa Y, 2006, NEUROSCI LETT, V400, P218, DOI 10.1016/j.neulet.2006.02.064; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	61	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					363	371		10.1074/jbc.M808126200	http://dx.doi.org/10.1074/jbc.M808126200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996843	Green Published, hybrid			2022-12-25	WOS:000261974800041
J	Wood, LK; Thiele, DJ				Wood, L. Kent; Thiele, Dennis J.			Transcriptional Activation in Yeast in Response to Copper Deficiency Involves Copper-Zinc Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SACCHAROMYCES-CEREVISIAE; REDOX SWITCH; CYTOCHROME-OXIDASE; HYDROGEN-PEROXIDE; OXYGEN-TOXICITY; GLOBAL ANALYSIS; BUDDING YEAST; CHAPERONE CCS; FACTOR MAC1	Copper is an essential trace element, yet excess copper can lead to membrane damage, protein oxidation, and DNA cleavage. To balance the need for copper with the necessity to prevent accumulation to toxic levels, cells have evolved sophisticated mechanisms to regulate copper acquisition, distribution, and storage. In Saccharomyces cerevisiae, transcriptional responses to copper deficiency are mediated by the copper-responsive transcription factor Mac1. Although Mac1 activates the transcription of genes involved in high affinity copper uptake during periods of deficiency, little is known about the mechanisms by which Mac1 senses or responds to reduced copper availability. Here we show that the copper-dependent enzyme Sod1 (Cu, Zn-superoxide dismutase) and its intracellular copper chaperone Ccs1 function in the activation of Mac1 in response to an external copper deficiency. Genetic ablation of either CCS1 or SOD1 results in a severe defect in the ability of yeast cells to activate the transcription of Mac1 target genes. The catalytic activity of Sod1 is essential for Mac1 activation and promotes a regulated increase in binding of Mac1 to copper response elements in the promoter regions of genomic Mac1 target genes. Although there is precedent for additional roles of Sod1 beyond protection of the cell from oxygen radicals, the involvement of this protein in copper-responsive transcriptional regulation has not previously been observed. Given the presence of both Sod1 and copper-responsive transcription factors in higher eukaryotes, these studies may yield important insights into how copper deficiency is sensed and appropriate cellular responses are coordinated.	[Wood, L. Kent; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Thiele, DJ (corresponding author), 3813 Res Dr,C 134B, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institutes of Health [GM41840-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41840-21 (to D.J.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S. C. Section 1734 solely to indicate this fact.	Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Bai C, 1997, METHOD ENZYMOL, V283, P141; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Brown KR, 2002, BIOCHEMISTRY-US, V41, P6469, DOI 10.1021/bi0160664; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; CHANG EC, 1989, J BIOL CHEM, V264, P12172; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Heredia J, 2001, J BIOL CHEM, V276, P8793, DOI 10.1074/jbc.M008179200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; Joshi A, 1999, J BIOL CHEM, V274, P218, DOI 10.1074/jbc.274.1.218; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Keller G, 2000, J BIOL CHEM, V275, P29193, DOI 10.1074/jbc.M001552200; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Liochev SI, 2005, FREE RADICAL BIO MED, V38, P146, DOI 10.1016/j.freeradbiomed.2004.10.017; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Maxfield AB, 2004, J BIOL CHEM, V279, P5072, DOI 10.1074/jbc.M311772200; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McDaniels CPJ, 1999, J BIOL CHEM, V274, P26962, DOI 10.1074/jbc.274.38.26962; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; SIKORSKI RS, 1989, GENETICS, V122, P19; Srinivasan C, 1998, BIOCHEMISTRY-US, V37, P7572, DOI 10.1021/bi980418y; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Yoshida T, 2000, CIRC RES, V86, P264, DOI 10.1161/01.RES.86.3.264; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	72	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					404	413		10.1074/jbc.M807027200	http://dx.doi.org/10.1074/jbc.M807027200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18977757	hybrid, Green Published			2022-12-25	WOS:000261974800045
J	Brown, TA; Tkachuk, AN; Clayton, DA				Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.			Native R-loops Persist throughout the Mouse Mitochondrial DNA Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEADING-STRAND ORIGIN; TRANSCRIPTION ELONGATION; RIBONUCLEASE-H; LAGGING-STRAND; COLE1 DNA; IN-VITRO; L-CELLS; REPLICATION; RNA; POLYMERASE	Mammalian mtDNA has been found here to harbor RNA-DNA hybrids at a variety of locations throughout the genome. The R-loop, previously characterized in vitro at the leading strand replication origin (OH), is isolated as a native RNA-DNA hybrid copurifying with mtDNA. Surprisingly, other mitochondrial transcripts also form stable partial R-loops. These are abundant and affect mtDNA conformation. Current models regarding the mechanism of mammalian mtDNA replication have been expanded by recent data and discordant hypotheses. The presence of stable, nonreplicative, and partially hybridized RNA on the mtDNA template is significant for the reevaluation of replication models based on two-dimensional agarose gel analyses. In addition, the close association of a subpopulation of mtRNA with the DNA template has further implications regarding the structure, maintenance, and expression of the mitochondrial genome. These results demonstrate that variously processed and targeted mtRNAs within mammalian mitochondria likely have multiple functions in addition to their conventional roles.	[Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Clayton, DA (corresponding author), 19700 Helix Dr, Ashburn, VA 20147 USA.	claytond@janelia.hhmi.org		Tkachuk, Ariana/0000-0001-8991-9643; Brown, Timothy/0000-0001-8941-7678	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ALONI Y, 1972, J MOL BIOL, V70, P363, DOI 10.1016/0022-2836(72)90545-1; BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Broccoli S, 2004, MOL MICROBIOL, V52, P1769, DOI 10.1111/j.1365-2958.2004.04092.x; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710; Camps M, 2005, FRONT BIOSCI-LANDMRK, V10, P689, DOI 10.2741/1564; CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014; CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; Kusov YY, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e57; Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; PIKO L, 1984, MECH AGEING DEV, V26, P113, DOI 10.1016/0047-6374(84)90170-2; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	40	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36743	36751		10.1074/jbc.M806174200	http://dx.doi.org/10.1074/jbc.M806174200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18986989	Green Published, hybrid			2022-12-25	WOS:000261840500072
J	Kelley, EE; Batthyany, CI; Hundley, NJ; Woodcock, SR; Bonacci, G; Del Rio, JM; Schopfer, FJ; Lancaster, JR; Freeman, BA; Tarpey, MM				Kelley, Eric E.; Batthyany, Carlos I.; Hundley, Nicholas J.; Woodcock, Steven R.; Bonacci, Gustavo; Del Rio, J. Mauricio; Schopfer, Francisco J.; Lancaster, Jack R., Jr.; Freeman, Bruce A.; Tarpey, Margaret M.			Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATED FATTY-ACIDS; HUMAN BLOOD-PLASMA; SUPEROXIDE-DISMUTASE; NITROLINOLEIC ACID; REACTIVE NITROGEN; OXIDASE; PEROXYNITRITE; BINDING; DEHYDROGENASE; TRANSDUCTION	Xanthine oxidoreductase (XOR) generates proinflammatory oxidants and secondary nitrating species, with inhibition of XOR proving beneficial in a variety of disorders. Electrophilic nitrated fatty acid derivatives, such as nitro-oleic acid (OA-NO2), display anti-inflammatory effects with pleiotropic properties. Nitro-oleic acid inhibits XOR activity in a concentration-dependent manner with an IC50 of 0.6 mu M, limiting both purine oxidation and formation of superoxide (O-2((center dot) over bar).). Enzyme inhibition by OA-NO2 is not reversed by thiol reagents, including glutathione, beta-mercaptoethanol, and dithiothreitol. Structure-function studies indicate that the carboxylic acid moiety, nitration at the 9 or 10 olefinic carbon, and unsaturation is required for XOR inhibition. Enzyme turnover and competitive reactivation studies reveal inhibition of electron transfer reactions at the molybdenum cofactor accounts for OA-NO2-induced inhibition. Importantly, OA-NO2 more potently inhibits cell-associated XOR-dependent O-2((center dot) over bar). production than does allopurinol. Combined, these data establish a novel role for OA-NO2 in the inhibition of XOR-derived oxidant formation.	[Kelley, Eric E.; Hundley, Nicholas J.; Del Rio, J. Mauricio; Tarpey, Margaret M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Batthyany, Carlos I.; Woodcock, Steven R.; Bonacci, Gustavo; Schopfer, Francisco J.; Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Batthyany, Carlos I.] Inst Pasteur Montevideo, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Kelley, EE (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, W-1357 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	ekelley@pitt.edu	Del Rio, J. Mauricio/Q-2580-2018; Schopfer, Francisco/AAW-6505-2021; Freeman, Bruce A/H-9342-2012; Schopfer, Francisco Jose/AAE-8125-2020; Woodcock, Steven/AAE-9199-2020	Del Rio, J. Mauricio/0000-0002-3961-2851; Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982	National Institutes of Health [HL58115, HL64937, HL71189, HL074391]; American Heart Association [0665378U, 0665418U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064937, R01HL058115, R37HL058115, R01HL071189, R01HL074391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58115 and HL64937 (to B. A. F.) and HL71189 and HL074391 (to J.L.). This work was also supported by the American Heart Association Beginning Grants-in-Aid 0665378U (to E. E. K.), 0665418U (to F.J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRITIGAN BE, 1990, J BIOL CHEM, V265, P17533; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GILER S, 1975, CLIN CHIM ACTA, V63, P37, DOI 10.1016/0009-8981(75)90375-7; GRANGER DN, 1981, GASTROENTEROLOGY, V81, P22; GURTOO HL, 1971, J BIOL CHEM, V246, P286; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985; Ichimori K, 1999, J BIOL CHEM, V274, P7763, DOI 10.1074/jbc.274.12.7763; Kelley EE, 2004, J BIOL CHEM, V279, P37231, DOI 10.1074/jbc.M402077200; KERDESKY FAJ, 1987, J MED CHEM, V30, P1177, DOI 10.1021/jm00390a010; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Manini P, 2005, CHEM PHYS LIPIDS, V134, P161, DOI 10.1016/j.chemphyslip.2005.01.005; Masuoka N, 2004, BBA-MOL BASIS DIS, V1688, P245, DOI 10.1016/j.bbadis.2003.12.010; Masuoka N, 2006, MOL NUTR FOOD RES, V50, P725, DOI 10.1002/mnfr.200500250; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Radi R, 1997, ARCH BIOCHEM BIOPHYS, V339, P125, DOI 10.1006/abbi.1996.9844; RAMBOER C, 1972, DIGESTION, V7, P183, DOI 10.1159/000197273; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Tamta H, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS49, DOI 10.1134/S0006297906130086; Tan S, 1998, J NEUROPATH EXP NEUR, V57, P544, DOI 10.1097/00005072-199806000-00002; WAUD WR, 1975, ARCH BIOCHEM BIOPHYS, V169, P695, DOI 10.1016/0003-9861(75)90214-3; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463	39	67	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36176	36184		10.1074/jbc.M802402200	http://dx.doi.org/10.1074/jbc.M802402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974051	Green Published, hybrid			2022-12-25	WOS:000261840500012
J	Kraft, CA; Garrido, JL; Fluharty, E; Leiva-Vega, L; Romero, G				Kraft, Catherine A.; Garrido, Jose Luis; Fluharty, Eric; Leiva-Vega, Luis; Romero, Guillermo			Role of Phosphatidic Acid in the Coupling of the ERK Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE-D; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; BINDING DOMAIN; RAF-1 KINASE; B-RAF; PATHWAY; FLUORESCENCE	The production of phosphatidic acid plays a crucial role in the activation of the ERK cascade. This role was linked to the binding of phosphatidate to a specific polybasic site within the kinase domain of Raf-1. Here we show that phosphatidate promotes ERK phosphorylation in intact cells but does not activate Raf in vitro. The kinase suppressor of Ras (KSR) contains a sequence homologous to the phosphatidate binding site of Raf-1. Direct binding of phosphatidate to synthetic peptides derived from the sequences of the binding domains of Raf-1 and KSR was demonstrated by spectroscopic techniques. The specificity of these interactions was confirmed using synthetic lipids and mutated peptides in which the core of the phosphatidic acid binding domain was disrupted. Insulin and exogenous dioleoyl phosphatidate induced a rapid translocation of a mouse KSR1-EGFP construct to the plasma membrane of HIRcB cells. Mutation of two arginines located in the core of the putative phosphatidate binding site abolished dioleoyl phosphatidate and insulin-induced translocation of KSR1. Overexpression of the mutant KSR1 in HIRcB cells inhibited insulin-dependent MEK and ERK phosphorylation. The addition of dioleoyl phosphatidate or insulin increased the co-localization of KSR1 and H-Ras and promoted the formation of plasma membrane patches enriched in both proteins and phosphatidic acid. These results, in conjunction with our previous work, suggest the formation of phosphatidate-enriched membrane microdomains that contain all components of the ERK cascade. We propose that these domains act as molecular scaffolds in the coupling of signaling events.	[Kraft, Catherine A.; Garrido, Jose Luis; Fluharty, Eric; Leiva-Vega, Luis; Romero, Guillermo] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Romero, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	ggr@pitt.edu			National Institutes of Health [R01-DK-54782, T32-GM-54813]; Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-54782 and T32-GM-54813. This work was also supported by an internal grant from the Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALMOG S, 1986, BIOCHEMISTRY-US, V25, P2597, DOI 10.1021/bi00357a048; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Chattopadhyay A, 1996, FEBS LETT, V391, P199, DOI 10.1016/0014-5793(96)00733-8; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Faraudo J, 2007, BIOPHYS J, V92, P2806, DOI 10.1529/biophysj.106.092015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; INOUYE K, 1985, BIOCHEM BIOPH RES CO, V128, P676, DOI 10.1016/0006-291X(85)90099-3; Koch T, 2003, J BIOL CHEM, V278, P9979, DOI 10.1074/jbc.M206709200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Panicker L, 2007, J COLLOID INTERF SCI, V311, P407, DOI 10.1016/j.jcis.2007.03.052; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; PERMYAKOV EA, 1983, BIOPHYS CHEM, V18, P145, DOI 10.1016/0301-4622(83)85009-1; Piret J, 2005, CHEM PHYS LIPIDS, V133, P1, DOI 10.1016/j.chemphyslip.2004.08.002; Poveda JA, 2002, BIOCHEMISTRY-US, V41, P12253, DOI 10.1021/bi0200099; RAABE T, 2002, SCI STKE, pPE28; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; SILVIUS JR, 1990, BIOCHEMISTRY-US, V29, P2930, DOI 10.1021/bi00464a007; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TAKAHASHI H, 1991, BIOCHIM BIOPHYS ACTA, V1069, P229, DOI 10.1016/0005-2736(91)90129-V; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; UEMURA A, 1983, BIOCHIM BIOPHYS ACTA, V729, P28, DOI 10.1016/0005-2736(83)90452-2; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	45	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36636	36645		10.1074/jbc.M804633200	http://dx.doi.org/10.1074/jbc.M804633200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18952605	Green Published, hybrid			2022-12-25	WOS:000261840500062
J	Pino, S; Ciciriello, F; Costanzo, G; Di Mauro, E				Pino, Samanta; Ciciriello, Fabiana; Costanzo, Giovanna; Di Mauro, Ernesto			Nonenzymatic RNA Ligation in Water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT HAIRPIN RIBOZYMES; INFORMATIONAL POLYMERS; POLYRIBOADENYLIC ACID; DIFFERENTIAL STABILITY; TEMPERATURE-DEPENDENCE; NUCLEIC-ACIDS; ORIGIN; STACKING; DNA; ADENINE	We describe the nonenzymatic ligation of RNA oligomers in water. Dimers and tetramers are formed in a time-, pH-, and temperature-dependent reaction. Ligation efficiency depends on oligonucleotide length and sequence and is strongly enhanced by adenine-based nucleotide cofactors. Ligation of short RNA fragments could have liberated the prebiotic polymerization systems from the thermodynamically demanding task of reaching a (pre) genetically meaningful size by stepwise addition of one precursor monomer at the time.	[Di Mauro, Ernesto] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Pino, Samanta; Ciciriello, Fabiana] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Di Mauro, E (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	Ernesto.dimauro@uniroma1.it	Ciciriello, Fabiana/AAA-8065-2020	Ciciriello, Fabiana/0000-0003-1493-9767	Italian Space Agency Molecules-to-Man (MoMa); Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF) [I/015/07/0]; National Science Foundation Chemical Bond Center (CBC)	Italian Space Agency Molecules-to-Man (MoMa); Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF)(Istituto Nazionale Astrofisica (INAF)); National Science Foundation Chemical Bond Center (CBC)(National Science Foundation (NSF))	This work was supported by the Italian Space Agency Molecules-to-Man (MoMa) Project, by Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF) Grant I/015/07/0 Esplorazione del Sistema Solare, and by the National Science Foundation Chemical Bond Center (CBC) Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin GS, 2008, J PHYS CHEM B, V112, P1060, DOI 10.1021/jp7112297; BRAHMS J, 1966, J MOL BIOL, V15, P467, DOI 10.1016/S0022-2836(66)80122-5; Ciciriello F, 2008, BIOCHEMISTRY-US, V47, P2732, DOI 10.1021/bi7021014; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DEKKER CA, 1954, J AM CHEM SOC, V76, P3522, DOI 10.1021/ja01642a049; FINCH JT, 1969, J MOL BIOL, V46, P597, DOI 10.1016/0022-2836(69)90201-0; FRITZ HJ, 1978, BIOCHEMISTRY-US, V17, P1257, DOI 10.1021/bi00600a020; GILHAM PT, 1958, J AM CHEM SOC, V80, P6212, DOI 10.1021/ja01556a016; HOLCOMB DN, 1965, BIOPOLYMERS, V3, P121, DOI 10.1002/bip.360030203; Jain SS, 2004, ANGEW CHEM INT EDIT, V43, P2004, DOI 10.1002/anie.200353155; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; Li YL, 2008, EUR BIOPHYS J BIOPHY, V37, P173, DOI 10.1007/s00249-007-0213-8; Meli M, 2003, J BIOL CHEM, V278, P9835, DOI 10.1074/jbc.M213058200; Meli M, 2002, J BIOL CHEM, V277, P2104, DOI 10.1074/jbc.M107130200; MORROW JR, 1995, J CHEM SOC CHEM COMM, P2431, DOI 10.1039/c39950002431; Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Norberg J, 1996, BIOPOLYMERS, V39, P765, DOI 10.1002/(SICI)1097-0282(199612)39:6<765::AID-BIP3>3.3.CO;2-G; NORBERG J, 1995, J AM CHEM SOC, V117, P10832, DOI 10.1021/ja00149a006; Norberg J, 1998, BIOPHYS J, V74, P394, DOI 10.1016/S0006-3495(98)77796-3; NORBERG J, 1995, J PHYS CHEM-US, V99, P13056, DOI 10.1021/j100035a002; OLSON WK, 1975, NUCLEIC ACIDS RES, V2, P2055, DOI 10.1093/nar/2.11.2055; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORO J, 1961, NATURE, V191, P1193, DOI 10.1038/1911193a0; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Petrovic AG, 2005, J PHYS CHEM B, V109, P23698, DOI 10.1021/jp054280m; PINDER JC, 1974, BIOCHEMISTRY-US, V13, P5373, DOI 10.1021/bi00723a019; Reader JS, 2002, NATURE, V420, P841, DOI 10.1038/nature01185; READER JS, 2001, RNA, V7, P395; Rich A., 1962, HORIZONS BIOCH, P103; Saenger W., 1984, PRINCIPLES NUCL ACID, P116, DOI DOI 10.1007/978-1-4612-5190-3_6; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2005, J BIOL CHEM, V280, P35658, DOI 10.1074/jbc.M504537200; Saladino R, 2007, CHEM BIODIVERS, V4, P694, DOI 10.1002/cbdv.200790059; Saladino R, 2006, CHEMBIOCHEM, V7, P1707, DOI 10.1002/cbic.200600139; SANCHEZ RA, 1968, J MOL BIOL, V38, P121, DOI 10.1016/0022-2836(68)90132-0; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; SUCK D, 1976, ACTA CRYSTALLOGR B, V32, P1727, DOI 10.1107/S0567740876006316; TSO POP, 1962, P NATL ACAD SCI USA, V48, P686, DOI 10.1073/pnas.48.4.686; VANHOLDE K, 1980, ORIGINS LIFE EVOL B, P31; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; WACHTERSHAUSER G, 1988, P NATL ACAD SCI USA, V85, P1134, DOI 10.1073/pnas.85.4.1134; ZUBAY G, 1991, CHEMTRACTS, V2, P439	48	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36494	36503		10.1074/jbc.M805333200	http://dx.doi.org/10.1074/jbc.M805333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977755	Green Published, hybrid			2022-12-25	WOS:000261840500047
J	Zhao, R; Du, LP; Huang, YL; Wu, YD; Gunst, SJ				Zhao, Rong; Du, Liping; Huang, Youliang; Wu, Yidi; Gunst, Susan J.			Actin Depolymerization Factor/Cofilin Activation Regulates Actin Polymerization and Tension Development in Canine Tracheal Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; TYROSINE PHOSPHORYLATION; COFILIN PHOSPHORYLATION; FILAMENT TURNOVER; LIM-KINASE; F-ACTIN; DYNAMICS; CONTRACTION; TROPOMYOSIN; ADF/COFILIN	The contractile activation of airway smooth muscle tissues stimulates actin polymerization, and the inhibition of actin polymerization inhibits tension development. Actin-depolymerizing factor (ADF) and cofilin are members of a family of actin-binding proteins that mediate the severing of F-actin when activated by dephosphorylation at serine 3. The role of ADF/cofilin activation in the regulation of actin dynamics and tension development during the contractile activation of smooth muscle was evaluated in intact canine tracheal smooth muscle tissues. Two-dimensional gel electrophoresis revealed that ADF and cofilin exist in similar proportions in the muscle tissues, and that similar to 40% of the total ADF/cofilin in unstimulated tissues is phosphorylated. Phospho-ADF/cofilin decreased concurrently with tension development in response to stimulation with acetylcholine (ACh) or potassium depolarization indicating the activation of ADF/cofilin. Expression of an inactive phospho-cofilin mimetic (cofilin S3E) but not wild type cofilin in the smooth muscle tissues inhibited endogenous ADF/cofilin dephosphorylation and ACh-induced actin polymerization. Expression of cofilin S3E in the tissues depressed tension development in response to ACh, but it did not affect myosin light chain phosphorylation. The ACh-induced dephosphorylation of ADF/cofilin required the Ca2+-dependent activation of calcineurin (PP2B). The results indicate that the activation of ADF/cofilin is regulated by contractile stimulation in tracheal smooth muscle and that cofilin activation is required for actin polymerization and tension development in response to contractile stimulation.	[Zhao, Rong; Du, Liping; Huang, Youliang; Wu, Yidi; Gunst, Susan J.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Gunst, SJ (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS313, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	National Institutes of Health [R01 HL 29289, R01 HL 074099]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029289, R01HL074099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL 29289 and R01 HL 074099 (USPHS). This work was also supported by a predoctoral fellowship from the American Heart Association (to R. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Barany M, 2001, J BIOL CHEM, V276, P48398, DOI 10.1074/jbc.M106227200; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen XM, 2004, INFECT IMMUN, V72, P3011, DOI 10.1128/IAI.72.5.3011-3021.2004; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hirshman CA, 1999, AM J PHYSIOL-LUNG C, V277, pL653, DOI 10.1152/ajplung.1999.277.3.L653; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jones KA, 1999, J PHYSIOL-LONDON, V519, P527, DOI 10.1111/j.1469-7793.1999.0527m.x; KIM HR, 2008, AM J PHYSIOL, V295, pC68; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Konakahara S, 2004, GENES CELLS, V9, P345, DOI 10.1111/j.1356-9597.2004.00726.x; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehman W, 1996, BIOCH SMOOTH MUSCLE, P47; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Mehta D, 2000, AM J PHYSIOL-CELL PH, V279, pC308, DOI 10.1152/ajpcell.2000.279.2.C308; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Rosok O, 1999, GENOMICS, V61, P44, DOI 10.1006/geno.1999.5922; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004	48	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36522	36531		10.1074/jbc.M805294200	http://dx.doi.org/10.1074/jbc.M805294200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957424	Green Published, hybrid			2022-12-25	WOS:000261840500050
J	Schoeman, MC; Jacobs, DS				Schoeman, M. Corrie; Jacobs, David S.			The Relative Influence of Competition and Prey Defenses on the Phenotypic Structure of Insectivorous Bat Ensembles in Southern Africa	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; SPECIES COMPOSITION; ECHOLOCATION CALLS; FISH COMMUNITIES; ECOLOGY; SIZE; ASSEMBLAGES; MORPHOLOGY; DIVERSITY; SUPPORT	Deterministic filters such as competition and prey defences should have a strong influence on the community structure of animals such as insectivorous bats that have life histories characterized by low fecundity, low predation risk, long life expectancy, and stable populations. We investigated the relative influence of these two deterministic filters on the phenotypic structure of insectivorous bat ensembles in southern Africa. We used null models to simulate the random phenotypic patterns expected in the absence of competition or prey defences and analysed the deviations of the observed phenotypic pattern from these expected random patterns. The phenotypic structure at local scales exhibited non-random patterns consistent with both competition and prey defense hypotheses. There was evidence that competition influenced body size distribution across ensembles. Competition also influenced wing and echolocation patterns in ensembles and in functional foraging groups with high species richness or abundance. At the same time, prey defense filters influenced echolocation patterns in two species-poor ensembles. Non-random patterns remained evident even after we removed the influence of body size from wing morphology and echolocation parameters taking phylogeny into account. However, abiotic filters such as geographic distribution ranges of small and large-bodied species, extinction risk, and the physics of flight and sound probably also interacted with biotic filters at local and/or regional scales to influence the community structure of sympatric bats in southern Africa. Future studies should investigate alternative parameters that define bat community structure such as diet and abundance to better determine the influence of competition and prey defences on the structure of insectivorous bat ensembles in southern Africa.	[Schoeman, M. Corrie; Jacobs, David S.] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Schoeman, M. Corrie] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Cape Town; University of Kwazulu Natal	Schoeman, MC (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa.	schoemanc@ukzn.ac.za	Jacobs, David Steve/L-9118-2013; Schoeman, Corrie/G-2616-2010	Jacobs, David Steve/0000-0002-3243-8571; Schoeman, Corrie/0000-0003-3736-0264	National Research Foundation; University of Cape Town Research Fund	National Research Foundation; University of Cape Town Research Fund	Funding for the work was provided by the National Research Foundation, and the University of Cape Town Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier PL, 1998, ECOLOGY, V79, P911, DOI 10.1890/0012-9658(1998)079[0911:LVRIOL]2.0.CO;2; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; Arita HT, 1999, OIKOS, V85, P310, DOI 10.2307/3546497; Arita HT, 1997, J ANIM ECOL, V66, P83, DOI 10.2307/5967; Biscardi S, 2004, ACTA CHIROPTEROL, V6, P347, DOI 10.3161/001.006.0212; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1985, AUK, V102, P251, DOI 10.2307/4086767; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; CASE TJ, 1983, EVOLUTION, V37, P832, DOI 10.1111/j.1558-5646.1983.tb05604.x; Cowling R. M., 1997, P99; DAYAN T, 1990, AM NAT, V136, P39, DOI 10.1086/285081; DAYAN T, 1989, ECOLOGY, V70, P1526, DOI 10.2307/1938210; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Fenton MB, 2001, J MAMMAL, V82, P721, DOI 10.1644/1545-1542(2001)082<0721:TEAZCP>2.0.CO;2; Findley J.S., 1993, BATS COMMUNITY PERSP; FRIEDMAN Y, RED DATA BOOK MAMMAL; Fullard JH, 2003, J EXP BIOL, V206, P281, DOI 10.1242/jeb.00085; Gaston K. J., 2000, PATTERNS PROCESS MAC; Gotelli N.J., 1996, NULL MODELS ECOLOGY, P368; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; HOLMES DJ, 1994, J MAMMAL, V75, P224, DOI 10.2307/1382255; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/cjfas-58-1-157; Jacobs DS, 1999, ACTA CHIROPTEROL, V1, P93; Jacobs DS, 2000, ACTA CHIROPTEROL, V2, P197; Jones G, 2003, BAT ECOLOGY, P301; Jones G, 1996, SYM ZOOL S, P111; JONES G, 1994, FUNCT ECOL, V8, P450, DOI 10.2307/2390068; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Kalko EKV, 1995, SYM ZOOL S, P259; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Lawton J., 2000, COMMUNITY ECOLOGY CH; LOSOS JB, 1990, EVOLUTION, V44, P558, DOI 10.1111/j.1558-5646.1990.tb05938.x; MANLY BFJ, 1991, RANDOMIZED MONTE CAR; Maurer BA, 1999, UNTANGLING ECOLOGICA; MCKENZIE NL, 1986, J ANIM ECOL, V55, P401, DOI 10.2307/4727; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; Midgley J. J., 1997, P278; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Orrock JL, 2005, AM NAT, V166, P107, DOI 10.1086/430641; Palmer A. R., 1997, P167; Patterson BD, 2003, BAT ECOLOGY, P536; POMEROY D, 1990, BIOL J LINN SOC, V40, P53, DOI 10.1111/j.1095-8312.1990.tb00534.x; POOLE RW, 1979, SCIENCE, V203, P470, DOI 10.1126/science.203.4379.470; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROUGHGARDEN J, 1983, AM NAT, V122, P583, DOI 10.1086/284160; Rutherford M. C., 1997, P91; RYDELL J, 1995, OIKOS, V73, P419, DOI 10.2307/3545970; SAUNDERS MB, 1992, ECOLOGY, V73, P1335, DOI 10.2307/1940680; SCHLUTER D, 1985, SCIENCE, V227, P1056, DOI 10.1126/science.227.4690.1056; Schnitzler Hans-Ulrich, 1998, P183; Schoeman MC, 2003, OECOLOGIA, V134, P154, DOI 10.1007/s00442-002-1107-1; SCHOEMAN MG, 2006, RELATIVE INFLUENCE C; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Scholes R. J., 1997, P258; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Skinner J. D., 1990, MAMMALS SO AFRICAN S; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stevens RD, 1999, J MAMMAL, V80, P644, DOI 10.2307/1383309; Stevens RD, 2000, OIKOS, V89, P367, DOI 10.1034/j.1600-0706.2000.890218.x; Stoffberg S, 2007, MOL PHYLOGENETICS EV; Strong D.R., 1984, ECOLOGICAL COMMUNITI; TAYLOR PJ, 2000, BATS SO AFRICA; Willig MR, 2003, BAT ECOLOGY, P580; WILLIG MR, 1989, J MAMMAL, V70, P323, DOI 10.2307/1381514	74	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3715	10.1371/journal.pone.0003715	http://dx.doi.org/10.1371/journal.pone.0003715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005563	Green Published, gold, Green Submitted			2022-12-25	WOS:000265166200003
J	Vollmer, SV; Kline, DI				Vollmer, Steven V.; Kline, David I.			Natural Disease Resistance in Threatened Staghorn Corals	PLOS ONE			English	Article							WHITE-BAND DISEASE; SHRIMP PENAEUS-JAPONICUS; CARIBBEAN CORAL; ACROPORA-PALMATA; EASTERN OYSTER; CRASSOSTREA-VIRGINICA; POPULATION-STRUCTURE; COMMUNITY STRUCTURE; CLIMATE-CHANGE; DIVERSITY	Disease epidemics have caused extensive damage to tropical coral reefs and to the reef-building corals themselves, yet nothing is known about the abilities of the coral host to resist disease infection. Understanding the potential for natural disease resistance in corals is critically important, especially in the Caribbean where the two ecologically dominant shallow-water corals, Acropora cervicornis and A. palmata, have suffered an unprecedented mass die-off due to White Band Disease (WBD), and are now listed as threatened under the US Threatened Species Act and as critically endangered under the IUCN Red List criteria. Here we examine the potential for natural resistance to WBD in the staghorn coral Acropora cervicornis by combining microsatellite genotype information with in situ transmission assays and field monitoring of WBD on tagged genotypes. We show that six percent of staghorn coral genotypes (3 out of 49) are resistant to WBD. This natural resistance to WBD in staghorn corals represents the first evidence of host disease resistance in scleractinian corals and demonstrates that staghorn corals have an innate ability to resist WBD infection. These resistant staghorn coral genotypes may explain why pockets of Acropora have been able to survive the WBD epidemic. Understanding disease resistance in these corals may be the critical link to restoring populations of these once dominant corals throughout their range.	[Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Vollmer, Steven V.; Kline, David I.] Smithsonian Trop Res Inst, Balboa, Panama; [Kline, David I.] Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4067, Australia	Northeastern University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Queensland	Vollmer, SV (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	s.vollmer@neu.edu		Kline, David/0000-0001-5128-9439	Smithsonian Marine Science Network [Postdoctoral Fellowships]; Smithsonian Tropical Research Institute [Hoch Fellowship]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	Smithsonian Marine Science Network Postdoctoral Fellowships to SVV and DIK, and a Smithsonian Tropical Research Institute Hoch Fellowship to SVV.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; Aronson RB, 2001, EVOLUTIONARY PALEOECOLOGY, P171; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; BAK RPM, 1982, MAR BIOL LETT, V3, P67; BAK RPM, 1983, ASPECTS COMMUNITY OR, P51; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Brown BL, 2005, AQUAC RES, V36, P1544, DOI 10.1111/j.1365-2109.2005.01377.x; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Calvo LMR, 2003, AQUACULTURE, V220, P69, DOI 10.1016/S0044-8486(02)00399-X; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Culloty SC, 2004, AQUACULTURE, V237, P41, DOI 10.1016/j.aquaculture.2004.04.007; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gaffney PM, 1996, J SHELLFISH RES, V15, P135; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; HOGARTH WT, 2006, FED REGISTER, P26852; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Lively CM, 1996, P ROY SOC B-BIOL SCI, V263, P891, DOI 10.1098/rspb.1996.0132; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller James E., 2007, Human-Wildlife Conflicts, V1, P13; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MOORE JD, 2002, REPORTS CALIFORNIA C, V43, P113; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETERS EC, 1983, J INVERTEBR PATHOL, V41, P394, DOI 10.1016/0022-2011(83)90260-4; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Quinn Norman J, 2006, Rev. biol. trop, V54, P105; Ritchie KB, 1998, REV BIOL TROP, V46, P199; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Yu ZN, 2006, AQUACULTURE, V254, P160, DOI 10.1016/j.aquaculture.2005.10.016; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; 2005, FED REG, V70, P24359	70	93	92	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3718	10.1371/journal.pone.0003718	http://dx.doi.org/10.1371/journal.pone.0003718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005565	Green Published, gold, Green Submitted			2022-12-25	WOS:000265166200006
J	Wringe, A; Fine, PEM; Sutter, RW; Kew, OM				Wringe, Alison; Fine, Paul E. M.; Sutter, Roland W.; Kew, Olen M.			Estimating the Extent of Vaccine-Derived Poliovirus Infection	PLOS ONE			English	Article								Background: Eight outbreaks of paralytic polio attributable to circulating vaccine-derived poliovirus (cVDPV) have highlighted the risks associated with oral poliovirus vaccine (OPV) use in areas of low vaccination coverage and poor hygiene. As the Polio Eradication Initiative enters its final stages, it is important to consider the extent to which these viruses spread under different conditions, so that appropriate strategies can be devised to prevent or respond to future cVDPV outbreaks. Methods and Findings: This paper examines epidemiological (temporal, geographic, age, vaccine history, social group, ascertainment), and virological (type, genetic diversity, virulence) parameters in order to infer the numbers of individuals likely to have been infected in each of these cVDPV outbreaks, and in association with single acute flaccid paralysis (AFP) cases attributable to VDPVs. Although only 114 virologically-confirmed paralytic cases were identified in the eight cVDPV outbreaks, it is likely that a minimum of hundreds of thousands, and more likely several million individuals were infected during these events, and that many thousands more have been infected by VDPV lineages within outbreaks which have escaped detection. Conclusions: Our estimates of the extent of cVDPV circulation suggest widespread transmission in some countries, as might be expected from endemic wild poliovirus transmission in these same settings. These methods for inferring extent of infection will be useful in the context of identifying future surveillance needs, planning for OPV cessation and preparing outbreak response plans.	[Wringe, Alison; Fine, Paul E. M.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Sutter, Roland W.] World Hlth Org, Polio Eradicat Dept, Geneva, Switzerland; [Kew, Olen M.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Centers for Disease Control & Prevention - USA	Wringe, A (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	alison.wringe@lshtm.ac.uk			Polio Eradication Initiative of the World Health Organisation	Polio Eradication Initiative of the World Health Organisation	This work was supported by the Polio Eradication Initiative of the World Health Organisation.	ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093; Aylward RB, 1997, J INFECT DIS, V175, pS56, DOI 10.1093/infdis/175.Supplement_1.S56; Bellmunt A, 1999, VIROLOGY, V265, P178, DOI 10.1006/viro.1999.0003; BENYESHM.M, 1967, AM J EPIDEMIOL, V86, P112, DOI 10.1093/oxfordjournals.aje.a120717; BERNIER RH, 1984, REV INFECT DIS, V6, pS371; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; BOUCHARD MJ, 1995, J VIROL, V69, P4972, DOI 10.1128/JVI.69.8.4972-4978.1995; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P855; Cherkasova EA, 2002, J VIROL, V76, P6791, DOI 10.1128/JVI.76.13.6791-6799.2002; Chiba Y, 2003, JPN J INFECT DIS, V56, P181; de Oliveira L H, 2000, Rev Panam Salud Publica, V7, P219; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Fine P E, 2001, Dev Biol (Basel), V105, P129; FINE PE, 2001, DEV BIOL BASEL, V105, P149; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; GELFAND HM, 1957, AM J HYG, V65, P367, DOI 10.1093/oxfordjournals.aje.a119876; Georgescu MM, 1997, J VIROL, V71, P7758, DOI 10.1128/JVI.71.10.7758-7768.1997; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; JOCE R, 1992, BRIT MED J, V305, P79, DOI 10.1136/bmj.305.6845.79; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P210; Korotkova EA, 2003, J VIROL, V77, P12460, DOI 10.1128/JVI.77.23.12460-12465.2003; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; MacCallum F O, 1971, Spec Rep Ser Med Res Counc (G B), V310, P72; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Martin J, 2000, J VIROL, V74, P3001, DOI 10.1128/JVI.74.7.3001-3010.2000; MELNICK JL, 1953, AM J HYG, V58, P207, DOI 10.1093/oxfordjournals.aje.a119602; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; POLLARD SR, 1989, J VIROL, V63, P4949, DOI 10.1128/JVI.63.11.4949-4951.1989; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; REN R, 1991, J VIROL, V65, P1377, DOI 10.1128/JVI.65.3.1377-1382.1991; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; SUTTER R, VACCINES; *UN HAB, UN HAB POP STAT; Vinje J, 2004, J INFECT DIS, V189, P1168, DOI 10.1086/382545; WESTROP GD, 1989, J VIROL, V63, P1338, DOI 10.1128/JVI.63.3.1338-1344.1989; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; World Health Organization, 2008, COR HLTH IND; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; 2004, MMWR MORB MORTAL WKL, V53, P820; 2003, MMWR MORB MORTAL WKL, V52, P252; 2002, WKLY EPIDEMIOL REC, V77, P133; 2003, MMWR MORB MORTAL WKL, V52, P913; 2001, MMWR MORB MORTAL WKL, V50, P874; 2005, MMWR MORB MORTAL WKL, V54, P1053; 2005, POLIOMYELITIS SURVEI; 2007, MMWR MORB MORTAL WKL, V56, P996	64	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3433	10.1371/journal.pone.0003433	http://dx.doi.org/10.1371/journal.pone.0003433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958288	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000265131100001
J	Klimova, TA; Bell, EL; Shroff, EH; Weinberg, FD; Snyder, CM; Dimri, GP; Schumacker, PT; Budinger, GRS; Chandel, NS				Klimova, Tatyana A.; Bell, Eric L.; Shroff, Emelyn H.; Weinberg, Frank D.; Snyder, Colleen M.; Dimri, Goberdan P.; Schumacker, Paul T.; Budinger, G. R. Scott; Chandel, Navdeep S.			Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS	FASEB JOURNAL			English	Article						AMPK; cell cycle; telomerase	REPLICATIVE LIFE-SPAN; FLUORESCENT PROTEIN INDICATORS; DIPLOID FIBROBLAST CELLS; OXIDATIVE DNA-DAMAGE; CELLULAR SENESCENCE; RETINOBLASTOMA PROTEIN; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; C-MYC; EXPRESSION	Senescence is a potential tumor-suppressing mechanism and a commonly used model of cellular aging. One current hypothesis to explain senescence, based in part on the correlation of oxygen with senescence, postulates that it is caused by oxidative damage from reactive oxygen species (ROS). Here, we further test this theory by determining the mechanisms of hyperoxia-induced senescence. Exposure to 70% O-2 led to stress-induced, telomere-independent senescence. Although hyperoxia elevated mitochondrial ROS production, overexpression of antioxidant proteins was not sufficient to prevent hyperoxia-induced senescence. Hyperoxia activated AMPK; however, overexpression of a kinase-dead mutant of LKB1, which prevented AMPK activation, did not prevent hyperoxia-induced senescence. Knocking down p21 via shRNA, or suppression of the p16/pRb pathway by either BMI1 or HPV16-E7 overexpression, was also insufficient to prevent hyperoxia-induced senescence. However, suppressing p53 function resulted in partial rescue from senescence, suggesting that hyperoxia-induced senescence involves p53. Suppressing both the p53 and pRb pathways resulted in almost complete protection, indicating that both pathways cooperate in hyperoxia-induced senescence. Collectively, these results indicate a ROS-independent but p53/pRb-dependent senescence mechanism during hyperoxia.-Klimova, T. A., Bell, E. L., Shroff, E. H., Weinberg, F. D., Snyder, C. M., Dimri, G. P., Schumacker, P. T., Budinger, G. R. S., Chandel, N. S. Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. FASEB J. 23, 783-794 (2009)	[Klimova, Tatyana A.; Bell, Eric L.; Shroff, Emelyn H.; Weinberg, Frank D.; Snyder, Colleen M.; Budinger, G. R. Scott; Chandel, Navdeep S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Dimri, Goberdan P.] Evanston NW Hosp, Res Inst, Div Canc Biol, Evanston, IL USA; [Dimri, Goberdan P.] Evanston NW Hosp, Res Inst, Dept Med, Evanston, IL USA; [Dimri, Goberdan P.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Northwestern University; NorthShore University Health System; NorthShore University Health System; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Chandel, NS (corresponding author), 240 E Huron Ave,Rm M-334, Chicago, IL 60611 USA.	nav@northwestern.edu	Bell, Eric/F-6368-2012; Weinberg, Frank/AAC-9915-2020	Schumacker, Paul T/0000-0001-9591-2034	U.S. National Institutes of Health [GM60472-09, P01HL071643-03004, R21AG027093]; American Heart Association [0715708Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027093] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Laimonis A. Laimins (Northwestern University) for his kind gift of packaging cells expressing HPV-E7 WT and mutant, and HPV-E6 and E7 in combination. This work was supported in part by U.S. National Institutes of Health grants to N.S.C. (GM60472-09, P01HL071643-03004, R21AG027093). T.A.K. is supported by an American Heart Association predoctoral grant (0715708Z).	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bond J, 2004, EXP CELL RES, V292, P151, DOI 10.1016/j.yexcr.2003.09.021; Boyer SN, 1996, CANCER RES, V56, P4620; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Fridovich I, 1998, J EXP BIOL, V201, P1203; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KIMURA RE, 1983, J APPL PHYSIOL, V55, P1501, DOI 10.1152/jappl.1983.55.5.1501; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Ruchko M, 2005, AM J PHYSIOL-LUNG C, V288, pL530, DOI 10.1152/ajplung.00255.2004; SAITO H, 1995, EXP CELL RES, V217, P272, DOI 10.1006/excr.1995.1087; Saretzki G, 1998, J GERONTOL A-BIOL, V53, pB438, DOI 10.1093/gerona/53A.6.B438; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHOONEN WGEJ, 1990, MUTAT RES, V237, P173; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446	47	50	52	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					783	794		10.1096/fj.08-114256	http://dx.doi.org/10.1096/fj.08-114256			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18948382	Green Published			2022-12-25	WOS:000265506300014
J	Lin, HY; Fridy, PC; Ribeiro, AA; Choi, JH; Barma, DK; Vogel, G; Falck, JR; Shears, SB; York, JD; Mayr, GW				Lin, Hongying; Fridy, Peter C.; Ribeiro, Anthony A.; Choi, Jae H.; Barma, Deb K.; Vogel, Guenter; Falck, J. R.; Shears, Stephen B.; York, John D.; Mayr, Georg W.			Structural Analysis and Detection of Biological Inositol Pyrophosphates Reveal That the Family of VIP/Diphosphoinositol Pentakisphosphate Kinases Are 1/3-Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; HEXAKISPHOSPHATE KINASE; DICTYOSTELIUM; TETRAKISPHOSPHATE; PHOSPHATES; IDENTIFICATION; PURIFICATION; METABOLISM; CELLS; POLYSPHONDYLIUM	We have characterized the positional specificity of the mammalian and yeast VIP/diphosphoinositol pentakisphosphate kinase (PPIP5K) family of inositol phosphate kinases. We deployed a microscale metal dye detection protocol coupled to a high performance liquid chromatography system that was calibrated with synthetic and biologically synthesized standards of inositol pyrophosphates. In addition, we have directly analyzed the structures of biological inositol pyrophosphates using two-dimensional H-1-H-1 and H-1-P-31 nuclear magnetic resonance spectroscopy. Using these tools, we have determined that the mammalian and yeast VIP/PPIP5K family phosphorylates the 1/3-position of the inositol ring in vitro and in vivo. For example, the VIP/PPIP5K enzymes convert inositol hexakisphosphate to 1/3-diphosphoinositol pentakisphosphate. The latter compound has not previously been identified in any organism. We have also unequivocally determined that 1/3,5-(PP)(2)-IP4 is the isomeric structure of the bis-diphosphoinositol tetrakisphosphate that is synthesized by yeasts and mammals, through a collaboration between the inositol hexakisphosphate kinase and VIP/PPIP5K enzymes. These data uncover phylogenetic variability within the crown taxa in the structures of inositol pyrophosphates. For example, in the Dictyostelids, the major bis-diphosphoinositol tetrakisphosphate is 5,6-(PP)(2)-IP4 (Laussmann, T., Eujen, R., Weisshuhn, C. M., Thiel, U., Falck, J. R., and Vogel, G. (1996) Biochem. J. 315, 715-725). Our study brings us closer to the goal of understanding the structure/function relationships that control specificity in the synthesis and biological actions of inositol pyrophosphates.	[Lin, Hongying; Mayr, Georg W.] Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol Zellulare Signaltransdukt, D-20246 Hamburg, Germany; [Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, NMR Ctr, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Choi, Jae H.; Shears, Stephen B.] NIEHS, Inositide Signaling Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Barma, Deb K.; Falck, J. R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Vogel, Guenter] Berg Univ Wuppertal, Fachbereich Math & Nat Wissensch Biochem, D-42097 Wuppertal, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wuppertal	Mayr, GW (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol Zellulare Signaltransdukt, Martinistr 52, D-20246 Hamburg, Germany.	mayr@uke.uni-hamburg.de	Falck, John R/B-3030-2011; Shears, Stephen B/C-6335-2019	Falck, John R/0000-0002-9219-7845; Shears, Stephen B/0000-0001-7309-8916; Fridy, Peter/0000-0002-8208-9154	National Institutes of Health (NIH) Intramural Research Program of the NIEHS; NIH [R01 HL-55672, R01 A1057588]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [MA 989/2-3]; National Science Foundation; NIH; North Carolina Biotechnology Center; Duke University;  [NCI P30CA- 14236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center; Duke University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH) Intramural Research Program of the NIEHS ( to S. B. S.) and NIH Grants R01 HL-55672 ( to J. D. Y.), R01 A1057588 ( to A. A. R.), and NCI P30CA- 14236 ( to A. A. R.). This research was also supported by the Howard Hughes Medical Institute ( to J. D. Y.) and Deutsche Forschungsgemeinschaft Grant MA 989/2-3 ( to G. W. M.). Instrumentation in the Duke NMR Center is funded by the National Science Foundation, the NIH, the North Carolina Biotechnology Center, and Duke University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Choi K, 2005, CELL SIGNAL, V17, P1533, DOI 10.1016/j.cellsig.2005.03.021; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Huang CF, 1998, BIOCHEMISTRY-US, V37, P14998, DOI 10.1021/bi981920l; Ingram SW, 2003, BIOCHEM J, V369, P519, DOI 10.1042/BJ20020733; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JOHNSON K, 1995, ANAL BIOCHEM, V231, P421, DOI 10.1006/abio.1995.0073; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Laussmann T, 1998, FEBS LETT, V426, P145, DOI 10.1016/S0014-5793(98)00329-9; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; LIN HY, 2009, METHODS MOL BIOL INO; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; MAYR GW, 1992, CARBOHYD RES, V234, P247, DOI 10.1016/0008-6215(92)85052-2; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Onnebo SMN, 2007, CELL, V129, P647, DOI 10.1016/j.cell.2007.05.002; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; SCHOLZ P, 1990, METHODS INOSITIDE RE; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Yang XN, 1999, J BIOL CHEM, V274, P35434, DOI 10.1074/jbc.274.50.35434; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	38	92	99	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1863	1872		10.1074/jbc.M805686200	http://dx.doi.org/10.1074/jbc.M805686200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18981179	Green Published, hybrid			2022-12-25	WOS:000262330100057
J	Mason, AJ; Moussaoui, W; Abdelrahman, T; Boukhari, A; Bertani, P; Marquette, A; Shooshtarizaheh, P; Moulay, G; Boehm, N; Guerold, B; Sawers, RJH; Kichler, A; Metz-Boutigue, MH; Candolfi, E; Prevost, G; Bechinger, B				Mason, A. James; Moussaoui, Wardi; Abdelrahman, Tamer; Boukhari, Alyae; Bertani, Philippe; Marquette, Arnaud; Shooshtarizaheh, Peiman; Moulay, Gilles; Boehm, Nelly; Guerold, Bernard; Sawers, Ruairidh J. H.; Kichler, Antoine; Metz-Boutigue, Marie-Helene; Candolfi, Ermanno; Prevost, Gilles; Bechinger, Burkhard			Structural Determinants of Antimicrobial and Antiplasmodial Activity and Selectivity in Histidine-rich Amphipathic Cationic Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; LACTOFERRIN-DERIVED PEPTIDES; DERMASEPTIN S4 DERIVATIVES; MEMBRANE-LIPID-COMPOSITION; CELL-PENETRATING PEPTIDE; PLASMODIUM-FALCIPARUM; IN-VITRO; HYDROPHOBIC MISMATCH; SECONDARY STRUCTURE; MAGNETIC-RESONANCE	Designed histidine-rich amphipathic cationic peptides, such as LAH4, have enhanced membrane disruption and antibiotic properties when the peptide adopts an alignment parallel to the membrane surface. Although this was previously achieved by lowering the pH, here we have designed a new generation of histidine-rich peptides that adopt a surface alignment at neutral pH. In vitro, this new generation of peptides are powerful antibiotics in terms of the concentrations required for antibiotic activity; the spectrum of target bacteria, fungi, and parasites; and the speed with which they kill. Further modifications to the peptides, including the addition of more hydrophobic residues at the N terminus, the inclusion of a helix-breaking proline residue or using D-amino acids as building blocks, modulated the biophysical properties of the peptides and led to substantial changes in toxicity to human and parasite cells but had only a minimal effect on the antibacterial and antifungal activity. Using a range of biophysical methods, in particular solid-state NMR, we show that the peptides are highly efficient at disrupting the anionic lipid component of model membranes. However, we also show that effective pore formation in such model membranes may be related to, but is not essential for, high antimicrobial activity by cationic amphipathic helical peptides. The information in this study comprises a new layer of detail in the understanding of the action of cationic helical antimicrobial peptides and shows that rational design is capable of producing potentially therapeutic membrane active peptides with properties tailored to their function.	[Mason, A. James; Bertani, Philippe; Marquette, Arnaud; Bechinger, Burkhard] Univ Strasbourg, CNRS, UMR7177, Inst Chim, F-67070 Strasbourg, France; [Moussaoui, Wardi; Boukhari, Alyae; Prevost, Gilles] Univ Strasbourg, Hop Univ Strasbourg, Inst Bacteriol, UPRES EA3432, F-67000 Strasbourg, France; [Abdelrahman, Tamer; Candolfi, Ermanno] Univ Strasbourg, Fac Med, Inst Parasitol & Pathol Trop, UPRES EA3950, F-67000 Strasbourg, France; [Shooshtarizaheh, Peiman; Guerold, Bernard; Metz-Boutigue, Marie-Helene] INSERM, U575, F-67084 Strasbourg, France; [Moulay, Gilles; Kichler, Antoine] CNRS, FRE Genethon 3087, F-91002 Evry, France; [Boehm, Nelly] Univ Strasbourg, INSERM, U666, F-67085 Strasbourg, France; [Boehm, Nelly] Univ Strasbourg, Serv Cent Microscopie Elect, F-67085 Strasbourg, France; [Sawers, Ruairidh J. H.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Mason, AJ (corresponding author), Kings Coll London, Div Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England.	james.mason@kcl.ac.uk	Mason, James/J-2273-2012	Mason, James/0000-0003-0411-602X; Abdelrahman, Tamir/0000-0003-0381-9524; MOULAY, Gilles/0000-0002-4913-9893; Kichler, Antoine/0000-0003-0593-2424; Sawers, Ruairidh James Hay/0000-0002-8945-3078	Vaincre la Mucoviscidose, Inserm [TG0501]; Hopitaux Universitaires de Strasbourg [PHRC3150]; CNRS; Universite Louis Pasteur [EA-3432]	Vaincre la Mucoviscidose, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Hopitaux Universitaires de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur	This work was supported by Vaincre la Mucoviscidose Grant TG0501 (to B. B.) Inserm, Hopitaux Universitaires de Strasbourg Grant PHRC3150 (to M.-H. M.-B.), and CNRS and Universite Louis Pasteur (postdoctoral grants to A.J.M. and EA-3432). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEY MC, 1988, CANCER RES, V48, P589; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; Bechinger B, 2004, CRIT REV PLANT SCI, V23, P271, DOI 10.1080/07352680490452825; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; Bechinger B., 2003, CONCEPT MAGN RESON A, V18A, P130; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; BENBASSAT I, 1972, J CLIN INVEST, V51, P1833, DOI 10.1172/JCI106985; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Doderer C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-19; Efron L, 2002, J BIOL CHEM, V277, P24067, DOI 10.1074/jbc.M202089200; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Gelhaus C, 2008, ANTIMICROB AGENTS CH, V52, P1713, DOI 10.1128/AAC.01342-07; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; Hallock KJ, 2002, BIOPHYS J, V82, P2499, DOI 10.1016/S0006-3495(02)75592-6; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harzer U, 2000, BIOCHEMISTRY-US, V39, P13106, DOI 10.1021/bi000770n; Hong SY, 1999, BIOCHEM PHARMACOL, V58, P1775, DOI 10.1016/S0006-2952(99)00259-2; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Krugliak M, 2000, ANTIMICROB AGENTS CH, V44, P2442, DOI 10.1128/AAC.44.9.2442-2451.2000; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; MAGUIRE PA, 1990, MOL BIOCHEM PARASIT, V38, P105, DOI 10.1016/0166-6851(90)90210-D; Marquette A, 2008, J PEPT SCI, V14, P488, DOI 10.1002/psc.966; Mason AJ, 2007, MINI-REV MED CHEM, V7, P491, DOI 10.2174/138955707780619563; Mason AJ, 2007, BIOCHEMISTRY-US, V46, P15175, DOI 10.1021/bi701344m; Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681; Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje; Mason AJ, 2006, ANTIMICROB AGENTS CH, V50, P3305, DOI 10.1128/AAC.00490-06; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Nishikawa M, 2004, FEMS MICROBIOL LETT, V239, P255, DOI 10.1016/j.femsle.2004.08.043; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; SCHAFER H, 1995, J MAGN RESON SER A, V116, P145, DOI 10.1006/jmra.1995.0002; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; SHERMAN IW, 1984, T ROY SOC TROP MED H, V78, P641, DOI 10.1016/0035-9203(84)90227-X; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STERNIN E, 1983, J MAGN RESON, V55, P274, DOI 10.1016/0022-2364(83)90239-1; TYTLER EM, 1993, J BIOL CHEM, V268, P22122; UTSUGI T, 1991, CANCER RES, V51, P3062; Vial Henri J., 1992, V18, P259; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Yoshida K, 2001, J PEPT RES, V57, P119, DOI 10.1034/j.1399-3011.2001.00802.x; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	67	81	84	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					119	133		10.1074/jbc.M806201200	http://dx.doi.org/10.1074/jbc.M806201200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984589	hybrid			2022-12-25	WOS:000261974800014
J	Sliter, DA; Kubota, K; Kirkpatrick, DS; Alzayady, KJ; Gygi, SP; Wojcikiewicz, RJH				Sliter, Danielle A.; Kubota, Kazuishi; Kirkpatrick, Donald S.; Alzayady, Kamil J.; Gygi, Steven P.; Wojcikiewicz, Richard J. H.			Mass Spectrometric Analysis of Type 1 Inositol 1,4,5-Trisphosphate Receptor Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CONJUGATING ENZYMES E2S; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; PROTEASOMAL DEGRADATION; TRISPHOSPHATE RECEPTORS; PROTEIN; CELLS	Inositol 1,4,5-trisphosphate (IP3)receptors form tetrameric channels in endoplasmic reticulum membranes of mammalian cells and mediate IP3-induced calcium mobilization. In response to various extracellular stimuli that persistently elevate IP3 levels, IP3 receptors are also ubiquitinated and then degraded by the proteasome. Here, for endogenous type 1 IP3 receptor (IP(3)R1) activated by endogenous signaling pathways and processed by endogenous enzymes, we sought to determine the sites of ubiquitination and the composition of attached ubiquitin conjugates. Our findings are (i) that at least 11 of the 167 lysines in IP(3)R1 can be ubiquitinated and that these are clustered in the regulatory domain and are found in surface regions, (ii) that at least similar to 40% of the IP(3)R1-associated ubiquitin is monoubiquitin, (iii) that both Lys(48) and Lys(63) linkages are abundant in attached ubiquitin chains, and (iv) that Lys(63) linkages accumulate most rapidly. Additionally, we find that not all IP(3)R1 subunits in a tetramer are ubiquitinated and that nontetrameric IP(3)R1 complexes form as degradation proceeds, suggesting that ubiquitinated subunits may be selectively extracted and degraded. Overall, these data show that endogenous IP3R1 is tagged with an array of ubiquitin conjugates at multiple sites and that both IP(3)R1 ubiquitination and degradation are highly complex processes.	[Sliter, Danielle A.; Alzayady, Kamil J.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Kubota, Kazuishi; Kirkpatrick, Donald S.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Kirkpatrick, Donald/0000-0003-3091-2804	National Institutes of Health [DK49194, GM67945]; American Heart Association [0815754D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49194 (to R. J. H. W.) and GM67945 ( to S. P. G.). This work was also supported by American Heart Association Grant 0815754D (to D. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; KIRKPATRICK DS, 2008, PROTOCOLS BIOANALYTI, P103; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	47	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35319	35328		10.1074/jbc.M807288200	http://dx.doi.org/10.1074/jbc.M807288200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955483	Green Published, hybrid			2022-12-25	WOS:000261687900003
J	Boukovinas, I; Papadaki, C; Mendez, P; Taron, M; Mavroudis, D; Koutsopoulos, A; Sanchez-Ronco, M; Sanchez, JJ; Trypaki, M; Staphopoulos, E; Georgoulias, V; Rosell, R; Souglakos, J				Boukovinas, Ioannis; Papadaki, Chara; Mendez, Pedro; Taron, Miquel; Mavroudis, Dimitris; Koutsopoulos, Anastasios; Sanchez-Ronco, Maria; Javier Sanchez, Jose; Trypaki, Maria; Staphopoulos, Eustathios; Georgoulias, Vassilis; Rosell, Rafael; Souglakos, John			Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; RIBONUCLEOTIDE REDUCTASE; PHASE-III; HUMAN BREAST; CISPLATIN; SURVIVAL; RESISTANCE; CHEMORESISTANCE; OVEREXPRESSION; REGIMENS	Background: Overexpression of RRM1 and RRM2 has been associated with gemcitabine resistance. BRCA1 overexpression increases sensitivity to paclitaxel and docetaxel. We have retrospectively examined the effect of RRM1, RRM2 and BRCA1 expression on outcome to gemcitabine plus docetaxel in advanced non-small-cell lung cancer (NSCLC) patients. Methodology and Principal Findings: Tumor samples were collected from 102 chemotherapy-naive advanced NSCLC patients treated with gemcitabine plus docetaxel as part of a randomized trial. RRM1, RRM2 and BRCA1 mRNA levels were assessed by quantitative PCR and correlated with response, time to progression and survival. As BRCA1 levels increased, the probability of response increased (Odds Ratio [OR], 1.09: p = 0.01) and the risk of progression decreased (hazard ratio [HR], 0.99; p = 0.36). As RRM1 and RRM2 levels increased, the probability of response decreased (RRM1: OR, 0.97; p = 0.82; RRM2: OR, 0.94; p<0.0001) and the risk of progression increased (RRM1: HR, 1.02; p = 0.001; RRM2: HR, 1.005; p = 0.01). An interaction observed between BRCA1 and RRM1 allowed patients to be classified in three risk groups according to combinations of gene expression levels, with times to progression of 10.13, 4.17 and 2.30 months (p = 0.001). Low BRCA1 expression was the only factor significantly associated with longer time to progression in 31 patients receiving cisplatin-based second-line therapy. Conclusions: The mRNA expression of BRCA1, RRM1 and RRM2 is potentially a useful tool for selecting NSCLC patients for individualized chemotherapy and warrants further investigation in prospective studies.	[Boukovinas, Ioannis] Theagenion Krankenhauses, Thessaloniki, Greece; [Papadaki, Chara; Mavroudis, Dimitris; Trypaki, Maria; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Lab Tumor Cell Biol, Iraklion, Greece; [Mendez, Pedro; Taron, Miquel; Rosell, Rafael] Hosp Germans Trias Pujol, Catalan Inst Oncol, Barcelona, Spain; [Taron, Miquel; Rosell, Rafael] USP Dexeus Univ, C Sabino Arana 5, Barcelona, Spain; [Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Koutsopoulos, Anastasios; Staphopoulos, Eustathios] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Greece; [Sanchez-Ronco, Maria] Univ Alcala Henares, Alcala De Henares, Spain; [Javier Sanchez, Jose] Univ Autonoma Madrid, E-28049 Madrid, Spain	University of Crete; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; University Hospital of Heraklion; University Hospital of Heraklion; Universidad de Alcala; Autonomous University of Madrid	Boukovinas, I (corresponding author), Theagenion Krankenhauses, Thessaloniki, Greece.	rrosell@ico.scs.es; georgsec@med.uoc.gr	Koutsopoulos, Anastasios/AAO-9498-2020	Koutsopoulos, Anastasios/0000-0002-8430-7565; PAPADAKI, CHARA/0000-0002-4591-3757	Cretan Association for Biomedical Research (CABR) [fellowship]	Cretan Association for Biomedical Research (CABR)	This work was partly supported by the Cretan Association for Biomedical Research (CABR). Dr. John Souglakos is the recipient of a CABR research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Booton R, 2007, J THORAC ONCOL, V2, P902, DOI 10.1097/JTO.0b013e318155a637; Burdett S, 2007, J THORAC ONCOL, V2, pS337, DOI 10.1097/01.JTO.0000283148.83670.80; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Duxbury MS, 2004, SURGERY, V136, P261, DOI 10.1016/j.surg.2004.04.029; Eelen G, 2008, ONCOGENE, V27, P4233, DOI 10.1038/onc.2008.51; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Georgoulias V, 2005, J CLIN ONCOL, V23, P2937, DOI 10.1200/JCO.2005.04.016; Georgoulias V, 2001, LANCET, V357, P1478, DOI 10.1016/S0140-6736(00)04644-4; Goan YG, 1999, CANCER RES, V59, P4204; Husain A, 1998, CANCER RES, V58, P1120; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873	37	106	115	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3695	10.1371/journal.pone.0003695	http://dx.doi.org/10.1371/journal.pone.0003695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002265	gold, Green Published, Green Submitted			2022-12-25	WOS:000265165600002
J	Urdinguio, RG; Lopez-Serra, L; Lopez-Nieva, P; Alaminos, M; Diaz-Uriarte, R; Fernandez, AF; Esteller, M				Urdinguio, Rocio G.; Lopez-Serra, Lidia; Lopez-Nieva, Pilar; Alaminos, Miguel; Diaz-Uriarte, Ramon; Fernandez, Agustin F.; Esteller, Manel			Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome	PLOS ONE			English	Article								Background: Rett syndrome (RTT) is a complex neurological disorder that is one of the most frequent causes of mental retardation in women. A great landmark in research in this field was the discovery of a relationship between the disease and the presence of mutations in the gene that codes for the methyl-CpG binding protein 2 (MeCP2). Currently, MeCP2 is thought to act as a transcriptional repressor that couples DNA methylation and transcriptional silencing. The present study aimed to identify new target genes regulated by Mecp2 in a mouse model of RTT. Methodology/Principal Findings: We have compared the gene expression profiles of wild type (WT) and Mecp2-null ( KO) mice in three regions of the brain (cortex, midbrain, and cerebellum) by using cDNA microarrays. The results obtained were confirmed by quantitative real-time PCR. Subsequent chromatin immunoprecipitation assays revealed seven direct target genes of Mecp2 bound in vivo (Fkbp5, Mobp, Plagl1, Ddc, Mllt2h, Eya2, and S100a9), and three overexpressed genes due to an indirect effect of a lack of Mecp2 (Irak1, Prodh and Dlk1). The regions bound by Mecp2 were always methylated, suggesting the involvement of the methyl-CpG binding domain of the protein in the mechanism of interaction. Conclusions: We identified new genes that are overexpressed in Mecp2-KO mice and are excellent candidate genes for involvement in various features of the neurological disease. Our results demonstrate new targets of MeCP2 and provide us with a better understanding of the underlying mechanisms of RTT.	[Urdinguio, Rocio G.; Lopez-Serra, Lidia; Lopez-Nieva, Pilar; Alaminos, Miguel; Fernandez, Agustin F.; Esteller, Manel] CNIO, Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid, Spain; [Diaz-Uriarte, Ramon] Spanish Natl Canc Res Ctr CNIO, Stat Comput Team, Madrid, Spain; [Esteller, Manel] Inst Investigac Biomed Bellvitge IDIBELL, Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Esteller, Manel] Inst Catalana Recerca Estudis Avancats ICREA, Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Urdinguio, RG (corresponding author), CNIO, Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid, Spain.	mesteller@idibell.org	Nieva, Pilar López/R-9516-2019; Fernandez, Agustin F./N-7302-2014; Diaz-Uriarte, Ramon/M-5517-2013; Esteller, Manel/L-5956-2014; Urdinguio, Rocio/AAA-9015-2020; ALAMINOS, MIGUEL/N-9960-2016	Nieva, Pilar López/0000-0001-6369-2444; Fernandez, Agustin F./0000-0002-3792-4085; Diaz-Uriarte, Ramon/0000-0002-6637-9039; Esteller, Manel/0000-0003-4490-6093; Urdinguio, Rocio/0000-0003-2736-5758; ALAMINOS, MIGUEL/0000-0003-4876-2672	E-Rare; Comunidad de Madrid FPI Programme; ICREA Funding Source: Custom	E-Rare; Comunidad de Madrid FPI Programme; ICREA(ICREA)	This work was supported by the E-Rare (ERA-Net for research programs on rare diseases) (EuroRETT). R.G.U. is funded by the Comunidad de Madrid FPI Programme. M.E. is an ICREA Research Professor. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFENJAR A, 2007, BRAIN DEV; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2005, HUM GENET, V116, P91, DOI 10.1007/s00439-004-1200-0; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Buckland PR, 1997, MOL BRAIN RES, V49, P266; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C; Delgado IJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-61; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Di Rosa G, 2008, PSYCHIAT GENET, V18, P40, DOI 10.1097/YPG.0b013e3282f08a3d; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; DYCK LE, 1983, J NEUROSCI RES, V10, P211, DOI 10.1002/jnr.490100209; Embry AC, 2004, MOL PHARMACOL, V66, P1325, DOI 10.1124/mol.104.004093; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Fox J, 2002, COX PROPORTIONAL HAZ; Fox Jr J., 2015, APPL REGRESSION ANAL; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hillman MA, 2001, J HUM GENET, V46, P251, DOI 10.1007/s100380170074; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KOH T, 1995, INT J CANCER, V60, P843, DOI 10.1002/ijc.2910600620; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Makedonski K, 2005, HUM MOL GENET, V14, P1049, DOI 10.1093/hmg/ddi097; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MILLER RG, 1997, ANOVA; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; PATERSON IA, 1990, J NEUROCHEM, V55, P1827, DOI 10.1111/j.1471-4159.1990.tb05764.x; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Phang J. M., 2001, METABOLIC MOL BASES; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; R Development Core Team, 2006, LANG ENV STAT COMP; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shimizu T, 2006, PHARMACOL BIOCHEM BE, V85, P643, DOI 10.1016/j.pbb.2006.10.020; Shimizu T, 2004, PAIN, V110, P246, DOI 10.1016/j.pain.2004.03.038; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Sokal RR, 1995, BIOMETRY; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vassiliou AG, 2005, NEUROCHEM RES, V30, P641, DOI 10.1007/s11064-005-2752-7; Yool D, 2002, GLIA, V39, P256, DOI 10.1002/glia.10103	86	88	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3669	10.1371/journal.pone.0003669	http://dx.doi.org/10.1371/journal.pone.0003669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989361	Green Published, gold, Green Submitted			2022-12-25	WOS:000265134600005
J	Katoh, A; Chapman, PJ; Raymond, JL				Katoh, Akira; Chapman, Peter J.; Raymond, Jennifer L.			Disruption of Learned Timing in P/Q Calcium Channel Mutants	PLOS ONE			English	Article								To optimize motor performance, both the amplitude and temporal properties of movements should be modifiable by motor learning. Here we report that the modification of movement timing is highly dependent on signaling through P/Q-type voltage-dependent calcium channels. Two lines of mutant mice heterozygous for P/Q-type voltage-dependent calcium channels exhibited impaired plasticity of eye movement timing, but relatively intact plasticity of movement amplitude during motor learning in the vestibulo-ocular reflex. The results thus demonstrate a distinction between the molecular signaling pathways regulating the timing versus amplitude of movements.	[Katoh, Akira; Chapman, Peter J.; Raymond, Jennifer L.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Katoh, A (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	jenr@stanford.edu	Katoh, Akira/B-2683-2010	Katoh, Akira/0000-0001-7867-2964; Raymond, Jennifer/0000-0002-8145-747X	EJLB Foundation Award; James S. Mcdonnell Foundation 21st Century Research Award; NIH [P01 NS0353862]; Human Frontier Science Program [fellowship]	EJLB Foundation Award; James S. Mcdonnell Foundation 21st Century Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program)	This research was supported by an EJLB Foundation Award, James S. Mcdonnell Foundation 21st Century Research Award and NIH P01 NS0353862 to J.L.R.. A.K. was supported by a long-term fellowship from the Human Frontier Science Program.	Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hirata Y, 2002, J NEUROPHYSIOL, V88, P3194, DOI 10.1152/jn.00698.2001; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Katoh A, 2007, J NEUROPHYSIOL, V97, P1280, DOI 10.1152/jn.00322.2006; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; KRAMER PD, 1995, EXP BRAIN RES, V106, P318; Kramer PD, 1998, EXP BRAIN RES, V120, P184, DOI 10.1007/s002210050392; LI J, 1995, J NEUROPHYSIOL, V74, P489, DOI 10.1152/jn.1995.74.1.489; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; NGUYENVU T, 2007, SOC NEUR ABSTR; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Safo P, 2008, NEUROPHARMACOLOGY, V54, P213, DOI 10.1016/j.neuropharm.2007.05.029; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2006, J NEUROPHYSIOL, V95, P1588, DOI 10.1152/jn.00318.2005; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3635	10.1371/journal.pone.0003635	http://dx.doi.org/10.1371/journal.pone.0003635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982062	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134300005
J	Alvarez-Buylla, ER; Chaos, A; Aldana, M; Benitez, M; Cortes-Poza, Y; Espinosa-Soto, C; Hartasanchez, DA; Lotto, RB; Malkin, D; Santos, GJE; Padilla-Longoria, P				Alvarez-Buylla, Elena R.; Chaos, Alvaro; Aldana, Maximino; Benitez, Mariana; Cortes-Poza, Yuriria; Espinosa-Soto, Carlos; Hartasanchez, Diego A.; Beau Lotto, R.; Malkin, David; Escalera Santos, Gerardo J.; Padilla-Longoria, Pablo			Floral Morphogenesis: Stochastic Explorations of a Gene Network Epigenetic Landscape	PLOS ONE			English	Article							CELL-CYCLE NETWORK; REGULATORY NETWORK; HOMEOTIC GENES; EXPRESSION; ROBUSTNESS; EVOLUTION; MOVEMENT; MODELS; MEMORY; NOISE	In contrast to the classical view of development as a preprogrammed and deterministic process, recent studies have demonstrated that stochastic perturbations of highly non-linear systems may underlie the emergence and stability of biological patterns. Herein, we address the question of whether noise contributes to the generation of the stereotypical temporal pattern in gene expression during flower development. We modeled the regulatory network of organ identity genes in the Arabidopsis thaliana flower as a stochastic system. This network has previously been shown to converge to ten fixed-point attractors, each with gene expression arrays that characterize inflorescence cells and primordial cells of sepals, petals, stamens, and carpels. The network used is binary, and the logical rules that govern its dynamics are grounded in experimental evidence. We introduced different levels of uncertainty in the updating rules of the network. Interestingly, for a level of noise of around 0.5-10%, the system exhibited a sequence of transitions among attractors that mimics the sequence of gene activation configurations observed in real flowers. We also implemented the gene regulatory network as a continuous system using the Glass model of differential equations, that can be considered as a first approximation of kinetic-reaction equations, but which are not necessarily equivalent to the Boolean model. Interestingly, the Glass dynamics recover a temporal sequence of attractors, that is qualitatively similar, although not identical, to that obtained using the Boolean model. Thus, time ordering in the emergence of cell-fate patterns is not an artifact of synchronous updating in the Boolean model. Therefore, our model provides a novel explanation for the emergence and robustness of the ubiquitous temporal pattern of floral organ specification. It also constitutes a new approach to understanding morphogenesis, providing predictions on the population dynamics of cells with different genetic configurations during development.	[Alvarez-Buylla, Elena R.; Chaos, Alvaro; Benitez, Mariana; Espinosa-Soto, Carlos; Escalera Santos, Gerardo J.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Alvarez-Buylla, Elena R.; Chaos, Alvaro; Aldana, Maximino; Benitez, Mariana; Cortes-Poza, Yuriria; Espinosa-Soto, Carlos; Hartasanchez, Diego A.; Escalera Santos, Gerardo J.; Padilla-Longoria, Pablo] Univ Nacl Autonoma Mexico, Cd Univ, Ctr Ciencias Complejidad, C3, Mexico City, DF, Mexico; [Aldana, Maximino; Hartasanchez, Diego A.] Univ Nacl Autonoma Mexico, Inst Ciencias Fisicas, Cuernavaca, Morelos, Mexico; [Cortes-Poza, Yuriria; Padilla-Longoria, Pablo] Univ Nacl Autonoma Mexico, Cd Univ, Inst Investigac Mat Aplicadas Sist, Mexico City, DF, Mexico; [Beau Lotto, R.; Malkin, David] UCL, Lottolab, London WC1E 6BT, England	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of London; University College London	Alvarez-Buylla, ER (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	elena.alvarezbuylla@gmail.com; pablo@mym.iimas.unam.mx	Malkin, David/AAW-8715-2021; Aldana, Maximino/D-9372-2017; Espinosa-Soto, Carlos/L-8473-2017; Benítez, Mariana/E-2997-2012; Santos, Gerardo J. Escalera/A-8880-2019	Aldana, Maximino/0000-0002-3419-6641; Espinosa-Soto, Carlos/0000-0002-9753-5807; Santos, Gerardo J. Escalera/0000-0002-6549-3737; Cortes-Poza, Yuriria/0000-0003-1856-9206; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473; Hartasanchez, Diego/0000-0003-2596-6883	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM) [IN230002, IX207104, IN112407-3]; University of California-MEXUS ECO IE 271; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CO1.41848/ A-1, CO1.0538/A-1, CO1.0435.B-1, P47836-F]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); University of California-MEXUS ECO IE 271; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM) IN230002 and IX207104, University of California-MEXUS ECO IE 271 and Consejo Nacional de Ciencia y Tecnologia (CONACYT) CO1.41848/ A-1, CO1.0538/A-1 and CO1.0435.B-1. Grants to E.A.B. PAPIIT-UNAM grant IN112407-3 y CONACyT grant and P47836-F grants to M.A. Ph.D. and postdoctoral scholarships from CONACYT and UNAM (CEP-UNAM) to C.E.-S, M.B., G.J. E. and A.C. These students were in the Doctorado en Ciencias Biomedicas graduate program at the Instituto de Ecologia from UNAM.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Adam H, 2007, ANN BOT-LONDON, V100, P1, DOI 10.1093/aob/mcm027; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldrich J, 1997, STAT SCI, V12, P162; Alvarez-Buylla ER, 2007, CURR OPIN PLANT BIOL, V10, P83, DOI 10.1016/j.pbi.2006.11.008; Ambrose BA, 2006, AM J BOT, V93, P15, DOI 10.3732/ajb.93.1.15; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bomblies K, 1999, DEV BIOL, V216, P260, DOI 10.1006/dbio.1999.9504; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; Chaos A, 2006, J PLANT GROWTH REGUL, V25, P278, DOI 10.1007/s00344-006-0068-8; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Escudero C, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.010103; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gershenson C, 2004, ARTIFICIAL LIFE IX, P238; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Han B, 2007, BIOPHYS J, V92, P3755, DOI 10.1529/biophysj.106.094821; Huang K., 1990, STAT MECH; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2006, Breast Dis, V26, P27; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kauffman S.A., 1993, ORIGINS ORDER; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; LOHMANN J, 1995, SCIENCE, V270, P1980; LUCAS WJ, 1995, CURR OPIN CELL BIOL, V7, P673, DOI 10.1016/0955-0674(95)80109-X; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; RUDALL P, 1987, ANATOMY FLOWERING PL; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington C., 1957, STRATEGY GENES; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Wang J, 2006, BIOPHYS J, V91, pL54, DOI 10.1529/biophysj.106.086777; Wang ZW, 2007, BIOPHYS CHEM, V125, P281, DOI 10.1016/j.bpc.2006.09.006; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101	48	79	80	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3626	10.1371/journal.pone.0003626	http://dx.doi.org/10.1371/journal.pone.0003626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978941	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134200009
J	Zhang, XN; Wu, YJ; Tobias, JW; Brunk, BP; Deitzer, GF; Liu, DM				Zhang, Xiao-Ning; Wu, Yingjie; Tobias, John W.; Brunk, Brian P.; Deitzer, Gerald F.; Liu, Dongmei			HFR1 Is Crucial for Transcriptome Regulation in the Cryptochrome 1-Mediated Early Response to Blue Light in Arabidopsis thaliana	PLOS ONE			English	Article								Cryptochromes are blue light photoreceptors involved in development and circadian clock regulation. They are found in both eukaryotes and prokaryotes as light sensors. Long Hypocotyl in Far-Red 1 (HFR1) has been identified as a positive regulator and a possible transcription factor in both blue and far-red light signaling in plants. However, the gene targets that are regulated by HFR1 in cryptochrome 1 (cry1)-mediated blue light signaling have not been globally addressed. We examined the transcriptome profiles in a cry1- and HFR1-dependent manner in response to 1 hour of blue light. Strikingly, more than 70% of the genes induced by blue light in an HFR1-dependent manner were dependent on cry1, and vice versa. High overrepresentation of W-boxes and OCS elements were found in these genes, indicating that this strong cry1 and HFR1 co-regulation on gene expression is possibly through these two cis-elements. We also found that cry1 was required for maintaining the HFR1 protein level in blue light, and that the HFR1 protein level is strongly correlated with the global gene expression pattern. In summary, HFR1, which is fine-tuned by cry1, is crucial for regulating global gene expression in cry1 mediated early blue light signaling, especially for the function of genes containing W-boxes and OCS elements.	[Zhang, Xiao-Ning; Wu, Yingjie; Liu, Dongmei] Univ Penn, Plant Sci Inst, Dept Biol, Philadelphia, PA 19104 USA; [Tobias, John W.; Brunk, Brian P.] Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Deitzer, Gerald F.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA	University of Pennsylvania; University of Pennsylvania; University System of Maryland; University of Maryland College Park	Zhang, XN (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	xnzhang@umd.edu	Zhang, Xiao-Ning/J-1737-2019	Zhang, Xiao-Ning/0000-0001-8650-1356	NIH [GM51956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant (GM51956) to Dr Anthony R. Cashmore at the University of Pennsylvania when the first authors were doing postdoctoral research in his lab. It is his request not to include his name in this manuscript. We still give our very sincere gratitude to him in the acknowledgment for his generous financial support and the workspace he provided. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; BOUCHEZ D, 1989, EMBO J, V8, P4197, DOI 10.1002/j.1460-2075.1989.tb08605.x; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Duek PD, 2003, PLANT J, V34, P827, DOI 10.1046/j.1365-313X.2003.01770.x; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fairchild CD, 2000, GENE DEV, V14, P2377; Foley RC, 2004, FEBS LETT, V563, P141, DOI 10.1016/S0014-5793(04)00288-1; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Inada S, 2004, PLANT CELL, V16, P887, DOI 10.1105/tpc.019901; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kang XJ, 2006, PLANT CELL, V18, P921, DOI 10.1105/tpc.105.037879; Kang XJ, 2005, PLANT CELL, V17, P822, DOI 10.1105/tpc.104.029165; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; Padegimas LS, 1998, ANAL BIOCHEM, V260, P149, DOI 10.1006/abio.1998.2719; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Soh MS, 2000, PLANT CELL, V12, P2061, DOI 10.1105/tpc.12.11.2061; Spiegelman JI, 2000, PLANT CELL, V12, P2485, DOI 10.1105/tpc.12.12.2485; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yang KY, 2003, PLANT PHYSIOL, V133, P1630, DOI 10.1104/pp.103.029751; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	42	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3563	10.1371/journal.pone.0003563	http://dx.doi.org/10.1371/journal.pone.0003563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974779	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131500002
J	Puhar, A; Dal Molin, F; Horvath, S; Ladants, D; Montecucco, C				Puhar, Andrea; Dal Molin, Federica; Horvath, Stephanie; Ladants, Daniel; Montecucco, Cesare			Anthrax Edema Toxin Modulates PKA- and CREB-Dependent Signaling in Two Phases	PLOS ONE			English	Article								Background: Anthrax edema toxin (EdTx) is an adenylate cyclase which operates in the perinuclear region of host cells. However, the action of EdTx is poorly understood, especially at molecular level. The ability of EdTx to modulate cAMP-dependent signaling was studied in Jurkat T cells and was compared with that of other cAMP-rising agents: Bordetella pertussis adenylate cyclase toxin, cholera toxin and forskolin. Methodology/Principal Findings: EdTx caused a prolonged increase of the intracellular cAMP concentration. This led to nuclear translocation of the cAMP-dependent protein kinase (PKA) catalytic subunit, phosphorylation of cAMP response element binding protein (CREB) and expression of a reporter gene under control of the cAMP response element. Neither p90 ribosomal S6 kinase nor mitogen- and stress-activated kinase, which mediate CREB phosphorylation during T cell activation, were involved. The duration of phospho-CREB binding to chromatin correlated with the spatio-temporal rise of cAMP levels. Strikingly, EdTx pre-treated T cells were unresponsive to other stimuli involving CREB phosphorylation such as addition of forskolin or T cell receptor cross-linking. Conclusions/Significance: We concluded that, in a first intoxication phase, EdTx induces PKA-dependent signaling, which culminates in CREB phosphorylation and activation of gene transcription. Subsequently CREB phosphorylation is impaired and therefore T cells are not able to respond to cues involving CREB. The present data functionally link the perinuclear localization of EdTx to its intoxication mechanism, indicating that this is a specific feature of its intoxication mechanism.	[Puhar, Andrea; Dal Molin, Federica; Horvath, Stephanie; Montecucco, Cesare] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy; [Ladants, Daniel] Institut Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol, Paris, France	University of Padua; Centre National de la Recherche Scientifique (CNRS)	Puhar, A (corresponding author), Inst Pasteur, INSERM, U786, Unite Pathogenie Microbienne Mol, F-75724 Paris, France.	andrea.puhar@pasteur.fr; cesare.montecucco@unipd.it		Puhar, Andrea/0000-0002-9915-002X; LADANT, Daniel/0000-0003-1955-548X	Anthrax-EuroNet; Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali"; Network of Excellence EuroPathoGenomics from the European Commission; Institut Pasteur; EU 6th Framework Programme [LSHB-CT-2004-503582]	Anthrax-EuroNet; Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali"; Network of Excellence EuroPathoGenomics from the European Commission; Institut Pasteur(European Commission); EU 6th Framework Programme(European Commission)	This work was supported by grants from the Anthrax-EuroNet, Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali", and Network of Excellence EuroPathoGenomics from the European Commission to C. M., and grants from Institut Pasteur and from the EU 6th Framework Programme Contract LSHB-CT-2004-503582 (Theravac) to D. L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Bailey JR, 2005, ACAD MANAG LEARN EDU, V4, P134; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Dal Molin F, 2008, BIOCHEM BIOPH RES CO, V376, P429, DOI 10.1016/j.bbrc.2008.09.012; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fimia GM, 2001, J CELL SCI, V114, P1971; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guidi-Rontani C, 2000, CELL MICROBIOL, V2, P259, DOI 10.1046/j.1462-5822.2000.00057.x; Hong J, 2007, J BIOL CHEM, V282, P19781, DOI 10.1074/jbc.M700128200; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kaiser M, 2007, EUR J IMMUNOL, V37, P2583, DOI 10.1002/eji.200636606; Kanda N, 2001, BIOCHEM PHARMACOL, V62, P495, DOI 10.1016/S0006-2952(01)00688-8; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Lissandron V, 2005, J MOL BIOL, V354, P546, DOI 10.1016/j.jmb.2005.09.089; Maldonado-Arocho FJ, 2006, MOL MICROBIOL, V61, P324, DOI 10.1111/j.1365-2958.2006.05232.x; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Puhar A, 2007, TRENDS MICROBIOL, V15, P477, DOI 10.1016/j.tim.2007.10.003; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; Sayner S, 2006, BIOCHEM SOC T, V34, P492, DOI 10.1042/BST0340492; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shen YQ, 2004, P NATL ACAD SCI USA, V101, P3242, DOI 10.1073/pnas.0306552101; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tonello F, 2004, BIOCHEM BIOPH RES CO, V313, P496, DOI 10.1016/j.bbrc.2003.11.134; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	66	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3564	10.1371/journal.pone.0003564	http://dx.doi.org/10.1371/journal.pone.0003564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958164	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131100020
J	Yakar, S; Rosen, CJ; Bouxsein, ML; Sun, H; Mejia, W; Kawashima, Y; Wu, YJ; Emerton, K; Williams, V; Jepsen, K; Schaffler, MB; Majeska, RJ; Gavrilova, O; Gutierrez, M; Hwang, D; Pennisi, P; Frystyk, J; Boisclair, Y; Pintar, J; Jasper, H; Domene, H; Cohen, P; Clemmons, D; LeRoith, D				Yakar, Shoshana; Rosen, Clifford J.; Bouxsein, Mary L.; Sun, Hui; Mejia, Wilson; Kawashima, Yuki; Wu, Yingjie; Emerton, Kelly; Williams, Valerie; Jepsen, Karl; Schaffler, Mitchell B.; Majeska, Robert J.; Gavrilova, Oksana; Gutierrez, Mariana; Hwang, David; Pennisi, Patricia; Frystyk, Jan; Boisclair, Yves; Pintar, John; Jasper, Hector; Domene, Horacio; Cohen, Pinchas; Clemmons, David; LeRoith, Derek			Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism	FASEB JOURNAL			English	Article						cortical bone; trabecular bone; osteoblast; osteoclast; ternary complex; binary complex	ACID-LABILE SUBUNIT; FACTOR-BINDING PROTEIN-5; TYPE-1 IGF RECEPTOR; BONE-MINERAL DENSITY; BREAST-CANCER CELLS; TRANSGENIC MICE; SECRETING CELLS; FACTOR SYSTEM; GENE; HORMONE	Serum insulin-like growth factor (IGF)-1 is secreted mainly by the liver and circulates bound to IGF-binding proteins (IGFBPs), either as binary complexes or ternary complexes with IGFBP-3 or IGFBP-5 and an acid-labile subunit (ALS). The purpose of this study was to genetically dissect the role of IGF-1 circulatory complexes in somatic growth, skeletal integrity, and metabolism. Phenotypic comparisons of controls and four mouse lines with genetic IGF-1 deficits liver-specific IGF-1 deficiency (LID), ALS knockout (ALSKO), IGFBP-3 (BP3) knockout, and a triply deficient LID/ALSKO/BP3 line-produced several novel findings. 1) All deficient strains had decreased serum IGF-1 levels, but this neither predicted growth potential or skeletal integrity nor defined growth hormone secretion or metabolic abnormalities. 2) IGF-1 deficiency affected development of both cortical and trabecular bone differently, effects apparently dependent on the presence of different circulating IGF-1 complexes. 3) IGFBP-3 deficiency resulted in increased linear growth. In summary, each IGF-1 complex constituent appears to play a distinct role in determining skeletal phenotype, with different effects on cortical and trabecular bone compartments.-Yakar, S., Rosen, C. J., Bouxsein, M. L., Sun, H., Mejia, W., Kawashima, Y., Wu, Y., Emerton, K., Williams, V., Jepsen, K., Schaffler, M. B., Majeska, R. J., Gavrilova, O., Gutierrez, M., Hwang, D., Pennisi, P., Frystyk, J., Boisclair, Y., Pintar, J., Jasper, H., Domene, H., Cohen, P., Clemmons, D., LeRoith, D. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J. 23, 709-719 (2009)	[Yakar, Shoshana; Sun, Hui; Mejia, Wilson; Kawashima, Yuki; Wu, Yingjie; Emerton, Kelly; Williams, Valerie; Jepsen, Karl; Schaffler, Mitchell B.; Majeska, Robert J.; LeRoith, Derek] Mt Sinai Sch Med, Div Endocrine, New York, NY 10029 USA; [Yakar, Shoshana; Sun, Hui; Mejia, Wilson; Kawashima, Yuki; Wu, Yingjie; Emerton, Kelly; Williams, Valerie; Jepsen, Karl; Schaffler, Mitchell B.; Majeska, Robert J.; LeRoith, Derek] Mt Sinai Sch Med, Orthoped Div, New York, NY 10029 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Bouxsein, Mary L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Orthoped Biomech Lab, Boston, MA 02215 USA; [Gavrilova, Oksana; Pennisi, Patricia] NIDDK, NIH, Bethesda, MD USA; [Gutierrez, Mariana; Jasper, Hector; Domene, Horacio] R Gutierrez Childrens Hosp, Div Endocrinol, Endocrinol Res Ctr, Buenos Aires, DF, Argentina; [Hwang, David; Cohen, Pinchas] Mattel Hosp Children, David Geffen Sch Med, Div Pediat Endocrinol, Los Angeles, CA USA; [Frystyk, Jan] Aarhus Univ Hosp, Inst Clin, Med Res Labs, DK-8000 Aarhus, Denmark; [Frystyk, Jan] Aarhus Univ Hosp, Med Dept M Diabet & Endocrinol, DK-8000 Aarhus, Denmark; [Boisclair, Yves] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Pintar, John] Univ Med & Dent New Jersey, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Clemmons, David] Univ N Carolina, Div Endocrinol, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Maine Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Hospital de Ninos Doctor Ricardo Gutierrez; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Aarhus University; Aarhus University; Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Yakar, S (corresponding author), Mt Sinai Sch Med, Div Endocrine, 1 Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	shoshana.yakar@mssm.edu		Frystyk, Jan/0000-0002-5379-0961; Pennisi, Patricia/0000-0001-5179-7353; Jasper, Hector/0000-0002-3451-8647	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041210, R01AR054919, R01AR045433, R01AR055141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR017868] Funding Source: Medline; NIAMS NIH HHS [AR45433, R01 AR041210, R01 AR054919, 1R01AR055141-01, AR054919-01A, R01 AR055141, R01 AR045433] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMO ML, 1993, ADV EXP MED BIOL, V343, P1; Banerjee I, 2008, EUR J ENDOCRINOL, V158, P473, DOI 10.1530/EJE-07-0769; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Boisclair YR, 2000, PEDIATR NEPHROL, V14, P562, DOI 10.1007/s004670000333; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Bouxsein ML, 2002, J BONE MINER RES, V17, P570, DOI 10.1359/jbmr.2002.17.4.570; Butt AJ, 2005, ENDOCRINOLOGY, V146, P3113, DOI 10.1210/en.2004-1408; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Chen JW, 2005, J CLIN ENDOCR METAB, V90, P366, DOI 10.1210/jc.2004-0039; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Daughaday WH, 2004, NEW ENGL J MED, V350, P1906; DE W, 1995, MOL CELL ENDOCRINOL, V114, P43, DOI 10.1016/0303-7207(95)03640-S; Domene H M, 2005, J Endocrinol Invest, V28, P43; Domene HM, 2004, NEW ENGL J MED, V350, P570, DOI 10.1056/NEJMoa013100; Domene HM, 2007, J CLIN ENDOCR METAB, V92, P4444, DOI 10.1210/jc.2007-1152; Domene HM, 2007, HORM RES, V67, P243, DOI 10.1159/000098479; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Haluzik M, 2003, DIABETES, V52, P2483, DOI 10.2337/diabetes.52.10.2483; Hedstrom M, 2004, ACTA ORTHOP SCAND, V75, P394, DOI 10.1080/00016470410001141-1; Hill DJ, 1999, J ENDOCRINOL, V160, P305, DOI 10.1677/joe.0.1600305; Holly J, 2006, NEUROENDOCRINOLOGY, V83, P154, DOI 10.1159/000095523; Hwa V, 2006, J CLIN ENDOCR METAB, V91, P1826, DOI 10.1210/jc.2005-2842; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; Joseph Cherian, 2005, Molecular Aspects of Medicine, V26, P181, DOI 10.1016/j.mam.2005.01.004; Kanatani M, 2000, J BONE MINER RES, V15, P902, DOI 10.1359/jbmr.2000.15.5.902; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Maitra A, 2003, CLIN CANCER RES, V9, P5988; Marsell R, 2007, ACTA ORTHOP, V78, P39, DOI 10.1080/17453670610013402; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Modric T, 2001, ENDOCRINOLOGY, V142, P1958, DOI 10.1210/en.142.5.1958; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; MohseniZadeh S, 1997, ENDOCRINOLOGY, V138, P5645, DOI 10.1210/en.138.12.5645; Murphy Liam J., 1995, Progress in Growth Factor Research, V6, P425, DOI 10.1016/0955-2235(95)00026-7; MURPHY LJ, 1995, J MOL ENDOCRINOL, V15, P293, DOI 10.1677/jme.0.0150293; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Ricort JM, 2001, ENDOCRINOLOGY, V142, P108, DOI 10.1210/en.142.1.108; Rosen CJ, 2004, BEST PRACT RES CL EN, V18, P423, DOI 10.1016/j.beem.2004.02.007; Schneider MR, 2000, FASEB J, V14, P629, DOI 10.1096/fasebj.14.5.629; Shim ML, 2004, GROWTH HORM IGF RES, V14, P216, DOI 10.1016/j.ghir.2003.12.009; Silha JV, 2005, ENDOCRINOLOGY, V146, P1523, DOI 10.1210/en.2004-0905; Silha JV, 2003, J BONE MINER RES, V18, P1834, DOI 10.1359/jbmr.2003.18.10.1834; Silha JV, 2001, ENDOCRINOLOGY, V142, P4305, DOI 10.1210/en.142.10.4305; Taniguchi T, 2003, INJURY, V34, P477, DOI 10.1016/S0020-1383(02)00380-7; Trejo JL, 2005, ADV EXP MED BIOL, V567, P27; Twigg SM, 2000, ENDOCRINOLOGY, V141, P454, DOI 10.1210/en.141.1.454; Ueki I, 2000, P NATL ACAD SCI USA, V97, P6868, DOI 10.1073/pnas.120172697; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Van Den Dolder J, 2006, TISSUE ENG, V12, P3067, DOI 10.1089/ten.2006.12.3067; Wang DS, 1999, ENDOCR J, V46, P125, DOI 10.1507/endocrj.46.125; Wang L, 2000, ENDOCRINOLOGY, V141, P1118, DOI 10.1210/en.141.3.1118; Wiren KM, 2008, BONE, V43, P440, DOI 10.1016/j.bone.2008.04.026; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yakar S, 2006, J ENDOCRINOL, V189, P289, DOI 10.1677/joe.1.06657	64	75	80	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2009	23	3					709	719		10.1096/fj.08-118976	http://dx.doi.org/10.1096/fj.08-118976			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18952711	Green Published			2022-12-25	WOS:000265506300007
J	Izu, Y; Mizoguchi, F; Kawamata, A; Hayata, T; Nakamoto, T; Nakashima, K; Inagami, T; Ezura, Y; Noda, M				Izu, Yayoi; Mizoguchi, Fumitaka; Kawamata, Aya; Hayata, Tadayoshi; Nakamoto, Testuya; Nakashima, Kazuhisa; Inagami, Tadashi; Ezura, Yoichi; Noda, Masaki			Angiotensin II Type 2 Receptor Blockade Increases Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; PARATHYROID-HORMONE; CELLS; OSTEOPOROSIS; EXPRESSION; RESORPTION; OSTEOPONTIN; MARROW; DIFFERENTIATION; OSTEOBLASTS	Renin angiotensin system (RAS) regulates circulating blood volume and blood pressure systemically, whereas RAS also plays a role in the local milieu. Previous in vitro studies suggested that RAS may be involved in the regulation of bone cells. However, it was not known whether molecules involved in RAS are present in bone in vivo. In this study, we examined the presence of RAS components in adult bone and the effects of angiotensin II type 2 (AT2) receptor blocker on bone mass. Immunohistochemistry revealed that AT2 receptor protein was expressed in both osteoblasts and osteoclasts. In addition, renin and angiotensin II-converting enzyme were expressed in bone cells in vivo. Treatment with AT2 receptor blocker significantly enhanced the levels of bone mass, and this effect was based on the enhancement of osteoblastic activity as well as the suppression of osteoclastic activity in vivo. These results indicate that RAS components are present in adult bone and that blockade of AT2 receptor results in alteration in bone mass.	[Izu, Yayoi; Mizoguchi, Fumitaka; Kawamata, Aya; Hayata, Tadayoshi; Nakamoto, Testuya; Nakashima, Kazuhisa; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Tokyo 1010062, Japan; [Mizoguchi, Fumitaka; Nakamoto, Testuya] Tokyo Med & Dent Univ, Dept Med & Rheumatol & Maxillofacial Surg, Tokyo 1138510, Japan; [Mizoguchi, Fumitaka; Nakamoto, Testuya; Nakashima, Kazuhisa; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1010062, Japan; [Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Vanderbilt University	Ezura, Y (corresponding author), 3-10 Kanda Surugadai,2 Chome,Chiyoda Ku, Tokyo 1010062, Japan.	ezura.mph@mri.tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Hayata, Tadayoshi/AAE-9712-2021; Ezura, Yoichi/L-9485-2016; Mizoguchi, Fumitaka/Y-3271-2018	Mizoguchi, Fumitaka/0000-0002-3956-7122; Nakashima, Kazuhisa/0000-0003-0491-2149	Japanese Ministry of Education [17012008, 18109011, 18659438, 18123456]; Japan Space Forum; NASDA; Advanced Bone and Joint Science Strategic Research Networks Projects	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum; NASDA; Advanced Bone and Joint Science Strategic Research Networks Projects	This work was supported by the Grants-in-aid from the Japanese Ministry of Education (21st Century Center of Excellence Program, Frontier Research for Molecular Destruction and Reconstitution of Tooth and Bone) 17012008, 18109011, 18659438, and 18123456, grants from Japan Space Forum, NASDA, and Advanced Bone and Joint Science Strategic Research Networks Projects (Japan Society for Promotion of Science Core to Core Program, Research for the Future Program, Genome Science). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspenberg P, 2008, ACTA ORTHOP, V79, P111, DOI 10.1080/17453670710014851; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Broulik PD, 2001, PHYSIOL RES, V50, P353; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Ishijima M, 2007, J ENDOCRINOL, V193, P235, DOI 10.1677/joe.1.06704; Kanis JA, 2008, BONE, V42, P4, DOI 10.1016/j.bone.2007.10.019; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Loghman-Adham M, 2005, J HISTOCHEM CYTOCHEM, V53, P979, DOI 10.1369/jhc.4A6494.2005; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Migliaccio S, 2007, CLIN INTERV AGING, V2, P55, DOI 10.2147/ciia.2007.2.1.55; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Morinobu M, 2005, J EXP MED, V201, P961, DOI 10.1084/jem.20041097; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Ono N, 2007, J BIOL CHEM, V282, P25509, DOI 10.1074/jbc.M610782200; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sakai K, 2007, J CLIN INVEST, V117, P1088, DOI 10.1172/JCI31242; Sanada M, 2004, ATHEROSCLEROSIS, V176, P387, DOI 10.1016/j.atherosclerosis.2004.05.021; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Trujillo E, 1999, HISTOL HISTOPATHOL, V14, P1023, DOI 10.14670/HH-14.1023; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	35	98	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4857	4864		10.1074/jbc.M807610200	http://dx.doi.org/10.1074/jbc.M807610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19004830	hybrid, Green Published			2022-12-25	WOS:000263416600014
J	Parisi, T; Bronson, RT; Lees, JA				Parisi, T.; Bronson, R. T.; Lees, J. A.			Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis	ONCOGENE			English	Article						E2f4; Rb; neuroendocrine tumors; urothelial cancer	CELLULAR PROLIFERATION; FAMILY PROTEINS; G(1) CONTROL; MICE; CANCER; PRB; IMMORTALIZATION; TUMORIGENESIS; CARCINOMA; GENES	The retinoblastoma protein pRB suppresses tumorigenesis largely through regulation of the E2F transcription factors. E2F4, the most abundant E2F protein, is thought to act in cooperation with pRB to restrain cell proliferation. In this study, we analyse how loss of E2f4 affects the tumorigenicity of pRB-deficient tissues. As Rb-/-; E2f4(-/-) germline mice die in utero, we generated Rb-/-; E2f4(-/-) chimeric animals to allow examination of adult tumor phenotypes. We found that loss of E2f4 had a differential effect on known Rb-associated neuroendocrine tumors. It did not affect thyroid and adrenal glands tumors but partially suppressed lung neuroendocrine hyperplasia. The most striking effect was in the pituitary where E2F4 loss delayed the development, and reduced the incidence, of Rb mutant tumors. This tumor suppression increased the longevity of the Rb-/-; E2f4(-/-) chimeric animals allowing us to identify novel tumor types. We observed ganglionic neuroendocrine neoplasms, lesions not associated earlier with mutation of either Rb or E2f4. Moreover, a subset of the Rb-/-; E2f4(-/-) chimeras developed either low- or high-grade carcinomas in the urothelium transitional epithelium supporting a key role for Rb in bladder cancer.	[Parisi, T.; Lees, J. A.] MIT, David H Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Bronson, R. T.] Tufts Cummings Sch Vet Med, Dept Pathol, North Grafton, MA USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Dept Biol, 77 Mass Ave,E17-517B, Cambridge, MA 02139 USA.	jalees@mit.edu			NIH [CA121921]; NATIONAL CANCER INSTITUTE [R01CA121921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the CCR Transgenic Facility, in particular to John M Mkandawire and Peimin Qu, for technical help, and to Alicia Caron in the Histology Facility. We are also thankful to SR Frank and P White for critical reading of the paper and helpful discussion. This project was supported by NIH grants to JAL (CA121921). JAL is a Ludwig Scholar.	CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gaubatz S, 2001, MOL CELL BIOL, V21, P1384, DOI 10.1128/MCB.21.4.1384-1392.2001; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Humbert PO, 2000, GENE DEV, V14, P690; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhang ZT, 1999, CANCER RES, V59, P3512; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	32	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					500	508		10.1038/onc.2008.406	http://dx.doi.org/10.1038/onc.2008.406			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997819	Green Accepted			2022-12-25	WOS:000262866500004
J	Alves, CS; Yakovlev, S; Medved, L; Konstantopoulos, K				Alves, Christina S.; Yakovlev, Sergiy; Medved, Leonid; Konstantopoulos, Konstantinos			Biomolecular Characterization of CD44-Fibrin(ogen) Binding DISTINCT MOLECULAR REQUIREMENTS MEDIATE BINDING OF STANDARD AND VARIANT ISOFORMS OF CD44 TO IMMOBILIZED FIBRIN(OGEN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; SELECTIN LIGAND; FLAVOBACTERIUM-HEPARINUM; STRUCTURAL ORGANIZATION; COLORECTAL-CANCER; HEPARAN-SULFATE; TUMOR-GROWTH; FIBRINOGEN; ADHESION; EXPRESSION	CD44 and fibrin(ogen) play critical roles in the hematogenous dissemination of tumor cells, including colon carcinomas. We recently reported that CD44 is the primary fibrin, but not fibrinogen, receptor on LS174T colon carcinomas. However, the biochemical nature of this interaction and the roles of CD44 standard (CD44s) versus CD44 variant (CD44v) isoforms in fibrin( ogen) recognition have yet to be delineated. Microspheres, coated with CD44 immunopurified from LS174T or T84 colon carcinoma cells, which express primarily CD44v, effectively bind to immobilized fibrin, but not fibrinogen, in shear flow. In contrast, CD44s from HL-60 cells binds to both immobilized fibrin and fibrinogen under flow. Use of highly specific enzymes and metabolic inhibitors reveals that LS174T CD44 binding to fibrin is dependent on O-glycosylation of CD44, whereas CD44s-fibrin(ogen) interaction has an absolute requirement for N-, but not O-, linked glycans. The presence of chondroitin and dermatan sulfate on CD44 standard and variant isoforms facilitates fibrin recognition. Use of the anti-CD44 function-blocking monoclonal antibody Hermes-1 nearly abolishes binding of LS174T CD44 to fibrin, although it has no effect on CD44s-fibrin(ogen) interaction. The CD44-binding site is localized within the N-terminal portion of the fibrin beta chains, including amino acid residues (beta 15-66). Surface plasmon resonance experiments revealed high affinity binding of immobilized CD44 with solubilized fibrin but not fibrinogen. Collectively, these data suggest that immobilization of fibrinogen exposes a cryptic site that mediates binding to CD44s but not CD44v. Our findings may provide a rational basis for designing novel therapeutic strategies to combat metastasis.	[Alves, Christina S.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Yakovlev, Sergiy; Medved, Leonid] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Yakovlev, Sergiy; Medved, Leonid] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011	Yakovlev, Sergiy/0000-0002-2078-5218; Medved, Leonid/0000-0002-3665-9849	National Institutes of Health [R01 CA101135, HL-56051]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA101135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA101135 (NCI) (to K.K.) and by National Institute of Health Grant HL-56051 (to L.M.). This work was also supported by a predoctoral fellowship from the American Heart Association (to C.S.A.).	ALVES CS, 2008, AM J PHYSL, V294; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Herbold KW, 1996, J INVEST DERMATOL, V106, P1230, DOI 10.1111/1523-1747.ep12348871; HOFMANN M, 1991, CANCER RES, V51, P5292; ISHII S, 1993, SURG ONCOL, V2, P255, DOI 10.1016/0960-7404(93)90015-Q; Iversen LH, 2003, THROMB HAEMOSTASIS, V89, P726; Jadhav S, 2002, AM J PHYSIOL-CELL PH, V283, pC1133, DOI 10.1152/ajpcell.00104.2002; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Madrazo J, 2001, P NATL ACAD SCI USA, V98, P11967, DOI 10.1073/pnas.211439798; MANNORI G, 1995, CANCER RES, V55, P4425; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Matsuka YV, 1996, BIOCHEMISTRY-US, V35, P5810, DOI 10.1021/bi952294k; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; MEDVED LV, 1983, FEBS LETT, V160, P291, DOI 10.1016/0014-5793(83)80985-5; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; NADER HB, 1990, J BIOL CHEM, V265, P16807; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Plaas AHK, 2001, GLYCOBIOLOGY, V11, P779, DOI 10.1093/glycob/11.10.779; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Tsurupa G, 2002, BIOCHEMISTRY-US, V41, P6449, DOI 10.1021/bi025584r; Tsurupa G, 2006, BIOCHEMISTRY-US, V45, P10624, DOI 10.1021/bi060526h; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; WIELENGA VJM, 1993, CANCER RES, V53, P4754; WOJTUKIEWICZ MZ, 1992, BLOOD COAGUL FIBRIN, V3, P429, DOI 10.1097/00001721-199203040-00010; Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a	51	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1177	1189		10.1074/jbc.M805144200	http://dx.doi.org/10.1074/jbc.M805144200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004834	Green Published, hybrid			2022-12-25	WOS:000262122900054
J	Shechter, D; Nicklay, JJ; Chitta, RK; Shabanowitz, J; Hunt, DF; Allis, CD				Shechter, David; Nicklay, Joshua J.; Chitta, Raghu K.; Shabanowitz, Jeffrey; Hunt, Donald F.; Allis, C. David			Analysis of Histones in Xenopus laevis I. A DISTINCT INDEX OF ENRICHED VARIANTS AND MODIFICATIONS EXISTS IN EACH CELL TYPE AND IS REMODELED DURING DEVELOPMENTAL TRANSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME ASSEMBLY INVITRO; ARGININE METHYLATION; CHROMATIN-STRUCTURE; OOCYTE MATURATION; BINDING MODULES; DNA-REPLICATION; EGG EXTRACTS; TRANSCRIPTION; ACETYLATION; PHOSPHORYLATION	Histone proteins contain epigenetic information that is encoded both in the relative abundance of core histones and variants and particularly in the post-translational modification of these proteins. We determined the presence of such variants and covalent modifications in seven tissue types of the anuran Xenopus laevis, including oocyte, egg, sperm, early embryo equivalent (pronuclei incubated in egg extract), S3 neurula cells, A6 kidney cells, and erythrocytes. We first developed a new robust method for isolating the stored, predeposition histones from oocytes and eggs via chromatography on heparin-Sepharose, whereas we isolated chromatinized histones via conventional acid extraction. We identified two previously unknown H1 isoforms (H1fx and H1B.Sp) present on sperm chromatin. We immunoblotted this global collection of histones with many specific post-translational modification antibodies, including antibodies against methylated histone H3 on Lys(4), Lys(9), Lys(27), Lys(79), Arg(2), Arg(17), and Arg(26); methylated histone H4 on Lys(20); methylated H2A and H4 on Arg(3); acetylated H4 on Lys(5), Lys(8), Lys(12), and Lys(16) and H3 on Lys(9) and Lys(14); and phosphorylated H3 on Ser(10) and H2A/H4 on Ser(1). Furthermore, we subjected a subset of these histones to two-dimensional gel analysis and subsequent immunoblotting and mass spectrometry to determine the global remodeling of histone modifications that occurs as development proceeds. Overall, our observations suggest that each metazoan cell type may have a unique histone modification signature correlated with its differentiation status.	[Shechter, David; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Nicklay, Joshua J.; Chitta, Raghu K.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA	Rockefeller University; University of Virginia; University of Virginia	Allis, CD (corresponding author), Box 78,1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Chitta, Raghu/T-8938-2019; Hunt, Donald F/I-6936-2012; Shechter, David/B-4660-2008	Hunt, Donald F/0000-0003-2815-6368; Shechter, David/0000-0001-9388-6004	National Institutes of Health National Research Service Award/Kirschstein Fellowship [GM075486, GM37537, GM53512]; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, F32GM075486, R01GM053512, R37GM053512] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award/Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award/Kirschstein Fellowship GM075486 (to D. S.), Grant GM37537 (to D. F. H.), and Grant GM53512 (to C. D. A.). This work was also supported by Rockefeller University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMSON ED, 1974, J MOL BIOL, V88, P263, DOI 10.1016/0022-2836(74)90481-1; ADAMSON ED, 1977, DEV BIOL, V57, P136, DOI 10.1016/0012-1606(77)90360-8; ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Czermin B, 2003, GENETICA, V117, P159, DOI 10.1023/A:1022927725945; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; Frehlick LJ, 2007, BIOCHEMISTRY-US, V46, P12700, DOI 10.1021/bi701274s; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; HUMPHRIES SE, 1979, BIOCHEMISTRY-US, V18, P3223, DOI 10.1021/bi00582a006; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; LASKEY RA, 1977, CELL, V10, P237, DOI 10.1016/0092-8674(77)90217-3; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; LIN R, 1989, J CELL BIOL, V108, P1577, DOI 10.1083/jcb.108.5.1577; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Maller JL, 2001, NOVART FDN SYMP, V237, P58, DOI 10.1002/0470846666.ch6; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; RUDERMAN JV, 1979, DEV BIOL, V71, P71, DOI 10.1016/0012-1606(79)90083-6; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SCHMIEDEKE TMJ, 1989, J EXP MED, V169, P1879, DOI 10.1084/jem.169.6.1879; Schmitt A, 2002, FEBS LETT, V518, P23, DOI 10.1016/S0014-5793(02)02630-3; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; WOODLAND HR, 1980, FEBS LETT, V121, P1, DOI 10.1016/0014-5793(80)81252-X; WOODLAND HR, 1979, DEV BIOL, V68, P360, DOI 10.1016/0012-1606(79)90210-0; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; ZUCKER K, 1990, J BIOL CHEM, V265, P14487	45	55	56	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1064	1074		10.1074/jbc.M807273200	http://dx.doi.org/10.1074/jbc.M807273200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957438	Green Published, hybrid			2022-12-25	WOS:000262122900043
J	Terrand, J; Bruban, V; Zhou, L; Gong, WF; El Asmar, Z; May, P; Zurhove, K; Haffner, P; Philippe, C; Woldt, E; Matz, RL; Gracia, C; Metzger, D; Auwerx, J; Herz, J; Boucher, P				Terrand, Jerome; Bruban, Veronique; Zhou, Li; Gong, Wanfeng; El Asmar, Zeina; May, Petra; Zurhove, Kai; Haffner, Philipp; Philippe, Claude; Woldt, Estelle; Matz, Rachel L.; Gracia, Celine; Metzger, Daniel; Auwerx, Johan; Herz, Joachim; Boucher, Philippe			LRP1 Controls Intracellular Cholesterol Storage and Fatty Acid Synthesis through Modulation of Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; GLYCOGEN-SYNTHASE KINASE; ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; CRE RECOMBINASE; PROTEIN-KINASE; VASCULAR WALL; PPAR-GAMMA; TISSUE; MICE	The low-density lipoprotein receptor-related protein LRP1 is a cell surface receptor with functions in diverse physiological pathways, including lipid metabolism. Here we show that LRP1-deficient fibroblasts accumulate high levels of intracellular cholesterol and cholesteryl-ester when stimulated for adipocyte differentiation. We demonstrate that LRP1 stimulates a canonical Wnt5a signaling pathway that prevents cholesterol accumulation. Moreover, we show that LRP1 is required for lipolysis and stimulates fatty acid synthesis independently of the noradrenergic pathway, through inhibition of GSK3 beta and its previously unknown target acetyl-CoA carboxylase (ACC). As a result of ACC inhibition, mature LRP1-deficient adipocytes of adult mice are hypotrophic, and lower uptake of fatty acids into adipose tissue leads to their redistribution to the liver. These results establish LRP1 as a novel integrator of adipogenic differentiation and fat storage signals.	[Terrand, Jerome; Bruban, Veronique; Gong, Wanfeng; El Asmar, Zeina; Philippe, Claude; Woldt, Estelle; Matz, Rachel L.; Gracia, Celine; Herz, Joachim; Boucher, Philippe] Univ Strasbourg 1, CNRS, UMR7175, F-67401 Illkirch Graffenstaden, France; [May, Petra; Zurhove, Kai; Haffner, Philipp] Univ Freiburg, Zentrum Neurowissensch, D-79104 Freiburg, Germany; [Metzger, Daniel] IGBMC, Dept Funct Genom, F-67400 Illkirch Graffenstaden, France; [Auwerx, Johan] Univ Strasbourg, Inst Clin Souris, F-67000 Strasbourg, France; [Zhou, Li; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Strasbourg 1, CNRS, UMR7175, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.	joachim.herz@utsouthwestern.edu; philippe.boucher@pharma.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021; Asmar, Zeina El/AAR-7053-2021	Boucher, Philippe/0000-0002-3928-9812; Terrand, jerome/0000-0002-8169-7713; MATZ, Rachel/0000-0001-5832-7063; Auwerx, Johan/0000-0002-5065-5393; Metzger, Daniel/0000-0002-5555-046X; Gracia, Celine/0000-0002-3312-6465	National Institutes of Health [HL20948, HL63762, NS43408, DK067320]; center national pour la recherche scientifique (CNRS); Fondation pour la Recherche Medicale (FRM); Fondation de France; Universite Louis Pasteur de Strasbourg; agence nationale de la recherche [ANR-05-PCOD-020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, R01HL063762, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); center national pour la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Universite Louis Pasteur de Strasbourg; agence nationale de la recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants HL20948, HL63762, NS43408, and DK067320 from the National Institutes of Health. This work was also supported by grants from the center national pour la recherche scientifique (CNRS), Fondation pour la Recherche Medicale (FRM), Fondation de France, Universite Louis Pasteur de Strasbourg, agence nationale de la recherche (ANR-05-PCOD-020). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herz J, 2004, CURR OPIN LIPIDOL, V15, P175, DOI 10.1097/00041433-200404000-00010; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	85	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					381	388		10.1074/jbc.M806538200	http://dx.doi.org/10.1074/jbc.M806538200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990694	Green Published, hybrid			2022-12-25	WOS:000261974800043
J	Passero, CJ; Mueller, GM; Rondon-Berrios, H; Tofovic, SP; Hughey, RP; Kleyman, TR				Passero, Christopher J.; Mueller, Gunhild M.; Rondon-Berrios, Helbert; Tofovic, Stevan P.; Hughey, Rebecca P.; Kleyman, Thomas R.			Plasmin Activates Epithelial Na+ Channels by Cleaving the gamma Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTASE ACTIVATION; NEPHROTIC SYNDROME; SODIUM-CHANNELS; ALPHA-SUBUNIT; EXPRESSION; PEPTIDE; FURIN; MESSENGER; CLEAVAGE	Proteolytic processing of epithelial sodium channel ( ENaC) subunits occurs as channels mature within the biosynthetic pathway. The proteolytic processing events of the alpha and gamma subunits are associated with channel activation. Furin cleaves the alpha subunit ectodomain at two sites, releasing an inhibitory tract and activating the channel. However, furin cleaves the gamma subunit ectodomain only once. A second distal cleavage in the gamma subunit induced by other proteases, such as prostasin and elastase, is required to release a second inhibitory tract and further activate the channel. We found that the serine protease plasmin activates ENaC in association with inducing cleavage of the gamma subunit at gamma Lys(194), a site distal to the furin site. A gamma K194A mutant prevented both plasmin-dependent activation of ENaC and plasmin-dependent production of a unique 70-kDa carboxyl-terminal gamma subunit cleavage fragment. Plasmin-dependent cleavage and activation of ENaC may have a role in extracellular volume expansion in human disorders associated with proteinuria, as filtered plasminogen may be processed by urokinase, released from renal tubular epithelium, to generate active plasmin.	[Passero, Christopher J.; Mueller, Gunhild M.; Rondon-Berrios, Helbert; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Tofovic, Stevan P.] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Dept Med, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S-933 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu	Rondon-Berrios, Helbert/H-3573-2019	Rondon-Berrios, Helbert/0000-0002-7109-146X	National Institutes of Health [R01/R56 DK065161, P30 DK079307, F32 DK080574]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, F32DK080574, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or part, by National Institutes of Health Grants R01/R56 DK065161 and P30 DK079307. This work was also supported by postdoctoral fellowship awards from the American Heart Association and the National Institutes of Health (F32 DK080574) (to C.J.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Gosalia DN, 2005, PROTEOMICS, V5, P1292, DOI 10.1002/pmic.200401011; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kim H, 2007, J COMPUT-MEDIAT COMM, V12, P1183, DOI 10.1111/j.1083-6101.2007.00369.x; Kim SW, 2006, AM J PHYSIOL-RENAL, V290, pF674, DOI 10.1152/ajprenal.00084.2005; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; KRISTENSEN P, 1991, J HISTOCHEM CYTOCHEM, V39, P341, DOI 10.1177/39.3.1899685; LAU SO, 1980, J PEDIATR-US, V96, P390, DOI 10.1016/S0022-3476(80)80678-0; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; Piedagnel R, 2006, J CELL PHYSIOL, V206, P394, DOI 10.1002/jcp.20485; Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; SVENNINGSEN P, 2009, J AM SOC NE IN PRESS; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; TROLL W, 1954, J BIOL CHEM, V208, P85; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; VAZIRI ND, 1994, J LAB CLIN MED, V124, P118; Wagner SN, 1996, HISTOCHEM CELL BIOL, V105, P53, DOI 10.1007/BF01450878	30	142	147	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36586	36591		10.1074/jbc.M805676200	http://dx.doi.org/10.1074/jbc.M805676200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981180	Green Published, hybrid			2022-12-25	WOS:000261840500056
J	Clifford, RL; Deacon, K; Knox, AJ				Clifford, Rachel L.; Deacon, Karl; Knox, Alan J.			Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor beta(1) REQUIREMENT FOR Smads, beta-CATENIN, AND GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; FACTOR GENE; SIGNALING ACTIVITY; FACTOR EXPRESSION; COLON-CANCER; ANGIOGENESIS; DISEASE; MECHANISMS; HYPOXIA	Vascular endothelial growth factor ( VEGF) is a vital angiogenic effector, regulating key angiogenic processes. Vascular development relies on numerous signaling pathways, of which those induced by transforming growth factor-beta(TGF beta) are critical. The Wnt/beta-catenin signaling pathway is emerging as necessary for vascular development. Although VEGF, TGF beta, and Wnt signal transductions are well studied individually, it has not been demonstrated previously that all three can interact or be dependent on each other. We show that regulation of VEGF by TGF beta(1), in human pulmonary artery smooth muscle cells (PASMCs), depends on a direct interaction between TGF beta signaling proteins, Smads, and members of the Wnt/beta- catenin signaling family. VEGF promoter reporter constructs identified a region of the VEGF promoter containing two T cell factor (TCF)-binding sites as necessary for TGF beta(1)-induced VEGF transcription. Mutation of TCF sites and expression of dominant negative TCF4 abolished TGF beta(1)-induced VEGF promoter activity. Studies in Smad2 and Smad3 knock-out mouse embryonic fibroblasts demonstrated that one or both are required for VEGF regulation by TGF beta(1), with transfection of dominant negative Smad2 or Smad3 into PASMCs confirming this. Chromatin immunoprecipitation assays showed in cell interactions of Smad2 and Smad3 with TCF4 and beta-catenin at the VEGF promoter, whereas co-immunoprecipitation showed a direct physical interaction between Smad2 and beta-catenin in the nucleus of PASMCs. Finally, we demonstrate that TGF beta 1 regulates TCF by modifying beta-catenin phosphorylation via regulation of glycogen synthase kinase 3 beta. These results provide new insight into the molecular regulation of VEGF by two interacting pathways necessary for vascular development, maintenance, and disease.	[Clifford, Rachel L.; Deacon, Karl; Knox, Alan J.] Univ Nottingham, Ctr Resp Res, Nottingham NG5 1PB, England	University of Nottingham	Knox, AJ (corresponding author), City Hosp, Ctr Resp Res, Hucknall Rd, Nottingham NG5 1PB, England.	alan.knox@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143; Clifford, Rachel/0000-0002-8677-452X	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ballara SC, 1999, INT J EXP PATHOL, V80, P235, DOI 10.1046/j.1365-2613.1999.00129.x; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Beck PL, 1999, INFLAMM BOWEL DIS, V5, P44, DOI 10.1097/00054725-199902000-00007; Benckert C, 2003, CANCER RES, V63, P1083; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen H, 2007, J CELL BIOCHEM, V102, P1281, DOI 10.1002/jcb.21358; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Hagen T, 2004, BIOCHEM J, V379, P471, DOI 10.1042/BJ20031749; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kanazawa H, 2003, AM J MED, V114, P354, DOI 10.1016/S0002-9343(02)01562-0; Kanazawa H, 2002, THORAX, V57, P885, DOI 10.1136/thorax.57.10.885; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Knox AJ, 2001, FASEB J, V15, P2480, DOI 10.1096/fj.01-0256com; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Nik SA, 2007, EXP CELL RES, V313, P2887, DOI 10.1016/j.yexcr.2007.05.024; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Ray BK, 2007, J IMMUNOL, V178, P1774, DOI 10.4049/jimmunol.178.3.1774; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Takahashi-Yanaga Fumi, 2007, Fukuoka Acta Medica, V98, P93; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; van Gijn ME, 2002, CARDIOVASC RES, V55, P16, DOI 10.1016/S0008-6363(02)00221-3; Xie WF, 1998, J BIOL CHEM, V273, P5026, DOI 10.1074/jbc.273.9.5026; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	45	81	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35337	35353		10.1074/jbc.M803342200	http://dx.doi.org/10.1074/jbc.M803342200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952601	hybrid			2022-12-25	WOS:000261687900005
J	Nafisi, H; Banihashemi, B; Daigle, M; Albert, PR				Nafisi, Houman; Banihashemi, Behzad; Daigle, Mireille; Albert, Paul R.			GAP1(IP4BP)/RASA3 Mediates G alpha(i)-induced Inhibition of Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; LACTOTROPH HYPERPLASIA; PITUITARY-CELLS; D2 RECEPTORS; GAP1 FAMILY; DOPAMINE; PROLACTIN; RAS; IDENTIFICATION; SPECIFICITY	The dopamine D2S receptor (short isoform) couples to inhibitory G alpha(i/o) proteins to inhibit thyrotropin-releasing hormone (TRH)-stimulated p42/p44 mitogen-activated protein kinase (ERK1/2) phosphorylation in GH4ZR7 rat pituitary cells, consistent with its actions to inhibit prolactin gene transcription and cell proliferation. However, the underlying mechanism is unclear. To identify novel G alpha(i) effectors, yeast two-hybrid screening of a GH4ZR7 cDNA library was done using constitutively active G alpha(i3)-Q204L, and multiple clone of the RasGAP cDNA GAP1(IP4BP)/RASA3 were identified. In yeast mating assay, RASA3 preferentially interacted with activated forms of G alpha(i/o/z) proteins, but not with G alpha(s). A direct interaction was indicated by in vitro pull-down assay, in which S-His-RASA3 preferentially bound guanosine 5'-O-(gamma-thio)triphosphate-activated G alpha(i3) and G alpha(i2) compared with guanosine 5'-O-(beta-thio) diphosphate-inactivated proteins. Similarly, in co-immunoprecipitation studies in HEK-293 cells, FLAG-tagged RASA3 preferentially interacted with activated mutants of G alpha(i3) and G alpha(i2) compared with wild type proteins. In GH4ZR7 cells, co-immunoprecipitation studies of endogenous proteins demonstrated a G alpha(i3)-RASA3 complex that was induced upon TRH/D2S receptor co-activation. To address RASA3 function in dopamine D2S receptor-induced inhibition of ERK1/2 activity, endogenous RASA3 protein expression was suppressed (70% knockdown) in GH4ZR7 cells stably transfected with full-length antisense cDNA of RASA3. The selected antisense clones had similar levels of dopamine D2S receptor binding and D2S-induced inhibition of cAMP formation compared with parental GH4ZR7 cells. In these clones, D2S-mediated inhibition of TRH-induced phospho-ERK1/2 was reversed by 70-80% compared with parental GH4ZR7 cells. Our results provide a novel mechanism for dopamine D2S-induced inhibition of ERK1/2 and indicate that RASA3 links G alpha(i) proteins to inhibit G(q)-induced Ras/ ERK1/2 activation.	[Nafisi, Houman; Banihashemi, Behzad; Daigle, Mireille; Albert, Paul R.] Univ Ottawa, Ottawa Hlth Res Inst Neurosci, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute		palbert@uottawa.ca	Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554	Canadian Institutes of Health; Ontario Mental Health Research	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Research	This work was supported by grants from the Canadian Institutes of Health and the Ontario Mental Health Research (to P.R.A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERT PR, 1994, TRENDS PHARMACOL SCI, V15, P250, DOI 10.1016/0165-6147(94)90320-4; Albert PR, 2002, MOL ENDOCRINOL, V16, P1903, DOI 10.1210/me.2001-0329; ALBERT PR, 1997, DOPAMINE RECEPTORS, P359; Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; Banihashemi B, 2002, MOL ENDOCRINOL, V16, P2393, DOI 10.1210/me.2001-0220; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433; Colao A, 2000, HORM RES, V53, P76, DOI 10.1159/000023539; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Cozier GE, 2003, J BIOL CHEM, V278, P39489, DOI 10.1074/jbc.M307785200; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Hnasko TS, 2007, NEUROENDOCRINOLOGY, V86, P48, DOI 10.1159/000105242; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2006, METHOD ENZYMOL, V407, P64, DOI 10.1016/S0076-6879(05)07007-2; Liu JC, 2005, MOL ENDOCRINOL, V19, P1904, DOI 10.1210/me.2004-0111; Liu JC, 2002, J BIOL CHEM, V277, P35819, DOI 10.1074/jbc.M202920200; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Liu YF, 1999, J BIOL CHEM, V274, P16444, DOI 10.1074/jbc.274.23.16444; LIU YF, 1994, J BIOL CHEM, V269, P13880; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; Lockyer PJ, 1999, BIOCHEM BIOPH RES CO, V255, P421, DOI 10.1006/bbrc.1999.0217; Lockyer PJ, 1999, CURR BIOL, V9, P265, DOI 10.1016/S0960-9822(99)80116-X; McNulty TJ, 2001, CELL SIGNAL, V13, P877, DOI 10.1016/S0898-6568(01)00197-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Pinzone JJ, 2000, J CLIN ENDOCR METAB, V85, P3053, DOI 10.1210/jc.85.9.3053; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Signore AP, 1999, J NEUROSCI RES, V55, P321, DOI 10.1002/(SICI)1097-4547(19990201)55:3<321::AID-JNR7>3.0.CO;2-A; Smith J, 2001, MOL ENDOCRINOL, V15, P1539, DOI 10.1210/me.15.9.1539; Trouillas J, 1999, ENDOCRINOLOGY, V140, P13, DOI 10.1210/en.140.1.13; Van-Ham II, 2007, J NEUROCHEM, V102, P1796, DOI 10.1111/j.1471-4159.2007.04650.x; Wang YH, 1999, MOL ENDOCRINOL, V13, P1094, DOI 10.1210/me.13.7.1094; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; [No title captured]	41	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35908	35917		10.1074/jbc.M803622200	http://dx.doi.org/10.1074/jbc.M803622200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952607	hybrid			2022-12-25	WOS:000261687900066
J	Okada, S; Yamada, E; Saito, T; Ohshima, K; Hashimoto, K; Yamada, M; Uehara, Y; Tsuchiya, T; Shimizu, H; Tatei, K; Izumi, T; Yamauchi, K; Hisanaga, S; Pessin, JE; Mori, M				Okada, Shuichi; Yamada, Eijiro; Saito, Tsugumichi; Ohshima, Kihachi; Hashimoto, Koshi; Yamada, Masanobu; Uehara, Yutaka; Tsuchiya, Takafumi; Shimizu, Hiroyuki; Tatei, Kazuaki; Izumi, Takashi; Yamauchi, Keishi; Hisanaga, Shin-ichi; Pessin, Jeffrey E.; Mori, Masatomo			CDK5-dependent Phosphorylation of the Rho Family GTPase TC10 alpha Regulates Insulin-stimulated GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PROTEIN INTERACTIONS; FILAMENTOUS ACTIN; PLASMA-MEMBRANE; CORTICAL ACTIN; CDK5 ACTIVATOR; ADIPOCYTES; TC10; P35; ENDOCYTOSIS	Insulin stimulation results in the activation of cyclin-dependent kinase-5 (CDK5) in lipid raft domains via a Fyn-dependent phosphorylation on tyrosine residue 15. In turn, activated CDK5 phosphorylates the Rho family GTP-binding protein TC10 alpha on threonine 197 that is sensitive to the CDK5 inhibitor olomoucine and blocked by small interfering RNA-mediated knockdown of CDK5. The phosphorylation deficient mutant T197A-TC10 alpha was not phosphorylated and excluded from the lipid raft domain, whereas the phosphorylation mimetic mutant (T197D-TC10 alpha) was lipid raft localized. Insulin resulted in the GTP loading of T197D-TC10 alpha but not T197A-TC10 alpha and in parallel, T197D-TC10 alpha but not T197A-TC10 alpha depolymerized cortical actin and inhibited insulin-stimulated GLUT4 translocation. These data demonstrate that CDK5-dependent phosphorylation maintains TC10 alpha in lipid raft compartments thereby disrupting cortical actin, whereas subsequent dephosphorylation of TC10 alpha through inactivation of CDK5 allows for the re-assembly of F-actin. Because cortical actin reorganization is required for insulin-stimulated GLUT4 translocation, these data are consistent with a CDK5-dependent TC10 alpha cycling between lipid raft and non-lipid raft compartments.	[Okada, Shuichi; Yamada, Eijiro; Saito, Tsugumichi; Hashimoto, Koshi; Yamada, Masanobu; Uehara, Yutaka; Tsuchiya, Takafumi; Shimizu, Hiroyuki; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma 3710034, Japan; [Tatei, Kazuaki; Izumi, Takashi] Gunma Univ, Grad Sch Med, Dept Mol Biochem, Gunma 3710034, Japan; [Ohshima, Kihachi] Gunma Univ, Hlth & Med Ctr, Gunma 3718511, Japan; [Yamauchi, Keishi] Nagano Red Cross Hosp, Dept Endocrinol & Diabet, Nagano 3808582, Japan; [Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Gunma University; Gunma University; Gunma University; Nagano Red Cross Hospital; Tokyo Metropolitan University; Yeshiva University; Albert Einstein College of Medicine	Okada, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Gunma 3710034, Japan.	okadash@showa.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X				Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	30	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35455	35463		10.1074/jbc.M806531200	http://dx.doi.org/10.1074/jbc.M806531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948252	hybrid			2022-12-25	WOS:000261687900017
J	Ruvolo, VR; Kurinna, SM; Karanjeet, KB; Schuster, TF; Martelli, AM; McCubrey, JA; Ruvolo, PP				Ruvolo, Vivian R.; Kurinna, Svitlana M.; Karanjeet, Kul B.; Schuster, Todd F.; Martelli, Alberto M.; McCubrey, James A.; Ruvolo, Peter P.			PKR Regulates B56 alpha-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PKR; CHRONIC LYMPHOCYTIC-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR; FUNCTIONAL-ROLE; BLAST CRISIS; 2A; PP2A; PHOSPHORYLATION; APOPTOSIS	Protein phosphatase 2A (PP2A) is a heterotrimer comprising catalytic, scaffold, and regulatory (B) subunits. There are at least 21 B subunit family members. Thus PP2A is actually a family of enzymes defined by which B subunit is used. The B56 family member B56 alpha is a phosphoprotein that regulates dephosphorylation of BCL2. The stress kinase PKR has been shown to phosphorylate B56 alpha at serine 28 in vitro, but it has been unclear how PKR might regulate the BCL2 phosphatase. In the present study, PKR regulation of B56 alpha in REH cells was examined, because these cells exhibit robust BCL2 phosphatase activity. PKR was found to be basally active in REH cells as would be predicted if the kinase supports B56 alpha-mediated dephosphorylation of BCL2. Suppression of PKR promoted BCL2 phosphorylation with concomitant loss of B56 alpha phosphorylation at serine 28 and inhibition of mitochondrial PP2A activity. PKR supports stress signaling in REH cells, as suppression of PKR promoted chemoresistance to etoposide. Suppression of PKR promoted B56 alpha proteolysis, which could be blocked by a proteasome inhibitor. However, the mechanism by which PKR supports B56 alpha protein does not involve PKR-mediated phosphorylation of the B subunit at serine 28 but may involve eIF2 alpha activation of AKT. Phosphorylation of serine 28 by PKR promotes mitochondrial localization of B56 alpha, because wild-type but not mutant S28A B56 alpha promoted mitochondrial PP2A activity. Cells expressing wildtype B56 alpha but not S28A B56 alpha were sensitized to etoposide. These results suggest that PKR regulates B56 alpha-mediated PP2A signaling in REH cells.	[Ruvolo, Vivian R.; Karanjeet, Kul B.; Schuster, Todd F.; Ruvolo, Peter P.] Univ Minnesota, Hormel Inst, Sect Signal Transduct & Apoptosis, Austin, MN 55912 USA; [Kurinna, Svitlana M.; Ruvolo, Peter P.] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Div Cell Signaling, Houston, TX 77030 USA; [Martelli, Alberto M.] Univ Bologna, Dept Human Anat Sci, I-40126 Bologna, Italy; [McCubrey, James A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA	University of Minnesota System; University of Texas System; University of Texas Health Science Center Houston; University of Bologna; University of North Carolina; East Carolina University	Ruvolo, PP (corresponding author), Univ Minnesota, Hormel Inst, Sect Signal Transduct & Apoptosis, 801 16th Ave NE, Austin, MN 55912 USA.	pruvolo@hi.umn.edu		McCubrey, James/0000-0001-6027-3156; Kurinna, Svitlana/0000-0002-2157-667X	National Institutes of Health [CA30715]; Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota; NATIONAL CANCER INSTITUTE [R01CA030715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA30715 ( to P. P. R.). This work was also supported by the Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota ( to P. P. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham N, 1998, EXP CELL RES, V244, P394, DOI 10.1006/excr.1998.4201; Basu S, 1997, CANCER RES, V57, P943; Beretta L, 1996, ONCOGENE, V12, P1593; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Guo CY, 2002, J BIOL CHEM, V277, P4839, DOI 10.1074/jbc.M110092200; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000	43	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35474	35485		10.1074/jbc.M800951200	http://dx.doi.org/10.1074/jbc.M800951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957415	hybrid, Green Published			2022-12-25	WOS:000261687900019
J	Zurbriggen, A; Jeckelmann, JM; Christen, S; Bieniossek, C; Baumann, U; Erni, B				Zurbriggen, Andreas; Jeckelmann, Jean-Marc; Christen, Sandra; Bieniossek, Christoph; Baumann, Ulrich; Erni, Bernhard			X-ray Structures of the Three Lactococcus lactis Dihydroxyacetone Kinase Subunits and of a Transient Intersubunit Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; NUCLEOTIDE-BINDING SUBUNIT; COVALENT SUBSTRATE-BINDING; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; CRYSTAL-STRUCTURE; CITROBACTER-FREUNDII; MANNOSE TRANSPORTER; ANGSTROM RESOLUTION; DOMAIN	Bacterial dihydroxyacetone (Dha) kinases do not exchange the ADP for ATP but utilize a subunit of the phosphoenolpyruvate carbohydrate phosphotransferase system for in situ rephosphorylation of a permanently bound ADP-cofactor. Here we report the 2.1-angstrom crystal structure of the transient complex between the phosphotransferase subunit DhaM of the phosphotransferase system and the nucleotide binding subunit DhaL of the Dha kinase of Lactococcus lactis, the 1.1-angstrom structure of the free DhaM dimer, and the 2.5-angstrom structure of the Dha-binding DhaK subunit. Conserved salt bridges and an edge-to-plane stacking contact between two tyrosines serve to orient DhaL relative to the DhaM dimer. The distance between the imidazole N epsilon 2 of the DhaM His-10 and the beta-phosphate oxygen of ADP, between which the gamma-phosphate is transferred, is 4.9 angstrom. An invariant arginine, which is essential for activity, is appropriately positioned to stabilize the gamma-phosphate in the transition state. The (beta alpha)(4)alpha fold of DhaM occurs a second time as a subfold, in the DhaK subunit. By docking DhaL-ADP to this subfold, the nucleotide bound to DhaL and the C1-hydroxyl of Dha bound to DhaK are positioned for in-line transfer of phosphate.	[Zurbriggen, Andreas; Jeckelmann, Jean-Marc; Christen, Sandra; Bieniossek, Christoph; Baumann, Ulrich; Erni, Bernhard] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch; bernhard.erni@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013	Jeckelmann, Jean-Marc/0000-0001-9973-2700	Swiss National Science Foundation [3100A0-105247]; Ciba-Geigy Jubilaumsstiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ciba-Geigy Jubilaumsstiftung	This work was supported by the Swiss National Science Foundation (Grant 3100A0-105247) and the Ciba-Geigy Jubilaumsstiftung. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bachler C, 2005, J BIOL CHEM, V280, P18321, DOI 10.1074/jbc.M500279200; Bachler C, 2005, EMBO J, V24, P283, DOI 10.1038/sj.emboj.7600517; Bressi JC, 2000, J MED CHEM, V43, P4135, DOI 10.1021/jm000287a; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chelli R, 2002, J AM CHEM SOC, V124, P6133, DOI 10.1021/ja0121639; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995; Deppenmeier U, 2002, APPL MICROBIOL BIOT, V60, P233, DOI 10.1007/s00253-002-1114-5; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0; ERNI B, 1982, J BIOL CHEM, V257, P13726; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Luers GH, 1998, YEAST, V14, P759; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2006, J MOL BIOL, V359, P539, DOI 10.1016/j.jmb.2006.03.057; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200	32	18	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35789	35796		10.1074/jbc.M804893200	http://dx.doi.org/10.1074/jbc.M804893200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957416	hybrid, Green Published			2022-12-25	WOS:000261687900053
J	Fox, KE; Colton, LA; Erickson, PF; Friedman, JE; Cha, HC; Keller, P; MacDougald, OA; Klemm, DJ				Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Cha, Hyuk C.; Keller, Pernille; MacDougald, Ormond A.; Klemm, Dwight J.			Regulation of Cyclin D1 and Wnt10b Gene Expression by cAMP-responsive Element-binding Protein during Early Adipogenesis Involves Differential Promoter Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; CREB; ACTIVATION; INHIBITION; INSULIN; RECEPTOR; ALPHA; CELLS	Cyclin D1 expression is elevated and Wnt10b is repressed by cAMP during the first few hours of adipogenesis. cAMP-responsive element-binding protein (CREB) is a primary target for cAMP signaling, and we have shown that activation of CREB promotes adipogenesis and adipocyte survival. Here we tested the impact of CREB on expression of cyclin D1 and wingless-related mouse mammary tumor virus integration site 10b (Wnt10b) in 3T3-L1 cells. Forced depletion of CREB blocked Bt2cAMP-stimulated cyclin D1 expression and basal Wnt10b gene expression. Two CREB-binding sites were identified in the Wnt10b promoter region. Ablation of either site partially blocked promoter activity, while mutation of both sites completely suppressed promoter activity. These results suggest that CREB activates transcription from both the cyclin D1 and Wnt10b gene promoters. What accounts for the differential regulation of cyclin D1 and Wnt10b genes by cAMP? Chromatin immunoprecipitation revealed CREB bound to the Wnt10b promoter in untreated preadipocytes but not following treatment with Bt(2)cAMP. CREB binding to the cyclin D1 promoter was detected in untreated cells and post-Bt(2)cAMP. Differences between CREB binding to the two genes correlated with increasing methylation of the Wnt10b promoter following Bt2cAMP treatment, whereas no methylation of the cyclin D1 promoter was observed. Treatment of cells with the methylase inhibitor 5-azacytidine restored CREB binding to the Wnt10b gene promoter and prevented the inhibition of Wnt10b RNA expression by Bt2cAMP. We conclude that cAMP stimulates phosphorylation and binding of CREB to the cyclin D1 gene promoter. Simultaneously, hypermethylation of the Wnt10b gene promoter suppresses binding of CREB, allowing adipogenesis to proceed.	[Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Klemm, Dwight J.] Univ Colorado Denver, Cardiovasc Pulm Res Lab, Aurora, CO 80045 USA; [Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Klemm, Dwight J.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Cha, Hyuk C.; Keller, Pernille; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan	Klemm, DJ (corresponding author), Univ Colorado Denver, Cardiovasc Pulm Res Lab, Res 2,Mail Stop B-133,12700 E 19th Ave, Aurora, CO 80045 USA.	Dwight.Klemm@UCHSC.edu		MacDougald, Ormond/0000-0001-6907-7960	National Institutes of Health [DK053969, DK51563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053969, R01DK051563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053969 (to D.J.K.) and DK51563 (to O.A.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ANTRAS J, 1989, BIOL CELL, V66, P247, DOI 10.1016/0248-4900(89)90177-9; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Casimir DA, 1996, J BIOL CHEM, V271, P29847, DOI 10.1074/jbc.271.47.29847; Cha HC, 2008, J BIOL CHEM, V283, P18002, DOI 10.1074/jbc.M800419200; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hishida T, 2008, BIOCHEM BIOPH RES CO, V370, P289, DOI 10.1016/j.bbrc.2008.03.091; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kim HS, 2001, OBES RES, V9, P572, DOI 10.1038/oby.2001.74; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; Kumar AP, 2007, CLIN CANCER RES, V13, P2784, DOI 10.1158/1078-0432.CCR-06-2974; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; POISSONNET CM, 1988, J PEDIATR-US, V113, P1, DOI 10.1016/S0022-3476(88)80520-1; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SAGER R, 1982, P NATL ACAD SCI-BIOL, V79, P480, DOI 10.1073/pnas.79.2.480; Sakamoto H, 2008, BIOCHEM BIOPH RES CO, V366, P360, DOI 10.1016/j.bbrc.2007.11.137; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Stoger R, 2006, EPIGENETICS-US, V1, P155; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Yokomori N, 1999, DIABETES, V48, P685, DOI 10.2337/diabetes.48.4.685; Zeng G, 1997, ONCOL RES, V9, P205; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	47	38	42	4	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35096	35105		10.1074/jbc.M806423200	http://dx.doi.org/10.1074/jbc.M806423200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18957421	Green Published, hybrid			2022-12-25	WOS:000261469100067
J	Heidary, F; Mahdavi, MRV; Momeni, F; Minaii, B; Rogani, M; Fallah, N; Heidary, R; Gharebaghi, R				Heidary, Fatemeh; Mahdavi, Mohammad Reza Vaeze; Momeni, Farshad; Minaii, Bagher; Rogani, Mehrdad; Fallah, Nader; Heidary, Roghayeh; Gharebaghi, Reza			Food Inequality Negatively Impacts Cardiac Health in Rabbits	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SOCIAL-STATUS; LIPOFUSCIN; ATHEROSCLEROSIS; INCREASE	Background: Individuals with lower socioeconomic status experience higher rates of mortality and are more likely to suffer from numerous diseases. While some studies indicate that humans who suffer from social inequality suffer generally worse health, to our knowledge no controlled experiments of this nature have been done in any species. Lipofuscin is a highly oxidized cross-linked aggregate consisting of oxidized protein and lipid clusters. This eminent terminal oxidation outcome accumulates within cells during aging process. Methodology/Principal Findings: Thirty two rabbits were assigned into four groups randomly of eight each. The first group encountered food deprivation for eight weeks and was kept in an isolated situation. The second group was food deprived for eight weeks but encountered to other groups continuously. The third group suffered two weeks of deprivation and then received free access to food. The fourth group had free access to diet without any deprivation. All hearts were removed for histopathological evaluation. Cross-sections of hearts were examined by light microscopy for the presence of yellow-brown Lpofuscin pigment granules. Here we show that relative food deprivation can cause accumulation of Lipofuscin pigmentation. We find that cardiac Lipofuscin deposition increases the most in the inequitable condition in which food deprived individuals observe well-fed individuals. Conclusions/Significance: Our findings demonstrate that a sense of inequality in food intake can promote aging more than food deprivation alone. These findings should be considered as a basis for further studies on the physiological mechanisms by which inequality negatively impacts health and well-being.	[Heidary, Fatemeh; Mahdavi, Mohammad Reza Vaeze; Rogani, Mehrdad] Shahed Univ, Sch Med, Dept Physiol, Tehran, Iran; [Momeni, Farshad] Allameh Tabatabaei Univ, Econ Dept, Tehran, Iran; [Minaii, Bagher] Univ Tehran Med Sci, Sch Med, Anat Dept, Histol Div, Tehran, Iran; [Fallah, Nader] Shahed Univ, Social Med Dept, Stat Analysis Div, Tehran, Iran; [Heidary, Roghayeh; Gharebaghi, Reza] Middle E Canc Inst, Tehran, Iran	Shahed University; Allameh Tabataba'i University; Tehran University of Medical Sciences; Shahed University	Heidary, F (corresponding author), Shahed Univ, Sch Med, Dept Physiol, Tehran, Iran.	Heidary@sbmu.ac.ir	Vaez-Mahdavi, Mohammad-Reza/I-8185-2016; Fallah, Nader/D-4145-2012	Fallah, Nader/0000-0002-7746-4773; Vaez-Mahdavi, Mohammad-Reza/0000-0002-1490-4364; Heidary, A/Prof. Fatemeh/0000-0002-6558-6132; Roghani, Mehrdad/0000-0002-9209-8484	Shahed University, Tehran, Iran	Shahed University, Tehran, Iran	This study was supported by Shahed University, Tehran, Iran as the thesis in a medical doctorate degree.	ADAMS MR, 1985, ARTERIOSCLEROSIS, V5, P192, DOI 10.1161/01.ATV.5.2.192; BEREGI E, 1991, AGE AGEING, V20, P55, DOI 10.1093/ageing/20.1.55; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Chaudhary A, 1995, GERONTOLOGY, V41, P229; Cooper RS, 2001, INT J EPIDEMIOL, V30, pS48, DOI 10.1093/ije/30.suppl_1.S48; Goldman N, 2001, ANN NY ACAD SCI, V954, P118; Jolly RD, 2002, ARCH GERONTOL GERIAT, V34, P205, DOI 10.1016/S0167-4943(01)00219-9; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; MANUCK SB, 1995, PSYCHOSOM MED, V57, P275, DOI 10.1097/00006842-199505000-00009; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Roffe C, 1998, BRIT J BIOMED SCI, V55, P136; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SCHNEIDERMAN N, 1987, CIRCULATION, V76, P41; Siems W G, 1992, EXS, V62, P124; SIEMS WG, 1995, LIFE SCI, V57, P785, DOI 10.1016/0024-3205(95)02006-5; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P27; Steptoe A, 2007, HEART, V93, P1567, DOI 10.1136/hrt.2006.113993; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3705	10.1371/journal.pone.0003705	http://dx.doi.org/10.1371/journal.pone.0003705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002245	gold, Green Published			2022-12-25	WOS:000265165600010
J	Sun, Z; Chen, Z; Hou, XL; Li, SP; Zhu, HH; Qian, J; Lu, DR; Liu, W				Sun, Zhen; Chen, Zhi; Hou, Xiaoli; Li, Shuping; Zhu, Haihong; Qian, Ji; Lu, Daru; Liu, Wei			Locked Nucleic Acid Pentamers as Universal PCR Primers for Genomic DNA Amplification	PLOS ONE			English	Article								Background: Multiplexing technologies, which allow for simultaneous detection of multiple nucleic acid sequences in a single reaction, can save a lot of time, cost and labor compared to traditional single reaction detection methods. However, the multiplexing method currently used requires precise handiwork and many complicated steps, making a new, simpler technique desirable. Oligonucleotides containing locked nucleic acid residues are an attractive tool because they have strong affinities for their complementary targets, they have been used to avoid dimer formation and mismatch hybridization and to enhance efficient priming. In this study, we aimed to investigate the use of locked nucleic acid pentamers for genomic DNA amplification and multiplex genotyping. Results: We designed locked nucleic acid pentamers as universal PCR primers for genomic DNA amplification. The locked nucleic acid pentamers were able to prime amplification of the selected sequences within the investigated genomes, and the resulting products were similar in length to those obtained by restriction digest. In Real Time PCR of genomic DNA from three bacterial species, locked nucleic acid pentamers showed high priming efficiencies. Data from bias tests demonstrated that locked nucleic acid pentamers have equal affinities for each of the six genes tested from the Klebsiella pneumoniae genome. Combined with suspension array genotyping, locked nucleic acid pentamer-based PCR amplification was able to identify a total of 15 strains, including 3 species of bacteria, by gene- and species-specific probes. Among the 32 species used in the assay, 28 species and 50 different genes were clearly identified using this method. Conclusion: As a novel genomic DNA amplification, the use of locked nucleic acid pentamers as universal primer pairs in conjunction with suspension array genotyping, allows for the identification of multiple distinct genes or species with a single amplification procedure. This demonstrates that locked nucleic acid pentamer-based PCR can be utilized extensively in pathogen identification.	[Sun, Zhen; Hou, Xiaoli; Liu, Wei] Zhejiang Univ, Sch Med, Dept Biochem & Mol Biol, Hangzhou, Peoples R China; [Sun, Zhen; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary & Anthropol, State Key Lab Genet Engn, Shanghai, Peoples R China; [Sun, Zhen; Chen, Zhi; Li, Shuping; Zhu, Haihong] Zhejiang Univ, Sch Med, Inst Med Biotechnol, Hangzhou, Peoples R China; [Sun, Zhen; Chen, Zhi; Li, Shuping; Zhu, Haihong] Zhejiang Univ, Affiliated Hosp 1st, Inst Infect Dis, Natl Key Lab Diagnosis & Treatment Infect Dis, Hangzhou, Peoples R China	Zhejiang University; Fudan University; Zhejiang University; Zhejiang University	Sun, Z (corresponding author), Eppendorf China, Shanghai Off, Unit 1702-1705,You You Int Plaza, Shanghai, Peoples R China.	drlu@fudan.edu.cn; liuwei666@zju.edu.cn		Liu, Wei/0000-0002-8033-4718	National Natural Science Foundation of China [30771090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30771090) to Wei Liu.	Diaz MR, 2004, J CLIN MICROBIOL, V42, P3696, DOI [10.1128/JCM.42.8.3696-3706.2004, 10.1128/jcm.42.8.3696-3706.2004]; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Dunbar SA, 2003, J MICROBIOL METH, V53, P245, DOI 10.1016/S0167-7012(03)00028-9; Gonzalez SF, 2004, J CLIN MICROBIOL, V42, P1414, DOI 10.1128/JCM.42.4.1414-1419.2004; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Hou XL, 2008, J ZHEJIANG UNIV-SC B, V9, P291, DOI 10.1631/jzus.B0710470; Jiang HL, 2006, J MED MICROBIOL, V55, P715, DOI 10.1099/jmm.0.46493-0; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; *LIQUICHIP, 2003, LIQUICHIP APPL HDB P; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Nolan JP, 2001, CELL MOL BIOL, V47, P1241; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Sanchez JJ, 2006, NAT PROTOC, V1, P1370, DOI 10.1038/nprot.2006.247; Smith PL, 1998, CLIN CHEM, V44, P2054; SOBRAL BWS, 1993, THEOR APPL GENET, V86, P105, DOI 10.1007/BF00223814; Spiro A, 2000, APPL ENVIRON MICROB, V66, P4258, DOI 10.1128/AEM.66.10.4258-4265.2000; Spiro A, 2002, APPL ENVIRON MICROB, V68, P1010, DOI 10.1128/AEM.68.2.1010-1013.2002; Sun Z, 2007, GENOMICS, V89, P151, DOI 10.1016/j.ygeno.2006.07.011; TADA M, 1993, CANCER RES, V53, P2472; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28; Zhu Hai-hong, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P524; Zsolnai A, 2003, ELECTROPHORESIS, V24, P634, DOI 10.1002/elps.200390074	25	9	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3701	10.1371/journal.pone.0003701	http://dx.doi.org/10.1371/journal.pone.0003701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002243	Green Published, gold, Green Submitted			2022-12-25	WOS:000265165600007
J	Renesto, P; Rovery, C; Schrenzel, J; Leroy, Q; Huyghe, A; Li, WJ; Lepidi, H; Francois, P; Raoult, D				Renesto, Patricia; Rovery, Clarisse; Schrenzel, Jacques; Leroy, Quentin; Huyghe, Antoine; Li, Wenjun; Lepidi, Hubert; Francois, Patrice; Raoult, Didier			Rickettsia conorii Transcriptional Response within Inoculation Eschar	PLOS ONE			English	Article							MEDITERRANEAN SPOTTED-FEVER; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; STRINGENT RESPONSE; PATHOGEN; HOST; RNA; IDENTIFICATION; RESISTANCE; EVOLUTION	Background: Rickettsia conorii, the causative agent of the Mediterranean spotted fever, is transmitted to humans by the bite of infected ticks Rhipicephalus sanguineus. The skin thus constitutes an important barrier for the entry and propagation of R. conorii. Given this, analysis of the survival strategies used by the bacterium within infected skin is critical for our understanding of rickettsiosis. Methodology/Principal Findings: Here, we report the first genome-wide analysis of R. conorii gene expression from infected human skin biopsies. Our data showed that R. conorii exhibited a striking transcript signature that is remarkably conserved across patients, regardless of genotype. The expression profiles obtained using custom Agilent microarrays were validated by quantitative RT-PCR. Within eschars, the amount of detected R. conorii transcripts was of 55%, this value being of 74% for bacteria grown in Vero cells. In such infected host tissues, approximately 15% (n = 211) of the total predicted R. conorii ORFs appeared differentially expressed compared to bacteria grown in standard laboratory conditions. These genes are mostly down-regulated and encode proteins essential for bacterial replication. Some of the strategies displayed by rickettsiae to overcome the host defense barriers, thus avoiding killing, were also pointed out. The observed up-regulation of rickettsial genes associated with DNA repair is likely to correspond to a DNA-damaging agent enriched environment generated by the host cells to eradicate the pathogens. Survival of R. conorii within eschars also involves adaptation to osmotic stress, changes in cell surface proteins and up-regulation of some virulence factors. Interestingly, in contrast to down-regulated transcripts, we noticed that up-regulated ones rather exhibit a small nucleotide size, most of them being exclusive for the spotted fever group rickettsiae. Conclusion/Significance: Because eschar is a site for rickettsial introduction, the pattern of rickettsial gene expression observed here may define how rickettsiae counteract the host defense.	[Renesto, Patricia; Rovery, Clarisse; Leroy, Quentin; Li, Wenjun; Lepidi, Hubert; Raoult, Didier] Fac Med Marseille, Unite Rickettsies, IRD CNRS, UMR 6236, F-13385 Marseille, France; [Schrenzel, Jacques; Huyghe, Antoine; Francois, Patrice] Univ Geneva, Hosp, Genom Res Lab, Serv Infect Dis, CH-1211 Geneva, Switzerland	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Renesto, P (corresponding author), Fac Med Marseille, Unite Rickettsies, IRD CNRS, UMR 6236, F-13385 Marseille, France.	patricia.renesto@medecine.univ-mrs.fr	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/AAC-5685-2021; Renesto, patricia/M-6105-2014; RAOULT, Didier/A-8434-2008; renesto, patricia/T-6446-2019; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; RAOULT, Didier/0000-0002-0633-5974; renesto, patricia/0000-0002-6749-7862; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X	"Hospital Clinical Research Program" from the French Health Ministry	"Hospital Clinical Research Program" from the French Health Ministry	This project was granted by a research program "Hospital Clinical Research Program" from the French Health Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aravind L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r30; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; de Sousa R, 2007, J INFECT DIS, V196, P770, DOI 10.1086/519739; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; DUJELLA J, 1991, ACTA VIROL, V35, P566; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Heithoff DM, 1997, TRENDS MICROBIOL, V5, P509, DOI 10.1016/S0966-842X(97)01153-0; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; La MV, 2008, FEMS MICROBIOL REV, V32, P440, DOI 10.1111/j.1574-6976.2008.00103.x; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Le Gall T, 2005, GENOME RES, V15, P260, DOI 10.1101/gr.2405905; Lepidi H, 2000, AM J CLIN PATHOL, V114, P880, DOI 10.1309/R0KQ-823A-BTC7-MUUJ; MONTENEGRO MR, 1983, VIRCHOWS ARCH A, V400, P309, DOI 10.1007/BF00612192; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; RAOULT D, 1984, J INFECT DIS, V150, P145, DOI 10.1093/infdis/150.1.145; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Scherl A, 2005, J MICROBIOL METH, V60, P247, DOI 10.1016/j.mimet.2004.09.017; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TEYSSEIRE N, 1995, INFECT IMMUN, V63, P366, DOI 10.1128/IAI.63.1.366-374.1995; TEYSSEIRE N, 1992, J CLIN MICROBIOL, V30, P455, DOI 10.1128/JCM.30.2.455-460.1992; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorner AR, 1998, CLIN INFECT DIS, V27, P1353, DOI 10.1086/515037; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; WALKER DH, 1988, HUM PATHOL, V19, P1449, DOI 10.1016/S0046-8177(88)80238-7	46	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3681	10.1371/journal.pone.0003681	http://dx.doi.org/10.1371/journal.pone.0003681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997861	Green Submitted, Green Published, gold			2022-12-25	WOS:000265165500004
J	Proekt, A; Wong, J; Zhurov, Y; Kozlova, N; Weiss, KR; Brezina, V				Proekt, Alex; Wong, Jane; Zhurov, Yuriy; Kozlova, Nataliya; Weiss, Klaudiusz R.; Brezina, Vladimir			Predicting Adaptive Behavior in the Environment from Central Nervous System Dynamics	PLOS ONE			English	Article							IDENTIFIED HISTAMINERGIC NEURON; NEUROMUSCULAR MODULATION; DISTINGUISHES INGESTION; FEEDING-BEHAVIOR; APLYSIA; NETWORK; MECHANISMS; PRINCIPLES; TRANSFORM; REJECTION	To generate adaptive behavior, the nervous system is coupled to the environment. The coupling constrains the dynamical properties that the nervous system and the environment must have relative to each other if adaptive behavior is to be produced. In previous computational studies, such constraints have been used to evolve controllers or artificial agents to perform a behavioral task in a given environment. Often, however, we already know the controller, the real nervous system, and its dynamics. Here we propose that the constraints can also be used to solve the inverse problem - to predict from the dynamics of the nervous system the environment to which they are adapted, and so reconstruct the production of the adaptive behavior by the entire coupled system. We illustrate how this can be done in the feeding system of the sea slug Aplysia. At the core of this system is a central pattern generator (CPG) that, with dynamics on both fast and slow time scales, integrates incoming sensory stimuli to produce ingestive and egestive motor programs. We run models embodying these CPG dynamics-in effect, autonomous Aplysia agents-in various feeding environments and analyze the performance of the entire system in a realistic feeding task. We find that the dynamics of the system are tuned for optimal performance in a narrow range of environments that correspond well to those that Aplysia encounter in the wild. In these environments, the slow CPG dynamics implement efficient ingestion of edible seaweed strips with minimal sensory information about them. The fast dynamics then implement a switch to a different behavioral mode in which the system ignores the sensory information completely and follows an internal "goal,'' emergent from the dynamics, to egest again a strip that proves to be inedible. Key predictions of this reconstruction are confirmed in real feeding animals.	[Proekt, Alex; Wong, Jane; Zhurov, Yuriy; Kozlova, Nataliya; Weiss, Klaudiusz R.; Brezina, Vladimir] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Proekt, A (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	Vladimir.Brezina@mssm.edu		Proekt, Alexander/0000-0002-9272-5337	NIH [R01 NS41497]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NIH R01 NS41497. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonov-Barki R, 2001, NEURAL COMPUT, V13, P691, DOI 10.1162/089976601300014529; ANDREWS PLR, 1988, BAILLIERE CLIN GASTR, V2, P141, DOI 10.1016/0950-3528(88)90025-5; Barandiaran X, 2006, ADAPT BEHAV, V14, P171, DOI 10.1177/105971230601400208; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Beer R. D., 1990, INTELLIGENCE ADAPTIV; Beer Randall D., 1992, Adaptive Behavior, V1, P91, DOI 10.1177/105971239200100105; Beer RD, 2003, ADAPT BEHAV, V11, P209, DOI 10.1177/1059712303114001; Beer RD, 1997, ROBOT AUTON SYST, V20, P257, DOI 10.1016/S0921-8890(96)00063-2; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; Belanger JH, 1996, ADAPT BEHAV, V4, P217, DOI 10.1177/105971239600400302; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brezina V, 2005, J NEUROPHYSIOL, V93, P1523, DOI 10.1152/jn.00475.2004; Brezina V, 2003, J NEUROPHYSIOL, V90, P2613, DOI 10.1152/jn.01093.2002; Brezina V, 2003, J NEUROPHYSIOL, V90, P2592, DOI 10.1152/jn.01091.2002; Brezina V, 2000, J NEUROPHYSIOL, V83, P260, DOI 10.1152/jn.2000.83.1.260; Brezina V, 2000, J NEUROPHYSIOL, V83, P232, DOI 10.1152/jn.2000.83.1.232; Brezina V, 2000, J NEUROPHYSIOL, V83, P207, DOI 10.1152/jn.2000.83.1.207; BREZINA V, 2006, SOC NEUROSCI ABSTR; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; Clark, 2001, MINDWARE; Clark A., 1997, BEING THERE; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Deodhar D, 2001, ADAPT BEHAV, V8, P267, DOI 10.1177/105971230000800304; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Elliott CJH, 2002, J EXP BIOL, V205, P877; Horn CC, 2004, J NEUROPHYSIOL, V92, P157, DOI 10.1152/jn.01190.2003; Horn CC, 2008, APPETITE, V50, P430, DOI 10.1016/j.appet.2007.09.015; Hornby PJ, 2001, AM J MED, V111, P106, DOI 10.1016/S0002-9343(01)00849-X; HURWITZ I, 1992, J EXP BIOL, V166, P215; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jonker CM, 2002, J THEOR BIOL, V214, P105, DOI 10.1006/jtbi.2001.2444; KANDEL E.R., 1979, BEHAV BIOL APLYSIA; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KUPFERMA.I, 1974, BEHAV BIOL, V12, P317, DOI 10.1016/S0091-6773(74)91503-X; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; Levi R, 2005, J NEUROSCI, V25, P9807, DOI 10.1523/JNEUROSCI.2249-05.2005; Levi R, 2004, J NEUROPHYSIOL, V91, P336, DOI 10.1152/jn.00753.2003; Lum CS, 2008, J NEUROPHYSIOL, V100, P2453, DOI 10.1152/jn.z9k-9150-corr.2008; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MCCLELLAN AD, 1982, J EXP BIOL, V98, P195; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MORTON DW, 1993, J COMP PHYSIOL A, V173, P519; Nepomnyashchikh VA, 2003, ADAPT BEHAV, V11, P245, DOI 10.1177/1059712303114002; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Proekt A, 2004, P NATL ACAD SCI USA, V101, P9447, DOI 10.1073/pnas.0402002101; Proekt A, 2007, J NEUROPHYSIOL, V97, P3046, DOI 10.1152/jn.01301.2006; ROSEN SC, 1991, J NEUROSCI, V11, P3630; ROSEN SC, 1982, BEHAV NEURAL BIOL, V35, P56, DOI 10.1016/S0163-1047(82)91279-1; Ruppin E, 2002, NAT REV NEUROSCI, V3, P132, DOI 10.1038/nrn729; Sasaki K, 2008, J NEUROSCI, V28, P1916, DOI 10.1523/JNEUROSCI.4755-07.2008; SCHWARZ M, 1986, J NEUROSCI, V6, P1528; Staddon J. E. R., 2001, ADAPTIVE DYNAMICS; Staddon JER, 2005, TRENDS COGN SCI, V9, P312, DOI 10.1016/j.tics.2005.05.013; SUSSWEIN AJ, 1976, J COMP PHYSIOL, V108, P75, DOI 10.1007/BF00625442; SUSSWEIN AJ, 1978, J COMP PHYSIOL, V123, P31, DOI 10.1007/BF00657341; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; van Gelder T, 1998, BEHAV BRAIN SCI, V21, P615, DOI 10.1017/S0140525X98001733; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Weiss K.R., 1982, P25; WEISS KR, 1986, J NEUROSCI, V6, P2403; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu JS, 2007, J NEUROSCI, V27, P10818, DOI 10.1523/JNEUROSCI.1806-07.2007; Ye H, 2006, J NEUROSCI, V26, P1470, DOI 10.1523/JNEUROSCI.3691-05.2006; Ye H, 2006, J NEUROSCI, V26, P10743, DOI 10.1523/JNEUROSCI.3143-06.2006; Zhurov Y, 2005, J NEUROPHYSIOL, V94, P531, DOI 10.1152/jn.01338.2004; Zhurov Y, 2005, J NEUROSCI, V25, P1268, DOI 10.1523/JNEUROSCI.3361-04.2005	75	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3678	10.1371/journal.pone.0003678	http://dx.doi.org/10.1371/journal.pone.0003678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989362	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134600010
J	Chow, HK; Xu, J; Shahravan, SH; De Jong, AT; Chen, G; Shin, JA				Chow, Hiu-Kwan; Xu, Jing; Shahravan, S. Hesam; De Jong, Antonia T.; Chen, Gang; Shin, Jumi A.			Hybrids of the bHLH and bZIP Protein Motifs Display Different DNA-Binding Activities In Vivo vs. In Vitro	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; CRYSTAL-STRUCTURE; LEUCINE-ZIPPER; ZINC-FINGER; COGNATE DNA; TRANSCRIPTION FACTORS; BASIC REGION; C-MYC; MAX; RECOGNITION	Minimalist hybrids comprising the DNA-binding domain of bHLH/PAS (basic-helix-loop-helix/Per-Arnt-Sim) protein Arnt fused to the leucine zipper (LZ) dimerization domain from bZIP (basic region-leucine zipper) protein C/EBP were designed to bind the E-box DNA site, CACGTG, targeted by bHLHZ (basic-helix-loop-helix-zipper) proteins Myc and Max, as well as the Arnt homodimer. The bHLHZ-like structure of ArntbHLH-C/EBP comprises the Arnt bHLH domain fused to the C/EBP LZ: i.e. swap of the 330 aa PAS domain for the 29 aa LZ. In the yeast one-hybrid assay (Y1H), transcriptional activation from the E-box was strong by ArntbHLH-C/EBP, and undetectable for the truncated ArntbHLH (PAS removed), as detected via readout from the HIS3 and lacZ reporters. In contrast, fluorescence anisotropy titrations showed affinities for the E-box with ArntbHLH-C/EBP and ArntbHLH comparable to other transcription factors (K-d 148.9 nM and 40.2 nM, respectively), but only under select conditions that maintained folded protein. Although in vivo yeast results and in vitro spectroscopic studies for ArntbHLH-C/EBP targeting the E-box correlate well, the same does not hold for ArntbHLH. As circular dichroism confirms that ArntbHLH-C/EBP is a much more strongly alpha-helical structure than ArntbHLH, we conclude that the nonfunctional ArntbHLH in the Y1H must be due to misfolding, leading to the false negative that this protein is incapable of targeting the E-box. Many experiments, including protein design and selections from large libraries, depend on protein domains remaining well-behaved in the nonnative experimental environment, especially small motifs like the bHLH (60-70 aa). Interestingly, a short helical LZ can serve as a folding-and/or solubility-enhancing tag, an important device given the focus of current research on exploration of vast networks of biomolecular interactions.	[Chow, Hiu-Kwan; Xu, Jing; Shahravan, S. Hesam; De Jong, Antonia T.; Chen, Gang; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Shin, Jumi A.] Univ Toronto, Inst Biomater & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Chow, HK (corresponding author), Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada.	jumi.shin@utoronto.ca		Chen, Gang/0000-0002-6304-9173	NIH [R01 GM069041]; Premier's Research Excellence Award (PREA); Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT); University of Toronto; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069041, R01GM063220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Premier's Research Excellence Award (PREA); Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT)(Canada Foundation for Innovation); University of Toronto(University of Toronto); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH (R01 GM069041), Premier's Research Excellence Award (PREA), Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT), and the University of Toronto. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Arpiainen S, 2007, J MOL BIOL, V369, P640, DOI 10.1016/j.jmb.2007.03.075; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; *CLONT, 2001, YEAST PROT HDB; Dervan Peter B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P373, DOI 10.2174/1568011054222346; Dhanasekaran M, 2006, ACCOUNTS CHEM RES, V39, P45, DOI 10.1021/ar050158u; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; GARDNER L, 2002, ENCY CANC; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hollenbeck JJ, 2000, BIOCHEMISTRY-US, V39, P6380, DOI 10.1021/bi992705n; Hu JZ, 2005, BIOCHEMISTRY-US, V44, P11855, DOI 10.1021/bi050206i; Huffman JL, 2001, J BIOL CHEM, V276, P40537, DOI 10.1074/jbc.M105675200; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jung KC, 2005, BIOCHEM BIOPH RES CO, V334, P269, DOI 10.1016/j.bbrc.2005.06.088; KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/jmbi.1995.0645; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; KONIG P, 1993, J MOL BIOL, V233, P139, DOI 10.1006/jmbi.1993.1490; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lajmi AR, 2000, PROTEIN EXPRES PURIF, V18, P394, DOI 10.1006/prep.2000.1209; Lajmi AR, 2000, J AM CHEM SOC, V122, P5638, DOI 10.1021/ja993025a; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE DK, 2003, CURR TOP MED CHEM, V3, P339; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meier-Andrejszki L, 2007, BIOCHEMISTRY-US, V46, P12427, DOI 10.1021/bi701081q; Mockli N, 2004, BIOTECHNIQUES, V36, P872; Nagaoka M, 2000, J INORG BIOCHEM, V82, P57, DOI 10.1016/S0162-0134(00)00154-9; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P1310, DOI 10.1021/bi00219a022; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; SELLERS JW, 1989, NATURE, V341, P74, DOI 10.1038/341074a0; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Shin JA, 1997, BIOORG MED CHEM LETT, V7, P2367, DOI 10.1016/S0960-894X(97)00436-8; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; Suga M, 2003, CURR GENET, V43, P206, DOI 10.1007/s00294-003-0385-4; Suga M, 2001, YEAST, V18, P1015, DOI 10.1002/yea.753; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Swanson HI, 1999, NUCLEIC ACIDS RES, V27, P3205, DOI 10.1093/nar/27.15.3205; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wu G, 2006, J BIOTECHNOL, V124, P496, DOI 10.1016/j.jbiotec.2006.01.015; Xie YS, 1996, PROTEIN SCI, V5, P517; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yin XY, 1998, ONCOGENE, V16, P2629, DOI 10.1038/sj.onc.1201777	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3514	10.1371/journal.pone.0003514	http://dx.doi.org/10.1371/journal.pone.0003514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949049	Green Published, gold, Green Submitted			2022-12-25	WOS:000265126400003
J	Chang, EI; Bonillas, RG; El-ftesi, S; Chang, EI; Ceradini, DJ; Vial, IN; Chan, DA; Michaels, J; Gurtner, GC				Chang, Edward I.; Bonillas, Robert G.; El-ftesi, Samyra; Chang, Eric I.; Ceradini, Daniel J.; Vial, Ivan N.; Chan, Denise A.; Michaels, Joseph, V; Gurtner, Geoffrey C.			Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds	FASEB JOURNAL			English	Article						stem cells; bioreactor; gene therapy	MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; SKELETAL-MUSCLE; IN-VIVO; ADULT; PERFUSION; LIVER; FLAP; RAT; TRANSPLANTATION	Classic tissue engineering paradigms are limited by the incorporation of a functional vasculature and a reliable means for reimplantation into the host circulation. We have developed a novel approach to overcome these obstacles using autologous explanted microcirculatory beds (EMBs) as bioscaffolds for engineering complex three-dimensional constructs. In this study, EMBs consisting of an afferent artery, capillary beds, efferent vein, and surrounding parenchymal tissue are explanted and maintained for 24 h ex vivo in a bioreactor that preserves EMB viability and function. Given the rapidly advancing field of stem cell biology, EMBs were subsequently seeded with three distinct stem cell populations, multipotent adult progenitor cells (MAPCs), and bone marrow and adipose tissuederived mesenchymal stem cells (MSCs). We demonstrate MAPCs, as well as MSCs, are able to egress from the microcirculation into the parenchymal space, forming proliferative clusters. Likewise, human adipose tissuederived MSCs were also found to egress from the vasculature and seed into the EMBs, suggesting feasibility of this technology for clinical applications. We further demonstrate that MSCs can be transfected to express a luciferase protein and continue to remain viable and maintain luciferase expression in vivo. By using the vascular network of EMBs, EMBs can be perfused ex vivo and seeded with stem cells, which can potentially be directed to differentiate into neoorgans or transfected to replace failing organs and deficient proteins.-Chang, E. I., Bonillas, R. G., Elftesi, S., Chang, E. I., Ceradini, D. J., Vial, I. N., Chan, D. A., Michaels, J., V, Gurtner, G. C. Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds. FASEB J. 23, 906-915 (2009)	[Gurtner, Geoffrey C.] Stanford Univ, Med Ctr, Dept Surg, Div Plast Surg, Stanford, CA 94305 USA; [Chan, Denise A.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Ceradini, Daniel J.; Michaels, Joseph, V] NYU, Dept Surg, Sch Med, New York, NY 10016 USA	Stanford University; Stanford University; New York University	Gurtner, GC (corresponding author), Stanford Univ, Med Ctr, Dept Surg, Div Plast Surg, 257 Campus Dr,GK-201, Stanford, CA 94305 USA.	ggurtner@stanford.edu	/ABE-5226-2021		National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [EB-02265]; National Institutes of Health Loan Repayment Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002265] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Human adipo-derived MSCs were a generous gift from Dr. Michael T. Longaker (Department of Surgery, Stanford University, Stanford, CA, USA). This research was supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering grant EB-02265 (G. C. G.) and the National Institutes of Health Loan Repayment Program (Edward I. Chang).	Armstrong MB, 2001, CLIN PLAST SURG, V28, P671; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; Black AF, 1998, FASEB J, V12, P1331, DOI 10.1096/fasebj.12.13.1331; Buncke HJ, 1996, PLAST RECONSTR SURG, V98, P1122, DOI 10.1097/00006534-199611000-00052; Butler AJ, 2002, TRANSPLANTATION, V73, P1212, DOI 10.1097/00007890-200204270-00005; Callan MB, 2003, VET CLIN N AM-SMALL, V33, P1277, DOI 10.1016/S0195-5616(03)00119-0; Dempsey MP, 2008, PLAST RECONSTR SURG, V121, P1541, DOI 10.1097/PRS.0b013e31816ff6aa; Dolderer JH, 2007, TISSUE ENG, V13, P673, DOI 10.1089/ten.2006.0212; Fiegel HC, 2008, J CELL MOL MED, V12, P56, DOI 10.1111/j.1582-4934.2007.00162.x; Hickey MJ, 1996, AM J PHYSIOL-HEART C, V271, pH1277, DOI 10.1152/ajpheart.1996.271.4.H1277; Hoganson DM, 2008, PEDIATR RES, V63, P520, DOI 10.1203/01.pdr.0000305879.38476.0c; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kaihara S, 1999, ARCH SURG-CHICAGO, V134, P1184, DOI 10.1001/archsurg.134.11.1184; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com; Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Messina A, 2005, FASEB J, V19, P1570, DOI 10.1096/fj.04-3241fje; Michaels J, 2006, PLAST RECONSTR SURG, V118, P54, DOI 10.1097/01.prs.0000220466.27521.22; Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379; Ochoa ER, 2002, ANN NY ACAD SCI, V979, P10, DOI 10.1111/j.1749-6632.2002.tb04863.x; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Pantazi G, 2000, ANN PLAS SURG, V44, P304, DOI 10.1097/00000637-200044030-00009; PETRY JJ, 1984, PLAST RECONSTR SURG, V74, P410, DOI 10.1097/00006534-198409000-00014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; RIDENOUR TR, 1992, STROKE, V23, P733, DOI 10.1161/01.STR.23.5.733; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Sipowicz MA, 1997, AM J PATHOL, V151, P933; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Tae SK, 2006, BIOMED MATER, V1, P63, DOI 10.1088/1748-6041/1/2/003; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; TOMINO Y, 1994, NEPHRON, V68, P207, DOI 10.1159/000188258; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Zacharowski K, 1999, ARTERIOSCL THROM VAS, V19, P2276, DOI 10.1161/01.ATV.19.9.2276; Zhang F, 2001, J RECONSTR MICROSURG, V17, P211, DOI 10.1055/s-2001-14353	43	40	40	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					906	915		10.1096/fj.08-114868	http://dx.doi.org/10.1096/fj.08-114868			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001054	Green Published			2022-12-25	WOS:000265506300026
J	Mosig, S; Rennert, K; Krause, S; Kzhyshkowska, J; Neunubel, K; Heller, R; Funke, H				Mosig, Sandy; Rennert, Knut; Krause, Siegfried; Kzhyshkowska, Julia; Neunuebel, Kerstin; Heller, Regine; Funke, Harald			Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14(+)CD16(+) monocytes in detoxification of oxidized LDL	FASEB JOURNAL			English	Article						atherosclerosis; lipoprotein uptake; adhesion; phagocytosis; macrophage surface markers	LOW-DENSITY-LIPOPROTEIN; HUMAN PERIPHERAL-BLOOD; SMOOTH-MUSCLE-CELLS; DENDRITIC CELLS; SCAVENGER RECEPTOR; HUMAN MACROPHAGES; APOPTOTIC CELLS; IN-VITRO; ATHEROSCLEROSIS; ADHESION	The study was undertaken to investigate whether the two major monocyte subsets defined by the surface markers CD14(+)CD16(+) and CD14(++)CD16(-) show differences in their responses to hypercholesterolemia. Monocytes were rapidly isolated from the blood of hypercholesterolemic, low-density lipoprotein (LDL) receptor-defective familial hypercholesterolemia (FH) patients and from control persons. Using flow cytometry and uptake, adhesion, and phagocytosis assays as well as laser scanning microscopy, we found significant differences between the monocyte subsets. FH-CD14(+)CD16(+) monocytes exhibit an increased uptake of oxidized LDL (oxLDL) via CD36, whereas FH-CD14(++)CD16(-) monocytes preferentially take up native LDL (nLDL). FH-CD14(+)CD16(+) monocytes have an increased expression of surface proteins CD68, stabilin-1, and CD11c and a higher adherence to activated endothelial cells in response to oxLDL and nLDL stimulation. In addition, all CD14(+)CD16(+) monocytes have an increased ability for phagocytosis and a higher resistance to phagocytosis impairment by oxLDL compared with CD14(++)CD16(-) monocytes. We conclude that FH-CD14(+)CD16(+) monocytes have specialized functions in the uptake of oxLDL at activated endothelial cell surfaces, and we hypothesize that these functions are critical for the clearance of oxLDL deposits and apoptotic cells from the vessel wall under hyperlipidemic conditions.-Mosig, S., Rennert, K., Krause, S., Kzhyshkowska, J., Neunubel, K., Heller, R., Funke, H. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14(+)CD16(+) monocytes in detoxification of oxidized LDL. FASEB J. 23, 866-874 (2009)	[Krause, Siegfried; Heller, Regine] Univ Jena, Inst Mol Cell Biol, Jena, Germany; [Kzhyshkowska, Julia] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, D-6800 Mannheim, Germany	Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Mosig, S (corresponding author), Bachstr 18, D-07743 Jena, Germany.	sandy.mosig@mti.uni-jena.de	Heller, Regine/AAC-9353-2019; Mosig, Alexander S./D-9620-2015; Kzhyshkowska, Julia G./J-5835-2016	Mosig, Alexander S./0000-0002-5687-2444; 	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by research funding from the German Federal Ministry of Education and Research to H. F. We thank all patients participating in the study and Prof. K. Oette, Prof. H. Borberg, Dr. T. Schreiber, and the staff of the German Hemapheresis Center in Cologne for help in recruiting FH patients and blood processing. We also thank Dr. M. Blaha and his department of the Charles University Hospital (Hradec Kralove, Czech Republic) for gaining access to FH patients.	Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; Ancuta P, 2004, IMMUNOBIOLOGY, V209, P11, DOI 10.1016/j.imbio.2004.04.001; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; DOHERTY DE, 1989, J IMMUNOL, V143, P3673; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; FROSTEGARD J, 1990, P NATL ACAD SCI USA, V87, P904, DOI 10.1073/pnas.87.3.904; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Grabner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO;2-3; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayden JM, 2002, J LIPID RES, V43, P26; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOLNESS CL, 1993, BLOOD, V81, P1607; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; ISSEKUTZ TB, 1995, J IMMUNOL, V154, P6533; Kashiwakura Y, 2004, CIRCULATION, V110, P3329, DOI 10.1161/01.CIR.0000147828.86593.85; Kounalakis NS, 2006, J SURG RES, V135, P137, DOI 10.1016/j.jss.2005.12.018; Kzhyshkowska J, 2004, J LEUKOCYTE BIOL, V76, P1151, DOI 10.1189/jlb.0504300; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Namgaladze D, 2008, J LIPID RES, V49, P58, DOI 10.1194/jlr.M700100-JLR200; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Radhika A, 2007, MOL CELL BIOCHEM, V305, P133, DOI 10.1007/s11010-007-9536-0; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Shih PT, 1999, J CLIN INVEST, V103, P613, DOI 10.1172/JCI5710; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; WHITELAW DM, 1972, CELL TISSUE KINET, V5, P311, DOI 10.1111/j.1365-2184.1972.tb00369.x; Wintergerst ES, 2000, EUR J BIOCHEM, V267, P6050, DOI 10.1046/j.1432-1327.2000.01682.x; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	47	92	99	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					866	874		10.1096/fj.08-118240	http://dx.doi.org/10.1096/fj.08-118240			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001052				2022-12-25	WOS:000265506300022
J	Andersson, T; Sodersten, E; Duckworth, JK; Cascante, A; Fritz, N; Sacchetti, P; Cervenka, I; Bryja, V; Hermanson, O				Andersson, Therese; Soedersten, Erik; Duckworth, Joshua K.; Cascante, Anna; Fritz, Nicolas; Sacchetti, Paola; Cervenka, Igor; Bryja, Vitezslav; Hermanson, Ola			CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-CORTEX; FATE CHOICE; DIFFERENTIATION; PATHWAY; BMP; IDENTIFICATION; NA,K-ATPASE; INHIBITION; EXPRESSION; RECEPTORS	Bone morphogenetic proteins such as BMP4 are essential for proper development of telencephalic forebrain structures and induce differentiation of telencephalic neural stem cells into a variety of cellular fates, including astrocytic, neuronal, and mesenchymal cells. Little is yet understood regarding the mechanisms that underlie the spatiotemporal differences in progenitor response to BMP4. In a screen designed to identify novel targets of BMP4 signaling in telencephalic neural stem cells, we found the mRNA levels of the previously uncharacterized factor CXXC5 reproducibly up-regulated upon BMP4 stimulation. In vivo, CXXC5 expression overlapped with BMP4 adjacent to Wnt3a expression in the dorsal regions of the telencephalon, including the developing choroid plexus. CXXC5 showed partial homology with Idax, a related protein previously shown to interact with the Wnt-signaling intermediate Dishevelled (Dvl). Indeed CXXC5 and Dvl co-localized in the cytoplasm and interacted in co-immunoprecipitation experiments. Moreover, fluorescence resonance energy transfer (FRET) experiments verified that CXXC5 and Dvl2 were located in close spatial proximity in neural stem cells. Studies of the functional role of CXXC5 revealed that overexpression of CXXC5 or exposure to BMP4 repressed the levels of the canonical Wnt signaling target Axin2, and CXXC5 attenuated Wnt3a-mediated increase in TOPflash reporter activity. Accordingly, RNA interference of CXXC5 attenuated the BMP4-mediated decrease in Axin2 levels and facilitated the response to Wnt3a in neural stem cells. We propose that CXXC5 is acting as a BMP4-induced inhibitor of Wnt signaling in neural stem cells.	[Andersson, Therese; Soedersten, Erik; Duckworth, Joshua K.; Cascante, Anna; Hermanson, Ola] Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Neurosci, SE-17177 Stockholm, Sweden; [Fritz, Nicolas; Sacchetti, Paola] Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Cervenka, Igor; Bryja, Vitezslav] Acad Sci Czech Republic, Dept Cytokinet, Brno 61137, Czech Republic; [Cervenka, Igor; Bryja, Vitezslav] Masaryk Univ, Inst Expt Biol, Fac Sci, CS-61137 Brno, Czech Republic	Karolinska Institutet; Karolinska Institutet; Czech Academy of Sciences; Masaryk University Brno	Hermanson, O (corresponding author), Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Neurosci, SE-17177 Stockholm, Sweden.	Ola.Hermanson@ki.se	Bryja, Vítězslav/P-4217-2019; Fritz, Nicolas/P-1290-2019; Fritz, Nicolas/N-1030-2013; , Ola/AAF-5126-2021; Bryja, Vít?zslav/H-1925-2014; Sacchetti, Paola/ABC-8884-2021	Bryja, Vítězslav/0000-0002-9136-5085; Fritz, Nicolas/0000-0002-9722-7425; Fritz, Nicolas/0000-0002-9722-7425; Bryja, Vít?zslav/0000-0002-9136-5085; Sacchetti, Paola/0000-0002-6390-2744; Cascante, Anna/0000-0002-8272-3098; Sodersten, Erik/0000-0002-2998-4889; Hermanson, Ola/0000-0001-9320-7921	K&A Wallenberg Foundation; Swedish Research Council (VR); Swedish Cancer Society (CF); Jeansson Foundation; Ake Wiberg Foundation; Ahlen Foundation; Swedish Medical Society; Karolinska Institutet; Swedish Foundation for Strategic Research (SSF); Swedish Children's Cancer Foundation (BCF)	K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society (CF)(Swedish Cancer Society); Jeansson Foundation; Ake Wiberg Foundation; Ahlen Foundation; Swedish Medical Society; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Children's Cancer Foundation (BCF)	This study was supported in part by grants from K&A Wallenberg Foundation, the Swedish Research Council (VR), the Swedish Cancer Society (CF), the Jeansson Foundation, the Ake Wiberg Foundation, the Ahlen Foundation, the Swedish Medical Society, Karolinska Institutet, the Swedish Foundation for Strategic Research (SSF), and the Swedish Children's Cancer Foundation (BCF) (to O. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Katoh M, 2004, INT J ONCOL, V25, P1193; Kawate T, 2005, ORG LETT, V7, P3865, DOI 10.1021/ol051144r; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Lee CS, 2001, P NATL ACAD SCI USA, V98, P11347, DOI 10.1073/pnas.201418298; Leonard JD, 2007, DEV BIOL, V306, P50, DOI 10.1016/j.ydbio.2007.02.041; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Marko NF, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-27; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Uhlen P, 2003, ANN NY ACAD SCI, V986, P514, DOI 10.1111/j.1749-6632.2003.tb07237.x; van Grunsven LA, 2005, CYTOKINE GROWTH F R, V16, P495, DOI 10.1016/j.cytogfr.2005.05.006; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	41	78	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3672	3681		10.1074/jbc.M808119200	http://dx.doi.org/10.1074/jbc.M808119200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19001364	hybrid			2022-12-25	WOS:000262872500035
J	Bergfeld, AK; Claus, H; Lorenzen, NK; Spielmann, F; Vogel, U; Muhlenhoff, M				Bergfeld, Anne K.; Claus, Heike; Lorenzen, Nina K.; Spielmann, Fabian; Vogel, Ulrich; Muehlenhoff, Martina			The Polysialic Acid-specific O-Acetyltransferase OatC from Neisseria meningitidis Serogroup C Evolved Apart from Other Bacterial Sialate O-Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA/BETA-HYDROLASE-FOLD; ESCHERICHIA-COLI K1; N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; SITE-DIRECTED MUTAGENESIS; SIALIC-ACID; MENINGOCOCCAL DISEASE; CRYSTAL-STRUCTURE; SERINE PROTEASES; CATALYTIC TRIAD; HOMOSERINE TRANSACETYLASE	Neisseria meningitidis serogroup C is a major cause of bacterial meningitis and septicaemia. This human pathogen is protected by a capsule composed of alpha 2,9-linked polysialic acid that represents an important virulence factor. In the majority of strains, the capsular polysaccharide is modified by O-acetylation at C-7 or C-8 of the sialic acid residues. The gene encoding the capsule modifying O-acetyltransferase is part of the capsule gene complex and shares no sequence similarities with other proteins. Here, we describe the purification and biochemical characterization of recombinant OatC. The enzyme was found as a homodimer, with the first 34 amino acids forming an efficient oligomerization domain that worked even in a different protein context. Using acetyl-CoA as donor substrate, OatC transferred acetyl groups exclusively onto polysialic acid joined by alpha 2,9-linkages and did not act on free or CMP-activated sialic acid. Motif scanning revealed a nucleophile elbow motif (GXS(286)XGG), which is a hallmark of alpha/beta-hydrolase fold enzymes. In a comprehensive site-directed mutagenesis study, we identified a catalytic triad composed of Ser-286, Asp-376, and His-399. Consistent with a double-displacement mechanism common to alpha/beta-hydrolase fold enzymes, a covalent acetylenzyme intermediate was found. Together with secondary structure prediction highlighting an alpha/beta-hydrolase fold topology, our data provide strong evidence that OatC belongs to the alpha/beta-hydrolase fold family. This clearly distinguishes OatC from all other bacterial sialate O-acetyltransferases known so far because these are members of the hexapeptide repeat family, a class of acyltransferases that adopt a left-handed beta-helix fold and assemble into catalytic trimers.	[Muehlenhoff, Martina] Hannover Med Sch, Abt Zellulare Chem, Dept Cellular Chem, D-30623 Hannover, Germany; [Claus, Heike; Spielmann, Fabian; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; University of Wurzburg	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Dept Cellular Chem, Carl Neuberg Str 1, D-30623 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [VO 718/4-1, MU 1774/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants VO 718/4-1 (to U. V.) and MU 1774/2-1 (to M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; BLONDEL A, 1991, PROTEIN ENG, V4, P457, DOI 10.1093/protein/4.4.457; BLONDEL A, 1990, EUR J BIOCHEM, V193, P325, DOI 10.1111/j.1432-1033.1990.tb19341.x; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Born TL, 2000, BIOCHEMISTRY-US, V39, P8556, DOI 10.1021/bi000462p; Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P189, DOI 10.1111/j.1574-695X.2000.tb01475.x; BUTOR C, 1993, J BIOL CHEM, V268, P10197; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Campobasso N, 2004, J BIOL CHEM, V279, P44883, DOI 10.1074/jbc.M407882200; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Connolly M, 1999, EPIDEMIOL INFECT, V122, P41, DOI 10.1017/S0950268898001848; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fujino S, 2006, BIOSCI BIOTECH BIOCH, V70, P377, DOI 10.1271/bbb.70.377; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; HIGA HH, 1988, J BIOL CHEM, V263, P8872; HILDEBRANDT H, 2008, NEUROCHEM RES, DOI DOI 10.1007/S11064-008-9724-7; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ho MM, 2001, BIOTECHNOL APPL BIOC, V33, P91, DOI 10.1042/BA20000078; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Ishida T, 2006, BIOCHEMISTRY-US, V45, P5413, DOI 10.1021/bi051515b; Ishida T, 2004, J AM CHEM SOC, V126, P7111, DOI 10.1021/ja030405u; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; JENNINGS HJ, 1977, J INFECT DIS, V136, pS78, DOI 10.1093/infdis/136.Supplement.S78; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Kolkenbrock S, 2006, J BACTERIOL, V188, P8430, DOI 10.1128/JB.01085-06; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Longworth E, 2002, FEMS IMMUNOL MED MIC, V32, P119, DOI 10.1111/j.1574-695X.2002.tb00543.x; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; Michon F, 2000, Dev Biol (Basel), V103, P151; Milkowski C, 2004, PHYTOCHEMISTRY, V65, P517, DOI 10.1016/j.phytochem.2003.12.018; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Nandhagopal N, 2001, J MOL BIOL, V309, P1139, DOI 10.1006/jmbi.2001.4737; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nazi I, 2005, BIOCHEMISTRY-US, V44, P13560, DOI 10.1021/bi0514764; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POOLMAN JT, 1995, CLIN DIAGN LAB IMMUN, V2, P69, DOI 10.1128/CDLI.2.1.69-72.1995; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Ravenscroft N, 1999, VACCINE, V17, P2802, DOI 10.1016/S0264-410X(99)00092-4; Rode B, 2008, J BIOTECHNOL, V135, P202, DOI 10.1016/j.jbiotec.2008.03.012; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Shen YQ, 2002, BIOL CHEM, V383, P307, DOI 10.1515/BC.2002.033; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; VANN WF, 1978, J BACTERIOL, V133, P1300, DOI 10.1128/JB.133.3.1300-1306.1978; Villwock A, 2008, INT J MED MICROBIOL, V298, P591, DOI 10.1016/j.ijmm.2007.11.003; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Wahab HA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-23; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; Wang M, 2007, BIOCHEM BIOPH RES CO, V363, P1050, DOI 10.1016/j.bbrc.2007.08.153; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Westwood IM, 2006, CURR TOP MED CHEM, V6, P1641, DOI 10.2174/156802606778108979; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105	87	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					6	16		10.1074/jbc.M807518200	http://dx.doi.org/10.1074/jbc.M807518200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986988	hybrid			2022-12-25	WOS:000261974800002
J	Chen, Q; Chen, HY; Zheng, DW; Kuang, CZ; Fang, H; Zou, BY; Zhu, WQ; Bu, GX; Jin, T; Wang, ZZ; Zhang, X; Chen, J; Field, LJ; Rubart, M; Shou, WN; Chen, Y				Chen, Qian; Chen, Hanying; Zheng, Dawei; Kuang, Chenzhong; Fang, Hong; Zou, Bingyu; Zhu, Wuqiang; Bu, Guixue; Jin, Ting; Wang, Zhenzhen; Zhang, Xin; Chen, Ju; Field, Loren J.; Rubart, Michael; Shou, Weinian; Chen, Yan			Smad7 Is Required for the Development and Function of the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY MOUSE EMBRYO; TGF-BETA; CARDIAC DEVELOPMENT; ENDOCARDIAL CUSHION; NEUREGULIN RECEPTOR; MESODERM INDUCTION; COLORECTAL-CANCER; CELL-MEMBRANE; MICE LACKING; EXPRESSION	Transforming growth factor-beta (TGF-beta) family members, including TGF-beta s, activins, and bone morphogenetic proteins, exert diverse biological activities in cell proliferation, differentiation, apoptosis, embryonic development, and many other processes. These effects are largely mediated by Smad proteins. Smad7 is a negative regulator for the signaling of TGF-beta family members. Dysregulation of Smad7 is associated with pathogenesis of a variety of human diseases. However, the in vivo physiological roles of Smad7 have not been elucidated due to the lack of a mouse model with significant loss of Smad7 function. Here we report generation and initial characterization of Smad7 mutant mice with targeted deletion of the indispensable MH2 domain. The majority of Smad7 mutant mice died in utero due to multiple defects in cardiovascular development, including ventricular septal defect and non-compaction, as well as outflow tract malformation. The surviving adult Smad7 mutant mice had impaired cardiac functions and severe arrhythmia. Further analyses suggest that Smad2/3 phosphorylation was elevated in atrioventricular cushion in the heart of Smad7 mutant mice, accompanied by increased apoptosis in this region. Taken together, these observations pinpoint an important role of Smad7 in the development and function of the mouse heart in vivo.	[Chen, Qian; Kuang, Chenzhong; Zou, Bingyu; Zhang, Xin; Shou, Weinian] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Chen, Qian; Chen, Hanying; Zhu, Wuqiang; Bu, Guixue; Field, Loren J.; Rubart, Michael; Shou, Weinian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediatr Res,Div Pediat Cardiol, Indianapolis, IN 46202 USA; [Fang, Hong; Shou, Weinian] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46202 USA; [Zheng, Dawei; Jin, Ting; Wang, Zhenzhen; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego	Shou, WN (corresponding author), Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	wshou@iupui.edu; ychen3@sibs.ac.cn	Chen, Ju/E-5579-2011; Chen, Qian/F-3590-2012; Bu, Guixue/E-8291-2010; Bu, Guixue/B-1957-2010		National Institutes of Health [R21-CA122764, 03-HD049556, R01-HL81092, R01-HL70259, P01-HL85098]; Indiana Genomics Initiative (INGEN); National Natural Science Foundation of China [30588002]; Ministry of Science and Technology of China [2006CB943902, 2007CB947100]; Science & Technology Commission of Shanghai Municipality [07DJ14005]; Riley Children Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD049556] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA122764] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075165, P01HL085098, R01HL070259, R01HL081092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Genomics Initiative (INGEN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Riley Children Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-CA122764 and R03-HD049556, by NIH Grants R01-HL81092 and R01-HL70259 (to W. S.), and by NIH Grant P01-HL85098 (to L.J.F. and W.S.). This work was also supported by the Indiana Genomics Initiative (INGEN), the National Natural Science Foundation of China (Grant 30588002), the Ministry of Science and Technology of China (Grants 2006CB943902 and 2007CB947100), the Science & Technology Commission of Shanghai Municipality (Grant 07DJ14005) (to Y.C.), and the Riley Children Foundation (to W. S. and L.J.F.).	Arnold NB, 2004, CANCER RES, V64, P3599, DOI 10.1158/0008-5472.CAN-03-2999; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Bartram U, 2001, CIRCULATION, V103, P2745; Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Keyes WM, 2002, AM J PHYSIOL-CELL PH, V282, pC1348, DOI 10.1152/ajpcell.00509.2001; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liang XQ, 2007, CIRC RES, V100, P527, DOI 10.1161/01.RES.0000259041.37059.8c; Liu XB, 2007, BBA-GENE STRUCT EXPR, V1769, P149, DOI 10.1016/j.bbaexp.2007.01.001; Lopes SMCD, 2003, GENE EXPR PATTERNS, V3, P355, DOI 10.1016/S1567-133X(03)00029-2; Luukko K, 2001, MECH DEVELOP, V101, P209, DOI 10.1016/S0925-4773(00)00556-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stockwell BR, 1998, CHEM BIOL, V5, P385, DOI 10.1016/S1074-5521(98)90072-2; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Yamaguchi T, 2006, J MOL ENDOCRINOL, V36, P569, DOI 10.1677/jme.1.01966; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zwijsen A, 2000, DEV DYNAM, V218, P663, DOI 10.1002/1097-0177(200008)218:4<663::AID-DVDY1020>3.0.CO;2-7	46	84	85	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					292	300		10.1074/jbc.M807233200	http://dx.doi.org/10.1074/jbc.M807233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952608	hybrid, Green Published			2022-12-25	WOS:000261974800033
J	Sellick, CA; Jowitt, TA; Reece, RJ				Sellick, Christopher A.; Jowitt, Thomas A.; Reece, Richard J.			The Effect of Ligand Binding on the Galactokinase Activity of Yeast Gal1p and Its Ability to Activate Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; MOLECULAR-STRUCTURE; GENE SWITCH; PROTEIN; GAL80P; INDUCTION; INDUCER; SPECIFICITY; COMPLEX	The galactokinase from Saccharomyces cerevisiae (ScGal1p) is a bifunctional protein. It is an enzyme responsible for the conversion of alpha-D-galactose into galactose 1-phosphate at the expense of ATP but can also function as a transcriptional inducer of the yeast GAL genes. For both of these activities, the protein requires two ligands; a sugar (galactose) and a nucleotide (ATP). Here we investigate the effect of these ligands on the stability and conformation of ScGal1p to determine how the ligands alter protein function. We show that nucleotide binding increases the thermal stability of ScGal1p, whereas binding of galactose alone had no effect on the stability of the protein. This nucleotide stabilization effect is also observed for the related proteins S. cerevisiae Gal3p and Kluyveromyces lactis Gal1p and suggests that nucleotide binding results in the formation of, or the unmasking of, the galactose-binding site. We also show that the increase in stability of ScGal1p does not result from a large conformational change but is instead the result of a smaller more energetically favorable stabilization event. Finally, we have used mutant versions of ScGal1p to show that the galactokinase and transcriptional induction functions of the protein are distinct and separable. Mutations resulting in constitutive induction do not function by mimicking the more stable active conformation but have highlighted a possible site of interaction between ScGal1p and ScGal80p. These data give significant insights into the mechanism of action of both a galactokinase and a transcriptional inducer.	[Sellick, Christopher A.; Jowitt, Thomas A.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Reece, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	richard.reece@manchester.ac.uk		Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	This research was supported by grants from the Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to R.J.R.).	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Anders A, 2006, J BIOL CHEM, V281, P29337, DOI 10.1074/jbc.M604271200; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BHAT PJ, 1992, MOL CELL BIOL, V12, P2701, DOI 10.1128/MCB.12.6.2701; Blank TE, 1997, MOL CELL BIOL, V17, P2566, DOI 10.1128/MCB.17.5.2566; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diep CQ, 2006, GENETICS, V172, P77, DOI 10.1534/genetics.105.050807; Diep CQ, 2008, GENETICS, V178, P725, DOI 10.1534/genetics.107.074799; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Inagaki E, 2006, ACTA CRYSTALLOGR F, V62, P169, DOI 10.1107/S1744309106001813; Kumar PR, 2008, SCIENCE, V319, P1090, DOI 10.1126/science.1151903; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; SALMERON JM, 1986, NUCLEIC ACIDS RES, V14, P7767, DOI 10.1093/nar/14.19.7767; SALMERON JM, 1989, MOL CELL BIOL, V9, P2950, DOI 10.1128/MCB.9.7.2950; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2006, J BIOL CHEM, V281, P17150, DOI 10.1074/jbc.M602086200; Thoden JB, 2008, J BIOL CHEM, V283, P30266, DOI 10.1074/jbc.M805200200; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEBSTER TD, 1988, NUCLEIC ACIDS RES, V16, P8011, DOI 10.1093/nar/16.16.8011; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	30	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					229	236		10.1074/jbc.M807878200	http://dx.doi.org/10.1074/jbc.M807878200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957435	hybrid			2022-12-25	WOS:000261974800026
J	Torres, VA; Mielgo, A; Barila, D; Anderson, DH; Stupack, D				Torres, Vicente A.; Mielgo, Ainhoa; Barila, Daniela; Anderson, Deborah H.; Stupack, Dwayne			Caspase 8 Promotes Peripheral Localization and Activation of Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB5; CELL-MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; MEMBRANE-FUSION; ENDOSOME FUSION; P85 SUBUNIT; CD95; APOPTOSIS; PROTEINS; MOTILITY	Caspase 8 is a cysteine protease that initiates apoptotic signaling via the extrinsic pathway in a manner dependent upon association with early endosomes. Previously, we identified caspase 8 as an effector of migration, promoting motility in a manner dependent upon phosphorylation on Tyr-380 by Src family kinases and its subsequent association with Src homology 2 domain-containing proteins. Here we demonstrate the regulation of the small GTPase Rab5, which mediates early endosome formation, homotypic fusion, and maturation by caspase 8. Regulation requires the Tyr-380 phosphorylation site but not caspase proteolytic activity. Tyr-380 is essential for interaction with the Src homology 2 domains of p85 alpha, a multifunctional adaptor for phosphatidylinositol 3-kinase, that possesses Rab-GAP activity. Interaction between caspase 8 and p85 alpha promotes Rab5 GTP loading, alters endosomal trafficking, and results in the accumulation of Rab5-positive endosomes at the edge of the cell. Conversely, caspase 8-dependent GTP loading of Rab5 is overcome by increased expression of p85 alpha in a Rab-GAP-dependent manner. Thus, we demonstrate a novel function for caspase 8 as a modulator of p85 alpha Rab-GAP activity and endosomal trafficking.	[Stupack, Dwayne] Univ Calif San Diego, Ctr Canc, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Torres, Vicente A.; Mielgo, Ainhoa; Stupack, Dwayne] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Barila, Daniela] Univ Roma Tor Vergata, Dept Biol, I-00179 Rome, Italy; [Barila, Daniela] Ist Ricovero, Lab Cell Signaling, I-00179 Rome, Italy; [Barila, Daniela] Cura Carattere Sci Fdn Santa Lucia, I-00179 Rome, Italy; [Anderson, Deborah H.] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK S7N 4H4, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Rome Tor Vergata; IRCCS Santa Lucia; University of Saskatchewan	Stupack, D (corresponding author), Univ Calif San Diego, Ctr Canc, Sch Med, Dept Pathol, 3855 Hlth Sci Way,MC0803, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Torres, Vicente/I-2437-2013; Barilà, Daniela/K-8506-2016	Barilà, Daniela/0000-0002-6192-1562; Torres, Vicente A/0000-0002-5973-7248	National Institutes of Health [CA107263]; Canadian Cancer Society [019040]; Italian Association for Cancer Research; International Association for Cancer Research [AICR 07-0461]; NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107263 (NCI, to D. S.). This work was also supported by Canadian Cancer Society, Saskatchewan Division Grant 019040 (to D. A.) and by grants from the Italian Association for Cancer Research and International Association for Cancer Research Grant AICR 07-0461 (to D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Reinehr R, 2008, J BIOL CHEM, V283, P2211, DOI 10.1074/jbc.M706853200; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wrasidlo W, 2008, P NATL ACAD SCI USA, V105, P2313, DOI 10.1073/pnas.0712198105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	38	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36280	36289		10.1074/jbc.M805878200	http://dx.doi.org/10.1074/jbc.M805878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974049	Green Published, hybrid			2022-12-25	WOS:000261840500024
J	Trentmann, O; Jung, B; Neuhaus, HE; Haferkamp, I				Trentmann, Oliver; Jung, Benjamin; Neuhaus, Horst Ekkehard; Haferkamp, Ilka			Nonmitochondrial ATP/ADP Transporters Accept Phosphate as Third Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICKETTSIA-PROWAZEKII; ESCHERICHIA-COLI; ATP TRANSPORT; CHLAMYDIA-TRACHOMATIS; ADENINE-NUCLEOTIDE; GENOME SEQUENCE; ARABIDOPSIS; MITOCHONDRIA; PROTEINS; CARRIER	Chlamydiales and Rickettsiales as metabolically impaired, intracellular pathogenic bacteria essentially rely on "energy parasitism" by the help of nucleotide transporters (NTTs). Also in plant plastids NTT-type carriers catalyze ATP/ADP exchange to fuel metabolic processes. The uptake of ATP(4-), followed by energy consumption and the release of ADP(3-), would lead to a metabolically disadvantageous accumulation of negative charges in form of inorganic phosphate (Pi) in the bacterium or organelle if no interacting P-i export system exists. We identified that Pi is a third substrate of several NTT-type ATP/ADP transporters. During adenine nucleotide hetero-exchange, Pi is cotransported with ADP in a one-to-one stoichiometry. Additionally, Pi can be transported in exchange with solely P-i. This P-i homo-exchange depends on the presence of ADP and provides a first indication for only one binding center involved in import and export. Furthermore, analyses of mutant proteins revealed that Pi interacts with the same amino acid residue as the gamma-phosphate of ATP. Import of ATP in exchange with ADP plus Pi is obviously an efficient way to couple energy provision with the export of the two metabolic products (ADP plus P-i) and to maintain cellular phosphate homeostasis in intracellular living "energy parasites" and plant plastids. The additional Pi transport capacity of NTT-type ATP/ADP transporters makes the existence of an interacting P-i exporter dispensable and might explain why a corresponding protein so far has not been identified.	[Trentmann, Oliver; Jung, Benjamin; Neuhaus, Horst Ekkehard; Haferkamp, Ilka] TU Kaiserslautern, D-67653 Kaiserslautern, Germany	University of Kaiserslautern	Haferkamp, I (corresponding author), TU Kaiserslautern, Erwin Schrodinger Str 22, D-67653 Kaiserslautern, Germany.	haferk@rhrk.uni-kl.de			Deutsche Forschungsgemeinschaft [SPP 1131]; Graduate Research School [845]; Stiftung Rheinland-Pfalz Innovation [766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate Research School; Stiftung Rheinland-Pfalz Innovation	This work was supported by the Deutsche Forschungsgemeinschaft Grant SPP 1131 and Graduate Research School Grant 845 and by the Stiftung Rheinland-Pfalz Innovation Project 766. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan FY, 1996, J BACTERIOL, V178, P3974, DOI 10.1128/jb.178.13.3974-3977.1996; Daugherty RM, 2004, J BACTERIOL, V186, P3262, DOI 10.1128/JB.186.10.3262-3265.2004; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hatch TP, 1999, CHLAMYDIA, P29; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; KRAUSE DC, 1985, P NATL ACAD SCI USA, V82, P3015, DOI 10.1073/pnas.82.9.3015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; MAHONY JB, 2003, MANUAL CLIN MICROBIO, P991; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Reinhold T, 2007, PLANT J, V50, P293, DOI 10.1111/j.1365-313X.2007.03049.x; Reiser J, 2004, PLANT PHYSIOL, V136, P3524, DOI 10.1104/pp.104.049502; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schmitz-Esser S, 2008, J BACTERIOL, V190, P5746, DOI 10.1128/JB.00391-08; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Trentmann O, 2007, PLOS BIOL, V5, P1938, DOI 10.1371/journal.pbio.0050231; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; WINKLER HH, 1986, METHOD ENZYMOL, V125, P253; WINKLER HH, 1984, J BACTERIOL, V169, P76	38	41	41	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36486	36493		10.1074/jbc.M806903200	http://dx.doi.org/10.1074/jbc.M806903200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	19001371	Green Published, hybrid			2022-12-25	WOS:000261840500046
J	Zhou, XL; Zhu, B; Wang, ED				Zhou, Xiao-Long; Zhu, Bin; Wang, En-Duo			The CP2 Domain of Leucyl-tRNA Synthetase Is Crucial for Amino Acid Activation and Post-transfer Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; TRNA(LEU); COMPLEX; DISCRIMINATION; PURIFICATION; POLYMERASE	Leucyl-tRNA synthetase (LeuRS) has an insertion domain, called connective peptide 2 (CP2), either directly preceding or following the editing domain (CP1 domain), depending on the species. The global structures of the CP2 domains from all LeuRSs are similar. Although the CP1 domain has been extensively explored to be responsible for hydrolysis of mischarged tRNALeu, the role of the CP2 domain remains undefined. In the present work, deletion of the CP2 domain of Giardia lamblia LeuRS (GlLeuRS) showed that the CP2 domain is indispensable for amino acid activation and post-transfer editing and that it contributes to LeuRS-tRNA(Leu) binding affinity. In addition, its functions are conserved in both eukaryotic/archaeal and prokaryotic LeuRSs from G. lamblia, Pyrococcus horikoshii (PhLeuRS), and Escherichia coli (EcLeuRS). Alanine scanning and site-directed mutagenesis assays of the CP2 domain identified several residues that are crucial for its various functions. Data from the chimeric mutants, which replaced the CP2 domain of GlLeuRS with either PhLeuRS or EcLeuRS, showed that the CP2 domain of PhLeuRS but not that of EcLeuRS can partially restore amino acid activation and post-transfer editing functions, suggesting that the functions of the CP2 domain are dependent on its location in the primary sequence of LeuRS.	Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn			National Key Basic Research Foundation of China [2006CB910301]; Natural Science Foundation of China [30670463]; Committee of Science and Technology in Shanghai [06JC14076]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee)	This work was funded by the National Key Basic Research Foundation of China (Grant 2006CB910301), the Natural Science Foundation of China (Grant 30670463), and the Committee of Science and Technology in Shanghai (Grant 06JC14076). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zuniga R, 2002, FEBS LETT, V532, P387, DOI 10.1016/S0014-5793(02)03720-1	20	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36608	36616		10.1074/jbc.M806745200	http://dx.doi.org/10.1074/jbc.M806745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955487	hybrid, Green Published			2022-12-25	WOS:000261840500059
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			Multiple Kv Channel-interacting Proteins Contain an N-terminal Transmembrane Domain That Regulates Kv4 Channel Trafficking and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; POTASSIUM CHANNELS; K+ CHANNELS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; STRUCTURAL BASIS; MODULATION; INACTIVATION; RETRIEVAL; KCHIP1	Kv channel-interacting proteins (KChIPs) are auxiliary subunits of the heteromultimeric channel complexes that underlie neuronal I-SA, the subthreshold transient K+ current that dynamically regulates membrane excitability, action potential firing properties, and long term potentiation. KChIPs form cytoplasmic associations with the principal pore-forming Kv4 subunits and typically mediate enhanced surface expression and accelerated recovery from depolarization-induced inactivation. An exception is KChIP4a, which dramatically suppresses Kv4 inactivation while promoting neither surface expression nor recovery. These unusual properties are attributed to the effects of a K channel inactivation suppressor domain (KISD) encoded within the variable N terminus of KChIP4a. Here, we have functionally and biochemically characterized two brain KChIP isoforms, KChIP2x and KChIP3x (also known as KChIP3b) and show that they also contain a functional KISD. Like KChIP4a and in contrast with non-KISD-containing KChIPs, both KChIP2x and KChIP3x strongly suppress inactivation and slow activation and inhibit the typical increases in surface expression of Kv4.2 channels. We then examined the properties of the KISD to determine potential mechanisms for its action. Subcellular fractionation shows that KChIP4a, KChIP2x, and KChIP3x are highly associated with the membrane fraction. Fluorescent confocal imaging of enhanced green fluorescent proteins (eGFP) N-terminally fused with KISD in HEK293T cells indicates that KISDs of KChIP4a, KChIP2x, and KChIP3x all autonomously target eGFP to intracellular membranes. Cell surface biotinylation experiments on KChIP4a indicate that the N terminus is exposed extracellularly, consistent with a transmembrane KISD. In summary, KChIP4a, KChIP2x, and KChIP3x comprise a novel class of KChIP isoforms characterized by an unusual transmembrane domain at their N termini that modulates Kv4 channel gating and trafficking.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza,S630, Houston, TX 77030 USA.	hjerng@cns.bcm.tmc.edu			National Institutes of Health [PO1 NS37444]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444, R01NS031583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 NS37444. Some of the data presented here have previously appeared in abstract form (17). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Baranauskas G, 2004, EUR J NEUROSCI, V20, P385, DOI 10.1111/j.1460-9568.2004.03494.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Dougherty K, 2006, J GEN PHYSIOL, V128, P745, DOI 10.1085/jgp.200609668; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JERNG H, 2008, BIOPHYS J, V94, P521; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; O'Callaghan DW, 2003, J CELL SCI, V116, P4833, DOI 10.1242/jcs.00803; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schultz JH, 2007, PFLUG ARCH EUR J PHY, V454, P195, DOI 10.1007/s00424-006-0203-1; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Woo HN, 2008, NEUROREPORT, V19, P1193, DOI 10.1097/WNR.0b013e3283089209; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	45	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36046	36059		10.1074/jbc.M806852200	http://dx.doi.org/10.1074/jbc.M806852200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957440	Green Published, hybrid			2022-12-25	WOS:000261687900079
J	Li, J; Taylor, IA; Lloyd, J; Clapperton, JA; Howell, S; MacMillan, D; Smerdon, SJ				Li, Jiejin; Taylor, Ian A.; Lloyd, Janette; Clapperton, Julie A.; Howell, Steven; MacMillan, Derek; Smerdon, Stephen J.			Chk2 Oligomerization Studied by Phosphopeptide Ligation IMPLICATIONS FOR REGULATION AND PHOSPHODEPENDENT INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; TUMOR-SUPPRESSOR KINASE; POLO-BOX DOMAIN; PROTEIN-KINASE; IN-VITRO; FHA DOMAIN; THREONINE-68 PHOSPHORYLATION; IONIZING-RADIATION; WIP1 PHOSPHATASE; MOLECULAR-BASIS	Chk2/CHEK2/hCds1 is a modular serine-threonine kinase involved in transducing DNA damage signals. Phosphorylation by ataxia telangiectasia-mutated kinase (ATM) promotes Chk2 self-association, autophosphorylation, and activation. Here we use expressed protein ligation to generate a Chk2 N-terminal regulatory region encompassing a fork-head-associated (FHA) domain, a stoichiometrically phosphorylated Thr-68 motif and intervening linker. Hydrodynamic analysis reveals that Thr-68 phosphorylation stabilizes weak FHA-FHA interactions that occur in the unphosphorylated species to form a high affinity dimer. Although clearly a prerequisite for Chk2 activation in vivo, we show that dimerization modulates potential phosphodependent interactions with effector proteins and substrates through either the pThr-68 site, or the canonical FHA phosphobinding surface with which it is tightly associated. We further show that the dimer-occluded pThr-68 motif is released by intra-dimer autophosphorylation of the FHA domain at the highly conserved Ser-140 position, a major pThr contact in all FHA-phosphopeptide complex structures, revealing a mechanism of Chk2 dimer dissociation following kinase domain activation.	[MacMillan, Derek] UCL, Dept Chem, London WC1H 0AJ, England; [Li, Jiejin; Taylor, Ian A.; Lloyd, Janette; Clapperton, Julie A.; Howell, Steven; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	MacMillan, D (corresponding author), UCL, Dept Chem, London WC1H 0AJ, England.	d.macmillan@ucl.ac.uk; stephen.smerdon@nimr.mrc.ac.uk	Li, Jiejin/G-4980-2010	Li, Jiejin/0000-0003-1525-7768; Smerdon, Stephen/0000-0001-5688-8465	Royal Society; Medical Research Council, UK; Association for International Cancer Research; MRC [MC_U117584228, MC_U117565647] Funding Source: UKRI; Medical Research Council [MC_U117565647, MC_U117584228] Funding Source: researchfish	Royal Society(Royal Society of London); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the laboratory for useful discussions. We also thank Graeme Smith for preliminary characterization of the pSer-140 antibody and Steve Martin for advice and discussions. DM acknowledges the Royal Society for financial support.; This work was supported by the Medical Research Council, UK and the Association for International Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Flavell RR, 2002, ORG LETT, V4, P165, DOI 10.1021/ol016859i; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gabant G, 2008, J MOL BIOL, V380, P489, DOI 10.1016/j.jmb.2008.04.053; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Ma NJL, 2008, CELL CYCLE, V7, P808, DOI 10.4161/cc.7.6.5595; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Qin DY, 2003, BIOCHEM BIOPH RES CO, V311, P803, DOI 10.1016/j.bbrc.2003.10.076; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shieh SY, 2000, GENE DEV, V14, P289; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tominaga K, 1999, J BIOL CHEM, V274, P31463, DOI 10.1074/jbc.274.44.31463; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Tsvetkov LM, 2005, CELL CYCLE, V4, P609; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200	50	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36019	36030		10.1074/jbc.M804075200	http://dx.doi.org/10.1074/jbc.M804075200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948271	hybrid			2022-12-25	WOS:000261687900076
J	Donovan, J; Caban, K; Ranaweera, R; Gonzalez-Flores, JN; Copeland, PR				Donovan, Jesse; Caban, Kelvin; Ranaweera, Ruchira; Gonzalez-Flores, Jonathan N.; Copeland, Paul R.			A Novel Protein Domain Induces High Affinity Selenocysteine Insertion Sequence Binding and Elongation Factor Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; INCORPORATION MACHINERY; DECODING APPARATUS; CROSS-LINKING; SECIS RNA; IN-VIVO; BINDING-PROTEIN-2; RIBOSOME; SBP2; FORMALDEHYDE	Selenocysteine (Sec) is incorporated at UGA codons in mRNAs possessing a Sec insertion sequence (SECIS) element in their 3'-untranslated region. At least three additional factors are necessary for Sec incorporation: SECIS-binding protein 2 (SBP2), Sec-tRNA(Sec), and a Sec-specific translation elongation factor (eEFSec). The C-terminal half of SBP2 is sufficient to promote Sec incorporation in vitro, which is carried out by the concerted action of a novel Sec incorporation domain and an L7Ae RNA-binding domain. Using alanine scanning mutagenesis, we show that two distinct regions of the Sec incorporation domain are required for Sec incorporation. Physical separation of the Sec incorporation and RNA-binding domains revealed that they are able to function in trans and established a novel role of the Sec incorporation domain in promoting SECIS and eEFSec binding to the SBP2 RNA-binding domain. We propose a model in which SECIS binding induces a conformational change in SBP2 that recruits eEFSec, which in concert with the Sec incorporation domain gains access to the ribosomal A site.	[Donovan, Jesse; Caban, Kelvin; Ranaweera, Ruchira; Gonzalez-Flores, Jonathan N.; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), 675 Hoes Ln, Piscataway, NJ 08854 USA.	copeland@umdnj.edu		Ranaweera, Ruchira/0000-0002-0671-2936; Copeland, Paul/0000-0003-3343-0587	Public Health Service [GM068077, GM077073, F31GM081920]; Virus Host Interactions Training [T32AI007403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073, R01GM068077, F31GM081920] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Virus Host Interactions Training; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM068077 and GM077073 (to P.R.C.) and F31GM081920 (to K.C.) and Virus Host Interactions Training Grant T32AI007403 (to J.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Fagegaltier D, 2000, BIOCHIMIE, V82, P117, DOI 10.1016/S0300-9084(00)00192-9; Fletcher JE, 2001, RNA, V7, P1442; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Lescure A, 2002, CURR PROTEIN PEPT SC, V3, P143, DOI 10.2174/1389203023380783; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; MOLLER K, 1977, EUR J BIOCHEM, V76, P175, DOI 10.1111/j.1432-1033.1977.tb11583.x; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	21	48	52	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35129	35139		10.1074/jbc.M806008200	http://dx.doi.org/10.1074/jbc.M806008200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948268	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000261469100070
J	Broughton, S; Alic, N; Slack, C; Bass, T; Ikeya, T; Vinti, G; Tommasi, AM; Driege, Y; Hafen, E; Partridge, L				Broughton, Susan; Alic, Nazif; Slack, Cathy; Bass, Timothy; Ikeya, Tomoatsu; Vinti, Giovanna; Tommasi, Anna Maria; Driege, Yasmine; Hafen, Ernst; Partridge, Linda			Reduction of DILP2 in Drosophila Triages a Metabolic Phenotype from Lifespan Revealing Redundancy and Compensation among DILPs	PLOS ONE			English	Article								The insulin/IGF-like signalling (IIS) pathway has diverse functions in all multicellular organisms, including determination of lifespan. The seven insulin-like peptides (DILPs) in Drosophila are expressed in a stage- and tissue-specific manner. Partial ablation of the median neurosecretory cells (mNSCs) in the brain, which produce three DILPs, extends lifespan, reduces fecundity, alters lipid and carbohydrate metabolism and increases oxidative stress resistance. To determine if reduced expression of DILPs is causal in these effects, and to investigate possible functional diversification and redundancy between DILPs, we used RNA interference to lower specifically the transcript and protein levels of dilp2, the most highly expressed of the mNSC-derived DILPs. We found that DILP2 was limiting only for the increased whole-body trehalose content associated with mNSC-ablation. We observed a compensatory increase in dilp3 and 5 mRNA upon dilp2 knock down. By manipulation of dfoxo and dInR, we showed that the increase in dilp3 is regulated via autocrine insulin signaling in the mNSCs. Our study demonstrates that, despite the correlation between reduced dilp2 mRNA levels and lifespan-extension often observed, DILP2 reduction is not sufficient to extend lifespan. Nor is the increased trehalose storage associated with reduced IIS sufficient to extend lifespan. To understand the normal regulation of expression of the dilps and any functional diversification between them will require independent control of the expression of different dilps.	[Broughton, Susan; Alic, Nazif; Slack, Cathy; Bass, Timothy; Ikeya, Tomoatsu; Vinti, Giovanna; Tommasi, Anna Maria; Driege, Yasmine; Partridge, Linda] UCL, Inst Healthy Ageing, GEE, London, England; [Hafen, Ernst] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich	Broughton, S (corresponding author), UCL, Inst Healthy Ageing, GEE, London, England.	l.partridge@ucl.ac.uk	Alic, Nazif/B-4665-2009; Partridge, Linda/A-5501-2010; Slack, Cathy/C-2016-2008; Partridge, Linda/E-7342-2015	Alic, Nazif/0000-0003-0356-6600; Partridge, Linda/0000-0001-9615-0094; Broughton, Sue/0000-0001-8168-5387; Slack, Cathy/0000-0002-7949-4079	Wellcome Trust; Biotechnology and Biological Science Research Council; Research into Aging; Marie Curie Fellowship; European Molecular Biology Organisation	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research into Aging; Marie Curie Fellowship(European Commission); European Molecular Biology Organisation	We acknowledge funding by the Wellcome Trust (LP and SB), the Biotechnology and Biological Science Research Council (TB), Research into Aging (CS), a Marie Curie Fellowship (NA) and a European Molecular Biology Organisation Long-term Fellowship (NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DORMAN JB, 1995, GENETICS, V141, P1399; Folk DG, 2004, J EXP BIOL, V207, P2671, DOI 10.1242/jeb.01048; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattaliano MD, 2007, MOL CELL NEUROSCI, V36, P211, DOI 10.1016/j.mcn.2007.06.008; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Nelson DW, 2003, GENE DEV, V17, P813, DOI 10.1101/gad.1090203; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Sokal RR, 1998, BIOMETRY; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P266, DOI 10.1016/0003-2697(65)90014-X; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	36	150	153	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3721	10.1371/journal.pone.0003721	http://dx.doi.org/10.1371/journal.pone.0003721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005568	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000265166200009
J	Nosho, K; Irahara, N; Shima, K; Kure, S; Kirkner, GJ; Schernhammer, ES; Hazra, A; Hunter, DJ; Quackenbush, J; Spiegelman, D; Giovannucci, EL; Fuchs, CS; Ogino, S				Nosho, Katsuhiko; Irahara, Natsumi; Shima, Kaori; Kure, Shoko; Kirkner, Gregory J.; Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Quackenbush, John; Spiegelman, Donna; Giovannucci, Edward L.; Fuchs, Charles S.; Ogino, Shuji			Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample	PLOS ONE			English	Article								Background: The CpG island methylator phenotype (CIMP) is a distinct phenotype associated with microsatellite instability (MSI) and BRAF mutation in colon cancer. Recent investigations have selected 5 promoters (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1) as surrogate markers for CIMP-high. However, no study has comprehensively evaluated an expanded set of methylation markers (including these 5 markers) using a large number of tumors, or deciphered the complex clinical and molecular associations with CIMP-high determined by the validated marker panel. Metholodology/Principal Findings: DNA methylation at 16 CpG islands [the above 5 plus CDKN2A (p16), CHFR, CRABP1, HIC1, IGFBP3, MGMT, MINT1, MINT31, MLH1, p14 (CDKN2A/ARF) and WRN] was quantified in 904 colorectal cancers by real-time PCR (MethyLight). In unsupervised hierarchical clustering analysis, the 5 markers (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1), CDKN2A, CRABP1, MINT31, MLH1, p14 and WRN were generally clustered with each other and with MSI and BRAF mutation. KRAS mutation was not clustered with any methylation marker, suggesting its association with a random methylation pattern in CIMP-low tumors. Utilizing the validated CIMP marker panel ( including the 5 markers), multivariate logistic regression demonstrated that CIMP-high was independently associated with older age, proximal location, poor differentiation, MSI-high, BRAF mutation, and inversely with LINE-1 hypomethylation and beta-catenin (CTNNB1) activation. Mucinous feature, signet ring cells, and p53-negativity were associated with CIMP-high in only univariate analysis. In stratified analyses, the relations of CIMP-high with poor differentiation, KRAS mutation and LINE-1 hypomethylation significantly differed according to MSI status. Conclusions: Our study provides valuable data for standardization of the use of CIMP-high-specific methylation markers. CIMP-high is independently associated with clinical and key molecular features in colorectal cancer. Our data also suggest that KRAS mutation is related with a random CpG island methylation pattern which may lead to CIMP-low tumors.	[Nosho, Katsuhiko; Irahara, Natsumi; Shima, Kaori; Kure, Shoko; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kirkner, Gregory J.; Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Spiegelman, Donna; Giovannucci, Edward L.; Fuchs, Charles S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Schernhammer, Eva S.] Applied Canc Res Inst Translat Res, Ludwig Boltzmann Inst Applied Canc Res, Vienna, Austria; [Schernhammer, Eva S.; Hazra, Aditi; Hunter, David J.; Spiegelman, Donna; Giovannucci, Edward L.; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Quackenbush, John] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat, Boston, MA USA; [Quackenbush, John; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ludwig Boltzmann Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Nosho, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	shuji_ogino@dfci.harvard.edu		Schernhammer, Eva/0000-0002-4337-9415; Quackenbush, John/0000-0002-2702-5879; Ogino, Shuji/0000-0002-3909-2323	U.S. National Institute of Health (NIH) [P01 CA87969, P01 CA55075, P50 CA127003, K07 CA122826]; Bennett Family Fund; Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA); Japanese Society for Promotion of Science; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, P50CA127003, K07CA122826] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institute of Health (NIH) grants P01 CA87969, P01 CA55075, P50 CA127003 and K07 CA122826 (to S.O.), and in part by grants from the Bennett Family Fund and from the Entertainment Industry Foundation (EIF) through the EIF National Colorectal Cancer Research Alliance (NCCRA). K.N. was supported by a fellowship grant from the Japanese Society for Promotion of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000964; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Grady WM, 2007, GUT, V56, P1498, DOI 10.1136/gut.2007.125732; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kawasaki T, 2008, MODERN PATHOL, V21, P245, DOI 10.1038/modpathol.3800982; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Muleris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001632; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2007, MODERN PATHOL, V20, P15, DOI 10.1038/modpathol.3800709; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Suehiro Y, 2008, CLIN CANCER RES, V14, P2560, DOI 10.1158/1078-0432.CCR-07-1802; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2002, CANCER RES, V62, P6011; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	50	247	249	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2008	3	11							e3698	10.1371/journal.pone.0003698	http://dx.doi.org/10.1371/journal.pone.0003698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WW	19002263	gold, Green Published, Green Submitted			2022-12-25	WOS:000265166000004
J	Silander, K; Alanne, M; Kristiansson, K; Saarela, O; Ripatti, S; Auro, K; Karvanen, J; Kulathinal, S; Niemela, M; Ellonen, P; Vartiainen, E; Jousilahti, P; Saarela, J; Kuulasmaa, K; Evans, A; Perola, M; Salomaa, V; Peltonen, L				Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Saarela, Olli; Ripatti, Samuli; Auro, Kirsi; Karvanen, Juha; Kulathinal, Sangita; Niemela, Matti; Ellonen, Pekka; Vartiainen, Erkki; Jousilahti, Pekka; Saarela, Janna; Kuulasmaa, Kari; Evans, Alun; Perola, Markus; Salomaa, Veikko; Peltonen, Leena			Gender Differences in Genetic Risk Profiles for Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; ASSOCIATION ANALYSIS; SEX-DIFFERENCES; WOMEN; IDENTIFICATION; COUNTRIES; GENOTYPE	Background: Cardiovascular disease (CVD) incidence, complications and burden differ markedly between women and men. Although there is variation in the distribution of lifestyle factors between the genders, they do not fully explain the differences in CVD incidence and suggest the existence of gender-specific genetic risk factors. We aimed to estimate whether the genetic risk profiles of coronary heart disease (CHD), ischemic stroke and the composite end-point of CVD differ between the genders. Methodology/Principal Findings: We studied in two Finnish population cohorts, using the case-cohort design the association between common variation in 46 candidate genes and CHD, ischemic stroke, CVD, and CVD-related quantitative risk factors. We analyzed men and women jointly and also conducted genotype-gender interaction analysis. Several allelic variants conferred disease risk for men and women jointly, including rs1801020 in coagulation factor XII (HR = 1.31 (1.08-1.60) for CVD, uncorrected p = 0.006 multiplicative model). Variant rs11673407 in the fucosyltransferase 3 gene was strongly associated with waist/hip ratio (uncorrected p = 0.00005) in joint analysis. In interaction analysis we found statistical evidence of variant-gender interaction conferring risk of CHD and CVD: rs3742264 in the carboxypeptidase B2 gene, p(interaction) = 0.009 for CHD, and rs2774279 in the upstream stimulatory factor 1 gene, p(interaction) = 0.007 for CHD and CVD, showed strong association in women but not in men, while rs2069840 in interleukin 6 gene, p(interaction) = 0.004 for CVD, showed strong association in men but not in women (uncorrected p-values). Also, two variants in the selenoprotein S gene conferred risk for ischemic stroke in women, p(interaction) = 0.003 and 0.007. Importantly, we identified a larger number of gender-specific effects for women than for men. Conclusions/Significance: A false discovery rate analysis suggests that we may expect half of the reported findings for combined gender analysis to be true positives, while at least third of the reported genotype-gender interaction results are true positives. The asymmetry in positive findings between the genders could imply that genetic risk loci for CVD are more readily detectable in women, while for men they are more confounded by environmental/lifestyle risk factors. The possible differences in genetic risk profiles between the genders should be addressed in more detail in genetic studies of CVD, and more focus on female CVD risk is also warranted in genome-wide association studies.	[Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Ripatti, Samuli; Auro, Kirsi; Ellonen, Pekka; Saarela, Janna; Perola, Markus; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; [Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Ripatti, Samuli; Auro, Kirsi; Ellonen, Pekka; Saarela, Janna; Perola, Markus; Peltonen, Leena] Inst Mol Med Finland, FIMM, Helsinki, Finland; [Saarela, Olli; Karvanen, Juha; Niemela, Matti; Vartiainen, Erkki; Jousilahti, Pekka; Kuulasmaa, Kari; Salomaa, Veikko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Ripatti, Samuli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kulathinal, Sangita] Indic Soc Ed & Dev, Nasik, India; [Evans, Alun] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [Perola, Markus; Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Peltonen, Leena] Harvard Univ, MIT, Broad Inst, Boston, MA USA	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Karolinska Institutet; Queens University Belfast; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Silander, K (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland.	kaisa.silander@ktl.fi	Ripatti, Samuli/H-9446-2014; Saarela, Janna S/E-5369-2014	Ripatti, Samuli/0000-0002-0504-1202; Karvanen, Juha/0000-0001-5530-769X; Kuulasmaa, Kari/0000-0003-2165-1411; Kristiansson, Kati/0000-0003-4688-107X; Saarela, Janna/0000-0002-0853-6219; Kinnunen, Mervi/0000-0002-2448-8763; Ellonen, Pekka/0000-0001-6072-0489	European Commission [QLG2-CT-2002-01254]; Nordic Centre of Excellence is Disease Genetics; Academy of Finland Centre of Excellence in Complex Disease Genetics; Biocentrum Helsinki; Sigrid Juselius Foundation; Jenny and Antti Wihuri Foundation; Aarne Koskelo Foundation; Finnish Foundation for Cardiovascular Research; Research Foundation of Orion Corporation; Paulo Foundation; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Nordic Centre of Excellence is Disease Genetics; Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jenny and Antti Wihuri Foundation; Aarne Koskelo Foundation; Finnish Foundation for Cardiovascular Research; Research Foundation of Orion Corporation; Paulo Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was part of the GenomEUtwin project www genomeutwin org, which was supported by the European Commission under the programme Quality of Life and Management of the Living Resources of 5th Framework Programme no (QLG2-CT-2002-01254). The Sigrid Juselius Foundation has supported Veikko Salomaa and Markus Perola. Jenny and Antti Wihuri Foundation, Aarne Koskelo Foundation, the Finnish Foundation for Cardiovascular Research, the Research Foundation of Orion Corporation, and the Paulo Foundation are acknowledged for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne M, 2007, HUM GENET, V122, P355, DOI 10.1007/s00439-007-0402-7; Auro K, 2006, ARTERIOSCL THROM VAS, V26, P942, DOI 10.1161/01.ATV.0000208365.45200.41; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cakir B, 2004, J INTERN MED, V255, P40, DOI 10.1046/j.1365-2796.2003.01263.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Endler G, 2001, BRIT J HAEMATOL, V115, P1007, DOI 10.1046/j.1365-2141.2001.03201.x; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Janis MT, 2004, J LIPID RES, V45, P2303, DOI 10.1194/jlr.M400250-JLR200; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Komulainen K, 2006, PLOS GENET, V2, P672, DOI 10.1371/journal.pgen.0020069; Kulathinal S, 2005, DESCRIPTION MORGAM C; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; LEE JC, 2007, ARTERIOSCLE IN PRESS; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McCarthy JJ, 2007, NUTR METAB CARDIOVAS, V17, P153, DOI 10.1016/j.numecd.2006.01.005; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; McCarthy JJ, 2003, HUM GENET, V114, P87, DOI 10.1007/s00439-003-1026-1; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Russo F, 1997, MATURITAS, V26, P193, DOI 10.1016/S0378-5122(96)01094-8; SAHI T, 1977, AM J CLIN NUTR, V30, P476, DOI 10.1093/ajcn/30.4.476; Salomaa V, 2000, J INTERN MED, V247, P689, DOI 10.1046/j.1365-2796.2000.00682.x; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHUNKERT H, 2008, CIRCULATION; Silander K, 2005, TWIN RES HUM GENET, V8, P368, DOI 10.1375/twin.8.4.368; Silander K, 2003, TWIN RES, V6, P391, DOI 10.1375/136905203770326394; SINNWELL J, 2007, HAPLO STATS PACKAGE; STRIMMER K, 2007, FDRTOOL PACKAGE VERS; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Tikka-Kleemola P, 2007, MOL CELL PROBE, V21, P216, DOI 10.1016/j.mcp.2006.12.003; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Touze E, 2007, LANCET NEUROL, V6, P125, DOI 10.1016/S1474-4422(06)70683-4; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Wang MM, 2006, SEMIN NEUROL, V26, P523, DOI 10.1055/s-2006-951625; *WHO, 2006, WORLD HLTH 2006; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yamada Y, 2006, THROMB HAEMOSTASIS, V96, P220, DOI 10.1160/TH06-02-0117; Yamada Y, 2006, ARTERIOSCL THROM VAS, V26, P1920, DOI 10.1161/01.ATV.0000229694.97827.38; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	65	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3615	10.1371/journal.pone.0003615	http://dx.doi.org/10.1371/journal.pone.0003615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974842	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131700029
J	Foerstner, KU; Doerks, T; Creevey, CJ; Doerks, A; Bork, P				Foerstner, Konrad U.; Doerks, Tobias; Creevey, Christopher J.; Doerks, Anja; Bork, Peer			A Computational Screen for Type I Polyketide Synthases in Metagenomics Shotgun Data	PLOS ONE			English	Article								Background: Polyketides are a diverse group of biotechnologically important secondary metabolites that are produced by multi domain enzymes called polyketide synthases (PKS). Methodology/Principal Findings: We have estimated frequencies of type I PKS (PKS I) - a PKS subgroup - in natural environments by using Hidden-Markov-Models of eight domains to screen predicted proteins from six metagenomic shotgun data sets. As the complex PKS I have similarities to other multi-domain enzymes (like those for the fatty acid biosynthesis) we increased the reliability and resolution of the dataset by maximum-likelihood trees. The combined information of these trees was then used to discriminate true PKS I domains from evolutionary related but functionally different ones. We were able to identify numerous novel PKS I proteins, the highest density of which was found in Minnesota farm soil with 136 proteins out of 183,536 predicted genes. We also applied the protocol to UniRef database to improve the annotation of proteins with so far unknown function and identified some new instances of horizontal gene transfer. Conclusions/Significance: The screening approach proved powerful in identifying PKS I sequences in large sequence data sets and is applicable to many other protein families.	[Foerstner, Konrad U.; Doerks, Tobias; Creevey, Christopher J.; Doerks, Anja; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Foerstner, KU (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	bork@embl.de	Creevey, Christopher James/A-1836-2013; Förstner, Konrad U./B-1531-2010; Bork, Peer/F-1813-2013	Creevey, Christopher James/0000-0001-7183-1555; Förstner, Konrad U./0000-0002-1481-2996; Bork, Peer/0000-0002-2627-833X	MetaHit [HEALTH-F4-2007-201052]	MetaHit	MetaHit (HEALTH-F4-2007-201052)	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Calestani C, 2003, DEVELOPMENT, V130, P4587, DOI 10.1242/dev.00647; Castoe TA, 2007, GENE, V392, P47, DOI 10.1016/j.gene.2006.11.005; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; John U, 2008, PROTIST, V159, P21, DOI 10.1016/j.protis.2007.08.001; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; Muller R, 2004, CHEM BIOL, V11, P4, DOI 10.1016/S1074-5521(04)00006-7; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Yadav G, 2003, NUCLEIC ACIDS RES, V31, P3654, DOI 10.1093/nar/gkg607; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9; Zucko J, 2007, BIOINFORMATICS, V23, P2543, DOI 10.1093/bioinformatics/btm381	43	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3515	10.1371/journal.pone.0003515	http://dx.doi.org/10.1371/journal.pone.0003515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953415	Green Published, gold			2022-12-25	WOS:000265130500001
J	Yang, JSJ; Bai, JM; Lee, TM				Yang, Jacob Shun-Jen; Bai, Jia-Min; Lee, Tzumin			Dynein-Dynactin Complex Is Essential for Dendritic Restriction of TM1-Containing Drosophila Dscam	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; KINESIN SUPERFAMILY MOTOR; CYTOPLASMIC DYNEIN; K+ CHANNEL; NEUROBLAST PROLIFERATION; MUSHROOM BODIES; SELF-AVOIDANCE; BETA-SUBUNIT; NEURONS; PROTEIN	Background: Many membrane proteins, including Drosophila Dscam, are enriched in dendrites or axons within neurons. However, little is known about how the differential distribution is established and maintained. Methodology/Principal Findings: Here we investigated the mechanisms underlying the dendritic targeting of Dscam[TM1]. Through forward genetic mosaic screens and by silencing specific genes via targeted RNAi, we found that several genes, encoding various components of the dynein-dynactin complex, are required for restricting Dscam[TM1] to the mushroom body dendrites. In contrast, compromising dynein/dynactin function did not affect dendritic targeting of two other dendritic markers, Nod and Rdl. Tracing newly synthesized Dscam[TM1] further revealed that compromising dynein/dynactin function did not affect the initial dendritic targeting of Dscam[TM1], but disrupted the maintenance of its restriction to dendrites. Conclusions/Significance: The results of this study suggest multiple mechanisms of dendritic protein targeting. Notably, dynein-dynactin plays a role in excluding dendritic Dscam, but not Rdl, from axons by retrograde transport.	[Yang, Jacob Shun-Jen; Lee, Tzumin] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Bai, Jia-Min] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Massachusetts System; University of Massachusetts Worcester; University of Illinois System; University of Illinois Urbana-Champaign	Yang, JSJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	Tzumin.Lee@umassmed.edu	Yang, Shun-Jen/G-2968-2015		March of Dimes Birth Defects Foundation; National Institutes of Health	March of Dimes Birth Defects Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The March of Dimes Birth Defects Foundation and the National Institutes of Health	Allen MJ, 1999, J NEUROSCI, V19, P9374; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Clark IE, 1997, DEVELOPMENT, V124, P461; Clark SW, 2005, MOL BIOL CELL, V16, P3999, DOI 10.1091/mbc.e05-02-0093; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Endoh T, 2004, BRAIN RES, V1024, P212, DOI 10.1016/j.brainres.2004.07.074; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2005, J NEUROSCI, V25, P4189, DOI 10.1523/JNEUROSCI.0149-05.2005	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3504	10.1371/journal.pone.0003504	http://dx.doi.org/10.1371/journal.pone.0003504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946501	Green Published, gold			2022-12-25	WOS:000265126200007
J	Kerrick, WGL; Kazmierczak, K; Xu, YY; Wang, YC; Szczesna-Cordary, D				Kerrick, W. Glenn L.; Kazmierczak, Katarzyna; Xu, Yuanyuan; Wang, Yingcai; Szczesna-Cordary, Danuta			Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice	FASEB JOURNAL			English	Article						phosphorylation; calcium and force transients; cross-bridge dissociation rate; energy cost; ATPase-pCa dependence	RABBIT PSOAS FIBERS; SKELETAL-MUSCLE; CROSS-BRIDGES; FORCE TRANSIENTS; CARDIAC-MUSCLE; E22K MUTATION; GENETIC-BASIS; CA2+ BINDING; TROPONIN-C; PHOSPHORYLATION	Transgenic (Tg) mice expressing similar to 95% of the D166V (aspartic acid to valine) mutation in the ventricular myosin regulatory light chain (RLC) shown to cause a malignant familial hypertrophic cardiomyopathy (FHC) phenotype were generated, and the skinned and intact papillary muscle fibers from the Tg-D166V mice were examined using a Guth muscle research system. A large increase in the Ca2+ sensitivity of force and ATPase (Delta pCa(50)>0.25) and a significant decrease in maximal force and ATPase were observed in skinned muscle fibers from Tg-D166V mice compared with control mice. The cross-bridge dissociation rate g was dramatically decreased, whereas the energy cost (ATPase/force) was slightly increased in Tg-D166V fibers compared with controls. The calculated average force per D166V cross-bridge was also reduced. Intact papillary muscle data demonstrated prolonged force transients with no change in calcium transients in Tg-D166V fibers compared with control fibers. Histopathological examination revealed fibrotic lesions in the hearts of the older D166V mice. Our results suggest that a charge effect of the D166V mutation and/or a mutation-dependent decrease in RLC phosphorylation could initiate the slower kinetics of the D166V cross-bridges and ultimately affect the regulation of cardiac muscle contraction. Profound cellular changes observed in Tg-D166V myocardium when placed in vivo could trigger a series of pathological responses and result in poor prognosis for D166V-positive patients.-Kerrick, W. G. L., Kazmierczak, K., Xu, Y., Wang, Y., Szczesna-Cordary, D. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice. FASEB J. 23, 855-865 (2009)	[Kazmierczak, Katarzyna; Wang, Yingcai; Szczesna-Cordary, Danuta] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol R189, Miami, FL 33101 USA; [Kerrick, W. Glenn L.; Xu, Yuanyuan] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA	University of Miami; University of Miami	Szczesna-Cordary, D (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol R189, POB 016189,1600 NW 10th Ave,Room 6113, Miami, FL 33101 USA.	dszczesna@med.miami.edu			NIH [HL071778]; American Heart Association [0555320B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge Dr. Neal Epstein at the National Heart, Lung, and Blood Institute, NIH, for the gift of + P-human RLC antibodies. We thank Georgianna Guzman and Zoraida Diaz-Perez for their excellent technical assistance. This work was supported by NIH grant HL071778 (D.S.-C.) and American Heart Association grant 0555320B (D.S.-C.).	Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Allen K, 2000, J APPL PHYSIOL, V88, P180, DOI 10.1152/jappl.2000.88.1.180; Baylor SM, 2000, NEWS PHYSIOL SCI, V15, P19; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Davis JS, 2002, COLD SPRING HARB SYM, V67, P345, DOI 10.1101/sqb.2002.67.345; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Doolittle RF, 2007, BIOCHEMISTRY-US, V46, P10033, DOI 10.1021/bi7010916; FERENCZI MA, 1984, J PHYSIOL-LONDON, V352, P575, DOI 10.1113/jphysiol.1984.sp015311; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Geeves Michael A, 2002, Results Probl Cell Differ, V36, P111; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; GUTH K, 1987, J BIOL CHEM, V262, P13627; GUTH K, 1986, PFLUG ARCH EUR J PHY, V407, P552, DOI 10.1007/BF00657515; HOFMANN PA, 1990, J GEN PHYSIOL, V95, P477, DOI 10.1085/jgp.95.3.477; Hougs L, 2005, EUR J HUM GENET, V13, P161, DOI 10.1038/sj.ejhg.5201310; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Huxley AF, 2000, J BIOMECH, V33, P1189, DOI 10.1016/S0021-9290(00)00060-9; Kabaeva ZT, 2002, EUR J HUM GENET, V10, P741, DOI 10.1038/sj.ejhg.5200872; KABAEVA ZT, 2002, THESIS HUMBOLDT U BE; Kerrick WGL, 2004, J MUSCLE RES CELL M, V25, P107, DOI 10.1023/B:JURE.0000035841.04314.16; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Mogensen J, 2001, J MED GENET, V38, P193, DOI 10.1136/jmg.38.3.193; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Omote H, 2004, BIOCHEMISTRY-US, V43, P3917, DOI 10.1021/bi035365l; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Prakash YS, 1999, J MUSCLE RES CELL M, V20, P717, DOI 10.1023/A:1005585807179; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson JM, 2002, J MOL BIOL, V322, P1065, DOI 10.1016/S0022-2836(02)00855-0; Sanbe A, 2000, CIRC RES, V87, P296, DOI 10.1161/01.RES.87.4.296; Seidman CE, 1998, BASIC RES CARDIOL, V93, P13; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna Danuta, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P187, DOI 10.2174/1568006033481474; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Szczesna-Cordary D, 2004, J BIOL CHEM, V279, P3535, DOI 10.1074/jbc.M307092200; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; Troughton RW, 2004, CIRCULATION, V109, pE325; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200	49	51	51	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					855	865		10.1096/fj.08-118182	http://dx.doi.org/10.1096/fj.08-118182			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18987303	Green Published			2022-12-25	WOS:000265506300021
J	Luker, KE; Gupta, M; Luker, GD				Luker, Kathryn E.; Gupta, Mudit; Luker, Gary D.			Imaging chemokine receptor dimerization with firefly luciferase complementation	FASEB JOURNAL			English	Article						bioluminescence; seven-transmembrane receptors	RESONANCE ENERGY-TRANSFER; PROTEIN-PROTEIN INTERACTIONS; BREAST-CANCER; T-LYMPHOCYTES; TUMOR-GROWTH; CXCR4; CELLS; HETERODIMERS; CXCL12/SDF-1; ANTAGONISTS	Seven-transmembrane (G-protein coupled) receptors are key regulators of normal physiology and a large number of diseases, and this family of receptors is the target for almost half of all drugs. Cell culture models suggest that homodimerization and heterodimerization of 7-transmembrane receptors regulate processes including specificity of ligand binding and activation of downstream signaling pathways, making receptor dimerization a critical determinant of receptor biology and a promising new therapeutic target. To monitor receptor dimerization in cell-based assays and living animals, we developed a protein fragment complementation assay based on firefly luciferase to investigate dimerization of chemokine receptors CXCR4 and CXCR7, two 7-transmembrane receptors with central functions in normal development, cancer, and other diseases. Treatment with chemokine ligands and pharmacologic agents produced time- and dose-dependent changes in reporter signal. Chemokines regulated reporter bioluminescence for CXCR4 or CXCR7 homodimers without affecting signals from receptor heterodimers. In a tumor xenograft model of breast cancer, we used bioluminescence imaging to measure changes in receptor homodimerization in response to pharmacologic agents. This technology should be valuable for analyzing function and therapeutic modulation of receptor dimerization in intact cells and living mice.-Luker, K. E., Gupta, M., Luker, G. D. Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J. 23, 823-834 (2009)	[Luker, Kathryn E.; Gupta, Mudit; Luker, Gary D.] Univ Michigan, Sch Med, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Sch Med, Ctr Mol Imaging, Dept Radiol, 109 Zina Pitcher Pl,A526 BSRB, Ann Arbor, MI 48109 USA.	gluker@umich.edu		luker, gary/0000-0001-6832-2581	Susan G. Komen Foundation [BCTR0503550]; U.S. National Institutes of Health (NIH) [P50CA093990, R24CA083099]; NATIONAL CANCER INSTITUTE [P50CA093990, R24CA083099] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant BCTR0503550 from the Susan G. Komen Foundation and U.S. National Institutes of Health (NIH) grants P50CA093990 and R24CA083099 for the University of Michigan Small Animal Imaging Resource. Experiments were performed and analyzed by all authors. K. E. L. and G. D. L. wrote the manuscript. The authors declare no conflicts of interest.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Ding ZQ, 2003, BLOOD, V101, P4245, DOI 10.1182/blood-2002-06-1782; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Gupta A, 2006, AAPS J, V8, pE153, DOI 10.1208/aapsj080118; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luker GD, 1997, BIOCHEMISTRY-US, V36, P14218, DOI 10.1021/bi971931z; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Luker KE, 2001, CANCER RES, V61, P6540; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Toth PT, 2004, J PHARMACOL EXP THER, V310, P8, DOI 10.1124/jpet.103.064956; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	35	94	99	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					823	834		10.1096/fj.08-116749	http://dx.doi.org/10.1096/fj.08-116749			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	19001056	Green Submitted, Green Published			2022-12-25	WOS:000265506300018
J	Balsera, M; Goetze, TA; Kovacs-Bogdan, E; Schurmann, P; Wagner, R; Buchanan, BB; Soll, J; Bolter, B				Balsera, Monica; Goetze, Tom A.; Kovacs-Bogdan, Erika; Schuermann, Peter; Wagner, Richard; Buchanan, Bob B.; Soll, Juergen; Boelter, Bettina			Characterization of Tic110, a Channel-forming Protein at the Inner Envelope Membrane of Chloroplasts, Unveils a Response to Ca2+ and a Stromal Regulatory Disulfide Bridge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; CIRCULAR-DICHROISM SPECTRA; IMPORT MACHINERY; CONDUCTING CHANNEL; CALCIUM REGULATION; TRANSLOCATION; COMPONENT; PRECURSOR; PLASTIDS; IDENTIFICATION	Tic110 has been proposed to be a channel-forming protein at the inner envelope of chloroplasts whose function is essential for the import of proteins synthesized in the cytosol. Sequence features and topology determination experiments presently summarized suggest that Tic110 consists of six transmembrane helices. Its topology has been mapped by limited proteolysis experiments in combination with mass spectrometric determinations and cysteine modification analysis. Two hydrophobic transmembrane helices located in the N terminus serve as a signal for the localization of the protein to the membrane as shown previously. The other amphipathic transmembrane helices are located in the region composed of residues 92-959 in the pea sequence. This results in two regions in the intermembrane space localized to form supercomplexes with the TOC machinery and to receive the transit peptide of preproteins. A large region also resides in the stroma for interaction with proteins such as molecular chaperones. In addition to characterizing the topology of Tic110, we show that Ca2+ has a dramatic effect on channel activity in vitro and that the protein has a redox-active disulfide with the potential to interact with stromal thioredoxin.	[Balsera, Monica; Kovacs-Bogdan, Erika; Soll, Juergen; Boelter, Bettina] Univ Munich, Munich Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Balsera, Monica; Kovacs-Bogdan, Erika; Buchanan, Bob B.; Soll, Juergen; Boelter, Bettina] Univ Munich, Dept Biol Bot 1, D-82152 Planegg Martinsried, Germany; [Goetze, Tom A.; Wagner, Richard] Univ Osnabruck, Dept Biophys, D-49076 Osnabruck, Germany; [Schuermann, Peter] Univ Neuchatel, Mol & Cellular Biol Lab, CH-2009 Neuchatel, Switzerland; [Buchanan, Bob B.] Univ Calif Berkeley, Dept Astrophys Planetary & Atmospher Sci, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Munich; University of Munich; University Osnabruck; University of Neuchatel; University of California System; University of California Berkeley	Balsera, M (corresponding author), Paul Scherrer Inst, Dept Biol Struct, CH-5232 Villigen, Switzerland.	monica.balsera@psi.ch	Balsera, Monica/K-2877-2014; Goetze, Tom/I-1891-2013	Balsera, Monica/0000-0002-5586-6050; 	Deutsche Forschungsgemeinschaft [SFB594]; Fundacion Ramon Areces; International Max-Planck Research School for Life Sciences; Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Ramon Areces; International Max-Planck Research School for Life Sciences; Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB594, Fundacion Ramon Areces ( to M. B.), International Max-Planck Research School for Life Sciences ( to E. K. B.), and Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa ( to E. K. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexandrov N N, 1996, Pac Symp Biocomput, P53; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BALSERA M, 2007, BMC EVOL BIOL, P7; BARTSCH S, 2008, NATL ACAD SCI US, V105, P4933; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chigri F, 2005, PLANT J, V42, P821, DOI 10.1111/j.1365-313X.2005.02414.x; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; DALMAS B, 1994, BIOCHEM MOL BIOL INT, V34, P17; DOMINGUEZSOLIS JR, 2008, NATL ACAD SCI US, V105, P16386; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eyre TA, 2004, PROTEIN ENG DES SEL, V17, P613, DOI 10.1093/protein/gzh072; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Goetze TA, 2006, J BIOL CHEM, V281, P17989, DOI 10.1074/jbc.M600700200; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hille B, 2001, ION CHANNELS EXCITAB, V3rd, P445; Hirohashi T, 2001, PLANT PHYSIOL, V125, P2154, DOI 10.1104/pp.125.4.2154; Horling F, 2002, PLANT PHYSIOL BIOCH, V40, P491, DOI 10.1016/S0981-9428(02)01396-7; Hormann F, 2004, J BIOL CHEM, V279, P34756, DOI 10.1074/jbc.M402817200; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; Lemker T, 2003, FEBS LETT, V544, P206, DOI 10.1016/S0014-5793(03)00496-4; Lubeck J, 1996, EMBO J, V15, P4230, DOI 10.1002/j.1460-2075.1996.tb00797.x; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stengel A, 2008, J BIOL CHEM, V283, P6656, DOI 10.1074/jbc.M706719200; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; Sveshnikova N, 2000, BIOL CHEM, V381, P687, DOI 10.1515/BC.2000.089; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vojta A, 2005, ANAL BIOCHEM, V347, P24, DOI 10.1016/j.ab.2005.09.003; Waegemann K, 1995, METHOD CELL BIOL, V50, P255, DOI 10.1016/S0091-679X(08)61035-3; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; WU CB, 1994, J BIOL CHEM, V269, P32264	59	79	84	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2603	2616		10.1074/jbc.M807134200	http://dx.doi.org/10.1074/jbc.M807134200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18986981	Green Submitted, hybrid			2022-12-25	WOS:000262700900003
J	Kim, I; Shu, CW; Xu, WJ; Shiau, CW; Grant, D; Vasile, S; Cosford, NDP; Reed, JC				Kim, InKi; Shu, Chih-Wen; Xu, Wenjie; Shiau, Chung-Wai; Grant, Daniel; Vasile, Stefan; Cosford, Nicholas D. P.; Reed, John C.			Chemical Biology Investigation of Cell Death Pathways Activated by Endoplasmic Reticulum Stress Reveals Cytoprotective Modulators of ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATING KINASE-1; PROTEIN-KINASE; ER STRESS; CANCER-CELLS; MAP KINASES; IN-VITRO; 18 KDA; APOPTOSIS; RECEPTOR; P38	The accumulation of unfolded proteins in the endoplasmic reticulum (ER) is caused by many disease-relevant conditions, inducing conserved signaling events collectively known as the unfolded protein response. When ER stress is excessive or prolonged, cell death (usually occurring by apoptosis) is triggered. We undertook a chemical biology approach for investigating mechanisms of ER stress-induced cell death. Using a cell-based high throughput screening assay to identify compounds that rescued a neuronal cell line from thapsigargin-induced cell death, we identified benzodiazepinones that selectively inhibit cell death caused by inducers of ER stress (thapsigargin and tunicamycin) but not by inducers of extrinsic (tumor necrosis factor) or intrinsic (mitochondrial) cell death pathways. The compounds displayed activity in several cell lines and primary cultured neurons. Mechanism of action studies revealed that these compounds inhibit ER stress-induced activation of p38 MAPK and kinases responsible for c-Jun phosphorylation. Active benzodiazepinones suppressed cell death at the level of apoptotic signal kinase-1 (ASK1) within the IRE1 pathway but without directly inhibiting the kinase activity of ASK1 or > 400 other kinases tested. Rather, active compounds enhanced phosphorylation of serine 967 of ASK1, promoting ASK1 binding to 14-3-3, an event associated with suppression of ASK1 function. Reducing ASK1 protein expression using small interfering RNA also protected cells from ER stress-induced apoptosis, confirming the importance of this protein kinase. Taken together, these findings demonstrate an essential role for ASK1 in cell death induced by ER stress. The compounds identified may prove useful for revealing endogenous mechanisms that regulate inhibitory phosphorylation of ASK1.	[Kim, InKi; Shu, Chih-Wen; Xu, Wenjie; Shiau, Chung-Wai; Grant, Daniel; Vasile, Stefan; Cosford, Nicholas D. P.; Reed, John C.] Burnham Inst Med Res, Burnham Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, Burnham Ctr Chem Genom, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Shu, Chih-Wen/AAE-9652-2019; Longo, Kenneth A/A-5631-2010; Xu, Wenjie/F-5453-2010	Cosford, Nic/0000-0001-7228-4709; Shu, Chih-Wen/0000-0002-7774-0002	National Institutes of Health [HG003916, DA024887, AG15393]; Department of Defense [W81XWH-07-1-0569]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HG003916, DA024887, and AG15393. This work was also supported by Department of Defense Grant W81XWH-07-1-0569. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzini M, 2003, J MED CHEM, V46, P3853, DOI 10.1021/jm0307640; Blatt NB, 2002, J CLIN INVEST, V110, P1123, DOI 10.1172/JCI200216029; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chelli B, 2008, J CELL BIOCHEM, V105, P712, DOI 10.1002/jcb.21865; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Cheng MF, 2004, J COMB CHEM, V6, P99, DOI 10.1021/cc030034d; Churcher I, 2003, J MED CHEM, V46, P2275, DOI 10.1021/jm034058a; Decaudin D, 2002, CANCER RES, V62, P1388; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Haas SJP, 2002, J ANAT, V201, P61, DOI 10.1046/j.1469-7580.2002.00072.x; HUANG SC, 1989, AM J PHYSIOL, V257, pG169, DOI 10.1152/ajpgi.1989.257.1.G169; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mills C, 2008, EUR J NEUROSCI, V27, P937, DOI 10.1111/j.1460-9568.2008.06065.x; Nelson FC, 2002, BIOORG MED CHEM LETT, V12, P2867, DOI 10.1016/S0960-894X(02)00633-9; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sundberg TB, 2006, CANCER RES, V66, P1775, DOI 10.1158/0008-5472.CAN-05-3476; TALLMAN JF, 1985, ANNU REV NEUROSCI, V8, P21, DOI 10.1146/annurev.ne.08.030185.000321; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TSUKAMOTO A, 1993, CELL BIOL INT, V17, P969, DOI 10.1006/cbir.1993.1021; Valladares A, 2000, ENDOCRINOLOGY, V141, P4383, DOI 10.1210/en.141.12.4383; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	54	105	121	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1593	1603		10.1074/jbc.M807308200	http://dx.doi.org/10.1074/jbc.M807308200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004820	hybrid, Green Published			2022-12-25	WOS:000262330100027
J	Ramakrishnan, NA; Drescher, MJ; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.			Direct Interaction of Otoferlin with Syntaxin 1A, SNAP-25, and the L-type Voltage-gated Calcium Channel Ca(V)1.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SURFACE-PLASMON RESONANCE; SYNAPTIC VESICLE; HAIR-CELLS; C2 DOMAIN; ENCODING OTOFERLIN; RECESSIVE DEAFNESS; MISSENSE MUTATION; RIBBON SYNAPSE; CA2+ CHANNELS	The molecular mechanisms underlying synaptic exocytosis in the hair cell, the auditory and vestibular receptor cell, are not well understood. Otoferlin, a C2 domain-containing Ca2+-binding protein, has been implicated as having a role in vesicular release. Mutations in the OTOF gene cause nonsyndromic deafness in humans, and OTOF knock-out mice are deaf. In the present study, we generated otoferlin fusion proteins containing two of the same amino acid substitutions detected in DFNB9 patients (P1825A in C2F and L1011P in C2D). The native otoferlin C2F domain bound syntaxin 1A and SNAP-25 in a Ca2+-dependent manner (with optimal 61 mu M free Ca2+ required for binding). These interactions were greatly diminished for C2F with the P1825A mutation, possibly because of a reduction in tertiary structural change, induced by Ca2+, for the mutated C2F compared with the native C2F. The otoferlin C2D domain also bound syntaxin 1A, but with weaker affinity (K-d = 1.7 x 10(-5) M) than for the C2F interaction (K-d = 2.6 x 10(-9) M). In contrast, it was the otoferlin C2D domain that bound the Ca(v)1.3 II-III loop, in a Ca2+- dependent manner. The L1011P mutation in C2D rendered this binding insensitive to Ca2+ and considerably diminished. Overall, we demonstrated that otoferlin interacts with two main target-SNARE proteins of the hair-cell synaptic complex, syntaxin 1A and SNAP-25, as well as the calcium channel, with the otoferlin C2F and C2D domains of central importance for binding. Because mutations in the otoferlin C2 domains that cause deafness in humans impair the ability of otoferlin to bind syntaxin, SNAP-25, and the Ca(v)1.3 calcium channel, it is these interactions that may mediate regulation by otoferlin of hair cell synaptic exocytosis critical to inner ear hair cell function.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Drescher, DG (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, 259 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	ddresche@med.wayne.edu			National Institutes of Health [DC000156, DC004076]; American Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000156, R01DC004076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC000156 and DC004076. This work was also supported by a grant from the American Hearing Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kee Y, 1996, J NEUROSCI, V16, P1975; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; MARKEY F, 1999, BIA J, V1, P5; Migliosi V, 2002, J MED GENET, V39, P502, DOI 10.1136/jmg.39.7.502; Mirghomizadeh F, 2002, NEUROBIOL DIS, V10, P157, DOI 10.1006/nbdi.2002.0488; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Schuck P, 1996, BIOPHYS J, V70, P1230, DOI 10.1016/S0006-3495(96)79681-9; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; Simons JWFA, 2002, ARCH BIOCHEM BIOPHYS, V406, P143, DOI 10.1016/S0003-9861(02)00429-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tekin M, 2005, AM J MED GENET A, V138A, P6, DOI 10.1002/ajmg.a.30907; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	36	84	87	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1364	1372		10.1074/jbc.M803605200	http://dx.doi.org/10.1074/jbc.M803605200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004828	Green Published, hybrid			2022-12-25	WOS:000262330100004
J	Berntzen, G; Andersen, JT; Ustgard, K; Michaelsen, TE; Mousavi, SA; Qian, JD; Kristiansen, PE; Lauvrak, V; Sandlie, I				Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Michaelsen, Terje E.; Mousavi, Seyed Ali; Qian, Julie Dee; Kristiansen, Per Eugen; Lauvrak, Vigdis; Sandlie, Inger			Identification of a High Affinity Fc gamma RIIA-binding Peptide That Distinguishes Fc gamma RIIA from Fc gamma RIIB and Exploits Fc gamma RIIA-mediated Phagocytosis and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; CRYSTAL-STRUCTURE; IGG FC; RECEPTOR-BINDING; IMMUNOGLOBULIN-G; DENDRITIC CELLS; PHAGE DISPLAY; POLYMORPHISMS; ANTIBODIES; RECOGNITION	Fc gamma RIIA is a key activating receptor linking immune complex formation with cellular effector functions. Fc gamma RIIA has 93% identity with an inhibitory receptor, Fc gamma RIIB, which negatively regulates Fc gamma RIIA. Fc gamma RIIA is important in the therapeutic action of several monoclonal antibodies. Binding molecules that discriminate Fc gamma RIIA from Fc gamma RIIB may optimize receptor activity and serve as a lead for development of therapeutics with Fc gamma RIIA as a key target. Here we report the use of phage display libraries to select short peptides with distinct Fc gamma RIIA binding properties. An 11-mer peptide (WAWVWLTETAV) was characterized that bound Fc gamma RIIA with a K-d of 500 nM. It mediated cell internalization and degradation of a model antigen. The peptide-binding site on Fc gamma RIIA was shown to involve Phe(163) and the IgG binding amino acids Trp(90) and Trp(113). It is thus overlapping but not identical to that of IgG. Neither activating receptors Fc gamma RI and Fc gamma RIII, nor Fc gamma RIIB, all of which lack Phe(163), bound the peptide.	[Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Mousavi, Seyed Ali; Qian, Julie Dee; Kristiansen, Per Eugen; Lauvrak, Vigdis; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Qian, Julie Dee; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Norwegian Inst Publ Hlth, N-0316 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Inst Pharm, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Berntzen, G (corresponding author), Univ Oslo, Dept Mol Biosci, POB 1041, N-0316 Oslo, Norway.	goril.berntzen@imbv.uio.no; inger.sandlie@imbv.uio.no	Kristiansen, Per Eugen/L-5798-2019; Andersen, Jan Terje/AAB-6209-2020	Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway, the Norwegian Cancer Society; Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo	Research Council of Norway, the Norwegian Cancer Society(Norwegian Cancer SocietyResearch Council of Norway); Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo	The work was supported by the Research Council of Norway, the Norwegian Cancer Society, and the Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albertsson PA, 2003, TRENDS IMMUNOL, V24, P603, DOI 10.1016/j.it.2003.09.007; Armour KL, 2003, MOL IMMUNOL, V40, P585, DOI 10.1016/j.molimm.2003.08.004; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Berntzen G, 2006, PROTEIN ENG DES SEL, V19, P121, DOI 10.1093/protein/gzj011; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cendron AC, 2008, MOL IMMUNOL, V45, P307, DOI 10.1016/j.molimm.2007.06.152; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Gebhardt K, 1996, PEPTIDE RES, V9, P269; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kaplan W, 1997, PROTEIN SCI, V6, P399; Lauvrak V, 2004, SCAND J IMMUNOL, V59, P373, DOI 10.1111/j.1365-3083.2004.01400.x; Liu Y, 2006, J IMMUNOL, V177, P8440, DOI 10.4049/jimmunol.177.12.8440; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Medgyesi W, 2004, EUR J IMMUNOL, V34, P1127, DOI 10.1002/eji.200324733; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Michaelsen TE, 2003, INFECT IMMUN, V71, P5714, DOI 10.1128/IAI.71.10.5714-5723.2003; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Platonov AE, 1998, CLIN INFECT DIS, V27, P746, DOI 10.1086/514935; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; RAINE ARC, 1995, PROTEIN SCI, V4, P2625, DOI 10.1002/pro.5560041222; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Sheridan JA, 1999, J PEPT SCI, V5, P555, DOI 10.1002/(SICI)1099-1387(199912)5:12<555::AID-PSC220>3.0.CO;2-G; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Stockmeyer B, 1997, CANCER RES, V57, P696; Sulica A, 2001, Int Rev Immunol, V20, P371, DOI 10.3109/08830180109054414; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Uray K, 2004, J MOL RECOGNIT, V17, P95, DOI 10.1002/jmr.652; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yuan FF, 2003, IMMUNOL CELL BIOL, V81, P192, DOI 10.1046/j.1440-1711.2003.01158.x; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8	47	5	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1126	1135		10.1074/jbc.M803584200	http://dx.doi.org/10.1074/jbc.M803584200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957413	Green Published, hybrid			2022-12-25	WOS:000262122900049
J	Isenberg, JS; Annis, DS; Pendrak, ML; Ptaszynska, M; Frazier, WA; Mosher, DF; Roberts, DD				Isenberg, Jeff S.; Annis, Douglas S.; Pendrak, Michael L.; Ptaszynska, Malgorzata; Frazier, William A.; Mosher, Deane F.; Roberts, David D.			Differential Interactions of Thrombospondin-1,-2, and-4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; C-TERMINAL DOMAIN; GROWTH-FACTOR-I; NITRIC-OXIDE; TISSUE SURVIVAL; SIGNATURE DOMAINS; CELL RESPONSES; LIGAND-BINDING; RECEPTOR; IDENTIFICATION	Thrombospondin-1 regulates nitric oxide (NO) signaling in vascular cells via CD47. Because CD47 binding motifs are conserved in the C-terminal signature domains of all five thrombospondins and indirect evidence has implied CD47 interactions with other family members, we compared activities of recombinant signature domains of thrombospondin-1, -2, and -4 to interact with CD47 and modulate cGMP signaling. Signature domains of thrombospondin-2 and -4 were less active than that of thrombospondin-1 for inhibiting binding of radiolabeled signature domain of thrombospondin-1 or SIRP alpha (signal-regulatory protein) to cells expressing CD47. Consistent with this binding selectivity, the signature domain of thrombospondin-1 was more potent than those of thrombospondin-2 or -4 for inhibiting NO-stimulated cGMP synthesis in vascular smooth muscle cells and downstream effects on cell adhesion. In contrast to thrombospondin-1-and CD47-null cells, primary vascular cells from thrombospondin-2-null mice lack enhanced basal and NO-stimulated cGMP signaling. Effects of endogenous thrombospondin-2 on NO/cGMP signaling could be detected only in thrombospondin-1-null cells. Furthermore, tissue survival of ischemic injury and acute recovery of blood flow in thrombospondin-2-nulls resembles that of wild type mice. Therefore, thrombospondin-1 is the dominant regulator of NO/cGMP signaling via CD47, and its limiting role in acute ischemic injury responses is not shared by thrombospondin-2.	[Isenberg, Jeff S.; Pendrak, Michael L.; Ptaszynska, Malgorzata; Roberts, David D.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Roberts, DD (corresponding author), NCI, Pathol Lab, NIH, Bldg 10,Rm 2A33,10 Ctr Dr MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981	National Institutes of Health [HL54462, HL54390]; Intramural Research Program of the NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIASC009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054390, R56HL054390, R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants National HL54462 (to D. F. M.) and HL54390 (to W. A. F.) and by the Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research (to D. D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chandrasekaran S, 1999, J BIOL CHEM, V274, P11408, DOI 10.1074/jbc.274.16.11408; Congote LF, 2004, FEBS LETT, V576, P343, DOI 10.1016/j.febslet.2004.09.035; Cui JX, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.002; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, ANN SURG, V247, P180, DOI 10.1097/SLA.0b013e31815685dc; Isenberg JS, 2007, ARTERIOSCL THROM VAS, V27, P2582, DOI 10.1161/ATVBAHA.107.155390; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Ticchioni M, 2001, FASEB J, V15, P341, DOI 10.1096/fj.99-0833com; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Wessel J, 2004, AM HEART J, V147, P905, DOI 10.1016/j.ahj.2003.12.013; Yamaguchi S, 2007, INT J MOL MED, V19, P631	48	98	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1116	1125		10.1074/jbc.M804860200	http://dx.doi.org/10.1074/jbc.M804860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004835	Green Published, hybrid			2022-12-25	WOS:000262122900048
J	Marmol, P; Pardo, B; Wiederkehr, A; del Arco, A; Wollheim, CB; Satrustegui, J				Marmol, Patricia; Pardo, Beatriz; Wiederkehr, Andreas; del Arco, Araceli; Wollheim, Claes B.; Satrustegui, Jorgina			Requirement for Aralar and Its Ca2+-binding Sites in Ca2+ Signal Transduction in Mitochondria from INS-1 Clonal beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; MEMBRANE-POTENTIAL CHANGES; ASPARTATE NADH SHUTTLE; INTRACELLULAR CA2+; CYTOSOLIC CA2+; PANCREATIC-ISLETS; GLUCAGON-RELEASE; METABOLIC-FATE; GLUCOSE; CALCIUM	Aralar, the mitochondrial aspartate-glutamate carrier present in beta-cells, is a component of the malate-aspartate NADH shuttle (MAS). MAS is activated by Ca2+ in mitochondria from tissues with aralar as the only AGC isoform with an S-0.5 of similar to 300 nM. We have studied the role of aralar and its Ca2+-binding EF-hand motifs in glucose-induced mitochondrial NAD(P)H generation by two-photon microscopy imaging in INS-1 beta-cells lacking aralar or expressing aralar mutants blocked for Ca2+ binding. Aralar knock-down in INS-1 beta-cell lines resulted in undetectable levels of aralar protein and complete loss of MAS activity in isolated mitochondria and in a 25% decrease in glucose-stimulated insulin secretion. MAS activity in mitochondria from INS-1 cells was activated 2-3-fold by extramitochondrial Ca2+, whereas aralar mutants were Ca2+ insensitive. In Ca2+-free medium, glucose-induced increases in mitochondrial NAD(P) H were small (1.3-fold) and unchanged regardless of the lack of aralar. In the presence of 1.5 mM Ca2+, glucose induced robust increases in mitochondrial NAD(P) H (similar to 2-fold) in cell lines with wild-type or mutant aralar. There was a similar to 20% reduction in NAD(P) H response in cells lacking aralar, illustrating the importance of MAS in glucose action. When small Ca2+ signals that resulted in extremely small mitochondrial Ca2+ transients were induced in the presence of glucose, the rise in mitochondrial NAD(P) H was maintained in cells with wild-type aralar but was reduced by similar to 50% in cells lacking or expressing mutant aralar. These results indicate that 1) glucose-induced activation of MAS requires Ca2+ potentiation; 2) Ca2+ activation of MAS represents a larger fraction of glucose-induced mitochondrial NAD(P) H production under conditions where suboptimal Ca2+ signals are associated with a glucose challenge (50 versus 20%, respectively); 3) inactivation of EF-hand motifs in aralar prevents activation of MAS by small Ca2+ signals. The results suggest a possible role for aralar and MAS in priming the beta-cell by Ca2+-mobilizing neurotransmitter or hormones.	[Marmol, Patricia; Pardo, Beatriz; del Arco, Araceli; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Dept Biol Mol, E-28049 Madrid, Spain; [Marmol, Patricia; Pardo, Beatriz; del Arco, Araceli; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Fac Ciencias Medio Ambiente, Area Bioquim, CRIB, Toledo 48071, Spain; [Wiederkehr, Andreas; Wollheim, Claes B.] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Castilla-La Mancha; University of Geneva	Satrustegui, J (corresponding author), Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Dept Biol Mol, E-28049 Madrid, Spain.	jsatrustegui@cbm.uam.es	del Arco, Araceli/R-5653-2019; Satrustegui, Jorgina/R-6732-2019; Pardo, Beatriz/C-3234-2016	Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X	Ministerio de Educacion y Ciencia [BFU2005-C02-01, GEN2003-20235-C05-03/NAC]; Comunidad de Madrid [S-GEN-0269-2006 MITOLAB-CM]; European Union [LSHM-CT-2006-518153]	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported in part by Ministerio de Educacion y Ciencia Grants BFU2005-C02-01 and GEN2003-20235-C05-03/NAC, Comunidad de Madrid Grant S-GEN-0269-2006 MITOLAB-CM ( to J.S.), and European Union Grant LSHM-CT-2006-518153 ( to J.S. and C. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Recipient of a Formacion de Personal Investigador fellowship from the Comunidad de Madrid.; 2 Supported by Swiss National Foundation Grant 310000-116750/1.	Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; GARCIA MC, 1988, BIOCHEM J, V254, P211, DOI 10.1042/bj2540211; GILON P, 1992, J BIOL CHEM, V267, P20713; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HELLMAN B, 1974, BIOCHEM J, V138, P33, DOI 10.1042/bj1380033; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; LI GD, 1991, J BIOL CHEM, V266, P3449; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; MARTINEZ A, 1988, NEUROSCI LETT, V88, P336, DOI 10.1016/0304-3940(88)90234-0; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Ruiz F, 1998, NEUROREPORT, V9, P1277; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1990, BIOCHIM BIOPHYS ACTA, V1019, P42, DOI 10.1016/0005-2728(90)90122-K; THELER JM, 1992, J BIOL CHEM, V267, P18110; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057	45	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					515	524		10.1074/jbc.M806729200	http://dx.doi.org/10.1074/jbc.M806729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996845	Green Published, hybrid			2022-12-25	WOS:000261974800056
J	Sanders, MA; Ampasala, D; Basson, MD				Sanders, Matthew A.; Ampasala, Dinakar; Basson, Marc D.			DOCK5 and DOCK1 Regulate Caco-2 Intestinal Epithelial Cell Spreading and Migration on Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE ACTIVITY; TERMINAL SH3 DOMAIN; CRYPT-VILLUS AXIS; IN-VITRO MODEL; MYOBLAST FUSION; ERK ACTIVATION; RAC-GEF; CRK; PROTEINS; EXPRESSION	We observed previously that combined small interfering RNAs (siRNAs) targeting CrkII and CrkL, known activators of guanine nucleotide exchange factor DOCK1, strongly inhibit Caco-2 intestinal epithelial cell spreading and migration on collagen IV. DOCK1 siRNA reduced its expression > 95% in Caco-2 cells but inhibited spreading much less than combined CrkII/CrkL siRNAs, suggesting that CrkII/CrkL interact with additional DOCK proteins. siRNA targeting DOCK5, a closely related DOCK1 family member, inhibited Caco-2 spreading similarly to DOCK1 siRNA, and the combined siRNAs synergistically inhibited spreading. Similar results were observed in human umbilical vein endothelial cells, and reverse transcriptase PCR demonstrated DOCK5 siRNA reduction of DOCK5 expression in both cell types. Combined DOCK1/DOCK5 siRNAs also inhibited Caco-2 migration and lamellipodial extension. Expression of DOCK5 cDNA, with silent mutations in the siRNA target region allowing expression simultaneously with DOCK5 siRNA, required CrkII/CrkL to restore cell spreading and DOCK5 coimmunoprecipitated with CrkII and CrkL. DOCK5 association with CrkII and CrkL was greatly reduced by mutations in their NH2-terminal SH3 domains. Expression of the DOCK5 COOH-terminal region (Met(1738) - Gln(1870)), containing potential Src homology 3 domain-binding proline-rich sites but lacking other functional regions, inhibited Caco-2 spreading and coimmunoprecipitated with CrkL. Coimmunoprecipitation of full-length DOCK5 with CrkL was strongly reduced by deletion of DOCK5 COOH-terminal amino acids 1832-1870. Green fluorescent protein-tagged DOCK5 localized to the membrane of Caco-2 cells spreading on collagen IV. In these studies, we describe human DOCK5 cloning and expression, our results indicating that, along with DOCK1, DOCK5 is an important mediator of CrkII/CrkL regulation of Caco-2 spreading and migration on collagen	[Sanders, Matthew A.; Ampasala, Dinakar] John D Dingell Vet Affairs Med Ctr, Res Serv, Detroit, MI 48201 USA; [Basson, Marc D.] John D Dingell Vet Affairs Med Ctr, Surg Serv, Detroit, MI 48201 USA; [Sanders, Matthew A.; Ampasala, Dinakar; Basson, Marc D.] Wayne State Univ, Dept Surg, Detroit, MI 48201 USA	Wayne State University	Sanders, MA (corresponding author), John D Dingell Vet Affairs Med Ctr, Res Serv, 4646 John R St, Detroit, MI 48201 USA.	matt.sanders2@gmail.com			National Institutes of Health [RO1DK067257]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK067257. This work was also supported by a Veterans Affairs Merit Award (to M. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; FELLER SM, 1995, ONCOGENE, V10, P1465; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; MADRI JA, 1988, AM J PATHOL, V132, P18; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Omi N, 2008, EXP EYE RES, V86, P828, DOI 10.1016/j.exer.2008.02.011; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1993, J CELL SCI, V105, P445; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sanders MA, 2000, J BIOL CHEM, V275, P38040, DOI 10.1074/jbc.M003871200; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Sanders MA, 2004, AM J PHYSIOL-GASTR L, V286, pG547, DOI 10.1152/ajpgi.00262.2003; Sattler M, 1996, ONCOGENE, V12, P839; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; VACHON PH, 1995, AM J PHYSIOL-GASTR L, V268, pG857, DOI 10.1152/ajpgi.1995.268.5.G857; Wolpert S, 1996, AM J SURG, V171, P109, DOI 10.1016/S0002-9610(99)80083-X; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yu CF, 2000, AM J PHYSIOL-GASTR L, V278, pG952, DOI 10.1152/ajpgi.2000.278.6.G952	47	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					27	35		10.1074/jbc.M808010200	http://dx.doi.org/10.1074/jbc.M808010200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004829	Green Published, hybrid			2022-12-25	WOS:000261974800004
J	Blodgett, DM; Graybill, C; Carruthers, A				Blodgett, David M.; Graybill, Christopher; Carruthers, Anthony			Analysis of Glucose Transporter Topology and Structural Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; OLIGOMERIC STRUCTURE; HEXOSE TRANSPORTER; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; SUGAR-TRANSPORT; CYTOCHALASIN-B	Homology modeling and scanning cysteine mutagenesis studies suggest that the human glucose transport protein GLUT1 and its distant bacterial homologs LacY and GlpT share similar structures. We tested this hypothesis by mapping the accessibility of purified, reconstituted human erythrocyte GLUT1 to aqueous probes. GLUT1 contains 35 potential tryptic cleavage sites. Fourteen of 16 lysine residues and 18 of 19 arginine residues were accessible to trypsin. GLUT1 lysine residues were modified by isothiocyanates and N-hydroxysuccinimide (NHS) esters in a substrate-dependent manner. Twelve lysine residues were accessible to sulfo-NHS-LC-biotin. GLUT1 trypsinization released full-length transmembrane helix 1, cytoplasmic loop 6-7, and the long cytoplasmic C terminus from membranes. Trypsin-digested GLUT1 retained cytochalasin B and D-glucose binding capacity and released full-length transmembrane helix 8 upon cytochalasin B (but not D-glucose) binding. Transmembrane helix 8 release did not abrogate cytochalasin B binding. GLUT1 was extensively proteolyzed by alpha-chymotrypsin, which cuts putative pore-forming amphipathic alpha-helices 1, 2, 4, 7, 8, 10, and 11 at multiple sites to release transmembrane peptide fragments into the aqueous solvent. Putative scaffolding membrane helices 3, 6, 9, and 12 are strongly hydrophobic, resistant to alpha-chymotrypsin, and retained by the membrane bilayer. These observations provide experimental support for the proposed GLUT1 architecture; indicate that the proposed topology of membrane helices 5, 6, and 12 requires adjustment; and suggest that the metastable conformations of transmembrane helices 1 and 8 within the GLUT1 scaffold destabilize a sugar translocation intermediate.	[Blodgett, David M.; Graybill, Christopher; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 364 Plantat St, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK44888, DK36081]; American Diabetes Association [1-06-IN-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036081, R56DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44888 and DK36081. This work was also supported by American Diabetes Association Grant 1-06-IN-04 ( Gail Patrick Innovation Award supported by a generous gift from the Estate of Gail Patrick). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe Y, 2004, J BIOCHEM, V136, P97, DOI 10.1093/jb/mvh100; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; APPLEMAN JR, 1989, BIOCHEMISTRY-US, V28, P8221, DOI 10.1021/bi00446a038; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2005, BIOCHEMISTRY-US, V44, P2650, DOI 10.1021/bi048247m; CAIRNS MT, 1987, BIOCHIM BIOPHYS ACTA, V905, P295, DOI 10.1016/0005-2736(87)90458-5; CODERRE PE, 1995, BIOCHEMISTRY-US, V34, P9762, DOI 10.1021/bi00030a014; Dahl SG, 2004, J PHARMACOL EXP THER, V309, P853, DOI 10.1124/jpet.103.059972; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Guo XL, 2005, BIOCHEM GENET, V43, P175, DOI 10.1007/s10528-005-1510-5; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; KARIM AR, 1987, BIOCHIM BIOPHYS ACTA, V902, P402, DOI 10.1016/0005-2736(87)90208-2; Kasho VN, 2006, J MOL BIOL, V358, P1060, DOI 10.1016/j.jmb.2006.02.049; Krokhin OV, 2004, MOL CELL PROTEOMICS, V3, P908, DOI 10.1074/mcp.M400031-MCP200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Sultzman LA, 1999, BIOCHEMISTRY-US, V38, P6640, DOI 10.1021/bi990130o; Weinglass A, 2004, J BIOL CHEM, V279, P41858, DOI 10.1074/jbc.M407555200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	42	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36416	36424		10.1074/jbc.M804802200	http://dx.doi.org/10.1074/jbc.M804802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981181	Green Published, hybrid			2022-12-25	WOS:000261840500039
J	Vaysberg, M; Hatton, O; Lambert, SL; Snow, AL; Wong, B; Krams, SM; Martinez, OM				Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Wong, Bonnie; Krams, Sheri M.; Martinez, Olivia M.			Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN EPITHELIAL-CELLS; LYMPHOCYTE GROWTH TRANSFORMATION; TERMINAL KINASE PATHWAY; EARLY GENE-PRODUCTS; NASOPHARYNGEAL CARCINOMA; FUNCTIONAL DIFFERENCES; ENCODED LMP1; BINDING-SITE; MEMBRANE-PROTEIN-1	Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is a proven oncogene that is essential for transformation of human B cells by the virus. LMP1 induces constitutive activation of several signal transduction pathways involving nuclear factor kappa B, phosphatidylinositol 3-kinase/Akt, and the mitogenactivated protein kinases (MAPK) p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (Erk). Sequencing of LMP1 isolated from a panel of EBV+ B cell lymphomas identified three different variants of LMP1, each distinct from the B95.8 prototype isoform. All tumor variants of LMP1 as well as the B95.8 LMP1 isoform were able to induce rapid p38 phosphorylation as well as Akt and JNK activation. Additionally all variants showed similar ability to activate nuclear factor kappa B. In contrast, only tumor-derived LMP1 variants induced prolonged Erk activation and c-Fos expression. Sequence analysis revealed only two amino acids, 212 and 366, shared by the tumor variants but distinct from B95.8. Point mutation of either amino acids 212 (glycine to serine) or 366 (serine to threonine) from the B95.8 isoform to the tumor variant version of LMP1 was sufficient for gain of function characterized by sustained activation of Erk and subsequent c-Fos induction and binding to the AP1 site. Our results indicate that the enhanced ability of tumorderived LMP1 to induce and stabilize the c-Fos oncogene can be localized to two amino acids in the C terminus of LMP1.	[Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Wong, Bonnie; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Div Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University	Martinez, OM (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	omm@stanford.edu	Wong, Bonnie/T-7110-2019	, Olivia/0000-0002-2798-0251; Snow, Andrew/0000-0002-8728-6691; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health [RO1AI41789, RO1 CA105157]; Mason Case Fellowship; American Cancer Society Fellowship; NATIONAL CANCER INSTITUTE [R01CA105157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mason Case Fellowship; American Cancer Society Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI41789 (to O.M.M.) and RO1 CA105157 (to O.M.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by the Mason Case Fellowship. Supported by an American Cancer Society Fellowship.	Beatty PR, 1997, J IMMUNOL, V158, P4045; Brodeur SR, 1997, J BIOL CHEM, V272, P19777, DOI 10.1074/jbc.272.32.19777; Chen RH, 1996, ONCOGENE, V12, P1493; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; CURRAN T, 1984, CELL, V36, P259; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Guiretti DM, 2007, J MED VIROL, V79, P1722, DOI 10.1002/jmv.21020; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; HU LF, 1993, ONCOGENE, V8, P1575; HUEN DS, 1995, ONCOGENE, V10, P549; Izumi KM, 1999, MOL CELL BIOL, V19, P5759; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Johnson RJ, 1998, J VIROL, V72, P4038, DOI 10.1128/JVI.72.5.4038-4048.1998; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Mehl AM, 2001, J BIOL CHEM, V276, P984, DOI 10.1074/jbc.M003758200; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nepomuceno RR, 2002, TRANSPLANTATION, V74, P396, DOI 10.1097/00007890-200208150-00017; Nicholson LJ, 1997, ONCOGENE, V15, P275, DOI 10.1038/sj.onc.1201187; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Sandberg M, 1997, J VIROL, V71, P4649, DOI 10.1128/JVI.71.6.4649-4656.1997; Sandvej K, 1997, BLOOD, V90, P323; SKARE J, 1982, J VIROL, V44, P1088, DOI 10.1128/JVI.44.3.1088-1091.1982; Song X, 2004, CELL SIGNAL, V16, P1153, DOI 10.1016/j.cellsig.2004.03.014; Tang WG, 2003, J BIOL CHEM, V278, P48942, DOI 10.1074/jbc.M307962200; Vockerodt M, 2001, GENES IMMUN, V2, P433, DOI 10.1038/sj.gene.6363803; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9	49	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36573	36585		10.1074/jbc.M802968200	http://dx.doi.org/10.1074/jbc.M802968200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18986987	hybrid, Green Published			2022-12-25	WOS:000261840500055
J	Kirby, K; Jensen, LT; Binnington, J; Hilliker, AJ; Ulloa, J; Culotta, VC; Phillips, JP				Kirby, Kim; Jensen, Laran T.; Binnington, Janet; Hilliker, Arthur J.; Ulloa, Janella; Culotta, Valeria C.; Phillips, John P.			Instability of Superoxide Dismutase 1 of Drosophila in Mutants Deficient for Its Cognate Copper Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; SOD1; METAL; CCS; CLUSTER; CU; MELANOGASTER; MECHANISMS; PROTECTION; CONTRIBUTE	Copper, zinc superoxide dismutase (SOD1) in mammals is activated principally via a copper chaperone (CCS) and to a lesser degree by a CCS-independent pathway of unknown nature. In this study, we have characterized the requirement for CCS in activating SOD1 from Drosophila. A CCS-null mutant (Ccs(n29E)) of Drosophila was created and found to phenotypically resemble Drosophila SOD1-null mutants in terms of reduced adult life span, hypersensitivity to oxidative stress, and loss of cytosolic aconitase activity. However, the phenotypes of CCS-null flies were less severe, consistent with some CCS-independent activation of Drosophila SOD1 (dSOD1). Yet SOD1 activity was not detectable in Ccsn29E flies, due largely to a striking loss of SOD1 protein. In contrast, human SOD1 expressed in CCS-null flies is robustly active and rescues the deficits in adult life span and sensitivity to oxidative stress. The dependence of dSOD1 on CCS was also observed in a yeast expression system where the dSOD1 polypeptide exhibited unusual instability in CCS-null (ccs1 Delta) yeast. The residual dSOD1 polypeptide in ccs1 Delta yeast was nevertheless active, consistent with CCS-independent activation. Stability of dSOD1 in ccs1 Delta cells was readily restored by expression of either yeast or Drosophila CCS, and this required copper insertion into the enzyme. The yeast expression system also revealed some species specificity for CCS. Yeast SOD1 exhibits preference for yeast CCS over Drosophila CCS, whereas dSOD1 is fully activated with either CCS molecule. Such variation in mechanisms of copper activation of SOD1 could reflect evolutionary responses to unique oxygen and/or copper environments faced by divergent species.	[Kirby, Kim; Binnington, Janet; Phillips, John P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jensen, Laran T.; Ulloa, Janella; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Hilliker, Arthur J.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Guelph; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; York University - Canada	Phillips, JP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jphillip@uoguelph.ca		Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [GM50016]; NIEHS; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016, R37GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM50016 ( to V. C. C.) and NIEHS ( Johns Hopkins University). This work was also supported by Natural Sciences and Engineering Research Council of Canada ( to J. P. P.) and the Canadian Institutes of Health Research ( to J. P. P. and A. J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BOYNTON S, 1992, GENETICS, V131, P655; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; HU J, 2004, THESIS U GUELPH GUEL; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; LIU XF, 1992, J BIOL CHEM, V267, P18298; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Parkes TL, 1998, GENOME, V41, P642; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sherman F., 1978, METHODS YEAST GENETI; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Stasser JP, 2007, BIOCHEMISTRY-US, V46, P11845, DOI 10.1021/bi700566h; Stasser JP, 2005, BIOCHEMISTRY-US, V44, P3143, DOI 10.1021/bi0478392; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Woodruff RC, 2004, GENOME, V47, P1029, DOI 10.1139/G04-083; Zhu HN, 2000, BIOCHEMISTRY-US, V39, P5413, DOI 10.1021/bi992727+	37	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35393	35401		10.1074/jbc.M807131200	http://dx.doi.org/10.1074/jbc.M807131200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948262	hybrid, Green Published			2022-12-25	WOS:000261687900010
J	Wertheimer, EV; Salicioni, AM; Liu, WM; Trevino, CL; Chavez, J; Hernandez-Gonzalez, EO; Darszon, A; Visconti, PE				Wertheimer, Eva V.; Salicioni, Ana M.; Liu, Weimin; Trevino, Claudia L.; Chavez, Julio; Hernandez-Gonzalez, Enrique O.; Darszon, Alberto; Visconti, Pablo E.			Chloride Is Essential for Capacitation and for the Capacitation-associated Increase in Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM CAPACITATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; INDUCED ACROSOMAL EXOCYTOSIS; CAMP-DEPENDENT PATHWAY; K-CL COTRANSPORTER; ADENYLYL-CYCLASE; ZONA-PELLUCIDA; NA+-K+-2CL(-) COTRANSPORTER; FERTILIZING-CAPACITY; SPERMATOGENIC CELLS	After epididymal maturation, sperm capacitation, which encompasses a complex series of molecular events, endows the sperm with the ability to fertilize an egg. This process can be mimicked in vitro in defined media, the composition of which is based on the electrolyte concentration of the oviductal fluid. It is well established that capacitation requires Na+, HCO3-, Ca-2(+), and a cholesterol acceptor; however, little is known about the function of Cl- during this important process. To determine whether Cl-, in addition to maintaining osmolarity, actively participates in signaling pathways that regulate capacitation, Cl- was replaced by either methanesulfonate or gluconate two nonpermeable anions. The absence of Cl- did not affect sperm viability, but capacitation-associated processes such as the increase in tyrosine phosphorylation, the increase in cAMP levels, hyperactivation, the zona pellucidae-induced acrosome reaction, and most importantly, fertilization were abolished or significantly reduced. Interestingly, the addition of cyclic AMP agonists to sperm incubated in Cl--free medium rescued the increase in tyrosine phosphorylation and hyperactivation suggesting that Cl- acts upstream of the cAMP/protein kinase A signaling pathway. To investigate Cl- transport, sperm incubated in complete capacitation medium were exposed to a battery of anion transport inhibitors. Among them, bumetanide and furosemide, two blockers of Na+/K+/Cl- cotransporters (NKCC), inhibited all capacitation-associated events, suggesting that these transporters may mediate Cl- movements in sperm. Consistent with these results, Western blots using anti-NKCC1 antibodies showed the presence of this cotransporter in mature sperm.	[Wertheimer, Eva V.; Salicioni, Ana M.; Liu, Weimin; Visconti, Pablo E.] Univ Massachusetts, Paige Labs 208, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Trevino, Claudia L.; Chavez, Julio; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Genet Desarrollo & Fisiiol Mol, Cuernavaca 62250, Morelos, Mexico; [Hernandez-Gonzalez, Enrique O.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico	University of Massachusetts System; University of Massachusetts Amherst; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Visconti, PE (corresponding author), Univ Massachusetts, Paige Labs 208, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021; Hernández-González, Enrique/AAU-8526-2020	Salicioni, Ana Maria/0000-0002-8951-3587; Darszon, Alberto/0000-0002-2502-0505; Chavez, Julio/0000-0002-7375-9531; Trevino, Claudia L/0000-0002-7281-0534	National Institutes of Health [HD38082, HD44044]; Eunice Kennedy Shriver NICHD; Fogarty International Research Collaboration [RO3 TW006121]; Consejo Nacional de Ciencia y Tecnologia [CONACyT 49113]; Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [DGAPA IN225406, IN227806-3]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD044044] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW006121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Research Collaboration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P E V.) from the Eunice Kennedy Shriver NICHD. This work was also supported by Fogarty International Research Collaboration Award Grant RO3 TW006121 (to P.E.V. and A.D.) and by funds from the Consejo Nacional de Ciencia y Tecnologia (CONACyT 49113 to A.D.), the Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico (DGAPA IN225406 to A. D. and IN227806-3 to C.T.), and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKABAS MH, 2001, ENCY LIFE SCI, P1; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; de Tassigny AD, 2003, FUND CLIN PHARMACOL, V17, P539, DOI 10.1046/j.1472-8206.2003.00197.x; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Garg P, 2007, AM J PHYSIOL-HEART C, V292, pH2100, DOI 10.1152/ajpheart.01402.2006; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hasannejad H, 2004, J PHARMACOL EXP THER, V308, P1021, DOI 10.1124/jpet.103.059139; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ianowski JP, 2004, J EXP BIOL, V207, P3707, DOI 10.1242/jeb.01203; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; KALAB P, 1994, J BIOL CHEM, V269, P3810; Kalab P, 1998, MOL REPROD DEV, V51, P304, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;304::AID-MRD10&gt;3.0.CO;2-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leclerc P, 1998, J ANDROL, V19, P434; Lopez-Gonzalez I, 2001, DEV BIOL, V236, P210, DOI 10.1006/dbio.2001.0314; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; McAvey BA, 2002, BIOL REPROD, V67, P1342, DOI 10.1095/biolreprod67.4.1342; Meizel S, 2004, BIOL REV, V79, P713, DOI 10.1017/S1464793103006407; MELENDREZ CS, 1995, BIOL REPROD, V53, P676, DOI 10.1095/biolreprod53.3.676; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; NEILL JM, 1987, GAMETE RES, V18, P121, DOI 10.1002/mrd.1120180204; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Proks P, 2001, BRIT J PHARMACOL, V132, P973, DOI 10.1038/sj.bjp.0703916; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SHI QX, 1995, BIOL REPROD, V52, P373, DOI 10.1095/biolreprod52.2.373; Simard CF, 2004, J BIOL CHEM, V279, P48449, DOI 10.1074/jbc.M407012200; Sokal R. R., 2012, BIOMETRY; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Tutuncu L, 2004, DEV BIOL, V270, P246, DOI 10.1016/j.ydbio.2004.02.008; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Visconti PE, 1996, MOL REPROD DEV, V43, P82; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1992, J BIOL CHEM, V267, P14061; WEBERSCHURHOLZ S, 1993, J BIOL CHEM, V268, P547; WHITE MM, 1990, MOL PHARMACOL, V37, P720; Wuttke M S, 2001, JOP, V2, P154; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Yanagimachi R., 1994, P189; YOSHIMATSU N, 1988, DEV GROWTH DIFFER, V30, P651	60	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35539	35550		10.1074/jbc.M804586200	http://dx.doi.org/10.1074/jbc.M804586200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957426	Green Published, hybrid			2022-12-25	WOS:000261687900026
J	Lucas, M; Guedon, Y; Jay-Allemand, C; Godin, C; Laplaze, L				Lucas, Mikael; Guedon, Yann; Jay-Allemand, Christian; Godin, Christophe; Laplaze, Laurent			An Auxin Transport-Based Model of Root Branching in Arabidopsis thaliana	PLOS ONE			English	Article							INITIATION; GRAVITROPISM; SHOOT; PHYLLOTAXIS; PERICYCLE; PATHWAYS; APEX	Root architecture is a crucial part of plant adaptation to soil heterogeneity and is mainly controlled by root branching. The process of root system development can be divided into two successive steps: lateral root initiation and lateral root development/emergence which are controlled by different fluxes of the plant hormone auxin. While shoot architecture appears to be highly regular, following rules such as the phyllotactic spiral, root architecture appears more chaotic. We used stochastic modeling to extract hidden rules regulating root branching in Arabidopsis thaliana. These rules were used to build an integrative mechanistic model of root ramification based on auxin. This model was experimentally tested using plants with modified rhythm of lateral root initiation or mutants perturbed in auxin transport. Our analysis revealed that lateral root initiation and lateral root development/emergence are interacting with each other to create a global balance between the respective ratio of initiation and emergence. A mechanistic model based on auxin fluxes successfully predicted this property and the phenotype alteration of auxin transport mutants or plants with modified rythms of lateral root initiation. This suggests that root branching is controlled by mechanisms of lateral inhibition due to a competition between initiation and development/ emergence for auxin.	[Lucas, Mikael; Laplaze, Laurent] Equipe Rhizogenese, INRA IRD Montpellier SupAgro UM2, DIAPC, UMR,IRD, Montpellier, France; [Lucas, Mikael; Guedon, Yann; Godin, Christophe] CIRAD INRIA INRA Montpellier SupAgro UM2, UMR DAP, INRIA, Montpellier, France; [Lucas, Mikael; Jay-Allemand, Christian] Univ Montpellier 2, UMR DIAPC, INRA IRD Montpellier SupAgro UM2, Equipe Rhizogenese, F-34095 Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; INRAE; Inria; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lucas, M (corresponding author), Equipe Rhizogenese, INRA IRD Montpellier SupAgro UM2, DIAPC, UMR,IRD, Montpellier, France.	laurent.laplaze@ird.fr	Han, Liqi/K-6127-2013; Laplaze, Laurent/I-5435-2016; Godin, Christophe/C-1218-2008; LUCAS, Mikaël/A-5925-2015	Laplaze, Laurent/0000-0002-6568-6504; Godin, Christophe/0000-0002-1202-8460; LUCAS, Mikael/0000-0001-6286-7759	IRD; INRIA; CIRAD; French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie	IRD; INRIA; CIRAD; French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie	This work was supported by IRD, INRIA (Virtual Plants project) and CIRAD. M.L. is the recipient of a PhD grant from the French Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Csiszar I, 2006, IEEE T INFORM THEORY, V52, P1007, DOI 10.1109/TIT.2005.864431; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; De Smet I, 2006, PLANT MOL BIOL, V60, P871, DOI 10.1007/s11103-005-4547-2; DOUADY S, 1992, PHYS REV LETT, V68, P2098, DOI 10.1103/PhysRevLett.68.2098; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P903, DOI 10.1093/aob/mcj604; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Godin C, 1999, AGRONOMIE, V19, P163, DOI 10.1051/agro:19990301; Guedon Y, 2005, COMPUT STAT DATA AN, V49, P663, DOI 10.1016/j.csda.2004.05.033; Guedon Y, 2003, J COMPUT GRAPH STAT, V12, P604, DOI 10.1198/1061860032030; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; HOFMEIESTER W, 1868, HDB PHYSL BOT, V2; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; PRADAL C, 2008, FUNCT PLANT IN PRESS; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; SNOW M, 1962, PHILOS T ROY SOC B, V244, P483, DOI 10.1098/rstb.1962.0003; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493	33	67	69	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2008	3	11							e3673	10.1371/journal.pone.0003673	http://dx.doi.org/10.1371/journal.pone.0003673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436XD	18989371	Green Submitted, gold, Green Published			2022-12-25	WOS:000265448500001
J	Tito, RY; Macmil, S; Wiley, G; Najar, F; Cleeland, L; Qu, CM; Wang, P; Romagne, F; Leonard, S; Ruiz, AJ; Reinhard, K; Roe, BA; Lewis, CM				Tito, Raul Y.; Macmil, Simone; Wiley, Graham; Najar, Fares; Cleeland, Lauren; Qu, Chunmei; Wang, Ping; Romagne, Frederic; Leonard, Sylvain; Jimenez Ruiz, Agustin; Reinhard, Karl; Roe, Bruce A.; Lewis, Cecil M., Jr.			Phylotyping and Functional Analysis of Two Ancient Human Microbiomes	PLOS ONE			English	Article								Background: The Human Microbiome Project (HMP) is one of the U. S. National Institutes of Health Roadmap for Medical Research. Primary interests of the HMP include the distinctiveness of different gut microbiomes, the factors influencing microbiome diversity, and the functional redundancies of the members of human microbiotas. In this present work, we contribute to these interests by characterizing two extinct human microbiotas. Methodology/Principal Findings: We examine two paleofecal samples originating from cave deposits in Durango Mexico and dating to approximately 1300 years ago. Contamination control is a serious issue in ancient DNA research; we use a novel approach to control contamination. After we determined that each sample originated from a different human, we generated 45 thousand shotgun DNA sequencing reads. The phylotyping and functional analysis of these reads reveals a signature consistent with the modern gut ecology. Interestingly, inter-individual variability for phenotypes but not functional pathways was observed. The two ancient samples have more similar functional profiles to each other than to a recently published profile for modern humans. This similarity could not be explained by a chance sampling of the databases. Conclusions/Significance: We conduct a phylotyping and functional analysis of ancient human microbiomes, while providing novel methods to control for DNA contamination and novel hypotheses about past microbiome biogeography. We postulate that natural selection has more of an influence on microbiome functional profiles than it does on the species represented in the microbial ecology. We propose that human microbiomes were more geographically structured during pre-Columbian times than today.	[Tito, Raul Y.; Cleeland, Lauren; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Tito, Raul Y.; Cleeland, Lauren; Romagne, Frederic; Leonard, Sylvain; Lewis, Cecil M., Jr.] Univ Oklahoma, Mol Anthropol Lab, Norman, OK 73019 USA; [Macmil, Simone; Wiley, Graham; Najar, Fares; Qu, Chunmei; Wang, Ping; Roe, Bruce A.] Univ Oklahoma, Advanced Ctr Genome Technol, Dept Chem & Biochem, Norman, OK 73019 USA; [Romagne, Frederic; Leonard, Sylvain] Univ Auvergne, Inst Technol, Clermont Ferrand, France; [Jimenez Ruiz, Agustin] Univ Nebraska, State Museum, Lincoln, NE 68583 USA; [Reinhard, Karl] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68583 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Universite Clermont Auvergne (UCA); Universite de Montpellier; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tito, RY (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.	cmlewis@ou.edu	Jimenez, Francisco Agustin/I-6010-2013; Wang, Pingshan/N-3808-2019; Tito, Raul/CAG-3546-2022; Reinhard, Karl/AAT-7881-2020	Jimenez, Francisco Agustin/0000-0002-1047-8185; Wang, Pingshan/0000-0002-1988-7604; Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Cree, Simone/0000-0002-7349-422X	University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry	University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry	We acknowledge that funding for this research was obtained from the University of Oklahoma Graduate College and the Departments of Anthropology and Chemistry/Biochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNPUB; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BROOKS RH, 1962, AM ANTIQUITY, V27, P356, DOI 10.2307/277801; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARSHALL BJ, 1984, LANCET, V1, P1311; Mell LK, 2005, PEDIATRICS, V116, P56, DOI 10.1542/peds.2004-2058; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rizzo R, 2006, J CHILD NEUROL, V21, P747, DOI 10.1177/08830738060210091001; Sidhu H, 2001, J UROLOGY, V166, P1487, DOI 10.1016/S0022-5347(05)65817-X; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TEAM RDC, 2007, R LANGUAGE ENV STAT; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; WILEY G, CURRENT PRO IN PRESS; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	39	64	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3703	10.1371/journal.pone.0003703	http://dx.doi.org/10.1371/journal.pone.0003703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002248	gold, Green Published			2022-12-25	WOS:000265165600008
J	Auger, CJ; Forbes-Lorman, RM				Auger, Catherine J.; Forbes-Lorman, Robin M.			Progestin Receptor-Mediated Reduction of Anxiety-Like Behavior in Male Rats	PLOS ONE			English	Article							FEMALE GUINEA-PIGS; ELEVATED PLUS-MAZE; MEDROXYPROGESTERONE ACETATE; SEXUAL-BEHAVIOR; ESTROUS-CYCLE; NEUROACTIVE STEROIDS; ANXIOLYTIC ACTIVITY; OVARIAN HORMONES; BED NUCLEUS; BRAIN	Background: It is well known progesterone can have anxiolytic-like effects in animals in a number of different behavioral testing paradigms. Although progesterone is known to influence physiology and behavior by binding to classical intracellular progestin receptors, progesterone's anxiety reducing effects have solely been attributed to its rapid non-genomic effects at the GABA(A) receptor. This modulation occurs following the bioconversion of progesterone to allopregnanolone. Seemingly paradoxical results from some studies suggested that the function of progesterone to reduce anxiety-like behavior may not be entirely clear; therefore, we hypothesized that progesterone might also act upon progestin receptors to regulate anxiety. Methodology/Principal Findings: To test this, we examined the anxiolytic-like effects of progesterone in male rats using the elevated plus maze, a validated test of anxiety, and the light/dark chamber in the presence or absence of a progestin receptor antagonist, RU 486. Here we present evidence suggesting that the anxiolytic-like effects of progesterone in male rats can be mediated, in part, by progestin receptors, as these effects are blocked by prior treatment with a progestin receptor antagonist. Conclusion/Significance: This indicates that progesterone can act upon progestin receptors to regulate anxiety-like behavior in the male rat brain.	[Auger, Catherine J.; Forbes-Lorman, Robin M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Auger, CJ (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	cauger@wisc.edu	Forbes-Lorman, Robin/R-4355-2019	Forbes-Lorman, Robin/0000-0003-3935-6541	Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison	Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison	This research was funded by start-up funds from the Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the Psychology Department at The University of Wisconsin-Madison for its continued support.	Andersen ML, 2004, BRAZ J MED BIOL RES, V37, P791, DOI 10.1590/S0100-879X2004000600003; Auger CJ, 2006, BRAIN RES, V1067, P58, DOI 10.1016/j.brainres.2005.10.033; Auger CJ, 2006, J NEUROENDOCRINOL, V18, P187, DOI 10.1111/j.1365-2826.2005.01400.x; Auger CJ, 2002, J NEUROENDOCRINOL, V14, P561, DOI 10.1046/j.1365-2826.2002.00809.x; BARBIERI RL, 1980, ACTA ENDOCRINOL-COP, V94, P419, DOI 10.1530/acta.0.0940419; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; BLAUSTEIN JD, 1977, J COMP PHYSIOL PSYCH, V91, P752, DOI 10.1037/h0077365; BLAUSTEIN JD, 1978, BRAIN RES, V140, P360, DOI 10.1016/0006-8993(78)90469-9; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BROWN TJ, 1986, BRAIN RES, V373, P103, DOI 10.1016/0006-8993(86)90320-3; BROWN TJ, 1984, BRAIN RES, V301, P343, DOI 10.1016/0006-8993(84)91103-X; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; DEBOLD JF, 1994, HORM BEHAV, V28, P445, DOI 10.1006/hbeh.1994.1042; DEBOLD JF, 1994, PSYCHONEUROENDOCRINO, V19, P563, DOI 10.1016/0306-4530(94)90041-8; DEVRIES GJ, 1985, J COMP NEUROL, V233, P236, DOI 10.1002/cne.902330206; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Dubrovsky B, 2006, PHARMACOL BIOCHEM BE, V84, P644, DOI 10.1016/j.pbb.2006.06.016; Frye CA, 2006, PSYCHOPHARMACOLOGY, V186, P312, DOI 10.1007/s00213-006-0309-3; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Frye CA, 2004, BRAIN RES, V1004, P116, DOI 10.1016/j.brainres.2004.01.020; FRYE CA, 1994, LIFE SCI, V54, P653, DOI 10.1016/0024-3205(94)00548-6; Gomez C, 2002, PHARMACOL BIOCHEM BE, V72, P543, DOI 10.1016/S0091-3057(02)00722-0; GORDON GG, 1970, J CLIN ENDOCR METAB, V30, P449, DOI 10.1210/jcem-30-4-449; KALRA PS, 1977, ENDOCRINOLOGY, V101, P1821, DOI 10.1210/endo-101-6-1821; Kellogg CK, 1999, PHARMACOL BIOCHEM BE, V63, P441, DOI 10.1016/S0091-3057(99)00041-6; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Mani SK, 1997, HORM BEHAV, V31, P244, DOI 10.1006/hbeh.1997.1393; MCCARTHY MM, 1991, NEUROENDOCRINOLOGY, V53, P473, DOI 10.1159/000125760; MCCARTHY MM, 1995, HORM BEHAV, V29, P279, DOI 10.1006/hbeh.1995.1020; MCEWEN BS, 1990, CIBA F SYMP, V153, P3; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Mora S, 1996, PSYCHONEUROENDOCRINO, V21, P609, DOI 10.1016/S0306-4530(96)00015-7; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PICAZO O, 1995, BRAIN RES, V680, P135, DOI 10.1016/0006-8993(95)00254-N; PLEIM ET, 1990, HORM BEHAV, V24, P139, DOI 10.1016/0018-506X(90)90001-E; POWERS JB, 1972, PHYSIOL BEHAV, V8, P673, DOI 10.1016/0031-9384(72)90093-5; POWERS JB, 1970, PHYSIOL BEHAV, V5, P831, DOI 10.1016/0031-9384(70)90167-8; RAINBOW TC, 1982, NATURE, V300, P648, DOI 10.1038/300648a0; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; RODRIGUEZSIERRA JF, 1984, PSYCHONEUROENDOCRINO, V9, P293, DOI 10.1016/0306-4530(84)90008-8; Rupprecht R, 1999, STEROIDS, V64, P83, DOI 10.1016/S0039-128X(98)00101-9; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; SAR M, 1973, SCIENCE, V182, P1266, DOI 10.1126/science.182.4118.1266; SATYASWAROOP PG, 1978, ENDOCRINOLOGY, V102, P1761, DOI 10.1210/endo-102-6-1761; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Toufexis DJ, 2004, J NEUROSCI, V24, P10280, DOI 10.1523/JNEUROSCI.1386-04.2004; TSAI MJ, 1994, ANNU REV BIOCHEM, P63451; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; ZUMPE D, 1988, PHYSIOL BEHAV, V42, P343, DOI 10.1016/0031-9384(88)90275-2	58	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3606	10.1371/journal.pone.0003606	http://dx.doi.org/10.1371/journal.pone.0003606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18958180	gold, Green Submitted, Green Published			2022-12-25	WOS:000265134400003
J	Nelson, BS; Takahashi, TT				Nelson, Brian S.; Takahashi, Terry T.			Independence of Echo-Threshold and Echo-Delay in the Barn Owl	PLOS ONE			English	Article							PAIRED SOUND SOURCES; INFERIOR COLLICULUS; AUDITORY SPACE; SIMULATED ECHOES; PRECEDENCE; LOCALIZATION; RESPONSES; DISCRIMINATION; INHIBITION; NEURONS	Despite their prevalence in nature, echoes are not perceived as events separate from the sounds arriving directly from an active source, until the echo's delay is long. We measured the head-saccades of barn owls and the responses of neurons in their auditory space-maps while presenting a long duration noise-burst and a simulated echo. Under this paradigm, there were two possible stimulus segments that could potentially signal the location of the echo. One was at the onset of the echo; the other, after the offset of the direct (leading) sound, when only the echo was present. By lengthening the echo's duration, independently of its delay, spikes and saccades were evoked by the source of the echo even at delays that normally evoked saccades to only the direct source. An echo's location thus appears to be signaled by the neural response evoked after the offset of the direct sound.	[Nelson, Brian S.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nelson, BS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	bsnelson@uoregon.edu			National Institutes of Deafness and Communication Disorders [DC008267, DC003925]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008267, R01DC003925] Funding Source: NIH RePORTER	National Institutes of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Deafness and Communication Disorders: (F32) DC008267 to B.S.N and (RO1) DC003925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBECK Y, 1995, J NEUROPHYSIOL, V74, P1689, DOI 10.1152/jn.1995.74.4.1689; AOKI S, 1992, HEARING RES, V59, P25, DOI 10.1016/0378-5955(92)90098-8; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Blauert J., 1997, SPATIAL HEARING PSYC; Braasch J., 2003, Acoustical Science and Technology, V24, P233, DOI 10.1250/ast.24.233; Burger RM, 2001, J NEUROSCI, V21, P4830, DOI 10.1523/JNEUROSCI.21-13-04830.2001; CRANFORD JL, 1982, J ACOUST SOC AM, V72, P1309, DOI 10.1121/1.388409; Dent ML, 2005, ACTA ACUST UNITED AC, V91, P463; Dent ML, 2004, J COMP PSYCHOL, V118, P325, DOI 10.1037/0735-7036.118.3.325; Dizon RM, 2006, J ACOUST SOC AM, V119, P2947, DOI 10.1121/1.2189451; Dye RH, 2006, J ACOUST SOC AM, V120, P3946, DOI 10.1121/1.2372588; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; Fitzpatrick DC, 1995, J NEUROPHYSIOL, V74, P2469, DOI 10.1152/jn.1995.74.6.2469; HAAS H, 1951, ACUSTICA, V1, P49; Hartung K, 2001, J ACOUST SOC AM, V110, P1505, DOI 10.1121/1.1390339; Keller CH, 1996, J COMP PHYSIOL A, V178, P499; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KELLY JB, 1974, J ACOUST SOC AM, V55, P1277, DOI 10.1121/1.1914697; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; LINDEMANN W, 1986, J ACOUST SOC AM, V80, P1608, DOI 10.1121/1.394325; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1285, DOI 10.1152/jn.1998.80.3.1285; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1302, DOI 10.1152/jn.1998.80.3.1302; Litovsky RY, 2002, J NEUROPHYSIOL, V87, P976, DOI 10.1152/jn.00568.2001; Litovsky RY, 2001, J ACOUST SOC AM, V109, P346, DOI 10.1121/1.1328792; Litovsky RY, 1997, J ACOUST SOC AM, V102, P1739, DOI 10.1121/1.420106; NELSON BS, 2008, ASS RES OTOLARYNGOL, V295, P295; Pecka M, 2007, J NEUROSCI, V27, P1782, DOI 10.1523/JNEUROSCI.5335-06.2007; PERROTT DR, 1974, J ACOUST SOC AM, V55, P1290, DOI 10.1121/1.1914699; PERROTT DR, 1989, J ACOUST SOC AM, V85, P2669, DOI 10.1121/1.397764; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Spitzer MW, 2006, J NEUROPHYSIOL, V95, P3571, DOI 10.1152/jn.00982.2005; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; Spitzer MW, 2003, J ACOUST SOC AM, V113, P1631, DOI 10.1121/1.1548152; Tollin DJ, 2004, J NEUROPHYSIOL, V92, P3286, DOI 10.1152/jn.00606.2004; Tollin DJ, 2003, J NEUROPHYSIOL, V90, P2149, DOI 10.1152/jn.00381.2003; TOLLIN DJ, 2004, AUDITORY SIGNAL PROC; Trahiotis C, 2002, HEARING RES, V168, P55, DOI 10.1016/S0378-5955(02)00357-X; WAGNER H, 1993, J NEUROSCI, V13, P371; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Whitchurch EA, 2006, J NEUROPHYSIOL, V96, P730, DOI 10.1152/jn.00072.2006; WYTTENBACH RA, 1993, J ACOUST SOC AM, V94, P777, DOI 10.1121/1.408207; YIN TCT, 1994, J NEUROSCI, V14, P5170; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3598	10.1371/journal.pone.0003598	http://dx.doi.org/10.1371/journal.pone.0003598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974886	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131700019
J	Andersson, ER; Prakash, N; Cajanek, L; Minina, E; Bryja, V; Bryjova, L; Yamaguchi, TP; Hall, AC; Wurst, W; Arenas, E				Andersson, Emma R.; Prakash, Nilima; Cajanek, Lukas; Minina, Eleonora; Bryja, Vitezslav; Bryjova, Lenka; Yamaguchi, Terry P.; Hall, Anita C.; Wurst, Wolfgang; Arenas, Ernest			Wnt5a Regulates Ventral Midbrain Morphogenesis and the Development of A9-A10 Dopaminergic Cells In Vivo	PLOS ONE			English	Article								Wnt5a is a morphogen that activates the Wnt/planar cell polarity (PCP) pathway and serves multiple functions during development. PCP signaling controls the orientation of cells within an epithelial plane as well as convergent extension (CE) movements. Wnt5a was previously reported to promote differentiation of A9-10 dopaminergic (DA) precursors in vitro. However, the signaling mechanism in DA cells and the function of Wnt5a during midbrain development in vivo remains unclear. We hereby report that Wnt5a activated the GTPase Rac1 in DA cells and that Rac1 inhibitors blocked the Wnt5a-induced DA neuron differentiation of ventral midbrain (VM) precursor cultures, linking Wnt5a-induced differentiation with a known effector of Wnt/PCP signaling. In vivo, Wnt5a was expressed throughout the VM at embryonic day (E) 9.5, and was restricted to the VM floor and basal plate by E11.5-E13.5. Analysis of Wnt5a-/- mice revealed a transient increase in progenitor proliferation at E11.5, and a precociously induced NR4A2+ (Nurr1) precursor pool at E12.5. The excess NR4A2+ precursors remained undifferentiated until E14.5, when a transient 25% increase in DA neurons was detected. Wnt5a-/- mice also displayed a defect in (mid) brain morphogenesis, including an impairment in midbrain elongation and a rounded ventricular cavity. Interestingly, these alterations affected mostly cells in the DA lineage. The ventral Sonic hedgehog-expressing domain was broadened and flattened, a typical CE phenotype, and the domains occupied by Ngn2+ DA progenitors, NR4A2+ DA precursors and TH+ DA neurons were rostrocaudally reduced and laterally expanded. In summary, we hereby describe a Wnt5a regulation of Wnt/PCP signaling in the DA lineage and provide evidence for multiple functions of Wnt5a in the VM in vivo, including the regulation of VM morphogenesis, DA progenitor cell division, and differentiation of NR4A2+ DA precursors.	[Andersson, Emma R.; Cajanek, Lukas; Bryja, Vitezslav; Bryjova, Lenka; Wurst, Wolfgang; Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Prakash, Nilima; Minina, Eleonora] Tech Univ Munich, Inst Dev Genet, German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Munich, Germany; [Bryja, Vitezslav; Bryjova, Lenka] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Bryja, Vitezslav; Bryjova, Lenka] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic; [Yamaguchi, Terry P.] Natl Canc Inst Frederick, Canc & Dev Biol Lab, Frederick, MD USA; [Hall, Anita C.] Imperial Coll London, Div Cell & Mol Biol, London, England; [Wurst, Wolfgang] Max Planck Inst Psychiat, Munich, Germany	Karolinska Institutet; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Max Planck Society	Andersson, ER (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	wurst@helmholtz-muenchen.de; ernest.arenas@ki.se	Bryja, Vít?zslav/H-1925-2014; Prakash, Nilima/AAC-9402-2019; Arenas, Ernest/AAO-5231-2020; Bryja, Vítězslav/P-4217-2019; Andersson, Emma R/J-4236-2012; Cajanek, Lukas/ABG-6559-2020; Andersson, Emma/AAB-8532-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Prakash, Nilima/0000-0002-0568-6262; Arenas, Ernest/0000-0003-0197-6577; Bryja, Vítězslav/0000-0002-9136-5085; Andersson, Emma R/0000-0002-8608-625X; Cajanek, Lukas/0000-0003-2914-8589; Andersson, Emma/0000-0002-8608-625X; Wurst, Wolfgang/0000-0003-4422-7410	Swedish Foundation for Strategic Research; Swedish Royal Academy of Sciences; Knut and Alice Wallenberg Foundation; European Union (Eurostemcell); Swedish MRC; Karolinska Institutet; Federal Ministry of Education and Research (BMBF) [01GN0512]; National Genome Research Network (NGFN); Forderkennzeichen [01GS0476]; Deutsche Forschungsgemeinschaft (DFG) [WU 164/3-1, WU 164/3-2]; Bayerische Forschungsverbund ForNeuroCell; Helmholtz Virtual Institute of Neurodegeneration&Aging [VH-VI-252]; European Union (Eumorphia); NATIONAL CANCER INSTITUTE [ZIABC010841, Z01BC010841] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Royal Academy of Sciences; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Union (Eurostemcell)(European Commission); Swedish MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Karolinska Institutet(Karolinska Institutet); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network (NGFN); Forderkennzeichen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerische Forschungsverbund ForNeuroCell; Helmholtz Virtual Institute of Neurodegeneration&Aging; European Union (Eumorphia)(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Swedish Foundation for Strategic Research, Swedish Royal Academy of Sciences, Knut and Alice Wallenberg Foundation, European Union (Eurostemcell), Swedish MRC and Karolinska Institutet (to EA), and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN), Forderkennzeichen 01GS0476, the BMBF Forderkennzeichen 01GN0512, the Deutsche Forschungsgemeinschaft (DFG) WU 164/3-1 and WU 164/3-2, the Bayerische Forschungsverbund ForNeuroCell, the Helmholtz Virtual Institute of Neurodegeneration&Aging (VH-VI-252) and by European Union (Eumorphia) (to WW). The authors are responsible for the contents of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Brodski C, 2003, J NEUROSCI, V23, P4199; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; BUSH KT, 1990, ANAT EMBRYOL, V181, P49; Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Cau E, 1997, DEVELOPMENT, V124, P1611; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi G, 2004, J NEUROSCI, V24, P3672, DOI 10.1523/JNEUROSCI.5327-03.2004; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; NEMETH MJ, 2007, P NATL ACAD SCI US; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; RAWAL N, 2006, EXP CELL RES; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shariatmadari M, 2005, MOL CELL NEUROSCI, V30, P437, DOI 10.1016/j.mcn.2005.08.008; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; WILSON PA, 1989, DEVELOPMENT, V105, P155; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; YBOTGONZALEZ P, 2007, CONVERGENT EXTENSION, P789	71	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3517	10.1371/journal.pone.0003517	http://dx.doi.org/10.1371/journal.pone.0003517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953410	Green Published, Green Submitted, gold			2022-12-25	WOS:000265130500002
J	Ogunniyi, AD; Grabowicz, M; Mahdi, LK; Cook, J; Gordon, DL; Sadlon, TA; Paton, JC				Ogunniyi, Abiodun D.; Grabowicz, Marcin; Mahdi, Layla K.; Cook, Jan; Gordon, David L.; Sadlon, Tania A.; Paton, James C.			Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H	FASEB JOURNAL			English	Article						Streptococcus pneumoniae; virulence; gene expression; innate immunity; protein vaccines	STREPTOCOCCUS-PNEUMONIAE INFECTION; VIRULENCE PROTEINS; SURFACE PROTEIN; GENE-EXPRESSION; ZINC; PROTECTION; MICE; DISEASE; VACCINE; FAMILY	The pneumococcal histidine triad (Pht) proteins are a recently recognized family of surface proteins, comprising 4 members: PhtA, PhtB, PhtD, and PhtE. They are being promoted for inclusion in a multicomponent pneumococcal protein vaccine currently under development, but to date, their biological functions and their relative contributions to pathogenesis have not been clarified. In this study, the involvement of these proteins in pneumococcal virulence was investigated in murine models of sepsis and pneumonia by using defined, nonpolar mutants of the respective genes in Streptococcus pneumoniae D39. In either challenge model, mutagenesis of all 4 genes was required to completely abolish virulence relative to the wild-type, suggesting significant functional redundancy among Pht proteins. The in vivo expression of pht genes was significantly up-regulated in the nasopharynx and lungs compared with blood. We provide unequivocal molecular evidence for Zn2+-dependent, AdcR-mediated, regulation of pht gene expression by real-time reverse transcriptase-polymerase chain reaction, Western blotting, and electrophoretic mobility-shift assays. We also present the first direct evidence for the biological function of this protein family by demonstrating that Pht proteins are required for inhibition of complement deposition on the pneumococcal surface through the recruitment of complement factor H.-Ogunniyi, A. D., Grabowicz, M., Mahdi, L. K., Cook, J., Gordon, D. L., Sadlon, T. A., Paton, J. C. Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J. 23, 731-738 (2009)	[Ogunniyi, Abiodun D.; Grabowicz, Marcin; Mahdi, Layla K.; Cook, Jan; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Gordon, David L.; Sadlon, Tania A.] Flinders Med Ctr, Dept Microbiol, Adelaide, SA, Australia; [Gordon, David L.; Sadlon, Tania A.] Flinders Med Ctr, Dept Infect Dis, Adelaide, SA, Australia; [Gordon, David L.; Sadlon, Tania A.] Flinders Univ S Australia, Adelaide, SA, Australia	University of Adelaide; Flinders Medical Centre; Flinders Medical Centre; Flinders University South Australia	Paton, JC (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	james.paton@adelaide.edu.au	Paton, James C/A-9920-2008; Johnson, Michael D. L./B-4352-2012	Mahdi, Layla/0000-0002-5878-8385; Grabowicz, Marcin/0000-0001-8000-2222; Gordon, David/0000-0003-3276-9685; Ogunniyi, Abiodun/0000-0001-9308-5629	National Health and Medical Research Council of Australia (NHMRC) [284214]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	We thank U. Stroeher and L. Purins for assistance with EMSA, H. Wang for assistance with flow cytometry, U. Talbot for assistance with purification of PhtA and PhtD, G. Bull for assistance with atomic absorption spectroscopy, L. Dent for helpful discussions, and Mohamed Daha (Leiden University Medical Centre, Leiden, The Netherlands) for generously supplying rabbit anti-mouse C3 antibody. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Program, grant 284214. J.C.P. is an NHMRC Australia Fellow. The authors have declared that no competing interests exist.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; BROWN MGM, 1979, FEMS MICROBIOL LETT, V5, P219; BUNKER VW, 1984, AM J CLIN NUTR, V40, P1096, DOI 10.1093/ajcn/40.5.1096; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duthy TG, 2002, INFECT IMMUN, V70, P5604, DOI 10.1128/IAI.70.10.5604-5611.2002; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Harlyk C, 1997, J TRACE ELEM MED BIO, V11, P137, DOI 10.1016/S0946-672X(97)80040-5; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hostetter MK, 1999, MICROB DRUG RESIST, V5, P85, DOI 10.1089/mdr.1999.5.85; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Li J, 2007, INFECT IMMUN, V75, P5877, DOI 10.1128/IAI.00839-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch JP, 2005, SEMIN RESP CRIT CARE, V26, P575, DOI 10.1055/s-2005-925524; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McGeer A, 2003, NAT MED, V9, P390, DOI 10.1038/nm0403-390; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Ogunniyi AD, 2001, INFECT IMMUN, V69, P5997, DOI 10.1128/IAI.69.10.5997-6003.2001; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Paton JC, 2004, PNEUMOCCOCUS, P382; Paton JC, 1998, TRENDS MICROBIOL, V6, P85, DOI 10.1016/S0966-842X(98)01220-7; Riboldi-Tunnicliffe A, 2005, FEBS LETT, V579, P5353, DOI 10.1016/j.febslet.2005.08.066; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Zhang Y, 2001, INFECT IMMUN, V69, P3827, DOI 10.1128/IAI.69.6.3827-3836.2001	44	94	100	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					731	738		10.1096/fj.08-119537	http://dx.doi.org/10.1096/fj.08-119537			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18971260				2022-12-25	WOS:000265506300009
J	Yue, S; Chen, Y; Cheng, SY				Yue, S.; Chen, Y.; Cheng, S. Y.			Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway	ONCOGENE			English	Article						hedgehog; Sufu; ubiquitin; lung cancer	CUBITUS INTERRUPTUS; NUCLEAR IMPORT; GLI; DROSOPHILA; COMPLEX; MEDULLOBLASTOMA; TRANSCRIPTION; TRANSDUCTION; DIVERGENCE; PARADIGMS	Sustained Sonic hedgehog (Shh) pathway activity is associated with tumorigenesis in a wide variety of tissues. Mutational inactivation of Shh receptor Patched (Ptch) and a downstream gene Suppressor of fused (Sufu), both of which are negative regulators of the pathway, increases susceptibility to cerebellum cancer in humans and mice. Sufu is a binding partner of Shh pathway transcription factor Gli. Recent data indicate that inactivation of Sufu, through either gene targeting in mice or RNAi-mediated silencing in cultured. broblasts, is sufficient to turn on Shh target gene expression. Here, we report that Sufu is degraded rapidly in certain cancer cells and we show that Shh signaling promotes ubiquitination of Sufu, which leads to its destruction in the proteasomes. We identified an ubiquitin attachment site on K257 of Sufu, and showed that Sufu-K257R mutant is more potent as a transcription repressor and cell growth inhibitor because of increased stability. These results indicate that Shh signaling regulates Sufu activity by inducing its turnover via the ubiquitin-proteasome system.	[Cheng, S. Y.] Nanjing Med Univ, Dept Dev Genet, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yue, S.; Cheng, S. Y.] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Cheng, SY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Lab Reprod Med, 140 Hanzhong Rd,Xianzhi Lou 1908, Nanjing, Jiangsu, Peoples R China.	sycheng@njmu.edu.cn			Chinese National Science Foundation [30771079]; 973 State Key Research Project [2009CB918403]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); 973 State Key Research Project(National Basic Research Program of China)	We thank Drs YE Zhang, A Ruiz i Altaba, R Toftgard, DJ Robbins and CM Fan for valuable reagents and suggestions. This work is supported by a Chinese National Science Foundation Grant (30771079 to SYC) and a 973 State Key Research Project Grant (2009CB918403 to SYC).	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JACOB L, 2007, SCI STKE, pCM6, DOI DOI 10.1126/STKE.4072007CM6; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; PREAT T, 1993, GENETICS, V135, P1047; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sisson BE, 2006, DEV BIOL, V294, P258, DOI 10.1016/j.ydbio.2006.02.050; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	28	63	72	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					492	499		10.1038/onc.2008.403	http://dx.doi.org/10.1038/onc.2008.403			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997815				2022-12-25	WOS:000262866500003
J	Davison, JM; Mellott, TJ; Kovacheva, VP; Blusztajn, JK				Davison, Jessica M.; Mellott, Tiffany J.; Kovacheva, Vesela P.; Blusztajn, Jan Krzysztof			Gestational Choline Supply Regulates Methylation of Histone H3, Expression of Histone Methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA Methylation of Their Genes in Rat Fetal Liver and Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVAILABILITY MODULATES HIPPOCAMPAL; ENHANCED VISUOSPATIAL MEMORY; PROGENITOR-CELL MITOSIS; LYSINE-9 METHYLATION; SUPPLEMENTATION INCREASES; EMBRYONIC-DEVELOPMENT; DEFICIENCY; PROTEIN; IGF2; HYPERMETHYLATION	Choline is an essential nutrient that, via its metabolite betaine, serves as a donor of methyl groups used in fetal development to establish the epigenetic DNA and histone methylation patterns. Supplementation with choline during embryonic days (E) 11-17 in rats improves memory performance in adulthood and protects against age-related memory decline, whereas choline deficiency impairs certain cognitive functions. We previously reported that global and gene-specific DNA methylation increased in choline-deficient fetal brain and liver, and these changes in DNA methylation correlated with an apparently compensatory up-regulation of the expression of DNA methyltransferase Dnmt1. In the current study, pregnant rats were fed a diet containing varying amounts of choline (mmol/kg: 0 (deficient), 8 (control), or 36 (supplemented)) during E11-17, and indices of histone methylation were assessed in liver and frontal cortex on E17. The mRNA and protein expression of histone methyltransferases G9a and Suv39h1 were directly related to the availability of choline. DNA methylation of the G9a and Suv39h1 genes was up-regulated by choline deficiency, suggesting that the expression of these enzymes is under negative control by methylation of their genes. The levels of H3K9Me2 and H3K27Me3, tags of transcriptionally repressed chromatin, were up-regulated by choline supplementation, whereas the levels of H3K4Me2, associated with active promoters, were highest in choline-deficient rats. These data show that maternal choline supply during pregnancy modifies fetal histone and DNA methylation, suggesting that a concerted epigenomic mechanism contributes to the long term developmental effects of varied choline intake in utero.	[Blusztajn, Jan Krzysztof] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Boston Univ, Sch Med, Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, Dept Pathol, 72 E Concord St,L804, Boston, MA 02118 USA.	jbluszta@bu.edu		/0000-0001-8438-3122; Mellott, Tiffany/0000-0003-3287-9374	National Institutes of Health [AG009525]; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG009525 from the NIA.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Albright CD, 1999, DEV BRAIN RES, V115, P123, DOI 10.1016/S0165-3806(99)00057-7; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BIERI JG, 1977, J NUTR, V107, P1394; Bieri JG., 1980, J NUTR, V110, P1726, DOI [10.1093/jn/110.8.1726, DOI 10.1093/JN/110.8.1726]; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cermak JM, 1998, FASEB J, V12, P349, DOI 10.1096/fasebj.12.3.349; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Dobosy JR, 2008, PROSTATE, V68, P1187, DOI 10.1002/pros.20782; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; Food andNutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R, DOI 10.17226/6015; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Higashimoto K, 2003, AM J HUM GENET, V73, P948, DOI 10.1086/378595; HolmesMcNary MQ, 1997, DEV BRAIN RES, V101, P9, DOI 10.1016/S0165-3806(97)00044-8; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jones JP, 1999, DEV BRAIN RES, V118, P159, DOI 10.1016/S0165-3806(99)00103-0; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kovacheva VP, 2009, FASEB J, V23, P1054, DOI 10.1096/fj.08-122168; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Nakayama T, 2001, LAB INVEST, V81, P1049, DOI 10.1038/labinvest.3780316; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Pogribny IP, 2007, J NUTR, V137, p216S, DOI 10.1093/jn/137.1.216S; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sandstrom NJ, 2002, BRAIN RES, V947, P9, DOI 10.1016/S0006-8993(02)02900-1; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; WAINFAN E, 1989, CANCER RES, V49, P4094; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Williams CL, 1998, BRAIN RES, V794, P225, DOI 10.1016/S0006-8993(98)00229-7; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2008, BRAIN RES, V1237, P5, DOI 10.1016/j.brainres.2008.08.059; Zhu XN, 2004, DEV BRAIN RES, V149, P121, DOI 10.1016/j.devbrainres.2004.01.004	83	99	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1982	1989		10.1074/jbc.M807651200	http://dx.doi.org/10.1074/jbc.M807651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19001366	Green Published, hybrid			2022-12-25	WOS:000262545600005
J	Kouchi, Z; Barthet, G; Serban, G; Georgakopoulos, A; Shioi, J; Robakis, NK				Kouchi, Zen; Barthet, Gael; Serban, Geo; Georgakopoulos, Anastasios; Shioi, Junichi; Robakis, Nikolaos K.			p120 Catenin Recruits Cadherins to gamma-Secretase and Inhibits Production of A beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CELL-CELL ADHESION; SYNAPTIC PLASTICITY; CYTOPLASMIC DOMAIN; DELTA-CATENIN; PRESENILIN-1; BINDING; P120-CATENIN; NEURODEGENERATION; ENDOPROTEOLYSIS	The gamma-secretase complex cleaves many transmembrane proteins, including amyloid precursor protein, EphB and ErbB tyrosine kinase receptors, Notch1 receptors, and adhesion factors. Presenilin 1, the catalytic subunit of gamma-secretase, associates with the cadherin/catenin cell-cell adhesion/communication system and promotes cadherin processing (Georgakopoulos, A., et al. (1999) Mol. Cell 4, 893-902; Marambaud, P., et al. (2002) EMBO J. 21, 1948-1956), but the mechanism by which gamma-secretase and cadherins associate is unclear. Here we report that p120 catenin (p120ctn), a component of the cadherin-catenin complex, recruits gamma-secretase to cadherins, thus stimulating their processing while inhibiting production of A beta peptide and the amyloid precursor protein intracellular domain. This function of p120ctn depends on both p120ctn-cadherin and p120ctn-presenilin 1 binding, indicating that p120ctn is the central factor that bridges gamma-secretase and cadherin-catenin complexes. Our data show that p120ctn is a unique positive regulator of the gamma-secretase processing of cadherins and a negative regulator of the amyloid precursor protein processing. Furthermore, our data suggest that specific members of the gamma-secretase complex may be used to recruit different substrates and that distinct PS1 sequences are required for processing of APP and cadherins.	[Shioi, Junichi] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Shioi, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1 Gustave L Levy Pl,Box 1229, New York, NY 10029 USA.	junichi.shioi@mssm.edu; nikos.robakis@mssm.edu	Serban, Geo/AAO-8819-2020; Robakis, Nikolaos/AAA-1838-2021	Barthet, Gael/0000-0003-4025-1616; Serban, Geo/0000-0002-4985-7035	National Institutes of Health [AG-17926, NS047229, AG-08200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, R01AG017926, R01AG008200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or part, by National Institutes of Health Grants AG-17926, NS047229, and AG-08200.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Onishi M, 1996, EXP HEMATOL, V24, P324; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; Soriano S, 2001, J BIOL CHEM, V276, P29045, DOI 10.1074/jbc.M102456200; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	36	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1954	1961		10.1074/jbc.M806250200	http://dx.doi.org/10.1074/jbc.M806250200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008223	Green Published, hybrid			2022-12-25	WOS:000262545600002
J	Morel, E; Gruenberg, J				Morel, Etienne; Gruenberg, Jean			Annexin A2 Binding to Endosomes and Functions in Endosomal Transport Are Regulated by Tyrosine 23 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; II TETRAMER; DISCONTINUOUS EPITOPE; INVITRO; FUSION; SITE; TRANSLOCATION; AGGREGATION; ASSOCIATION; DEGRADATION	The phospholipid-binding annexin A2 (AnxA2) is known to play a role in the regulation of membrane and actin dynamics, in particular in the endocytic pathway. The protein is present on early endosomes, where it regulates membrane traffic, including the biogenesis of multivesicular transport intermediates destined for late endosomes. AnxA2 membrane association depends on the protein N terminus and membrane cholesterol but does not involve the AnxA2 ligand p11/S100A10. However, the precise mechanisms that control AnxA2 membrane association and function are not clear. In the present study, we have investigated the role of AnxA2 N-terminal phosphorylation in controlling association to endosomal membranes and functions. We found that endosomal AnxA2 was partially tyrosine-phosphorylated and that mutation of Tyr-23 to Ala (AnxA2Y23A), but not of Ser-25 to Ala, impaired AnxA2 endosome association. We then found that the AnxA2Y23A mutant was unable to bind endosomes in vivo, whereas a phospho-mimicking AnxA2 mutant (Y23D) showed efficient endosome binding capacity. Similarly, we found that AnxA2Y23D interacted more efficiently with liposomes in vitro when compared with AnxA2Y23A. To investigate the role of Tyr-23 in vivo, AnxA2 was knocked down with small interfering RNAs, and then cells were recomplemented with RNA interferenceresistant forms of the protein. Using this strategy, we could show that AnxA2Y23D, but not AnxA2Y23A, could restore earlytolate endosome transport after AnxA2 depletion. We conclude that phosphorylation of Tyr-23 is essential for proper endosomal association and function of AnxA2, perhaps because it stabilizes membrane-associated protein via a conformational change.	[Morel, Etienne; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, Sci 2,30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Telethon Foundation; Fondation pour la Recherche Medicale; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon Foundation(Fondazione Telethon); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Roche Research Foundation	This work was supported by grants from the Swiss National Science Foundation and the Telethon Foundation (to J. G.), as well as grants from the Fondation pour la Recherche Medicale (FRM) and the Roche Research Foundation (to E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bellagamba C, 1997, J BIOL CHEM, V272, P3195, DOI 10.1074/jbc.272.6.3195; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; JOHNSSON N, 1988, FEBS LETT, V236, P201, DOI 10.1016/0014-5793(88)80314-4; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; Jost M, 1997, J CELL SCI, V110, P221; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Rescher U, 2000, J CELL SCI, V113, P3931; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rety S, 1999, NAT STRUCT BIOL, V6, P89; THIEL C, 1991, FEBS LETT, V285, P59, DOI 10.1016/0014-5793(91)80724-H; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	34	77	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1604	1611		10.1074/jbc.M806499200	http://dx.doi.org/10.1074/jbc.M806499200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18990701	hybrid, Green Accepted			2022-12-25	WOS:000262330100028
J	Kimura, Y; Yu, LJ; Hirano, Y; Suzuki, H; Wang, ZY				Kimura, Yukihiro; Yu, Long-Jiang; Hirano, Yu; Suzuki, Hiroaki; Wang, Zheng-Yu			Calcium Ions Are Required for the Enhanced Thermal Stability of the Light-harvesting-Reaction Center Core Complex from Thermophilic Purple Sulfur Bacterium Thermochromatium tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; CHROMATIUM-TEPIDUM; RHODOSPIRILLUM-RUBRUM; RHODOPSEUDOMONAS-VIRIDIS; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RHODOBACTER-SPHAEROIDES; ROSEOSPIRILLUM-PARVUM; PROJECTION STRUCTURE; NONSULFUR BACTERIUM	sThermochromatium tepidum is a thermophilic purple sulfur photosynthetic bacterium collected from the Mammoth Hot Springs, Yellowstone National Park. A previous study showed that the light-harvesting-reaction center core complex (LH1-RC) purified from this bacterium is highly stable at room temperature (Suzuki, H., Hirano, Y., Kimura, Y., Takaichi, S., Kobayashi, M., Miki, K., and Wang, Z.-Y. (2007) Biochim. Biophys. Acta 1767, 1057 - 1063). In this work, we demonstrate that thermal stability of the Tch. tepidum LH1-RC is much higher than that of its mesophilic counterparts, and the enhanced thermal stability requires Ca2+ as a cofactor. Removal of the Ca2+ from Tch. tepidum LH1-RC resulted in a complex with the same degree of thermal stability as that of the LH1-RCs purified from mesophilic bacteria. The enhanced thermal stability can be restored by addition of Ca2+ to the Ca2+-depleted LH1-RC, and this process is fully reversible. Interchange of the thermal stability between the two forms is accompanied by a shift of the LH1 Q(y) transition between 915 nm for the native and 880 nm for the Ca2+-depleted LH1-RC. Differential scanning calorimetry measurements reveal that degradation temperature of the native LH1-RC is 15 degrees C higher and the enthalpy change is about 28% larger than the Ca2+-depleted LH1-RC. Substitution of the Ca2+ with other metal cations caused a decrease in thermal stability of an extent depending on the properties of the cations. These results indicate that Ca2+ ions play a dual role in stabilizing the structure of the pigment-membrane protein complex and in altering its spectroscopic properties, and hence provide insight into the adaptive strategy of this photosynthetic organism to survive in extreme environments using natural resources.	[Kimura, Yukihiro; Yu, Long-Jiang; Hirano, Yu; Suzuki, Hiroaki; Wang, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan	Ibaraki University	Wang, ZY (corresponding author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan.	wang@mx.ibaraki.ac.jp	Kimura, Yukihiro/AAI-6300-2020	, Wang-Otomo/0000-0003-1676-2002	Ministry of Education, Culture, Sports, Science and Technology of Japan; The Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by grants-in-aid for scientific research on priority areas "Structures of Biological Macromolecular Assemblies" from the Ministry of Education, Culture, Sports, Science and Technology of Japan and in part by The Kurata Memorial Hitachi Science and Technology Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN JP, 1986, P NATL ACAD SCI USA, V83, P8589, DOI 10.1073/pnas.83.22.8589; Arluison W, 2004, BIOCHEMISTRY-US, V43, P1276, DOI 10.1021/bi030205v; Christova P, 2000, PROTEINS, V40, P177, DOI 10.1002/(SICI)1097-0134(20000801)40:2<177::AID-PROT10>3.0.CO;2-T; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dudev T, 2007, ACCOUNTS CHEM RES, V40, P85, DOI 10.1021/ar068181i; Fathir I, 1997, PHOTOSYNTH RES, V51, P71, DOI 10.1023/A:1005718404736; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; HEDA GD, 1989, EUR J BIOCHEM, V184, P313, DOI 10.1111/j.1432-1033.1989.tb15021.x; HEDA GD, 1988, FEMS MICROBIOL LETT, V51, P45; Henzl MT, 2003, BIOCHEMISTRY-US, V42, P3594, DOI 10.1021/bi027060x; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; Kimura Y, 2008, J BIOL CHEM, V283, P13867, DOI 10.1074/jbc.M800256200; Kobayashi M, 2005, B CHEM SOC JPN, V78, P2164, DOI 10.1246/bcsj.78.2164; Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1130, DOI 10.1271/bbb.69.1130; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; Ma F, 2008, BIOPHYS J, V95, P3349, DOI 10.1529/biophysj.108.133835; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Madigan MT, 2003, PHOTOSYNTH RES, V76, P157, DOI 10.1023/A:1024998212684; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; MOULIS JM, 1993, ARCH BIOCHEM BIOPHYS, V305, P186, DOI 10.1006/abbi.1993.1409; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; NOZAWA T, 1991, J BIOCHEM-TOKYO, V110, P588, DOI 10.1093/oxfordjournals.jbchem.a123624; Pandit A, 2001, BIOCHEMISTRY-US, V40, P12913, DOI 10.1021/bi010163f; Permentier HP, 2001, BIOCHEMISTRY-US, V40, P5573, DOI 10.1021/bi0024308; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; Tuschak C, 2004, PHOTOSYNTH RES, V81, P181, DOI 10.1023/B:PRES.0000035046.91126.bd; Vegh AP, 2002, FEBS LETT, V528, P222, DOI 10.1016/S0014-5793(02)03314-8; Wang ZY, 2003, PHOTOSYNTH RES, V78, P133, DOI 10.1023/B:PRES.0000004328.11219.79; Watson AJ, 2005, PHOTOSYNTH RES, V86, P81, DOI 10.1007/s11120-005-4047-x	36	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					93	99		10.1074/jbc.M806840200	http://dx.doi.org/10.1074/jbc.M806840200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18977753	hybrid			2022-12-25	WOS:000261974800011
J	Zhang, XF; Zhang, J; Wang, T; Esteban, MA; Pei, DQ				Zhang, Xiaofei; Zhang, Juan; Wang, Tao; Esteban, Miguel A.; Pei, Duanqing			Esrrb Activates Oct4 Transcription and Sustains Self-renewal and Pluripotency in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTORS; MOUSE EMBRYOS; ES CELLS; REGULATORY CIRCUITRY; SOMATIC-CELLS; NANOG; EXPRESSION; NETWORK; GENE; EMBRYOGENESIS	The genetic program of embryonic stem (ES) cells is orchestrated by a core of transcription factors that has OCT4, SOX2, and NANOG as master regulators. Protein levels of these core factors are tightly controlled by autoregulatory and feed-forward transcriptional mechanisms in order to prevent early differentiation. Recent studies have shown that knockdown of Esrrb (estrogen-related-receptor beta), a member of the nuclear orphan receptor family, induces differentiation of mouse ES cells cultured in the presence of leukemia inhibitory factor. It was however not known how knocking down Esrrb exerts this effect. Herein we have identified two ESRRB binding sites in the proximal 5'-untranslated region of the mouse Oct4 gene, one of which is in close proximity to a NANOG binding site. Both ESRRB and NANOG are necessary for maintaining the activity of this promoter in ES cell lines. We have also demonstrated that the two transcription factors interact through their DNA binding domains. This interaction reciprocally modulates their transcriptional activities and may be important to fine-tune ES cell pluripotency. Supporting all of these data, stable transfection of Esrrb in ES cell lines proved sufficient to sustain their characteristics in the absence of leukemia-inhibitory factor. In summary, our experiments help to understand how Esrrb coordinates with Nanog and Oct4 to activate the internal machinery of ES cells.	[Zhang, Xiaofei; Wang, Tao; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Xiaofei] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Zhang, Juan] Tsinghua Univ, Inst Biomed, Sch Med, Dept Biol Sci & Biotechnol,Lab Stem Cell Biol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Zhang, Xiafoei/C-8471-2014; zhou, xingru/G-4442-2012		Natural Science Foundation of China [30725012, 30630039, 90813033]; Chinese Academy of Science [KSCX2-YW-R-48]; Guangzhou Science and Technology [2008A1-E4011]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of China Grants 30725012, 30630039, and 90813033; Chinese Academy of Science Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2008A1-E4011; and Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, and 2007CB947804. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu DS, 2001, CANCER RES, V61, P6755; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Niakan KK, 2005, MOL GENET METAB, V86, P70, DOI 10.1016/j.ymgme.2005.07.019; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; WILMUT I, 1997, NATURE, V385, P813; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	32	116	117	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35825	35833		10.1074/jbc.M803481200	http://dx.doi.org/10.1074/jbc.M803481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957414	hybrid			2022-12-25	WOS:000261687900057
J	Zhang, ZY; Zheng, Y; Mazon, H; Milgrom, E; Kitagawa, N; Kish-Trier, E; Heck, AJR; Kane, PM; Wilkens, S				Zhang, Zhenyu; Zheng, Yesha; Mazon, Hortense; Milgrom, Elena; Kitagawa, Norton; Kish-Trier, Erik; Heck, Albert J. R.; Kane, Patricia M.; Wilkens, Stephan			Structure of the Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-C VMA5P; RENAL TUBULAR-ACIDOSIS; V-ATPASE; H+-ATPASE; 3-DIMENSIONAL STRUCTURE; MASS-SPECTROMETRY; PERIPHERAL STALK; MANDUCA-SEXTA; MUTATIONAL ANALYSIS; CROSS-LINKING	The subunit architecture of the yeast vacuolar ATPase (V-ATPase) was analyzed by single particle transmission electron microscopy and electrospray ionization (ESI) tandem mass spectrometry. A three-dimensional model of the intact V-ATPase was calculated from two-dimensional projections of the complex at a resolution of 25 angstrom. Images of yeast V-ATPase decorated with monoclonal antibodies against subunits A, E, and G position subunit A within the pseudo-hexagonal arrangement in the V-1, the N terminus of subunit G in the V-1-V-0 interface, and the C terminus of subunit E at the top of the V1 domain. ESI tandem mass spectrometry of yeast V-1-ATPase showed that subunits E and G are most easily lost in collision-induced dissociation, consistent with a peripheral location of the subunits. An atomic model of the yeast V-ATPase was generated by fitting of the available x-ray crystal structures into the electron microscopy-derived electron density map. The resulting atomic model of the yeast vacuolar ATPase serves as a framework to help understand the role the peripheral stalk subunits are playing in the regulation of the ATP hydrolysis driven proton pumping activity of the vacuolar ATPase.	[Milgrom, Elena; Kitagawa, Norton; Kish-Trier, Erik; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Zhang, Zhenyu; Zheng, Yesha; Kitagawa, Norton; Wilkens, Stephan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Proteom Grp, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of California System; University of California Riverside; Utrecht University; Utrecht University	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	National Institutes of Health [GM58600, CA100246, GM50322]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322, R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58600 and CA100246 (to S.W.) and GM50322 (to P.M.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Clare DK, 2006, STRUCTURE, V14, P1149, DOI 10.1016/j.str.2006.05.014; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dunn SD, 2000, BBA-BIOENERGETICS, V1458, P356, DOI 10.1016/S0005-2728(00)00086-4; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Hahn H, 2003, AM J KIDNEY DIS, V41, P238, DOI 10.1053/ajkd.2003.50014; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Li Z, 2004, PLANTA, V219, P948, DOI 10.1007/s00425-004-1298-2; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rizzo VF, 2003, J BIOL CHEM, V278, P270, DOI 10.1074/jbc.M208623200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Supekova L, 1996, J EXP BIOL, V199, P1147; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	77	95	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35983	35995		10.1074/jbc.M805345200	http://dx.doi.org/10.1074/jbc.M805345200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955482	Green Published, hybrid			2022-12-25	WOS:000261687900073
J	Wolthers, KR; Rigby, SEJ; Scrutton, NS				Wolthers, Kirsten R.; Rigby, Stephen E. J.; Scrutton, Nigel S.			Mechanism of Radical-based Catalysis in the Reaction Catalyzed by Adenosylcobalamin-dependent Ornithine 4,5-Aminomutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHANOLAMINE AMMONIA-LYASE; METHYLMALONYL-COA MUTASE; PARTIAL-PROTON-TRANSFER; HYDROGEN-ATOM ABSTRACTION; CARBON BOND HOMOLYSIS; GLUTAMATE MUTASE; CLOSTRIDIUM-STICKLANDII; LYSINE 5,6-AMINOMUTASE; 2-METHYLENEGLUTARATE MUTASE; SUICIDE INACTIVATION	We report an analysis of the reaction mechanism of ornithine 4,5-aminomutase, an adenosylcobalamin (AdoCbl)- and pyridoxal L-phosphate (PLP)-dependent enzyme that catalyzes the 1,2-rearrangement of the terminal amino group of D-ornithine to generate (2R,4S)-2,4-diaminopentanoic acid. We show by stopped-flow absorbance studies that binding of the substrate D-ornithine or the substrate analogue D-2,4-diaminobutryic acid (DAB) induces rapid homolysis of the AdoCbl Co-C bond (781 s(-1), D-ornithine; 513 s(-1), DAB). However, only DAB results in the stable formation of a cob(II) alamin species. EPR spectra of DAB and [2,4,4-2H3] DAB bound to holo-ornithine 4,5-aminomutase suggests strong electronic coupling between cob(II) alamin and a radical form of the substrate analog. Loading of substrate/analogue onto PLP (i.e. formation of an external aldimine) is also rapid (532 s(-1), D-ornithine; 488 s(-1), DAB). In AdoCbl-depleted enzyme, formation of the external aldimine occurs over long time scales (similar to 50 s) and occurs in three resolvable kinetic phases, identifying four distinct spectral intermediates (termed A-D). We infer that these represent the internal aldimine (lambda(max) 416 nm; A), two different unliganded PLP states of the enzyme (lambda(max) at 409 nm; B and C), and the external aldimine (lambda(max) 426 nm; D). An imine linkage with D-ornithine and DAB generates both tautomeric forms of the external aldimine, but with D-ornithine the equilibrium is shifted toward the ketoimine state. The influence of this equilibrium distribution of prototropic isomers in driving homolysis and stabilizing radical intermediate states is discussed. Our work provides the first detailed analysis of radical-based catalysis in this Class III AdoCbl-dependent enzyme.	[Wolthers, Kirsten R.; Rigby, Stephen E. J.; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester	Wolthers, KR (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	kirsten.wolthers@manchester.ac.uk	Wolthers, Kirsten/M-6833-2019		United Kingdom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish; BBSRC [BB/D01963X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the United Kingdom Biotechnology and Biological Sciences Research Council (to N. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abend A, 2000, BIOCHEMISTRY-US, V39, P6250, DOI 10.1021/bi992963k; Bach RD, 1999, J AM CHEM SOC, V121, P6542, DOI 10.1021/ja9907616; BAKER JJ, 1973, BIOCHEMISTRY-US, V12, P1054, DOI 10.1021/bi00730a006; Bandarian V, 2000, BIOCHEMISTRY-US, V39, P12069, DOI 10.1021/bi001014k; Bandarian V, 2002, BIOCHEMISTRY-US, V41, P8580, DOI 10.1021/bi0201217; Bandarian V, 1999, BIOCHEMISTRY-US, V38, P12394, DOI 10.1021/bi990620g; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BARKER JJ, 1984, B 12, V2, P203; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Chen HP, 2004, EUR J BIOCHEM, V271, P4293, DOI 10.1111/j.1432-1033.2004.04369.x; Chen HP, 2001, J BIOL CHEM, V276, P44744, DOI 10.1074/jbc.M108365200; Cheng MC, 2007, BIOCHEMISTRY-US, V46, P883, DOI 10.1021/bi0616908; FINKE RG, 1984, INORG CHEM, V23, P3041, DOI 10.1021/ic00188a002; Jones AR, 2007, J AM CHEM SOC, V129, P15718, DOI 10.1021/ja077124x; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Marsh ENG, 2001, CURR OPIN CHEM BIOL, V5, P499, DOI 10.1016/S1367-5931(00)00238-6; Marsh ENG, 1998, BIOCHEMISTRY-US, V37, P11864, DOI 10.1021/bi980512e; MICHEL C, 1992, EUR J BIOCHEM, V205, P767, DOI 10.1111/j.1432-1033.1992.tb16841.x; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; PADMAKUMAR R, 1995, J BIOL CHEM, V270, P9295, DOI 10.1074/jbc.270.16.9295; Padmakumar R, 1997, BIOCHEMISTRY-US, V36, P3713, DOI 10.1021/bi962503g; Reed GH, 2003, CURR OPIN STRUC BIOL, V13, P716, DOI 10.1016/j.sbi.2003.10.011; Roymoulik I, 1999, J BIOL CHEM, V274, P11619, DOI 10.1074/jbc.274.17.11619; Smith DM, 1999, J AM CHEM SOC, V121, P5700, DOI 10.1021/ja990209g; Smith DM, 1999, J AM CHEM SOC, V121, P1037, DOI 10.1021/ja9827245; Smith DM, 1999, J AM CHEM SOC, V121, P1383, DOI 10.1021/ja983512a; Smith DM, 1999, J AM CHEM SOC, V121, P9388, DOI 10.1021/ja991649a; Tang KH, 2003, ARCH BIOCHEM BIOPHYS, V418, P49, DOI 10.1016/S0003-9861(03)00346-1; Tang KH, 2001, BIOCHEMISTRY-US, V40, P5190, DOI 10.1021/bi010157j; Toney MD, 2001, BIOCHEMISTRY-US, V40, P1378, DOI 10.1021/bi0012383; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Tseng CH, 2007, FEMS MICROBIOL LETT, V274, P148, DOI 10.1111/j.1574-6968.2007.00820.x; Wetmore SD, 2000, J AM CHEM SOC, V122, P10208, DOI 10.1021/ja001651y; Wetmore SD, 2001, J AM CHEM SOC, V123, P8678, DOI 10.1021/ja010211j; Wetmore SD, 2001, J AM CHEM SOC, V123, P7963, DOI 10.1021/ja004246f; ZELDER O, 1994, EUR J BIOCHEM, V226, P577, DOI 10.1111/j.1432-1033.1994.tb20083.x	39	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34615	34625		10.1074/jbc.M807911200	http://dx.doi.org/10.1074/jbc.M807911200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948256	hybrid, Green Published			2022-12-25	WOS:000261469100016
J	Friedrich, B; Weyrich, P; Stancakova, A; Wang, J; Kuusisto, J; Laakso, M; Sesti, G; Succurro, E; Smith, U; Hansen, T; Pedersen, O; Machicao, F; Schafer, S; Lang, F; Risler, T; Ullrich, S; Stefan, N; Fritsche, A; Haring, HU				Friedrich, Bjoern; Weyrich, Peter; Stancakova, Alena; Wang, Jianjung; Kuusisto, Johanna; Laakso, Markku; Sesti, Giorgio; Succurro, Elena; Smith, Ulf; Hansen, Torben; Pedersen, Oluf; Machicao, Fausto; Schaefer, Silke; Lang, Florian; Risler, Teut; Ullrich, Susanne; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich			Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies	PLOS ONE			English	Article								Hypothesis: Serum and Glucocorticoid-inducible Kinase 1 (SGK1) is involved in the regulation of insulin secretion and may represent a candidate gene for the development of type 2 diabetes mellitus in humans. Methods: Three independent European populations were analyzed for the association of SGK1 gene (SGK) variations and insulin secretion traits. The German TUEF project provided the screening population (N = 725), and four tagging SNPs (rs1763527, rs1743966, rs1057293, rs9402571) were investigated. EUGENE2 (N = 827) served as a replication cohort for the detected associations. Finally, the detected associations were validated in the METSIM study, providing 3798 non-diabetic and 659 diabetic (type 2) individuals. Results: Carriers of the minor G allele in rs9402571 had significantly higher C-peptide levels in the 2 h OGTT (+10.8%, p=0.04; dominant model) and higher AUC(C-Peptide)/AUC(Glc) ratios (+7.5%, p=0.04) compared to homozygous wild type TT carriers in the screening population. As interaction analysis for BMIxrs9402571 was significant (p=0.04) for the endpoint insulin secretion, we stratified the TUEF cohort for BMI, using a cut off point of BMI=25. The effect on insulin secretion only remained significant in lean TUEF participants (BMI <= 25). This finding was replicated in lean EUGENE2 rs9402571 minor allele carriers, who had a significantly higher AUC(Ins)/AUC(Glc) (TT: 226 +/- 7, XG: 246 +/- 9; p = 0.019). Accordingly, the METSIM trial revealed a lower prevalence of type 2 diabetes (OR: 0.85; 95%CI: 0.71-1.01; p = 0.065, dominant model) in rs9402571 minor allele carriers. Conclusions: The rs9402571 SGK genotype associates with increased insulin secretion in lean non-diabetic TUEF/EUGENE2 participants and with lower diabetes prevalence in METSIM. Our study in three independent European populations supports the conclusion that SGK variability affects diabetes risk.	[Friedrich, Bjoern; Weyrich, Peter; Machicao, Fausto; Schaefer, Silke; Risler, Teut; Ullrich, Susanne; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany; [Lang, Florian] Univ Tubingen, Dept Physiol, D-72074 Tubingen, Germany; [Stancakova, Alena; Wang, Jianjung; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Sesti, Giorgio; Succurro, Elena] Magna Graecia Univ Catanzaro, Polyclin Mater Domini, Dept Expt & Clin Med, Catanzaro, Italy; [Smith, Ulf] Sahlgrens Univ Hosp, Dept Internal Med, Lundberg Lab Diabetes Res, Gothenburg, Sweden; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Kuopio University Hospital; University of Eastern Finland; Magna Graecia University of Catanzaro; Sahlgrenska University Hospital; Steno Diabetes Center; University of Copenhagen	Friedrich, B (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-7400 Tubingen, Germany.	andreas.fritsche@med.uni-tuebingen.de	Sesti, Giorgio/B-1509-2012; Stancakova, Alena/AAN-6723-2020; Pedersen, Oluf/AAG-8015-2020; Succurro, Elena/K-4138-2016; Pedersen, Oluf/Z-1731-2019	Stancakova, Alena/0000-0002-1375-0252; Succurro, Elena/0000-0003-2578-692X; Pedersen, Oluf/0000-0002-3321-3972; Sesti, Giorgio/0000-0002-1618-7688; Stefan, Norbert/0000-0002-2186-9595; Hansen, Torben/0000-0001-8748-3831	Deutsche Forschungsgemeinschaft [KFO 114, STE 1096/1-1]; European Community's FP6 EUGENE2 [LSHM-CT-2004-512013]; Medical Faculty of the University of Tubingen [1212-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community's FP6 EUGENE2; Medical Faculty of the University of Tubingen	The study was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 114, Heisenberg-Grant to NS: STE 1096/1-1), the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013) and by an intramural grant from the Medical Faculty of the University of Tubingen (Fortune Program Nr. 1212-0-0 to BF).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Grahammer F, 2006, AM J PHYSIOL-GASTR L, V290, pG1114, DOI 10.1152/ajpgi.00231.2005; Grarup N, 2007, CURR OPIN CLIN NUTR, V10, P420, DOI 10.1097/MCO.0b013e3281e2c9ab; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Jeyaraj S, 2007, BIOCHEM BIOPH RES CO, V356, P629, DOI 10.1016/j.bbrc.2007.03.029; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Palmada M, 2006, DIABETES, V55, P421, DOI 10.2337/diabetes.55.02.06.db05-0720; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Thamer C, 2003, DIABETES CARE, V26, P2126, DOI 10.2337/diacare.26.7.2126; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Ullrich S, 2007, BIOCHEM BIOPH RES CO, V352, P662, DOI 10.1016/j.bbrc.2006.11.065; Utzschneider KM, 2007, DIABETOLOGIA, V50, P2516, DOI 10.1007/s00125-007-0819-5; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3506	10.1371/journal.pone.0003506	http://dx.doi.org/10.1371/journal.pone.0003506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18985156	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134400001
J	Saidi, H; Melki, MT; Gougeon, ML				Saidi, Hela; Melki, Marie-Therese; Gougeon, Marie-Lise			HMGB1-Dependent Triggering of HIV-1 Replication and Persistence in Dendritic Cells as a Consequence of NK-DC Cross-Talk	PLOS ONE			English	Article								Background: HIV-1 has evolved ways to exploit DCs, thereby facilitating viral dissemination and allowing evasion of antiviral immunity. Recently, the fate of DCs has been found to be extremely dependent on the interaction with autologous NK cells, but the mechanisms by which NK-DC interaction controls viral infections remain unclear. Here, we investigate the impact of NK-DC cross-talk on maturation and functions of HIV-infected immature DCs. Methodology/Principal Findings: Immature DCs were derived from primary monocytes, cultured in the presence of IL-4 and GM-CSF. In some experiments, DCs were infected with R5-HIV-1(BaL) or X4-HIV-1(NDK), and viral replication, proviral HIV-DNA and the frequency of infected DCs were measured. Autologous NK cells were sorted and either kept unstimulated in the presence of suboptimal concentration of IL-2, or activated by a combination of PHA and IL-2. The impact of 24 h NK-DC cross-talk on the fate of HIV-1-infected DCs was analyzed. We report that activated NK cells were required for the induction of maturation of DCs, whether uninfected or HIV-1-infected, and this process involved HMGB1. However, the cross-talk between HIV-1-infected DCs and activated NK cells was functionally defective, as demonstrated by the strong impairment of DCs to induce Th1 polarization of naive CD4 T cells. This was associated with the defective production of IL-12 and IL-18 by infected DCs. Moreover, the crosstalk between activated NK cells and HIV-infected DCs resulted in a dramatic increase in viral replication and proviral DNA expression in DCs. HMGB1, produced both by NK cells and DCs, was found to play a pivotal role in this process, and inhibition of HMGB1 activity by glycyrrhizin, known to bind specifically to HMGB1, or blocking anti-HMGB1 antibodies, abrogated NK-dependent HIV-1 replication in DCs. Conclusion: These observations provide evidence for the crucial role of NK-DC cross-talk in promoting viral dissemination, and challenge the question of the in vivo involvement of HMGB1 in the triggering of HIV-1 replication and replenishment of viral reservoirs in AIDS.	[Saidi, Hela; Melki, Marie-Therese; Gougeon, Marie-Lise] Inst Pasteur, INSERM, Antiviral Immun Biotherapy & Vaccine Unit, U668, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Saidi, H (corresponding author), Inst Pasteur, INSERM, Antiviral Immun Biotherapy & Vaccine Unit, U668, F-75724 Paris, France.	mlgougeo@pasteur.fr	Saïdi, Héla/P-2519-2014		Institut Pasteur; Sidaction [postdoctoral fellowship]; Ministere de la Recherche	Institut Pasteur(European Commission); Sidaction; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This research was supported by Institutional grant from Institut Pasteur. HS was supported by a postdoctoral fellowship from Sidaction, and MTM by a PhD grant from the Ministere de la Recherche.	AGAUGUE S, 2008, BLOOD; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Clynes R, 2007, CURR MOL MED, V7, P743; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Ledru E, 2003, BLOOD, V101, P3102, DOI 10.1182/blood-2002-08-2499; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Manfredi AA, 2008, J IMMUNOL, V180, P2270, DOI 10.4049/jimmunol.180.4.2270; Marcenaro E, 2005, J IMMUNOL, V174, P3992, DOI 10.4049/jimmunol.174.7.3992; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Moser B, 2006, ARTHRITIS RHEUM-US, V54, P14, DOI 10.1002/art.21522; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Nowak P, 2006, CYTOKINE, V34, P17, DOI 10.1016/j.cyto.2006.03.010; Nowak P, 2007, AIDS, V21, P869, DOI 10.1097/QAD.0b013e3280b079b6; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Saidi Hela, 2008, AIDS Res Ther, V5, P10, DOI 10.1186/1742-6405-5-10; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001	57	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3601	10.1371/journal.pone.0003601	http://dx.doi.org/10.1371/journal.pone.0003601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974890	gold, Green Published, Green Submitted			2022-12-25	WOS:000265131700022
J	Rutvisuttinunt, W; Meyer, PR; Scott, WA				Rutvisuttinunt, Wiriya; Meyer, Peter R.; Scott, Walter A.			Interactions between HIV-1 Reverse Transcriptase and the Downstream Template Strand in Stable Complexes with Primer-Template	PLOS ONE			English	Article								Background: Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) forms stable ternary complexes in which RT is bound tightly at fixed positions on the primer-template (P/T). We have probed downstream interactions between RT and the template strand in the complex containing the incoming dNTP (+1 dNTP.RT.P/T complex) and in the complex containing the pyrophosphate analog, foscarnet (foscarnet.RT.P/T complex). Methods and Results: UV-induced cross-linking between RT and the DNA template strand was most efficient when a bromodeoxyuridine residue was placed in the +2 position (the first template position downstream from the incoming dNTP). Furthermore, formation of the +1 dNT.RT.P/T complex on a biotin-containing template inhibited binding of streptavidin when biotin was in the +2 position on the template but not when the biotin was in the +3 position. Streptavidin pre-bound to a biotin residue in the template caused RT to stall two to three nucleotides upstream from the biotin residue. The downstream border of the complex formed by the stalled RT was mapped by digestion with exonuclease RecJF. UV-induced cross-linking of the complex formed by the pyrophosphate analog, foscarnet, with RT and P/T occurred preferentially with bromodeoxyuridine in the +1 position on the template in keeping with the location of RT one base upstream in the foscarnet.RT.P/T complex (i.e., in the pre-translocation position). Conclusions: For +1 dNTP.RT.P/T and foscarnetNRTNP/T stable complexes, tight interactions were observed between RT and the first unpaired template nucleotide following the bound dNTP or the primer terminus, respectively.	[Rutvisuttinunt, Wiriya; Meyer, Peter R.; Scott, Walter A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33124 USA	University of Miami	Rutvisuttinunt, W (corresponding author), Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand.	wscott@med.miami.edu			National Institute of Allergy and Infectious Disease [AI-39973]; American Heart Association Predoctoral Fellowship [025082B]; American Foundation for AIDS Research Postdoctoral Fellowship [70567-31-RF]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039973, P30AI073961] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association Predoctoral Fellowship(American Heart Association); American Foundation for AIDS Research Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institute of Allergy and Infectious Disease (AI-39973 to W.A.S.), the American Heart Association Predoctoral Fellowship (025082B to W.R.), and the American Foundation for AIDS Research Postdoctoral Fellowship (70567-31-RF to P.R.M.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; BOYER PL, 1994, P NATL ACAD SCI USA, V91, P4882, DOI 10.1073/pnas.91.11.4882; Coman MM, 2004, J MOL BIOL, V342, P1457, DOI 10.1016/j.jmb.2004.07.097; Cruchaga C, 2006, J BIOL CHEM, V281, P27744, DOI 10.1074/jbc.M603360200; DAQUILA RT, 1989, J ACQ IMMUN DEF SYND, V2, P579; Dash C, 2006, J BIOL CHEM, V281, P27873, DOI 10.1074/jbc.M603970200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; Peletskaya EN, 2004, J VIROL, V78, P3387, DOI 10.1128/JVI.78.7.3387-3397.2004; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sharma B, 2002, BIOCHEMISTRY-US, V41, P15685, DOI 10.1021/bi026311z; Srivastava A, 2003, BIOCHEMISTRY-US, V42, P3645, DOI 10.1021/bi026699y; TAN CK, 1991, BIOCHEMISTRY-US, V30, P2651, DOI 10.1021/bi00224a013; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Winshell J, 2004, J BIOL CHEM, V279, P52924, DOI 10.1074/jbc.M409134200; Winshell J, 2001, J MOL BIOL, V306, P931, DOI 10.1006/jmbi.2001.4439; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3561	10.1371/journal.pone.0003561	http://dx.doi.org/10.1371/journal.pone.0003561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974785	Green Published, Green Submitted, gold			2022-12-25	WOS:000265131500001
J	Hertz-Fowler, C; Figueiredo, LM; Quail, MA; Becker, M; Jackson, A; Bason, N; Brooks, K; Churcher, C; Fahkro, S; Goodhead, I; Heath, P; Kartvelishvili, M; Mungall, K; Harris, D; Hauser, H; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Taylor, JE; Walker, D; White, B; Young, R; Cross, GAM; Rudenko, G; Barry, JD; Louis, EJ; Berriman, M				Hertz-Fowler, Christiane; Figueiredo, Luisa M.; Quail, Michael A.; Becker, Marion; Jackson, Andrew; Bason, Nathalie; Brooks, Karen; Churcher, Carol; Fahkro, Samah; Goodhead, Ian; Heath, Paul; Kartvelishvili, Magdalena; Mungall, Karen; Harris, David; Hauser, Heidi; Sanders, Mandy; Saunders, David; Seeger, Kathy; Sharp, Sarah; Taylor, Jesse E.; Walker, Danielle; White, Brian; Young, Rosanna; Cross, George A. M.; Rudenko, Gloria; Barry, J. David; Louis, Edward J.; Berriman, Matthew			Telomeric Expression Sites Are Highly Conserved in Trypanosoma brucei	PLOS ONE			English	Article							GENE-EXPRESSION; ANTIGENIC VARIATION; MEGABASE CHROMOSOMES; TRANSFERRIN RECEPTOR; MOLECULAR KARYOTYPE; PROTEIN; PROMOTER; SEQUENCE; FAMILY; RECOMBINATION	Subtelomeric regions are often under-represented in genome sequences of eukaryotes. One of the best known examples of the use of telomere proximity for adaptive purposes are the bloodstream expression sites (BESs) of the African trypanosome Trypanosoma brucei. To enhance our understanding of BES structure and function in host adaptation and immune evasion, the BES repertoire from the Lister 427 strain of T. brucei were independently tagged and sequenced. BESs are polymorphic in size and structure but reveal a surprisingly conserved architecture in the context of extensive recombination. Very small BESs do exist and many functioning BESs do not contain the full complement of expression site associated genes (ESAGs). The consequences of duplicated or missing ESAGs, including ESAG9, a newly named ESAG12, and additional variant surface glycoprotein genes (VSGs) were evaluated by functional assays after BESs were tagged with a drug-resistance gene. Phylogenetic analysis of constituent ESAG families suggests that BESs are sequence mosaics and that extensive recombination has shaped the evolution of the BES repertoire. This work opens important perspectives in understanding the molecular mechanisms of antigenic variation, a widely used strategy for immune evasion in pathogens, and telomere biology.	[Hertz-Fowler, Christiane; Quail, Michael A.; Jackson, Andrew; Bason, Nathalie; Brooks, Karen; Churcher, Carol; Fahkro, Samah; Goodhead, Ian; Heath, Paul; Mungall, Karen; Harris, David; Hauser, Heidi; Sanders, Mandy; Saunders, David; Seeger, Kathy; Walker, Danielle; White, Brian; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Figueiredo, Luisa M.; Kartvelishvili, Magdalena; Cross, George A. M.] Rockefeller Univ, New York, NY USA; [Becker, Marion; Sharp, Sarah; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham, England; [Taylor, Jesse E.] Univ Oxford, Dept Stat, Oxford OX1 2JD, England; [Young, Rosanna; Rudenko, Gloria] Univ Oxford, Peter Medawar Building Pathogen Res, Oxford OX1 2JD, England; [Barry, J. David] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland	Wellcome Trust Sanger Institute; Rockefeller University; University of Nottingham; University of Oxford; University of Oxford; University of Glasgow	Hertz-Fowler, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	chf@sanger.ac.uk	Cross, George A M/B-7444-2011; Figueiredo, Luisa Miranda/C-3908-2018; Hall, Neil/A-8717-2013; Goodhead, Ian/ABC-9200-2020; Berriman, Matthew/A-7618-2011; Louis, Edward/B-7920-2008; Quail, michael/ABE-6131-2020	Cross, George A M/0000-0003-1374-6955; Figueiredo, Luisa Miranda/0000-0002-5752-6586; Hall, Neil/0000-0002-7995-3810; Berriman, Matthew/0000-0002-9581-0377; Louis, Edward/0000-0003-1157-3608; Rudenko, Gloria/0000-0003-1884-4933; Young, Rosanna/0000-0002-1062-5691; Goodhead, Ian/0000-0002-3110-9442; Hertz-Fowler, Christiane/0000-0002-0729-6479	The Wellcome Trust; Sanger Institute Pathogen Genomics group; National Institute of Allergy And Infectious Diseases (NIAID) [R01AI021729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729] Funding Source: NIH RePORTER	The Wellcome Trust(Wellcome TrustEuropean Commission); Sanger Institute Pathogen Genomics group; National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Wellcome Trust supports the Sanger Institute Pathogen Genomics group. LMF, MK and GAMC are supported in part by Grant Number R01AI021729 from the National Institute of Allergy And Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitcheson N, 2005, MOL MICROBIOL, V57, P1608, DOI 10.1111/j.1365-2958.2005.04795.x; Ansorge I, 1999, MOL BIOCHEM PARASIT, V101, P81, DOI 10.1016/S0166-6851(99)00060-2; Barnes RL, 2007, NUCLEIC ACIDS RES, V35, P3478, DOI 10.1093/nar/gkm249; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Callejas S, 2006, GENOME RES, V16, P1109, DOI 10.1101/gr.5147406; Carruthers VB, 1996, MOL BIOCHEM PARASIT, V81, P65, DOI 10.1016/0166-6851(96)02672-2; Cross M, 1998, MOL CELL BIOL, V18, P198, DOI 10.1128/MCB.18.1.198; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, MOL CELL BIOL, V26, P4911, DOI 10.1128/MCB.00212-06; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; FLORENT IC, 1991, MOL CELL BIOL, V11, P2180, DOI 10.1128/MCB.11.4.2180; GOTTESDIENER KM, 1992, MOL CELL BIOL, V12, P4784, DOI 10.1128/MCB.12.10.4784; GOTTESDIENER KM, 1994, MOL BIOCHEM PARASIT, V63, P143, DOI 10.1016/0166-6851(94)90017-5; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Haber JE, 2006, GENETICS, V173, P1181; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Hoek M, 2000, J CELL SCI, V113, P3959; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-54; JOHNSON JG, 1979, BIOCHEM J, V178, P689, DOI 10.1042/bj1780689; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; LAMONT GS, 1986, PARASITOLOGY, V92, P355, DOI 10.1017/S003118200006412X; Leech V, 2004, METH MOL B, V270, P335; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Melville SE, 1998, MOL BIOCHEM PARASIT, V94, P155, DOI 10.1016/S0166-6851(98)00054-1; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Morgan RW, 1996, J BIOL CHEM, V271, P9771, DOI 10.1074/jbc.271.16.9771; MYLER PJ, 1988, MOL BIOCHEM PARASIT, V29, P227, DOI 10.1016/0166-6851(88)90078-3; Navarro M, 1996, MOL CELL BIOL, V16, P3615; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pays E, 2005, TRENDS PARASITOL, V21, P517, DOI 10.1016/j.pt.2005.08.016; PAYS E, 1983, CELL, V35, P721, DOI 10.1016/0092-8674(83)90105-8; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Redpath MB, 2000, MOL BIOCHEM PARASIT, V111, P223, DOI 10.1016/S0166-6851(00)00305-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rudenko G, 1998, MOL BIOCHEM PARASIT, V95, P97, DOI 10.1016/S0166-6851(98)00099-1; RUDENKO G, 1995, CELL, V83, P547, DOI 10.1016/0092-8674(95)90094-2; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	58	191	192	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3527	10.1371/journal.pone.0003527	http://dx.doi.org/10.1371/journal.pone.0003527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953401	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000265130500005
J	Yin, S; Ai, JS; Shi, LH; Wei, L; Yuan, J; Ouyang, YC; Hou, Y; Chen, DY; Schatten, H; Sun, QY				Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Chen, Da-Yuan; Schatten, Heide; Sun, Qing-Yuan			Shugoshin1 May Play Important Roles in Separation of Homologous Chromosomes and Sister Chromatids during Mouse Oocyte Meiosis	PLOS ONE			English	Article								Background: Homologous chromosomes separate in meiosis I and sister chromatids separate in meiosis II, generating haploid gametes. To address the question why sister chromatids do not separate in meiosis I, we explored the roles of Shogoshin1 (Sgo1) in chromosome separation during oocyte meiosis. Methodology/Principal Findings: Sgo1 function was evaluated by exogenous overexpression to enhance its roles and RNAi to suppress its roles during two meioses of mouse oocytes. Immunocytochemistry and chromosome spread were used to evaluate phenotypes. The exogenous Sgo1 overexpression kept homologous chromosomes and sister chromatids not to separate in meiosis I and meiosis II, respectively, while the Sgo1 RNAi promoted premature separation of sister chromatids. Conclusions: Our results reveal that prevention of premature separation of sister chromatids in meiosis I requires the retention of centromeric Sgo1, while normal separation of sister chromatids in meiosis II requires loss of centromeric Sgo1.	[Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Chen, Da-Yuan; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Yin, S (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017; Yin, Shen/N-6607-2013		National Basic Research Program of China [2006CB944001, 2006CB504004]; National Natural Science Foundation of China [30430530, 30570944]; Knowledge Innovation Program of the CAS [KSCX2-YW-R-52]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the CAS(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2006CB944001, 2006CB504004), National Natural Science Foundation of China (No. 30430530, 30570944) and Knowledge Innovation Program of the CAS (KSCX2-YW-R-52).	Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CHOI AHC, 1980, CAN J GENET CYTOL, V22, P261, DOI 10.1139/g80-031; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; HAN F, 2007, PLANT CELL; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LEE J, 2007, NAT CELL BIOL; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; MOLNAR M, 1995, GENETICS, V141, P61; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Puschendorf M, 2006, BIOCHEM BIOPH RES CO, V347, P36, DOI 10.1016/j.bbrc.2006.06.106; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yin S, 2006, CELL CYCLE, V5, P2130, DOI 10.4161/cc.5.18.3170	31	21	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3516	10.1371/journal.pone.0003516	http://dx.doi.org/10.1371/journal.pone.0003516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949044	Green Published, Green Submitted, gold			2022-12-25	WOS:000265126400004
J	Ehnman, M; Li, H; Fredriksson, L; Pietras, K; Eriksson, U				Ehnman, M.; Li, H.; Fredriksson, L.; Pietras, K.; Eriksson, U.			The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth	ONCOGENE			English	Article						PDGF-D; uPA/uPAR; PDGFR beta; retention motif; proteolytic processing; tumorigenesis	UROKINASE PLASMINOGEN-ACTIVATOR; CELL-SURFACE; RECEPTOR; IDENTIFICATION; RETENTION; LIGAND; PROGRESSION; MECHANISM; ISOFORMS; SIGNAL	Members of the platelet-derived growth factor (PDGF) family are mitogens for cells of mesenchymal origin and have important functions during embryonic development, blood vessel maturation, fibrotic diseases and cancer. In contrast to the two classical PDGFs, the novel and less well-characterized members, PDGF-CC and PDGF-DD, are latent factors that need to be processed extracellularly by activating proteases, before they can mediate PDGF receptor activation. Here, we elucidate the structural requirements for urokinase plasminogen activator (uPA)-mediated activation of PDGF-DD, as well as the intricate interplay with uPA receptor (uPAR) signalling. Furthermore, we show that activated PDGF-DD, in comparison to latent, more potently transforms NIH/3T3 cells in vitro. Conversely, xenograft studies in nude mice demonstrate that cells expressing latent PDGF-DD are more tumorigenic than those expressing activated PDGF-DD. These findings imply that a fine-tuned proteolytic activation, in the local milieu, controls PDGF-DD bioavailability. Moreover, we suggest that proteolytic activation of PDGF-DD reveals a retention motif mediating interactions with pericellular components. Our proposed mechanism, where uPA not only generates active PDGF-DD, but also regulates its spatial distribution, provides novel insights into the biological function of PDGF-DD.	[Eriksson, U.] Ludwig Inst Canc Res Ltd, Karolinska Inst, Stockholm Branch, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research	Eriksson, U (corresponding author), Ludwig Inst Canc Res Ltd, Karolinska Inst, Stockholm Branch, Box 240, S-17177 Stockholm, Sweden.	ulf.eriksson@licr.ki.se	Pietras, Kristian/ABE-8727-2020; Pietras, Kristian/ABG-2097-2021; Ehnman, Monika/R-3687-2016	Pietras, Kristian/0000-0001-6738-4705; Ehnman, Monika/0000-0003-0468-2531; Fredriksson, Linda/0000-0003-4952-2742	Swedish Cancer Foundation; Swedish Research Council; Novo Nordisk Foundation; Karolinska Institutet	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Karolinska Institutet(Karolinska Institutet)	We thank Carl-Henrik Heldin (Ludwig Institute for Cancer Research Ltd, Uppsala Branch) for kindly providing PAE cell lines, R33 antiserum against human PDGFRb and purified PDGF-BB protein. Soheilla Rezaian and Sara Cunha helpfully assisted with PDGF-DD protein puri. cation and tissue preparations; Erika Folestad and Christina Fieber generously provided us with human PDGF-D and VEGF-B plasmids. The Swedish Cancer Foundation, the Swedish Research Council, the Novo Nordisk Foundation and Karolinska Institutet supported this study.	Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Fredriksson L, 2005, J BIOL CHEM, V280, P26856, DOI 10.1074/jbc.M503388200; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; LaRochelle WJ, 2002, CANCER RES, V62, P2468; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Miyake H, 1999, PROSTATE, V39, P123, DOI 10.1002/(SICI)1097-0045(19990501)39:2<123::AID-PROS7>3.0.CO;2-2; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Workman P, 1998, BRIT J CANCER, V77, P1; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313	28	18	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					534	544		10.1038/onc.2008.410	http://dx.doi.org/10.1038/onc.2008.410			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997817				2022-12-25	WOS:000262866500007
J	Malecka, KA; Ho, WC; Marmorstein, R				Malecka, K. A.; Ho, W. C.; Marmorstein, R.			Crystal structure of a p53 core tetramer bound to DNA	ONCOGENE			English	Article						p53; tumor suppressor; protein/DNA complex; crystal structure	BINDING DOMAIN PEPTIDES; TUMOR-SUPPRESSOR; SEQUENCE; RECOGNITION; COMPLEX; MULTIPLE; ELEMENTS; LOOP	The tumor suppressor p53 regulates downstream genes in response to many cellular stresses and is frequently mutated in human cancers. Here, we report the use of a crosslinking strategy to trap a tetrameric p53 DNA-binding domain (p53DBD) bound to DNA and the X-ray crystal structure of the protein/DNA complex. The structure reveals that two p53DBD dimers bind to B form DNA with no relative twist and that a p53 tetramer can bind to DNA without introducing significant DNA bending. The numerous dimer-dimer interactions involve several strictly conserved residues, thus suggesting a molecular basis for p53DBD-DNA binding cooperativity. Surface residue conservation of the p53DBD tetramer bound to DNA highlights possible regions of other p53 domain or p53 cofactor interactions.	[Malecka, K. A.; Ho, W. C.; Marmorstein, R.] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Malecka, K. A.; Ho, W. C.; Marmorstein, R.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, Program Gene Express & Regulat, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			NIGMS NIH HHS [T32 GM008275, R01 GM052880, R01 GM052880-11] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052880, T32GM008275] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DeLano WL, 2002, PYMOL USERS MANUAL; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; He CA, 2002, CHEM BIOL, V9, P1297, DOI 10.1016/S1074-5521(02)00283-1; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MACMILLAN AM, 1991, TETRAHEDRON, V47, P2603, DOI 10.1016/S0040-4020(01)81793-2; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; MCNAMARA PT, 1990, J BIOMOL STRUCT DYN, V8, P529, DOI 10.1080/07391102.1990.10507827; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; NAGAICH AK, 1994, J BIOL CHEM, V269, P7824; Nagaich AK, 1997, J BIOL CHEM, V272, P14830, DOI 10.1074/jbc.272.23.14830; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YP, 2007, J BIOL CHEM, V282, P691, DOI 10.1074/jbc.M605908200; Pan YP, 2008, J PHYS CHEM B, V112, P6716, DOI 10.1021/jp800680w; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Zhao KH, 2001, J BIOL CHEM, V276, P12120, DOI 10.1074/jbc.M011644200; ZHURKIN VB, 1991, P NATL ACAD SCI USA, V88, P7046, DOI 10.1073/pnas.88.16.7046; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	34	65	67	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					325	333		10.1038/onc.2008.400	http://dx.doi.org/10.1038/onc.2008.400			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18978813	Green Accepted			2022-12-25	WOS:000262550300002
J	Ooe, N; Motonaga, K; Kobayashi, K; Saito, K; Kaneko, H				Ooe, Norihisa; Motonaga, Kozo; Kobayashi, Kentaro; Saito, Koichi; Kaneko, Hideo			Functional Characterization of Basic Helix-Loop-Helix-PAS Type Transcription Factor NXF in Vivo PUTATIVE INVOLVEMENT IN AN "ON DEMAND" NEUROPROTECTION SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; INDUCTION; DEATH; SIM2; MICE; LOCALIZATION; ACTIVATION; APOPTOSIS	NXF, a member of the basic helix-loop-helix-PAS transcription factor family, is thought to be involved in functional regulation of neurons, because significant expression is found in the mature brain. To elucidate functions of NXF in vivo, here we generated mice lacking NXF using homologous recombination with embryonic stem cells. NXF-/- mice were morphologically indistinguishable (with no growth retardation) from their littermates (wild type) at birth. However, they started to die at a rate of 1 death/20-30 animals per week under specific pathogen-free grade breeding conditions when over 3 months old. Histological analyses revealed age-dependent neurodegeneration in brain, and only 20-30% of the NXF-/- mice survived for 16 months. To clarify the role of NXF in protection against neurodegeneration in normal cells, we analyzed gene expression under several conditions in vitro and in vivo. The NXF gene was up-regulated by several neurodegenerative cell-stress inducers such as thapsigargin (endoplasmic reticulum stress), SIN-1 (oxidative stress), and sorbitol (osmotic stress) in cultured cells. Furthermore, elevated NXF gene expression was apparent with in vivo stroke models featuring kainate-induced hippocampal injury and transient global ischemia. When NXF-/- mice were evaluated in the glutamate excitotoxicity model, they proved more susceptible to hippocampal injury at 15 weeks after birth. The findings in this study suggest that the NXF gene could be induced in response to several neurodegenerative stimuli/excitations for the cell protection, and thus provide an "on demand" cell-protection system in nervous tissue.	[Ooe, Norihisa; Motonaga, Kozo; Kobayashi, Kentaro; Saito, Koichi; Kaneko, Hideo] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana ku, Osaka 5548558, Japan	Sumitomo Chem Co Ltd	Ooe, N (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana ku, Osaka 5548558, Japan.	ooe@sc.sumitomo-chem.co.jp		Saito, Koichi/0000-0001-6497-5286				Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Barone FC, 2004, METH MOLEC MED, V104, P105; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Jiang L, 2006, MOL CELL BIOL, V26, P6547, DOI 10.1128/MCB.00284-06; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Lei XG, 2001, BIOFACTORS, V14, P93, DOI 10.1002/biof.5520140113; MORI K, 1993, CELL, V74, P743; Naoi M, 2005, MOL NEUROBIOL, V31, P81, DOI 10.1385/MN:31:1-3:081; NITATORI T, 1995, J NEUROSCI, V15, P1001; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Puig B, 2002, NEUROSCI LETT, V321, P182, DOI 10.1016/S0304-3940(01)02518-6; Rachidi M, 2005, INT J DEV NEUROSCI, V23, P475, DOI 10.1016/j.ijdevneu.2005.05.004; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200	30	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1057	1063		10.1074/jbc.M805196200	http://dx.doi.org/10.1074/jbc.M805196200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001414	hybrid			2022-12-25	WOS:000262122900042
J	Zheng, WH; Quirion, R				Zheng, Wen-Hua; Quirion, Remi			Glutamate Acting on N-Methyl-D-aspartate Receptors Attenuates Insulin-like Growth Factor-1 Receptor Tyrosine Phosphorylation and Its Survival Signaling Properties in Rat Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHRL1; CEREBELLAR GRANULE NEURONS; PROTEIN-KINASE-B; FACTOR-1-INDUCED PHOSPHORYLATION; DEPENDENT REGULATION; PHOSPHATASE SHP-2; AKT ACTIVATION; CELL-SURVIVAL; PC12 CELLS; EXCITOTOXICITY	Impairing intracellular signaling induced by survival factors and excess glutamate have recently been suggested to play important role in neurodegenerative processes. However, the underlying mechanism(s) and interrelationships between these factors mostly remain to be established. In the present study, we show that glutamate attenuates the tyrosine phosphorylation of the insulin-like growth factor-1 (IGF-1) receptor and the survival effect of IGF-1 (100 nM) in hippocampal cultured neurons. Pretreatment of cultured hippocampal neurons with glutamate concentration dependently inhibited the tyrosine phosphorylation of IGF-1 receptors as well as that of IRS-1 and Shc, two IGF-1 receptor adapter proteins. The effect of glutamate was also evident on the phosphorylation of Akt, as well as its upstream kinase PI3K/PDK1 and downstream targets, GSK3 beta and FOXO3a. The inhibitory effect of glutamate (1 mM) was blocked by antagonists of the N-methyl-D-aspartate (NMDA) receptor, including MK801 (20 mu M) and AP5 (100 mu M), but not by blockers of other ionotropic or metabotropic glutamate receptor sub-types demonstrating the involvement of the NMDA receptor. This hypothesis is supported further by the observation that treatment with NMDA concentration dependently inhibited the activation and phosphorylation of IGF-1 receptors and downstream targets induced by IGF-1 (100 nM). These findings demonstrate that glutamate can block the effect of IGF-1 by decreasing IGF-1 receptor signaling and responsiveness, hence attenuating the survival properties of this trophic factor in neuronal cells. Our results also suggest a novel mechanism by which glutamate can reduce cell viability and induce neurotoxicity.	[Zheng, Wen-Hua; Quirion, Remi] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Zheng, Wen-Hua] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	McGill University; Sun Yat Sen University	Quirion, R (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	remi.quirion@douglas.mcgill.ca			Canadian Institutes of Health Research; National Natural Science Fund of China [30670652, 30711120565]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Canadian Institutes of Health Research and by the National Natural Science Fund of China (Grants 30670652 and 30711120565). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulleit RF, 1998, TOXICOL APPL PHARM, V153, P161, DOI 10.1006/taap.1998.8561; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DEL PL, 1997, SCIENCE, V278, P687; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Loddick SA, 1999, P NATL ACAD SCI USA, V96, P9449, DOI 10.1073/pnas.96.17.9449; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maniar R, 2005, MOL CELL BIOCHEM, V275, P15, DOI 10.1007/s11010-005-7264-x; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Rocchi S, 1996, ENDOCRINOLOGY, V137, P4944, DOI 10.1210/en.137.11.4944; Rusanescu G, 2005, EMBO J, V24, P305, DOI 10.1038/sj.emboj.7600522; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Tagami M, 1997, LAB INVEST, V76, P613; Venters HD, 1999, P NATL ACAD SCI USA, V96, P9879, DOI 10.1073/pnas.96.17.9879; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zheng WH, 2000, J BIOL CHEM, V275, P13377, DOI 10.1074/jbc.275.18.13377; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	40	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					855	861		10.1074/jbc.M807914200	http://dx.doi.org/10.1074/jbc.M807914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981172	hybrid			2022-12-25	WOS:000262122900020
J	Bouet, JY; Lane, D				Bouet, Jean-Yves; Lane, David			Molecular Basis of the Supercoil Deficit Induced by the Mini-F Plasmid Partition Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; ESCHERICHIA-COLI; P1 PLASMID; CENTROMERE; SEGREGATION; LOCUS; SOPA; REPLICATION; SEGROSOME; MECHANISM	Formation of a partition complex on plasmid F by binding of SopB protein to the sopC centromere is the first step in the partition process that ensures stability of F in dividing cells. Establishment of the complex enables nonspecific binding of SopB to neighboring DNA, which extends the partition complex and provokes reduction of negative supercoiling of the plasmid. This reduction is believed to reflect winding of DNA into positive supercoils about SopB to create a nucleoprotein structure of probable importance to partition. We have searched for evidence that SopB alters plasmid topology. Permutation analysis indicated only modest bending of linear DNA fragments, and in vivo DNase I footprinting revealed no enhanced cleavages indicating curvature. In vitro, SopB binding left no topological trace in relaxed-circular DNA treated with topoisomerase I or in nicked circles closed by ligase. In vivo, novobiocin-mediated inhibition of DNA gyrase relaxed a plasmid carrying the partition complex but left no residue of positive supercoils. Hence, SopB does not reduce plasmid supercoiling directly. We did observe that SopB partly prevented removal of negative supercoils from plasmid DNA by topoisomerase I and partly prevented ligation of nicked circles, indicating that it acts as a physical obstacle. The supercoil deficit is thus better explained as SopB recoating of just-replicated DNA, which shelters it from gyrase and from topological changes in SopB-free DNA. This topological simplicity distinguishes the Sop partition complex from other complexes described.	[Bouet, Jean-Yves; Lane, David] CNRS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Bouet, Jean-Yves] Univ Toulouse, UPS, LMGM, F-31000 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bouet, JY (corresponding author), Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, Bat IBCG, 118 Route Narbonne, F-31062 Toulouse, France.	jean-yves.bouet@ibcg.biotoul.fr	Bouet, Jean-Yves/H-8469-2019	Bouet, Jean-Yves/0000-0003-1488-5455	soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires; Agence National de Recherche [06-BLAN-0280-01]	soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires; Agence National de Recherche(French National Research Agency (ANR))	This work was supported by the soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires and Agence National de Recherche Grant 06-BLAN-0280-01. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIEK DP, 1995, J MOL BIOL, V246, P388, DOI 10.1006/jmbi.1994.0094; BIEK DP, 1994, P NATL ACAD SCI USA, V91, P8027, DOI 10.1073/pnas.91.17.8027; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2006, MOL MICROBIOL, V62, P1447, DOI 10.1111/j.1365-2958.2006.05454.x; Bouet JY, 2005, MOL MICROBIOL, V55, P511, DOI 10.1111/j.1365-2958.2004.04396.x; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Breuner A, 1996, MOL MICROBIOL, V20, P581, DOI 10.1046/j.1365-2958.1996.5351063.x; Cassler MR, 1999, NUCLEIC ACIDS RES, V27, P4570, DOI 10.1093/nar/27.23.4570; CODERONI S, 1990, MOL BIOL REP, V14, P255, DOI 10.1007/BF00429894; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Derome A, 2008, P NATL ACAD SCI USA, V105, P2151, DOI 10.1073/pnas.0704681105; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; HAYAKAWA Y, 1985, J BACTERIOL, V163, P349, DOI 10.1128/JB.163.1.349-354.1985; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hirano M, 1998, MOL GEN GENET, V257, P392, DOI 10.1007/s004380050663; Hoischen C, 2008, NUCLEIC ACIDS RES, V36, P607, DOI 10.1093/nar/gkm672; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KOLB A, 1983, NUCLEIC ACIDS RES, V11, P7833, DOI 10.1093/nar/11.22.7833; Lemonnier M, 2000, MOL MICROBIOL, V38, P493, DOI 10.1046/j.1365-2958.2000.02101.x; Lewis DEA, 1999, MOL MICROBIOL, V31, P451, DOI 10.1046/j.1365-2958.1999.01186.x; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; LLOUBES R, 1988, J MOL BIOL, V204, P1049, DOI 10.1016/0022-2836(88)90062-9; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; LOCKSHON D, 1983, NUCLEIC ACIDS RES, V11, P2999, DOI 10.1093/nar/11.10.2999; LYNCH AS, 1994, J MOL BIOL, V236, P679, DOI 10.1006/jmbi.1994.1179; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; MORI H, 1989, J BIOL CHEM, V264, P15535; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ravin N, 1999, J BACTERIOL, V181, P6898, DOI 10.1128/JB.181.22.6898-6906.1999; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; SCHROTH GP, 1991, NUCLEIC ACIDS RES, V19, P511, DOI 10.1093/nar/19.3.511; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2007, J BIOL CHEM, V282, P10456, DOI 10.1074/jbc.M610603200; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TIMMIS K, 1976, NATURE, V261, P512, DOI 10.1038/261512a0; WATANABE E, 1989, MOL GEN GENET, V218, P431, DOI 10.1007/BF00332406; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Yates P, 1999, J MOL BIOL, V290, P627, DOI 10.1006/jmbi.1999.2909	52	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					165	173		10.1074/jbc.M802752200	http://dx.doi.org/10.1074/jbc.M802752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001378	hybrid			2022-12-25	WOS:000261974800019
J	Dhakal, BK; Mulvey, MA				Dhakal, Bijaya K.; Mulvey, Matthew A.			Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED BACTERIAL INVASION; POSTTRANSLATIONAL MODIFICATIONS; DYNAMIC MICROTUBULES; FOCAL ADHESIONS; STRESS FIBERS; ALPHA-TUBULIN; PROTEIN; HDAC6; ACETYLATION; CYTOSKELETON	Strains of uropathogenic Escherichia coli (UPEC) encode filamentous adhesive organelles called type 1 pili that promote bacterial colonization and invasion of the bladder epithelium. Type 1 pilus-mediated interactions with host receptors, including alpha 3 beta 1 integrin, trigger localized actin rearrangements that lead to internalization of adherent bacteria via a zipper-like mechanism. Here we report that type 1 pilus-mediated bacterial invasion of bladder cells also requires input from host microtubules and histone deacetylase 6 (HDAC6), a cytosolic enzyme that, by deacetylating alpha-tubulin, can alter the stability of microtubules along with the recruitment and directional trafficking of the kinesin-1 motor complex. We found that disruption of microtubules by nocodazole or vinblastine treatment, as well as microtubule stabilization by taxol, inhibited host cell invasion by UPEC, as did silencing of HDAC6 expression or pharmacological inhibition of HDAC6 activity. Invasion did not require two alternate HDAC6 substrates, Hsp90 and cortactin, but was dependent upon the kinesin-1 light chain KLC2 and an upstream activator of HDAC6, aurora A kinase. These results indicate that HDAC6 and microtubules act as vital regulatory elements during the invasion process, possibly via indirect effects on kinesin-1 and associated cargos.	[Dhakal, Bijaya K.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Mulvey, MA (corresponding author), Rm 2100 JMRB,15 N Med Dr E, Salt Lake City, UT 84112 USA.	mulvey@path.utah.edu		Mulvey, Matthew/0000-0002-6016-7510	National Institutes of Health [DK068585]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK068585. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; BELLESTRAM C, 2004, CELL MOTILITY MOL OR; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Bower JM, 2005, TRAFFIC, V6, P18, DOI 10.1111/j.1600-0854.2004.00251.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; DANOWSKI BA, 1989, J CELL SCI, V93, P255; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Foxman B, 2002, AM J MED, V113, p5S; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Hopkins SC, 2000, BIOCHEMISTRY-US, V39, P2805, DOI 10.1021/bi992474k; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kerrn MB, 2005, J ANTIMICROB CHEMOTH, V55, P383, DOI 10.1093/jac/dki002; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LIAO GJ, 1995, J CELL SCI, V108, P3473; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Martinez JJ, 2002, CELL MICROBIOL, V4, P19, DOI 10.1046/j.1462-5822.2002.00166.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Ronald A, 2002, AM J MED, V113, p14S; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Wang HB, 2008, J HISTOCHEM CYTOCHEM, V56, P597, DOI 10.1369/jhc.2008.950923; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	68	41	58	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					446	454		10.1074/jbc.M805010200	http://dx.doi.org/10.1074/jbc.M805010200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996840	Green Published, hybrid			2022-12-25	WOS:000261974800049
J	Eliezer, Y; Argaman, L; Rhie, A; Doherty, AJ; Goldberg, M				Eliezer, Yifat; Argaman, Liron; Rhie, Alexandre; Doherty, Aidan J.; Goldberg, Michal			The Direct Interaction between 53BP1 and MDC1 Is Required for the Recruitment of 53BP1 to Sites of Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; TUMOR-SUPPRESSOR; BRCT DOMAINS; FHA DOMAIN; CHECKPOINT; BINDING; REPAIR; CHROMATIN; PROTEINS	The DNA damage response mediators, 53BP1 and MDC1, play a central role in checkpoint activation and DNA repair. Here we establish that human 53BP1 and MDC1 interact directly through the tandem BRCT domain of MDC1 and residues 1288-1409 of 53BP1. Following induction of DNA double strand breaks the interaction is reduced, probably due to competition between gamma-H2AX and 53BP1 for the binding of the tandem BRCT domain of MDC1. Furthermore, the MDC1 binding region of 53BP1 is required for focus formation by 53BP1. During mitosis the interaction between 53BP1 and MDC1 is enhanced. The interaction is augmented in a phospho-dependent manner, and the MDC1 binding region of 53BP1 is phosphorylated in vivo in mitotic cells; therefore, it is probably modulated by cell cycle-regulated kinases. Our results demonstrate that the 53BP1-MDC1 interaction per se is required for the recruitment of 53BP1 to sites of DNA breaks, which is known to be crucial for an efficient activation of the DNA damage response. Moreover, the results presented here suggest that the interaction between 53BP1 and MDC1 plays a role in the regulation of mitosis.	[Eliezer, Yifat; Argaman, Liron; Goldberg, Michal] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Rhie, Alexandre; Doherty, Aidan J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Hebrew University of Jerusalem; University of Sussex	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il		Goldberg, Michal/0000-0001-9397-2383; Doherty, Aidan/0000-0002-6370-1109	Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK); the Royal Society; Medical Research Council [G0801130B] Funding Source: researchfish	Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Cancer Research UK); the Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Association for International Cancer Research (AICR), Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK), and the Royal Society.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jullien D, 2002, J CELL SCI, V115, P71; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	37	44	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					426	435		10.1074/jbc.M807375200	http://dx.doi.org/10.1074/jbc.M807375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986980	hybrid			2022-12-25	WOS:000261974800047
J	Rokudai, S; Aikawa, Y; Tagata, Y; Tsuchida, N; Taya, Y; Kitabayashi, I				Rokudai, Susumu; Aikawa, Yukiko; Tagata, Yusuke; Tsuchida, Nobuo; Taya, Yoichi; Kitabayashi, Issay			Monocytic Leukemia Zinc Finger (MOZ) Interacts with p53 to Induce p21 Expression and Cell-cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE; NUCLEAR RECEPTORS; PROTEIN KINASE-2; AMINO-TERMINUS; ACETYLATION; ACTIVATION; PHOSPHORYLATION; APOPTOSIS	Upon DNA damage, p53 can induce either cell-cycle arrest or apoptosis. Here we show that monocytic leukemia zinc finger (MOZ) forms a complex with p53 to induce p21 expression and cell-cycle arrest. The levels of the p53-MOZ complex increased in response to DNA damage to levels that induce cell-cycle arrest. MOZ(-/-) mouse embryonic fibroblasts failed to arrest in G(1) in response to DNA damage, and DNA damage-induced expression of p21 was impaired in MOZ(-/-) cells. These results suggest that MOZ is involved in regulating cell-cycle arrest in the G(1) phase. Screening of tumor-associated p53 mutants demonstrated that the G279E mutation in p53 disrupts interactions between p53 and MOZ, but does not affect the DNA binding activity of p53. The leukemia-associated MOZ-CBP fusion protein inhibits p53-mediated transcription. These results suggest that inhibition of p53/MOZ-mediated transcription is involved in tumor pathogenesis and leukemogenesis.	[Rokudai, Susumu; Aikawa, Yukiko; Tagata, Yusuke; Kitabayashi, Issay] Natl Canc Ctr, Res Inst, Div Mol Oncol, Tokyo 1040045, Japan; [Taya, Yoichi] Natl Canc Ctr, Res Inst, Div Radiobiol, Tokyo 1040045, Japan; [Tsuchida, Nobuo] Tokyo Med & Dent Univ, Dept Mol Cellular Oncol & Microbiol, Tokyo 1138510, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Kitabayashi, I (corresponding author), 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan.	ikitabay@ncc.go.jp	Rokudai, Susumu/O-6771-2018; Kitabayashi, Issay/G-2204-2017	Rokudai, Susumu/0000-0003-0300-0391; Kitabayashi, Issay/0000-0002-8409-0407	Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology; Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.	Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology; Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.(National Institute of Biomedical Innovation)	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Bristow CAP, 2003, NUCLEIC ACIDS RES, V31, P2735, DOI 10.1093/nar/gkg401; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; CHITTENDEN T, 1993, MOL CELL BIOL, V13, P3975, DOI 10.1128/MCB.13.7.3975; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; EL DW, 1993, CELL, V75, P817; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang J, 1998, BLOOD, V92, P2118, DOI 10.1182/blood.V92.6.2118.418k09_2118_2122; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Prives C, 1999, J PATHOL, V187, P112; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	52	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					237	244		10.1074/jbc.M805101200	http://dx.doi.org/10.1074/jbc.M805101200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001415	hybrid			2022-12-25	WOS:000261974800027
J	Wu, YD; Evers, BM; Zhou, BHP				Wu, Yadi; Evers, B. Mark; Zhou, Binhua P.			Small C-terminal Domain Phosphatase Enhances Snail Activity through Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTORS SNAIL; E-CADHERIN; TUMOR PROGRESSION; GENE-EXPRESSION; TGF-BETA; BREAST-CARCINOMA; CELL-DEATH; CANCER; METASTASIS	Down-regulation of E-cadherin plays an important role in epithelial-mesenchymal transition (EMT), which is critical in normal development and disease states such as tissue fibrosis and metastasis. Snail, a key transcription repressor of E-cadherin, is a labile protein with a short half-life and is regulated through phosphorylation, ubiquitination, and degradation. Previously, we showed that GSK-3 beta phosphorylated two stretches of serine residues within the nuclear export signal and the destruction box of Snail, provoking its cytoplasmic export for ubiquitin-mediated proteasome degradation. However, the mechanism of Snail dephosphorylation and the identity of the Snail-specific phosphatase remain elusive. Using a functional genomic screening, we found that the small C-terminal domain phosphatase (SCP) is a specific phosphatase for Snail. SCP interacted and co-localized with Snail in the nucleus. We also found that SCP expression induced Snail dephosphorylation and stabilization in vitro and in vivo. However, a catalytically inactive mutant of SCP had no effect on Snail. Furthermore, we found that Snail stabilization induced by SCP enhanced snail activity in the suppression of E-cadherin and increased cell migration. Thus, our findings indicate that SCP functions as a Snail phosphatase to control its phosphorylation and stabilization, and our study provides novel insights for the regulation of Snail during EMT and cancer metastasis.	[Wu, Yadi; Zhou, Binhua P.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Evers, B. Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Wu, Yadi; Evers, B. Mark; Zhou, Binhua P.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Zhou, BHP (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	bpzhou@utmb.edu			National Institutes of Health [R01CA125454]; ACS [IRG-110376]; Susan G. Komen Foundation [KG081310]; NATIONAL CANCER INSTITUTE [T32CA117834, R01CA125454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA125454 ( to B. P. Z.). This work was also supported by the John Sealy Memorial Endowment Fund, a pilot award from the ACS (IRG-110376), and grants from the Susan G. Komen Foundation (KG081310). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Davidson NE, 2005, CANCER CELL, V8, P173, DOI 10.1016/j.ccr.2005.08.006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Schlessinger K, 2004, NAT CELL BIOL, V6, P913, DOI 10.1038/ncb1004-913; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	43	82	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					640	648		10.1074/jbc.M806916200	http://dx.doi.org/10.1074/jbc.M806916200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004823	Green Published, hybrid			2022-12-25	WOS:000261974800069
J	Li, M; Li, CG; Liu, YH; Xing, YM; Hu, LY; Borok, Z; Kwong, KYC; Minoo, P				Li, Min; Li, Changgong; Liu, Yi-hsin; Xing, Yiming; Hu, Lingyan; Borok, Zea; Kwong, Kenny Y. -C.; Minoo, Parviz			Mesodermal Deletion of Transforming Growth Factor-beta Receptor II Disrupts Lung Epithelial Morphogenesis CROSS-TALK BETWEEN TGF-beta AND SONIC HEDGEHOG PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYONIC LUNG; SMOOTH-MUSCLE-CELLS; IN-VIVO; CONDITIONAL INACTIVATION; BRANCHING MORPHOGENESIS; TRANSGENIC MICE; EXPRESSION; DEFECTS; NKX2.1; FGF10	In vertebrates, Sonic hedgehog (Shh) and transforming growth factor-beta(TGF-beta) signaling pathways occur in an overlapping manner in many morphogenetic processes. In vitro data indicate that the two pathways may interact. Whether such interactions occur during embryonic development remains unknown. Using embryonic lung morphogenesis as a model, we generated transgenic mice in which exon 2 of the T beta RII gene, which encodes the type II TGF-beta receptor, was deleted via a mesodermal-specific Cre. Mesodermal-specific deletion of T beta RII (T beta RII Delta/Delta) resulted in embryonic lethality. The lungs showed abnormalities in both number and shape of cartilage in trachea and bronchi. In the lung parenchyma, where epithelial-mesenchymal interactions are critical for normal development, deletion of mesenchymal T beta RII caused abnormalities in epithelial morphogenesis. Failure in normal epithelial branching morphogenesis in the T beta RII Delta/Delta lungs caused cystic airway malformations. Interruption of the T beta RII locus in the lung mesenchyme increased mRNA for Patched and Gli-1, two downstream targets of Shh signaling, without alterations in Shh ligand levels produced in the epithelium. Therefore, we conclude that T beta RII-mediated signaling in the lung mesenchyme modulates transduction of Shh signaling that originates from the epithelium. To our knowledge, this is the first in vivo evidence for a reciprocal and novel mode of cross-communication between Shh and TGF-beta pathways during embryonic development.	[Li, Min; Li, Changgong; Xing, Yiming; Hu, Lingyan; Kwong, Kenny Y. -C.; Minoo, Parviz] Univ So Calif, Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90033 USA; [Liu, Yi-hsin] Univ So Calif, Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Borok, Zea] Univ So Calif, Sch Med, Pulm Res Ctr, Will Rogers Inst,Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Minoo, P (corresponding author), Gen Labs Bldg,1801 E Marengo St,Rm 1G1, Los Angeles, CA 90033 USA.	minoo@usc.edu	Borok, Zea/J-9015-2013	Borok, Zea/0000-0001-8673-8177	NHLBI; National Institutes of Health; Hastings Foundation	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation	This work was supported, in whole or in part, by NHLBI, National Institutes of Health. This work was also supported by the Hastings Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Black PN, 1996, AM J PHYSIOL-LUNG C, V271, pL910, DOI 10.1152/ajplung.1996.271.6.L910; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; del Moral PM, 2006, DEV BIOL, V293, P77, DOI 10.1016/j.ydbio.2006.01.020; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Hamdan H, 1998, BBA-GENE STRUCT EXPR, V1396, P336, DOI 10.1016/S0167-4781(97)00210-8; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Miller LAD, 2001, J HISTOCHEM CYTOCHEM, V49, P1593, DOI 10.1177/002215540104901213; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Pan QP, 2004, GENE, V331, P73, DOI 10.1016/j.gene.2004.01.026; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P1988, DOI 10.1210/en.2003-0842; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; WRANA JL, 2000, SCI STKE, pRE1; Xing YM, 2008, DEV BIOL, V320, P340, DOI 10.1016/j.ydbio.2008.04.044; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zeng X, 2001, DEV DYNAM, V221, P289, DOI 10.1002/dvdy.1140; Zhao Y, 2000, EXP MOL PATHOL, V69, P67, DOI 10.1006/exmp.2000.2319; Zhou L, 1996, DEV BIOL, V175, P227, DOI 10.1006/dbio.1996.0110	46	28	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36257	36264		10.1074/jbc.M806786200	http://dx.doi.org/10.1074/jbc.M806786200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990706	Green Published, hybrid			2022-12-25	WOS:000261840500021
J	Taguchi, H; Planque, S; Sapparapu, G; Boivin, S; Hara, M; Nishiyama, Y; Paul, S				Taguchi, Hiroaki; Planque, Stephanie; Sapparapu, Gopal; Boivin, Stephane; Hara, Mariko; Nishiyama, Yasuhiro; Paul, Sudhir			Exceptional Amyloid beta Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY LIGHT-CHAIN; VASOACTIVE-INTESTINAL-PEPTIDE; ALZHEIMERS-DISEASE; PROTEOLYTIC ANTIBODY; IRREVERSIBLE INHIBITORS; REPERTOIRE DEVELOPMENT; SERINE PROTEASES; LIGAND-BINDING; FC FUSIONS; SITE	Nucleophilic sites in the paired variable domains of the light and heavy chains (V-L and V-H domains) of Ig can catalyze peptide bond hydrolysis. Amyloid beta(A beta)-binding Igs are under consideration for immunotherapy of Alzheimer disease. We searched for A beta-hydrolyzing human IgV domains (IgVs) in a library containing a majority of single chain Fv clones mimicking physiological V-L-V-H-combining sites and minority IgV populations with nonphysiological structures generated by cloning errors. Random screening and covalent selection of phage- displayed IgVs with an electrophilic A beta analog identified rare IgVs that hydrolyzed A beta mainly at His(14)-Gln(15). Inhibition of IgV catalysis and irreversible binding by an electrophilic hapten suggested a nucleophilic catalytic mechanism. Structural analysis indicated that the catalytic IgVs are nonphysiological structures, a two domain heterodimeric VL (IgV(L2)-t) and single domain V-L clones with aberrant polypeptide tags (IgV(L)-t'). The IgVs hydrolyzed A beta at rates superior to naturally occurring Igs by 3-4 orders of magnitude. Forced pairing of the single domain V-L with V-H or V-L domains resulted in reduced A beta hydrolysis, suggesting catalysis by the unpaired V-L domain. angstrom ngstrom level amino acid displacements evident in molecular models of the two domain and unpaired V-L domain clones explain alterations of catalytic activity. In view of their superior catalytic activity, the V-L domain IgVs may help attain clearance of medically important antigens more efficiently than natural Igs.	[Taguchi, Hiroaki; Planque, Stephanie; Sapparapu, Gopal; Boivin, Stephane; Hara, Mariko; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Sapparapu, Gopal/B-5896-2009; Boivin, Stephane/K-4018-2012	Boivin, Stephane/0000-0003-1460-326X	National Institutes of Health [R01AG025304]; NATIONAL INSTITUTE ON AGING [R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG025304. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BJORK I, 1971, BIOCHEMISTRY-US, V10, P1280; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burbach GJ, 2007, NEUROBIOL AGING, V28, P202, DOI 10.1016/j.neurobiolaging.2005.12.003; Chakrabarti R, 2005, P NATL ACAD SCI USA, V102, P10153, DOI 10.1073/pnas.0504023102; COLOMA MJ, 1992, J IMMUNOL METHODS, V152, P89, DOI 10.1016/0022-1759(92)90092-8; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dijkstra BW, 2003, CURR OPIN STRUC BIOL, V13, P706, DOI 10.1016/j.sbi.2003.10.014; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; EDMUNDSON AB, 1987, MOL IMMUNOL, V24, P915, DOI 10.1016/0161-5890(87)90003-4; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Forloni G, 1996, PROG NEUROBIOL, V49, P287, DOI 10.1016/0301-0082(96)00013-5; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; GRUNDMAN M, 2008, INT C ALZH DIS JUL 2; Hanson CV, 2005, CURR OPIN BIOTECH, V16, P631, DOI 10.1016/j.copbio.2005.10.003; Harris DL, 2000, J MOL RECOGNIT, V13, P198, DOI 10.1002/1099-1352(200007/08)13:4<198::AID-JMR499>3.0.CO;2-D; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; HOOD L, 1975, ANNU REV GENET, V9, P305, DOI 10.1146/annurev.ge.09.120175.001513; Hosia W, 2005, J MASS SPECTROM, V40, P142, DOI 10.1002/jms.732; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; KOHEN F, 1979, FEBS LETT, V100, P137, DOI 10.1016/0014-5793(79)81149-7; Krasnorutskii MA, 2008, J MOL RECOGNIT, V21, P233, DOI 10.1002/jmr.890; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu R, 2004, BIOCHEMISTRY-US, V43, P9999, DOI 10.1021/bi0492354; Lue LF, 2002, J NEUROSCI RES, V70, P599, DOI 10.1002/jnr.10422; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; MEI S, 1991, J BIOL CHEM, V266, P15571; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; OLEKSYSZYN J, 1994, J MED CHEM, V37, P226, DOI 10.1021/jm00028a004; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; RAO G, 1991, J PROTEIN CHEM, V10, P117, DOI 10.1007/BF01024661; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Thayer MM, 1999, J MOL BIOL, V291, P329, DOI 10.1006/jmbi.1999.2960; Tucker HM, 2002, J NEUROSCI RES, V70, P249, DOI 10.1002/jnr.10417; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Yang K, 2003, PROTEIN ENG, V16, P761, DOI 10.1093/protein/gzg093	62	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36724	36733		10.1074/jbc.M806766200	http://dx.doi.org/10.1074/jbc.M806766200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974093	Green Published, hybrid			2022-12-25	WOS:000261840500070
J	Huynh, KK; Gershenzon, E; Grinstein, S				Huynh, Kassidy K.; Gershenzon, Elena; Grinstein, Sergio			Cholesterol Accumulation by Macrophages Impairs Phagosome Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RIIA; LIPOPROTEIN-DERIVED CHOLESTEROL; HAMSTER OVARY CELLS; INTRACELLULAR-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; LIPID RAFTS; FOAM CELLS; IN-VITRO; LYSOSOMES; RAB7	Macrophages are key to the pathogenesis of atherosclerosis. They take up and store excessive amounts of cholesterol associated with modified low density lipoprotein, eventually becoming foam cells that display altered immune responsiveness. We studied the effects of cholesterol accumulation on phagosome formation and maturation, using lipid transport antagonists and cholesterol transport-deficient mutants. In macrophages treated with U18666A, a transport antagonist that prevents cholesterol exit from late endosomes/lysosomes, the early stages of maturation proceeded normally; phagosomes acquired Rab5, phosphatidylinositol 3-phosphate, and EEA1 and merged with LAMP-containing vesicles. However, fusion with lysosomes was impaired. Rab7, which is required for phagolysosome formation, was acquired by phagosomes but remained inactive. Maturation was also studied in fibroblasts from Niemann-Pick type C individuals that have defective cholesterol transport. Transfection of Fc gamma IIA receptors was used to confer phagocytic capability to these fibroblasts. Niemann-Pick type C phagosomes failed to fuse with lysosomes, whereas wild type fibroblasts formed normal phagolysosomes. These findings indicate that cholesterol accumulation can have a detrimental effect on phagosome maturation by impairing the activation of Rab7, sequestering it and its effectors in cholesterol-enriched multilamellar compartments.	[Huynh, Kassidy K.; Gershenzon, Elena; Grinstein, Sergio] Univ Toronto, Cell Biol Programme, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Huynh, Kassidy K.; Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Gershenzon, Elena; Grinstein, Sergio] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Grinstein, S (corresponding author), Univ Toronto, Cell Biol Programme, Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca			Heart and Stroke Foundation of Ontario, Canada; Canadian Institutes of Health Research [T5944]	Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Heart and Stroke Foundation of Ontario, Canada and by the Canadian Institutes of Health Research Grant T5944. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; CLINTON SK, 1992, AM J PATHOL, V140, P301; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Kono H, 2002, J IMMUNOL, V169, P193, DOI 10.4049/jimmunol.169.1.193; Lange Y, 1997, J BIOL CHEM, V272, P17018, DOI 10.1074/jbc.272.27.17018; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lucas A D, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003696; Mansfield PJ, 2005, BIOCHEM BIOPH RES CO, V331, P132, DOI 10.1016/j.bbrc.2005.02.191; ROFF CF, 1991, DEV NEUROSCI-BASEL, V13, P315, DOI 10.1159/000112179; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Takahashi M, 2007, MOL BIOL CELL, V18, P2667, DOI 10.1091/mbc.E06-10-0924; TANGIRALA RK, 1993, J BIOL CHEM, V268, P9653; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x	33	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35745	35755		10.1074/jbc.M806232200	http://dx.doi.org/10.1074/jbc.M806232200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955491	hybrid			2022-12-25	WOS:000261687900048
J	Shirra, MK; McCartney, RR; Zhang, C; Shokat, KM; Schmidt, MC; Arndt, KM				Shirra, Margaret K.; McCartney, Rhonda R.; Zhang, Chao; Shokat, Kevan M.; Schmidt, Martin C.; Arndt, Karen M.			A Chemical Genomics Study Identifies Snf1 as a Repressor of GCN4 Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; TRANSFER-RNA BINDING; PROTEIN-KINASE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; MASTER REGULATOR; BETA-SUBUNITS; YEAST SNF1; IN-VIVO; ACTIVATION	The Saccharomyces cerevisiae Snf1 kinase plays a critical role in recalibrating cellular metabolism in response to glucose depletion. Hundreds of genes show changes in expression levels when the SNF1 gene is deleted. However, cells can adapt to the absence of a specific gene when grown in long term culture. Here we apply a chemical genetic method to rapidly and selectively inactivate a modified Snf1 kinase using a pyrazolopyrimidine inhibitor. By allowing cells to adjust to a change in carbon source prior to inhibition of the Snf1 kinase activity, we identified a set of genes whose expression increased when Snf1 was inhibited. Prominent in this set are genes that are activated by Gcn4, a transcriptional activator of amino acid biosynthetic genes. Deletion of Snf1 increased Gcn4 protein levels without affecting its mRNA levels. The increased Gcn4 protein levels required the Gcn2 kinase and Gcn20, regulators of GCN4 translation. These data indicate that Snf1 functions upstream of Gcn20 to regulate control of GCN4 translation in S. cerevisiae.	[Shirra, Margaret K.; Arndt, Karen M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Biochem & Mol Genet Program, Pittsburgh, PA 15261 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Arndt, KM (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	arndt@pitt.edu			National Institutes of Health [GM46443, GM52593, DK74654, AI44009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593, R29GM046443, R01GM046443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46443 (to M.C.S.), GM52593 (to K.M.A.), DK74654 (to K.M.A.), and AI44009 (to K.M.S.) from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNDT KM, 1995, EMBO J, V14, P1490, DOI 10.1002/j.1460-2075.1995.tb07135.x; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Brachmann CB, 1998, YEAST, V14, P115; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Irniger S, 2003, CURR GENET, V44, P8, DOI 10.1007/s00294-003-0422-3; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Liu Y, 2005, MOL CELL BIOL, V25, P10566, DOI 10.1128/MCB.25.23.10566-10579.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROSE MD, 1990, METHODS YEAST GENETI, P179; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Shirra MK, 2005, GENETICS, V169, P1957, DOI 10.1534/genetics.104.038075; Shirra MK, 1999, GENETICS, V152, P73; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Van de Velde S, 2008, EUKARYOT CELL, V7, P286, DOI 10.1128/EC.00276-07; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35889	35898		10.1074/jbc.M805325200	http://dx.doi.org/10.1074/jbc.M805325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955495	Green Published, hybrid			2022-12-25	WOS:000261687900064
J	Watanabe, H; Nakanishi, T; Umetsu, M; Kumagai, I				Watanabe, Hideki; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi			Human Anti-gold Antibodies BIOFUNCTIONALIZATION OF GOLD NANOPARTICLES AND SURFACES WITH ANTI-GOLD ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISPECIFIC DIABODY; QUANTUM DOTS; BINDING; CANCER; SPECIFICITY; RECOGNITION; FRAGMENTS; SELECTION; PHAGE; SEMICONDUCTOR	The interface molecules designed to exhibit molecular recognitions between different species have become attractive tools for the bottom-up fabrication and hybridization of nanostructured units. Here, we focus on antibodies with high binding ability and specificity to construct a novel biomolecule interface for recognizing an inorganic material. Careful selection from a phage-displayed library of variable region heavy and light Fv chains of human antibodies using enzyme-linked immunosorbent assay and surface plasmon resonance assay resulted in the identification of an antibody fragment, A14P-b2, with high affinity (K-D = 1.7 nM) and specificity for gold materials. Our results indicated the potential usefulness of human antibody libraries and the effectiveness of the antibody framework for recognizing bulk material surfaces. Construction of bivalent and bispecific antibodies on the A14P-b2 platform with high affinity by means of fusion technology enabled the functionalization of gold nanoparticles and allowed selective protein accumulation on gold spots patterned on a silicon substrate. This type of antibody engineering is potentially applicable to bio-inspired materials and nanobiosensing.	[Watanabe, Hideki; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Watanabe, Hideki/M-2711-2018	Watanabe, Hideki/0000-0002-9561-4077	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-aid for Scientific Research and Grant-in-aid for Young Scientists from Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P6385, DOI 10.1073/pnas.90.14.6385; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Braden BC, 2000, P NATL ACAD SCI USA, V97, P12193, DOI 10.1073/pnas.210396197; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j; Hayashi H, 2004, CANCER IMMUNOL IMMUN, V53, P497, DOI 10.1007/s00262-003-0465-9; Helfrich W, 1998, INT J CANCER, V76, P232, DOI 10.1002/(SICI)1097-0215(19980413)76:2<232::AID-IJC11>3.3.CO;2-N; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; Kasuya K, 1999, INT J BIOL MACROMOL, V24, P329, DOI 10.1016/S0141-8130(99)00046-X; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; MIRKIN CA, 1996, NATURE, V382, P609; Murcia M. J., 2005, NANOTECHNOLOGIES LIF; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; Oguri H, 2003, J AM CHEM SOC, V125, P7608, DOI 10.1021/ja034990a; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Schaferling M, 2004, PROTEIN MICROARRAY T, P11; Schnirman AA, 2006, NANO LETT, V6, P1870, DOI 10.1021/nl0607636; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; Umetsu M, 2005, ADV MATER, V17, P2571, DOI 10.1002/adma.200500863; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Watanabe H, 2002, BIOCHEM BIOPH RES CO, V295, P31, DOI 10.1016/S0006-291X(02)00616-2; Watanabe H, 2007, BIOCONJUGATE CHEM, V18, P645, DOI 10.1021/bc060203y; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	44	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36031	36038		10.1074/jbc.M805547200	http://dx.doi.org/10.1074/jbc.M805547200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955492	hybrid			2022-12-25	WOS:000261687900077
J	Dashtsoodol, N; Watarai, H; Sakata, S; Taniguchi, M				Dashtsoodol, Nyambayar; Watarai, Hiroshi; Sakata, Sakura; Taniguchi, Masaru			Identification of CD4(-)CD8(-) Double-Negative Natural Killer T Cell Precursors in the Thymus	PLOS ONE			English	Article								Background: It is well known that CD1d-restricted V alpha 14 invariant natural killer T (NKT) cells are derived from cells in the CD4(+)CD8(+) double-positive (DP) population in the thymus. However, the developmental progression of NKT cells in the earlier stages remains unclear, and the possible existence of NKT cell presursors in the earlier stages than DP stage remains to be tested. Principal Findings: Here, we demonstrate that NKT cell precursors that express invariant V alpha 14-J alpha 18 transcripts but devoid of surface expression of the invariant Va14 receptor are present in the late CD4(-)CD8(-) double-negative (DN) 4 stage and have the potential to generate mature NKT cells in both in vivo and in vitro experimental conditions. Moreover, the DN4 population in CD1d knock-out (CD1dKO) mice was similar to those with an NKT cell potential in wild-type (WT) C57BL/6 (B6) mice, but failed to develop into NKT cells in vitro. However, these precursors could develop into NKT cells when co-cultured with normal thymocytes or in an in vivo experimental setting, indicating that functional NKT cell precursors are present in CD1dKO mice. Conclusions: Together, these results demonstrate that thymic DN4 fraction contains NKT cell precursors. Our findings provide new insights into the early development of NKT cells prior to surface expression of the invariant Va14 antigen receptor and suggest the possible alternative developmental pathway of NKT cells.	[Dashtsoodol, Nyambayar; Watarai, Hiroshi; Sakata, Sakura; Taniguchi, Masaru] RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Tsurumi Ku, Kanagawa, Japan	RIKEN	Dashtsoodol, N (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Tsurumi Ku, Kanagawa, Japan.	taniguti@rcai.riken.jp	Watarai, Hiroshi/G-9894-2012	Watarai, Hiroshi/0000-0003-1511-2593; Dashtsoodol, Nyambayar/0000-0003-4890-9267	Ministry of Education, Culture, Sports, Science and Technology, Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bezbradica JS, 2006, IMMUNITY, V25, P487, DOI 10.1016/j.immuni.2006.06.017; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nakagawa K, 1997, P NATL ACAD SCI USA, V94, P2472, DOI 10.1073/pnas.94.6.2472; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515	28	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3688	10.1371/journal.pone.0003688	http://dx.doi.org/10.1371/journal.pone.0003688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997862	Green Published, Green Submitted, gold			2022-12-25	WOS:000265165500011
J	Lucchetta, EM; Vincent, ME; Ismagilov, RF				Lucchetta, Elena M.; Vincent, Meghan E.; Ismagilov, Rustem F.			A Precise Bicoid Gradient Is Nonessential during Cycles 11-13 for Precise Patterning in the Drosophila Blastoderm	PLOS ONE			English	Article								Background: During development, embryos decode maternal morphogen inputs into highly precise zygotic gene expression. The discovery of the morphogen Bicoid and its profound effect on developmental programming in the Drosophila embryo has been a cornerstone in understanding the decoding of maternal inputs. Bicoid has been described as a classical morphogen that forms a concentration gradient along the antero-posterior axis of the embryo by diffusion and initiates expression of target genes in a concentration-dependent manner in the syncytial blastoderm. Recent work has emphasized the stability of the Bicoid gradient as a function of egg length and the role of nuclear dynamics in maintaining the Bicoid gradient. Bicoid and nuclear dynamics were observed but not modulated under the ideal conditions used previously. Therefore, it has not been tested explicitly whether a temporally stable Bicoid gradient prior to cellularization is required for precise patterning. Principal Findings: Here, we modulate both nuclear dynamics and the Bicoid gradient using laminar flows of different temperature in a microfluidic device to determine if stability of the Bicoid gradient prior to cellularization is essential for precise patterning. Dramatic motion of both cytoplasm and nuclei was observed prior to cellularization, and the Bicoid gradient was disrupted by nuclear motion and was highly abnormal as a function of egg length. Despite an abnormal Bicoid gradient during cycles 11-13, Even-skipped patterning in these embryos remained precise. Conclusions: These results indicate that the stability of the Bicoid gradient as a function of egg length is nonessential during syncytial blastoderm stages. Further, presumably no gradient formed by simple diffusion on the scale of egg length could be responsible for the robust antero-posterior patterning observed, as severe cytoplasmic and nuclear motion would disrupt such a gradient. Additional mechanisms for how the embryo could sense its dimensions and interpret the Bicoid gradient are discussed.	[Lucchetta, Elena M.; Vincent, Meghan E.; Ismagilov, Rustem F.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago	Lucchetta, EM (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	r-ismagilov@uchicago.edu			NIH [R01 GM077331]; Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Grant No. R01 GM077331 and the Yen Postdoctoral Fellowship (E.M.L.).	BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bialek W, 2008, CELL, V132, P17, DOI 10.1016/j.cell.2007.12.023; Bird R. B., 2002, INTERPHASE TRANSPORT; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Crest J, 2007, GENETICS, V175, P567, DOI 10.1534/genetics.106.065219; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FOE VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lucchetta EM, 2006, LAB CHIP, V6, P185, DOI 10.1039/b516119c; MIYAMOTO DM, 1982, ROUX ARCH DEV BIOL, V191, P95, DOI 10.1007/BF00848446; OTTINO JM, 1990, ANNU REV FLUID MECH, V22, P207, DOI 10.1146/annurev.fl.22.010190.001231; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Song H, 2003, APPL PHYS LETT, V83, P4664, DOI 10.1063/1.1630378; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318	33	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3651	10.1371/journal.pone.0003651	http://dx.doi.org/10.1371/journal.pone.0003651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989373	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265134600002
J	Chiao, JY; Bowman, NE; Gill, H				Chiao, Joan Y.; Bowman, Nicholas E.; Gill, Harleen			The Political Gender Gap: Gender Bias in Facial Inferences that Predict Voting Behavior	PLOS ONE			English	Article							HUMAN MATE PREFERENCES; ATTRACTIVENESS; METAANALYSIS; WOMEN; APPEARANCE; DOMINANCE; LEADERS; FACES	Background: Throughout human history, a disproportionate degree of political power around the world has been held by men. Even in democracies where the opportunity to serve in top political positions is available to any individual elected by the majority of their constituents, most of the highest political offices are occupied by male leaders. What psychological factors underlie this political gender gap? Contrary to the notion that people use deliberate, rational strategies when deciding whom to vote for in major political elections, research indicates that people use shallow decision heuristics, such as impressions of competence solely from a candidate's facial appearance, when deciding whom to vote for. Because gender has previously been shown to affect a number of inferences made from the face, here we investigated the hypothesis that gender of both voter and candidate affects the kinds of facial impressions that predict voting behavior. Methodology/Principal Finding: Male and female voters judged a series of male and female political candidates on how competent, dominant, attractive and approachable they seemed based on their facial appearance. Then they saw a series of pairs of political candidates and decided which politician they would vote for in a hypothetical election for President of the United States. Results indicate that both gender of voter and candidate affect the kinds of facial impressions that predict voting behavior. All voters are likely to vote for candidates who appear more competent. However, male candidates that appear more approachable and female candidates who appear more attractive are more likely to win votes. In particular, men are more likely to vote for attractive female candidates whereas women are more likely to vote for approachable male candidates. Conclusions/Significance: Here we reveal gender biases in the intuitive heuristics that voters use when deciding whom to vote for in major political elections. Our findings underscore the impact of gender and physical appearance on shaping voter decision-making and provide novel insight into the psychological foundations underlying the political gender gap.	[Chiao, Joan Y.; Gill, Harleen] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Chiao, Joan Y.; Bowman, Nicholas E.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA; [Gill, Harleen] Smith Coll, Neurosci Program, Northampton, MA USA	Northwestern University; Northwestern University; Smith College	Chiao, JY (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	jchiao@northwestern.edu		Gill, Harleen/0000-0002-6654-9878	Praxis; NSF [BCS-0720312, BCS-0722326]	Praxis; NSF(National Science Foundation (NSF))	This work is supported by Praxis grant to H.G. and NSF BCS-0720312 and BCS-0722326 grants to J.Y.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; BEAMAN L, 2008, 0814 MIT DEP EC; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; EAGLY AH, 1995, PSYCHOL BULL, V117, P125, DOI 10.1037/0033-2909.117.1.125; Eagly AH, 2003, PSYCHOL BULL, V129, P569, DOI 10.1037/0033-2909.129.4.569; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; GALLUP, 2002, GALLUP POLL PUBLIC O; Hess U, 2004, EMOTION, V4, P378, DOI 10.1037/1528-3542.4.4.378; Jalalzai F, 2004, WOMEN POLIT, V26, P85, DOI 10.1300/J014v26n03_04; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; LAMMERS J, 2008, EUROPEAN J SOCIAL PS; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; MACRAE CN, 1994, J PERS SOC PSYCHOL, V66, P37, DOI 10.1037/0022-3514.66.1.37; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; Rhodes G, 2002, FACIAL ATTRACTIVENES; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Senior C, 1999, BEHAV RES METH INS C, V31, P341, DOI 10.3758/BF03207730; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; UNICEF, 2007, STAT WORLDS CHILDR W; Zebrowitz L. A., 1997, READING FACES WINDOW	25	58	58	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3666	10.1371/journal.pone.0003666	http://dx.doi.org/10.1371/journal.pone.0003666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432KK	18974841	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131700033
J	Liesa, M; Borda-d'Agua, B; Medina-Gomez, G; Lelliott, CJ; Paz, JC; Rojo, M; Palacin, M; Vidal-Puig, A; Zorzano, A				Liesa, Marc; Borda-d'Agua, Barbara; Medina-Gomez, Gema; Lelliott, Christopher J.; Carlos Paz, Jose; Rojo, Manuel; Palacin, Manuel; Vidal-Puig, Antonio; Zorzano, Antonio			Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1 beta	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ADAPTIVE THERMOGENESIS; INSULIN-RESISTANCE; IN-VITRO; 2A GENE; MITOFUSIN-2; METABOLISM; DISEASE; MFN2; PGC-1-ALPHA	Background: There is no evidence to date on whether transcriptional regulators are able to shift the balance between mitochondrial fusion and fission events through selective control of gene expression. Methodology/Principal Findings: Here, we demonstrate that reduced mitochondrial size observed in knock-out mice for the transcriptional regulator PGC-1 beta is associated with a selective reduction in Mitofusin 2 (Mfn2) expression, a mitochondrial fusion protein. This decrease in Mfn2 is specific since expression of the remaining components of mitochondrial fusion and fission machinery were not affected. Furthermore, PGC-1 beta increases mitochondrial fusion and elongates mitochondrial tubules. This PGC-1 beta-induced elongation specifically requires Mfn2 as this process is absent in Mfn2-ablated cells. Finally, we show that PGC-1 beta increases Mfn2 promoter activity and transcription by coactivating the nuclear receptor Estrogen Related Receptor alpha (ERR alpha). Conclusions/Significance: Taken together, our data reveal a novel mechanism by which mammalian cells control mitochondrial fusion. In addition, we describe a novel role of PGC-1 beta in mitochondrial physiology, namely the control of mitochondrial fusion mainly through Mfn2.	[Liesa, Marc; Borda-d'Agua, Barbara; Carlos Paz, Jose; Palacin, Manuel; Zorzano, Antonio] IRB Barcelona, Barcelona, Spain; [Liesa, Marc; Borda-d'Agua, Barbara; Carlos Paz, Jose; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim Biol Mol, E-08007 Barcelona, Spain; [Liesa, Marc; Carlos Paz, Jose; Zorzano, Antonio] CIBERDEM, Barcelona, Spain; [Medina-Gomez, Gema; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metabol Res Lab, Inst Metabol Sci, Cambridge CB2 1TN, England; [Lelliott, Christopher J.] AstraZeneca R&D, Dept Biosci, Molndal, Sweden; [Rojo, Manuel] Univ Victor Segalen, CNRS, UMR5095, IBGC, Bordeaux, France	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; AstraZeneca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Zorzano, A (corresponding author), IRB Barcelona, Barcelona, Spain.	antonio.zorzano@irbbarcelona.org	Zorzano, Antonio/R-5479-2018; Medina-Gomez, Gema/CAI-1063-2022; Medina-Gomez, Gema/CAF-4668-2022; Paz, Jose Carlos/I-5783-2015; Medina-Gomez, Gema/F-5667-2016; Liesa, Marc/K-8590-2019; Lelliott, Christopher J/G-4620-2011; Rojo, Manuel/AAM-7352-2021	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Paz, Jose Carlos/0000-0001-9684-9735; Medina-Gomez, Gema/0000-0001-8169-681X; Liesa, Marc/0000-0002-5909-8570; Lelliott, Christopher J/0000-0001-8087-4530; Rojo, Manuel/0000-0002-9680-9263; Vidal-Puig, Antonio/0000-0003-4220-9577; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Educacion y Cultura [SAF 2005-00445, SAF2008-03803, predoctoral fellowship]; Generalitat de Catalunya [2005SGR00947]; CIBERDEM (Instituto de Salud Carlos III); University of Barcelona [Science Intensification Award]; MRC [G0400192] Funding Source: UKRI	Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Generalitat de Catalunya(Generalitat de Catalunya); CIBERDEM (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); University of Barcelona; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by research grants from the Ministerio de Educacion y Cultura (SAF 2005-00445; SAF2008-03803), Grant 2005SGR00947 from the Generalitat de Catalunya, and CIBERDEM (Instituto de Salud Carlos III). A.Z. is the recipient of a Science Intensification Award from the University of Barcelona. M.L. is the recipient of a predoctoral fellowship from the Ministerio de Educacion y Cultura, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSADI G, 1994, GENE THER, V1, P338; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Baumgartner BG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001183; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Staiger H, 2006, DIABETOLOGIA, V49, P212, DOI 10.1007/s00125-005-0061-y; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	33	137	140	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3613	10.1371/journal.pone.0003613	http://dx.doi.org/10.1371/journal.pone.0003613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974884	gold, Green Published, Green Submitted			2022-12-25	WOS:000265131700027
J	Haskew-Layton, RE; Rudkouskaya, A; Jin, YQ; Feustel, PJ; Kimelberg, HK; Mongin, AA				Haskew-Layton, Renee E.; Rudkouskaya, Alena; Jin, Yiqiang; Feustel, Paul J.; Kimelberg, Harold K.; Mongin, Alexander A.			Two Distinct Modes of Hypoosmotic Medium-Induced Release of Excitatory Amino Acids and Taurine in the Rat Brain In Vivo	PLOS ONE			English	Article							SH-SY5Y NEUROBLASTOMA-CELLS; ISCHEMIC CORTICAL PENUMBRA; REGULATORY VOLUME DECREASE; SENSITIVE ANION CHANNELS; CEREBRAL-CORTEX; CULTURED ASTROCYTES; CHLORIDE CHANNELS; GLIAL-CELLS; HIPPOCAMPAL SLICES; MOLECULAR IDENTITY	A variety of physiological and pathological factors induce cellular swelling in the brain. Changes in cell volume activate several types of ion channels, which mediate the release of inorganic and organic osmolytes and allow for compensatory cell volume decrease. Volume-regulated anion channels (VRAC) are thought to be responsible for the release of some of organic osmolytes, including the excitatory neurotransmitters glutamate and aspartate. In the present study, we compared the in vivo properties of the swelling-activated release of glutamate, aspartate, and another major brain osmolyte taurine. Cell swelling was induced by perfusion of hypoosmotic (low [NaCl]) medium via a microdialysis probe placed in the rat cortex. The hypoosmotic medium produced several-fold increases in the extracellular levels of glutamate, aspartate and taurine. However, the release of the excitatory amino acids differed from the release of taurine in several respects including: (i) kinetic properties, (ii) sensitivity to isoosmotic changes in [NaCl], and (iii) sensitivity to hydrogen peroxide, which is known to modulate VRAC. Consistent with the involvement of VRAC, hypoosmotic medium-induced release of the excitatory amino acids was inhibited by the anion channel blocker DNDS, but not by the glutamate transporter inhibitor TBOA or Cd(2+), which inhibits exocytosis. In order to elucidate the mechanisms contributing to taurine release, we studied its release properties in cultured astrocytes and cortical synaptosomes. Similarities between the results obtained in vivo and in synaptosomes suggest that the swelling-activated release of taurine in vivo may be of neuronal origin. Taken together, our findings indicate that different transport mechanisms and/or distinct cellular sources mediate hypoosmotic medium-induced release of the excitatory amino acids and taurine in vivo.	[Haskew-Layton, Renee E.; Rudkouskaya, Alena; Feustel, Paul J.; Mongin, Alexander A.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Haskew-Layton, Renee E.] Cornell Univ, Burke Med Res Inst, White Plains, NY USA; [Jin, Yiqiang; Kimelberg, Harold K.] Ordway Res Inst, Albany, NY USA	Albany Medical College; Cornell University; Ordway Research Institute	Mongin, AA (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	MonginA@mail.amc.edu	Mongin, Alexander A./A-5526-2008; Feustel, Paul/AAW-5157-2021	Mongin, Alexander A./0000-0002-2501-3778; Feustel, Paul/0000-0002-6963-4349; Rudkouskaya, Alena/0000-0002-3632-9743	NIH [F31 NS046961, R01 NS035205, R21 NS052516]; AMC [201-311053]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS046961, R01NS035205, R21NS052516] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grants F31 NS046961 (to REH-L), R01 NS035205 (to HKK), R21 NS052516 (to AAM), and AMC grant 201-311053 (to AAM). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Anderson CM, 2000, GLIA, V32, P1; BANDERALI U, 1992, AM J PHYSIOL, V263, pC1200, DOI 10.1152/ajpcell.1992.263.6.C1200; Basarsky TA, 1999, J NEUROSCI, V19, P6439; Boese SH, 1996, AM J PHYSIOL-RENAL, V271, pF498, DOI 10.1152/ajprenal.1996.271.3.F498; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; Calvert DT, 1998, ACTA PHYSIOL SCAND, V162, P97, DOI 10.1046/j.1365-201X.1998.0267f.x; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEBABO SR, 1995, J PHYSIOL-LONDON, V487, P685, DOI 10.1113/jphysiol.1995.sp020910; Cheema TA, 2007, J PHARMACOL EXP THER, V320, P1068, DOI 10.1124/jpet.106.115741; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DECAVEL C, 1995, J COMP NEUROL, V354, P13, DOI 10.1002/cne.903540103; Estevez AY, 1999, NEUROCHEM RES, V24, P447, DOI 10.1023/A:1020902104056; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Franco R, 2003, ADV EXP MED BIOL, V526, P189; Franco R, 2001, PFLUG ARCH EUR J PHY, V442, P791; Franco R, 2000, J NEUROSCI RES, V61, P701, DOI 10.1002/1097-4547(20000915)61:6<701::AID-JNR14>3.3.CO;2-K; HAJOS F, 1975, BRAIN RES, V93, P485, DOI 10.1016/0006-8993(75)90186-9; Haskew RE, 2002, J NEUROCHEM, V82, P903, DOI 10.1046/j.1471-4159.2002.01037.x; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Heacock AM, 2004, J PHARMACOL EXP THER, V311, P1097, DOI 10.1124/jpet.104.072553; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Junankar PR, 2000, CELL PHYSIOL BIOCHEM, V10, P355, DOI 10.1159/000016368; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kirk K, 1998, ANNU REV PHYSIOL, V60, P719, DOI 10.1146/annurev.physiol.60.1.719; KOHUT JJ, 1992, STROKE, V23, P93, DOI 10.1161/01.STR.23.1.93; LAMBERT IH, 1994, J MEMBRANE BIOL, V142, P289; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LAW RO, 1994, BBA-MOL CELL RES, V1221, P21, DOI 10.1016/0167-4889(94)90211-9; Law RO, 1996, BBA-MOL CELL RES, V1314, P34, DOI 10.1016/S0167-4889(96)00070-5; LEHMANN A, 1990, J NEUROCHEM, V54, P126, DOI 10.1111/j.1471-4159.1990.tb13291.x; LEHMANN A, 1989, J NEUROCHEM, V53, P525, DOI 10.1111/j.1471-4159.1989.tb07365.x; Liu X, 2001, J NEUROENDOCRINOL, V13, P894, DOI 10.1046/j.1365-2826.2001.00711.x; MADSEN S, 1985, NEUROSCI LETT, V60, P255, DOI 10.1016/0304-3940(85)90586-5; Minami A, 2001, BRAIN RES, V894, P336, DOI 10.1016/S0006-8993(01)02022-4; Mongin AA, 1999, AM J PHYSIOL-CELL PH, V276, pC1226, DOI 10.1152/ajpcell.1999.276.5.C1226; Mongin AA, 1997, NEUROCHEM INT, V31, P835, DOI 10.1016/S0197-0186(97)00033-8; Mongin AA, 1999, AM J PHYSIOL-CELL PH, V277, pC823, DOI 10.1152/ajpcell.1999.277.4.C823; MONGIN AA, 2005, NEUROGLIA, P550; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Morales I, 2007, AM J PHYSIOL-CELL PH, V292, pC1934, DOI 10.1152/ajpcell.00593.2006; MORAN J, 1994, ADV EXP MED BIOL, V359, P361; Nedvetsky PI, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1027; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2006, CONTRIB NEPHROL, V152, P9, DOI 10.1159/000096285; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Phillis JW, 1999, BRAIN RES, V828, P1, DOI 10.1016/S0006-8993(99)01235-4; Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026; ROY G, 1995, J MEMBRANE BIOL, V147, P35; Rutledge EM, 1996, J NEUROSCI, V16, P7803; SANCHEZOLEA R, 1993, NEUROSCI LETT, V156, P141, DOI 10.1016/0304-3940(93)90458-W; Saransaari P, 2006, AMINO ACIDS, V31, P35, DOI 10.1007/s00726-006-0290-5; SCHOUSBOE A, 1991, J NEUROSCI RES, V30, P661, DOI 10.1002/jnr.490300409; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; SHARP T, 1990, NEUROSCIENCE, V39, P629, DOI 10.1016/0306-4522(90)90247-2; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; SHENNAN DB, 1994, EXP PHYSIOL, V79, P797, DOI 10.1113/expphysiol.1994.sp003808; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STORMMATHISEN J, 1986, MED BIOL, V64, P127; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Sykova E, 2000, PROG BRAIN RES, V125, P155; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Tomassen SFB, 2004, AM J PHYSIOL-CELL PH, V286, pC1417, DOI 10.1152/ajpcell.00468.2003; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tuz K, 2004, EUR J NEUROSCI, V19, P916, DOI 10.1111/j.0953-816X.2004.03209.x; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Waseem TV, 2005, NEUROCHEM INT, V46, P235, DOI 10.1016/j.neuint.2004.09.002; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027	86	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3543	10.1371/journal.pone.0003543	http://dx.doi.org/10.1371/journal.pone.0003543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958155	Green Submitted, Green Published, gold			2022-12-25	WOS:000265130900005
J	Zito, G; Richiusa, P; Bommarito, A; Carissimi, E; Russo, L; Coppola, A; Zerilli, M; Rodolico, V; Criscimanna, A; Amato, M; Pizzolanti, G; Galluzzo, A; Giordano, C				Zito, Giovanni; Richiusa, Pierina; Bommarito, Alessandra; Carissimi, Elvira; Russo, Leonardo; Coppola, Antonina; Zerilli, Monica; Rodolico, Vito; Criscimanna, Angela; Amato, Marco; Pizzolanti, Giuseppe; Galluzzo, Aldo; Giordano, Carla			In Vitro Identification and Characterization of CD133(pos) Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines	PLOS ONE			English	Article							HEMATOPOIETIC STEM; EXPRESSION; CARCINOGENESIS; FRAMEWORK; MARKER; LUNG; RNA	Background: Recent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown. Methodology/Principal Findings: ATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64 +/- 9% and 57 +/- 12%, respectively). These data were confirmed by qRT-PCR and immunocytochemistry. ARO and KAT-4 were also positive for fetal marker oncofetal fibronectin and negative for thyrocyte-specific differentiating markers thyroglobulin, thyroperoxidase and sodium/iodide symporter. Sorted ARO/CD133(pos) cells exhibited higher proliferation, self-renewal, colony-forming ability in comparison with ARO/CD133(neg). Furthermore, ARO/CD133(pos) showed levels of thyroid transcription factor TTF-1 similar to the fetal thyroid cell line TAD-2, while the expression in ARO/CD133(neg) was negligible. The expression of the stem cell marker OCT-4 detected by RT-PCR and flow cytometry was markedly higher in ARO/CD133(pos) in comparison to ARO/CD133(neg) cells. The stem cell markers c-KIT and THY-1 were negative. Sensitivity to chemotherapy agents was investigated, showing remarkable resistance to chemotherapy-induced apoptosis in ARO/CD133(pos) when compared with ARO/CD133(neg) cells. Conclusions/Significance: We describe CD133(pos) cells in ATC cell lines. ARO/CD133(pos) cells exhibit stem cell-like features such as high proliferation, self-renewal ability, expression of OCT-4 - and are characterized by higher resistance to chemotherapy. The simultaneous positivity for thyroid specific factor TTF-1 and onfFN suggest they might represent putative thyroid cancer stem-like cells. Our in vitro findings might provide new insights for novel therapeutic approaches.	[Zito, Giovanni; Richiusa, Pierina; Bommarito, Alessandra; Carissimi, Elvira; Russo, Leonardo; Coppola, Antonina; Criscimanna, Angela; Amato, Marco; Pizzolanti, Giuseppe; Galluzzo, Aldo; Giordano, Carla] Univ Palermo, DOSAC, Mol Endocrinol Lab, Endocrinol Sect, Palermo, Italy; [Zerilli, Monica; Rodolico, Vito] Univ Palermo, Dept Human Pathol, I-90133 Palermo, Italy	University of Palermo; University of Palermo	Giordano, C (corresponding author), Univ Palermo, DOSAC, Mol Endocrinol Lab, Endocrinol Sect, Palermo, Italy.	cgiordan@unipa.it	Coppola, Antonina/AAE-5901-2021; Coppola, Antonina/AAO-8203-2020; , Zito/O-3836-2019; GIORDANO, Carla/R-4296-2017; Pizzolanti, Giuseppe/I-4547-2019; Coppola, Antonina/AAJ-6763-2020; Pizzolanti, Giuseppe/K-7097-2016	Coppola, Antonina/0000-0001-6664-8553; , Zito/0000-0002-0482-6729; GIORDANO, Carla/0000-0003-1731-9395; Pizzolanti, Giuseppe/0000-0001-6052-8438; RODOLICO, VITO/0000-0003-1409-4207	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) 60% (C.G.)	AACE/AME, 2006, ENDOCR PRACT, V12, P63; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Alderden RA, 2006, J CHEM EDUC, V83, P728, DOI 10.1021/ed083p728; Baguley BC, 2006, RECENT PAT ANTI-CANC, V1, P121, DOI 10.2174/157489206775246494; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; CHO W, 2008, CURR OPIN GENE DEV, V18, P1; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Lin RY, 2007, THYROID, V17, P1019, DOI 10.1089/thy.2007.0183; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Michael M, 2005, J CLIN ONCOL, V23, P205, DOI 10.1200/JCO.2005.02.120; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHWEPPE RE, 2008, J CLIN ENDOCRINOL ME; Seigel GM, 2007, MOL VIS, V13, P823; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takano T, 2005, THYROID, V15, P432, DOI 10.1089/thy.2005.15.432; Takano T, 2007, JPN J CLIN ONCOL, V37, P647, DOI 10.1093/jjco/hym084; Takano T, 2007, SEMIN CANCER BIOL, V17, P233, DOI 10.1016/j.semcancer.2006.02.001; Thomas D, 2008, ENDOCR-RELAT CANCER, V15, P51, DOI 10.1677/ERC-07-0210; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611	43	79	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3544	10.1371/journal.pone.0003544	http://dx.doi.org/10.1371/journal.pone.0003544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958156	Green Published, Green Submitted, gold			2022-12-25	WOS:000265130900006
J	Lehky, SR; Peng, XM; McAdams, CJ; Sereno, AB				Lehky, Sidney R.; Peng, Xinmiao; McAdams, Carrie J.; Sereno, Anne B.			Spatial Modulation of Primate Inferotemporal Responses by Eye Position	PLOS ONE			English	Article							INFERIOR TEMPORAL NEURONS; PARIETAL CORTEX; COORDINATE TRANSFORMATIONS; OBJECT REPRESENTATIONS; STRIATE CORTEX; SHAPE; PERCEPTION; MONKEY; AREA; RECOGNITION	Background: A key aspect of representations for object recognition and scene analysis in the ventral visual stream is the spatial frame of reference, be it a viewer-centered, object-centered, or scene-based coordinate system. Coordinate transforms from retinocentric space to other reference frames involve combining neural visual responses with extraretinal postural information. Methodology/Principal Findings: We examined whether such spatial information is available to anterior inferotemporal (AIT) neurons in the macaque monkey by measuring the effect of eye position on responses to a set of simple 2D shapes. We report, for the first time, a significant eye position effect in over 40% of recorded neurons with small gaze angle shifts from central fixation. Although eye position modulates responses, it does not change shape selectivity. Conclusions/Significance: These data demonstrate that spatial information is available in AIT for the representation of objects and scenes within a non-retinocentric frame of reference. More generally, the availability of spatial information in AIT calls into questions the classic dichotomy in visual processing that associates object shape processing with ventral structures such as AIT but places spatial processing in a separate anatomical stream projecting to dorsal structures.	[Lehky, Sidney R.] Salk Inst Biol Studies, Computat Neurosci Lab, La Jolla, CA USA; [Lehky, Sidney R.; Peng, Xinmiao; Sereno, Anne B.] Univ Texas, Houston Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX USA; [McAdams, Carrie J.] Univ Texas, Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA	Salk Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lehky, SR (corresponding author), Salk Inst Biol Studies, Computat Neurosci Lab, La Jolla, CA USA.	anne.b.sereno@uth.tmc.edu	McAdams, Carrie J./M-6822-2017	McAdams, Carrie J./0000-0002-4768-6703	NIH [R01 MH63340]; National Alliance for Research on Schizophrenia and Depression (NARSAD); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by NIH grant R01 MH63340, the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the J. S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelopoulos NC, 2005, EUR J NEUROSCI, V22, P2903, DOI 10.1111/j.1460-9568.2005.04487.x; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Barrow H., 1978, COMPUT VIS SYST, V2, P2; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Bremmer F, 2000, NEUROREPORT, V11, P1277, DOI 10.1097/00001756-200004270-00027; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; COWEY A, 1967, Q J EXP PSYCHOL, V19, P246, DOI 10.1080/14640746708400099; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale Melvyn A, 2003, Adv Neurol, V93, P249; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOMATSU H, 1993, J NEUROPHYSIOL, V70, P677, DOI 10.1152/jn.1993.70.2.677; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lehky SR, 2007, J NEUROPHYSIOL, V97, P1298, DOI 10.1152/jn.00167.2006; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOWE DG, 1989, ARTIF INTELL, V31, P355; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; Merleau-Ponty M., 2002, HUSSERL LIMITS PHENO; MOTTER BC, 1981, J NEUROSCI, V1, P3, DOI 10.1523/JNEUROSCI.01-01-00003.1981; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Nowicka A, 2000, EUR J NEUROSCI, V12, P751, DOI 10.1046/j.1460-9568.2000.00943.x; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Saleem KS, 1996, J NEUROSCI, V16, P4757; Salinas E, 2001, Prog Brain Res, V130, P175; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; SCHLAG J, 1992, EXP BRAIN RES, V90, P302; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vishwanath D, 2003, VISION RES, V43, P1637, DOI 10.1016/S0042-6989(03)00168-8; Vogels R, 2001, J COGNITIVE NEUROSCI, V13, P444, DOI 10.1162/08989290152001871; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	70	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3492	10.1371/journal.pone.0003492	http://dx.doi.org/10.1371/journal.pone.0003492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946508	Green Submitted, gold, Green Published			2022-12-25	WOS:000265126200001
J	Yi, YH; Ho, PY; Chen, TW; Lin, WJ; Gukassyan, V; Tsai, TH; Wang, DW; Lew, TS; Tang, CY; Lo, SJ; Chen, TY; Kao, FJ; Lin, CH				Yi, Yung-Hsiang; Ho, Pei-Yun; Chen, Tung-Wei; Lin, Wen-Jie; Gukassyan, Vladimir; Tsai, Tsung-Heng; Wang, Da-Wei; Lew, Tien-Shen; Tang, Chih-Yung; Lo, Szecheng J.; Chen, Tsung-Yu; Kao, Fu-Jen; Lin, Chi-Hung			Membrane Targeting and Coupling of NHE1-Integrin alpha(IIb)beta(3)-NCX1 by Lipid Rafts following Integrin-Ligand Interactions Trigger Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; HUMAN-PLATELETS; NA+/CA2+ EXCHANGER; PLASMA-MEMBRANE; CALCIUM; SODIUM; CELLS; ACTIVATION; FIBRINOGEN; TRANSPORT	The cyclic calcium release and uptake during calcium oscillation are thought to result from calcium-induced calcium release (CICR); however, it is unclear, especially in nonexcitable cells, how the initial calcium mobilization that triggers CICR occurs. We report here a novel mechanism, other than conventional calcium channels or the phopholipase C-inositol trisphosphate system, for initiating calcium oscillation downstream of integrin signaling. Upon integrin alpha(IIb)beta(3) binding to fibrinogen ligand or the disintegrin rhodostomin, sodium-proton exchanger NHE1 and sodium-calcium exchanger NCX1 are actively transported to the plasma membrane, and they become physically coupled to integrin alpha(IIb)beta(3). Lipid raft-dependent mechanisms modulate the membrane targeting and formation of the NHE1-integrin alpha(IIb)beta(3)-NCX1 protein complex. NHE1 and NCX1 within such protein complex are functionally coupled, such that a local increase of sodium concentration caused by NHE1 can drive NCX1 to generate sodium efflux in exchange for calcium influx. The resulting calcium increase inside the cell can then trigger CICR as a prelude to calcium oscillation downstream of integrin alpha(IIb)beta(3) signaling. Fluorescence resonance energy transfer based on fluorescence lifetime measurements is employed here to monitor the intermolecular interactions among NHE1-integrin alpha(IIb)beta(3)-NCX1, which could not be properly detected using conventional biochemical assays.	[Ho, Pei-Yun; Chen, Tung-Wei; Gukassyan, Vladimir; Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Tsai, Tsung-Heng; Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan; [Lew, Tien-Shen] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Dept Physiol, Taipei 100, Taiwan; [Lo, Szecheng J.] Chang Gung Univ, Dept Life Sci, Taipei 333, Taiwan; [Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95618 USA; [Lin, Chi-Hung] Taipei Vet Gen Hosp, Dept Surg, Taipei 112, Taiwan; [Lin, Chi-Hung] Taipei City Hosp, Dept Med Educ & Res, Taipei 10341, Taiwan; [Lin, Chi-Hung] Natl Nano Device Lab, Hsinchu 30078, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; Chang Gung University; University of California System; University of California Davis; University of California System; University of California Davis; Taipei Veterans General Hospital; Taipei City Hospital	Lin, CH (corresponding author), 155,Sec 2,Linong St, Taipei 112, Taiwan.	linch@ym.edu.tw	Kao, Fu-Jen/GYQ-6902-2022; Kao, Fu-Jen/C-8269-2012	TANG, CHIH-YUNG/0000-0003-1065-2865; Tsai, Tsung-Heng/0000-0001-5211-2985; Kao, Fu-Jen/0000-0001-8361-3942	Ministry of Education; Aim for the Top University Plan; National Science Council, Taiwan [NSC 91-2320-B-010-051, NSC (94-96)-2627-B-010-005, NSC 97-3112-B-010-017, NSC 95-2321-B-010-005]	Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Microscopy for this study was supported by the Biophotonics Interdisciplinary Research Center and the Genome Research Center of National Yang-Ming University. This work was supported by Ministry of Education, Aim for the Top University Plan and National Science Council, Taiwan Grants NSC 91-2320-B-010-051, NSC (94-96)-2627-B-010-005, NSC 97-3112-B-010-017, and NSC 95-2321-B-010-005. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTIERI DC, 1990, J BIOL CHEM, V265, P12119; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bodin S, 2003, BBA-BIOMEMBRANES, V1610, P247, DOI 10.1016/S0005-2736(03)00022-1; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BORLE AB, 1991, AM J PHYSIOL, V261, pC482, DOI 10.1152/ajpcell.1991.261.3.C482; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Cingolani HE, 2001, NEWS PHYSIOL SCI, V16, P88; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Ghukasyan V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718582; GILLESPIE JI, 1992, EXP PHYSIOL, V77, P141, DOI 10.1113/expphysiol.1992.sp003568; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Huang J, 2008, AM J PHYSIOL-CELL PH, V294, pC516, DOI 10.1152/ajpcell.00417.2007; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto T, 2006, KIDNEY INT, V69, P2148, DOI 10.1038/sj.ki.5000421; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Jen CJ, 1996, BLOOD, V87, P3775, DOI 10.1182/blood.V87.9.3775.bloodjournal8793775; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; Lian WN, 1999, HEPATOLOGY, V30, P748, DOI 10.1002/hep.510300302; Lian WN, 2006, J CELL SCI, V119, P11, DOI 10.1242/jcs.02706; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; LIU PS, 1990, CELL CALCIUM, V11, P573, DOI 10.1016/0143-4160(90)90011-I; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Orlov SN, 1999, AM J PHYSIOL-CELL PH, V276, pC511, DOI 10.1152/ajpcell.1999.276.3.C511; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Rosskopf D, 1999, J THROMB THROMBOLYS, V8, P15, DOI 10.1023/A:1008986329267; Shiraga M, 1998, BLOOD, V92, P3710, DOI 10.1182/blood.V92.10.3710.422k13_3710_3720; SIFFERT W, 1987, NATURE, V325, P456, DOI 10.1038/325456a0; SIFFERT W, 1988, TRENDS BIOCHEM SCI, V13, P148, DOI 10.1016/0968-0004(88)90074-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Thomas MJ, 2003, J MOL CELL CARDIOL, V35, P1325, DOI 10.1016/j.yjmcc.2003.08.005; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Viatchenko-Karpinski S, 2005, J PHYSIOL-LONDON, V567, P493, DOI 10.1113/jphysiol.2005.091280; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang Y, 2007, METHOD ENZYMOL, V426, P177, DOI 10.1016/S0076-6879(07)26009-4; Xie X, 2004, NEUROCHEM RES, V29, P2135, DOI 10.1007/s11064-004-6887-8; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	51	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3855	3864		10.1074/jbc.M804334200	http://dx.doi.org/10.1074/jbc.M804334200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18996841	hybrid			2022-12-25	WOS:000262872500054
J	Metral, S; Machnicka, B; Bigot, S; Colin, Y; Dhermy, D; Lecomte, MC				Metral, Sylvain; Machnicka, Beata; Bigot, Sylvain; Colin, Yves; Dhermy, Didier; Lecomte, Marie-Christine			alpha II-Spectrin Is Critical for Cell Adhesion and Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; BETA-SPECTRIN; ANKYRIN-G; EXTRACELLULAR-MATRIX; ACTIN POLYMERIZATION; ENA/VASP PROTEINS; LATERAL MEMBRANE; ELF; INACTIVATION; CYTOSKELETON	Spectrins are ubiquitous scaffolding components of the membrane skeleton that organize and stabilize microdomains on both the plasma membrane and the intracellular organelles. By way of their numerous interactions with diverse protein families, they are implicated in various cellular functions. Using small interfering RNA strategy in the WM-266 cell line derived from human melanoma, we found that alpha II-spectrin deficiency is associated with a defect in cell proliferation, which is related to a cell cycle arrest at the G(1) phase (first gap phase), as evaluated by DNA analysis and Rb phosphorylation. These observations coincided with elevated expression of the cyclin-dependent kinase inhibitor, p21(Cip). Concomitantly, spectrin loss impaired cell adhesion and spreading. These cell adhesion defects were associated with modifications of the actin cytoskeleton, such as loss of stress fibers, alterations of focal adhesions, and modified expression of some integrins. Our results provide novel insights into spectrin functions by demonstrating the involvement of alpha II-spectrin in cell cycle regulation and actin organization.	[Lecomte, Marie-Christine] Inst Natl Transfus Sanguine, INSERM, U665, F-75015 Paris, France; [Metral, Sylvain; Machnicka, Beata; Bigot, Sylvain; Colin, Yves; Dhermy, Didier; Lecomte, Marie-Christine] Univ Paris 07, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecomte, MC (corresponding author), Inst Natl Transfus Sanguine, INSERM, U665, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	marie-christine.lecomte@inserm.fr	Machnicka, Beata/AAF-1814-2019; Machnicka, Beata/AAF-1677-2019; colin, yves/O-1910-2017; METRAL, Sylvain/P-5833-2017	Machnicka, Beata/0000-0002-9664-8252; colin, yves/0000-0001-5196-4254; METRAL, Sylvain/0000-0001-6244-8546				Baek HJ, 2006, BIOCHEM BIOPH RES CO, V346, P1150, DOI 10.1016/j.bbrc.2006.05.195; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Gallagher Patrick G, 2004, Curr Hematol Rep, V3, P85; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Grimber Gisele, 1992, Transgenic Research, V1, P268, DOI 10.1007/BF02525168; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kim SS, 2006, BIOCHEM BIOPH RES CO, V344, P1216, DOI 10.1016/j.bbrc.2006.03.236; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LECOMTE MC, 1993, BRIT J HAEMATOL, V85, P584; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; Praitis V, 2005, DEV BIOL, V283, P157, DOI 10.1016/j.ydbio.2005.04.002; Pugacheva EN, 2006, CURR OPIN CELL BIOL, V18, P507, DOI 10.1016/j.ceb.2006.08.014; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003; Wandersee NJ, 2003, BLOOD, V101, P325, DOI 10.1182/blood-2002-01-0113; Wong GK, 1996, DEV BIOL, V180, P199, DOI 10.1006/dbio.1996.0295; Zuhlke C, 2007, J NEUROL, V254, P1649, DOI 10.1007/s00415-007-0600-1	43	50	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2409	2418		10.1074/jbc.M801324200	http://dx.doi.org/10.1074/jbc.M801324200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18978357	hybrid			2022-12-25	WOS:000262545600049
J	Oestreich, EA; Malik, S; Goonasekera, SA; Blaxall, BC; Kelley, GG; Dirksen, RT; Smrcka, AV				Oestreich, Emily A.; Malik, Sundeep; Goonasekera, Sanjeewa A.; Blaxall, Burns C.; Kelley, Grant G.; Dirksen, Robert T.; Smrcka, Alan V.			Epac and Phospholipase C epsilon Regulate Ca2+ Release in the Heart by Activation of Protein Kinase C epsilon and Calcium-Calmodulin Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; SIGNALING PATHWAY; CONTRACTION; EFFECTOR; RAS; HYPERTROPHY; CHANNEL; DELTA	Recently, we identified a novel signaling pathway involving Epac, Rap, and phospholipase C (PLC)epsilon that plays a critical role in maximal beta-adrenergic receptor (beta AR) stimulation of Ca2+-induced Ca2+ release (CICR) in cardiac myocytes. Here we demonstrate that PLC epsilon phosphatidylinositol 4,5-bisphosphate hydrolytic activity and PLC epsilon-stimulated Rap1 GEF activity are both required for PLC epsilon-mediated enhancement of sarcoplasmic reticulum Ca2+ release and that PLC epsilon significantly enhances Rap activation in response to beta AR stimulation in the heart. Downstream of PLC epsilon hydrolytic activity, pharmacological inhibition of PKC significantly inhibited both beta AR- and Epac-stimulated increases in CICR in PLC epsilon(+/+) myocytes but had no effect in PLC epsilon(-/-) myocytes. beta AR and Epac activation caused membrane translocation of PKC epsilon in PLC epsilon(+/+) but not PLC epsilon(-/-) myocytes and small interfering RNA- mediated PKC epsilon knockdown significantly inhibited both beta AR and Epac-mediated CICR enhancement. Further downstream, the Ca2+/calmodulin-dependent protein kinase II (CamKII) inhibitor, KN93, inhibited beta AR- and Epac-mediated CICR in PLC epsilon(+/+) but not PLC epsilon(-/-) myocytes. Epac activation increased CamKII Thr(286) phosphorylation and enhanced phosphorylation at CamKII phosphorylation sites on the ryanodine receptor (RyR2) (Ser(2815)) and phospholamban (Thr(17)) in a PKC-dependent manner. Perforated patch clamp experiments revealed that basal and beta AR-stimulated peak L-type current density are similar in PLC epsilon(+/+) and PLC epsilon(-/-) myocytes suggesting that control of sarcoplasmic reticulum Ca2+ release, rather than Ca2+ influx through L-type Ca2+ channels, is the target of regulation of a novel signal transduction pathway involving sequential activation of Epac, PLC epsilon, PKC epsilon, and CamKII downstream of beta AR activation.	[Oestreich, Emily A.; Malik, Sundeep; Goonasekera, Sanjeewa A.; Blaxall, Burns C.; Dirksen, Robert T.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Blaxall, Burns C.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Kelley, Grant G.] SUNY Upstate Med Ctr, Dept Pharmacol, Syracuse, NY 14620 USA; [Kelley, Grant G.] SUNY Upstate Med Ctr, Dept Med, Syracuse, NY 14620 USA	University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Smrcka, AV (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	Alan_Smrcka@urmc.rochester.edu	Blaxall, Burns/ABD-8289-2021		National Institutes of Health [GMR01053536, AR044657, DK56294]; American Heart Association Scientist Development [045343T]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GMR01053536 (to A.V.S.), AR044657 (to R.T.D.), and DK56294 (to G.G.K.). This work was also supported by American Heart Association Scientist Development Grant 045343T (to B.C.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Currie S, 2004, BIOCHEM J, V377, P357, DOI 10.1042/BJ20031043; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Woodcock EA, 2005, PHARMACOL THERAPEUT, V107, P240, DOI 10.1016/j.pharmthera.2005.04.002	28	143	147	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1514	1522		10.1074/jbc.M806994200	http://dx.doi.org/10.1074/jbc.M806994200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18957419	Green Published, hybrid			2022-12-25	WOS:000262330100019
J	Tocchini-Valentini, GD; Rochel, N; Escriva, H; Germain, P; Peluso-Iltis, C; Paris, M; Sanglier-Cianferani, S; Van Dorsselaer, A; Moras, D; Laudet, V				Tocchini-Valentini, Giuseppe D.; Rochel, Natacha; Escriva, Hector; Germain, Pierre; Peluso-Iltis, Carole; Paris, Mathilde; Sanglier-Cianferani, Sarah; Van Dorsselaer, Alain; Moras, Dino; Laudet, Vincent			Structural and Functional Insights into the Ligand-binding Domain of a Nonduplicated Retinoid X Nuclear Receptor from the Invertebrate Chordate Amphioxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNION-OF-PHARMACOLOGY; CRYSTAL-STRUCTURE; MASS-SPECTROMETRY; HETERODIMERIC COMPLEX; ECDYSONE RECEPTOR; ORPHAN RECEPTOR; ACID RECEPTORS; RXR-ALPHA; EVOLUTION; SUPERFAMILY	Retinoid X nuclear receptors (RXRs), as well as their insect orthologue, ultraspiracle protein (USP), play an important role in the transcription regulation mediated by the nuclear receptors as the common partner of many other nuclear receptors. Phylogenetic and structural studies have shown that the several evolutionary shifts have modified the ligand binding ability of RXRs. To understand the vertebrate-specific character of RXRs, we have studied the RXR ligand-binding domain of the cephalochordate amphioxus (Branchiostoma floridae), an invertebrate chordate that predates the genome duplication that produced the three vertebrates RXRs (alpha, beta, and gamma). Here we report the crystal structure of a novel apotetramer conformation of the AmphiRXR ligand-binding domain, which shows some similarity with the structures of the arthropods RXR/USPs. AmphiRXR adopts an apo antagonist conformation with a peculiar conformation of helix H11 filling the binding pocket. In contrast to the arthropods RXR/USPs, which cannot be activated by any RXR ligands, our functional data show that AmphiRXR, like the vertebrates/mollusk RXRs, is able to bind and be activated by RXR ligands but less efficiently than vertebrate RXRs. Our data suggest that amphioxus RXR is, functionally, an intermediate between arthropods RXR/USPs and vertebrate RXRs.	[Tocchini-Valentini, Giuseppe D.; Rochel, Natacha; Peluso-Iltis, Carole; Moras, Dino] Univ Strasbourg 1, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France; [Germain, Pierre] Univ Strasbourg 1, Dept Canc Biol, Inst Genet & Biol Mol & Celluaire, CNRS,UMR7104,U596,INSERM, F-67400 Illkirch Graffenstaden, France; [Escriva, Hector; Paris, Mathilde; Laudet, Vincent] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS,INRA,Inst Federatif Biosci Gerland 128, F-69364 Lyon, France; [Sanglier-Cianferani, Sarah; Van Dorsselaer, Alain] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, CNRS,UMR 7178, Inst Pluridisciplinaire Hubert CURIEN,Ecole Chim, F-67087 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laudet, V (corresponding author), Ecole Normale Super Lyon 1, Inst Genom Fonct Lyon, Mol Zool Team, Inst Federatif Biosci Gerland 128, F-69364 Lyon, France.	vincent.laudet@ens-lyon.fr	Escriva, Hector/K-8325-2013; Tocchini-Valentini, Giuseppe D./AAL-4889-2021; Rochel, Natacha/A-5718-2016	Escriva, Hector/0000-0001-7577-5028; Tocchini-Valentini, Giuseppe D./0000-0002-4454-9543; Rochel, Natacha/0000-0002-3573-5889; PARIS, Mathilde/0000-0001-6166-6672; Germain, Pierre/0000-0003-2962-9593; Cianferani, Sarah/0000-0003-4013-4129	CNRS; INSERM; Universite Louis Pasteur; European Commission on Structural Proteomics in Europe (SPINE) [QLG2CT-220-0098]; SPINE2-Complexes [LSHG-CT-2006-031220]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Louis Pasteur; European Commission on Structural Proteomics in Europe (SPINE)(European CommissionEuropean Commission Joint Research Centre); SPINE2-Complexes	This study was supported by CNRS, INSERM, Universite Louis Pasteur, European Commission on Structural Proteomics in Europe (SPINE) Grant QLG2CT-220-0098, and SPINE2-Complexes Grant LSHG-CT-2006-031220 under the integrated program, Quality of Life and Management of Living Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Bonneton F, 2003, MOL BIOL EVOL, V20, P541, DOI 10.1093/molbev/msg054; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bovet C, 2007, PROTEIN SCI, V16, P938, DOI 10.1110/ps.062664107; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; de Groot A, 2005, J MOL BIOL, V354, P841, DOI 10.1016/j.jmb.2005.09.090; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2002, DEVELOPMENT, V129, P2905; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Escriva H, 2000, BIOESSAYS, V22, P717; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gustafsson JA, 1999, SCIENCE, V284, P1285, DOI 10.1126/science.284.5418.1285; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Kostrouch Z, 1998, P NATL ACAD SCI USA, V95, P13442, DOI 10.1073/pnas.95.23.13442; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Laudet V., 2002, NUCL RECEPTOR FACTS; Lengqvist J, 2005, J AM SOC MASS SPECTR, V16, P1631, DOI 10.1016/j.jasms.2005.06.003; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Peschke M, 2004, J AM SOC MASS SPECTR, V15, P1424, DOI 10.1016/j.jasms.2004.05.005; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Sanglier S, 2004, EUR J BIOCHEM, V271, P4958, DOI 10.1111/j.1432-1033.2004.04466.x; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87	50	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1938	1948		10.1074/jbc.M805692200	http://dx.doi.org/10.1074/jbc.M805692200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986992	Green Published, hybrid			2022-12-25	WOS:000262330100064
J	Timmer, AM; Timmer, JC; Pence, MA; Hsu, LC; Ghochani, M; Frey, TG; Karin, M; Salvesen, GS; Nizet, V				Timmer, Anjuli M.; Timmer, John C.; Pence, Morgan A.; Hsu, Li-Chung; Ghochani, Mariam; Frey, Terrence G.; Karin, Michael; Salvesen, Guy S.; Nizet, Victor			Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE; GENE-EXPRESSION; III SECRETION; CYTOCHROME-C; ACTIVATION; CASPASE-1; PROGRAM; CYTOLYSIN; BACTERIA; NECROSIS	Group A Streptococcus ( GAS) is a leading human bacterial pathogen capable of producing invasive infections even in previously healthy individuals. As frontline components of host innate defense, macrophages play a key role in control and clearance of GAS infections. We find GAS induces rapid, dose-dependent apoptosis of primary and cultured macrophages and neutrophils. The cell death pathway involves apoptotic caspases, is partly dependent on caspase-1, and requires GAS internalization by the phagocyte. Analysis of GAS virulence factor mutants, heterologous expression, and purified toxin studies identified the pore-forming cytolysin streptolysin O (SLO) as necessary and sufficient for the apoptosis-inducing phenotype. SLO-deficient GAS mutants induced less macrophage apoptosis in vitro and in vivo, allowed macrophage cytokine secretion, and were less virulent in a murine systemic infection model. Ultrastructural evidence of mitochondrial membrane remodeling, coupled with loss of mitochondrial depolarization and cytochrome c release, suggests a direct attack of the toxin initiates the intrinsic apoptosis pathway. A general caspase inhibitor blocked SLO-induced apoptosis and enhanced macrophage killing of GAS. We conclude that accelerated, caspase-dependent macrophage apoptosis induced by the pore-forming cytolysin SLO contributes to GAS immune evasion and virulence.	[Nizet, Victor] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Timmer, Anjuli M.; Timmer, John C.; Pence, Morgan A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hsu, Li-Chung; Karin, Michael] Univ Calif San Diego, Lab Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Timmer, John C.; Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10002, Taiwan; [Ghochani, Mariam] San Diego State Univ, Dept Phys, San Diego, CA 92182 USA; [Frey, Terrence G.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; National Taiwan University; California State University System; San Diego State University; California State University System; San Diego State University	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, E Rm 1066,9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Pence, Morgan A./N-1620-2019; Nizet, Victor/AAF-3190-2019	Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422; Hsu, Li-Chung/0000-0001-7206-5231	National Institutes of Health [T32-CA77109]; Crohn's & Colitis Foundation; NATIONAL CANCER INSTITUTE [T32CA077109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants ( to V. N., M. K., T. G. F., and G. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant T32-CA77109 (training grant).; Supported by the Crohn's & Colitis Foundation.	Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Boise LH, 2001, TRENDS MICROBIOL, V9, P64, DOI 10.1016/S0966-842X(00)01937-5; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Denault Jean-Bernard, 2008, V414, P191; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999	42	117	118	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					862	871		10.1074/jbc.M804632200	http://dx.doi.org/10.1074/jbc.M804632200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001420	hybrid, Green Published			2022-12-25	WOS:000262122900021
J	Abriata, LA; Cassina, A; Tortora, V; Marin, M; Souza, JM; Castro, L; Vila, AJ; Radi, R				Abriata, Luciano A.; Cassina, Adriana; Tortora, Veronica; Marin, Monica; Souza, Jose M.; Castro, Laura; Vila, Alejandro J.; Radi, Rafael			Nitration of Solvent-exposed Tyrosine 74 on Cytochrome c Triggers Heme Iron-Methionine 80 Bond Disruption NUCLEAR MAGNETIC RESONANCE AND OPTICAL SPECTROSCOPY STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE CONFORMATIONAL TRANSITION; FERRICYTOCHROME-C; NITRIC-OXIDE; NITROCYTOCHROME-C; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; PROTEIN; PEROXYNITRITE; MITOCHONDRIAL; APOPTOSIS	Cytochrome c, a mitochondrial electron transfer protein containing a hexacoordinated heme, is involved in other physiologically relevant events, such as the triggering of apoptosis, and the activation of a peroxidatic activity. The latter occurs secondary to interactions with cardiolipin and/or post-translational modifications, including tyrosine nitration by peroxynitrite and other nitric oxide-derived oxidants. The gain of peroxidatic activity in nitrated cytochrome c has been related to a heme site transition in the physiological pH region, which normally occurs at alkaline pH in the native protein. Herein, we report a spectroscopic characterization of two nitrated variants of horse heart cytochrome c by using optical spectroscopy studies and NMR. Highly pure nitrated cytochrome c species modified at solvent-exposed Tyr-74 or Tyr-97 were generated after treatment with a flux of peroxynitrite, separated, purified by preparative high pressure liquid chromatography, and characterized by mass spectrometry-based peptide mapping. It is shown that nitration of Tyr-74 elicits an early alkaline transition with a pK(a) = 7.2, resulting in the displacement of the sixth and axial iron ligand Met-80 and replacement by a weaker Lys ligand to yield an alternative low spin conformation. Based on the study of site-specific Tyr to Phe mutants in the four conserved Tyr residues, we also show that this transition is not due to deprotonation of nitro-Tyr-74, but instead we propose a destabilizing steric effect of the nitro group in the mobile Omega-loop of cytochrome c, which is transmitted to the iron center via the nearby Tyr-67. The key role of Tyr-67 in promoting the transition through interactions with Met-80 was further substantiated in the Y67F mutant. These results therefore provide new insights into how a remote post-translational modification in cytochrome c such as tyrosine nitration triggers profound structural changes in the heme ligation and microenvironment and impacts in protein function.	[Cassina, Adriana; Tortora, Veronica; Souza, Jose M.; Castro, Laura; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Abriata, Luciano A.; Vila, Alejandro J.] Univ Nacl Rosario, Biophys Sect, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Cassina, Adriana; Tortora, Veronica; Marin, Monica; Souza, Jose M.; Castro, Laura; Radi, Rafael] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay; [Marin, Monica] Univ Republica, Fac Ciencias, Secc Bioquim Biol Mol, Montevideo 11400, Uruguay	Universidad de la Republica, Uruguay; National University of Rosario; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Avda Gen Flores 2125, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy	Marin, Monica-Paula/Y-3387-2019	Vila, Alejandro/0000-0002-7978-3233	National Institutes of Health [R01-GM068682]; Howard Hughes Medical Institute; International Centre of Genetic Engineering and Biotechnology; Comision Sectorial de Investigacion Cientifica (CSIC); Universidad de la Republica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Centre of Genetic Engineering and Biotechnology; Comision Sectorial de Investigacion Cientifica (CSIC); Universidad de la Republica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM068682 (to A.J.V.). This work was also supported by grants from the Howard Hughes Medical Institute (to A.J.V. and R. R.), International Centre of Genetic Engineering and Biotechnology (to R. R.), and Comision Sectorial de Investigacion Cientifica (CSIC), Universidad de la Republica (to L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams P.A., 1991, PEROXIDASES CHEM BIO, V2, P171; Alonso D, 2002, NEUROSCIENCE, V111, P47, DOI 10.1016/S0306-4522(01)00571-1; Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; Banci L, 1998, EUR J BIOCHEM, V256, P271, DOI 10.1046/j.1432-1327.1998.2560271.x; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; Belikova NA, 2007, INT J RADIAT ONCOL, V69, P176, DOI 10.1016/j.ijrobp.2007.03.043; BERGHUIS AM, 1994, J MOL BIOL, V235, P1326, DOI 10.1006/jmbi.1994.1086; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; BLAUER G, 1993, BIOCHEMISTRY-US, V32, P6674, DOI 10.1021/bi00077a021; BOSWELL AP, 1983, BIOCHEM J, V213, P679, DOI 10.1042/bj2130679; Bren KL, 2004, INORG CHEM, V43, P7934, DOI 10.1021/ic048925t; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; BUTLER J, 1982, J BIOL CHEM, V257, P747; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P14; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Dickerson R., 1975, ENZYMES, V11, P397; Dopner S, 1998, J AM CHEM SOC, V120, P11246, DOI 10.1021/ja9717572; Droghetti E, 2006, BIOPHYS J, V91, P3022, DOI 10.1529/biophysj.106.079749; FENG YQ, 1990, BIOPHYS J, V57, P15, DOI 10.1016/S0006-3495(90)82502-9; FERRER JC, 1993, J AM CHEM SOC, V115, P7507, DOI 10.1021/ja00069a062; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; HEINEMAN WR, 1975, ANAL CHEM, V47, P79, DOI 10.1021/ac60351a001; HONG XL, 1989, FEBS LETT, V246, P105, DOI 10.1016/0014-5793(89)80262-5; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; LIU GH, 1995, J INORG BIOCHEM, V60, P123, DOI 10.1016/0162-0134(95)00007-B; LUNTZ TL, 1989, P NATL ACAD SCI USA, V86, P3524, DOI 10.1073/pnas.86.10.3524; Maity H, 2006, PROTEINS, V63, P349, DOI 10.1002/prot.20756; MARGOLIASH E, 1962, J BIOL CHEM, V237, P3397; MARGOLIASH E, 1996, CYTOCHROME C MULTIDI; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; OCHI H, 1983, J MOL BIOL, V166, P407, DOI 10.1016/S0022-2836(83)80092-8; OSHEROFF N, 1980, J BIOL CHEM, V255, P1689; PEARCE LL, 1989, BIOCHEMISTRY-US, V28, P3152, DOI 10.1021/bi00434a006; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Pepaj M, 2006, J CHROMATOGR A, V1120, P132, DOI 10.1016/j.chroma.2006.02.031; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Radi R, 1996, CHEM RES TOXICOL, V9, P828, DOI 10.1021/tx950176s; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; RODRIGUEZROLDAN V, 2008, BIOCHEMISTR IN PRESS; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; Rumbley JN, 2002, BIOCHEMISTRY-US, V41, P13894, DOI 10.1021/bi026543y; Salamon Z, 1997, J BIOENERG BIOMEMBR, V29, P211, DOI 10.1023/A:1022401825287; SANTUCCI R, 1995, J INORG BIOCHEM, V170, P3197; SCHEJTER A, 1970, BIOCHEMISTRY-US, V9, P5118, DOI 10.1021/bi00828a012; SCHEJTER A, 1971, EUR J BIOCHEM, V20, P414, DOI 10.1111/j.1432-1033.1971.tb01407.x; SCOTT RA, 1996, CYTOCHROME C MULTIDI, P475; SENN H, 1985, Q REV BIOPHYS, V18, P111, DOI 10.1017/S0033583500005151; SKOV K, 1969, CAN J BIOCHEM CELL B, V47, P750, DOI 10.1139/o69-114; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; SOKOLOVS.M, 1970, BIOCHEMISTRY-US, V9, P5113, DOI 10.1021/bi00828a011; SOUSSI B, 1990, BIOCHEM J, V265, P227, DOI 10.1042/bj2650227; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Souza JM, 2008, METHOD ENZYMOL, V441, P197, DOI 10.1016/S0076-6879(08)01211-1; TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5; WILKSTROM M, 1984, BIOENERGETICS, V9, P49; WILSON MT, 1971, EUR J BIOCHEM, V22, P11, DOI 10.1111/j.1432-1033.1971.tb01508.x	78	84	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					17	26		10.1074/jbc.M807203200	http://dx.doi.org/10.1074/jbc.M807203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974097	hybrid, Green Published			2022-12-25	WOS:000261974800003
J	Boyd, JM; Sondelski, JL; Downs, DM				Boyd, Jeffrey M.; Sondelski, Jamie L.; Downs, Diana M.			Bacterial ApbC Protein Has Two Biochemical Activities That Are Required for in Vivo Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; ENTERICA SEROVAR TYPHIMURIUM; DEHYDROGENASE TCUA ENZYME; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; AZOTOBACTER-VINELANDII; NUCLEOTIDE-BINDING; 4FE-4S CLUSTERS; PHOTOSYSTEM-I; FE(II) TRAFFICKING	The ApbC protein has been shown previously to bind and rapidly transfer iron-sulfur ([Fe-S]) clusters to an apoprotein (Boyd, J. M., Pierik, A. J., Netz, D. J., Lill, R., and Downs, D. M. (2008) Biochemistry 47, 8195-8202. This study utilized both in vivo and in vitro assays to examine the function of variant ApbC proteins. The in vivo assays assessed the ability of ApbC proteins to function in pathways with low and high demand for [Fe-S] cluster proteins. Variant ApbC proteins were purified and assayed for the ability to hydrolyze ATP, bind [Fe-S] cluster, and transfer [Fe-S] cluster. This study details the first kinetic analysis of ATP hydrolysis for a member of the ParA subfamily of "deviant" Walker A proteins. Moreover, this study details the first functional analysis of mutant variants of the ever expanding family of ApbC/Nbp35 [Fe-S] cluster biosynthetic proteins. The results herein show that ApbC protein needs ATPase activity and the ability to bind and rapidly transfer [Fe-S] clusters for in vivo function.	[Boyd, Jeffrey M.; Sondelski, Jamie L.; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu		Boyd, Jeffrey/0000-0001-7721-3926	National Institutes of Health [GM47296]; J.M. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047296, F32GM079938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.M. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47296 (to D. M. D.) and a National Institutes of Health Ruth Kirschstein postdoctoral training fellowship (to J.M.B.). This work was also supported by a 21st Century Scientist Scholars Award from the J.M. McDonnell Foundation (to D. M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Antonkine ML, 2007, BBA-BIOENERGETICS, V1767, P712, DOI 10.1016/j.bbabio.2007.02.003; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; BATES PA, 1999, PROTEINS, V3, pS47; BATES PA, 2001, PROTEINS, V5, pS39; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2008, J BACTERIOL, V190, P4596, DOI 10.1128/JB.00262-08; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Cui Q, 2006, PROTEINS, V62, P578, DOI 10.1002/prot.20781; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Enos-Berlage JL, 1999, J BACTERIOL, V181, P841, DOI 10.1128/JB.181.3.841-848.1999; Foster MW, 2000, J AM CHEM SOC, V122, P6805, DOI 10.1021/ja000800+; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; Gibney BR, 1996, P NATL ACAD SCI USA, V93, P15041, DOI 10.1073/pnas.93.26.15041; Gralnick J, 2000, J BACTERIOL, V182, P5180, DOI 10.1128/JB.182.18.5180-5187.2000; Gralnick J, 2001, P NATL ACAD SCI USA, V98, P8030, DOI 10.1073/pnas.151243198; Gralnick JA, 2003, J BIOL CHEM, V278, P20708, DOI 10.1074/jbc.M301577200; GROSS SR, 1963, BIOCHEMISTRY-US, V2, P1046, DOI 10.1021/bi00905a023; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jin Z, 2008, J BIOL CHEM, V283, P28426, DOI 10.1074/jbc.M803395200; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonardi R, 2003, FEBS LETT, V539, P95, DOI 10.1016/S0014-5793(03)00204-7; Lewis JA, 2004, J BACTERIOL, V186, P1629, DOI 10.1128/JB.186.6.1629-1637.2004; Lewis JA, 2007, BIOCHEMISTRY-US, V46, P9107, DOI 10.1021/bi7006564; Lewis JA, 2006, J BACTERIOL, V188, P5479, DOI 10.1128/JB.00514-06; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2004, J BIOL CHEM, V279, P40505, DOI 10.1074/jbc.M403985200; Mulholland SE, 1998, J AM CHEM SOC, V120, P10296, DOI 10.1021/ja981279a; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, P198; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; PARSONAGE D, 1988, J BIOL CHEM, V263, P4740; Petersen L, 1996, J BACTERIOL, V178, P5676, DOI 10.1128/jb.178.19.5676-5682.1996; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; RYLE MJ, 1995, J BIOL CHEM, V270, P13112, DOI 10.1074/jbc.270.22.13112; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; SEEFELDT LC, 1992, J BIOL CHEM, V267, P6680; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Segel I.H., 1975, ENZYME KINETICS; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Shimomura Y, 2007, J BIOCHEM, V142, P577, DOI 10.1093/jb/mvm163; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Skovran E, 2003, J BACTERIOL, V185, P98, DOI 10.1128/JB.185.1.98-106.2003; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005	80	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					110	118		10.1074/jbc.M807003200	http://dx.doi.org/10.1074/jbc.M807003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001370	Green Published, hybrid			2022-12-25	WOS:000261974800013
J	Kenny, AV; Cousins, SL; Pinho, L; Stephenson, FA				Kenny, Anna V.; Cousins, Sarah L.; Pinho, Leonor; Stephenson, F. Anne			The Integrity of the Glycine Co-agonist Binding Site of N-Methyl-D-aspartate Receptors Is a Functional Quality Control Checkpoint for Cell Surface Delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; LIGAND-BINDING; GLUTAMATE RECEPTORS; PHARMACOLOGICAL CHAPERONES; NR1 SUBUNIT; MOLECULAR DETERMINANTS; NR2A SUBUNIT; SPINAL-CORD	N-Methyl-D-aspartate receptors are a subclass of ligandgated, heteromeric glutamatergic neurotransmitter receptors whose cell surface expression is regulated by quality control mechanisms. Functional quality control checkpoints are known to contribute to cell surface trafficking of non-N-methyl-D-aspartate glutamate receptors. Here we investigated if similar mechanisms operate for the surface delivery of NMDA receptors. Point mutations in the glycine binding domain of the NR1-1a subunit were generated: D732A, a mutation that results in an similar to 3 x 10(4) decrease in glycine binding affinity; D732E, a conservative change; and D723A, a residue in the same NR1-1a domain that has no effect on glycine binding affinity. Each NR1-1a subunit was co-expressed with NR2A in mammalian cells. Immunoblotting and immunoprecipitations showed that all mutants were expressed to similar levels as wild-type NR1-1a and associated with NR2A. Cell surface expression measured by an enzyme-linked immunosorbent assay found that whereas NR1-1a (D732E)/NR2A and NR1-1a (D723A)/NR2A trafficked as efficiently as NR1-1a/NR2A, there was a 90% decrease in surface expression for NR1-1a (D732A)/NR2A. This was confirmed by confocal microscopy imaging and cell surface biotinylation. Further imaging showed that NR1-1a (D732A) and co-transfected NR2A co-localized with an endoplasmic reticulum marker. Dichlorokynurenic acid, a competitive glycine site antagonist, partially rescued surface expression. Mutation of the NR1-1a ER retention motif showed that the ligand binding checkpoint is an early event preceding endoplasmic reticulum sorting mechanisms. These findings demonstrate that integrity of the glycine co-agonist binding site is a functional checkpoint requisite for efficient cell surface trafficking of assembled NMDA receptors.	[Kenny, Anna V.; Cousins, Sarah L.; Pinho, Leonor; Stephenson, F. Anne] Univ London, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D002753/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C. Section 1734 solely to indicate this fact.	Anson LC, 1998, J NEUROSCI, V18, P581; BERGER SJ, 1977, J NEUROCHEM, V28, P149, DOI 10.1111/j.1471-4159.1977.tb07720.x; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen PE, 2004, J PHYSIOL-LONDON, V558, P45, DOI 10.1113/jphysiol.2004.063800; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fujiwara K, 1998, BRAIN RES, V806, P210, DOI 10.1016/S0006-8993(98)00744-6; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kong MMC, 2006, MOL PHARMACOL, V70, P78, DOI 10.1124/mol.105.021246; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Lummis SCR, 2002, NEUROPHARMACOLOGY, V42, P437, DOI 10.1016/S0028-3908(02)00002-3; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okabe S, 1999, J NEUROSCI, V19, P7781; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; PRYBLYOWSKI K, 2003, J BIOL CHEM, V279, P9672; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rutter AR, 2002, J NEUROCHEM, V81, P1298, DOI 10.1046/j.1471-4159.2002.00923.x; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; VANDENPOL AN, 1988, J NEUROSCI, V8, P472; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Williams K, 1996, MOL PHARMACOL, V50, P701; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	54	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					324	333		10.1074/jbc.M804023200	http://dx.doi.org/10.1074/jbc.M804023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990687	hybrid			2022-12-25	WOS:000261974800037
J	Pittman, JK; Edmond, C; Sunderland, PA; Bray, CM				Pittman, Jon K.; Edmond, Clare; Sunderland, Paul A.; Bray, Clifford M.			A Cation-regulated and Proton Gradient-dependent Cation Transporter from Chlamydomonas reinhardtii Has a Role in Calcium and Sodium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR CA2+/H+ EXCHANGER; SACCHAROMYCES-CEREVISIAE; NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; CATION/PROTON ANTIPORTERS; H+/CA2+ ANTIPORTER; SALT TOLERANCE; ARABIDOPSIS; CAX1; IDENTIFICATION	The CrCAX1 gene encoding a Ca2+/H+ and Na+/H+ exchanger was cloned and characterized from the unicellular green alga Chlamydomonas reinhardtii to begin to understand the mechanisms of cation homeostasis in this model organism. CrCAX1 was more closely related to fungal cation exchanger (CAX) genes than those from higher plants but has structural characteristics similar to plant Ca2(+)/H+ exchangers including a long N-terminal tail. When CrCAX1-GFP was expressed in Saccharomyces cerevisiae, it localized at the vacuole. CrCAX1 could suppress the Ca2+-hypersensitive phenotype of a yeast mutant and mediated proton gradient-dependent Ca2+/H+ exchange activity in vacuolar membrane vesicles. Ca2+ transport activity was increased following N-terminal truncation of CrCAX1, suggesting the existence of an N-terminal auto-regulatory mechanism. CrCAX1 could also provide tolerance to Na+ stress when expressed in yeast or Arabidopsis thaliana because of Na+/H+ exchange activity. This Na+/H+ exchange activity was not regulated by the N terminus of the CrCAX1 protein. A subtle tolerance by CrCAX1 in yeast to Co2+ stress was also observed. CrCAX1 was transcriptionally regulated in Chlamydomonas cells grown in elevated Ca2+ or Na+. This study has thus uncovered a novel eukaryotic proton-coupled transporter, CrCAX1, that can transport both monovalent and divalent cations and that appears to play a role in cellular cation homeostasis by the transport of Ca2+ and Na+ into the vacuole.	[Pittman, Jon K.; Edmond, Clare; Sunderland, Paul A.; Bray, Clifford M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pittman, JK (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	jon.pittman@manchester.ac.uk		Pittman, Jon/0000-0001-7197-1494	Biotechnology and Biological Sciences Research Council [BB/B502152/1, BB/C502030/1]; Leverhulme Trust [F/00120/BG]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust)	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/B502152/1 (to J.K.P.) and BB/C502030/1 (to C. M. B.) and Leverhulme Trust Grant F/00120/BG (to J.K.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Komine Y, 2000, PLANTA, V210, P897, DOI 10.1007/s004250050695; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maser P, 2002, PLANT SOIL, V247, P43, DOI 10.1023/A:1021159130729; MCAINSH MR, 2008, NEW PHYTOL IN PRESS; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mendez-Alvarez S, 1999, Int Microbiol, V2, P15; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Pittman JK, 2005, FEBS LETT, V579, P2648, DOI 10.1016/j.febslet.2005.03.085; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Pittman JK, 2002, J BIOL CHEM, V277, P26452, DOI 10.1074/jbc.M202563200; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Primavesi LF, 2008, TRANSGENIC RES, V17, P529, DOI 10.1007/s11248-007-9126-7; QUARMBY LM, 1994, J CELL BIOL, V124, P807, DOI 10.1083/jcb.124.5.807; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Spijkerman E, 2007, EXTREMOPHILES, V11, P551, DOI 10.1007/s00792-007-0067-0; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Tanaka S, 2007, FEMS MICROBIOL LETT, V271, P48, DOI 10.1111/j.1574-6968.2007.00696.x; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Wei Y, 2007, MICROBIOL-SGM, V153, P2168, DOI 10.1099/mic.0.2007/007450-0; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wheeler GL, 2008, PLANT J, V53, P401, DOI 10.1111/j.1365-313X.2007.03349.x	49	36	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					525	533		10.1074/jbc.M807173200	http://dx.doi.org/10.1074/jbc.M807173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001368	hybrid			2022-12-25	WOS:000261974800057
J	Erlich, RL; Fry, RC; Begley, TJ; Daee, DL; Lahue, RS; Samson, LD				Erlich, Rachel L.; Fry, Rebecca C.; Begley, Thomas J.; Daee, Danielle L.; Lahue, Robert S.; Samson, Leona D.			Anc1, a Protein Associated with Multiple Transcription Complexes, Is Involved in Postreplication Repair Pathway in S-cerevisiae	PLOS ONE			English	Article								Yeast strains lacking Anc1, a member of the YEATS protein family, are sensitive to several DNA damaging agents. The YEATS family includes two human genes that are common fusion partners with MLL in human acute leukemias. Anc1 is a member of seven multi-protein complexes involved in transcription, and the damage sensitivity observed in anc1 Delta cells is mirrored in strains deleted for some other non-essential members of several of these complexes. Here we show that ANC1 is in the same epistasis group as SRS2 and RAD5, members of the postreplication repair (PRR) pathway, but has additive or synergistic interactions with several other members of this pathway. Although PRR is traditionally divided into an "errorprone'' and an "error-free'' branch, ANC1 is not epistatic with all members of either established branch, and instead defines a new error-free branch of the PRR pathway. Like several genes involved in PRR, an intact ANC1 gene significantly suppresses spontaneous mutation rates, including the expansion of (CAG) 25 repeats. Anc1's role in the PRR pathway, as well as its role in suppressing triplet repeats, point to a possible mechanism for a protein of potential medical interest.	[Erlich, Rachel L.; Fry, Rebecca C.; Samson, Leona D.] MIT, Broad Inst, Dept Biol, Cambridge, MA 02139 USA; [Erlich, Rachel L.; Fry, Rebecca C.; Begley, Thomas J.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA USA; [Begley, Thomas J.; Samson, Leona D.] MIT, Dept Biol Engn, Cambridge, MA USA; [Daee, Danielle L.; Lahue, Robert S.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Nebraska System; University of Nebraska Medical Center	Erlich, RL (corresponding author), MIT, Broad Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu		Fry, Rebecca/0000-0003-0899-9018; Lahue, Robert/0000-0002-8870-5616	National Institute of Health [CA055042, ES002109, CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants CA055042, ES002109 and CA14051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brachmann CB, 1998, YEAST, V14, P115; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Cejka P, 2001, GENETICS, V159, P953; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Dixon Michael J., 2004, V277, P29; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Hanna M, 2004, DNA REPAIR, V3, P51, DOI 10.1016/j.dnarep.2003.09.005; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; John S, 2000, GENE DEV, V14, P1196; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Kaplan Y, 2007, CURR GENET, V51, P123, DOI 10.1007/s00294-006-0113-y; KRAMER B, 1989, MOL CELL BIOL, V9, P4432, DOI 10.1128/MCB.9.10.4432; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KUPIEC M, 1986, MUTAT RES, V162, P33, DOI 10.1016/0027-5107(86)90068-0; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Lea D, 1948, J GENET, V49, P264; Minesinger BK, 2005, GENETICS, V169, P1939, DOI 10.1534/genetics.104.033894; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Odagiri N, 2003, DNA REPAIR, V2, P347, DOI 10.1016/S1568-7864(02)00234-3; OSMAN F, 2007, DNA REPAIR AMST; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Paulovich AG, 1997, GENETICS, V145, P45; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1990, GENETICS, V124, P817; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Timchenko LT, 1996, FASEB J, V10, P1589, DOI 10.1096/fasebj.10.14.9002550; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; TREICH I, 1995, MOL CELL BIOL, V15, P4240; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Ulrich Helle D., 2006, P549; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; VINH DBN, 1993, GENETICS, V135, P275; WACH A, 1994, YEAST, V10, P1808; Xiao W, 2000, GENETICS, V155, P1633; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004	70	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3717	10.1371/journal.pone.0003717	http://dx.doi.org/10.1371/journal.pone.0003717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005567	Green Submitted, gold, Green Published			2022-12-25	WOS:000265166200005
J	Colinas, J; Schmidler, SC; Bohrer, G; Iordanov, B; Benfey, PN				Colinas, Juliette; Schmidler, Scott C.; Bohrer, Gil; Iordanov, Borislav; Benfey, Philip N.			Intergenic and Genic Sequence Lengths Have Opposite Relationships with Respect to Gene Expression	PLOS ONE			English	Article								Eukaryotic genomes are mostly composed of noncoding DNA whose role is still poorly understood. Studies in several organisms have shown correlations between the length of the intergenic and genic sequences of a gene and the expression of its corresponding mRNA transcript. Some studies have found a positive relationship between intergenic sequence length and expression diversity between tissues, and concluded that genes under greater regulatory control require more regulatory information in their intergenic sequences. Other reports found a negative relationship between expression level and gene length and the interpretation was that there is selection pressure for highly expressed genes to remain small. However, a correlation between gene sequence length and expression diversity, opposite to that observed for intergenic sequences, has also been reported, and to date there is no testable explanation for this observation. To shed light on these varied and sometimes conflicting results, we performed a thorough study of the relationships between sequence length and gene expression using cell-type ( tissue) specific microarray data in Arabidopsis thaliana. We measured median gene expression across tissues ( expression level), expression variability between tissues ( expression pattern uniformity), and expression variability between replicates ( expression noise). We found that intergenic ( upstream and downstream) and genic ( coding and noncoding) sequences have generally opposite relationships with respect to expression, whether it is tissue variability, median, or expression noise. To explain these results we propose a model, in which the lengths of the intergenic and genic sequences have opposite effects on the ability of the transcribed region of the gene to be epigenetically regulated for differential expression. These findings could shed light on the role and influence of noncoding sequences on gene expression.	[Colinas, Juliette; Benfey, Philip N.] Duke Univ, Dept Biol & IGSP, Ctr Syst Biol, Durham, NC 27708 USA; [Schmidler, Scott C.] Duke Univ, Dept Stat Sci, Durham, NC 27706 USA; [Bohrer, Gil] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA	Duke University; Duke University; University System of Ohio; Ohio State University	Colinas, J (corresponding author), Duke Univ, Dept Biol & IGSP, Ctr Syst Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Bohrer, Gil/A-9731-2008	Bohrer, Gil/0000-0002-9209-9540	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the National Science Foundation, Arabidopsis 2010 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; COLINAS J, 2006, NONCODING DNA SEQUEN, P147; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gondor A, 2006, NAT GENET, V38, P1229, DOI 10.1038/ng1106-1229; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Mace DL, 2006, BIOINFORMATICS, V22, pE323, DOI 10.1093/bioinformatics/btl228; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; PINHEIRO JC, 2000, MIXED EFFECTS MODELS, P16; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; SEARLE SR, 2006, VARIANCE COMPONENTS, P23; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2006, NUCLEIC ACIDS RES, V34, P5906, DOI 10.1093/nar/gkl773; WALTHER D, 2007, PLOS GENETICS, V3; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	28	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3670	10.1371/journal.pone.0003670	http://dx.doi.org/10.1371/journal.pone.0003670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989364	Green Published, gold			2022-12-25	WOS:000265134600006
J	Yang, YL; Iyer, LK; Adelstein, SJ; Kassis, AI				Yang, Yongliang; Iyer, Lakshmanan K.; Adelstein, S. James; Kassis, Amin I.			Integrative Genomic Data Mining for Discovery of Potential Blood-Borne Biomarkers for Early Diagnosis of Cancer	PLOS ONE			English	Article								Background: With the arrival of the postgenomic era, there is increasing interest in the discovery of biomarkers for the accurate diagnosis, prognosis, and early detection of cancer. Blood-borne cancer markers are favored by clinicians, because blood samples can be obtained and analyzed with relative ease. We have used a combined mining strategy based on an integrated cancer microarray platform, Oncomine, and the biomarker module of the Ingenuity Pathways Analysis (IPA) program to identify potential blood-based markers for six common human cancer types. Methodology/Principal Findings: In the Oncomine platform, the genes overexpressed in cancer tissues relative to their corresponding normal tissues were filtered by Gene Ontology keywords, with the extracellular environment stipulated and a corrected Q value (false discovery rate) cut-off implemented. The identified genes were imported to the IPA biomarker module to separate out those genes encoding putative secreted or cell-surface proteins as blood-borne (blood/serum/plasma) cancer markers. The filtered potential indicators were ranked and prioritized according to normalized absolute Student t values. The retrieval of numerous marker genes that are already clinically useful or under active investigation confirmed the effectiveness of our mining strategy. To identify the biomarkers that are unique for each cancer type, the upregulated marker genes that are in common between each two tumor types across the six human tumors were also analyzed by the IPA biomarker comparison function. Conclusion/Significance: The upregulated marker genes shared among the six cancer types may serve as a molecular tool to complement histopathologic examination, and the combination of the commonly upregulated and unique biomarkers may serve as differentiating markers for a specific cancer. This approach will be increasingly useful to discover diagnostic signatures as the mass of microarray data continues to grow in the 'omics' era.	[Yang, Yongliang; Adelstein, S. James; Kassis, Amin I.] Harvard Univ, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Ctr Neurosci Res, Boston, MA USA	Harvard University; Harvard Medical School; Tufts University	Yang, YL (corresponding author), Harvard Univ, Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA.	amin_kassis@hms.harvard.edu	Kassis, Amin I./O-5175-2014	Iyer, Lakshmanan/0000-0001-9167-6396	US Department of Defense [W81XWH-06-1-0043, W81XWH-04-1-0499, W81XWH-06-1-0204]	US Department of Defense(United States Department of Defense)	This work was supported in part by US Department of Defense grants (to AIK) W81XWH-06-1-0043, Radioimaging and Radiotherapy of Prostate Cancer; W81XWH-04-1-0499, Radiodetection and Radiotherapy of Breast Cancer; and W81XWH-06-1-0204, Radiodiagnosis and Radiotherapy of Ovarian Cancer.	Algul H, 2007, INT J CANCER, V121, P1410, DOI 10.1002/ijc.22779; Baker M, 2005, NAT BIOTECHNOL, V23, P297, DOI 10.1038/nbt0305-297; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomston M, 2002, ANN SURG ONCOL, V9, P668, DOI 10.1007/BF02574483; Campagne F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-481; Chen K, 2006, MOL CANCER THER, V5, P3001, DOI 10.1158/1535-7163.MCT-06-0465; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-25; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; Csernus VJ, 1999, P NATL ACAD SCI USA, V96, P3098, DOI 10.1073/pnas.96.6.3098; Diamandis EP, 2004, CLIN CHEM, V50, P793, DOI 10.1373/clinchem.2004.032177; Ellenrieder V, 2000, INT J CANCER, V85, P14, DOI 10.1002/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.3.CO;2-F; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; He Yudong D., 2006, Cancer Biomarkers, V2, P103; Hoeflich A, 2001, CANCER RES, V61, P8601; Holzman T, 2004, CURR OPIN BIOTECH, V15, P52, DOI 10.1016/j.copbio.2003.12.004; Hough CD, 2001, CANCER RES, V61, P3869; *ING SYST, ING PATHW AN IPA; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kirby J, 2007, ADV CLIN CHEM, V44, P247, DOI 10.1016/S0065-2423(07)44008-2; Koshiba T, 1997, SURG TODAY, V27, P302, DOI 10.1007/BF00941802; Li SH, 2004, ST HEAL T, V107, P778; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Masson D, 1999, BRIT J CANCER, V80, P1995, DOI 10.1038/sj.bjc.6690633; Migita T, 1999, INT J CANCER, V84, P74, DOI 10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Pospisil P, 2007, CANCER RES, V67, P2197, DOI 10.1158/0008-5472.CAN-06-3309; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Ransohoff DF, 2003, SCIENCE, V299, P1679, DOI 10.1126/science.1083158; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, ANN NY ACAD SCI, V1020, P32, DOI 10.1196/annals.1310.005; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Sowter HM, 2005, CARCINOGENESIS, V26, P1651, DOI 10.1093/carcin/bgi136; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sumiya J, 1997, J BIOCHEM-TOKYO, V122, P983; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Troyer DA, 2004, DIS MARKERS, V20, P117, DOI 10.1155/2004/509276; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; YU H, 1995, CANCER RES, V55, P2104; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhou W, 1998, CANCER EPIDEM BIOMAR, V7, P109; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P285, DOI 10.1136/mp.54.5.285	56	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3661	10.1371/journal.pone.0003661	http://dx.doi.org/10.1371/journal.pone.0003661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987750	Green Submitted, Green Published, gold			2022-12-25	WOS:000265134500007
J	Aranda-Orgilles, B; Aigner, J; Kunath, M; Lurz, R; Schneider, R; Schweiger, S				Aranda-Orgilles, Beatriz; Aigner, Johanna; Kunath, Melanie; Lurz, Rudi; Schneider, Rainer; Schweiger, Susann			Active Transport of the Ubiquitin Ligase MID1 along the Microtubules Is Regulated by Protein Phosphatase 2A	PLOS ONE			English	Article							LINKED OPITZ-SYNDROME; SYNDROME GENE-PRODUCT; CATALYTIC SUBUNIT; NEURONAL POLARITY; MOTOR PROTEINS; G/BBB SYNDROME; MUTATIONS; BINDING; COMPLEX; DOMAIN	Mutations in the MID1 protein have been found in patients with Opitz BBB/G syndrome (OS), which is characterised by multiple malformations of the ventral midline. MID1 is a microtubule-associated protein that stabilizes microtubules and, in association with the regulatory subunit of protein phosphatase 2A (PP2A), alpha 4, provides ubiquitin ligase activity for the ubiquitin-specific modification of PP2A. Using Fluorescence Recovery After Photobleaching (FRAP) technology, we show here that MID1 is actively and bi-directionally transported along the microtubules, and that this movement is directly linked to its MAP kinase and PP2A-mediated phosphorylation status. Intact transport depends on both kinesins and dyneins and is inhibited upon colcemide treatments. MID1 proteins carrying missense mutations in the alpha 4 binding domain still bind the microtubules but cannot be actively transported. Likewise, knock-down of the alpha 4 protein, inhibition of PP2A activity by okadaic acid and fostriecin or the simulation of permanent phosphorylation at Ser96 in MID1 stop the migration of MID1-GFP, while preserving its microtubule-association. In summary, our data uncover an unexpected and novel function for PP2A, its regulatory subunit alpha 4 and PP2A/alpha 4/mTOR signaling in the active transport of the MID1 ubiquitin ligase complex along the cytoskeleton. Furthermore, a failure in the microtubule directed transport of this protein complex would be an attractive mechanism underlying the pathogenesis of OS in patients with B-box1 mutations.	[Aranda-Orgilles, Beatriz; Aigner, Johanna; Kunath, Melanie; Lurz, Rudi; Schweiger, Susann] Max Planck Inst Mol Genet, Berlin, Germany; [Schneider, Rainer] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Schweiger, Susann] Univ Dundee, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 4HN, Scotland	Max Planck Society; University of Innsbruck; University of Dundee	Aranda-Orgilles, B (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	schweiger@molgen.mpg.de			Volkswagen Stiftung; Deutsche Forschungsgemeinschaft [SFB 577]; Austrian Science Fund [FWF-SFB021/03]	Volkswagen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF))	Financial support was given by the Volkswagen Stiftung (Lichtenberg Professur to S.S.), the Deutsche Forschungsgemeinschaft (DFG, SFB 577) and the Austrian Science Fund (FWF-SFB021/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANDAORGILLES B, 2008, HUM GENET; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Gaudenz K, 1998, AM J HUM GENET, V63, P703, DOI 10.1086/302010; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jiang XY, 2006, CANCER RES, V66, P5258, DOI 10.1158/0008-5472.CAN-05-4510; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Mnayer L, 2006, MOL GENET METAB, V87, P198, DOI 10.1016/j.ymgme.2005.10.014; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pinson L, 2004, J MED GENET, V41, P381, DOI 10.1136/jmg.2003.014829; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SHIMIZU T, 1995, METHOD CELL BIOL, V47, P497, DOI 10.1016/S0091-679X(08)60851-1; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Steinhauer J, 2006, DEV DYNAM, V235, P1455, DOI 10.1002/dvdy.20770; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	35	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3507	10.1371/journal.pone.0003507	http://dx.doi.org/10.1371/journal.pone.0003507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949047	Green Published, gold			2022-12-25	WOS:000265126400002
J	Lauffer, BEL; Chen, S; Melero, C; Kortemme, T; von Zastrow, M; Vargas, GA				Lauffer, Benjamin E. L.; Chen, Stanford; Melero, Cristina; Kortemme, Tanja; von Zastrow, Mark; Vargas, Gabriel A.			Engineered Protein Connectivity to Actin Mimics PDZ-dependent Recycling of G Protein-coupled Receptors but Not Its Regulation by Hrs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; MEMBRANE TRAFFICKING; ENDOCYTIC PATHWAY; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; PLASMA-MEMBRANE; SIGNAL; DOMAIN; RESENSITIZATION; BINDING	Many G protein-coupled receptors (GPCRs) recycle after agonist-induced endocytosis by a sequence-dependent mechanism, which is distinct from default membrane flow and remains poorly understood. Efficient recycling of the beta 2-adrenergic receptor (beta 2AR) requires a C-terminal PDZ (PSD-95/Discs Large/ZO-1) protein-binding determinant (PDZbd), an intact actin cytoskeleton, and is regulated by the endosomal protein Hrs (hepatocyte growth factor-regulated substrate). The PDZbd is thought to link receptors to actin through a series of protein interaction modules present in NHERF/EBP50 (Na+/H+ exchanger 3 regulatory factor/ezrin-binding phosphoprotein of 50 kDa) family and ERM(ezrin/radixin/moesin) family proteins. It is not known, however, if such actin connectivity is sufficient to recapitulate the natural features of sequence-dependent recycling. We addressed this question using a receptor fusion approach based on the sufficiency of the PDZbd to promote recycling when fused to a distinct GPCR, the delta-opioid receptor, which normally recycles inefficiently in HEK293 cells. Modular domains mediating actin connectivity promoted receptor recycling with similarly high efficiency as the PDZbd itself, and recycling promoted by all of the domains was actin-dependent. Regulation of receptor recycling by Hrs, however, was conferred only by the PDZbd and not by downstream interaction modules. These results suggest that actin connectivity is sufficient to mimic the core recycling activity of a GPCR-linked PDZbd but not its cellular regulation.	[Chen, Stanford; von Zastrow, Mark; Vargas, Gabriel A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Lauffer, Benjamin E. L.] Univ Calif San Francisco, Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94158 USA; [Melero, Cristina; Kortemme, Tanja] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Kortemme, Tanja/0000-0002-8494-680X	National Institutes of Health; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by research grants from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Galet C, 2004, MOL ENDOCRINOL, V18, P434, DOI 10.1210/me.2003-0293; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; GORDON DJ, 1976, J BIOL CHEM, V251, P4778; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; VON ZM, 1992, J BIOL CHEM, V267, P3530; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679	44	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2448	2458		10.1074/jbc.M806370200	http://dx.doi.org/10.1074/jbc.M806370200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19001361	hybrid, Green Published			2022-12-25	WOS:000262545600052
J	Li, HB; Ray, G; Yoo, BH; Erdogan, M; Rosen, KV				Li, Hongbing; Ray, Gibanananda; Yoo, Byong Hoon; Erdogan, Mete; Rosen, Kirill V.			Down-regulation of Death-associated Protein Kinase-2 Is Required for beta-Catenin-induced Anoikis Resistance of Malignant Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS-INDUCED TRANSFORMATION; COLON-CANCER; UP-REGULATION; C-MYC; EXPRESSION; APOPTOSIS; GROWTH; ACTIVATION; DETACHMENT; TARGET	Resistance of solid tumor cells to anoikis, apoptosis induced by cell detachment from the extracellular matrix, is thought to be critical for the ability of these cells to grow anchorage independently within thee-dimensional tumor masses and from metastases. beta-Catenin, a major oncoprotein, can inhibit anoikis of cancer cells via unknown mechanisms. In an effort to identify these mechanisms we found that beta-catenin blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating death-associated protein kinase-2 (DAPk-2), a pro-apoptotic protein whose cellular functions have so far remained unexplored. We found that beta-catenin-induced down-regulation of DAPk-2 requires the presence of the transcription factor Tcf-4, a known mediator of beta-catenin signaling. We also observed that DAPk-2 contributes to the execution of anoikis of the non-malignant epithelial cells. Thus, beta-catenin-induced down-regulation of DAPk-2 represents a novel signaling mechanism by which beta-catenin promotes the survival of malignant epithelial cells following their detachment from the ECM and enables these cells to grow in an anchorage-independent manner.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat & Biochem, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat & Biochem, Rm C-302,CRC,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca		Rosen, Kirill/0000-0002-4317-9907	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Weng ZG, 2002, J BIOL CHEM, V277, P18677, DOI 10.1074/jbc.M105331200; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651	39	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2012	2022		10.1074/jbc.M805612200	http://dx.doi.org/10.1074/jbc.M805612200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18957423	hybrid			2022-12-25	WOS:000262545600008
J	Palhano, FL; Leme, LP; Busnardo, RG; Foguel, D				Palhano, Fernando L.; Leme, Larissa P.; Busnardo, Roberta G.; Foguel, Debora			Trapping the Monomer of a Non-amyloidogenic Variant of Transthyretin EXPLORING ITS POSSIBLE USE AS A THERAPEUTIC STRATEGY AGAINST TRANSTHYRETIN AMYLOIDOGENIC DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE; PROTEIN; BINDING; DENATURATION; POLYNEUROPATHY; DISSOCIATION; STABILITY; FIBRIL; INTERMEDIATE; INHIBITORS	Transthyretin (TTR) is a 127-residue homotetrameric beta-sheet-rich protein that transports thyroxine in the blood and cerebrospinal fluid. The deposition of fibrils and amorphous aggregates of TTR in patients' tissues is a hallmark of TTR amyloid disease. Familial amyloidotic polyneuropathy is a hereditary form of TTR amyloidosis that is associated with one among 80 different variants of TTR. The most aggressive variants of TTR are V30M, L55P, and A25T, and the propensity to undergo aggregation seems to be linked to tetramer stability. T119M is a very stable, non-amyloidogenic variant of TTR. Here we show that the combination of high hydrostatic pressure with subdenaturing concentrations of urea (4 M) at 1 degrees C irreversibly dissociates T119M into monomers in less than 30 min in a concentration-dependent fashion. After pressure and urea removal, long lived monomers are the only species present in solution. We took advantage of the slow reassociation kinetics of these monomers into tetramers to produce heterotetramers by mixing the T119M monomers with the tetramers of the aggressive mutants of TTR. Our data show that T119M monomers can be successfully incorporated into all of these tetramers even when the exchange is performed in a more physiological environment such as human plasma; these monomers render the resultant heterotetramers less amyloidogenic. The data presented here are relevant for the understanding of T119M folding and association reactions and provide a protocol for producing T119M monomers that function as inhibitors of TTR aggregation when incorporated into tetramers. This protocol may provide a new strategy for treating TTR diseases for which there is no therapy available other than liver transplantation.	[Foguel, Debora] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Inst Milenio Biol Estrutural & Biotecnol, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.	foguel@bioqmed.ufrj.br	Palhano, Fernando/C-2586-2008; Palhano, Fernando/AAB-3144-2021	Palhano, Fernando/0000-0001-5336-632X; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Comissao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comissao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Comissao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Alves IL, 1997, EUR J BIOCHEM, V249, P662, DOI 10.1111/j.1432-1033.1997.00662.x; Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1; BRANDTS JF, 1970, BIOCHEMISTRY-US, V9, P1038, DOI 10.1021/bi00806a045; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; KITAMURA Y, 1987, J SOLUTION CHEM, V16, P715, DOI 10.1007/BF00652574; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Niraula TN, 2002, J MOL BIOL, V320, P333, DOI 10.1016/S0022-2836(02)00425-4; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; RASBAND W, 2007, IMAGEJ; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; SCHREIBER G, 1995, EXP CLIN ENDOCR DIAB, V103, P75, DOI 10.1055/s-0029-1211332; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; TAKASHI R, 1977, P NATL ACAD SCI USA, V74, P2334, DOI 10.1073/pnas.74.6.2334; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843	44	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1443	1453		10.1074/jbc.M807100200	http://dx.doi.org/10.1074/jbc.M807100200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18984591	hybrid			2022-12-25	WOS:000262330100012
J	Guo, J; Longshore, S; Nair, R; Warner, BW				Guo, Jun; Longshore, Shannon; Nair, Rajalakshmi; Warner, Brad W.			Retinoblastoma Protein (pRb), but Not p107 or p130, Is Required for Maintenance of Enterocyte Quiescence and Differentiation in Small Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN SYNTHESIS; CELL-SURFACE MEMBRANE; RB FAMILY PROTEINS; CRYPT-VILLUS AXIS; STEM-CELLS; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; POCKET PROTEINS	The function of retinoblastoma protein (pRb) in the regulation of small intestine epithelial cell homeostasis has been challenged by several groups using various promoter-based Cre transgenic mouse lines. Interestingly, different pRb deletion systems yield dramatically disparate small intestinal phenotypes. These findings confound the function of pRb in this dynamic tissue. In this study, Villin-Cre transgenic mice were crossed with Rb (flox/flox) mice to conditionally delete pRb protein in small intestine enterocytes. We discovered a novel hyperplasia phenotype as well as ectopic cell cycle reentry within villus enterocytes in the small intestine. This phenotype was not seen in other pRb family member (p107 or p130) null mice. Using a newly developed crypt/villus isolation method, we uncovered that expression of pRb was undetectable, whereas proliferating cell nuclear antigen, p107, cyclin E, cyclin D3, Cdk2, and Cdc2 were dramatically increased in pRb-deficient villus cells. Cyclin A, cyclin D1, cyclin D2, and Cdk4/6 expression was not affected by absent pRb expression. pRb-deficient villus cells appeared capable of progressing to mitosis but with higher rates of apoptosis. However, the cycling villus enterocytes were not completely differentiated as gauged by significant reduction of intestinal fatty acid-binding protein expression. In summary, pRb, but not p107 or p130, is required for maintaining the postmitotic villus cell in quiescence, governing the expression of cell cycle regulatory proteins, and completing of absorptive enterocyte differentiation in the small intestine.	[Guo, Jun; Longshore, Shannon; Nair, Rajalakshmi; Warner, Brad W.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat Surg, St Louis, MO 63110 USA	St. Louis Children's Hospital; Washington University (WUSTL)	Warner, BW (corresponding author), Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat Surg, 1 Childrens Pl,Ste 5S60, St Louis, MO 63110 USA.	Brad.Warner@wustl.edu			National Institutes of Health [RO1 DK53234, T32 CA009621, P30DK52574]; NATIONAL CANCER INSTITUTE [T32CA009621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK053234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK53234 (to B. W. W.), T32 CA009621 (to S. L.), and P30DK52574 (to Morphology and Murine Models Cores of the Digestive Diseases Research Core Center of the Washington University School of Medicine). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; Kucherlapati MH, 2008, P NATL ACAD SCI USA, V105, P15493, DOI 10.1073/pnas.0802933105; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Levine RA, 1998, EXP CELL RES, V239, P264, DOI 10.1006/excr.1997.3898; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Marino S, 2000, GENE DEV, V14, P994; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rathi AV, 2007, J VIROL, V81, P9481, DOI 10.1128/JVI.00922-07; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Saenz-Robles MT, 2007, J VIROL, V81, P13191, DOI 10.1128/JVI.01658-07; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Smartt HJM, 2007, GASTROENTEROLOGY, V133, P232, DOI 10.1053/j.gastro.2007.04.043; Taylor JA, 2008, J PEDIATR SURG, V43, P1018, DOI 10.1016/j.jpedsurg.2008.02.025; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; Vidal A, 2007, FRONT BIOSCI-LANDMRK, V12, P4483, DOI 10.2741/2403; Wang Y, 2007, DEV BIOL, V311, P478, DOI 10.1016/j.ydbio.2007.08.052; WEISER MM, 1973, J BIOL CHEM, V248, P2542; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Yang HS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-6	37	57	58	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					134	140		10.1074/jbc.M806133200	http://dx.doi.org/10.1074/jbc.M806133200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981186	Green Published, hybrid			2022-12-25	WOS:000261974800015
J	Furuta, K; Edamatsu, M; Maeda, Y; Toyoshima, YY				Furuta, Ken'ya; Edamatsu, Masaki; Maeda, Yurina; Toyoshima, Yoko Y.			Diffusion and Directed Movement IN VITRO MOTILE PROPERTIES OF FISSION YEAST KINESIN-14 Pkl1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; MITOTIC SPINDLE FUNCTION; DIRECTIONAL MOTILITY; COILED-COIL; TAIL DOMAIN; NCD; MOLECULES; KAR3; GENE; ORGANIZATION	Fission yeast Pkl1 is a kinesin-14A family member that is known to be localized at the cellular spindle and is capable of hydrolyzing ATP. However, its motility has not been detected. Here, we show that Pkl1 is a slow, minus end-directed microtubule motor with a maximum velocity of 33 +/- 9 nm/s. The K-m,K-MT value of steady-state ATPase activity of Pkl1 was as low as 6.4 +/- 1.1 nM, which is 20-30 times smaller than that of kinesin-1 and another kinesin-14A family member, Ncd, indicating a high affinity of Pkl1 for microtubules. However, the duty ratio of 0.05 indicates that Pkl1 spends only a small fraction of the ATPase cycle strongly associated with a microtubule. By using total internal reflection fluorescence microscopy, we demonstrated that single molecules of Pkl1 were not highly processive but only exhibited biased one-dimensional diffusion along microtubules, whereas several molecules of Pkl1, probably fewer than 10 molecules, cooperatively moved along microtubules and substantially reduced the diffusive component in the movement. Our results suggest that Pkl1 molecules work in groups to move and generate forces in a cooperative manner for their mitotic functions.	[Furuta, Ken'ya; Edamatsu, Masaki; Maeda, Yurina; Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Toyoshima, YY (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science (JSPS), a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology, a Core Research for Evolutional Science and Technology program grant from the Japan Science and Technology Agency, and a grant-in-aid for JSPS fellows from JSPS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P591; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HATSUMI M, 1992, J CELL SCI, V103, P1013; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lakamper S, 2003, BIOPHYS J, V84, P1833, DOI 10.1016/S0006-3495(03)74991-1; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; OCONNELL MJ, 1993, J CELL BIOL, V120, P153, DOI 10.1083/jcb.120.1.153; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; Pierce DW, 1999, BIOCHEMISTRY-US, V38, P5412, DOI 10.1021/bi9830009; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodriguez AS, 2008, CELL CYCLE, V7, P1246, DOI 10.4161/cc.7.9.5808; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Stock MF, 2003, J BIOL CHEM, V278, P52315, DOI 10.1074/jbc.M309419200; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	47	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36465	36473		10.1074/jbc.M803730200	http://dx.doi.org/10.1074/jbc.M803730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984586	Green Published, hybrid			2022-12-25	WOS:000261840500044
J	Hashimoto, K; Suzuki, H; Taniguchi, K; Noguchi, T; Yohda, M; Odaka, M				Hashimoto, Koichi; Suzuki, Hiroyuki; Taniguchi, Kayoko; Noguchi, Takumi; Yohda, Masafumi; Odaka, Masafumi			Catalytic Mechanism of Nitrile Hydratase Proposed by Time-resolved X-ray Crystallography Using a Novel Substrate, tert-Butylisonitrile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONHEME IRON CENTER; CRYSTAL-STRUCTURE; CO(III) COMPLEXES; ACTIVE-SITE; PROTEIN; OXIDE	Nitrile hydratases (NHases) have an unusual iron or cobalt catalytic center with two oxidized cysteine ligands, cysteinesulfinic acid and cysteine-sulfenic acid, catalyzing the hydration of nitriles to amides. Recently, we found that the NHase of Rhodococcus erythropolis N771 exhibited an additional catalytic activity, converting tert-butylisonitrile (tBuNC) to tert-butylamine. Taking advantage of the slow reactivity of tBuNC and the photoreactivity of nitrosylated NHase, we present the first structural evidence for the catalytic mechanism of NHase with time-resolved x-ray crystallography. By monitoring the reaction with attenuated total reflectance Fourier transform infrared spectroscopy, the product from the isonitrile carbon was identified as a CO molecule. Crystals of nitrosylated inactive NHase were soaked with tBuNC. The catalytic reaction was initiated by photo-induced denitrosylation and stopped by flash cooling. tBuNC was first trapped at the hydrophobic pocket above the iron center and then coordinated to the iron ion at 120 min. At 440 min, the electron density of tBuNC was significantly altered, and a new electron density was observed near the isonitrile carbon as well as the sulfenate oxygen of alpha Cys(114). These results demonstrate that the substrate was coordinated to the iron and then attacked by a solvent molecule activated by alpha Cys(114)-SOH.	[Hashimoto, Koichi; Yohda, Masafumi] Tokyo Univ Agr & Technol, Grad Sch Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Suzuki, Hiroyuki; Noguchi, Takumi; Odaka, Masafumi] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Taniguchi, Kayoko] RIKEN, Ecosoft Mat Res Units, Wako, Saitama 3510198, Japan	Tokyo University of Agriculture & Technology; University of Tsukuba; RIKEN	Odaka, M (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	modaka@cc.tuat.ac.jp	Odaka, Masafumi/C-2378-2013; Noguchi, Takumi/I-7105-2014; Yohda, Masafumi/A-5149-2013	Yohda, Masafumi/0000-0001-8307-9671	21st Century Center of Excellence" Project [19350080]; Creative Scientific Research [17GS0314]; Japanese Society for the Promotion of Science Fellows [19252]; Ministry of Education, Science, Sports and Culture of Japan	21st Century Center of Excellence" Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for scientific research from the "Future nano materials" section of the "21st Century Center of Excellence" Project, Grant-in-Aid for Scientific Research (B) KAKENHI 19350080 (to M.O.), Grant-in-Aid for Creative Scientific Research 17GS0314 (to T.N.), Grant-in-Aid from the Japanese Society for the Promotion of Science Fellows 19252 ( to H. S.), and a grant from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, Sports and Culture of Japan (to M.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonnet D, 1997, FEBS LETT, V409, P216, DOI 10.1016/S0014-5793(97)00511-5; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo I, 2001, J INORG BIOCHEM, V83, P247, DOI 10.1016/S0162-0134(00)00171-9; Heinrich L, 2001, EUR J INORG CHEM, P2203; Hopmann KH, 2008, EUR J INORG CHEM, P1406, DOI 10.1002/ejic.200701137; Hopmann KH, 2007, INORG CHEM, V46, P4850, DOI 10.1021/ic061894c; Hourai S, 2003, BIOCHEM BIOPH RES CO, V312, P340, DOI 10.1016/j.bbrc.2003.10.124; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Kubiak K, 2008, BIOPHYS J, V94, P3824, DOI 10.1529/biophysj.107.116665; Lugo-Mas P, 2006, J AM CHEM SOC, V128, P11211, DOI 10.1021/ja062706k; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Noguchi T, 1996, BIOCHEMISTRY-US, V35, P16777, DOI 10.1021/bi961562r; Noveron JC, 1999, J AM CHEM SOC, V121, P3553, DOI 10.1021/ja9833523; Odaka M, 1997, J AM CHEM SOC, V119, P3785, DOI 10.1021/ja962179c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shearer J, 2001, J AM CHEM SOC, V123, P463, DOI 10.1021/ja002642s; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; Takarada H, 2006, BIOSCI BIOTECH BIOCH, V70, P881, DOI 10.1271/bbb.70.881; Taniguchi K, 2008, J BIOSCI BIOENG, V106, P174, DOI 10.1263/jbb.106.174; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Tsujimura M, 1996, J BIOCHEM-TOKYO, V119, P407; Tyler LA, 2003, INORG CHEM, V42, P5751, DOI 10.1021/ic030088s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yano T, 2007, INORG CHEM, V46, P10345, DOI 10.1021/ic701107x	34	45	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36617	36623		10.1074/jbc.M806577200	http://dx.doi.org/10.1074/jbc.M806577200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948265	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000261840500060
J	Willard, FS; Zheng, Z; Guo, J; Digby, GJ; Kimple, AJ; Conley, JM; Johnston, CA; Bosch, D; Willard, MD; Watts, VJ; Lambert, NA; Ikeda, SR; Du, QS; Siderovski, DP				Willard, Francis S.; Zheng, Zhen; Guo, Juan; Digby, Gregory J.; Kimple, Adam J.; Conley, Jason M.; Johnston, Christopher A.; Bosch, Dustin; Willard, Melinda D.; Watts, Val J.; Lambert, Nevin A.; Ikeda, Stephen R.; Du, Quansheng; Siderovski, David P.			A Point Mutation to G alpha(i) Selectively Blocks GoLoco Motif Binding DIRECT EVIDENCE FOR G alpha.GoLoco COMPLEXES IN MITOTIC SPINDLE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEIN; DISSOCIATION INHIBITOR ACTIVITY; G-ALPHA-I; CAENORHABDITIS-ELEGANS EMBRYOS; VOLTAGE-DEPENDENT MODULATION; GUANINE-NUCLEOTIDE EXCHANGE; RAT SYMPATHETIC NEURONS; ENDOGENOUS RGS PROTEINS; BETA-GAMMA-SUBUNITS	Heterotrimeric G-protein G alpha subunits and GoLoco motif proteins are key members of a conserved set of regulatory proteins that influence invertebrate asymmetric cell division and vertebrate neuroepithelium and epithelial progenitor differentiation. GoLoco motif proteins bind selectively to the inhibitory subclass (G alpha(i)) of G alpha subunits, and thus it is assumed that a G alpha(i.)GoLoco motif protein complex plays a direct functional role in microtubule dynamics underlying spindle orientation and metaphase chromosomal segregation during cell division. To address this hypothesis directly, we rationally identified a point mutation to G alpha(i) subunits that renders a selective loss-of-function for GoLoco motif binding, namely an asparagine-to-isoleucine substitution in the alpha D-alpha E loop of the G alpha helical domain. This GoLoco-insensitivity ("GLi") mutation prevented G alpha(i1) association with all human GoLoco motif proteins and abrogated interaction between the Caenorhabditis elegans G alpha sub-unit GOA-1 and the GPR-1 GoLoco motif. In contrast, the GLi mutation did not perturb any other biochemical or signaling properties of G alpha(i) subunits, including nucleotide binding, intrinsic and RGS protein-accelerated GTP hydrolysis, and interactions with G beta gamma dimers, adenylyl cyclase, and seven transmembrane-domain receptors. GoLoco insensitivity rendered G alpha(i) subunits unable to recruit GoLoco motif proteins such as GPSM2/LGN and GPSM3 to the plasma membrane, and abrogated the exaggerated mitotic spindle rocking normally seen upon ectopic expression of wild type G alpha(i) subunits in kidney epithelial cells. This GLi mutation should prove valuable in establishing the physiological roles of G alpha(i).GoLoco motif protein complexes in microtubule dynamics and spindle function during cell division as well as to delineate potential roles for GoLoco motifs in receptor-mediated signal transduction.	[Willard, Francis S.; Kimple, Adam J.; Johnston, Christopher A.; Bosch, Dustin; Willard, Melinda D.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Zheng, Zhen; Du, Quansheng] Med Coll Georgia, Inst Mol Med & Genet, Dept Neurol, Augusta, GA 30912 USA; [Digby, Gregory J.; Lambert, Nevin A.] Med Coll Georgia, Inst Mol Med & Genet, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Guo, Juan; Ikeda, Stephen R.] NIAAA, Lab Mol Physiol, Bethesda, MD 20892 USA; [Conley, Jason M.; Watts, Val J.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47906 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Willard, FS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	willardfs@lilly.com	Siderovski, David Peter/AAA-9603-2019; Watts, Val/A-4633-2012	Siderovski, David Peter/0000-0002-0688-8210; Ikeda, Stephen/0000-0002-4088-9508; Bosch, Dustin/0000-0002-7430-2939; Kimple, Adam/0000-0003-1670-8401; Du, Quansheng/0000-0003-4079-8662	National Institutes of Health [R01 GM074268, GM079506, GM078319, MH060397, F32 GM07694, F30 MH074266]; NIAAA intramural program; American Cancer Society [RSG0717601CSM]; National Science Foundation [0620024]; American Heart Association; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079506, R01GM078319, R01GM074268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH074266, R01MH060397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM074268 (to D.P.S.), GM079506 (to Q.D.), GM078319 (to N.A.L.), MH060397 (to V.J.W.), F32 GM07694 (to C.A.J.), and F30 MH074266 (to A.J.K.). This work was also supported by the NIAAA intramural program (to S. R. I.), American Cancer Society Grant RSG0717601CSM (to Q.D.), National Science Foundation Grant MCB 0620024 (to N.A.L.), and fellowships from the American Heart Association (to G.J.D.) and the PhRMA Foundation (to M.D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2004, METHOD ENZYMOL, V389, P229; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Ikeda SR, 2004, METHOD ENZYMOL, V389, P170; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Jeong SW, 1999, J NEUROSCI, V19, P4755; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Johnston CA, 2008, J BIOL CHEM, V283, P21550, DOI 10.1074/jbc.M803023200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kammermeier PJ, 2003, MOL PHARMACOL, V63, P183, DOI 10.1124/mol.63.1.183; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Nguyen CH, 2005, BIOCHEM BIOPH RES CO, V332, P913, DOI 10.1016/j.bbrc.2005.05.041; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vidi PA, 2008, MOL PHARMACOL, V74, P544, DOI 10.1124/mol.108.047472; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watts VJ, 1999, PSYCHOPHARMACOLOGY, V141, P83, DOI 10.1007/s002130050810; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2006, BIOCHEM BIOPH RES CO, V339, P1107, DOI 10.1016/j.bbrc.2005.11.132; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; WILLARD MD, 2009, HDB CELL SIGNALING; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	80	38	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36698	36710		10.1074/jbc.M804936200	http://dx.doi.org/10.1074/jbc.M804936200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984596	Green Published, hybrid			2022-12-25	WOS:000261840500068
J	Chen, ZB; Feng, JN; Buzin, CH; Sommer, SS				Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Sommer, Steve S.			Epidemiology of Doublet/Multiplet Mutations in Lung Cancers: Evidence that a Subset Arises by Chronocoordinate Events	PLOS ONE			English	Article								Background: Evidence strongly suggests that spontaneous doublet mutations in normal mouse tissues generally arise from chronocoordinate events. These chronocoordinate mutations sometimes reflect "mutation showers'', which are multiple chronocoordinate mutations spanning many kilobases. However, little is known about mutagenesis of doublet and multiplet mutations (domuplets) in human cancer. Lung cancer accounts for about 25% of all cancer deaths. Herein, we analyze the epidemiology of domuplets in the EGFR and TP53 genes in lung cancer. The EGFR gene is an oncogene in which doublets are generally driver plus driver mutations, while the TP53 gene is a tumor suppressor gene with a more typical situation in which doublets derive from a driver and passenger mutation. Methodology/Principal Findings: EGFR mutations identified by sequencing were collected from 66 published papers and our updated EGFR mutation database (www.egfr.org). TP53 mutations were collected from IARC version 12 (www-p53.iarc.fr). For EGFR and TP53 doublets, no clearly significant differences in race, ethnicity, gender and smoking status were observed. Doublets in the EGFR and TP53 genes in human lung cancer are elevated about eight-and three-fold, respectively, relative to spontaneous doublets in mouse (6% and 2.3% versus 0.7%). Conclusions/Significance: Although no one characteristic is definitive, the aggregate properties of doublet and multiplet mutations in lung cancer are consistent with a subset derived from chronocoordinate events in the EGFR gene: i) the eight frameshift doublets (present in 0.5% of all patients with EGFR mutations) are clustered and produce a net in-frame change; ii) about 32% of doublets are very closely spaced (<= 30 nt); and iii) multiplets contain two or more closely spaced mutations. TP53 mutations in lung cancer are very closely spaced (<= 30 nt) in 33% of doublets, and multiplets generally contain two or more very closely spaced mutations. Work in model systems is necessary to confirm the significance of chronocoordinate events in lung and other cancers.	[Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Sommer, Steve S.] City Hope Natl Med Ctr, Dept Mol Genet, Duarte, CA 91010 USA	City of Hope	Chen, ZB (corresponding author), City Hope Natl Med Ctr, Dept Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	sommerlab@coh.org						Bielas JH, 2005, ENVIRON MOL MUTAGEN, V45, P206, DOI 10.1002/em.20111; Buettner VL, 2000, MUTAT RES-FUND MOL M, V452, P219, DOI 10.1016/S0027-5107(00)00090-7; Buettner VL, 1999, ENVIRON MOL MUTAGEN, V33, P320, DOI 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Cooper D. N., 1993, HUMAN GENE MUTATION; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Drake JW, 2005, P NATL ACAD SCI USA, V102, P12849, DOI 10.1073/pnas.0503009102; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Halangoda A, 2001, ENVIRON MOL MUTAGEN, V37, P311, DOI 10.1002/em.1038; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill KA, 2004, MUTAT RES-FUND MOL M, V554, P223, DOI 10.1016/j.mrfmmm.2004.05.005; Hill KA, 2003, MUTAT RES-GEN TOX EN, V534, P173, DOI 10.1016/S1383-5718(02)00277-2; Hill KA, 2002, ENVIRON MOL MUTAGEN, V39, P216, DOI 10.1002/em.10065; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; ROBERTS AR, 1994, CRISIS INTERV TIME-L, V1, P1; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; SOMMER SS, 1990, NATURE, V346, P22, DOI 10.1038/346022b0; SOMMER SS, 1980, J MOL EVOL, V15, P37, DOI 10.1007/BF01732582; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Yokoyama T, 2006, CANCER SCI, V97, P753, DOI 10.1111/j.1349-7006.2006.00233.x	31	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3714	10.1371/journal.pone.0003714	http://dx.doi.org/10.1371/journal.pone.0003714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005564	Green Published, gold, Green Submitted			2022-12-25	WOS:000265166200002
J	Volodin, AA; Bocharova, TN; Smirnova, EA; Camerini-Otero, RD				Volodin, Alexander A.; Bocharova, Tatiana N.; Smirnova, Elena A.; Camerini-Otero, R. Daniel			Reversibility, Equilibration, and Fidelity of Strand Exchange Reaction between Short Oligonucleotides Promoted by RecA Protein from Escherichia coli and Human Rad51 and Dmc1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP HYDROLYSIS; HOMOLOGOUS RECOMBINATION; DUPLEX DNA; HETERODUPLEX PRODUCT; BINDING; RECOGNITION; COMPLEX; FILAMENTS; SEQUENCE; INHIBITION	We demonstrate the reversibility of RecA-promoted strand exchange reaction between short oligonucleotides in the presence of adenosine 5'-O-(thiotriphosphate). The reverse reaction proceeds without the dissociation of RecA from DNA. The reaction reaches equilibrium and its yield depends on the homology between the reaction substrates. We estimate the tolerance of the RecA-promoted strand exchange to individual base substitutions for a comprehensive set of possible base combinations in a selected position along oligonucleotide substrates for strand exchange and find, in agreement with previously reported estimations, that this tolerance is higher than in the case of free DNA. It is demonstrated that the short oligonucleotide-based approach can be applied to the human recombinases Rad51 and Dmc1 when strand exchange is performed in the presence of calcium ions and ATP. Remarkably, despite the commonly held belief that the eukaryotic recombinases have an inherently lower strand exchange activity, in our system their efficiencies in strand exchange are comparable with that of RecA. Under our experimental conditions, the human recombinases exhibit a significantly higher tolerance to interruptions of homology due to point base substitutions than RecA. Finding conditions where a chemical reaction is reversible and reaches equilibrium is critically important for its thermodynamically correct description. We believe that the experimental system described here will substantially facilitate further studies on different aspects of the mechanisms of homologous recombination.	[Volodin, Alexander A.; Bocharova, Tatiana N.; Smirnova, Elena A.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Camerini-Otero, RD (corresponding author), Bldg 5,Rm 205A,5 Mem Dr,MSC0538, Bethesda, MD 20892 USA.	camerini@ncifcrf.gov	Volodin, Alexander/B-9656-2012		National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052033, Z01DK052033, ZIADK052032, Z01DK052032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHOW SA, 1988, J BIOL CHEM, V263, P200; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; Dorfman KD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268102; Dutreix Marie, 2003, ComPlexUs, V1, P89, DOI 10.1159/000070465; Egel R, 2007, DNA REPAIR, V6, P669, DOI 10.1016/j.dnarep.2006.12.013; Egelman E, 2000, TRENDS BIOCHEM SCI, V25, P183, DOI 10.1016/S0968-0004(00)01570-X; Egelman E, 2000, Trends Biochem Sci, V25, P179, DOI 10.1016/S0968-0004(00)01555-8; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; GOLUB EI, 1993, P NATL ACAD SCI USA, V90, P7186, DOI 10.1073/pnas.90.15.7186; Gumbs OH, 1998, BIOCHEMISTRY-US, V37, P11692, DOI 10.1021/bi980646s; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Igoucheva O, 2004, CURR MOL MED, V4, P445, DOI 10.2174/1566524043360465; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Lee AM, 2006, J MOL BIOL, V360, P343, DOI 10.1016/j.jmb.2006.04.065; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; MAKINO O, 1987, J BIOL CHEM, V262, P12237; Malkov VA, 1998, J MOL BIOL, V278, P317, DOI 10.1006/jmbi.1998.1706; Malkov VA, 1997, J MOL BIOL, V271, P168, DOI 10.1006/jmbi.1997.1164; Malkov VA, 2000, J MOL BIOL, V299, P629, DOI 10.1006/jmbi.2000.3770; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Prevost C, 2003, Q REV BIOPHYS, V36, P429, DOI 10.1017/S0033583504003956; PUGH BF, 1987, J BIOL CHEM, V262, P1337; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; RIDDLES PW, 1985, J BIOL CHEM, V260, P170; ROSSELLI W, 1990, J MOL BIOL, V216, P335, DOI 10.1016/S0022-2836(05)80325-0; Sangiuolo F, 2004, CYTOGENET GENOME RES, V105, P435, DOI 10.1159/000078216; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Volodin AA, 2005, TRENDS BIOTECHNOL, V23, P97, DOI 10.1016/j.tibtech.2004.12.005; VOLODIN AA, 1994, FEBS LETT, V349, P65, DOI 10.1016/0014-5793(94)00640-7; Volodin AA, 1997, FEBS LETT, V407, P325, DOI 10.1016/S0014-5793(97)00367-0; Volodin AA, 2000, FEBS LETT, V473, P53, DOI 10.1016/S0014-5793(00)01497-6; Volodin AA, 2003, FEBS LETT, V546, P203, DOI 10.1016/S0014-5793(03)00572-6; Volodin AA, 2002, J BIOL CHEM, V277, P1614, DOI 10.1074/jbc.M108871200; Voloshin ON, 2000, J MOL BIOL, V303, P709, DOI 10.1006/jmbi.2000.4163; Voloshin ON, 1997, GENES CELLS, V2, P303, DOI 10.1046/j.1365-2443.1997.1240322.x; Voloshin ON, 2004, MOL CELL, V15, P846, DOI 10.1016/j.molcel.2004.09.010; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Xiao J, 2006, BIOPOLYMERS, V81, P473, DOI 10.1002/bip.20446; Xiao J, 2002, J MOL BIOL, V320, P529, DOI 10.1016/S0022-2836(02)00462-X; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038; Yu X, 2004, CURR PROTEIN PEPT SC, V5, P73, DOI 10.2174/1389203043486883; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650; Zaitsev EN, 2000, GENE DEV, V14, P740	65	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1495	1504		10.1074/jbc.M800612200	http://dx.doi.org/10.1074/jbc.M800612200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004837	Green Published, hybrid			2022-12-25	WOS:000262330100017
J	Bair, AM; Thippegowda, PB; Freichel, M; Cheng, N; Ye, RD; Vogel, SM; Yu, YN; Flockerzi, V; Malik, AB; Tiruppathi, C				Bair, Angela M.; Thippegowda, Prabhakar B.; Freichel, Marc; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Flockerzi, Veit; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-kappa B Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE-1; GENE-EXPRESSION; P38 MAPK; PHOSPHORYLATION; TRANSACTIVATION; INCREASE; PATHWAY; BETA; TRANSCRIPTION	The transient receptor potential canonical (TRPC) family channels are proposed to be essential for store-operated Ca2+ entry in endothelial cells. Ca2+ signaling is involved in NF-kappa B activation, but the role of store-operated Ca2+ entry is unclear. Here we show that thrombin-induced Ca2+ entry and the resultant AMP-activated protein kinase (AMPK) activation targets the Ca2+-independent protein kinase C delta (PKC delta) to mediate NF-kappa B activation in endothelial cells. We observed that thrombin-induced p65/RelA, AMPK, and PKC delta activation were markedly reduced by knockdown of the TRPC isoform TRPC1 expressed in human endothelial cells and in endothelial cells obtained from Trpc4 knock-out mice. Inhibition of Ca2+/calmodulin-dependent protein kinase kinase beta downstream of the Ca2+ influx or knockdown of the downstream Ca2+/calmodulin-dependent protein kinase kinase beta target kinase, AMPK, also prevented NF-kappa B activation. Further, we observed that AMPK interacted with PKC delta and phosphorylated Thr(505) in the activation loop of PKC delta in thrombin-stimulated endothelial cells. Expression of a PKC delta-T505A mutant suppressed the thrombin-induced but not the TNF-alpha-induced NF-kappa B activation. These findings demonstrate a novel mechanism for TRPC channels to mediate NF-kappa B activation in endothelial cells that involves the convergence of the TRPC-regulated signaling at AMPK and PKC delta and that may be a target of interference of the inappropriate activation of NF-kappa B associated with thrombosis.	[Bair, Angela M.; Thippegowda, Prabhakar B.; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Malik, Asrar B.; Tiruppathi, Chinnaswamy] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Bair, Angela M.; Thippegowda, Prabhakar B.; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Malik, Asrar B.; Tiruppathi, Chinnaswamy] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA; [Freichel, Marc; Flockerzi, Veit] Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saarland University	Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, M-C868,835 S Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu	Ye, Richard/ABF-2413-2020; BT, Prabhakar/AAU-5199-2021; Ye, Richard/O-5223-2016	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Malik, Asrar/0000-0002-8205-7128; BT, Prabhakar/0000-0003-2377-9179	National Institutes of Health [P01HL077806, GM058531, GM066182, T32HL072742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, T32HL072742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531, R01GM066182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL077806, GM058531, GM066182, and T32HL072742. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cao HQ, 2006, AM J PHYSIOL-CELL PH, V290, pC172, DOI 10.1152/ajpcell.00284.2005; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Freichel M, 1999, CELL PHYSIOL BIOCHEM, V9, P270, DOI 10.1159/000016321; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2001, AM J PHYSIOL-LUNG C, V281, pL958, DOI 10.1152/ajplung.2001.281.4.L958; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137	53	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					563	574		10.1074/jbc.M803984200	http://dx.doi.org/10.1074/jbc.M803984200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990707	Green Published, hybrid			2022-12-25	WOS:000261974800062
J	Corsini, L; Hothorn, M; Stier, G; Rybin, V; Scheffzek, K; Gibson, TJ; Sattler, M				Corsini, Lorenzo; Hothorn, Michael; Stier, Gunter; Rybin, Vladimir; Scheffzek, Klaus; Gibson, Toby J.; Sattler, Michael			Dimerization and Protein Binding Specificity of the U2AF Homology Motif of the Splicing Factor Puf60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 NMR RELAXATION; STAPHYLOCOCCAL ALPHA-TOXIN; BACKBONE DYNAMICS; STRUCTURAL BASIS; BRANCH SITE; POLYPYRIMIDINE TRACT; INTERACTION NETWORK; RNA-BINDING; FACTOR SF1; RECOGNITION	PUF60 is an essential splicing factor functionally related and homologous to U2AF(65). Its C-terminal domain belongs to the family of U2AF (U2 auxiliary factor) homology motifs (UHM), a subgroup of RNA recognition motifs that bind to tryptophan-containing linear peptide motifs (UHM ligand motifs, ULMs) in several nuclear proteins. Here, we show that the Puf60 UHM is mainly monomeric in physiological buffer, whereas its dimerization is induced upon the addition of SDS. The crystal structure of PUF60-UHM at 2.2 angstrom resolution, NMR data, and mutational analysis reveal that the dimer interface is mediated by electrostatic interactions involving a flexible loop. Using glutathione S-transferase pulldown experiments, isothermal titration calorimetry, and NMR titrations, we find that Puf60-UHM binds to ULM sequences in the splicing factors SF1, U2AF(65), and SF3b155. Compared with U2AF(65)-UHM, Puf60-UHM has distinct binding preferences to ULMs in the N terminus of SF3b155. Our data suggest that the functional cooperativity between U2AF(65) and Puf60 may involve simultaneous interactions of the two proteins with SF3b155.	[Corsini, Lorenzo; Hothorn, Michael; Stier, Gunter; Rybin, Vladimir; Scheffzek, Klaus; Gibson, Toby J.; Sattler, Michael] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Sattler, Michael] Tech Univ Munich, Dept Chem, Chair Biomol NMR, D-85747 Garching, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Sattler, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Sattler, Michael/C-1169-2010; Corsini, Lorenzo/GSR-5058-2022; Hothorn, Michael/C-6807-2011	Sattler, Michael/0000-0002-1594-0527; Corsini, Lorenzo/0000-0002-8077-6559; Hothorn, Michael/0000-0002-3597-5698; Gibson, Toby James/0000-0003-0657-5166	Deutsche Forschungsgemeinschaft Grant Sa [823/5]; European Commission [LSHG-CT-2005-512028]; Peter and Traudl Engelhorn Foundation	Deutsche Forschungsgemeinschaft Grant Sa(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Peter and Traudl Engelhorn Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant Sa 823/5 and European Commission 3D Repertoire Grant LSHG-CT-2005-512028, and funds from the Peter and Traudl Engelhorn Foundation ( to M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chung SH, 2008, ONCOGENE, V27, P1412, DOI 10.1038/sj.onc.1210784; CORSINI L, 2008, PROTEIN SCI IN PRESS; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Crichlow GV, 2008, EMBO J, V27, P277, DOI 10.1038/sj.emboj.7601936; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Poleev A, 2000, EUR J BIOCHEM, V267, P4002, DOI 10.1046/j.1432-1327.2000.01431.x; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Quinn LM, 2004, DEVELOPMENT, V131, P1411, DOI 10.1242/dev.01019; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramu C, 2003, NUCLEIC ACIDS RES, V31, P3771, DOI 10.1093/nar/gkg546; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	59	44	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					630	639		10.1074/jbc.M805395200	http://dx.doi.org/10.1074/jbc.M805395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974054	Green Published, hybrid			2022-12-25	WOS:000261974800068
J	Kawaai, K; Hisatsune, C; Kuroda, Y; Mizutani, A; Tashiro, T; Mikoshiba, K				Kawaai, Katsuhiro; Hisatsune, Chihiro; Kuroda, Yukiko; Mizutani, Akihiro; Tashiro, Tomoko; Mikoshiba, Katsuhiko			80K-H Interacts with Inositol 1,4,5-Trisphosphate (IP3) Receptors and Regulates IP3-induced Calcium Release Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; POLYCYSTIC LIVER-DISEASE; HIPPOCAMPAL CA1 NEURONS; TRISPHOSPHATE RECEPTOR; MONOCLONAL-ANTIBODIES; BINDING PROTEIN; INSP3 RECEPTOR; CA2+; TYPE-1; EXPRESSION	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) are intracellular channel proteins that mediate calcium (Ca2+) release from the endoplasmic reticulum, and they are involved in many biological processes (e. g. fertilization, secretion, and synaptic plasticity). Recent reports show that IP3R activity is strictly regulated by several interacting molecules (e. g. IP3R binding protein released with inositol 1,4,5-trisphosphate, huntingtin, presenilin, DANGER, and cytochrome c), and perturbation of this regulation causes intracellular Ca2+ elevation leading to several diseases (e. g. Huntington disease and Alzheimer disease). In this study, we identified protein kinase C substrate 80K-H (80K-H) to be a novel molecule interacting with the COOH-terminal tail of IP3Rs by yeast two-hybrid screening. 80K-H directly interacted with IP3R type 1 (IP(3)R1) in vitro and co-immunoprecipitated with IP3R1 in cell lysates. Immunocytochemical and immunohistochemical staining revealed that 80K-H colocalized with IP(3)R1 in COS-7 cells and in hippocampal neurons. We also showed that the purified recombinant 80K-H protein directly enhanced IP3-induced Ca2+ release activity by a Ca2+ release assay using mouse cerebellar microsomes. Furthermore 80K-H was found to regulate ATP-induced Ca2+ release in living cells. Thus, our findings suggest that 80K-H is a novel regulator of IP3R activity, and it may contribute to neuronal functions.	[Kawaai, Katsuhiro; Hisatsune, Chihiro; Kuroda, Yukiko; Mizutani, Akihiro; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Kawaai, Katsuhiro; Tashiro, Tomoko] Aoyama Gakuin Univ, Dept Chem & Biol Sci, Kanagawa 2298558, Japan; [Hisatsune, Chihiro; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Wako, Saitama 3510198, Japan	RIKEN; Aoyama Gakuin University; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Mizutani, Akihiro/GPS-4809-2022; Kuroda, Yukiko/L-6332-2013; Mikoshiba, Katsuhiko/N-7943-2015; Hisatsune, Chihiro/C-6661-2017; Kawaai, Katsuhiro/C-9216-2017; Kuroda, Yukiko/L-6332-2013	Mizutani, Akihiro/0000-0003-4155-802X; Kuroda, Yukiko/0000-0002-5335-4238; Hisatsune, Chihiro/0000-0001-7811-7784; Kawaai, Katsuhiro/0000-0002-7502-0722; Kuroda, Yukiko/0000-0001-7713-9471	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Cai WH, 2004, J BIOL CHEM, V279, P23691, DOI 10.1074/jbc.M313296200; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Everson GT, 2004, HEPATOLOGY, V40, P774, DOI 10.1002/hep.20431; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Gkika D, 2004, J BIOL CHEM, V279, P26351, DOI 10.1074/jbc.M403801200; Glaser S, 2000, HEPATOLOGY, V32, P17; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; KAWAAI K, 2008, BIOCHEMICA, V1, P21; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Maes K, 1999, CELL CALCIUM, V25, P143, DOI 10.1054/ceca.1998.0011; Mailhot G, 2000, ENDOCRINOLOGY, V141, P891, DOI 10.1210/en.141.3.891; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Taufiq AM, 2005, LEARN MEMORY, V12, P594, DOI 10.1101/lm.17405; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200	47	34	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					372	380		10.1074/jbc.M805828200	http://dx.doi.org/10.1074/jbc.M805828200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990696	hybrid			2022-12-25	WOS:000261974800042
J	Boulay, PL; Cotton, M; Melancon, P; Claing, A				Boulay, Pierre-Luc; Cotton, Mathieu; Melancon, Paul; Claing, Audrey			ADP-ribosylation Factor 1 Controls the Activation of the Phosphatidylinositol 3-Kinase Pathway to Regulate Epidermal Growth Factor-dependent Growth and Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF ACTIVATION; INVASION; PROTEIN; TRANSPORT; DOMAINS; BINDING; FAMILY; RAC1; ARNO; P85	Activation of intracellular signaling pathways by growth factors is one of the major causes of cancer development and progression. Recent studies have demonstrated that monomeric G proteins of the Ras family are key regulators of cell proliferation, migration, and invasion. Using an invasive breast cancer cell lines, we demonstrate that the ADP-ribosylation factor 1 (ARF1), a small GTPase classically associated with the Golgi, is an important regulator of the biological effects induced by epidermal growth factor. Here, we show that this ARF isoform is activated following epidermal growth factor stimulation and that, in MDA-MB-231 cells, ARF1 is found in dynamic plasma membrane ruffles. Inhibition of endogenous ARF1 expression results in the inhibition of breast cancer cell migration and proliferation. The underlying mechanism involves the activation of the phosphatidylinositol 3-kinase pathway. Our data demonstrate that depletion of ARF1 markedly impairs the recruitment of the phosphatidylinositol 3-kinase catalytic subunit (p110 alpha) to the plasma membrane, and the association of the regulatory subunit (p85 alpha) to the activated receptor. These results uncover a novel molecular mechanism by which ARF1 regulates breast cancer cell growth and invasion during cancer progression.	[Boulay, Pierre-Luc; Cotton, Mathieu; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Melancon, Paul] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	Universite de Montreal; University of Alberta	Claing, A (corresponding author), POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Melancon, Paul/P-1304-2018	Melancon, Paul/0000-0002-8085-3032	Canadian Institutes of Health Research (CIHR) [MOP-79470]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research (CIHR, Grant MOP-79470 to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; KLIJN JGM, 1992, ENDOCR REV, V13, P3, DOI 10.1210/er.13.1.3; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; NORMANNO N, 1994, BREAST CANCER RES TR, V29, P11, DOI 10.1007/BF00666178; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wells A, 2000, ADV CANCER RES, V78, P31; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	35	72	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36425	36434		10.1074/jbc.M803603200	http://dx.doi.org/10.1074/jbc.M803603200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990689	Green Published, hybrid			2022-12-25	WOS:000261840500040
J	Hazelwood, LA; Free, RB; Cabrera, DM; Skinbjerg, M; Sibley, DR				Hazelwood, Lisa A.; Free, R. Benjamin; Cabrera, David M.; Skinbjerg, Mette; Sibley, David R.			Reciprocal Modulation of Function between the D-1 and D-2 Dopamine Receptors and the Na+, K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; NA+,K+-ATPASE ENDOCYTOSIS; INTERACTING PROTEINS; D1; DESENSITIZATION; RECRUITMENT; PHOSPHORYLATION; NA,K-ATPASE; INHIBITION	It is well documented that dopamine can increase or decrease the activity of the Na+, K+-ATPase (NKA, sodium pump) in an organ-specific fashion. This regulation can occur, at least partially, via receptor-mediated second messenger activation and can promote NKA insertion or removal from the plasma membrane. Using co-immunoprecipitation and mass spectrometry, we now show that, in both brain and HEK293T cells, D-1 and D-2 dopamine receptors (DARs) can exist in a complex with the sodium pump. To determine the impact of NKA on DAR function, biological assays were conducted with NKA and DARs co-expressed in HEK293T cells. In this system, expression of NKA dramatically decreased D-1 and D-2 DAR densities with a concomitant functional decrease in DAR-mediated regulation of cAMP levels. Interestingly, pharmacological inhibition of endogenous or overexpressed NKA enhanced DAR function without altering receptor number or localization. Similarly, DAR function was also augmented by small interfering RNA reduction of the endogenous NKA. These data suggest that, under basal conditions, NKA negatively regulates DAR function via protein-protein interactions. In reciprocal fashion, expression of DARs decreases endogenous NKA function in the absence of dopamine, implicating DAR proteins as regulators of NKA activity. Notably, dopamine stimulation or pertussis toxin inhibition of D-2 receptor signaling did not alter NKA activity, indicating that the D-2-mediated decrease in NKA function is dependent upon protein-protein interactions rather than signaling molecules. This evidence for reciprocal regulation between DARs and NKA provides a novel control mechanism for both DAR signaling and cellular ion balance.	[Hazelwood, Lisa A.; Free, R. Benjamin; Cabrera, David M.; Skinbjerg, Mette; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, 5625 Fishers Ln,Rm 4S-04,MSC 9405, Bethesda, MD 20852 USA.	sibley@helix.nih.gov	Cabrera, David/I-1013-2014; Sibley, David/AAC-3591-2019; Skinbjerg, Mette/D-6436-2014		National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003028, ZIANS003028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grant (Intramural Research Program of NINDS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnard ML, 1997, AM J RESP CRIT CARE, V156, P709, DOI 10.1164/ajrccm.156.3.9610013; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Bertorello AM, 2005, AM J RESP CELL MOL, V33, P432, DOI 10.1165/rcmb.2005-0297TR; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Efendiev R, 2002, J BIOL CHEM, V277, P44108, DOI 10.1074/jbc.M205173200; El-Ghundi M, 2007, REV NEUROSCIENCE, V18, P37; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HEINZEL SS, 1988, J VIROL, V62, P3738, DOI 10.1128/JVI.62.10.3738-3746.1988; Heusler P, 2007, NEUROPHARMACOLOGY, V52, P1106, DOI 10.1016/j.neuropharm.2006.11.008; Jose PA, 2003, NEPHRON PHYSIOL, V95, P19, DOI DOI 10.1159/000073676; Kabbani N, 2007, EUR J PHARMACOL, V572, P83, DOI 10.1016/j.ejphar.2007.06.059; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2005, MOL PHARMACOL, V68, P275, DOI 10.1124/mol.105.015263; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; Ogimoto G, 2000, P NATL ACAD SCI USA, V97, P3242, DOI 10.1073/pnas.060025597; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sealfon SC, 2000, TRENDS NEUROSCI, V23, pS34, DOI 10.1016/S1471-1931(00)00025-2; Strange PE, 1999, CLIN EXP PHARMACOL P, V26, pS3; Teixeira VL, 2003, ANN NY ACAD SCI, V986, P587, DOI 10.1111/j.1749-6632.2003.tb07257.x; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tonini M, 2004, ALIMENT PHARM THER, V19, P379, DOI 10.1111/j.1365-2036.2004.01867.x; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Woods AS, 2005, J MOL NEUROSCI, V26, P125, DOI 10.1385/JMN:26:2-3:125; Zeng Chunyu, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P241; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	36	32	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36441	36453		10.1074/jbc.M805520200	http://dx.doi.org/10.1074/jbc.M805520200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984584	hybrid, Green Published			2022-12-25	WOS:000261840500042
J	London, TBC; Barber, LJ; Mosedale, G; Kelly, GP; Balasubramanian, S; Hickson, ID; Boulton, SJ; Hiom, K				London, Timothy B. C.; Barber, Louise J.; Mosedale, Georgina; Kelly, Gavin P.; Balasubramanian, Shankar; Hickson, Ian D.; Boulton, Simon J.; Hiom, Kevin			FANCJ Is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; G-QUADRUPLEX DNA; CAENORHABDITIS-ELEGANS; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; G4 DNA; ANEMIA; BACH1; BRIP1; PROTEIN	Fanconi anemia (FA) is a heritable human cancer-susceptibility disorder, delineating a genetically heterogenous pathway for the repair of replication-blocking lesions such as interstrand DNA cross-links. Here we demonstrate that one component of this pathway, FANCJ, is a structure-specific DNA helicase that dissociates guanine quadruplex DNA (G4 DNA) in vitro. Moreover, in contrast with previously identified G4 DNA helicases, such as the Bloom's helicase (BLM), FANCJ unwinds G4 substrates with 5'-3' polarity. In the FA-J human patient cell line EUFA0030 the loss of FANCJ G4 unwinding function correlates with the accumulation of large genomic deletions in the vicinity of sequences, which match the G4 DNA signature. Together these findings support a role for FANCJ in the maintenance of potentially unstable genomic G/C tracts during replication.	[London, Timothy B. C.; Hiom, Kevin] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Mosedale, Georgina; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Kelly, Gavin P.] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England; [Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barber, Louise J.; Boulton, Simon J.] Imperial Canc Res Fund, Clare Hall Labs, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England	MRC Laboratory Molecular Biology; University of Oxford; Cancer Research UK; University of Cambridge	Hiom, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hiom@mrc-lmb.cam.ac.uk	Hiom, Kevin/B-4374-2009; Barber, Louise J./L-8579-2019; Balasubramanian, Shankar/C-1671-2009; Hickson, Ian/AAJ-7548-2020; Kelly, Gavin/ABG-2715-2021	Barber, Louise J./0000-0001-9265-3516; Kelly, Gavin/0000-0001-7219-560X; Balasubramanian, Shankar/0000-0002-0281-5815; Hickson, Ian/0000-0002-0583-566X	Cancer Research UK; Medical Research Council [MC_U105184300] Funding Source: researchfish; MRC [MC_U105184300] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Cancer Research UK.	Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2006, GENETICS, V173, P697, DOI 10.1534/genetics.106.056879; Zhao Y, 2008, DNA REPAIR, V7, P1846, DOI 10.1016/j.dnarep.2008.07.011	28	173	175	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36132	36139		10.1074/jbc.M808152200	http://dx.doi.org/10.1074/jbc.M808152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18978354	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000261840500008
J	Assil-Kishawi, I; Samra, TA; Mierke, DF; Abou-Samra, AB				Assil-Kishawi, Iman; Samra, Tareq A.; Mierke, Dale F.; Abou-Samra, Abdul B.			Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PARATHYROID-HORMONE PTH; N-TERMINAL DOMAIN; FACTOR TYPE-1 RECEPTOR; EXTRACELLULAR DOMAIN; BINDING DOMAIN; LIGAND-BINDING; 1ST-EXTRACELLULAR DOMAIN; CONFORMATIONAL STATES; AMINO-TERMINUS	Corticotropin-releasing factor receptor 1 (CRFR1) mediates the physiological actions of corticotropin-releasing factor in the anterior pituitary gland and the central nervous system. Using chemical cross-linking we have previously reported that residue 16 of sauvagine (SVG) is in a close proximity to the second extracellular loop of CRFR1. Here we introduced p-benzoylphenylalanine (Bpa) at position 17 of a sauvagine analog, [Tyr(0), Gln(1),Bpa(17)] SVG, to covalently label CRFR1 and characterize the cross-linking site. Using a combination of receptor mutagenesis, peptide mapping, and N-terminal sequencing, we identified His(117) within the first transmembrane domain (TM1) of CRFR1 as the cross-linking site for Bpa17 of I-125-[Tyr(0), Gln(1), Bpa17] SVG. These data indicate that, within the SVG-CRFR1 complex, residue 17 of the ligand lies within a 9 angstrom distance from residue 117 of the TM1 of CRFR1. The molecular proximity between residue 17 of the ligand and TM1 of CRFR1 described here and between residue 16 of the ligand and the CRFR1 second extracellular loop described previously provides useful molecular constraints for modeling ligand-receptor interaction in mammalian cells expressing CRFR1.	[Assil-Kishawi, Iman; Samra, Tareq A.; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Dept Internal Med, Div Endocrine,Univ Hlth Ctr, Detroit, MI 48201 USA; [Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Wayne State University; Dartmouth College	Abou-Samra, AB (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Chief Endocrine Div, 4H-UHC,4201 St Antoine, Detroit, MI 48201 USA.	asamra@med.wayne.edu	Abou-Samra, Abdul/ABE-8723-2020	Abou-Samra, Abdul/0000-0001-8735-1142	National Institutes of Health [7RO1 DK63211, GM54082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054082, R01GM054082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 7RO1 DK63211 ( to A.B.A.-S.) and GM54082 ( to D.F.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ABOUSAMRA AB, 1987, J BIOL CHEM, V262, P1129; Adams AE, 1998, MOL ENDOCRINOL, V12, P1673, DOI 10.1210/me.12.11.1673; Arai M, 2001, ENDOCRINOLOGY, V142, P446, DOI 10.1210/en.142.1.446; Assil IQ, 2001, PEPTIDES, V22, P1055, DOI 10.1016/S0196-9781(01)00424-7; Assil IQ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1015, DOI 10.1152/ajpendo.2001.281.5.E1015; Assil IQ, 2001, BIOCHEMISTRY-US, V40, P1187, DOI 10.1021/bi001758y; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Behar V, 1999, ENDOCRINOLOGY, V140, P4251, DOI 10.1210/en.140.9.4251; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2006, J BIOL CHEM, V281, P32485, DOI 10.1074/JBC.M606179200; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grammatopoulos DK, 2000, MOL ENDOCRINOL, V14, P2076, DOI 10.1210/me.14.12.2076; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hoare SRJ, 2008, MOL PHARMACOL, V73, P1371, DOI 10.1124/mol.107.042978; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2003, PEPTIDES, V24, P1881, DOI 10.1016/j.peptides.2003.09.002; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; INGLIS AS, 1970, ANAL BIOCHEM, V37, P73, DOI 10.1016/0003-2697(70)90259-9; Jean-Rene B, 2005, J BIOL CHEM, V280, P23771, DOI 10.1074/jbc.M500817200; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; Klose J, 2004, PROTEIN SCI, V13, P2470, DOI 10.1110/ps.04835904; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; LEDERIS K, 1982, SCIENCE, V218, P162, DOI 10.1126/science.6981844; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Markovic D, 2008, MOL ENDOCRINOL, V22, P689, DOI 10.1210/me.2007-0136; MONTECUCCHI PC, 1980, INT J PEPT PROT RES, V16, P191; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pellegrini M, 1998, BIOCHEMISTRY-US, V37, P12737, DOI 10.1021/bi981265h; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2006, ANN NY ACAD SCI, V1070, P105, DOI 10.1196/annals.1317.065; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Qi LJ, 1997, BIOCHEMISTRY-US, V36, P12442, DOI 10.1021/bi970997r; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Shimizu N, 2005, J BIOL CHEM, V280, P1797, DOI 10.1074/jbc.M408270200; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; XIONG YT, 1995, ENDOCRINOLOGY, V136, P1828, DOI 10.1210/en.136.5.1828	64	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35644	35651		10.1074/jbc.M806351200	http://dx.doi.org/10.1074/jbc.M806351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955489	hybrid, Green Published			2022-12-25	WOS:000261687900038
J	Schlee, W; Weisz, N; Bertrand, O; Hartmann, T; Elbert, T				Schlee, Winfried; Weisz, Nathan; Bertrand, Olivier; Hartmann, Thomas; Elbert, Thomas			Using Auditory Steady State Responses to Outline the Functional Connectivity in the Tinnitus Brain	PLOS ONE			English	Article								Background: Tinnitus is an auditory phantom perception that is most likely generated in the central nervous system. Most of the tinnitus research has concentrated on the auditory system. However, it was suggested recently that also non-auditory structures are involved in a global network that encodes subjective tinnitus. We tested this assumption using auditory steady state responses to entrain the tinnitus network and investigated long-range functional connectivity across various non-auditory brain regions. Methods and Findings: Using whole-head magnetoencephalography we investigated cortical connectivity by means of phase synchronization in tinnitus subjects and healthy controls. We found evidence for a deviating pattern of long-range functional connectivity in tinnitus that was strongly correlated with individual ratings of the tinnitus percept. Phase couplings between the anterior cingulum and the right frontal lobe and phase couplings between the anterior cingulum and the right parietal lobe showed significant condition x group interactions and were correlated with the individual tinnitus distress ratings only in the tinnitus condition and not in the control conditions. Conclusions: To the best of our knowledge this is the first study that demonstrates existence of a global tinnitus network of long-range cortical connections outside the central auditory system. This result extends the current knowledge of how tinnitus is generated in the brain. We propose that this global extend of the tinnitus network is crucial for the continuos perception of the tinnitus tone and a therapeutical intervention that is able to change this network should result in relief of tinnitus.	[Schlee, Winfried; Weisz, Nathan; Hartmann, Thomas; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany; [Weisz, Nathan; Bertrand, Olivier] INSERM, U821, Lyon, France	University of Konstanz; Institut National de la Sante et de la Recherche Medicale (Inserm)	Schlee, W (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.	Winfried.Schlee@uni-konstanz.de	Bertrand, Olivier/B-6165-2008; Elbert, Thomas/C-8556-2009; Schlee, Winfried/C-8983-2011; Weisz, Nathan/K-3325-2015; Hartmann, Thomas/ABH-6731-2020	Bertrand, Olivier/0000-0003-0733-7979; Elbert, Thomas/0000-0003-1332-4939; Schlee, Winfried/0000-0001-7942-1788; Weisz, Nathan/0000-0001-7816-0037; Hartmann, Thomas/0000-0002-8298-8125; Lauwereyns, Jan/0000-0003-0551-2550				ALAIN C, 2008, CEREB CORTEX; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Dandy WE, 1941, ANN SURG, V114, P336, DOI 10.1097/00000658-194109000-00003; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Dehaene S., 2004, COGNITIVE NEUROSCIEN, VIII; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Goebel G, 1998, INSTRUMENT ERFASSUNG; GOLDMANRAKIC PS, ANN REV NEUROSCI; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; KALIN NH, 2007, BIOL PSYCHIAT; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Morris JS, 2001, J NEUROSCI, V21, P5304, DOI 10.1523/JNEUROSCI.21-14-05304.2001; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; PANTEV C, 1993, ELECTROENCEPHALOGR C; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; SILVERSTEIN H, 1976, LARYNGOSCOPE, V86, P1777, DOI 10.1002/lary.5540861201; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2004, CLIN NEUROPHYSIOL, V115, P1249, DOI 10.1016/j.clinph.2003.12.034; Weisz N, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-8; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023	41	133	137	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3720	10.1371/journal.pone.0003720	http://dx.doi.org/10.1371/journal.pone.0003720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005566	Green Published, Green Submitted, gold			2022-12-25	WOS:000265166200008
J	Riehle, MM; Xu, JN; Lazzaro, BP; Rottschaefer, SM; Coulibaly, B; Sacko, M; Niare, O; Morlais, I; Traore, SF; Vernick, KD				Riehle, Michelle M.; Xu, Jiannong; Lazzaro, Brian P.; Rottschaefer, Susan M.; Coulibaly, Boubacar; Sacko, Madjou; Niare, Oumou; Morlais, Isabelle; Traore, Sekou F.; Vernick, Kenneth D.			Anopheles gambiae APL1 Is a Family of Variable LRR Proteins Required for Rel1-Mediated Protection from the Malaria Parasite, Plasmodium berghei	PLOS ONE			English	Article								Background: We previously identified by genetic mapping an Anopheles gambiae chromosome region with strong influence over the outcome of malaria parasite infection in nature. Candidate gene studies in the genetic interval, including functional tests using the rodent malaria parasite Plasmodium berghei, identified a novel leucine-rich repeat gene, APL1, with functional activity against P. berghei. Principal Findings: Manual reannotation now reveals APL1 to be a family of at least 3 independently transcribed genes, APL1A, APL1B, and APL1C. Functional dissection indicates that among the three known APL1 family members, APL1C alone is responsible for host defense against P. berghei. APL1C functions within the Rel1-Cactus immune signaling pathway, which regulates APL1C transcript and protein abundance. Gene silencing of APL1C completely abolishes Rel1-mediated host protection against P. berghei, and thus the presence of APL1C is required for this protection. Further highlighting the influence of this chromosome region, allelic haplotypes at the APL1 locus are genetically associated with and have high explanatory power for the success or failure of P. berghei parasite infection. Conclusions: APL1C functions as a required transducer of Rel1-dependent immune signal(s) to efficiently protect mosquitoes from P. berghei infection, and allelic genetic haplotypes of the APL1 locus display distinct levels of susceptibility and resistance to P. berghei.	[Riehle, Michelle M.; Xu, Jiannong; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Lazzaro, Brian P.; Rottschaefer, Susan M.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Coulibaly, Boubacar; Sacko, Madjou; Niare, Oumou; Traore, Sekou F.] Univ Bamako, Malaria Res & Train Ctr, Bamako, Mali; [Morlais, Isabelle] Inst Rech pour Devel IRD OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Vernick, Kenneth D.] Inst Pasteur, CNRS, Dept Parasitol & Mycol, Unit Insect Vector Genet & Genom, Paris, France	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University of Bamako; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Riehle, MM (corresponding author), Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA.	kvernick@pasteur.fr	Xu, Jiannong/N-1583-2019; Morlais, Isabelle/F-5078-2014; Morlais, Isabelle/Q-2171-2019	Xu, Jiannong/0000-0001-7332-4370; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670	NIH [AI042361, AI073685]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361, R01AI062995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The reported work was supported by NIH AI042361 and AI073685 to KDV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; NENE V, 2007, SCIENCE; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Vernick KD, 2004, NEW ENGL J MED, V351, P1901, DOI 10.1056/NEJMcibr042899; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x	26	59	60	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3672	10.1371/journal.pone.0003672	http://dx.doi.org/10.1371/journal.pone.0003672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LM	18989366	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134600008
J	Letenneur, L; Peres, K; Fleury, H; Garrigue, I; Barberger-Gateau, P; Helmer, C; Orgogozo, JM; Gauthier, S; Dartigues, JF				Letenneur, Luc; Peres, Karine; Fleury, Herve; Garrigue, Isabelle; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Gauthier, Serge; Dartigues, Jean-Francois			Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study	PLOS ONE			English	Article								Background: Herpes Simplex Virus (HSV) infection has been proposed as a possible risk factor of Alzheimer's Disease (AD) notably because it is neurotropic, ubiquitous in the general population and able to establish lifelong latency in the host. The fact that HSV was present in elderly subjects with AD suggests that the virus could be a co-factor of the disease. We investigated the risk of developing AD in anti-HSV immunoglobulin G (IgG) positive subjects (indicator of a lifelong infection to HSV) and IgM-positive subjects (indicator of primary infection or reactivation of the virus) in a longitudinal population-based cohort of elderly subjects living in the community. Methods: Cox proportional hazard models were used to study the risk of developing AD according to the presence or not of anti-HSV IgG and IgM antibodies, assessed in the sera of 512 elderly initially free of dementia followed for 14 years. Results: During the follow-up, 77 incident AD cases were diagnosed. Controlled for age, gender, educational level and Apolipoprotein E4 (APOE4) status, IgM-positive subjects showed a significant higher risk of developing AD (HR = 2.55; 95% CI [1.38-4.72]), although no significant increased risk was observed in IgG-positive subjects (HR = 1.67; 95% CI [0.75-3.73]). No modification effect with APOE4 status was found. Conclusion: Reactivation of HSV seropositivity is highly correlated with incident AD. HSV chronic infection may therefore be contributive to the progressive brain damage characteristic of AD.	[Letenneur, Luc; Peres, Karine; Fleury, Herve; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] INSERM, U897, Bordeaux, France; [Letenneur, Luc; Peres, Karine; Fleury, Herve; Garrigue, Isabelle; Barberger-Gateau, Pascale; Helmer, Catherine; Orgogozo, Jean-Marc; Dartigues, Jean-Francois] Univ Victor Segalen Bordeaux 2, Bordeaux, France; [Garrigue, Isabelle] Univ Victor Segalen Bordeaux 2, Lab Virol, Bordeaux, France; [Gauthier, Serge] McGill Univ, Ctr Studies Aging, Montreal, PQ H3A 2T5, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; McGill University	Letenneur, L (corresponding author), INSERM, U897, Bordeaux, France.	luc.letenneur@inserm.fr	LETENNEUR, Luc/T-4424-2019; PERES, Karine/T-4128-2019; HELMER, Catherine/AAG-5126-2021; Garrigue, isabelle/AGZ-8837-2022; HELMER, Catherine/I-6581-2015; DARTIGUES, Jean François/T-4513-2019	LETENNEUR, Luc/0000-0002-3274-937X; PERES, Karine/0000-0002-0720-0684; HELMER, Catherine/0000-0002-5169-7421; 	Fondation de France; Novartis Laboratories; IPSEN laboratories; Conseil General de la Gironde; Conseil Regional d'Aquitaine; SCOR Insurance (France)	Fondation de France(Fondation de France); Novartis Laboratories; IPSEN laboratories(Ipsen); Conseil General de la Gironde(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); SCOR Insurance (France)	The PAQUID study was supported by grants from Fondation de France, Novartis Laboratories, IPSEN laboratories, Conseil General de la Gironde, Conseil Regional d'Aquitaine, SCOR Insurance (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; APA, 1987, DIAGN STAT MAN MENT, V3rd; Beffert U, 1998, LANCET, V351, P1330, DOI 10.1016/S0140-6736(05)79057-7; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10; Chaudhuri A, 2002, POSTGRAD MED J, V78, P575, DOI 10.1136/pmj.78.924.575; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; FORSGREN M, 1989, SERODIAG IMMUN INF D, V3, P259, DOI 10.1016/0888-0786(89)90006-1; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki Ruth, 2004, Herpes, V11 Suppl 2, p77A; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Kammerman EM, 2006, MED HYPOTHESES, V66, P294, DOI 10.1016/j.mehy.2005.07.033; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Knipe D.M., 2001, FIELDS VIROLOGY; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x; OUNANIAN A, 1990, J CLIN LAB ANAL, V4, P367, DOI 10.1002/jcla.1860040510; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pyles R B, 2001, Herpes, V8, P64; RENVOIZE EB, 1987, AGE AGEING, V16, P311, DOI 10.1093/ageing/16.5.311; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; Thackray AM, 2004, J VIROL, V78, P13697, DOI 10.1128/JVI.78.24.13697-13707.2004; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	28	154	163	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3637	10.1371/journal.pone.0003637	http://dx.doi.org/10.1371/journal.pone.0003637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LJ	18982063	Green Published, gold			2022-12-25	WOS:000265134300007
J	Mouw, T; Koster, A; Wright, ME; Blank, MM; Moore, SC; Hollenbeck, A; Schatzkin, A				Mouw, Traci; Koster, Annemarie; Wright, Margaret E.; Blank, Madeleine M.; Moore, Steven C.; Hollenbeck, Albert; Schatzkin, Arthur			Education and Risk of Cancer in a Large Cohort of Men and Women in the United States	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ASSOCIATION; ALCOHOL; HEALTH; LEVEL; DIET	Background: Education inequalities in cancer incidence have long been noted. It is not clear, however, whether such inequalities persist in the United States, especially for less common malignancies and after adjustment for individual risk factors. Methodology/Principal Findings: Within the NIH-AARP Diet and Health Study, we examined the association between education and the risk of developing cancers in a prospective cohort of 498 455 participants who were 50-71 year old and without cancer at enrollment in 1995/96. During a maximum 8.2 years of follow-up we identified 40 443 cancers in men and 18 367 in women. In age-adjusted models, the least educated men (, high school), compared to those with the most education (post-graduate), had increased risks of developing cancers of the esophagus (RR: 2.64, 95% CI: 1.86-3.75), head and neck ( 1.98, 1.54-2.54), stomach (2.32, 1.68-3.18), colon (1.31, 1.12-1.53), rectum (1.68, 1.32-2.13), liver (1.90, 1.22-2.95), lung (3.67, 3.25-4.15), pleura (4.01, 1.91-8.42), bladder (1.56, 1.33-1.83) and combined smoking-related cancers (2.41, 2.22-2.62). In contrast, lower education level was associated with a decreased risk of melanoma of the skin (0.43, 0.35-0.54) and local prostate cancers (0.79, 0.74-0.85). Women with the least education had increased risks of colon (1.60, 1.24-2.05), lung (2.14, 1.79-2.56), kidney (1.68, 1.12-2.54) and combined smoking-related cancers (1.66, 1.43-1.92) but a lower risk of melanoma of the skin (0.33, 0.22-0.51), endometrial (0.67, 0.51-0.89) and invasive breast cancers (0.72, 0.61-0.84). Adjustment for smoking and other risk factors did not eliminate these associations, except those for cancers of the head and neck, colon, and liver in men and kidney in women. Conclusions/Significance: We found a higher risk of malignant disease, particularly smoking-related cancers, among those in the lowest educational attainment category. Only some of the educational gradient is attributable to smoking. The persistence of substantial education inequalities in cancer incidence poses a challenge for etiologic research and public health policy.	[Mouw, Traci] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, Fac Med, London, England; [Koster, Annemarie] NIA, Lab Epidemiol, Demography, & Biomet, NIH, Bethesda, MD USA; [Koster, Annemarie] Univ Maastricht, Fac Hlth, Med & Life Sci, Maastricht, Netherlands; [Wright, Margaret E.] Univ Illinois, Dept Pathol, Chicago, IL 60680 USA; [Blank, Madeleine M.; Moore, Steven C.; Schatzkin, Arthur] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD USA; [Hollenbeck, Albert] AARP, Washington, DC USA	Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Mouw, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, Fac Med, London, England.	schatzka@mail.nih.gov	Moore, Steven/D-8760-2016; Koster, Annemarie/E-7438-2010; Hollenbeck, Albert/AAG-9461-2020	Moore, Steven/0000-0002-8169-1661; Koster, Annemarie/0000-0003-1583-7391; Wright, Margaret/0000-0002-4410-4157	Intramural Research Programs at the National Cancer Institute; National Institute on Aging, NIH; NATIONAL CANCER INSTITUTE [Z01CP010196] Funding Source: NIH RePORTER	Intramural Research Programs at the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported (in part) by the Intramural Research Programs at the National Cancer Institute and the National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; BERKMAN LF, 1997, IARC SCI PUBL, V5164; Braaten T, 2005, CANCER EPIDEM BIOMAR, V14, P2591, DOI 10.1158/1055-9965.EPI-05-0345; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dano H, 2003, INT J EPIDEMIOL, V32, P218, DOI 10.1093/ije/dyg049; FAGGIANO F, 1994, J EPIDEMIOL COMMUN H, V48, P447, DOI 10.1136/jech.48.5.447; FAGGIANO F, 1997, IARC SCI PUBL; Freedman ND, 2007, BRIT J CANCER, V96, P1469, DOI 10.1038/sj.bjc.6603713; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Harrison RA, 1998, ANN EPIDEMIOL, V8, P327, DOI 10.1016/S1047-2797(97)00231-7; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P796; Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284; Louwman WJ, 2004, EUR J CANCER PREV, V13, P119, DOI 10.1097/00008469-200404000-00005; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; NAGEL G, 2007, INT J EPIDEMIOL; Pamuk E., 1998, SOCIOECONOMIC STATUS; Price B, 1997, AM J EPIDEMIOL, V145, P211, DOI 10.1093/oxfordjournals.aje.a009093; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; SCHOTTENFELD D, 2006, CANC EPIDEMIOLOGY PR, P174; Stolzenberg-Solomon RZ, 2006, AM J EPIDEMIOL, V163, pS109, DOI 10.1093/aje/163.suppl_11.S109-b; Wright ME, 2007, CANCER EPIDEM BIOMAR, V16, P1128, DOI 10.1158/1055-9965.EPI-06-1071; 2007, SURVEILLANCE EPIDEMI	23	71	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2008	3	11							e3639	10.1371/journal.pone.0003639	http://dx.doi.org/10.1371/journal.pone.0003639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LJ	18982064	Green Submitted, Green Published, gold			2022-12-25	WOS:000265134300009
J	King, TE; Pawar, SC; Majuta, L; Sroka, IC; Wynn, D; Demetriou, MC; Nagle, RB; Porreca, F; Cress, AE				King, Tamara E.; Pawar, Sangita C.; Majuta, Lisa; Sroka, Isis C.; Wynn, Danyel; Demetriou, Manolis C.; Nagle, Raymond B.; Porreca, Frank; Cress, Anne E.			The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain in a Novel Xenograft Model	PLOS ONE			English	Article							ALPHA-6-INTEGRIN CLEAVAGE; DIFFERENTIAL EXPRESSION; BINDING INTEGRINS; MURINE MODEL; MARROW; ECTODOMAIN; CELLS; IDENTIFICATION; METASTASIS; MOLECULES	Of the estimated 565,650 people in the U. S. who will die of cancer in 2008, almost all will have metastasis. Breast, prostate, kidney, thyroid and lung cancers metastasize to the bone. Tumor cells reside within the bone using integrin type cell adhesion receptors and elicit incapacitating bone pain and fractures. In particular, metastatic human prostate tumors express and cleave the integrin A6, a receptor for extracellular matrix components of the bone, i.e., laminin 332 and laminin 511. More than 50% of all prostate cancer patients develop severe bone pain during their remaining lifetime. One major goal is to prevent or delay cancer induced bone pain. We used a novel xenograft mouse model to directly determine if bone pain could be prevented by blocking the known cleavage of the A6 integrin adhesion receptor. Human tumor cells expressing either the wildtype or mutated A6 integrin were placed within the living bone matrix and 21 days later, integrin expression was confirmed by RT-PCR, radiographs were collected and behavioral measurements of spontaneous and evoked pain performed. All animals independent of integrin status had indistinguishable tumor burden and developed bone loss 21 days after surgery. A comparison of animals containing the wild type or mutated integrin revealed that tumor cells expressing the mutated integrin resulted in a dramatic decrease in bone loss, unicortical or bicortical fractures and a decrease in the ability of tumor cells to reach the epiphyseal plate of the bone. Further, tumor cells within the bone expressing the integrin mutation prevented cancer induced spontaneous flinching, tactile allodynia, and movement evoked pain. Preventing A6 integrin cleavage on the prostate tumor cell surface decreased the migration of tumor cells within the bone and the onset and degree of bone pain and fractures. These results suggest that strategies for blocking the cleavage of the adhesion receptors on the tumor cell surface can significantly prevent cancer induced bone pain and slow disease progression within the bone. Since integrin cleavage is mediated by Urokinase-type Plasminogen Activator (uPA), further work is warranted to test the efficacy of uPA inhibitors for prevention or delay of cancer induced bone pain.	[King, Tamara E.; Majuta, Lisa; Porreca, Frank] Univ Arizona, Arizona Canc Ctr, Dept Pharmacol, Tucson, AZ 85721 USA; [Pawar, Sangita C.; Sroka, Isis C.; Cress, Anne E.] Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA; [Wynn, Danyel] Univ Arizona, Arizona Canc Ctr, Dept Physiol, Tucson, AZ 85721 USA; [Demetriou, Manolis C.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [King, Tamara E.; Pawar, Sangita C.; Nagle, Raymond B.] Univ Arizona, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; Arizona Center Cancer Care; University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Cyprus; Arizona Center Cancer Care; University of Arizona	Porreca, F (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Pharmacol, Tucson, AZ 85721 USA.	frankp@u.arizona.edu; acress@azcc.arizona.edu	Cress, Anne/V-6527-2019	Cress, Anne/0000-0001-6194-0061	NIH [CA56666, CA23074, GM008718]; NATIONAL CANCER INSTITUTE [P30CA023074, P01CA056666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by NIH grants CA56666, CA23074, and GM008718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONKHOFF H, 1993, HUM PATHOL, V24, P243, DOI 10.1016/0046-8177(93)90033-D; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Davis TL, 2001, PROSTATE, V46, P240; Davis TL, 2002, CELL GROWTH DIFFER, V13, P107; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Demetriou MC, 2004, EXP CELL RES, V294, P550, DOI 10.1016/j.yexcr.2003.11.023; Demetriou MC, 2004, J CELL BIOCHEM, V91, P26, DOI 10.1002/jcb.10675; Dina OA, 2004, EUR J NEUROSCI, V19, P634, DOI 10.1111/j.1460-9568.2004.03169.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Gu YC, 2003, BLOOD, V101, P877, DOI 10.1182/blood-2002-03-0796; Gu YC, 1999, BLOOD, V93, P2533, DOI 10.1182/blood.V93.8.2533.408k22_2533_2542; JEMAL A, 2008, CA CANC J CLIN; King T, 2007, PAIN, V132, P154, DOI 10.1016/j.pain.2007.06.026; KNOX JD, 1994, AM J PATHOL, V145, P167; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; MAJDA JA, 1994, EXP CELL RES, V210, P46, DOI 10.1006/excr.1994.1007; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Mercurio A M, 2001, Surg Oncol Clin N Am, V10, P313; MERCURIO AM, 2001, SURG ONCOL CLIN N AM, V10, pR8; Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NAGLE RB, 1994, J CELL BIOCHEM, P232; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Pawar SC, 2007, INT J RADIAT BIOL, V83, P761, DOI 10.1080/09553000701633135; Pawar SC, 2007, EXP CELL RES, V313, P1080, DOI 10.1016/j.yexcr.2007.01.006; Putz E, 1999, CANCER RES, V59, P241; RABINOVITZ I, 1995, CLIN EXP METASTAS, V13, P481, DOI 10.1007/BF00118187; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Siler U, 2000, BLOOD, V96, P4194; Siler U, 2002, BRIT J HAEMATOL, V119, P212, DOI 10.1046/j.1365-2141.2002.03800.x; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vessella RL, 2006, CLIN CANCER RES, V12, p6285S, DOI 10.1158/1078-0432.CCR-06-0813; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877	39	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3535	10.1371/journal.pone.0003535	http://dx.doi.org/10.1371/journal.pone.0003535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958175	Green Published, Green Submitted, gold			2022-12-25	WOS:000265130900001
J	Durcova-Hills, G; Tang, FC; Doody, G; Tooze, R; Surani, MA				Durcova-Hills, Gabriela; Tang, Fuchou; Doody, Gina; Tooze, Reuben; Surani, M. Azim			Reprogramming Primordial Germ Cells into Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLASTS; REPRESSION; DERIVATION; BLIMP-1	Background: Specification of primordial germ cells (PGCs) results in the conversion of pluripotent epiblast cells into monopotent germ cell lineage. Blimp1/Prmt5 complex plays a critical role in the specification and maintenance of the early germ cell lineage. However, PGCs can be induced to dedifferentiate back to a pluripotent state as embryonic germ (EG) cells when exposed to exogenous signaling molecules, FGF-2, LIF and SCF. Methodology and Principal Findings: Here we show that Trichostatin A (TSA), an inhibitor of histone deacetylases, is a highly potent agent that can replace FGF-2 to induce dedifferentiation of PGCs into EG cells. A key early event during dedifferentiation of PGCs in response to FGF-2 or TSA is the down-regulation of Blimp1, which reverses and apparently relieves the cell fate restriction imposed by it. Notably, the targets of Blimp1, which include c-Myc and Klf-4, which represent two of the key factors known to promote reprogramming of somatic cells to pluripotent state, are up-regulated. We also found early activation of the LIF/Stat-3 signaling pathway with the translocation of Stat-3 into the nucleus. By contrast, while Prmt5 is retained in EG cells, it translocates from the nucleus to the cytoplasm where it probably has an independent role in regulating pluripotency. Conclusions/Significance: We propose that dedifferentiation of PGCs into EG cells may provide significant mechanistic insights on early events associated with reprogramming of committed cells to a pluripotent state.	[Durcova-Hills, Gabriela; Tang, Fuchou; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Doody, Gina; Tooze, Reuben] Univ Leeds, Leeds Inst Mol Med, Div Expt Haematol, Leeds LS2 9JT, W Yorkshire, England	University of Cambridge; University of Leeds	Durcova-Hills, G (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	gd225@camac.uk; as10021@mole.bio.cam.ac.uk	Doody, Gina/AAN-8246-2021	Doody, Gina/0000-0003-0665-6759; Tooze, Reuben/0000-0003-2915-7119; Surani, Azim/0000-0002-8640-4318	BBSRC; MRC; Wellcome Trust; Medical Research Council [G108/500] Funding Source: researchfish; MRC [G108/500] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.D-H is BBSRC-funded MRC Career Development Stem Cell Fellow. We are grateful to the Wellcome Trust (M.A.S), BBSRC (G.D-H), and MRC (G.D-H) for financial support.	Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; CHENG LZ, 1994, DEVELOPMENT, V120, P3145; Durcova-Hills G, 2004, HDB STEM CELLS, V1, P451; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Muller AJ, 2000, P NATL ACAD SCI USA, V97, P8421, DOI 10.1073/pnas.140208197; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	24	118	127	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3531	10.1371/journal.pone.0003531	http://dx.doi.org/10.1371/journal.pone.0003531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953407	Green Published, gold, Green Submitted			2022-12-25	WOS:000265130500009
J	Randhawa, M; Huff, T; Valencia, JC; Younossi, Z; Chandhoke, V; Hearing, VJ; Baranova, A				Randhawa, Manpreet; Huff, Tom; Valencia, Julio C.; Younossi, Zobair; Chandhoke, Vikas; Hearing, Vincent J.; Baranova, Ancha			Evidence for the ectopic synthesis of melanin in human adipose tissue	FASEB JOURNAL			English	Article						obesity; metabolic syndrome; inflammation; alpha-MSH; pigmentation	EUMELANIN; SKIN; PATHOGENESIS; MELANOCYTES; MELANOSOMES; EXPRESSION; RADICALS	Melanin is a common pigment in animals. In humans, melanin is produced in melanocytes, in retinal pigment epithelium (RPE) cells, in the inner ear, and in the central nervous system. Previously, we noted that human adipose tissue expresses several melanogenesis-related genes. In the current study, we confirmed the expression of melanogenesis-related mRNAs and proteins in human adipose tissue using real-time polymerase chain reaction and immunohistochemical staining. TYR mRNA signals were also detected by in situ hybridization in visceral adipocytes. The presence of melanin in human adipose tissue was revealed both by Fontana-Masson staining and by permanganate degradation of melanin coupled with liquid chromatography/ultraviolet/mass spectrometry determination of the pyrrole-2,3,5-tricarboxylic acid ( PTCA) derivative of melanin. We also compared melanogenic activities in adipose tissues and in other human tissues using the L-[U-C-14] tyrosine assay. A marked heterogeneity in the melanogenic activities of individual adipose tissue extracts was noted. We hypothesize that the ectopic synthesis of melanin in obese adipose may serve as a compensatory mechanism that uses its anti-inflammatory and its oxidative damage-absorbing properties. In conclusion, our study demonstrates for the first time that the melanin biosynthesis pathway is functional in adipose tissue.-Randhawa, M., Huff, T., Valencia, J. C., Younossi, Z., Chandhoke, V., Hearing, V. J., Baranova, A. Evidence for the ectopic synthesis of melanin in human adipose tissue. FASEB J. 23, 835-843 (2009)	[Randhawa, Manpreet; Chandhoke, Vikas; Baranova, Ancha] George Mason Univ, Mol & Microbiol Dept, Manassas, VA USA; [Randhawa, Manpreet; Chandhoke, Vikas; Baranova, Ancha] George Mason Univ, Ctr Study Genom Liver Dis, Manassas, VA USA; [Huff, Tom] George Mason Univ, Coll Sci, Shared Instrumentat Res Facil, Manassas, VA USA; [Valencia, Julio C.; Hearing, Vincent J.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Younossi, Zobair; Baranova, Ancha] INOVA Fairfax Hosp, Ctr Liver Dis, Fairfax, VA USA	George Mason University; George Mason University; George Mason University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Inova Fairfax Hospital	Baranova, A (corresponding author), George Mason Univ, David King Hall,MSN 3E1, Fairfax, VA 22030 USA.	abaranov@gmu.edu	, Ancha/B-4608-2012; Baranova, Anna/HGB-3721-2022	, Ancha/0000-0001-6810-5982; 	Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust; U.S. National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010786] Funding Source: NIH RePORTER	Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by a grant from the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust and by the Intramural Research Program of the National Cancer Institute at the U.S. National Institutes of Health. A. B. and M. R. are grateful to Shobha M. Gowder and Jenefir Ibister for initial technical assistance with the project, V. Espina for cryoslicing of adipose, and F. Otaizo for the help with the first round of RT-PCR experiments.	Baranova A, 2005, OBES SURG, V15, P758, DOI 10.1381/0960892054222876; BOLT A. G., 1967, LIFE SCI, V6, P1277, DOI 10.1016/0024-3205(67)90022-7; Gallone A, 2002, PIGM CELL RES, V15, P32, DOI 10.1034/j.1600-0749.2002.00052.x; HEARING VJ, 1976, BIOCHEM J, V157, P549, DOI 10.1042/bj1570549; Hoch M, 2007, OBESITY, V15, P40, DOI 10.1038/oby.2007.525; Hoggard N, 2004, CLIN ENDOCRINOL, V61, P31, DOI 10.1111/j.1365-2265.2004.02056.x; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; ITO S, 1989, Journal of Investigative Dermatology, V92, p261S, DOI 10.1111/1523-1747.ep13076587; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x; Mohagheghpour N, 2000, CELL IMMUNOL, V199, P25, DOI 10.1006/cimm.1999.1599; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Seagle BLL, 2005, J AM CHEM SOC, V127, P11220, DOI 10.1021/ja052773z; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Szekely-Klepser G, 2005, J CHROMATOGR B, V826, P31, DOI 10.1016/j.jchromb.2005.08.002; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Zecca L, 2006, NEUROLOGY, V67, pS8, DOI 10.1212/WNL.67.7_suppl_2.S8	22	37	38	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2009	23	3					835	843		10.1096/fj.08-116327	http://dx.doi.org/10.1096/fj.08-116327			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	437SD	18971261	Green Published			2022-12-25	WOS:000265506300019
J	Quevillon-Cheruel, S; Leulliot, N; Muniz, CA; Vincent, M; Gallay, J; Argentini, M; Cornu, D; Boccard, F; Lemaitre, B; van Tilbeurgh, H				Quevillon-Cheruel, Sophie; Leulliot, Nicolas; Muniz, Carlos Acosta; Vincent, Michel; Gallay, Jacques; Argentini, Manuela; Cornu, David; Boccard, Frederic; Lemaitre, Bruno; van Tilbeurgh, Herman			Evf, a Virulence Factor Produced by the Drosophila Pathogen Erwinia carotovora, Is an S-Palmitoylated Protein with a New Fold That Binds to Lipid Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; YERSINIA-PESTIS; VAR ATROSEPTICA; TRANSMISSION; FLUORESCENCE; REFINEMENT; VECTOR; PALMITOYLTRANSFERASE; REPRESENTATION	Erwinia carotovora are phytopathogenic Gram-negative bacteria of agronomic interest as these bacteria are responsible for fruit soft rot and use insects as dissemination vectors. The Erwinia carotovora carotovora strain 15 (Ecc15) is capable of persisting in the Drosophila gut by the sole action of one protein, Erwinia virulence factor (Evf). However, the precise function of Evf is elusive, and its sequence does not provide any indication as to its biochemical function. We have solved the 2.0-angstrom crystal structure of Evf and found a protein with a complex topology and a novel fold. The structure of Evf confirms that Evf is unlike any virulence factors known to date. Most remarkably, we identified palmitoic acid covalently bound to the totally conserved Cys(209), which provides important clues as to the function of Evf. Mutation of the palmitoic binding cysteine leads to a loss of virulence, proving that palmitoylation is at the heart of Evf infectivity and may be a membrane anchoring signal. Fluorescence studies of the sole tryptophan residue (Trp(94)) demonstrated that Evf was indeed able to bind to model membranes containing negatively charged phospholipids and to promote their aggregation.	[Quevillon-Cheruel, Sophie; Leulliot, Nicolas; Vincent, Michel; Gallay, Jacques; van Tilbeurgh, Herman] Univ Paris 11, CNRS, UMR8619, Inst Biochem & Biophys Mol & Cellulaire,IFR115, F-91405 Orsay, France; [Muniz, Carlos Acosta; Boccard, Frederic; Lemaitre, Bruno] CNRS, UPR, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Lab Spectrometrie Masse, UPR 2301, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	van Tilbeurgh, H (corresponding author), Univ Paris 11, CNRS, UMR8619, Inst Biochem & Biophys Mol & Cellulaire,IFR115, F-91405 Orsay, France.	herman.vantilbeurgh@u-psud.fr	Leulliot, Nicolas/AAA-7160-2019; Lemaitre, Bruno/T-8146-2019	Leulliot, Nicolas/0000-0003-0283-4298; Lemaitre, Bruno/0000-0001-7970-1667; Acosta-Muniz, Carlos/0000-0001-6329-3507; Boccard, Frederic/0000-0002-1866-2489				Abrahams JP, 1998, CURR OPIN STRUC BIOL, V8, P601, DOI 10.1016/S0959-440X(98)80151-6; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Basset A, 2003, EMBO REP, V4, P205, DOI 10.1038/sj.embor.embor730; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; ICHIYE T, 1983, BIOCHEMISTRY-US, V22, P2884, DOI 10.1021/bi00281a017; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Leulliot N, 2004, J BIOL CHEM, V279, P23447, DOI 10.1074/jbc.M401336200; Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025; Leulliot N, 2007, J MOL BIOL, V371, P1338, DOI 10.1016/j.jmb.2007.06.031; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; Muniz CA, 2007, CELL MICROBIOL, V9, P106, DOI 10.1111/j.1462-5822.2006.00771.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quevillon-Cheruel Sophie, 2007, Methods Mol Biol, V363, P21, DOI 10.1007/978-1-59745-209-0_2; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veit M, 1998, BBA-LIPID LIPID MET, V1394, P90, DOI 10.1016/S0005-2760(98)00097-6; VINCENT M, 1991, EUR BIOPHYS J, V20, P183, DOI 10.1007/BF01561141; Vincent M, 2007, BBA-BIOMEMBRANES, V1768, P538, DOI 10.1016/j.bbamem.2006.11.021; Westhead DR, 1999, PROTEIN SCI, V8, P897	50	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3552	3562		10.1074/jbc.M808334200	http://dx.doi.org/10.1074/jbc.M808334200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18978353	Green Published, hybrid			2022-12-25	WOS:000262872500023
J	Wang, T; Chen, YH; Hong, H; Zeng, Y; Zhang, J; Lu, JP; Jeansonne, B; Lu, Q				Wang, T.; Chen, Y-H; Hong, H.; Zeng, Y.; Zhang, J.; Lu, J-P; Jeansonne, B.; Lu, Q.			Increased nucleotide polymorphic changes in the 5 '-untranslated region of delta-catenin (CTNND2) gene in prostate cancer	ONCOGENE			English	Article						single-strand conformation polymorphism; single nucleotide polymorphism; 5 '-UTR mutation; methylation; gene amplification	CARCINOMA-CELL-LINE; DU-CHAT SYNDROME; E-CADHERIN; EXPRESSION; PROTEIN; JUNCTION; PAX6; PCR; OVEREXPRESSION; IDENTIFICATION	Cancer pathogenesis involves multiple genetic and epigenetic alterations, which result in oncogenic changes in gene expression. delta-Catenin (CTNND2) is overexpressed in cancer, although the mechanisms of its upregulation are highly variable. Here we report that in prostate cancer, the methylation of CpG islands in the delta-catenin promoter was not a primary regulatory event. There was also no delta-catenin gene amplification. However, using the single-strand conformation polymorphism analysis, we observed the increased nucleotide changes in the 5'-untranslated region of delta-catenin gene in human prostate cancer. At least one such change (-9 G>A) is a true somatic point mutation associated with a high Gleason's score, poorly differentiated prostatic adenocarcinoma. Laser capture microdissection coupled with PCR analyses detected the mutation only in cancerous but not in the adjacent benign prostatic tissues. Using chimeric genes encoding the luciferase reporter, we found that this mutation, but not a random mutation or a mutation that disrupts an upstream open reading frame, resulted in a remarkably higher expression and enzyme activity. This mutation did not affect transcriptional efficiency, suggesting that it promotes delta-catenin translation. This is the first report of delta-catenin gene mutation in cancer and supports the notion that multiple mechanisms contribute to its increased expression in carcinogenesis.	[Wang, T.; Chen, Y-H; Zeng, Y.; Zhang, J.; Lu, J-P; Jeansonne, B.; Lu, Q.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Hong, H.] E Carolina Univ, Brody Sch Med, Dept Pathol & Lab Med, Greenville, NC 27834 USA; [Lu, Q.] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC 27834 USA; [Wang, T.] Capital Med Univ, Dept Oncol, Beijing, Peoples R China	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Capital Medical University	Lu, Q (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 7N84 Brody Sci Bldg,600 Moye Blvd, Greenville, NC 27834 USA.	luq@ecu.edu	Lu, Jianping/AFL-6811-2022	Lu, Jianping/0000-0001-9601-0040	NIH; NCI [CA111891]; Department of Defense [PC040569]; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Melissa Clark and GW Lanford for excellent technical assistance, and Lu laboratory members for many helpful discussions. This study was supported in part by NIH/NCI (CA111891) and the Department of Defense (PC040569) grants (QL).	Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Cervera M, 2005, AM J MED GENET A, V136A, P381, DOI 10.1002/ajmg.a.30791; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Fatima S, 2006, INT J MOL MED, V17, P159; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Ho C, 2000, J COMP NEUROL, V420, P261; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang FY, 2006, GYNECOL ONCOL, V103, P219, DOI 10.1016/j.ygyno.2006.02.028; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim K, 2008, BIOCHEM BIOPH RES CO, V369, P414, DOI 10.1016/j.bbrc.2008.02.069; Kindich R, 2005, CLIN CHEM, V51, P649, DOI 10.1373/clinchem.2004.045013; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marinescu RC, 1999, AM J MED GENET, V86, P66, DOI 10.1002/(SICI)1096-8628(19990903)86:1<66::AID-AJMG13>3.0.CO;2-N; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Murthy SK, 2005, ARCH PATHOL LAB MED, V129, P39; Nakayama S, 2001, INT J CANCER, V93, P667, DOI 10.1002/ijc.1386; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; UMBAS R, 1994, CANCER RES, V54, P3929; WEIJERMAN PC, 1994, CANCER RES, V54, P5579; Zhang HT, 2004, CLIN CANCER RES, V10, P2359, DOI 10.1158/1078-0432.CCR-0959-3; Zheng M, 2004, AM J PATHOL, V165, P63, DOI 10.1016/S0002-9440(10)63275-0; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	33	32	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					555	564		10.1038/onc.2008.399	http://dx.doi.org/10.1038/onc.2008.399			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18978817	Green Submitted, Green Accepted			2022-12-25	WOS:000262866500009
J	Chen, Y; Chen, CG; Kotsikorou, E; Lynch, DL; Reggio, PH; Liu-Chen, LY				Chen, Yong; Chen, Chongguang; Kotsikorou, Evangelia; Lynch, Diane L.; Reggio, Patricia H.; Liu-Chen, Lee-Yuan			GEC1-kappa Opioid Receptor Binding Involves Hydrophobic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TRANSPORT MODULATOR; PROTEIN GABARAP; CRYSTAL-STRUCTURE; GABA(A)-RECEPTOR-ASSOCIATED PROTEIN; CONFORMATIONAL MEMORIES; GABA(A) RECEPTORS; DOWN-REGULATION; MESSENGER-RNAS; IDENTIFICATION; EXPRESSION	We demonstrated previously that the protein GEC1 (glandular epithelial cell 1) bound to the human kappa opioid receptor (hKOPR) and promoted cell surface expression of the receptor by facilitating its trafficking along the secretory pathway. Here we showed that three hKOPR residues (Phe(345), Pro(346), and Met(350)) and seven GEC1 residues (Tyr(49), Val(51), Leu(55), Thr(56), Val(57), Phe(60), and Ile(64)) are indispensable for the interaction. Modeling studies revealed that the interaction was mediated via direct contacts between the kinked hydrophobic fragment in hKOPR C-tail and the curved hydrophobic surface in GEC1 around the S2 beta-strand. Intramolecular Leu(44)-Tyr(109) interaction in GEC1 was important, likely by maintaining its structural integrity. Microtubule binding mediated by the GEC1 N-terminal domain was essential for the GEC1 effect. Expression of GEC1 also increased cell surface levels of the GluR1 subunit and the prostaglandin EP3.f receptor, which have FPXXM and FPXM sequences, respectively. With its widespread distribution in the nervous system and its predominantly hydrophobic interactions, GEC1 may have chaperone-like effects for many cell surface proteins along the biosynthesis pathway.	[Chen, Yong; Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kotsikorou, Evangelia; Lynch, Diane L.; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Greensboro	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	lliuche@temple.edu		Kotsikorou, Evangelia/0000-0002-8398-2139	National Institutes of Health [DA17302, P30 DA13429]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017302, P30DA013429, R01DA011263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA17302 and P30 DA13429. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnett-Norris J, 2002, INT J QUANTUM CHEM, V88, P76, DOI 10.1002/qua.10093; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Guarnieri F, 1996, J AM CHEM SOC, V118, P5580, DOI 10.1021/ja952745o; Hassan SA, 2000, J PHYS CHEM B, V104, P6478, DOI 10.1021/jp993895e; Hassan SA, 2001, INT J QUANTUM CHEM, V83, P193, DOI 10.1002/qua.1210; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malyala A, 2004, NEUROCHEM RES, V29, P1189, DOI 10.1023/B:NERE.0000023606.13670.1d; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Mansuy-Schlick V, 2006, BRAIN RES, V1073, P83, DOI 10.1016/j.brainres.2005.11.004; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nymann-Andersen J, 2002, NEUROPHARMACOLOGY, V43, P476, DOI 10.1016/S0028-3908(02)00165-X; Nymann-Andersen J, 2002, J NEUROCHEM, V80, P815, DOI 10.1046/j.0022-3042.2002.00762.x; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PELLERIN I, 1993, MOL CELL ENDOCRINOL, V90, pR17, DOI 10.1016/0303-7207(93)90161-C; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schlenkrich M., 1996, BIOL MEMBRANES MOL P; Soellick TR, 2001, GENOME BIOL, V2; Stangler T, 2002, J BIOL CHEM, V277, P13363, DOI 10.1074/jbc.C200050200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Whitnell RM, 2008, J COMPUT CHEM, V29, P741, DOI 10.1002/jcc.20822; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Xin YR, 2001, GENOMICS, V74, P408, DOI 10.1006/geno.2001.6555; Zhang FQ, 2002, J PHARMACOL EXP THER, V302, P1184, DOI 10.1124/jpet.302.3.1184	53	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1673	1685		10.1074/jbc.M808303200	http://dx.doi.org/10.1074/jbc.M808303200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19001416	hybrid, Green Published			2022-12-25	WOS:000262330100036
J	Kondo, M; Shibata, R; Miura, R; Shimano, M; Kondo, K; Li, P; Ohashi, T; Kihara, S; Maeda, N; Walsh, K; Ouchi, N; Murohara, T				Kondo, Megumi; Shibata, Rei; Miura, Rie; Shimano, Masayuki; Kondo, Kazuhisa; Li, Ping; Ohashi, Taiki; Kihara, Shinji; Maeda, Norikazu; Walsh, Kenneth; Ouchi, Noriyuki; Murohara, Toyoaki			Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONKEYS MACACA-MULATTA; PROTEIN-KINASE; DIETARY RESTRICTION; TISSUE ISCHEMIA; NO SYNTHASE; ANGIOGENESIS; OBESITY; MICE; EXPRESSION; DISEASE	Caloric restriction (CR) can extend longevity and modulate the features of obesity-related metabolic and vascular diseases. However, the functional roles of CR in regulation of revascularization in response to ischemia have not been examined. Here we investigated whether CR modulates vascular response by employing a murine hindlimb ischemia model. Wild-type (WT) mice were randomly divided into two groups that were fed either ad libitum (AL) or CR (65% of the diet consumption of AL). Four weeks later, mice were subjected to unilateral hindlimb ischemic surgery. Body weight of WT mice fed CR (CR-WT) was decreased by 26% compared with WT mice fed AL (AL-WT). Revascularization of ischemic hindlimb relative to the contralateral limb was accelerated in CR-WT compared with AL-WT as evaluated by laser Doppler blood flow and capillary density analyses. CR-WT mice had significantly higher plasma levels of the fat-derived hormone adiponectin compared with AL-WT mice. In contrast to WT mice, CR did not affect the revascularization of ischemic limbs of adiponectindeficient (APN-KO) mice. CR stimulated the phosphorylation of endothelial nitric-oxide synthase (eNOS) in the ischemic limbs of WT mice. CR increased plasma adiponectin levels in eNOS-KO mice but did not stimulate limb perfusion in this strain. CR-WT mice showed enhanced phosphorylation of AMP-activated protein kinase (AMPK) in ischemic muscle, and administration of AMPK inhibitor compound C abolished CR-induced increase in limb perfusion and eNOS phosphorylation in WT mice. Our observations indicate that CR can promote revascularization in response to tissue ischemia via an AMPK-eNOS-dependent mechanism that is mediated by adiponectin.	[Kondo, Megumi; Shibata, Rei; Miura, Rie; Shimano, Masayuki; Kondo, Kazuhisa; Li, Ping; Ohashi, Taiki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Walsh, Kenneth; Ouchi, Noriyuki] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kihara, Shinji; Maeda, Norikazu] Osaka Univ, Dept Metab Med, Suita, Osaka 5650871, Japan	Nagoya University; Boston University; Osaka University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp	Li, Ping/GYV-4914-2022; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014		National Institutes of Health [HL86785, HL91949, HL81587]; The Nakashima Foundation; The Aichi D. R. G. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086785, R01HL091949, P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Nakashima Foundation; The Aichi D. R. G. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL86785, HL91949, and HL81587 (to K. W.). This work was also supported by a grant-in-aid for young scientists A, The Nakashima Foundation, and The Aichi D. R. G. Foundation (to R. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" U. S. C. Section 1734 solely to indicate this fact.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Iwashima Y, 2006, ATHEROSCLEROSIS, V188, P384, DOI 10.1016/j.atherosclerosis.2005.10.039; Kanda T, 2007, INT J CARDIOL, V119, P310, DOI 10.1016/j.ijcard.2006.07.181; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lane MA, 2000, MECH AGEING DEV, V112, P185, DOI 10.1016/S0047-6374(99)00087-1; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Li P, 2008, HYPERTENSION, V51, P252, DOI 10.1161/HYPERTENSIONAHA.107.097394; Mahoney LB, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-13; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Seymour EM, 2006, J MOL CELL CARDIOL, V41, P661, DOI 10.1016/j.yjmcc.2006.07.012; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Stein O, 2003, BIOCHEM BIOPH RES CO, V308, P29, DOI 10.1016/S0006-291X(03)01313-5; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Verdery RB, 1998, ARCH INTERN MED, V158, P900, DOI 10.1001/archinte.158.8.900; Verdery RB, 1997, AM J PHYSIOL-ENDOC M, V273, pE714, DOI 10.1152/ajpendo.1997.273.4.E714; Williams IL, 2002, INT J OBESITY, V26, P754, DOI 10.1038/sj.ijo.0801995; YAROM R, 1992, J PATHOL, V166, P265, DOI 10.1002/path.1711660308; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024; ZIMMERMAN J, 1984, ARTERIOSCLEROSIS, V4, P115, DOI 10.1161/01.ATV.4.2.115	41	98	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1718	1724		10.1074/jbc.M805301200	http://dx.doi.org/10.1074/jbc.M805301200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18990685	Green Published, hybrid			2022-12-25	WOS:000262330100041
J	Culyba, MJ; Hwang, Y; Minkah, N; Bushman, FD				Culyba, Matthew J.; Hwang, Young; Minkah, Nana; Bushman, Frederic D.			DNA Binding and Cleavage by the Fowlpox Virus Resolvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; ENZYME CCE1; QUATERNARY STRUCTURE; VACCINIA VIRUS; ENDONUCLEASE; SPECIFICITY; RESOLUTION; DISTORTION; SEQUENCE; RUVC	The first steps of poxvirus DNA synthesis yield concatemeric arrays of covalently linked genomes. The virus-encoded Holliday junction resolvase is required to process concatemers into unit-length genomes for packaging. Previous studies of the vaccinia virus resolvase have been problematic due to poor protein solubility. We found that fowlpox virus resolvase was much more tractable. Fowlpox resolvase formed complexes with a variety of branched DNA substrates, but not linear DNA, and had the highest affinity for a Holliday junction substrate, illustrating a previously unappreciated affinity for Holliday junctions over other substrates. The cleavage activity was monitored in fixed time assays, showing that, as with vaccinia resolvase, the fowlpox enzyme could cleave a wide array of branched DNA substrates. Single turnover kinetic analysis revealed the Holliday junction substrate was cleaved 90-fold faster than a splayed duplex substrate containing a single to double strand transition. Multiple turnover kinetic analysis, however, showed that the cleavage step was not limiting for the full reaction cycle. Cleavage by resolvase was also tightly coupled at symmetrical positions across the junction, and coupling required the complete Holliday junction structure. Last, we found that cleavage of an extruded cruciform yielded a product, which after treatment with ligase, had the properties expected for covalently closed DNA hairpin ends, as is seen for poxvirus genome monomers. These findings provide a tractable poxvirus resolvase usable for the development of small molecule inhibitors.	[Culyba, Matthew J.; Hwang, Young; Minkah, Nana; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bushman, FD (corresponding author), 402C Johnson Pavilion,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056	National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324, U54AI057168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Mid-Atlantic Regional Center of Excellence for Biodefense Research Grant U54 AI057168.	BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; Culyba MJ, 2007, J BIOL CHEM, V282, P34644, DOI 10.1074/jbc.M705322200; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; DICKIE P, 1987, J MOL BIOL, V196, P541, DOI 10.1016/0022-2836(87)90031-3; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P16125, DOI 10.1021/bi001886m; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; Garcia AD, 2006, J BIOL CHEM, V281, P11618, DOI 10.1074/jbc.M600182200; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Giraud-Panis MJE, 1998, J MOL BIOL, V278, P117, DOI 10.1006/jmbi.1998.1681; GiraudPanis MJE, 1996, J BIOL CHEM, V271, P33148, DOI 10.1074/jbc.271.51.33148; GREAVES DR, 1985, J MOL BIOL, V185, P461, DOI 10.1016/0022-2836(85)90064-6; Moss B, 2001, VIROLOGY, P2637; Parkinson MJ, 1997, J MOL BIOL, V270, P169, DOI 10.1006/jmbi.1997.1128; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795	17	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1190	1201		10.1074/jbc.M807864200	http://dx.doi.org/10.1074/jbc.M807864200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004818	Green Published, hybrid			2022-12-25	WOS:000262122900055
J	Ilari, A; Franceschini, S; Bonamore, A; Arenghi, F; Botta, B; Macone, A; Pasquo, A; Bellucci, L; Boffi, A				Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Arenghi, Fabio; Botta, Bruno; Macone, Alberto; Pasquo, Alessandra; Bellucci, Luca; Boffi, Alberto			Structural Basis of Enzymatic (S)-Norcoclaurine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; NORCOCLAURINE SYNTHASE; X-RAY; PROTEIN; STRICTOSIDINE; CLONING	The enzyme norcoclaurine synthase (NCS) catalyzes the stereospecific Pictet-Spengler cyclization between dopamine and 4-hydroxyphenylacetaldehyde, the key step in the benzylisoquinoline alkaloid biosynthetic pathway. The crystallographic structure of norcoclaurine synthase from Thalictrum flavum in its complex with dopamine substrate and the nonreactive substrate analogue 4-hydroxybenzaldehyde has been solved at 2.1 angstrom resolution. NCS shares no common features with the functionally correlated "Pictet-Spenglerases" that catalyze the first step of the indole alkaloids pathways and conforms to the overall fold of the Bet v1-like protein. The active site of NCS is located within a 20-angstrom-long catalytic tunnel and is shaped by the side chains of a tyrosine, a lysine, an aspartic, and a glutamic acid. The geometry of the amino acid side chains with respect to the substrates reveals the structural determinants that govern the mechanism of the stereoselective Pictet-Spengler cyclization, thus establishing an excellent foundation for the understanding of the finer details of the catalytic process. Site-directed mutations of the relevant residues confirm the assignment based on crystallographic findings.	[Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Macone, Alberto; Boffi, Alberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Macone, Alberto; Boffi, Alberto] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, I-00185 Rome, Italy; [Arenghi, Fabio] CPC Biotech Srl, I-80121 Naples, Italy; [Botta, Bruno] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Pasquo, Alessandra] ENEA Casaccia Res Ctr, Dipartimento BIOTEC, Sez Genet & Genom Vegetale, I-00100 Rome, Italy; [Bellucci, Luca] Univ Siena, Ist Tecn Chim Farmacol, I-53110 Siena, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Siena	Boffi, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alberto.boffi@uniroma1.it	Bellucci, Luca/AAB-2834-2021; Macone, Alberto/AAB-2570-2019; Ilari, Andrea/AAC-7670-2022; Bonamore, Alessandra/AAB-2587-2019; Ilari, Andrea/T-5501-2017; Bellucci, Luca/J-9096-2016	Bellucci, Luca/0000-0003-2031-064X; Macone, Alberto/0000-0003-0455-1400; Ilari, Andrea/0000-0002-7754-399X; Bonamore, Alessandra/0000-0002-3940-4657; Ilari, Andrea/0000-0002-7754-399X; Bellucci, Luca/0000-0003-2031-064X; Botta, Bruno/0000-0001-8707-4333	Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica; European Community Research Infrastructure Action; European Research Area Programme [R II 3-CT-2004-506008]	Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); European Community Research Infrastructure Action(European Commission); European Research Area Programme	This work was supported by Project FIRB 2003 from Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica ( to A. B., B. B., and F. A.), local university grants ( to A. B. and B. B.), and the European Community Research Infrastructure Action under the FP6 Structuring the European Research Area Programme ( through the Integrated Infrastructure Initiative" Integrating Activity on Synchroton and Free Electron Laser Science, Contract R II 3-CT-2004-506008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Berkner H, 2008, BIOCHEM J, V413, P281, DOI 10.1042/BJ20080306; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Hazen SL, 1997, J BIOL CHEM, V272, P16990, DOI 10.1074/jbc.272.27.16990; KUTCHAN TM, 1993, PHYTOCHEMISTRY, V32, P493, DOI 10.1016/S0031-9422(00)95128-8; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luk LYP, 2007, BIOCHEMISTRY-US, V46, P10153, DOI 10.1021/bi700752n; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Maryanoff BE, 2004, CHEM REV, V104, P1431, DOI 10.1021/cr0306182; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minami H, 2007, J BIOL CHEM, V282, P6274, DOI 10.1074/jbc.M608933200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NOYORI R, 1989, Patent No. 4851537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquo A, 2008, ACTA CRYSTALLOGR F, V64, P281, DOI 10.1107/S1744309108005678; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Seayad J, 2006, J AM CHEM SOC, V128, P1086, DOI 10.1021/ja057444l; STADLER R, 1990, LIEBIGS ANN CHEM, P555; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	30	84	91	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					897	904		10.1074/jbc.M803738200	http://dx.doi.org/10.1074/jbc.M803738200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004827	hybrid			2022-12-25	WOS:000262122900024
J	Wang, XJ; Levic, S; Gratton, MA; Doyle, KJ; Yamoah, EN; Pegg, AE				Wang, Xiaojing; Levic, Snezana; Gratton, Michael Anne; Doyle, Karen Jo; Yamoah, Ebenezer N.; Pegg, Anthony E.			Spermine Synthase Deficiency Leads to Deafness and a Profound Sensitivity to alpha-Difluoromethylornithine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECARBOXYLATED-S-ADENOSYLMETHIONINE; X-LINKED HYPOPHOSPHATEMIA; ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; MAMMALIAN-CELLS; INWARD RECTIFICATION; CLINICAL-TRIAL; PEX GENE; GY MICE; MOUSE	Male gyro (Gy) mice, which have an X chromosomal deletion inactivating the SpmS and Phex genes, were found to be profoundly hearing impaired. This defect was due to alteration in polyamine content due to the absence of spermine synthase, the product of the SpmS gene. It was reversed by breeding the Gy strain with CAG/SpmS mice, a transgenic line that ubiquitously expresses spermine synthase under the control of a composite cytomegalovirus-IE enhancer/chicken beta-actin promoter. There was an almost complete loss of the endocochlear potential in the Gy mice, which parallels the hearing deficiency, and this was also reversed by the production of spermine from the spermine synthase transgene. Gy mice showed a striking toxic response to treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO). Within 2-3 days of exposure to DFMO in the drinking water, the Gy mice suffered a catastrophic loss of motor function resulting in death within 5 days. This effect was due to an inability to maintain normal balance and was also prevented by the transgenic expression of spermine synthase. DFMO treatment of control mice or Gy-CAG/SpmS had no effect on balance. The loss of balance in Gy mice treated with DFMO was due to inhibition of polyamine synthesis because it was prevented by administration of putrescine. Our results are consistent with a critical role for polyamines in regulation of Kir channels that maintain the endocochlear potential and emphasize the importance of normal spermidine: spermine ratio in the hearing and balance functions of the inner ear.	[Wang, Xiaojing; Pegg, Anthony E.] Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Gratton, Michael Anne] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19014 USA; [Levic, Snezana; Doyle, Karen Jo; Yamoah, Ebenezer N.] Univ Calif Davis, Program Commun Sci, Ctr Neurosci, Davis, CA 95618 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; University of California System; University of California Davis	Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	aep1@psu.edu		Levic, Snezana/0000-0002-6171-896X	National Institutes of Health (USPHS) [R01 GM26290, DC007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007592] Funding Source: NIH RePORTER	National Institutes of Health (USPHS)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (USPHS) Grants R01 GM26290 (to A. E. P.) and DC007592 (to E. N. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABELOFF MD, 1986, CANCER TREAT REP, V70, P843; BARKER BO, 1989, AM J DISTANCE ED, V3, P20, DOI DOI 10.1080/08923648909526647; BARKWAY C, 1988, HERED DEAFNESS NEWSL, V1, P20; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; BROCK M, 1994, HEARING RES, V72, P37, DOI 10.1016/0378-5955(94)90203-8; Casimiro MC, 2004, GENOMICS, V84, P555, DOI 10.1016/j.ygeno.2004.06.007; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Danzin C., 1987, INHIBITION POLYAMINE, P141; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; Doyle KJ, 2001, ARCH OTOLARYNGOL, V127, P553, DOI 10.1001/archotol.127.5.553; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feith DJ, 2005, CANCER RES, V65, P572; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fong LYY, 1998, CANCER RES, V58, P5380; Grieff M, 1997, GENOMICS, V44, P227, DOI 10.1006/geno.1997.4876; HAEGELE KD, 1987, CANCER RES, V47, P890; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; Hamzavi I, 2007, J AM ACAD DERMATOL, V57, P54, DOI 10.1016/j.jaad.2006.09.025; HENLEY CM, 1995, HEARING RES, V84, P99, DOI 10.1016/0378-5955(95)00017-X; Hoffmann R, 2008, EUR J DERMATOL, V18, P65; HORN Y, 1987, EUR J CANCER CLIN ON, V23, P1103, DOI 10.1016/0277-5379(87)90141-6; Hoshino K, 2005, J BIOL CHEM, V280, P42801, DOI 10.1074/jbc.M505445200; Ikeguchi Y, 2004, BIOCHEM J, V381, P701, DOI 10.1042/BJ20040419; Imai A, 2004, FEBS LETT, V556, P148, DOI 10.1016/S0014-5793(03)01395-4; John SA, 2004, J GEN PHYSIOL, V123, P623, DOI 10.1085/jgp.200409017; Kato M, 1999, MOL REPROD DEV, V54, P43, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;43::AID-MRD6&gt;3.0.CO;2-N; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Korhonen VP, 2001, MOL PHARMACOL, V59, P231, DOI 10.1124/mol.59.2.231; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lao CD, 2004, CANCER EPIDEM BIOMAR, V13, P1250; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lorenz B, 1998, HUM MOL GENET, V7, P541, DOI 10.1093/hmg/7.3.541; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; MARKS SC, 1991, HEARING RES, V53, P230, DOI 10.1016/0378-5955(91)90057-G; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MEYER RA, 1995, J ORTHOPAED RES, V13, P30, DOI 10.1002/jor.1100130107; Meyer RA, 1998, GENOMICS, V48, P289, DOI 10.1006/geno.1997.5169; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MEYSKENS FL, 2008, CANC PREV RES, P9; Nie LP, 2005, J BIOL CHEM, V280, P15097, DOI 10.1074/jbc.M409856200; Nilsson J, 2000, BIOCHEM J, V352, P381, DOI 10.1042/0264-6021:3520381; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; PAJULA RL, 1979, EUR J BIOCHEM, V101, P619, DOI 10.1111/j.1432-1033.1979.tb19756.x; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Pasic TR, 1997, ARCH OTOLARYNGOL, V123, P1281; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; PEGG AE, 1985, BIOCHEM BIOPH RES CO, V133, P82, DOI 10.1016/0006-291X(85)91844-3; PEGG AE, 1984, BIOCHEM J, V224, P29, DOI 10.1042/bj2240029; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; SEILER N, 1985, J CHROMATOGR, V339, P45, DOI 10.1016/S0378-4347(00)84626-5; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; Smith MC, 2004, LARYNGOSCOPE, V114, P1113, DOI 10.1097/00005537-200406000-00029; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Williamson RE, 2007, AM J MED GENET A, V143A, P1630, DOI 10.1002/ajmg.a.31724; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041	72	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					930	937		10.1074/jbc.M807758200	http://dx.doi.org/10.1074/jbc.M807758200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001365	Green Published, hybrid			2022-12-25	WOS:000262122900028
J	Yu, SR; Smirnova, JB; Friedberg, EC; Stillman, B; Akiyama, M; Owen-Hughes, T; Waters, R; Reed, SH				Yu, Shirong; Smirnova, Julia B.; Friedberg, Errol C.; Stillman, Bruce; Akiyama, Masahiro; Owen-Hughes, Tom; Waters, Raymond; Reed, Simon H.			ABF1-binding Sites Promote Efficient Global Genome Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SEQUENCE BINDING-FACTOR; III-SENSITIVE SITES; IN-VITRO; DNA TRANSLOCATION; DIRECTIONAL ESTABLISHMENT; UV-IRRADIATION; BUDDING YEAST; ABF1 PROTEIN; HML-ALPHA	Global genome nucleotide excision repair (GG-NER) removes DNA damage from nontranscribing DNA. In Saccharomyces cerevisiae, the RAD7 and RAD16 genes are specifically required for GG-NER. We have reported that autonomously replicating sequence-binding factor 1 (ABF1) protein forms a stable complex with Rad7 and Rad16 proteins. ABF1 functions in transcription, replication, gene silencing, and NER in yeast. Here we show that binding of ABF1 to its DNA recognition sequence found at multiple genomic locations promotes efficient GG-NER in yeast. Mutation of the I silencer ABF1-binding site at the HML alpha locus caused loss of ABF1 binding, which resulted in a domain of reduced GG-NER efficiency on one side of the ABF1-binding site. During GG-NER, nucleosome positioning at this site was not altered, and this correlated with an inability of the GG-NER complex to reposition nucleosomes in vitro. We discuss how the GG-NER complex might facilitate GG-NER while preventing unregulated gene transcription during this process.	[Yu, Shirong; Smirnova, Julia B.; Waters, Raymond; Reed, Simon H.] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales; [Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Lab Mol Pathol, Dallas, TX 75390 USA; [Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Akiyama, Masahiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 63001, Japan; [Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat, Dundee DD1 5EH, Scotland	Cardiff University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cold Spring Harbor Laboratory; Nara Institute of Science & Technology; University of Dundee	Reed, SH (corresponding author), Cardiff Univ, Sch Med, Dept Pathol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	reedsh1@cardiff.ac.uk		Reed, Simon/0000-0002-4711-0560; Owen-Hughes, Tom/0000-0002-0618-8185; Stillman, Bruce/0000-0002-9453-4091	Medical Research Council (MRC); MRC [G9900118, G0400113] Funding Source: UKRI; Medical Research Council [G0400113, G9900118] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045436] Funding Source: NIH RePORTER	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Medical Research Council (MRC) career development award and career establishment grant (to S. H. R.) and an MRC program award (to R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beinoraviciute-Kellner R, 2005, FEBS LETT, V579, P4535, DOI 10.1016/j.febslet.2005.07.009; Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; Flaus A, 1999, METH MOL B, V119, P45; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; MCBROOM LDB, 1994, J BIOL CHEM, V269, P16455; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Reed SH, 1996, MOL GEN GENET, V250, P505; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Reed SH, 1996, MOL GEN GENET, V250, P515; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; RHODE PR, 1992, MOL CELL BIOL, V12, P1064, DOI 10.1128/MCB.12.3.1064; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; SHEI GJ, 1995, MOL CELL BIOL, V15, P3496; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Teng Y, 2001, Nucleic Acids Res, V29, pE64, DOI 10.1093/nar/29.13.e64; Teng YM, 1997, J MOL BIOL, V267, P324, DOI 10.1006/jmbi.1996.0908; TERLETH C, 1990, MOL CELL BIOL, V10, P4678, DOI 10.1128/MCB.10.9.4678; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Verhage RA, 1996, MUTAT RES-DNA REPAIR, V362, P155, DOI 10.1016/0921-8777(95)00045-3; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; WANG ZG, 1992, BIOCHEMISTRY-US, V31, P3694, DOI 10.1021/bi00129a019; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; Wang Zhigang, 1995, Methods (Orlando), V7, P177, DOI 10.1006/meth.1995.1023; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu SR, 2004, DNA REPAIR, V3, P277, DOI 10.1016/j.dnarep.2003.11.004; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zou YF, 2006, MOL CELL BIOL, V26, P7806, DOI 10.1128/MCB.01197-06	47	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					966	973		10.1074/jbc.M806830200	http://dx.doi.org/10.1074/jbc.M806830200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18996839	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000262122900032
J	Edinger, RS; Lebowitz, J; Li, H; Alzamora, R; Wang, HM; Johnson, JP; Hallows, KR				Edinger, Robert S.; Lebowitz, Jonathan; Li, Hui; Alzamora, Rodrigo; Wang, Huamin; Johnson, John P.; Hallows, Kenneth R.			Functional Regulation of the Epithelial Na+ Channel by I kappa B Kinase-beta Occurs via Phosphorylation of the Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; DUCT PRINCIPAL CELLS; SODIUM RETENTION; DOWN-REGULATION; TNF-ALPHA; IKK-BETA; SERUM; SGK1; ENAC	We have previously shown that I kappa B kinase-beta(IKK beta) interacts with the epithelial Na+ channel (ENaC) beta-subunit and enhances ENaC activity by increasing its surface expression in Xenopus oocytes. Here, we show that the IKK beta-ENaC interaction is physiologically relevant in mouse polarized kidney cortical collecting duct (mpkCCD(c14)) cells, as RNA interference-mediated knockdown of endogenous IKK beta in these cells by similar to 50% resulted in a similar reduction in transepithelial ENaC-dependent equivalent short circuit current. Although IKK beta binds to ENaC, there was no detectable phosphorylation of ENaC subunits by IKK beta in vitro. Because IKK beta stimulation of ENaC activity occurs through enhanced channel surface expression and the ubiquitin-protein ligase Nedd4-2 has emerged as a central locus for ENaC regulation at the plasma membrane, we tested the role of Nedd4-2 in this regulation. IKK beta-dependent phosphorylation of Xenopus Nedd4-2 expressed in HEK-293 cells occurred both in vitro and in vivo, suggesting a potential mechanism for regulation of Nedd4-2 and thus ENaC activity. P-32 labeling studies utilizing wild-type or mutant forms of Xenopus Nedd4-2 demonstrated that Ser-444, a key SGK1 and protein kinase A-phosphorylated residue, is also an important IKK beta phosphorylation target. ENaC stimulation by IKK beta was preserved in oocytes expressing wild-type Nedd4-2 but blocked in oocytes expressing either a dominant-negative (C938S) or phospho-deficient (S444A) Nedd4-2 mutant, suggesting that Nedd4-2 function and phosphorylation by IKK beta are required for IKK beta regulation of ENaC. In summary, these results suggest a novel mode of ENaC regulation that occurs throughIKK beta-dependent Nedd4-2 phosphorylation at a recognized SGK1 and protein kinase A target site.	[Edinger, Robert S.; Lebowitz, Jonathan; Li, Hui; Alzamora, Rodrigo; Wang, Huamin; Johnson, John P.; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Johnson, John P.; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hallows, KR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu		Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [K08 DK067143, R01 DK057718, DK047874, R01 DK075048]; American Heart Association [0825540D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047874, K08DK067143, R01DK075048, R01DK057718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK067143 (to J.L.), R01 DK057718 and DK047874 (to J.P.J.), and R01 DK075048 (to K. R. H.). This work was also supported by American Heart Association Postdoctoral Fellowship Award AHA 0825540D (to R. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; BUTTERWORTH MB, 2008, AM J PHYSL IN PRESS; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; de Seigneux S, 2008, J BIOL CHEM, V283, P25671, DOI 10.1074/jbc.M803812200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; DiPetrillo K, 2004, KIDNEY INT, V65, P1676, DOI 10.1111/j.1523-1755.2004.00606.x; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fukuda N, 2001, AM J PHYSIOL-LUNG C, V280, pL1258, DOI 10.1152/ajplung.2001.280.6.L1258; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; HUANG NL, 2008, INT J CARDI IN PRESS; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Palmada M, 2004, BIOCHEM BIOPH RES CO, V321, P1001, DOI 10.1016/j.bbrc.2004.07.064; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Rezaiguia S, 1997, J CLIN INVEST, V99, P325, DOI 10.1172/JCI119161; Rodriguez-Iturbe B, 2002, KIDNEY INT, V62, P1379, DOI 10.1111/j.1523-1755.2002.kid561.x; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Vinciguerra M, 2005, J AM SOC NEPHROL, V16, P2576, DOI 10.1681/ASN.2005040448; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	39	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					150	157		10.1074/jbc.M807358200	http://dx.doi.org/10.1074/jbc.M807358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981174	hybrid, Green Published			2022-12-25	WOS:000261974800017
J	Mooers, AO; Faith, DP; Maddison, WP				Mooers, Arne O.; Faith, Daniel P.; Maddison, Wayne P.			Converting Endangered Species Categories to Probabilities of Extinction for Phylogenetic Conservation Prioritization	PLOS ONE			English	Article								Background: Categories of imperilment like the global IUCN Red List have been transformed to probabilities of extinction and used to rank species by the amount of imperiled evolutionary history they represent ( e. g. by the Edge of Existence programme). We investigate the stability of such lists when ranks are converted to probabilities of extinction under different scenarios. Methodology and Principal Findings: Using a simple example and computer simulation, we show that preserving the categories when converting such list designations to probabilities of extinction does not guarantee the stability of the resulting lists. Significance: Care must be taken when choosing a suitable transformation, especially if conservation dollars are allocated to species in a ranked fashion. We advocate routine sensitivity analyses.	[Mooers, Arne O.; Faith, Daniel P.; Maddison, Wayne P.] Inst Adv Study, Berlin, Germany; [Mooers, Arne O.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Faith, Daniel P.] Australian Museum, Sydney, NSW, Australia; [Maddison, Wayne P.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; Australian Museum; University of British Columbia	Mooers, AO (corresponding author), Inst Adv Study, Berlin, Germany.	amooers@sfu.ca			Institute for Advanced Study in Berlin [fellowship]; NSERC Canada; Australian Research Foundation [RN0457921]	Institute for Advanced Study in Berlin; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Foundation(Australian Research Council)	This contribution was supported by fellowships (AOM and WPM ) and a visiting stipend (DPF) from the Institute for Advanced Study in Berlin. AOM and WPM each acknowledge NSERC Canada, and DPF acknowledges the Australian Research Foundation (RN0457921) for further research support.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Faith Daniel P., 2008, P99; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gardenfors Ulf, 1999, Species, V31-32, P58; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hartmann K, 2006, SYST BIOL, V55, P644, DOI 10.1080/10635150600873876; Hartmann Klaas, 2007, P171; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2001, IUCN RED LIST CAT CR; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Maddison W. P., 2007, TUATARA CONSERVATION; Munton P., 1987, P71; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Regan HM, 2000, BIOL CONSERV, V92, P101, DOI 10.1016/S0006-3207(99)00060-9; Steel M, 2007, EVOL BIOINFORM, V3, P237; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Williams Paul H., 1994, Biodiversity Letters, V2, P67, DOI 10.2307/2999760; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	27	88	88	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2008	3	11							e3700	10.1371/journal.pone.0003700	http://dx.doi.org/10.1371/journal.pone.0003700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WS	19002251	Green Published, gold, Green Submitted			2022-12-25	WOS:000265165600006
J	Kuparinen, A; O'Hara, RB; Merila, J				Kuparinen, Anna; O'Hara, Robert B.; Merila, Juha			Probabilistic Models for Continuous Ontogenetic Transition Processes	PLOS ONE			English	Article							MATURATION REACTION NORMS; REGRESSION-MODELS; AGE; SIZE; EVOLUTION; RISK	Background: Probabilistic reaction norms (PRNs) are an extension of the concept of reaction norms, developed to account for stochasticity in ontogenetic transitions. However, logistic regression based PRNs are restricted to discrete time intervals, whereas previously proposed models for continuous transitions are demanding in terms of modelling effort and data needed. Methodology/Principal Findings: Here we introduce two alternative approaches for the probabilistic modelling of continuous ontogenetic transitions. The models are simplified in their description of forces underlying transitions, thus being empirical rather than mechanistic by their nature, but therefore applicable to situations where data and prior knowledge of transitions are limited. The models provide continuous time description of the transition pattern, insights into how it is affected by covariates, at the same time allowing for fine scale transition probability predictions. Performance of the models is demonstrated using empirical data on metamorphosis in common frogs (Rana temporaria) reared in a common garden experiment. Conclusions/Significance: As being user-friendly and methodologically easily accessible, the models introduced in this study aid the concept of probabilistic reaction norms becoming as general and applicable tool in the studies of life-history variation as the deterministic reaction norms are today.	[Kuparinen, Anna; Merila, Juha] Univ Helsinki, Ecol Genet Res Unit, Dept Biol & Environm Sci, Helsinki, Finland; [O'Hara, Robert B.] Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Kuparinen, A (corresponding author), Univ Helsinki, Ecol Genet Res Unit, Dept Biol & Environm Sci, Helsinki, Finland.	anna.kuparinen@helsinki.fi	O'Hara, Bob/A-7499-2008; Merila, Juha/A-4061-2008	O'Hara, Bob/0000-0001-9737-3724; Merila, Juha/0000-0001-9614-0072	University of Helsinki; Academy of Finland	University of Helsinki; Academy of Finland(Academy of Finland)	This study was funded by the University of Helsinki and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; ALLISON PD, 2004, SURVIVAL ANAL USING; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Barot S, 2004, ECOL APPL, V14, P1257, DOI 10.1890/03-5066; COX DR, 1972, J R STAT SOC B, V34, P187; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; Do KA, 2000, STAT MED, V19, P1217; Engelhard GH, 2004, MAR ECOL PROG SER, V272, P245, DOI 10.3354/meps272245; Grift RE, 2007, MAR ECOL PROG SER, V334, P213, DOI 10.3354/meps334213; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Klein JP, 2003, SURVIVAL ANAL; Kraak SBM, 2007, MAR ECOL PROG SER, V335, P295, DOI 10.3354/meps335295; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lynch M., 1998, GENETICS ANAL QUANTI; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Pereira E, 2006, J ANIM BREED GENET, V123, P64, DOI 10.1111/j.1439-0388.2006.00567.x; Pigliucci M., 2001, SYN ECO EVO; R Core Team, 2022, R LANG ENV STAT COMP; Roff Derek A., 1992; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Stearns S.C., 1992, pi; Tarres J, 2005, J ANIM SCI, V83, P543; Van Dooren TJM, 2005, EVOLUTION, V59, P500, DOI 10.1554/04-356; Venables W., 2013, MODERN APPL STAT S, V53, P86; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3677	10.1371/journal.pone.0003677	http://dx.doi.org/10.1371/journal.pone.0003677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997864	gold, Green Published, Green Submitted			2022-12-25	WOS:000265165500002
J	Go, T; Konishi, Y				Go, Tohshin; Konishi, Yukuo			Neonatal Oral Imitation in Patients with Severe Brain Damage	PLOS ONE			English	Article								Background: Neonates reproduce facial movements in response to an adult model just after birth. This neonatal oral imitation usually disappears at about 2- to 3-months of age following the development of cortical control. There is controversy relating to the nature and neural basis of such neonatal imitation. To address this issue, we studied the relationship between oral imitation, primitive reflexes, and residual voluntary movement in patients with severe brain damage. Methods: Six male and six female patients with cerebral palsy, from 4 to 39 years, were included in this study. Oral imitation was examined when they were awake and looked at the experimenter. Patients were evaluated as performing oral imitation when they opened their mouth repeatedly without visual feedback regarding their own behavior in response to the experimenter's oral movement. Tongue or lip protrusion was not examined because none of patients were able to do those behaviors due to their physical disability. Rooting and sucking reflexes were also investigated as representatives of primitive reflexes. Results: Six patients (50%) performed oral imitation. Mouth opening was not observed repeatedly in response to other facial expression without opening the mouth such as surprise or smile, excluding the possibility of nonspecific oral reaction. They exhibited little voluntary movement of their extremities. Half of them also manifested at least one primitive reflex. No patients exhibiting residual voluntary movements of their extremities performed oral imitation or primitive reflexes. Conclusions: Oral imitation reappears in a similar way to primitive reflexes in patients showing severely impaired cortical function and little voluntary movement of their extremities due to severe brain damage, suggesting that neonatal oral imitation is mainly controlled by the subcortical brain region.	[Go, Tohshin; Konishi, Yukuo] Tokyo Womens Med Univ, Dept Infants Brain & Cognit Dev, Shinjuku Ku, Tokyo, Japan; [Go, Tohshin; Konishi, Yukuo] Japan Sci & Technol Agcy, Core Res Evolutional Sci & Technol CREST, Saitama, Japan	Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Go, T (corresponding author), Tokyo Womens Med Univ, Dept Infants Brain & Cognit Dev, Shinjuku Ku, Tokyo, Japan.	go-go@umin.ac.jp			Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	The present study was supported in part by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST).	ABRAVANEL E, 1984, CHILD DEV, V55, P381, DOI 10.2307/1129950; Amiel-Tison C, 2006, J PERINAT MED, V34, P437, DOI 10.1515/JPM.2006.088; Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; FIELD TM, 1982, SCIENCE, V218, P179, DOI 10.1126/science.7123230; FONTAINE R, 1984, INFANT BEHAV DEV, V7, P323, DOI 10.1016/S0163-6383(84)80047-8; Heimann M, 2001, EMERGING COGNITIVE ABILITIES IN EARLY INFANCY, P231; Kawakami K, 2007, INFANT BEHAV DEV, V30, P146, DOI 10.1016/j.infbeh.2006.08.004; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Myowa-Yamakoshi M, 2004, DEVELOPMENTAL SCI, V7, P437, DOI 10.1111/j.1467-7687.2004.00364.x; Takeshita H, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P37, DOI 10.1007/4-431-30248-4_2; TRIMBLE MR, 2000, NEUROLOGY CLIN PRACT, V1, P89	15	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2008	3	11							e3668	10.1371/journal.pone.0003668	http://dx.doi.org/10.1371/journal.pone.0003668			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432LM	18989360	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134600004
J	Fridley, JD				Fridley, Jason D.			Of Asian Forests and European Fields: Eastern US Plant Invasions in a Global Floristic Context	PLOS ONE			English	Article							ALIEN PLANTS; INVASIVENESS; DIVERSITY; AMERICA; PATTERN	Background: Biogeographic patterns of species invasions hold important clues to solving the recalcitrant 'who', 'where', and 'why' questions of invasion biology, but the few existing studies make no attempt to distinguish alien floras (all non-native occurrences) from invasive floras (rapidly spreading species of significant management concern), nor have invasion biologists asked whether particular habitats are consistently invaded by species from particular regions. Methodology/Principal Findings: Here I describe the native floristic provenances of the 2629 alien plant taxa of the Eastern Deciduous Forest of the Eastern U. S. (EUS), and contrast these to the subset of 449 taxa that EUS management agencies have labeled 'invasive'. Although EUS alien plants come from all global floristic regions, nearly half (45%) have native ranges that include central and northern Europe or the Mediterranean (39%). In contrast, EUS invasive species are most likely to come from East Asia (29%), a pattern that is magnified when the invasive pool is restricted to species that are native to a single floristic region (25% from East Asia, compared to only 11% from northern/central Europe and 2% from the Mediterranean). Moreover, East Asian invaders are mostly woody (56%, compared to just 23% of the total alien flora) and are significantly more likely to invade intact forests and riparian areas than European species, which dominate managed or disturbed ecosystems. Conclusions/Significance: These patterns suggest that the often-invoked 'imperialist dogma' view of global invasions equating invasion events with the spread of European colonialism is at best a restricted framework for invasion in disturbed ecosystems. This view must be superseded by a biogeographic invasion theory that is explicitly habitat-specific and can explain why particular world biotas tend to dominate particular environments.	[Fridley, Jason D.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Fridley, JD (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	fridley@syr.edu						Binggeli P, 1996, J VEG SCI, V7, P121, DOI 10.2307/3236424; BOUFFORD DE, 1983, ANN MO BOT GARD, V70, P423, DOI 10.2307/2992081; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Brown JH, 2004, AUSTRAL ECOL, V29, P530, DOI 10.1111/j.1442-9993.2004.01340.x; Cassey P, 2005, AUSTRAL ECOL, V30, P475, DOI 10.1111/j.1442-9993.2005.01505.x; Cox CB, 2001, J BIOGEOGR, V28, P511; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Crosby Alfred W., 1986, ECOLOGICAL IMPERIALI; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Darwin Charles, 1859, ORIGIN SPECIES FACSI; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Diamond, 1999, GUNS GERMS STEEL FAT; diCastri F, 1989, BIOL INVASIONS GLOBA, P1; *FLOR N AM ED COMM, 1993, FLOR N AM N MEX; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Good R, 1964, GEOGRAPHY FLOWERING; Good R., 1974, GEOGRAPHY FLOWERING; Good R., 1947, GEOGRAPHY FLOWERING; Good R., 1953, GEOGRAPHY FLOWERING; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Groves R. H., 1991, Biogeography of mediterranean invasions., P427, DOI 10.1017/CBO9780511525544.034; HARAGAN PD, 1991, WEEDS KENTUCKY ADJAC; Heywood VH, 1989, BIOL INVASIONS GLOBA, V37, P31; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoffman R., 1997, WISCONSIN MANUAL CON; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mack RN, 2003, ANN MO BOT GARD, V90, P77, DOI 10.2307/3298528; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Qian H, 2002, AM NAT, V160, P317, DOI 10.1086/341523; R Development Core Team, 2006, R LANG ENV STAT COMP; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Ruesink J. L., 1995, BioScience, V45, P465, DOI 10.2307/1312790; Salisbury E. J., 1961, WEEDS ALIENS; *SE EX PEST PLANT, 1996, INV EX PEST PLANTS T; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; SWEARINGEN J, 2008, WEEDUS DATABASE PLAN; Takhtajan A, 1986, FLORISTIC REGIONS WO, P522; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; *USDA ARS, 2007, GERMPL RES INF NETW; USDA NRCS, 2007, PLANTS DAT; Uva RH., 1997, WEEDS NE, P408; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vermeij GJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P315; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; WEAKLEY A, 2008, FLORA CAROLINAS VIRG; Webster CR, 2006, J FOREST, V104, P366; WHITE PS, 1983, ANN MO BOT GARD, V70, P734, DOI 10.2307/2398988; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0	63	54	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3630	10.1371/journal.pone.0003630	http://dx.doi.org/10.1371/journal.pone.0003630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978940	Green Published, gold			2022-12-25	WOS:000265134200012
J	Kwak, J; Willse, A; Matsumura, K; Opiekun, MC; Yi, WG; Preti, G; Yamazaki, K; Beauchamp, GK				Kwak, Jae; Willse, Alan; Matsumura, Koichi; Opiekun, Maryanne Curran; Yi, Weiguang; Preti, George; Yamazaki, Kunio; Beauchamp, Gary K.			Genetically-Based Olfactory Signatures Persist Despite Dietary Variation	PLOS ONE			English	Article								Individual mice have a unique odor, or odortype, that facilitates individual recognition. Odortypes, like other phenotypes, can be influenced by genetic and environmental variation. The genetic influence derives in part from genes of the major histocompatibility complex (MHC). A major environmental influence is diet, which could obscure the genetic contribution to odortype. Because odortype stability is a prerequisite for individual recognition under normal behavioral conditions, we investigated whether MHC-determined urinary odortypes of inbred mice can be identified in the face of large diet-induced variation. Mice trained to discriminate urines from panels of mice that differed both in diet and MHC type found the diet odor more salient in generalization trials. Nevertheless, when mice were trained to discriminate mice with only MHC differences (but on the same diet), they recognized the MHC difference when tested with urines from mice on a different diet. This indicates that MHC odor profiles remain despite large dietary variation. Chemical analyses of urinary volatile organic compounds (VOCs) extracted by solid phase microextraction (SPME) and analyzed by gas chromatography/mass spectrometry (GC/MS) are consistent with this inference. Although diet influenced VOC variation more than MHC, with algorithmic training (supervised classification) MHC types could be accurately discriminated across different diets. Thus, although there are clear diet effects on urinary volatile profiles, they do not obscure MHC effects.	[Kwak, Jae; Matsumura, Koichi; Opiekun, Maryanne Curran; Yi, Weiguang; Preti, George; Yamazaki, Kunio; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Willse, Alan] Battelle Mem Inst, Pacific NW Div, Richland, WA USA; [Preti, George] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Battelle Memorial Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Pennsylvania	Kwak, J (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	beauchamp@monell.org	Kwak, Jae/E-5781-2011	Kwak, Jae/0000-0003-4216-2019	ARO [DAAD19-03-1-0109]	ARO	This work is supported by ARO contract DAAD19-03-1-0109. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Government.	ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brown RE, 1996, PHYSIOL BEHAV, V60, P365, DOI 10.1016/0031-9384(96)00030-3; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Ferkin MH, 1997, ANIM BEHAV, V53, P133, DOI 10.1006/anbe.1996.0284; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gallagher M, 2008, ENVIRON SCI TECHNOL, V42, P243, DOI 10.1021/es071555y; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Kayali-Sayadi MN, 2003, J CHROMATOGR B, V796, P55, DOI 10.1016/j.jchromb.2003.08.001; KWAK J, 2007, 29 ANN M ASS CHEM SC; KWAK J, PHYSL BEHAV IN PRESS; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEON M, 1975, PHYSIOL BEHAV, V14, P311, DOI 10.1016/0031-9384(75)90039-6; LIEBICH HM, 1977, BIOMED MASS SPECTROM, V4, P69, DOI 10.1002/bms.1200040202; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lynch M., 1998, GENETICS ANAL QUANTI; Novotny MV, 2007, J CHEM ECOL, V33, P417, DOI 10.1007/s10886-006-9230-9; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Saini S, 2001, Biologist (London), V48, P229; Schellinck HM, 1997, ANIM LEARN BEHAV, V25, P193, DOI 10.3758/BF03199058; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; SINGER AG, 1993, J CHEM ECOL, V19, P569, DOI 10.1007/BF00994326; VALENTA JG, 1968, SCIENCE, V161, P599, DOI 10.1126/science.161.3841.599; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Walker V, 2001, CLIN CHIM ACTA, V306, P51, DOI 10.1016/S0009-8981(01)00390-4; Willse A, 2005, ANAL CHEM, V77, P2348, DOI 10.1021/ac048711t; Willse A, 2006, IMMUNOGENETICS, V58, P967, DOI 10.1007/s00251-006-0162-x; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1994, P NATL ACAD SCI USA, V91, P3735, DOI 10.1073/pnas.91.9.3735; YAMAZAKI K, 1986, P NATL ACAD SCI USA, V83, P4438, DOI 10.1073/pnas.83.12.4438; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099	41	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3591	10.1371/journal.pone.0003591	http://dx.doi.org/10.1371/journal.pone.0003591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974891	Green Submitted, Green Published, gold			2022-12-25	WOS:000265131700012
J	McCallum, FJ; Persson, KEM; Mugyenyi, CK; Fowkes, FJI; Simpson, JA; Richards, JS; Williams, TN; Marsh, K; Beeson, JG				McCallum, Fiona J.; Persson, Kristina E. M.; Mugyenyi, Cleopatra K.; Fowkes, Freya J. I.; Simpson, Julie A.; Richards, Jack S.; Williams, Thomas N.; Marsh, Kevin; Beeson, James G.			Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL FRAGMENT; INVASION IN-VITRO; CLINICAL MALARIA; ERYTHROCYTE INVASION; SERUM ANTIBODIES; PARASITE GROWTH; PREGNANT-WOMEN; PROTECTION; RESPONSES	Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood. Methods: We tested dialysed serum and purified immunoglobulins from Kenyan children and adults for inhibition of P. falciparum blood-stage growth in vitro using different parasite lines. Serum antibodies were measured by ELISA to blood-stage parasite antigens, extracted from P. falciparum schizonts, and to recombinant merozoite surface protein 1 (42 kDa C-terminal fragment, MSP1-42). Results: Antibodies to blood-stage antigens present in schizont protein extract and to recombinant MSP1-42 significantly increased with age and were highly correlated. In contrast, growth-inhibitory activity was not strongly associated with age and tended to decline marginally with increasing age and exposure, with young children demonstrating the highest inhibitory activity. Comparison of growth-inhibitory activity among samples collected from the same population at different time points suggested that malaria transmission intensity influenced the level of growth-inhibitory antibodies. Antibodies to recombinant MSP1-42 were not associated with growth inhibition and high immunoglobulin G levels were poorly predictive of inhibitory activity. The level of inhibitory activity against different isolates varied. Conclusions: Children can acquire growth-inhibitory antibodies at a young age, but once they are acquired they do not appear to be boosted by on-going exposure. Inhibitory antibodies may play a role in protection from early childhood malaria.	[McCallum, Fiona J.; Persson, Kristina E. M.; Fowkes, Freya J. I.; Richards, Jack S.; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [McCallum, Fiona J.; Richards, Jack S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mugyenyi, Cleopatra K.; Williams, Thomas N.; Marsh, Kevin] CGMRC, Wellcome Trust Collaborat Program, Kenya Med Res Inst, Kilifi, Kenya; [Simpson, Julie A.] Univ Melbourne, Ctr Mol, Environm, Genet & Anal Epidemiol, Carlton, Vic, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Kenya Medical Research Institute; University of Melbourne	McCallum, FJ (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	beeson@wehi.edu.au	Simpson, Julie A/P-7299-2014	Simpson, Julie/0000-0002-2660-2013; Fowkes, Freya/0000-0001-5832-9464; Persson, Kristina E M/0000-0003-2661-3115; Richards, Jack/0000-0001-5786-6989	National Health and Medical Research Council of Australia [Career Development Award, Postgraduate Research Fellowships]; Welcome Trust; Walter and Eliza Hall Institute [Miller Fellowship]; Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse; Wenner-Gren Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Welcome Trust(Wellcome Trust); Walter and Eliza Hall Institute; Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse; Wenner-Gren Fellowship	National Health and Medical Research Council of Australia (Project grant and Career Development Award to J. Beeson; Postgraduate Research Fellowships to F. McCallum and J. Richards), the Welcome Trust (Project grant to K. Marsh and J. Beeson; Program grant to K. Marsh; Fellowships to K. Marsh and T. Williams), the Miller Fellowship of the Walter and Eliza Hall Institute (to J. Beeson), the Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse (K. E. M. Persson) and Wenner-Gren Fellowship (K. E. M Persson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; BROWN GV, 1982, NATURE, V297, P591, DOI 10.1038/297591a0; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cavanagh DR, 1998, J IMMUNOL, V161, P347; CHAPPEL JA, 1993, MOL BIOCHEM PARASIT, V60, P303, DOI 10.1016/0166-6851(93)90141-J; COHEN S, 1969, NATURE, V223, P368, DOI 10.1038/223368a0; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; DENT AE, PLOS ONE IN PRESS; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Elliott SR, 2008, CLIN INFECT DIS, V46, P1794, DOI 10.1086/588049; Good MF, 2004, IMMUNOL REV, V201, P254, DOI 10.1111/j.0105-2896.2004.00178.x; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Nwuba RI, 2002, INFECT IMMUN, V70, P5328, DOI 10.1128/IAI.70.9.5328-5331.2002; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Rotman HL, 1998, J IMMUNOL, V161, P1908; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; SY NE, 1990, AM J TROP MED HYG, V43, P243, DOI 10.4269/ajtmh.1990.43.243; WILSON RJM, 1976, NATURE, V263, P132, DOI 10.1038/263132a0; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x	49	79	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3571	10.1371/journal.pone.0003571	http://dx.doi.org/10.1371/journal.pone.0003571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958278	Green Published, gold			2022-12-25	WOS:000265131100024
J	Qi, HY; Chen, YJ; Fu, X; Lin, CP; Zheng, XFS; Liu, LF				Qi, Haiyan; Chen, Yongjie; Fu, Xuan; Lin, Chao-Po; Zheng, X. F. Steven; Liu, Leroy F.			TOR Regulates Cell Death Induced by Telomere Dysfunction in Budding Yeast	PLOS ONE			English	Article								Telomere dysfunction is known to induce growth arrest (senescence) and cell death. However, the regulation of the senescence-death process is poorly understood. Here using a yeast dysfunctional telomere model cdc13-1, which carries a temperature sensitive-mutant telomere binding protein Cdc13p, we demonstrate that inhibition of TOR (Target of Rapamycin), a central regulator of nutrient pathways for cell growth, prevents cell death, but not growth arrest, induced by inactivation of Cdc13-1p. This function of TOR is novel and separable from its G1 inhibition function, and not associated with alterations in the telomere length, the amount of G-tails, and the telomere position effect (TPE) in cdc13-1 cells. Furthermore, antioxidants were also shown to prevent cell death initiated by inactivation of cdc13-1. Moreover, inhibition of TOR was also shown to prevent cell death induced by inactivation of telomerase in an est1 mutant. Interestingly, rapamycin did not prevent cell death induced by DNA damaging agents such as etoposide and UV. In the aggregate, our results suggest that the TOR signaling pathway is specifically involved in the regulation of cell death initiated by telomere dysfunction.	[Qi, Haiyan; Chen, Yongjie; Fu, Xuan; Lin, Chao-Po; Zheng, X. F. Steven; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Qi, HY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	qiha@umdnj.edu		Liu, Leroy/0000-0001-9396-763X; Lin, Chao-Po/0000-0002-1457-1635	NIH [CA102463, CA39662]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Chao-Po Lin and Leroy Liu were supported by NIH grants CA102463 and CA39662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDAPE RA, 1992, J BIOL CHEM, V267, P16029; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Barberis M, 2005, BIOCHEM J, V387, P639, DOI 10.1042/BJ20041299; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qi HY, 2003, J BIOL CHEM, V278, P15136, DOI 10.1074/jbc.M212808200; Qi HY, 2000, GENE DEV, V14, P1777; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; STAN R, 1994, J BIOL CHEM, V269, P32027; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3520	10.1371/journal.pone.0003520	http://dx.doi.org/10.1371/journal.pone.0003520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949037	gold, Green Submitted, Green Published			2022-12-25	WOS:000265126400006
J	Li, NF; Kocher, HM; Salako, MA; Obermueller, E; Sandle, J; Balkwill, F				Li, N. F.; Kocher, H. M.; Salako, M. A.; Obermueller, E.; Sandle, J.; Balkwill, F.			A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells	ONCOGENE			English	Article						colony-stimulating factor 1 receptor; hTERT; immortalization; human epithelial cells	CSF-1 M-CSF; TELOMERASE; EXPRESSION; GROWTH; CYTOKINE; MARKER; P53	The receptor for macrophage colony-stimulating factor 1 receptor (CSF1R) is a product of the proto-oncogene c-fms and a member of the class III transmembrane tyrosine kinase receptor family. Earlier, we described increased mRNA expression of CSF1R in human telomerase reverse transcriptase (hTERT) immortalized human ovarian surface epithelial (IOSE) cell lines derived from a single donor. Here, we further describe that CSF1R is upregulated at both the mRNA and protein level in hTERT immortalized human normal OSE cells from two different donors and in hTERT immortalized human pancreatic ductal epithelial cells. CSF1R was not upregulated in hTERT immortalized epithelial clones that subsequently underwent senescence or in immortalized fibroblasts. Upon stimulation by the CSF1R ligand CSF1, the immortalized epithelial cell lines showed rapid internalization of CSF1R with concomitant down-modulation and colocalization of phosphorylated NF kappa Bp65 with hTERT protein, hTERT translocation into the nucleus and the binding of c-Myc to the hTERT promoter region. Reducing the expression of CSF1R using short hairpin interfering RNA abolished these effects and also decreased cell survival and the number of population doublings under suboptimal culture conditions. The telomerase inhibitor GRN163L confirmed a role for telomerase in the cleavage of the intracellular domain of CSF1R. On the basis of these findings, we suggest that CSF1R may be a critical factor facilitating hTERT immortalization of epithelial cells.	[Li, N. F.; Salako, M. A.; Obermueller, E.; Balkwill, F.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Li, N. F.; Kocher, H. M.; Salako, M. A.; Obermueller, E.; Sandle, J.; Balkwill, F.] Barts & London Queen Marys Sch Med & Dent, Canc Res UK Clin Ctr, London EC1M 6BQ, England; [Kocher, H. M.; Sandle, J.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Tumor Biol Ctr, London EC1M 6BQ, England	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; University of London; Queen Mary University London	Balkwill, F (corresponding author), Barts & London Queen Marys Sch Med & Dent, Inst Canc, Ctr Canc & Inflammat, Charter House Sq, London EC1M 6BQ, England.	frances.balkwill@cancer.org.uk		LI, Ningfeng/0000-0001-5908-9976; Kocher, Hemant M/0000-0001-6771-1905; Balkwill, Frances/0000-0002-5587-9759	Medical Research Council [G0501974] Funding Source: Medline; MRC [G0501974] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akiyama M, 2003, CANCER RES, V63, P18; Hahn WC, 2002, MOL CELLS, V13, P351; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; KACINSKI BM, 1989, INT J RADIAT ONCOL, V17, P159, DOI 10.1016/0360-3016(89)90383-0; KACINSKI BM, 1990, INT J RADIAT ONCOL, V19, P619, DOI 10.1016/0360-3016(90)90488-6; KACINSKI BM, 1988, INT J RADIAT ONCOL, V15, P823, DOI 10.1016/0360-3016(88)90113-7; Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Rohrschneider LR, 1997, MOL REPROD DEV, V46, P96; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; SHERR CJ, 1988, J CELL BIOCHEM, V38, P179, DOI 10.1002/jcb.240380305; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; WHITAKER NJ, 1995, ONCOGENE, V11, P971; Yang G, 2007, ONCOGENE, V26, P1492, DOI 10.1038/sj.onc.1209905	18	28	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					773	780		10.1038/onc.2008.412	http://dx.doi.org/10.1038/onc.2008.412			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	18997822				2022-12-25	WOS:000263076400014
J	Miyake, I; Ohira, M; Nakagawara, A; Sakai, R				Miyake, I.; Ohira, M.; Nakagawara, A.; Sakai, R.			Distinct role of ShcC docking protein in the differentiation of neuroblastoma	ONCOGENE			English	Article						Shc family; ERK; neuroblastoma; differentiation; RNAi	PHOSPHOTYROSINE-BINDING DOMAINS; ANAPLASTIC LYMPHOMA KINASE; GROWTH-FACTOR RECEPTOR; SRC HOMOLOGY 2; ADAPTER PROTEIN; PLASMA-MEMBRANE; P190 RHOGAP; N-SHC; ACTIVATION; EXPRESSION	The biological and clinical heterogeneityof neuroblastoma is closely associated with signaling pathways that control cellular characteristics such as proliferation, survival and differentiation. The Shc family of docking proteins is important in these pathways by mediating cellular signaling. In this study, we analysed the expression levels of ShcA and ShcC proteins in 46 neuroblastoma samples and showed that a significantly high er level of ShcC protein is observed in neuroblastomas with poor prognostic factors such as advanced stage and MYCN amplification (P < 0.005), whereas the expression level of ShcA showed no signi. cant association with these factors. Using TNB1 cells that express a high level of ShcC protein, it was demonstrated that knockdown of ShcC by RNAi caused elevation in the phosphorylation of ShcA, which resulted in sustained extracellular signal-regulated kinase activation and neurite outgrowth. The neurites induced by ShcC knockdown expressed several markers of neuronal differentiation suggesting that the expression of ShcC potentially has a function in inhibiting the differentiation of neuroblastoma cells. In addition, marked suppression of in vivo tumorigenicity of TNB1 cells in nude mice was observed by stable knockdown of ShcC protein. These findings indicate that ShcC is a therapeutic target that might induce differentiation in the aggressive type of neuroblastomas.	[Sakai, R.] Natl Canc Ctr, Res Inst, Div Growth Factor, Chuo Ku, Tokyo 1040045, Japan; [Ohira, M.; Nakagawara, A.] Chiba Canc Ctr, Res Inst, Div Biochem, Chiba 2608717, Japan	National Cancer Center - Japan; Chiba Cancer Center	Sakai, R (corresponding author), Natl Canc Ctr, Res Inst, Div Growth Factor, Chuo Ku, Tokyo 1040045, Japan.	rsakai@ncc.go.jp		Sakai, Ryuichi/0000-0001-6833-1103	Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control.	Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; BRODEUR GM, 1992, AM J PEDIAT HEMATOL, V14, P111; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; GIUDICI AM, 1992, EUR J CELL BIOL, V58, P383; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Hecker TP, 2002, CANCER RES, V62, P2699; Hinsby AM, 2004, J NEUROCHEM, V91, P694, DOI 10.1111/j.1471-4159.2004.02772.x; IWAMOTO T, 1993, BRIT J CANCER, V67, P504, DOI 10.1038/bjc.1993.94; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Magrassi L, 2005, ONCOGENE, V24, P5198, DOI 10.1038/sj.onc.1208708; Marshall GM, 1997, CANCER RES, V57, P5399; Miyake I, 2005, ONCOGENE, V24, P3206, DOI 10.1038/sj.onc.1208523; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nakagawara A, 1997, EUR J CANCER, V33, P2050, DOI 10.1016/S0959-8049(97)00280-3; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Nakamura T, 1996, ONCOGENE, V13, P1111; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729; Ohira M, 2003, ONCOGENE, V22, P5525, DOI 10.1038/sj.onc.1206853; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Pelicci G, 1996, ONCOGENE, V13, P633; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Terui E, 2005, CLIN CANCER RES, V11, P3280, DOI 10.1158/1078-0432.CCR-04-1681; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; Yaka R, 1998, J CELL BIOCHEM, V70, P425, DOI 10.1002/(SICI)1097-4644(19980901)70:3<425::AID-JCB15>3.0.CO;2-J; Yamada M, 2002, BRAIN RES, V955, P183, DOI 10.1016/S0006-8993(02)03432-7	39	15	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2009	28	5					662	673		10.1038/onc.2008.413	http://dx.doi.org/10.1038/onc.2008.413			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	403IN	18997821				2022-12-25	WOS:000263076400004
J	Sun, W; Hu, W; Xu, RJ; Jin, JF; Szulc, ZM; Zhang, GF; Galadari, SH; Obeid, LM; Mao, CG				Sun, Wei; Hu, Wei; Xu, Ruijuan; Jin, Junfei; Szulc, Zdzislaw M.; Zhang, Guofeng; Galadari, Sehamuddin H.; Obeid, Lina M.; Mao, Cungui			Alkaline ceramidase 2 regulates beta 1 integrin maturation and cell adhesion	FASEB JOURNAL			English	Article						retinoic acid; protein kinase C; Golgi; sphingolipid	INTEGRIN RECEPTORS; MOLECULAR-CLONING; SPHINGOID BASES; DOWN-REGULATION; RETINOIC ACID; GLYCOSYLATION; EXPRESSION; APOPTOSIS; DIFFERENTIATION; TRANSPORT	The polypeptide core of the integrin beta 1 subunit (beta 1) is glycosylated sequentially in the endoplasmic reticulum and the Golgi complex to form beta 1 precursor and mature beta 1, respectively. The beta 1 precursor to mature beta 1 conversion, termed beta 1 maturation, regulates the cell surface levels and function of beta 1-containing integrins, beta 1 integrins. Here we demonstrate that the human alkaline ceramidase 2 (ACER2), a Golgi enzyme, regulates beta 1 maturation by controlling the generation of sphingosine. ACER2 overexpression inhibited beta 1 maturation, thus leading to a decrease in the levels of mature beta-1 in T-REx HeLa cells, whereas RNA interference-mediated knockdown of ACER2 enhanced beta 1 maturation in MCF-7 cells. ACER2 overexpression decreased the cell surface levels of beta 1 integrins, thus inhibiting cell adhesion to fibronectin or collagen, whereas ACER2 knockdown has the opposite effects. Treatment with all-trans retinoic acid (ATRA) increased both the expression of ACER2 and the generation of sphingosine in HeLa cells and inhibited beta 1 maturation. ACER2 knockdown attenuated the inhibitory effects of ATRA on both beta 1 maturation and cell adhesion. In contrast, treatment with phorbol myristate acetate (PMA), a protein kinase C activator, decreased the expression of ACER2 and sphingosine in T-REx HeLa cells, thus enhancing beta 1 maturation. ACER2 overexpression inhibited the stimulatory effects of PMA on both beta 1 maturation and cell adhesion. These results suggest that the ACER2/sphingosine pathway plays an important role in regulating beta 1 maturation and cell adhesion mediated by beta 1 integrins. Sun, W., Hu, W., Xu, R., Jin, J., Szulc, Z. M., Zhang, G., Galadari, S. H., Obeid, L. M, Mao, C. Alkaline ceramidase 2 regulates beta 1 integrin maturation and cell adhesion. FASEB J. 23, 656-666 (2009)	[Sun, Wei; Xu, Ruijuan; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Hu, Wei; Jin, Junfei; Szulc, Zdzislaw M.; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Zhang, Guofeng] NIH, Div Bioengn & Phys Sci, Bethesda, MD 20892 USA; [Galadari, Sehamuddin H.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Obeid, Lina M.] Ralph H Johnson Vet Adm Hosp, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; United Arab Emirates University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Div Gen Internal Med, 114 Doughty St,Rm 605 STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022; Galadari, Sehamuddin/AAK-6039-2020	obeid, lina/0000-0002-0734-0847	National Institutes of Health [R01CA104834]; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health grant R01CA104834 (to C.M.) and a Veterans Affairs Merit award (to L.M.O.).	AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; Bellis SL, 1999, J CELL PHYSIOL, V181, P33, DOI 10.1002/(SICI)1097-4652(199910)181:1<33::AID-JCP4>3.0.CO;2-#; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boles BK, 2000, AM J PHYSIOL-LUNG C, V278, pL703, DOI 10.1152/ajplung.2000.278.4.L703; Chattopadhyay N, 1999, GYNECOL ONCOL, V75, P215, DOI 10.1006/gyno.1999.5574; Chen XN, 2006, BIOCHEM BIOPH RES CO, V343, P910, DOI 10.1016/j.bbrc.2006.03.046; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; Jee BK, 2007, BIOCHEM BIOPH RES CO, V359, P703, DOI 10.1016/j.bbrc.2007.05.159; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; KIM LT, 1992, J CELL SCI, V103, P743; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Morini M, 1997, EXP CELL RES, V232, P304, DOI 10.1006/excr.1997.3528; Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P194; Obeid L.M., 2001, J BIOL CHEM, V16, P16; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Rozzo C, 1997, INT J CANCER, V70, P688, DOI 10.1002/(SICI)1097-0215(19970317)70:6<688::AID-IJC11>3.3.CO;2-V; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Sengupta S, 2000, J EXP CLIN CANC RES, V19, P81; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tani M, 2005, J BIOL CHEM, V280, P36592, DOI 10.1074/jbc.M506827200; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	40	30	33	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					656	666		10.1096/fj.08-115634	http://dx.doi.org/10.1096/fj.08-115634			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18945876	Green Published			2022-12-25	WOS:000262892900036
J	Takai, A; Toyoshima, T; Uemura, M; Kitawaki, Y; Marusawa, H; Hiai, H; Yamada, S; Okazaki, IM; Honjo, T; Chiba, T; Kinoshita, K				Takai, A.; Toyoshima, T.; Uemura, M.; Kitawaki, Y.; Marusawa, H.; Hiai, H.; Yamada, S.; Okazaki, I. M.; Honjo, T.; Chiba, T.; Kinoshita, K.			A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations	ONCOGENE			English	Article						hepatic cancer; stem cell marker; activation-induced cytidine deaminase; Cre recombinase; somatic mutation; animal model	INDUCED CYTIDINE DEAMINASE; HEPATOCELLULAR-CARCINOMA; CONSTITUTIVE EXPRESSION; STEM-CELLS; HBX GENE; CANCER; VIRUS; STEATOHEPATITIS; PROLIFERATION; GENERATION	Activation-induced cytidine deaminase (AID), the only enzyme that is known to be able to induce mutations in the human genome, is required for somatic hypermutation and class-switch recombination in B lymphocytes. Recently, we showed that AID is implicated in the pathogenesis of human cancers including hepatitis C virus (HCV)-induced human hepatocellular carcinoma (HCC). In this study, we established a new AID transgenic mouse model (TNAP-AID) in which AID is expressed in cells producing tissue-nonspeci. c alkaline phosphatase (TNAP), which is a marker of primordial germ cells and immature stem cells, including ES cells. High expression of TNAP was found in the liver of the embryos and adults of TNAP-AID mice. HCC developed in 27% of these mice at the age of approximately 90 weeks. The HCC that developed in TNAP-AID mice expressed alpha-fetoprotein and had deleterious mutations in the tumour suppressor gene Trp53, some of which corresponded to those found in human cancer. In conclusion, TNAP-AID is a mouse model that spontaneously develops HCC, sharing genetic and phenotypic features with human HCC, which develops in the inflamed liver as a result of the accumulation of genetic changes.	[Toyoshima, T.; Uemura, M.; Hiai, H.; Kinoshita, K.] Shiga Med Ctr Res Inst, Shiga 5248524, Japan; [Takai, A.; Marusawa, H.; Chiba, T.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Kitawaki, Y.; Okazaki, I. M.; Honjo, T.] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Yamada, S.] Immunobiol Labs Co Ltd, Mikasa Lab, Mikasa, Japan	Kyoto University; Kyoto University; Immuno-Biological Laboratories Co. Ltd.	Kinoshita, K (corresponding author), Shiga Med Ctr Res Inst, 5-4-1930, Shiga 5248524, Japan.	kkinoshi.shigamed@mac.com	Honjo, Tasuku/N-4470-2016	Marusawa, Hiroyuki/0000-0002-4286-2712; Okazaki, Il-mi/0000-0001-8644-0100	Grant-in-Aid for Scientific Research [17013042, 18390122]; Takeda Science Foundation	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr Andras Nagy for his generous gift of TNAP-Cre mice, Dr Takashi Shinohara for suggesting the choice of the Cre mouse strain, Dr Yoshinobu Toda for the preparation of tissue sections and Dr Masayuki Tsuji for technical help with the immunohistochemical analyses. We also thank Dr Sidonia Fagarasan for critical reading of the manuscript and discussions. This study was supported by Grant-in-Aid for Scientific Research (17013042 and 18390122) and the Takeda Science Foundation.	Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Factor VM, 1997, CANCER RES, V57, P2089; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kinoshita K, 2006, INT J HEMATOL, V83, P201, DOI 10.1532/IJH97.06011; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; Koike K, 2002, J GASTROEN HEPATOL, V17, P394, DOI 10.1046/j.1440-1746.2002.02763.x; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Kotani A, 2005, P NATL ACAD SCI USA, V102, P4506, DOI 10.1073/pnas.0500830102; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Kues WA, 2005, BIOL REPROD, V72, P1020, DOI 10.1095/biolreprod.104.031229; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marusawa H, 2008, INT J BIOCHEM CELL B, V40, P1399, DOI 10.1016/j.biocel.2008.01.018; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; MURAKAMI H, 1993, CANCER RES, V53, P1719; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nakau M, 2002, CANCER RES, V62, P4549; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; SANDGREN EP, 1989, ONCOGENE, V4, P715; Schreck S, 2006, J PATHOL, V210, P26, DOI 10.1002/path.2014; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; URVEN LE, 1993, BIOL REPROD, V48, P564, DOI 10.1095/biolreprod48.3.564; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	56	56	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2009	28	4					469	478		10.1038/onc.2008.415	http://dx.doi.org/10.1038/onc.2008.415			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	400KM	18997814	Green Submitted			2022-12-25	WOS:000262866500001
J	Li, S; Szymborski, A; Miron, MJ; Marcellus, R; Binda, O; Lavoie, JN; Branton, PE				Li, S.; Szymborski, A.; Miron, M-J; Marcellus, R.; Binda, O.; Lavoie, J. N.; Branton, P. E.			The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells	ONCOGENE			English	Article						adenovirus; E4orf4; cell death; growth arrest; mitotic catastrophe; apoptosis	CYCLIN-E OVEREXPRESSION; P53-INDEPENDENT APOPTOSIS; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL CONTROL; TRANSFORMED-CELLS; PHOSPHATASE 2A; DEATH; PROLIFERATION; CANCER; INHIBITION	The human adenovirus E4orf4 protein, when expressed alone, induces p53-independent death in a wide range of cancer cells. Earlier studies by our groups suggested that although in some cases cell death can be associated with some hallmarks of apoptosis, it is not always affected by caspase inhibitors. Thus it is unlikely that E4orf4-induced cell death occurs uniquely through apoptosis. In the present studies using H1299 human lung carcinoma cells as a model system we found that death is induced in the absence of activation of any of the caspases tested, accumulation of reactive oxygen species, or release of cytochrome c from mitochondria. E4orf4 caused a substantial change in cell morphology, including vigorous membrane blebbing, multiple nuclei in many cells and increased cell volume. Most of these characteristics are not typical of apoptosis, but they are of necrosis. FACS analysis and western blotting for cell cycle markers showed that E4orf4-expressing cells became arrested in G(2)/M and also accumulated high levels of cyclin E. The presence of significant numbers of tetraploid and polyploid cells and some cells with micronuclei suggested that E4orf4 appears to induce death in these cells through a process resulting from mitotic catastrophe.	[Li, S.; Szymborski, A.; Miron, M-J; Binda, O.; Branton, P. E.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Lavoie, J. N.] Univ Laval, Ctr Rech Cancerol, Hotel Dieu Quebec, Quebec City, PQ, Canada; [Marcellus, R.] Gemin X Biotechnol Inc, Montreal, PQ, Canada; [Branton, P. E.] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Branton, P. E.] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; Laval University; McGill University; McGill University	Branton, PE (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,Room 701,365 Promenade Sir, Montreal, PQ H3G 1Y6, Canada.	philip.branton@mcgill.ca	Binda, Olivier/A-5941-2009	Binda, Olivier/0000-0002-1539-0828; Lavoie, Josee N/0000-0001-6912-1132	Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Institutes of Health Research; Gemin X Biotechnologics Inc	Canadian Cancer Society through the National Cancer Institute of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Gemin X Biotechnologics Inc	We thank Dennis Takayesu for technical support and Denis Paquette, Helen Chan and Mark Watson from Gemin X Biotechnologies Inc. for making some of the DNA constructs and for help in some experimental protocols. We also thank Eric Massicotte and Nathalie Tessier of Institut des reserches cliniques de Montreal and Ken McDonald at McGill Life Sciences Complex for performing flow cytometry analyses, and Jacynthe Lalibete from the Department of Pharmacology and Therapeutics at McGill University for confocal microscopy study. Gordon Shore provided anti-caspase and anti-actin antibodies. This work was supported by grants from the Canadian Cancer Society through the National Cancer Institute of Canada (PEB, JNL), the Canadian Institutes of Health Research (PEB, JNL), and from Gemin X Biotechnologics Inc (PEB).	BACCHETTI S, 1993, INT J ONCOL, V3, P781; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Jaattela M, 2002, ANN MED, V34, P480, DOI 10.1080/078538902321012423; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Kelekar A, 2005, ANN NY ACAD SCI, V1066, P259, DOI 10.1196/annals.1363.015; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Koutsami MK, 2006, J PATHOL, V209, P512, DOI 10.1002/path.2005; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Marcellus RC, 1998, J VIROL, V72, P7144, DOI 10.1128/JVI.72.9.7144-7153.1998; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; VOJTA PJ, 1995, BBA-REV CANCER, V1242, P29, DOI 10.1016/0304-419X(95)00002-W; Wang XD, 2001, GENE DEV, V15, P2922	37	38	39	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					390	400		10.1038/onc.2008.393	http://dx.doi.org/10.1038/onc.2008.393			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18955965				2022-12-25	WOS:000262550300007
J	Seng, S; Avraham, HK; Birrane, G; Jiang, S; Li, H; Katz, G; Bass, CE; Zagozdzon, R; Avraham, S				Seng, S.; Avraham, H. K.; Birrane, G.; Jiang, S.; Li, H.; Katz, G.; Bass, C. E.; Zagozdzon, R.; Avraham, S.			NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors	ONCOGENE			English	Article						NRP/B mutation; Nrf2; NQO1; primary brain tumors	NUCLEAR-MATRIX PROTEINS; ANTIOXIDANT RESPONSIVE ELEMENTS; DT-DIAPHORASE; CANCER CELLS; GENE; NRF2; EXPRESSION; ENC-1; OXIDOREDUCTASE-1; DIFFERENTIATION	Brain tumors are associated with genetic alterations of oncogenes and tumor suppressor genes. Accumulation of reactive oxygen species (ROS) in cells leads to oxidative stress-induced damage, resulting in tumorigenesis. Here, we showed that the nuclear matrix protein nuclear restricted protein in brain (NRP/B) was colocalized and interacted with NF-E2-related factor 2 (Nrf2). During oxidative stress response, NRP/B expression and its interaction with Nrf2 were upregulated in SH-SY5Y cells. Association of NRP/B with Nrf2 was crucial for NAD(P)H:quinone oxidoreductase 1 (NQO1) expression. NRP/B was localized predominantly in the nucleus of normal brain cells, whereas in primary brain tumors NRP/B was almost exclusively contained in the cytoplasm. In addition, unlike wild-type NRP/B, the expression of NRP/B mutants isolated from primary brain tumors was found in the cytoplasm, and these mutants failed to induce Nrf2-dependent NQO1 transcription. Thus, NRP/B mutations and their altered localization resulted in changes in NRP/B function and deregulation of Nrf2-dependent NQO1 activation in brain tumors. This study provides insights into the mechanism by which the NRP/B modulates Nrf2-dependent NQO1 induction in cellular protection against ROS in brain tumors.	[Seng, S.; Avraham, H. K.; Birrane, G.; Jiang, S.; Li, H.; Katz, G.; Bass, C. E.; Zagozdzon, R.; Avraham, S.] Harvard Univ, Sch Med, Harvard Inst Med, Beth Israel Deaconess Med Ctr,Div Expt Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Avraham, S (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Beth Israel Deaconess Med Ctr,Div Expt Med, 4 Blackfan Circle, Boston, MA 02115 USA.	savraham@bidmc.harvard.edu	Zagozdzon, Radoslaw/AAC-4298-2019; Zagozdzon, Radoslaw/K-2141-2012	Zagozdzon, Radoslaw/0000-0002-7957-2372; Birrane, Gabriel/0000-0002-1759-5499; Katz, Gabrielle/0000-0002-9233-5654; Avraham, Hava/0000-0002-7545-3640; Bass, Caroline/0000-0002-5856-6387	NIH [HL80699, CA096805]; Department of Defense Cancer Concept Award; NATIONAL CANCER INSTITUTE [R01CA096805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Cancer Concept Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Janet Delahanty and Makara Men for editing the paper. This study was supported by NIH grants HL80699 (SA), CA096805 (HKA) and the Department of Defense Cancer Concept Award (SA).	Alberti I, 2000, J CELL BIOCHEM, V79, P471, DOI 10.1002/1097-4644(20001201)79:3<471::AID-JCB120>3.3.CO;2-F; Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Begleiter A, 1997, ONCOL RES, V9, P371; Berezney R, 1995, INT REV CYTOL, V162A, P1; Bode J, 2000, J CELL BIOCHEM, P3; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; FEY EG, 1984, P NATL ACAD SCI-BIOL, V81, P4409, DOI 10.1073/pnas.81.14.4409; Fujita M, 2001, CANCER RES, V61, P7722; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Getzenberg RH, 1996, CANCER RES, V56, P1690; Hammarsund M, 2004, HUM MOL GENET, V13, P2925, DOI 10.1093/hmg/ddh315; He D, 1995, INT REV CYTOL, V162B, P1; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kim TA, 2000, GENE, V255, P105, DOI 10.1016/S0378-1119(00)00297-3; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Konety BR, 1999, J CELL BIOCHEM, P183; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; Loidl P, 1995, INT REV CYTOL, V162B, P377; Long DJ, 2002, CANCER RES, V62, P3030; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P1657, DOI 10.1016/0006-2952(92)90694-E; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Seng S, 2007, CANCER RES, V67, P8596, DOI 10.1158/0008-5472.CAN-06-3785; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	37	16	17	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					378	389		10.1038/onc.2008.396	http://dx.doi.org/10.1038/onc.2008.396			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18981988				2022-12-25	WOS:000262550300006
J	Brunk, I; Blex, C; Speidel, D; Brose, N; Ahnert-Hilger, G				Brunk, Irene; Blex, Christian; Speidel, Dina; Brose, Nils; Ahnert-Hilger, Gudrun			Ca2+-dependent Activator Proteins of Secretion Promote Vesicular Monoamine Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLES; BINDING-PROTEIN; FAMILY; CAPS; TRANSPORTER; EXOCYTOSIS; EXPRESSION; CLONING; MEMBERS; BRAIN	Ca2+-dependent activator proteins of secretion (CAPS) 1 and 2 are essential regulators of synaptic vesicle and large dense core vesicle priming in mammalian neurons and neuroendocrine cells. CAPS1 appears to have an additional and as yet unexplained function in vesicular catecholamine uptake or storage as CAPS1-deficient chromaffin cells exhibit strongly reduced vesicular catecholamine levels. Here we describe a role of CAPS proteins in vesicular monoamine uptake. Both CAPS1 and CAPS2 promote monoamine uptake and storage mediated by the vesicular monoamine transporters VMAT1 and VMAT2. Monoamine uptake of vesicular preparations from embryonic brains of CAPS1 deletion mutants is decreased as compared with corresponding preparations from wild type littermates, and anti-CAPS1 or anti-CAPS2 antibodies inhibit monoamine sequestration by synaptic vesicles from adult mouse brain. In addition, overexpression of CAPS1 or CAPS2 enhances vesicular monoamine uptake in Chinese hamster ovary cells that stably express VMAT1 or VMAT2. CAPS function has been linked to the heterotrimeric GTPase Go, which modulates vesicular monoamine uptake. We found that the expression of CAPS1 is decreased in brain membrane preparations from mice lacking G(o2)alpha, which may explain the reduced monoamine uptake by G(o2)alpha-deficient synaptic vesicles. Accordingly, anti-CAPS1 antibodies do not further reduce monoamine uptake by G(o2)alpha-deficient synaptic vesicles, whereas antibodies directed against CAPS2, whose expression is not altered in G(o2)alpha-deficient brain, still reduce monoamine uptake into G(o2)alpha-deficient vesicles. We conclude that CAPS proteins are involved in optimizing vesicular monoamine uptake and storage mediated by VMAT1 and VMAT2.	[Brunk, Irene; Blex, Christian; Ahnert-Hilger, Gudrun] Charite Ctr 2 Basic Med, Inst Integrat Neuroanat, AG Funct Cell Biol, D-10115 Berlin, Germany; [Speidel, Dina; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Ahnert-Hilger, G (corresponding author), Charite Ctr 2 Basic Med, Inst Integrat Neuroanat, AG Funct Cell Biol, Philippstr 12, D-10115 Berlin, Germany.	gudrun.ahnert@charite.de		Blex, Christian/0000-0002-8493-3523; Brunk, Irene/0000-0002-2668-7002	Max Planck Society [AH67/3-3]; German Research Foundation [SFB406/A1]	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	This work was supported by Max Planck Society Grant AH67/3-3 (to G. A.-H.) and German Research Foundation Grant SFB406/A1 (to N.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Becher A, 1999, J NEUROSCI, V19, P1922; Brunk I, 2006, HANDB EXP PHARM, V175, P305; Brunk I, 2008, FASEB J, V22, P3736, DOI 10.1096/fj.08-111245; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Holtje M, 2000, J NEUROSCI, V20, P2131; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Pahner I, 2002, EUR J CELL BIOL, V81, P449, DOI 10.1078/0171-9335-00269; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x	26	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1050	1056		10.1074/jbc.M805328200	http://dx.doi.org/10.1074/jbc.M805328200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008227	hybrid			2022-12-25	WOS:000262122900041
J	Fujii, T; Takahashi, Y; Ikari, A; Morii, M; Tabuchi, Y; Tsukada, K; Takeguchi, N; Sakai, H				Fujii, Takuto; Takahashi, Yuji; Ikari, Akira; Morii, Magotoshi; Tabuchi, Yoshiaki; Tsukada, Kazuhiro; Takeguchi, Noriaki; Sakai, Hideki			Functional Association between K+-Cl- Cotransporter-4 and H+,K+-ATPase in the Apical Canalicular Membrane of Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SECRETION; ATPASE; LOCALIZATION; EXPRESSION; POTASSIUM; CHANNELS; CLONING; H+; TRAFFICKING; CONDUCTANCE	We studied whether K+-Cl- cotransporters (KCCs) are involved in gastric HCl secretion. We found that KCC4 is expressed in the gastric parietal cells more abundantly at the luminal region of the gland than at the basal region. KCC4 was found in the stimulation-associated vesicles (SAV) derived from the apical canalicular membrane but not in the intracellular tubulovesicles, whereas H+,K+-ATPase was expressed in both of them. In contrast, KCC1, KCC2, and KCC3 were not found in either SAV or tubulovesicles. KCC4 coimmunoprecipitated with H+,K+-ATPase in the lysate of SAV. Interestingly the MgATP-dependent uptake of Cl-36(-) into the SAV was suppressed by either the H+, K+-ATPase inhibitor (SCH28080) or the KCC inhibitor ((R)-(+)-[(2-n-butyl-6,7-dichloro-2-cyclo-pentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid). The KCC inhibitor suppressed the H+ uptake into SAV and the H+,K+-ATPase activity of SAV, but the inhibitor had no effects on these activities in the freeze-dried leaky SAV. These results indicate that the K+-Cl- cotransport by KCC4 is tightly coupled with H+/K+ antiport by H+,K (+)-ATPase, resulting in HCl accumulation in SAV. In the tetracycline-regulated expression system of KCC4 in the HEK293 cells stably expressing gastric H+,K+-ATPase, KCC4 was coimmunoprecipitated with H+,K+-ATPase. The rate of recovery of intracellular pH in the KCC4-expressing cells after acid loading through an ammonium pulse was significantly faster than that in the KCC4-nonexpressing cells. Our results suggest that KCC4 and H+,K+-ATPase are the main machineries for basal HCl secretion in the apical canalicular membrane of the resting parietal cell. They also may contribute in part to massive acid secretion in the stimulated state.	[Fujii, Takuto; Takahashi, Yuji; Takeguchi, Noriaki; Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, Toyama 9300194, Japan; [Tsukada, Kazuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Surg 2, Toyama 9300194, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Toyama 9300194, Japan; [Ikari, Akira] Univ Shizuoka, Dept Pharmacobiochem, Shizuoka 4228526, Japan; [Morii, Magotoshi] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Lab Phys Sci, Matsusaka, Mie 5138670, Japan	University of Toyama; University of Toyama; University of Toyama; University of Shizuoka	Sakai, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, 2630 Sugitani, Toyama 9300194, Japan.	sakaih@pha.u-toyama.ac.jp		Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [15390062, 18390064, 20010617]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16657042, 18059012, 20056010]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 15390062 and 18390064 ( to H. S.) and for JSPS Fellows 20010617 ( to T. F.) from the Japan Society for the Promotion of Science and Grants-in-aid for Scientific Research 16657042, 18059012, and 20056010 ( to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; ASANO S, 1988, J BIOCHEM-TOKYO, V103, P672, DOI 10.1093/oxfordjournals.jbchem.a122327; ASANO S, 1994, BIOCHEM J, V299, P59, DOI 10.1042/bj2990059; Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; BAMBERG K, 1994, BBA-BIOMEMBRANES, V1190, P355, DOI 10.1016/0005-2736(94)90094-9; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Calhoun BC, 1997, BIOCHEM J, V325, P559, DOI 10.1042/bj3250559; Carmosino M, 2001, J CELL BIOL, V154, P1235, DOI 10.1083/jcb.200103010; DEMAREST JR, 1990, ANNU REV PHYSIOL, V52, P307; Fujii T, 2008, J BIOL CHEM, V283, P6869, DOI 10.1074/jbc.M708429200; Fujii T, 2007, EUR J PHARMACOL, V560, P123, DOI 10.1016/j.ejphar.2006.12.031; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GARAY RP, 1988, MOL PHARMACOL, V33, P696; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Grishin AV, 1996, AM J PHYSIOL-RENAL, V271, pF539, DOI 10.1152/ajprenal.1996.271.3.F539; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heitzmann D, 2007, PHYSIOLOGY, V22, P335, DOI 10.1152/physiol.00016.2007; Jons T, 1999, HISTOCHEM CELL BIOL, V111, P313, DOI 10.1007/s004180050362; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG161, DOI 10.1152/ajpgi.1997.272.1.G161; Karvar S, 2005, TRAFFIC, V6, P654, DOI 10.1111/j.1600-0854.2005.00306.x; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Kimura T, 2002, J BIOL CHEM, V277, P20671, DOI 10.1074/jbc.M200523200; Kimura T, 2002, J BIOCHEM, V131, P923, DOI 10.1093/oxfordjournals.jbchem.a003183; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; LEE HC, 1979, BIOCHIM BIOPHYS ACTA, V553, P107, DOI 10.1016/0005-2736(79)90034-8; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; MORII M, 1993, J BIOL CHEM, V268, P21553; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Okamoto CT, 2001, J PHYSIOL-LONDON, V532, P287, DOI 10.1111/j.1469-7793.2001.0287f.x; Sachs G, 2001, EUR J GASTROEN HEPAT, V13, pS35; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Sakai H, 2003, J PHYSIOL-LONDON, V551, P207, DOI 10.1113/jphysiol.2003.041921; Sidani SM, 2007, J BIOL CHEM, V282, P6068, DOI 10.1074/jbc.M608427200; TAKEGUCHI N, 1986, J BIOL CHEM, V261, P2560; Urushidani T, 1997, J MEMBRANE BIOL, V159, P99, DOI 10.1007/s002329900274; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	45	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					619	629		10.1074/jbc.M806562200	http://dx.doi.org/10.1074/jbc.M806562200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984587	hybrid			2022-12-25	WOS:000261974800067
J	Hu, Y; Suarez, J; Fricovsky, E; Wang, H; Scott, BT; Trauger, SA; Han, WL; Hu, Y; Oyeleye, MO; Dillmann, WH				Hu, Yong; Suarez, Jorge; Fricovsky, Eduardo; Wang, Hong; Scott, Brian T.; Trauger, Sunia A.; Han, Wenlong; Hu, Ying; Oyeleye, Mary O.; Dillmann, Wolfgang H.			Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; POSTTRANSLATIONAL MODIFICATION; DIABETIC CARDIOMYOPATHY; GLCNAC MODIFICATION; CYTOSOLIC PROTEINS; NUCLEAR; INSULIN; IDENTIFICATION; GLYCOSYLATION; OVEREXPRESSION	Increased nuclear protein O-linked beta-N-acetylglucosamine glycosylation (O-GlcNAcylation) mediated by high glucose treatment or the hyperglycemia of diabetes mellitus contributes to cardiac myocyte dysfunction. However, whether mitochondrial proteins in cardiac myocytes are also submitted to O-GlcNAcylation or excessive O-GlcNAcylation alters mitochondrial function is unknown. In this study, we determined if mitochondrial proteins are O-GlcNAcylated and explored if increased O-GlcNAcylation is linked to high glucose-induced mitochondrial dysfunction in neonatal rat cardiomyocytes. By immunoprecipitation, we found that several mitochondrial proteins, which are members of complexes of the respiratory chain, like subunit NDUFA9 of complex I, subunits core 1 and core 2 of complex III, and the mitochondrial DNA-encoded subunit I of complex IV ( COX I) are O-GlcNAcylated. By mass spectrometry, we identified that serine 156 on NDUFA9 is O-GlcNAcylated. High glucose treatment ( 30 mM glucose) increases mitochondrial protein O-GlcNAcylation, including those of COX I and NDUFA9 which are reduced by expression of O-GlcNAcase ( GCA). Increased mitochondrial O-GlcNAcylation is associated with impaired activity of complex I, III, and IV in addition to lower mitochondrial calcium and cellular ATP content. When the excessive O-GlcNAc modification is reduced by GCA expression, mitochondrial function improves; the activity of complex I, III, and IV increases to normal and mitochondrial calcium and cellular ATP content are returned to control levels. From these results we conclude that specific mitochondrial proteins of cardiac myocytes are O-GlcNAcylated and that exposure to high glucose increases mitochondrial protein O-GlcNAcylation, which in turn contributes to impaired mitochondrial function.	[Hu, Yong; Suarez, Jorge; Fricovsky, Eduardo; Wang, Hong; Scott, Brian T.; Han, Wenlong; Hu, Ying; Oyeleye, Mary O.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Trauger, Sunia A.] Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Dillmann, WH (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wdillmann@ucsd.edu		Scott, Brian/0000-0002-1321-7204; Trauger, Sunia/0000-0002-1678-8715	NHLBI, National Institutes of Health [HL-66917]; San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health [P60 MD00220]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066917] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL-66917 (to W. H. D.) and by Grant Number P60 MD00220, from the San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belke DD, 2007, AM J PHYSIOL-HEART C, V292, pH1755, DOI 10.1152/ajpheart.00884.2006; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; BHIMJI S, 1986, ACTA ANAT, V125, P195; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chretien D, 2003, BIOCHEM BIOPH RES CO, V301, P222, DOI 10.1016/S0006-291X(02)03016-4; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Davidoff AJ, 1997, AM J PHYSIOL-HEART C, V272, pH159, DOI 10.1152/ajpheart.1997.272.1.H159; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartong R, 1996, J MOL CELL CARDIOL, V28, P2467, DOI 10.1006/jmcc.1996.0239; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hollander JM, 2003, FREE RADICAL BIO MED, V35, P742, DOI 10.1016/S0891-5849(03)00400-3; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HOLT GD, 1986, J BIOL CHEM, V261, P8049; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	39	174	180	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					547	555		10.1074/jbc.M808518200	http://dx.doi.org/10.1074/jbc.M808518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004814	Green Published, hybrid			2022-12-25	WOS:000261974800060
J	Okroj, M; Mark, L; Stokowska, A; Wong, SW; Rose, N; Blackbourn, DJ; Villoutreix, BO; Spiller, OB; Blom, AM				Okroj, Marcin; Mark, Linda; Stokowska, Anna; Wong, Scott W.; Rose, Nicola; Blackbourn, David J.; Villoutreix, Bruno O.; Spiller, O. Brad; Blom, Anna M.			Characterization of the Complement Inhibitory Function of Rhesus Rhadinovirus Complement Control Protein (RCP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CHARGED AMINO-ACIDS; FACTOR-I; IMMUNE EVASION; BINDING SITES; HEPARIN; SEQUENCE; KCP; IMMUNOLOGY; MACAQUES	Rhesus rhadinovirus (RRV) is currently the closest known, fully sequenced homolog of human Kaposi sarcoma-associated herpesvirus. Both these viruses encode complement inhibitors as follows: Kaposi sarcoma-associated herpesvirus-complement control protein (KCP) and RRV-complement control protein (RCP). Previously we characterized in detail the functional properties of KCP as a complement inhibitor. Here, we performed comparative analyses for two variants of RCP protein, encoded by RRV strains H26-95 and 17577. Both RCP variants and KCP inhibited human and rhesus complement when tested in hemolytic assays measuring all steps of activation via the classical and the alternative pathway. RCP variants from both RRV strains supported C3b and C4b degradation by factor I and decay acceleration of the classical C3 convertase, similar to KCP. Additionally, the 17577 RCP variant accelerated decay of the alternative C3 convertase, which was not seen for KCP. In contrast to KCP, RCP showed no affinity to heparin and is the first described complement inhibitor in which the binding site for C3b/C4b does not interact with heparin. Molecular modeling shows a structural disruption in the region of RCP that corresponds to the KCP-heparin-binding site. This makes RRV a superior model for future in vivo investigations of complement evasion, as RCP does not play a supportive role in viral attachment as KCP does.	[Okroj, Marcin; Mark, Linda; Stokowska, Anna; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo Univ Hosp, S-20502 Malmo, Sweden; [Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Rose, Nicola] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Blackbourn, David J.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM MTi, F-75013 Paris, France; [Spiller, O. Brad] Cardiff Univ, Wales Sch Med, Dept Child Hlth, Cardiff CF14 4XN, S Glam, Wales	Lund University; Skane University Hospital; Oregon Health & Science University; National Institute for Biological Standards & Control; Cancer Research UK; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cardiff University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, MAS, Entrance 46,Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Villoutreix, Bruno/I-4565-2015; Rose, Nicola/E-9366-2013; Blom, Anna/AFS-7369-2022; Spiller, Owen Brad/AAC-2474-2020; Blom, Anna/B-9607-2009	Villoutreix, Bruno/0000-0002-6456-7730; Spiller, Owen Brad/0000-0002-9117-6911; Blom, Anna/0000-0002-1348-1734; Blackbourn, David/0000-0002-6703-4497	Cancerfonden; The Swedish Foundation for Strategic Research; Swedish Research Council; American Cancer Foundation; University Hospital in Malmo; The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg; The Tom Owen Bequest Fund; Cancer Research UK [C7934]; Medical Research Council [G0400408]; FEBS; MRC [G0400408] Funding Source: UKRI	Cancerfonden(Swedish Cancer Society); The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Foundation; University Hospital in Malmo; The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg; The Tom Owen Bequest Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FEBS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancerfonden, The Swedish Foundation for Strategic Research, Swedish Research Council, American Cancer Foundation, research grants from the University Hospital in Malmo r, The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg ( to A. M. B.), The Tom Owen Bequest Fund ( to O. B. S.), and Cancer Research UK Grant C7934 and the Medical Research Council Grant G0400408 ( to D. J. B.), and a FEBS short term fellowship ( to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2007, ADV EXP MED BIOL, V598, P105; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; COOPER NR, 1984, J INVEST DERMATOL, V83, pS121, DOI 10.1111/1523-1747.ep12281847; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; Ensser A, 2005, ADV CANCER RES, V93, P91, DOI 10.1016/S0065-230X(05)93003-0; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Judson KA, 2003, J VIROL, V77, P12639, DOI 10.1128/JVI.77.23.12639-12645.2003; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Krushkal J, 2000, MOL BIOL EVOL, V17, P1718, DOI 10.1093/oxfordjournals.molbev.a026270; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Liszewski MK, 2006, J IMMUNOL, V176, P3725, DOI 10.4049/jimmunol.176.6.3725; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Mansfield KG, 1999, J VIROL, V73, P10320, DOI 10.1128/JVI.73.12.10320-10328.1999; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; Mark L, 2004, J BIOL CHEM, V279, P45093, DOI 10.1074/jbc.M407558200; Mark L, 2007, MOL IMMUNOL, V44, P11, DOI 10.1016/j.molimm.2006.06.018; Mark L, 2007, J VIROL, V81, P4166, DOI 10.1128/JVI.02069-06; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; O'Connor CM, 2006, J VIROL, V80, P1574, DOI 10.1128/JVI.80.3.1574-1583.2006; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Okroj M, 2007, VACCINE, V25, P8102, DOI 10.1016/j.vaccine.2007.09.046; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Ruppert J, 1997, PROTEIN SCI, V6, P524; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Spiller OB, 2006, J VIROL, V80, P4068, DOI 10.1128/JVI.80.8.4068-4078.2006; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wong SW, 1999, J EXP MED, V190, P827, DOI 10.1084/jem.190.6.827	40	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					505	514		10.1074/jbc.M806669200	http://dx.doi.org/10.1074/jbc.M806669200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990693	hybrid			2022-12-25	WOS:000261974800055
J	Gleitsman, KR; Kedrowski, SMA; Lester, HA; Dougherty, DA				Gleitsman, Kristin Rule; Kedrowski, Sean M. A.; Lester, Henry A.; Dougherty, Dennis A.			An Intersubunit Hydrogen Bond in the Nicotinic Acetylcholine Receptor That Contributes to Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE DISULFIDE; UNNATURAL AMINO-ACIDS; IN-VIVO INCORPORATION; AGONIST BINDING; DELTA-SUBUNIT; ANGSTROM RESOLUTION; ION CHANNELS; ACH-BINDING; M2 DOMAIN; RESIDUES	The muscle nicotinic acetylcholine receptor is a large, allosteric, ligand-gated ion channel with the subunit composition alpha(2)beta gamma delta. Although much is now known about the structure of the binding site, relatively little is understood about how the binding event is communicated to the channel gate, causing the pore to open. Here we identify a key hydrogen bond near the binding site that is involved in the gating pathway. Using mutant cycle analysis with the novel unnatural residue alpha-hydroxyserine, we find that the backbone N-H of alpha Ser-191 in loop C makes a hydrogen bond to an anionic side chain of the complementary subunit upon agonist binding. However, the anionic partner is not the glutamate predicted by the crystal structures of the homologous acetylcholine-binding protein. Instead, the hydrogen-bonding partner is the extensively researched aspartate gamma Asp-174/delta Asp-180, which had originally been identified as a key binding residue for cationic agonists.	[Gleitsman, Kristin Rule; Kedrowski, Sean M. A.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health Grants [NS 34407, NS 11756]; National Science Foundation; National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R01NS011756, R37NS034407] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 and NS 11756. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Partially supported by a National Science Foundation graduate research fellowship.; Partially supported by a National Research Service Award training grant.	Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; England PM, 1999, TETRAHEDRON LETT, V40, P6189, DOI 10.1016/S0040-4039(99)01300-3; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LAGANIS ED, 1984, TETRAHEDRON LETT, V25, P5831, DOI 10.1016/S0040-4039(01)81697-X; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; Martin MD, 1997, BIOCHEMISTRY-US, V36, P10742, DOI 10.1021/bi970896t; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MU T, 2006, THESIS CALIFORNIA I; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VENKATACHALAN SP, 2008, P NATL ACAD SCI US; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	34	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35638	35643		10.1074/jbc.M807226200	http://dx.doi.org/10.1074/jbc.M807226200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952603	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000261687900037
J	Etzel, JA; Gazzola, V; Keysers, C				Etzel, Joset A.; Gazzola, Valeria; Keysers, Christian			Testing Simulation Theory with Cross-Modal Multivariate Classification of fMRI Data	PLOS ONE			English	Article								The discovery of mirror neurons has suggested a potential neural basis for simulation and common coding theories of action perception, theories which propose that we understand other people's actions because perceiving their actions activates some of our neurons in much the same way as when we perform the actions. We propose testing this model directly in humans with functional magnetic resonance imaging (fMRI) by means of cross-modal classification. Cross-modal classification evaluates whether a classifier that has learned to separate stimuli in the sensory domain can also separate the stimuli in the motor domain. Successful classification provides support for simulation theories because it means that the fMRI signal, and presumably brain activity, is similar when perceiving and performing actions. In this paper we demonstrate the feasibility of the technique by showing that classifiers which have learned to discriminate whether a participant heard a hand or a mouth action, based on the activity patterns in the premotor cortex, can also determine, without additional training, whether the participant executed a hand or mouth action. This provides direct evidence that, while perceiving others' actions, (1) the pattern of activity in premotor voxels with sensory properties is a significant source of information regarding the nature of these actions, and (2) that this information shares a common code with motor execution.	[Etzel, Joset A.; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands	University of Groningen	Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	j.a.etzel@med.umcg.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619	Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI; European Commission [Marie Curie Excellence]	Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI; European Commission(European CommissionEuropean Commission Joint Research Centre)	The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Oderzoek VIDI and a Marie Curie Excellence grant of the European Commission to C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bennett K., 2000, SIGKDD EXPLORATIONS, V2, P1, DOI DOI 10.1145/380995.380999; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; DAMASIO AR, 1994, DESCARTES ERROR EMOT, pR19; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; EDGINGTON ES, 1995, RANDOMIZATION TESTS, pR22; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; MUKHERJEE S, 2003, 2003019 MIT COMP SCI; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oouchida Y, 2004, NEUROREPORT, V15, P2019, DOI 10.1097/00001756-200409150-00005; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; R Development Core Team, 2006, R LANG ENV STAT COMP; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	46	83	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3690	10.1371/journal.pone.0003690	http://dx.doi.org/10.1371/journal.pone.0003690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997869	gold, Green Published, Green Submitted			2022-12-25	WOS:000265165500013
J	Ghisovan, N; Nemri, A; Shumikhina, S; Molotchnikoff, S				Ghisovan, Narcis; Nemri, Abdellatif; Shumikhina, Svetlana; Molotchnikoff, Stephane			Visual Cells Remember Earlier Applied Target: Plasticity of Orientation Selectivity	PLOS ONE			English	Article								Background: A canonical proposition states that, in mature brain, neurons responsive to sensory stimuli are tuned to specific properties installed shortly after birth. It is amply demonstrated that that neurons in adult visual cortex of cats are orientation-selective that is they respond with the highest firing rates to preferred oriented stimuli. Methodology/Principal Findings: In anesthetized cats, prepared in a conventional fashion for single cell recordings, the present investigation shows that presenting a stimulus uninterruptedly at a non-preferred orientation for twelve minutes induces changes in orientation preference. Across all conditions orientation tuning curves were investigated using a trial by trial method. Contrary to what has been previously reported with shorter adaptation duration, twelve minutes of adaptation induces mostly attractive shifts, i. e. toward the adapter. After a recovery period allowing neurons to restore their original orientation tuning curves, we carried out a second adaptation which produced three major results: (1) more frequent attractive shifts, (2) an increase of their magnitude, and (3) an additional enhancement of responses at the new or acquired preferred orientation. Additionally, we also show that the direction of shifts depends on the duration of the adaptation: shorter adaptation in most cases produces repulsive shifts, whereas adaptation exceeding nine minutes results in attractive shifts, in the same unit. Consequently, shifts in preferred orientation depend on the duration of adaptation. Conclusion/Significance: The supplementary response improvements indicate that neurons in area 17 keep a memory trace of the previous stimulus properties, thereby upgrading cellular performance. It also highlights the dynamic nature of basic neuronal properties in adult cortex since repeated adaptations modified both the orientation tuning selectivity and the response strength to the preferred orientation. These enhanced neuronal responses suggest that the range of neuronal plasticity available to the visual system is broader than anticipated.	[Ghisovan, Narcis; Nemri, Abdellatif; Shumikhina, Svetlana; Molotchnikoff, Stephane] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada	Universite de Montreal	Ghisovan, N (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	stephane.molotchnikoff@umontreal.ca	Shumikhina, Svetlana/AAC-3533-2022	/0000-0003-3044-8730; Nemri, Abdellatif/0000-0003-1459-5634	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bex PJ, 1999, PERCEPT PSYCHOPHYS, V61, P1066, DOI 10.3758/BF03207614; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BOUCHARD M, 2008, EXP BRAIN R IN PRESS; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Ghisovan N, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-60; HENRY GH, 1974, VISION RES, V14, P767, DOI 10.1016/0042-6989(74)90141-2; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; HENRY GH, 1978, EXP BRAIN RES, V32, P245; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Ibbotson M. R., 2005, FITTING MIND WORLD A, P17; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Krekelberg B, 2006, J NEUROPHYSIOL, V95, P255, DOI 10.1152/jn.00750.2005; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mather G., 1998, MOTION AFTEREFFECT M; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; NELSON SB, 1991, J NEUROSCI, V11, P357; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; ORBAN GA, 1981, J NEUROPHYSIOL, V45, P1043, DOI 10.1152/jn.1981.45.6.1043; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Sabatini BL, 2007, NATURE, V450, P1173, DOI 10.1038/4501173a; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; VIDYASAGAR TR, 1990, NEUROSCIENCE, V36, P175, DOI 10.1016/0306-4522(90)90360-G	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2008	3	11							e3689	10.1371/journal.pone.0003689	http://dx.doi.org/10.1371/journal.pone.0003689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WR	18997867	gold, Green Submitted, Green Published			2022-12-25	WOS:000265165500012
J	Saint-Geniez, M; Maharaj, ASR; Walshe, TE; Tucker, BA; Sekiyama, E; Kurihara, T; Darland, DC; Young, MJ; D'Amore, PA				Saint-Geniez, Magali; Maharaj, Arindel S. R.; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Kurihara, Tomoki; Darland, Diane C.; Young, Michael J.; D'Amore, Patricia A.			Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Muller Cells and Photoreceptors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; FIBRILLARY ACIDIC PROTEIN; TGF-BETA; IN-VITRO; IMMUNOCYTOCHEMICAL LOCALIZATION; INTRAVITREAL BEVACIZUMAB; VASCULAR-PERMEABILITY; CHOROIDAL ISCHEMIA; PROLONGS SURVIVAL	Background: Vascular endothelial growth factor ( VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical. Methods and Findings: Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Muller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Muller cell line in vitro supports the existence of an autocrine role for VEGF in Muller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective. Conclusions: These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.	[Saint-Geniez, Magali; Maharaj, Arindel S. R.; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Kurihara, Tomoki; Young, Michael J.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA; [Saint-Geniez, Magali; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Young, Michael J.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; [Darland, Diane C.] Univ N Dakota, Grand Forks, ND USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of North Dakota Grand Forks	Saint-Geniez, M (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA.	patricia.damore@schepens.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019; Walshe, Tony/AAJ-8833-2020; D'Amore, Patricia A/G-5660-2017	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; D'Amore, Patricia A/0000-0001-9652-8974; Tucker, Budd/0000-0003-2178-1742	NIH [EY05318, EY015435]; Core grant for Vision Research [P30EY14104]; NSF [R15 NSF057807]; Lincy Foundation; Discovery Eye Foundation; NSERC; NATIONAL EYE INSTITUTE [R01EY015435, P30EY014104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core grant for Vision Research; NSF(National Science Foundation (NSF)); Lincy Foundation; Discovery Eye Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH grant EY05318 and EY015435 to P.D and by the Core grant for Vision Research P30EY14104. ND-EPSCOR (NSF) and R15 NSF057807 to D.C.D, by the Lincy Foundation and Discovery Eye Foundation to M.Y. B.D. is supported by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brekken RA, 2000, CANCER RES, V60, P5117; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BRYAN BA, 2007, MOL BIOL CELL; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; COGAN DG, 1967, ARCH OPHTHALMOL-CHIC, V78, P133; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; DAMORE PA, 2007, AM J PATHOL; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Duh EJ, 2004, AM J OPHTHALMOL, V137, P668, DOI 10.1016/j.ajo.2003.11.015; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Famiglietti EV, 2003, BRAIN RES, V969, P195, DOI 10.1016/S0006-8993(02)03766-6; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Fontaine V, 1998, J NEUROSCI, V18, P9662; Fragoso R, 2007, LEUKEMIA LYMPHOMA, V48, P481, DOI 10.1080/10428190601064720; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 1998, AM J PATHOL, V152, P1453; Gilbert RE, 1998, LAB INVEST, V78, P1017; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim I, 1999, INVEST OPHTH VIS SCI, V40, P2115; KIM I, 2000, INVEST OPHTH VIS SCI, V41, P368; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Saito Y, 1998, RETINA-J RET VIT DIS, V18, P103, DOI 10.1097/00006982-199818020-00002; Sathish S, 2000, CLIN EXP OPHTHALMOL, V28, P387, DOI 10.1046/j.1442-9071.2000.00342.x; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Spandau UHM, 2006, AM J OPHTHALMOL, V142, P1068, DOI 10.1016/j.ajo.2006.06.048; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Stitt AW, 1998, J PATHOL, V186, P306, DOI 10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Tilton RG, 1997, J CLIN INVEST, V99, P2192, DOI 10.1172/JCI119392; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; VECINO E, 1998, UNDERSTANDING GLIA, P103; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinores SA, 2001, HISTOL HISTOPATHOL, V16, P1061, DOI 10.14670/HH-16.1061; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Weinberger AWA, 2007, AM J OPHTHALMOL, V144, P294, DOI 10.1016/j.ajo.2007.03.024; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375	83	487	505	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3554	10.1371/journal.pone.0003554	http://dx.doi.org/10.1371/journal.pone.0003554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978936	gold, Green Published, Green Submitted			2022-12-25	WOS:000265134200001
J	Puppo, A; Chun, JT; Gragnaniello, G; Garante, E; Santella, L				Puppo, A.; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			Alteration of the Cortical Actin Cytoskeleton Deregulates Ca2+ Signaling, Monospermic Fertilization, and Sperm Entry	PLOS ONE			English	Article								Background: When preparing for fertilization, oocytes undergo meiotic maturation during which structural changes occur in the endoplasmic reticulum (ER) that lead to a more efficient calcium response. During meiotic maturation and subsequent fertilization, the actin cytoskeleton also undergoes dramatic restructuring. We have recently observed that rearrangements of the actin cytoskeleton induced by actin-depolymerizing agents, or by actin-binding proteins, strongly modulate intracellular calcium (Ca2+) signals during the maturation process. However, the significance of the dynamic changes in F-actin within the fertilized egg has been largely unclear. Methodology/Principal Findings: We have measured changes in intracellular Ca2+ signals and F-actin structures during fertilization. We also report the unexpected observation that the conventional antagonist of the InsP(3) receptor, heparin, hyperpolymerizes the cortical actin cytoskeleton in postmeiotic eggs. Using heparin and other pharmacological agents that either hypo- or hyperpolymerize the cortical actin, we demonstrate that nearly all aspects of the fertilization process are profoundly affected by the dynamic restructuring of the egg cortical actin cytoskeleton. Conclusions/Significance: Our findings identify important roles for subplasmalemmal actin fibers in the process of sperm-egg interaction and in the subsequent events related to fertilization: the generation of Ca2+ signals, sperm penetration, cortical granule exocytosis, and the block to polyspermy.	[Puppo, A.; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Stn Zool A Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Puppo, A (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	santella@szn.it	Santella, Luigia/AAM-3524-2020; Chun, Jong Tai/AAM-3394-2020	Santella, Luigia/0000-0001-7159-0499; Chun, Jong Tai/0000-0002-6070-4953	Regione di Campania	Regione di Campania	This work was partly supported by Regione di Campania Research Grant to L.S. The funder had no roles in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boyle JA, 2001, ZYGOTE, V9, P167, DOI 10.1017/S0967199401001186; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Calaghan SC, 2004, PROG BIOPHYS MOL BIO, V84, P29, DOI 10.1016/S0079-6107(03)00057-9; Carafoli E, 2004, TRENDS BIOCHEM SCI, V29, P371, DOI 10.1016/j.tibs.2004.05.006; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chun JT, 2007, N COMP BIOC, V41, P425; CLINE CA, 1983, CELL MOTIL CYTOSKEL, V3, P513, DOI 10.1002/cm.970030518; DALE B, 1981, EXP CELL RES, V132, P505, DOI 10.1016/0014-4827(81)90132-4; DALE B, 1981, GAMETE RES, V4, P151, DOI 10.1002/mrd.1120040209; DAN JC, 1954, BIOL BULL, V107, P203, DOI 10.2307/1538607; Ducibella T, 2008, DEV BIOL, V315, P257, DOI 10.1016/j.ydbio.2007.12.012; Eliyahu E, 2005, REPRODUCTION, V129, P161, DOI 10.1530/rep.1.00424; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; FUJIMOTO T, 1995, J CELL SCI, V108, P7; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; Giusti AF, 2000, ZYGOTE, V8, pS16; IKADAI H, 1981, DEV GROWTH DIFFER, V23, P73; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Kuroda R, 2001, DEVELOPMENT, V128, P4405; KYOZUKA K, 1988, GAMETE RES, V20, P275, DOI 10.1002/mrd.1120200304; Lange K, 1999, J CELL PHYSIOL, V180, P19, DOI 10.1002/(SICI)1097-4652(199907)180:1<19::AID-JCP3>3.0.CO;2-K; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; McAvey BA, 2002, BIOL REPROD, V67, P1342, DOI 10.1095/biolreprod67.4.1342; MEIJER L, 1984, INT REV CYTOL, V86, P129, DOI 10.1016/S0074-7696(08)60179-5; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Miyata K, 2006, DEV GROWTH DIFFER, V48, P605, DOI 10.1111/j.1440-169x.2006.00896.x; MIYAZAKI S, 1979, DEV BIOL, V70, P327, DOI 10.1016/0012-1606(79)90031-9; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MOHRI T, 1995, DEV BIOL, V172, P139, DOI 10.1006/dbio.1995.0011; NUCCITELLI R, 1993, DEV BIOL, V158, P200, DOI 10.1006/dbio.1993.1179; Nusco GA, 2002, BIOCHEM BIOPH RES CO, V290, P1015, DOI 10.1006/bbrc.2001.6286; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Parrington J, 2007, DEV DYNAM, V236, P2027, DOI 10.1002/dvdy.21255; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; RAKOW TL, 1990, P NATL ACAD SCI USA, V87, P9285, DOI 10.1073/pnas.87.23.9285; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Sabala P, 2002, BIOCHEM BIOPH RES CO, V296, P484, DOI 10.1016/S0006-291X(02)00893-8; Sanchez-Gutierrez M, 2002, MOL REPROD DEV, V63, P518, DOI 10.1002/mrd.10203; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SARDET C, 1992, DEV GROWTH DIFFER, V34, P37; Schuel H., 1985, BIOL FERTILIZATION, V3, P1; SELDEN LA, 1987, FEBS LETT, V217, P89, DOI 10.1016/0014-5793(87)81249-8; SHEN SS, 1993, DEV BIOL, V157, P157, DOI 10.1006/dbio.1993.1120; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; STRICKER SA, 1994, DEV BIOL, V166, P34, DOI 10.1006/dbio.1994.1295; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; Terada Y, 2000, MOL REPROD DEV, V56, P89, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;89::AID-MRD11&gt;3.0.CO;2-I; Thaler CD, 2004, DEV GROWTH DIFFER, V46, P413, DOI 10.1111/j.1440-169x.2004.00758.x; TILNEY LG, 1980, J CELL BIOL, V87, P771, DOI 10.1083/jcb.87.3.771; Turvey MR, 2005, J CELL SCI, V118, P971, DOI 10.1242/jcs.01693; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; WEHLAND J, 1977, P NATL ACAD SCI USA, V74, P5613, DOI 10.1073/pnas.74.12.5613; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	67	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3588	10.1371/journal.pone.0003588	http://dx.doi.org/10.1371/journal.pone.0003588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974786	Green Published, gold, Green Submitted			2022-12-25	WOS:000265131500012
J	Bebas, P; Goodall, CP; Majewska, M; Neumann, A; Giebultowicz, JM; Chappell, PE				Bebas, Piotr; Goodall, Cheri P.; Majewska, Magda; Neumann, Adam; Giebultowicz, Jadwiga M.; Chappell, Patrick E.			Circadian clock and output genes are rhythmically expressed in extratesticular ducts and accessory organs of mice	FASEB JOURNAL			English	Article						V-ATPase; carbonic anhydrase; prostate; sperm maturation; testis	MALE REPRODUCTIVE-TRACT; CARBONIC-ANHYDRASE-II; ADULT-RAT EPIDIDYMIS; PERIPHERAL-TISSUES; V-ATPASE; SPODOPTERA-LITTORALIS; ANDROGEN REGULATION; COTTON LEAFWORM; CONSTANT LIGHT; SPERM RELEASE	Circadian clocks regulate multiple rhythms in mammalian tissues. In most organs core clock gene expression is oscillatory, with negative components Per and Cry peaking in antiphase to Bmal1. A notable exception is the testis, where clock genes seem non-rhythmic. Earlier mammalian studies, however, did not examine clock expression patterns in accessory ductal tissue required for sperm maturation and transport. Previous studies in insects demonstrated control of sperm maturation in vas deferens by a local circadian system. Sperm ducts express clock genes and display circadian pH changes controlled by vacuolar-type H+-ATPase and carbonic anhydrase (CA-II). It is unknown whether sperm-processing rhythms are conserved beyond insects. To address this question in mice housed in a light-dark environment, we examined temporal patterns of mPer1 and Bmal1 gene expression and protein abundance in epididymis, vas deferens, seminal vesicles, and prostate. Results demonstrate variable tissue-specific patterns of expression of the two genes, with variations in levels of clock proteins and their nucleo-cytoplasmic cycling observed among examined tissues. Strikingly, mPer1 and Bmal1 mRNA and proteins oscillate in antiphase in the prostate, with similar peak-trough patterns as observed in the suprachiasmatic nuclei, the brain's central clock. Genes encoding CA and a V-ATPase subunit, which are rhythmically expressed in sperm ducts of moths, are also rhythmic in some segments of murine sperm ducts. Our data suggest that some sperm duct segments may contain peripheral circadian systems whereas others may express clock genes in a pleiotropic manner. - Bebas, P., Goodall, C. P., Majewska, M., Neumann, A., Giebultowicz, J. M., Chappell, P. E. Circadian clock and output genes are rhythmically expressed in extratesticular ducts and accessory organs of mice. FASEB J. 23, 523-533 (2009)	[Bebas, Piotr; Goodall, Cheri P.; Majewska, Magda; Giebultowicz, Jadwiga M.; Chappell, Patrick E.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Bebas, Piotr; Neumann, Adam] Univ Warsaw, Dept Anim Physiol, Fac Biol, Warsaw, Poland	Oregon State University; University of Warsaw	Chappell, PE (corresponding author), Oregon State Univ, Dept Zool, Cordley Hall 3029, Corvallis, OR 97331 USA.	patrick.chappell@science.oregonstate.edu		Bebas, Piotr/0000-0003-2956-5892	National Institutes of Health-National Institute of General Medical Studies (NIH-NIGMS) [GM073792]; Polish Science Foundation (MNiSzW) [NN303342235]; NIH [R01 DK075357, K01 DK064919]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073792] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of General Medical Studies (NIH-NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Polish Science Foundation (MNiSzW)(Foundation for Polish Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David Weaver (University of Massachusetts Medical School, Worcester, MA, USA) for the gift of anti-mPER1 antibody, antigen, and tissues of mPER1 K/O mice. This research was supported by National Institutes of Health-National Institute of General Medical Studies (NIH-NIGMS) grant GM073792 to J.M.G., Polish Science Foundation (MNiSzW) grant NN303342235 to P.B., and NIH grants R01 DK075357 and K01 DK064919 to P.E.C.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Bebas P, 1999, PHYSIOL ENTOMOL, V24, P165, DOI 10.1046/j.1365-3032.1999.00127.x; Bebas P, 2002, J EXP BIOL, V205, P37; Bebas P, 2002, BMC Physiol, V2, P15, DOI 10.1186/1472-6793-2-15; Bebas P, 2001, J INSECT PHYSIOL, V47, P859, DOI 10.1016/S0022-1910(01)00058-0; Bebas P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-64; Bittman EL, 2003, AM J PHYSIOL-REG I, V285, pR561, DOI 10.1152/ajpregu.00783.2002; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Breton S, 2001, JOP, V2, P159; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 1998, AM J PHYSIOL-CELL PH, V275, pC1134, DOI 10.1152/ajpcell.1998.275.4.C1134; Brown D, 1997, J EXP BIOL, V200, P257; Chappell PE, 2003, J NEUROSCI, V23, P11202; Davidson Alec J, 2003, Novartis Found Symp, V253, P110; Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Giebultowicz JM, 1996, J COMP PHYSIOL A, V178, P629, DOI 10.1007/BF00227376; GIEBULTOWICZ JM, 1990, PHYSIOL ENTOMOL, V15, P149, DOI 10.1111/j.1365-3032.1990.tb00502.x; GIEBULTOWICZ JM, 1989, SCIENCE, V245, P1098, DOI 10.1126/science.245.4922.1098; HARKONEN PL, 1988, BIOL REPROD, V38, P377, DOI 10.1095/biolreprod38.2.377; He PJ, 2007, J ENDOCRINOL, V194, P511, DOI 10.1677/JOE-07-0172; Herak-Kramberger CM, 2001, BIOL REPROD, V64, P1699, DOI 10.1095/biolreprod64.6.1699; Hermo L, 2005, J HISTOCHEM CYTOCHEM, V53, P699, DOI 10.1369/jhc.4A6575.2005; HOFFMANN K, 1977, ACTA ENDOCRINOL-COP, V86, P193, DOI 10.1530/acta.0.0860193; Karman BN, 2006, BIOL REPROD, V75, P624, DOI 10.1095/biolreprod.106.050732; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; Ko GYP, 2004, BRAIN RES, V1021, P277, DOI 10.1016/j.brainres.2004.05.072; Kotwica J, 2006, J PHYSIOL PHARMACOL, V57, P107; Lambert CM, 2006, J BIOL RHYTHM, V21, P77, DOI 10.1177/0748730405281843; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Mewe M, 2006, ENDOCRINOLOGY, V147, P2051, DOI 10.1210/en.2005-1324; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; Tong YH, 2004, J BIOL RHYTHM, V19, P113, DOI 10.1177/0748730403262871; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WINTERS SJ, 1991, ENDOCRINOLOGY, V129, P1755, DOI 10.1210/endo-129-4-1755; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	52	39	41	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					523	533		10.1096/fj.08-113191	http://dx.doi.org/10.1096/fj.08-113191			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18945877	Green Published			2022-12-25	WOS:000262892900024
J	Sakai, A; Cox, MM				Sakai, Akiko; Cox, Michael M.			RecFOR and RecOR as Distinct RecA Loading Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECF; REPLICATION PROTEIN-A; PHAGE-LAMBDA ORF; BINDING-PROTEIN; GENETIC-RECOMBINATION; SSB PROTEIN; GAPPED DNA; FILAMENTS; MUTATIONS	The molecular role of the RecF protein in loading RecA protein onto single-stranded DNA (ssDNA)-binding protein-coated ssDNA has been obscured by the facility with which the RecO and RecR proteins alone perform this function. We now show that RecFOR and RecOR define distinct RecA loading functions that operate optimally in different contexts. RecFOR, but not RecOR, is most effective when RecF( R) is bound near an ssDNA/double-stranded ( dsDNA) junction. However, RecF( R) has no enhanced binding affinity for such a junction. RecO and RecR proteins are both required under all conditions in which the RecFOR pathway operates. The RecOR pathway is uniquely distinguished by a required interaction between RecO protein and the ssDNA binding protein C terminus. The RecOR pathway is more efficient for RecA loading onto ssDNA when no proximal dsDNA is available. A merger of new and published results leads to a new model for RecFOR function.	[Sakai, Akiko; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@Biochem.wisc.edu	SAKAI, AKIKO/AAC-9814-2020	SAKAI, AKIKO/0000-0002-1258-1725	National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 (NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO JC, 1993, J BIOL CHEM, V268, P1424; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DEFAIS M, 2000, ENCY LIFE SCI; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Grompone G, 2004, MOL MICROBIOL, V52, P551, DOI 10.1111/j.1365-2958.2004.03997.x; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOLODNER R, 1985, J BACTERIOL, V163, P1060, DOI 10.1128/JB.163.3.1060-1066.1985; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LAVERY PE, 1988, J MOL BIOL, V203, P861, DOI 10.1016/0022-2836(88)90112-X; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P55073, DOI 10.1074/jbc.M410371200; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; MADIRAJU MVVS, 1992, BIOCHEMISTRY-US, V31, P10529, DOI 10.1021/bi00158a016; MAHDI AA, 1989, NUCLEIC ACIDS RES, V17, P6781, DOI 10.1093/nar/17.17.6781; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Sandler SJ, 1996, GENETICS, V143, P5; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; SAWITZKE JA, 1992, GENETICS, V130, P7; SAWITZKE JA, 1994, J BACTERIOL, V176, P6730, DOI 10.1128/JB.176.21.6730-6737.1994; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SMITH GR, 1989, GENOME, V31, P520, DOI 10.1139/g89-100; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; Wernegreen JJ, 2000, J BACTERIOL, V182, P3867, DOI 10.1128/JB.182.13.3867-3869.2000; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680	71	60	64	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3264	3272		10.1074/jbc.M807220200	http://dx.doi.org/10.1074/jbc.M807220200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18986990	Green Published, hybrid			2022-12-25	WOS:000262700900069
J	Boissonneault, V; Plante, I; Rivest, S; Provost, P				Boissonneault, Vincent; Plante, Isabelle; Rivest, Serge; Provost, Patrick			MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse beta-Amyloid Precursor Protein-converting Enzyme 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; HUMAN DICER; RNASE-III; BACE1; IDENTIFICATION; BRAIN; THERAPEUTICS; HIPPOCAMPUS	MicroRNAs (miRNAs) are key regulatory RNAs known to repress mRNA translation through recognition of specific binding sites located mainly in their 3'-untranslated region (UTR). Loss of specific miRNA control of gene expression is thus expected to underlie serious genetic diseases. Intriguingly, previous post-mortem analyses showed higher beta-amyloid precursor protein-converting enzyme (BACE) protein, but not mRNA, levels in the brain of patients that suffered from Alzheimer disease (AD). Here we also observed a loss of correlation between BACE1 mRNA and protein levels in the hippocampus of a mouse model of AD. Consistent with an impairment of miRNA-mediated regulation of BACE1 expression, these findings prompted us to investigate the regulatory role of the BACE1 3'-UTR element and the possible involvement of specific miRNAs in cultured neuronal (N2a) and fibroblastic (NIH 3T3) cells. Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and miR-328 recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells. Our results may provide the molecular basis underlying BACE1 deregulation in AD and offer new perspectives on the etiology of this neurological disorder.	[Boissonneault, Vincent; Plante, Isabelle; Provost, Patrick] Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Boissonneault, Vincent; Plante, Isabelle; Rivest, Serge; Provost, Patrick] Univ Laval, Fac Med, Dept Anat & Physiol, Quebec City, PQ G1V 0A6, Canada; [Rivest, Serge] Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Mol Endocrinol Lab, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Provost, P (corresponding author), Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Ctr Rech Rhumatol & Immunol, 2705 Blvd Laurier,Local T1-49, Quebec City, PQ G1V 4G2, Canada.	patrick.provost@crchul.ulaval.ca	Provost, Patrick/G-2786-2010	Provost, Patrick/0000-0002-6099-6562; Rivest, Serge/0000-0002-6082-770X	NARSAD; The World's Leading Charity Dedicated to Mental Health Research	NARSAD(NARSAD); The World's Leading Charity Dedicated to Mental Health Research	This work was supported by NARSAD, The World's Leading Charity Dedicated to Mental Health Research, young investigator award ( to P. P.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ouellet DL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69616; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/16806; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; WHITEHOUSE PJ, 1985, CRC CR REV CL NEUROB, V1, P319; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	44	238	254	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1971	1981		10.1074/jbc.M807530200	http://dx.doi.org/10.1074/jbc.M807530200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18986979	hybrid, Green Accepted			2022-12-25	WOS:000262545600004
J	Li, CM; Chan, J; Haeseleer, F; Mikoshiba, K; Palczewski, K; Ikura, M; Ames, JB				Li, Congmin; Chan, Jenny; Haeseleer, Franciose; Mikoshiba, Katsuhiko; Palczewski, Krzysztof; Ikura, Mitsuhiko; Ames, James B.			Structural Insights into Ca2+-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptors by CaBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN-1; CHEMICAL-SHIFT ASSIGNMENTS; CA2+ RELEASE CHANNELS; CRYSTAL-STRUCTURE; CA2+-BINDING PROTEIN-1; CONFORMATIONAL-CHANGES; TROPONIN-C; CALMODULIN; LIGAND; DOMAIN	Calcium-binding protein 1 (CaBP1), a neuron-specific member of the calmodulin (CaM) superfamily, modulates Ca2+-dependent activity of inositol 1,4,5-trisphosphate receptors (InsP(3)Rs). Here we present NMR structures of CaBP1 in both Mg2+-bound and Ca2+-bound states and their structural interaction with InsP(3)Rs. CaBP1 contains four EF-hands in two separate domains. The N-domain consists of EF1 and EF2 in a closed conformation with Mg2+-bound at EF1. The C-domain binds Ca2+ at EF3 and EF4, and exhibits a Ca2+-induced closed to open transition like that of CaM. The Ca2+-bound C-domain contains exposed hydrophobic residues (Leu(132), His(134), Ile(141), Ile(144), and Val(148)) that may account for selective binding to InsP(3)Rs. Isothermal titration calorimetry analysis reveals a Ca2+-induced binding of the CaBP1 C-domain to the N-terminal region of InsP(3)R (residues 1-587), whereas CaM and the CaBP1 N-domain did not show appreciable binding. CaBP1 binding to InsP(3)Rs requires both the suppressor and ligand-binding core domains, but has no effect on InsP(3) binding to the receptor. We propose that CaBP1 may regulate Ca2+-dependent activity of InsP(3)Rs by promoting structural contacts between the suppressor and core domains.	[Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Haeseleer, Franciose] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Brain Dev Res Grp, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Washington; University of Washington Seattle; RIKEN; Case Western Reserve University	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Mikoshiba, Katsuhiko/N-7943-2015	Ikura, Mitsuhiko/0000-0002-9524-1303	National Institutes of Health [EY012347, NS045909, RR11973]; Canadian Institutes of Health Research and the Canada Foundation for Innovation; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969, R01NS045909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research and the Canada Foundation for Innovation(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS045909 (to J.B.A.). This work was also supported by Grant RR11973 to the University of California Davis NMR Facility from the National Institutes of Health, the Canadian Institutes of Health Research and the Canada Foundation for Innovation (to M. I.), and a fellowship from the Canadian Institutes of Health Research (to J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; Andersson M, 1997, PROTEIN SCI, V6, P1139, DOI 10.1002/pro.5560060602; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Chang SL, 2003, J AM CHEM SOC, V125, P11379, DOI 10.1021/ja034064w; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; COX JA, 1994, J BIOL CHEM, V269, P32807; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Finley NL, 2004, BIOCHEMISTRY-US, V43, P11371, DOI 10.1021/bi049672i; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Li CM, 2007, BIOMOL NMR ASSIGM, V1, P77, DOI 10.1007/s12104-007-9019-y; Li CM, 2008, BIOMOL NMR ASSIGN, V2, P61, DOI 10.1007/s12104-008-9085-9; Malmendal A, 1998, J BIOL CHEM, V273, P28994, DOI 10.1074/jbc.273.44.28994; Menger N, 1999, CELL TISSUE RES, V298, P21, DOI 10.1007/s004419900060; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; SCHWIETERS CD, 2003, J BIOL CHEM, V278, P37461; Seidenbecher CI, 2002, ADV EXP MED BIOL, V514, P451; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	57	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2472	2481		10.1074/jbc.M806513200	http://dx.doi.org/10.1074/jbc.M806513200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008222	Green Published, hybrid			2022-12-25	WOS:000262545600054
J	Thayaparasingham, B; Kunz, A; Peters, N; Kulms, D				Thayaparasingham, B.; Kunz, A.; Peters, N.; Kulms, D.			Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappa B-mediated downregulation of xIAP	ONCOGENE			English	Article						apoptosis; TRAIL; UVB; xIAP; NF-kappa B	X-LINKED INHIBITOR; INDUCED APOPTOSIS; MALIGNANT-MELANOMA; FLIP EXPRESSION; LIGAND; ACTIVATION; RESISTANCE; CASPASE-8; PROTEINS; MEMBER	Effective treatment of malignant melanoma with the tumor-selective death ligand tumor necrosis-related apoptosis-inducing ligand (TRAIL) is curtailed by the fact that many melanoma cell lines are a priori resistant against TRAIL-induced apoptosis. By investigating 18 melanoma cell lines, we show that TRAIL susceptibility is completely independent of the tumor progression stage but can be positively stimulated by co-exposure to a sublethal ultraviolet B light (UVB) dose, providing an excellent tool to study the mechanism underlying TRAIL resistance. TRAIL resistance could be linked to the ratio of x-linked inhibitor of apoptosis proteins (xIAP) and caspase-3 levels within the cell. UVB-induced sensitization coincides with enhanced xIAP degradation, allowing full caspase-3 processing and activation. It is also accompanied by concomitant I kappa B alpha degradation, resulting in nuclear factor-kappa B (NF-kappa B)-dependent transcriptional repression of xIAP. Loss of xIAP in turn was reduced upon overexpression of an I kappa B alpha super-repressor, thus NF-kappa B activation seems to be responsible for differential regulation of xIAP and consequently determines TRAIL susceptibility. As xIAP-mediated blockade of apoptosis seems to be the dominant cause of TRAIL resistance of all melanoma cell lines investigated here, our data suggest that direct chemical xIAP inhibition or combination treatment with DNA-damaging agents may offer new therapeutic strategies to generally sensitize melanoma toward TRAIL-induced apoptosis.	[Thayaparasingham, B.; Kunz, A.; Peters, N.; Kulms, D.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Stuttgart	Kulms, D (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	Dagmar.Kulms@izi.uni-stuttgart.de	Kulms, Dagmar/H-1653-2014		Deutsche Krebshilfe [106699]	Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Amgen/Genentech (Seattle, USA) for providing TRAIL antibodies. We are grateful to F Meier (Department of Dermato-Oncology, University of Tubingen) for providing melanoma cell lines and melanocytes, H Walczak (Tumour Immunology Unit, Imperial College London) for supplying iz-TRAIL and to H Kashkar (Institute for Medical Microbiology, University of Cologne) for the xIAP-pEGFPC3 construct. This study was funded by Deutsche Krebshilfe 106699.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Bullani RR, 2001, J INVEST DERMATOL, V117, P360, DOI 10.1046/j.0022-202x.2001.01418.x; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; CLARK WH, 1991, CANCER METAST REV, V10, P83, DOI 10.1007/BF00049406; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; ELDER DE, 1993, SEMIN DIAGN PATHOL, V10, P18; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Geserick P, 2008, ONCOGENE, V27, P3211, DOI 10.1038/sj.onc.1210985; Griffith TS, 1998, J IMMUNOL, V161, P2833; Jeremias I, 1998, EUR CYTOKINE NETW, V9, P687; Kashkar H, 2003, J EXP MED, V198, P341, DOI 10.1084/jem.20021279; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Kurbanov BM, 2005, J INVEST DERMATOL, V125, P1010, DOI 10.1111/j.0022-202X.2005.23900.x; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Lasithiotakis KG, 2006, CANCER-AM CANCER SOC, V107, P1331, DOI 10.1002/cncr.22126; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Meier F., 1998, FRONT BIOSCI J VIS L, V3, P1005, DOI [10.2741/a341, DOI 10.2741/A341]; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2004, LEUKEMIA, V18, P1578, DOI 10.1038/sj.leu.2403497; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Shi RX, 2005, CANCER RES, V65, P7815, DOI 10.1158/0008-5472.CAN-04-3875; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Strozyk E, 2006, ONCOGENE, V25, P6239, DOI 10.1038/sj.onc.1209655; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xiao C, 2005, EXP CELL RES, V304, P244, DOI 10.1016/j.yexcr.2004.11.002; Zeise E, 2004, J INVEST DERMATOL, V123, P746, DOI 10.1111/j.0022-202X.2004.23420.x; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084	54	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2009	28	3					345	362		10.1038/onc.2008.397	http://dx.doi.org/10.1038/onc.2008.397			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395UZ	18978816				2022-12-25	WOS:000262550300004
J	Shah, GV; Muralidharan, A; Gokulgandhi, M; Soan, K; Thomas, S				Shah, Girish V.; Muralidharan, Anbalagan; Gokulgandhi, Mitan; Soan, Kamal; Thomas, Shibu			Cadherin Switching and Activation of beta-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MESENCHYMAL TRANSITION; N-CADHERIN; INCREASES INVASIVENESS; ADHESION MOLECULES; TIGHT JUNCTIONS; LUMEN FORMATION; CELL-ADHESION; BREAST-CANCER; EXPRESSION	Calcitonin, a neuroendocrine peptide, and its receptor are localized in the basal epithelium of benign prostate but in the secretory epithelium of malignant prostates. The abundance of calcitonin and calcitonin receptor mRNA displays positive correlation with the Gleason grade of primary prostate cancers. Moreover, calcitonin increases tumorigenicity and invasiveness of multiple prostate cancer cell lines by cyclic AMP-dependent protein kinase-mediated actions. These actions include increased secretion of matrix metalloproteinases and urokinase-type plasminogen activator and an increase in prostate cancer cell invasion. Activation of calcitonin-calcitonin receptor autocrine loop in prostate cancer cell lines led to the loss of cell-cell adhesion, destabilization of tight and adherens junctions, and internalization of key integral membrane proteins. In addition, the activation of calcitonin-calcitonin receptor axis induced epithelial-mesenchymal transition of prostate cancer cells as characterized by cadherin switch and the expression of the mesenchymal marker, vimentin. The activated calcitonin receptor phosphorylated glycogen synthase kinase-3, a key regulator of cytosolic beta-catenin degradation within the WNT signaling pathway. This resulted in the accumulation of intracellular beta-catenin, its translocation in the nucleus, and transactivation of beta-catenin-responsive genes. These results for the first time identify actions of calcitonin-calcitonin receptor axis on prostate cancer cells that lead to the destabilization of cell-cell junctions, epithelial to mesenchymal transition, and activation ofWNT/beta-catenin signaling. The results also suggest that cyclic AMP-dependent protein kinase plays a key role in calcitonin receptor-induced destabilization of cell-cell junctions and activation of WNT-beta-catenin signaling.	[Shah, Girish V.; Muralidharan, Anbalagan; Gokulgandhi, Mitan; Soan, Kamal; Thomas, Shibu] Univ Louisiana, Coll Pharm, Dept Pharmacol, Monroe, LA 71209 USA	University of Louisiana System; University of Louisiana Monroe	Shah, GV (corresponding author), 700 Univ Ave, Monroe, LA 71209 USA.	shah@ulm.edu		Anbalagan, Muralidharan/0000-0001-5797-7558	National Institutes of Health [CA96534]; NATIONAL CANCER INSTITUTE [R56CA096534, R01CA096534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96534 (to G. V. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bello-Deocampo D, 2001, PROSTATE, V46, P142, DOI 10.1002/1097-0045(20010201)46:2<142::AID-PROS1018>3.0.CO;2-B; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Chien J, 2001, INT J CANCER, V91, P46, DOI 10.1002/1097-0215(20010101)91:1<46::AID-IJC1008>3.0.CO;2-0; Chien J, 1999, ONCOGENE, V18, P3376, DOI 10.1038/sj.onc.1202690; Chien J, 2001, MOL CELL ENDOCRINOL, V181, P69, DOI 10.1016/S0303-7207(01)00530-5; Chigurupati S, 2005, CANCER RES, V65, P8519, DOI 10.1158/0008-5472.CAN-05-0848; Cooper CR, 2000, PROSTATE CANCER P D, V3, P6, DOI 10.1038/sj.pcan.4500387; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Furuya Y, 1999, INT J UROL, V6, P240, DOI 10.1046/j.1442-2042.1999.00060.x; Gaujoux S, 2008, J CLIN ENDOCR METAB, V93, P4135, DOI 10.1210/jc.2008-0631; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; He B, 2007, ERNST SCHERING FOUND, V5, P27, DOI 10.1007/2789_2007_043; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jankowski JA, 1997, J CLIN PATHOL-MOL PA, V50, P289; KAIGHN ME, 1979, INVEST UROL, V17, P16; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keiper T, 2005, HISTOL HISTOPATHOL, V20, P197, DOI 10.14670/HH-20.197; Lam JS, 2006, UROL ONCOL-SEMIN ORI, V24, P131, DOI 10.1016/j.urolonc.2005.11.038; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; MOORE EE, 1995, MOL ENDOCRINOL, V9, P959, DOI 10.1210/me.9.8.959; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Polakis P, 2000, GENE DEV, V14, P1837; Presti JC, 2000, RADIOL CLIN N AM, V38, P49, DOI 10.1016/S0033-8389(05)70149-4; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Sabbisetti V, 2006, INT J CANCER, V118, P2694, DOI 10.1002/ijc.21625; Sabbisetti VS, 2005, INT J CANCER, V117, P551, DOI 10.1002/ijc.21158; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Segawa N, 2001, PATHOL INT, V51, P452, DOI 10.1046/j.1440-1827.2001.01226.x; SHAH GV, 1994, ENDOCRINOLOGY, V134, P596, DOI 10.1210/en.134.2.596; SHAH GV, 2008, ENDOCR-RELAT CANCER, V15, P1; Shih IM, 2000, CANCER RES, V60, P1671; SOMMERS CL, 1992, CANCER RES, V52, P5190; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; THIERY JP, 1988, CIBA F SYMP, V141, P48; Thomas S, 2005, CANCER BIOL THER, V4, P1226, DOI 10.4161/cbt.4.11.2093; Thomas S, 2007, INT J ONCOL, V31, P1425; Thomas S, 2006, MOL ENDOCRINOL, V20, P1894, DOI 10.1210/me.2005-0284; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Torer N, 2007, J SURG ONCOL, V96, P419, DOI 10.1002/jso.20654; Tsukamoto T, 1999, J BIOL CHEM, V274, P24579, DOI 10.1074/jbc.274.35.24579; Tsukita S, 1996, CELL STRUCT FUNCT, V21, P381, DOI 10.1247/csf.21.381; Tyagi N, 1993, J Postgrad Med, V39, P197; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wu GA, 1996, UROLOGY, V47, P376, DOI 10.1016/S0090-4295(99)80456-7; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086	66	29	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1018	1030		10.1074/jbc.M807823200	http://dx.doi.org/10.1074/jbc.M807823200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001380	Green Published, hybrid			2022-12-25	WOS:000262122900038
J	Wang, SY; Yu, WM; Zhang, WM; McCrae, KR; Neel, BG; Qu, CK				Wang, Siying; Yu, Wen-Mei; Zhang, Wanming; McCrae, Keith R.; Neel, Benjamin G.; Qu, Cheng-Kui			Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; TYROSINE-PHOSPHATASE; SIGNALING PATHWAY; ANTIANGIOGENIC ACTIVITY; FOCAL ADHESION; MOUSE MODEL; STEM-CELLS; IN-VITRO; ACTIVATION; LEUKEMIA	Mutations in SHP-2 phosphatase (PTPN11) that cause hyperactivation of its catalytic activity have been identified in Noonan syndrome and various childhood leukemias. Recent studies suggest that the gain-of-function (GOF) mutations of SHP-2 play a causal role in the pathogenesis of these diseases. However, the molecular mechanisms by which GOF mutations of SHP-2 induce these phenotypes are not fully understood. Here, we show that GOF mutations in SHP-2, such as E76K and D61G, drastically increase spreading and migration of various cell types, including hematopoietic cells, endothelial cells, and fibroblasts. More importantly, in vivo angiogenesis in SHP-2 D61G knock-in mice is also enhanced. Mechanistic studies suggest that the increased cell migration is attributed to the enhanced beta 1 integrin outside-in signaling. In response to beta 1 integrin cross-linking or fibronectin stimulation, activation of ERK and Akt kinases is greatly increased by SHP-2 GOF mutations. Also, integrin-induced activation of RhoA and Rac1 GTPases is elevated. Interestingly, mutant cells with the SHP-2 GOF mutation (D61G) are more sensitive than wild-type cells to the suppression of cell motility by inhibition of these pathways. Collectively, these studies reaffirm the positive role of SHP-2 phosphatase in cell motility and suggest a new mechanism by which SHP-2 GOF mutations contribute to diseases.	[Wang, Siying; Yu, Wen-Mei; Zhang, Wanming; McCrae, Keith R.; Qu, Cheng-Kui] Case Western Reserve Univ Hosp, Dept Med, Div Hematol Oncol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Cancer Biol Program, Boston, MA 02215 USA	Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Qu, CK (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	cxq6@case.edu		wang, siying/0000-0003-4793-7389	National Institutes of Health [HL068212, HL082670, HL076810, CA049152, CA66600]; NATIONAL CANCER INSTITUTE [R01CA066600, R01CA049152, R37CA049152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212, R01HL076810, R21HL082670, R01HL089796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068212 and HL082670 (to C. K. Q.), HL076810 (to K. R. M.), CA049152 and CA66600 (to B. G. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Juarez JC, 2002, CANCER RES, V62, P5344; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299	44	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					913	920		10.1074/jbc.M804129200	http://dx.doi.org/10.1074/jbc.M804129200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008228	hybrid, Green Published			2022-12-25	WOS:000262122900026
J	Kalamajski, S; Oldberg, A				Kalamajski, Sebastian; Oldberg, Ake			Homologous Sequence in Lumican and Fibromodulin Leucine-rich Repeat 5-7 Competes for Collagen Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; DIFFERENTIAL EXPRESSION; PROTEOGLYCAN LUMICAN; TARGETED DISRUPTION; CORNEAL STRUCTURE; SKIN FRAGILITY; NULL MICE; PROTEINS; TENDON; FIBRILS	Lumican and fibromodulin compete for collagen type I binding in vitro, and fibromodulin-deficient mice have 4-fold more lumican in tendons. These observations indicate that homologous sequences in lumican and fibromodulin bind to collagen type I. Here, we demonstrate that lumican binding to collagen type I is mediated mainly by Asp-213 in leucine-rich repeat ( LRR) 7. The mutation D213N in lumican impairs interaction with collagen, and the lumican fragment spanning LRRs 5-7 is an efficient inhibitor of collagen binding. Also, the lumican LRR 7 sequence-based synthetic peptide CYLDNNKC inhibits the binding to collagen. Homologous collagen-binding site in fibromodulin, located in LRRs 5-7, inhibits the binding of lumican to collagen, and the mutation E251Q in this fibromodulin fragment does not inhibit the lumican-collagen binding. Lumican, but not the D213N mutation, lowers the melting point and affects the packing of collagen fibrils.	[Kalamajski, Sebastian; Oldberg, Ake] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Kalamajski, S (corresponding author), Lund Univ, Dept Expt Med Sci, BMC B12, SE-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se		Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Research Council; Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Royal Physiographic Society in Lund; European Commission [NMP2-CT-2003-504017]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Royal Physiographic Society in Lund; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council, the Greta and Johan Kock Foundation, the Alfred Osterlund Foundation, and the Royal Physiographic Society in Lund, and the European Commission (Cornea Engineering Project, Grant NMP2-CT-2003-504017). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall RC, 1997, ARCH ORAL BIOL, V42, P783, DOI 10.1016/S0003-9969(97)00024-1; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; Nurminskaya MV, 1996, BIOCHEM J, V317, P785, DOI 10.1042/bj3170785; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	31	76	78	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					534	539		10.1074/jbc.M805721200	http://dx.doi.org/10.1074/jbc.M805721200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19008226	hybrid			2022-12-25	WOS:000261974800058
J	Kleefeld, A; Ackermann, B; Bauer, J; Kramer, J; Unden, G				Kleefeld, Alexandra; Ackermann, Bianca; Bauer, Julia; Kraemer, Jens; Unden, Gottfried			The Fumarate/Succinate Antiporter DcuB of Escherichia coli Is a Bifunctional Protein with Sites for Regulation of DcuS-dependent Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-4-DICARBOXYLATE TRANSPORT; FUMARATE REDUCTASE; BINDING-SITE; SYSTEM; SENSOR; KINASE; DNA; IDENTIFICATION; INACTIVATION; PERMEASE	DcuB of Escherichia coli catalyzes C-4-dicarboxylate/succinate antiport during growth by fumarate respiration. The expression of genes of fumarate respiration, including the genes for DcuB (dcuB) and fumarate reductase (frdABCD) is transcriptionally activated by C-4-dicarboxylates via the DcuS-DcuR two-component system, comprising the sensor kinase DcuS, which contains a periplasmic sensing domain forC(4)-dicarboxylates. Deletion or inactivation of dcuB caused constitutive expression of DcuS-regulated genes in the absence of C-4-dicarboxylates. The effect was specific for DcuB and not observed after inactivation of the homologous DcuA or the more distantly related DcuC transporter. Random and site-directed mutation identified three point mutations (T394I, D398N, and K353A) in DcuB that caused a similar derepression as dcuB deletion, whereas the transport activity of the DcuB mutants was retained. Constitutive expression in the dcuB mutants depended on the presence of a functional DcuS-DcuR two-component system. Mutation of residues E79A, R83A, and R127A of DcuB, on the other hand, inactivated growth by fumarate respiration and transport of [C-14] succinate, whereas the expression of dcuB'-lacZ was not affected. Therefore, the antiporter DcuB is a bifunctional protein and has a regulatory function that is independent from transport, and sites for transport and regulation can be differentiated.	[Kleefeld, Alexandra; Ackermann, Bianca; Bauer, Julia; Kraemer, Jens; Unden, Gottfried] Johannes Gutenberg Univ Mainz, Inst Mikrobiol & Weinforsch, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Unden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mikrobiol & Weinforsch, Becherweg 15, D-55099 Mainz, Germany.	unden@uni-mainz.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges.	Abo-Amer AE, 2004, J BACTERIOL, V186, P1879, DOI 10.1128/JB.186.6.1879-1889.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies SJ, 1999, J BACTERIOL, V181, P5624, DOI 10.1128/JB.181.18.5624-5635.1999; ENGEL P, 1994, EUR J BIOCHEM, V222, P605, DOI 10.1111/j.1432-1033.1994.tb18903.x; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; FARINHA MA, 1990, FEMS MICROBIOL LETT, V70, P221, DOI 10.1016/S0378-1097(05)80043-6; Golby P, 1998, J BACTERIOL, V180, P4821, DOI 10.1128/JB.180.18.4821-4827.1998; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Golby P, 1998, J BACTERIOL, V180, P6586, DOI 10.1128/JB.180.24.6586-6596.1998; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; HUMPHREYS GO, 1976, MOL GEN GENET, V145, P101, DOI 10.1007/BF00331564; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KADNER RJ, 1994, RES MICROBIOL, V145, P381, DOI 10.1016/0923-2508(94)90085-X; Kim OB, 2007, ARCH MICROBIOL, V188, P583, DOI 10.1007/s00203-007-0279-9; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reid CJ, 1998, J BACTERIOL, V180, P2660, DOI 10.1128/JB.180.10.2660-2669.1998; Sambrook J, 2001, MOL CLONING LAB MANU; Schwoppe C, 2003, EUR J BIOCHEM, V270, P1450, DOI 10.1046/j.1432-1033.2003.03507.x; Silhavy T.J., 1984, EXPT GENE FUSIONS; SIX S, 1994, J BACTERIOL, V176, P6470, DOI 10.1128/JB.176.21.6470-6478.1994; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Unden G., 2004, ECOSAL ESCHERICHIA C; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YAROSH OK, 1989, MOL MICROBIOL, V3, P813, DOI 10.1111/j.1365-2958.1989.tb00230.x; Zientz E, 1999, J BACTERIOL, V181, P3716, DOI 10.1128/JB.181.12.3716-3720.1999; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998; Zientz E, 1996, J BACTERIOL, V178, P7241, DOI 10.1128/jb.178.24.7241-7247.1996	46	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					265	275		10.1074/jbc.M807856200	http://dx.doi.org/10.1074/jbc.M807856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957436	hybrid			2022-12-25	WOS:000261974800030
J	Sooksa-Nguan, T; Yakubov, B; Kozlovskyy, VI; Barkume, CM; Howe, KJ; Thannhauser, TW; Rutzke, MA; Hart, JJ; Kochian, LV; Rea, PA; Vatamaniuk, OK				Sooksa-nguan, Thanwalee; Yakubov, Bakhtiyor; Kozlovskyy, Volodymyr I.; Barkume, Caitlin M.; Howe, Kevin J.; Thannhauser, Theodore W.; Rutzke, Michael A.; Hart, Jonathan J.; Kochian, Leon V.; Rea, Philip A.; Vatamaniuk, Olena K.			Drosophila ABC Transporter, DmHMT-1, Confers Tolerance to Cadmium DmHMT-1 AND ITS YEAST HOMOLOG, SpHMT-1, ARE NOT ESSENTIAL FOR VACUOLAR PHYTOCHELATIN SEQUESTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-METAL DETOXIFICATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; BINDING PEPTIDES; GENE FAMILY; SYNTHASE; PROTEIN	Half-molecule ATP-binding cassette transporters of the HMT-1 (heavy metal tolerance factor 1) subfamily are required for Cd2+ tolerance in Schizosaccharomyces pombe, Caenorhabditis elegans, and Chlamydomonas reinhardtii. Based on studies of S. pombe, it has been proposed that SpHMT-1 transports heavy metal center dot phytochelatin (PC) complexes into the vacuolysosomal compartment. PCs are glutathione derivatives synthesized by PC synthases (PCS) in plants, fungi, and C. elegans in response to heavy metals. Our previous studies in C. elegans, however, suggested that HMT-1 and PCS-1 do not necessarily act in concert in metal detoxification. To further explore this inconsistency, we have gone on to test whether DmHMT-1, an HMT-1 from a new source, Drosophila, whose genome lacks PCS homologs, functions in heavy metal detoxification. In so doing, we show that heterologously expressed DmHMT-1 suppresses the Cd2+ hypersensitivity of S. pombe hmt-1 mutants and localizes to the vacuolar membrane but does not transport Cd center dot PC complexes. Crucially, similar analyses of S. pombe hmt-1 mutants extend this finding to show that SpHMT-1 itself either does not transport Cd center dot PC complexes or is not the principal Cd center dot PC/apoPC transporter. Consistent with this discovery and with our previous suggestion that HMT-1 and PCS-1 do not operate in a simple linear metal detoxification pathway, we demonstrate that, unlike PCS-deficient cells, which are hypersensitive to several heavy metals, SpHMT-1-deficient cells are hypersensitive to Cd2+, but not to Hg2+ or As3+. These findings significantly change our current understanding of the function of HMT-1 proteins and invoke PC-independent role for these transporters in Cd2+ detoxification.	[Sooksa-nguan, Thanwalee; Yakubov, Bakhtiyor; Kozlovskyy, Volodymyr I.; Barkume, Caitlin M.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Howe, Kevin J.; Thannhauser, Theodore W.; Rutzke, Michael A.; Hart, Jonathan J.; Kochian, Leon V.] Cornell Univ, USDA, Robert W Holley Ctr Agr & Hlth, Agr Res Serv, Ithaca, NY 14853 USA; [Rea, Philip A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); University of Pennsylvania	Vatamaniuk, OK (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Kochian, Leon/ABH-6148-2020	Kochian, Leon/0000-0003-3416-089X; Kozlovskyy, Volodymyr/0000-0002-2401-3178	Cornell's College of Agriculture and Life Sciences	Cornell's College of Agriculture and Life Sciences	This work was supported by Cornell's College of Agriculture and Life Sciences Start-up Funds (to O.K.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Hyman MH, 2004, ALTERN THER HEALTH M, V10, P70; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lill R, 2001, RES MICROBIOL, V152, P331, DOI 10.1016/S0923-2508(01)01204-9; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Poyton RO, 1995, METHOD ENZYMOL, V260, P97, DOI 10.1016/0076-6879(95)60133-3; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	34	50	52	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					354	362		10.1074/jbc.M806501200	http://dx.doi.org/10.1074/jbc.M806501200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001374	hybrid			2022-12-25	WOS:000261974800040
J	Zuo, Y; Zhuang, DZ; Han, R; Isaac, G; Tobin, JJ; Mckee, M; Welti, R; Brissette, JL; Fitzgerald, ML; Freeman, MW				Zuo, Ying; Zhuang, Debbie Z.; Han, Rong; Isaac, Giorgis; Tobin, Jennifer J.; Mckee, Mary; Welti, Ruth; Brissette, Janice L.; Fitzgerald, Michael L.; Freeman, Mason W.			ABCA12 Maintains the Epidermal Lipid Permeability Barrier by Facilitating Formation of Ceramide Linoleic Esters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER 1; HARLEQUIN ICHTHYOSIS; TANGIER-DISEASE; PULMONARY SURFACTANT; LAMELLAR GRANULES; RESPIRATORY-FAILURE; GAUCHER-DISEASE; GENE ABCR; MUTATIONS; MICE	Harlequin ichthyosis is a congenital scaling syndrome of the skin in which affected infants have epidermal hyperkeratosis and a defective permeability barrier. Mutations in the gene encoding a member of the ABCA transporter family, ABCA12, have been linked to harlequin ichthyosis, but the molecular function of the protein is unknown. To investigate the activity of ABCA12, we generated Abca12 null mice and analyzed the impact on skin function and lipid content. Abca12(-/-) mice are born with a thickened epidermis and die shortly after birth, as water rapidly evaporates from their skin. In vivo skin proliferation measurements suggest a lack of desquamation of the skin cells, rather than enhanced proliferation of basal layer keratinocytes, accounts for the 5-fold thickening of the Abca12(-/-) stratum corneum. Electron microscopy revealed a loss of the lamellar permeability barrier in Abca12(-/-) skin. This was associated with a profound reduction in skin linoleic esters of long-chain omega-hydroxyceramides and a corresponding increase in their glucosyl ceramide precursors. Because omega-hydroxyceramides are required for the barrier function of the skin, these results establish that ABCA12 activity is required for the generation of long-chain ceramide esters that are essential for the development of normal skin structure and function.	[Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA; [Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Han, Rong; Brissette, Janice L.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Mckee, Mary] Massachusetts Gen Hosp, Ctr Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; [Isaac, Giorgis; Welti, Ruth] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kansas State University	Freeman, MW (corresponding author), Massachusetts Gen Hosp, Dept Med, Simches 7214,185 Cambridge St, Boston, MA 02114 USA.	freeman@molbio.mgh.harvard.edu		Welti, Ruth/0000-0003-4373-2538; Han, Rong/0000-0002-5766-8277	National Institutes of Health [RR020345, HL074136]; Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center Award [DK57521]; National Science Foundation (NSF) [MCB0455318, 0521587]; NSF EPSCoR [EPS-0236913]; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; NIH [P20 RR16475]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR020345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055218, R01AR045284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center Award; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants RR020345 (to M.W.F.) and HL074136 (to M.L.F.). The electron microscopy core is supported by an Inflammatory Bowel Disease Grant (DK43351) and a Boston Area Diabetes and Endocrinology Research Center Award (DK57521). The Kansas Lipidomics Research Center (KLRC) was supported by National Science Foundation (NSF) Grants MCB0455318 and DBI 0521587, and NSF EPSCoR Grant EPS-0236913, with matching support from the State of Kansas through Kansas Technology Enterprise Corporation and Kansas State University. The KLRC was also supported by Kansas Idea Network of Biomedical Research Excellence from NIH Grant P20 RR16475, from the Idea Network of Biomedical Research Excellence program of the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama M, 2008, BRIT J DERMATOL, V158, P864, DOI 10.1111/j.1365-2133.2008.08439.x; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2006, J DERMATOL SCI, V42, P83, DOI 10.1016/j.jdermsci.2006.01.003; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Annilo T, 2002, CYTOGENET GENOME RES, V98, P169, DOI 10.1159/000069811; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; DALE BA, 1990, J INVEST DERMATOL, V94, P6, DOI 10.1111/1523-1747.ep12873301; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Doering T, 1999, FEBS LETT, V447, P167, DOI 10.1016/S0014-5793(99)00274-4; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; FREINKEL RK, 1985, J INVEST DERMATOL, V85, P295, DOI 10.1111/1523-1747.ep12276831; Hammel M, 2007, BIOCHEM BIOPH RES CO, V359, P947, DOI 10.1016/j.bbrc.2007.05.219; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HOLLERAN WM, 1993, J CLIN INVEST, V91, P1656, DOI 10.1172/JCI116374; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; HOU SYE, 1991, J INVEST DERMATOL, V96, P215, DOI 10.1111/1523-1747.ep12461361; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; MILNER ME, 1992, J INVEST DERMATOL, V99, P824, DOI 10.1111/1523-1747.ep12614791; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Rajpar SF, 2006, BRIT J DERMATOL, V155, P204, DOI 10.1111/j.1365-2133.2006.07291.x; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SAITO M, 1985, J BIOL CHEM, V260, P2295; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204	42	79	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36624	36635		10.1074/jbc.M807377200	http://dx.doi.org/10.1074/jbc.M807377200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957418	Green Published, hybrid			2022-12-25	WOS:000261840500061
J	Webb, KJ; Laganowsky, A; Whitelegge, JP; Clarke, SG				Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.			Identification of Two SET Domain Proteins Required for Methylation of Lysine Residues in Yeast Ribosomal Protein Rpl42ab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC MEMBRANE-PROTEINS; HUMAN HISTONE H4; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; 80S RIBOSOME; SUBUNIT; METHYLTRANSFERASE; RPL23AB	We show that the Saccharomyces cerevisiae ribosomal protein Rpl42ab (the identical product of the RPL42A and RPL42B genes) is monomethylated at Lys-40 and Lys-55. The methylation of Lys-40 is dependent upon the Ybr030w gene product; the methylation of Lys-55 is dependent upon the Set7 gene product. Ybr030w and SET7 genes both encode SET domain containing proteins homologous to known protein lysine methyltransferases, suggesting that their products are the specific enzymes responsible for the monomethylation of the two sites in Rpl42ab. We thus designate Ybr030w as Rkm3 and Set7 as Rkm4. Yeast strains with deletions in both the Ybr030w and SET7 genes produce unmethylated Rpl42ab. A slow growth phenotype was seen for the SET7 deletion strain and the double knock-out when grown in low concentrations of the eukaryotic protein synthesis inhibitor, cycloheximide. These results suggest that modification of Rpl42ab at Lys-55 can fine-tune its structure to avoid inhibition. An intact mass fragmentation approach ("top down mass spectrometry") was used to quantitate the extent of methylation of Rpl42ab. In wild-type strains, it was found that 78% was monomethylated at both Lys-40 and Lys-55 and that 22% was a mixture of species with either Lys-40 or Lys-55 monomethylated. The top down approach was also used to reevaluate the methylation sites of Rpl12ab. We found that the yeast Rpl12ab protein is dimethylated at the N-terminal proline residue, trimethylated at Lys-3 by Rkm2, and monomethylated at Arg-66.	[Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Laganowsky, Arthur/0000-0001-5012-5547; Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020, S10 RR023045, 5T32GM008496]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 and Grant S10 RR023045 purchase of the LTQ FT Ultra mass spectrometer). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the National Institutes of Health Chemistry Biology Interface Training Program Grant 5T32GM008496.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Culhane JC, 2007, CURR OPIN CHEM BIOL, V11, P561, DOI 10.1016/j.cbpa.2007.07.014; Dirk LMA, 2006, ENZYMES, V24, P179, DOI 10.1016/S1874-6047(06)80009-0; ITOH T, 1978, FEBS LETT, V96, P399, DOI 10.1016/0014-5793(78)80447-5; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge Julian P, 2004, Methods Mol Biol, V251, P323; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003	27	36	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35561	35568		10.1074/jbc.M806006200	http://dx.doi.org/10.1074/jbc.M806006200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957409	Green Published, hybrid			2022-12-25	WOS:000261687900028
J	Zhang, L; Bukulin, M; Kojro, E; Roth, A; Metz, VV; Fahrenholz, F; Nawroth, PP; Bierhaus, A; Postina, R				Zhang, Ling; Bukulin, Monika; Kojro, Elzbieta; Roth, Annette; Metz, Verena V.; Fahrenholz, Falk; Nawroth, Peter P.; Bierhaus, Angelika; Postina, Rolf			Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BLOOD-BRAIN-BARRIER; SOLUBLE RECEPTOR; SPLICE VARIANTS; ALPHA-SECRETASE; MATRIX METALLOPROTEINASES; MULTILIGAND RECEPTOR; RAGE RECEPTOR; EXPRESSION; CELLS	The receptor for advanced glycation end products ( RAGE) is a 55-kDa type I membrane glycoprotein of the immunoglobulin superfamily. Ligand-induced up-regulation of RAGE is involved in various pathophysiological processes, including late diabetic complications and Alzheimer disease. Application of recombinant soluble RAGE has been shown to block RAGE-mediated pathophysiological conditions. After expression of full-length RAGE in HEK cells we identified a 48-kDa soluble RAGE form (sRAGE) in the culture medium. This variant of RAGE is smaller than a 51-kDa soluble version derived from alternative splicing. The release of sRAGE can be induced by the phorbol ester PMA and the calcium ionophore calcimycin via calcium-dependent protein kinase C subtypes. Hydroxamic acid-based metalloproteinase inhibitors block the release of sRAGE, and by RNA interference experiments we identified ADAM10 and MMP9 to be involved in RAGE shedding. In protein biotinylation experiments we show that membrane-anchored full-length RAGE is the precursor of sRAGE and that sRAGE is efficiently released from the cell surface. We identified cleavage of RAGE to occur close to the cell membrane. Ectodomain shedding of RAGE simultaneously generates sRAGE and a membrane-anchored C-terminal RAGE fragment (RAGE-CTF). The amount of RAGE-CTF increases when RAGE-expressing cells are treated with a gamma-secretase inhibitor, suggesting that RAGE-CTF is normally further processed by gamma-secretase. Identification of these novel mechanisms involved in regulating the availability of cell surface-located RAGE and its soluble ectodomain may influence further research in RAGE-mediated processes in cell biology and pathophysiology.	[Zhang, Ling; Bukulin, Monika; Kojro, Elzbieta; Roth, Annette; Metz, Verena V.; Fahrenholz, Falk; Postina, Rolf] Johannes Gutenberg Univ Mainz, Inst Biochem, D-55099 Mainz, Germany; [Nawroth, Peter P.; Bierhaus, Angelika] Univ Heidelberg, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg	Postina, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Biochem, Becherweg 30, D-55099 Mainz, Germany.	postina@uni-mainz.de			Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany); Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease); DFG/SFB 405; Netzwerk Altersforschung	Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany); Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease)(German Research Foundation (DFG)); DFG/SFB 405(German Research Foundation (DFG)); Netzwerk Altersforschung	This work was supported in part by the Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany) ( to R. P.) and the Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease) ( to R. P. and F. F.), DFG/SFB 405 (to P. P. N.), and the Netzwerk Altersforschung ( to A. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Belotti D, 2003, CANCER RES, V63, P5224; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Geroldi D, 2005, J HYPERTENS, V23, P1725, DOI 10.1097/01.hjh.0000177535.45785.64; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Humpert PM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-9; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ozaki N, 2005, BIOCHEM BIOPH RES CO, V329, P765, DOI 10.1016/j.bbrc.2005.02.031; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Racchi M, 1999, J NEUROCHEM, V72, P2464, DOI 10.1046/j.1471-4159.1999.0722464.x; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35	41	217	230	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35507	35516		10.1074/jbc.M806948200	http://dx.doi.org/10.1074/jbc.M806948200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952609	hybrid			2022-12-25	WOS:000261687900022
J	Ferrante, A; Anderson, MW; Klug, CS; Gorski, J				Ferrante, Andrea; Anderson, Matthew W.; Klug, Candice S.; Gorski, Jack			HLA-DM Mediates Epitope Selection by a "Compare-Exchange'' Mechanism when a Potential Peptide Pool Is Available	PLOS ONE			English	Article								Background: HLA-DM (DM) mediates exchange of peptides bound to MHC class II (MHCII) during the epitope selection process. Although DM has been shown to have two activities, peptide release and MHC class II refolding, a clear characterization of the mechanism by which DM facilitates peptide exchange has remained elusive. Methodology/Principal Findings: We have previously demonstrated that peptide binding to and dissociation from MHCII in the absence of DM are cooperative processes, likely related to conformational changes in the peptide-MHCII complex. Here we show that DM promotes peptide release by a non-cooperative process, whereas it enhances cooperative folding of the exchange peptide. Through electron paramagnetic resonance (EPR) and fluorescence polarization (FP) we show that DM releases prebound peptide very poorly in the absence of a candidate peptide for the exchange process. The affinity and concentration of the candidate peptide are also important for the release of the prebound peptide. Increased fluorescence energy transfer between the prebound and exchange peptides in the presence of DM is evidence for a tetramolecular complex which resolves in favor of the peptide that has superior folding properties. Conclusion/Significance: This study shows that both the peptide releasing activity on loaded MHCII and the facilitating of MHCII binding by a candidate exchange peptide are integral to DM mediated epitope selection. The exchange process is initiated only in the presence of candidate peptides, avoiding possible release of a prebound peptide and loss of a potential epitope. In a tetramolecular transitional complex, the candidate peptides are checked for their ability to replace the prebound peptide with a geometry that allows the rebinding of the original peptide. Thus, DM promotes a "compare-exchange'' sorting algorithm on an available peptide pool. Such a "third party''-mediated mechanism may be generally applicable for diverse ligand recognition in other biological systems.	[Ferrante, Andrea; Anderson, Matthew W.; Gorski, Jack] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Ferrante, A (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA.	andrea.ferrante@bcw.edu			NIH [RO1AI63016]; National Biomedical EPR Center [EB001980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Biomedical EPR Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grants RO1AI63016 (J.G.) and EB001980 (National Biomedical EPR Center). The authors have no conflicting financial interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MW, 2005, BIOCHEMISTRY-US, V44, P5617, DOI 10.1021/bi048675s; Anderson MW, 2003, J IMMUNOL, V171, P5683, DOI 10.4049/jimmunol.171.11.5683; Anderson TG, 1999, BIOPHYS J, V77, P2451, DOI 10.1016/S0006-3495(99)77081-5; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; DEKROON AIPM, 1994, J IMMUNOL, V152, P609; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; DONALD E, 1998, ART COMPUTER PROGRAM, V3; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GREEN JM, 1995, J IMMUNOL, V155, P3759; GROTENBERG GM, 2007, J BIOL CHEM; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3; Klug Candice S., 2004, V24, P269; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; KROPSHOFER H, 1993, P NATL ACAD SCI USA, V90, P403, DOI 10.1073/pnas.90.2.403; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nelson C A, 1999, Rev Immunogenet, V1, P47; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Schmitt L, 1998, BIOCHEMISTRY-US, V37, P17371, DOI 10.1021/bi9815593; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schmitt L, 1999, P NATL ACAD SCI USA, V96, P6581, DOI 10.1073/pnas.96.12.6581; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; TAMPE R, 1991, SCIENCE, V254, P87, DOI 10.1126/science.1656526; Watts C, 1999, Rev Immunogenet, V1, P60; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zavala-Ruiz Z, 2003, J BIOL CHEM, V278, P44904, DOI 10.1074/jbc.M307652200	45	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2008	3	11							e3722	10.1371/journal.pone.0003722	http://dx.doi.org/10.1371/journal.pone.0003722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432WY	19005572	Green Published, Green Submitted, gold			2022-12-25	WOS:000265166200010
J	Inzelberg, R; Schechtman, E; Hocherman, S				Inzelberg, Rivka; Schechtman, Edna; Hocherman, Shraga			Visuo-Motor Coordination Deficits and Motor Impairments in Parkinson's Disease	PLOS ONE			English	Article							TRACKING; ABNORMALITIES; MECHANISMS; FEEDBACK; BEHAVIOR	Background: Visuo-motor coordination (VMC) requires normal cognitive executive functionality, an ability to transform visual inputs into movement plans and motor-execution skills, all of which are known to be impaired in Parkinson's disease (PD). Not surprisingly, a VMC deficit in PD is well documented. Still, it is not known how this deficit relates to motor symptoms that are assessed routinely in the neurological clinic. Such relationship should reveal how particular motor dysfunctions combine with cognitive and sensory-motor impairments to produce a complex behavioral disability. Methods and Findings: Thirty nine early/moderate PD patients were routinely evaluated, including motor Unified Parkinson's Disease Rating Scale (UPDRS) based assessment, A VMC testing battery in which the subjects had to track a target moving on screen along 3 different paths, and to freely trace these paths followed. Detailed kinematic analysis of tracking/tracing performance was done. Statistical analysis of the correlations between measures depicting various aspects of VMC control and UPDRS items was performed. The VMC measures which correlated most strongly with clinical symptoms represent the ability to organize tracking movements and program their direction, rather than measures representing motor-execution skills of the hand. The strong correlations of these VMC measures with total UPDRS score were weakened when the UPDRS hand-motor part was considered specifically, and were insignificant in relation to tremor of the hand. In contrast, all correlations of VMC measures with the gait/posture part of the UPDRS were found to be strongest. Conclusions: Our apparently counterintuitive findings suggest that the VMC deficit pertains more strongly to a PD related change in cognitive-executive control, than to a reduction in motor capabilities. The recently demonstrated relationship between gait/posture impairment and a cognitive decline, as found in PD, concords with this suggestion and may explain the strong correlation between VMC dysfunction and gait/posture impairment. Accordingly, we propose that what appears to reflect a motor deficit in fact represents a multisystem failure, dominated by a cognitive decline.	[Inzelberg, Rivka] Sheba Med Ctr, Sagol Neurosci Ctr, Tel Hashomer, Israel; [Schechtman, Edna] Ben Gurion Univ Negev, Dept Industrial Engn & Managem, IL-84105 Beer Sheva, Israel; [Hocherman, Shraga] Technion, Fac Med, Dept Physiol, Haifa, Israel	Chaim Sheba Medical Center; Ben Gurion University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Inzelberg, R (corresponding author), Sheba Med Ctr, Sagol Neurosci Ctr, Tel Hashomer, Israel.	Shraga@tx.technion.ac.il	SCHECHTMAN, EDNA/F-1160-2012; Inzelberg, Rivka/E-5861-2010	SCHECHTMAN, EDNA/0000-0001-7350-9068; Inzelberg, Rivka/0000-0002-0720-0502				Bloem BR, 2000, ANN NEUROL, V48, P268, DOI 10.1002/1531-8249(200008)48:2<268::AID-ANA21>3.0.CO;2-4; Bond JM, 2000, ARCH PHYS MED REHAB, V81, P110, DOI 10.1016/S0003-9993(00)90230-2; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; DAY BL, 1984, J NEUROL NEUROSUR PS, V47, P1299, DOI 10.1136/jnnp.47.12.1299; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; FLOWERS K, 1978, BRAIN, V101, P35, DOI 10.1093/brain/101.1.35; FLOWERS K, 1978, BRAIN, V101, P19, DOI 10.1093/brain/101.1.19; Fucetola R, 1997, ACTA PSYCHOL, V95, P255, DOI 10.1016/S0001-6918(96)00043-1; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Hocherman S, 1998, NEUROLOGY, V50, P1648, DOI 10.1212/WNL.50.6.1648; HOCHERMAN S, 1994, NEUROLOGY, V44, P111, DOI 10.1212/WNL.44.1.111; Hocherman S, 2000, PERCEPT MOTOR SKILL, V90, P1235, DOI 10.2466/PMS.90.3.1235-1248; Hocherman S, 2004, COGNITIVE BRAIN RES, V21, P77, DOI 10.1016/j.cogbrainres.2004.05.008; Hocherman S, 1998, J NEURAL TRANSM-SUPP, P63; Hocherman S, 1998, Parkinsonism Relat Disord, V4, P129, DOI 10.1016/S1353-8020(98)00034-0; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; Johnson MTV, 1996, BRAIN, V119, P801, DOI 10.1093/brain/119.3.801; Kurata K, 2002, J NEUROPHYSIOL, V88, P3118, DOI 10.1152/jn.00070.2002; LEVIN BE, 1991, NEUROLOGY, V41, P365, DOI 10.1212/WNL.41.3.365; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Schwartz M, 1999, MOVEMENT DISORD, V14, P988, DOI 10.1002/1531-8257(199911)14:6<988::AID-MDS1012>3.0.CO;2-M; Schwartz M, 2004, PARKINSONISM RELAT D, V10, P385, DOI 10.1016/j.parkreldis.2004.03.004; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; van der Kooij H, 2007, J NEURAL TRANSM, V114, P1333, DOI 10.1007/s00702-007-0801-x; WEISSBLUETH E, 2008, PARKINSONIS IN PRESS; Williams ZM, 2005, EXP BRAIN RES, V162, P407, DOI 10.1007/s00221-004-2035-6	32	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2008	3	11							e3663	10.1371/journal.pone.0003663	http://dx.doi.org/10.1371/journal.pone.0003663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LL	18987752	Green Published, Green Submitted, gold			2022-12-25	WOS:000265134500009
J	Tan, Y; Wei, QH; Chen, LJ; Chan, PC; Lai, WS; He, ML; Kung, HF; Lee, SS				Tan, Yi; Wei, Qi Hou; Chen, Liu Jun; Chan, Pui Chung; Lai, Wen Sheng; He, Ming Liang; Kung, Hsiang Fu; Lee, Shui Shan			Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China	PLOS ONE			English	Article								Background: Hepatitis C virus (HCV) mono-infection and HCV/HIV (human immunodeficiency virus) co-infection are growing problems in injection drug users (IDU). Their prevalence and genotypic patterns vary with geographic locations. Access to harm reduction measures is opening up opportunities for improving the HIV/HCV profiling of IDU in China, where IDUs account for a significant proportion of the two infections especially in the southern part of the country. Methodology/Principal Findings: A cross sectional study was conducted. Through the Liuzhou Methadone Clinic, a total of 117 injection drug users (IDUs) were recruited from Guangxi, Southern China. A majority of the IDUs (96%) were HCV antibody positive, of which 21% were HIV infected. Unlike HCV monoinfection, there was spatial heterogeneity in the distribution of HIV/HCV coinfection, the latter also characterized by a higher prevalence of needle-sharing. Phylogenetic analysis revealed that genotype 6a was predominant in the study population. There were shorter genetic distances among the 6a sequences compared to the other HCV subtypes-1a, 3a, and 3b. Conclusion/Significance: The results suggested that HIV and HCV were introduced at around the same time to the IDU populations in Southern China, followed by their differential spread as determined by the biologic characteristics of the virus and the intensity of behavioural risk. This pattern is different from that in other South East Asian countries where HCV infections have probably predated HIV.	[Tan, Yi; Chan, Pui Chung; He, Ming Liang; Kung, Hsiang Fu; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wei, Qi Hou; Chen, Liu Jun; Lai, Wen Sheng] Liuzhou Ctr Dis Control & Prevent, Guangxi, Peoples R China; [Lee, Shui Shan] Chinese Univ Hong Kong, Dept Microbiol, Sha Tin 100083, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Tan, Y (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; HE, Ming-Liang/AAG-3397-2022; HE, Ming-Liang/AFK-4738-2022	Lee, Shui Shan/0000-0003-1448-765X; He, Ming-Liang/0000-0002-4317-2836; HE, Mingliang/0000-0002-9942-9151	Liuzhou CDC; Stanley Ho Centre for Emerging Infectious Diseases	Liuzhou CDC; Stanley Ho Centre for Emerging Infectious Diseases	Studies included in this report were funded directly by Liuzhou CDC and Stanley Ho Centre for Emerging Infectious Diseases. No external fundings have been received.	Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Amini S, 2006, VIRUS GENES, V33, P271, DOI 10.1007/s11262-006-0065-9; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Djebbi A, 2004, EUR J EPIDEMIOL, V19, P555, DOI 10.1023/B:EJEP.0000032348.83087.01; Du WJ, 2008, DRUG ALCOHOL DEPEN, V94, P158, DOI 10.1016/j.drugalcdep.2007.11.009; Franco S, 2007, VIRUS RES, V123, P161, DOI 10.1016/j.virusres.2006.09.001; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Kurbanov F, 2003, J MED VIROL, V69, P367, DOI 10.1002/jmv.10298; Lee DS, 1996, J MED VIROL, V49, P55, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt;55::AID-JMV9&gt;3.0.CO;2-J; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; RUXRUNGTHAM K, 2001, J MED ASS THAI S1, V84, P1; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Todd CS, 2007, EMERG INFECT DIS, V13, P1327, DOI 10.3201/eid1309.070036; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014	23	55	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3608	10.1371/journal.pone.0003608	http://dx.doi.org/10.1371/journal.pone.0003608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974888	gold, Green Submitted, Green Published			2022-12-25	WOS:000265131700024
J	Koyama, N; Zhang, J; Huqun; Miyazawa, H; Tanaka, T; Su, X; Hagiwara, K				Koyama, N.; Zhang, J.; Huqun; Miyazawa, H.; Tanaka, T.; Su, X.; Hagiwara, K.			Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B	ONCOGENE			English	Article						semaphorin 3B; insulin-like growth factor-binding protein-6; beta-catenin; microarray; tumor suppression	INSULIN-LIKE-GROWTH; FACTOR BINDING PROTEIN-6; CHEMOREPELLENT SEMAPHORIN-III; CANCER CELLS; MEDIATED APOPTOSIS; BREAST-CANCER; RECEPTOR; LUNG; GENES; DIFFERENTIATION	SEMA3B, a member of class 3 semaphorins, is a tumor suppressor. Competition with vascular endothelial growth factor ( VEGF)(165) explains a portion of the activity, whereas the VEGF-independent mechanism was not elucidated. We employed a microarray and screened for the genes whose expression was increased by SEMA3B in NCI-H1299 cells. Insulin-like growth factor-binding protein-6 (IGFBP-6), a tumor suppressor, showed greatest difference in the expression level. Introduction of IGFBP-6 cDNA reduced colony formation both on the dish surface and in soft agar. Insulin-like growth factor II, which antagonizes IGFBP-6, partly abrogated the effect. Inhibition of IGFBP-6 by small interfering RNA diminished the sub-G0/G1 population that was induced by SEMA3B and abrogated the growth suppressive effect of SEMA3B. We concluded that IGFBP-6 is the effector of tumor suppressor activity of SEMA3B in NCI-H1299 cells. It has been reported that beta-catenin suppresses the expression of IGFBP-6. Introduction of beta-catenin into the cells partly abrogated the growth suppressive effect of SEMA3B. Our result indicates that semaphorin signaling and beta-catenin signaling converge on IGFBP-6 and antithetically affect their functions.	[Koyama, N.; Zhang, J.; Huqun; Miyazawa, H.; Tanaka, T.; Hagiwara, K.] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama 3500495, Japan; [Zhang, J.; Su, X.] Inner Mongolia Med Coll, Clin Res Ctr, Hohhot, Inner Mongolia, Peoples R China	Saitama Medical University; Inner Mongolia Medical University	Koyama, N (corresponding author), Saitama Med Univ, Dept Resp Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	nkoyama@saitama-med.ac.jp			Japan Society for the Promotion of Science [18390242, 16590738]; Comprehensive Research on Aging and Health from the Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Comprehensive Research on Aging and Health from the Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	We thank Ms Akemi Yokote for technical assistance. This study was supported in part by the following grants-in-aid: 1) for scientific research ( nos. 18390242 and 16590738) from the Japan Society for the Promotion of Science and 2) for Comprehensive Research on Aging and Health from the Ministry of Health, Labor and Welfare, Japan.	Bach LA, 1999, HORM METAB RES, V31, P226, DOI 10.1055/s-2007-978723; BACH LA, 1995, ENDOCRINOLOGY, V136, P5061, DOI 10.1210/en.136.11.5061; BACH LA, 1994, ENDOCRINOLOGY, V135, P2168, DOI 10.1210/en.135.5.2168; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Chow LSN, 2006, ONCOGENE, V25, P310, DOI 10.1038/sj.onc.1209001; Christensen CRL, 1998, CANCER RES, V58, P1238; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Denys H, 2004, ONCOGENE, V23, P654, DOI 10.1038/sj.onc.1207160; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gallicchio MA, 2001, INT J CANCER, V94, P645, DOI 10.1002/ijc.1519; Grellier P, 1998, CANCER RES, V58, P1670; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; KATO M, 1995, J BIOL CHEM, V270, P12373, DOI 10.1074/jbc.270.21.12373; Koike H, 2005, BRIT J CANCER, V92, P1538, DOI 10.1038/sj.bjc.6602520; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Leng SL, 2001, MOL CELL ENDOCRINOL, V174, P121, DOI 10.1016/S0303-7207(00)00444-5; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1649, DOI 10.1371/journal.pcbi.0020180; MARTIN JL, 1990, J BIOL CHEM, V265, P4124; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ochi K, 2002, NEOPLASIA, V4, P82, DOI 10.1038/sj.neo.7900211; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Sueoka N, 2000, ONCOGENE, V19, P4432, DOI 10.1038/sj.onc.1203813; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; Yao RS, 2002, ONCOGENE, V21, P5814, DOI 10.1038/sj.onc.1205422; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	40	19	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 30	2008	27	51					6581	6589		10.1038/onc.2008.263	http://dx.doi.org/10.1038/onc.2008.263			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	366RS	18985860				2022-12-25	WOS:000260501700005
